Psyllid ID: psy11805

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-
Protein Sequence
MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV
Secondary Structure (PSIPRED)
ccccccccccccccccEEEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHcccccccHHHHHHcccccEEEEEEEcccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEEccccccEEEEEccccEEEcccccEEEcccccccccccccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHHccEEEccccHHHHHcHHHHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
ccccEEEEEEEccEccEEEEEEEEcccccEEEEEEEEcccHHHHHHHHHHHHHHcccccccEccEEEEEEcccEEEEEEEcccccEHHHHcccccccEcHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccccEEEccccccEEccccccEEEEcccHHHccHHHHccccEcHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccHHccccc
Coil and Loop (DISEMBL)
mtthqnqhsafsfgkfgtvyrckekatGMTLAAKFVGIakrndrrnVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEggelfervidddfVLTEKAVAIFMRQICEGVefihsknvlhldmkpenilcltktgnrikiidfglarkfdpekklqvlfgtpefvapevvnfdaigfgtdmWSVGVICYVLLsglspfmgetdvqTMANVTIAqydfddecfNEISDDAKDFIRKLLLKdredapev
Flexible Loop (DISEMBL)
mtthqnqhsafsfgkfgTVYRCKEKATGmtlaakfvgiakrndrrnVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLllkdredapev
Low Complexity Region (SEG)
MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKrndrrnvereveIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV
Disordered region (IsUnstruct)
**********FSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL*********
Disordered Region (DISOPRED)
MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA******NVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP**
Disordered Region (DISEMBL)
*********AFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV
Disordered Region (DISPRO)
MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR******
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	251	2.2.26 [Sep-21-2011]
Q28824	1176	Myosin light chain kinase	yes	N/A	0.932	0.198	0.585	1e-83
Q6PDN3	1941	Myosin light chain kinase	yes	N/A	0.920	0.119	0.597	2e-82
Q15746	1914	Myosin light chain kinase	yes	N/A	0.920	0.120	0.593	9e-82
P29294	1147	Myosin light chain kinase	yes	N/A	0.920	0.201	0.593	1e-81
P11799	1906	Myosin light chain kinase	yes	N/A	0.920	0.121	0.593	1e-81
Q32MK0	819	Myosin light chain kinase	no	N/A	0.952	0.291	0.548	4e-81
Q5RDG7	819	Myosin light chain kinase	no	N/A	0.948	0.290	0.550	8e-81
E9PT87	786	Myosin light chain kinase	yes	N/A	0.956	0.305	0.541	3e-80
Q3UIZ8	795	Myosin light chain kinase	no	N/A	0.956	0.301	0.541	4e-80
A8C984	715	Myosin light chain kinase	yes	N/A	0.912	0.320	0.567	4e-80

>sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus GN=MYLK PE=1 SV=1

 Score =  309 bits (791), Expect = 1e-83,   Method: Composition-based stats.
 Identities = 137/234 (58%), Positives = 179/234 (76%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           GKFG V+R  EK TG   A KF       ++ N+ +E+ IM  L HP+L+Q  DAFE   
Sbjct: 734 GKFGQVFRLVEKKTGKIWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKA 793

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +VLE++ GGELFER+ID+DF LTE+    +M+QI EGVE+IH + ++HLD+KPENI+
Sbjct: 794 NIVMVLEIVSGGELFERIIDEDFELTERECIKYMKQISEGVEYIHKQGIVHLDLKPENIM 853

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
           C+ KTG RIK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++ IG+ TDMWS+GVICY
Sbjct: 854 CVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICY 913

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EISDDAKDFI  LL KD ++
Sbjct: 914 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKN 967

Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells.
Bos taurus (taxid: 9913)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 8

>sp|Q6PDN3|MYLK_MOUSE Myosin light chain kinase, smooth muscle OS=Mus musculus GN=Mylk PE=1 SV=3

 Score =  305 bits (781), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 138/231 (59%), Positives = 177/231 (76%)

Query: 14   GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
            GKFG V+R  EK TG   A KF       ++ N+ +E+ IM  L HP+L+Q  DAFE   
Sbjct: 1495 GKFGQVFRLVEKKTGKIWAGKFFKAYSAKEKDNIRQEISIMNCLHHPKLVQCVDAFEEKA 1554

Query: 74   VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
             + +VLE++ GGELFER+ID+DF LTE+    +MRQI EGVE+IH + ++HLD+KPENI+
Sbjct: 1555 NIVMVLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIM 1614

Query: 134  CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
            C+ KTG RIK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++ IG+ TDMWS+GVICY
Sbjct: 1615 CVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICY 1674

Query: 194  VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EISDDAKDFI  LL KD
Sbjct: 1675 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 1725

Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|Q15746|MYLK_HUMAN Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4

 Score =  303 bits (775), Expect = 9e-82,   Method: Compositional matrix adjust.
 Identities = 137/231 (59%), Positives = 176/231 (76%)

Query: 14   GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
            GKFG V+R  EK T    A KF       ++ N+ +E+ IM  L HP+L+Q  DAFE   
Sbjct: 1473 GKFGQVFRLVEKKTRKVWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKA 1532

Query: 74   VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
             + +VLE++ GGELFER+ID+DF LTE+    +MRQI EGVE+IH + ++HLD+KPENI+
Sbjct: 1533 NIVMVLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIM 1592

Query: 134  CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
            C+ KTG RIK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++ IG+ TDMWS+GVICY
Sbjct: 1593 CVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICY 1652

Query: 194  VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EISDDAKDFI  LL KD
Sbjct: 1653 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 1703

Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Responsible for high proliferative ability of breast cancer cells through anti-apoptosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus GN=MYLK PE=1 SV=2

 Score =  302 bits (774), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 137/231 (59%), Positives = 175/231 (75%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           GKFG V+R  EK TG   A KF       ++ N+  E+ IM  L HP+L+Q  DAFE   
Sbjct: 705 GKFGQVFRLVEKKTGKIWAGKFFKAYSAKEKENIPAEIGIMNCLHHPKLVQCVDAFEEKA 764

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +VLE++ GGELFER+ID+DF LTE+    +MRQI EGVE+IH + ++HLD+KPENI+
Sbjct: 765 NIVMVLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIM 824

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
           C+ KTG RIK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++ I + TDMWS+GVICY
Sbjct: 825 CVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPISYATDMWSIGVICY 884

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EISDDAKDFI  LL KD
Sbjct: 885 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 935

Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|P11799|MYLK_CHICK Myosin light chain kinase, smooth muscle OS=Gallus gallus PE=1 SV=2

 Score =  302 bits (774), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 137/231 (59%), Positives = 175/231 (75%)

Query: 14   GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
            GKFG V+R  EK TG   A KF       ++ N+  E+ IM  L HP+L+Q  DAFE   
Sbjct: 1462 GKFGQVFRLVEKKTGKVWAGKFFKAYSAKEKENIRDEISIMNCLHHPKLVQCVDAFEEKA 1521

Query: 74   VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
             + +VLE++ GGELFER+ID+DF LTE+    +MRQI EGVE+IH + ++HLD+KPENI+
Sbjct: 1522 NIVMVLEMVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIM 1581

Query: 134  CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
            C+ KTG  IK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++ IG+ TDMWS+GVICY
Sbjct: 1582 CVNKTGTSIKLIDFGLARRLESAGSLKVLFGTPEFVAPEVINYEPIGYETDMWSIGVICY 1641

Query: 194  VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EISDDAKDFI  LL KD
Sbjct: 1642 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 1692

Phosphorylates a specific serine in the N-terminus of a myosin light chain, which leads to the formation of calmodulin/MLCK signal transduction complexes which allow selective transduction of calcium signals.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|Q32MK0|MYLK3_HUMAN Myosin light chain kinase 3 OS=Homo sapiens GN=MYLK3 PE=2 SV=3

 Score =  300 bits (769), Expect = 4e-81,   Method: Composition-based stats.
 Identities = 131/239 (54%), Positives = 182/239 (76%)

Query: 7   QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIY 66
           QH     G+FG V+RC EK+TG+ LAAK + +    DR +V+ E+ IM +L H  LIQ+Y
Sbjct: 517 QHEVLGGGRFGQVHRCTEKSTGLPLAAKIIKVKSAKDREDVKNEINIMNQLSHVNLIQLY 576

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
           DAFES +   +V+E ++GGELF+R+ D+ + LTE  V +F RQICEGV ++H   +LHLD
Sbjct: 577 DAFESKHSCTLVMEYVDGGELFDRITDEKYHLTELDVVLFTRQICEGVHYLHQHYILHLD 636

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KPENILC+ +TG++IKIIDFGLAR++ P +KL+V FGTPEF+APEVVN++ + F TDMW
Sbjct: 637 LKPENILCVNQTGHQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYEFVSFPTDMW 696

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           SVGVI Y+LLSGLSPF+GETD +TM  +    +DFD + F  +S++AKDF+ +LL+K++
Sbjct: 697 SVGVITYMLLSGLSPFLGETDAETMNFIVNCSWDFDADTFEGLSEEAKDFVSRLLVKEK 755

May play a role in smooth muscle contraction.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|Q5RDG7|MYLK3_PONAB Myosin light chain kinase 3 OS=Pongo abelii GN=MYLK3 PE=2 SV=3

 Score =  300 bits (767), Expect = 8e-81,   Method: Composition-based stats.
 Identities = 131/238 (55%), Positives = 181/238 (76%)

Query: 7   QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIY 66
           QH     G+FG V+RC EK+TG+ LAAK + +    DR +V+ E+ IM +L H  LIQ+Y
Sbjct: 517 QHEVLGGGRFGQVHRCTEKSTGLPLAAKIIKVKSAKDREDVKNEINIMNQLSHVNLIQLY 576

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
           DAFES +   +V+E ++GGELF+R+ D+ + LTE  V +F RQICEGV ++H   +LHLD
Sbjct: 577 DAFESKHSCTLVMEYVDGGELFDRITDEKYHLTELDVVLFTRQICEGVHYLHQHYILHLD 636

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KPENILC+ +TG++IKIIDFGLAR++ P +KL+V FGTPEF+APEVVN++ + F TDMW
Sbjct: 637 LKPENILCVNQTGHQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYEFVSFPTDMW 696

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           SVGVI Y+LLSGLSPF+GETD +TM  +    +DFD + F  +S++AKDF+ +LL+K+
Sbjct: 697 SVGVITYMLLSGLSPFLGETDAETMNFIVNCSWDFDADTFEGLSEEAKDFVSRLLVKE 754

May play a role in smooth muscle contraction.

Pongo abelii (taxid: 9601)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|E9PT87|MYLK3_RAT Myosin light chain kinase 3 OS=Rattus norvegicus GN=Mylk3 PE=1 SV=1

 Score =  298 bits (763), Expect = 3e-80,   Method: Compositional matrix adjust.
 Identities = 130/240 (54%), Positives = 184/240 (76%)

Query: 6   NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQI 65
           +QH     G+FG V+RC E++TG+ LAAK + +    DR +V+ E+ IM +L H  LIQ+
Sbjct: 483 SQHEVLGGGRFGQVHRCTERSTGLALAAKIIKVKNIKDREDVKNEINIMNQLSHVNLIQL 542

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           YDAFES N   +++E ++GGELF+R+ D+ + LTE  V +F RQICEGV ++H   +LHL
Sbjct: 543 YDAFESKNSFTLIMEYVDGGELFDRITDEKYHLTELDVVLFTRQICEGVHYLHQHYILHL 602

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           D+KPENILC+++TG++IKIIDFGLAR++ P +KL+V FGTPEF+APEVVN++ + F TDM
Sbjct: 603 DLKPENILCVSQTGHQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYEFVSFPTDM 662

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           WSVGVI Y+LLSGLSPF+GETD +TM  +    +DFD + F  +S++AKDF+ +LL+K++
Sbjct: 663 WSVGVITYMLLSGLSPFLGETDAETMNFIVNCSWDFDADTFKGLSEEAKDFVSRLLVKEK 722

Calmodulin-dependent kinase that phosphorylates MYL2 in vitro. Promotes sarcomere formation in cardiomyocytes. Increases cardiomyocyte contractility.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|Q3UIZ8|MYLK3_MOUSE Myosin light chain kinase 3 OS=Mus musculus GN=Mylk3 PE=1 SV=1

 Score =  297 bits (761), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 130/240 (54%), Positives = 184/240 (76%)

Query: 6   NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQI 65
           +QH     G+FG V+RC E++TG+ LAAK + +    DR +V+ EV IM +L H  LIQ+
Sbjct: 492 SQHEVLGGGRFGQVHRCTERSTGLALAAKIIKVKNVKDREDVKNEVNIMNQLSHVNLIQL 551

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           YDAFES +   +++E ++GGELF+R+ D+ + LTE  V +F RQICEGV ++H   +LHL
Sbjct: 552 YDAFESKSSFTLIMEYVDGGELFDRITDEKYHLTELDVVLFTRQICEGVHYLHQHYILHL 611

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           D+KPENILC+++TG++IKIIDFGLAR++ P +KL+V FGTPEF+APEVVN++ + F TDM
Sbjct: 612 DLKPENILCVSQTGHQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYEFVSFPTDM 671

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           WSVGVI Y+LLSGLSPF+GETD +TM  +    +DFD + F  +S++AKDF+ +LL+K++
Sbjct: 672 WSVGVITYMLLSGLSPFLGETDAETMNFIVNCSWDFDADTFKGLSEEAKDFVSRLLVKEK 731

May play a role in smooth muscle contraction.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|A8C984|MYLK3_DANRE Myosin light chain kinase 3 OS=Danio rerio GN=mylk3 PE=2 SV=1

 Score =  297 bits (761), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 130/229 (56%), Positives = 178/229 (77%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G+FG V++C E ++G+TLAAK + +    +R  V+ E+ +M +L H  LIQ+YDAFES  
Sbjct: 413 GRFGQVHKCAELSSGLTLAAKIIKVRGMKERDEVKNEIGVMNQLNHVNLIQLYDAFESRT 472

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E +EGGELFER+ID+ + LTE    +F RQICEGV+++H + +LHLD+KPENIL
Sbjct: 473 NLTLIMEYVEGGELFERIIDESYQLTELDAIVFTRQICEGVQYLHQQYILHLDLKPENIL 532

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
           C+  TGN+IKIIDFGLARK+ P +KL+V FGTPEF+APEVVN+D + F TDMWSVGVI Y
Sbjct: 533 CVNSTGNQIKIIDFGLARKYRPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVITY 592

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           +LLSGLSPFMG+ D +TM N+  A+++FD E F  +S++AKDFI  LL+
Sbjct: 593 MLLSGLSPFMGDNDAETMNNILHAKWEFDTEAFENVSEEAKDFISSLLV 641

Kinase that phosphorylates MYL2 in vitro (By similarity). Increases cardiomyocyte contractility (By similarity). Required for sarcomere formation in the developing heart.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	251
328707750	676	PREDICTED: hypothetical protein LOC10016	0.980	0.363	0.817	1e-119
189234922	621	PREDICTED: similar to myosin light chain	0.940	0.380	0.817	1e-115
270001409	620	hypothetical protein TcasGA2_TC000228 [T	0.940	0.380	0.817	1e-114
357624001	660	hypothetical protein KGM_05472 [Danaus p	0.960	0.365	0.792	1e-114
345490460	725	PREDICTED: hypothetical protein LOC10011	0.960	0.332	0.784	1e-111
242006853	668	calcium/calmodulin-dependent protein kin	0.928	0.348	0.793	1e-110
383852519	764	PREDICTED: uncharacterized protein LOC10	0.968	0.318	0.765	1e-110
110766631	703	PREDICTED: calcium-dependent protein kin	0.968	0.345	0.757	1e-108
380020129	690	PREDICTED: CBL-interacting serine/threon	0.968	0.352	0.757	1e-108
350398821	697	PREDICTED: hypothetical protein LOC10074	0.968	0.348	0.744	1e-108

>gi|328707750|ref|XP_001947806.2| PREDICTED: hypothetical protein LOC100163829 isoform 1 [Acyrthosiphon pisum]

 Score =  433 bits (1113), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 201/246 (81%), Positives = 222/246 (90%)

Query: 1   MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHP 60
           M  H    S    GKFGTV++C+EKAT + LAAKFVGI  + DRRNVEREVEIM ELQHP
Sbjct: 30  MKEHYELQSEIGRGKFGTVFKCREKATSLMLAAKFVGIVHKQDRRNVEREVEIMCELQHP 89

Query: 61  RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           RLIQ+YDAFE++N MC +LEL+EGGELFERVI DDFVLTEKAV IFMRQICEGV+FIHSK
Sbjct: 90  RLIQLYDAFEANNAMCFILELVEGGELFERVIGDDFVLTEKAVTIFMRQICEGVQFIHSK 149

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIG 180
           N+LHLD+KPENILCLTKTGNRIKIIDFGLARKF+PE KLQVLFGTPEFVAPEVVNFDAIG
Sbjct: 150 NILHLDLKPENILCLTKTGNRIKIIDFGLARKFNPENKLQVLFGTPEFVAPEVVNFDAIG 209

Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
           FGTDMWSVGVICYVLLSGLSPFMGETDV+TM+NVTIAQYDFDDE F+ IS+DAKDFI+KL
Sbjct: 210 FGTDMWSVGVICYVLLSGLSPFMGETDVETMSNVTIAQYDFDDEAFDSISNDAKDFIKKL 269

Query: 241 LLKDRE 246
           L+KD +
Sbjct: 270 LVKDHK 275

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|189234922|ref|XP_970841.2| PREDICTED: similar to myosin light chain kinase [Tribolium castaneum]

 Score =  419 bits (1077), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 193/236 (81%), Positives = 216/236 (91%)

Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           S    GKFGTVY+C+EKATG++LAAKF+ + K+ DRRNVEREV+IM+ LQHPRLIQ+YDA
Sbjct: 38  SEIGRGKFGTVYKCREKATGLSLAAKFIAVPKKEDRRNVEREVDIMKTLQHPRLIQLYDA 97

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           FE+  VMCV+LELIEGGELFERVIDDDFVLTEK+  +FMRQICEGV+FIH + +LHLDMK
Sbjct: 98  FENGKVMCVILELIEGGELFERVIDDDFVLTEKSCTVFMRQICEGVDFIHKQRILHLDMK 157

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PENILCLT+TGNRIKIIDFGLAR+FDP+KKLQVLFGTPEFVAPEVVNFD IGFGTDMWSV
Sbjct: 158 PENILCLTRTGNRIKIIDFGLARRFDPDKKLQVLFGTPEFVAPEVVNFDQIGFGTDMWSV 217

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GVICYVLLSGLSPFMG TDV+TMANVTIA+YDFDDE F EISD AKDFI+KLL KD
Sbjct: 218 GVICYVLLSGLSPFMGATDVETMANVTIAKYDFDDEAFQEISDTAKDFIQKLLKKD 273

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270001409|gb|EEZ97856.1| hypothetical protein TcasGA2_TC000228 [Tribolium castaneum]

 Score =  418 bits (1075), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 193/236 (81%), Positives = 216/236 (91%)

Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           S    GKFGTVY+C+EKATG++LAAKF+ + K+ DRRNVEREV+IM+ LQHPRLIQ+YDA
Sbjct: 70  SEIGRGKFGTVYKCREKATGLSLAAKFIAVPKKEDRRNVEREVDIMKTLQHPRLIQLYDA 129

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           FE+  VMCV+LELIEGGELFERVIDDDFVLTEK+  +FMRQICEGV+FIH + +LHLDMK
Sbjct: 130 FENGKVMCVILELIEGGELFERVIDDDFVLTEKSCTVFMRQICEGVDFIHKQRILHLDMK 189

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PENILCLT+TGNRIKIIDFGLAR+FDP+KKLQVLFGTPEFVAPEVVNFD IGFGTDMWSV
Sbjct: 190 PENILCLTRTGNRIKIIDFGLARRFDPDKKLQVLFGTPEFVAPEVVNFDQIGFGTDMWSV 249

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GVICYVLLSGLSPFMG TDV+TMANVTIA+YDFDDE F EISD AKDFI+KLL KD
Sbjct: 250 GVICYVLLSGLSPFMGATDVETMANVTIAKYDFDDEAFQEISDTAKDFIQKLLKKD 305

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357624001|gb|EHJ74929.1| hypothetical protein KGM_05472 [Danaus plexippus]

 Score =  418 bits (1074), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 191/241 (79%), Positives = 218/241 (90%)

Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           S    GKFGTVY C+EK+TG+ LAAK V + +R++RRNVEREV++MR L+HPRLIQ+YDA
Sbjct: 38  SEIGRGKFGTVYLCREKSTGLELAAKLVSVNRRDERRNVEREVDVMRRLRHPRLIQLYDA 97

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           +E    MCVVLELI GGELFERVID+DFVLTE+A  +FMRQICEG+EF+H +N+LHLDMK
Sbjct: 98  YEWGKCMCVVLELITGGELFERVIDEDFVLTERACTVFMRQICEGIEFVHRQNILHLDMK 157

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PENILCLTKTGNRIKIIDFGLAR +DPEKKLQVLFGTPEFVAPEVVNFD IG+GTDMWSV
Sbjct: 158 PENILCLTKTGNRIKIIDFGLARFYDPEKKLQVLFGTPEFVAPEVVNFDQIGYGTDMWSV 217

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           GVICYVLLSGLSPFMGETD++TMANVTIA+YDFDDE FNEIS+DAKDFIRKLL+KD+E  
Sbjct: 218 GVICYVLLSGLSPFMGETDIETMANVTIAKYDFDDEAFNEISEDAKDFIRKLLVKDKESR 277

Query: 249 P 249
           P
Sbjct: 278 P 278

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345490460|ref|XP_001602778.2| PREDICTED: hypothetical protein LOC100118913 [Nasonia vitripennis]

 Score =  406 bits (1043), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 189/241 (78%), Positives = 214/241 (88%)

Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLI 63
           H +  S    GKFGTVYRCKEK TG+TLAAK V   ++ DRR VEREVEIMR LQHPRLI
Sbjct: 33  HYDIESEIGRGKFGTVYRCKEKKTGLTLAAKVVNTTRKEDRRAVEREVEIMRRLQHPRLI 92

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           Q+YDA E+   + VVLELIEGGELFERVIDDDFVLTE++ A+FMRQICEG+EF+HS+N++
Sbjct: 93  QLYDAIENGKQIYVVLELIEGGELFERVIDDDFVLTERSCAVFMRQICEGIEFVHSQNII 152

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           HLDMKPENILCLTK GNRIKIIDFGLAR++DP+KKLQVLFGTPEFVAPEVVNFD IGFGT
Sbjct: 153 HLDMKPENILCLTKEGNRIKIIDFGLAREWDPKKKLQVLFGTPEFVAPEVVNFDQIGFGT 212

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWS+GVICYVLLSGLSPFMG+TDV+TMANVTIA+YDFD E F +IS+DAKDFIR LL+K
Sbjct: 213 DMWSIGVICYVLLSGLSPFMGDTDVETMANVTIAKYDFDHEAFADISEDAKDFIRCLLVK 272

Query: 244 D 244
           D
Sbjct: 273 D 273

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242006853|ref|XP_002424259.1| calcium/calmodulin-dependent protein kinase type 1G, putative [Pediculus humanus corporis] gi|212507628|gb|EEB11521.1| calcium/calmodulin-dependent protein kinase type 1G, putative [Pediculus humanus corporis]

 Score =  404 bits (1037), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 185/233 (79%), Positives = 211/233 (90%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           GKFGTVY+CKEK+TG+ LAAK V   ++ D+RNVERE++IM+ LQHPRLIQ+YDAFE   
Sbjct: 43  GKFGTVYKCKEKSTGLFLAAKIVPTGRKEDKRNVEREIDIMKTLQHPRLIQLYDAFEKDK 102

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            M VVLELIEGGELFERVI DDFVLTEK+   FMRQICEG+EFIH +N+LHLDMKPENIL
Sbjct: 103 TMVVVLELIEGGELFERVISDDFVLTEKSCTAFMRQICEGMEFIHKQNILHLDMKPENIL 162

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
           CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD IG+ TDMWS+GVICY
Sbjct: 163 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDRIGYETDMWSIGVICY 222

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           V+LSGLSPFMGETD++TMANVTIA++DFDDE FNEIS++AKDFI  LL+K++E
Sbjct: 223 VMLSGLSPFMGETDIETMANVTIAKWDFDDEAFNEISENAKDFISNLLVKEKE 275

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383852519|ref|XP_003701774.1| PREDICTED: uncharacterized protein LOC100879777 [Megachile rotundata]

 Score =  403 bits (1036), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 186/243 (76%), Positives = 215/243 (88%)

Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLI 63
           H +  S    GKFGTVYRCKEKA+G+ LAAK V  AK+ DRR VEREVEIMR LQHPRLI
Sbjct: 33  HYDIQSEIGRGKFGTVYRCKEKASGLMLAAKVVNTAKKEDRRAVEREVEIMRRLQHPRLI 92

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           Q+YDA ++   + V+LELIEGGELFERVIDDDFVLTE++  +FMRQICEG+EFIH +N+L
Sbjct: 93  QLYDAIDTGKQIYVILELIEGGELFERVIDDDFVLTERSCTVFMRQICEGIEFIHRQNIL 152

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           HLD+KPENILCLTK GNRIKIIDFGLAR++DP+KKLQVLFGTPEFVAPEVVNFD IGFGT
Sbjct: 153 HLDLKPENILCLTKEGNRIKIIDFGLAREYDPKKKLQVLFGTPEFVAPEVVNFDQIGFGT 212

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWS+GVICYVLLSGLSPFMG+TD++TMANVTIA+YDFD + F +IS+DAKDFIR LL+K
Sbjct: 213 DMWSIGVICYVLLSGLSPFMGDTDIETMANVTIAKYDFDHDAFADISEDAKDFIRCLLVK 272

Query: 244 DRE 246
           D+E
Sbjct: 273 DKE 275

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|110766631|ref|XP_396640.3| PREDICTED: calcium-dependent protein kinase 4-like [Apis mellifera]

 Score =  398 bits (1022), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 184/243 (75%), Positives = 214/243 (88%)

Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLI 63
           H +  S    GKFGTVYRCKEK +G+ LAAK V  AK+ DRR VEREVEIMR LQHPRLI
Sbjct: 33  HYDIASEIGRGKFGTVYRCKEKVSGLMLAAKVVNTAKKEDRRAVEREVEIMRRLQHPRLI 92

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           Q+YDA ++   + V+LELIEGGELFERVIDDDFVLTE++ A+FMRQICEG+EFIH +N+L
Sbjct: 93  QLYDAIDNGQQIYVILELIEGGELFERVIDDDFVLTERSCAVFMRQICEGIEFIHRQNIL 152

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           HLD+KPENILCLTK GNRIKIIDFGLAR++DP+KKLQVLFGTPEFVAPEVVNFD IG+GT
Sbjct: 153 HLDLKPENILCLTKEGNRIKIIDFGLAREYDPKKKLQVLFGTPEFVAPEVVNFDQIGYGT 212

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWS+GVICYVLLSGLSPFMG+TD++TMANVTIA+YDFD + F  IS+DAKDFIR LL+K
Sbjct: 213 DMWSIGVICYVLLSGLSPFMGDTDIETMANVTIAKYDFDHDAFANISEDAKDFIRCLLVK 272

Query: 244 DRE 246
           D++
Sbjct: 273 DKD 275

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380020129|ref|XP_003693948.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 3-like [Apis florea]

 Score =  397 bits (1021), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 184/243 (75%), Positives = 214/243 (88%)

Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLI 63
           H +  S    GKFGTVYRCKEK +G+ LAAK V  AK+ DRR VEREVEIMR LQHPRLI
Sbjct: 33  HYDIASEIGRGKFGTVYRCKEKVSGLMLAAKVVNTAKKEDRRAVEREVEIMRRLQHPRLI 92

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           Q+YDA ++   + V+LELIEGGELFERVIDDDFVLTE++ A+FMRQICEG+EFIH +N+L
Sbjct: 93  QLYDAIDNGRQIYVILELIEGGELFERVIDDDFVLTERSCAVFMRQICEGIEFIHRQNIL 152

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           HLD+KPENILCLTK GNRIKIIDFGLAR++DP+KKLQVLFGTPEFVAPEVVNFD IG+GT
Sbjct: 153 HLDLKPENILCLTKEGNRIKIIDFGLAREYDPKKKLQVLFGTPEFVAPEVVNFDQIGYGT 212

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWS+GVICYVLLSGLSPFMG+TD++TMANVTIA+YDFD + F  IS+DAKDFIR LL+K
Sbjct: 213 DMWSIGVICYVLLSGLSPFMGDTDIETMANVTIAKYDFDHDAFANISEDAKDFIRCLLVK 272

Query: 244 DRE 246
           D++
Sbjct: 273 DKD 275

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350398821|ref|XP_003485314.1| PREDICTED: hypothetical protein LOC100741566 [Bombus impatiens]

 Score =  395 bits (1015), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 181/243 (74%), Positives = 214/243 (88%)

Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLI 63
           H +  S    GKFGTVYRCKEK + + LAAK V  AK+ D+R+VEREVEIMR LQHPRLI
Sbjct: 33  HYDIESEIGRGKFGTVYRCKEKVSDLMLAAKVVNTAKKEDKRSVEREVEIMRRLQHPRLI 92

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           Q+YDA ++   + V+LELIEGGELFERVIDDDFVLTE++ A+FMRQICEG+EF+H +N+L
Sbjct: 93  QLYDAIDTGKQIYVILELIEGGELFERVIDDDFVLTERSCAVFMRQICEGIEFVHRQNIL 152

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           HLD+KPENILCLTK GNRIKIIDFGLAR++DP+KKLQVLFGTPEFVAPEVVNFD IG+GT
Sbjct: 153 HLDLKPENILCLTKEGNRIKIIDFGLAREYDPKKKLQVLFGTPEFVAPEVVNFDQIGYGT 212

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWS+GVICYVLLSGLSPFMG+TD++TMANVTIA+YDFD + F  IS+DAKDFIR LL+K
Sbjct: 213 DMWSIGVICYVLLSGLSPFMGDTDIETMANVTIAKYDFDHDAFANISEDAKDFIRCLLVK 272

Query: 244 DRE 246
           D++
Sbjct: 273 DKD 275

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	251
FB|FBgn0259678	888	sqa "spaghetti-squash activato	0.920	0.260	0.679	3.8e-85
UNIPROTKB|B4DUE3	714	MYLK "cDNA FLJ53659, highly si	0.932	0.327	0.576	4.8e-71
UNIPROTKB|Q28824	1176	MYLK "Myosin light chain kinas	0.932	0.198	0.576	1e-70
MGI|MGI:894806	1941	Mylk "myosin, light polypeptid	0.932	0.120	0.581	2.5e-70
ZFIN|ZDB-GENE-030131-8207	899	mylka "myosin, light chain kin	0.920	0.256	0.562	3.3e-70
UNIPROTKB|E1BMP3	782	MYLK3 "Uncharacterized protein	0.952	0.305	0.535	5.5e-70
ZFIN|ZDB-GENE-041111-150	966	mylkb "myosin light chain kina	0.920	0.239	0.558	5.5e-70
RGD|1310915	1942	Mylk "myosin light chain kinas	0.932	0.120	0.576	6.6e-70
UNIPROTKB|F1PIF6	1960	MYLK "Uncharacterized protein"	0.932	0.119	0.581	6.7e-70
RGD|1305801	786	Mylk3 "myosin light chain kina	0.956	0.305	0.525	7e-70

FB|FBgn0259678 sqa "spaghetti-squash activator" [Drosophila melanogaster (taxid:7227)]

 Score = 852 (305.0 bits), Expect = 3.8e-85, P = 3.8e-85
 Identities = 157/231 (67%), Positives = 188/231 (81%)

Query:    14 GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
             GKFGTVY+C++KA G+ LAAKFV I K            IM  LQH  +IQ+Y A+E   
Sbjct:    43 GKFGTVYKCRDKANGLQLAAKFVPIPKREDKRNVEREVEIMNSLQHHLIIQLYAAYEYQK 102

Query:    74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
             +MCVVLELIEGGELF+RV+DD+FVLTE+   +F+RQ+CE + FIH   ++HLD+KPENIL
Sbjct:   103 MMCVVLELIEGGELFDRVVDDEFVLTERVCRVFIRQVCEAMAFIHGNGIVHLDLKPENIL 162

Query:   134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
              LT+ GNRIKIIDFGLARKFDP+K+L+VLFGTPEFVAPEVVNFD I +GTDMWSVGVICY
Sbjct:   163 VLTQKGNRIKIIDFGLARKFDPDKRLRVLFGTPEFVAPEVVNFDCISYGTDMWSVGVICY 222

Query:   194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             VL+SGLSPFMGE D++TM+NVTIA+YDF+DECFN IS +  DFI KLL KD
Sbjct:   223 VLISGLSPFMGENDIETMSNVTIAKYDFEDECFNGISPECLDFIAKLLAKD 273

GO:0004687 "myosin light chain kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IGI;NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IMP;NAS

GO:0005575 "cellular_component" evidence=ND

GO:0008360 "regulation of cell shape" evidence=IMP

GO:0007015 "actin filament organization" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IGI

GO:0032008 "positive regulation of TOR signaling cascade" evidence=IGI

GO:0006914 "autophagy" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IMP

UNIPROTKB|B4DUE3 MYLK "cDNA FLJ53659, highly similar to Myosin light chain kinase, smooth muscle (EC2.7.11.18)" [Homo sapiens (taxid:9606)]

 Score = 719 (258.2 bits), Expect = 4.8e-71, P = 4.8e-71
 Identities = 135/234 (57%), Positives = 171/234 (73%)

Query:    14 GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
             GKFG V+R  EK T    A KF                 IM  L HP+L+Q  DAFE   
Sbjct:   273 GKFGQVFRLVEKKTRKVWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKA 332

Query:    74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              + +VLE++ GGELFER+ID+DF LTE+    +MRQI EGVE+IH + ++HLD+KPENI+
Sbjct:   333 NIVMVLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIM 392

Query:   134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             C+ KTG RIK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++ IG+ TDMWS+GVICY
Sbjct:   393 CVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICY 452

Query:   194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
             +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EISDDAKDFI  LL KD ++
Sbjct:   453 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKN 506

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q28824 MYLK "Myosin light chain kinase, smooth muscle" [Bos taurus (taxid:9913)]

 Score = 723 (259.6 bits), Expect = 1.0e-70, P = 1.0e-70
 Identities = 135/234 (57%), Positives = 172/234 (73%)

Query:    14 GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
             GKFG V+R  EK TG   A KF                 IM  L HP+L+Q  DAFE   
Sbjct:   734 GKFGQVFRLVEKKTGKIWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKA 793

Query:    74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              + +VLE++ GGELFER+ID+DF LTE+    +M+QI EGVE+IH + ++HLD+KPENI+
Sbjct:   794 NIVMVLEIVSGGELFERIIDEDFELTERECIKYMKQISEGVEYIHKQGIVHLDLKPENIM 853

Query:   134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             C+ KTG RIK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++ IG+ TDMWS+GVICY
Sbjct:   854 CVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICY 913

Query:   194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
             +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EISDDAKDFI  LL KD ++
Sbjct:   914 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKN 967

GO:0032154 "cleavage furrow" evidence=IEA

GO:0030027 "lamellipodium" evidence=IEA

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004687 "myosin light chain kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005516 "calmodulin binding" evidence=IEA

GO:0003779 "actin binding" evidence=IEA

MGI|MGI:894806 Mylk "myosin, light polypeptide kinase" [Mus musculus (taxid:10090)]

 Score = 726 (260.6 bits), Expect = 2.5e-70, P = 2.5e-70
 Identities = 136/234 (58%), Positives = 172/234 (73%)

Query:    14 GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
             GKFG V+R  EK TG   A KF                 IM  L HP+L+Q  DAFE   
Sbjct:  1495 GKFGQVFRLVEKKTGKIWAGKFFKAYSAKEKDNIRQEISIMNCLHHPKLVQCVDAFEEKA 1554

Query:    74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              + +VLE++ GGELFER+ID+DF LTE+    +MRQI EGVE+IH + ++HLD+KPENI+
Sbjct:  1555 NIVMVLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIM 1614

Query:   134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             C+ KTG RIK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++ IG+ TDMWS+GVICY
Sbjct:  1615 CVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICY 1674

Query:   194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
             +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EISDDAKDFI  LL KD ++
Sbjct:  1675 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKN 1728

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001725 "stress fiber" evidence=ISO

GO:0003779 "actin binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004687 "myosin light chain kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005516 "calmodulin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005856 "cytoskeleton" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006939 "smooth muscle contraction" evidence=IMP

GO:0014820 "tonic smooth muscle contraction" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019899 "enzyme binding" evidence=IPI

GO:0030027 "lamellipodium" evidence=ISO

GO:0030335 "positive regulation of cell migration" evidence=ISO

GO:0032060 "bleb assembly" evidence=ISO

GO:0032154 "cleavage furrow" evidence=ISO

GO:0042995 "cell projection" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0051928 "positive regulation of calcium ion transport" evidence=ISO

GO:0060414 "aorta smooth muscle tissue morphogenesis" evidence=ISO

GO:0071476 "cellular hypotonic response" evidence=ISO

GO:0090303 "positive regulation of wound healing" evidence=ISO

ZFIN|ZDB-GENE-030131-8207 mylka "myosin, light chain kinase a" [Danio rerio (taxid:7955)]

 Score = 711 (255.3 bits), Expect = 3.3e-70, P = 3.3e-70
 Identities = 130/231 (56%), Positives = 173/231 (74%)

Query:    14 GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
             GKFGTV++  EK+T    A KF+                IM +L HP+L+Q  DAFE   
Sbjct:   478 GKFGTVFKLIEKSTKKVWAGKFIKAYSAKEKENVRQEIAIMNDLHHPKLVQCIDAFEGKT 537

Query:    74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              + +VLE+I GGELF+R+ID+DF LTE+ V  +M QI +GV FIH K ++HLD+KPENI+
Sbjct:   538 DIVMVLEMISGGELFDRIIDEDFELTEREVIKYMLQIVDGVNFIHKKGIVHLDLKPENIM 597

Query:   134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             C+ KTG++IK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++AI + TDMWS+GVICY
Sbjct:   598 CVNKTGSKIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEAISYATDMWSIGVICY 657

Query:   194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             +L+SGLSPFMG+ D +T++NVT A +DF+DE F+EIS++AKDFI  LL KD
Sbjct:   658 ILVSGLSPFMGDNDNETLSNVTSATWDFEDEAFDEISEEAKDFISNLLKKD 708

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0007596 "blood coagulation" evidence=IMP

UNIPROTKB|E1BMP3 MYLK3 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
 Identities = 128/239 (53%), Positives = 176/239 (73%)

Query:     7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
             QH     G+FG V+RC EKATG++LAAK + +              IM +L H  LIQ+Y
Sbjct:   480 QHEVLGGGRFGQVHRCTEKATGLSLAAKIIKVKSAKDREDVKNEINIMNQLSHVNLIQLY 539

Query:    67 DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
             DAFES N   +V+E ++GGELF+R+ ++ + LTE  V +F +QICEGV ++H   VLHLD
Sbjct:   540 DAFESKNSFTLVMEYVDGGELFDRITEEKYHLTELDVVLFTKQICEGVHYLHQHYVLHLD 599

Query:   127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
             +KPENILC+ +TG++IKIIDFGLAR++ P +KL+V FGTPEF+APEVVN++ + F TDMW
Sbjct:   600 LKPENILCVNQTGHQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYEFVSFPTDMW 659

Query:   187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
             SVGVI Y+LLSGLSPF+GETD +TM  +    +DFD + F  +S++AKDF+ +LL+K++
Sbjct:   660 SVGVITYMLLSGLSPFLGETDAETMNFIVNCNWDFDADTFEGLSEEAKDFVSRLLVKEK 718

GO:0071347 "cellular response to interleukin-1" evidence=IEA

GO:0045214 "sarcomere organization" evidence=IEA

GO:0015629 "actin cytoskeleton" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004687 "myosin light chain kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IEA

GO:0002528 "regulation of vascular permeability involved in acute inflammatory response" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

ZFIN|ZDB-GENE-041111-150 mylkb "myosin light chain kinase b" [Danio rerio (taxid:7955)]

 Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
 Identities = 129/231 (55%), Positives = 173/231 (74%)

Query:    14 GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
             GKFG V++  EK++    A KF+                IM  L HP+L+Q  DAFE  +
Sbjct:   536 GKFGQVFKLVEKSSKKVWAGKFIKAFSQKEKENVRQEIGIMNSLHHPKLVQCMDAFEGKS 595

Query:    74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              M +V+E+I GGELFER++D+DF LTE+ V  +M QI +GV+FIH + ++HLD+KPENI+
Sbjct:   596 DMVMVMEMISGGELFERIVDEDFELTEREVIKYMLQIIDGVQFIHKQGIVHLDLKPENIM 655

Query:   134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             C+ KTG++IK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++AI + TDMWS+GVICY
Sbjct:   656 CINKTGSKIKLIDFGLARRLEDSGSLKVLFGTPEFVAPEVINYEAISYPTDMWSIGVICY 715

Query:   194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             +L+SGLSPFMG+ D +T+ANVT A +DF+DE F+EISD AKDFI +LL KD
Sbjct:   716 ILVSGLSPFMGDNDNETLANVTSATWDFEDEAFDEISDQAKDFISRLLKKD 766

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

RGD|1310915 Mylk "myosin light chain kinase" [Rattus norvegicus (taxid:10116)]

 Score = 722 (259.2 bits), Expect = 6.6e-70, P = 6.6e-70
 Identities = 135/234 (57%), Positives = 172/234 (73%)

Query:    14 GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
             GKFG V+R  EK TG   A KF                 IM  L HP+L+Q  DAFE   
Sbjct:  1497 GKFGQVFRLVEKRTGKIWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKA 1556

Query:    74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              + +VLE++ GGELFER+ID+DF LTE+    +MRQI EGVE+IH + ++HLD+KPENI+
Sbjct:  1557 NIVMVLEIVSGGELFERIIDEDFELTERECIKYMRQISEGVEYIHKQGIVHLDLKPENIM 1616

Query:   134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             C+ KTG RIK+IDFGLAR+ +    L+VLFGTPEFVAPEV+N++ IG+ TDMWS+GVICY
Sbjct:  1617 CVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICY 1676

Query:   194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
             +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EIS+DAKDFI  LL KD ++
Sbjct:  1677 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISEDAKDFISNLLKKDMKN 1730

GO:0001725 "stress fiber" evidence=IEA

GO:0004687 "myosin light chain kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0030027 "lamellipodium" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0032060 "bleb assembly" evidence=IEA

GO:0032154 "cleavage furrow" evidence=IEA

GO:0051928 "positive regulation of calcium ion transport" evidence=IEA

GO:0060414 "aorta smooth muscle tissue morphogenesis" evidence=IEA

GO:0071476 "cellular hypotonic response" evidence=IEA

GO:0090303 "positive regulation of wound healing" evidence=IEA

UNIPROTKB|F1PIF6 MYLK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 722 (259.2 bits), Expect = 6.7e-70, P = 6.7e-70
 Identities = 136/234 (58%), Positives = 171/234 (73%)

Query:    14 GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
             GKFG V+R  EK TG   A KF                 IM  L HP+L+Q  DAFE   
Sbjct:  1517 GKFGQVFRLVEKKTGKIWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKA 1576

Query:    74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              + +VLE++ GGELFER+ID+DF LTE+    +MRQI  GVE+IH + ++HLD+KPENI+
Sbjct:  1577 NIVMVLEIVSGGELFERIIDEDFELTERECIQYMRQISAGVEYIHRQGIVHLDLKPENIM 1636

Query:   134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             C+ KTG RIK+IDFGLARK +    L+VLFGTPEFVAPEV+N++ IG+ TDMWS+GVICY
Sbjct:  1637 CVNKTGTRIKLIDFGLARKLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICY 1696

Query:   194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
             +L+SGLSPFMG+ D +T+ANVT A +DFDDE F+EISDDAKDFI  LL KD ++
Sbjct:  1697 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKDMKN 1750

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

RGD|1305801 Mylk3 "myosin light chain kinase 3" [Rattus norvegicus (taxid:10116)]

 Score = 708 (254.3 bits), Expect = 7.0e-70, P = 7.0e-70
 Identities = 126/240 (52%), Positives = 177/240 (73%)

Query:     6 NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI 65
             +QH     G+FG V+RC E++TG+ LAAK + +              IM +L H  LIQ+
Sbjct:   483 SQHEVLGGGRFGQVHRCTERSTGLALAAKIIKVKNIKDREDVKNEINIMNQLSHVNLIQL 542

Query:    66 YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
             YDAFES N   +++E ++GGELF+R+ D+ + LTE  V +F RQICEGV ++H   +LHL
Sbjct:   543 YDAFESKNSFTLIMEYVDGGELFDRITDEKYHLTELDVVLFTRQICEGVHYLHQHYILHL 602

Query:   126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
             D+KPENILC+++TG++IKIIDFGLAR++ P +KL+V FGTPEF+APEVVN++ + F TDM
Sbjct:   603 DLKPENILCVSQTGHQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYEFVSFPTDM 662

Query:   186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
             WSVGVI Y+LLSGLSPF+GETD +TM  +    +DFD + F  +S++AKDF+ +LL+K++
Sbjct:   663 WSVGVITYMLLSGLSPFLGETDAETMNFIVNCSWDFDADTFKGLSEEAKDFVSRLLVKEK 722

GO:0002528 "regulation of vascular permeability involved in acute inflammatory response" evidence=IEA;ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISO;IDA

GO:0004687 "myosin light chain kinase activity" evidence=ISO;IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005829 "cytosol" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0015629 "actin cytoskeleton" evidence=IEA;ISO

GO:0045214 "sarcomere organization" evidence=ISO;IMP

GO:0048769 "sarcomerogenesis" evidence=IMP

GO:0055003 "cardiac myofibril assembly" evidence=IMP

GO:0060298 "positive regulation of sarcomere organization" evidence=IDA

GO:0071347 "cellular response to interleukin-1" evidence=IEA;ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
E9PT87	MYLK3_RAT	2, ., 7, ., 1, 1, ., 1, 8	0.5416	0.9561	0.3053	yes	N/A
Q869W6	MYLKG_DICDI	2, ., 7, ., 1, 1, ., 1, 8	0.3675	0.9163	0.6590	yes	N/A
A8C984	MYLK3_DANRE	2, ., 7, ., 1, 1, ., 1, 8	0.5676	0.9123	0.3202	yes	N/A
Q28824	MYLK_BOVIN	2, ., 7, ., 1, 1, ., 1, 8	0.5854	0.9322	0.1989	yes	N/A
Q15746	MYLK_HUMAN	2, ., 7, ., 1, 1, ., 1, 8	0.5930	0.9203	0.1206	yes	N/A
P29294	MYLK_RABIT	2, ., 7, ., 1, 1, ., 1, 8	0.5930	0.9203	0.2013	yes	N/A
P11799	MYLK_CHICK	2, ., 7, ., 1, 1, ., 1, 8	0.5930	0.9203	0.1211	yes	N/A
Q6PDN3	MYLK_MOUSE	2, ., 7, ., 1, 1, ., 1, 8	0.5974	0.9203	0.1190	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	251
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-85
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-72
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-57
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-53
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-49
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-48
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-46
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-46
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-42
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-42
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-37
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-37
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-37
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-36
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-36
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-35
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-35
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-35
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-35
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-35
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-33
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-33
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-33
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-32
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-32
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-32
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-31
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-31
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-31
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-31
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-31
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-30
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-30
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-30
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-30
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-29
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-29
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-29
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-29
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-29
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-29
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-29
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-29
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-29
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-28
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-28
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-28
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-28
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-28
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-28
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-28
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-28
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-27
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-27
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-27
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-27
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-27
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-27
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-27
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-27
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-27
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-27
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-27
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-27
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-26
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-26
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-26
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-26
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-26
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-26
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-25
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-25
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-25
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-25
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-25
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-25
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-25
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-25
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-24
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-24
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-24
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-24
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-23
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-23
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-23
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-23
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-23
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-23
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-23
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-23
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-23
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-22
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-22
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-21
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-21
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-21
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-21
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-21
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-21
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-21
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-20
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-20
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-20
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-20
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-20
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-20
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-20
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-19
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-19
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-19
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-19
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-19
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-19
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-18
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-18
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-18
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-18
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-18
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-17
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-17
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-17
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-17
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-17
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-17
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-17
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-11
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-06
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-04
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	4e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.002

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  253 bits (649), Expect = 4e-85
 Identities = 95/235 (40%), Positives = 146/235 (62%), Gaps = 4/235 (1%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG VY  ++K TG  +A K +   K + DR  + RE++I+++L+HP ++++YD FE  
Sbjct: 10  GSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDE 69

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           + + +V+E  EGG+LF+ ++     L+E     ++RQI   +E++HSK ++H D+KPENI
Sbjct: 70  DKLYLVMEYCEGGDLFD-LLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENI 128

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
           L L + G+ +K+ DFGLAR+ DP +KL    GTPE++APEV+     G   D+WS+GVI 
Sbjct: 129 L-LDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVIL 186

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           Y LL+G  PF G+  +  +                +IS +AKD IRKLL+KD E 
Sbjct: 187 YELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEK 241

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  220 bits (564), Expect = 3e-72
 Identities = 91/241 (37%), Positives = 134/241 (55%), Gaps = 10/241 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K K TG  +A K +          +   RE+ I+R L HP ++++ DAFE 
Sbjct: 10  GSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFED 69

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            + + +V+E  EGG+LF   +     L+E        QI  G+E++HS  ++H D+KPEN
Sbjct: 70  KDHLYLVMEYCEGGDLF-DYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPEN 128

Query: 132 ILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVG 189
           IL L + G  +KI DFGLA+K       L    GTP ++APEV+   +  G   D+WS+G
Sbjct: 129 IL-LDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLG 186

Query: 190 VICYVLLSGLSPFMGETDV---QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           VI Y LL+G  PF GE  +   Q +  +     +FD+  ++  S++AKD I+K L KD  
Sbjct: 187 VILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPS 246

Query: 247 D 247
            
Sbjct: 247 K 247

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  180 bits (458), Expect = 8e-57
 Identities = 67/185 (36%), Positives = 112/185 (60%), Gaps = 4/185 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN-VEREVEIMRELQHPRLIQIYDAFESS 72
           G FGTVY  ++K TG  +A K +     +     + RE+EI+++L HP ++++Y  FE  
Sbjct: 4   GGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE 63

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N + +V+E  EGG L + + +++  L+E  +   + QI EG+E++HS  ++H D+KPENI
Sbjct: 64  NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENI 123

Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDA-IGFGTDMWSVGV 190
           L L     ++K+ DFGL++     +  L+ + GTP ++APEV+         +D+WS+GV
Sbjct: 124 L-LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182

Query: 191 ICYVL 195
           I Y L
Sbjct: 183 ILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  173 bits (441), Expect = 1e-53
 Identities = 78/239 (32%), Positives = 124/239 (51%), Gaps = 11/239 (4%)

Query: 13  FGKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
            G FG V   ++K TG   A K +    I KR +  +   E  I+  + HP +++++ AF
Sbjct: 3   KGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF 62

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++   + +VLE   GGELF   +  +   +E+    +  +I   +E++HS  +++ D+KP
Sbjct: 63  QTEEKLYLVLEYAPGGELF-SHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSV 188
           ENIL L   G+ IK+ DFGLA++   E      F GTPE++APEV+     G   D WS+
Sbjct: 122 ENIL-LDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSL 179

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           GV+ Y +L+G  PF  E   +    +      F +     +S +A+D I  LL KD   
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDPTK 234

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  162 bits (413), Expect = 2e-49
 Identities = 69/244 (28%), Positives = 131/244 (53%), Gaps = 11/244 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G FG VY  + K+ G     K + ++  +  +R +   EV+I+++L HP +I+ Y++FE 
Sbjct: 11  GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE 70

Query: 72  SNVMCVVLELIEGGELFERV---IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
              +C+V+E  +GG+L +++     +     E+ +  +  Q+C  ++++HS+ +LH D+K
Sbjct: 71  KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK 130

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWS 187
           P+NI  LT  G  +K+ DFG+++       L     GTP +++PE+       + +D+WS
Sbjct: 131 PQNIF-LTSNGL-VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWS 188

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           +G + Y L +   PF GE  ++    +   QY      +   S + ++ +  LL KD E+
Sbjct: 189 LGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQY---SSELRNLVSSLLQKDPEE 245

Query: 248 APEV 251
            P +
Sbjct: 246 RPSI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  160 bits (408), Expect = 2e-48
 Identities = 88/268 (32%), Positives = 125/268 (46%), Gaps = 38/268 (14%)

Query: 11  FSFGK------FGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMREL-QHP 60
           F FGK      F TV   KEK T    A K +    + K    + V+ E E++  L  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 61  RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
            +I++Y  F+    +  VLE    GEL +  I     L EK    +  +I   +E++HSK
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQ-YIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF----------------- 163
            ++H D+KPENIL L K    IKI DFG A+  DP    +                    
Sbjct: 122 GIIHRDLKPENIL-LDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 164 ----GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY 219
               GT E+V+PE++N    G  +D+W++G I Y +L+G  PF G  +  T   +   +Y
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239

Query: 220 DFDDECFNEISDDAKDFIRKLLLKDRED 247
            F          DAKD I KLL+ D +D
Sbjct: 240 SFP----PNFPPDAKDLIEKLLVLDPQD 263

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  160 bits (406), Expect = 2e-48
 Identities = 78/247 (31%), Positives = 136/247 (55%), Gaps = 25/247 (10%)

Query: 11  FSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-------DRRNVEREVEIMRELQHPRLI 63
            S G +G V+  K+K+TG   A K   I K +       D+   ER+  I+ + Q P ++
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKV--IKKADMIRKNQVDQVLTERD--ILSQAQSPYVV 56

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           ++Y +F+    + +V+E + GG+L   ++++   L E    I++ +I   +E++HS  ++
Sbjct: 57  KLYYSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLAR---------KFDPEKKLQVLFGTPEFVAPEVV 174
           H D+KP+NIL +   G+ +K+ DFGL++           D EK+ + + GTP+++APEV+
Sbjct: 116 HRDLKPDNIL-IDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK 234
                    D WS+G I Y  L G+ PF GET  +   N+   + ++ ++   E+SD+A 
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAI 231

Query: 235 DFIRKLL 241
           D I KLL
Sbjct: 232 DLISKLL 238

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  155 bits (394), Expect = 1e-46
 Identities = 74/239 (30%), Positives = 125/239 (52%), Gaps = 13/239 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR--RNVEREVEIMRELQHPRLIQIYDAFES 71
           G FG+VY   +K TG  +A K V ++  ++     +ERE+ I+  LQHP +++ Y +   
Sbjct: 11  GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD 70

Query: 72  S--NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              N + + LE + GG L   ++     L E  +  + RQI EG+ ++HS  ++H D+K 
Sbjct: 71  EEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKG 129

Query: 130 ENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
            NIL +   G  +K+ DFG A++    +  +    + GTP ++APEV+  +  G   D+W
Sbjct: 130 ANIL-VDSDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIW 187

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVT-IAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           S+G     + +G  P+    +   MA +  I       E    +S++AKDF+RK L +D
Sbjct: 188 SLGCTVIEMATGKPPWSELGNP--MAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  158 bits (400), Expect = 2e-46
 Identities = 78/259 (30%), Positives = 125/259 (48%), Gaps = 29/259 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLI-QIYDAF 69
           G FG VY  +++     +A K +     +K  +     RE++I+  L HP  I ++YD F
Sbjct: 11  GSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67

Query: 70  ESSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           +    + +V+E ++GG L +  + I     L+E      + QI   +E++HSK ++H D+
Sbjct: 68  QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDI 127

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK-------KLQVLFGTPEFVAPEVV---NFD 177
           KPENIL L + G  +K+IDFGLA+                   GTP ++APEV+   +  
Sbjct: 128 KPENIL-LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLA 186

Query: 178 AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA---------NVTIAQYDFDDECFNE 228
                +D+WS+G+  Y LL+GL PF GE +    +                         
Sbjct: 187 YASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPEL 246

Query: 229 ISDDAKDFIRKLLLKDRED 247
           IS  A D ++KLL KD ++
Sbjct: 247 ISKAASDLLKKLLAKDPKN 265

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  150 bits (381), Expect = 2e-44
 Identities = 77/240 (32%), Positives = 136/240 (56%), Gaps = 11/240 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  G VY+  ++ATG  +A K + + K+N    +  E+ IM++ +HP ++  YD++   +
Sbjct: 30  GASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPNIVDYYDSYLVGD 88

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E ++GG L + +  +   + E  +A   R++ +G+E++HS+NV+H D+K +NIL
Sbjct: 89  ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNIL 148

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L+K G  +K+ DFG A +   EK K   + GTP ++APEV+     G   D+WS+G++C
Sbjct: 149 -LSKDG-SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMC 206

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQY---DFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +  G  P++ E  ++ +    I         +    + S + KDF+ K L+KD E  P
Sbjct: 207 IEMAEGEPPYLREPPLRALF--LITTKGIPPLKNP--EKWSPEFKDFLNKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  144 bits (366), Expect = 2e-42
 Identities = 71/237 (29%), Positives = 129/237 (54%), Gaps = 5/237 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ + K TG  +A K + +  +  +  +  E++I+++ +HP +++ Y ++   +
Sbjct: 11  GGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD 70

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E   GG L + +   +  LTE  +A   +++ +G+E++HS  ++H D+K  NIL
Sbjct: 71  ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL 130

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
            LT  G  +K+IDFGL+ +    K    + GTP ++APEV+N     +  D+WS+G+   
Sbjct: 131 -LTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAI 188

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDF-DDECFNEISDDAKDFIRKLLLKDREDAP 249
            L  G  P+     ++ +    IA           + SD+ KDF++K L K+ E  P
Sbjct: 189 ELAEGKPPYSELPPMKAL--FKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  143 bits (364), Expect = 4e-42
 Identities = 75/236 (31%), Positives = 126/236 (53%), Gaps = 11/236 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   +++ T    A K++      ++   RNV  E  I++EL HP L+ ++ +F+
Sbjct: 11  GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ 70

Query: 71  SSNVMCVVLELIEGGELFERV-IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
               M +V++L+ GG+L  R  +      +E+ V  ++ +I   +E++HSK ++H D+KP
Sbjct: 71  DEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKP 128

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           +NIL L + G+ + I DF +A K  P+       GTP ++APEV+         D WS+G
Sbjct: 129 DNIL-LDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLG 186

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF-NEISDDAKDFIRKLLLKD 244
           V  Y  L G  P+ G +  +T+ +   A+ +  D  +    S +A D I KLL +D
Sbjct: 187 VTAYECLRGKRPYRGHS--RTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD 240

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  135 bits (341), Expect = 1e-38
 Identities = 71/237 (29%), Positives = 123/237 (51%), Gaps = 14/237 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   K K+   T A K V    I +   + ++  E EI+ E  HP ++++Y  F+
Sbjct: 4   GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + +++E   GGEL+  ++ D  +  E     ++  +    E++H++ +++ D+KPE
Sbjct: 64  DKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPE 122

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L L   G  +K++DFG A+K    +K     GTPE+VAPE++      F  D WS+G+
Sbjct: 123 NLL-LDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180

Query: 191 ICYVLLSGLSPFMGETDVQ--TMANV--TIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           + Y LL+G  PF  + +       ++     + +F     N I   AKD I++LL +
Sbjct: 181 LLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIKQLLRR 233

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  131 bits (333), Expect = 1e-37
 Identities = 74/243 (30%), Positives = 127/243 (52%), Gaps = 16/243 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G FG VY+     TG  +A K + + K      +++ +E+++++ L+HP +++   + E+
Sbjct: 11  GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET 70

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           S+ + ++LE  E G L  ++I       E  VA+++ Q+ +G+ ++H + V+H D+K  N
Sbjct: 71  SDSLYIILEYAENGSL-RQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAAN 129

Query: 132 ILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           IL  TK G  +K+ DFG+A K  D  K    + GTP ++APEV+        +D+WS+G 
Sbjct: 130 IL-TTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGC 187

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF--NEISDDAKDFIRKLLLKD---R 245
               LL+G  P+     +  +    I Q   DD       IS + KDF+ +   KD   R
Sbjct: 188 TVIELLTGNPPYYDLNPMAALFR--IVQ---DDHPPLPEGISPELKDFLMQCFQKDPNLR 242

Query: 246 EDA 248
             A
Sbjct: 243 PTA 245

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  131 bits (333), Expect = 3e-37
 Identities = 76/237 (32%), Positives = 123/237 (51%), Gaps = 16/237 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G FG V   + K +G   A K +  AK    + VE    E  I++ ++HP L+ +Y +F+
Sbjct: 12  GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71

Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             + + +V+E + GGELF   R         E     +  Q+   +E++HS ++++ D+K
Sbjct: 72  DDSNLYLVMEYVPGGELFSHLRKSGR---FPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L L   G  IKI DFG A++   + +   L GTPE++APE++     G   D W++
Sbjct: 129 PENLL-LDSDGY-IKITDFGFAKRV--KGRTYTLCGTPEYLAPEIILSKGYGKAVDWWAL 184

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           G++ Y +L+G  PF  +  +Q    +   +  F     +  S DAKD IR LL  D 
Sbjct: 185 GILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIRNLLQVDL 237

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  131 bits (331), Expect = 8e-37
 Identities = 81/267 (30%), Positives = 129/267 (48%), Gaps = 50/267 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--------REVEIMRELQHPRLIQI 65
           G +  VY+ ++K TG  +A K +   K  +R+  +        RE+++++EL+HP +I +
Sbjct: 11  GTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
            D F   + + +V E +E     E+VI D   VLT   +  +M     G+E++HS  +LH
Sbjct: 68  LDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILH 125

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKL--QVLFGTPEFVAPEVVNFDA--I 179
            D+KP N+L +   G  +K+ DFGLAR F  P +K+  QV+  T  + APE++ F A   
Sbjct: 126 RDLKPNNLL-IASDG-VLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELL-FGARHY 180

Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV------------------------- 214
           G G DMWSVG I   LL  +    G++D+  +  +                         
Sbjct: 181 GVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK 240

Query: 215 TIAQYDFDDECFNEISDDAKDFIRKLL 241
                      F   SDDA D +++LL
Sbjct: 241 PFPPTPLKQ-IFPAASDDALDLLQRLL 266

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 2e-36
 Identities = 65/204 (31%), Positives = 110/204 (53%), Gaps = 17/204 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G VY+ ++K TG  +A K + +   ++   +   RE+++++EL HP +I++ D F  
Sbjct: 10  GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH 69

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V E ++  +L++ + D    L E  +  ++ Q+ +G+ F HS  +LH D+KPEN
Sbjct: 70  KGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPEN 128

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APEVVNFDAIGFGT--D 184
           +L    T   +K+ DFGLAR F       V   T   V     APE++     G+ T  D
Sbjct: 129 LLI--NTEGVLKLADFGLARSFGS----PVRPYTHYVVTRWYRAPELL-LGDKGYSTPVD 181

Query: 185 MWSVGVICYVLLSGLSPFMGETDV 208
           +WSVG I   LLS    F G++++
Sbjct: 182 IWSVGCIFAELLSRRPLFPGKSEI 205

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  127 bits (322), Expect = 8e-36
 Identities = 67/243 (27%), Positives = 121/243 (49%), Gaps = 13/243 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G  G VY+ + K TG   A K + +      R+ + RE++ +R  + P +++ Y AF   
Sbjct: 12  GSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPEN 131
             + +VLE ++GG L   ++     + E  +A   RQI +G++++H+K +++H D+KP N
Sbjct: 72  GEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSN 130

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           +L +   G  +KI DFG+++  +        F GT  +++PE +  ++  +  D+WS+G+
Sbjct: 131 LL-INSKGE-VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGL 188

Query: 191 ICYVLLSGLSPFM--GETDVQTM--ANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
                  G  PF+  G+     +  A           E F   S + +DFI   L KD +
Sbjct: 189 TLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF---SPEFRDFISACLQKDPK 245

Query: 247 DAP 249
             P
Sbjct: 246 KRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 3e-35
 Identities = 79/269 (29%), Positives = 132/269 (49%), Gaps = 40/269 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G  G V+  + K TG   A K +    + KRN  + V  E EI+  L HP L  +Y +F+
Sbjct: 12  GDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVID--DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           +   +C+V++   GGELF R++       L+E+    +  ++   +E++H   +++ D+K
Sbjct: 72  TETYLCLVMDYCPGGELF-RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLK 130

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPE-----------------KKLQVLF-------- 163
           PENIL L ++G+ I + DF L+++ D E                   +            
Sbjct: 131 PENIL-LHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR 188

Query: 164 -----GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
                GT E++APEV++ D  G   D W++G++ Y +L G +PF G    +T +N+   +
Sbjct: 189 SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE 248

Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDRED 247
             F       +S  A+D IRKLL+KD   
Sbjct: 249 VTFPGS--PPVSSSARDLIRKLLVKDPSK 275

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  125 bits (317), Expect = 3e-35
 Identities = 72/244 (29%), Positives = 120/244 (49%), Gaps = 15/244 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR-----RNVEREVEIMRELQHPRLIQIYDA 68
           G FG+VY       G   A K V +A          + +E+E+ ++ +LQHP ++Q    
Sbjct: 11  GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGT 70

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
               + + + LEL+ GG L  +++       E  + ++ RQI  G+E++H +N +H D+K
Sbjct: 71  EREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIK 129

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN-FDAIGFGTDMWS 187
             NIL +   G  +K+ DFG+A++       +   G+P ++APEV+      G   D+WS
Sbjct: 130 GANIL-VDTNG-VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWS 187

Query: 188 VGVICYVL--LSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           +G  C VL   +G  P+     V  +    I +        + +SD+AKDFI K L +D 
Sbjct: 188 LG--CTVLEMATGKPPWSQLEGVAAVFK--IGRSKELPPIPDHLSDEAKDFILKCLQRDP 243

Query: 246 EDAP 249
              P
Sbjct: 244 SLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 4e-35
 Identities = 74/252 (29%), Positives = 129/252 (51%), Gaps = 28/252 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK-----RNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG VY C +  TG  LA K V         + +   +E E+++++ LQH R++Q Y  
Sbjct: 13  GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
                 + + +E + GG + ++ +     LTE     + RQI EGVE++HS  ++H D+K
Sbjct: 73  LRDDETLSIFMEYMPGGSVKDQ-LKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIK 131

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL----------FGTPEFVAPEVVNFDA 178
             NIL     GN +K+ DFG +      K+LQ +           GTP +++PEV++ + 
Sbjct: 132 GANIL-RDSAGN-VKLGDFGAS------KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV-TIAQYDFDDECFNEISDDAKDFI 237
            G   D+WSVG     +L+   P+    + + MA +  IA    + +  + +S DA++F+
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240

Query: 238 RKLLLKDREDAP 249
           R+  +++ +  P
Sbjct: 241 RRTFVENAKKRP 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  126 bits (318), Expect = 4e-35
 Identities = 69/211 (32%), Positives = 116/211 (54%), Gaps = 18/211 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G  G V++ K++ TG T+A K V + +          RE++ ++  QHP ++++ D F  
Sbjct: 11  GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH 70

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            +   +V+E +   +L E + D++  L E  V  +MR + +GV ++H+  ++H D+KP N
Sbjct: 71  GSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPAN 129

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKL----QVLFGTPEFVAPEVV----NFDAIGFGT 183
           +L ++  G  +KI DFGLAR F  E+      QV   T  + APE++     +D    G 
Sbjct: 130 LL-ISADGV-LKIADFGLARLFSEEEPRLYSHQV--ATRWYRAPELLYGARKYDP---GV 182

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           D+W+VG I   LL+G   F GE D++ +A V
Sbjct: 183 DLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  126 bits (317), Expect = 7e-35
 Identities = 67/235 (28%), Positives = 120/235 (51%), Gaps = 12/235 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER---EVEIMRELQHPRLIQIYDAFE 70
           G FG V+  +++ +    A K + I +    +  +    E  +++E+ HP +I+++    
Sbjct: 12  GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + +++E + GGELF   + +    +      +  +I   +E++HSK +++ D+KPE
Sbjct: 72  DQRFLYMLMEYVPGGELFS-YLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPE 130

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           NIL L K G+ IK+ DFG A+K     +   L GTPE++APEV+         D W++G+
Sbjct: 131 NIL-LDKEGH-IKLTDFGFAKKL--RDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGI 186

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           + Y +L G  PF  +        +   + +F     +     AKD I+KLL+ DR
Sbjct: 187 LIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH-LDLY---AKDLIKKLLVVDR 237

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 1e-34
 Identities = 77/238 (32%), Positives = 128/238 (53%), Gaps = 12/238 (5%)

Query: 12  SFGKFGTVYRCKEKATGMTLAAKFVG----IAKRNDRRNVEREVEIMR-ELQHPRLIQIY 66
           S G FG+VY  K+++TG   A K +     IAK N   NV+ E  IM  + + P + ++Y
Sbjct: 5   SKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-NQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            +F+S + + +V+E + GG+    +I     L E     ++ ++  GVE +H + ++H D
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KPEN+L + +TG+ +K+ DFGL+R     KK     GTP+++APE +        +D W
Sbjct: 123 IKPENLL-IDQTGH-LKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGDDKMSDWW 177

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           S+G + +  L G  PF  ET      N+   + ++ +E     S +A D I +LL  D
Sbjct: 178 SLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  121 bits (306), Expect = 2e-33
 Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 29/254 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN---VEREVEIMRELQHPRLIQIYDAFE 70
           G FG VY      TG  +A K + I + ND +    +  E++++  L+HP L++ Y    
Sbjct: 11  GTFGKVYTAVNLDTGELMAVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV 69

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + + +E   GG L E +++   +L E  + ++  Q+ EG+ ++HS  ++H D+KP 
Sbjct: 70  HREKVYIFMEYCSGGTL-EELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPA 128

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEK-----KLQVLFGTPEFVAPEVV---NFDAIGFG 182
           NI  L   G  IK+ DFG A K          ++Q L GTP ++APEV+        G  
Sbjct: 129 NIF-LDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA 186

Query: 183 TDMWSVGVICYVLLSGLSPFMG-ETDVQTMANV------TIAQYDFDDECFNEISDDAKD 235
            D+WS+G +   + +G  P+   + + Q M +V       I           ++S + KD
Sbjct: 187 ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL-------QLSPEGKD 239

Query: 236 FIRKLLLKDREDAP 249
           F+ + L  D +  P
Sbjct: 240 FLDRCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  123 bits (309), Expect = 2e-33
 Identities = 78/241 (32%), Positives = 123/241 (51%), Gaps = 26/241 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    I K    ++V +E  I+ EL HP ++ +  +F+
Sbjct: 29  GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKA------VAIFMR-QICEGVEFIHSKNVL 123
             N +  +LE + GGELF  +         KA      VA F   ++    E++HSK+++
Sbjct: 89  DENRVYFLLEFVVGGELFTHL--------RKAGRFPNDVAKFYHAELVLAFEYLHSKDII 140

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           + D+KPEN+L L   G+ +K+ DFG A+K  P++    L GTPE++APEV+     G   
Sbjct: 141 YRDLKPENLL-LDNKGH-VKVTDFGFAKKV-PDRTF-TLCGTPEYLAPEVIQSKGHGKAV 196

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           D W++GV+ Y  ++G  PF  +T  +    +   +  F     N     A+D ++ LL  
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLVKGLLQT 252

Query: 244 D 244
           D
Sbjct: 253 D 253

Length = 329

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  121 bits (304), Expect = 3e-33
 Identities = 63/200 (31%), Positives = 114/200 (57%), Gaps = 11/200 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND---RRNVEREVEIMRELQHPRLIQIYDAFE 70
           G+F  VY+      G  +A K V I +  D   R++  +E++++++L HP +I+   +F 
Sbjct: 13  GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72

Query: 71  SSNVMCVVLELIEGGELFERVI----DDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            +N + +VLEL + G+L  R+I        ++ E+ +  +  Q+C  +E +HSK ++H D
Sbjct: 73  ENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRD 131

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           +KP N+  +T TG  +K+ D GL R F  +      L GTP +++PE ++ +   F +D+
Sbjct: 132 IKPANVF-ITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 189

Query: 186 WSVGVICYVLLSGLSPFMGE 205
           WS+G + Y + +  SPF G+
Sbjct: 190 WSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 1e-32
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 27/209 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE------REVEIMRELQHPRLIQIYD 67
           G +G VY+ ++K TG  +A K +    R D           RE+ +++EL+HP ++++ D
Sbjct: 10  GTYGVVYKARDKKTGEIVALKKI----RLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 68  AFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
              +   + +V E  +     ++ +D     L+   +   M Q+  G+ + HS  +LH D
Sbjct: 66  VIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRD 123

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFV-----APEV-VNFDAI 179
           +KP+NIL + + G  +K+ DFGLAR F  P +       T E V     APE+ +     
Sbjct: 124 LKPQNIL-INRDGV-LKLADFGLARAFGIPLRTY-----THEVVTLWYRAPEILLGSKHY 176

Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDV 208
               D+WSVG I   +++G   F G++++
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDSEI 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 2e-32
 Identities = 75/268 (27%), Positives = 126/268 (47%), Gaps = 39/268 (14%)

Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG V+  ++K TG    M +  K   + KRN   +V  E +I+ +   P ++++Y +F
Sbjct: 12  GAFGEVWLVRDKDTGQVYAMKVLRKSD-MIKRNQIAHVRAERDILADADSPWIVKLYYSF 70

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +    + +V+E + GG+L   +I  D V  E+    ++ ++   ++ +H    +H D+KP
Sbjct: 71  QDEEHLYLVMEYMPGGDLMNLLIRKD-VFPEETARFYIAELVLALDSVHKLGFIHRDIKP 129

Query: 130 ENILCLTKTGNRIKIIDFGLARKF--------------------------DPEKKLQVLF 163
           +NIL +   G+ IK+ DFGL +K                              K+ +V  
Sbjct: 130 DNIL-IDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187

Query: 164 ----GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY 219
               GTP+++APEV+     G   D WS+GVI Y +L G  PF  +T  +T   +   + 
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKE 247

Query: 220 DFDDECFNEISDDAKDFIRKLLLKDRED 247
                    +S +A D I + LL D ED
Sbjct: 248 SLRFPPDPPVSPEAIDLICR-LLCDPED 274

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 2e-32
 Identities = 76/236 (32%), Positives = 129/236 (54%), Gaps = 14/236 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G +G V+  K+K TG  +A K +    + K N+ R+V  E +I+   +   L+++  AF+
Sbjct: 12  GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + + +E + GG+ F  ++++  VL+E     +M ++ E V+ +H    +H D+KPE
Sbjct: 72  DDEYLYLAMEYVPGGD-FRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPE 130

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N L +  +G+ IK+ DFGL++         V  G+P+++APEV+      F  D WS+G 
Sbjct: 131 NFL-IDASGH-IKLTDFGLSKGIVTYANSVV--GSPDYMAPEVLRGKGYDFTVDYWSLGC 186

Query: 191 ICYVLLSGLSPFMGETDVQTMANV-----TIAQYDFDDECFNEISDDAKDFIRKLL 241
           + Y  L G  PF G T  +T  N+     T+ +  +DD  FN +SD+A D I KL+
Sbjct: 187 MLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN-LSDEAWDLITKLI 241

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  119 bits (299), Expect = 5e-32
 Identities = 71/210 (33%), Positives = 121/210 (57%), Gaps = 6/210 (2%)

Query: 12  SFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           SFGK   V +      G   A K +  A  K  DR   + E +I+ E+ HP +++++ AF
Sbjct: 8   SFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF 67

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++   + ++L+ + GG+LF R +  + + TE+ V  ++ ++   ++ +HS  +++ D+KP
Sbjct: 68  QTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP 126

Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           ENIL L + G+ IK+ DFGL+++  D EKK     GT E++APEVVN        D WS 
Sbjct: 127 ENIL-LDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
           GV+ + +L+G  PF G+   +TM  +  A+
Sbjct: 185 GVLMFEMLTGSLPFQGKDRKETMTMILKAK 214

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  116 bits (294), Expect = 1e-31
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 12/210 (5%)

Query: 14  GKFGTVYRCK----EKATGMTLAAK-FVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG VY+ K         + +A K     A         RE  IMR+L HP ++++   
Sbjct: 10  GAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGV 69

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
                 + +V+E +EGG+L   +  +   L+   +  F  QI  G+E++ SKN +H D+ 
Sbjct: 70  CTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLA 129

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV---APEVVNFDAIGFGTDM 185
             N  CL      +KI DFGL+R    +       G    +   APE +        +D+
Sbjct: 130 ARN--CLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDV 186

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           WS GV+ + + + G  P+ G ++ + +  +
Sbjct: 187 WSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  116 bits (291), Expect = 2e-31
 Identities = 65/232 (28%), Positives = 114/232 (49%), Gaps = 11/232 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G FG V+ C+ KA    +  K + + +  +++R   + E ++++ L HP +I+ Y+ F  
Sbjct: 11  GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE 70

Query: 72  SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V+E   GG L E +    + +L E  +  F  QI   +  +H+K +LH D+K +
Sbjct: 71  DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQ 130

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           NIL L K    +KI DFG+++    + K   + GTP +++PE+         +D+W++G 
Sbjct: 131 NIL-LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGC 189

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           + Y L S    F         AN+           F  ISD     +R+L+L
Sbjct: 190 VLYELASLKRAFEA-------ANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  116 bits (291), Expect = 3e-31
 Identities = 68/232 (29%), Positives = 125/232 (53%), Gaps = 6/232 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  G V    +K+TG  +A K + + K+  R  +  EV IMR+ QHP ++++Y ++   +
Sbjct: 30  GSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD 89

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     + + + F+H++ V+H D+K ++IL
Sbjct: 90  ELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSIL 147

Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   E  + + L GTP ++APEV++    G   D+WS+G++ 
Sbjct: 148 -LTSDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             ++ G  P+  E  +Q M  +              +S   + F+ ++L++D
Sbjct: 206 IEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK-VSPRLRSFLDRMLVRD 256

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  117 bits (293), Expect = 3e-31
 Identities = 73/235 (31%), Positives = 125/235 (53%), Gaps = 11/235 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   +EKATG   A K +    I  +++  +   E  +++  +HP L  +  AF+
Sbjct: 6   GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 65

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           + + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K E
Sbjct: 66  THDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 124

Query: 131 NILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +G
Sbjct: 125 NLM-LDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           V+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD
Sbjct: 183 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD 233

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  116 bits (291), Expect = 4e-31
 Identities = 73/248 (29%), Positives = 127/248 (51%), Gaps = 22/248 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A K + + ++  +  +  E+ +MRE +HP ++   D++   +
Sbjct: 30  GASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +    + E  +A   R+  + +EF+HS  V+H D+K +NIL
Sbjct: 90  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 147

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 148 -LGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205

Query: 193 YVLLSGLSPFMGET--------------DVQTMANVTIAQYDFDDECFN---EISDDAKD 235
             ++ G  P++ E               ++Q    ++    DF + C     E    AK+
Sbjct: 206 IEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 265

Query: 236 FIRKLLLK 243
            ++   LK
Sbjct: 266 LLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  114 bits (287), Expect = 1e-30
 Identities = 73/245 (29%), Positives = 121/245 (49%), Gaps = 22/245 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V  C+ KATG   A K +    + KR   +    E +I+ ++    ++ +  AFE
Sbjct: 4   GGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE 63

Query: 71  SSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           + + +C+V+ L+ GG+L   + +  +    E     +  QI  G+E +H + +++ D+KP
Sbjct: 64  TKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKP 123

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           EN+L L   GN ++I D GLA +    KK++   GTP ++APEV+  +   F  D +++G
Sbjct: 124 ENVL-LDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALG 181

Query: 190 VICYVLLSGLSPFMG--------ETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
              Y +++G SPF          E   +T+         F        S +AKD    LL
Sbjct: 182 CTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF--------SPEAKDLCEALL 233

Query: 242 LKDRE 246
            KD E
Sbjct: 234 QKDPE 238

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 1e-30
 Identities = 74/249 (29%), Positives = 127/249 (51%), Gaps = 21/249 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ + K TG+  AAK + I    +  +   E++I+ E +HP ++ +Y+A+   N
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E  +GG L   +++ +  LTE  +    RQ+ E + F+HS  V+H D+K  NIL
Sbjct: 76  KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNIL 135

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNF-----DAIGFGTDMWS 187
            LT  G+ +K+ DFG++ K     + +  F GTP ++APEVV       +   +  D+WS
Sbjct: 136 -LTLDGD-VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWS 193

Query: 188 VGVICYVLL------SGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           +G+    L         L+P      +      T+ Q        ++ S    DF++  L
Sbjct: 194 LGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQP-------SKWSSSFNDFLKSCL 246

Query: 242 LKDREDAPE 250
           +KD +D P 
Sbjct: 247 VKDPDDRPT 255

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (284), Expect = 2e-30
 Identities = 72/255 (28%), Positives = 124/255 (48%), Gaps = 28/255 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI----AKRNDRRN-----VEREVEIMRELQHPRLIQ 64
           G FG+VY     ++G  +A K V +    A   DR+      + RE+ +++ELQH  ++Q
Sbjct: 11  GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ 70

Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
              +   ++ + + LE + GG +   ++++     E  V  F+RQI +G+ ++H++ ++H
Sbjct: 71  YLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIH 129

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFD 177
            D+K  NIL   K G  IKI DFG+++K +              L G+  ++APEVV   
Sbjct: 130 RDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187

Query: 178 AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY---DFDDECFNEISDDAK 234
           +     D+WS+G +   +L+G  PF   T +Q  A   I +    +         S +A 
Sbjct: 188 SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIFKIGENASPEIPSNI----SSEAI 241

Query: 235 DFIRKLLLKDREDAP 249
           DF+ K    D    P
Sbjct: 242 DFLEKTFEIDHNKRP 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (284), Expect = 3e-30
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 13/211 (6%)

Query: 14  GKFGTVYRCK----EKATGMTLAAK-FVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG VY+           + +A K     A         RE  IMR+L HP ++++   
Sbjct: 10  GAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGV 69

Query: 69  FESSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
                 + +V+E + GG+L + +       L+   +  F  QI  G+E++ SKN +H D+
Sbjct: 70  CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDL 129

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV---APEVVNFDAIGFGTD 184
              N  CL      +KI DFGL+R    +     + G    +   APE +        +D
Sbjct: 130 AARN--CLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSD 186

Query: 185 MWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +WS GV+ + + + G  P+ G ++ + +  +
Sbjct: 187 VWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  114 bits (286), Expect = 5e-30
 Identities = 74/250 (29%), Positives = 127/250 (50%), Gaps = 19/250 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   +EKATG   A K +    I  +++  +   E  +++  +HP L  +  +F+
Sbjct: 6   GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ 65

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           + + +C V+E   GGELF  +   + V +E     +  +I   + ++HS +V++ D+K E
Sbjct: 66  THDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLE 124

Query: 131 NILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +G
Sbjct: 125 NLM-LDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD----- 244
           V+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD     
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRL 238

Query: 245 ---REDAPEV 251
               EDA E+
Sbjct: 239 GGGPEDAKEI 248

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  112 bits (281), Expect = 5e-30
 Identities = 72/247 (29%), Positives = 121/247 (48%), Gaps = 16/247 (6%)

Query: 14  GKFG--TVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG  T+YR  E      +  K V + +    +RR+   E+ I+  LQHP +I  Y+ F
Sbjct: 11  GAFGEATLYRRTED--DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF 68

Query: 70  ESSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
              N + + +E   GG L+++++     +  E+ V  ++ QI   V +IH   +LH D+K
Sbjct: 69  MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIK 128

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
             NI  LTK G  IK+ DFG+++    E  + + + GTP +++PE+       F +D+W+
Sbjct: 129 TLNIF-LTKAG-LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWA 186

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD--- 244
           +G + Y LL+    F  +        V I Q ++     +  S +    +  LL +D   
Sbjct: 187 LGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPV-VSVYSSELISLVHSLLQQDPEK 243

Query: 245 REDAPEV 251
           R  A EV
Sbjct: 244 RPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  112 bits (281), Expect = 7e-30
 Identities = 72/245 (29%), Positives = 127/245 (51%), Gaps = 9/245 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND---RRNVEREVEIMRELQHPRLIQIYDAFE 70
           G+F  VYR      G+ +A K V I    D   R +  +E++++++L HP +I+ Y +F 
Sbjct: 13  GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72

Query: 71  SSNVMCVVLELIEGGELFERV---IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
             N + +VLEL + G+L   +        ++ EK V  +  Q+C  +E +HS+ V+H D+
Sbjct: 73  EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDI 132

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KP N+  +T TG  +K+ D GL R F  +      L GTP +++PE ++ +   F +D+W
Sbjct: 133 KPANVF-ITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 190

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           S+G + Y + +  SPF G+          I Q D+     +  S++ +  +   +  D E
Sbjct: 191 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPE 250

Query: 247 DAPEV 251
             P++
Sbjct: 251 KRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  112 bits (280), Expect = 2e-29
 Identities = 62/199 (31%), Positives = 114/199 (57%), Gaps = 5/199 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  GTV+   + ATG  +A K + + K+  +  +  E+ +M+EL++P ++   D+F   +
Sbjct: 30  GASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +    + E  +A   R+  + +EF+H+  V+H D+K +N+L
Sbjct: 90  ELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVL 147

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 148 -LGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205

Query: 193 YVLLSGLSPFMGETDVQTM 211
             ++ G  P++ E  ++ +
Sbjct: 206 IEMVEGEPPYLNENPLRAL 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  111 bits (278), Expect = 2e-29
 Identities = 64/199 (32%), Positives = 112/199 (56%), Gaps = 9/199 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND---RRNVEREVEIMRELQHPRLIQIYDAFE 70
           G+F  VYR         +A K V I +  D   R++  +E++++++L HP +I+  D+F 
Sbjct: 13  GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72

Query: 71  SSNVMCVVLELIEGGELFERVI---DDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
             N + +VLEL + G+L + +        ++ E+ V  +  Q+C  VE +HS+ V+H D+
Sbjct: 73  EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDI 132

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KP N+  +T TG  +K+ D GL R F  +      L GTP +++PE ++ +   F +D+W
Sbjct: 133 KPANVF-ITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 190

Query: 187 SVGVICYVLLSGLSPFMGE 205
           S+G + Y + +  SPF G+
Sbjct: 191 SLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  111 bits (279), Expect = 2e-29
 Identities = 62/199 (31%), Positives = 113/199 (56%), Gaps = 5/199 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A + + + ++  +  +  E+ +MRE ++P ++   D++   +
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +    + E  +A   R+  + +EF+HS  V+H D+K +NIL
Sbjct: 91  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 149 -LGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206

Query: 193 YVLLSGLSPFMGETDVQTM 211
             ++ G  P++ E  ++ +
Sbjct: 207 IEMIEGEPPYLNENPLRAL 225

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  111 bits (279), Expect = 2e-29
 Identities = 62/199 (31%), Positives = 113/199 (56%), Gaps = 5/199 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A K + + ++  +  +  E+ +MRE ++P ++   D++   +
Sbjct: 30  GASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 89

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +    + E  +A   R+  + ++F+HS  V+H D+K +NIL
Sbjct: 90  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNIL 147

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 148 -LGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205

Query: 193 YVLLSGLSPFMGETDVQTM 211
             ++ G  P++ E  ++ +
Sbjct: 206 IEMVEGEPPYLNENPLRAL 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  110 bits (277), Expect = 3e-29
 Identities = 74/257 (28%), Positives = 130/257 (50%), Gaps = 26/257 (10%)

Query: 14  GKFGTVYRCKEKATGMT-LAAKFVGIAKRNDR----------RNVEREVEIMRE-LQHPR 61
           G FG VY+ ++K  G   LA K + +                 ++  EV I++E L+HP 
Sbjct: 11  GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70

Query: 62  LIQIYDAFESSNVMCVVLELIEG---GELFERVIDDDFVLTEKAV-AIFMRQICEGVEFI 117
           +++ Y  F  ++ + +V++LIEG   GE F  + +     TE+ +  IF+ Q+   + ++
Sbjct: 71  IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV-QMVLALRYL 129

Query: 118 H-SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF 176
           H  K ++H D+ P NI+      +++ I DFGLA++  PE KL  + GT  +  PE+V  
Sbjct: 130 HKEKRIVHRDLTPNNIMLGED--DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN 187

Query: 177 DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA-NVTIAQYD-FDDECFNEISDDAK 234
           +  G   D+W+ G I Y + + L P    T++ ++A  +  A Y+   +  +   S+D  
Sbjct: 188 EPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLATKIVEAVYEPLPEGMY---SEDVT 243

Query: 235 DFIRKLLLKDREDAPEV 251
           D I   L  D E  P++
Sbjct: 244 DVITSCLTPDAEARPDI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  109 bits (275), Expect = 5e-29
 Identities = 68/241 (28%), Positives = 124/241 (51%), Gaps = 14/241 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G +G+VY+   K TG  +A K V +    D + + +E+ I+++   P +++ Y ++  + 
Sbjct: 14  GSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNT 71

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E    G + + +   +  LTE+ +A  + Q  +G+E++HS   +H D+K  NIL
Sbjct: 72  DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNIL 131

Query: 134 CLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L + G   K+ DFG++ +  D   K   + GTP ++APEV+         D+WS+G+  
Sbjct: 132 -LNEEGQ-AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITA 189

Query: 193 YVLLSGLSPFMGETDVQTM-ANVTIAQY---DFDDECFNEISDDAKDFIRKLLLKDREDA 248
             +  G  P+   +D+  M A   I         D    + S +  DF++K L+KD E+ 
Sbjct: 190 IEMAEGKPPY---SDIHPMRAIFMIPNKPPPTLSDP--EKWSPEFNDFVKKCLVKDPEER 244

Query: 249 P 249
           P
Sbjct: 245 P 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  111 bits (279), Expect = 5e-29
 Identities = 75/246 (30%), Positives = 121/246 (49%), Gaps = 17/246 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNV---EREVEIMRELQHPRLIQIYDAFE 70
           G FG V   +EKATG   A K +  +    +  V   E E +I+     P + Q+  AF+
Sbjct: 12  GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             + + +V+E   GG+L   +   +    E     ++ ++   +  +H    +H D+KPE
Sbjct: 72  DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPE 131

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF--GTPEFVAPEV---VNFD---AIGFG 182
           N+L + +TG+ IK+ DFG A +    K +      GTP+++APEV   +N D     G  
Sbjct: 132 NVL-IDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE 189

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ--YDFDDECFNEISDDAKDFIRKL 240
            D WS+GVI Y ++ G SPF   T  +T  N+   Q    F ++   ++S D  D I+ L
Sbjct: 190 CDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP--KVSSDFLDLIQSL 247

Query: 241 LLKDRE 246
           L   +E
Sbjct: 248 LCGQKE 253

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  111 bits (278), Expect = 5e-29
 Identities = 69/235 (29%), Positives = 123/235 (52%), Gaps = 11/235 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   +EKA+G   A K +    I  +++  +   E  +++  +HP L  +  +F+
Sbjct: 6   GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ 65

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           + + +C V+E + GGELF   +  + V +E     +  +I   ++++HS  +++ D+K E
Sbjct: 66  TKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLE 124

Query: 131 NILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +G
Sbjct: 125 NLM-LDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           V+ Y ++ G  PF  +   +    + +    F       +S DAK  +  LL+KD
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIKD 233

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  109 bits (274), Expect = 5e-29
 Identities = 61/243 (25%), Positives = 111/243 (45%), Gaps = 11/243 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G+VY+ K  +     A K V +   +   R +   E+ I+  + HP +I   +AF  
Sbjct: 11  GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70

Query: 72  SNVMCVVLELIEGGELFERVIDDDFV---LTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            N +C+V+E    G+L + +         + E+ +     Q+  G++ +H + +LH D+K
Sbjct: 71  GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK 130

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
             NIL +    + +KI D G++ K   +   +   GTP ++APEV       + +D+WS+
Sbjct: 131 SANILLVA--NDLVKIGDLGIS-KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G + Y + +   PF   +       V   +Y          S D ++FIR +L    +  
Sbjct: 188 GCLLYEMATFAPPFEARSMQDLRYKVQRGKY---PPIPPIYSQDLQNFIRSMLQVKPKLR 244

Query: 249 PEV 251
           P  
Sbjct: 245 PNC 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 6e-29
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 16/242 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR-RNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG VY+  +K T   +A K + + +  D   ++++E++ + + + P + + Y +F   
Sbjct: 12  GSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71

Query: 73  NVMCVVLELIEGG---ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           + + +++E   GG   +L +    D     E  +A  +R++  G+E++H +  +H D+K 
Sbjct: 72  SKLWIIMEYCGGGSCLDLLKPGKLD-----ETYIAFILREVLLGLEYLHEEGKIHRDIKA 126

Query: 130 ENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
            NIL L++ G+ +K+ DFG++ +      K     GTP ++APEV+         D+WS+
Sbjct: 127 ANIL-LSEEGD-VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSL 184

Query: 189 GVICYVLLSGLSPFMGETDVQTM-ANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           G+    L  G  P    +D+  M     I + +      N+ S   KDF+   L KD ++
Sbjct: 185 GITAIELAKGEPPL---SDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKE 241

Query: 248 AP 249
            P
Sbjct: 242 RP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  109 bits (274), Expect = 1e-28
 Identities = 68/238 (28%), Positives = 127/238 (53%), Gaps = 18/238 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  G V   +EK +G  +A K + + K+  R  +  EV IMR+ QH  ++++Y ++    
Sbjct: 32  GSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE 91

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + V++E ++GG L +  I     L E+ +A     + + + ++HS+ V+H D+K ++IL
Sbjct: 92  ELWVLMEFLQGGALTD--IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSIL 149

Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   +  K + L GTP ++APEV++    G   D+WS+G++ 
Sbjct: 150 -LTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMV 207

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDE------CFNEISDDAKDFIRKLLLKD 244
             ++ G  P+  ++ VQ M  +        D         ++IS   +DF+ ++L ++
Sbjct: 208 IEMVDGEPPYFSDSPVQAMKRLR-------DSPPPKLKNAHKISPVLRDFLERMLTRE 258

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  109 bits (276), Expect = 1e-28
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 30/197 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG-------IAKRNDRRNVEREVEIMRELQHPRLIQIY 66
           G +G V    +K TG  +A K +         AKR     + RE++++R L+H  +I + 
Sbjct: 11  GAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-----ILREIKLLRHLRHENIIGLL 65

Query: 67  DAFESSNVMC-----VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           D     +        +V EL+E      +VI     LT+  +  F+ QI  G++++HS N
Sbjct: 66  DILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN 123

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEVV- 174
           V+H D+KP NI  L  +   +KI DFGLAR  DP++  +    T E+V      APE++ 
Sbjct: 124 VIHRDLKPSNI--LVNSNCDLKICDFGLARGVDPDEDEKGFL-T-EYVVTRWYRAPELLL 179

Query: 175 NFDAIGFGTDMWSVGVI 191
           +        D+WSVG I
Sbjct: 180 SSSRYTKAIDIWSVGCI 196

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 2e-28
 Identities = 63/203 (31%), Positives = 109/203 (53%), Gaps = 14/203 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G V +C+ KATG  +A K    ++ ++  ++   REV+++R+L+H  ++ + +AF  
Sbjct: 12  GAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71

Query: 72  SNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V E +E    EL E        L   AV  ++ Q+ + + + HS N++H D+KP
Sbjct: 72  KGRLYLVFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKP 128

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL---FGTPEFVAPEV-VNFDAIGFGTDM 185
           ENIL ++++G  +K+ DFG AR     +    L     T  + APE+ V     G   D+
Sbjct: 129 ENIL-VSESG-VLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDV 185

Query: 186 WSVGVICYVLLSGLSPFMGETDV 208
           W++G I   LL G   F G++D+
Sbjct: 186 WAIGCIMAELLDGEPLFPGDSDI 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  108 bits (271), Expect = 3e-28
 Identities = 70/242 (28%), Positives = 121/242 (50%), Gaps = 6/242 (2%)

Query: 7   QHSAFSFGKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLI 63
           Q+     G FG V  C+ +ATG   A K +    I KR        E +I+ ++    ++
Sbjct: 4   QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVV 63

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
            +  A+E+ + +C+VL ++ GG+L   + +  +    E+    +  +I  G+E +H +N 
Sbjct: 64  NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
           ++ D+KPENIL L   G+ I+I D GLA K    + ++   GT  ++APEV+N       
Sbjct: 124 VYRDLKPENIL-LDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
            D W +G + Y ++ G SPF G  +      V     + ++    + S++AK   + LL 
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 243 KD 244
           KD
Sbjct: 242 KD 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 5e-28
 Identities = 71/236 (30%), Positives = 120/236 (50%), Gaps = 8/236 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE----REVEIMRELQHPRLIQIYDAF 69
           G FG V  C+ +ATG   A K +   KR  +R  E     E +I+ ++    ++ +  A+
Sbjct: 11  GGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 69

Query: 70  ESSNVMCVVLELIEGGEL-FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           E+ + +C+VL L+ GG+L F      +    E+    +  +I  G+E +H + +++ D+K
Sbjct: 70  ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK 129

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PENIL L   G+ I+I D GLA +    + ++   GT  ++APEVV  +   F  D W +
Sbjct: 130 PENIL-LDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGL 187

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           G + Y ++ G SPF    +      V     +  +E   + S+ A+   R+LL KD
Sbjct: 188 GCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKD 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  107 bits (269), Expect = 5e-28
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 11/210 (5%)

Query: 14  GKFGTVYRCKEKA----TGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG VY+   K     T   +A K +   A   +R     E  IM++L HP ++++   
Sbjct: 10  GAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGV 69

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
                 + +V E + GG+L + +      LT K +     QI +G+E++ SKN +H D+ 
Sbjct: 70  CTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLA 129

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV---APEVVNFDAIGFGTDM 185
             N  CL      +KI DFGL+R    +   +   G    +   APE +        +D+
Sbjct: 130 ARN--CLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDV 187

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           WS GV+ + + + G  P+ G ++ + +  +
Sbjct: 188 WSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217

Length = 258

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  107 bits (269), Expect = 6e-28
 Identities = 72/242 (29%), Positives = 119/242 (49%), Gaps = 6/242 (2%)

Query: 7   QHSAFSFGKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLI 63
           Q+     G FG V  C+ +ATG   A K +    I KR        E +I+ ++    ++
Sbjct: 4   QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVV 63

Query: 64  QIYDAFESSNVMCVVLELIEGGEL-FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
            +  A+E+ + +C+VL L+ GG+L F      +    E     +  +IC G+E +H + +
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
           ++ D+KPENIL L   G+ I+I D GLA      + ++   GT  ++APEVV  +   F 
Sbjct: 124 VYRDLKPENIL-LDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
            D W++G + Y +++G SPF           V     +  +E   + S DA+   + LL 
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241

Query: 243 KD 244
           KD
Sbjct: 242 KD 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  107 bits (270), Expect = 6e-28
 Identities = 71/259 (27%), Positives = 128/259 (49%), Gaps = 37/259 (14%)

Query: 12  SFGKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           S G +G VY  + K T    A K +    +  RN  + V  E +I+   ++P ++ ++ +
Sbjct: 10  SNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCS 69

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           FE+   +C+V+E +EGG+    ++ +   L      ++  +    +E++H+  ++H D+K
Sbjct: 70  FETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128

Query: 129 PENILCLTKTGNRIKIIDFGL--------------------ARKFDPEKKLQVLFGTPEF 168
           P+N+L +T  G+ IK+ DFGL                     R+F  ++    + GTPE+
Sbjct: 129 PDNLL-ITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ----VCGTPEY 182

Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVT---IAQYDFDDEC 225
           +APEV+     G   D W++G+I Y  L G  PF G+T  +    V    I   + D+  
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE-- 240

Query: 226 FNEISDDAKDFIRKLLLKD 244
              +  DA+D I +LL ++
Sbjct: 241 --ALPADAQDLISRLLRQN 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 8e-28
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 30/215 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE----REVEIMRELQ---HPRLIQIY 66
           G +GTVY+ ++  TG  +A K V +        +     RE+ ++++L+   HP ++++ 
Sbjct: 10  GAYGTVYKARDLNTGRFVALKKVRV--PLSEEGIPLSTLREIALLKQLESFEHPNIVRLL 67

Query: 67  DAFESSNVM-CVVLELIEGGELFERVIDDDF----------VLTEKAVAIFMRQICEGVE 115
           D          + L L+     FE V D D            L  + +   MRQ+  GV+
Sbjct: 68  DVCHGPRTDRELKLTLV-----FEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121

Query: 116 FIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN 175
           F+HS  ++H D+KP+NIL +T  G ++KI DFGLAR +  E  L  +  T  + APEV+ 
Sbjct: 122 FLHSHRIVHRDLKPQNIL-VTSDG-QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLL 179

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSP-FMGETDVQ 209
             +     DMWSVG I   L     P F G ++  
Sbjct: 180 QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEAD 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  107 bits (270), Expect = 1e-27
 Identities = 72/238 (30%), Positives = 124/238 (52%), Gaps = 14/238 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNV--EREVEIMRELQHPRLIQIYDA 68
           G FG V   K KA G   A K +    I K+ +++++  ER V +++ ++HP L+ ++ +
Sbjct: 6   GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGLHYS 64

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F++++ +  VL+ + GGELF  +  +      +A   +  +I   + ++HS N+++ D+K
Sbjct: 65  FQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA-RFYAAEIASALGYLHSLNIIYRDLK 123

Query: 129 PENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           PENIL L   G+ + + DFGL ++  +  K      GTPE++APEV+         D W 
Sbjct: 124 PENIL-LDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           +G + Y +L GL PF    D   M +  + +          IS  A+  +  LL KDR
Sbjct: 182 LGAVLYEMLYGLPPFYSR-DTAEMYDNILNK---PLRLKPNISVSARHLLEGLLQKDR 235

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  106 bits (265), Expect = 1e-27
 Identities = 61/241 (25%), Positives = 107/241 (44%), Gaps = 9/241 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIYDAFES 71
           G FG V++   KA     A K + ++K N R   E   E  ++ +L    +I+ Y++F  
Sbjct: 11  GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD 70

Query: 72  SNVMCVVLELIEGGELFERV-IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V+E  E G+L + + +     L E  V  F  QI  G+  +HSK +LH D+K  
Sbjct: 71  KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSL 130

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N+       + +KI D G+A+           + GTP +++PE+         +D+W++G
Sbjct: 131 NL--FLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALG 188

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           V+ Y   +G  PF        +  +    +    + +   S      I + L KD    P
Sbjct: 189 VVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLAQLIDQCLTKDYRQRP 245

Query: 250 E 250
           +
Sbjct: 246 D 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  107 bits (267), Expect = 1e-27
 Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 5/202 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  G V    EK TG  +A K + + K+  R  +  EV IMR+  H  ++ +Y+++   +
Sbjct: 33  GSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD 92

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     +   + ++H++ V+H D+K ++IL
Sbjct: 93  ELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSIL 150

Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G RIK+ DFG   +   E  K + L GTP ++APEV++    G   D+WS+G++ 
Sbjct: 151 -LTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208

Query: 193 YVLLSGLSPFMGETDVQTMANV 214
             ++ G  P+  E  +Q M  +
Sbjct: 209 IEMIDGEPPYFNEPPLQAMRRI 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  106 bits (267), Expect = 1e-27
 Identities = 67/217 (30%), Positives = 121/217 (55%), Gaps = 10/217 (4%)

Query: 33  AKFVGIAKRNDRRNVEREV-EIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERV 91
           A  V  AK  +    ER+V E +R  + P L+ ++ AF++   + ++L+ + GGELF  +
Sbjct: 39  ATIVQKAKTAEHTRTERQVLEAVR--RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHL 96

Query: 92  IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR 151
              +   TE  V +++ +I   ++ +H   +++ D+K ENIL L   G+ + + DFGL++
Sbjct: 97  YQREH-FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL-LDSEGH-VVLTDFGLSK 153

Query: 152 KFDPEKKLQV--LFGTPEFVAPEVVNFDAIGFG--TDMWSVGVICYVLLSGLSPFMGETD 207
           +F  E++ +     GT E++APEV+   + G     D WS+GV+ + LL+G SPF  + +
Sbjct: 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213

Query: 208 VQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             + + ++             +S +A+DFI+KLL KD
Sbjct: 214 QNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKD 250

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  106 bits (267), Expect = 2e-27
 Identities = 68/239 (28%), Positives = 123/239 (51%), Gaps = 22/239 (9%)

Query: 13  FGKFGTVYRCKEKATGMTLAAKFVGIAK--RN--DRRNVEREVEIMRELQHPRLIQIYDA 68
           +GK   V +     TG   A K +  A   RN  D  + + E  I+  ++HP ++ +  A
Sbjct: 9   YGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYA 68

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F++   + ++LE + GGELF   ++ + +  E     ++ +I   +E +H + +++ D+K
Sbjct: 69  FQTGGKLYLILEYLSGGELFMH-LEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLK 127

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWS 187
           PENIL L   G+ +K+ DFGL ++   E  +   F GT E++APE++     G   D WS
Sbjct: 128 PENIL-LDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWS 185

Query: 188 VGVICYVLLSGLSPFMGETDVQTM-----ANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           +G + Y +L+G  PF  E   +T+       + +  Y         ++ +A+D ++KLL
Sbjct: 186 LGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPY---------LTPEARDLLKKLL 235

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  106 bits (266), Expect = 3e-27
 Identities = 70/238 (29%), Positives = 122/238 (51%), Gaps = 14/238 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNV--EREVEIMRELQHPRLIQIYDA 68
           G FG V   + KA     A K +    I K+ + +++  ER V +++ ++HP L+ ++ +
Sbjct: 6   GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGLHFS 64

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F++++ +  VL+ I GGELF  +  +   L  +A   +  +I   + ++HS N+++ D+K
Sbjct: 65  FQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASALGYLHSLNIVYRDLK 123

Query: 129 PENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           PENIL L   G+ I + DFGL ++  +         GTPE++APEV++        D W 
Sbjct: 124 PENIL-LDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           +G + Y +L GL PF      +   N+              I++ A+  +  LL KDR
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLLEGLLQKDR 235

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  106 bits (266), Expect = 4e-27
 Identities = 63/187 (33%), Positives = 103/187 (55%), Gaps = 20/187 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G  GTVY+   + TG   A K + G  +   RR + RE+EI+R++ HP +++ +D F+ +
Sbjct: 85  GAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + V+LE ++GG L    I D     E+ +A   RQI  G+ ++H ++++H D+KP N+
Sbjct: 145 GEIQVLLEFMDGGSLEGTHIAD-----EQFLADVARQILSGIAYLHRRHIVHRDIKPSNL 199

Query: 133 LCLTKTGNRIKIIDFG----LARKFDPEKKLQVLFGTPEFVAPEVVNFDA-----IGFGT 183
             L  +   +KI DFG    LA+  DP        GT  +++PE +N D       G+  
Sbjct: 200 --LINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINTDLNHGAYDGYAG 254

Query: 184 DMWSVGV 190
           D+WS+GV
Sbjct: 255 DIWSLGV 261

Length = 353

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  105 bits (264), Expect = 5e-27
 Identities = 76/251 (30%), Positives = 129/251 (51%), Gaps = 20/251 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   KEKATG   A K +    I  +++  +   E  +++  +HP L  +  +F+
Sbjct: 6   GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 65

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKP 129
           + + +C V+E   GGELF   +  + V +E     +  +I   ++++HS KNV++ D+K 
Sbjct: 66  THDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 124

Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 125 ENLM-LDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 182

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---- 244
           GV+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD    
Sbjct: 183 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLKKDPKQR 238

Query: 245 ----REDAPEV 251
                +DA E+
Sbjct: 239 LGGGPDDAKEI 249

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 5e-27
 Identities = 66/244 (27%), Positives = 123/244 (50%), Gaps = 13/244 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G +G VY+ ++ ATG  +A K + +   +D   +++E+ +++E +HP ++  + ++   +
Sbjct: 14  GTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E   GG L +        L+E  +A   R+  +G+ ++H    +H D+K  NIL
Sbjct: 74  KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANIL 133

Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIG---FGTDMWSVG 189
            LT+ G+ +K+ DFG++ +      K +   GTP ++APEV   +  G      D+W++G
Sbjct: 134 -LTEDGD-VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG 191

Query: 190 VICYVLLSGLSPFMGETDVQTM-ANVTIAQYDFDDECFNE---ISDDAKDFIRKLLLKDR 245
           +    L     P     D+  M A   I++ +F      +    S    DFI+K L KD 
Sbjct: 192 ITAIELAELQPPMF---DLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDP 248

Query: 246 EDAP 249
           +  P
Sbjct: 249 KKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 5e-27
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 19/205 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESS 72
           G +G VY+ + K TG  +A K + I +  +   ++ E  I+R+   HP +   Y AF   
Sbjct: 17  GTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEEYNILRKYSNHPNIATFYGAFIKK 75

Query: 73  NVMCV------VLELIEGG---ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           N          V+EL  GG   +L + +      L E+ +A  +R+   G+ ++H   V+
Sbjct: 76  NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVI 135

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVV----NFDA 178
           H D+K +NIL LTK    +K++DFG++ + D    +     GTP ++APEV+      DA
Sbjct: 136 HRDIKGQNIL-LTKNA-EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDA 193

Query: 179 -IGFGTDMWSVGVICYVLLSGLSPF 202
                +D+WS+G+    L  G  P 
Sbjct: 194 SYDARSDVWSLGITAIELADGKPPL 218

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  104 bits (260), Expect = 6e-27
 Identities = 56/188 (29%), Positives = 103/188 (54%), Gaps = 6/188 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G FG     K K  G     K + I+K    +R    +EV ++  ++HP ++Q  ++FE 
Sbjct: 11  GSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE 70

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVL-TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +  + +V++  EGG+L++++     VL  E  +  +  QIC  ++ +H + +LH D+K +
Sbjct: 71  NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQ 130

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           NI  LTK G  IK+ DFG+AR  +   +L +   GTP +++PE+         +D+W++G
Sbjct: 131 NIF-LTKDGT-IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALG 188

Query: 190 VICYVLLS 197
            + Y + +
Sbjct: 189 CVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  105 bits (263), Expect = 7e-27
 Identities = 66/204 (32%), Positives = 114/204 (55%), Gaps = 11/204 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNV--EREVEIMRELQHPRLIQIYDA 68
           G FG V   K K+ G   A K +    I K+ ++ ++  ER V +++ L+HP L+ ++ +
Sbjct: 6   GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGLHYS 64

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F+++  +  VL+ + GGELF  +  +   L  +A   +  ++   + ++HS N+++ D+K
Sbjct: 65  FQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA-RFYAAEVASAIGYLHSLNIIYRDLK 123

Query: 129 PENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           PENIL L   G+ + + DFGL ++  +PE+      GTPE++APEV+  +      D W 
Sbjct: 124 PENIL-LDSQGH-VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWC 181

Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G + Y +L GL PF    DV  M
Sbjct: 182 LGAVLYEMLYGLPPFYSR-DVSQM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  104 bits (261), Expect = 9e-27
 Identities = 69/243 (28%), Positives = 126/243 (51%), Gaps = 11/243 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K K TG   AAK +      +  +   E+EI+    HP ++++  AF    
Sbjct: 23  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GG +   +++ D  LTE  + +  RQ+ E ++++HS  ++H D+K  N+L
Sbjct: 83  KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVL 142

Query: 134 CLTKTGNRIKIIDFGL-ARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-----GFGTDMWS 187
            LT  G+ IK+ DFG+ A+     ++     GTP ++APEVV  + +      +  D+WS
Sbjct: 143 -LTLDGD-IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 200

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-ECFNEISDDAKDFIRKLLLKDRE 246
           +G I  + ++ + P   E +   +  + IA+ +       ++ S + +DF++  L K  E
Sbjct: 201 LG-ITLIEMAQIEPPHHELNPMRVL-LKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPE 258

Query: 247 DAP 249
             P
Sbjct: 259 TRP 261

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  103 bits (259), Expect = 2e-26
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 19/233 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREV-EIMRELQHPRLIQIYDAFESS 72
           GKFG V   K K T      K   I K  +   +E  V ++M++  +P  I++Y +  + 
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQK---IIKAKNFNAIEPMVHQLMKD--NPNFIKLYYSVTTL 81

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
               ++++ I+ G+LF+ +  +   L+E  V   +RQ+ E +  +H  N++H D+K EN+
Sbjct: 82  KGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
           L   +  +RI + D+GL +            GT ++ +PE +         D W+VGV+ 
Sbjct: 141 LY-DRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLT 196

Query: 193 YVLLSGLSPFMG----ETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           Y LL+G  PF      E D++++      +          +S +A DF++ +L
Sbjct: 197 YELLTGKHPFKEDEDEELDLESLLK----RQQKKLPFIKNVSKNANDFVQSML 245

Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  102 bits (256), Expect = 2e-26
 Identities = 71/252 (28%), Positives = 126/252 (50%), Gaps = 20/252 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN-----VEREVEIMRELQHPRLIQIYDA 68
           G FG VY C +  TG  LA K V     +   +     +E E+++++ L H R++Q Y  
Sbjct: 13  GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72

Query: 69  FESS--NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
                   + + +E + GG + ++ +     LTE     + RQI EGV ++HS  ++H D
Sbjct: 73  LRDPMERTLSIFMEHMPGGSIKDQ-LKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRD 131

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFD----PEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
           +K  NIL     GN +K+ DFG +++          ++ + GTP +++PEV++ +  G  
Sbjct: 132 IKGANIL-RDSVGN-VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRK 189

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANV-TIAQYDFDDECFNEISDDAKDFIRKLL 241
            D+WSVG     +L+   P+    + + MA +  IA    +      +SD  +DF++++ 
Sbjct: 190 ADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246

Query: 242 L--KDREDAPEV 251
           +  K R  A E+
Sbjct: 247 VEAKLRPSADEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  103 bits (258), Expect = 2e-26
 Identities = 71/217 (32%), Positives = 119/217 (54%), Gaps = 10/217 (4%)

Query: 33  AKFVGIAKRNDRRNVEREV-EIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERV 91
           A  V  AK  +    ER+V E +R  Q P L+ ++ AF++   + ++L+ I GGELF  +
Sbjct: 39  ATIVQKAKTTEHTRTERQVLEHIR--QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL 96

Query: 92  IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR 151
              +    E+ V I+  +I   +E +H   +++ D+K ENIL L   G+ + + DFGL++
Sbjct: 97  SQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL-LDSNGH-VVLTDFGLSK 153

Query: 152 KF--DPEKKLQVLFGTPEFVAPEVVNFDAIGF--GTDMWSVGVICYVLLSGLSPFMGETD 207
           +F  D  ++     GT E++AP++V     G     D WS+GV+ Y LL+G SPF  + +
Sbjct: 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213

Query: 208 VQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             + A ++      +     E+S  AKD I++LL+KD
Sbjct: 214 KNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKD 250

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  103 bits (257), Expect = 3e-26
 Identities = 68/235 (28%), Positives = 119/235 (50%), Gaps = 6/235 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V  C+ +ATG   A K +    I KR        E  I+ ++    ++ +  A+E
Sbjct: 11  GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE 70

Query: 71  SSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           + + +C+VL ++ GG+L   + +  +    E+    +  ++C G+E +  + +++ D+KP
Sbjct: 71  TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKP 130

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           ENIL L   G+ I+I D GLA +    + ++   GT  ++APEV+N +   F  D W +G
Sbjct: 131 ENIL-LDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLG 188

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            + Y ++ G SPF    +      V     +  +E   + S+DAK   R LL K+
Sbjct: 189 CLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKN 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 4e-26
 Identities = 68/250 (27%), Positives = 128/250 (51%), Gaps = 21/250 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKRNDRRNVEREVEIMRELQH---PRLIQIYDAF 69
           G +G VYR K   TG  +A K + +    +D  +++REV ++ +L+    P + + Y ++
Sbjct: 12  GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY 71

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
                + +++E  EGG +  R +     + EK +++ +R++   +++IH   V+H D+K 
Sbjct: 72  LKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKA 129

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLFGTPEFVAPEVV----NFDAIGFGTD 184
            NIL +T TGN +K+ DFG+A   +    K     GTP ++APEV+     +D      D
Sbjct: 130 ANIL-VTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK---AD 184

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL--- 241
           +WS+G+  Y + +G  P+      + M  +  ++    ++  N  S   ++F+   L   
Sbjct: 185 IWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLED--NGYSKLLREFVAACLDEE 242

Query: 242 LKDREDAPEV 251
            K+R  A E+
Sbjct: 243 PKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  102 bits (254), Expect = 5e-26
 Identities = 67/245 (27%), Positives = 126/245 (51%), Gaps = 18/245 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN-----VEREVEIMRELQHPRLIQIYDA 68
           G FG VY C +  TG  LAAK V     +   +     +E E+++++ LQH R++Q Y  
Sbjct: 13  GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72

Query: 69  FE--SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
               +   + + +E + GG + ++ +     LTE     + RQI EG+ ++HS  ++H D
Sbjct: 73  LRDRAEKTLTIFMEYMPGGSVKDQ-LKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRD 131

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFD----PEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
           +K  NI  L  +   +K+ DFG +++          ++ + GTP +++PEV++ +  G  
Sbjct: 132 IKGANI--LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK 189

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANV-TIAQYDFDDECFNEISDDAKDFIRKLL 241
            D+WS+G     +L+   P+    + + MA +  IA    + +  + IS+ A+DF+  + 
Sbjct: 190 ADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIF 246

Query: 242 LKDRE 246
           ++ R 
Sbjct: 247 VEARH 251

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  101 bits (254), Expect = 5e-26
 Identities = 58/195 (29%), Positives = 107/195 (54%), Gaps = 5/195 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G FG +Y  K K+       K + + K    ++   ++EV ++ +++HP ++  + +F+ 
Sbjct: 11  GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE 70

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVL-TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +  + +V+E  +GG+L +R+     VL +E  +  +  QI  G++ IH + +LH D+K +
Sbjct: 71  NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQ 130

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           NI  L+K G   K+ DFG+AR+ +   +L     GTP +++PE+         TD+WS+G
Sbjct: 131 NIF-LSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLG 189

Query: 190 VICYVLLSGLSPFMG 204
            + Y L +   PF G
Sbjct: 190 CVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  101 bits (253), Expect = 8e-26
 Identities = 67/249 (26%), Positives = 118/249 (47%), Gaps = 18/249 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G +GTVY C     G  +A K V +      A   +   ++ EV++++ L+H  ++Q   
Sbjct: 11  GAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG 69

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
                N + + +E + GG +   +++    L E     + +QI +GV ++H+  V+H D+
Sbjct: 70  TCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDI 128

Query: 128 KPENILCLTKTGNRIKIIDFGLARKF-------DPEKKLQVLFGTPEFVAPEVVNFDAIG 180
           K  N++ L   G  IK+IDFG AR+             L+ + GTP ++APEV+N    G
Sbjct: 129 KGNNVM-LMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG 186

Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
             +D+WS+G   + + +G  P      +  M  +  A         +  S  A DF+   
Sbjct: 187 RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAAIDFVTSC 245

Query: 241 LLKDREDAP 249
           L +D+ + P
Sbjct: 246 LTRDQHERP 254

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  102 bits (256), Expect = 1e-25
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK-----RNDRRNVE---------REVEIMRELQH 59
           G +G V +  +  TG  +A K V I +       DR+ V          RE++IM E++H
Sbjct: 20  GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH 79

Query: 60  PRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS 119
             ++ + D +   + + +V++++      ++V+D    LTE  V   + QI  G+  +H 
Sbjct: 80  ENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILNGLNVLHK 137

Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF------DPEKKLQV----LFGTPEFV 169
              +H D+ P NI  +   G   KI DFGLAR++      D   K +        T + V
Sbjct: 138 WYFMHRDLSPANIF-INSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195

Query: 170 -----APEVV-NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV 208
                APE++   +   F  DMWSVG I   LL+G   F GE ++
Sbjct: 196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240

Length = 335

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 1e-25
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 44/222 (19%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE------REVEIMRELQHP---RLIQ 64
           G +G VY+ + K TG  +A K +    R +           RE++++++L+HP   RL +
Sbjct: 10  GTYGQVYKARNKKTGELVALKKI----RMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           I  +    ++  +V E ++       ++D  +   TE  +  +M+Q+ EG++++HS  +L
Sbjct: 66  IVTSKGKGSIY-MVFEYMDHD--LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--------------QVLFGTPEFV 169
           H D+K  NIL +   G  +K+ DFGLAR +                    ++L G   + 
Sbjct: 123 HRDIKGSNIL-INNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY- 179

Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
            PEV          DMWSVG I   L  G   F G T+++ +
Sbjct: 180 GPEV----------DMWSVGCILAELFLGKPIFQGSTELEQL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-25
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 18/218 (8%)

Query: 14  GKFGTVYRCK---EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG VY+ K   +      +A K +   A   +R++  +E  +M++L HP ++++    
Sbjct: 6   GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC 65

Query: 70  ESSNVMCVVLELIEGGEL--------FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
                + +VLE +EGG+L              +   L+ K +  F  QI +G+E++ SK 
Sbjct: 66  TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK 125

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV---APEVVNFDA 178
            +H D+   N  CL      +KI DFGL+R    +   +   G    +   APE +    
Sbjct: 126 FVHRDLAARN--CLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183

Query: 179 IGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
               +D+WS GV+ + + + G +P+ G ++ + +  + 
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  100 bits (251), Expect = 2e-25
 Identities = 66/237 (27%), Positives = 128/237 (54%), Gaps = 16/237 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  G V     K++G  +A K + + K+  R  +  EV IMR+ QH  ++++Y+++   +
Sbjct: 31  GSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 90

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     + + +  +H++ V+H D+K ++IL
Sbjct: 91  ELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSIL 148

Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   E  + + L GTP ++APE+++    G   D+WS+G++ 
Sbjct: 149 -LTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 206

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDD-----ECFNEISDDAKDFIRKLLLKD 244
             ++ G  P+  E  ++ M  +       D+     +  +++S   K F+ +LL++D
Sbjct: 207 IEMVDGEPPYFNEPPLKAMKMIR------DNLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  100 bits (252), Expect = 2e-25
 Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 15/207 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIYDAFES 71
           G +G VYR ++K TG  +A K + + K  +   +   RE+ I+ +LQHP ++ + +    
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 72  SNVMCV--VLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           SN+  +  V+E +E     L E  +   F+ +E  V   M Q+  GV  +H   +LH D+
Sbjct: 76  SNLDKIYMVMEYVEHDLKSLMET-MKQPFLQSE--VKCLMLQLLSGVAHLHDNWILHRDL 132

Query: 128 KPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGT--D 184
           K  N+L L   G  +KI DFGLAR++  P K    L  T  + APE++   A  + T  D
Sbjct: 133 KTSNLL-LNNRG-ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL-LGAKEYSTAID 189

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTM 211
           MWSVG I   LL+    F G++++  +
Sbjct: 190 MWSVGCIFAELLTKKPLFPGKSEIDQL 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 3e-25
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 25/191 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRR--NVE-----REVEIMRELQ-HPRLIQI 65
           G FG+VY  + K TG     + V I K+  ++  + E     REV+ +R+L  HP ++++
Sbjct: 10  GTFGSVYLARNKETG-----ELVAI-KKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLH 124
            + F  ++ +  V E +EG  L++ + D      +E  +   + QI +G+  IH     H
Sbjct: 64  KEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV----NFDAIG 180
            D+KPEN+L        +KI DFGLAR+            T  + APE++    ++ +  
Sbjct: 123 RDLKPENLLV--SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSS-- 178

Query: 181 FGTDMWSVGVI 191
              D+W++G I
Sbjct: 179 -PVDIWALGCI 188

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 99.6 bits (249), Expect = 3e-25
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 15/209 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF-- 69
           G FGTV + + K+ G  L  K +  G     +++ +  EV I+REL+HP +++ YD    
Sbjct: 11  GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID 70

Query: 70  ESSNVMCVVLELIEGGEL---FERVIDDDFVLTEKAVAIFMRQICEGVEFIH-----SKN 121
            S+  + +V+E  EGG+L    ++   +   + E+ +   + Q+   +   H        
Sbjct: 71  RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT 130

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIG 180
           VLH D+KP NI       N +K+ DFGLA+    +      + GTP +++PE +N  +  
Sbjct: 131 VLHRDLKPANIFLDAN--NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYD 188

Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQ 209
             +D+WS+G + Y L +   PF     +Q
Sbjct: 189 EKSDIWSLGCLIYELCALSPPFTARNQLQ 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  100 bits (250), Expect = 3e-25
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 11/202 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +GTV++ K + T   +A K V +   ++    +  RE+ +++EL+H  ++++YD   S
Sbjct: 11  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS 70

Query: 72  SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V E  +  +  ++  D  +  +  + V  FM Q+ +G+ F HS NVLH D+KP+
Sbjct: 71  DKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQ 128

Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWS 187
           N+L + K G  +K+ DFGLAR F  P +       T  +  P+V+ F A  + T  DMWS
Sbjct: 129 NLL-INKNGE-LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL-FGAKLYSTSIDMWS 185

Query: 188 VGVICYVLLSGLSPFMGETDVQ 209
            G I   L +   P     DV 
Sbjct: 186 AGCIFAELANAGRPLFPGNDVD 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  101 bits (252), Expect = 4e-25
 Identities = 70/217 (32%), Positives = 117/217 (53%), Gaps = 11/217 (5%)

Query: 33  AKFVGIAKRNDRRNVEREV-EIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERV 91
           A  V  AK  +    ER V E +R  Q P L+ ++ AF++   + ++L+ + GGE+F  +
Sbjct: 39  AALVQKAKTVEHTRTERNVLEHVR--QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL 96

Query: 92  IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR 151
              D   +E  V  +  +I   +E +H   +++ D+K ENIL L   G+ + + DFGL++
Sbjct: 97  YQRDN-FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL-LDSEGH-VVLTDFGLSK 153

Query: 152 KFDPEKKLQV--LFGTPEFVAPEVVNFDAIGFG--TDMWSVGVICYVLLSGLSPFMGETD 207
           +F  E+K +     GT E++APE++     G G   D WS+G++ + LL+G SPF  E +
Sbjct: 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKG-GHGKAVDWWSLGILIFELLTGASPFTLEGE 212

Query: 208 VQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             T + V+      D    + I  +A+D + KLL KD
Sbjct: 213 RNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKD 249

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  101 bits (253), Expect = 4e-25
 Identities = 78/246 (31%), Positives = 125/246 (50%), Gaps = 20/246 (8%)

Query: 14  GKFGTVYRCKEKAT----GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG V   + K++     M L +KF  I KR+D      E +IM       ++Q++ AF
Sbjct: 54  GAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAF 112

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +    + +V+E + GG+L   + + D  + EK    +  ++   ++ IHS   +H D+KP
Sbjct: 113 QDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDA----IGFGT 183
           +N+L L K+G+ +K+ DFG   K D    ++     GTP++++PEV+         G   
Sbjct: 171 DNML-LDKSGH-LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ--YDFDDECFNEISDDAKDFIRKLL 241
           D WSVGV  Y +L G +PF  ++ V T + +   +    F D+   EIS  AKD I    
Sbjct: 229 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEISKQAKDLICA-F 285

Query: 242 LKDRED 247
           L DRE 
Sbjct: 286 LTDREV 291

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  100 bits (250), Expect = 9e-25
 Identities = 79/245 (32%), Positives = 128/245 (52%), Gaps = 20/245 (8%)

Query: 14  GKFGTVYRCKEKAT----GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG V   + K+T     M L +KF  I KR+D      E +IM     P ++Q++ AF
Sbjct: 54  GAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAF 112

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +    + +V+E + GG+L   + + D  + EK    +  ++   ++ IHS   +H D+KP
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEK--KLQVLFGTPEFVAPEVVNFDA----IGFGT 183
           +N+L L K+G+ +K+ DFG   K + E   +     GTP++++PEV+         G   
Sbjct: 171 DNML-LDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ--YDFDDECFNEISDDAKDFIRKLL 241
           D WSVGV  Y +L G +PF  ++ V T + +   +    F D+  N+IS +AK+ I    
Sbjct: 229 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKEAKNLICA-F 285

Query: 242 LKDRE 246
           L DRE
Sbjct: 286 LTDRE 290

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 99.0 bits (246), Expect = 1e-24
 Identities = 61/233 (26%), Positives = 120/233 (51%), Gaps = 9/233 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR-RNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG VY+  +  T   +A K + + +  D   ++++E+ ++ +   P + + Y ++   
Sbjct: 15  GSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG 74

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +++E + GG   + +      L E  +A  +R+I +G++++HS+  +H D+K  N+
Sbjct: 75  TKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSERKIHRDIKAANV 132

Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G+ +K+ DFG+A +  D + K     GTP ++APEV+   A  F  D+WS+G+ 
Sbjct: 133 L-LSEQGD-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGIT 190

Query: 192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
              L  G  P    +D+  M  + +   +       + S   K+F+   L KD
Sbjct: 191 AIELAKGEPPN---SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKD 240

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 99.4 bits (248), Expect = 1e-24
 Identities = 72/254 (28%), Positives = 117/254 (46%), Gaps = 43/254 (16%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND---RRNVE------REVEIMRELQHPRLIQ 64
           G FG V   + K TG   A K     K+ D   R  VE      R  E     +HP L+ 
Sbjct: 10  GHFGKVLLAEYKKTGELYAIK---ALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           ++  F++ + +C V+E   GG+L   +  D F  +E     +   +  G++++H   +++
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF--SEPRAVFYAACVVLGLQYLHENKIVY 124

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
            D+K +N+L L   G  +KI DFGL ++      +     GTPEF+APEV+   +     
Sbjct: 125 RDLKLDNLL-LDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-----------SDD 232
           D W +GV+ Y +L G SPF G+                ++E F+ I           S +
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDD---------------EEEVFDSIVNDEVRYPRFLSRE 227

Query: 233 AKDFIRKLLLKDRE 246
           A   +R+LL ++ E
Sbjct: 228 AISIMRRLLRRNPE 241

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.9 bits (244), Expect = 2e-24
 Identities = 70/262 (26%), Positives = 125/262 (47%), Gaps = 40/262 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER----------EVEIMRELQHPRLI 63
           G +G VY      TG  +A K V +      R+  R          E+E +++L H  ++
Sbjct: 12  GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIV 71

Query: 64  QIYDAFESS-NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           Q Y  FE++   + + LE + GG +    +       E+ V  F  Q+ EG+ ++HSK +
Sbjct: 72  Q-YLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGI 129

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARK----FDPEKKLQVLFGTPEFVAPEVVNFDA 178
           LH D+K +N+L +   G   KI DFG+++K    +D ++ +  + G+  ++APEV++  +
Sbjct: 130 LHRDLKADNLL-VDADGI-CKISDFGISKKSDDIYDNDQNMS-MQGSVFWMAPEVIHSYS 186

Query: 179 IGFG--TDMWSVGVICYVLLSGLSPFMGETDVQTM-----------------ANVTIAQY 219
            G+    D+WS+G +   + +G  P+  E  +  M                  N++    
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVAL 246

Query: 220 DFDDECFNEISDDAKDFIRKLL 241
           DF + CF  I+ D +   R+LL
Sbjct: 247 DFLNACF-TINPDNRPTARELL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.9 bits (244), Expect = 3e-24
 Identities = 73/251 (29%), Positives = 128/251 (50%), Gaps = 19/251 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAF--E 70
           G  G+V +C+ K TGM  A K +      D ++ + RE+EI +  + P +++ Y AF  E
Sbjct: 12  GAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71

Query: 71  SSNVMCVVLELIEGGEL---FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           SS+ + + +E  EGG L   +++V      + EK +      + +G+ ++HS+ ++H D+
Sbjct: 72  SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDI 131

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           KP NIL LT+ G  +K+ DFG++ +           GT  ++APE +        +D+WS
Sbjct: 132 KPSNIL-LTRKGQ-VKLCDFGVSGEL-VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWS 188

Query: 188 VGVICYVLLSGLSPF-------MGETDVQTMANVTIAQYDFDDECFNEI--SDDAKDFIR 238
           +G+    +     PF       +G  ++ +   V +   +  DE  N I  S++ KDFI+
Sbjct: 189 LGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI-VNMPNPELKDEPGNGIKWSEEFKDFIK 247

Query: 239 KLLLKDREDAP 249
           + L KD    P
Sbjct: 248 QCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.6 bits (240), Expect = 5e-24
 Identities = 66/244 (27%), Positives = 125/244 (51%), Gaps = 18/244 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV----GIAKRNDRRN-VEREVEIMRELQHPRLIQIYDA 68
           G FG VY C +  TG  LA K V       + +   N +E E+++++ L+H R++Q Y  
Sbjct: 13  GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72

Query: 69  FE--SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
                   + + +E + GG + ++ +     LTE     + RQI +GV ++HS  ++H D
Sbjct: 73  LRDPEEKKLSIFVEYMPGGSIKDQ-LKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRD 131

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFD----PEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
           +K  NIL     GN +K+ DFG +++          ++ + GTP +++PEV++ +  G  
Sbjct: 132 IKGANIL-RDSAGN-VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRK 189

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANV-TIAQYDFDDECFNEISDDAKDFIRKLL 241
            D+WSV      +L+   P+    + + MA +  IA         + +SD  +DF++++ 
Sbjct: 190 ADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF 246

Query: 242 LKDR 245
           ++++
Sbjct: 247 VEEK 250

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 95.8 bits (238), Expect = 9e-24
 Identities = 57/192 (29%), Positives = 97/192 (50%), Gaps = 5/192 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG     +   +    A K + + K  +   +  +E  ++ +++HP ++   ++FE+ 
Sbjct: 11  GSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD 70

Query: 73  NVMCVVLELIEGGELFERVIDDDFVL-TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
             + +V+E  +GG+L +++      L  E  +  +  Q+C GV+ IH K VLH D+K +N
Sbjct: 71  GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKN 130

Query: 132 ILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           I  LT+ G  +K+ DFG AR    P        GTP +V PE+         +D+WS+G 
Sbjct: 131 IF-LTQNGK-VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGC 188

Query: 191 ICYVLLSGLSPF 202
           I Y L +   PF
Sbjct: 189 ILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 96.1 bits (239), Expect = 1e-23
 Identities = 69/242 (28%), Positives = 122/242 (50%), Gaps = 13/242 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER---EVEIMRELQHPRLIQIYDAFE 70
           G FG V  C+ +ATG   A K +   +   R+  E    E  I+ ++    ++ +  AF+
Sbjct: 4   GGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ 63

Query: 71  SSNVMCVVLELIEGGEL---FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           +   +C+V+ ++ GG+L      V +++    E     +  QI  G+E +H + +++ D+
Sbjct: 64  TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDL 123

Query: 128 KPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L L   GN ++I D GLA +  D + K +   GTP F+APE++  +   F  D +
Sbjct: 124 KPENVL-LDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYF 181

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF--NEISDDAKDFIRKLLLKD 244
           ++GV  Y +++   PF      + + N  + Q   +D     ++ S  +K F   LL KD
Sbjct: 182 ALGVTLYEMIAARGPF--RARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239

Query: 245 RE 246
            E
Sbjct: 240 PE 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 95.9 bits (238), Expect = 1e-23
 Identities = 54/183 (29%), Positives = 98/183 (53%), Gaps = 8/183 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ + K TG+  AAK +      +  +   E++I+    HP ++++ DAF   N
Sbjct: 16  GAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GG +   +++ +  LTE  + +  +Q  E + ++H   ++H D+K  NIL
Sbjct: 76  NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNIL 135

Query: 134 CLTKTGNRIKIIDFGL-ARKFDPEKKLQVLFGTPEFVAPEVVNFDA-----IGFGTDMWS 187
             T  G+ IK+ DFG+ A+     ++     GTP ++APEVV  +        +  D+WS
Sbjct: 136 -FTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 193

Query: 188 VGV 190
           +G+
Sbjct: 194 LGI 196

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 96.2 bits (239), Expect = 2e-23
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNV--EREVEIMRELQHPRLIQIYDA 68
           G FG V   K K  G   A K +    +  R +++++  ER V +++ ++HP L+ ++ +
Sbjct: 6   GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGLHYS 64

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F+++  +  VL+ + GGELF   +  +    E     +  +I   + ++HS N+++ D+K
Sbjct: 65  FQTTEKLYFVLDFVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLK 123

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWS 187
           PENIL L   G+ + + DFGL ++   +      F GTPE++APEV+         D W 
Sbjct: 124 PENIL-LDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWC 181

Query: 188 VGVICYVLLSGLSPF 202
           +G + Y +L GL PF
Sbjct: 182 LGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 96.0 bits (239), Expect = 2e-23
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 9/201 (4%)

Query: 47  VEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           VER V  +   +HP L  ++  F++   +  V+E + GG+L    I       E     +
Sbjct: 44  VERRVLAL-AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFH-IQSSGRFDEARARFY 101

Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGT 165
             +I  G++F+H K +++ D+K +N+L L K G  IKI DFG+ +   + E K     GT
Sbjct: 102 AAEIICGLQFLHKKGIIYRDLKLDNVL-LDKDG-HIKIADFGMCKENMNGEGKASTFCGT 159

Query: 166 PEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
           P+++APE++         D WS GV+ Y +L G SPF GE + +   ++   +  F    
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP--- 216

Query: 226 FNEISDDAKDFIRKLLLKDRE 246
              IS +AKD + KL  +D  
Sbjct: 217 -RWISKEAKDCLSKLFERDPT 236

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 95.2 bits (237), Expect = 2e-23
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 18/204 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G + TVY+ + + TG  +A K + + A+        RE+ +M+EL+H  +++++D   + 
Sbjct: 11  GTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE 70

Query: 73  NVMCVVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           N + +V E ++     ++ +D       L    V  F  Q+ +G+ F H   VLH D+KP
Sbjct: 71  NKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKP 128

Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGT----- 183
           +N+L + K G  +K+ DFGLAR F  P         T  + AP+V+    +G  T     
Sbjct: 129 QNLL-INKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL----LGSRTYSTSI 182

Query: 184 DMWSVGVICYVLLSGLSPFMGETD 207
           D+WSVG I   +++G   F G  +
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNN 206

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (238), Expect = 3e-23
 Identities = 70/237 (29%), Positives = 126/237 (53%), Gaps = 16/237 (6%)

Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKRNDRRNV-EREVEIMREL-QHPRLIQIYD 67
           G FG VY+ ++K T     M + +K   +AK+     + ER + +   L + P ++ +  
Sbjct: 4   GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKF 63

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           +F++ + + +V + + GGELF   +  +   +E     ++ ++   +E +H  ++++ D+
Sbjct: 64  SFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDL 122

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFG--TD 184
           KPENIL L  TG+ I + DFGL++    + K    F GT E++APEV+  D  G+    D
Sbjct: 123 KPENIL-LDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL-LDEKGYTKHVD 179

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
            WS+GV+ + +  G SPF  E   Q   N+   +  F     N +SD+ + F++ LL
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLL 233

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.3 bits (235), Expect = 3e-23
 Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 11/198 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G    VY          +A K + + K       + +EV+ M +  HP +++ Y +F   
Sbjct: 12  GATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71

Query: 73  NVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           + + +V+  + GG L +  +       L E  +A  ++++ +G+E++HS   +H D+K  
Sbjct: 72  DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAG 131

Query: 131 NILCLTKTGNRIKIIDFGL-ARKFDP----EKKLQVLFGTPEFVAPEVVNFD-AIGFGTD 184
           NIL L + G+ +KI DFG+ A   D      K  +   GTP ++APEV+       F  D
Sbjct: 132 NIL-LGEDGS-VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKAD 189

Query: 185 MWSVGVICYVLLSGLSPF 202
           +WS G+    L +G +P+
Sbjct: 190 IWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 95.0 bits (236), Expect = 5e-23
 Identities = 72/244 (29%), Positives = 123/244 (50%), Gaps = 24/244 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVE-IMRE-------LQHPRLIQI 65
           G FG V+  + K T    A K    A + D   ++ +VE  M E        +HP L  +
Sbjct: 6   GSFGKVFLAELKGTNQFFAIK----ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 66  YDAFESSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           Y  F++   +  V+E + GG+L   +     F L       +  +I  G++F+HSK +++
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRAT--FYAAEIICGLQFLHSKGIVY 119

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
            D+K +NIL L   G+ IKI DFG+ ++    + K     GTP+++APE++         
Sbjct: 120 RDLKLDNIL-LDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE-ISDDAKDFIRKLLL 242
           D WS GV+ Y +L G SPF G  + +   ++ +     D+ C+   ++ +AKD + KL +
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-----DNPCYPRWLTREAKDILVKLFV 232

Query: 243 KDRE 246
           ++ E
Sbjct: 233 REPE 236

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 93.9 bits (233), Expect = 5e-23
 Identities = 51/185 (27%), Positives = 105/185 (56%), Gaps = 7/185 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI--AKRNDRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G V   + +  G     K + +  A R +R+  E+E +++ +L+HP ++   +++E 
Sbjct: 11  GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG 70

Query: 72  SNVMC-VVLELIEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            + +  +V+   EGG+L+ ++ +    +L E  V  +  QI   ++++H K++LH D+K 
Sbjct: 71  EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKT 130

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           +N+  LT+T N IK+ D G+AR  + +  +   L GTP +++PE+ +     + +D+W++
Sbjct: 131 QNVF-LTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWAL 188

Query: 189 GVICY 193
           G   Y
Sbjct: 189 GCCVY 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.8 bits (233), Expect = 6e-23
 Identities = 65/252 (25%), Positives = 114/252 (45%), Gaps = 18/252 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE------REVEIMRELQHPRLIQIYD 67
           G F + Y+ ++  TG  +A K V   +       E      +E+ +M  L HP +I++  
Sbjct: 11  GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI-FMRQICEGVEFIHSKNVLHLD 126
           A    +   + +E + GG +    +   +   ++AV I +  Q+  G+ ++H   ++H D
Sbjct: 71  ATCEDSHFNLFVEWMAGGSV--SHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRD 128

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDP------EKKLQVLFGTPEFVAPEVVNFDAIG 180
           +K  N+L +  TG R++I DFG A +         E + Q+L GT  F+APEV+  +  G
Sbjct: 129 VKGANLL-IDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL-GTIAFMAPEVLRGEQYG 186

Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV-TIAQYDFDDECFNEISDDAKDFIRK 239
              D+WSVG +   + +   P+  E     +A +  IA           +S   +D   +
Sbjct: 187 RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLR 246

Query: 240 LLLKDREDAPEV 251
            L    ED P  
Sbjct: 247 CLELQPEDRPPS 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 95.5 bits (237), Expect = 7e-23
 Identities = 75/243 (30%), Positives = 124/243 (51%), Gaps = 16/243 (6%)

Query: 14  GKFGTV----YRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG V    ++  +K   M L +KF  I KR+D      E +IM     P ++Q++ AF
Sbjct: 54  GAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAF 112

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +    + +V+E + GG+L   + + D  + EK    +  ++   ++ IHS  ++H D+KP
Sbjct: 113 QDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKP 170

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDA----IGFGT 183
           +N+L L K G+ +K+ DFG   K D    ++     GTP++++PEV+         G   
Sbjct: 171 DNML-LDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           D WSVGV  + +L G +PF  ++ V T + +   +   +     EIS  AK+ I    L 
Sbjct: 229 DWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICA-FLT 287

Query: 244 DRE 246
           DRE
Sbjct: 288 DRE 290

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 8e-23
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 59/277 (21%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   ++K TG   A K +    + ++    +V  E +I+ E  +P ++++Y +F+
Sbjct: 12  GAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             N + +++E + GG++   ++  D   TE+    ++ +    ++ IH    +H D+KP+
Sbjct: 72  DENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPD 130

Query: 131 NILCLTKTGNRIKIIDFGLARKFD---------------PEKKLQVLF------------ 163
           N+L L   G+ IK+ DFGL                    P   L  +             
Sbjct: 131 NLL-LDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETW 188

Query: 164 ------------GTPEFVAPEVVNFDAIGFG--TDMWSVGVICYVLLSGLSPFMGETDVQ 209
                       GTP+++APEV  F   G+    D WS+GVI Y +L G  PF  +   +
Sbjct: 189 KRNRRALAYSTVGTPDYIAPEV--FLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE 246

Query: 210 TMANV-----TIAQYDFDDECFNEISDDAKDFIRKLL 241
           T   +     T+    F DE    +S +AKD I++L 
Sbjct: 247 TYRKIINWKETLQ---FPDEV--PLSPEAKDLIKRLC 278

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 95.5 bits (237), Expect = 1e-22
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 11/225 (4%)

Query: 31  LAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFER 90
           + AKFV +           E+  +    H  +++ +D F+S + + +++E   GG+L ++
Sbjct: 96  VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155

Query: 91  V---IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDF 147
           +   + +     E  V +   QI   ++ +HS+ ++H D+K  NI  L  TG  IK+ DF
Sbjct: 156 IKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF-LMPTG-IIKLGDF 213

Query: 148 GLARKFDPEKKLQV---LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
           G ++++     L V     GTP ++APE+          DMWS+GVI Y LL+   PF G
Sbjct: 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273

Query: 205 ETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
            +  + M  V   +Y   D     +S   K  +  LL K+    P
Sbjct: 274 PSQREIMQQVLYGKY---DPFPCPVSSGMKALLDPLLSKNPALRP 315

Length = 478

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 94.0 bits (234), Expect = 1e-22
 Identities = 65/239 (27%), Positives = 119/239 (49%), Gaps = 18/239 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQ--HPRLIQIYDA 68
           G FG V   + K T    A K +    I + +D      E  ++  L   HP L Q++  
Sbjct: 6   GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVL-ALAGKHPFLTQLHSC 64

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F++ + +  V+E + GG+L    I       E     +  +I  G++F+H + +++ D+K
Sbjct: 65  FQTKDRLFFVMEYVNGGDLMFH-IQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLK 123

Query: 129 PENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
            +N+L L   G+ IKI DFG+ ++            GTP+++APE++++   G   D W+
Sbjct: 124 LDNVL-LDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWA 181

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF--NEISDDAKDFIRKLLLKD 244
           +GV+ Y +L+G SPF G+ + +   ++       +DE      +S +AK  ++  L K+
Sbjct: 182 LGVLLYEMLAGQSPFEGDDEDELFQSI------LEDEVRYPRWLSKEAKSILKSFLTKN 234

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (232), Expect = 2e-22
 Identities = 68/237 (28%), Positives = 115/237 (48%), Gaps = 11/237 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V + +++ T    A K +    I  R++  +   E  ++ ++  P ++ +  +F+
Sbjct: 4   GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ 63

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           S   + +VL  I GGELF  +  +      +A   +  ++   +E +H  NV++ D+KPE
Sbjct: 64  SPEKLYLVLAFINGGELFHHLQREGRFDLSRA-RFYTAELLCALENLHKFNVIYRDLKPE 122

Query: 131 NILCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           NIL L   G+ I + DFGL +     + K     GTPE++APE++         D W++G
Sbjct: 123 NIL-LDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           V+ Y +L+GL PF  E   +    +      F D        DAKD +  LL +D  
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDPT 233

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 93.7 bits (233), Expect = 2e-22
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 31/222 (13%)

Query: 13  FGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
            G  G V+   +      +A K + +      ++  RE++I+R L H  ++++Y+    S
Sbjct: 15  CGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74

Query: 73  --------------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
                         N + +V E +E       V++    L+E+   +FM Q+  G+++IH
Sbjct: 75  GSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQG-PLSEEHARLFMYQLLRGLKYIH 131

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK----LQVLFGTPEFVAPEVV 174
           S NVLH D+KP N+   T+    +KI DFGLAR  DP       L     T  + +P ++
Sbjct: 132 SANVLHRDLKPANVFINTED-LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190

Query: 175 ----NFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
               N+  AI    DMW+ G I   +L+G   F G  +++ M
Sbjct: 191 LSPNNYTKAI----DMWAAGCIFAEMLTGKPLFAGAHELEQM 228

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 3e-22
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 30/194 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE----REVEIMRELQHPRLIQIYDAF 69
           G +G VY+ ++K TG  +A K   I    +   V     RE+ +++EL HP ++++ D  
Sbjct: 10  GTYGVVYKARDKLTGEIVALK--KIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV 67

Query: 70  ESSNVMCVVLELIEGGELFERVIDD--DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S N + +V E ++     ++ +D      L    +  ++ Q+ +G+ + HS  VLH D+
Sbjct: 68  HSENKLYLVFEFLDLD--LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDL 125

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APEVVNFDAIG-- 180
           KP+N+L + + G  +K+ DFGLAR F     + V   T E V     APE++    +G  
Sbjct: 126 KPQNLL-IDREGA-LKLADFGLARAFG----VPVRTYTHEVVTLWYRAPEIL----LGSR 175

Query: 181 ---FGTDMWSVGVI 191
                 D+WS+G I
Sbjct: 176 QYSTPVDIWSIGCI 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.7 bits (225), Expect = 1e-21
 Identities = 60/255 (23%), Positives = 116/255 (45%), Gaps = 11/255 (4%)

Query: 2   TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR 61
                +      G +G VY  ++ +T + +A K +        + +  E+ +   L+H  
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 62  LIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHS 119
           ++Q   +   +    + +E + GG L    R         E+ +  + +QI EG++++H 
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDA 178
             ++H D+K +N+L  T +G  +KI DFG +++          F GT +++APEV++   
Sbjct: 127 NQIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185

Query: 179 IGFG--TDMWSVGVICYVLLSGLSPF--MGETDVQTMANVTIAQYDFDDECFNEISDDAK 234
            G+G   D+WS+G     + +G  PF  +GE      A   +  +    E    +S +AK
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKIHPEIPESLSAEAK 242

Query: 235 DFIRKLLLKDREDAP 249
           +FI +    D +   
Sbjct: 243 NFILRCFEPDPDKRA 257

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 90.1 bits (224), Expect = 2e-21
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 21/206 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAK-FVGIAKRND---RRNVEREVEIMRELQHPRLIQIYDAF 69
           G +G V++C+ + TG  +A K FV     +D   ++   RE+ ++++L+HP L+ + + F
Sbjct: 12  GSYGVVFKCRNRETGQIVAIKKFV--ESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF 69

Query: 70  ESSNVMCVVLELIEGGELFE-----RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
                + +V E  +   L E     R + +  +   K +   + Q  + V F H  N +H
Sbjct: 70  RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI---KKI---IWQTLQAVNFCHKHNCIH 123

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFD-AIGFG 182
            D+KPENIL +TK G +IK+ DFG AR    P         T  + APE++  D   G  
Sbjct: 124 RDVKPENIL-ITKQG-QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPP 181

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDV 208
            D+W++G +   LL+G   + G++DV
Sbjct: 182 VDVWAIGCVFAELLTGQPLWPGKSDV 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 90.3 bits (224), Expect = 2e-21
 Identities = 56/202 (27%), Positives = 110/202 (54%), Gaps = 11/202 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G VY+ +++ T  T+A K + + + ++       RE+ +++E+QH  ++++ D   S
Sbjct: 13  GTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72

Query: 72  SNVMCVVLELIEGGELFERVIDD--DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V E ++     ++ +D   DF    + +  ++ QI  G+ + HS  VLH D+KP
Sbjct: 73  EKRLYLVFEYLDLD--LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKP 130

Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMW 186
           +N+L + +  N +K+ DFGLAR F  P +       T  + APE++   +  + T  D+W
Sbjct: 131 QNLL-IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL-LGSRHYSTPVDIW 188

Query: 187 SVGVICYVLLSGLSPFMGETDV 208
           SVG I   +++    F G++++
Sbjct: 189 SVGCIFAEMVNQKPLFPGDSEI 210

Length = 294

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.8 bits (222), Expect = 2e-21
 Identities = 51/190 (26%), Positives = 103/190 (54%), Gaps = 6/190 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR-RNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG V++  +  T   +A K + + +  D   ++++E+ ++ +   P + + Y ++   
Sbjct: 15  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 74

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +++E + GG   + +  +   L E  +A  +R+I +G++++HS+  +H D+K  N+
Sbjct: 75  TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 132

Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G  +K+ DFG+A +  D + K     GTP ++APEV+   A     D+WS+G+ 
Sbjct: 133 L-LSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 190

Query: 192 CYVLLSGLSP 201
              L  G  P
Sbjct: 191 AIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 90.5 bits (225), Expect = 3e-21
 Identities = 73/242 (30%), Positives = 112/242 (46%), Gaps = 24/242 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAF-- 69
           G +G V   K   T   +A K +  A  N  D +   RE++++R L H  +I I D    
Sbjct: 16  GAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPP 75

Query: 70  ---ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
              E+ N + +V EL++      ++I     L++     F+ Q+  G+++IHS NVLH D
Sbjct: 76  PHREAFNDVYIVYELMDTD--LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRD 133

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APEVV-NFDAIG 180
           +KP N+  L      +KI DFGLAR    +      F T   V     APE++ N     
Sbjct: 134 LKPSNL--LLNANCDLKICDFGLARTTSEKGD----FMTEYVVTRWYRAPELLLNCSEYT 187

Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVT--IAQYDFDDECFNEISDDAKDFIR 238
              D+WSVG I   LL     F G+  V  +  +T  +     +D  F   ++ A+ +IR
Sbjct: 188 TAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR-NEKARRYIR 246

Query: 239 KL 240
            L
Sbjct: 247 SL 248

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 90.0 bits (223), Expect = 4e-21
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 31/242 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVE-IMRE-------LQHPRLIQI 65
           G FG V   + K  G   A K    A + D   ++ +VE  M E        ++P L  +
Sbjct: 6   GSFGKVLLAELKGKGEYFAVK----ALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           Y  F++   +  V+E + GG+L   + D       +A   +  +I  G++F+HSK +++ 
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRA-TFYAAEIVCGLQFLHSKGIIYR 120

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTD 184
           D+K +N++ L + G  IKI DFG+ ++    + +     GTP+++APE++      F  D
Sbjct: 121 DLKLDNVM-LDRDG-HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVD 178

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            WS GV+ Y +L G SPF G               D +DE F  I  D   + R +  + 
Sbjct: 179 WWSFGVLLYEMLIGQSPFHG---------------DDEDELFESIRVDTPHYPRWITKES 223

Query: 245 RE 246
           ++
Sbjct: 224 KD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 89.3 bits (222), Expect = 4e-21
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAK-----FVGIAKRNDRRNVEREVEIMRELQ-HPRLIQ--- 64
           G F  V + + + TG   A K     F  + + N+ R    E++ +R L  HP +++   
Sbjct: 10  GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR----EIQALRRLSPHPNILRLIE 65

Query: 65  -IYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
            ++D    +  + +V EL++   L+E +      L EK V  +M Q+ + ++ +H   + 
Sbjct: 66  VLFD--RKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFG 182
           H D+KPENIL      + +K+ DFG  R    +        T  + APE +  D   G  
Sbjct: 123 HRDIKPENILI---KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPK 179

Query: 183 TDMWSVGVICYVLLSGLSP-FMGETDV 208
            D+W+VG + + +LS L P F G  ++
Sbjct: 180 MDIWAVGCVFFEILS-LFPLFPGTNEL 205

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 88.7 bits (220), Expect = 6e-21
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 15/247 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G  G+V + K   TG  +A K V I AK + R+ + RE++IM E + P ++  Y AF + 
Sbjct: 16  GNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLDMKPEN 131
           N +C+ +E ++ G L +R+      +  + +      + EG+ ++++ + ++H D+KP N
Sbjct: 76  NNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSN 134

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           I  L  +  +IK+ DFG++ +           GT  +++PE +        +D+WS+G+ 
Sbjct: 135 I--LVNSRGQIKLCDFGVSGEL-INSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191

Query: 192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE---------ISDDAKDFIRKLLL 242
              L  G  PF          +  +   D   +   E           +D +DF+   LL
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLL 251

Query: 243 KDREDAP 249
           KD  + P
Sbjct: 252 KDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 89.3 bits (222), Expect = 6e-21
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 38/201 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG-------IAKRNDRRNVEREVEIMRELQHPRLIQIY 66
           G +G V    +  +G  +A K +        +AKR       RE++I+R  +H  +I I 
Sbjct: 16  GAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT-----LRELKILRHFKHDNIIAIR 70

Query: 67  DAFESS-----NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           D          +V  VV++L+E       +I  D  LTE+ +  F+ Q+  G+++IHS N
Sbjct: 71  DILRPPGADFKDVY-VVMDLMESD--LHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN 127

Query: 122 VLHLDMKPENIL----CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------AP 171
           V+H D+KP N+L    C       ++I DFG+AR           F T E+V      AP
Sbjct: 128 VIHRDLKPSNLLVNEDCE------LRIGDFGMARGLSSSPTEHKYFMT-EYVATRWYRAP 180

Query: 172 EVV-NFDAIGFGTDMWSVGVI 191
           E++ +        DMWSVG I
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCI 201

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 89.9 bits (223), Expect = 8e-21
 Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 58/281 (20%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   ++K TG   A K +    + K++   +V+ E +++ E   P ++ +Y +F+
Sbjct: 12  GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + +++E + GG+L   +I  D   +E     +M +    +E +H    +H D+KP+
Sbjct: 72  DAQYLYLIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPD 130

Query: 131 NILCLTKTGNRIKIIDFGLA---RKFDPEKKLQVLF------------------------ 163
           NIL + + G+ IK+ DFGL+    K       Q L                         
Sbjct: 131 NIL-IDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188

Query: 164 ---------------------GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPF 202
                                GTP+++APE+      G   D WS+G I +  L G  PF
Sbjct: 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPF 248

Query: 203 MGETDVQTMANVTIAQYD--FDDECFNEISDDAKDFIRKLL 241
             E   +T   +   +    F D+    +S +A+D IR+L+
Sbjct: 249 CSENSHETYRKIINWRETLYFPDDI--HLSVEAEDLIRRLI 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 88.2 bits (218), Expect = 8e-21
 Identities = 60/233 (25%), Positives = 119/233 (51%), Gaps = 9/233 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR-RNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG V++  +  T   +A K + + +  D   ++++E+ ++ +   P + + Y ++   
Sbjct: 15  GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +++E + GG   + +    F   E  +A  +++I +G++++HS+  +H D+K  N+
Sbjct: 75  TKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV 132

Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G+ +K+ DFG+A +  D + K     GTP ++APEV+   A     D+WS+G+ 
Sbjct: 133 L-LSEQGD-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGIT 190

Query: 192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
              L  G  P    +D+  M  + +   +       E S   K+FI   L KD
Sbjct: 191 AIELAKGEPP---NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 87.1 bits (216), Expect = 3e-20
 Identities = 66/213 (30%), Positives = 114/213 (53%), Gaps = 21/213 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAK-FVGIAKRNDRRNVE----REVEIMRELQHPRLIQIYDA 68
           G +G V +CK K TG  +A K F+   +  D + V+    RE+ ++++L+H  L+ + + 
Sbjct: 12  GSYGMVMKCKHKETGQIVAIKKFL---ESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 69  FESSNVMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           F     + +V E ++       V+DD       L E  V  ++ QI  G+EF HS N++H
Sbjct: 69  FRRKKRLYLVFEFVD-----HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDA-IGFG 182
            D+KPENIL ++++G  +K+ DFG AR    P +       T  + APE++  D   G  
Sbjct: 124 RDIKPENIL-VSQSG-VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVT 215
            D+W+VG +   +L+G   F G++D+  + ++ 
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 87.5 bits (217), Expect = 3e-20
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 49  REVEIMRELQ-HPRLIQIYD---AFESS-NVMCVVLELIEGGELFERVIDDDFVLTEKAV 103
           RE++++R  + H  +  +YD    F  + N + +  EL+E      ++I     LT+   
Sbjct: 50  RELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHF 107

Query: 104 AIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF 163
             F+ QI  G+++IHS NVLH D+KP N+L        +KI DFGLAR F         F
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLV--NADCELKICDFGLARGFSENPGENAGF 165

Query: 164 GTPEFV------APEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI 216
            T E+V      APE+ ++F +     D+WSVG I   LL     F G+  V  +  +  
Sbjct: 166 MT-EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224

Query: 217 AQYDFDDECFNEI-SDDAKDFIRKL 240
                D+E  + I S  A+++IR L
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSL 249

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 86.6 bits (214), Expect = 3e-20
 Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 8/194 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G +G VY+ +   TG   A K + +    D   V++E+ +M++ +H  ++  + ++   +
Sbjct: 20  GTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + + +E   GG L + +      L+E  +A   R+  +G+ ++HSK  +H D+K  NIL
Sbjct: 80  KLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANIL 138

Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGT---DMWSVG 189
            LT  G+ +K+ DFG++ +      K +   GTP ++APEV   +  G      D+W+VG
Sbjct: 139 -LTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVG 196

Query: 190 VICYVLLSGLSPFM 203
            I  + L+ L P M
Sbjct: 197 -ITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 87.4 bits (216), Expect = 4e-20
 Identities = 65/239 (27%), Positives = 117/239 (48%), Gaps = 13/239 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   K K T    A K +    + KR +      E  ++       +  ++ AF+
Sbjct: 12  GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             N + +V++   GG+L   +   +  L E     ++ ++   +  IH  + +H D+KP+
Sbjct: 72  DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPD 131

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAIGFGT----- 183
           N+L L   G+ I++ DFG   K + +  +Q  V  GTP++++PE++     G G      
Sbjct: 132 NVL-LDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-DECFNEISDDAKDFIRKLL 241
           D WS+GV  Y +L G +PF  E+ V+T   +   +  F       ++S++AKD I++L+
Sbjct: 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 87.2 bits (217), Expect = 4e-20
 Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 66/278 (23%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMREL-QHPRLIQIYDAFE 70
           G +G V++  ++ T   +A K +  A RN  D +   RE+  ++EL  HP ++++ +  +
Sbjct: 18  GAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIK 77

Query: 71  SSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           + N   + +V E +E       VI  + +L +      M Q+ + +++IHS NV+H D+K
Sbjct: 78  AENDKDIYLVFEYMETD--LHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLK 134

Query: 129 PENIL----CLTKTGNRIKIIDFGLARKFDP---EKKLQVLFGTPEFVA------PEVVN 175
           P NIL    C      R+K+ DFGLAR         +  VL    ++VA      PE++ 
Sbjct: 135 PSNILLNSDC------RVKLADFGLARSLSELEENPENPVL---TDYVATRWYRAPEIL- 184

Query: 176 FDAIG-----FGTDMWSVGVICYVLLSGLSPFMG------------------ETDVQTM- 211
              +G      G DMWSVG I   +L G   F G                    D++++ 
Sbjct: 185 ---LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241

Query: 212 ---ANVTIAQYDFD-----DECFNEISDDAKDFIRKLL 241
              A   +           DE   + SDDA D ++KLL
Sbjct: 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 86.6 bits (214), Expect = 5e-20
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 27/219 (12%)

Query: 14  GKFGTVYRCKE-KATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQ---HPRLIQIYD 67
           G +G V++ ++ K  G  +A K V +    +   +   REV ++R L+   HP +++++D
Sbjct: 12  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 71

Query: 68  AFESSNVMCVVLELIEGGEL---FERVIDDDFVLTEKA---------VAIFMRQICEGVE 115
                  +C V       +L   FE V  D     +K          +   M Q+  G++
Sbjct: 72  -------VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 116 FIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN 175
           F+HS  V+H D+KP+NIL    +  +IK+ DFGLAR +  +  L  +  T  + APEV+ 
Sbjct: 125 FLHSHRVVHRDLKPQNIL--VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
             +     D+WSVG I   +      F G +DV  +  +
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 87.0 bits (215), Expect = 5e-20
 Identities = 64/239 (26%), Positives = 115/239 (48%), Gaps = 13/239 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   K K      A K +    + KR +      E +++    +  +  ++ AF+
Sbjct: 12  GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             N + +V++   GG+L   +   +  L E     ++ ++   ++ +H  + +H D+KP+
Sbjct: 72  DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPD 131

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAIGFG-----T 183
           NI  L      I++ DFG   K   +  +Q  V  GTP++++PE++     G G      
Sbjct: 132 NI--LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPEC 189

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC-FNEISDDAKDFIRKLL 241
           D WS+GV  Y +L G +PF  E+ V+T   +   +  F       ++S+DAKD IR+L+
Sbjct: 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 85.8 bits (212), Expect = 6e-20
 Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 12/189 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKF-----VGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FGTVY  K+K        K      VG    N+     +E +++ +L HP +++ + +
Sbjct: 11  GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHAS 70

Query: 69  FESSNVMCVVLELIEGGEL---FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           F   +  C++ E  EG +L    E +      L+E  V  +  Q+  GV ++H + +LH 
Sbjct: 71  FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHR 130

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTD 184
           D+K +NI       N +KI DFG++R       L   F GTP +++PE +        +D
Sbjct: 131 DLKAKNIFL---KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSD 187

Query: 185 MWSVGVICY 193
           +WS+G I Y
Sbjct: 188 IWSLGCILY 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 85.9 bits (212), Expect = 6e-20
 Identities = 58/194 (29%), Positives = 103/194 (53%), Gaps = 8/194 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G +G VY+ +   TG   A K + +   +D   +++E+ +++E +H  ++  + ++ S  
Sbjct: 20  GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + + +E   GG L + +      L+E  +A   R+  +G+ ++HSK  +H D+K  NIL
Sbjct: 80  KLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANIL 138

Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGT---DMWSVG 189
            LT  G+ +K+ DFG+A K      K +   GTP ++APEV   +  G      D+W+VG
Sbjct: 139 -LTDNGD-VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVG 196

Query: 190 VICYVLLSGLSPFM 203
            I  + L+ L P M
Sbjct: 197 -ITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 86.0 bits (213), Expect = 7e-20
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 42/225 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE-------REVEIMRELQHP----RL 62
           G +G VY+ ++K TG     K V + K     + E       RE+ +++ L       RL
Sbjct: 12  GTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 63  IQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-------------LTEKAVAIFMRQ 109
           + +    E +    + L       +FE  +D D               L  K +  FM Q
Sbjct: 67  LDVEHVEEKNGKPSLYL-------VFE-YLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEF 168
           + +GV   H   V+H D+KP+N+L + K    +KI D GL R F  P K       T  +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLL-VDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWY 177

Query: 169 VAPEVVNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTM 211
            APEV+   +  + T  D+WSVG I   +      F G++++Q +
Sbjct: 178 RAPEVL-LGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 86.5 bits (214), Expect = 8e-20
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 8/199 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMR-ELQHPRLIQIYDAF 69
           G FG V   + K +G   A K +    I + +D      E  I+     HP L Q+Y  F
Sbjct: 6   GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF 65

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +  V+E + GG+L    I       E     +  +I   + F+H K +++ D+K 
Sbjct: 66  QTPDRLFFVMEFVNGGDLMFH-IQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKL 124

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSV 188
           +N+L L   G+  K+ DFG+ ++     K    F GTP+++APE++     G   D W++
Sbjct: 125 DNVL-LDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAM 182

Query: 189 GVICYVLLSGLSPFMGETD 207
           GV+ Y +L G +PF  E +
Sbjct: 183 GVLLYEMLCGHAPFEAENE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 85.8 bits (212), Expect = 8e-20
 Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 26/195 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQ---HPRLIQIYDA 68
           G +GTVY+ ++  +G  +A K V +    D   +   REV +++ L+   HP ++++ D 
Sbjct: 11  GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70

Query: 69  FESSNV---MCVVLELIEGGELFERVIDDDFVLTEKA---------VAIFMRQICEGVEF 116
             +S       V L       +FE V  D     +K          +   MRQ   G++F
Sbjct: 71  CATSRTDRETKVTL-------VFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF 176
           +H+  ++H D+KPENI  L  +G ++K+ DFGLAR +  +  L  +  T  + APEV+  
Sbjct: 124 LHANCIVHRDLKPENI--LVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 177 DAIGFGTDMWSVGVI 191
                  DMWSVG I
Sbjct: 182 STYATPVDMWSVGCI 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 86.2 bits (213), Expect = 1e-19
 Identities = 54/165 (32%), Positives = 88/165 (53%), Gaps = 5/165 (3%)

Query: 38  IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV 97
           I K+    +V  E +I+  + HP  + +Y +F+  + + +VLE + GGE F   +  +  
Sbjct: 69  IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKR 127

Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
                   +  QI    E++ S N+++ D+KPEN+L L K G  IK+ DFG A+  D   
Sbjct: 128 FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLL-LDKDG-FIKMTDFGFAKVVD--T 183

Query: 158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPF 202
           +   L GTPE++APE++     G   D W++G+  Y +L G  PF
Sbjct: 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 85.5 bits (211), Expect = 1e-19
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 8/200 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRR-NVEREVEIMRELQHPRLIQIYDAFESS 72
           G + TVY+ K K  G  +A K + + +         RE  +++ L+H  ++ ++D   + 
Sbjct: 16  GSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK 75

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +V E +   +L + +      L  + V +F+ Q+  G+ +IH + +LH D+KP+N+
Sbjct: 76  ETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNL 134

Query: 133 LCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWSVG 189
           L ++ TG  +K+ DFGLAR K  P         T  +  P+V+   +  + T  DMW VG
Sbjct: 135 L-ISDTG-ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL-LGSTEYSTCLDMWGVG 191

Query: 190 VICYVLLSGLSPFMGETDVQ 209
            I   ++ G++ F G  D+Q
Sbjct: 192 CIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 85.0 bits (210), Expect = 1e-19
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 13/242 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER----EVEIMRELQHPRLIQIYDAF 69
           G FG V   + K TG   A K +   KR  +++ E+    E EI+ ++  P ++ +  AF
Sbjct: 4   GGFGEVCAVQVKNTGKMYACKKLD-KKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF 62

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR-QICEGVEFIHSKNVLHLDMK 128
           ES   +C+V+ L+ GG+L   + +      E    I    QI  G+  +HS ++++ DMK
Sbjct: 63  ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK 122

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L L   GN  ++ D GLA +    K +    GT  ++APE++  +   +  D +++
Sbjct: 123 PENVL-LDDQGN-CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE---ISDDAKDFIRKLLLKDR 245
           G   Y +++G +PF      + +A   + +   +DE   E    ++++KD  R  L K  
Sbjct: 181 GCSIYEMVAGRTPFKDHK--EKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP 238

Query: 246 ED 247
           ED
Sbjct: 239 ED 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 85.0 bits (210), Expect = 2e-19
 Identities = 71/247 (28%), Positives = 118/247 (47%), Gaps = 24/247 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER---EVEIMREL----QHPRLIQIY 66
           G FG VY C++  TG   A K +   KR   +  E       IM  L      P ++ + 
Sbjct: 5   GGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 63

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            AF + + +  +L+L+ GG+L    +    V +E  +  +  +I  G+E +H++ V++ D
Sbjct: 64  YAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRD 122

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV----VNFDAIGFG 182
           +KP NIL L + G+ ++I D GLA  F  +KK     GT  ++APEV    V +D+    
Sbjct: 123 LKPANIL-LDEHGH-VRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYDS---S 176

Query: 183 TDMWSVGVICYVLLSGLSPFMG--ETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
            D +S+G + + LL G SPF      D   +  +T+       E  +  S + +  +  L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---AVELPDSFSPELRSLLEGL 233

Query: 241 LLKDRED 247
           L +D   
Sbjct: 234 LQRDVNR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 37/251 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + KR +      E +++       +  ++ AF+
Sbjct: 12  GAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71

Query: 71  SSNVMCVVLELIEGGEL------FERVIDDD---FVLTEKAVAIFMRQICEGVEFIHSKN 121
             N + +V++   GG+L      FE  + +D   F L E  +AI         + +H   
Sbjct: 72  DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI---------DSVHQLG 122

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAI 179
            +H D+KP+N+L L K G+ I++ DFG   +   +  +Q  V  GTP++++PE++   A+
Sbjct: 123 YVHRDIKPDNVL-LDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ--AM 178

Query: 180 GFGT-------DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ--YDFDDECFNEIS 230
             G        D WS+GV  Y +L G +PF  E+ V+T   +   +  + F  +   ++S
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVS 237

Query: 231 DDAKDFIRKLL 241
           ++AKD IR+L+
Sbjct: 238 EEAKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 84.3 bits (209), Expect = 3e-19
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 33/214 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIYDAF-- 69
           G +G VYR ++  +G  +A K V +    D   +   RE+ ++  L+HP ++++ +    
Sbjct: 18  GTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG 77

Query: 70  ESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           +  + + +V+E  E  +    ++D+     +E  V   M Q+  G++++H   ++H D+K
Sbjct: 78  KHLDSIFLVMEYCE--QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLK 135

Query: 129 PENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEVVNFDAIGFG 182
             N+L LT  G  +KI DFGLAR +  P K +     TP+ V     APE++       G
Sbjct: 136 VSNLL-LTDKGC-LKIADFGLARTYGLPAKPM-----TPKVVTLWYRAPELL------LG 182

Query: 183 T-------DMWSVGVICYVLLSGLSPFMGETDVQ 209
                   DMW+VG I   LL+      G+++++
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 85.1 bits (210), Expect = 4e-19
 Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 54/278 (19%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   ++  T    A K +    +  RN   +V+ E +I+ E  +  ++++Y +F+
Sbjct: 12  GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             + +  V++ I GG++   +I    +  E     ++ ++   VE +H    +H D+KP+
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPD 130

Query: 131 NILCLTKTGNRIKIIDFGLARKF---------------------------DPE------- 156
           NIL + + G+ IK+ DFGL   F                           DP        
Sbjct: 131 NIL-IDRDGH-IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR 188

Query: 157 -KKLQ-------------VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPF 202
            K L+              L GTP ++APEV+         D WSVGVI Y +L G  PF
Sbjct: 189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248

Query: 203 MGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
           + +T ++T   V   Q         ++S +A D I KL
Sbjct: 249 LAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 84.3 bits (208), Expect = 5e-19
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 10/200 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKRNDRRN---VEREVEIMRELQHPRLIQIYDA 68
           G FG V   + K T    A K +   +  ++D      VE+ V  +++ + P L Q++  
Sbjct: 11  GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-KPPFLTQLHSC 69

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F++ + +  V+E + GG+L    I       E     +  +I  G+ F+H + +++ D+K
Sbjct: 70  FQTVDRLYFVMEYVNGGDLMYH-IQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLK 128

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWS 187
            +N++ L   G+ IKI DFG+ ++   +      F GTP+++APE++ +   G   D W+
Sbjct: 129 LDNVM-LDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186

Query: 188 VGVICYVLLSGLSPFMGETD 207
            GV+ Y +L+G  PF GE +
Sbjct: 187 YGVLLYEMLAGQPPFDGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 83.6 bits (207), Expect = 5e-19
 Identities = 60/192 (31%), Positives = 99/192 (51%), Gaps = 25/192 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE----REVEIMRELQHPRLIQIYDAF 69
           G +G VY+ + K TG  +A K   I   ++   V     RE+ +++ELQHP ++ + D  
Sbjct: 11  GTYGVVYKGRNKKTGQIVAMK--KIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL 68

Query: 70  ESSNVMCVVLELIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
              + + ++ E +      ++ +D       +  + V  ++ QI +G+ F HS+ VLH D
Sbjct: 69  MQESRLYLIFEFLSMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APEVVNFDAIGF 181
           +KP+N+L +   G  IK+ DFGLAR F     + V   T E V     APEV+   +  +
Sbjct: 127 LKPQNLL-IDNKGV-IKLADFGLARAFG----IPVRVYTHEVVTLWYRAPEVL-LGSPRY 179

Query: 182 GT--DMWSVGVI 191
            T  D+WS+G I
Sbjct: 180 STPVDIWSIGTI 191

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.7 bits (205), Expect = 7e-19
 Identities = 66/255 (25%), Positives = 121/255 (47%), Gaps = 36/255 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G  G V +   + TG  +A K + +      ++ + RE++I+ +   P ++  Y AF ++
Sbjct: 12  GNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71

Query: 73  NVMCVVLELIEGGEL---FERVID--DDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLD 126
             + + +E ++GG L    + V     + +L + AVA+      +G+ ++H K  ++H D
Sbjct: 72  GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL-----KGLTYLHEKHKIIHRD 126

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           +KP NIL  ++ G  IK+ DFG++ +  +   K  V  GT  ++APE +  +     +D+
Sbjct: 127 VKPSNILVNSR-GQ-IKLCDFGVSGQLVNSLAKTFV--GTSSYMAPERIQGNDYSVKSDI 182

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD--DECFNE---------ISDDAK 234
           WS+G+    L +G  P+  E D             F+      NE          S D +
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDG--------IFELLQYIVNEPPPRLPSGKFSPDFQ 234

Query: 235 DFIRKLLLKDREDAP 249
           DF+   L+KD  + P
Sbjct: 235 DFVNLCLIKDPRERP 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 83.7 bits (207), Expect = 7e-19
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 8/207 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPR-LIQIYDAF 69
           G FG V   + K T    A K +    I + +D      E  ++     P  L Q++  F
Sbjct: 11  GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 70

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +  V+E + GG+L    I       E     +  +I  G+ F+HSK +++ D+K 
Sbjct: 71  QTMDRLYFVMEYVNGGDLMYH-IQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129

Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           +N++ L   G+ IKI DFG+ ++     K  +   GTP+++APE++ +   G   D W+ 
Sbjct: 130 DNVM-LDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVT 215
           GV+ Y +L+G  PF GE + +   ++ 
Sbjct: 188 GVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.5 bits (207), Expect = 8e-19
 Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 34/222 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIYD-AFE 70
           G FG VY+ ++  TG  +A K + +    D   +   RE++I+++L+HP ++ + D A E
Sbjct: 19  GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVE 78

Query: 71  SS-------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                      + +V   ++  +L   + +    LTE  +  +M Q+ EG+ ++H  ++L
Sbjct: 79  RPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHIL 137

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFG------TPEFV-----AP 171
           H D+K  NIL +   G  +KI DFGLAR +D P    +   G      T   V      P
Sbjct: 138 HRDIKAANIL-IDNQGI-LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP 195

Query: 172 EVVNFDAIG---FGT--DMWSVGVICYVLLSGLSPFMGETDV 208
           E++    +G   + T  D+W +G +   + +      G++D+
Sbjct: 196 ELL----LGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 82.8 bits (204), Expect = 1e-18
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 28/207 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRR-NVEREVEIMRELQHPRLIQIYDAFESS 72
           G + TV++ + K T   +A K + +           REV +++ L+H  ++ ++D   + 
Sbjct: 16  GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +V E ++  +L + + +   +++   V IFM Q+  G+ + H + +LH D+KP+N+
Sbjct: 76  RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL 134

Query: 133 LCLTKTGNRIKIIDFGLAR-KFDPEKKLQ------------VLFGTPEFVAPEVVNFDAI 179
           L   K    +K+ DFGLAR K  P K               VL G+ E+  P        
Sbjct: 135 LINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP-------- 184

Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGET 206
               DMW VG I Y + +G   F G T
Sbjct: 185 ---IDMWGVGCILYEMATGRPMFPGST 208

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 84.8 bits (209), Expect = 1e-18
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 35/222 (15%)

Query: 14  GKFGTVYRCKEKATGMTL---AAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF- 69
           G+FG V+  K K T       A  + G+ +R ++  +  EV +MREL+H  +++  D F 
Sbjct: 24  GRFGEVFLVKHKRTQEFFCWKAISYRGLKER-EKSQLVIEVNVMRELKHKNIVRYIDRFL 82

Query: 70  -ESSNVMCVVLELIEGGELFERVIDDDFVL----TEKAVAIFMRQICEGVEFIHS----- 119
            +++  + +++E  + G+L  R I   + +     E A+    RQ+   + + H+     
Sbjct: 83  NKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGP 141

Query: 120 --KNVLHLDMKPENILC---------LTKTGNRI------KIIDFGLARKFDPEKKLQVL 162
             + VLH D+KP+NI           +T   N +      KI DFGL++    E      
Sbjct: 142 NGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC 201

Query: 163 FGTPEFVAPEVVNFDAIGFG--TDMWSVGVICYVLLSGLSPF 202
            GTP + +PE++  +   +   +DMW++G I Y L SG +PF
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 50/274 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   ++  T    A K +    +  RN   +V+ E +I+ E  +  ++++Y +F+
Sbjct: 12  GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             + +  V++ I GG++   +I    +  E     ++ ++   +E +H    +H D+KP+
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPD 130

Query: 131 NILCLTKTGNRIKIIDFGLARKF-------------------------------DPEKKL 159
           NIL + + G+ IK+ DFGL   F                                  K L
Sbjct: 131 NIL-IDRDGH-IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL 188

Query: 160 QV-------------LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET 206
           +              L GTP ++APEV+         D WSVGVI Y +L G  PF+ +T
Sbjct: 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT 248

Query: 207 DVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
             +T   V   +         ++S +A D I +L
Sbjct: 249 PAETQLKVINWETTLHIPSQAKLSREASDLILRL 282

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-18
 Identities = 65/168 (38%), Positives = 93/168 (55%), Gaps = 19/168 (11%)

Query: 49  REVEIMRELQHPRLIQIYD-----AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAV 103
           RE++I+R  +H  +I I D     +FES N + +V EL+E  +L+ ++I     L+   +
Sbjct: 52  REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQ-HLSNDHI 108

Query: 104 AIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF 163
             F+ QI  G+++IHS NVLH D+KP N+L L    + +KI DFGLAR  DPE      F
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLL-LNTNCD-LKICDFGLARIADPEHD-HTGF 165

Query: 164 GTPEFV------APEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
            T E+V      APE+ +N        D+WSVG I   +LS    F G
Sbjct: 166 LT-EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 82.6 bits (204), Expect = 2e-18
 Identities = 73/258 (28%), Positives = 118/258 (45%), Gaps = 30/258 (11%)

Query: 2   TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFV-------GIAKRNDRRNVEREVEIM 54
           T           G FG V   +++ TG  +A K +        +AKR       RE++++
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR-----TYRELKLL 63

Query: 55  RELQHPRLIQIYDAFES-SNVMCVVLELIEGGELFE----RVIDDDFVLTEKAVAIFMRQ 109
           + L+H  +I + D F S    +  V EL+ G +L      R ++  F+        F+ Q
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFI------QYFLYQ 116

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV 169
           I  G++++HS  V+H D+KP NI  L      +KI DFGLAR  DP+    V   T  + 
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNI--LINENCDLKICDFGLARIQDPQMTGYV--STRYYR 172

Query: 170 APEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE 228
           APE+ + +       D+WS G I   +L G   F G+  V   + +T       D+  N 
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232

Query: 229 I-SDDAKDFIRKLLLKDR 245
           I S++   F++ L  ++ 
Sbjct: 233 ICSENTLRFVQSLPKREP 250

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 82.4 bits (203), Expect = 2e-18
 Identities = 44/154 (28%), Positives = 88/154 (57%), Gaps = 4/154 (2%)

Query: 59  HPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
           +P L+ ++  F++++ + +V+E + GG+L    +     L E+    +  +IC  + F+H
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEHARFYAAEICIALNFLH 113

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFD 177
            + +++ D+K +N+L L   G+ IK+ D+G+ ++   P        GTP ++APE++  +
Sbjct: 114 ERGIIYRDLKLDNVL-LDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 178 AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
             GF  D W++GV+ + +++G SPF   TD   M
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM 205

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 81.6 bits (201), Expect = 2e-18
 Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 37/262 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESS 72
           G +G VY+   K  G   A K +      D   +E E  I++ L  HP +++ Y  F  +
Sbjct: 33  GTYGKVYKVTNKKDGSLAAVKILDPISDVDEE-IEAEYNILQSLPNHPNVVKFYGMFYKA 91

Query: 73  N-----VMCVVLELIEGG---ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           +      + +VLEL  GG   EL + ++     L E  ++  +     G++ +H+  ++H
Sbjct: 92  DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIH 151

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVV--------N 175
            D+K  NIL  T+ G  +K++DFG++ +    + +     GTP ++APEV+        +
Sbjct: 152 RDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYS 209

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV------TIAQYDFDDECFNEI 229
           +DA     D+WS+G+    L  G  P      V+T+  +      T+   +     FN  
Sbjct: 210 YDA---RCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNH- 265

Query: 230 SDDAKDFIRKLLLKDREDAPEV 251
                 FI + L+KD E  P V
Sbjct: 266 ------FISQCLIKDFEARPSV 281

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 81.3 bits (201), Expect = 2e-18
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 37/223 (16%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNV--------EREVEIMRELQHPRLIQI 65
           G FG V R        T   K + +A +  + +          +E  IM  L H  LI++
Sbjct: 6   GSFGVVRR----GEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDF------VLTEKAVAIFMRQICEGVEFIHS 119
           Y    +  +M +V EL   G L +R+  D         L + AV     QI  G+ ++ S
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAV-----QIANGMRYLES 115

Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-------LQVLFGTPEFVAPE 172
           K  +H D+   NIL  +   +++KI DFGL R     +        L+V F    + APE
Sbjct: 116 KRFIHRDLAARNILLASD--DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA---WCAPE 170

Query: 173 VVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
            +        +D+W  GV  + + + G  P+ G +  Q +  +
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.4 bits (201), Expect = 3e-18
 Identities = 61/216 (28%), Positives = 110/216 (50%), Gaps = 40/216 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---------REVEIMRELQHPRLIQ 64
           G +G VY+ + K TG  +A K +       R + E         RE+ +++EL HP +++
Sbjct: 11  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 63

Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNV 122
           + D   + N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  V
Sbjct: 64  LLDVIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APEVVNFD 177
           LH D+KP+N+  L  T   IK+ DFGLAR F     + V   T E V     APE++   
Sbjct: 122 LHRDLKPQNL--LINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLWYRAPEIL--- 172

Query: 178 AIG---FGT--DMWSVGVICYVLLSGLSPFMGETDV 208
            +G   + T  D+WS+G I   +++  + F G++++
Sbjct: 173 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 81.3 bits (201), Expect = 3e-18
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 31/204 (15%)

Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQI--- 65
           G FG V  C+       TG  +A K +  +     R + ERE+EI+R L H  +++    
Sbjct: 15  GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGV 74

Query: 66  -YDAFESSNVMCVVLELIEGGELFERVIDDDFV------LTEKAVAIFMRQICEGVEFIH 118
                  S  + +++E +  G L       D++      +  K + +F  QIC+G++++ 
Sbjct: 75  CEKPGGRS--LRLIMEYLPSGSL------RDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK----LQVLFGTPEF-VAPEV 173
           S+  +H D+   NI  L ++ + +KI DFGLA K  PE K    ++    +P F  APE 
Sbjct: 127 SQRYIHRDLAARNI--LVESEDLVKISDFGLA-KVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 174 VNFDAIGFGTDMWSVGVICYVLLS 197
           +        +D+WS GV  Y L +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 80.8 bits (200), Expect = 3e-18
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 16/175 (9%)

Query: 49  REVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFM 107
           +E +IM++L+H +L+Q+Y        + +V E +  G L + +   +   L    +    
Sbjct: 50  QEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109

Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPE------KKLQ 160
            QI EG+ ++ S+N +H D+   NI  L       KI DFGLAR   D E       K  
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNI--LVGENLVCKIADFGLARLIEDDEYTAREGAKFP 167

Query: 161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +     ++ APE  N+      +D+WS G++   +++ G  P+ G T+ + +  V
Sbjct: 168 I-----KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 81.6 bits (201), Expect = 3e-18
 Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 8/197 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRR-NVEREVEIMRELQHPRLIQIYDAFESS 72
           G + TV++ + K T   +A K + +           REV ++++L+H  ++ ++D   + 
Sbjct: 17  GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +V E ++  +L + + D   +++   V IF+ QI  G+ + H + VLH D+KP+N+
Sbjct: 77  KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135

Query: 133 LCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWSVG 189
           L   +    +K+ DFGLAR K  P K       T  +  P+V+   +  + T  DMW VG
Sbjct: 136 LINER--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL-LGSSEYSTQIDMWGVG 192

Query: 190 VICYVLLSGLSPFMGET 206
            I + + SG   F G T
Sbjct: 193 CIFFEMASGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 81.6 bits (201), Expect = 4e-18
 Identities = 53/201 (26%), Positives = 103/201 (51%), Gaps = 10/201 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN---VEREVEIMREL-QHPRLIQIYDAF 69
           G +  V   + K T    A K V     ND  +   V+ E  +  +   HP L+ ++  F
Sbjct: 6   GSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 65

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +  V+E + GG+L    +     L E+    +  +I   + ++H + +++ D+K 
Sbjct: 66  QTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 124

Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           +N+L L   G+ IK+ D+G+ ++   P        GTP ++APE++  +  GF  D W++
Sbjct: 125 DNVL-LDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182

Query: 189 GVICYVLLSGLSPF--MGETD 207
           GV+ + +++G SPF  +G +D
Sbjct: 183 GVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 4e-18
 Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 16/175 (9%)

Query: 49  REVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR 108
            E +IM++L+HP+LIQ+Y        + +V EL++ G L E +        +    I M 
Sbjct: 50  AEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA 109

Query: 109 -QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-------PEKKLQ 160
            Q+  G+ ++ ++N +H D+   N+  L    N  K+ DFGLAR             K  
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNV--LVGENNICKVADFGLARVIKEDIYEAREGAKFP 167

Query: 161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +     ++ APE   ++     +D+WS G++   +++ G  P+ G T+ + +  V
Sbjct: 168 I-----KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 80.6 bits (199), Expect = 5e-18
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 22/213 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G FG V+    K   + +A K   I K +D    +   +EV+ ++ L+H  LI ++    
Sbjct: 17  GYFGEVWEGLWKNR-VRVAIK---ILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 71  SSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
               + ++ EL+E G L   +   +  VL   ++     Q+ EG+ ++  +N +H D+  
Sbjct: 73  VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAA 132

Query: 130 ENILCLTKTGNRIKIIDFGLARKF-DP-----EKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
            NI  L       K+ DFGLAR   +      +KK+       ++ APE  +       +
Sbjct: 133 RNI--LVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY-----KWTAPEAASHGTFSTKS 185

Query: 184 DMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           D+WS G++ Y + + G  P+ G  + +    +T
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.5 bits (198), Expect = 5e-18
 Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 17/203 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIY-DAFESS 72
           G +G VY+ +   TG   A K + +   ++   +++E+ ++++  H R I  Y  AF   
Sbjct: 17  GTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75

Query: 73  N------VMCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           N       + +V+E    G + + + +     L E+ +A   R+I  G+  +H   V+H 
Sbjct: 76  NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR 135

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVV----NFDAI- 179
           D+K +N+L LT+    +K++DFG++ + D    +     GTP ++APEV+    N DA  
Sbjct: 136 DIKGQNVL-LTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 193

Query: 180 GFGTDMWSVGVICYVLLSGLSPF 202
            F +D+WS+G+    +  G  P 
Sbjct: 194 DFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.5 bits (198), Expect = 9e-18
 Identities = 69/247 (27%), Positives = 113/247 (45%), Gaps = 24/247 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAK---FVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG VY      T   +A K   + G       +++ +EV+ +++L+HP  I+    + 
Sbjct: 32  GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL 91

Query: 71  SSNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             +   +V+E   G   +L E        L E  +A       +G+ ++HS N++H D+K
Sbjct: 92  KEHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV------NFDAIGFG 182
             NIL LT+ G ++K+ DFG A K  P        GTP ++APEV+       +D     
Sbjct: 149 AGNIL-LTEPG-QVKLADFGSASKSSPANS---FVGTPYWMAPEVILAMDEGQYDG---K 200

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
            D+WS+G+ C  L     P      +  + +  IAQ D      NE +D  + F+   L 
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNDSPTLQSNEWTDSFRGFVDYCLQ 258

Query: 243 KDREDAP 249
           K  ++ P
Sbjct: 259 KIPQERP 265

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 80.0 bits (197), Expect = 9e-18
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 13/197 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER---EVEIMRELQH----PRLIQIY 66
           G FG VY C++  TG   A K +   KR   +  E       IM  L      P ++ + 
Sbjct: 5   GGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMT 63

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            AF + + +C +L+L+ GG+L    +    V +EK +  +  +I  G+E +H++ V++ D
Sbjct: 64  YAFHTPDKLCFILDLMNGGDLHYH-LSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRD 122

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDM 185
           +KP NIL L + G+ ++I D GLA  F  +KK     GT  ++APEV+    A     D 
Sbjct: 123 LKPANIL-LDEHGH-VRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 186 WSVGVICYVLLSGLSPF 202
           +S+G + + LL G SPF
Sbjct: 180 FSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 1e-17
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 42/217 (19%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--------REVEIMRELQHPRLIQI 65
           G + TVY+ + K TG  +A K +       R   E        RE  ++++L+H  ++ +
Sbjct: 16  GSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           +D   +   + +V E ++  +L + + D    L+   V +F+ Q+  G+ + H + VLH 
Sbjct: 69  HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127

Query: 126 DMKPENILCLTKTGNRIKIIDFGLAR-KFDPEKKLQ------------VLFGTPEFVAPE 172
           D+KP+N+L +++ G  +K+ DFGLAR K  P K               VL G+ E+    
Sbjct: 128 DLKPQNLL-ISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTS- 184

Query: 173 VVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ 209
                      DMW VG I Y + +G   F G TDV+
Sbjct: 185 ----------LDMWGVGCIFYEMATGRPLFPGSTDVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 80.0 bits (197), Expect = 1e-17
 Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 8/199 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL----QHPRLIQIYDAF 69
           G FG V   + K T    A K +         +VE  +   R L    + P L Q++  F
Sbjct: 11  GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF 70

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +  V+E + GG+L  + I       E     +  +I  G+ F+HSK +++ D+K 
Sbjct: 71  QTMDRLYFVMEYVNGGDLMYQ-IQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSV 188
           +N++ L   G+ IKI DFG+ ++   +      F GTP+++APE++ +   G   D W+ 
Sbjct: 130 DNVM-LDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187

Query: 189 GVICYVLLSGLSPFMGETD 207
           GV+ Y +L+G +PF GE +
Sbjct: 188 GVLLYEMLAGQAPFEGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 79.7 bits (196), Expect = 1e-17
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 8/197 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRR-NVEREVEIMRELQHPRLIQIYDAFESS 72
           G + TVY+ + K T   +A K + +           REV ++++L+H  ++ ++D   + 
Sbjct: 17  GTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +V E ++  +L + + D    +    V +F+ Q+  G+ + H + VLH D+KP+N+
Sbjct: 77  KSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135

Query: 133 LCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWSVG 189
           L   +    +K+ DFGLAR K  P K       T  +  P+++   +  + T  DMW VG
Sbjct: 136 LINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL-LGSTDYSTQIDMWGVG 192

Query: 190 VICYVLLSGLSPFMGET 206
            I Y + +G   F G T
Sbjct: 193 CIFYEMSTGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 79.3 bits (195), Expect = 2e-17
 Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 37/262 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESS 72
           G +G V++   K  G   A K +      D   +E E  I++ L  HP +++ Y  +   
Sbjct: 29  GTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE-IEAEYNILKALSDHPNVVKFYGMYYKK 87

Query: 73  NV-----MCVVLELIEGG---ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           +V     + +VLEL  GG   +L +  +     + E  +A  + +   G++ +H    +H
Sbjct: 88  DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIH 147

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVV--------N 175
            D+K  NIL  T+ G  +K++DFG++ +    + +     GTP ++APEV+         
Sbjct: 148 RDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST 205

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV------TIAQYDFDDECFNEI 229
           +DA     D+WS+G+    L  G  P      ++ +  +      T+ Q +     FN  
Sbjct: 206 YDA---RCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFN-- 260

Query: 230 SDDAKDFIRKLLLKDREDAPEV 251
                DFIRK L KD E  P V
Sbjct: 261 -----DFIRKCLTKDYEKRPTV 277

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.0 bits (195), Expect = 2e-17
 Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 16/196 (8%)

Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQI---- 65
           G FG+V  C+    +  TG  +A K +  +     R+ ERE+EI++ LQH  +++     
Sbjct: 15  GNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVC 74

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           Y A      + +V+E +  G L + +      L  + + ++  QIC+G+E++ SK  +H 
Sbjct: 75  YSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHR 132

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEF-VAPEVVNFDAIGF 181
           D+   NI  L ++ NR+KI DFGL +    +K+   +     +P F  APE +       
Sbjct: 133 DLATRNI--LVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSV 190

Query: 182 GTDMWSVGVICYVLLS 197
            +D+WS GV+ Y L +
Sbjct: 191 ASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 79.8 bits (197), Expect = 2e-17
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 21/217 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G V    +  TG  +A K +     +  D   + RE++++R L+HP +++I      
Sbjct: 11  GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP 70

Query: 72  SNV-----MCVVLELIEGGELFERVI--DDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
            +      + VV EL+E      +VI  +DD  LT +    F+ Q+   +++IH+ NV H
Sbjct: 71  PSRREFKDIYVVFELMESD--LHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVFH 126

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF----GTPEFVAPEVVN--FDA 178
            D+KP+NI  L     ++KI DFGLAR    +    + +     T  + APE+    F  
Sbjct: 127 RDLKPKNI--LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 184

Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVT 215
                D+WS+G I   +L+G   F G+  V  +  +T
Sbjct: 185 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLIT 221

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.4 bits (195), Expect = 2e-17
 Identities = 68/247 (27%), Positives = 114/247 (46%), Gaps = 24/247 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAK---FVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG VY  ++  T   +A K   + G       +++ +EV+ ++ ++HP  I+    + 
Sbjct: 36  GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95

Query: 71  SSNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             +   +V+E   G   +L E        L E  +A       +G+ ++HS N++H D+K
Sbjct: 96  REHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 152

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV------NFDAIGFG 182
             NIL LT+ G ++K+ DFG A    P        GTP ++APEV+       +D     
Sbjct: 153 AGNIL-LTEPG-QVKLADFGSASIASPANS---FVGTPYWMAPEVILAMDEGQYDG---K 204

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
            D+WS+G+ C  L     P      +  + +  IAQ +      NE SD  ++F+   L 
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNESPTLQSNEWSDYFRNFVDSCLQ 262

Query: 243 KDREDAP 249
           K  +D P
Sbjct: 263 KIPQDRP 269

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 2e-17
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 7/169 (4%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQ 109
           E ++M +L HP L+Q+Y        + +V E +  G L   + +    L  + +      
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP--- 166
           +CE +E++ S   +H D+   N  CL    N +K+ DFGLAR +  + +     GT    
Sbjct: 109 VCEAMEYLESNGFIHRDLAARN--CLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPV 165

Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           ++  PEV ++      +D+WS GV+ + + S G  P+   ++ + + +V
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.5 bits (193), Expect = 2e-17
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 20/204 (9%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDD--FVLTEKAVAIFM 107
           E  +M+ LQH +L+++Y        + ++ E +  G L + +  D+   VL  K +  F 
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID-FS 109

Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTP 166
            QI EG+ +I  KN +H D++  N+L         KI DFGLAR   D E   +     P
Sbjct: 110 AQIAEGMAYIERKNYIHRDLRAANVL--VSESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMA------------ 212
            ++ APE +NF +    +D+WS G++ Y +++ G  P+ G ++   M+            
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRME 227

Query: 213 NVTIAQYDFDDECFNEISDDAKDF 236
           N     YD    C+ E +++   F
Sbjct: 228 NCPDELYDIMKTCWKEKAEERPTF 251

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.4 bits (193), Expect = 3e-17
 Identities = 52/206 (25%), Positives = 102/206 (49%), Gaps = 9/206 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G+FG V+  K +A  + +A K +     ++   +E E ++M +L HP+L+Q+Y       
Sbjct: 15  GQFGVVHLGKWRAQ-IKVAIKAINEGAMSEEDFIE-EAKVMMKLSHPKLVQLYGVCTQQK 72

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V E +E G L   +      L++  +    + +CEG+E++   + +H D+   N  
Sbjct: 73  PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN-- 130

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVGV 190
           CL  +   +K+ DFG+ R +  + +     G     ++  PEV NF      +D+WS GV
Sbjct: 131 CLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189

Query: 191 ICY-VLLSGLSPFMGETDVQTMANVT 215
           + + V   G  PF  +++ + +  ++
Sbjct: 190 LMWEVFTEGKMPFEKKSNYEVVEMIS 215

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 79.7 bits (196), Expect = 3e-17
 Identities = 69/266 (25%), Positives = 117/266 (43%), Gaps = 42/266 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNV---EREVEIMRELQHPRLIQIYDAFE 70
           G FG V   ++K TG   A K +  A   ++  V     E +I+ E     +++++ +F+
Sbjct: 12  GAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + +++E + GG++   ++  D  LTE+    ++ +    ++ IH    +H D+KP+
Sbjct: 72  DKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD 130

Query: 131 NILCLTKTGNRIKIIDFGLA-------------------------------RKFDPEK-- 157
           N+L  +K    +K+ DFGL                                RK +  K  
Sbjct: 131 NLLLDSK--GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188

Query: 158 KLQVLF---GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           + Q+ F   GTP+++APEV          D WS+GVI Y +L G  PF  ET  +T   V
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248

Query: 215 TIAQYDFDDECFNEISDDAKDFIRKL 240
              +          IS+ AKD I + 
Sbjct: 249 MNWKETLIFPPEVPISEKAKDLILRF 274

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 78.9 bits (194), Expect = 3e-17
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 11/204 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G V +C+ K T   +A K    ++ N+  +    RE++++R L+   ++++ +AF  
Sbjct: 12  GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71

Query: 72  SNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V E +E    EL E + +   V  EK V  ++ Q+ + + + H  +++H D+KP
Sbjct: 72  RGKLYLVFEYVEKNMLELLEEMPNG--VPPEK-VRSYIYQLIKAIHWCHKNDIVHRDIKP 128

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDP--EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           EN+  L    + +K+ DFG AR               T  + +PE++     G   DMWS
Sbjct: 129 ENL--LISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWS 186

Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           VG I   L  G   F GE+++  +
Sbjct: 187 VGCILGELSDGQPLFPGESEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 78.9 bits (195), Expect = 4e-17
 Identities = 75/265 (28%), Positives = 119/265 (44%), Gaps = 51/265 (19%)

Query: 14  GKFGTVYRCKEKATGMTLAAK-----FVGI--AKRNDRRNVEREVEIMRELQHPRLIQIY 66
           G +G V    +  TG  +A K     F     AKR       RE+ +++ + H  +I + 
Sbjct: 26  GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR-----TYRELRLLKHMDHENVIGLL 80

Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E    + +V  L+ G +L   ++     L++  +   + QI  G+++IHS 
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSA 137

Query: 121 NVLHLDMKPENIL----CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV-N 175
            ++H D+KP NI     C       +KI+DFGLAR  D E    V   T  + APE++ N
Sbjct: 138 GIIHRDLKPSNIAVNEDC------ELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLN 189

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF--------DDECFN 227
           +       D+WSVG I   LL+G + F G           I Q           D+E   
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSD--------HIDQLKRIMNLVGTPDEELLQ 241

Query: 228 EI-SDDAKDFIRKLLLKDREDAPEV 251
           +I S+ A+++I+ L    ++D  EV
Sbjct: 242 KISSESARNYIQSLPQMPKKDFKEV 266

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.1 bits (192), Expect = 4e-17
 Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQ 109
           E ++M +L HP+L+Q+Y      + +C+V E +E G L + +       +++ +      
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP--- 166
           +CEG+ ++ S NV+H D+   N  CL      +K+ DFG+ R F  + +     GT    
Sbjct: 109 VCEGMAYLESSNVIHRDLAARN--CLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPV 165

Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTI--------- 216
           ++ +PEV +F      +D+WS GV+ + + S G +P+   ++ + +  +           
Sbjct: 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL 225

Query: 217 ---AQYDFDDECFNEISDDAKDFIRKL 240
              + Y+    C+ E  +D   F   L
Sbjct: 226 ASQSVYELMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 78.4 bits (193), Expect = 4e-17
 Identities = 65/255 (25%), Positives = 115/255 (45%), Gaps = 31/255 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR-RNVEREVEIMRELQHPRLIQIYDAF--E 70
           G +G+VY+   + TG+T+A K + +     +   +  E++I+ +   P ++  Y AF  E
Sbjct: 12  GNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71

Query: 71  SSNVMCVVLELIEGGEL-------FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NV 122
            +  MC  +E ++ G L              + VL     A+       G++F+  + N+
Sbjct: 72  GAVYMC--MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVK-----GLKFLKEEHNI 124

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPE-VVNFDAIG 180
           +H D+KP N+L       ++K+ DFG++        L +   G   ++APE + +     
Sbjct: 125 IHRDVKPTNVLVNGN--GQVKLCDFGVSGNL--VASLAKTNIGCQSYMAPERIKSGGPNQ 180

Query: 181 FGT-----DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF-NEISDDAK 234
             T     D+WS+G+    +  G  P+  ET     A ++ A  D D     +  SDDA+
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-AIVDGDPPTLPSGYSDDAQ 239

Query: 235 DFIRKLLLKDREDAP 249
           DF+ K L K     P
Sbjct: 240 DFVAKCLNKIPNRRP 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 7e-17
 Identities = 69/220 (31%), Positives = 102/220 (46%), Gaps = 39/220 (17%)

Query: 14  GKFGTVYRCKEKA--TGMTLAAK-FVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDA 68
           G +G VY+ K K    G   A K F G  ++     ++  RE+ ++REL+H  ++ + + 
Sbjct: 11  GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEV 70

Query: 69  FESSNVMCVVLELIEGGE--LFERVIDDDFVLTEKAVAI-------FMRQICEGVEFIHS 119
           F       V L L +  E  L++ +I   F    K V+I        + QI  GV ++HS
Sbjct: 71  FLEHADKSVYL-LFDYAEHDLWQ-IIK--FHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126

Query: 120 KNVLHLDMKPENILCLTKTGN---RIKIIDFGLARKFDPEKKLQVLF-GTPEFV-----A 170
             VLH D+KP NIL +   G     +KI D GLAR F+    L+ L    P  V     A
Sbjct: 127 NWVLHRDLKPANIL-VMGEGPERGVVKIGDLGLARLFNA--PLKPLADLDPVVVTIWYRA 183

Query: 171 PEVV-----NFDAIGFGTDMWSVGVICYVLLSGLSPFMGE 205
           PE++        AI    D+W++G I   LL+    F G 
Sbjct: 184 PELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 77.5 bits (191), Expect = 7e-17
 Identities = 62/254 (24%), Positives = 109/254 (42%), Gaps = 39/254 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE------REVEIMRELQHPRLIQIYD 67
           G FG VY+ +       L+A  V I    +    +      +E E+M +LQHP ++ +  
Sbjct: 16  GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLG 75

Query: 68  AFESSNVMCVVLELIEGGELFERVI------------DDDFVLTEKAVAIFMR---QICE 112
                   C++ E +  G+L E ++             D+ V +    + F+    QI  
Sbjct: 76  VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135

Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+E++ S + +H D+   N  CL   G  +KI DFGL+R        +V   +     ++
Sbjct: 136 GMEYLSSHHFVHRDLAARN--CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWM 193

Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ---------- 218
            PE + +      +D+WS GV+ + + S GL P+ G ++ + +  +   Q          
Sbjct: 194 PPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPA 253

Query: 219 --YDFDDECFNEIS 230
             Y    EC+NEI 
Sbjct: 254 RVYALMIECWNEIP 267

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 78.1 bits (192), Expect = 8e-17
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 46/265 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER---EVEIMRELQHPRLIQIYDAFE 70
           G FG V   ++K TG   A K +  A   ++  V     E +I+ E     +++++ +F+
Sbjct: 12  GAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + +++E + GG++   ++  D  L+E+A   ++ +    ++ IH    +H D+KP+
Sbjct: 72  DKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPD 130

Query: 131 NILCLTKTGNRIKIIDFGLA-------------------------------RKFDPEKK- 158
           N+L   K    +K+ DFGL                                RK +  KK 
Sbjct: 131 NLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188

Query: 159 -LQVLF---GTPEFVAPEVVNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMA 212
             Q+ +   GTP+++APEV  F   G+    D WS+GVI Y +L G  PF  ET  +T  
Sbjct: 189 RRQLAYSTVGTPDYIAPEV--FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR 246

Query: 213 NVTIAQYDFDDECFNEISDDAKDFI 237
            V   +          IS+ AKD I
Sbjct: 247 KVMNWKETLVFPPEVPISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 9e-17
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 16/206 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHP---RLIQIYDAF 69
           G FG VY+   K     +A K        + +R   +E EI+++  HP   +LI +    
Sbjct: 6   GNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV--CV 62

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +   +  +V+EL+ GG L   +      LT K +         G+E++ SKN +H D+  
Sbjct: 63  QKQPIY-IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE----FVAPEVVNFDAIGFGTDM 185
            N  CL    N +KI DFG++R+ +      V  G  +    + APE +N+      +D+
Sbjct: 122 RN--CLVGENNVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQT 210
           WS G++ +   S G +P+ G ++ QT
Sbjct: 179 WSYGILLWETFSLGDTPYPGMSNQQT 204

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.8 bits (189), Expect = 9e-17
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G++G VY    K   +T+A K      + D   VE   +E  +M+E++HP L+Q+     
Sbjct: 17  GQYGEVYEGVWKKYSLTVAVK----TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKP 129
                 ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+  
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFDAIGFG 182
            N  CL    + +K+ DFGL+R    +        K  +     ++ APE + ++     
Sbjct: 133 RN--CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-----KWTAPESLAYNKFSIK 185

Query: 183 TDMWSVGVICYVLLS-GLSPFMG 204
           +D+W+ GV+ + + + G+SP+ G
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 77.9 bits (192), Expect = 9e-17
 Identities = 53/205 (25%), Positives = 103/205 (50%), Gaps = 12/205 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN---VEREVEIMREL-QHPRLIQIYDAF 69
           G +  V   + K T    A K +     ND  +   V+ E  +      HP L+ ++  F
Sbjct: 6   GSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF 65

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +  V+E + GG+L    +     L E+    +  +I   + F+H + +++ D+K 
Sbjct: 66  QTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKL 124

Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           +N+L L   G+ IK+ D+G+ ++   P        GTP ++APE++  +  GF  D W++
Sbjct: 125 DNVL-LDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182

Query: 189 GVICYVLLSGLSPFMGETDVQTMAN 213
           GV+ + +++G SPF    D+  M++
Sbjct: 183 GVLMFEMMAGRSPF----DIVGMSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 77.2 bits (190), Expect = 9e-17
 Identities = 54/193 (27%), Positives = 99/193 (51%), Gaps = 13/193 (6%)

Query: 13  FGKFGTVYRCKEKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAFES 71
            G  GTVY+     T   LA K + +    + ++ +  E+EI+ +   P +I  Y AF  
Sbjct: 11  HGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV 70

Query: 72  SNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +  E ++GG L  + ++   + VL   AVA+      +G+ ++ S  +LH D+KP
Sbjct: 71  ENRISICTEFMDGGSLDVYRKI--PEHVLGRIAVAVV-----KGLTYLWSLKILHRDVKP 123

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
            N+L  T+   ++K+ DFG++ +       +   GT  ++APE ++ +  G  +D+WS+G
Sbjct: 124 SNMLVNTR--GQVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLG 180

Query: 190 VICYVLLSGLSPF 202
           +    L  G  P+
Sbjct: 181 ISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 69/278 (24%), Positives = 113/278 (40%), Gaps = 54/278 (19%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V    +  T    A K +    +  RN   +V+ E +I+ E  +  ++++Y +F+
Sbjct: 12  GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ 71

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             + +  V++ I GG++   +I  + V  E     ++ ++   +E +H    +H D+KP+
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPD 130

Query: 131 NILCLTKTGNRIKIIDFGLARKF-----------------------------------DP 155
           NI  L      IK+ DFGL   F                                   D 
Sbjct: 131 NI--LIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188

Query: 156 EKKLQ-------------VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPF 202
            K L+              L GTP ++APEV+         D WSVGVI + +L G  PF
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248

Query: 203 MGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
           +  T  +T   V   +         ++S +A D I KL
Sbjct: 249 LAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 76.8 bits (189), Expect = 2e-16
 Identities = 69/252 (27%), Positives = 111/252 (44%), Gaps = 34/252 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAK---FVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG VY  ++  T   +A K   + G       +++ +EV  +++L+HP  I+    + 
Sbjct: 26  GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFV------LTEKAVAIFMRQICEGVEFIHSKNVLH 124
             +   +V+E   G          D +      L E  +A       +G+ ++HS   +H
Sbjct: 86  REHTAWLVMEYCLGSA-------SDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV------NFDA 178
            D+K  NIL LT+ G  +K+ DFG A    P        GTP ++APEV+       +D 
Sbjct: 139 RDIKAGNIL-LTEPG-TVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM-ANVTIAQYDFDDECFNEISDDAKDFI 237
                D+WS+G+ C  L     P     ++  M A   IAQ D      N+ SD  ++F+
Sbjct: 194 ---KVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247

Query: 238 RKLLLKDREDAP 249
              L K  +D P
Sbjct: 248 DSCLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 46/216 (21%)

Query: 14  GKFGTVYR-----------------CKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRE 56
           G+FG VY+                 CK   +  ++  KF+             E  IMR+
Sbjct: 17  GQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-SVREKFLQ------------EAYIMRQ 63

Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEF 116
             HP ++++       N + +V+EL   GEL   +  + + L   ++ ++  Q+   + +
Sbjct: 64  FDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122

Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-------KLQVLFGTPEFV 169
           + SK  +H D+   N+L  +     +K+ DFGL+R  + E        KL +     +++
Sbjct: 123 LESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESYYKASKGKLPI-----KWM 175

Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           APE +NF      +D+W  GV  + +L  G+ PF G
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 75.3 bits (185), Expect = 3e-16
 Identities = 55/175 (31%), Positives = 95/175 (54%), Gaps = 19/175 (10%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR- 108
           E  +M++LQHPRL+++Y A  +   + ++ E +E G L       DF+ T + + + +  
Sbjct: 51  EANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPEGIKLTINK 103

Query: 109 ------QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQV 161
                 QI EG+ FI  KN +H D++  NIL +++T    KI DFGLAR   D E   + 
Sbjct: 104 LIDMAAQIAEGMAFIERKNYIHRDLRAANIL-VSETLC-CKIADFGLARLIEDNEYTARE 161

Query: 162 LFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
               P ++ APE +N+      +D+WS G++   +++ G  P+ G T+ + + N+
Sbjct: 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.8 bits (186), Expect = 3e-16
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 17/203 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIY-DAF--- 69
           G +G VY+ +   TG   A K + + + ++   ++ E+ ++++  H R I  Y  AF   
Sbjct: 27  GTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85

Query: 70  ---ESSNVMCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
                 + + +V+E    G + + V +     L E  +A   R+I  G+  +H+  V+H 
Sbjct: 86  SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHR 145

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVV----NFDAI- 179
           D+K +N+L LT+    +K++DFG++ + D    +     GTP ++APEV+    N DA  
Sbjct: 146 DIKGQNVL-LTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 203

Query: 180 GFGTDMWSVGVICYVLLSGLSPF 202
            + +D+WS+G+    +  G  P 
Sbjct: 204 DYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 76.3 bits (188), Expect = 4e-16
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 32/222 (14%)

Query: 13  FGKFGTVYRCKEKATGMTLAAK-----FVGI--AKRNDRRNVEREVEIMRELQHPRLIQI 65
           +G FG V+   +   G  +A K     F  +   KR     V RE++++   +H  ++  
Sbjct: 10  YGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKR-----VFRELKMLCFFKHDNVLSA 64

Query: 66  YDAFESSNVMC-----VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
            D  +  ++       VV EL++      ++I     L+   V +F+ QI  G++++HS 
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSD--LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA 122

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APEVVN 175
            +LH D+KP N+  L  +   +KI DFGLAR  +P++   +   T E V     APE++ 
Sbjct: 123 GILHRDIKPGNL--LVNSNCVLKICDFGLARVEEPDESKHM---TQEVVTQYYRAPEIL- 176

Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANVT 215
             +  + +  D+WSVG I   LL     F  ++ +Q +  +T
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.0 bits (187), Expect = 4e-16
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 8/199 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMR-ELQHPRLIQIYDAF 69
           G FG V   + K T    A K +    I + +D      E  I+    +HP L  ++  F
Sbjct: 6   GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF 65

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +  V+E + GG+L  + I       E     +  ++   + F+H   V++ D+K 
Sbjct: 66  QTKDRLFFVMEYVNGGDLMFQ-IQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKL 124

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSV 188
           +NIL L   G+  K+ DFG+ ++          F GTP+++APE++     G   D W++
Sbjct: 125 DNIL-LDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWAL 182

Query: 189 GVICYVLLSGLSPFMGETD 207
           GV+ Y +++G  PF  + +
Sbjct: 183 GVLMYEMMAGQPPFEADNE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 75.8 bits (186), Expect = 5e-16
 Identities = 72/242 (29%), Positives = 117/242 (48%), Gaps = 27/242 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAK-----FVGI--AKRNDRRNVEREVEIMRELQHPRLIQIY 66
           G +G+V    +  TG+ +A K     F  I  AKR       RE+ +++ ++H  +I + 
Sbjct: 28  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-----YRELRLLKHMKHENVIGLL 82

Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 83  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 139

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 140 DIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 195

Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255

Query: 239 KL 240
            L
Sbjct: 256 SL 257

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 75.2 bits (185), Expect = 6e-16
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 28/198 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE----REVEIMRELQHPRLIQIYDAF 69
           G +G VY+ ++K TG  +A K V +   N++        RE++I+R+L H  ++ + +  
Sbjct: 18  GTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAIREIKILRQLNHRNIVNLKEIV 75

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFV---------LTEKAVAIFMRQICEGVEFIHSK 120
                     +      L    +D D +          +E  +  FM+Q+ EG+ + H K
Sbjct: 76  TDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK 135

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-------LQVLFGTPEFVAPEV 173
           N LH D+K  NIL   K   +IK+ DFGLAR ++ E+        + + +  PE +  E 
Sbjct: 136 NFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE- 192

Query: 174 VNFDAIGFGTDMWSVGVI 191
              +  G   D+WS G I
Sbjct: 193 ---ERYGPAIDVWSCGCI 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 76.3 bits (188), Expect = 6e-16
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 42/225 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND-------RRNVEREVEIMRELQHPRLIQIY 66
           G  G VY   +      +A K +    R D       ++   RE +I  +L HP ++ +Y
Sbjct: 13  GGMGEVYLAYDPVCSRRVALKKI----REDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 67  DAFESSNVMCVVLELIEG---GELFERVIDDDFV---LTEK-AVAIFMR---QICEGVEF 116
                 + +   +  IEG     L + V   + +   L EK +V  F+    +IC  +E+
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV--------------- 161
           +HSK VLH D+KP+NIL L   G  + I+D+G A     E++  +               
Sbjct: 129 VHSKGVLHRDLKPDNIL-LGLFG-EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186

Query: 162 ----LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPF 202
               + GTP+++APE +        TD++++GVI Y +L+   P+
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 74.2 bits (182), Expect = 1e-15
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 12/201 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G + TVY+   +  G  +A K + +  +        RE  +++ L+H  ++ ++D   + 
Sbjct: 16  GSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK 75

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             +  V E +   +L + +I     L    V +FM Q+  G+ +IH +++LH D+KP+N+
Sbjct: 76  ETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134

Query: 133 L--CLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWS 187
           L   L      +K+ DFGLAR K  P +       T  +  P+V+   A  + +  D+W 
Sbjct: 135 LISYL----GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL-LGATDYSSALDIWG 189

Query: 188 VGVICYVLLSGLSPFMGETDV 208
            G I   +L G   F G +DV
Sbjct: 190 AGCIFIEMLQGQPAFPGVSDV 210

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.8 bits (181), Expect = 1e-15
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 13/198 (6%)

Query: 14  GKFGTV----YRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG V    Y+ ++K   + +        K + R  + RE EIM +L +P ++++    
Sbjct: 6   GNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMIGVC 64

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           E+  +M +V+E+  GG L + +      +T   V   M Q+  G++++  KN +H D+  
Sbjct: 65  EAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAA 123

Query: 130 ENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDM 185
            N+L + +  +  KI DFGL++     D   K +     P ++ APE +NF      +D+
Sbjct: 124 RNVLLVNQ--HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181

Query: 186 WSVGVICYVLLS-GLSPF 202
           WS G+  +   S G  P+
Sbjct: 182 WSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 31/200 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHP---RLIQI--- 65
           G FG V++ + K T   +A K V +    +   +   RE++I++ L+H     LI+I   
Sbjct: 23  GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82

Query: 66  ----YDAFESSNVMCVVLELIE---GGELFERVIDDDFVLTE-KAVAIFMRQICEGVEFI 117
               Y+ ++ S    +V E  E    G L  + +   F L+E K V   M+ +  G+ +I
Sbjct: 83  KATPYNRYKGS--FYLVFEFCEHDLAGLLSNKNVK--FTLSEIKKV---MKMLLNGLYYI 135

Query: 118 HSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APE 172
           H   +LH DMK  NIL +TK G  +K+ DFGLAR F   K  +    T   V      PE
Sbjct: 136 HRNKILHRDMKAANIL-ITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Query: 173 VVNFDA-IGFGTDMWSVGVI 191
           ++  +   G   DMW  G I
Sbjct: 194 LLLGERDYGPPIDMWGAGCI 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.3 bits (182), Expect = 2e-15
 Identities = 48/190 (25%), Positives = 98/190 (51%), Gaps = 6/190 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN-VEREVEIMRELQHPRLIQIYDAFESS 72
           G  G V + + K +G+ +A K + +  +   RN + RE++++ E   P ++  Y AF S 
Sbjct: 16  GNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLDMKPEN 131
             + + +E ++GG L ++V+ +   + E+ +      +  G+ ++  K+ ++H D+KP N
Sbjct: 76  GEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSN 134

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           IL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+WS+G+ 
Sbjct: 135 ILVNSR--GEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191

Query: 192 CYVLLSGLSP 201
              L  G  P
Sbjct: 192 LVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.9 bits (181), Expect = 2e-15
 Identities = 65/247 (26%), Positives = 110/247 (44%), Gaps = 24/247 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAK---FVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG VY  ++      +A K   + G       +++ +EV  +++L+HP  IQ    + 
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85

Query: 71  SSNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             +   +V+E   G   +L E        L E  +A       +G+ ++HS N++H D+K
Sbjct: 86  REHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV------NFDAIGFG 182
             NIL L++ G  +K+ DFG A    P        GTP ++APEV+       +D     
Sbjct: 143 AGNIL-LSEPG-LVKLGDFGSASIMAPANX---FVGTPYWMAPEVILAMDEGQYDG---K 194

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
            D+WS+G+ C  L     P      +  + +  IAQ +         S+  ++F+   L 
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNESPALQSGHWSEYFRNFVDSCLQ 252

Query: 243 KDREDAP 249
           K  +D P
Sbjct: 253 KIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.7 bits (178), Expect = 3e-15
 Identities = 57/204 (27%), Positives = 107/204 (52%), Gaps = 21/204 (10%)

Query: 14  GKFGTVYR--CKEKATGMTLAAKFVGIAKRNDRRN------VEREVEIMRELQHPRLIQI 65
           G FGTV +   K K +  T+A K +    +ND  +      + RE  +M++L +P ++++
Sbjct: 6   GNFGTVKKGMYKMKKSEKTVAVKIL----KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
               E+ + M +V+EL E G L  + +  +  +TEK +   + Q+  G++++   N +H 
Sbjct: 62  IGICEAESWM-LVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EFVAPEVVNFDAIGF 181
           D+   N+L +T+  +  KI DFGL++    ++   K +     P ++ APE +N+     
Sbjct: 120 DLAARNVLLVTQ--HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177

Query: 182 GTDMWSVGVICYVLLS-GLSPFMG 204
            +D+WS GV+ +   S G  P+ G
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKG 201

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.5 bits (180), Expect = 3e-15
 Identities = 46/184 (25%), Positives = 96/184 (52%), Gaps = 6/184 (3%)

Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN-VEREVEIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  +   RN + RE++++ E   P ++  Y 
Sbjct: 11  SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 71  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 129

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+W
Sbjct: 130 VKPSNILVNSR--GEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186

Query: 187 SVGV 190
           S+G+
Sbjct: 187 SMGL 190

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 72.0 bits (176), Expect = 5e-15
 Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 19/175 (10%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFM 107
           E  I+++  HP ++++         + +V+EL+ GG+   F R   D+  L  K +  F 
Sbjct: 42  EARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFA 99

Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-------KKLQ 160
                G+ ++ SKN +H D+   N  CL    N +KI DFG++R+ D         K++ 
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARN--CLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157

Query: 161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +     ++ APE +N+      +D+WS G++ +   S G+ P+ G T+ Q    V
Sbjct: 158 I-----KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 70.8 bits (173), Expect = 1e-14
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG V+  + +A    +A K        D +    +E  I+++  HP ++++       
Sbjct: 6   GNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 65

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +V+EL++GG+    +  +   L  K +   +     G+E++ SK+ +H D+   N 
Sbjct: 66  QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARN- 124

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP-------EFVAPEVVNFDAIGFGTDM 185
            CL    N +KI DFG++R    E++  V   T        ++ APE +N+      +D+
Sbjct: 125 -CLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQT 210
           WS G++ +   S G  P+   ++ QT
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQT 205

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 31/217 (14%)

Query: 14  GKFGTV----YRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHP---RLIQI 65
           G FG+V    Y  K     + +A K +        ++   RE  +M +L HP   RLI +
Sbjct: 6   GNFGSVVKGVYLMK-SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV 64

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
                    + +V+EL   G L + +     +     +     Q+  G+ ++ SK+ +H 
Sbjct: 65  CKG----EPLMLVMELAPLGPLLKYLKKRREI-PVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 126 DMKPENILCLTKTGNRIKIIDFGLAR---------KFDPEKKLQVLFGTPEFVAPEVVNF 176
           D+   N+L + +  ++ KI DFG++R         +     +  +     ++ APE +N+
Sbjct: 120 DLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPL-----KWYAPECINY 172

Query: 177 DAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMA 212
                 +D+WS GV  +   S G  P+      + +A
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA 209

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 71.1 bits (174), Expect = 2e-14
 Identities = 52/196 (26%), Positives = 98/196 (50%), Gaps = 15/196 (7%)

Query: 14  GKFGTVYRCKEKA----TGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG V  C+       TG  +A K +      N   ++++E+EI+R L H  +++ Y  
Sbjct: 15  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK-YKG 73

Query: 69  F---ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
               +  N + +++E +  G L E +  +   +  K    +  QIC+G++++ S+  +H 
Sbjct: 74  ICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR 133

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL---FGTPEF-VAPEVVNFDAIGF 181
           D+   N+  L ++ +++KI DFGL +  + +K+   +     +P F  APE +       
Sbjct: 134 DLAARNV--LVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYI 191

Query: 182 GTDMWSVGVICYVLLS 197
            +D+WS GV  Y LL+
Sbjct: 192 ASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 7/163 (4%)

Query: 45  RNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVA 104
           +   RE++I++ + H  +I +  A+   + +C+V+   +  +LF   +D    L  +   
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFT-YVDRSGPLPLEQAI 188

Query: 105 IFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD--PEK-KLQV 161
              R++ E + ++H + ++H D+K ENI  L +  N + + DFG A K D  P+  +   
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIF-LDEPENAV-LGDFGAACKLDAHPDTPQCYG 246

Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
             GT E  +PE++  D     TD+WS G++ + +        G
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 25/220 (11%)

Query: 45  RNVEREVEIMRELQHPRLIQIYDAF------ESSNVMCVVLELIEGGEL-----FERVID 93
           R   RE+ +++ ++H  +I + D F      E+ N + +V  L+ G +L      +++ D
Sbjct: 59  RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSD 117

Query: 94  DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF 153
           +        V   + Q+  G+++IHS  ++H D+KP N+         ++I+DFGLAR+ 
Sbjct: 118 EH-------VQFLIYQLLRGLKYIHSAGIIHRDLKPSNV--AVNEDCELRILDFGLARQA 168

Query: 154 DPEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
           D E    V   T  + APE+ +N+       D+WSVG I   LL G + F G   +  + 
Sbjct: 169 DDEMTGYV--ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK 226

Query: 213 NVTIAQYDFDDECFNEISDD-AKDFIRKLLLKDREDAPEV 251
            +         E   +IS + A+ +I+ L    ++D  ++
Sbjct: 227 RIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKI 266

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 69.6 bits (170), Expect = 4e-14
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 41/252 (16%)

Query: 16  FGTVYRCKEKATGMTLAAKFVGIAKRNDRRN------VEREVEIMRELQHPRLIQIYDAF 69
           FG +Y+      GM   A+ V I    D  N       ++E  +M EL HP ++ +    
Sbjct: 18  FGKIYKGHLYLPGMD-HAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV 76

Query: 70  ESSNVMCVVLELIEGGELFERVI-------------DDDFVLTEKAVAIFMR---QICEG 113
                +C++ E +  G+L E +I             +D  V +      F+    QI  G
Sbjct: 77  TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAG 136

Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT--P-EFVA 170
           +E++ S   +H D+   NIL   +    +KI D GL+R+       +V   +  P  ++ 
Sbjct: 137 MEYLSSHFFVHKDLAARNILIGEQL--HVKISDLGLSREIYSADYYRVQPKSLLPIRWMP 194

Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ----------- 218
           PE + +      +D+WS GV+ + + S GL P+ G ++ + +  V   Q           
Sbjct: 195 PEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPR 254

Query: 219 -YDFDDECFNEI 229
            Y    EC+ E 
Sbjct: 255 MYSLMTECWQEG 266

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 8e-14
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 16/202 (7%)

Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIY 66
           G FGTVY+      G    + +A K   + +    +  +    E  +M  + HP ++++ 
Sbjct: 18  GAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPHVVRLL 75

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
               SS  + ++ +L+  G L + V +    +  + +  +  QI +G+ ++  K ++H D
Sbjct: 76  GICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG--TP-EFVAPEVVNFDAIGFGT 183
           +   N+L   KT   +KI DFGLA+  D ++K     G   P +++A E +        +
Sbjct: 135 LAARNVL--VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKS 192

Query: 184 DMWSVGVICYVLLS-GLSPFMG 204
           D+WS GV  + L++ G  P+ G
Sbjct: 193 DVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 69.6 bits (170), Expect = 8e-14
 Identities = 63/237 (26%), Positives = 120/237 (50%), Gaps = 17/237 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +GTV    ++ TG  +A K +    +++   +   RE+ +++ ++H  +I + D F  
Sbjct: 26  GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85

Query: 72  S------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
                  +   +V+  + G +L + +  +   L+E  +   + Q+ +G+++IH+  ++H 
Sbjct: 86  DLSLDRFHDFYLVMPFM-GTDLGKLMKHEK--LSEDRIQFLVYQMLKGLKYIHAAGIIHR 142

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV-NFDAIGFGTD 184
           D+KP N+         +KI+DFGLAR+ D E    V+  T  + APEV+ N+       D
Sbjct: 143 DLKPGNL--AVNEDCELKILDFGLARQTDSEMTGYVV--TRWYRAPEVILNWMHYTQTVD 198

Query: 185 MWSVGVICYVLLSGLSPFMGETDV-QTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
           +WSVG I   +L+G   F G   + Q M  + +      +      S+DAK++++KL
Sbjct: 199 IWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 69.5 bits (170), Expect = 9e-14
 Identities = 71/256 (27%), Positives = 114/256 (44%), Gaps = 42/256 (16%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG-------IAKRNDRRNVEREVEIMRELQHPRLIQIY 66
           G +G+V    +K TG  +A K +         AKR       RE+ +++ +QH  +I + 
Sbjct: 26  GAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR-----AYRELTLLKHMQHENVIGLL 80

Query: 67  DAFESSNV-------------MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           D F S+               M   L+ I G  L           +E  V   + Q+  G
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPL-----------SEDKVQYLVYQMLCG 129

Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV 173
           +++IHS  ++H D+KP N+         +KI+DFGLAR  D E    V+  T  + APEV
Sbjct: 130 LKYIHSAGIIHRDLKPGNL--AVNEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEV 185

Query: 174 V-NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD- 231
           + N+       D+WSVG I   +L+G + F G+  +  +  +         E   ++ D 
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 232 DAKDFIRKLLLKDRED 247
            AK +I+ L    R+D
Sbjct: 246 AAKSYIKSLPKYPRKD 261

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 69.3 bits (170), Expect = 9e-14
 Identities = 48/217 (22%), Positives = 95/217 (43%), Gaps = 22/217 (10%)

Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIY 66
             F       + + K   T   +A K + +   +        +E+   R+LQHP ++   
Sbjct: 8   KCFEDLMIVHLAKHK--PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLH 124
            +F   + + VV  L+  G   E ++   F   L E A+A  ++ +   +++IHSK  +H
Sbjct: 66  TSFIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEF-------VAPEVVNF 176
             +K  +IL L+  G ++ +     +       K+ +V+   P+        ++PEV+  
Sbjct: 125 RSVKASHIL-LSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 177 DAIGFG--TDMWSVGVICYVLLSGLSPFMGETDVQTM 211
           +  G+   +D++SVG+    L +G  PF    D+   
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVPF---KDMPAT 216

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 68.6 bits (167), Expect = 9e-14
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI---AKRNDRRNVEREVEIMREL-QHPRLIQIYDAF 69
           G FG V + + K  G+ + A    +   A ++D R+   E+E++ +L  HP +I +  A 
Sbjct: 6   GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 65

Query: 70  ESSNVMCVVLELIEGGELFE-----RVIDDD----------FVLTEKAVAIFMRQICEGV 114
           E    + + +E    G L +     RV++ D            L+ + +  F   +  G+
Sbjct: 66  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 125

Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV 174
           +++  K  +H D+   NIL         KI DFGL+R  +   K  +      ++A E +
Sbjct: 126 DYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 183

Query: 175 NFDAIGFGTDMWSVGVICYVLLS-GLSPFMGET 206
           N+      +D+WS GV+ + ++S G +P+ G T
Sbjct: 184 NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.9 bits (168), Expect = 1e-13
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 26/215 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI---AKRNDRRNVEREVEIMREL-QHPRLIQIYDAF 69
           G FG V R   K  G+ + A    +   A  ND R+   E+E++ +L  HP +I +  A 
Sbjct: 13  GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC 72

Query: 70  ESSNVMCVVLELIEGGELFE-----RVIDDD----------FVLTEKAVAIFMRQICEGV 114
           E+   + + +E    G L +     RV++ D            LT + +  F   +  G+
Sbjct: 73  ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGM 132

Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKFDPEKKLQVLFGTPEFVAPE 172
           +++  K  +H D+   N+L     G  +  KI DFGL+R  +   K  +      ++A E
Sbjct: 133 QYLSEKQFIHRDLAARNVL----VGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIE 188

Query: 173 VVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGET 206
            +N+      +D+WS GV+ + ++S G +P+ G T
Sbjct: 189 SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.6 bits (165), Expect = 2e-13
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 14  GKFGTVYRCKEKATG---MTLAAKF--VGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G+FG V R + K  G   + +A K    G  ++  RR+   E  IM +  HP +I +   
Sbjct: 15  GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIHLEGV 73

Query: 69  FESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
              S  + ++ E +E G L  F R  D  F + +  +   +R I  G++++   N +H D
Sbjct: 74  VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYLSEMNYVHRD 131

Query: 127 MKPENILCLTKTGNRI-KIIDFGLARKF-----DPEKKLQVLFGTP-EFVAPEVVNFDAI 179
           +   NIL      N + K+ DFGL+R       DP     +    P  + APE + +   
Sbjct: 132 LAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188

Query: 180 GFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
              +D+WS G++ + ++S G  P+  M   DV
Sbjct: 189 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 220

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 67.4 bits (164), Expect = 2e-13
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 19/172 (11%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI---- 105
           E  +M+ LQH +L++++ A  +   + ++ E +  G L       DF+ +++        
Sbjct: 51  EANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLL------DFLKSDEGSKQPLPK 103

Query: 106 ---FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQV 161
              F  QI EG+ FI  +N +H D++  NI  L       KI DFGLAR   D E   + 
Sbjct: 104 LIDFSAQIAEGMAFIEQRNYIHRDLRAANI--LVSASLVCKIADFGLARVIEDNEYTARE 161

Query: 162 LFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTM 211
               P ++ APE +NF +    +D+WS G++   +++ G  P+ G ++ + +
Sbjct: 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 67.2 bits (164), Expect = 4e-13
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 25/206 (12%)

Query: 14  GKFGTV----YRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIY 66
           G FG V    Y      TG  +A K   + +   ++N     +E+ I++ L H  +++  
Sbjct: 15  GHFGKVSLYCYDPANDGTGEMVAVK--TLKRECGQQNTSGWKKEINILKTLYHENIVKYK 72

Query: 67  DAFESS--NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
                     + +++E +  G L + +      L +  + +F +QICEG+ ++HS++ +H
Sbjct: 73  GCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLFAQQICEGMAYLHSQHYIH 130

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG----TPEF-VAPEVVNFDAI 179
            D+   N+  L      +KI DFGLA+   PE            +P F  A E +  +  
Sbjct: 131 RDLAARNV--LLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLKENKF 187

Query: 180 GFGTDMWSVGVICYVLL----SGLSP 201
            + +D+WS GV  Y LL    S  SP
Sbjct: 188 SYASDVWSFGVTLYELLTHCDSKQSP 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 67.3 bits (164), Expect = 4e-13
 Identities = 56/223 (25%), Positives = 109/223 (48%), Gaps = 34/223 (15%)

Query: 13  FGKF--GTVYRCKEKATGMTLAAKFVGI-AKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           FGK    T +R K +A   T+A K +   A  ++ R++  E  +++++ HP +I++Y A 
Sbjct: 13  FGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72

Query: 70  ESSNVMCVVLELIEGGEL-----FERVI------------------DDDFVLTEKAVAIF 106
                + +++E  + G L       R +                   D+  LT   +  F
Sbjct: 73  SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132

Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFG- 164
             QI  G++++    ++H D+   N+  L   G ++KI DFGL+R  ++ +  ++   G 
Sbjct: 133 AWQISRGMQYLAEMKLVHRDLAARNV--LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGR 190

Query: 165 TP-EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
            P +++A E + FD I    +D+WS GV+ + +++ G +P+ G
Sbjct: 191 IPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 46/194 (23%), Positives = 90/194 (46%), Gaps = 16/194 (8%)

Query: 27  TGMTLAAKFVGIAKRNDRRNV---EREVEIMRELQHPRLIQIYDAFESS-NVMCVVLELI 82
           TG  +A K +      +        RE  +   L HP ++ + D+ E+   ++  V E +
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 83  EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR- 141
            G  L E +  D  +   +   + M Q+ + +   H++ ++H D+KP+NI+ +++TG R 
Sbjct: 62  PGRTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIM-VSQTGVRP 119

Query: 142 -IKIIDFG---LARKFDPEKKLQV-----LFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
             K++DFG   L           +     + GTP + APE +  + +   +D+++ G+I 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 193 YVLLSGLSPFMGET 206
              L+G     G +
Sbjct: 180 LECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.4 bits (162), Expect = 8e-13
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)

Query: 12  SFGKF--GTVYRCKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQIYD 67
           +FGK    T Y   +    M +A K +   A  ++R  +  E++IM  L  H  ++ +  
Sbjct: 47  AFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLG 106

Query: 68  AFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           A      + V+ E    G+L  F R   + F+  E  ++ F  Q+ +G+ F+ SKN +H 
Sbjct: 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS-FSYQVAKGMAFLASKNCIHR 165

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV---LFGTPEFVAPEVVNFDAIGFG 182
           D+   N+L LT  G  +KI DFGLAR    +    V        +++APE +      F 
Sbjct: 166 DLAARNVL-LTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 223

Query: 183 TDMWSVGVICYVLLS-GLSPFMG 204
           +D+WS G++ + + S G +P+ G
Sbjct: 224 SDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 65.9 bits (160), Expect = 1e-12
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 14/201 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND----RRNVE--REVEIMRELQHPRLIQIYD 67
           G FGTVY+      G T+    V I   N+    + NVE   E  IM  + HP L+++  
Sbjct: 18  GAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLG 76

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
              S  +  +V +L+  G L + V +    +  + +  +  QI +G+ ++  + ++H D+
Sbjct: 77  VCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDL 135

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTD 184
              N+L   K+ N +KI DFGLAR  + ++K     G     +++A E +++      +D
Sbjct: 136 AARNVL--VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 193

Query: 185 MWSVGVICYVLLS-GLSPFMG 204
           +WS GV  + L++ G  P+ G
Sbjct: 194 VWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.5 bits (159), Expect = 2e-12
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 25/224 (11%)

Query: 14  GKFGTVYR------CKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG V+       C E+   + +A K +  A  N R++  RE E++  LQH  +++ Y 
Sbjct: 16  GAFGKVFLAECYNLCPEQDK-ILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYG 74

Query: 68  AFESSNVMCVVLELIEGGEL--FERVIDDDFV----------LTEKAVAIFMRQICEGVE 115
                + + +V E ++ G+L  F R    D V          LT+  +    +QI  G+ 
Sbjct: 75  VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMV 134

Query: 116 FIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPE 172
           ++ S++ +H D+   N  CL      +KI DFG++R        +V   T     ++ PE
Sbjct: 135 YLASQHFVHRDLATRN--CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192

Query: 173 VVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
            + +      +D+WS+GV+ + + + G  P+   ++ + +  +T
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 2e-12
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 3/148 (2%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQ 109
           E  +++ + HP +I++ D   S  + C+VL      +L+  +      L      I  +Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV 169
           I EG+ ++H++ ++H D+K ENI       +++ I D G A+          L GT E  
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENI--FINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223

Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS 197
           APEV+  D      D+WS G++ + +L+
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 64.2 bits (156), Expect = 3e-12
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 11/210 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK----RNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G+FG V+R   K  G    A  +   K       R++   E  IM +  H  +I++    
Sbjct: 16  GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
                  ++ E +E G L + + D D   +   +   +R I  G++++   N +H D+  
Sbjct: 76  TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAA 135

Query: 130 ENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGT-P-EFVAPEVVNFDAIGFGTDM 185
            NI  L  +    K+ DFGL+R    DPE       G  P  + APE + +      +D+
Sbjct: 136 RNI--LVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDV 193

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           WS G++ + ++S G  P+   ++ + M  +
Sbjct: 194 WSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 64.1 bits (156), Expect = 3e-12
 Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 5/169 (2%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQ 109
           E ++M +L H +L+Q+Y        + +V E +  G L   + +         +    + 
Sbjct: 49  EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTP-E 167
           +CEG+ ++ SK  +H D+   N  CL      +K+ DFGL+R   D E    V    P  
Sbjct: 109 VCEGMAYLESKQFIHRDLAARN--CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166

Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           +  PEV+ +      +D+W+ GV+ + + S G  P+    + +T+  V+
Sbjct: 167 WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 64.3 bits (156), Expect = 3e-12
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 11/171 (6%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMR 108
           E +IM++L+H +L+Q+Y A  S   + +V E +  G L + + D +   L    +     
Sbjct: 51  EAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109

Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVLFGT 165
           Q+  G+ +I   N +H D++  NIL     G+ +  KI DFGLAR   D E   +     
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANIL----VGDGLVCKIADFGLARLIEDNEYTARQGAKF 165

Query: 166 P-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           P ++ APE   +      +D+WS G++   L++ G  P+ G  + + +  V
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.6 bits (157), Expect = 3e-12
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAA---KFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAF 69
           G FG V + + K  G+ + A   +    A ++D R+   E+E++ +L  HP +I +  A 
Sbjct: 18  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 77

Query: 70  ESSNVMCVVLELIEGGELFE-----RVIDDD----------FVLTEKAVAIFMRQICEGV 114
           E    + + +E    G L +     RV++ D            L+ + +  F   +  G+
Sbjct: 78  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 137

Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV 174
           +++  K  +H D+   NI  L       KI DFGL+R  +   K  +      ++A E +
Sbjct: 138 DYLSQKQFIHRDLAARNI--LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 195

Query: 175 NFDAIGFGTDMWSVGVICYVLLS-GLSPFMGET 206
           N+      +D+WS GV+ + ++S G +P+ G T
Sbjct: 196 NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 64.7 bits (157), Expect = 6e-12
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF---- 69
           G FG VY      T   +A K V      D +   RE+ IM+ L H  +I + D +    
Sbjct: 77  GSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132

Query: 70  ----ESSNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
               E +  + VV+E I     +  +    ++  L    V ++  Q+C  + +IHSK + 
Sbjct: 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFIC 192

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           H D+KP+N+L    T + +K+ DFG A+     ++      +  + APE++   A  + T
Sbjct: 193 HRDLKPQNLLIDPNT-HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM-LGATNYTT 250

Query: 184 --DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
             D+WS+G I   ++ G   F G++ V  +  +
Sbjct: 251 HIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283

Length = 440

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.4 bits (154), Expect = 7e-12
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 21/210 (10%)

Query: 14  GKFGTVYRCKEKATG---MTLAAKF--VGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G+FG V   + K  G   + +A K    G  ++  RR+   E  IM +  HP +I +   
Sbjct: 15  GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNIIHLEGV 73

Query: 69  FESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
              S  + +V E +E G L  F R  D  F + +  +   +R I  G++++     +H D
Sbjct: 74  VTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYLSDMGYVHRD 131

Query: 127 MKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P-EFVAPEVVNFDAIGF 181
           +   NIL      N + K+ DFGL+R    DPE       G  P  + APE + +     
Sbjct: 132 LAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188

Query: 182 GTDMWSVGVICYVLLS-GLSPF--MGETDV 208
            +D+WS G++ + ++S G  P+  M   DV
Sbjct: 189 ASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 9e-12
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAK---FVGI------AKRNDRRNVEREVEIMRELQHPRLIQ 64
           G+FG V R       + L  K    V I      +    R +   E  IM +  HP +I+
Sbjct: 15  GEFGEVCR-----GRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 65  IYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           +      S  + ++ E +E G L  F R  D  F +  + V + +R I  G++++   N 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVG-QLVGM-LRGIASGMKYLSEMNY 127

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG-TP-EFVAPEVVNFDAI 179
           +H D+   NI  L  +    K+ DFGL+R+  D E       G  P  + APE + +   
Sbjct: 128 VHRDLAARNI--LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185

Query: 180 GFGTDMWSVGVICYVLLS 197
              +D+WS G++ + ++S
Sbjct: 186 TSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 63.2 bits (153), Expect = 1e-11
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 20/202 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G +G VY+ K K            I       +  RE+ ++REL+HP +I +   F S +
Sbjct: 12  GTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHS 71

Query: 74  VMCVVLELIEGGE-------LFERVIDDD---FVLTEKAVAIFMRQICEGVEFIHSKNVL 123
              V L L +  E        F R    +     L    V   + QI +G+ ++H+  VL
Sbjct: 72  DRKVWL-LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVL 130

Query: 124 HLDMKPENILCLTK--TGNRIKIIDFGLARKFD----PEKKLQVLFGTPEFVAPEVVNFD 177
           H D+KP NIL + +     R+KI D G AR F+    P   L  +  T  + APE++   
Sbjct: 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL-LG 189

Query: 178 AIGF--GTDMWSVGVICYVLLS 197
           A  +    D+W++G I   LL+
Sbjct: 190 ARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 62.6 bits (152), Expect = 1e-11
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 34/217 (15%)

Query: 14  GKFGTVYRCK---EKATGMTLAAKFV--GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G+FG+V   +   E  +   +A K +   I   +D     RE   M+E  HP +I++   
Sbjct: 10  GEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGV 69

Query: 69  FESSN------VMCVVLELIEGGEL-----FERVIDDDFVLTEKAVAIFMRQICEGVEFI 117
              S       +  V+L  ++ G+L       R+ ++ F L  + +  FM  I  G+E++
Sbjct: 70  SLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL 129

Query: 118 HSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--------DPEKKLQVLFGTPEFV 169
            SKN +H D+   N  C+      + + DFGL++K             KL V +   E +
Sbjct: 130 SSKNFIHRDLAARN--CMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESL 187

Query: 170 APEV--VNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
           A  V   + D   FG  MW       ++  G +P+ G
Sbjct: 188 ADNVYTTHSDVWAFGVTMWE------IMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.0 bits (153), Expect = 1e-11
 Identities = 55/240 (22%), Positives = 102/240 (42%), Gaps = 42/240 (17%)

Query: 14  GKFGTVYRCK----------------EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRE 56
           G+FG V+ C+                 K   + +A K +   A +N R +  +EV+I+  
Sbjct: 16  GQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSR 75

Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGELFE----RVIDDD--------------FVL 98
           L+ P +I++       + +C++ E +E G+L +      +DD                 +
Sbjct: 76  LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAI 135

Query: 99  TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPE 156
           +  ++     QI  G++++ S N +H D+   N  CL      IKI DFG++R       
Sbjct: 136 SYSSLLHVALQIASGMKYLSSLNFVHRDLATRN--CLVGENLTIKIADFGMSRNLYAGDY 193

Query: 157 KKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS--GLSPFMGETDVQTMAN 213
            ++Q     P  ++A E +        +D+W+ GV  + +L      P+   TD Q + N
Sbjct: 194 YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 30/158 (18%)

Query: 49  REVEIMRELQHPRLIQIYDAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKA 102
           RE+ +M+ + H  +I + + F      E    + +V+EL++      +VI  D  L  + 
Sbjct: 64  RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMD--LDHER 119

Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL 162
           ++  + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR           
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLAR-----TAGTSF 172

Query: 163 FGTPEFV-----APEVVNFDAIGFG----TDMWSVGVI 191
             TP  V     APEV+    +G G     D+WSVG I
Sbjct: 173 MMTPYVVTRYYRAPEVI----LGMGYKENVDIWSVGCI 206

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 62.4 bits (151), Expect = 2e-11
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 20/202 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G +G VY+ K K            I       +  RE+ ++REL+HP +I +   F S  
Sbjct: 12  GTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA 71

Query: 74  VMCVVLELIEGGE-------LFERVIDDD---FVLTEKAVAIFMRQICEGVEFIHSKNVL 123
              V L L +  E        F R    +     L    V   + QI +G+ ++H+  VL
Sbjct: 72  DRKVWL-LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 130

Query: 124 HLDMKPENILCLTK--TGNRIKIIDFGLARKFD----PEKKLQVLFGTPEFVAPEVVNFD 177
           H D+KP NIL + +     R+KI D G AR F+    P   L  +  T  + APE++   
Sbjct: 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL-LG 189

Query: 178 AIGF--GTDMWSVGVICYVLLS 197
           A  +    D+W++G I   LL+
Sbjct: 190 ARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 66/253 (26%), Positives = 116/253 (45%), Gaps = 23/253 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAF-- 69
           G  GTV   K  + G   A K V +   +  D+   + EV  +       +++ ++ F  
Sbjct: 43  GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102

Query: 70  ------ESSNVMCVVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSK 120
                 E+  ++ +VL+    G+L + +      +    E    +   Q+   V  +HSK
Sbjct: 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK 162

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV---LFGTPEFVAPEVVNFD 177
           +++H D+K  NIL L   G  +K+ DFG ++ +       V     GTP +VAPE+    
Sbjct: 163 HMIHRDIKSANIL-LCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK 220

Query: 178 AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIA-QYDFDDECFNEISDDAKDF 236
                 DM+S+GV+ Y LL+   PF GE +++ + + T+A +Y   D     IS + ++ 
Sbjct: 221 PYSKKADMFSLGVLLYELLTLKRPFDGE-NMEEVMHKTLAGRY---DPLPPSISPEMQEI 276

Query: 237 IRKLLLKDREDAP 249
           +  LL  D +  P
Sbjct: 277 VTALLSSDPKRRP 289

Length = 496

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 62.4 bits (151), Expect = 2e-11
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 14/206 (6%)

Query: 7   QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDR--RNVEREVEIMRELQHPRLIQ 64
           Q      G  G V    +   G+ +A K +    +N    +   RE+ +++ + H  +I 
Sbjct: 25  QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIIS 84

Query: 65  IYDAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
           + + F      E    + +V+EL++      +VI  +  L  + ++  + Q+  G++ +H
Sbjct: 85  LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHME--LDHERMSYLLYQMLCGIKHLH 140

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA 178
           S  ++H D+KP NI  + K+   +KI+DFGLAR       +     T  + APEV+    
Sbjct: 141 SAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 198

Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMG 204
                D+WSVG I   L+ G   F G
Sbjct: 199 YKENVDIWSVGCIMGELVKGSVIFQG 224

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 14/207 (6%)

Query: 49  REVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFM 107
           +E ++M++L+H +L+Q+Y A  S   + +V E +  G L + +  +    L    +    
Sbjct: 50  QEAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 108

Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVLFG 164
            QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +    
Sbjct: 109 AQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTARQGAK 164

Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD 222
            P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +  + 
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERGYR 221

Query: 223 DECFNEISDDAKDFIRKLLLKDREDAP 249
             C  E  +   D + +   K+ E+ P
Sbjct: 222 MPCPPECPESLHDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 61.2 bits (149), Expect = 4e-11
 Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 29/165 (17%)

Query: 14  GKFGTVYRCK---------------EKATGMTL-AAKFVGI-AKRNDRRNVEREVEIMRE 56
           G+FG V+ C+               + A    L A K +   A  N R +  +EV+I+  
Sbjct: 16  GQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSR 75

Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGE----LFERVIDDDFVLTEK-----AVAIFM 107
           L  P + ++         +C+++E +E G+    L + V +   +         +  ++M
Sbjct: 76  LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYM 135

Query: 108 -RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR 151
             QI  G+ ++ S N +H D+   N  CL      IKI DFG++R
Sbjct: 136 ATQIASGMRYLESLNFVHRDLATRN--CLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.8 bits (147), Expect = 5e-11
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)

Query: 15  KFGTVYRCKEKATGMTLAAKFVGIAKRND------RRNVEREVEIMRELQHPRLIQIYDA 68
           +FG VY+     T      + V I    D      R   + E  +   LQHP ++ +   
Sbjct: 17  RFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGV 76

Query: 69  FESSNVMCVVLELIEGGELFERVI------------DDDFVLTEKAVAIFMR---QICEG 113
                 + ++       +L E ++            DD  V +    A F+    QI  G
Sbjct: 77  VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAG 136

Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVA 170
           +EF+ S +V+H D+   N+L   K    +KI D GL R+    D  K +        +++
Sbjct: 137 MEFLSSHHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADYYKLMGNSLLPIRWMS 194

Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETD 207
           PE + +      +D+WS GV+ + + S GL P+ G ++
Sbjct: 195 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 61.2 bits (148), Expect = 6e-11
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 21/180 (11%)

Query: 49  REVEIMRELQHPRLIQIYDAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKA 102
           RE+ +M+ + H  +I + + F      E    + +V+EL++      +VI  +  L  + 
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHER 127

Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL 162
           ++  + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +   
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPY 185

Query: 163 FGTPEFVAPEVVNFDAIGFG----TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
             T  + APEV+    +G G     D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 186 VVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 60.1 bits (146), Expect = 9e-11
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 22/170 (12%)

Query: 50  EVEIMRELQHPRLIQ-IYDAFESSNVMCVVLELIEGGELFERVIDDDF-------VLTEK 101
           E  +M  L+HP L+Q +    + + +  +V E +  G L       D+       V+T  
Sbjct: 50  EASVMTTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLV------DYLRSRGRAVITLA 102

Query: 102 AVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV 161
               F   +CEG+E++  KN +H D+   N+  L       K+ DFGLA+  +  +    
Sbjct: 103 QQLGFALDVCEGMEYLEEKNFVHRDLAARNV--LVSEDLVAKVSDFGLAK--EASQGQDS 158

Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
                ++ APE +        +D+WS G++ + + S G  P+  +   DV
Sbjct: 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 46/186 (24%), Positives = 88/186 (47%), Gaps = 22/186 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN-VEREVEIMRELQHPRLIQIYDAFESS 72
           G  G V +   + +G+ +A K + +  +   RN + RE++++ E   P ++  Y AF S 
Sbjct: 12  GNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPEN 131
             + + +E ++GG L ++V+     + E  +      +  G+ ++  K  ++H D+KP N
Sbjct: 72  GEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN 130

Query: 132 ILCLTKTGNRIKIIDFG--------LARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           I  L  +   IK+ DFG        +A  F          GT  +++PE +        +
Sbjct: 131 I--LVNSRGEIKLCDFGVSGQLIDSMANSF---------VGTRSYMSPERLQGTHYTVQS 179

Query: 184 DMWSVG 189
           D+WS+G
Sbjct: 180 DIWSLG 185

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 60.1 bits (145), Expect = 1e-10
 Identities = 49/172 (28%), Positives = 87/172 (50%), Gaps = 11/172 (6%)

Query: 49  REVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM- 107
           +E +IM++L+H +L+ +Y A  S   + +V E +  G L + + + D    +    + M 
Sbjct: 50  QEAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA 108

Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVLFG 164
            QI +G+ +I   N +H D++  NIL     G+ +  KI DFGLAR   D E   +    
Sbjct: 109 AQIADGMAYIERMNYIHRDLRAANIL----VGDNLVCKIADFGLARLIEDNEYTARQGAK 164

Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
            P ++ APE   +      +D+WS G++   L++ G  P+ G  + + +  V
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.3 bits (146), Expect = 1e-10
 Identities = 40/117 (34%), Positives = 63/117 (53%), Gaps = 8/117 (6%)

Query: 93  DDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK 152
           +D+  L  + +  F  Q+ +G+ F+ SKN +H D+   NIL LT  G   KI DFGLAR 
Sbjct: 206 EDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNIL-LTH-GRITKICDFGLARD 263

Query: 153 FDPEKKLQVLFGTP----EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
              +    V+ G      +++APE +      F +D+WS G++ + + S G SP+ G
Sbjct: 264 IRNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 60/236 (25%), Positives = 94/236 (39%), Gaps = 51/236 (21%)

Query: 14  GKFGTVYR-----CKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQ-IY 66
           G FG VY          A  + +A K +       D  +   E  IM +  H  +++ I 
Sbjct: 17  GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIG 76

Query: 67  DAFESSNVMCVVLELIEGGEL--FERV----IDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
            +FE      ++LEL+ GG+L  F R      +    LT K +    R + +G +++   
Sbjct: 77  VSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135

Query: 121 NVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF-------------------DPEKKLQ 160
           + +H D+   N L   K   R+ KI DFG+AR                      PE  L 
Sbjct: 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD 195

Query: 161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
            +F +                 TD+WS GV+ + + S G  P+ G T+ + M  VT
Sbjct: 196 GIFTSK----------------TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.1 bits (145), Expect = 1e-10
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 20/153 (13%)

Query: 49  REVEIMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKA 102
           RE+ +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + 
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQME--LDHER 120

Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL 162
           ++  + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +   
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPY 178

Query: 163 FGTPEFVAPEVVNFDAIGFG----TDMWSVGVI 191
             T  + APEV+    +G G     D+WSVG I
Sbjct: 179 VVTRYYRAPEVI----LGMGYKENVDIWSVGCI 207

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 43/236 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI--------------------AKRNDRRNVEREVEI 53
           G+FG V+ C+  A G+   A+F+G                       +  R +  +E++I
Sbjct: 16  GQFGEVHLCE--AEGL---AEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGE----LFERVIDDDFVLT------EKAV 103
           M  L++P +I++     S + +C++ E +E G+    L +R I+  F           A 
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 104 AIFMR-QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--KLQ 160
            ++M  QI  G++++ S N +H D+   N  CL      IKI DFG++R        ++Q
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRN--CLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVL--LSGLSPFMGETDVQTMAN 213
                P  ++A E +        +D+W+ GV  + +  L    P+   +D Q + N
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.9 bits (143), Expect = 3e-10
 Identities = 64/257 (24%), Positives = 115/257 (44%), Gaps = 36/257 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-----H--PRLIQIY 66
           G  G VY+ + K TG  +A K +   +R    N E    I+ +L      H  P +++ Y
Sbjct: 26  GTCGQVYKMRFKKTGHVMAVKQM---RRTG--NKEENKRILMDLDVVLKSHDCPYIVKCY 80

Query: 67  DAFESSNVMCVVLELIEGGELFERVID------DDFVLTEKAVAIFMRQICEGVEFIHSK 120
             F + + + + +EL+      ++++        + +L +  VAI      + + ++  K
Sbjct: 81  GYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIV-----KALHYLKEK 133

Query: 121 -NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN---- 175
             V+H D+KP NIL L  +GN +K+ DFG++ +    K      G   ++APE ++    
Sbjct: 134 HGVIHRDVKPSNIL-LDASGN-VKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDP 191

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMG-ETDVQTMANVTIAQYDFDDECFNE-ISDDA 233
                   D+WS+G+    L +G  P+   +T+ + +    I Q +      NE  S D 
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK--ILQEEPPSLPPNEGFSPDF 249

Query: 234 KDFIRKLLLKDREDAPE 250
             F+   L KD    P+
Sbjct: 250 CSFVDLCLTKDHRKRPK 266

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.1 bits (143), Expect = 3e-10
 Identities = 38/123 (30%), Positives = 63/123 (51%), Gaps = 12/123 (9%)

Query: 39  AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELF---------E 89
           A +N R +  +E++IM  L+ P +I++     +S+ +C++ E +E G+L          E
Sbjct: 58  ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117

Query: 90  RVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFG 148
                D V    +  IFM  QI  G++++ S N +H D+   N  CL      IKI DFG
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN--CLVGKNYTIKIADFG 175

Query: 149 LAR 151
           ++R
Sbjct: 176 MSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 26/225 (11%)

Query: 6   NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNV-EREVEIMRELQHPRLIQ 64
            + +  S GK G  Y+ K    GM    +FV + + ND  ++   E+  M +LQHP +++
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGM----QFV-VKEINDVNSIPSSEIADMGKLQHPNIVK 747

Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH---SKN 121
           +     S     ++ E IEG  L E + +  +    K        I + + F+H   S  
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRK----IAIGIAKALRFLHCRCSPA 803

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           V+  ++ PE I+   K    +++    L      + K    F +  +VAPE      I  
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLRL---SLPGLLCTDTK---CFISSAYVAPETRETKDITE 857

Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI---AQYDFDD 223
            +D++  G+I   LL+G SP     D +   + +I   A+Y + D
Sbjct: 858 KSDIYGFGLILIELLTGKSP----ADAEFGVHGSIVEWARYCYSD 898

Length = 968

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 28/221 (12%)

Query: 14  GKFGTV-----YRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG V     Y        M +A K +       R++ +RE E++  LQH  +++ Y  
Sbjct: 16  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 75

Query: 69  FESSNVMCVVLELIEGGEL--FERVIDDDFVLT----------EKAVAIFMR---QICEG 113
               + + +V E ++ G+L  F R    D ++           E  ++  +    QI  G
Sbjct: 76  CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 135

Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVA 170
           + ++ S++ +H D+   N  CL      +KI DFG++R        +V   T     ++ 
Sbjct: 136 MVYLASQHFVHRDLATRN--CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 193

Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
           PE + +      +D+WS GVI + + + G  P+  +  T+V
Sbjct: 194 PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 22/188 (11%)

Query: 28  GMTLAAKFVG--IAKRNDRRNVE-----REVEIMRELQHPRLIQIYDAFESSNVMCVVLE 80
           G  L  ++ G  +A +N + +V       E  +M +L H  L+++       N + +V+E
Sbjct: 20  GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI-LHNGLYIVME 78

Query: 81  LIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT 138
           L+  G L  F R      V   + +  F   + EG+E++ SK ++H D+   NI  L   
Sbjct: 79  LMSKGNLVNFLRTRGRALVSVIQLLQ-FSLDVAEGMEYLESKKLVHRDLAARNI--LVSE 135

Query: 139 GNRIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVL 195
               K+ DFGLAR         KL V     ++ APE +        +D+WS GV+ + +
Sbjct: 136 DGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSKSDVWSYGVLLWEV 190

Query: 196 LS-GLSPF 202
            S G +P+
Sbjct: 191 FSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 40/113 (35%), Positives = 64/113 (56%), Gaps = 8/113 (7%)

Query: 97  VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--D 154
           VLT + +  +  Q+ +G+EF+ S+  +H D+   NIL      N +KI DFGLAR    D
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN--NVVKICDFGLARDIYKD 232

Query: 155 PEKKLQVLFGTP-EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
           P+   +     P +++APE + FD +    +D+WS GV+ + + S G SP+ G
Sbjct: 233 PDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 43/183 (23%), Positives = 75/183 (40%), Gaps = 17/183 (9%)

Query: 50  EVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQ 109
           E  ++R L HP ++ + D      + C+VL      +L+  +      L    V    RQ
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVARQ 268

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTP 166
           +   +++IH + ++H D+K EN+  L      I + DFG A            +   GT 
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENV--LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF 226
           +  APEV+  D      D+WS G++ +           E  V T +  + ++ D      
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIF-----------EAAVHTASLFSASRGDERRPYD 375

Query: 227 NEI 229
            +I
Sbjct: 376 AQI 378

Length = 461

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 43/185 (23%), Positives = 82/185 (44%), Gaps = 23/185 (12%)

Query: 49  REVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDF------VLTEKA 102
           +E  +M    HP ++++      +    +++EL+EGG+L   + D         +LT K 
Sbjct: 48  KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE 107

Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR---IKIIDFGLAR-------- 151
           +      + +G  ++   + +H D+   N L   K  +    +KI DFGLAR        
Sbjct: 108 LLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY 167

Query: 152 KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           + + E  L V +  PE +             +D+WS GV+ + +L+ G  P+    + + 
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQ-----SDVWSFGVLMWEILTLGQQPYPALNNQEV 222

Query: 211 MANVT 215
           + +VT
Sbjct: 223 LQHVT 227

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 35/219 (15%)

Query: 14  GKFGTVYR---CKEKATG--MTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG V+       +       +A K +   A  + R++ ERE E++   QH  +++ Y 
Sbjct: 16  GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYG 75

Query: 68  AFESSNVMCVVLELIEGGEL--FERVIDDDFV-----------LTEKAVAIFMRQICEGV 114
                +   +V E +E G+L  F R    D             LT   +     QI  G+
Sbjct: 76  VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM 135

Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--------KFDPEKKLQVLFGTP 166
            ++ S++ +H D+   N  CL      +KI DFG++R        +      L +     
Sbjct: 136 VYLASQHFVHRDLATRN--CLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI----- 188

Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            ++ PE + +      +D+WS GV+ + + + G  P+ G
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.8 bits (134), Expect = 3e-09
 Identities = 49/210 (23%), Positives = 98/210 (46%), Gaps = 21/210 (10%)

Query: 14  GKFGTVY--RCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G+FG+V   +  +  + + +A K + IA   R++  +   E   M+E  HP ++++    
Sbjct: 10  GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVC 69

Query: 70  ------ESSNVMCVVLELIEGGEL-----FERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
                 E      V+L  ++ G+L     + R+ D    L  + +  FM  I  G+E++ 
Sbjct: 70  LQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS 129

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVN 175
           SK+ +H D+   N  C+      + + DFGL++K    D  ++ ++     +++A E + 
Sbjct: 130 SKSFIHRDLAARN--CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA 187

Query: 176 FDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
                  +D+WS GV  + +   G +P+ G
Sbjct: 188 DRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.2 bits (133), Expect = 4e-09
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 21/217 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE-------REVEIMRELQHPRLIQIY 66
           G+FG V+  K K          V + K   +   E       RE+++ R+L H  ++++ 
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLV-LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLL 74

Query: 67  DAFESSNVMCVVLELIEGGEL--FERVI--DDDFV----LTEKAVAIFMRQICEGVEFIH 118
                +    ++LE  + G+L  F R     D+ +    L+ K       QI  G++ + 
Sbjct: 75  GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR-KFDPE-KKLQVLFGTPEFVAPEVVNF 176
           +   +H D+   N  CL  +   +K+    L++  ++ E  KL+       ++APE V  
Sbjct: 135 NARFVHRDLAARN--CLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE 192

Query: 177 DAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMA 212
           D     +D+WS GV+ + V   G  PF G +D + + 
Sbjct: 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN 229

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.8 bits (132), Expect = 6e-09
 Identities = 50/220 (22%), Positives = 94/220 (42%), Gaps = 40/220 (18%)

Query: 14  GKFGTVYRC---KEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHP---RLIQ 64
           G+FG+V      ++  + + +A K + +        +E    E   M++  HP   +LI 
Sbjct: 10  GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIG 68

Query: 65  IYDAFESSNVM-----CVVLELIEGGEL-----FERVIDDDFVLTEKAVAIFMRQICEGV 114
           +   FE+S++       V+L  ++ G+L     + R+      L  + +  FM  I  G+
Sbjct: 69  V--CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE--------KKLQVLFGTP 166
           E++ ++N +H D+   N  C+ +    + + DFGL++K             K+ V +   
Sbjct: 127 EYLSNRNFIHRDLAARN--CMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184

Query: 167 EFVAPEV--VNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
           E +A  V     D   FG  MW       +   G +P+ G
Sbjct: 185 ESLADRVYTSKSDVWAFGVTMWE------IATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 6e-09
 Identities = 41/122 (33%), Positives = 66/122 (54%), Gaps = 10/122 (8%)

Query: 90  RVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDF 147
           +  DD +   LT + +  +  Q+  G+EF+ S+  +H D+   NI  L    N +KI DF
Sbjct: 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNI--LLSENNVVKICDF 218

Query: 148 GLARKF--DPEKKLQVLFGTP-EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPF 202
           GLAR    DP+   +     P +++APE + FD +    +D+WS GV+ + + S G SP+
Sbjct: 219 GLARDIYKDPDYVRKGSARLPLKWMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Query: 203 MG 204
            G
Sbjct: 278 PG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 54.6 bits (131), Expect = 7e-09
 Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 25/225 (11%)

Query: 14  GKFGTVY--RCKE---KATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG V+   C     +   M +A K +  A  + R++ +RE E++  LQH  +++ Y  
Sbjct: 16  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGV 75

Query: 69  FESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAI------------FMRQICEGV 114
                 + +V E +  G+L  F R    D  +      +               QI  G+
Sbjct: 76  CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM 135

Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT--P-EFVAP 171
            ++ S + +H D+   N  CL   G  +KI DFG++R        +V   T  P  ++ P
Sbjct: 136 VYLASLHFVHRDLATRN--CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 193

Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           E + +      +D+WS GV+ + + + G  P+   ++ + +  +T
Sbjct: 194 ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 25/165 (15%)

Query: 50  EVEIMRELQHPRLIQIYDAF-ESSNVMCVVLELIEGGELFE-------RVIDDDFVLTEK 101
           E  +M +L+H  L+Q+     E    + +V E +  G L +        V+  D +L   
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK-- 106

Query: 102 AVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---K 158
               F   +CE +E++ + N +H D+   N+  L    N  K+ DFGL ++    +   K
Sbjct: 107 ----FSLDVCEAMEYLEANNFVHRDLAARNV--LVSEDNVAKVSDFGLTKEASSTQDTGK 160

Query: 159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
           L V     ++ APE +        +D+WS G++ + + S G  P+
Sbjct: 161 LPV-----KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 54.1 bits (130), Expect = 1e-08
 Identities = 49/234 (20%), Positives = 97/234 (41%), Gaps = 37/234 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKR--------NDRRNVEREVEIMRELQHPRLIQI 65
           G FG V+  + +A G+     F  +A +        + + + +RE  +M E  HP ++++
Sbjct: 16  GAFGRVF--QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKL 73

Query: 66  YDAFESSNVMCVVLELIEGGELFE--------------------RVIDDDFV-LTEKAVA 104
                    MC++ E +  G+L E                    R    + + L+     
Sbjct: 74  LGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL 133

Query: 105 IFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQV 161
              +Q+  G+ ++  +  +H D+   N  CL      +KI DFGL+R     D  K  + 
Sbjct: 134 CIAKQVAAGMAYLSERKFVHRDLATRN--CLVGENMVVKIADFGLSRNIYSADYYKASEN 191

Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
                 ++ PE + ++     +D+W+ GV+ + + S G+ P+ G    + +  V
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV 245

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 26/110 (23%)

Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF 168
           Q+  G+EF+ S+  +H D+   NIL      N +KI DFGLAR          ++  P++
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSEN--NVVKICDFGLARD---------IYKDPDY 229

Query: 169 V------------APEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
           V            APE + FD +    +D+WS GV+ + + S G SP+ G
Sbjct: 230 VRKGDARLPLKWMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 28/189 (14%)

Query: 39  AKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEGGELFE-------- 89
           A   D  ++  E+E+M+ + +H  +I +  A      + V++E    G L E        
Sbjct: 59  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 118

Query: 90  ---------RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN 140
                    RV D+   +T K +     Q+  G+E++ S+  +H D+   N+  L    N
Sbjct: 119 GMEYSYDIARVPDEQ--MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV--LVTENN 174

Query: 141 RIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLL 196
            +KI DFGLAR     D  KK        +++APE + FD +    +D+WS GV+ + + 
Sbjct: 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIF 233

Query: 197 S-GLSPFMG 204
           + G SP+ G
Sbjct: 234 TLGGSPYPG 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 46/190 (24%), Positives = 84/190 (44%), Gaps = 12/190 (6%)

Query: 11  FSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           F+ G  G  + C +  T   +      + K   R     E  I+R + HP +IQ+   F 
Sbjct: 100 FTPGAEGFAFACIDNKTCEHV------VIKAGQRGGTATEAHILRAINHPSIIQLKGTFT 153

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +   C++L   +  +L+  +     +     +AI  R +   ++++H   ++H D+K E
Sbjct: 154 YNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAI-ERSVLRAIQYLHENRIIHRDIKAE 211

Query: 131 NILCLTKTGNRIKIIDFGLA-RKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           NI  +   G+ + + DFG A    D    K     GT    APE++  D  G   D+WS 
Sbjct: 212 NIF-INHPGD-VCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269

Query: 189 GVICYVLLSG 198
           G++ + + + 
Sbjct: 270 GIVLFEMATC 279

Length = 391

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 61/261 (23%), Positives = 105/261 (40%), Gaps = 41/261 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER---EVE-IMRELQHPRLIQIYDAF 69
           G FGTV +   K +G  +A K   I    D +  +R   +++ +MR    P +++ Y A 
Sbjct: 15  GAFGTVNKMLHKPSGTIMAVK--RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL 72

Query: 70  ESSNVMCVVLEL--------------IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVE 115
                  + +EL              +    + E ++    V T KA+     ++     
Sbjct: 73  FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL----- 127

Query: 116 FIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN 175
                 ++H D+KP NIL L + GN IK+ DFG++ +           G   ++APE ++
Sbjct: 128 -----KIIHRDVKPSNIL-LDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 180

Query: 176 ---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV----QTMANVTIAQYDFDDECFNE 228
               D     +D+WS+G+  Y + +G  P+     V      +           +E   E
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE--RE 238

Query: 229 ISDDAKDFIRKLLLKDREDAP 249
            S    +FI   L+KD    P
Sbjct: 239 FSPSFVNFINLCLIKDESKRP 259

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)

Query: 31  LAAKFVGIAKRNDRR---NVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL 87
           L AK V    +   R    +E E+  +  L H  +++I +   S     ++ +  +  +L
Sbjct: 195 LIAKRV----KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DL 249

Query: 88  FERVIDDDFVLTE----KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK 143
           +  + D+ F   +    K     M+Q+   VE+IH K ++H D+K ENI  L   G +I 
Sbjct: 250 YSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF-LNCDG-KIV 307

Query: 144 IIDFGLARKFDPEKKLQVL--FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS 197
           + DFG A  F+ E++       GT    +PE++  D     TD+WS G+I   +LS
Sbjct: 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 47/188 (25%), Positives = 96/188 (51%), Gaps = 15/188 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKRNDRRNVEREVEI-MRELQHPRLIQIYDA-F 69
           G +G V + +   TG  +A K +   +  +  +R +  +++I MR +  P  +  Y A F
Sbjct: 12  GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLL-MDLDISMRSVDCPYTVTFYGALF 70

Query: 70  ESSNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLD 126
              +V  + +E+++    + +++V D    + E  +      I + +E++HSK +V+H D
Sbjct: 71  REGDVW-ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRD 129

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG---- 182
           +KP N+L + + G  +K+ DFG++          +  G   ++APE +N +    G    
Sbjct: 130 VKPSNVL-INRNGQ-VKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVK 187

Query: 183 TDMWSVGV 190
           +D+WS+G+
Sbjct: 188 SDVWSLGI 195

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 24/187 (12%)

Query: 39  AKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEGGELFERV------ 91
           A   D  ++  E+E+M+ + +H  +I +  A      + V++E    G L E +      
Sbjct: 56  ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPP 115

Query: 92  -IDDDF--------VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI 142
            +D  F         LT K +     Q+  G+E++ S+  +H D+   N+  L    N +
Sbjct: 116 GMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV--LVTEDNVM 173

Query: 143 KIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS- 197
           KI DFGLAR     D  KK        +++APE + FD +    +D+WS GV+ + + + 
Sbjct: 174 KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTL 232

Query: 198 GLSPFMG 204
           G SP+ G
Sbjct: 233 GGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)

Query: 23  KEKATGMT-LAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVL 79
           KEK   +T +A K +   A   D  ++  E+E+M+ + +H  +I +  A      + V++
Sbjct: 44  KEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 103

Query: 80  ELIEGGELFERV---------------IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           E    G L E +                  +  L+ K +     Q+  G+E++ SK  +H
Sbjct: 104 EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIH 163

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARK---FDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
            D+   N+  L    N +KI DFGLAR     D  KK        +++APE + FD I  
Sbjct: 164 RDLAARNV--LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYT 220

Query: 181 FGTDMWSVGVICYVLLS-GLSPFMG 204
             +D+WS GV+ + + + G SP+ G
Sbjct: 221 HQSDVWSFGVLLWEIFTLGGSPYPG 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)

Query: 91  VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL-CLTKTGNRIKIIDFGL 149
           +I++   L+   +  F  Q+  G+EF+ SKN +H D+   N+L C    G  +KI DFGL
Sbjct: 229 LINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGL 285

Query: 150 ARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
           AR    +         F   +++APE +  +     +D+WS G++ + + + G +P+
Sbjct: 286 ARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.9 bits (124), Expect = 8e-08
 Identities = 38/125 (30%), Positives = 62/125 (49%), Gaps = 7/125 (5%)

Query: 85  GELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK 143
            E+   + DD    LT   +  F  Q+  G+EF+ SKN +H D+   N+  L   G  +K
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV--LLAQGKIVK 277

Query: 144 IIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GL 199
           I DFGLAR    +         F   +++APE +  +     +D+WS G++ + + S G 
Sbjct: 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337

Query: 200 SPFMG 204
           +P+ G
Sbjct: 338 TPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 31/209 (14%)

Query: 14  GKFGTVYR---CKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPR---LIQ 64
           G FG VY           +  A K   + +  D   VE   +E  IM++  HP    L+ 
Sbjct: 6   GHFGCVYHGTLIDSDGQKIHCAVK--SLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLG 63

Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           I    E S +  VVL  ++ G+L   +  +    T K +  F  Q+ +G+E++ SK  +H
Sbjct: 64  ICLPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARK-FDPE---------KKLQVLFGTPEFVAPEVV 174
            D+   N  C+      +K+ DFGLAR  +D E          KL V     +++A E +
Sbjct: 122 RDLAARN--CMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV-----KWMALESL 174

Query: 175 NFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
                   +D+WS GV+ + L++ G  P+
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 16/202 (7%)

Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIY 66
           G FGTVY+      G    + +A K +  A   K N  + +  E  +M  + +P + ++ 
Sbjct: 18  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVCRLL 75

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
               +S V  ++ +L+  G L + V +    +  + +  +  QI +G+ ++  + ++H D
Sbjct: 76  GICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRD 134

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG--TP-EFVAPEVVNFDAIGFGT 183
           +   N+L   KT   +KI DFGLA+    ++K     G   P +++A E +        +
Sbjct: 135 LAARNVL--VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS 192

Query: 184 DMWSVGVICYVLLS-GLSPFMG 204
           D+WS GV  + L++ G  P+ G
Sbjct: 193 DVWSYGVTVWELMTFGSKPYDG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 36/222 (16%)

Query: 14  GKFGTVYRCKEKATGM---------TLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRL 62
           G FG V R +  A G+         T+A K +   A   D  ++  E+E+M+ + +H  +
Sbjct: 23  GCFGQVVRAE--AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNI 80

Query: 63  IQIYDAFESSNVMCVVLELIEGGELFERV-------IDDDFVLTE--------KAVAIFM 107
           I +         + V++E    G L E +        D  F +T+        K +    
Sbjct: 81  INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140

Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFG 164
            Q+  G+E++ S+  +H D+   N+  L    N +KI DFGLAR     D  KK      
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNV--LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198

Query: 165 TPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             +++APE + FD +    +D+WS G++ + + + G SP+ G
Sbjct: 199 PVKWMAPEAL-FDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 38/105 (36%), Positives = 60/105 (57%), Gaps = 10/105 (9%)

Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT 165
           F  Q+ +G++F+ SKN +H D+   N+L LT  G   KI DFGLAR    +    V+ G 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVL-LT-DGRVAKICDFGLARDIMNDSNY-VVKGN 273

Query: 166 P----EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
                +++APE + FD +    +D+WS G++ + + S G SP+ G
Sbjct: 274 ARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 47/194 (24%), Positives = 93/194 (47%), Gaps = 33/194 (17%)

Query: 12  SFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDA 68
           S G FG VY  ++K      A K V  A    +N    V+ E + +   + P ++ +Y +
Sbjct: 13  SRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72

Query: 69  FESSNVMCVVLELIEGGELFERV-----IDDD---FVLTEKAVAIFMRQICEGVEFIHSK 120
            +S+N + +V+E + GG++   +      D++     ++E A+A+         +++H  
Sbjct: 73  LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL---------DYLHRH 123

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNF--- 176
            ++H D+KP+N+L ++  G+ IK+ DFGL++   + E  +  +  TP    P+       
Sbjct: 124 GIIHRDLKPDNML-ISNEGH-IKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTP 181

Query: 177 -------DAIGFGT 183
                   ++GF T
Sbjct: 182 GQVLSLISSLGFNT 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 47/222 (21%), Positives = 89/222 (40%), Gaps = 31/222 (13%)

Query: 14  GKFGTVY-----RCKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG VY        +      +A K V   A   +R     E  +M+E     ++++  
Sbjct: 17  GSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLG 76

Query: 68  AFESSNVMCVVLELIEGGEL----FERVIDDDF-----VLTEKAVAIFMRQICEGVEFIH 118
              +     VV+EL+  G+L      R  + +        T +       +I +G+ ++ 
Sbjct: 77  VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA 136

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--------KFDPEKKLQVLFGTPEFVA 170
           +K  +H D+   N  C+      +KI DFG+ R        +   +  L V +  PE + 
Sbjct: 137 AKKFVHRDLAARN--CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194

Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTM 211
             V  F      +D+WS GV+ + + +    P+ G ++ + +
Sbjct: 195 DGV--FTT---KSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 40/223 (17%)

Query: 14  GKFGTVYR-----CKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQIY 66
           G FG V +             T+A K +   A   D  ++  E+E+M+ + +H  +I + 
Sbjct: 23  GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 82

Query: 67  DAFESSNVMCVVLELIEGGEL--FERV---------IDDDFV----LTEKAVAIFMRQIC 111
                   + VV+E    G L  F R           DD       LT+K +  F  Q+ 
Sbjct: 83  GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVA 142

Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKK-----LQVLF 163
            G+EF+ SK  +H D+   N+  L    + +KI DFGLAR     D  +K     L V  
Sbjct: 143 RGMEFLASKKCIHRDLAARNV--LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV-- 198

Query: 164 GTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
              +++APE + FD +    +D+WS GV+ + + + G SP+ G
Sbjct: 199 ---KWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.9 bits (116), Expect = 6e-07
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKF-VGIAKRNDRRNVEREV----EIMRELQHPRLIQIYDA 68
           G FGTVY+      G  +     + + + N      +E+     +M  +  P + ++   
Sbjct: 18  GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGI 77

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             +S V  +V +L+  G L + V ++   +  + +  +  QI +G+ ++    ++H D+ 
Sbjct: 78  CLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLA 136

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDM 185
             N+L   K+ N +KI DFGLAR  D ++      G     +++A E +        +D+
Sbjct: 137 ARNVL--VKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDV 194

Query: 186 WSVGVICYVLLS-GLSPFMG 204
           WS GV  + L++ G  P+ G
Sbjct: 195 WSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.2 bits (110), Expect = 2e-06
 Identities = 32/128 (25%), Positives = 56/128 (43%), Gaps = 19/128 (14%)

Query: 38  IAKRNDRR----NVEREVEIMREL-QHPRLI-QIYDAFESSNVMCVVLELIEGGELFERV 91
           + K N  R    + EREV I++ L +    + ++  + ES     +++E IEG  L E  
Sbjct: 25  VLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVS 84

Query: 92  IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL---HLDMKPENILCLTKTGNRIKIIDFG 148
            ++   + E+   + + ++       H   +L   H D+ P NIL     G  + IID+ 
Sbjct: 85  EEEKEDIAEQLAEL-LAKL-------HQLPLLVLCHGDLHPGNILV--DDGKILGIIDWE 134

Query: 149 LARKFDPE 156
            A    P 
Sbjct: 135 YAGYGPPA 142

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.0 bits (111), Expect = 5e-06
 Identities = 26/68 (38%), Positives = 38/68 (55%), Gaps = 4/68 (5%)

Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT- 165
           MRQ+  G+  +H   ++H D+KPEN+L +T  G ++KIIDFG A           L+G  
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLL-VTVDG-QVKIIDFGAAVDMCTGINFNPLYGML 372

Query: 166 -PEFVAPE 172
            P +  PE
Sbjct: 373 DPRYSPPE 380

Length = 507

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 5e-06
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 41/214 (19%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIMRELQHPR------LIQ 64
           G FG V    ++      A K V    RN     R+ + E++ M +++         L++
Sbjct: 140 GTFGKVVEAWDRKRKEYCAVKIV----RNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 65  IYDAFES-SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NV 122
           I   F++ +  MC+V+   + G      I      + + +A  + Q    +++ H++ ++
Sbjct: 196 IQRYFQNETGHMCIVMP--KYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHL 253

Query: 123 LHLDMKPENILCLTKTGN--------------RIKIIDFGLARKFDPEKKLQVLFGTPEF 168
           +H D+KPENIL  T                  R++I D G     D       +  T  +
Sbjct: 254 MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAIVSTRHY 311

Query: 169 VAPEVVNFDAIGFG----TDMWSVGVICYVLLSG 198
            +PEVV    +G G    TDMWS+G I Y L +G
Sbjct: 312 RSPEVV----LGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 46.1 bits (109), Expect = 5e-06
 Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 16/202 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEI------MRELQHPRLIQIYD 67
           G FGTV++      G ++    V I    DR   +   EI      M  L H  ++++  
Sbjct: 18  GVFGTVHKGIWIPEGDSIKIP-VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLG 76

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
               +++  +V +L   G L + V      L  + +  +  QI +G+ ++    ++H ++
Sbjct: 77  ICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNL 135

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG---TP-EFVAPEVVNFDAIGFGT 183
              NIL   K+ + ++I DFG+A    P+ K +  +    TP +++A E + F      +
Sbjct: 136 AARNIL--LKSDSIVQIADFGVADLLYPDDK-KYFYSEHKTPIKWMALESILFGRYTHQS 192

Query: 184 DMWSVGVICYVLLS-GLSPFMG 204
           D+WS GV  + ++S G  P+ G
Sbjct: 193 DVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 6e-06
 Identities = 36/136 (26%), Positives = 61/136 (44%), Gaps = 15/136 (11%)

Query: 118 HSKNVLHLDMKPENILCLTKTGNRIKI---------IDFGLARKFDPEKKLQVLFGTPEF 168
            S   +    KP     L +T  ++KI         +  G A   + E+ L    GTP++
Sbjct: 492 GSYPAITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRG-AAPVEGERIL----GTPDY 546

Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE 228
           +APE++     G   D W++GV  +  L+G+ PF  ET  Q   N+      + +    +
Sbjct: 547 LAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEG-EEK 605

Query: 229 ISDDAKDFIRKLLLKD 244
           +S +A++ I  LL  D
Sbjct: 606 LSVNAQNAIEILLTMD 621

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 52/239 (21%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE------REVEIMRELQHPRLIQIYD 67
           G FG V    E   GM+ A   V + +       +      +EV+  REL HP ++Q   
Sbjct: 6   GWFGKVLL-GEAHRGMSKAR--VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 68  AFESSNVMCVVLELIEGGEL---------FERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
               S    +VLE    G+L             +    VL   A      ++  G+ ++H
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC-----EVASGLLWLH 117

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE-------FVAP 171
             + +H D+   N  C       +KI D+GLA +  PE      + T +       ++AP
Sbjct: 118 QADFIHSDLALRN--CQLTADLSVKIGDYGLALEQYPED----YYITKDCHAVPLRWLAP 171

Query: 172 EVVNFDAIGFGTDM-----------WSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
           E+V       G D+           WS+GV  + L +    P+   +D Q +  V   Q
Sbjct: 172 ELVEI----RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.4 bits (102), Expect = 4e-05
 Identities = 23/68 (33%), Positives = 38/68 (55%), Gaps = 6/68 (8%)

Query: 86  ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKII 145
           E+F+R+   +    +K +   M+ +   +E+IH   + H D+KPENI  +    NR  II
Sbjct: 115 EIFKRIKCKN----KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENI--MVDGNNRGYII 168

Query: 146 DFGLARKF 153
           D+G+A  F
Sbjct: 169 DYGIASHF 176

Length = 294

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 43.4 bits (102), Expect = 5e-05
 Identities = 54/238 (22%), Positives = 98/238 (41%), Gaps = 22/238 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND----RRNVE--REVEIMRELQHPRLIQIYD 67
           G FG VY    +      A   V +   N+    R  +E   E  +M+      ++++  
Sbjct: 17  GSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLG 76

Query: 68  AFESSNVMCVVLELIEGGEL--FERVIDDD-------FVLTEKAVAIFMRQICEGVEFIH 118
                    VV+EL+  G+L  + R +  +          T + +     +I +G+ +++
Sbjct: 77  VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 136

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVN 175
           +K  +H D+   N  C+      +KI DFG+ R     D  +K         ++APE + 
Sbjct: 137 AKKFVHRDLAARN--CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194

Query: 176 FDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQY-DFDDECFNEISD 231
                  +DMWS GV+ + + S    P+ G ++ Q +  V    Y D  D C   ++D
Sbjct: 195 DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTD 252

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 20/50 (40%), Positives = 30/50 (60%), Gaps = 1/50 (2%)

Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLA 150
           K +   MRQI   ++ +HS  ++H D+KP+NI+    +G   KIID G A
Sbjct: 255 KIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAA 303

Length = 566

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 43/217 (19%), Positives = 89/217 (41%), Gaps = 21/217 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVE------IMRELQHPRLIQIYD 67
           G FG VY    K          V I   N+  ++   +E      +M+E     ++++  
Sbjct: 17  GSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 76

Query: 68  AFESSNVMCVVLELIEGGEL--FERVIDDDF-------VLTEKAVAIFMRQICEGVEFIH 118
                    V++EL+  G+L  + R +  +          + K +     +I +G+ +++
Sbjct: 77  VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN 136

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVN 175
           +   +H D+   N  C+      +KI DFG+ R     D  +K         +++PE + 
Sbjct: 137 ANKFVHRDLAARN--CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194

Query: 176 FDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTM 211
                  +D+WS GV+ + + +    P+ G ++ Q +
Sbjct: 195 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.4 bits (97), Expect = 2e-04
 Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 29/181 (16%)

Query: 44  RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTE- 100
           RR    E   + +  H  ++++       N M +V E +  G L  F R  +   V  + 
Sbjct: 50  RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL 109

Query: 101 ----KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE 156
                 +A  M+ + E + ++H     H  +   +++C        KI  F        E
Sbjct: 110 MGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDLVC--------KISGFRRL----QE 156

Query: 157 KKLQVLFGTPE------FVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETD 207
            K + ++ T        + APE + +      +D+WS G++ + ++S G  P+  M   D
Sbjct: 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216

Query: 208 V 208
           V
Sbjct: 217 V 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.4 bits (97), Expect = 2e-04
 Identities = 33/141 (23%), Positives = 67/141 (47%), Gaps = 5/141 (3%)

Query: 60  PRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS 119
           P ++ ++    S + + +VL+  EGG+L+   I     + E+ V  +  ++   ++ +H 
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH-ISKFLNIPEECVKRWAAEMVVALDALHR 103

Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI 179
           + ++  D+ P NIL L   G+ I++  F    + +     + +     + APEV      
Sbjct: 104 EGIVCRDLNPNNIL-LDDRGH-IQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGISEE 159

Query: 180 GFGTDMWSVGVICYVLLSGLS 200
               D WS+G I + LL+G +
Sbjct: 160 TEACDWWSLGAILFELLTGKT 180

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 56/234 (23%), Positives = 89/234 (38%), Gaps = 42/234 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG V    E  +G T A   V   + +    ++     E +  R LQH  L+Q     
Sbjct: 6   GWFGKVI-LGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC 64

Query: 70  ESSNVMCVVLELIEGGEL---------FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
                  +V+E    G+L          E +  D   L   A      +I  G+  +H  
Sbjct: 65  TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC-----EIALGLLHLHKN 119

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE-------FVAPEV 173
           N +H D+   N  CL      +KI D+GL+      K  +  + TP+       ++APE+
Sbjct: 120 NFIHSDLALRN--CLLTADLTVKIGDYGLSHN----KYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 174 VN--------FDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
           V+         D      ++WS+GV  + L   G  P+   +D Q +      Q
Sbjct: 174 VDEVHGNLLVVDQTKES-NVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ 226

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 40/215 (18%), Positives = 87/215 (40%), Gaps = 37/215 (17%)

Query: 13  FGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRR--NVEREVEIMRELQHPRLIQIYDAFE 70
           F    +VY  +   TG  +  +   +    +     ++ EV +    +HP ++  +  F 
Sbjct: 10  FCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT 69

Query: 71  SSNVMCVVLELIEGG---ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           + + + V+   +  G    L +    +   ++E  +   +     G+ ++H    +H ++
Sbjct: 70  TGSWLWVISPFMAYGSANSLLKTYFPEG--MSEALIGNILFGALRGLNYLHQNGYIHRNI 127

Query: 128 KPENIL----------------CLTKTGNRIKII-DFGLARKFDPEKKLQVLFGTPEFVA 170
           K  +IL                 L + G + K++ DF       P+    VL     +++
Sbjct: 128 KASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF-------PQFSTSVL----PWLS 176

Query: 171 PEVVNFDAIGFG--TDMWSVGVICYVLLSGLSPFM 203
           PE++  D  G+   +D++SVG+    L +G  PF 
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 11/111 (9%)

Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE- 167
           QI  G+ ++H + V+H D+   N  C+     ++KI D  L+R   P        G  E 
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARN--CVIDEELQVKITDNALSRDLFPMD--YHCLGDNEN 180

Query: 168 ----FVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN 213
               ++A E +        +D+WS GV+ + L++ G +P++ E D   MA 
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV-EIDPFEMAA 230

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 39.8 bits (94), Expect = 4e-04
 Identities = 29/111 (26%), Positives = 48/111 (43%), Gaps = 25/111 (22%)

Query: 44  RRNVEREVEIMRELQH-----PRLIQIYDAFESSNVMCVVLELIEGGELFE-RVIDD-DF 96
           R   ++E   ++ L       P+ I         N   VV+E I+G EL+  RV++D + 
Sbjct: 77  RLAAQKEFAALKALYEEGFPVPKPI-------DWNRHAVVMEYIDGVELYRVRVLEDPEE 129

Query: 97  VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDF 147
           VL          +I E +   +   ++H D+   NI  L     +I IID+
Sbjct: 130 VL---------DEILEEIVKAYKHGIIHGDLSEFNI--LVDDDEKIYIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 46/213 (21%), Positives = 97/213 (45%), Gaps = 35/213 (16%)

Query: 13  FGKFGTVYRCKEKATGMTLAAKFVGI-AKRNDRRN-VEREVEIMRELQHPRLIQIYDAFE 70
           F    TV   + K TG  +  + + + A  N+    ++ E+ + +   HP ++     F 
Sbjct: 10  FEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI 69

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           + N + VV   +  G   + +I   F+  ++E A+A  ++ + + +++IH    +H  +K
Sbjct: 70  ADNELWVVTSFMAYGSA-KDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVK 128

Query: 129 PENIL----------------CLTKTGNRIKII-DFGLARKFDPEKKLQVLFGTPEFVAP 171
             +IL                 +   G R++++ DF       P+  ++VL     +++P
Sbjct: 129 ASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDF-------PKYSVKVL----PWLSP 177

Query: 172 EVVNFDAIGFG--TDMWSVGVICYVLLSGLSPF 202
           EV+  +  G+   +D++SVG+    L +G  PF
Sbjct: 178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 28/104 (26%), Positives = 45/104 (43%), Gaps = 10/104 (9%)

Query: 44  RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAV 103
           R   ERE E ++ L +P  +++       N   VV+E IEG EL+   +  D    E   
Sbjct: 153 RLAAEREFEALQRL-YPEGVKVPKPIAW-NRHAVVMEYIEGVELYR--LRLD---VENPD 205

Query: 104 AIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDF 147
            I  + + E  +      ++H D+   NI  L      I +ID+
Sbjct: 206 EILDKILEEVRKAYRR-GIVHGDLSEFNI--LVTEDGDIVVIDW 246

Length = 304

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	251
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0581|consensus	364		100.0
KOG0595|consensus	429		100.0
KOG0598|consensus	357		100.0
KOG0591|consensus	375		100.0
KOG0583|consensus	370		100.0
KOG0592|consensus	604		100.0
KOG0616|consensus	355		100.0
KOG0600|consensus	560		100.0
KOG0192|consensus	362		100.0
KOG0605|consensus	550		100.0
KOG0593|consensus	396		100.0
KOG0198|consensus	313		100.0
KOG0588|consensus	786		100.0
KOG0578|consensus	550		100.0
KOG0033|consensus	355		100.0
KOG0032|consensus	382		100.0
KOG0597|consensus	808		100.0
KOG0659|consensus	318		100.0
KOG0611|consensus	668		100.0
KOG0661|consensus	538		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585|consensus	576		100.0
KOG0197|consensus	468		100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589|consensus	426		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0599|consensus	411		100.0
KOG0582|consensus	516		100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0580|consensus	281		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0694|consensus	694		100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0660|consensus	359		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0610|consensus	459		100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG4717|consensus	864		100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0663|consensus	419		100.0
KOG2345|consensus	302		100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0594|consensus	323		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0667|consensus	586		100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG1026|consensus	774		100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG1989|consensus	738		100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0658|consensus	364		100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0604|consensus	400		100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0194|consensus	474		100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG1187|consensus	361		100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0193|consensus	678		100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0586|consensus	596		100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0596|consensus	677		100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG1095|consensus	1025		100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0607|consensus	463		100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0690|consensus	516		100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0986|consensus	591		100.0
KOG4721|consensus	904		100.0
KOG0612|consensus	1317		100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0577|consensus	948		100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0983|consensus	391		100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0579|consensus	1187		100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4279|consensus	1226		100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG4236|consensus	888		100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0584|consensus	632		100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0603|consensus	612		100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0662|consensus	292		100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0574|consensus	502		100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0199|consensus	1039		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0671|consensus	415		100.0
KOG1035|consensus	1351		100.0
KOG0614|consensus	732		100.0
KOG4645|consensus	1509		100.0
KOG4257|consensus	974		100.0
KOG1094|consensus	807		100.0
KOG4250|consensus	732		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0196|consensus	996		100.0
KOG0696|consensus	683		100.0
KOG4278|consensus	1157		100.0
KOG0666|consensus	438		100.0
KOG0695|consensus	593		100.0
KOG0669|consensus	376		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0587|consensus	953		100.0
KOG1006|consensus	361		100.0
KOG0668|consensus	338		100.0
KOG0200|consensus	609		100.0
KOG0608|consensus	1034		100.0
KOG1025|consensus	1177		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0665|consensus	369		100.0
KOG1151|consensus	775		100.0
KOG0664|consensus	449		100.0
KOG0984|consensus	282		100.0
KOG1290|consensus	590		100.0
KOG1345|consensus	378		100.0
KOG0670|consensus	752		100.0
KOG3653|consensus	534		100.0
KOG2052|consensus	513		100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1152|consensus	772		100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1027|consensus	903		100.0
KOG1024|consensus	563		100.0
KOG0576|consensus	829		100.0
KOG1164|consensus	322		99.98
KOG1167|consensus	418		99.98
KOG1163|consensus	341		99.97
KOG1165|consensus	449		99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.94
KOG1240|consensus	1431		99.94
KOG0590|consensus	601		99.93
KOG0195|consensus	448		99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG0606|consensus	1205		99.9
KOG0603|consensus	612		99.9
KOG4158|consensus	598		99.89
KOG1166|consensus	974		99.89
PRK10345	210	hypothetical protein; Provisional	99.88
smart00090	237	RIO RIO-like kinase.	99.87
KOG1023|consensus	484		99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.83
KOG1033|consensus	516		99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
KOG0590|consensus	601		99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
KOG1243|consensus	690		99.72
KOG0601|consensus	524		99.67
KOG1266|consensus	458		99.65
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.62
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.57
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.57
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
KOG3087|consensus	229		99.55
KOG0606|consensus	1205		99.55
KOG3741|consensus	655		99.53
COG4248	637	Uncharacterized protein with protein kinase and he	99.42
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.37
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.34
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.32
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.32
KOG0601|consensus	524		99.32
KOG2137|consensus	700		99.26
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.13
PRK09902	216	hypothetical protein; Provisional	99.11
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.09
COG0661	517	AarF Predicted unusual protein kinase [General fun	99.06
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.94
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.93
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.88
PF01636	239	APH: Phosphotransferase enzyme family This family	98.85
KOG1235|consensus	538		98.73
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.73
PLN02876	822	acyl-CoA dehydrogenase	98.66
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.66
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.45
KOG0576|consensus	829		98.41
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.37
PRK10593	297	hypothetical protein; Provisional	98.33
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.33
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.33
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.32
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.32
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.29
KOG1035|consensus	1351		98.26
PRK05231	319	homoserine kinase; Provisional	98.13
KOG2270|consensus	520		98.13
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.08
KOG2268|consensus	465		98.07
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.96
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.95
PLN02756	418	S-methyl-5-thioribose kinase	97.77
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.75
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.73
PLN02236	344	choline kinase	97.72
PRK12396	409	5-methylribose kinase; Reviewed	97.71
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.49
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.42
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.4
KOG1093|consensus	725		97.4
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.34
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.28
COG2334	331	Putative homoserine kinase type II (protein kinase	97.23
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.06
PRK11768	325	serine/threonine protein kinase; Provisional	96.94
KOG1826|consensus	2724		96.81
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.78
PTZ00296	442	choline kinase; Provisional	96.71
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.5
PTZ00384	383	choline kinase; Provisional	96.42
KOG1236|consensus	565		96.37

>KOG0615|consensus

Probab=100.00  E-value=4e-59  Score=363.85  Aligned_cols=250  Identities=34%  Similarity=0.590  Sum_probs=225.7

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-------chHHHHHHHHHHHHcCCCceeeEeEEEeeCC
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-------DRRNVEREVEIMRELQHPRLIQIYDAFESSN   73 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (251)
                      +++.|.+.+.||+|+||.|-+|..+.+++.||+|++......       .....++|+++|++++|||||++.++++...
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            357899999999999999999999999999999998632211       2334679999999999999999999999999


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLARK  152 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~  152 (251)
                      ..|+||||++||.|.+.+..++ .+.+.....+++|++.|+.|||+.||.||||||+|||+..+ .+..+||+|||++..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999999999999998876 68999999999999999999999999999999999999544 447899999999999


Q ss_pred             cCCCCcceeeccCcccccccccccCCC---CcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccccCCCccccC
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNFDAI---GFGTDMWSVGVICYVLLSGLSPFMGETDVQ-TMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  228 (251)
                      ........+.||||.|.|||++.+...   ..+.|+||+||+||-+++|.+||....... ..+.+..+.+.+..+.|..
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            888888899999999999999976543   347799999999999999999999887666 7889999999999999999


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.+..+||++||..||++|||+
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~  431 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSA  431 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCH
Confidence            99999999999999999999985

>KOG0575|consensus

Probab=100.00  E-value=4.2e-57  Score=368.05  Aligned_cols=242  Identities=36%  Similarity=0.619  Sum_probs=226.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecc---ccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGI---AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .+|+..+.||.|+|+.||.+.+..+|..||+|++..   ......+.+.+|+++.++|+|||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            579999999999999999999999999999999853   33556889999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~  158 (251)
                      |.|+.++|..++. ..+.+++.+++.++.||+.||.|||+.+|+|||||..|+++  +++.++||+|||+|+....+ ..
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL--~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL--NENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee--cCcCcEEecccceeeeecCcccc
Confidence            9999999988877 45589999999999999999999999999999999999999  99999999999999998744 77


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ..+.||||.|.|||++.....+..+||||+||+||.|+.|++||+..+-.+++.++....+..+    ..++.++++||.
T Consensus       175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P----~~ls~~A~dLI~  250 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP----SHLSAEAKDLIR  250 (592)
T ss_pred             cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc----cccCHHHHHHHH
Confidence            7889999999999999999999999999999999999999999999999999999999988877    578999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      ++|++||.+|||+
T Consensus       251 ~lL~~~P~~Rpsl  263 (592)
T KOG0575|consen  251 KLLRPNPSERPSL  263 (592)
T ss_pred             HHhcCCcccCCCH
Confidence            9999999999996

>KOG0581|consensus

Probab=100.00  E-value=2.4e-56  Score=344.93  Aligned_cols=242  Identities=24%  Similarity=0.435  Sum_probs=214.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-EEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-VMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~   81 (251)
                      +.+....||+|..|+||+|+++.+++.+|+|++.... ....+++.+|+++++..+||+||.+++.|.+++ .+.++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            5677889999999999999999999999999985433 345889999999999999999999999999988 59999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      |++|+|...+... +++++.....++.++++||.|||+ .+|+||||||+|+|+  +..|.+||||||.+.....+ ...
T Consensus       160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv--NskGeVKicDFGVS~~lvnS-~a~  235 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV--NSKGEVKICDFGVSGILVNS-IAN  235 (364)
T ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee--ccCCCEEeccccccHHhhhh-hcc
Confidence            9999998887765 479999999999999999999995 999999999999999  99999999999999887665 557


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE-----TDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      +..||..|||||.+.++.|+.++||||||+.++|+++|+.||...     +..+.+..+..+..+..+.  ..+++++++
T Consensus       236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~ef~~  313 (364)
T KOG0581|consen  236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSPEFRS  313 (364)
T ss_pred             cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCHHHHH
Confidence            778999999999999999999999999999999999999999875     4455666665544332221  248999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      ||..||++||.+|||+
T Consensus       314 FV~~CL~Kdp~~R~s~  329 (364)
T KOG0581|consen  314 FVSCCLRKDPSERPSA  329 (364)
T ss_pred             HHHHHhcCCcccCCCH
Confidence            9999999999999985

>KOG0595|consensus

Probab=100.00  E-value=8.4e-55  Score=339.57  Aligned_cols=247  Identities=28%  Similarity=0.511  Sum_probs=220.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ..+|.+.+.||+|+|++||+|+++.++..||+|.+...  +.+..+.+..|+.+|+.++|+|||+++++...++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            46899999999999999999999999999999998765  4556888999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CC---CcEEEeecccccccCC
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TG---NRIKIIDFGLARKFDP  155 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~---~~~~l~df~~~~~~~~  155 (251)
                      |||+||+|.++++..+ .+++..++.++.||+.||++||+++|+||||||+|||+... .+   -.+||.|||+++...+
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            9999999999998875 69999999999999999999999999999999999998443 22   4689999999999998


Q ss_pred             CCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        156 EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      .....+.||+|-|||||++..+.|+.|+|+||+|+++|++++|+.||...+..|....+..+....+. ....+++...+
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-~~~~~s~~~~~  246 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-LPAELSNPLRE  246 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc-hhhhccCchhh
Confidence            88888999999999999999999999999999999999999999999999999988876665543222 22456667778


Q ss_pred             HHHHhcccCcCCCCC
Q psy11805        236 FIRKLLLKDREDAPE  250 (251)
Q Consensus       236 li~~~l~~~p~~Rps  250 (251)
                      ++...++.+|..|.+
T Consensus       247 Ll~~ll~~~~~~~~~  261 (429)
T KOG0595|consen  247 LLISLLQRNPKDRIS  261 (429)
T ss_pred             hhhHHHhcCccccCc
Confidence            888888888887754

>KOG0598|consensus

Probab=100.00  E-value=8.7e-55  Score=336.15  Aligned_cols=241  Identities=27%  Similarity=0.537  Sum_probs=221.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecc---ccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGI---AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||.|+||+||+++.+.+++.+|+|+++.   ....+.+....|..+|.+++||.|+.+.-.|++.+.+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            689999999999999999999999999999999863   33446788899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc-CCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~-~~~~~  158 (251)
                      ||+.||.|..++...+ .++++.+.-++..|+.||.|||+.||+|||+||+|||+  +.+|+++|+|||++... ..+..
T Consensus       105 d~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL--d~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL--DEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             eccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee--cCCCcEEEeccccchhcccCCCc
Confidence            9999999998887665 79999999999999999999999999999999999999  99999999999999864 44455


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ..+.|||+.|+|||++.+..++..+|.||||+++|+|++|..||.+.+..+...++..+..+...   ..++.+.+++++
T Consensus       182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardll~  258 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDLLK  258 (357)
T ss_pred             cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHHHH
Confidence            66789999999999999999999999999999999999999999999999999999988855443   347899999999


Q ss_pred             HhcccCcCCCC
Q psy11805        239 KLLLKDREDAP  249 (251)
Q Consensus       239 ~~l~~~p~~Rp  249 (251)
                      ++|+.||++|.
T Consensus       259 ~LL~rdp~~RL  269 (357)
T KOG0598|consen  259 KLLKRDPRQRL  269 (357)
T ss_pred             HHhccCHHHhc
Confidence            99999999995

>KOG0591|consensus

Probab=100.00  E-value=2.7e-55  Score=327.56  Aligned_cols=243  Identities=27%  Similarity=0.526  Sum_probs=216.4

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeE-EEeeCC-EEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYD-AFESSN-VMCVVL   79 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~-~~~lv~   79 (251)
                      +|+|+++||.|.||+||+|++..+++.+|.|.+....  .+.++....|+.+|++++||||+++++ .+..++ .+++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            5999999999999999999999999999999987433  445788999999999999999999999 454444 489999


Q ss_pred             EeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhh--CC--ceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         80 ELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHS--KN--VLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        80 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~--~g--i~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      |++++|+|.+++..   .+..+++..+|+++.|++.||+.+|+  ..  ++||||||.||++  +.+|.+||+|||+++.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl--~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL--TANGVVKLGDFGLGRF  177 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE--cCCCceeeccchhHhH
Confidence            99999999888864   34569999999999999999999999  45  9999999999999  9999999999999998


Q ss_pred             cCCCCcc-eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        153 FDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       153 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ....... ....|||.|||||.+.+.+|+.+|||||+||++|||+.-+.||.+.+-.+...++..+.+++.+.  ...|.
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~--~~YS~  255 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD--EHYST  255 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--HHhhh
Confidence            7655443 45679999999999999999999999999999999999999999999999999999887653321  46789


Q ss_pred             HHHHHHHHhcccCcCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps  250 (251)
                      ++..+|..|+.+||+.||+
T Consensus       256 ~l~~li~~ci~vd~~~RP~  274 (375)
T KOG0591|consen  256 DLRELINMCIAVDPEQRPD  274 (375)
T ss_pred             HHHHHHHHHccCCcccCCC
Confidence            9999999999999999997

>KOG0583|consensus

Probab=100.00  E-value=7.9e-52  Score=335.73  Aligned_cols=243  Identities=29%  Similarity=0.545  Sum_probs=220.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc----cc-cchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA----KR-NDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   75 (251)
                      ..+|++.+.||+|.||+|+.|.+..++..||+|++...    .. ...+.+.+|+.+++.+. ||||+++++++.....+
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            45899999999999999999999999999999976542    11 34667789999999998 99999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC-CcEEEeeccccccc-
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG-NRIKIIDFGLARKF-  153 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~-~~~~l~df~~~~~~-  153 (251)
                      ++||||+.||.|.+.+.. .+++++..+..++.|+++|++|||+.||+||||||+|+++  +.+ +++||+|||++... 
T Consensus        96 ~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill--d~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL--DGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             EEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe--cCCCCCEEEeccccccccC
Confidence            999999999999999998 5689999999999999999999999999999999999999  777 99999999999988 


Q ss_pred             CCCCcceeeccCcccccccccccCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCC-C
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDA-IG-FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-S  230 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  230 (251)
                      .......+.+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||...+......++..+.+..+    ..+ +
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p----~~~~S  248 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP----SYLLS  248 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC----CCcCC
Confidence            4667778889999999999998876 74 789999999999999999999999998889998888877766    344 9


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++++|+++||.+||.+|+|+
T Consensus       249 ~~~~~Li~~mL~~~P~~R~t~  269 (370)
T KOG0583|consen  249 PEARSLIEKMLVPDPSTRITL  269 (370)
T ss_pred             HHHHHHHHHHcCCCcccCCCH
Confidence            999999999999999999984

>KOG0592|consensus

Probab=100.00  E-value=3.1e-52  Score=335.23  Aligned_cols=242  Identities=31%  Similarity=0.583  Sum_probs=220.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecc---ccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGI---AKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +||+.++.||.|+|++|++|.++.+++.||+|++..   ...........|-..|.+| .||.|++++-.|.++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            689999999999999999999999999999999852   2233456677888889999 799999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      +||.++|.|.+++...+ .+++.-++.++.+|+.||+|||+.||+||||||+|||+  +.+++++|+|||.+..+++...
T Consensus       153 Le~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL--d~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL--DKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE--cCCCcEEEeeccccccCChhhc
Confidence            99999999999998765 79999999999999999999999999999999999999  9999999999999987643322


Q ss_pred             c--------------eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        159 L--------------QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       159 ~--------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                      .              ....||..|++||++.....+..+|+|+|||+||+|+.|.+||.+.+.--+.+++....+.++  
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp--  307 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP--  307 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC--
Confidence            1              346799999999999999999999999999999999999999999999999999999888777  


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                        .++|+.+++||+++|..||.+|+++
T Consensus       308 --~~fp~~a~dLv~KLLv~dp~~Rlt~  332 (604)
T KOG0592|consen  308 --EGFPEDARDLIKKLLVRDPSDRLTS  332 (604)
T ss_pred             --CCCCHHHHHHHHHHHccCccccccH
Confidence              6789999999999999999999974

>KOG0616|consensus

Probab=100.00  E-value=1.4e-51  Score=309.45  Aligned_cols=238  Identities=29%  Similarity=0.553  Sum_probs=222.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||.|+||.|.+++.+.++..+|+|++....   ....+...+|..+|+.+.||.++++++.+.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            57999999999999999999999999999999986543   334566779999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||.+||.|.++++..+ ++++..++-++.|++.||+|||+.+|++||+||+|||+  +.+|.+|++|||++......  .
T Consensus       124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl--D~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL--DQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee--ccCCcEEEEeccceEEecCc--E
Confidence            9999999999998775 79999999999999999999999999999999999999  99999999999999886543  6


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      .+.||||.|+|||.+.+.++..++|.||||+++|||+.|..||...+....++++..+...++    +.++.++++||+.
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP----~~fs~~~kdLl~~  274 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP----SYFSSDAKDLLKK  274 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC----cccCHHHHHHHHH
Confidence            788999999999999999999999999999999999999999999999999999999998888    7889999999999


Q ss_pred             hcccCcCCCC
Q psy11805        240 LLLKDREDAP  249 (251)
Q Consensus       240 ~l~~~p~~Rp  249 (251)
                      +|+.|-.+|.
T Consensus       275 LL~vD~t~R~  284 (355)
T KOG0616|consen  275 LLQVDLTKRF  284 (355)
T ss_pred             HHhhhhHhhh
Confidence            9999999984

>KOG0600|consensus

Probab=100.00  E-value=2.7e-51  Score=327.27  Aligned_cols=246  Identities=28%  Similarity=0.443  Sum_probs=218.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESS--NVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv   78 (251)
                      +.|+.+++||+|+||.||+|++..+++.||+|.+...+  ........+|+.+|+++.||||+++.+...+.  +.+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            56889999999999999999999999999999998776  44578899999999999999999999998776  689999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      +|||+. +|.-++...+-.|++.++.-++.||+.||.|||++|+.|||||.+|||+  +.+|.+||+|||+++.++....
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi--dn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI--DNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE--cCCCCEEeccccceeeccCCCC
Confidence            999987 8888887777789999999999999999999999999999999999999  9999999999999998765543


Q ss_pred             --ceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc--------
Q psy11805        159 --LQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN--------  227 (251)
Q Consensus       159 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------  227 (251)
                        ......|.=|.|||++.|. .|+.+.|+||.||||.||+.|+..|.+.+..+++..+.+.-..+....|+        
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence              3445678899999999875 68999999999999999999999999999999998885554443333332        


Q ss_pred             -----------------CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 -----------------EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 -----------------~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                       .+|....+|+..+|..||.+|.||
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA  394 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA  394 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH
Confidence                             478889999999999999999885

>KOG0192|consensus

Probab=100.00  E-value=3.3e-50  Score=323.66  Aligned_cols=241  Identities=28%  Similarity=0.457  Sum_probs=209.6

Q ss_pred             cCCcccccccCCceEEEEEEEccCCce-EEEEEeccccccc--hHHHHHHHHHHHHcCCCceeeEeEEEeeCC-EEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMT-LAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFESSN-VMCVVL   79 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~-~~~K~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~   79 (251)
                      +..+.+.+|+|+||+||++.++.  .. ||+|++.......  .+.+.+|+.++.+++||||++++|++.... ..++||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            34566779999999999999984  45 9999986433222  569999999999999999999999999887 799999


Q ss_pred             EeccCCchhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhCC-ceecCCCCCcEEEeecCCC-cEEEeecccccccCCC
Q psy11805         80 ELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPE  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~g-i~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~~~~  156 (251)
                      ||+++|+|.+++.. .+..++...+..|+.||+.|+.|||+.+ |+|+||||+|+|+  +.++ ++||+|||+++.....
T Consensus       120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv--~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV--DLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE--cCCCCEEEECCCccceeeccc
Confidence            99999999999987 3678999999999999999999999999 9999999999999  8887 9999999999876544


Q ss_pred             -CcceeeccCcccccccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        157 -KKLQVLFGTPEFVAPEVVN--FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       157 -~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                       .......||+.|+|||++.  ...++.++||||||++||||+||..||.+....+....+.....++..+  ..+++.+
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~~~l  275 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECPPHL  275 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHH
Confidence             3333367999999999999  5689999999999999999999999999999866666666555555443  4489999


Q ss_pred             HHHHHHhcccCcCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPE  250 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps  250 (251)
                      ..++..||+.||.+||+
T Consensus       276 ~~l~~~CW~~dp~~RP~  292 (362)
T KOG0192|consen  276 SSLMERCWLVDPSRRPS  292 (362)
T ss_pred             HHHHHHhCCCCCCcCCC
Confidence            99999999999999997

>KOG0605|consensus

Probab=100.00  E-value=1.5e-50  Score=325.20  Aligned_cols=243  Identities=29%  Similarity=0.510  Sum_probs=217.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|+++..||.|+||.||+|+-+.+|..+|+|++....   ....+-...|-.+|....++.||+++-.|++.+.+||||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            68999999999999999999999999999999987544   334666778888999889999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC---
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE---  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~---  156 (251)
                      ||++||++..++...+ .++++.+.-++.+++.|+..+|+.|++|+||||+|+|+  +..|++||+|||++......   
T Consensus       221 EylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi--D~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI--DAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee--cCCCCEeeccccccchhhhhhhh
Confidence            9999999999888765 69999999999999999999999999999999999999  99999999999999543210   


Q ss_pred             -------------------C-c-----c--------------------eeeccCcccccccccccCCCCcchhHHHHHHH
Q psy11805        157 -------------------K-K-----L--------------------QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI  191 (251)
Q Consensus       157 -------------------~-~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~  191 (251)
                                         . .     .                    ....|||.|+|||++.+..++..+|.||||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                               0 0     0                    01348999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       192 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      ||||+.|.+||.+.+..+++.++......+..+.-..++++++|||.+||. ||++|.
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            999999999999999999999999988766666557889999999999999 999985

>KOG0593|consensus

Probab=100.00  E-value=1.7e-51  Score=310.01  Aligned_cols=245  Identities=23%  Similarity=0.402  Sum_probs=210.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +.|+...++|+|+||.||+|+++.+|+.||+|.+.-..  ..-.+-..+|+++|++++|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            57999999999999999999999999999999985322  2336677899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      |++. ++.+-+...+..++.+.+..+++|++.|+.|+|+++++||||||+||++  +.+|.+||||||+|+.........
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi--t~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI--TQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE--ecCCcEEeccchhhHhhcCCcchh
Confidence            9987 6667777777779999999999999999999999999999999999999  999999999999999877433333


Q ss_pred             e-eccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC---------------
Q psy11805        161 V-LFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD---------------  223 (251)
Q Consensus       161 ~-~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  223 (251)
                      + ...|.-|+|||++.| ..|+...||||+||++.||++|...|.+.++.+++..+...-..+.+               
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            3 345667899999988 67899999999999999999999999999998888766443322221               


Q ss_pred             ------------ccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        224 ------------ECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       224 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                                  ...+.++.-+.||++.||+.||++|++
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s  277 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS  277 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc
Confidence                        122356778999999999999999986

>KOG0198|consensus

Probab=100.00  E-value=6.8e-51  Score=318.65  Aligned_cols=245  Identities=31%  Similarity=0.535  Sum_probs=208.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC--EEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN--VMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e   80 (251)
                      .+|...+.||+|+||+||++.+..++...|+|.....+....+.+.+|+.+|.+++|||||++++......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45888999999999999999999989999999987654444778999999999999999999999754333  6999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeecccccccCC----
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFGLARKFDP----  155 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~~~~~~~----  155 (251)
                      |+++|+|.+++...++++++..+..+.+|+++||.|||++|++|+||||+|||+  +. ++.+||.|||.+.....    
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl--~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL--DPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE--eCCCCeEEeccCcccccccccccc
Confidence            999999999998877689999999999999999999999999999999999999  77 79999999999987663    


Q ss_pred             CCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        156 EKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMG-ETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ........||+.|+|||++.. .....++|||||||++.||+||+.||.. ....+....+....  ..+.++..+|.+.
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCcccCHHH
Confidence            222345679999999999985 3344699999999999999999999987 44444444444333  2225557799999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      ++||.+|++.+|++||||
T Consensus       253 ~~Fl~~C~~~~p~~Rpta  270 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTA  270 (313)
T ss_pred             HHHHHHHhhcCcccCcCH
Confidence            999999999999999986

>KOG0588|consensus

Probab=100.00  E-value=1.3e-50  Score=332.46  Aligned_cols=241  Identities=34%  Similarity=0.570  Sum_probs=226.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      -|++++.||.|+.|.|-+|++..||+.+|+|++....   ......+++|+-+++.+.|||+++++++|++..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            3889999999999999999999999999999986542   3347889999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      |++||-|.+++..++ ++++.++.++++||+.|+.|+|..+|+|+|+||+|+|+  +.++++||+|||+|....++....
T Consensus        93 yv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL--d~~~nIKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL--DVKNNIKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             ecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh--hcccCEeeeccceeecccCCcccc
Confidence            999999999998876 69999999999999999999999999999999999999  888889999999999988888899


Q ss_pred             eeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      +.||+|.|+|||+..|.+| +.++||||-|++||.|++|++||++.+....+.++..+.+..+    ..+|.++++||++
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLLr~  245 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLLRR  245 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHHHH
Confidence            9999999999999999988 5799999999999999999999999999999999999988777    7889999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||..||+.|+|+
T Consensus       246 ml~VDp~~RiT~  257 (786)
T KOG0588|consen  246 MLDVDPSTRITT  257 (786)
T ss_pred             HhccCccccccH
Confidence            999999999874

>KOG0578|consensus

Probab=100.00  E-value=9.4e-51  Score=328.49  Aligned_cols=244  Identities=27%  Similarity=0.520  Sum_probs=221.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ..|....+||+|+.|.||.|....+++.||+|.+........+-+.+|+.+++..+|+|||.+++.|.-.+.+++||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            56888999999999999999999999999999998888888999999999999999999999999998889999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-ccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~~  161 (251)
                      +|++|.+.+...  .+++.+++.|++++++||+|||.+||+|+|||.+|||+  ..+|.+||+|||+|....... ....
T Consensus       353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL--~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL--TMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe--ccCCcEEEeeeeeeeccccccCcccc
Confidence            999999988664  49999999999999999999999999999999999999  999999999999999887665 4466


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhc
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL  241 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (251)
                      ..|||+|||||+.....|+++.||||||+|.+||+.|.+||-..+....+..+... .++....+..++..+++|+.+||
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~klS~~~kdFL~~cL  507 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEKLSPELKDFLDRCL  507 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccccCHHHHHHHHHHh
Confidence            78999999999999999999999999999999999999999987776666555433 34455555789999999999999


Q ss_pred             ccCcCCCCCC
Q psy11805        242 LKDREDAPEV  251 (251)
Q Consensus       242 ~~~p~~Rps~  251 (251)
                      ..|+++|+||
T Consensus       508 ~~dv~~RasA  517 (550)
T KOG0578|consen  508 VVDVEQRASA  517 (550)
T ss_pred             hcchhcCCCH
Confidence            9999999986

>KOG0033|consensus

Probab=100.00  E-value=3.9e-52  Score=305.28  Aligned_cols=250  Identities=30%  Similarity=0.594  Sum_probs=226.5

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +.+.|.+.+.||.|+|+.|+++.+..+|+.+++|++...  ....-+.+.+|+.+.+.++||||+++.+...+++..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            357899999999999999999999999999999987532  233688999999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC-CcEEEeecccccccCCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG-NRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~-~~~~l~df~~~~~~~~~~  157 (251)
                      +|.++|+.|..-+... ...++-.+...++||+++|.|+|++||+|||++|.|+++....+ .-+||+|||++...+.+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            9999999886665554 35899999999999999999999999999999999999844333 368999999999887555


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .-....|+|.|+|||++...+++..+|||+-|++||-|+.|.+||.+.+....++.+..+.+..+.+.|++++++.++||
T Consensus       168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv  247 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI  247 (355)
T ss_pred             ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence            55566799999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||..||.+|+|+
T Consensus       248 rrML~~dP~kRIta  261 (355)
T KOG0033|consen  248 RRMLTVNPKKRITA  261 (355)
T ss_pred             HHHhccChhhhccH
Confidence            99999999999985

>KOG0032|consensus

Probab=100.00  E-value=2.8e-49  Score=320.74  Aligned_cols=248  Identities=44%  Similarity=0.766  Sum_probs=231.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   77 (251)
                      ...|++.+.||.|.||.||.|..+.+++.+|+|++......   ....+.+|++++++++ |||++.+.+++++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            46799999999999999999999999999999998654432   4579999999999998 9999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC--CcEEEeecccccccCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG--NRIKIIDFGLARKFDP  155 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~--~~~~l~df~~~~~~~~  155 (251)
                      |||+++||.|.+.+... . +++..+..++.|++.++.|||+.|++|+|+||+|+++....+  +.++++|||++.....
T Consensus       114 vmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            99999999999999877 3 999999999999999999999999999999999999866544  4799999999999888


Q ss_pred             CCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        156 EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      .......+||+.|+|||++....++...||||+|+++|.|++|..||.+.+..+....+..+.+.+..+.|+.++..+++
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd  271 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKD  271 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHH
Confidence            77788899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|+.||..||.+|+++
T Consensus       272 ~i~~ll~~dp~~R~ta  287 (382)
T KOG0032|consen  272 FIRKLLEFDPRKRLTA  287 (382)
T ss_pred             HHHHhcccCcccCCCH
Confidence            9999999999999985

>KOG0597|consensus

Probab=100.00  E-value=1.1e-50  Score=327.92  Aligned_cols=240  Identities=31%  Similarity=0.545  Sum_probs=220.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|.+.+.||+|.||.||+++.+.+.+.||+|.+....  .++.+.+.+|+++++.++||||++++++|++....++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            68999999999999999999999999999999986543  3458889999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      |+.| +|...+...+ .++++.+..++.+++.||.|||+.+|.|+|+||+||++  ..+|.+|+||||+++.....+...
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl--~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL--EKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee--cCCCceeechhhhhhhcccCceee
Confidence            9988 8988887665 79999999999999999999999999999999999999  999999999999999887766554


Q ss_pred             e-eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 V-LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~-~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      + .-|||-|+|||+..+++++..+|+|||||++||++.|++||-...-.+....+......++    ...+..+.+|+..
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----STASSSFVNFLQG  233 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----ccccHHHHHHHHH
Confidence            3 4599999999999999999999999999999999999999999888888888887776665    5789999999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      +|.+||.+|.+
T Consensus       234 LL~kdP~~Rlt  244 (808)
T KOG0597|consen  234 LLIKDPAQRLT  244 (808)
T ss_pred             HhhcChhhccc
Confidence            99999999986

>KOG0659|consensus

Probab=100.00  E-value=1.7e-49  Score=294.06  Aligned_cols=246  Identities=28%  Similarity=0.507  Sum_probs=218.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccc--hHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|...+.+|+|.||.||+|++..+++.||+|.+...+..+  .....+|++.|+.++|+||+.++|+|.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            68999999999999999999999999999999997665443  5677899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      |++. +|...++++.-.++..++..++.+++.||+|||++.|.|||+||.|+|+  +.+|.+||.|||+++.+.......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi--s~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI--SSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE--cCCCcEEeecccchhccCCCCccc
Confidence            9976 8999999888889999999999999999999999999999999999999  999999999999999986555444


Q ss_pred             ee-ccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc-----------
Q psy11805        161 VL-FGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN-----------  227 (251)
Q Consensus       161 ~~-~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------  227 (251)
                      .. ..|.=|+|||++.|. .|+...|+||.||++.||+-|.+.|.+.++.+++..+......+.+..|+           
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            33 567788999998764 68999999999999999999999999999999998886655544444333           


Q ss_pred             -------------CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 -------------EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 -------------~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                   ..++++.||+.+||..||.+|+|+
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita  275 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITA  275 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccH
Confidence                         356688999999999999999985

>KOG0611|consensus

Probab=100.00  E-value=1.7e-50  Score=315.96  Aligned_cols=243  Identities=33%  Similarity=0.592  Sum_probs=226.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      ++.+|++.+.||.|+||+|-+|.....|+.||+|.++.+.   ..+.-.+.+|++++..++||||+.++++|++.+.+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            3679999999999999999999999999999999986443   4456678899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      ||||..+|.|.+++...+ .+++..++.+++||++|+.|+|.++++|+|||.+|||+  +.++++||.|||++-.+....
T Consensus       131 vMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL--D~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL--DQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheee--cCCCCeeeeccchhhhhcccc
Confidence            999999999999998876 69999999999999999999999999999999999999  999999999999999999999


Q ss_pred             cceeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ..++.||+|-|.+||+..|.+| ++..|.||||++||.|+.|..||++.+......++..+-+..+.     -|.+...|
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSdA~gL  282 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSDASGL  282 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCchHHHH
Confidence            9999999999999999999988 57899999999999999999999999999999999998887654     37789999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |+.||..+|++|.|+
T Consensus       283 IRwmLmVNP~RRATi  297 (668)
T KOG0611|consen  283 IRWMLMVNPERRATI  297 (668)
T ss_pred             HHHHHhcCcccchhH
Confidence            999999999999874

>KOG0661|consensus

Probab=100.00  E-value=1.1e-50  Score=321.73  Aligned_cols=247  Identities=28%  Similarity=0.434  Sum_probs=211.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcC-CCceeeEeEEEeeCC-EEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQ-HPRLIQIYDAFESSN-VMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~~~lv   78 (251)
                      -++|.++++||.|+||.||+|+...++..||+|.++..-.. +...-.+|++.|++++ ||||+++.+++.+.. .+|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            36899999999999999999999999999999998532211 2233458999999998 999999999998777 89999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      ||+|+. +|.+++.+.+..+++..++.|+.||++||+++|.+|++|||+||+|||+  ..+..+||+|||+|+.......
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi--~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI--SGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe--cccceeEecccccccccccCCC
Confidence            999987 8999999988899999999999999999999999999999999999999  7788999999999998876665


Q ss_pred             ceeeccCcccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc-------------
Q psy11805        159 LQVLFGTPEFVAPEVVN-FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE-------------  224 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  224 (251)
                      -.....|.=|+|||++. ...|+.+.|+||+||+++|+++-++.|.+.+..+++.++..-...+...             
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            55566677789999885 5678999999999999999999999999998888877664333222211             


Q ss_pred             -------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 -------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                   ..+..+.++.++|.+||+.||.+||||
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA  285 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA  285 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH
Confidence                         123478899999999999999999996

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-49  Score=316.40  Aligned_cols=239  Identities=27%  Similarity=0.530  Sum_probs=211.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            58999999999999999999999999999999986432   223566889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.+||++|++|+||+|+||++  +.++.++|+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli--~~~~~~kl~Dfg~~~~~~~~--~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL--DKEGHIKLTDFGFAKKLRDR--T  155 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--CCCCCEEEEecCcchhccCC--c
Confidence            9999999988887654 68999999999999999999999999999999999999  88999999999998765432  2


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+...++    ..++..++++|++
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~  231 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIKK  231 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHHHH
Confidence            334688999999999988899999999999999999999999999888887777776654443    4568899999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      ||+.||.+||+
T Consensus       232 ~l~~dp~~R~~  242 (291)
T cd05612         232 LLVVDRTRRLG  242 (291)
T ss_pred             HcCCCHHHccC
Confidence            99999999995

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6e-49  Score=312.85  Aligned_cols=245  Identities=26%  Similarity=0.463  Sum_probs=206.1

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....   ......+.+|+.++++++|++++++.+.+.+++..++++|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            4888999999999999999999999999999875432   2224467789999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ++++++|.+.+... ...+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--DDRGHIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE--CCCCCEEEeeCCCcEEcCCCCee
Confidence            99999998777543 3358999999999999999999999999999999999999  88899999999999775444333


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+..............++..+.+||++
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  238 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM  238 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence            44568999999999999899999999999999999999999998765433333222222222233446789999999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      ||+.||++||+
T Consensus       239 ~l~~~P~~R~~  249 (285)
T cd05631         239 LLTKNPKERLG  249 (285)
T ss_pred             HhhcCHHHhcC
Confidence            99999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.3e-49  Score=320.27  Aligned_cols=239  Identities=28%  Similarity=0.538  Sum_probs=211.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.|++|++....   ......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67999999999999999999999999999999986432   234567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.......  
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL--DNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE--CCCCCEEEeeccCceEcCCCc--
Confidence            9999999988887654 68999999999999999999999999999999999999  899999999999997654332  


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..+....+    ..++..+++||++
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~  248 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLVKG  248 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHHHHH
Confidence            345689999999999988899999999999999999999999998888777777766554333    4578899999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      ||+.||.+||+
T Consensus       249 ~L~~dP~~R~~  259 (329)
T PTZ00263        249 LLQTDHTKRLG  259 (329)
T ss_pred             HhhcCHHHcCC
Confidence            99999999996

>KOG0585|consensus

Probab=100.00  E-value=3.9e-49  Score=312.94  Aligned_cols=244  Identities=29%  Similarity=0.559  Sum_probs=210.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--------------ccchHHHHHHHHHHHHcCCCceeeEeEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--------------RNDRRNVEREVEIMRELQHPRLIQIYDA   68 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~   68 (251)
                      |+|++++.||+|.||.|-+|++..+++.||+|++....              ....+...+|+.+++++.|+|||+++++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            78999999999999999999999999999999985211              1134688999999999999999999999


Q ss_pred             Eee--CCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEee
Q psy11805         69 FES--SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        69 ~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                      ..+  .+.+|+|+|||..|.+...- ..+..+++.+++.++++++.||+|||.+||+||||||+|+|+  +.+|++||.|
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl--~~~g~VKIsD  253 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL--SSDGTVKISD  253 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE--cCCCcEEeec
Confidence            965  45799999999998774432 222238999999999999999999999999999999999999  8899999999


Q ss_pred             cccccccCC------CCcceeeccCcccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q psy11805        147 FGLARKFDP------EKKLQVLFGTPEFVAPEVVNFDA----IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI  216 (251)
Q Consensus       147 f~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  216 (251)
                      ||.+.....      +.......|||.|+|||...++.    .+.+.||||+|++||.|+.|+.||.+....+...++..
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn  333 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN  333 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence            999987622      22234467999999999987633    35788999999999999999999999999999999988


Q ss_pred             ccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.++..  +.+...+++||.+||.+||++|+++
T Consensus       334 ~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l  366 (576)
T KOG0585|consen  334 DPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITL  366 (576)
T ss_pred             CcccCCCc--ccccHHHHHHHHHHhhcChhheeeh
Confidence            87766654  5678899999999999999999874

>KOG0197|consensus

Probab=100.00  E-value=8e-49  Score=315.98  Aligned_cols=240  Identities=25%  Similarity=0.403  Sum_probs=210.7

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      .++.++.||+|-||.||.+.++.+ ..|++|.+... ....+.+.+|++++++++|++|+++++++..++.++||||||+
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            356788999999999999999853 47888887543 3345777899999999999999999999999889999999999


Q ss_pred             CCchhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--e
Q psy11805         84 GGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--Q  160 (251)
Q Consensus        84 ~~~L~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--~  160 (251)
                      .|+|.++++. .+..++..+.+.++.||++|.+||+++++|||||.++|||+  +++..+|++|||+++....+.-.  .
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV--~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV--DEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee--ccCceEEEcccccccccCCCceeecC
Confidence            9999999997 66679999999999999999999999999999999999999  99999999999999954332221  1


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ..--+..|.|||.+....++.+|||||||++|||++| |+.||..++..+..+.+..+...   +++..+|+++.+++..
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl---p~P~~CP~~vY~lM~~  439 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL---PRPEGCPDEVYELMKS  439 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC---CCCCCCCHHHHHHHHH
Confidence            1223458999999999999999999999999999999 99999999999999999877643   3337899999999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      ||+.+|++|||
T Consensus       440 CW~~~P~~RPt  450 (468)
T KOG0197|consen  440 CWHEDPEDRPT  450 (468)
T ss_pred             HhhCCcccCCC
Confidence            99999999998

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-48  Score=315.81  Aligned_cols=244  Identities=27%  Similarity=0.483  Sum_probs=211.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+..++.++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999986432   223567888999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+++++|.+++...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.....  ..
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI--DASGHIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--CCCCCEEEEeCcCCccccc--cc
Confidence            9999999998886544 68999999999999999999999999999999999999  8899999999999976543  23


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccc----cCCCHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF----NEISDDAKD  235 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  235 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.........+..    ..++.++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            3456889999999999889999999999999999999999999988887777666544332222221    256899999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|.+||+.+|.+||++
T Consensus       236 li~~~l~~~~~rr~s~  251 (333)
T cd05600         236 LITKLINDPSRRFGSL  251 (333)
T ss_pred             HHHHHhhChhhhcCCH
Confidence            9999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589|consensus

Probab=100.00  E-value=4e-49  Score=316.47  Aligned_cols=245  Identities=24%  Similarity=0.472  Sum_probs=225.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCE-EEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNV-MCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv   78 (251)
                      -++|..++.+|.|+||.+++++++.+++.+++|.+......  ......+|+.++.+++||||+.+.+.|+.++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            36899999999999999999999999999999998755533  35678899999999999999999999998888 9999


Q ss_pred             EEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         79 LELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |+|++||++.+.+...+ .-++++.+..|+.|++.|+.|||+++|+|||||+.||++  +.++.|+|+|||++....+..
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl--tk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL--TKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc--cccCceeecchhhhhhcCCch
Confidence            99999999999988654 669999999999999999999999999999999999999  999999999999999988776


Q ss_pred             -cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        158 -KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                       ...+..|||.|++||.+.+.+|+.++|||||||++|||++-+.+|.+.+..+...++....+.+..   ...+.+++.+
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~~l  237 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELRSL  237 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHHHH
Confidence             667788999999999999999999999999999999999999999999999999999888754443   5679999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |+.||+.+|..||++
T Consensus       238 v~~~l~~~P~~RPsa  252 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSA  252 (426)
T ss_pred             HHHHhhcCCccCCCH
Confidence            999999999999985

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.6e-48  Score=306.64  Aligned_cols=246  Identities=23%  Similarity=0.370  Sum_probs=205.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||.|+||.||+|.+..++..|++|.+..... .....+.+|+..++.++|+||+++++++.+++..++|||+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            579999999999999999999999999999999864432 2355678999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +++ +|.+.+...+..++...+..++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++....... ...
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~--~~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI--NEKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--CCCCCEEECcCcceeeccCCCcccc
Confidence            986 8888887766678999999999999999999999999999999999999  889999999999987643222 223


Q ss_pred             eeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC----------------
Q psy11805        161 VLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD----------------  223 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------  223 (251)
                      ...+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+..+....+.........                
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            3457889999999865 56789999999999999999999999887766655444322111110                


Q ss_pred             ----------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ----------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                .....++.++.+||++||+.||.+|||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~  279 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA  279 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH
Confidence                      0113467889999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.1e-48  Score=313.88  Aligned_cols=235  Identities=28%  Similarity=0.516  Sum_probs=204.5

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      +.||+|+||.||+|.+..+++.+|+|++....   ......+.+|+.++++++|+||+++.+.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999986432   233566778999999999999999999999999999999999999


Q ss_pred             chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeecc
Q psy11805         86 ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFG  164 (251)
Q Consensus        86 ~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~  164 (251)
                      +|.+.+...+ .+++..+..++.|++.||+|||+.|++|+||||+||++  +.++.++|+|||++.... .........+
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll--~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  157 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE--CCCCCEEEeeCCCCcccccCCCcccceec
Confidence            9988876544 68999999999999999999999999999999999999  889999999999986532 2223344568


Q ss_pred             CcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        165 TPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      ++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......++    ..+++++.+||++||+.|
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~d  233 (323)
T cd05571         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCC
Confidence            9999999999988999999999999999999999999998887777766655544333    568999999999999999


Q ss_pred             cCCCCC
Q psy11805        245 REDAPE  250 (251)
Q Consensus       245 p~~Rps  250 (251)
                      |++||+
T Consensus       234 P~~R~~  239 (323)
T cd05571         234 PKQRLG  239 (323)
T ss_pred             HHHcCC
Confidence            999993

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0599|consensus

Probab=100.00  E-value=1.6e-49  Score=295.94  Aligned_cols=246  Identities=34%  Similarity=0.615  Sum_probs=225.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--------chHHHHHHHHHHHHc-CCCceeeEeEEEeeCC
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--------DRRNVEREVEIMREL-QHPRLIQIYDAFESSN   73 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--------~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   73 (251)
                      +.|.-.+.+|.|..++|-++.++.+++.+++|++......        -.+.-.+|+.+|+++ .||+|+.+.++++++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4577788999999999999999999999999998532211        145566899999998 5999999999999999


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..++|+|.|+.|.|.+++.+. -.+++.....|++|+++|+.|||.++|||+|+||+||++  +++.+++|+|||+++..
T Consensus        97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl--ddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL--DDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee--ccccceEEeccceeecc
Confidence            999999999999999998654 469999999999999999999999999999999999999  99999999999999999


Q ss_pred             CCCCcceeeccCcccccccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFD------AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      .++......||||+|+|||.+.+.      .|+...|+||.|++||.|+.|..||....+.-.+..+..+.+.+..+.|.
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa  253 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA  253 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence            999999999999999999998653      46678999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +++...++||++||+.||++|.|+
T Consensus       254 dis~~~KdLIsrlLqVdp~~Rita  277 (411)
T KOG0599|consen  254 DISATVKDLISRLLQVDPTKRITA  277 (411)
T ss_pred             hccccHHHHHHHHHeeCchhcccH
Confidence            999999999999999999999984

>KOG0582|consensus

Probab=100.00  E-value=8.1e-48  Score=303.40  Aligned_cols=248  Identities=23%  Similarity=0.422  Sum_probs=213.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccc-hHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++...||.|..++||+|+...++..|++|++..++..+ ...+.+|++.++.++||||++.+-.|..++.+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            368999999999999999999999999999999997666443 6999999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cc
Q psy11805         81 LIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KK  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~  158 (251)
                      +|.+|++.+.+... +..+++..+..|+++++.||.|||.+|.+|||+|+.|||+  +.+|.|+|.|||.+...... .+
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi--~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI--DSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE--cCCCcEEEcCceeeeeecccCce
Confidence            99999999998863 4459999999999999999999999999999999999999  99999999999987665332 22


Q ss_pred             c----eeeccCccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc------CCCccc
Q psy11805        159 L----QVLFGTPEFVAPEVVNF--DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD------FDDECF  226 (251)
Q Consensus       159 ~----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------~~~~~~  226 (251)
                      .    ....+++.|+|||++..  ..|+.|+||||||+...||++|+.||......+.+-.-..+..+      .+....
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~  262 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDED  262 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHh
Confidence            2    33478999999999643  46899999999999999999999999988877765444444432      222333


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..++..++.+|..||+.||++||||
T Consensus       263 k~~~ksf~e~i~~CL~kDP~kRptA  287 (516)
T KOG0582|consen  263 KKFSKSFREMIALCLVKDPSKRPTA  287 (516)
T ss_pred             hhhcHHHHHHHHHHhhcCcccCCCH
Confidence            4678899999999999999999996

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-47  Score=309.42  Aligned_cols=233  Identities=27%  Similarity=0.469  Sum_probs=203.6

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      ||+|+||.||+|.+..+++.||+|++...   .......+.+|+.++++++||||+++++.+.+.+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999998642   233456778899999999999999999999999999999999999999


Q ss_pred             hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-CcceeeccCc
Q psy11805         88 FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTP  166 (251)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~  166 (251)
                      .+.+...+ .+++..+..++.|++.||.|||+.|++||||+|+||++  +.++.++|+|||++...... .......+++
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE--CCCCcEEEEECcccccCccCCCccccccCCc
Confidence            88887654 68999999999999999999999999999999999999  89999999999998754222 2223456899


Q ss_pred             ccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcC
Q psy11805        167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE  246 (251)
Q Consensus       167 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  246 (251)
                      .|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..+++.+.++|.+||+.||.
T Consensus       158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCHH
Confidence            99999999998999999999999999999999999998888777776665544333    56889999999999999999


Q ss_pred             CCCC
Q psy11805        247 DAPE  250 (251)
Q Consensus       247 ~Rps  250 (251)
                      +||+
T Consensus       234 ~R~~  237 (312)
T cd05585         234 RRLG  237 (312)
T ss_pred             HcCC
Confidence            9986

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0580|consensus

Probab=100.00  E-value=8.1e-49  Score=286.37  Aligned_cols=241  Identities=30%  Similarity=0.540  Sum_probs=221.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|+++++||.|.||.||+|+.+.++..|++|++....   .....++.+|+++-..++||||++++++|.++..+|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            68999999999999999999999999999999974322   334678899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      ||.+.|++...+.+. ...+++..++.++.|++.||.|+|..+++||||||+|+|+  ...+.+++.|||.+...+ ...
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl--g~~~~lkiAdfGwsV~~p-~~k  178 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SNK  178 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc--CCCCCeeccCCCceeecC-CCC
Confidence            999999999988853 3469999999999999999999999999999999999999  999999999999997765 556


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ..+.|||..|++||...+...+...|+|++|++.||++.|..||.+....++++++.+.....+    +.++.+++|+|.
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dlI~  254 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADLIS  254 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHHHH
Confidence            6788999999999999999999999999999999999999999999999999999988887766    788999999999


Q ss_pred             HhcccCcCCCCC
Q psy11805        239 KLLLKDREDAPE  250 (251)
Q Consensus       239 ~~l~~~p~~Rps  250 (251)
                      +||..+|.+|.+
T Consensus       255 ~ll~~~p~~r~~  266 (281)
T KOG0580|consen  255 RLLVKNPIERLA  266 (281)
T ss_pred             HHhccCcccccc
Confidence            999999999976

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.8e-47  Score=308.48  Aligned_cols=241  Identities=25%  Similarity=0.449  Sum_probs=208.5

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCC-CceeeEeEEEeeCCEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQH-PRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+..|...+..+.| ++++.+.+.+.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            6899999999999999999999999999999986432   2345677888999998875 56888999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~  158 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--DAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--cCCCCEEEeecCcceecCCCCCc
Confidence            9999999988876654 68999999999999999999999999999999999999  889999999999986532 2233


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||...+..+....+.......+    ..++..+.++++
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            3455689999999999998999999999999999999999999999888888777766544333    567899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|.+|+++
T Consensus       234 ~~l~~~P~~R~~~  246 (324)
T cd05587         234 GLLTKHPAKRLGC  246 (324)
T ss_pred             HHhhcCHHHcCCC
Confidence            9999999999963

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.8e-48  Score=312.74  Aligned_cols=238  Identities=27%  Similarity=0.456  Sum_probs=209.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCC-ceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATG-MTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||.||+|.+..++ ..|++|.+....   ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            57999999999999999999877654 689999885432   23456788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+.+...+ .+++..+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++......  
T Consensus       110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl--~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE--CCCCCEEEecCCCCeecCCC--
Confidence            99999999988887654 68999999999999999999999999999999999999  88999999999999765432  


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..+....+    ..+++.+.++|+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  260 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHLMK  260 (340)
T ss_pred             cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence            2345689999999999888899999999999999999999999999888777777766654433    567899999999


Q ss_pred             HhcccCcCCCC
Q psy11805        239 KLLLKDREDAP  249 (251)
Q Consensus       239 ~~l~~~p~~Rp  249 (251)
                      +||+.+|++|+
T Consensus       261 ~~l~~dp~~R~  271 (340)
T PTZ00426        261 KLLSHDLTKRY  271 (340)
T ss_pred             HHcccCHHHcC
Confidence            99999999996

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-47  Score=309.69  Aligned_cols=235  Identities=29%  Similarity=0.537  Sum_probs=203.4

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      +.||+|+||.||++.+..+++.||+|++....   ......+.+|+..++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999999999999999986432   234556778999999999999999999999999999999999999


Q ss_pred             chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcceeecc
Q psy11805         86 ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLFG  164 (251)
Q Consensus        86 ~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~  164 (251)
                      +|...+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++..... ........+
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  157 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--cCCCCEEecccHHhccccCCCCccccccC
Confidence            9987776543 68999999999999999999999999999999999999  8899999999999865322 222234568


Q ss_pred             CcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        165 TPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      ++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..+++++.++|++||+.|
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~d  233 (323)
T cd05595         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccCC
Confidence            8999999999988899999999999999999999999998887777766665544433    567999999999999999


Q ss_pred             cCCCCC
Q psy11805        245 REDAPE  250 (251)
Q Consensus       245 p~~Rps  250 (251)
                      |++||+
T Consensus       234 P~~R~~  239 (323)
T cd05595         234 PKQRLG  239 (323)
T ss_pred             HHHhCC
Confidence            999983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-48  Score=316.46  Aligned_cols=244  Identities=26%  Similarity=0.462  Sum_probs=209.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            58999999999999999999999999999999986432   233566788999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.......  
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--CCCCCEEEeecccceeccccccc
Confidence            9999999998887654 69999999999999999999999999999999999999  899999999999986542111  


Q ss_pred             -------------------------------------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11805        158 -------------------------------------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLS  200 (251)
Q Consensus       158 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~  200 (251)
                                                           .....+||+.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 0112358999999999998889999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        201 PFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       201 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      ||...+..+....+.........+....+++.+.++|++||. +|.+|++
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            999888777776665544333333334678999999999997 8999986

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-47  Score=305.09  Aligned_cols=246  Identities=23%  Similarity=0.387  Sum_probs=203.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|++|.||+|.++.+++.+++|++....  ....+.+.+|+..++.++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            58999999999999999999999999999999986432  2335678899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--c
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--K  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--~  158 (251)
                      |++++++ +.+......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.......  .
T Consensus        81 ~~~~~~l-~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          81 YVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             cCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCcEEEeeccCccccccccccc
Confidence            9998665 4444444569999999999999999999999999999999999999  889999999999997754322  2


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC----------------
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD----------------  222 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  222 (251)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.....+.+                
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            2234578899999999888899999999999999999999999988765544333222110000                


Q ss_pred             ------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                  ......+|..+.+||++||+.||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~  278 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT  278 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH
Confidence                        00112478889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-48  Score=316.17  Aligned_cols=244  Identities=29%  Similarity=0.526  Sum_probs=212.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            58999999999999999999999999999999986432   234667889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      ||+++++|.+.+... ..+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++.......  
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--CCCCCEEeecCCCCccCcccCcc
Confidence            999999999988766 469999999999999999999999999999999999999  899999999999997654332  


Q ss_pred             ----------------------------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy11805        158 ----------------------------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ  209 (251)
Q Consensus       158 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  209 (251)
                                                  ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                        2234468899999999999999999999999999999999999999988777


Q ss_pred             HHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        210 TMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      ....+.........+....+++.+.+||.+||. +|.+||+
T Consensus       238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~  277 (350)
T cd05573         238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG  277 (350)
T ss_pred             HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCC
Confidence            777776532222333234579999999999998 9999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-47  Score=309.28  Aligned_cols=238  Identities=26%  Similarity=0.489  Sum_probs=204.8

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHH---HcCCCceeeEeEEEeeCCEEEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMR---ELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      |++.+.||+|++|.||+|.+..+++.|++|++....   ....+.+.+|++.+.   .++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            788999999999999999999999999999986432   233456777766654   55799999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~  157 (251)
                      |||+++++|...+..  ..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++..... ..
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL--DTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE--CCCCcEEeCcccCCccCCCCCC
Confidence            999999999877654  359999999999999999999999999999999999999  8899999999998865322 22


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..++..+.++|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  232 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISIM  232 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Confidence            23345689999999999998999999999999999999999999999888887777766554433    46799999999


Q ss_pred             HHhcccCcCCCCC
Q psy11805        238 RKLLLKDREDAPE  250 (251)
Q Consensus       238 ~~~l~~~p~~Rps  250 (251)
                      ++||+.||.+||+
T Consensus       233 ~~~L~~dP~~R~~  245 (324)
T cd05589         233 RRLLRRNPERRLG  245 (324)
T ss_pred             HHHhhcCHhHcCC
Confidence            9999999999995

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.1e-47  Score=308.51  Aligned_cols=234  Identities=28%  Similarity=0.539  Sum_probs=202.7

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      +.||+|+||.||++.+..+++.||+|++....   ......+.+|+..++.++||||+++.+.+..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999986432   234567788999999999999999999999999999999999999


Q ss_pred             chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcceeecc
Q psy11805         86 ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLFG  164 (251)
Q Consensus        86 ~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~  164 (251)
                      +|...+... ..+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++..... ........+
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll--~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML--DKDGHIKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE--CCCCcEEEecCcCCccCCCcccccccccC
Confidence            998777654 369999999999999999999999999999999999999  8899999999999865322 222234568


Q ss_pred             CcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        165 TPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      ++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..++.++.++|++||+.|
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~d  233 (328)
T cd05593         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIKD  233 (328)
T ss_pred             CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCCC
Confidence            9999999999988899999999999999999999999988877776666654444333    567999999999999999


Q ss_pred             cCCCC
Q psy11805        245 REDAP  249 (251)
Q Consensus       245 p~~Rp  249 (251)
                      |++||
T Consensus       234 P~~R~  238 (328)
T cd05593         234 PNKRL  238 (328)
T ss_pred             HHHcC
Confidence            99998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.4e-47  Score=311.20  Aligned_cols=242  Identities=26%  Similarity=0.439  Sum_probs=205.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.++|++|+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999986432   223567888999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi--~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE--CCCCCEEEeeccCcccccccccc
Confidence            9999999998887654 69999999999999999999999999999999999999  889999999999986542211  


Q ss_pred             ----------------------------------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11805        158 ----------------------------------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFM  203 (251)
Q Consensus       158 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  203 (251)
                                                        .....+||+.|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                              0123468999999999998899999999999999999999999999


Q ss_pred             CCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCC
Q psy11805        204 GETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA  248 (251)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  248 (251)
                      ..+..+...++.........+....++++++++|.+++. +|.+|
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r  281 (363)
T cd05628         238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHR  281 (363)
T ss_pred             CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Chhhc
Confidence            988888777776543333333224578999999999775 45554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0694|consensus

Probab=100.00  E-value=1.8e-47  Score=315.52  Aligned_cols=239  Identities=26%  Similarity=0.499  Sum_probs=217.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||.|.||+|+++..+.+++.+|+|+++...   ..+.+....|.+++.... ||.++.++..|++++++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            57899999999999999999999999999999987543   445788888999888875 99999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc-CCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~-~~~~  157 (251)
                      |||+.||++.... . ...+++..+.-++..++.||.|||++||++||||.+|||+  +.+|++||+|||++... ..+.
T Consensus       448 mey~~Ggdm~~~~-~-~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL--D~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  448 MEYVAGGDLMHHI-H-TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL--DTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEecCCCcEEEEE-e-cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE--cccCcEEecccccccccCCCCC
Confidence            9999999843333 2 2469999999999999999999999999999999999999  99999999999999774 3566


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ...+.||||.|+|||++.+..|+.+.|.||||++||||+.|..||.+.+.++...++......++    ..++.+..+++
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP----~~ls~ea~~il  599 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSKEAIAIM  599 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CcccHHHHHHH
Confidence            77889999999999999999999999999999999999999999999999999999988877766    56799999999


Q ss_pred             HHhcccCcCCCC
Q psy11805        238 RKLLLKDREDAP  249 (251)
Q Consensus       238 ~~~l~~~p~~Rp  249 (251)
                      +++|.++|++|.
T Consensus       600 ~~ll~k~p~kRL  611 (694)
T KOG0694|consen  600 RRLLRKNPEKRL  611 (694)
T ss_pred             HHHhccCccccc
Confidence            999999999996

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.1e-48  Score=312.15  Aligned_cols=246  Identities=28%  Similarity=0.436  Sum_probs=211.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|++....   ......+.+|+.+++.++|++|+++.+.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            57999999999999999999999999999999986432   234567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+++++|.+++......+++..+..++.|++.||.+||+.|++||||+|+||++  +.++.++|+|||++.........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll--~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE--CCCCCEEeccCCCCeECCCCCce
Confidence            9999999999988765679999999999999999999999999999999999999  89999999999999775433322


Q ss_pred             --eeeccCcccccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        160 --QVLFGTPEFVAPEVVN------FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       160 --~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                        ....+++.|+|||.+.      +..++.++||||||+++|+|++|..||...+..+...++.........+....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS  238 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence              2346889999999986      45677899999999999999999999998887777776654433222233346799


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+||++||+ +|.+|||+
T Consensus       239 ~~~~li~~ll~-~p~~R~t~  257 (330)
T cd05601         239 DFLDLIQSLLC-GQKERLGY  257 (330)
T ss_pred             HHHHHHHHHcc-ChhhCCCH
Confidence            99999999998 99999984

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.5e-47  Score=306.14  Aligned_cols=236  Identities=25%  Similarity=0.449  Sum_probs=203.9

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.++.+++.||+|++....   ......+..|...+..+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999986432   23456677888888776 699999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~  163 (251)
                      ++|.+.+.... .+++..+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++.... .........
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli--~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL--DHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE--CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            99988776654 69999999999999999999999999999999999999  889999999999986532 222233456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.......+    ..++.++.++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence            89999999999988899999999999999999999999999888888777766554333    45789999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      ||++||++
T Consensus       234 dP~~R~~~  241 (320)
T cd05590         234 NPTMRLGS  241 (320)
T ss_pred             CHHHCCCC
Confidence            99999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.5e-47  Score=306.18  Aligned_cols=240  Identities=24%  Similarity=0.441  Sum_probs=207.3

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +|++.+.||+|+||.||+|.+..+++.+|+|++....   .........|...+..+ +|++++++.+++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            6899999999999999999999999999999986432   22344566777777777 5899999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~  158 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill--~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--DSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE--CCCCcEEEccCCCceecCCCCCc
Confidence            9999999988876654 68999999999999999999999999999999999999  8999999999999875332 222


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+......++    ..++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence            3345689999999999999999999999999999999999999999888887777766554433    467899999999


Q ss_pred             HhcccCcCCCCC
Q psy11805        239 KLLLKDREDAPE  250 (251)
Q Consensus       239 ~~l~~~p~~Rps  250 (251)
                      +||+.+|++|++
T Consensus       234 ~~l~~~p~~R~~  245 (323)
T cd05616         234 GLMTKHPGKRLG  245 (323)
T ss_pred             HHcccCHHhcCC
Confidence            999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0660|consensus

Probab=100.00  E-value=1.1e-47  Score=295.87  Aligned_cols=246  Identities=29%  Similarity=0.427  Sum_probs=207.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEec--cccccchHHHHHHHHHHHHcCCCceeeEeEEEee-----CCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES-----SNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   74 (251)
                      ..+|...+.||.|+||.|..|.++.+++.||+|.+.  ..+....++..+|+..|+.++|+||+.+.+++..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            456777899999999999999999999999999987  6667778999999999999999999999999865     346


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      +|+|+|.|+ .+|.+.+... ..++.+.+..++.|++.||+|+|+++++|||+||+|+++  +.++.+|++|||+++..+
T Consensus       101 vYiV~elMe-tDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~--n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL--NADCDLKICDFGLARYLD  176 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheee--ccCCCEEeccccceeecc
Confidence            999999994 4776666554 459999999999999999999999999999999999999  999999999999999876


Q ss_pred             C---CCcceeeccCcccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC--------
Q psy11805        155 P---EKKLQVLFGTPEFVAPEVVN-FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD--------  222 (251)
Q Consensus       155 ~---~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  222 (251)
                      .   .........|.-|.|||++. ...|+.+.||||+||++.||++|+..|.+.+..++++.+..-...+.        
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            4   22234445677899999874 46789999999999999999999999999887776664422211111        


Q ss_pred             -------------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 -------------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                         ...+++.++.+.+|+.+||..||.+|+|+
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita  304 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA  304 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH
Confidence                               12345788899999999999999999985

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-46  Score=302.44  Aligned_cols=247  Identities=23%  Similarity=0.391  Sum_probs=199.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++..... .......+|+..++.++|+||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4789999999999999999999999999999999864432 234567789999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~  159 (251)
                      |+++ +|.+.+......+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++...... ...
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          84 YVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             CCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEECCCCcceeccCCCccC
Confidence            9965 7777777666679999999999999999999999999999999999999  88999999999998654322 222


Q ss_pred             eeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccccCC--------------C
Q psy11805        160 QVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIAQYDFD--------------D  223 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~--------------~  223 (251)
                      ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+..+. +....+........              .
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            34457889999999865 45788999999999999999999999875442 22222211100000              0


Q ss_pred             c------------cc--cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 E------------CF--NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ~------------~~--~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .            .+  ...++.+.+|+++||+.||++|||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~  282 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA  282 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH
Confidence            0            00  1245688999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-47  Score=301.11  Aligned_cols=245  Identities=26%  Similarity=0.429  Sum_probs=205.5

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +|++.+.||+|+||.||++.+..+++.||+|.+.....   .....+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            58999999999999999999999999999999854322   223456789999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |+++++|.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL--DDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE--CCCCCEEEeeCCCceecCCCCcc
Confidence            99999998877543 3468999999999999999999999999999999999999  88899999999999775444333


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+..++.++||||+|+++|++++|..||.+.+.......+..............++..+.+||.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ  238 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence            44568899999999988889999999999999999999999998876544333332222222223335689999999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      ||+.||++||+
T Consensus       239 ~l~~~P~~R~~  249 (285)
T cd05605         239 LLTKDPGFRLG  249 (285)
T ss_pred             HccCCHHHhcC
Confidence            99999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.5e-47  Score=304.22  Aligned_cols=236  Identities=28%  Similarity=0.474  Sum_probs=200.7

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.+..+++.||+|++....   .........|...+... +|+||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999986432   22344555666666654 799999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~  163 (251)
                      ++|.+.+...+ .+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++..... .......+
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill--~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL--DKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE--CCCCCEEEccCcCCeECCCCCCcccccc
Confidence            99988876654 69999999999999999999999999999999999999  8899999999999975432 22334456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+.......    ...++.++.++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF----PRWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHccC
Confidence            8999999999998889999999999999999999999999988877777665443322    246789999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      +|++||++
T Consensus       234 ~P~~R~~~  241 (316)
T cd05592         234 DPTKRLGV  241 (316)
T ss_pred             CHHHcCCC
Confidence            99999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-47  Score=314.46  Aligned_cols=243  Identities=26%  Similarity=0.470  Sum_probs=204.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+++++.++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            58999999999999999999999999999999985432   223567888999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-  158 (251)
                      ||+++++|.+.+... ..+++..+..++.|++.||+|||+.|++|+||||+||++  +.++.++|+|||++........ 
T Consensus        81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI--DRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--CCCCCEEEeeccccccccccccc
Confidence            999999998888754 468999999999999999999999999999999999999  8899999999999863211000 


Q ss_pred             -----------------------------------------------ceeeccCcccccccccccCCCCcchhHHHHHHH
Q psy11805        159 -----------------------------------------------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI  191 (251)
Q Consensus       159 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~  191 (251)
                                                                     .....|++.|+|||.+.+..++.++||||||++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                           002358899999999998889999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       192 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      +|+|++|..||...+..+....+.........+....++.++++||++||. +|.+|+
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~  294 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL  294 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence            999999999998887777666655433222222224678999999999998 777764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.4e-47  Score=314.81  Aligned_cols=243  Identities=28%  Similarity=0.463  Sum_probs=207.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999985432   223567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC---
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE---  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~---  156 (251)
                      ||+++++|.+++...+ .+++..+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++......   
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill--~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE--CCCCCEEEEeCCCCccccccccc
Confidence            9999999999887654 68999999999999999999999999999999999999  89999999999987432100   


Q ss_pred             -----------------------------------------CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHH
Q psy11805        157 -----------------------------------------KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVL  195 (251)
Q Consensus       157 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l  195 (251)
                                                               .......|++.|+|||.+.+..++.++||||||+++|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                     000123588999999999999999999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        196 LSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       196 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      ++|+.||...+..+....+.........+....++..+.++|.+|+ .+|.+|+
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~  290 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRL  290 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence            9999999988877766665544433343444578999999999977 5999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-46  Score=304.61  Aligned_cols=246  Identities=22%  Similarity=0.392  Sum_probs=205.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||.|++|.||++.+..++..+++|.+..... .....+.+|++.+++++|+||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            4789999999999999999999999999999999865422 235679999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++  +.++.++|+|||++...... ..
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~-~~  159 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS-MA  159 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE--cCCCcEEEccCccccccccc-cc
Confidence            999999988887654 589999999999999999999986 69999999999999  88999999999998765332 22


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc--------------------
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY--------------------  219 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------------  219 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.....                    
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            334688999999999988899999999999999999999999987665443322211000                    


Q ss_pred             ------------------------cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 ------------------------DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                              ..+......+++++++||++||+.||++|||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~  295 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL  295 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH
Confidence                                    00000012467899999999999999999985

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.2e-47  Score=311.70  Aligned_cols=245  Identities=27%  Similarity=0.428  Sum_probs=209.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++....   ......+.+|+.+++.++|+||+++++++.+++..++||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999985322   234556788999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      ||+++++|.+++...  .+++..+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||.+.......  
T Consensus       123 Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl--~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         123 EYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--cCCCCEEEEeccceeeccCCCcc
Confidence            999999998887654  48999999999999999999999999999999999999  899999999999997654332  


Q ss_pred             cceeeccCcccccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFD----AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ......+++.|+|||.+.+.    .++.++||||||+++|+|++|..||...+.......+.........+....++.++
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            12345689999999998653    37889999999999999999999999988877777776544333333334689999


Q ss_pred             HHHHHHhcccCcCC--CCCC
Q psy11805        234 KDFIRKLLLKDRED--APEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~--Rps~  251 (251)
                      .+||++||+.+|.+  |+|+
T Consensus       279 ~~li~~~L~~~p~r~~R~s~  298 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGV  298 (370)
T ss_pred             HHHHHHHccChhhccCCCCH
Confidence            99999999999988  8874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9e-47  Score=311.71  Aligned_cols=246  Identities=27%  Similarity=0.437  Sum_probs=205.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ..|++++.||+|+||+||+|.+..+++.+|+|++....   ......+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            36899999999999999999999999999999986432   234567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.+||+.||+||||||+||++  +.+++++|+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili--~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE--CCCCCEEEeeCcCCccccccccc
Confidence            9999999988887654 68999999999999999999999999999999999999  889999999999875321000  


Q ss_pred             ----------------------------------------------cceeeccCcccccccccccCCCCcchhHHHHHHH
Q psy11805        158 ----------------------------------------------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI  191 (251)
Q Consensus       158 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~  191 (251)
                                                                    ......|++.|+|||.+.+..++.++||||||++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                          0012358899999999998889999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhc--ccCcCCCCCC
Q psy11805        192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL--LKDREDAPEV  251 (251)
Q Consensus       192 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l--~~~p~~Rps~  251 (251)
                      +|+|++|..||...+..+....+.........+.+..+++++.+||.+|+  ..+|..||++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            99999999999988776666655543333333334568999999999955  5556568874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-46  Score=317.95  Aligned_cols=243  Identities=24%  Similarity=0.403  Sum_probs=211.1

Q ss_pred             cCCcccccccCCceEEEEEEEccC-CceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKAT-GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      .|.+.+.||.|++|.||+|....+ +..+++|.+..........+.+|+..++.++||||+++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            489999999999999999998877 7788888876555555677888999999999999999999999999999999999


Q ss_pred             cCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-
Q psy11805         83 EGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-  158 (251)
Q Consensus        83 ~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-  158 (251)
                      ++++|.+.+..   ....+++..+..++.|++.||.+||+.|++||||||+||++  +.++.++|+|||++........ 
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll--~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE--CCCCcEEEEeCcCceecCCcccc
Confidence            99999887653   23468999999999999999999999999999999999999  8899999999999987543322 


Q ss_pred             --ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        159 --LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                        ....++++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+....   ....++..++++
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~l  302 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPVSSGMKAL  302 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccCCHHHHHH
Confidence              234468999999999998889999999999999999999999999888877777766554432   224678999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |.+||+.+|++||++
T Consensus       303 i~~~L~~dP~~Rps~  317 (478)
T PTZ00267        303 LDPLLSKNPALRPTT  317 (478)
T ss_pred             HHHHhccChhhCcCH
Confidence            999999999999984

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.2e-47  Score=307.53  Aligned_cols=246  Identities=21%  Similarity=0.328  Sum_probs=197.3

Q ss_pred             CccCCcccccccCCceEEEEEEEc-----cCCceEEEEEeccccc-cchHHHHHHHHHHHHc-CCCceeeEeEEEeeC-C
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAKR-NDRRNVEREVEIMREL-QHPRLIQIYDAFESS-N   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~   73 (251)
                      +++|++.+.||+|+||.||+|.+.     .+++.||+|.+..... .....+.+|+.+++.+ +||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            468999999999999999999753     3456899999864322 2356788999999999 899999999988654 4


Q ss_pred             EEEEEEEeccCCchhHHHhhCC----------------------------------------------------------
Q psy11805         74 VMCVVLELIEGGELFERVIDDD----------------------------------------------------------   95 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~----------------------------------------------------------   95 (251)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5899999999999988886421                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc---ceeeccCcccc
Q psy11805         96 ---FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFV  169 (251)
Q Consensus        96 ---~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~  169 (251)
                         ..++...+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++........   .....+++.|+
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~--~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE--cCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence               247788899999999999999999999999999999999  8889999999999976432211   11223457899


Q ss_pred             cccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCC
Q psy11805        170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA  248 (251)
Q Consensus       170 aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  248 (251)
                      |||.+.+..++.++||||||+++|+|++ |..||......+.............  ....++..+.+++.+||+.||++|
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--APENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCChhhC
Confidence            9999988889999999999999999997 9999987654433322222222211  225678899999999999999999


Q ss_pred             CCC
Q psy11805        249 PEV  251 (251)
Q Consensus       249 ps~  251 (251)
                      ||+
T Consensus       322 Ps~  324 (338)
T cd05102         322 PTF  324 (338)
T ss_pred             cCH
Confidence            985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-46  Score=302.85  Aligned_cols=236  Identities=26%  Similarity=0.483  Sum_probs=201.6

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.+..+++.||+|.+....   .........|...+... +|++++++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999986432   23455667777777754 799999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~  163 (251)
                      ++|...+... ..++...+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++..... ........
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML--DRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--CCCCCEEeCccCCCeecccCCCceeccC
Confidence            9998887664 368999999999999999999999999999999999999  8899999999999865322 22234456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..++.+++++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence            89999999999999999999999999999999999999998887777776655443322    45788999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      ||++||++
T Consensus       234 dP~~R~~~  241 (316)
T cd05620         234 DPTRRLGV  241 (316)
T ss_pred             CHHHcCCC
Confidence            99999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.7e-47  Score=312.72  Aligned_cols=244  Identities=29%  Similarity=0.462  Sum_probs=207.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++....   ......+.+|+.+++.++|+||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            47999999999999999999999999999999986432   233567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC---
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE---  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~---  156 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.+||+.||+|+||||+|||+  +.++.++|+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl--~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEEeECCCCccccccccc
Confidence            9999999988887654 68999999999999999999999999999999999999  89999999999987432100   


Q ss_pred             ---------------------------------------------CcceeeccCcccccccccccCCCCcchhHHHHHHH
Q psy11805        157 ---------------------------------------------KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI  191 (251)
Q Consensus       157 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~  191 (251)
                                                                   .......|++.|+|||.+.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         00012358899999999998899999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       192 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      +|+|++|..||...+..+....+.........+....+++++.++|.+|+ .+|.+|++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~  295 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG  295 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence            99999999999988877776666554444444444678999999999987 49999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-46  Score=304.08  Aligned_cols=236  Identities=26%  Similarity=0.533  Sum_probs=202.7

Q ss_pred             ccccccCCceEEEEEEEc---cCCceEEEEEecccc----ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK----RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .+.||+|+||.||+|.+.   .+++.||+|++....    ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999874   467899999986422    2335567889999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~  159 (251)
                      |+++++|.+.+...+ .+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++..... ....
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          81 YLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCCEEEeeCcCCeecccCCCcc
Confidence            999999988886654 68899999999999999999999999999999999999  8899999999999865322 2222


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+....+    ..+++.+.++|++
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~  233 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKK  233 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            334688999999999888889999999999999999999999999888877777766554333    5678999999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      ||+.+|++||+
T Consensus       234 ~l~~~p~~R~~  244 (323)
T cd05584         234 LLKRNPSSRLG  244 (323)
T ss_pred             HcccCHhHcCC
Confidence            99999999993

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-46  Score=302.96  Aligned_cols=236  Identities=25%  Similarity=0.488  Sum_probs=203.5

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||+||+|.+..++..||+|++....   ......+.+|..+++.+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999986432   23456677888888887 699999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~  163 (251)
                      ++|...+...+ .+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++.... .........
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL--DSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE--CCCCcEEecccCCCeecCcCCCccccee
Confidence            99988776653 69999999999999999999999999999999999999  889999999999986532 222233446


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..++..+.+||++||+.
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence            88999999999999999999999999999999999999998887777776655544332    46789999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      ||.+||++
T Consensus       234 dP~~R~s~  241 (318)
T cd05570         234 NPEKRLGC  241 (318)
T ss_pred             CHHHcCCC
Confidence            99999985

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-46  Score=304.62  Aligned_cols=236  Identities=28%  Similarity=0.513  Sum_probs=200.2

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHH-HHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVE-IMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||+||+|.+..+++.|++|++....   ......+..|.. .++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999999999999999986432   122334445544 55778999999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~  163 (251)
                      ++|...+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++.... .........
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (323)
T cd05575          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKEGIEHSKTTSTFC  157 (323)
T ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE--CCCCcEEEeccCCCcccccCCCcccccc
Confidence            9998887664 368999999999999999999999999999999999999  889999999999986532 222233456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+........    ..++..+.++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (323)
T cd05575         158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQK  233 (323)
T ss_pred             CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhc
Confidence            89999999999998999999999999999999999999998887777776665543332    56799999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      ||.+||++
T Consensus       234 ~p~~R~~~  241 (323)
T cd05575         234 DRTKRLGA  241 (323)
T ss_pred             CHHhCCCC
Confidence            99999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0610|consensus

Probab=100.00  E-value=8.9e-47  Score=295.06  Aligned_cols=244  Identities=31%  Similarity=0.532  Sum_probs=214.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +++++.+.||.|..|+||+|+.+.++..+|+|++....   .....+.+-|-++|..+.||.++++++.++.+.+.|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            46889999999999999999999999999999986433   334677888999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC---
Q psy11805         80 ELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP---  155 (251)
Q Consensus        80 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~---  155 (251)
                      |||+||+|....+. .+..++++.++-++.+++.||+|||-.||++|||||+|||+  .++|++.|+||.++..-..   
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv--redGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV--REDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE--ecCCcEEeeeccccccCCCCCe
Confidence            99999999776654 45679999999999999999999999999999999999999  9999999999998744210   


Q ss_pred             -------------------------------CC-----------------------cceeeccCcccccccccccCCCCc
Q psy11805        156 -------------------------------EK-----------------------KLQVLFGTPEFVAPEVVNFDAIGF  181 (251)
Q Consensus       156 -------------------------------~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~  181 (251)
                                                     ..                       ......||-.|+|||++.|...+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                           00                       001123677899999999999999


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       182 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      +.|.|+||+++|||+.|+.||.+.+..+++.++......++..  ..++..++|||+++|.+||++|.-
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg  381 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLG  381 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhc
Confidence            9999999999999999999999999999999998887777665  478899999999999999999963

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.8e-46  Score=298.20  Aligned_cols=246  Identities=25%  Similarity=0.403  Sum_probs=200.5

Q ss_pred             ccCCcccccccCCceEEEEEEEcc-CCceEEEEEecccccc--chHHHHHHHHHHHHc---CCCceeeEeEEEe-----e
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKA-TGMTLAAKFVGIAKRN--DRRNVEREVEIMREL---QHPRLIQIYDAFE-----S   71 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~   71 (251)
                      ++|++.+.||+|+||.||+|.+.. +++.+|+|.+......  ......+|+..++.+   .||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            489999999999999999999854 4678999987643322  234566777777766   6999999999885     3


Q ss_pred             CCEEEEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccc
Q psy11805         72 SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLA  150 (251)
Q Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~  150 (251)
                      ....+++||++++ +|.+.+... ...+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~--~~~~~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE--cCCCCEEEccccce
Confidence            4568999999975 787877653 3458999999999999999999999999999999999999  88999999999999


Q ss_pred             cccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC-------
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-------  223 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  223 (251)
                      .............+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+.........       
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  237 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence            7765444444556889999999998888999999999999999999999999998877776665432211100       


Q ss_pred             ----------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ----------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                      ...+.++..+++++.+||+.||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  281 (290)
T cd07862         238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  281 (290)
T ss_pred             cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH
Confidence                            1123578889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.1e-46  Score=300.42  Aligned_cols=236  Identities=27%  Similarity=0.476  Sum_probs=201.4

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||+||+|.+..+++.||+|++....   .........|...+... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999999999999999986432   23345566777777764 899999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~  163 (251)
                      ++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++..... ........
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL--DTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE--CCCCCEEEccCCcceECCCCCCceeeec
Confidence            9998888764 368999999999999999999999999999999999999  8899999999999865322 22234456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||+|+++|+|++|..||...+..+....+.......+    ..++.+++++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence            89999999999988899999999999999999999999998888777776655443322    35788999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      +|++||++
T Consensus       234 ~P~~R~~~  241 (316)
T cd05619         234 EPERRLGV  241 (316)
T ss_pred             CHhhcCCC
Confidence            99999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-46  Score=303.28  Aligned_cols=235  Identities=22%  Similarity=0.399  Sum_probs=203.0

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.+..+++.||+|++....   ......+..|..+++.+ +||+|+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999986432   23345667788888766 799999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~  163 (251)
                      ++|...+.... .+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.... .........
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL--DAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--CCCCCEEEeecccceecccCCccccccc
Confidence            99988876554 68999999999999999999999999999999999999  889999999999987532 222233456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..++.++.++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence            88999999999988899999999999999999999999999988888887776654433    45789999999999999


Q ss_pred             CcCCCCC
Q psy11805        244 DREDAPE  250 (251)
Q Consensus       244 ~p~~Rps  250 (251)
                      ||++||+
T Consensus       234 dp~~R~~  240 (321)
T cd05591         234 NPNKRLG  240 (321)
T ss_pred             CHHHcCC
Confidence            9999993

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.7e-47  Score=309.74  Aligned_cols=244  Identities=26%  Similarity=0.448  Sum_probs=207.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++..++|++++++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999986432   334567888999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli--~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE--CCCCCEEEeeccCCccccccccc
Confidence            9999999988887654 68999999999999999999999999999999999999  889999999999986432110  


Q ss_pred             ----------------------------------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy11805        158 ----------------------------------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFM  203 (251)
Q Consensus       158 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  203 (251)
                                                        .....+|++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                              0112468899999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        204 GETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      ..+..+....+.........+....++.+++++|.+|+. +|.+|++
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~  283 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIG  283 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCC
Confidence            888877777665433222222223578899999999875 9999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3e-46  Score=302.23  Aligned_cols=240  Identities=23%  Similarity=0.451  Sum_probs=206.5

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +|+..+.||+|+||.||+|.++.+++.||+|++....   ....+.+..|...++.+. |++++++.+.+.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            5788999999999999999999999999999986432   223456778888888875 677888999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~  158 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill--~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML--DSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--CCCCCEEEeccccccccCCCCcc
Confidence            9999999988876554 69999999999999999999999999999999999999  88999999999998753222 22


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||.+.+..++.++||||+|+++|+|++|..||...+.......+.......+    ..++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  233 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence            2344588999999999988899999999999999999999999999888777777766554433    567899999999


Q ss_pred             HhcccCcCCCCC
Q psy11805        239 KLLLKDREDAPE  250 (251)
Q Consensus       239 ~~l~~~p~~Rps  250 (251)
                      +||+.+|.+|++
T Consensus       234 ~~l~~~p~~R~~  245 (323)
T cd05615         234 GLMTKHPSKRLG  245 (323)
T ss_pred             HHcccCHhhCCC
Confidence            999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.3e-47  Score=305.52  Aligned_cols=234  Identities=29%  Similarity=0.529  Sum_probs=202.3

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      +.||+|+||.||+|.+..+++.+++|++....   ......+.+|++.++.++|+||+++.+.+..++..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999986432   223566778999999999999999999999999999999999999


Q ss_pred             chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeec
Q psy11805         86 ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLF  163 (251)
Q Consensus        86 ~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~  163 (251)
                      +|...+... ..+++..+..++.|++.||.|||+ .|++|+||||+||++  +.++.++|+|||++.... .........
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (325)
T cd05594          81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGATMKTFC  157 (325)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE--CCCCCEEEecCCCCeecCCCCccccccc
Confidence            998777654 368999999999999999999997 799999999999999  899999999999986532 222233456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..+++++.++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~  233 (325)
T cd05594         158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLKK  233 (325)
T ss_pred             CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhhc
Confidence            89999999999988899999999999999999999999998887777776655544433    56789999999999999


Q ss_pred             CcCCCC
Q psy11805        244 DREDAP  249 (251)
Q Consensus       244 ~p~~Rp  249 (251)
                      ||++|+
T Consensus       234 dP~~R~  239 (325)
T cd05594         234 DPKQRL  239 (325)
T ss_pred             CHHHhC
Confidence            999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.9e-47  Score=305.83  Aligned_cols=237  Identities=29%  Similarity=0.536  Sum_probs=204.1

Q ss_pred             ccccccCCceEEEEEEEc---cCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          8 HSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      .+.||+|+||.||++.+.   .+++.+++|++.....  .....+.+|++++++++|+||+++++++.+++..|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            367999999999999874   5678999999864332  23456778999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~~  161 (251)
                      ++++|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++...... .....
T Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          81 RGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE--CCCCcEEEeeccCCcccCCCCCceec
Confidence            999998887654 368999999999999999999999999999999999999  88999999999998765433 22334


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhc
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL  241 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (251)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.......+    ..+++.+.++|++||
T Consensus       158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~l  233 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRALF  233 (318)
T ss_pred             ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHh
Confidence            5688999999999888889999999999999999999999998888777777665544333    467899999999999


Q ss_pred             ccCcCCCCCC
Q psy11805        242 LKDREDAPEV  251 (251)
Q Consensus       242 ~~~p~~Rps~  251 (251)
                      +.||++||++
T Consensus       234 ~~~P~~R~~a  243 (318)
T cd05582         234 KRNPANRLGA  243 (318)
T ss_pred             hcCHhHcCCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.3e-46  Score=305.58  Aligned_cols=240  Identities=27%  Similarity=0.474  Sum_probs=198.4

Q ss_pred             cCCcccccccCCceEEEEEEEc---cCCceEEEEEecccc----ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK----RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   75 (251)
                      +|++.+.||+|+||.||+|++.   .+++.+++|++....    ....+.+.+|+.+++.+ +|++|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999874   467899999985322    22356678899999999 499999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++||||+++++|.+.+.... .+++..+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili--~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL--DSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE--CCCCCEEEeeCcCCccccc
Confidence            99999999999988886654 58999999999999999999999999999999999999  8899999999999876432


Q ss_pred             CC--cceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccccCCCccccC
Q psy11805        156 EK--KLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETD----VQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      ..  ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.....    .+....+...    .......
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC----DPPFPSF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC----CCCCCCC
Confidence            22  22334689999999999765 478899999999999999999999975322    2222333222    2233356


Q ss_pred             CCHHHHHHHHHhcccCcCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      ++..+.++|.+||+.||++||+
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~  255 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLG  255 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCC
Confidence            8999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.7e-46  Score=295.50  Aligned_cols=238  Identities=24%  Similarity=0.440  Sum_probs=196.4

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      ||+|+||+||++.+..+++.+++|.+.....   ...+.+..|+.+++.++|++++++.+++..++..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999999999999999999864322   2245677899999999999999999999999999999999999999


Q ss_pred             hHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ceeec
Q psy11805         88 FERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQVLF  163 (251)
Q Consensus        88 ~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~  163 (251)
                      .+.+..   ....+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||.+........ .....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL--DNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEeeCccceecCCCCccccccC
Confidence            876643   33468999999999999999999999999999999999999  8889999999999876543322 22346


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+..............++..+.+++.+||+.
T Consensus       159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  238 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK  238 (280)
T ss_pred             CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence            78899999999999999999999999999999999999987543322222222222222233356899999999999999


Q ss_pred             CcCCCCC
Q psy11805        244 DREDAPE  250 (251)
Q Consensus       244 ~p~~Rps  250 (251)
                      ||++||+
T Consensus       239 ~P~~R~~  245 (280)
T cd05608         239 DPEKRLG  245 (280)
T ss_pred             CHHHhcC
Confidence            9999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.6e-46  Score=302.96  Aligned_cols=236  Identities=27%  Similarity=0.507  Sum_probs=199.4

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHH-HHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVE-IMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.+..+++.+++|++....   ......+..|.. .++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999986432   122333444443 56778999999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~  163 (251)
                      ++|.+.+...+ .+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.... .........
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili--~~~~~~kl~DfG~a~~~~~~~~~~~~~~  157 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNGTTSTFC  157 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--CCCCCEEEccCCCCcccccCCCCccccc
Confidence            99988876643 68899999999999999999999999999999999999  889999999999986532 222234456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......    ...+++.+.++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~  233 (325)
T cd05602         158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGLLQK  233 (325)
T ss_pred             CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHHccc
Confidence            8999999999999999999999999999999999999999888877777665544332    256899999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      +|.+||++
T Consensus       234 ~p~~R~~~  241 (325)
T cd05602         234 DRTKRLGA  241 (325)
T ss_pred             CHHHCCCC
Confidence            99999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG4717|consensus

Probab=100.00  E-value=3.6e-47  Score=305.09  Aligned_cols=243  Identities=28%  Similarity=0.559  Sum_probs=226.5

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      =|.+.+.||+|.|..|.+|++..+|..||+|++..+...  ....+.+|++.++.++|||||+++++...+..+|+|.|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            488999999999999999999999999999998755433  467788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCccee
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV  161 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~  161 (251)
                      -++|.|.+++..+...++++.+.+++.||+.|+.|+|...+||+||||+||+++. .-|-+||+|||++-.+.++....+
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-KlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-KLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-ecCceEeeeccccccCCCcchhhc
Confidence            9999999999998888999999999999999999999999999999999998643 567899999999999999999999


Q ss_pred             eccCcccccccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        162 LFGTPEFVAPEVVNFDAIG-FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      .||+..|.|||++.|..|+ ++.||||||++||.|++|+.||+..++.|.+..++.-.+..+    ++++.++++||..|
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS~eCrdLI~sM  253 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVSKECRDLIQSM  253 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhhHHHHHHHHHH
Confidence            9999999999999999886 578999999999999999999999999999999999888777    78999999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |..||++|.|+
T Consensus       254 LvRdPkkRAsl  264 (864)
T KOG4717|consen  254 LVRDPKKRASL  264 (864)
T ss_pred             HhcCchhhccH
Confidence            99999999873

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.5e-46  Score=295.06  Aligned_cols=245  Identities=27%  Similarity=0.454  Sum_probs=207.9

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .|+..+.||+|+||+||++.+..+++.+++|.+....   ......+.+|+++++.++|++++++.+.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4788899999999999999999999999999985432   2234557889999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ++++++|.+.+... ...+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili--~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL--DDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE--CCCCCEEEecCCcceecCCCCcc
Confidence            99999998777653 3369999999999999999999999999999999999999  88889999999998765443333


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....++..|+|||.+.+..++.++|+||||+++|++++|..||...........+..............++..+.+|+..
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM  238 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence            44568899999999988889999999999999999999999998876655544443333333333446788999999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      ||+.+|++||+
T Consensus       239 ~l~~~P~~R~~  249 (285)
T cd05632         239 LLTKDPKQRLG  249 (285)
T ss_pred             HccCCHhHcCC
Confidence            99999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0663|consensus

Probab=100.00  E-value=1.2e-46  Score=287.19  Aligned_cols=246  Identities=26%  Similarity=0.384  Sum_probs=212.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESS--NVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv   78 (251)
                      +.|+....|++|+||.||+|+++.++..||+|.++.....  ..-.-.+|+.+|.+.+|||||.+-.+.+..  +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4688899999999999999999999999999998755544  356677999999999999999999988654  469999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-C
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-K  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~  157 (251)
                      |||++. +|..++...+.++...+..-+..|++.|++|||++.|+||||||+|+|+  +..|.+|++|||+|+.+... .
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm--~~~G~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL--SHKGILKIADFGLAREYGSPLK  232 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee--ccCCcEEecccchhhhhcCCcc
Confidence            999987 8888888887889999999999999999999999999999999999999  99999999999999987654 3


Q ss_pred             cceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccC--------
Q psy11805        158 KLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE--------  228 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------  228 (251)
                      .......|.=|+|||++.+. .|+.+.|+||+||++.|++++++.|.+....+++.++......+...+|+.        
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK  312 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence            33445678899999999875 588999999999999999999999999999888887755544444433332        


Q ss_pred             --------------------CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 --------------------ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 --------------------~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                          +++...+|++.+|..||.+|.||
T Consensus       313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA  355 (419)
T KOG0663|consen  313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA  355 (419)
T ss_pred             ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH
Confidence                                45778899999999999999986

>KOG2345|consensus

Probab=100.00  E-value=3.2e-48  Score=284.67  Aligned_cols=246  Identities=24%  Similarity=0.339  Sum_probs=203.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeC-----CEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS-----NVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   76 (251)
                      .+||+|.+.||.|||+.||+++...+++.+|+|.+.+.+.++.+...+|++..++++|||+++++++...+     ...|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            47999999999999999999999999999999999888888899999999999999999999999986433     3499


Q ss_pred             EEEEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         77 VVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      ++++|...|+|.+.+..   .+..+++.+++.|+.+++.||++||+..  +.|+||||.||++  ...+.++|.|||.++
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl--s~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL--SDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe--cCCCceEEEeccCcc
Confidence            99999999999988864   4557999999999999999999999999  9999999999999  778999999999997


Q ss_pred             ccCCCCcc----------eeeccCcccccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHh
Q psy11805        152 KFDPEKKL----------QVLFGTPEFVAPEVVNFD---AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT--MANVTI  216 (251)
Q Consensus       152 ~~~~~~~~----------~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~  216 (251)
                      .....-..          ...-+|..|+|||++.-.   ..+.++|||||||+||.|+.|..||+.......  .-.+..
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n  257 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN  257 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence            75321111          112368899999999644   467899999999999999999999954322111  111222


Q ss_pred             ccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+.++..  ..+|..+.++|+.||++||.+||++
T Consensus       258 ~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i  290 (302)
T KOG2345|consen  258 AQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTI  290 (302)
T ss_pred             cccccCCC--CCccHHHHHHHHHHhcCCcccCCCH
Confidence            22223322  4589999999999999999999985

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2e-46  Score=307.90  Aligned_cols=246  Identities=27%  Similarity=0.434  Sum_probs=207.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|+||.||++.+..+++.+|+|++...   .......+.+|+.+++.++||||+++++.+.+++..++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            36899999999999999999999999999999998532   223456688999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+++...  .+++..+..++.|++.||.+||+.|++||||||+||++  +.++.++|+|||++........
T Consensus       122 ~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl--~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         122 MEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL--DKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--CCCCCEEEEecccceecccCCc
Confidence            9999999999888654  48999999999999999999999999999999999999  8999999999999977543222


Q ss_pred             --ceeeccCcccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        159 --LQVLFGTPEFVAPEVVNFDA----IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       159 --~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                        .....+++.|+|||.+.+..    ++.++||||||+++|+|++|..||...+..+....+.........+....++..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence              23456899999999986543    678999999999999999999999988887777777654433333333467999


Q ss_pred             HHHHHHHhcccCcCC--CCCC
Q psy11805        233 AKDFIRKLLLKDRED--APEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~--Rps~  251 (251)
                      +++++..||..+|.+  |+++
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~  298 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGV  298 (370)
T ss_pred             HHHHHHHHccCchhccCCCCH
Confidence            999999999855543  6663

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.1e-46  Score=302.16  Aligned_cols=235  Identities=23%  Similarity=0.425  Sum_probs=196.8

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.+..+++.||+|++....   ......+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999986432   23356678899999888 699999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc-CCCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~-~~~~~~~~~~  163 (251)
                      ++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++... ..........
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--CCCCCEEECcCccccccccCCCcccccc
Confidence            9998877654 469999999999999999999999999999999999999  88999999999998652 2223334457


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------h-HHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET--------D-VQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      +++.|+|||.+.+..++.++|+||||+++|+|++|+.||....        . ....+.+.......    ...++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI----PRSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC----CCCCCHHHH
Confidence            8999999999999899999999999999999999999996321        1 11223333333222    256789999


Q ss_pred             HHHHHhcccCcCCCCC
Q psy11805        235 DFIRKLLLKDREDAPE  250 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps  250 (251)
                      ++|++||+.||.+||+
T Consensus       234 ~li~~~L~~dP~~R~~  249 (329)
T cd05588         234 SVLKGFLNKDPKERLG  249 (329)
T ss_pred             HHHHHHhccCHHHcCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.9e-46  Score=307.23  Aligned_cols=241  Identities=29%  Similarity=0.472  Sum_probs=205.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++....   ......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999985322   223556788999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      ||+++++|.+++...  .+++..+..++.|++.||.+||++|++|+||||+||++  +.++.++|+|||++.......  
T Consensus       123 Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll--~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         123 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE--CCCCCEEEEeCCceeEcCcCCcc
Confidence            999999998887654  48999999999999999999999999999999999999  889999999999997754322  


Q ss_pred             cceeeccCcccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDA----IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ......+++.|+|||.+.+..    ++.++||||||+++|+|++|..||...+.......+.........+....++..+
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  278 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence            223456899999999986543    6789999999999999999999999988877777776554433444445789999


Q ss_pred             HHHHHHhcccCcCCC
Q psy11805        234 KDFIRKLLLKDREDA  248 (251)
Q Consensus       234 ~~li~~~l~~~p~~R  248 (251)
                      +++|.+||. +|..|
T Consensus       279 ~~li~~~L~-~~~~r  292 (371)
T cd05622         279 KNLICAFLT-DREVR  292 (371)
T ss_pred             HHHHHHHcC-Chhhh
Confidence            999999998 55554

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-45  Score=292.16  Aligned_cols=236  Identities=26%  Similarity=0.432  Sum_probs=195.8

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      ||+|+||.||++.++.+++.+++|.+.....   .....+..|+++++.++||||+++.+.+.++...+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999999999999999999853221   1234556799999999999999999999999999999999999999


Q ss_pred             hHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCc
Q psy11805         88 FERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP  166 (251)
Q Consensus        88 ~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  166 (251)
                      .+.+.... ..+++..+..++.|++.||++||+.|++|+||+|+||++  +.++.++|+|||++.............+++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili--~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL--DDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE--cCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            88775433 358999999999999999999999999999999999999  889999999999987765444334456888


Q ss_pred             ccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhccccCCCccccCCCHHHHHHHHHhcc
Q psy11805        167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV----QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL  242 (251)
Q Consensus       167 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (251)
                      .|+|||.+.+..++.++||||||+++|+|++|..||......    +............   ....++.+++++|++||+
T Consensus       159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~  235 (277)
T cd05607         159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDICRLFLA  235 (277)
T ss_pred             CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHHHHHhc
Confidence            999999998888999999999999999999999999765332    2222222222111   124679999999999999


Q ss_pred             cCcCCCCCC
Q psy11805        243 KDREDAPEV  251 (251)
Q Consensus       243 ~~p~~Rps~  251 (251)
                      .||++||++
T Consensus       236 ~~P~~R~~~  244 (277)
T cd05607         236 KKPEDRLGS  244 (277)
T ss_pred             cCHhhCCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0594|consensus

Probab=100.00  E-value=6.6e-46  Score=286.44  Aligned_cols=245  Identities=24%  Similarity=0.426  Sum_probs=209.3

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCc-eeeEeEEEeeCC------E
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPR-LIQIYDAFESSN------V   74 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~------~   74 (251)
                      .|...++||+|+||+||+|+.+.+|+.||+|.+......  ......+|+.+++.++|+| |+++.+++.+++      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            477888999999999999999999999999999766543  5677889999999999999 999999998777      7


Q ss_pred             EEEEEEeccCCchhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         75 MCVVLELIEGGELFERVIDDD---FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      .++|+|+++. .|..++...+   ..++...+..+++||+.||.|||++||+||||||+|+++  +.+|.+||+|||+++
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi--~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI--SSSGVLKLADFGLAR  168 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE--CCCCcEeeeccchHH
Confidence            9999999976 7888877655   358889999999999999999999999999999999999  889999999999998


Q ss_pred             ccCCCCc-ceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc--
Q psy11805        152 KFDPEKK-LQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN--  227 (251)
Q Consensus       152 ~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  227 (251)
                      ....... ......|.-|.|||++.+. .|+...||||+||+++||++++..|.+....+++.++......+....|+  
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            7663333 3445677789999999876 68899999999999999999999999999988888775444333332222  


Q ss_pred             ------------------------CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 ------------------------EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ------------------------~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                              ..+.+..+++.+||+.+|.+|.||
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa  296 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA  296 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH
Confidence                                    233488999999999999999985

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.2e-46  Score=298.09  Aligned_cols=246  Identities=22%  Similarity=0.353  Sum_probs=203.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|+||.||+|.+..+++.+++|.+...... ....+.+|+..+++++|+|++++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            5799999999999999999999999999999998644322 345677899999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +++ +|.+.+...+..++...+..++.|++.||.+||+.|++||||+|+||++  +.++.++|+|||.+....... ...
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI--NERGELKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEECccccceecCCCccccc
Confidence            976 7878777666678999999999999999999999999999999999999  889999999999987643222 223


Q ss_pred             eeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC-----------------
Q psy11805        161 VLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-----------------  222 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------  222 (251)
                      ...+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+........                 
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            3457889999998865 4578899999999999999999999988776555443322111000                 


Q ss_pred             ---------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ---------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               ......++.++.++|.+||+.||.+|||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  280 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA  280 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH
Confidence                     01123578899999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-45  Score=288.77  Aligned_cols=244  Identities=27%  Similarity=0.516  Sum_probs=207.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-----cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-----NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      +.|++.+.||+|++|.||.|.+..+++.+++|.+.....     .....+.+|++.+++++|+||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            679999999999999999999998999999998764321     124578899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      ++|++++++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv--~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR--DSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEeecccceeccccc
Confidence            999999999988876654 58999999999999999999999999999999999999  888999999999987643221


Q ss_pred             cc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        158 KL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       158 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ..    ....++..|+|||.+.+..++.++||||||+++|++++|+.||...+..+...+........  .....++..+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSPDA  236 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCHHH
Confidence            11    22346779999999998889999999999999999999999998877666655544433322  2335789999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .++|++||..+|.+|||+
T Consensus       237 ~~li~~~l~~~p~~Rpt~  254 (263)
T cd06625         237 RNFLRRTFVENAKKRPSA  254 (263)
T ss_pred             HHHHHHHhhcCcccCCCH
Confidence            999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.5e-46  Score=300.88  Aligned_cols=236  Identities=23%  Similarity=0.422  Sum_probs=195.9

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||+||+|.+..+++.+++|++....   ......+.+|+..+.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999986432   23355677888888776 799999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~  163 (251)
                      ++|...+... ..+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.... .........
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili--~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE--CCCCCEEEeeCCccccccCCCCcccccc
Confidence            9998777654 369999999999999999999999999999999999999  899999999999986532 222233456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET---------DVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||....         .......+......    .+..++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----~p~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----IPRSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----CCCCCCHHHH
Confidence            8999999999999999999999999999999999999995311         11122233332222    2356788999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      ++|++||+.||++||++
T Consensus       234 ~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         234 SVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHhcCCHHHcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.6e-46  Score=304.90  Aligned_cols=244  Identities=24%  Similarity=0.382  Sum_probs=198.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC------
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN------   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   73 (251)
                      -++|++.+.||+|+||.||++.+..++..+++|.+...  .......+.+|+..++.++|+||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46899999999999999999999999999999998543  2334567789999999999999999999986443      


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..++|||++++ +|.+.+..   .++...+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++...
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~--~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTA  173 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--CCCCCEEEecCCCcccc
Confidence            47999999976 55555532   48899999999999999999999999999999999999  88999999999999765


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc--------------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY--------------  219 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  219 (251)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+.....              
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            444444445688899999999998999999999999999999999999988765443332211100              


Q ss_pred             --------cCC----------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 --------DFD----------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 --------~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                              ...                .......+..+++||.+||+.||++|||+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  309 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV  309 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH
Confidence                    000                00111246789999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.5e-46  Score=291.97  Aligned_cols=244  Identities=16%  Similarity=0.262  Sum_probs=205.7

Q ss_pred             ccCCcccccccCCceEEEEEEEc---cCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||.||++.++   ..+..+++|.+.... ......+.+|+..+++++|||++++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            57999999999999999999875   345689999876432 22346788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++++|||.+........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili--~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV--NSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE--cCCCcEEECCCcccccccccch
Confidence            99999999998887766679999999999999999999999999999999999999  8899999999998765422211


Q ss_pred             c--eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        159 L--QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       159 ~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      .  ....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+..+...   +....+|..+.+
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  239 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---PAPRNCPNLLHQ  239 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCHHHHH
Confidence            1  12234568999999998899999999999999999775 99999988887777766544322   223578999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      ++.+||+.+|.+||++
T Consensus       240 li~~c~~~~p~~RP~~  255 (266)
T cd05064         240 LMLDCWQKERGERPRF  255 (266)
T ss_pred             HHHHHcCCCchhCCCH
Confidence            9999999999999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.4e-46  Score=300.19  Aligned_cols=236  Identities=27%  Similarity=0.506  Sum_probs=198.8

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHH-HHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVE-IMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.+..++..+++|++....   ......+.+|.. .++.++|+||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999985322   222344555554 57888999999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc-CCCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~-~~~~~~~~~~  163 (251)
                      ++|...+... ..+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++... ..........
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05603          81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEETTSTFC  157 (321)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--CCCCCEEEccCCCCccCCCCCCcccccc
Confidence            9998777654 468999999999999999999999999999999999999  88999999999998753 2222233456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......    ....+..+.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~  233 (321)
T cd05603         158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQL----PGGKTVAACDLLVGLLHK  233 (321)
T ss_pred             CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHccC
Confidence            8899999999998889999999999999999999999999888777666665543332    256788999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      +|.+||++
T Consensus       234 ~p~~R~~~  241 (321)
T cd05603         234 DQRRRLGA  241 (321)
T ss_pred             CHhhcCCC
Confidence            99999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0201|consensus

Probab=100.00  E-value=2.7e-48  Score=305.52  Aligned_cols=243  Identities=22%  Similarity=0.462  Sum_probs=212.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ..|+..+.||+|.||.||+|.+..+++.||+|++.....+ +.+.+++|+.+|.+++++||.+.++.+..+..+.++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4688899999999999999999999999999999765544 478999999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +.||++.+.+...+ .+++..+..++++++.||.|||..+.+|+|||+.||++  ..+|.++|+|||.+.+...... ..
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~--s~~g~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL--SESGDVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeE--eccCcEEEEecceeeeeechhhccc
Confidence            99999988876544 45999999999999999999999999999999999999  8889999999999988654433 36


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      +..|||.|||||++.+..|+.++||||||++.+||++|.+|+........+..+-+...+   .....+++.+++||..|
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP---~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPP---RLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCC---ccccccCHHHHHHHHHH
Confidence            778999999999999889999999999999999999999999888773333333222222   22247899999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.||+.||||
T Consensus       247 L~k~P~~RpsA  257 (467)
T KOG0201|consen  247 LDKNPEFRPSA  257 (467)
T ss_pred             hhcCcccCcCH
Confidence            99999999996

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.3e-46  Score=301.12  Aligned_cols=236  Identities=27%  Similarity=0.480  Sum_probs=199.9

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHH-HHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVE-IMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||+||+|.+..+++.+++|++....   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999999999999999986432   223344555554 46778999999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~  163 (251)
                      ++|...+... ..+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.... .........
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (325)
T cd05604          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL--DSQGHVVLTDFGLCKEGIAQSDTTTTFC  157 (325)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--CCCCCEEEeecCCcccCCCCCCCccccc
Confidence            9998777654 469999999999999999999999999999999999999  899999999999986532 222233456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+........    ...+..+.++|++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~~  233 (325)
T cd05604         158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLEK  233 (325)
T ss_pred             CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhcc
Confidence            89999999999998899999999999999999999999998887777776665443332    46788999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      +|.+||++
T Consensus       234 ~p~~R~~~  241 (325)
T cd05604         234 DRQRRLGA  241 (325)
T ss_pred             CHHhcCCC
Confidence            99999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-45  Score=292.04  Aligned_cols=234  Identities=15%  Similarity=0.190  Sum_probs=198.9

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEeccccccc---hHHHHHHHHHHHHcCCCceeeEeEEEee----CCEEEEEEEe
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND---RRNVEREVEIMRELQHPRLIQIYDAFES----SNVMCVVLEL   81 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~   81 (251)
                      ..|++|+++.||++.+  +++.||+|.+.......   .+.+.+|+..+++++||||+++++++.+    ....+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6789999999999987  47899999987544333   4677899999999999999999999876    3468999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+.+...+ .+++.....++.+++.||.+||+ .+++|+||+|+||++  +.++.++|+|||++.......  .
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill--~~~~~~kl~dfg~~~~~~~~~--~  178 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV--TENYKLKIICHGLEKILSSPP--F  178 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE--CCCCcEEEcccchHhhhcccc--c
Confidence            99999999887654 68999999999999999999998 499999999999999  889999999999987643322  2


Q ss_pred             eeccCccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNF--DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ...++..|+|||.+.+  ..++.++||||||+++|+|++|..||...+..+....+.....++..+  ..+|..+++++.
T Consensus       179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~  256 (283)
T PHA02988        179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIVE  256 (283)
T ss_pred             cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHHH
Confidence            3457889999999976  678999999999999999999999999888777776665444433322  467899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       257 ~cl~~dp~~Rps~  269 (283)
T PHA02988        257 ACTSHDSIKRPNI  269 (283)
T ss_pred             HHhcCCcccCcCH
Confidence            9999999999985

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.3e-46  Score=303.50  Aligned_cols=242  Identities=26%  Similarity=0.434  Sum_probs=195.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|+..+.||+|+||.||+|.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            468889999999999999999999999999999854332 2356788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +++++|.+.     ...++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++....... ...
T Consensus       154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~~~~  226 (353)
T PLN00034        154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI--NSAKNVKIADFGVSRILAQTMDPCN  226 (353)
T ss_pred             CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE--cCCCCEEEcccccceeccccccccc
Confidence            999988542     235778889999999999999999999999999999999  889999999999987654322 223


Q ss_pred             eeccCccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNF-----DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      ...++..|+|||.+..     ...+.++||||||+++|+|++|+.||......+...................++.++++
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  306 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH  306 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHH
Confidence            3468899999998743     23456899999999999999999999754332222211111111222233567899999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      ||.+||+.||++|||+
T Consensus       307 li~~~l~~~P~~Rpt~  322 (353)
T PLN00034        307 FISCCLQREPAKRWSA  322 (353)
T ss_pred             HHHHHccCChhhCcCH
Confidence            9999999999999985

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8e-46  Score=301.72  Aligned_cols=244  Identities=28%  Similarity=0.424  Sum_probs=196.4

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeC-----CEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS-----NVMC   76 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   76 (251)
                      +|++.+.||+|+||.||+|.+..++..|++|.+...  .......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            699999999999999999999999999999987532  223456788999999999999999999988543     3489


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +|||++. ++|.+.+.... .+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++......
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA--NADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCcEEEccCccccccccc
Confidence            9999996 47878776544 69999999999999999999999999999999999999  89999999999998754221


Q ss_pred             Cc----ceeeccCccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Q psy11805        157 KK----LQVLFGTPEFVAPEVVNF--DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIA-------------  217 (251)
Q Consensus       157 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------------  217 (251)
                      ..    .....+++.|+|||.+.+  ..++.++||||||+++|+|++|+.||...+.......+...             
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            11    123458889999999865  57889999999999999999999999876654333221110             


Q ss_pred             --------------cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 --------------QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 --------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                    ........++.++..+.++|.+||+.+|++|||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  284 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA  284 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH
Confidence                          0000011224578889999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.1e-45  Score=291.84  Aligned_cols=247  Identities=25%  Similarity=0.419  Sum_probs=208.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .+.|++.+.||.|++|.||++.+..+++.+++|.+..........+.+|+..++.++|+|++++.+.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            35799999999999999999999999999999998766655677888999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~  160 (251)
                      +++++|...+......+++..+..++.|++.+|.+||+.|++|+|++|+||++  +.++.++|+|||.+...... ....
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL--TLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE--cCCCCEEEccCccceeccccccccc
Confidence            99999988776655679999999999999999999999999999999999999  88899999999988654322 2223


Q ss_pred             eeccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        161 VLFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      ...+++.|+|||.+.     ...++.++|+||||+++|+|++|..||...+..+...+......+ .......++.++.+
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  247 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKWSMEFRD  247 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCcccCHHHHH
Confidence            445778999999984     344678999999999999999999999877665555444333221 12223467889999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|++||+.+|++||++
T Consensus       248 li~~~l~~~p~~Rp~~  263 (292)
T cd06644         248 FLKTALDKHPETRPSA  263 (292)
T ss_pred             HHHHHhcCCcccCcCH
Confidence            9999999999999984

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-45  Score=288.59  Aligned_cols=248  Identities=23%  Similarity=0.430  Sum_probs=212.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +++|++.+.||.|++|.||+|.+..+++.+++|++........+.+.+|+..+++++|+|++++++.+.+.+..+++||+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            57899999999999999999999988999999998766666778899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... ...
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL--TEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE--CCCCCEEECccccchhhhhhhhccc
Confidence            99999988887764579999999999999999999999999999999999999  889999999999987654332 223


Q ss_pred             eeccCcccccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC-ccccCCCHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFD---AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-ECFNEISDDAKDF  236 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  236 (251)
                      ...++..|+|||.+.+.   .++.++|+||||+++++|++|..||...+..+.............. .....++.++.++
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            34577789999999776   7889999999999999999999999887766655544444222211 1123467889999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      +++||+.+|.+|||+
T Consensus       240 i~~~l~~~p~~Rpt~  254 (262)
T cd06613         240 IKKCLTKDPKKRPTA  254 (262)
T ss_pred             HHHHcCCChhhCCCH
Confidence            999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.7e-45  Score=297.78  Aligned_cols=246  Identities=21%  Similarity=0.386  Sum_probs=202.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||.|+||.||++.+..++..+++|.+.... ......+.+|++.++.++|+||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999999999999999876542 2235678999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |+++++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||+|+||++  +.++.++|+|||++...... ..
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~-~~  159 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS-MA  159 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE--cCCCCEEEeeCCcchhhhhh-cc
Confidence            999999998887654 589999999999999999999975 79999999999999  88899999999998654322 12


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------------------
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI-----------------------  216 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-----------------------  216 (251)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|..||......+.......                       
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence            234578899999999988899999999999999999999999976554332211100                       


Q ss_pred             -----------------c--cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 -----------------A--QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 -----------------~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                       .  ....+......++.++++||.+||+.||++|||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~  293 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL  293 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH
Confidence                             0  0000000012367889999999999999999985

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=292.18  Aligned_cols=246  Identities=28%  Similarity=0.488  Sum_probs=210.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||.|++|.||++.+..++..+++|.+..........+.+|+..+++++|+|++++++.+..+...++|||++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            68999999999999999999999889999999987665556778889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~~  161 (251)
                      ++++|.+++...+..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... .....
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL--TLDGDVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE--CCCCCEEEccCccchhhcccccccce
Confidence            9999999887766679999999999999999999999999999999999999  88999999999988664322 22233


Q ss_pred             eccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        162 LFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       162 ~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ..+++.|+|||.+.     ...++.++|+||||+++|+|++|..||...+..+...++.....+ .......++..+.++
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  241 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP-TLDQPSKWSSSFNDF  241 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC-CcCCcccCCHHHHHH
Confidence            45788999999874     345678999999999999999999999888776666555443321 112234678999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |.+||+.+|.+||++
T Consensus       242 i~~~l~~~p~~Rps~  256 (280)
T cd06611         242 LKSCLVKDPDDRPTA  256 (280)
T ss_pred             HHHHhccChhhCcCH
Confidence            999999999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-45  Score=312.37  Aligned_cols=245  Identities=25%  Similarity=0.404  Sum_probs=208.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC------
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN------   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   73 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....  ......+.+|+..+..++|+|++++.+.+....      
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            478999999999999999999999999999999986433  334667889999999999999999988764322      


Q ss_pred             --EEEEEEEeccCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         74 --VMCVVLELIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        74 --~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                        ..++||||+++++|.+.+...   ...+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl--~~~~~vkL~DFG  188 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL--CSNGLVKLGDFG  188 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--eCCCCEEEEecc
Confidence              378999999999999888642   3468999999999999999999999999999999999999  889999999999


Q ss_pred             cccccCCC---CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcc
Q psy11805        149 LARKFDPE---KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC  225 (251)
Q Consensus       149 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (251)
                      ++......   .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+.......+....   .
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~---~  265 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP---L  265 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC---C
Confidence            98765322   22234568999999999999899999999999999999999999999888777777665554332   2


Q ss_pred             ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        226 FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...+++++.+++.+||+.+|.+||++
T Consensus       266 ~~~~~~~l~~li~~~L~~dP~~RPs~  291 (496)
T PTZ00283        266 PPSISPEMQEIVTALLSSDPKRRPSS  291 (496)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCH
Confidence            35789999999999999999999984

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.4e-45  Score=287.60  Aligned_cols=243  Identities=24%  Similarity=0.442  Sum_probs=209.5

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      +|++.+.||.|++|.||++.+..++..+++|.+.... ....+.+.+|+..++.++|+|++++.+.+.+++..++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            6899999999999999999999999999999985432 334677889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         83 EGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        83 ~~~~L~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      ++++|.+.+.. .+..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++++|||.+........ ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL--TQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE--CCCCcEEEcccCcceeecccccccc
Confidence            99999888765 34458999999999999999999999999999999999999  8899999999999876543222 22


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..+.....   ...++..+.++|++|
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~  235 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSLIKQM  235 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHHHHHH
Confidence            34578899999999888899999999999999999999999998877666666655443322   245788999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.+|++|||+
T Consensus       236 l~~~P~~Rp~~  246 (255)
T cd08219         236 FKRNPRSRPSA  246 (255)
T ss_pred             HhCCcccCCCH
Confidence            99999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.8e-45  Score=290.21  Aligned_cols=247  Identities=22%  Similarity=0.380  Sum_probs=204.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+++|+...........+.+|+..+++++|+|++++++.+..++..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            46899999999999999999999999999999998765555567788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++++|.+.+... ..+++..+..++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||.+........ ..
T Consensus        88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          88 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL--TDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--CCCCCEEECcCccceeecccccccC
Confidence            9999998887654 368999999999999999999999999999999999999  8889999999999976543221 22


Q ss_pred             eeccCcccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc-cccCCCHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE-CFNEISDDAKDF  236 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  236 (251)
                      ...+++.|+|||.+.   ...++.++|+||+|+++++|++|..||......+....+.......+.. ....++..+.++
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            345778999999874   3446789999999999999999999997665444333332222221111 113578899999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |++||+.+|++|||+
T Consensus       245 i~~~l~~~P~~Rp~~  259 (267)
T cd06646         245 VKISLTKNPKKRPTA  259 (267)
T ss_pred             HHHHhhCChhhCcCH
Confidence            999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-45  Score=297.81  Aligned_cols=236  Identities=23%  Similarity=0.437  Sum_probs=197.1

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||+||+|.+..+++.+++|++....   ......+.+|+.++.++ +|++|+.+++.+.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999986432   23456688899998888 599999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~  163 (251)
                      ++|...+...+ .+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.... .........
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL--DADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--eCCCCEEEeccccceeccCCCCceeccc
Confidence            99988776543 69999999999999999999999999999999999999  889999999999987532 223334456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------hHH-HHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET------DVQ-TMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||....      ..+ ..+.+......    .+..++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----IPRFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----CCCCCCHHHHHH
Confidence            8999999999999999999999999999999999999996422      122 22333222222    235678999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |++||+.||++|+++
T Consensus       234 i~~~L~~dP~~R~~~  248 (327)
T cd05617         234 LKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHhccCHHHcCCC
Confidence            999999999999973

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4e-45  Score=286.40  Aligned_cols=243  Identities=25%  Similarity=0.421  Sum_probs=210.3

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|.+.+.||+|++|.||+|.+..+++.+++|.+....  ......+.+|+..++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            5889999999999999999999999999999986432  34577888999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-c
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-L  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~  159 (251)
                      +++++|.+.+... +..++...++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........ .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili--~~~~~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--eCCCCEEEcccccceeccCccchh
Confidence            9999999988764 4568999999999999999999999999999999999999  8889999999999876543322 2


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+..+..+..   ...++..+.+++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~  235 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQLIDQ  235 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHHHHH
Confidence            234577899999999888899999999999999999999999988887666666655443222   23678899999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|++||++
T Consensus       236 ~l~~~p~~Rp~~  247 (256)
T cd08529         236 CLTKDYRQRPDT  247 (256)
T ss_pred             HccCCcccCcCH
Confidence            999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-45  Score=294.70  Aligned_cols=248  Identities=20%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             CccCCcccccccCCceEEEEEEEcc----------------CCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceee
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA----------------TGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQ   64 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~   64 (251)
                      .++|++.+.||+|+||.||+|.+..                ++..|++|.+...... ....+.+|+..+++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999998643                2347999988653322 3567889999999999999999


Q ss_pred             EeEEEeeCCEEEEEEEeccCCchhHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecC
Q psy11805         65 IYDAFESSNVMCVVLELIEGGELFERVIDDD------------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLD  126 (251)
Q Consensus        65 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~d  126 (251)
                      +++++.+.+..+++|||+++++|.+++....                  ..+++..++.++.|++.||.+||+.|++|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d  163 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD  163 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            9999999999999999999999988875421                  2467788999999999999999999999999


Q ss_pred             CCCCcEEEeecCCCcEEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh--CCCC
Q psy11805        127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS--GLSP  201 (251)
Q Consensus       127 l~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p  201 (251)
                      |||+||++  +.++.++|+|||++.........   ....++..|+|||.+.+..++.++||||||+++|+|++  +..|
T Consensus       164 lkp~Nill--~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         164 LATRNCLV--GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cchhheEE--cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999  88899999999999765332211   12234678999999988889999999999999999987  6788


Q ss_pred             CCCCChHHHHHHHHhcc----ccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        202 FMGETDVQTMANVTIAQ----YDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       202 f~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      |...+..+.........    ..........+|..+.+++.+||+.+|++|||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence            88776665554332211    111111224678899999999999999999985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-46  Score=292.31  Aligned_cols=244  Identities=33%  Similarity=0.597  Sum_probs=202.9

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccc--hHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      |++.+.||+|+||+||++.+..+++.+|+|.+.......  .....+|+..+++++|+||+++++++..++..+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            789999999999999999999999999999987655433  223456999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc-CCCCccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~-~~~~~~~~  161 (251)
                      ++++|.+.+... ..++...++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+... ........
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~--~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL--DENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE--STTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccccc-ccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccc
Confidence            998998888733 468999999999999999999999999999999999999  89999999999999763 33334455


Q ss_pred             eccCcccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        162 LFGTPEFVAPEVVN-FDAIGFGTDMWSVGVICYVLLSGLSPFMGETD---VQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       162 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ..+++.|.|||.+. +...+.++||||||+++++|++|..||.....   ......................+..+.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence            66888999999998 78899999999999999999999999998733   223332322222222111122347999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.||++|||+
T Consensus       238 ~~~l~~~p~~R~~~  251 (260)
T PF00069_consen  238 KKMLSKDPEQRPSA  251 (260)
T ss_dssp             HHHSSSSGGGSTTH
T ss_pred             HHHccCChhHCcCH
Confidence            99999999999984

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.9e-45  Score=291.62  Aligned_cols=242  Identities=27%  Similarity=0.469  Sum_probs=202.1

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +|++.+.||.|+||.||++.+..+++.+++|.+......   ....+.+|+.+++.++|++++++.+.+.+.+..+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            488899999999999999999999999999987543222   23456789999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |+++++|.+.+...+ ..+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++.........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE--CCCCCEEEeeccceeecCCCccc
Confidence            999999988775432 358999999999999999999999999999999999999  88899999999998765443333


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ---TMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ....++..|+|||.+.+..++.++||||+|+++|+|++|..||.......   ........   ........+++++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l  235 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSPDARSL  235 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCHHHHHH
Confidence            44568899999999998889999999999999999999999998754321   22221111   1112235678999999


Q ss_pred             HHHhcccCcCCCCC
Q psy11805        237 IRKLLLKDREDAPE  250 (251)
Q Consensus       237 i~~~l~~~p~~Rps  250 (251)
                      +++||+.||++|||
T Consensus       236 i~~~l~~~p~~R~s  249 (285)
T cd05630         236 CKMLLCKDPKERLG  249 (285)
T ss_pred             HHHHhhcCHHHccC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-45  Score=303.17  Aligned_cols=245  Identities=23%  Similarity=0.360  Sum_probs=199.6

Q ss_pred             ccCCcccccccCCceEEEEEEE-----ccCCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKE-----KATGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   75 (251)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4799999999999999999975     3456789999986433 23456788999999999 799999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC------------------------------------------------------------
Q psy11805         76 CVVLELIEGGELFERVIDDD------------------------------------------------------------   95 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~------------------------------------------------------------   95 (251)
                      ++||||+++++|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999988876422                                                            


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         96 --------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        96 --------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                                    ..+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.........  
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE--ECCCcEEEecCccceeccCcccccc
Confidence                          247888999999999999999999999999999999999  78889999999999765432211  


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..........+.........  .+...+.++.+|+
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li  350 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEMYDIM  350 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHHHHHH
Confidence             11224567999999998899999999999999999998 8999987655444333333332222  1245688999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.||++|||+
T Consensus       351 ~~cl~~dP~~RPs~  364 (375)
T cd05104         351 KSCWDADPLKRPTF  364 (375)
T ss_pred             HHHccCChhHCcCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.7e-45  Score=308.49  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=195.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--------CE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS--------NV   74 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~   74 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|+||+++.+++...        ..
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            5799999999999999999999999999999987432    23446799999999999999999876432        24


Q ss_pred             EEEEEEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC-CcEEEeecccc
Q psy11805         75 MCVVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG-NRIKIIDFGLA  150 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~-~~~~l~df~~~  150 (251)
                      .++||||+++ +|.+.+..   ....++...++.++.|++.||.|||+.|++||||||+||++  +.+ +.++|+|||++
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl--~~~~~~vkL~DFGla  218 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI--DPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE--cCCCCceeeeccccc
Confidence            7799999986 66555542   44569999999999999999999999999999999999998  654 47999999999


Q ss_pred             cccCCCCcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC--------
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF--------  221 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  221 (251)
                      .............+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+...++......+        
T Consensus       219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~  298 (440)
T PTZ00036        219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM  298 (440)
T ss_pred             hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            876554444455688999999998654 68999999999999999999999999887766555443221100        


Q ss_pred             ---------CC--------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 ---------DD--------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ---------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               +.        ......|.++.+||++||+.||.+|||+
T Consensus       299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta  345 (440)
T PTZ00036        299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP  345 (440)
T ss_pred             chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH
Confidence                     00        0112467899999999999999999985

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.6e-45  Score=292.73  Aligned_cols=246  Identities=22%  Similarity=0.359  Sum_probs=203.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+..... .....+.+|+..++.++|+||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            579999999999999999999999999999999864432 2345678899999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +++ +|.+.+...+..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... ...
T Consensus        86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE--CCCCcEEECcCcchhccCCCCCccc
Confidence            975 8888887766678999999999999999999999999999999999999  889999999999987643222 122


Q ss_pred             eeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC-----------------
Q psy11805        161 VLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-----------------  222 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------  222 (251)
                      ...+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+........                 
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            33467899999998653 478899999999999999999999988776555443322111000                 


Q ss_pred             ---------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ---------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               ......+++.+++||.+||+.||.+|||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~  280 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA  280 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence                     01123578899999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-45  Score=296.99  Aligned_cols=246  Identities=25%  Similarity=0.438  Sum_probs=204.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|..+++.++|++|+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            5899999999999999999999999999999998532   2234566888999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+++++|.+.+......+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE--CCCCCEEEEECCceeecCCCCCc
Confidence            9999999999887656679999999999999999999999999999999999999  88999999999998765433221


Q ss_pred             --eeeccCccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC-ccccCCCH
Q psy11805        160 --QVLFGTPEFVAPEVVNF-----DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-ECFNEISD  231 (251)
Q Consensus       160 --~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  231 (251)
                        ....+++.|+|||.+..     ..++.++||||||+++|+|++|+.||...+..+....+......... .....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence              23458999999999863     45678999999999999999999999888777766666443322211 12245799


Q ss_pred             HHHHHHHHhcccCcCC--CCC
Q psy11805        232 DAKDFIRKLLLKDRED--APE  250 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~--Rps  250 (251)
                      .++++|++||..++++  |++
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~  259 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNG  259 (331)
T ss_pred             HHHHHHHHHccCcccccCCCC
Confidence            9999999999764333  554

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.9e-45  Score=285.58  Aligned_cols=242  Identities=21%  Similarity=0.375  Sum_probs=205.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||.||++.++. +..+++|.+.. .......+.+|+..++.++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEeccc-CCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            579999999999999999998764 55789998753 2334567889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce--
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--  160 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~--  160 (251)
                      ++++|.+.+....+.+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+..........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i--~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV--SSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE--cCCCeEEECCCCCccccCCCceeccC
Confidence            9999999887655578999999999999999999999999999999999999  888999999999887643222111  


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+....+..+......   ...+..+.+++.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~  236 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVYEVMYS  236 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHHHHHHH
Confidence            1124458999999988889999999999999999999 99999988888777777655433222   3467889999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|++|||+
T Consensus       237 c~~~~p~~Rps~  248 (256)
T cd05114         237 CWHEKPEGRPTF  248 (256)
T ss_pred             HccCCcccCcCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.1e-45  Score=291.28  Aligned_cols=245  Identities=27%  Similarity=0.495  Sum_probs=208.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ..+|++.+.||+|++|.||++.+..++..+++|.+..........+.+|+..++.+.|+|++++++.+..+...++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            46899999999999999999999989999999998766666677888999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++++|.+++...  .++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........ ..
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill--~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--cCCCCEEECccccchhccccccccC
Confidence            9999998887543  48999999999999999999999999999999999999  8889999999998876543322 12


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...+............. ........++..+.++|.+|
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~  253 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDFLNRC  253 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccCHHHHHHHHHH
Confidence            34578899999999888889999999999999999999999987766444433332221 12222356788999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |..+|++||++
T Consensus       254 l~~~p~~Rpt~  264 (296)
T cd06654         254 LDMDVEKRGSA  264 (296)
T ss_pred             CcCCcccCcCH
Confidence            99999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7e-45  Score=289.07  Aligned_cols=245  Identities=24%  Similarity=0.424  Sum_probs=207.5

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      -|++.+.||+|++|.||++.+..++..+++|.+..........+.+|++.++.+.|+|++++++.+...+..++++||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            46899999999999999999999999999999865555567788899999999999999999999999999999999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccceee
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVL  162 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~~~  162 (251)
                      +++|...+......+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++...... ......
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili--~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE--ccCCCEEEccccccccccccccccccc
Confidence            999988776655679999999999999999999999999999999999999  88999999999998664322 122334


Q ss_pred             ccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        163 FGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       163 ~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .+++.|+|||.+.     +..++.++||||+|+++|+|++|..||...+..+....+....... ......++..+.++|
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li  242 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSEFKDFL  242 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCHHHHHHH
Confidence            5788999999973     3456789999999999999999999998877766655554433221 122356789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.+|.+||++
T Consensus       243 ~~~l~~~p~~Rp~~  256 (282)
T cd06643         243 KKCLEKNVDARWTT  256 (282)
T ss_pred             HHHccCChhhCcCH
Confidence            99999999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-45  Score=288.16  Aligned_cols=243  Identities=23%  Similarity=0.460  Sum_probs=208.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|++|.||++.+..++..+++|.+.... ......+.+|++.++.++|+|++++.+.+.++...++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            58999999999999999999999999999999986543 33456788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~  160 (251)
                      +++++|.+.+...  .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... ....
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL--SEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--CCCCCEEEcccccceeecccccccc
Confidence            9999998888764  68999999999999999999999999999999999999  88999999999999776543 2223


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.....+....  ..++..+.+++.+|
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~  234 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG--NKFSKPFKDFVSLC  234 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc--cccCHHHHHHHHHH
Confidence            3457788999999988889999999999999999999999998777655555444433222211  12788999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |..+|++|||+
T Consensus       235 l~~~p~~Rpt~  245 (274)
T cd06609         235 LNKDPKERPSA  245 (274)
T ss_pred             hhCChhhCcCH
Confidence            99999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4e-45  Score=291.27  Aligned_cols=245  Identities=24%  Similarity=0.415  Sum_probs=198.8

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHc---CCCceeeEeEEEee-----CC
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMREL---QHPRLIQIYDAFES-----SN   73 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~   73 (251)
                      +|++.+.||+|++|.||+|.+..+++.+++|.+......  ......+|+..++.+   +|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            589999999999999999999999999999988643222  234556777777665   69999999998864     34


Q ss_pred             EEEEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ..++++|++++ +|.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili--~~~~~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARI  157 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEECccCcccc
Confidence            58999999976 777777653 2358999999999999999999999999999999999999  8899999999999977


Q ss_pred             cCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc------------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD------------  220 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  220 (251)
                      ...........+++.|+|||.+.+..++.++||||||+++|+|++|..||......+...++......            
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence            65444444456788999999998888999999999999999999999999887666555444321100            


Q ss_pred             -----------CCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 -----------FDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                 ......+.++..+.++|.+||+.||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  279 (288)
T cd07863         238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA  279 (288)
T ss_pred             cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH
Confidence                       0011224578889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.9e-45  Score=302.68  Aligned_cols=245  Identities=21%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccC-----CceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKAT-----GMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   75 (251)
                      ++|++.+.||.|+||.||+|.+...     +..|++|.+.... ......+.+|+.+++.+ +|+||+++++.+...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            5799999999999999999986543     3579999986433 22356788999999999 799999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC------------------------------------------------------------
Q psy11805         76 CVVLELIEGGELFERVIDDD------------------------------------------------------------   95 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~------------------------------------------------------------   95 (251)
                      ++||||+++++|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999988875321                                                            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce---eec
Q psy11805         96 ---------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ---VLF  163 (251)
Q Consensus        96 ---------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~  163 (251)
                               ..++...++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++..........   ...
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~--~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL--TDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE--eCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                     247888999999999999999999999999999999999  888999999999987654322111   112


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL  242 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (251)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||....................  .....|.++.+++.+||+
T Consensus       276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHHHHcC
Confidence            3457999999988889999999999999999997 9999987665444444443333222  224568999999999999


Q ss_pred             cCcCCCCCC
Q psy11805        243 KDREDAPEV  251 (251)
Q Consensus       243 ~~p~~Rps~  251 (251)
                      .||++|||+
T Consensus       354 ~dp~~RPs~  362 (374)
T cd05106         354 LEPTERPTF  362 (374)
T ss_pred             CChhhCcCH
Confidence            999999985

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8e-45  Score=290.57  Aligned_cols=245  Identities=27%  Similarity=0.503  Sum_probs=210.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ..+|++.+.||.|++|.||++.+..+++.+++|.+........+.+.+|+..++.++|+|++++++.+...+..++|+|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            35799999999999999999999999999999998765555677889999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++++|.+.+...  .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++........ ..
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili--~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL--GMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEccCccchhcccccccCC
Confidence            9999998877653  48999999999999999999999999999999999999  8899999999998876543322 22


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...++..|+|||.+.+..++.++|+||||+++|++++|..||...+.......+..... ........+++.+.++|++|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  252 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPIFRDFLNRC  252 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHHHHHHHHHH
Confidence            34577899999999888889999999999999999999999988877655544433322 22223356889999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |..+|++||++
T Consensus       253 l~~dp~~Rpt~  263 (296)
T cd06655         253 LEMDVEKRGSA  263 (296)
T ss_pred             hhcChhhCCCH
Confidence            99999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.2e-45  Score=290.67  Aligned_cols=245  Identities=19%  Similarity=0.330  Sum_probs=206.8

Q ss_pred             CccCCcccccccCCceEEEEEEEc-----cCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      +++|.+.+.||+|+||+||++.+.     .++..+++|.+..........+.+|+..+++++|+|++++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            467999999999999999999863     345678889876555555678999999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEE
Q psy11805         77 VVLELIEGGELFERVIDDD------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKI  144 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l  144 (251)
                      +++|++++++|.+++...+            ..+++..++.++.|++.||++||+.|++|+||+|+||++  +.++.++|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili--~~~~~~kl  161 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV--GENLLVKI  161 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE--ccCCcEEe
Confidence            9999999999988886433            248999999999999999999999999999999999999  88999999


Q ss_pred             eecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccc
Q psy11805        145 IDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD  220 (251)
Q Consensus       145 ~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  220 (251)
                      +|||.+........   .....++..|+|||.+.+..++.++||||||+++++|++ |..||......+....+..+...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~  241 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  241 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999876432211   112234668999999998889999999999999999998 99999888877777766655432


Q ss_pred             CCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 FDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..   ...++..+.+|+.+||+++|.+|||+
T Consensus       242 ~~---~~~~~~~l~~li~~~l~~~p~~Rpt~  269 (288)
T cd05093         242 QR---PRTCPKEVYDLMLGCWQREPHMRLNI  269 (288)
T ss_pred             CC---CCCCCHHHHHHHHHHccCChhhCCCH
Confidence            22   24578899999999999999999984

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-45  Score=290.02  Aligned_cols=241  Identities=24%  Similarity=0.419  Sum_probs=199.6

Q ss_pred             CcccccccCCceEEEEEEEc----cCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          6 NQHSAFSFGKFGTVYRCKEK----ATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         6 ~~~~~lg~g~~~~v~~~~~~----~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++.+.||.|.||.||+|.+.    ..+..|++|.+..... .....+.+|++.+++++||||+++++++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46789999999999999998    3457899999854333 247889999999999999999999999998888999999


Q ss_pred             eccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ++++++|.+++... ...+++..++.|+.|++.||.|||+++++|++|+++||++  +.++.+||+|||++.........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill--~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL--DSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE--ETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence            99999999999886 5679999999999999999999999999999999999999  88999999999999776322211


Q ss_pred             ---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        160 ---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       160 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                         ........|+|||.+.+..++.++||||||+++||+++ |..||...+..+....+..+....   ....+|..+.+
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  236 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPKDIYS  236 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhHHHHH
Confidence               22345668999999988889999999999999999999 789999998888887775554322   23568999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|.+||+.+|++|||+
T Consensus       237 li~~C~~~~p~~RPs~  252 (259)
T PF07714_consen  237 LIQQCWSHDPEKRPSF  252 (259)
T ss_dssp             HHHHHT-SSGGGS--H
T ss_pred             HHHHHcCCChhhCcCH
Confidence            9999999999999984

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-45  Score=301.32  Aligned_cols=244  Identities=23%  Similarity=0.346  Sum_probs=200.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeC------C
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS------N   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   73 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+++|.+...  .......+.+|+..++.++|+||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            47899999999999999999999999999999998643  233456788999999999999999999987543      3


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..|+|||++++ +|.+.+..   .++...+..++.|++.||.+||++|++|+||||+||++  +.++.++|+|||++...
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTA  176 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE--CCCCcEEEEeCCCcccc
Confidence            57999999976 66666542   47899999999999999999999999999999999999  88999999999999876


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC-----------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-----------  222 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  222 (251)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+........           
T Consensus       177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            554444455688999999999998999999999999999999999999998877665554432111100           


Q ss_pred             ---------------------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ---------------------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                 .......+..+++||.+||+.||.+|||+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~  312 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV  312 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH
Confidence                                       00111235678999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.1e-45  Score=287.62  Aligned_cols=246  Identities=22%  Similarity=0.397  Sum_probs=205.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+..........+.+|+..++.++|+|++++++.+...+..++++|++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            58999999999999999999999999999999987655555667889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-ccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~~  161 (251)
                      ++++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||.+....... ....
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili--~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKS  165 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEECcceeeeEccCccccccc
Confidence            9999988876554 69999999999999999999999999999999999999  889999999999986653222 2233


Q ss_pred             eccCcccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc-cccCCCHHHHHHH
Q psy11805        162 LFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE-CFNEISDDAKDFI  237 (251)
Q Consensus       162 ~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li  237 (251)
                      ..+++.|+|||.+.   ...++.++|+||||+++|+|++|..||...................... ....++..+.++|
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  245 (267)
T cd06645         166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV  245 (267)
T ss_pred             ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence            46788999999874   4557889999999999999999999997655444433333332222111 1125678999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.+|++|||+
T Consensus       246 ~~~l~~~P~~R~~~  259 (267)
T cd06645         246 KMALTKNPKKRPTA  259 (267)
T ss_pred             HHHccCCchhCcCH
Confidence            99999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-45  Score=300.22  Aligned_cols=244  Identities=23%  Similarity=0.340  Sum_probs=199.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC------C
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESS------N   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   73 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+++|.+....  ......+.+|+..++.++|+||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            478999999999999999999999999999999986432  23356778899999999999999999988543      3


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..+++||++++ ++.+.+..   .++...+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++...
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill--~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTA  169 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE--CCCCCEEEeeCcccccC
Confidence            57999999976 56565542   48999999999999999999999999999999999999  88999999999999876


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-------------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD-------------  220 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  220 (251)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+...........             
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            5544445557889999999999888999999999999999999999999887654443322111000             


Q ss_pred             -------------------------CCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 -------------------------FDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                               .........+..+++||.+||+.||++|||+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~  305 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV  305 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH
Confidence                                     0001112345678999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3e-45  Score=297.35  Aligned_cols=243  Identities=25%  Similarity=0.434  Sum_probs=205.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++....   ......+.+|..++..++|++|+++.+++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999985422   223456788899999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||++|++|.+++......+++..+..++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++.........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE--cCCCCEEEEeccceeeccCCCce
Confidence            9999999999988755679999999999999999999999999999999999999  88999999999998765433222


Q ss_pred             --eeeccCccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC-ccccCCCH
Q psy11805        160 --QVLFGTPEFVAPEVVNF-----DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-ECFNEISD  231 (251)
Q Consensus       160 --~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  231 (251)
                        ....+++.|+|||.+.+     ..++.++||||||+++|+|++|+.||...+..+....+......... .....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence              23468999999999865     45788999999999999999999999988877777766554332221 22346789


Q ss_pred             HHHHHHHHhcccCcCC
Q psy11805        232 DAKDFIRKLLLKDRED  247 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~  247 (251)
                      +++++|.+||...+.+
T Consensus       239 ~~~~li~~ll~~~~~~  254 (331)
T cd05624         239 EAKDLIQRLICSRERR  254 (331)
T ss_pred             HHHHHHHHHccCchhh
Confidence            9999999999875544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7e-45  Score=289.16  Aligned_cols=244  Identities=21%  Similarity=0.392  Sum_probs=205.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCC-----ceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATG-----MTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      ++|++.+.||+|++|.||+|.+...+     ..+++|.+..... .....+.+|+..++.++|+|++++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            57999999999999999999886554     6789998754332 23567889999999999999999999999989999


Q ss_pred             EEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc
Q psy11805         77 VVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR  141 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~  141 (251)
                      ++||++++++|.+++....               ..++...++.++.|++.||.+||+.|++|+||+|+||++  +.++.
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~--~~~~~  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLT  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE--cCCCc
Confidence            9999999999988886531               357889999999999999999999999999999999999  88899


Q ss_pred             EEEeecccccccCCCC---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q psy11805        142 IKIIDFGLARKFDPEK---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA  217 (251)
Q Consensus       142 ~~l~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  217 (251)
                      ++|+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+...
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR  242 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999987643221   1122345678999999988889999999999999999998 99999988877776666544


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....   ....+|+++.+|+.+||+.+|.+||++
T Consensus       243 ~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~  273 (283)
T cd05048         243 QLLP---CPEDCPARVYALMIECWNEIPARRPRF  273 (283)
T ss_pred             CcCC---CcccCCHHHHHHHHHHccCChhhCcCH
Confidence            4322   235789999999999999999999984

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.6e-45  Score=289.40  Aligned_cols=239  Identities=30%  Similarity=0.551  Sum_probs=208.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||.|++|.||++.+..+++.+++|++....   ......+.+|++.+++++|+||+++++++.+++..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            57999999999999999999999999999999985432   234567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |++++++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili--~~~~~~kl~dfg~~~~~~~~--~  155 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL--DSDGYIKITDFGFAKRVKGR--T  155 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--CCCCCEEEeeCCCccccCCC--C
Confidence            999999998888765 469999999999999999999999999999999999999  88899999999999775443  2


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+...+.++||||||+++++|++|..||...+..+....+..+....+    ..++..++++|++
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~  231 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIRN  231 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHHH
Confidence            344578899999999888889999999999999999999999988876666666654443333    4568999999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      ||+.+|.+|++
T Consensus       232 ~l~~~p~~R~~  242 (290)
T cd05580         232 LLQVDLTKRLG  242 (290)
T ss_pred             HccCCHHHccC
Confidence            99999999983

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-44  Score=285.47  Aligned_cols=245  Identities=26%  Similarity=0.512  Sum_probs=203.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+....   ......+.+|+..++.++|+|++++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            58999999999999999999999999999999875422   233556889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         80 ELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      |++++++|.+.+..   ....+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||.+......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~--~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE--cCCCCEEECccccceeccch
Confidence            99999999877753   33458999999999999999999999999999999999999  88899999999998765432


Q ss_pred             Cc-ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhccccCCCccccCCCHHH
Q psy11805        157 KK-LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD--VQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      .. .....+++.|+|||.+.+...+.++|+||+|+++|+|++|..||.....  .+....+.....+.  ......+..+
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  237 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP--LPTEHYSEKL  237 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC--CChhhcCHHH
Confidence            22 1233577899999999888889999999999999999999999965432  33444433322221  1224578899


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .+++.+||+.+|++|||+
T Consensus       238 ~~li~~cl~~~p~~Rp~~  255 (267)
T cd08228         238 RELVSMCIYPDPDQRPDI  255 (267)
T ss_pred             HHHHHHHCCCCcccCcCH
Confidence            999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0667|consensus

Probab=100.00  E-value=1.3e-45  Score=303.70  Aligned_cols=208  Identities=28%  Similarity=0.450  Sum_probs=185.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC------CCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ------HPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~   76 (251)
                      -+|.|.+.||+|+||.|.+|.+..+++.||+|+++ ....-..+...|+.+|..++      .-|+|+++++|...++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK-N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK-NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeec-cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            37899999999999999999999999999999984 33445677788999999886      348999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         77 VVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      +|+|.+.. +|.+++..+. ..++...++.++.||+.||.+||+.||+|+||||+|||+.+.....+|++|||.++....
T Consensus       265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            99999965 8999998754 358999999999999999999999999999999999999887788999999999988654


Q ss_pred             CCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy11805        156 EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV  214 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  214 (251)
                      .  ....+.+..|+|||++.|.+++.+.|||||||+++||++|.+.|.+.+..+++..+
T Consensus       344 ~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I  400 (586)
T KOG0667|consen  344 R--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI  400 (586)
T ss_pred             c--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence            3  34667888999999999999999999999999999999999999999887777655

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-44  Score=282.41  Aligned_cols=243  Identities=25%  Similarity=0.473  Sum_probs=211.9

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|+..+.||.|++|.||.+++..++..+++|.+....  ......+.+|++.+++++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            6999999999999999999999999999999876433  33466788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cc
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KL  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~  159 (251)
                      +++++|.+.+... +..+++..+..++.|++.+|.+||+.|++|+||+|+||++  +.++.++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~--~~~~~~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE--eCCCCEEECcCcceEEcccccccc
Confidence            9999999988764 4568999999999999999999999999999999999999  888999999999987654333 22


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||...+..++.++|+||||+++++|++|..||...+..+....+..+.....   ...++..+.++|.+
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~  235 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV---VSVYSSELISLVHS  235 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHHHHH
Confidence            334578899999999888888999999999999999999999998887777777665544332   25678999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|.+||++
T Consensus       236 ~l~~~p~~R~s~  247 (256)
T cd08221         236 LLQQDPEKRPTA  247 (256)
T ss_pred             HcccCcccCCCH
Confidence            999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.4e-45  Score=288.58  Aligned_cols=244  Identities=20%  Similarity=0.319  Sum_probs=207.5

Q ss_pred             ccCCcccccccCCceEEEEEEEcc-----CCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      ++|.+.+.||.|++|.||+|.+..     +++.+++|.+...... ....+.+|++.++.++|+|++++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            579999999999999999998753     3578999998654433 4578999999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         77 VVLELIEGGELFERVIDDD-------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      ++||++++++|.+++...+             ..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili--~~~~~~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE--cCCCeEE
Confidence            9999999999999887542             347889999999999999999999999999999999999  8889999


Q ss_pred             EeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc
Q psy11805        144 IIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQY  219 (251)
Q Consensus       144 l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  219 (251)
                      |+|||.+........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+..
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~  242 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL  242 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence            999999875432211   122334678999999999999999999999999999998 9999988888777776665544


Q ss_pred             cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...   ...++..+.+++.+||+.||++||++
T Consensus       243 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~  271 (280)
T cd05049         243 LQR---PRTCPSEVYDIMLGCWKRDPQQRINI  271 (280)
T ss_pred             CCC---CCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            332   24678999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-44  Score=283.58  Aligned_cols=245  Identities=24%  Similarity=0.434  Sum_probs=208.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|++|.||++.+..+++.+++|.+.....  .+.+.+|++.++.++|+|++++++.+.++...++++|+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3789999999999999999999998889999999864432  77899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +++++|.+.+...+..+++..++.++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||.+....... ...
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~--~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL--NEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--CCCCcEEEcccccchhcccCccccc
Confidence            99999999887766679999999999999999999999999999999999999  888999999999987754433 223


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...++..|+|||.+.+..++.++||||+|+++++|++|+.||...........+..... ........++..+.++|.+|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFNDFVKKC  236 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCC-CCCCchhhcCHHHHHHHHHH
Confidence            34477899999999888899999999999999999999999987665544433322111 11112235778999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.+|++|||+
T Consensus       237 l~~~P~~Rps~  247 (256)
T cd06612         237 LVKDPEERPSA  247 (256)
T ss_pred             HhcChhhCcCH
Confidence            99999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-44  Score=285.07  Aligned_cols=243  Identities=21%  Similarity=0.352  Sum_probs=206.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|.+.+.||+|++|.||+|.++.+++.+++|.+... ......+.+|+..++.++|+|++++++++..++..+++||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            5688999999999999999999988999999997543 334667889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce-
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ-  160 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~-  160 (251)
                      ++++|.+.+... ...++...++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.......... 
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~--~~~~~~kl~df~~~~~~~~~~~~~~  162 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAH  162 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE--cCCCcEEeCCCccccccccceeecc
Confidence            999999888653 3458999999999999999999999999999999999999  889999999999987654322111 


Q ss_pred             -eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        161 -VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       161 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                       ....+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.... .  ......+|..+.++|.
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~  239 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-R--MERPEGCPPKVYELMR  239 (263)
T ss_pred             CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-C--CCCCCCCCHHHHHHHH
Confidence             1123457999999988889999999999999999998 999998877766665554432 1  2223568999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       240 ~cl~~~p~~Rp~~  252 (263)
T cd05052         240 ACWQWNPSDRPSF  252 (263)
T ss_pred             HHccCCcccCCCH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-44  Score=282.66  Aligned_cols=238  Identities=21%  Similarity=0.389  Sum_probs=199.2

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      +.||+|+||.||+|.+..+++.+++|.+.... ......+.+|++.++.++|+||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999999899999999875433 22356789999999999999999999999999999999999999999


Q ss_pred             hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc---eeecc
Q psy11805         88 FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL---QVLFG  164 (251)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~  164 (251)
                      .+.+...+..+++..++.++.|+++||.|||+.|++|+||+|+||++  +.++.++|+|||.+.........   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV--TEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE--cCCCcEEECccccCcccccccccccCCCCCC
Confidence            99887666678999999999999999999999999999999999999  88899999999998654322111   11122


Q ss_pred             CcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        165 TPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +..|+|||.+.+..++.++||||||+++|++++ |..||...+.......+....   .......++..+.+++.+||+.
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~  235 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---RLPCPELCPDAVYRLMERCWEY  235 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---CCCCcccCCHHHHHHHHHHcCC
Confidence            457999999988889999999999999999998 999998777655554443322   1223356789999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      +|++|||+
T Consensus       236 ~p~~Rps~  243 (252)
T cd05084         236 DPGQRPSF  243 (252)
T ss_pred             ChhhCcCH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-45  Score=299.74  Aligned_cols=239  Identities=21%  Similarity=0.327  Sum_probs=193.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|...      ...+.+|++++++++||||+++++++..++..++++|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999999999999999743      345689999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC--Ccce
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE--KKLQ  160 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~--~~~~  160 (251)
                      . ++|...+.... .++...++.++.|++.||.|||+.||+|+||||+||++  +.++.++|+|||++......  ....
T Consensus       166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll--~~~~~vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI--NHPGDVCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE--cCCCCEEEEeCCcccccccccccccc
Confidence            6 47777776543 58999999999999999999999999999999999999  88899999999998653221  2223


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhc----------------
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD-------VQTMANVTIA----------------  217 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~----------------  217 (251)
                      ...+++.|+|||++.+..++.++||||||+++|+|++|..||.....       ......+...                
T Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~  321 (391)
T PHA03212        242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL  321 (391)
T ss_pred             cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence            45689999999999988999999999999999999999987643221       1111111100                


Q ss_pred             ----------ccc--CCCccc---cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 ----------QYD--FDDECF---NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ----------~~~--~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                ...  ...+.|   ..+|.++.+||.+||+.||++|||+
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta  370 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA  370 (391)
T ss_pred             HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH
Confidence                      000  000111   1357789999999999999999985

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-44  Score=289.71  Aligned_cols=244  Identities=23%  Similarity=0.382  Sum_probs=201.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCc--eEEEEEeccc-cccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGM--TLAAKFVGIA-KRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~~K~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||.|+||.||+|.++.++.  .+++|.+... .....+.+.+|+..++++ +|||++++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            689999999999999999999877664  4677776532 223456788999999999 699999999999999999999


Q ss_pred             EEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         79 LELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      +|++++++|.+++....               ..++...++.++.|++.||.+||+.|++|+||+|+||++  +.++.++
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill--~~~~~~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV--GENLASK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE--CCCCeEE
Confidence            99999999998886532               248889999999999999999999999999999999999  8889999


Q ss_pred             EeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCC
Q psy11805        144 IIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       144 l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      |+|||++..............+..|+|||...+..++.++||||||+++|+|++ |..||...+..+....+..+..   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~---  236 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---  236 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC---
Confidence            999999864332211122223457999999988889999999999999999997 9999998887776666544321   


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ......++..+.+|+.+||+.+|.+|||+
T Consensus       237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  265 (297)
T cd05089         237 MEKPRNCDDEVYELMRQCWRDRPYERPPF  265 (297)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            12224678999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.2e-45  Score=290.40  Aligned_cols=245  Identities=26%  Similarity=0.494  Sum_probs=208.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ..+|++.+.||+|++|.||++.+..+++.|++|.+........+.+.+|+..++.++|+|++++++.+...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            46899999999999999999999989999999998765555667788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++++|.+++...  .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........ ..
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili--~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEECcCccceEccCCccCcC
Confidence            9999998887653  48999999999999999999999999999999999999  8899999999999876543322 22


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++|+||||+++|++++|..||...+............ .........++..+++++.+|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~  252 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDFLNRC  252 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHHHHHHHH
Confidence            3457889999999988888999999999999999999999998766544433332222 111122346788999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.+|++||++
T Consensus       253 l~~~p~~Rps~  263 (297)
T cd06656         253 LEMDVDRRGSA  263 (297)
T ss_pred             ccCChhhCcCH
Confidence            99999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-44  Score=283.24  Aligned_cols=242  Identities=28%  Similarity=0.465  Sum_probs=204.5

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc---------chHHHHHHHHHHHHcCCCceeeEeEEEeeCCE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---------DRRNVEREVEIMRELQHPRLIQIYDAFESSNV   74 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (251)
                      +|.+.+.||.|++|.||.|.+..+++.+++|.+......         ..+.+.+|+..+++++|+|++++++++..++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            588999999999999999999988999999987543322         13568899999999999999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .++++|++++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~--~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV--DNKGGIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE--cCCCCEEecccCCCcccc
Confidence            99999999999998888665 468999999999999999999999999999999999999  889999999999987654


Q ss_pred             CCC-------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc
Q psy11805        155 PEK-------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       155 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      ...       ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+....   ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~  234 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SPEIPS  234 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CCcCCc
Confidence            211       1112346788999999988888999999999999999999999998877665554443321   122235


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++..+.++|++||+++|++||++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~  258 (267)
T cd06628         235 NISSEAIDFLEKTFEIDHNKRPTA  258 (267)
T ss_pred             ccCHHHHHHHHHHccCCchhCcCH
Confidence            678999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG1026|consensus

Probab=100.00  E-value=6.7e-46  Score=313.08  Aligned_cols=244  Identities=22%  Similarity=0.413  Sum_probs=216.6

Q ss_pred             ccCCcccccccCCceEEEEEEEc-----cCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .+.+..+.||+|+||+||+|+..     .+...||||.++..... ..++|++|++++..++|||||+++|++..++.++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            35677899999999999999874     23468999999766655 6899999999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         77 VVLELIEGGELFERVIDDD-------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      +|+|||+.|+|.++++.+.             .+++..+.+.|+.||+.|+.||-++.+|||||-++|+|+  .++-.||
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV--ge~l~VK  643 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV--GENLVVK  643 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee--ccceEEE
Confidence            9999999999999997532             238889999999999999999999999999999999999  9999999


Q ss_pred             EeecccccccCCC---CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc
Q psy11805        144 IIDFGLARKFDPE---KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQY  219 (251)
Q Consensus       144 l~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  219 (251)
                      |+|||+++.....   .......-+.+|||||.+..+.++.+|||||+|++|||+++ |+.||.+.+..|.++.+..+..
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l  723 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL  723 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence            9999999875322   11223446679999999999999999999999999999999 9999999999999999988876


Q ss_pred             cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                         .+++.++|.++.+|+..||+.+|++||+.
T Consensus       724 ---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF  752 (774)
T KOG1026|consen  724 ---LSCPENCPTEVYSLMLECWNENPKRRPSF  752 (774)
T ss_pred             ---ccCCCCCCHHHHHHHHHHhhcCcccCCCH
Confidence               55668999999999999999999999983

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.9e-45  Score=285.28  Aligned_cols=243  Identities=22%  Similarity=0.389  Sum_probs=209.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      .+|++.+.||.|++|.||+|.+.. +..+++|.+..........+.+|+..++.++|+|++++++++...+..+++|||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            579999999999999999999987 8899999987666656788999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-e
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-Q  160 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-~  160 (251)
                      ++++|.+++... +..++...++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......... .
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv--~~~~~~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV--GEDLVCKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE--cCCceEEEccccchhhcCCcccccc
Confidence            999999998763 3468999999999999999999999999999999999999  88999999999999765332211 1


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...++..|+|||...+..++.++||||||+++++|++ |..||...+..+....+.... ..  +.....+..+.+++.+
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~i~~  239 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-RM--PCPAKCPQEIYKIMLE  239 (261)
T ss_pred             CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-cC--CCCCCCCHHHHHHHHH
Confidence            2234568999999988889999999999999999998 899998887777766665432 22  2235778999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|++|||+
T Consensus       240 ~l~~~p~~Rpt~  251 (261)
T cd05148         240 CWAAEPEDRPSF  251 (261)
T ss_pred             HcCCCchhCcCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-45  Score=297.81  Aligned_cols=234  Identities=26%  Similarity=0.481  Sum_probs=196.3

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHc---CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMREL---QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      ||+|+||+||+|.+..+++.||+|++.....   ........|...+...   .||+|+.+.+.+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            6999999999999999999999999853221   2233344556666554   699999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~  163 (251)
                      ++|...+... ..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++..... ........
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL--DATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            9998887654 469999999999999999999999999999999999999  8899999999999865322 22233456


Q ss_pred             cCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcc
Q psy11805        164 GTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL  242 (251)
Q Consensus       164 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (251)
                      +++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+..+....+.   ..+++++.++|++||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence            89999999998754 4789999999999999999999999988887777777666554442   3478999999999999


Q ss_pred             cCcCCCCC
Q psy11805        243 KDREDAPE  250 (251)
Q Consensus       243 ~~p~~Rps  250 (251)
                      .+|.+||+
T Consensus       235 ~~P~~R~~  242 (330)
T cd05586         235 RNPQHRLG  242 (330)
T ss_pred             CCHHHCCC
Confidence            99999995

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG1989|consensus

Probab=100.00  E-value=1.1e-45  Score=312.72  Aligned_cols=241  Identities=25%  Similarity=0.417  Sum_probs=204.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEE-Eee---C---CE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDA-FES---S---NV   74 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~---~---~~   74 (251)
                      .+++|++.|.+|||+.||+|++...++.+|+|++-..+....+.+.+|++++++|+ |+|||.++|. ...   +   -.
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            46889999999999999999999888999999987777888999999999999997 9999999993 321   1   24


Q ss_pred             EEEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         75 MCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      ++|+||||.|+.|.+++... ...|++.++++|+.++++|+.+||...  |+|||||-+|||+  ..+|++||||||.++
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--s~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--SADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE--cCCCCEEeCcccccc
Confidence            78999999988999998742 234999999999999999999999997  9999999999999  999999999999987


Q ss_pred             ccCCCCcc----------eeeccCccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q psy11805        152 KFDPEKKL----------QVLFGTPEFVAPEVV---NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ  218 (251)
Q Consensus       152 ~~~~~~~~----------~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  218 (251)
                      ..-.....          -....|+.|+|||.+   .+.+.+.|+|||+|||+||.|+....||+......    |..+.
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Ilng~  270 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILNGN  270 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEecc
Confidence            64322211          113478999999987   56788999999999999999999999997764433    33555


Q ss_pred             ccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        219 YDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++..  +..++.+++||+.||++||.+||++
T Consensus       271 Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI  301 (738)
T KOG1989|consen  271 YSFPPF--PNYSDRLKDLIRTMLQPNPDERPNI  301 (738)
T ss_pred             ccCCCC--ccHHHHHHHHHHHHhccCcccCCCH
Confidence            555543  6789999999999999999999985

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-44  Score=285.13  Aligned_cols=245  Identities=27%  Similarity=0.527  Sum_probs=203.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....   ......+.+|+..++.++|+|++++++.+..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57999999999999999999999899999999875432   223567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         80 ELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      |++++++|.+.+..   ....+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCCEEECcchhhhccccC
Confidence            99999999887753   23468999999999999999999999999999999999999  88899999999988765432


Q ss_pred             Cc-ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhccccCCCccccCCCHHH
Q psy11805        157 KK-LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD--VQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      .. .....++..|+|||.+.+...+.++|+||||+++|+|++|..||.....  .+....+.....  .......++..+
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  237 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEEL  237 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC--CCCCcccccHHH
Confidence            22 2234578899999999888889999999999999999999999975533  223333332222  211224578899


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      ++++.+||+.+|++|||+
T Consensus       238 ~~li~~~l~~~p~~Rpt~  255 (267)
T cd08229         238 RQLVNMCINPDPEKRPDI  255 (267)
T ss_pred             HHHHHHhcCCCcccCCCH
Confidence            999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.1e-44  Score=282.49  Aligned_cols=242  Identities=20%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|++|.||.+.+.. +..+++|.+... ......+.+|+..+++++||||+++++++...+..+++||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            579999999999999999998764 456899987533 234567899999999999999999999999888899999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce--
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--  160 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~--  160 (251)
                      .+++|.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+..........  
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili--~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV--DDQGCVKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE--cCCCCEEECCCccceecCCCceeecC
Confidence            9999999887765578999999999999999999999999999999999999  888999999999887543322111  


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.....   ....+..+.+++.+
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~  236 (256)
T cd05113         160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVYAIMYS  236 (256)
T ss_pred             CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHH
Confidence            1224467999999988889999999999999999998 9999988877766666655433322   23568899999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|.+||++
T Consensus       237 cl~~~p~~Rp~~  248 (256)
T cd05113         237 CWHEKAEERPTF  248 (256)
T ss_pred             HcCCCcccCCCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0658|consensus

Probab=100.00  E-value=6.7e-46  Score=286.49  Aligned_cols=242  Identities=26%  Similarity=0.415  Sum_probs=203.4

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--C---EEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS--N---VMCVV   78 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~---~~~lv   78 (251)
                      .|+-.+.+|+|+||.||.|....+++.+|+|..-.    +.+.-.+|+++++.+.||||+++.-+|...  +   +..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~----d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQ----DKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecC----CCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            46778999999999999999999999999998633    233446889999999999999999988432  2   45699


Q ss_pred             EEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         79 LELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      |||++. +|.+.++.   .+..++...+.-+.+||+.||+|||+.||+||||||+|+|+ +...|.+||||||.|.....
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLv-D~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLV-DPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEE-cCCCCeEEeccCCcceeecc
Confidence            999987 88888774   35578999999999999999999999999999999999995 44569999999999999988


Q ss_pred             CCcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC------------
Q psy11805        156 EKKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD------------  222 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  222 (251)
                      +.......++-.|+|||++.|. .|+.+.||||.||++.||+-|++.|.+.+...++..+.+-...+.            
T Consensus       179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~  258 (364)
T KOG0658|consen  179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT  258 (364)
T ss_pred             CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence            8888888899999999999765 689999999999999999999999999988777765532221111            


Q ss_pred             --------C-----ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 --------D-----ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 --------~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                              .     -.....+++..+|+.++|+.+|.+|.++
T Consensus       259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~  300 (364)
T KOG0658|consen  259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA  300 (364)
T ss_pred             cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH
Confidence                    0     1224588999999999999999999874

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-44  Score=286.14  Aligned_cols=244  Identities=20%  Similarity=0.323  Sum_probs=205.7

Q ss_pred             ccCCcccccccCCceEEEEEEEc-----cCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      ++|.+.+.||+|+||.||++...     .++..+++|.+..........+.+|++.++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            67899999999999999999753     3466888998765555567789999999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         78 VLELIEGGELFERVIDDD--------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      +||++++++|.+++...+              ..+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~--~~~~~~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV--GQGLVVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE--cCCCCEE
Confidence            999999999998886543              247899999999999999999999999999999999999  7889999


Q ss_pred             EeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc
Q psy11805        144 IIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQY  219 (251)
Q Consensus       144 l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  219 (251)
                      |+|||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.......+..
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  242 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE  242 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence            999999875432221   112234578999999998889999999999999999998 9999988877776666654432


Q ss_pred             cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .   .....+|+.+.++|.+||+.||.+||++
T Consensus       243 ~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~  271 (280)
T cd05092         243 L---ERPRTCPPEVYAIMQGCWQREPQQRMVI  271 (280)
T ss_pred             C---CCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            2   2225678999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-44  Score=293.77  Aligned_cols=243  Identities=25%  Similarity=0.435  Sum_probs=204.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||++.++.+++.+++|++....   ......+.+|+..+..++|++++++.+.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999985321   223455788899999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-  158 (251)
                      ||+++++|.+++......+++..+..++.|++.||.+||+.|++||||||+||++  +.++.++|+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili--~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--CCCCCEEEeecchheecccCCcc
Confidence            9999999999998765679999999999999999999999999999999999999  8899999999999866433222 


Q ss_pred             -ceeeccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC-ccccCCCH
Q psy11805        159 -LQVLFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-ECFNEISD  231 (251)
Q Consensus       159 -~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  231 (251)
                       .....+++.|+|||.+.     ...++.++||||||+++|+|++|+.||...+..+....+......... .....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence             22346899999999985     345788999999999999999999999998888877777654432221 12246899


Q ss_pred             HHHHHHHHhcccCcCC
Q psy11805        232 DAKDFIRKLLLKDRED  247 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~  247 (251)
                      ++++||++||..+|.+
T Consensus       239 ~~~~li~~ll~~~~~r  254 (332)
T cd05623         239 DAKDLIRRLICSREHR  254 (332)
T ss_pred             HHHHHHHHHccChhhh
Confidence            9999999999765544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-44  Score=290.80  Aligned_cols=244  Identities=23%  Similarity=0.400  Sum_probs=199.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCce--EEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMT--LAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||.||+|.++.++..  +++|.+.... ......+.+|+..+.++ +|+|++++++++..++..+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            5799999999999999999999877654  4666654322 22356788999999999 899999999999999999999


Q ss_pred             EEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         79 LELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      |||+++++|.+++....               ..+++..++.++.|++.||++||++|++|+||+|+||++  +.++.++
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili--~~~~~~k  164 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAK  164 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe--cCCCcEE
Confidence            99999999998886432               257899999999999999999999999999999999999  8899999


Q ss_pred             EeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCC
Q psy11805        144 IIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       144 l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      |+|||++..............+..|+|||.+.+..++.++||||||+++++|++ |..||...+..+........ ..  
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~--  241 (303)
T cd05088         165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YR--  241 (303)
T ss_pred             eCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-Cc--
Confidence            999999864322211122223567999999988888999999999999999998 99999887776665544322 11  


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+..++..+.+++.+||+.+|++||++
T Consensus       242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  270 (303)
T cd05088         242 LEKPLNCDDEVYDLMRQCWREKPYERPSF  270 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            12224578899999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-44  Score=298.32  Aligned_cols=244  Identities=24%  Similarity=0.405  Sum_probs=199.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-----EEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-----VMC   76 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   76 (251)
                      +|++.+.||+|+||.||++.+..+++.||+|.+...  +......+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            588999999999999999999999999999987532  2234567889999999999999999999998776     789


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +|+||+.+ +|.+.+... ..++...+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++......
T Consensus        81 lv~e~~~~-~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili--~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQS-DLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV--NSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeecccc-CHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE--CCCCCEEeccccceeecccC
Confidence            99999975 676766544 469999999999999999999999999999999999999  88999999999999765332


Q ss_pred             C--cceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---------------
Q psy11805        157 K--KLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ---------------  218 (251)
Q Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------------  218 (251)
                      .  ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....+....               
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            2  12233567899999998764 47889999999999999999999998877655544432210               


Q ss_pred             --------ccCCC-----ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        219 --------YDFDD-----ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       219 --------~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                              ...+.     ......+.++.+||.+||+.||++|||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  282 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA  282 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH
Confidence                    00000     1223468899999999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-44  Score=287.75  Aligned_cols=246  Identities=22%  Similarity=0.401  Sum_probs=202.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+... .......+.+|+..+++++|+|++++++.+..++..++++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            5799999999999999999999989999999987643 233456788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         82 IEGGELFERVIDD--DFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+ .|++|+||+|+||++  +.++.++|+|||.+...... .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~-~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV--NGNGQVKLCDFGVSGNLVAS-L  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE--CCCCCEEEeecCCcccccCC-c
Confidence            9999998777653  2368999999999999999999997 599999999999999  88999999999998765322 2


Q ss_pred             ceeeccCcccccccccccCC------CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDA------IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      .....+++.|+|||.+.+..      ++.++|+||||+++|+|++|..||...+.......+...........+..++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD  237 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence            23345778999999985443      478999999999999999999999776554443333222222222333568999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++|.+||+.+|++||++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~  256 (286)
T cd06622         238 AQDFVAKCLNKIPNRRPTY  256 (286)
T ss_pred             HHHHHHHHcccCcccCCCH
Confidence            9999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-44  Score=290.73  Aligned_cols=244  Identities=21%  Similarity=0.316  Sum_probs=202.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCc----eEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGM----TLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||+|+||.||+|.+..++.    .|++|.+.... ....+.+.+|+..++.++|+||+++++++..+ ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            3689999999999999999999866554    38899875432 23467788999999999999999999998765 467


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ++++++++++|.+.+......++...++.++.|++.||+|||+.|++|+||||+||++  +.++.++|+|||++......
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill--~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe--cCCCcEEEccccccccccCC
Confidence            8999999999999998876678999999999999999999999999999999999999  88899999999999876433


Q ss_pred             Cccee---eccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        157 KKLQV---LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       157 ~~~~~---~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      .....   ...+..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+........ ...+.  ...++.+
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~  239 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ--PPICTID  239 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-CCCCC--CCCCCHH
Confidence            32211   223567999999998899999999999999999998 99999887766554433332 22222  2457889


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+++.+||+.+|.+||++
T Consensus       240 ~~~li~~cl~~~p~~Rps~  258 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKF  258 (316)
T ss_pred             HHHHHHHHccCChhhCcCH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.9e-44  Score=285.14  Aligned_cols=245  Identities=24%  Similarity=0.407  Sum_probs=199.2

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||+|++|.||+|.+..++..|++|.+.....  .....+.+|+..++++.|+|++++++++.+++..++|||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            58999999999999999999999999999999864432  2356788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         82 IEGGELFERVIDD--DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      +++ +|.+.+...  +..+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++.........
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE--cCCCcEEECcccceeecCCCccc
Confidence            975 777776542  2468999999999999999999999999999999999999  88999999999998765332211


Q ss_pred             -eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC----------------
Q psy11805        160 -QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF----------------  221 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  221 (251)
                       ....+++.|+|||.+.+. .++.++||||||+++++|++|+.||...+...............                
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence             223467899999988654 46889999999999999999999998776544433221111000                


Q ss_pred             ---------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 ---------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               .......+++++.++|++||+.||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  276 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA  276 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH
Confidence                     011123578899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-44  Score=281.22  Aligned_cols=242  Identities=21%  Similarity=0.341  Sum_probs=203.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      .+|++.+.||+|++|.||++.+. ++..+++|.+... ......+.+|+..++.++|+|++++++++...+..+++||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            47899999999999999999876 4667899987532 234567888999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce--
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--  160 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~--  160 (251)
                      ++++|.+.+...+..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+..........  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i--~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV--GEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE--CCCCcEEECCcccceecccccccccC
Confidence            9999999987766678999999999999999999999999999999999999  889999999999987643221111  


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+.....   .......|..+.+++.+
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~  236 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---LYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCHHHHHHHHH
Confidence            1112347999999998889999999999999999998 8999988777776666554322   12224579999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||..+|++|||+
T Consensus       237 cl~~~p~~Rpt~  248 (256)
T cd05059         237 CWHEKPEDRPAF  248 (256)
T ss_pred             HhcCChhhCcCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0604|consensus

Probab=100.00  E-value=4.4e-46  Score=280.44  Aligned_cols=246  Identities=34%  Similarity=0.557  Sum_probs=216.7

Q ss_pred             CCccCCcc-cccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEee----CCE
Q psy11805          1 MTTHQNQH-SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFES----SNV   74 (251)
Q Consensus         1 ~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~   74 (251)
                      +.++|++. +.||-|-.|+|-.|.++.++..+|+|++..     .....+|++..-.. .|+|||.+++++++    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35677775 568999999999999999999999999742     45556777765444 69999999999864    346


Q ss_pred             EEEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecccccc
Q psy11805         75 MCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLARK  152 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~  152 (251)
                      +.+|||.++||.|.+.+.+.+ ..+++.++..|++||..|+.|||+.+|.|||+||+|+|..+. .+..+||+|||++..
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence            889999999999999998865 369999999999999999999999999999999999997443 455799999999999


Q ss_pred             cCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhccccCCCccccC
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET----DVQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      ........+.+.||.|.|||++..+.++...|+||+|++||-|++|.+||.+..    ......++..+.+.++.+-|+.
T Consensus       214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~  293 (400)
T KOG0604|consen  214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC  293 (400)
T ss_pred             cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence            887788888999999999999999999999999999999999999999997754    3556788999999999999999


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +|...+|+|+.+|..+|++|.|+
T Consensus       294 VSe~aKdlIR~LLkt~PteRlTI  316 (400)
T KOG0604|consen  294 VSEAAKDLIRKLLKTEPTERLTI  316 (400)
T ss_pred             HHHHHHHHHHHHhcCCchhheeH
Confidence            99999999999999999999874

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-44  Score=282.01  Aligned_cols=245  Identities=21%  Similarity=0.353  Sum_probs=206.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccC---CceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT---GMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|++.+.||+|+||+||+|.+..+   ...+++|.+.... ......+.+|+..++.++|+|++++++.+...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            36899999999999999999998644   4578999876433 2235678889999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      +||++++++|.+++......+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili--~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE--cCCCCEEECccchhhcccccc
Confidence            999999999999987766679999999999999999999999999999999999999  889999999999998764221


Q ss_pred             cc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        158 KL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       158 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ..   .....+..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+......   +.....+..+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  237 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---PPPMDCPSAL  237 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHH
Confidence            11   11224568999999988889999999999999999998 99999888777766666543221   1224678999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .+++.+||+.+|++||++
T Consensus       238 ~~li~~cl~~~p~~Rp~~  255 (266)
T cd05033         238 YQLMLDCWQKDRNERPTF  255 (266)
T ss_pred             HHHHHHHcCCCcccCcCH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-44  Score=289.12  Aligned_cols=244  Identities=30%  Similarity=0.540  Sum_probs=208.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+......   ....+.+|++.++.++|+||+++++.+......+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            5799999999999999999999989999999998654322   4567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |++.+++|.+.+... +..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE--cCCCCEEEeecchhhccccccc
Confidence            999999998887653 3568999999999999999999999999999999999999  8889999999998865432211


Q ss_pred             c------------------------------eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy11805        159 L------------------------------QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV  208 (251)
Q Consensus       159 ~------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  208 (251)
                      .                              ....++..|+|||.+.+..++.++||||||+++|+|++|..||...+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            1                              1224677899999999888999999999999999999999999988877


Q ss_pred             HHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        209 QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      +....+.......+..  ...+..+.++|.+||..+|++||+
T Consensus       239 ~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         239 ETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             HHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCC
Confidence            7776665444333322  337899999999999999999998

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.9e-44  Score=286.07  Aligned_cols=244  Identities=27%  Similarity=0.484  Sum_probs=207.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+....   ......+.+|++.++.++|+||+++++.+..++..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999876433   223567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      |+++|++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.......  
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll--~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE--CCCCCEEEeeCCCccccCcCccc
Confidence            9999999988887654 68999999999999999999999999999999999999  889999999999875321000  


Q ss_pred             --------------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC
Q psy11805        158 --------------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD  223 (251)
Q Consensus       158 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (251)
                                    ......++..|+|||.+.+..++.++|+||||+++|++++|..||.+.+..+............+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                          001124677899999998888999999999999999999999999988777767666555443333


Q ss_pred             ccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        224 ECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      .. ..+|..+.++|++||+.+|++||+
T Consensus       238 ~~-~~~~~~~~~li~~~l~~~P~~R~~  263 (305)
T cd05609         238 GD-EALPADAQDLISRLLRQNPLERLG  263 (305)
T ss_pred             cc-ccCCHHHHHHHHHHhccChhhccC
Confidence            22 367899999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.6e-44  Score=284.81  Aligned_cols=245  Identities=30%  Similarity=0.486  Sum_probs=205.2

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||+|++|.||+|.+..+++.+++|.+....  ......+.+|+..+++++|+|++++++++...+..++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            6899999999999999999999899999999986544  23357788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc--c
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK--L  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~--~  159 (251)
                      + +++|.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........  .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE--cCCCcEEEeeeeecccccCCCCCcc
Confidence            9 889999887766679999999999999999999999999999999999999  8899999999999877644321  2


Q ss_pred             eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC----------------
Q psy11805        160 QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD----------------  222 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  222 (251)
                      ....++..|+|||.+.+. .++.++||||+|+++++|++|..+|...+..+....+........                
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            334578899999998654 458899999999999999999988987776555544332111000                


Q ss_pred             ----------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ----------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                ....+..+..+.++|++||+.+|++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  276 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA  276 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence                      01123567899999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.2e-44  Score=279.16  Aligned_cols=243  Identities=23%  Similarity=0.463  Sum_probs=205.9

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee-CCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES-SNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   80 (251)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....  ......+.+|++.+++++|+|++++.+.+.. +...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5899999999999999999999999999999986433  2345678899999999999999999998764 456899999


Q ss_pred             eccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-c
Q psy11805         81 LIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-K  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~  158 (251)
                      ++++++|.+.+... +..+++.++..++.+++.||.+||+.|++|+||+|+||++  +.++.++|+|||++....... .
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~--~~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL--TRTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE--ecCCcEEEecccceEEecccCCc
Confidence            99999998888763 3458999999999999999999999999999999999999  888999999999987653322 2


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||.+.+..++.++|+||||++++++++|..||...+.......+..+..+.   ....++..+.+++.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~  235 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGELIA  235 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHHHHH
Confidence            233457889999999998889999999999999999999999998877666655554443322   22568899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       236 ~~l~~~p~~Rp~~  248 (257)
T cd08223         236 TMLSKRPEKRPSV  248 (257)
T ss_pred             HHhccCcccCCCH
Confidence            9999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.1e-44  Score=284.09  Aligned_cols=246  Identities=26%  Similarity=0.420  Sum_probs=201.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+.....  ...+.+.+|+.++++++|+|++++++++...+..+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            579999999999999999999999999999998754322  234567899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~  159 (251)
                      |+++++|...... ...+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... ..
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI--TKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE--cCCCcEEECccccceecCCCcccc
Confidence            9998777665543 4469999999999999999999999999999999999999  888999999999997754433 12


Q ss_pred             eeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc------------------
Q psy11805        160 QVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD------------------  220 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------  220 (251)
                      ....++..|+|||.+.+ ..++.++||||||+++++|++|..||.+.+..+....+......                  
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            23346778999999865 45788999999999999999999999887765544433211100                  


Q ss_pred             -CC--------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 -FD--------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 -~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                       .+        ....+.++..+.+||.+||+.+|++||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  277 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC  277 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH
Confidence             00        01124578899999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1e-43  Score=277.35  Aligned_cols=245  Identities=27%  Similarity=0.542  Sum_probs=211.2

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      +|.+.+.||+|++|.||++.+..++..+++|.+..........+.+|+..++.++|++++++.+.+...+..++++|+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            58899999999999999999998899999999876555567889999999999999999999999999999999999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeec
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF  163 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~  163 (251)
                      +++|.+.+......+++..++.++.|++.+|.+||+.|++|+||+|+||++  +.++.++|+|||.+.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL--TSDGEVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE--ccCCeEEEeecccccccccccccccee
Confidence            999998887765579999999999999999999999999999999999999  888999999999997765544234456


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      ++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+..........+ .......++..+.++|.+||+.
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP-GLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCC-CcCcccccCHHHHHHHHHHccC
Confidence            788999999998888899999999999999999999999887655555444432221 1111123488999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      +|++|||+
T Consensus       238 ~p~~R~t~  245 (253)
T cd05122         238 NPEKRPTA  245 (253)
T ss_pred             ChhhCCCH
Confidence            99999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0194|consensus

Probab=100.00  E-value=3.6e-45  Score=298.83  Aligned_cols=245  Identities=25%  Similarity=0.423  Sum_probs=214.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCc---e-EEEEEecc---ccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGM---T-LAAKFVGI---AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~-~~~K~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      ++..+.++||+|+||.||++..+..+.   . ||+|....   .......++.+|++++++++|+||++++|+...+..+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            456677999999999999999875422   3 89998864   2245688899999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++|||+|+||+|.+++..++..++..+...++.+.+.||+|||+.+++||||-.+|+|+  ..++.+|++|||+++....
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~--~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY--SKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee--cCCCeEEeCccccccCCcc
Confidence            99999999999999999988789999999999999999999999999999999999999  8888899999999977542


Q ss_pred             CCcceee-ccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        156 EKKLQVL-FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       156 ~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ....... -.+..|+|||.+....++.++||||+|+++||+++ |..||.+....+..+.+....++...+  ...|..+
T Consensus       315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~~~  392 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPKEL  392 (474)
T ss_pred             eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHHHH
Confidence            2222212 24569999999999999999999999999999999 899999999999999997766665554  4779999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      ..++.+|+..+|+.|||+
T Consensus       393 ~~~~~~c~~~~p~~R~tm  410 (474)
T KOG0194|consen  393 AKVMKQCWKKDPEDRPTM  410 (474)
T ss_pred             HHHHHHhccCChhhccCH
Confidence            999999999999999984

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-44  Score=280.35  Aligned_cols=243  Identities=23%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|++|.||+|.+.. ++.+++|.+.... ...+.+.+|+..+++++|+|++++++++...+..+++||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            4689999999999999999998764 5689999986433 3467788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+++.... ..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++..........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV--GENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE--cCCCCEEECCcceEEEccCCcccc
Confidence            99999999887543 468999999999999999999999999999999999999  889999999999997754221111


Q ss_pred             --eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        161 --VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       161 --~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                        ....+..|+|||.+.+..++.++||||||+++++|++ |+.||.+.+..+....+.... ..  +.....+..+.+++
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li  237 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RM--PCPPGCPKELYDIM  237 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC--CCCCcCCHHHHHHH
Confidence              1112347999999988889999999999999999999 999998887776666654432 22  22256789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.+|++||++
T Consensus       238 ~~~l~~~P~~Rp~~  251 (261)
T cd05068         238 LDCWKEDPDDRPTF  251 (261)
T ss_pred             HHHhhcCcccCCCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.1e-44  Score=316.54  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=202.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l   77 (251)
                      .++|++.+.||.|+||+||+|.+..++..+++|++....  ......+.+|+.+++.++||||+++++++.+  ...+|+
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            368999999999999999999999999999999986432  2346778899999999999999999998854  456899


Q ss_pred             EEEeccCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhC-------CceecCCCCCcEEEeec----------
Q psy11805         78 VLELIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSK-------NVLHLDMKPENILCLTK----------  137 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~-------gi~h~dl~~~nil~~~~----------  137 (251)
                      ||||+++++|.+.+...   ...+++..++.|+.||+.||.|||+.       +|+|+||||+|||+...          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            99999999998888642   34699999999999999999999985       49999999999998321          


Q ss_pred             -----CCCcEEEeecccccccCCCCcceeeccCccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy11805        138 -----TGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF--DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT  210 (251)
Q Consensus       138 -----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  210 (251)
                           ....++|+|||++.............+++.|+|||++.+  ..++.++|||||||+||+|++|..||...+....
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q  251 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ  251 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence                 123589999999977654444445568999999999854  4578899999999999999999999987665554


Q ss_pred             HHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        211 MANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...........+   ....+.++.+||..||+.+|.+||++
T Consensus       252 li~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa  289 (1021)
T PTZ00266        252 LISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSA  289 (1021)
T ss_pred             HHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCH
Confidence            443333222221   14568899999999999999999985

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.3e-44  Score=296.06  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=199.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccC-----CceEEEEEeccccc-cchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT-----GMTLAAKFVGIAKR-NDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+...     +..||+|++..... ...+.+.+|+++++++. ||||+++++++...+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            36788999999999999999987432     34699999864433 23567889999999996 9999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCC-----------------------------------------------------------
Q psy11805         75 MCVVLELIEGGELFERVIDDD-----------------------------------------------------------   95 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-----------------------------------------------------------   95 (251)
                      .++||||+++++|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999988765321                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC
Q psy11805         96 ------------------------------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG  139 (251)
Q Consensus        96 ------------------------------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~  139 (251)
                                                          ..+++..+..++.|++.||.|||+.|++|+||+|+||++  +.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill--~~~  273 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL--AQG  273 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE--eCC
Confidence                                                237788889999999999999999999999999999999  888


Q ss_pred             CcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy11805        140 NRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT  215 (251)
Q Consensus       140 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~  215 (251)
                      +.++|+|||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence            8999999999876532221   122345678999999988889999999999999999997 999998765444333333


Q ss_pred             hccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        216 IAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .......  ....++..+.+++.+||+.+|++|||+
T Consensus       354 ~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~  387 (400)
T cd05105         354 KSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSF  387 (400)
T ss_pred             hcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCH
Confidence            3332222  235688999999999999999999984

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.3e-44  Score=286.49  Aligned_cols=244  Identities=19%  Similarity=0.315  Sum_probs=205.4

Q ss_pred             ccCCcccccccCCceEEEEEEEcc-----CCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .+|.+.+.||.|++|.||++.+..     ++..+++|.+..........+.+|+..+++++|+|++++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            578999999999999999998643     345688888765555556788999999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcE
Q psy11805         78 VLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI  142 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~  142 (251)
                      ||||+++++|.+++...+               ..+++..++.++.|++.||.+||++|++|+||+|+||++  +.++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~--~~~~~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE--ccCCcE
Confidence            999999999999886532               347899999999999999999999999999999999999  888999


Q ss_pred             EEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q psy11805        143 KIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ  218 (251)
Q Consensus       143 ~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  218 (251)
                      +|+|||++........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  242 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR  242 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence            9999999876433221   122335678999999998889999999999999999998 999998887777666654443


Q ss_pred             ccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        219 YDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....   ...+|..+.+++.+||+.+|++|||+
T Consensus       243 ~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~  272 (291)
T cd05094         243 VLER---PRVCPKEVYDIMLGCWQREPQQRLNI  272 (291)
T ss_pred             CCCC---CccCCHHHHHHHHHHcccChhhCcCH
Confidence            3222   24578899999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.9e-44  Score=282.96  Aligned_cols=244  Identities=22%  Similarity=0.299  Sum_probs=202.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCc----eEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGM----TLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||.|+||+||+|.+..++.    .|++|++.... ......+.+|+..++.++|+|++++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            4689999999999999999999876665    47899876433 23466788999999999999999999998754 467


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ++++++++++|.+.+......+++..+..++.|++.||.|||++|++|+||+|+||++  ..++.++|+|||++......
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~--~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE--cCCCcEEECCCCceeecccc
Confidence            8999999999999988766679999999999999999999999999999999999999  88889999999999776433


Q ss_pred             Ccce---eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        157 KKLQ---VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       157 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      ....   ...+++.|+|||...+..++.++||||||+++|+|++ |..||...........+...... +  .....+.+
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~  239 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-P--QPPICTID  239 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-C--CCccCCHH
Confidence            2221   1224568999999988889999999999999999998 99999887766655544433222 1  22567899


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+++.+||+.||++||++
T Consensus       240 ~~~li~~~l~~dp~~Rp~~  258 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRF  258 (279)
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.3e-44  Score=280.92  Aligned_cols=242  Identities=22%  Similarity=0.404  Sum_probs=204.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.++||+|++|.||+|.+. ++..+++|.+... ....+.+.+|+.+++.++|+|++++++.+...+..++++|++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            68999999999999999999865 4567899987543 234678899999999999999999999999999999999999


Q ss_pred             cCCchhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         83 EGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        83 ~~~~L~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      ++++|.+.+.. .+..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.........  
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe--cCCCcEEECCCccceecCCCceecc
Confidence            99999998865 34568999999999999999999999999999999999999  88999999999999765432211  


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....++..|+|||...+..++.++||||||+++|+|++ |..||...+..+....+.... ..  +....+|..+.+++.
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~  238 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RM--PRMENCPDELYDIMK  238 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CC--CCCCCCCHHHHHHHH
Confidence            11224567999999988888999999999999999998 999998877766666654432 22  223568899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       239 ~~l~~~p~~Rp~~  251 (261)
T cd05072         239 TCWKEKAEERPTF  251 (261)
T ss_pred             HHccCCcccCcCH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.7e-44  Score=313.64  Aligned_cols=245  Identities=24%  Similarity=0.311  Sum_probs=201.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+++++.++|||++++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            58999999999999999999999999999999986432   223567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccc
Q psy11805         80 ELIEGGELFERVIDD----------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGL  149 (251)
Q Consensus        80 e~~~~~~L~~~~~~~----------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~  149 (251)
                      ||++|++|.+.+...          ....+...+..++.|++.||.+||+.|++||||||+||++  +.++.++|+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL--d~dg~vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE--cCCCCEEEEecCc
Confidence            999999998887531          1235667889999999999999999999999999999999  8899999999999


Q ss_pred             ccccCCCC-------------------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy11805        150 ARKFDPEK-------------------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT  210 (251)
Q Consensus       150 ~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  210 (251)
                      +.......                   ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+....
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            97652110                   01123589999999999999999999999999999999999999987655443


Q ss_pred             HHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        211 MANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      ........ +........+|+.+.+++.+||+.||++||+
T Consensus       240 ~~~~~i~~-P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s  278 (932)
T PRK13184        240 SYRDVILS-PIEVAPYREIPPFLSQIAMKALAVDPAERYS  278 (932)
T ss_pred             hhhhhccC-hhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence            32211111 1111123578999999999999999999986

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.4e-44  Score=283.30  Aligned_cols=245  Identities=18%  Similarity=0.278  Sum_probs=202.0

Q ss_pred             CccCCcccccccCCceEEEEEEEcc-----CCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      +++|++.+.||.|++|.||.+.+..     ++..+++|.+.... ......+.+|+..++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            5789999999999999999998752     34679999875322 22355688999999999999999999999998999


Q ss_pred             EEEEEeccCCchhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEee
Q psy11805         76 CVVLELIEGGELFERVIDDD---------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                      ++|||++++++|.+++....         ..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~--~~~~~~~l~d  162 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE--cCCCCEEECC
Confidence            99999999999988886532         235778899999999999999999999999999999999  8899999999


Q ss_pred             cccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCC
Q psy11805        147 FGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       147 f~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      ||++.........   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+....... 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-  241 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD-  241 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC-
Confidence            9998654322211   11234678999999988889999999999999999999 789998887766666554443322 


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                        ....++..+.+++.+||+.+|++|||+
T Consensus       242 --~~~~~~~~~~~li~~~l~~~p~~Rps~  268 (277)
T cd05062         242 --KPDNCPDMLFELMRMCWQYNPKMRPSF  268 (277)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence              225678899999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-44  Score=279.19  Aligned_cols=238  Identities=25%  Similarity=0.412  Sum_probs=206.3

Q ss_pred             cccccCCceEEEEEEEccC---CceEEEEEeccccccc-hHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKAT---GMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.+...   +..+++|.+....... ...+.+|+..++.++|+|++++++++......+++||++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999866   8899999986544333 78899999999999999999999999999999999999999


Q ss_pred             CchhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         85 GELFERVIDD--------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        85 ~~L~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ++|.+.+...        ...+++..++.++.|++.||.+||++|++|+||+|+||++  +.++.++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili--~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV--GEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE--CCCCcEEEcccccccccccc
Confidence            9999998775        4679999999999999999999999999999999999999  88899999999999876543


Q ss_pred             C---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        157 K---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      .   ......+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+..+..   ......+|.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  235 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPKPEYCPDE  235 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCccCChH
Confidence            2   2233446779999999988889999999999999999999 6999999887777776665332   2223567899


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+++.+||+.+|++|||+
T Consensus       236 ~~~li~~~l~~~p~~Rps~  254 (262)
T cd00192         236 LYELMLSCWQLDPEDRPTF  254 (262)
T ss_pred             HHHHHHHHccCCcccCcCH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.9e-44  Score=282.07  Aligned_cols=239  Identities=23%  Similarity=0.391  Sum_probs=197.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+.... ......+.+|+..++++.|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            57999999999999999999999999999999986432 22356788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCccee
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV  161 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~  161 (251)
                      +++++|...     ..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++....... ...
T Consensus        81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill--~~~~~~~l~dfg~~~~~~~~~-~~~  152 (279)
T cd06619          81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV--NTRGQVKLCDFGVSTQLVNSI-AKT  152 (279)
T ss_pred             CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE--CCCCCEEEeeCCcceeccccc-ccC
Confidence            999888543     247889999999999999999999999999999999999  889999999999997654322 233


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhccccCCCccccCCCHHHH
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV-------QTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||......       +....+.....  ........+.++.
T Consensus       153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  230 (279)
T cd06619         153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEKFV  230 (279)
T ss_pred             CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCHHHH
Confidence            46788999999999888999999999999999999999999653321       11122111111  1111235788999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      +++.+||+.+|++||++
T Consensus       231 ~li~~~l~~~P~~Rp~~  247 (279)
T cd06619         231 HFITQCMRKQPKERPAP  247 (279)
T ss_pred             HHHHHHhhCChhhCCCH
Confidence            99999999999999984

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-44  Score=294.46  Aligned_cols=244  Identities=25%  Similarity=0.406  Sum_probs=197.2

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC------
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESS------   72 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   72 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|+..+++++|+||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3579999999999999999999999999999999986432  22345677899999999999999999987533      


Q ss_pred             CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         73 NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ...+++++++ +++|.+.+..  ..+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++..
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV--NEDCELRILDFGLARQ  167 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE--CCCCCEEEcCCcccee
Confidence            3478999988 5688776643  359999999999999999999999999999999999999  8899999999999977


Q ss_pred             cCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC---------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD---------  222 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  222 (251)
                      ....  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+........         
T Consensus       168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            5432  233457889999999876 4678899999999999999999999987765554443322111000         


Q ss_pred             ------------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ------------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        ...+...++.+.+||.+||+.||.+|||+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~  292 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA  292 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence                              00122456678999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-43  Score=280.04  Aligned_cols=247  Identities=23%  Similarity=0.415  Sum_probs=208.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||.|++|+||+|....++..+++|++.... ......+.+|+..++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            58999999999999999999998889999999986433 22567889999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         82 IEGGELFERVIDD--DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      +++++|.+.+...  ...+++..++.++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~--~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL--GEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE--cCCCCEEEcccchHHHhccCccc
Confidence            9999999888653  2468999999999999999999999999999999999999  88899999999998765433222


Q ss_pred             -----eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcc--ccCCCH
Q psy11805        160 -----QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC--FNEISD  231 (251)
Q Consensus       160 -----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  231 (251)
                           ....++..|+|||.+... ..+.++|+||||+++++|++|+.||...+..+...+............  +..++.
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence                 233578899999998766 788999999999999999999999988776665555444332211111  236789


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+++.+||+.+|++|||+
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~  258 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTA  258 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            99999999999999999984

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.6e-44  Score=278.54  Aligned_cols=243  Identities=25%  Similarity=0.454  Sum_probs=209.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||.|++|.||+|.+..++..+++|.+....  ......+.+|+..++.++|+|++++++.+..++..++|+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5899999999999999999999999999999986432  23467889999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeecccccccCCCCcc
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~~~~~~~~~~~  159 (251)
                      +++++|.+.+... +..+++..+..++.+++.+|.+||++|++|+||+|+||++  +. ++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~--~~~~~~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEEccCCCceecCCCccc
Confidence            9999999988764 3458999999999999999999999999999999999998  54 446899999999876554444


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....++..|+|||.+.+..++.++||||||+++++|++|..||...+.......+......   .....++..+.+++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~  235 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQLILS  235 (256)
T ss_pred             cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHHHHHHH
Confidence            4456788999999998888899999999999999999999999888776666555443322   2224678999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|.+|||+
T Consensus       236 ~l~~~p~~Rpt~  247 (256)
T cd08220         236 MLNLDPSKRPQL  247 (256)
T ss_pred             HccCChhhCCCH
Confidence            999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-43  Score=279.22  Aligned_cols=245  Identities=26%  Similarity=0.515  Sum_probs=204.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.++...   ......+.+|+..+++++|++++++++.+...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999899999999875422   233678899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         80 ELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ||+++++|.+.+..   ....++...++.++.+++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~--~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI--TATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE--CCCCcEEEeccceeeeccCC
Confidence            99999999888754   23458999999999999999999999999999999999999  88999999999998765432


Q ss_pred             Cc-ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        157 KK-LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET--DVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      .. .....+++.|.|||.+.+..++.++|+||||+++|++++|..||....  ..+....+..+......  ...++..+
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  237 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP--ADHYSEEL  237 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC--hhhcCHHH
Confidence            21 233457889999999988889999999999999999999999996543  22333333332222111  13678899


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .++|.+||..+|++|||+
T Consensus       238 ~~~i~~cl~~~p~~Rp~~  255 (267)
T cd08224         238 RDLVSRCINPDPEKRPDI  255 (267)
T ss_pred             HHHHHHHcCCCcccCCCH
Confidence            999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-44  Score=283.01  Aligned_cols=241  Identities=31%  Similarity=0.504  Sum_probs=207.3

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+....   ....+.+.+|++.+++++|||++++++.+.+....++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999999899999999986433   2346788999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      ++.+++|.+.+... ..+++..+..++.|+++||.+||+.|++|+||+|+||++  +.++.++|+|||.+..........
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~--~~~~~~~l~d~~~~~~~~~~~~~~  157 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL--DEQGHVHITDFNIATKVTPDTLTT  157 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE--cCCCCEEEeecccccccCCCcccc
Confidence            99999998888765 469999999999999999999999999999999999999  889999999999997765443344


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD---VQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ...++..|+|||.+.+..++.++|+||||+++|++++|..||...+.   .+........    .......+|..+.++|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~i  233 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA----DVLYPATWSTEAIDAI  233 (258)
T ss_pred             ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc----cccCcccCcHHHHHHH
Confidence            45678899999999888889999999999999999999999988764   3333322221    2222356789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.+|.+||++
T Consensus       234 ~~~l~~~p~~R~~~  247 (258)
T cd05578         234 NKLLERDPQKRLGD  247 (258)
T ss_pred             HHHccCChhHcCCc
Confidence            99999999999984

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.7e-44  Score=285.97  Aligned_cols=245  Identities=24%  Similarity=0.375  Sum_probs=198.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||.|++|.||+|.+..++..+++|.+.....  .....+.+|+..++.++|+|++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            58999999999999999999999999999999864322  2345678899999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++ +|.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........ ..
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI--NKNGELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--cCCCcEEECccchhhccCCCCCCcC
Confidence            975 7777776656679999999999999999999999999999999999999  8889999999999876543222 12


Q ss_pred             eeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhccccCC----------------
Q psy11805        161 VLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMG-ETDVQTMANVTIAQYDFD----------------  222 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~----------------  222 (251)
                      ...+++.|+|||.+.+. .++.++||||||+++|+|++|..||.. .+..+....+........                
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            33467899999998764 468899999999999999998888544 333333333321110000                


Q ss_pred             ---------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ---------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               ....+.+++++.++|.+||+.||.+|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~  275 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA  275 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH
Confidence                     01123578899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-43  Score=284.10  Aligned_cols=248  Identities=22%  Similarity=0.332  Sum_probs=204.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCC----------------ceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceee
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATG----------------MTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQ   64 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~----------------~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~   64 (251)
                      .++|++.+.||+|+||.||+|.+...+                ..+++|.+..... ...+.+.+|++.+++++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            468999999999999999999876543                4578998764432 34677889999999999999999


Q ss_pred             EeEEEeeCCEEEEEEEeccCCchhHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE
Q psy11805         65 IYDAFESSNVMCVVLELIEGGELFERVIDDD----------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILC  134 (251)
Q Consensus        65 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~  134 (251)
                      +++++..++..++++|++++++|.+++....          ..+++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili  163 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence            9999999999999999999999988886543          258999999999999999999999999999999999999


Q ss_pred             eecCCCcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHH
Q psy11805        135 LTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS--GLSPFMGETDVQ  209 (251)
Q Consensus       135 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~  209 (251)
                        +.++.++|+|||.+........   .....+++.|+|||.+.+..++.++||||||+++|+|++  |..||...+..+
T Consensus       164 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         164 --GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             --cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence              8889999999999876433221   122235668999999988889999999999999999998  788998877766


Q ss_pred             HHHHHHhc----cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        210 TMANVTIA----QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       210 ~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ........    ......+....+|.++.+++.+||+.+|++|||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~  287 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF  287 (296)
T ss_pred             HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence            66555432    1111122234578899999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.5e-44  Score=279.69  Aligned_cols=242  Identities=22%  Similarity=0.363  Sum_probs=201.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.++||+|++|.||+|.+..+ ..+++|.+... ....+.+.+|++.++.++|+|++++++.+.. +..+++||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            36899999999999999999988755 46899988642 2335678999999999999999999998754 557999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-  159 (251)
                      +++++|.+.+... +..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill--~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE--cCCCcEEeccCCceeecccccccc
Confidence            9999999888753 3458999999999999999999999999999999999999  88899999999999765433221 


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       ....++..|+|||...+..++.++||||||+++|++++ |..||......+....+.....   .+....++..+.+++
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li  236 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPESLHDLM  236 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC---CCCccccCHHHHHHH
Confidence             12234568999999988889999999999999999999 8999988877766665543321   122356789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+++|++|||+
T Consensus       237 ~~~l~~~p~~Rp~~  250 (262)
T cd05071         237 CQCWRKEPEERPTF  250 (262)
T ss_pred             HHHccCCcccCCCH
Confidence            99999999999984

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-43  Score=278.37  Aligned_cols=243  Identities=23%  Similarity=0.492  Sum_probs=209.2

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||+|++|.+|++.+..+++.+++|.+....  ......+.+|+..+++++|+|++++.+.+...+..++|+|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            6999999999999999999999999999999986432  23456789999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-c
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-L  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~  159 (251)
                      +++++|.+.+... ...+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++++|||.+........ .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~--~~~~~~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL--TKDGTIKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--cCCCCEEEeeccceeecCcchhhh
Confidence            9999998888654 3358999999999999999999999999999999999999  8889999999999976543221 1


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+...+.++|+||||++++++++|..||...+..+....+..+....   ....++.++.++|.+
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~  235 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNLVSQ  235 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHHHHH
Confidence            23346788999999988889999999999999999999999999887777766665544322   225678999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|++||++
T Consensus       236 ~l~~~p~~Rp~~  247 (256)
T cd08218         236 LFKRNPRDRPSV  247 (256)
T ss_pred             HhhCChhhCcCH
Confidence            999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-43  Score=280.35  Aligned_cols=245  Identities=22%  Similarity=0.447  Sum_probs=202.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeC------CE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESS------NV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~~   74 (251)
                      +++|++.+.||.|+||.||+|.+..+++.+++|.+.... .....+.+|+..++.+ +|+|++++.+.+...      ..
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            467999999999999999999999999999999986433 3456788999999998 699999999998653      46


Q ss_pred             EEEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         75 MCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      .+++||++++++|.+.+... ...+++..+..++.|++.||.|||+.|++|+|++|+||++  +.++.++|+|||++...
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili--~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQL  161 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE--CCCCCEEEccCCCceec
Confidence            89999999999999988764 3468999999999999999999999999999999999999  88999999999998765


Q ss_pred             CCC-CcceeeccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc
Q psy11805        154 DPE-KKLQVLFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       154 ~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      ... .......+++.|+|||.+.     +..++.++||||+|+++|+|++|..||.................+.  ....
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  239 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR--LKSK  239 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC--CCCC
Confidence            432 2223446788999999985     3357789999999999999999999998766555444433322211  1224


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++..+.+|+.+||..+|.+|||+
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rpt~  263 (272)
T cd06637         240 KWSKKFQSFIESCLVKNHSQRPTT  263 (272)
T ss_pred             CcCHHHHHHHHHHcCCChhhCCCH
Confidence            678899999999999999999984

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-43  Score=277.88  Aligned_cols=243  Identities=28%  Similarity=0.488  Sum_probs=206.8

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc-----ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-----RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +|+..+.||+|++|.||+|.+..++..+++|.+....     ......+.+|+..++.++|+|++++.+++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5889999999999999999999889999999986533     22456788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      +||+++++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~--~~~~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEccCccceecccccc
Confidence            99999999988887654 58999999999999999999999999999999999999  8899999999999876544433


Q ss_pred             ceeeccCcccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDA-IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....+++.|++||.+.... ++.++|+||||+++|++++|..||......+.........  .....+..++..+.+++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li  235 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHHHHHHH
Confidence            34455788999999987666 8899999999999999999999998877555554443311  12223356789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.+|.+||++
T Consensus       236 ~~~l~~~p~~Rp~~  249 (258)
T cd06632         236 LKCLQRDPSLRPTA  249 (258)
T ss_pred             HHHhhcCcccCcCH
Confidence            99999999999984

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7e-44  Score=281.45  Aligned_cols=244  Identities=22%  Similarity=0.390  Sum_probs=204.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCc---eEEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGM---TLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||.|++|.||+|.+..+++   .|++|.+... .......+..|+..++.++|||++++.+++..++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            578999999999999999999887664   5999997643 233467899999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      ||++++++|.+++...++.++...++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili--~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE--cCCCcEEECCCccccccccCcc
Confidence            99999999998887766678999999999999999999999999999999999999  8889999999998865433221


Q ss_pred             ceee------ccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        159 LQVL------FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       159 ~~~~------~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ....      ..+..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+... ...  +....+|.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~--~~~~~~~~  238 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRL--PPPMDCPT  238 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcC--CCcccCCH
Confidence            1111      11347999999988889999999999999999886 99999888776666655432 222  22256788


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+++.+||+.+|.+||++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~  258 (269)
T cd05065         239 ALHQLMLDCWQKDRNARPKF  258 (269)
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            99999999999999999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-43  Score=278.41  Aligned_cols=244  Identities=27%  Similarity=0.457  Sum_probs=204.8

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||+|++|.||++.+..+++.+++|.+......  ..+.+.+|+..++.++|+||+++++...+.+..++++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            699999999999999999999988999999998755443  678899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      +++++|.+.+... ..+++..+..++.+++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.........  
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~--~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEcccccccccCCCCCccc
Confidence            9999998887764 358999999999999999999999999999999999999  88999999999998775433221  


Q ss_pred             ---eeeccCcccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccccCCCccccCCCHH
Q psy11805        160 ---QVLFGTPEFVAPEVVNFDA---IGFGTDMWSVGVICYVLLSGLSPFMGETDVQ-TMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       160 ---~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                         ....+++.|+|||.+.+..   .+.++||||||++++++++|..||....... ....+.. ......+.+..++..
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  236 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPE  236 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccCHH
Confidence               1235678999999997766   7889999999999999999999997664333 2323322 222222233456889


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++|++||+.+|++|||+
T Consensus       237 ~~~li~~~l~~~p~~R~~~  255 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTA  255 (264)
T ss_pred             HHHHHHHHccCCcccCCCH
Confidence            9999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-43  Score=285.49  Aligned_cols=245  Identities=21%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|+||.||++.+..++..+++|.+.... ......+.+|++.+++++|+||+++++.+.+++..++++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            57999999999999999999999999999999876432 22356688999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++  +.++.++|+|||.+...... ...
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~-~~~  156 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS-MAN  156 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE--ecCCcEEEccCCCccccccc-ccc
Confidence            9999998888765 468999999999999999999998 599999999999999  88899999999988654322 123


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC-------------------
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF-------------------  221 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------  221 (251)
                      ...+++.|+|||.+.+..++.++|+||||++++++++|..||...+...............                   
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP  236 (308)
T ss_pred             cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence            3457889999999988888999999999999999999999997655433222221110000                   


Q ss_pred             ---------------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 ---------------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                     +......++.++++|+.+||+.+|++|||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  281 (308)
T cd06615         237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL  281 (308)
T ss_pred             hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH
Confidence                           000012367889999999999999999985

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-43  Score=281.82  Aligned_cols=244  Identities=20%  Similarity=0.367  Sum_probs=202.4

Q ss_pred             ccCCcccccccCCceEEEEEEEc----cCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK----ATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      ++|++.+.||+|+||.||+|.+.    .++..+++|.+.... ......+.+|+..++.++|+|++++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            57899999999999999999863    345789999886433 2234678899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhC----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc
Q psy11805         78 VLELIEGGELFERVIDD----------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR  141 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~  141 (251)
                      +|||+++++|.+++...                ...+++..+..++.|++.||.|||++|++|+||+|+||++  +.++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili--~~~~~  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI--GEQLH  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE--cCCCc
Confidence            99999999998887532                1247889999999999999999999999999999999999  88899


Q ss_pred             EEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q psy11805        142 IKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA  217 (251)
Q Consensus       142 ~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  217 (251)
                      ++|+|||++........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+...
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  242 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR  242 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999976532221   122234567999999988889999999999999999998 99999887766666555443


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...   +.+..++..+.+++.+||+.+|++||++
T Consensus       243 ~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~  273 (283)
T cd05090         243 QLL---PCSEDCPPRMYSLMTECWQEGPSRRPRF  273 (283)
T ss_pred             CcC---CCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence            322   2335689999999999999999999984

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-43  Score=279.81  Aligned_cols=244  Identities=21%  Similarity=0.371  Sum_probs=204.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCC---ceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATG---MTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .+|++.+.||+|+||.||+|.+..++   ..+++|.+.... ......+.+|+..++.++||||+++++++..++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            58999999999999999999886544   368888875432 22356789999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      ||++++++|.+++......++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili--~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE--CCCCeEEeCCCCcccccccccc
Confidence            99999999999988766678999999999999999999999999999999999999  8899999999999876543322


Q ss_pred             ce----eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        159 LQ----VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       159 ~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ..    ....+..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+.... ..  +....+|..+
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~  238 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RL--PAPMDCPAAL  238 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cC--CCCCCCCHHH
Confidence            11    1122457999999998889999999999999999886 999998877666665554432 22  2235678999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .+++.+||+.+|.+||++
T Consensus       239 ~~li~~~l~~~p~~Rp~~  256 (267)
T cd05066         239 HQLMLDCWQKDRNERPKF  256 (267)
T ss_pred             HHHHHHHcccCchhCCCH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-43  Score=281.50  Aligned_cols=245  Identities=19%  Similarity=0.317  Sum_probs=194.9

Q ss_pred             CCccC-CcccccccCCceEEEEEEE----ccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEee--C
Q psy11805          1 MTTHQ-NQHSAFSFGKFGTVYRCKE----KATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFES--S   72 (251)
Q Consensus         1 ~~~~y-~~~~~lg~g~~~~v~~~~~----~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   72 (251)
                      +.++| ++.+.||.|+||+||++..    ..++..+++|.+..... .....+.+|++.+++++|+|++++++++..  .
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             CChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            35677 9999999999999988653    34677899999864332 245678899999999999999999998765  3


Q ss_pred             CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         73 NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ...+++||++++++|.+.+...  .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++..
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~~l~dfg~~~~  156 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL--DNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE--cCCCcEEEeecccccc
Confidence            4689999999999998888664  49999999999999999999999999999999999999  8889999999999876


Q ss_pred             cCCCCcc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHH
Q psy11805        153 FDPEKKL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ--------------TMANV  214 (251)
Q Consensus       153 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~  214 (251)
                      .......    ....++..|+|||.+.+..++.++||||||+++++|++|..||.......              .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            5432211    11234557999999988889999999999999999999999986543210              00001


Q ss_pred             HhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....  ...+....++..+.+++.+||+++|++|||+
T Consensus       237 ~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~  271 (283)
T cd05080         237 LERG--MRLPCPKNCPQEVYILMKNCWETEAKFRPTF  271 (283)
T ss_pred             hhcC--CCCCCCCCCCHHHHHHHHHHhccChhhCCCH
Confidence            0111  1112235678999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.4e-43  Score=277.13  Aligned_cols=242  Identities=23%  Similarity=0.380  Sum_probs=201.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|++|.||+|.+. ++..+++|.+.... .....+.+|+..+++++|++++++++++. .+..+++||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            468999999999999999999776 45678999876433 24567899999999999999999999875 4558899999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-  159 (251)
                      +++++|.+.+... ...+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili--~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV--GDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE--eCCceEEeCCceeeeeccCccccc
Confidence            9999999988753 3458999999999999999999999999999999999999  88889999999999765332211 


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+....   ..+.....+..+.+++
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li  236 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---RMPCPQDCPISLHELM  236 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCcCCHHHHHHH
Confidence             11224557999999988889999999999999999999 999998887777666664432   1223356789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||.++|++|||+
T Consensus       237 ~~~l~~~p~~Rpt~  250 (260)
T cd05070         237 LQCWKKDPEERPTF  250 (260)
T ss_pred             HHHcccCcccCcCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-44  Score=292.35  Aligned_cols=240  Identities=22%  Similarity=0.313  Sum_probs=192.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      .+|++.+.||+|+||.||+|.+..+++.|++|+...      .....|+.++++++|+||+++++++...+..++|++++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            469999999999999999999998899999998432      22356899999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL  162 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~  162 (251)
                      .+ +|.+.+......+++..++.++.|++.||.|||+.|++||||||+||++  +.++.++|+|||.+............
T Consensus       140 ~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~~~~~  216 (357)
T PHA03209        140 SS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI--NDVDQVCIGDLGAAQFPVVAPAFLGL  216 (357)
T ss_pred             CC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEEecCccccccccCcccccc
Confidence            65 7878887766679999999999999999999999999999999999999  88999999999999754433333445


Q ss_pred             ccCcccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChH---------HHHHHHHhccc----cCC------
Q psy11805        163 FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSG-LSPFMGETDV---------QTMANVTIAQY----DFD------  222 (251)
Q Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~---------~~~~~~~~~~~----~~~------  222 (251)
                      .+++.|+|||.+.+..++.++||||||+++|+|+++ ..+|......         ..+..+.....    .++      
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  296 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR  296 (357)
T ss_pred             cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence            688999999999988999999999999999999985 4444432211         11111111000    000      


Q ss_pred             --------------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 --------------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                          ......++.++.+||.+||+.||++|||+
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta  345 (357)
T PHA03209        297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA  345 (357)
T ss_pred             HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH
Confidence                                00012457788899999999999999985

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-43  Score=280.64  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=201.7

Q ss_pred             CccCCcccccccCCceEEEEEEEcc-----CCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      +++|.+.+.||.|++|.||+|.+..     ++..+++|.+..... .....+.+|+..++.++|+|++++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            3679999999999999999999987     678899998754332 2345688899999999999999999999888889


Q ss_pred             EEEEEeccCCchhHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeecc
Q psy11805         76 CVVLELIEGGELFERVIDDD------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFG  148 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~  148 (251)
                      +++||++++++|.+.+....      ..+++..+..++.|++.||.+||+.|++|+||+|+||++.+.. ...++|+|||
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence            99999999999998886543      2589999999999999999999999999999999999983222 2368999999


Q ss_pred             cccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        149 LARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       149 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                      ++.........   .....+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.....   ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~  241 (277)
T cd05036         165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR---LD  241 (277)
T ss_pred             cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc---CC
Confidence            99765322111   11223457999999988889999999999999999997 9999998877666555443321   12


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....+|..+.+++.+||+.+|++|||+
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~  268 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPNF  268 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            235678999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.8e-43  Score=280.32  Aligned_cols=242  Identities=22%  Similarity=0.439  Sum_probs=205.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ..|+..+.||.|++|.||.|.+..++..+++|.+.... ......+.+|+..++++.|+|++++++.+.++...++|||+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            57899999999999999999999889999999986433 23467788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++++|.+.+...  .+++..+..++.|++.||.+||+.+++|+||+|+||++  +.++.++++|||.+........ ..
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE--cCCCCEEEcccccceeccCCccccc
Confidence            9999998887653  58999999999999999999999999999999999999  8889999999999866543221 22


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...++..|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+....   .......++..+.+++.+|
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHHHHHH
Confidence            3346778999999988889999999999999999999999998877655554432222   1222345788999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.+|++||++
T Consensus       237 l~~~p~~Rp~~  247 (277)
T cd06640         237 LNKDPSFRPTA  247 (277)
T ss_pred             cccCcccCcCH
Confidence            99999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-43  Score=275.85  Aligned_cols=239  Identities=22%  Similarity=0.348  Sum_probs=204.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||.|++|.||+|...  ++.+++|.+..... ....+.+|+..++.++|+|++++++++.+.+..+++||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            68999999999999999999876  77899999865433 5678899999999999999999999999888999999999


Q ss_pred             cCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCccee
Q psy11805         83 EGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~  161 (251)
                      ++++|.+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili--~~~~~~~l~d~g~~~~~~~~~~--~  158 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV--SEDLVAKVSDFGLAKEASQGQD--S  158 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE--eCCCCEEEcccccccccccccc--c
Confidence            9999999887543 358999999999999999999999999999999999999  8899999999999977633222  2


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+..|+|||.+.+..++.++||||||++++++++ |..||...+..+....+..... .  .....+|+.+.++|++|
T Consensus       159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~  235 (256)
T cd05039         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-M--EAPEGCPPEVYKVMKDC  235 (256)
T ss_pred             CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCCHHHHHHHHHH
Confidence            234567999999988888999999999999999997 9999988877666655544322 1  22256789999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |..+|++|||+
T Consensus       236 l~~~p~~Rp~~  246 (256)
T cd05039         236 WELDPAKRPTF  246 (256)
T ss_pred             hccChhhCcCH
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.6e-44  Score=282.66  Aligned_cols=244  Identities=20%  Similarity=0.331  Sum_probs=203.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccC-----CceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKAT-----GMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .+|++.+.||.|+||.||++.+..+     ++.+++|++...... ....+.+|+..+..++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            4689999999999999999987543     578999998643322 2466889999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc
Q psy11805         77 VVLELIEGGELFERVIDD---------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR  141 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~  141 (251)
                      +++|++++++|.+++...               ...++...+..++.|++.||.+||+.|++|+||||+||++  +.++.
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~--~~~~~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDKLN  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe--cCCCc
Confidence            999999999998887421               2347888999999999999999999999999999999999  78889


Q ss_pred             EEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q psy11805        142 IKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA  217 (251)
Q Consensus       142 ~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  217 (251)
                      ++|+|||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+...
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR  242 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999876432221   122335678999999988889999999999999999998 88999888777777766655


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....   ....++..+.+++.+||+.+|.+||++
T Consensus       243 ~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~  273 (283)
T cd05091         243 QVLP---CPDDCPAWVYTLMLECWNEFPSRRPRF  273 (283)
T ss_pred             CcCC---CCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence            4322   235789999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-43  Score=277.09  Aligned_cols=243  Identities=26%  Similarity=0.479  Sum_probs=208.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+..... .....+.+|+..+..++|+|++++++.+...+..++++|+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            579999999999999999999999999999999865443 3467899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-  159 (251)
                      +++++|.+.+... ..+++..++.++.|++.|+.+||+ .|++|+||+|+||++  +.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~--~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI--NSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE--CCCCCEEEccCccceecccCCCcc
Confidence            9999999988765 469999999999999999999999 999999999999999  88999999999998776443332 


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccccCCCccccC-CCHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET---DVQTMANVTIAQYDFDDECFNE-ISDDAKD  235 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  235 (251)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....   ..+....+.....   ...... ++..+.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~  234 (264)
T cd06623         158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---PSLPAEEFSPEFRD  234 (264)
T ss_pred             cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---CCCCcccCCHHHHH
Confidence            24457789999999988888999999999999999999999998774   3333433332221   122234 7899999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|.+||.++|++||++
T Consensus       235 li~~~l~~~p~~R~~~  250 (264)
T cd06623         235 FISACLQKDPKKRPSA  250 (264)
T ss_pred             HHHHHccCChhhCCCH
Confidence            9999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.3e-43  Score=276.98  Aligned_cols=243  Identities=26%  Similarity=0.473  Sum_probs=202.4

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc------ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK------RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      +|++.+.||.|+||.||++.+. ++..+++|.+....      ......+.+|++.++.++|+|++++.+++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            6899999999999999999864 67889999875432      1224668899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-  156 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-  156 (251)
                      ++|++++++|.+.+...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... 
T Consensus        80 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          80 FMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE--CCCCeEEeccchhhHhhhhcc
Confidence            999999999998887654 58999999999999999999999999999999999999  88999999999988754211 


Q ss_pred             ------CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCC
Q psy11805        157 ------KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEIS  230 (251)
Q Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (251)
                            .......++..|+|||.+.+..++.++|+||||++++++++|..||...+..+....+..... ........++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  235 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG-LMPRLPDSFS  235 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-CCCCCCCCCC
Confidence                  111233577899999999888889999999999999999999999988766554433332211 1222335688


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.++|++||+.+|.+||++
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~  256 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSA  256 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCH
Confidence            999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-43  Score=277.03  Aligned_cols=243  Identities=23%  Similarity=0.369  Sum_probs=205.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|++|.||+|.+. +++.+++|.+... ....+.+.+|+..++.++|+|++++++++......+++||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            478999999999999999999876 4578999988643 33467889999999999999999999999988899999999


Q ss_pred             ccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-
Q psy11805         82 IEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-  159 (251)
                      +++++|.+.+.... ..++...+..++.+++.|+.+||++|++|+||+|+||++  +.++.++|+|||.+......... 
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV--GENLVCKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE--cCCCCEEECccccceeccchhhhh
Confidence            99999999887643 468999999999999999999999999999999999999  88899999999998765432111 


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       .....+..|+|||.+.+..++.++|+||||++++++++ |+.||...+.......+.....   .+.....|..+.+++
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i  237 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR---MPRPPNCPEELYDLM  237 (261)
T ss_pred             hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHH
Confidence             11223468999999998889999999999999999998 9999988887777766654322   122245688999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.+|++||++
T Consensus       238 ~~~l~~~p~~Rp~~  251 (261)
T cd05034         238 LQCWDKDPEERPTF  251 (261)
T ss_pred             HHHcccCcccCCCH
Confidence            99999999999984

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-43  Score=280.10  Aligned_cols=238  Identities=28%  Similarity=0.476  Sum_probs=198.1

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      ||+|+||+||+|.+..+++.+++|.+....   ......+.+|+.+++.++|+|++++.+.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999999999999999985422   22345567899999999999999999999999999999999999999


Q ss_pred             hHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCc
Q psy11805         88 FERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP  166 (251)
Q Consensus        88 ~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  166 (251)
                      .+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL--DDHGNVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--CCCCCEEEccCcchhhhccCCccccccCCC
Confidence            88886643 358999999999999999999999999999999999999  889999999999987654433334445778


Q ss_pred             ccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcC
Q psy11805        167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE  246 (251)
Q Consensus       167 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  246 (251)
                      .|+|||.+.+..++.++||||||+++++|++|+.||...........+..............+++.+.++|++||+.+|+
T Consensus       159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (277)
T cd05577         159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE  238 (277)
T ss_pred             CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence            99999999888899999999999999999999999987654222222222222223333456799999999999999999


Q ss_pred             CCCC
Q psy11805        247 DAPE  250 (251)
Q Consensus       247 ~Rps  250 (251)
                      +||+
T Consensus       239 ~R~~  242 (277)
T cd05577         239 KRLG  242 (277)
T ss_pred             HccC
Confidence            9995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-43  Score=277.31  Aligned_cols=243  Identities=26%  Similarity=0.468  Sum_probs=208.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVMCVVL   79 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~   79 (251)
                      +|++.+.||.|++|.||+|.+..++..+++|.+....  ....+.+.+|++.++.++|+|++++++.+..  ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5899999999999999999999999999999886432  3345678899999999999999999997753  45689999


Q ss_pred             EeccCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHh-----hCCceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         80 ELIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIH-----SKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        80 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh-----~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      |++++++|.+.+...   ...+++..++.++.|++.||.+||     +.+++|+||+|+||++  +.++.++|+|||.+.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili--~~~~~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL--DANNNVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE--ecCCCEEEecccccc
Confidence            999999998888653   457899999999999999999999     9999999999999999  888999999999998


Q ss_pred             ccCCCCc-ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCC
Q psy11805        152 KFDPEKK-LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEIS  230 (251)
Q Consensus       152 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (251)
                      ....... .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+..+..+.   ....++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~  235 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPYRYS  235 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---CccccC
Confidence            7654443 334467889999999988888999999999999999999999999887666666665544322   224678


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.+++.+||+.+|++||++
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~  256 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPST  256 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCH
Confidence            999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.8e-44  Score=300.67  Aligned_cols=243  Identities=24%  Similarity=0.354  Sum_probs=190.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC------CCceeeEeEEEeeC-CE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ------HPRLIQIYDAFESS-NV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~-~~   74 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++... .........|+.+++.++      +.+++.+.+++..+ +.
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            36799999999999999999999999999999998532 223445566777777764      44688999988754 56


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCC-------------
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGN-------------  140 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~-------------  140 (251)
                      .++||+++ +++|.+.+...+ .+++..+..++.|++.||.|||+ .||+||||||+|||+  +.++             
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl--~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILM--ETSDTVVDPVTNRALPP  282 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE--ecCCcccccccccccCC
Confidence            89999988 567878776653 69999999999999999999998 599999999999998  4443             


Q ss_pred             ---cEEEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q psy11805        141 ---RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIA  217 (251)
Q Consensus       141 ---~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  217 (251)
                         .++|+|||.+.....  ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus       283 ~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~  360 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT  360 (467)
T ss_pred             CCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence               599999998865322  223456899999999999999999999999999999999999999887766555443222


Q ss_pred             cccCCCccc--------------------------------------cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECF--------------------------------------NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~--------------------------------------~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...++..+.                                      ...++.+.+||.+||+.||++|||+
T Consensus       361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            111110000                                      0113567899999999999999985

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-43  Score=283.97  Aligned_cols=243  Identities=26%  Similarity=0.497  Sum_probs=206.8

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      -|.....||+|+||.||++.+..++..+++|.+........+.+.+|+..++.+.|+|++++++.+..++..++++|+++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            45567789999999999999998999999999866555556778899999999999999999999999999999999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cceee
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVL  162 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~~~  162 (251)
                      +++|...+..  ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++....... .....
T Consensus       102 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill--~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659         102 GGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE--ccCCcEEEeechhHhhcccccccccce
Confidence            9999887654  358999999999999999999999999999999999999  889999999999986543322 12334


Q ss_pred             ccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcc
Q psy11805        163 FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL  242 (251)
Q Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (251)
                      .++..|+|||.+.+..++.++||||||+++++|++|+.||...+..+....+..... .....+..++..+.++|++||+
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~  256 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNAHKISPVLRDFLERMLT  256 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-CCccccCCCCHHHHHHHHHHhc
Confidence            578899999999888899999999999999999999999988777666655543322 1222235678899999999999


Q ss_pred             cCcCCCCCC
Q psy11805        243 KDREDAPEV  251 (251)
Q Consensus       243 ~~p~~Rps~  251 (251)
                      .+|++||++
T Consensus       257 ~~P~~Rps~  265 (297)
T cd06659         257 REPQERATA  265 (297)
T ss_pred             CCcccCcCH
Confidence            999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.6e-43  Score=276.88  Aligned_cols=242  Identities=24%  Similarity=0.393  Sum_probs=203.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.++||+|+||.||+|... +++.+++|.+... ......+.+|+..+++++|+|++++++++. .+..+++||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            478999999999999999999865 5678999987543 334678889999999999999999999875 4568999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-  159 (251)
                      +++++|.+.+... +..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV--SETLCCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE--cCCCCEEEccCcceeecCCCCccc
Confidence            9999998887653 3468999999999999999999999999999999999999  88999999999999765422211 


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       ....++..|+|||.+.+..++.++||||||++++++++ |+.||...+..+....+.....   .+.....|.++.+++
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li  236 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNCPEELYELM  236 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCHHHHHHH
Confidence             12234568999999988889999999999999999998 9999998887777666644322   223356789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.+|++||++
T Consensus       237 ~~~l~~~p~~Rp~~  250 (260)
T cd05067         237 RLCWKEKPEERPTF  250 (260)
T ss_pred             HHHccCChhhCCCH
Confidence            99999999999984

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.1e-43  Score=283.15  Aligned_cols=246  Identities=23%  Similarity=0.361  Sum_probs=202.3

Q ss_pred             CccCCcccccccCCceEEEEEEEc-----cCCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   74 (251)
                      .++|.+.+.||.|+||.||++.+.     .++..+++|.+.... ....+.+.+|+..++++ +|+||+++++.+...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357899999999999999999863     345679999876443 23356788999999999 79999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         75 MCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      .+++|||+++++|.+.+.... ..+++.++..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||.+...
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDI  191 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE--cCCCeEEECCCcccccc
Confidence            999999999999999887543 348999999999999999999999999999999999999  88889999999998764


Q ss_pred             CCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCC
Q psy11805        154 DPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       154 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (251)
                      ......   ....++..|+|||.+.+..++.++||||+|+++|++++ |..||......+.............  .....
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  269 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--QPEHA  269 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--CCCCC
Confidence            332211   11234568999999988889999999999999999998 9999987766555444433333222  22457


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+.+++.+||+++|++|||+
T Consensus       270 ~~~~~~li~~cl~~~p~~Rpt~  291 (302)
T cd05055         270 PAEIYDIMKTCWDADPLKRPTF  291 (302)
T ss_pred             CHHHHHHHHHHcCCCchhCcCH
Confidence            8899999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.8e-43  Score=277.82  Aligned_cols=245  Identities=21%  Similarity=0.360  Sum_probs=205.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCc---eEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGM---TLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|+..+.||+|++|.||+|.+..++.   .+++|.+.... ....+.+.+|+..++.++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3678999999999999999999876554   68888875432 3346678899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      +||++++++|.+.+......+++..+..++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||.+.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV--NSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE--cCCCcEEECCCccceeccccc
Confidence            999999999999887766679999999999999999999999999999999999999  888999999999987653322


Q ss_pred             cce----eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        158 KLQ----VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       158 ~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      ...    ....+..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+.... .  .+.....+..
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~--~~~~~~~~~~  238 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-R--LPAPMDCPSA  238 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-C--CCCCCCCCHH
Confidence            111    1123457999999988888999999999999999997 999998887777666665432 2  2222467899


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+++.+||+.+|++||++
T Consensus       239 ~~~li~~c~~~~p~~Rp~~  257 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRF  257 (268)
T ss_pred             HHHHHHHHcCCCcccCcCH
Confidence            9999999999999999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-43  Score=282.08  Aligned_cols=246  Identities=27%  Similarity=0.408  Sum_probs=201.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESS--NVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv   78 (251)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+......  ....+.+|+..+++++|+|++++.+++...  +..+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            5799999999999999999999989999999998644322  234567899999999999999999998877  889999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-C
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-K  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~  157 (251)
                      +|++++ +|.+.+......+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||.+...... .
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE--CCCCcEEEeecCceeeccCCcc
Confidence            999975 8888877665579999999999999999999999999999999999999  88999999999998775443 2


Q ss_pred             cceeeccCcccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC--------------
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDA-IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD--------------  222 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  222 (251)
                      ......+++.|+|||.+.+.. .+.++|+||||+++++|++|..||...+..+...++........              
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            223345678899999986543 58899999999999999999999998877665554432111000              


Q ss_pred             ------------CccccC--CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ------------DECFNE--ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ------------~~~~~~--~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                  ....+.  +++.+.++|++||+.+|++|||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~  284 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA  284 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence                        001111  58889999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.3e-43  Score=279.22  Aligned_cols=244  Identities=27%  Similarity=0.504  Sum_probs=207.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      .+|.-.+.||.|++|.||++.+..++..+++|.+........+.+.+|+..++.+.|+|++++++++...+..++++|++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            35677789999999999999999889999999986555555667889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-cee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~~  161 (251)
                      ++++|.+.+..  ..++...+..++.|++.||++||+.|++|+||+|+||++  +.++.++|+|||.+........ ...
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL--TSDGRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE--cCCCcEEEcccccchhhccCCccccc
Confidence            99999888776  358999999999999999999999999999999999999  8899999999998765433221 223


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhc
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL  241 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (251)
                      ..+++.|+|||.+.+..++.++||||+|+++++|++|..||...+..+....+.....+.. .....++..+.+++++||
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l  253 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSFLDRML  253 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHHHHHHc
Confidence            4578899999999888899999999999999999999999988777666665554422221 112347889999999999


Q ss_pred             ccCcCCCCCC
Q psy11805        242 LKDREDAPEV  251 (251)
Q Consensus       242 ~~~p~~Rps~  251 (251)
                      +.+|++||++
T Consensus       254 ~~~p~~Rpt~  263 (285)
T cd06648         254 VRDPAQRATA  263 (285)
T ss_pred             ccChhhCcCH
Confidence            9999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=280.83  Aligned_cols=246  Identities=23%  Similarity=0.354  Sum_probs=197.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|++|.||++.++.+++.|++|.+...... ....+.+|+++++.++|+||+++.+++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            6899999999999999999999989999999998643322 245567899999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++ +|.+.+...+..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........ ..
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~~~~  161 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYS  161 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE--cCCCCEEECccccccccCCCCcccc
Confidence            986 8888887666678999999999999999999999999999999999999  8899999999999865432211 12


Q ss_pred             eeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccccC-----------------
Q psy11805        161 VLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGET-DVQTMANVTIAQYDF-----------------  221 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~-----------------  221 (251)
                      ...++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+ ..+....+.......                 
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY  241 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence            2245778999999865 457889999999999999999999997765 222222221100000                 


Q ss_pred             ---------CCccccCCC--HHHHHHHHHhcccCcCCCCCC
Q psy11805        222 ---------DDECFNEIS--DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ---------~~~~~~~~~--~~~~~li~~~l~~~p~~Rps~  251 (251)
                               .......++  ..+.+++.+||+.+|++|||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~  282 (291)
T cd07844         242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA  282 (291)
T ss_pred             cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH
Confidence                     000111334  788999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-43  Score=279.58  Aligned_cols=244  Identities=22%  Similarity=0.418  Sum_probs=204.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+.... ......+.+|++.++.++|+|++++++.+..++..++++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            57999999999999999999999999999999986543 23456788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+.+......+++..+..++.|++.||.+||+ .|++|+||+|+||++  +.++.++|+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~--~~~~~~~l~d~g~~~~~~~~~~~~  158 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV--NSRGQIKLCDFGVSGQLVNSLAKT  158 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE--CCCCCEEEeecccchhhHHHHhhc
Confidence            99999999887765679999999999999999999999 999999999999999  889999999999986653222212


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET-----DVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                       ..++..|+|||.+.+..++.++||||||++++++++|..||....     ..+....+.....+ ..+ ...++..+.+
T Consensus       159 -~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~  235 (265)
T cd06605         159 -FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP-RLP-SGKFSPDFQD  235 (265)
T ss_pred             -ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC-CCC-hhhcCHHHHH
Confidence             567889999999988899999999999999999999999997652     22223332222111 111 1127889999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|.+||..+|++|||+
T Consensus       236 li~~~l~~~p~~Rpt~  251 (265)
T cd06605         236 FVNLCLIKDPRERPSY  251 (265)
T ss_pred             HHHHHcCCCchhCcCH
Confidence            9999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-43  Score=288.36  Aligned_cols=246  Identities=21%  Similarity=0.316  Sum_probs=196.8

Q ss_pred             CccCCcccccccCCceEEEEEEEcc-----CCceEEEEEeccccc-cchHHHHHHHHHHHHc-CCCceeeEeEEEee-CC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAKR-NDRRNVEREVEIMREL-QHPRLIQIYDAFES-SN   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~   73 (251)
                      .++|++.+.||.|+||.||+|.+..     +++.|++|++..... .....+.+|+..++++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            3689999999999999999997543     357899999864332 2345678899999999 79999999998764 45


Q ss_pred             EEEEEEEeccCCchhHHHhhCC----------------------------------------------------------
Q psy11805         74 VMCVVLELIEGGELFERVIDDD----------------------------------------------------------   95 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~----------------------------------------------------------   95 (251)
                      ..++++||+++++|.+.+....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6889999999999988875421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc---ceeeccCccccc
Q psy11805         96 --FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVA  170 (251)
Q Consensus        96 --~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~a  170 (251)
                        ..+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++........   .....++..|+|
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill--~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE--eCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence              257899999999999999999999999999999999999  7889999999999976532211   122234568999


Q ss_pred             ccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       171 PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      ||.+.+..++.++||||||+++++|++ |..||......+..............  ....+.++.+++.+||+.+|++||
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChhhCc
Confidence            999999999999999999999999998 99999875543433332222222221  245788999999999999999999


Q ss_pred             CC
Q psy11805        250 EV  251 (251)
Q Consensus       250 s~  251 (251)
                      ++
T Consensus       322 s~  323 (337)
T cd05054         322 TF  323 (337)
T ss_pred             CH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.9e-43  Score=275.26  Aligned_cols=242  Identities=24%  Similarity=0.394  Sum_probs=207.5

Q ss_pred             CCcccccccCCceEEEEEEEccCC----ceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATG----MTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +++.+.||.|+||.||++.+..++    ..+++|.+...... ....+.+|+..++.++|+|++++++.+.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999998766    88999998654433 5778999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~-~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |++++++|.+.+...... +++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~--~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV--GENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE--ccCCeEEEcccCCceecccccc
Confidence            999999999988765444 8999999999999999999999999999999999999  8889999999999977644322


Q ss_pred             ce--eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        159 LQ--VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       159 ~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      ..  ...+++.|+|||.+.+..++.++|+||||+++++|++ |..||...+.....+.+........   ...++.++.+
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  235 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPEIYK  235 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHHHH
Confidence            11  1235679999999988888999999999999999998 8999988877777776655543322   2457999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      ++.+||..+|++|||+
T Consensus       236 ~i~~~l~~~p~~Rpt~  251 (258)
T smart00219      236 LMLQCWAEDPEDRPTF  251 (258)
T ss_pred             HHHHHCcCChhhCcCH
Confidence            9999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.7e-43  Score=274.99  Aligned_cols=235  Identities=23%  Similarity=0.407  Sum_probs=195.4

Q ss_pred             ccccCCceEEEEEEE--ccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805         10 AFSFGKFGTVYRCKE--KATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus        10 ~lg~g~~~~v~~~~~--~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      .||+|+||.||+|.+  ..++..+++|++......  ..+.+.+|+..++.+.|+||+++++++.. +..+++||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999965  456789999997643322  35678899999999999999999998864 4568999999999


Q ss_pred             chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc----ee
Q psy11805         86 ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL----QV  161 (251)
Q Consensus        86 ~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~----~~  161 (251)
                      +|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.........    ..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE--cCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9988886543 68999999999999999999999999999999999999  88899999999999765433221    11


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..+...   +....++.++.++|.+|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~  234 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM---ECPQRCPPEMYDLMKLC  234 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHHHHHHHHH
Confidence            223468999999988888999999999999999998 99999888777776666554321   22356899999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.||++||++
T Consensus       235 ~~~~p~~Rp~~  245 (257)
T cd05116         235 WTYGVDERPGF  245 (257)
T ss_pred             hccCchhCcCH
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.4e-43  Score=274.65  Aligned_cols=236  Identities=24%  Similarity=0.415  Sum_probs=196.1

Q ss_pred             ccccCCceEEEEEEEc--cCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCc
Q psy11805         10 AFSFGKFGTVYRCKEK--ATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGE   86 (251)
Q Consensus        10 ~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   86 (251)
                      .||+|+||.||++.+.  .++..+++|+....... ..+.+.+|+..+++++|+||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999875  34557899987644322 35678899999999999999999998864 46789999999999


Q ss_pred             hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce----ee
Q psy11805         87 LFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ----VL  162 (251)
Q Consensus        87 L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~----~~  162 (251)
                      |.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+..........    ..
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL--VNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE--cCCCcEEeccCCccccccCCccceeccCCC
Confidence            999887666679999999999999999999999999999999999999  888999999999987654332211    11


Q ss_pred             ccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhc
Q psy11805        163 FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL  241 (251)
Q Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (251)
                      .++..|+|||.+.+..++.++||||||+++|++++ |..||......+....+..+..   .......+.++.++|.+||
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~c~  235 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR---LDCPAECPPEMYALMKDCW  235 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHHHHHc
Confidence            22468999999988888999999999999999996 9999998887776666655432   2233567899999999999


Q ss_pred             ccCcCCCCCC
Q psy11805        242 LKDREDAPEV  251 (251)
Q Consensus       242 ~~~p~~Rps~  251 (251)
                      ..+|++||++
T Consensus       236 ~~~~~~Rp~~  245 (257)
T cd05115         236 IYKWEDRPNF  245 (257)
T ss_pred             CCChhhCcCH
Confidence            9999999984

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.3e-43  Score=279.73  Aligned_cols=246  Identities=24%  Similarity=0.368  Sum_probs=197.6

Q ss_pred             CccCCcccccccCCceEEEEEEE----ccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKE----KATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   75 (251)
                      .++|++.+.||+|+||.||.+..    ..++..+++|.+........+.+.+|++.++.++|+|++++.+++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            36899999999999999999974    45678999999876555556788999999999999999999998643  3468


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++|+||+++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili--~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV--ESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE--CCCCeEEECCCcccccccC
Confidence            99999999999999887766678999999999999999999999999999999999999  8889999999999987543


Q ss_pred             CCcc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH---------------HHHHHh
Q psy11805        156 EKKL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT---------------MANVTI  216 (251)
Q Consensus       156 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------------~~~~~~  216 (251)
                      ....    .....+..|+|||.+.+..++.++||||||+++++|++|..++........               ......
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3221    111233469999999888899999999999999999998777644322110               011111


Q ss_pred             ccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....  .+....++..+.+|+.+||+.+|++|||+
T Consensus       241 ~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  273 (284)
T cd05081         241 NNGR--LPAPPGCPAEIYAIMKECWNNDPSQRPSF  273 (284)
T ss_pred             cCCc--CCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            1111  12225678899999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-43  Score=279.52  Aligned_cols=245  Identities=19%  Similarity=0.292  Sum_probs=203.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccC-----CceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT-----GMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||++.+...     +..+++|.+.... ......+.+|+..++.++|+|++++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            47899999999999999999998643     3789999975432 23356788999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEee
Q psy11805         76 CVVLELIEGGELFERVIDDD---------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                      +++||++++++|.+++....         ..+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill--~~~~~~kl~d  162 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV--AEDLTVKIGD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE--cCCCCEEECC
Confidence            99999999999998886422         246888999999999999999999999999999999999  8899999999


Q ss_pred             cccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCC
Q psy11805        147 FGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       147 f~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      ||.+........   .....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+..... ..
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~  241 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH-LD  241 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC-CC
Confidence            999876433221   122335678999999988889999999999999999998 9999988877776665553322 11


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                        ....++..+.+++.+||+.+|++|||+
T Consensus       242 --~~~~~~~~~~~li~~~l~~~p~~Rpt~  268 (277)
T cd05032         242 --LPENCPDKLLELMRMCWQYNPKMRPTF  268 (277)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence              224568999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.2e-43  Score=275.85  Aligned_cols=238  Identities=24%  Similarity=0.394  Sum_probs=200.8

Q ss_pred             cccccCCceEEEEEEEcc-CC--ceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKA-TG--MTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~-~~--~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|++|.||+|.+.. .+  ..+++|.+..... ...+.+.+|+..+++++|+|++++++.+.. ...++++|++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 33  3689999876554 457789999999999999999999999988 889999999999


Q ss_pred             CchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc----
Q psy11805         85 GELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL----  159 (251)
Q Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~----  159 (251)
                      ++|.+.+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.........    
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE--ecCCEEEeccccccccccccccceecc
Confidence            99999887754 568999999999999999999999999999999999999  88899999999998775432111    


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....++..|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+........  .....|..+.+++.
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~  235 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIYNVML  235 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHHHHHH
Confidence            12335678999999988889999999999999999998 9999988877776666654332222  22467899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       236 ~~l~~~p~~Rps~  248 (257)
T cd05040         236 QCWAHNPADRPTF  248 (257)
T ss_pred             HHCCCCcccCCCH
Confidence            9999999999984

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.3e-43  Score=274.82  Aligned_cols=243  Identities=27%  Similarity=0.574  Sum_probs=211.8

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||.|++|.||++.+..++..+++|.+.....  .....+.+|++.++.++|+|++++.+.+...+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            68999999999999999999998999999999865443  4577889999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-
Q psy11805         82 IEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-  157 (251)
Q Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-  157 (251)
                      +++++|.+.+...   +..++...+..++.+++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~--~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL--TSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE--cCCCcEEECCccceeecccCcc
Confidence            9999999888764   3679999999999999999999999999999999999999  888999999999997754433 


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ......+++.|+|||...+..++.++|+||+|+++++|++|..||...+..+............   ....++..+.+++
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i  235 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELRNLV  235 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHHHHH
Confidence            2234467889999999988889999999999999999999999998887766666655443322   2246789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||..+|++|||+
T Consensus       236 ~~~l~~~p~~Rp~~  249 (258)
T cd08215         236 SSLLQKDPEERPSI  249 (258)
T ss_pred             HHHcCCChhhCcCH
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.5e-43  Score=278.28  Aligned_cols=243  Identities=20%  Similarity=0.281  Sum_probs=198.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCc----eEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGM----TLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      ++|++.+.||.|+||.||+|.+..++.    .+++|.+..... .....+.+|+..++++.|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            689999999999999999999976665    467777643222 234667788888899999999999998764 44678


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      ++|++++++|.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||.+.......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili--~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL--KSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE--cCCCcEEEcCCccceeccCCC
Confidence            999999999999998766679999999999999999999999999999999999999  889999999999997653322


Q ss_pred             c---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        158 K---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      .   .....++..|+|||.+.+..++.++||||||+++|++++ |..||.+....+....+..+....   .....+.++
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  240 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA---QPQICTIDV  240 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC---CCCCCCHHH
Confidence            1   122335668999999988889999999999999999998 999998876655544443333222   124567889


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .+++.+||..+|.+|||+
T Consensus       241 ~~li~~c~~~~p~~Rps~  258 (279)
T cd05111         241 YMVMVKCWMIDENVRPTF  258 (279)
T ss_pred             HHHHHHHcCCCcccCcCH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-43  Score=279.07  Aligned_cols=246  Identities=27%  Similarity=0.493  Sum_probs=202.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCC------E
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSN------V   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~------~   74 (251)
                      +++|++.+.||.|++|.||+|.++.+++.+++|++..... ....+.+|+..++++ .|+|++++++.+....      .
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            4789999999999999999999998899999999865433 457789999999999 6999999999996544      4


Q ss_pred             EEEEEEeccCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         75 MCVVLELIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      .+++||++++++|.+.+...   +..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~--~~~~~~~l~d~~~~~  161 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL--TKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE--ccCCeEEECCCccce
Confidence            89999999999998877642   3578999999999999999999999999999999999999  888999999999986


Q ss_pred             ccCCCC-cceeeccCccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcc
Q psy11805        152 KFDPEK-KLQVLFGTPEFVAPEVVNF-----DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC  225 (251)
Q Consensus       152 ~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (251)
                      ...... ......+++.|+|||.+..     ..++.++||||||++++++++|+.||...........+...... ....
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~  240 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP-TLKS  240 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC-CCCc
Confidence            643322 2233457889999998753     34677899999999999999999999876665555554443321 1111


Q ss_pred             ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        226 FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...++..++++|++||..||++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~  266 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFM  266 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCH
Confidence            23478899999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-43  Score=282.76  Aligned_cols=245  Identities=29%  Similarity=0.495  Sum_probs=201.7

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-----chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-----DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+......     ....+.+|++.++.++|+|++++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999999988999999998654322     245667899999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-  157 (251)
                      ||++ +++|.+.+......+++..+..++.|+++||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI--ASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE--cCCCCEEEccceeeeeccCCCc
Confidence            9999 779988887655469999999999999999999999999999999999999  889999999999997764432 


Q ss_pred             cceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC--------------
Q psy11805        158 KLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD--------------  222 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  222 (251)
                      ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..+|...+..+...++........              
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            2222345678999998854 4568899999999999999999888887776555544432211100              


Q ss_pred             ----------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ----------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                .......+..+.++|.+||+++|++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  276 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA  276 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH
Confidence                      01123457889999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3e-43  Score=278.01  Aligned_cols=244  Identities=21%  Similarity=0.365  Sum_probs=203.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccC---CceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT---GMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      +++|.+.+.||.|++|.||+|.+...   ...+++|...... ....+.+.+|+..++.+.|+|++++++++.++ ..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence            46799999999999999999987643   3578889876443 34467889999999999999999999988764 4689


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      +||++++++|.+++......++...++.++.+++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV--SSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE--ecCCCeEEccCceeeeccccc
Confidence            999999999999987766568999999999999999999999999999999999999  888999999999987653332


Q ss_pred             cc--eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        158 KL--QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       158 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      ..  ....+++.|+|||.+.+..++.++||||||++++++++ |..||...+..+....+..+...   +....+|..+.
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  238 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLY  238 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHH
Confidence            11  11223457999999988889999999999999999986 99999888877766665544322   22356789999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      +++.+|+..+|.+|||+
T Consensus       239 ~li~~~l~~~P~~Rpt~  255 (270)
T cd05056         239 SLMTKCWAYDPSKRPRF  255 (270)
T ss_pred             HHHHHHcCCChhhCcCH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-43  Score=278.55  Aligned_cols=246  Identities=29%  Similarity=0.553  Sum_probs=209.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .+.|++...||+|++|.||.+.+..++..+++|++..... ....+.+|++.++.++|+|++++++.+..++..++++|+
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            4679999999999999999999998899999999865444 567788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++++|.+++......++...++.++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||.+........ ..
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL--SKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE--cCCCCEEECccchhhhhccchhhhc
Confidence            99999999988765579999999999999999999999999999999999999  8899999999998866433221 12


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+....... ......++..+.++|++|
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~  253 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEFKDFLNKC  253 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCCHHHHHHHHHH
Confidence            3346778999999988888999999999999999999999998876665555443332221 112234789999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.+|.+|||+
T Consensus       254 l~~~p~~Rpt~  264 (286)
T cd06614         254 LVKDPEKRPSA  264 (286)
T ss_pred             hccChhhCcCH
Confidence            99999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.4e-43  Score=282.91  Aligned_cols=246  Identities=23%  Similarity=0.381  Sum_probs=201.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccc--hHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFESS--NVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv   78 (251)
                      ++|++.+.||.|++|.||+|.+..++..|++|.+.......  .....+|+..+++++|+|++++.+++...  +..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            68999999999999999999999999999999986543222  34566899999999999999999998754  568999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-  157 (251)
                      ||++++ +|.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... 
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~--~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL--TDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEECccceeeecCCccC
Confidence            999975 7877777655679999999999999999999999999999999999999  889999999999997754332 


Q ss_pred             cceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc------------
Q psy11805        158 KLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE------------  224 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  224 (251)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+..........            
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            2222335678999999865 457889999999999999999999999888777666554321111000            


Q ss_pred             --------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 --------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                    .....+..+.++|++||+.||++|||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~  284 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA  284 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH
Confidence                          012357889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-43  Score=281.47  Aligned_cols=248  Identities=20%  Similarity=0.329  Sum_probs=199.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccC--------------CceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT--------------GMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIY   66 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~--------------~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~   66 (251)
                      +++|++.+.||+|+||.||+|.+..+              ...|++|.+.... ......+.+|++.+++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            36899999999999999999987543              2358899886432 22356788999999999999999999


Q ss_pred             EEEeeCCEEEEEEEeccCCchhHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEe
Q psy11805         67 DAFESSNVMCVVLELIEGGELFERVIDDD-----------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCL  135 (251)
Q Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~  135 (251)
                      +++...+..++||||+++++|.+.+....           ..+++..++.++.|++.||.+||+.|++|+||+|+||++ 
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill-  162 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV-  162 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE-
Confidence            99999999999999999999988875432           136888999999999999999999999999999999999 


Q ss_pred             ecCCCcEEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHH
Q psy11805        136 TKTGNRIKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS--GLSPFMGETDVQT  210 (251)
Q Consensus       136 ~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~  210 (251)
                       +.++.++|+|||++.........   ....++..|+|||.+.+..++.++||||||+++++|++  |..||...+..+.
T Consensus       163 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         163 -GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             -cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence             78889999999998764322211   11234568999999988889999999999999999988  6788988776655


Q ss_pred             HHHHHhc----cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        211 MANVTIA----QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       211 ~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ......-    ...........+|..+.+|+.+||+.+|++|||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~  286 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF  286 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            5443211    1111111234578999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.8e-43  Score=275.37  Aligned_cols=241  Identities=22%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|++|.||+|.+..+ ..+++|..... ....+.+.+|+++++.++|+|++++++++.. +..+++||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence            6799999999999999999988755 46888987533 2345678899999999999999999998754 5578999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      ++++|.+.+... +..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.........  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill--~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV--GDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE--cCCCeEEECCCccceEccCCccccc
Confidence            999999988753 3358999999999999999999999999999999999999  88999999999999765332211  


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....++..|+|||...+...+.++||||||+++|+|++ |..||......+....+.... .  .+.....+..+.++++
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~  237 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R--MPCPQGCPESLHELMK  237 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C--CCCCcccCHHHHHHHH
Confidence            12234568999999988889999999999999999999 999999887777666554432 2  2233567899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+++|++||++
T Consensus       238 ~~l~~~p~~Rp~~  250 (260)
T cd05069         238 LCWKKDPDERPTF  250 (260)
T ss_pred             HHccCCcccCcCH
Confidence            9999999999984

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.9e-43  Score=284.63  Aligned_cols=244  Identities=16%  Similarity=0.255  Sum_probs=194.3

Q ss_pred             CcccccccC--CceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          6 NQHSAFSFG--KFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         6 ~~~~~lg~g--~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++.+.||+|  ++++||++.++.+++.||+|.+....  ......+++|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            367889999  67899999999999999999986543  23356788899999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CC--
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EK--  157 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~--  157 (251)
                      +++++|.+++..+ ...+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.+++.||+.+..... ..  
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~--~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE--ecCCcEEEcccchhhccccccccc
Confidence            9999999888653 3458999999999999999999999999999999999999  8889999999976543211 10  


Q ss_pred             -----cceeeccCccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC---------
Q psy11805        158 -----KLQVLFGTPEFVAPEVVNF--DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF---------  221 (251)
Q Consensus       158 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------  221 (251)
                           ......++..|+|||.+.+  ..++.++||||||+++|+|++|..||..............+..+.         
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 0112235667999999875  457899999999999999999999998765544333222211100         


Q ss_pred             ---------------------------------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 ---------------------------------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ---------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                       ..+....+++.+.+||++||+.||++|||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  301 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA  301 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH
Confidence                                             001112356789999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-43  Score=283.33  Aligned_cols=244  Identities=26%  Similarity=0.475  Sum_probs=205.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      +.|.....||.|++|.||++.+..++..+++|.+........+.+.+|+..++.++|+|++++++.+...+..+++||++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            45666788999999999999999899999999986555556777889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-ccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~~  161 (251)
                      ++++|.+.+..  ..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++....... ....
T Consensus       102 ~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill--~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658         102 EGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL--TSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE--cCCCCEEEccCcchhhcccccccCce
Confidence            99999887644  358999999999999999999999999999999999999  888999999999986543222 1233


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhc
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL  241 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (251)
                      ..+++.|+|||.+.+..++.++|+||||++++++++|+.||...+..+....+.... ..........+..+.+++.+||
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l  256 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLRGFLDLML  256 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccCHHHHHHHHHHc
Confidence            457889999999988889999999999999999999999998877666554443221 1221222357889999999999


Q ss_pred             ccCcCCCCCC
Q psy11805        242 LKDREDAPEV  251 (251)
Q Consensus       242 ~~~p~~Rps~  251 (251)
                      ..+|.+|||+
T Consensus       257 ~~~P~~Rpt~  266 (292)
T cd06658         257 VREPSQRATA  266 (292)
T ss_pred             cCChhHCcCH
Confidence            9999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.9e-43  Score=282.30  Aligned_cols=245  Identities=27%  Similarity=0.502  Sum_probs=206.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|++|.||++.+..+++.+++|.+........+.+.+|+..++.++|||++++.+.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            36899999999999999999999888999999998665555667888999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++++|.+++...  .++...+..++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||++........ ..
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili--~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE--cCCCCEEEccCcceecccccccccc
Confidence            9999998887654  47899999999999999999999999999999999999  8889999999998866543322 22


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++|+||||+++|++++|..||...+..+....+..... ........++..++++|++|
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~  252 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDFLNRC  252 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHHHHHHHH
Confidence            33577889999999888889999999999999999999999987765544333322221 11122345788999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |..+|++||++
T Consensus       253 l~~~p~~Rp~~  263 (293)
T cd06647         253 LEMDVEKRGSA  263 (293)
T ss_pred             ccCChhhCcCH
Confidence            99999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG1187|consensus

Probab=100.00  E-value=1.3e-43  Score=287.23  Aligned_cols=247  Identities=22%  Similarity=0.321  Sum_probs=198.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-EEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-VMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e   80 (251)
                      +++|.-...||.|+||.||++.... +..||+|.+.........++.+|+.++.+++|+|+++++|+|.+.+ ..++|+|
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE  152 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE  152 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence            4678888999999999999998775 4899999875543321455999999999999999999999999888 5999999


Q ss_pred             eccCCchhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhCC---ceecCCCCCcEEEeecCCCcEEEeecccccccCC-
Q psy11805         81 LIEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKN---VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-  155 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lh~~g---i~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-  155 (251)
                      |++.|+|.+.+..... .++|..+.+|+.+++.||.|||+..   |+||||||+|||+  |.+.+.||+|||++..... 
T Consensus       153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL--D~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL--DEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE--CCCCCEEccCccCcccCCcc
Confidence            9999999999987665 8999999999999999999999864   9999999999999  9999999999999966554 


Q ss_pred             CCcceee-ccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------hHHHH-HHHHhccc-cCCCcc-
Q psy11805        156 EKKLQVL-FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET------DVQTM-ANVTIAQY-DFDDEC-  225 (251)
Q Consensus       156 ~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~-~~~~~~~~-~~~~~~-  225 (251)
                      ....... .||.+|++||....+..+.++||||||++|+|+++|+.+.+...      ..+.. ..+..+.. ....+. 
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            4444444 79999999999998899999999999999999999998877532      12211 11111111 111111 


Q ss_pred             c-cCCC-----HHHHHHHHHhcccCcCCCCCC
Q psy11805        226 F-NEIS-----DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       226 ~-~~~~-----~~~~~li~~~l~~~p~~Rps~  251 (251)
                      . ...+     ..+..+..+|++.+|..||++
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m  342 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTM  342 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence            1 1222     136678899999999999985

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.8e-43  Score=275.65  Aligned_cols=243  Identities=26%  Similarity=0.507  Sum_probs=201.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-----cchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-----NDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   75 (251)
                      ++|++.+.||+|++|.||.+.+..++..|++|.+.....     .....+.+|+..++.+.|+|++++++.+.+  ....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            689999999999999999999999999999998753221     234678899999999999999999998865  3568


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      +++||++++++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~--~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR--DSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe--cCCCCEEECcCcccccccc
Confidence            89999999999988876553 58999999999999999999999999999999999999  8889999999998875432


Q ss_pred             C----CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        156 E----KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       156 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      .    .......++..|+|||.+.+...+.++||||||+++|+|++|+.||...+......+......  ........+.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPHVSD  236 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchhhCH
Confidence            1    112223477899999999888889999999999999999999999987766655554433222  1222346778


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.++|++|+. +|++||++
T Consensus       237 ~~~~~i~~~l~-~p~~Rp~~  255 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRPSA  255 (265)
T ss_pred             HHHHHHHHHhc-ChhhCCCH
Confidence            89999999995 89999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0193|consensus

Probab=100.00  E-value=7e-45  Score=296.23  Aligned_cols=242  Identities=24%  Similarity=0.409  Sum_probs=207.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +...+.+.||+|.||+||+++|-.   .||||++....  .+..+.|++|+..+++-+|.||+-+.|++...+. .||+.
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            456788999999999999999873   68999986443  3358899999999999999999999999998887 89999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc---CCCC
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEK  157 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~---~~~~  157 (251)
                      +|.|.+|..++.....+|+......|++|+++|+.|||.++|+|+|||..||++  .+++.|+|+|||++..-   ....
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl--~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL--HEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE--ccCCcEEEecccceeeeeeecccc
Confidence            999999999998877889999999999999999999999999999999999999  88899999999999653   2222


Q ss_pred             cceeeccCccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc-cccCCCHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNF---DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE-CFNEISDDA  233 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  233 (251)
                      ......+..-|+|||++..   .++++++||||||+++|||++|..||.....+.++-.+.++....... ...+.+.++
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m  625 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM  625 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence            2333446678999999853   468999999999999999999999999777777777777775544433 235788899


Q ss_pred             HHHHHHhcccCcCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPE  250 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps  250 (251)
                      ++|+..||..++++||.
T Consensus       626 k~Ll~~C~~~~~~eRP~  642 (678)
T KOG0193|consen  626 KRLLSDCWKFDREERPL  642 (678)
T ss_pred             HHHHHHHHhcCcccCcc
Confidence            99999999999999996

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.2e-43  Score=278.19  Aligned_cols=243  Identities=25%  Similarity=0.420  Sum_probs=196.7

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcC-CCceeeEeEEEeeC--CEEEEEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQ-HPRLIQIYDAFESS--NVMCVVLE   80 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~e   80 (251)
                      |++.+.||+|++|.||++.+..+++.+++|.+.... ........+|+..++++. |+|++++++++.++  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            788999999999999999999999999999986432 222334457888888885 99999999999887  88999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      ++++ +|.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||++  +. +.++|+|||.+..........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l--~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI--KD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE--cC-CCeEEEecccccccccCCCcC
Confidence            9976 7778777655678999999999999999999999999999999999998  66 999999999997765443333


Q ss_pred             eeccCcccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc------------------C
Q psy11805        161 VLFGTPEFVAPEVVN-FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD------------------F  221 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------~  221 (251)
                      ...+++.|+|||.+. +...+.++||||||+++|+|++|..||...+..+....+......                  .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            445788999999764 455688999999999999999999999887765544433221100                  0


Q ss_pred             CC-------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 DD-------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +.       .....++..+.++|.+||+++|++||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  273 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA  273 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence            00       1113568899999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-43  Score=277.08  Aligned_cols=245  Identities=24%  Similarity=0.401  Sum_probs=203.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc----------chHHHHHHHHHHHHcCCCceeeEeEEEeeCC
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN----------DRRNVEREVEIMRELQHPRLIQIYDAFESSN   73 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (251)
                      +|.+.+.||+|++|.||+|.+..+++.+++|.+......          ..+.+.+|+..++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            688999999999999999999988999999987532111          1346788999999999999999999999999


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..++|+|++++++|.+.+... ..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~--~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV--DADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE--cCCCeEEEeeccccccc
Confidence            999999999999998888765 468999999999999999999999999999999999999  88999999999998764


Q ss_pred             CCCC---cceeeccCcccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc--cCCCccc
Q psy11805        154 DPEK---KLQVLFGTPEFVAPEVVNFDA--IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY--DFDDECF  226 (251)
Q Consensus       154 ~~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~  226 (251)
                      ....   ......++..|+|||.+.+..  ++.++|+||||++++++++|..||...+..+..........  ..+....
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS  238 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence            3221   112234678999999987654  78899999999999999999999987666554444332221  2222333


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..++..+.++|.+||+++|++|||+
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~  263 (272)
T cd06629         239 MNLSPVALDFLNACFTINPDNRPTA  263 (272)
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCH
Confidence            5679999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.4e-43  Score=276.35  Aligned_cols=242  Identities=20%  Similarity=0.322  Sum_probs=198.3

Q ss_pred             CCcccccccCCceEEEEEEEccCCc--eEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeC------CE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGM--TLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS------NV   74 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~--~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   74 (251)
                      |.+.+.||+|+||.||++.+..++.  .+++|.+...  .....+.+.+|+..++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999999877664  6889987543  233467788999999999999999999976421      24


Q ss_pred             EEEEEEeccCCchhHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccc
Q psy11805         75 MCVVLELIEGGELFERVID-----DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGL  149 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~  149 (251)
                      .++++||+++++|.+.+..     ....+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML--NENMNVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE--cCCCCEEECCCCc
Confidence            6899999999999877642     23458999999999999999999999999999999999999  8899999999999


Q ss_pred             ccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCcc
Q psy11805        150 ARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDEC  225 (251)
Q Consensus       150 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (251)
                      +........   ......++.|++||...+..++.++||||||+++|+|++ |..||...+..+....+..+....   .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~  235 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK---Q  235 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence            977543221   122235668999999998889999999999999999999 899998877766666655443321   2


Q ss_pred             ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        226 FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...++..+.++|.+||+.+|++|||+
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~  261 (272)
T cd05075         236 PPDCLDGLYSLMSSCWLLNPKDRPSF  261 (272)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            24678899999999999999999985

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9e-43  Score=280.20  Aligned_cols=242  Identities=24%  Similarity=0.393  Sum_probs=202.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|++|.||++.+..+++.|++|.+.....   .....+.+|+..++.++|+|++++.+++.+++..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            4679999999999999999999998899999998864332   2345688999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      +||+++ ++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++......  
T Consensus        94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~--~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL--TEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE--CCCCCEEEeecCcceecCCC--
Confidence            999975 6767766555579999999999999999999999999999999999999  88999999999998664332  


Q ss_pred             ceeeccCcccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                       ....+++.|+|||.+.   ...++.++||||||+++|+|++|..||...+.......+.....+...  ...++..+.+
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  245 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS--SNDWSDYFRN  245 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC--chhhCHHHHH
Confidence             2335778999999874   355788999999999999999999999888776655544433221111  1346889999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|.+||+.+|++||++
T Consensus       246 li~~~l~~~p~~Rp~~  261 (307)
T cd06607         246 FVDSCLQKIPQDRPSS  261 (307)
T ss_pred             HHHHHhcCChhhCcCH
Confidence            9999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-43  Score=276.48  Aligned_cols=242  Identities=18%  Similarity=0.321  Sum_probs=199.7

Q ss_pred             CCcccccccCCceEEEEEEEccCC---ceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCC------
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATG---MTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSN------   73 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   73 (251)
                      |++.+.||+|+||.||.|.+..++   ..+++|.+.....  .....+.+|+..++.++|+|++++++++...+      
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            678999999999999999886543   7899999864332  23567889999999999999999999875544      


Q ss_pred             EEEEEEEeccCCchhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         74 VMCVVLELIEGGELFERVIDD-----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                      ..++++||+++++|...+...     ...++...+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML--REDMTVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE--CCCCeEEECCcc
Confidence            379999999999998877432     2358999999999999999999999999999999999999  888999999999


Q ss_pred             cccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        149 LARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       149 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                      .+.........   .....+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+...   .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~  235 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL---K  235 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---C
Confidence            98765432211   11234568999999988889999999999999999999 99999888777776666544322   2


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....++..+.+++.+||+.||++|||+
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~  262 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTF  262 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCH
Confidence            235688999999999999999999984

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-43  Score=277.17  Aligned_cols=243  Identities=23%  Similarity=0.331  Sum_probs=204.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCc----eEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGM----TLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .+|++.+.||+|+||.||+|.+..++.    .+++|....... .....+.+|+..++.++|+|++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            579999999999999999999876654    588888754432 235678899999999999999999999887 67899


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      ++|++++++|.+.+......+++..+..++.|++.||++||+.|++|+||+|+||++  +.++.++|+|||.+.......
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~--~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE--cCCCeEEECCCcccccccCcc
Confidence            999999999999988766679999999999999999999999999999999999999  888999999999997654332


Q ss_pred             ccee---eccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        158 KLQV---LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       158 ~~~~---~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ....   ...+..|+|||.+....++.++|+||||++++++++ |..||......+....+..+.....   ....+..+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  240 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ---PPICTIDV  240 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCCHHH
Confidence            2111   123457999999988888999999999999999998 9999998877776666654432222   24567899


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .+++.+||..+|.+||++
T Consensus       241 ~~~~~~~l~~~p~~Rp~~  258 (279)
T cd05057         241 YMVLVKCWMIDAESRPTF  258 (279)
T ss_pred             HHHHHHHcCCChhhCCCH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.4e-43  Score=274.06  Aligned_cols=238  Identities=21%  Similarity=0.346  Sum_probs=200.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEE-eeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF-ESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|++|.||++...  +..+++|.+..  ......+.+|+..++.++|++++++++++ ...+..++++|+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCC--CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            57999999999999999999765  67899998753  23456788999999999999999999976 455678999999


Q ss_pred             ccCCchhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+.+...+. .+++..+..++.|++.||.+||++|++|+||+|+||++  +.++.++|+|||.+.......  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~--~  157 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEASSTQ--D  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE--cCCCcEEecCCccceeccccC--C
Confidence            999999998876443 48899999999999999999999999999999999999  889999999999987643322  2


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+..+..   ....+.+|..+.+++.+
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~  234 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVYDVMKQ  234 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHHHHHHH
Confidence            2234568999999988889999999999999999997 9999988777666665544322   22335789999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|++|||+
T Consensus       235 ~l~~~p~~Rpt~  246 (256)
T cd05082         235 CWHLDAATRPSF  246 (256)
T ss_pred             HhcCChhhCcCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.1e-43  Score=274.97  Aligned_cols=243  Identities=26%  Similarity=0.511  Sum_probs=201.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-----cchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-----NDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   75 (251)
                      .+|++.+.||+|++|.||+|.+..++..+++|.+.....     .....+.+|+..++.++|+|++++++.+..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            579999999999999999999999999999998754321     234568899999999999999999998865  3578


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++++|++++++|.+.+...+ .++....+.++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~--~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR--DSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--CCCCCEEEccCCCcccccc
Confidence            99999999999988887654 58999999999999999999999999999999999999  8889999999999865432


Q ss_pred             C----CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        156 E----KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       156 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      .    .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+..+..........  .......++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--NPQLPSHISE  236 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC--CCCCchhcCH
Confidence            1    111223467899999999988899999999999999999999999988776665554433222  2222345788


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+++++ +||..+|++||++
T Consensus       237 ~~~~li-~~~~~~p~~Rp~~  255 (266)
T cd06651         237 HARDFL-GCIFVEARHRPSA  255 (266)
T ss_pred             HHHHHH-HHhcCChhhCcCH
Confidence            899999 5777899999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.8e-43  Score=279.16  Aligned_cols=243  Identities=20%  Similarity=0.345  Sum_probs=200.0

Q ss_pred             cCCcccccccCCceEEEEEEEcc-----CCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+..... .....+.+|+..++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58899999999999999998753     225688888754332 235678899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE
Q psy11805         78 VLELIEGGELFERVIDD-----------------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILC  134 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~-----------------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~  134 (251)
                      ++||+++++|.+++...                       ...++...++.++.|++.||.+||+.|++|+||+|+||++
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999998877532                       1247889999999999999999999999999999999999


Q ss_pred             eecCCCcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy11805        135 LTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT  210 (251)
Q Consensus       135 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  210 (251)
                        +.++.++|+|||.+........   .....++..|+|||.+.+..++.++||||||+++++|++ |..||.+....+.
T Consensus       161 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         161 --AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             --cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence              8889999999999876432211   122234568999999988889999999999999999998 9999988777666


Q ss_pred             HHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        211 MANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+...... ...  ....++.++.+++.+||+.+|++||++
T Consensus       239 ~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~  276 (290)
T cd05045         239 FNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTF  276 (290)
T ss_pred             HHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCH
Confidence            65544332 222  235678999999999999999999984

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.7e-43  Score=281.84  Aligned_cols=244  Identities=21%  Similarity=0.308  Sum_probs=201.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccC-------CceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCC
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKAT-------GMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSN   73 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   73 (251)
                      ++|.+.+.||+|+||.||++.+...       ...+++|.+.... ......+.+|+..++.+ +|+|++++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            6899999999999999999987532       2468999886532 23456788899999999 7999999999999999


Q ss_pred             EEEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC
Q psy11805         74 VMCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT  138 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~  138 (251)
                      ..+++||++++++|.+++....               ..++...+..++.|++.||++||+.|++|+||+|+||++  +.
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--~~  175 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TE  175 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE--cC
Confidence            9999999999999999987532               247889999999999999999999999999999999999  88


Q ss_pred             CCcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy11805        139 GNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV  214 (251)
Q Consensus       139 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  214 (251)
                      ++.++|+|||.+........   ......++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~  255 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  255 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            89999999999865432211   111223468999999988889999999999999999998 89999877766655555


Q ss_pred             HhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .... ..  .....++.++.+++.+||+.+|++|||+
T Consensus       256 ~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~  289 (307)
T cd05098         256 KEGH-RM--DKPSNCTNELYMMMRDCWHAVPSQRPTF  289 (307)
T ss_pred             HcCC-CC--CCCCcCCHHHHHHHHHHcccChhhCcCH
Confidence            4332 21  2235678999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.9e-43  Score=280.89  Aligned_cols=248  Identities=20%  Similarity=0.350  Sum_probs=199.3

Q ss_pred             CccCCcccccccCCceEEEEEEEcc----------------CCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceee
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA----------------TGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQ   64 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~   64 (251)
                      .++|++.+.||+|+||.||++.+..                +...+++|.+.... ......+.+|+..++.++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            4689999999999999999986542                34568899876432 223567899999999999999999


Q ss_pred             EeEEEeeCCEEEEEEEeccCCchhHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE
Q psy11805         65 IYDAFESSNVMCVVLELIEGGELFERVIDDD----------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILC  134 (251)
Q Consensus        65 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~  134 (251)
                      +++++...+..+++||++++++|.+++....          ..++...++.++.|++.||.+||+.|++|+||+|+||++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili  163 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence            9999999999999999999999988886532          236778999999999999999999999999999999999


Q ss_pred             eecCCCcEEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHH
Q psy11805        135 LTKTGNRIKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS--GLSPFMGETDVQ  209 (251)
Q Consensus       135 ~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~  209 (251)
                        +.++.++|+|||.+.........   .....++.|++||...+..++.++|+||||+++|+|++  |..||...+..+
T Consensus       164 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         164 --GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             --cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence              88899999999998765332211   11223568999999888889999999999999999998  789998776655


Q ss_pred             HHHHHHhc----cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        210 TMANVTIA----QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       210 ~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ........    ......+....++..+.+|+.+||+.||.+||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  287 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF  287 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            54433211    0111112224678999999999999999999985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-43  Score=281.50  Aligned_cols=243  Identities=23%  Similarity=0.440  Sum_probs=204.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .+.|++.+.||+|++|.||+|.+..++..+++|.+.... ......+.+|+..++++.|+|++++++.+..++..++|+|
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            356888999999999999999999889999999976433 2345678999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-c
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-L  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~  159 (251)
                      |+++++|.+.+..  ..+++..+..++.|++.|+.+||+.|++|+||+|+||++  +.++.++|+|||++........ .
T Consensus        83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE--eCCCCEEEccccccccccCcchhh
Confidence            9999999887754  358999999999999999999999999999999999999  8889999999999876543221 1


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....++..|+|||.+.+..++.++|+||||+++++|++|..||...........+......   .....++..+.++|.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~  235 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKEFVEA  235 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHHHHHH
Confidence            2234677899999998888899999999999999999999999876655544433322211   1223578899999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|++||++
T Consensus       236 ~l~~~p~~Rp~~  247 (277)
T cd06642         236 CLNKDPRFRPTA  247 (277)
T ss_pred             HccCCcccCcCH
Confidence            999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-42  Score=271.74  Aligned_cols=237  Identities=23%  Similarity=0.404  Sum_probs=198.1

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      +.||+|++|.||++... ++..+++|.+..... .....+.+|++.++.++|+|++++++++...+..++|||++++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            46899999999999865 578899998764332 2245688999999999999999999999999999999999999999


Q ss_pred             hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--eeeccC
Q psy11805         88 FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--QVLFGT  165 (251)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~  165 (251)
                      .+.+......+++..+..++.|++.+|.++|+.|++|+||+|+||++  +.++.++|+|||++.........  .....+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV--GENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE--cCCCeEEECCCccceeccccccccCCCCCCc
Confidence            99887665668999999999999999999999999999999999999  88999999999998654322211  112335


Q ss_pred             cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        166 PEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       166 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      ..|+|||.+.+..++.++||||||+++|++++ |..||...........+.....   ......++..+.+++.+||+.+
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---MSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcccC
Confidence            67999999988889999999999999999998 9999988877666655544321   1223567899999999999999


Q ss_pred             cCCCCCC
Q psy11805        245 REDAPEV  251 (251)
Q Consensus       245 p~~Rps~  251 (251)
                      |++|||+
T Consensus       235 p~~Rp~~  241 (250)
T cd05085         235 PENRPKF  241 (250)
T ss_pred             cccCCCH
Confidence            9999984

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-42  Score=272.87  Aligned_cols=242  Identities=21%  Similarity=0.384  Sum_probs=204.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      .+|++.+.||.|++|.||++.+.. +..+++|.+... ......+.+|++.+++++|++++++++++......++++|++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            578999999999999999998864 668899987532 234567889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--e
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--Q  160 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--~  160 (251)
                      ++++|.+.+......++++.++.++.|++.+|.+||+.|++|+||+|+||++  +.++.++|+|||.+.........  .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV--GENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE--cCCCeEEECCCcceeecccCcccccC
Confidence            9999999887766678999999999999999999999999999999999999  88899999999988754322111  1


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+..|+|||.+.+..++.++||||||+++|++++ |..||......+....+..+.....   ....+..+.+|+.+
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~  236 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVYELMQH  236 (256)
T ss_pred             CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHHHHHHH
Confidence            1224568999999988889999999999999999998 9999998887777776655432222   13468899999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|++|||+
T Consensus       237 ~l~~~p~~Rp~~  248 (256)
T cd05112         237 CWKERPEDRPSF  248 (256)
T ss_pred             HcccChhhCCCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-43  Score=279.16  Aligned_cols=246  Identities=27%  Similarity=0.444  Sum_probs=202.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+....  ......+.+|++.++.++|+|++++++++...+..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999999999999999876432  3346788999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--c
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--K  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--~  158 (251)
                      |++++.+. .+......++...++.++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||.+.......  .
T Consensus        81 ~~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~--~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          81 YVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV--SESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             cCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCCEEEEeeecccccCCCcccc
Confidence            99886554 444444569999999999999999999999999999999999999  889999999999987765443  2


Q ss_pred             ceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC---------------
Q psy11805        159 LQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD---------------  222 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  222 (251)
                      .....++..|+|||.+.+. .++.++||||||+++|++++|..||...+..+....+........               
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            2334567889999999877 788999999999999999999999987765544333221110000               


Q ss_pred             ----C---------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ----D---------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ----~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                          .         .....++..+.+||++||..+|++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  279 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC  279 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH
Confidence                0         0112348889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.5e-43  Score=277.17  Aligned_cols=245  Identities=19%  Similarity=0.350  Sum_probs=204.8

Q ss_pred             ccCCcccccccCCceEEEEEEEcc-----CCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      ++|++.+.||+|+||.||+|..+.     +.+.+++|.+...... ....+.+|++++++++|+|++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            689999999999999999999754     3467899987544333 4678999999999999999999999999989999


Q ss_pred             EEEEeccCCchhHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         77 VVLELIEGGELFERVIDDD--------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                      +|||++++++|.+++....        ..+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++++|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili--~~~~~~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV--SSQREVKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE--eCCCcEEEcccc
Confidence            9999999999998887543        158999999999999999999999999999999999999  888999999999


Q ss_pred             cccccCCCC--cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCcc
Q psy11805        149 LARKFDPEK--KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDEC  225 (251)
Q Consensus       149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (251)
                      ++.......  ......+++.|+|||.+.+...+.++||||||++++++++ |..||..............+......  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--  240 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV--  240 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC--
Confidence            886432211  1122345667999999988888899999999999999998 88999887776666666544433322  


Q ss_pred             ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        226 FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...+|..+.+++.+||+.+|++|||+
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~  266 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSF  266 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            25688999999999999999999985

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=272.73  Aligned_cols=236  Identities=20%  Similarity=0.348  Sum_probs=196.4

Q ss_pred             cccccCCceEEEEEEEccCC---ceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATG---MTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.+...+   ..+++|.+..... .....+.+|++.++.+.|+|++++++++.. +..+++||++++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            47999999999999876554   7899999864443 245678899999999999999999998764 457999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce----
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ----  160 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~----  160 (251)
                      ++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+..........    
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili--~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL--VNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE--cCCCcEEeccccccceeecCCccccccc
Confidence            99999887655 68999999999999999999999999999999999999  889999999999987654332211    


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+.....   .+....++..++++|.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~  233 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER---LPRPEECPQEIYSIMLS  233 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---CCCCCCCCHHHHHHHHH
Confidence            1112357999999988889999999999999999998 9999988877666555544332   22335678999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|++|||+
T Consensus       234 cl~~~p~~Rp~~  245 (257)
T cd05060         234 CWKYRPEDRPTF  245 (257)
T ss_pred             HhcCChhhCcCH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.2e-43  Score=287.99  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=199.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeC------C
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS------N   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   73 (251)
                      .++|++.+.||+|++|.||+|.+..+++.+++|.+...  +......+.+|+..++.++|+|++++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            47899999999999999999999999999999997532  223456677899999999999999999988643      3


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..++|||++++ +|.+.+...   ++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTA  168 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--CCCCCEEEccCccceeC
Confidence            57999999976 776766432   8999999999999999999999999999999999999  88999999999999876


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC----------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD----------  223 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  223 (251)
                      ..........+++.|+|||.+.+..++.++||||||+++++|++|+.||...+......++.........          
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence            5444334455788999999999889999999999999999999999999877655444433221110000          


Q ss_pred             -----------------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 -----------------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                   ......++.++++|.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  305 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV  305 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH
Confidence                                         0011346678999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.3e-43  Score=280.93  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=203.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccC-----CceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKAT-----GMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   75 (251)
                      ++|++.+.||+|++|.||++.+...     ...+++|.+.... ......+.+|+..++.+ +|+|++++++++..++..
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            6899999999999999999988643     3688999876432 22356688999999999 799999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC
Q psy11805         76 CVVLELIEGGELFERVIDD---------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN  140 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~  140 (251)
                      +++|||+++++|.+++...               ...+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--~~~~  169 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDH  169 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE--cCCC
Confidence            9999999999998888532               3468999999999999999999999999999999999999  8899


Q ss_pred             cEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q psy11805        141 RIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTI  216 (251)
Q Consensus       141 ~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  216 (251)
                      .++|+|||.+........   .....++..|+|||.+.+..++.++||||||+++|++++ |..||......+....+..
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  249 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE  249 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999976543221   111224467999999988889999999999999999997 9999988877776665544


Q ss_pred             ccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +...   ......+..+.+|+.+||+.+|++|||+
T Consensus       250 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~  281 (293)
T cd05053         250 GYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTF  281 (293)
T ss_pred             CCcC---CCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence            4321   2224678899999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.6e-43  Score=276.54  Aligned_cols=245  Identities=23%  Similarity=0.414  Sum_probs=201.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc------cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR------NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      +|+..+.||+|++|.||++.+..++..+++|++.....      .....+.+|+..++.++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            58899999999999999999999999999999864331      135678899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-cEEEeecccccccCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPE  156 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~~~~  156 (251)
                      ++|++++++|.+.+...+ .+++..+..++.|++.||.+||++|++|+||+|+||++  +.++ .++|+|||.+......
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~--~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI--DSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEEcccccccccccc
Confidence            999999999988886544 68999999999999999999999999999999999998  6655 6999999998765432


Q ss_pred             Cc-----ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-ccccCCCccccCCC
Q psy11805        157 KK-----LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI-AQYDFDDECFNEIS  230 (251)
Q Consensus       157 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (251)
                      ..     .....++..|+|||.+.+..++.++|+||||++++++++|..||...+.......+.. ............++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            11     1223467899999999888889999999999999999999999976543222221111 11111222335678


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.+++.+||+.+|.+||++
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~  258 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPS  258 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCH
Confidence            899999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-43  Score=275.80  Aligned_cols=238  Identities=23%  Similarity=0.407  Sum_probs=195.0

Q ss_pred             cccccCCceEEEEEEEccCCc--eEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGM--TLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~--~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|++|.||++.+..++.  .+++|.+.... ......+.+|++.++++ +|+||+++++++...+..+++||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999987765  46778765322 23456788999999999 799999999999999999999999999


Q ss_pred             CchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccc
Q psy11805         85 GELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGL  149 (251)
Q Consensus        85 ~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~  149 (251)
                      ++|.+++....               ..++...+..++.|++.||++||+.|++|+||+|+||++  +.++.++|+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili--~~~~~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE--cCCCeEEECCCCC
Confidence            99999886532               247899999999999999999999999999999999999  8899999999999


Q ss_pred             ccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccC
Q psy11805        150 ARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      +..............+..|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+.... ...  ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~--~~~~  235 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLE--KPLN  235 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CCC--CCCc
Confidence            854322211122223567999999988889999999999999999997 999998877766665554332 111  2245


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.++.+++.+||+.+|.+|||+
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~  258 (270)
T cd05047         236 CDDEVYDLMRQCWREKPYERPSF  258 (270)
T ss_pred             CCHHHHHHHHHHcccChhhCCCH
Confidence            78899999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=271.71  Aligned_cols=237  Identities=24%  Similarity=0.391  Sum_probs=199.9

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      +.||.|++|.||++.+.. ++.+++|.+...... ....+.+|++.+++++|+||+++++++.+.+..++++|++++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999887 899999987654333 467889999999999999999999999999999999999999999


Q ss_pred             hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc---eeecc
Q psy11805         88 FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL---QVLFG  164 (251)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~  164 (251)
                      .+.+......++...+..++.+++.+|.+||++|++|+||+|+||++  +.++.++|+|||.+.........   .....
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV--GENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE--cCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99887766678999999999999999999999999999999999999  88999999999998764321111   11223


Q ss_pred             CcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        165 TPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +..|+|||.+.+..++.++|+||||++++++++ |..||...........+.... ..  .....+|..+.+++.+||..
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RM--PAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CC--CCCccCCHHHHHHHHHHhcc
Confidence            457999999988889999999999999999999 899998877666555554332 11  22356789999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      +|++|||+
T Consensus       235 ~p~~Rp~~  242 (251)
T cd05041         235 DPENRPSF  242 (251)
T ss_pred             ChhhCcCH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.8e-43  Score=280.32  Aligned_cols=246  Identities=27%  Similarity=0.465  Sum_probs=200.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+......  ..+.+.+|++.++.++|+|++++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            5799999999999999999999988999999987543322  35668899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-  159 (251)
                      |+++++|...... ...+++..+..++.|++.||.|||+.|++|+|++|+||++  +.++.++|+|||++......... 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--CCCCcEEEEeeeeeeeccCCcccc
Confidence            9999887665544 3458999999999999999999999999999999999999  88999999999998765433222 


Q ss_pred             eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC-----------------
Q psy11805        160 QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF-----------------  221 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  221 (251)
                      ....++..|+|||.+.+. .++.++||||||+++++|++|..||......+...++.......                 
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            223467789999998653 46789999999999999999999998766554443332111100                 


Q ss_pred             --C--------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 --D--------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 --~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                        +        ...++.++..+.+++++||+.+|++||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~  277 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS  277 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH
Confidence              0        01124678899999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0586|consensus

Probab=100.00  E-value=4e-44  Score=292.52  Aligned_cols=242  Identities=33%  Similarity=0.548  Sum_probs=222.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .-|.+...||+|.|++|.++.+..++..||+|.+..+...  ..+.+.+|+++++.++||||++++.+.+.+..+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            3589999999999999999999999999999998654433  34668999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      |..++.+.+++..++ ...+..+..++.|+++|++|||+++|+|+|||++|+++  +.+.+++|+|||++..++.+...+
T Consensus       136 ya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL--~~~mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  136 YASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL--DENMNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             eccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc--ccccceeeeccccceeeccccccc
Confidence            999999999998876 46669999999999999999999999999999999999  999999999999999999999999


Q ss_pred             eeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      +.||++.|.|||++.+..+ +++.|+||+|+++|.|+.|.+||++.+..+...+...+.++.+..    ++.++.++|++
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~----ms~dce~lLrk  288 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY----MSCDCEDLLRK  288 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce----eechhHHHHHH
Confidence            9999999999999998776 679999999999999999999999999999999998888887754    57789999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      +|-++|.+|+++
T Consensus       289 ~lvl~Pskr~~~  300 (596)
T KOG0586|consen  289 FLVLNPSKRGPC  300 (596)
T ss_pred             hhccCccccCCH
Confidence            999999999874

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.4e-43  Score=277.85  Aligned_cols=244  Identities=22%  Similarity=0.388  Sum_probs=194.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHH-HHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEI-MRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+..... .....+..|+.. ++..+|+|++++++++..++..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            589999999999999999999999999999999864332 233455556664 566789999999999999999999999


Q ss_pred             eccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         81 LIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        81 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ++++ +|.+.+..   .+..+++..++.++.|++.||.+||++ +++|+||+|+||++  +.++.++|+|||.+......
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI--NRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE--CCCCCEEEeecccccccccc
Confidence            9975 77666643   334689999999999999999999997 99999999999999  88999999999998765433


Q ss_pred             CcceeeccCccccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccccCCCccccCCCH
Q psy11805        157 KKLQVLFGTPEFVAPEVVNF----DAIGFGTDMWSVGVICYVLLSGLSPFMGET-DVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      .......++..|+|||.+.+    ..++.++|+||||+++|+|++|..||.... ..+............. + ...+|.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~  235 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL-P-AEKFSP  235 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC-C-ccccCH
Confidence            32233457788999998865    345789999999999999999999997543 2333333322211111 1 135789


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.++|.+||..+|++||++
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~  255 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNY  255 (283)
T ss_pred             HHHHHHHHHccCChhhCcCH
Confidence            99999999999999999984

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.4e-43  Score=278.63  Aligned_cols=245  Identities=20%  Similarity=0.372  Sum_probs=204.2

Q ss_pred             CccCCcccccccCCceEEEEEEEcc-----CCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||.|+||.||+|.+..     ++..+++|.+..... .....+.+|+..++++.|+|++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            3689999999999999999998753     567899998764332 2356788999999999999999999999998899


Q ss_pred             EEEEEeccCCchhHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE
Q psy11805         76 CVVLELIEGGELFERVIDDD---------------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILC  134 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~---------------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~  134 (251)
                      ++++|++++++|.+++....                     ..+++..++.++.|++.||.+||++|++|+||+|+||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~  163 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV  163 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence            99999999999988886421                     246788899999999999999999999999999999999


Q ss_pred             eecCCCcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy11805        135 LTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT  210 (251)
Q Consensus       135 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  210 (251)
                        +.++.++|+|||.+........   ......+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus       164 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         164 --GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             --cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence              8899999999999875432211   112234567999999988889999999999999999998 8899988877777


Q ss_pred             HHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        211 MANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...+..+....   ....++..+.+++.+||+.+|++|||+
T Consensus       242 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~  279 (288)
T cd05050         242 IYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSF  279 (288)
T ss_pred             HHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCH
Confidence            76665544322   224678999999999999999999985

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.6e-43  Score=277.37  Aligned_cols=244  Identities=23%  Similarity=0.440  Sum_probs=199.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEe------eCCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFE------SSNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------~~~~~   75 (251)
                      ..|++.+.||.|+||.||+|.+..+++.+++|++.... .....+..|+..++++ +|+|++++++++.      ..+..
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            57999999999999999999999999999999975433 3456788899999988 6999999999984      34678


Q ss_pred             EEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         76 CVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      +++|||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+|++|+||++  +.++.++|+|||++....
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili--~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEeeCcchhhhh
Confidence            9999999999998888753 3458899999999999999999999999999999999999  888999999999987643


Q ss_pred             CCC-cceeeccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccC
Q psy11805        155 PEK-KLQVLFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      ... ......+++.|+|||.+.     ...++.++|+||||+++|+|++|..||......+....+.....  .......
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~  250 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--PKLKSKK  250 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--CCCcccc
Confidence            221 223345788999999875     34577899999999999999999999987665444443322221  1111246


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++..+.+||++||+.||.+|||+
T Consensus       251 ~~~~~~~li~~cl~~~p~~Rp~~  273 (282)
T cd06636         251 WSKKFIDFIEGCLVKNYLSRPST  273 (282)
T ss_pred             cCHHHHHHHHHHhCCChhhCcCH
Confidence            78999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9e-43  Score=281.03  Aligned_cols=244  Identities=21%  Similarity=0.306  Sum_probs=200.8

Q ss_pred             ccCCcccccccCCceEEEEEEEcc-------CCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCC
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKA-------TGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSN   73 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   73 (251)
                      ++|.+.+.||+|++|.||+|++..       ....+++|.+.... ......+.+|+..++.+ +|+||+++++++..++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            578999999999999999998642       24568889876432 22356788999999999 5999999999999999


Q ss_pred             EEEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC
Q psy11805         74 VMCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT  138 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~  138 (251)
                      ..+++|||+++++|.+++....               ..++...+..++.|++.||.+||+.|++|+||+|+||++  +.
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--~~  169 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV--TE  169 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE--cC
Confidence            9999999999999999886532               348889999999999999999999999999999999999  88


Q ss_pred             CCcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy11805        139 GNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV  214 (251)
Q Consensus       139 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  214 (251)
                      ++.++|+|||.+........   .....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~  249 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL  249 (314)
T ss_pred             CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            89999999999976532211   112223457999999988889999999999999999999 89999887776666655


Q ss_pred             HhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ......   .....++.++.+++.+||+.+|++|||+
T Consensus       250 ~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~  283 (314)
T cd05099         250 REGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTF  283 (314)
T ss_pred             HcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            443221   1225678899999999999999999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=272.99  Aligned_cols=237  Identities=29%  Similarity=0.461  Sum_probs=198.0

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHHHH-HHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIM-RELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||.|++|.||+|.+..+++.+++|.+......   ....+..|...+ ...+|+|++++++.+..++..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999999989999999998543221   222334444443 344799999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeecc
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG  164 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~  164 (251)
                      ++|.+++...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.....   .....+
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI--DQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCcEEEeecccceeccc---cccCCC
Confidence            99988886654 68999999999999999999999999999999999999  8889999999998865432   223347


Q ss_pred             CcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        165 TPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      +..|+|||.+.+..++.++||||||+++|++++|..||...+..+....+..............++..+.++|.+||+.+
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            78999999998888899999999999999999999999988877776666555544444444568999999999999999


Q ss_pred             cCCCCCC
Q psy11805        245 REDAPEV  251 (251)
Q Consensus       245 p~~Rps~  251 (251)
                      |++||++
T Consensus       236 p~~R~~~  242 (260)
T cd05611         236 PAKRLGA  242 (260)
T ss_pred             HHHccCC
Confidence            9999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1e-42  Score=277.18  Aligned_cols=246  Identities=25%  Similarity=0.441  Sum_probs=199.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEe-----eCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFE-----SSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~~   75 (251)
                      .++|++.+.||+|++|.||+|.+..+++.+++|+..... .....+.+|+..++.+ +|+|++++++++.     .++..
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            478999999999999999999999999999999875422 2346678899999999 6999999999873     34578


Q ss_pred             EEEEEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         76 CVVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      +++|||+++++|.+.+..   ....+++..++.++.|++.||.+||+.+++|+|++|+||++  +.++.++|+|||++..
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili--~~~~~~kl~dfg~~~~  173 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQ  173 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE--CCCCCEEEccCCceee
Confidence            999999999999887653   33468999999999999999999999999999999999999  8888999999999876


Q ss_pred             cCCCC-cceeeccCccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccc
Q psy11805        153 FDPEK-KLQVLFGTPEFVAPEVVNF-----DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF  226 (251)
Q Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (251)
                      ..... ......+++.|+|||.+.+     ..++.++||||+|+++|+|++|..||................. ......
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~  252 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP-PTLHQP  252 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC-CcccCC
Confidence            54322 2233457889999998753     4478899999999999999999999987765554433322211 111112


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..++..+.++|.+||+.+|++|||+
T Consensus       253 ~~~~~~~~~li~~~l~~~p~~Rps~  277 (286)
T cd06638         253 ELWSNEFNDFIRKCLTKDYEKRPTV  277 (286)
T ss_pred             CCcCHHHHHHHHHHccCCcccCCCH
Confidence            3467889999999999999999985

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.3e-43  Score=278.12  Aligned_cols=243  Identities=25%  Similarity=0.427  Sum_probs=202.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|++|+||++.+..+++.+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            68999999999999999999999999999999876433 23467889999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+.+... +.++...+..++.+++.+|.|||+ .|++|+||+|+||++  +.++.++|+|||++....... ..
T Consensus        85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~--~~~~~~~l~d~gl~~~~~~~~-~~  160 (284)
T cd06620          85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV--NSRGQIKLCDFGVSGELINSI-AD  160 (284)
T ss_pred             CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE--CCCCcEEEccCCcccchhhhc-cC
Confidence            9999998877654 368999999999999999999997 599999999999999  888999999999886542221 22


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhccccCCCccccCC
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV-----------QTMANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~  229 (251)
                      ...++..|+|||.+.+..++.++|+||||+++|++++|..||......           +....+.....+  ......+
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  238 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--RLPSSDF  238 (284)
T ss_pred             ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--CCCchhc
Confidence            346788999999998888899999999999999999999999865442           222222221111  1111237


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+.+|+.+||+.||++|||+
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~  260 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTP  260 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCH
Confidence            8899999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-43  Score=290.78  Aligned_cols=241  Identities=22%  Similarity=0.358  Sum_probs=193.0

Q ss_pred             CccCCcccccccCCceEEEEEEEc--cCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK--ATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ..+|++.+.||.|++|.||+|...  .+++.|++|.+...     ....+|++++++++|+||+++++++...+..+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999764  34578899986432     34568999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-  158 (251)
                      +++.+ +|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++........ 
T Consensus       166 e~~~~-~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill--~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        166 PKYKC-DLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL--DEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             hhcCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--cCCCCEEEccCccccccCccccc
Confidence            99965 77777743 3469999999999999999999999999999999999999  8899999999999976543322 


Q ss_pred             --ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccc--------------
Q psy11805        159 --LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD---VQTMANVTIAQY--------------  219 (251)
Q Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~--------------  219 (251)
                        .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+...   ...+..+.....              
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL  321 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence              1234689999999999988999999999999999999999999976532   111211111000              


Q ss_pred             -----------c--CCCc---cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 -----------D--FDDE---CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 -----------~--~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                 .  ...+   ....++.++.++|++||..||++|||+
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa  369 (392)
T PHA03207        322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA  369 (392)
T ss_pred             HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH
Confidence                       0  0000   012456789999999999999999985

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-42  Score=273.63  Aligned_cols=244  Identities=28%  Similarity=0.495  Sum_probs=204.4

Q ss_pred             cCCcccccccCCceEEEEEEEcc-CCceEEEEEecccc----------ccchHHHHHHHHHHHH-cCCCceeeEeEEEee
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKA-TGMTLAAKFVGIAK----------RNDRRNVEREVEIMRE-LQHPRLIQIYDAFES   71 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~~----------~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~   71 (251)
                      +|++.+.||+|++|.||++.+.. +++.+++|.+....          ......+.+|+..+.+ ++|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58999999999999999999987 67889999875322          1234556778887765 689999999999999


Q ss_pred             CCEEEEEEEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeec
Q psy11805         72 SNVMCVVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDF  147 (251)
Q Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df  147 (251)
                      ++..+++|||+++++|.+.+..   .+..+++..++.++.|++.+|.+||+ .|++|+||+|+||++  +.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~--~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE--CCCCcEEEecc
Confidence            9999999999999999877643   44568999999999999999999996 789999999999999  88999999999


Q ss_pred             ccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc
Q psy11805        148 GLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      |.+.............++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.........  ..
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  236 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--EG  236 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC--cc
Confidence            9997765444334456788999999999888999999999999999999999999887776666655544433222  13


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++..+.++|.+||+.||++||++
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~  260 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDI  260 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCH
Confidence            578899999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-43  Score=292.59  Aligned_cols=241  Identities=22%  Similarity=0.300  Sum_probs=193.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ..+|.+.+.||.|+||.||+|.+..+++.|++|...      .....+|++++++++|+||+++++++..++..+++|++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999999999999999642      23457899999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc---
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---  158 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~---  158 (251)
                      +. ++|.+.+......+++..++.++.|++.||.|||++||+|+||||+||++  +.++.++|+|||++........   
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl--~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV--NGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE--CCCCCEEEcccCCceeccccccccc
Confidence            96 47878777665679999999999999999999999999999999999999  8889999999999976533221   


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhccccC---------
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET--------DVQTMANVTIAQYDF---------  221 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~---------  221 (251)
                      .....+++.|+|||++.+..++.++||||||++||||++|..++-...        ..+..+.+.......         
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            123458999999999999999999999999999999999775542211        122222222111100         


Q ss_pred             ------------------CCccc---cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 ------------------DDECF---NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ------------------~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        ....|   ..++..+.+||++||+.||.+|||+
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa  449 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA  449 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH
Confidence                              00111   1356689999999999999999985

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=275.58  Aligned_cols=243  Identities=23%  Similarity=0.458  Sum_probs=202.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcC---CCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQ---HPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +.|++.+.||+|++|.||+|.+..+++.+++|.+.... ......+.+|+..++.++   |+|++++++++..+...+++
T Consensus         1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            35899999999999999999999999999999986442 334667889999999986   99999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+.+...  .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........
T Consensus        81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE--cCCCCEEEccCCceeecCCCcc
Confidence            9999999998887553  68999999999999999999999999999999999999  8899999999999877644322


Q ss_pred             -ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        159 -LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       159 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                       .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....  +......++.++.++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  234 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--PRLEDNGYSKLLREF  234 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCC--CCCCcccCCHHHHHH
Confidence             223357788999998865 4468899999999999999999999987766554433322211  111112478899999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      +.+||+.+|++||++
T Consensus       235 i~~~l~~~p~~R~~~  249 (277)
T cd06917         235 VAACLDEEPKERLSA  249 (277)
T ss_pred             HHHHcCCCcccCcCH
Confidence            999999999999984

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.2e-43  Score=279.79  Aligned_cols=245  Identities=22%  Similarity=0.312  Sum_probs=202.9

Q ss_pred             CccCCcccccccCCceEEEEEEEc-------cCCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-------ATGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESS   72 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   72 (251)
                      .++|.+.+.||+|+||.||+|++.       .++..+++|...... ......+.+|+..++.+ +|+||+++++.+...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            357999999999999999999753       234578999875432 23467789999999999 799999999999999


Q ss_pred             CEEEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec
Q psy11805         73 NVMCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK  137 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~  137 (251)
                      +..+++|||+++++|.+++....               ..++...+..++.|++.||.|||+.|++|+||+|+||++  +
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili--~  171 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV--T  171 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE--c
Confidence            99999999999999998886531               247888999999999999999999999999999999999  8


Q ss_pred             CCCcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy11805        138 TGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN  213 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  213 (251)
                      .++.++|+|||.+........   .....+++.|+|||.+.+..++.++||||||+++|++++ |..||...+..+....
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  251 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  251 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence            889999999999976543221   122234568999999988889999999999999999998 8899988877777666


Q ss_pred             HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+... .  ....++..+.+++.+||+.+|++|||+
T Consensus       252 ~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rps~  286 (304)
T cd05101         252 LKEGHRM-D--KPANCTNELYMMMRDCWHAIPSHRPTF  286 (304)
T ss_pred             HHcCCcC-C--CCCCCCHHHHHHHHHHcccChhhCCCH
Confidence            6444322 1  225678999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-42  Score=272.67  Aligned_cols=235  Identities=29%  Similarity=0.556  Sum_probs=200.8

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      ||.|++|.||+|.+..+++.+++|++....   ....+.+.+|+..++.++|+|++++++.+.+++..++++|++++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999999889999999986433   23457789999999999999999999999999999999999999999


Q ss_pred             hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCcc
Q psy11805         88 FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE  167 (251)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  167 (251)
                      .+.+.... .++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.............+++.
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  157 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE  157 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE--cCCCCEEEeeCCcccccCcccccccccCCcC
Confidence            98887653 58999999999999999999999999999999999999  8899999999999987655433344567889


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCc
Q psy11805        168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET--DVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR  245 (251)
Q Consensus       168 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  245 (251)
                      |++||.+.+..++.++|+||+|+++|++++|..||....  ..+....+..+....  ......++++.++|.+||+.+|
T Consensus       158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL--EFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC--CCCcccCHHHHHHHHHHccCCh
Confidence            999999988888999999999999999999999998776  455555544322222  2224458899999999999999


Q ss_pred             CCCCC
Q psy11805        246 EDAPE  250 (251)
Q Consensus       246 ~~Rps  250 (251)
                      ++||+
T Consensus       236 ~~R~~  240 (262)
T cd05572         236 EERLG  240 (262)
T ss_pred             hhCcC
Confidence            99998

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-42  Score=273.86  Aligned_cols=243  Identities=23%  Similarity=0.428  Sum_probs=197.9

Q ss_pred             CcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          6 NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         6 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      .....||+|+||.||++.+..++..+++|.+........+.+.+|+..++.++|+||+++++++..++..++++|+++++
T Consensus        11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            34568999999999999999899999999887655556778999999999999999999999999999999999999999


Q ss_pred             chhHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeecccccccCCCCc-cee
Q psy11805         86 ELFERVIDDDFVL--TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFGLARKFDPEKK-LQV  161 (251)
Q Consensus        86 ~L~~~~~~~~~~~--~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~~~~~~~~~~-~~~  161 (251)
                      +|.+.+......+  +...+..++.|++.||.+||+.|++|+||+|+||++  +. ++.++|+|||.+........ ...
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~--~~~~~~~~l~dfg~~~~~~~~~~~~~~  168 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINPCTET  168 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE--cCCCCeEEEecchhheecccCCCcccc
Confidence            9999887654445  888999999999999999999999999999999997  54 67899999999876532222 223


Q ss_pred             eccCcccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        162 LFGTPEFVAPEVVNFDA--IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ..+++.|+|||.+.+..  ++.++|+||+|+++|+|++|..||............ .............+++++.+++++
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~  247 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAKNFILR  247 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHHHHHHH
Confidence            34788999999986543  678999999999999999999999765432221111 111111222335678899999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.+|++|||+
T Consensus       248 ~l~~~p~~Rpt~  259 (268)
T cd06624         248 CFEPDPDKRASA  259 (268)
T ss_pred             HcCCCchhCCCH
Confidence            999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-42  Score=270.91  Aligned_cols=243  Identities=29%  Similarity=0.517  Sum_probs=207.9

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESS--NVMCVVL   79 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~   79 (251)
                      +|++.+.||+|++|.||+|.+..+++.+++|++.....  .....+.+|+..+++++|+|++++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            58899999999999999999998999999999865442  3578889999999999999999999999988  8899999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-  158 (251)
                      |++++++|.+.+.... .+++..++.++.|++.+|.+||+.|++|+|++|+||++  +.++.++|+|||.+........ 
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV--DSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--cCCCCEEEcccccEEeccccccc
Confidence            9999999998887665 79999999999999999999999999999999999999  7889999999999987665543 


Q ss_pred             --ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        159 --LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET-DVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                        .....++..|+|||.+.+...+.++||||||+++++|++|..||.... .......+....  ........++..+.+
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~  235 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG--EPPEIPEHLSEEAKD  235 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccC--CCcCCCcccCHHHHH
Confidence              344567889999999988889999999999999999999999998776 222233332211  122233566899999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|.+||+.+|++||++
T Consensus       236 ~i~~~l~~~p~~Rp~~  251 (260)
T cd06606         236 FLRKCLRRDPKKRPTA  251 (260)
T ss_pred             HHHHhCcCChhhCCCH
Confidence            9999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.3e-43  Score=277.10  Aligned_cols=245  Identities=24%  Similarity=0.421  Sum_probs=199.4

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+......  ....+.+|++.+++++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            589999999999999999999999999999988643322  346788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-c
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-L  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~  159 (251)
                      +++ +|.+.+... +..+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||.+........ .
T Consensus        81 ~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill--~~~~~~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          81 LHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             ccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEEeeccchhhcccCcccc
Confidence            964 777777543 3568999999999999999999999999999999999999  8899999999999876543221 1


Q ss_pred             eeeccCcccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC----------------
Q psy11805        160 QVLFGTPEFVAPEVVNFDA-IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD----------------  222 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  222 (251)
                      ....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..+...++........                
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            2234577899999886644 58889999999999999999999987766554443322111110                


Q ss_pred             ---------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ---------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               ......++..++++|.+||+.||++||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  275 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA  275 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence                     01123467889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.9e-42  Score=275.28  Aligned_cols=246  Identities=26%  Similarity=0.438  Sum_probs=201.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeC-----CEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESS-----NVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~~~   75 (251)
                      .++|++.+.||+|++|.||+|.+..+++.+++|++... ......+.+|+..++++ +|+|++++++++...     +..
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            46899999999999999999999999999999997543 22356678899999998 799999999998643     358


Q ss_pred             EEEEEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         76 CVVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ++|+||+++++|.+.+..   .+..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+..
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili--~~~~~~kl~dfg~~~~  177 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL--TTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--cCCCCEEEeecccchh
Confidence            999999999999887753   34568999999999999999999999999999999999999  8889999999999876


Q ss_pred             cCCCC-cceeeccCcccccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccc
Q psy11805        153 FDPEK-KLQVLFGTPEFVAPEVVNFD-----AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF  226 (251)
Q Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (251)
                      ..... ......++..|+|||.+...     .++.++||||||+++|+|++|+.||...+..+....+........ ...
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~  256 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL-LHP  256 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC-Ccc
Confidence            54322 12234577899999987543     357899999999999999999999988877666655543322111 112


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...+..+.++|.+||+.+|++||++
T Consensus       257 ~~~~~~l~~li~~~l~~~p~~Rps~  281 (291)
T cd06639         257 EKWCRSFNHFISQCLIKDFEARPSV  281 (291)
T ss_pred             cccCHHHHHHHHHHhhcChhhCcCH
Confidence            3467789999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.7e-42  Score=276.18  Aligned_cols=245  Identities=20%  Similarity=0.301  Sum_probs=199.5

Q ss_pred             CccCCcccccccCCceEEEEEEEcc-----CCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.++.     .+..+++|.+..... .....+.+|+..++.++|+|++++++++...+..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3689999999999999999997652     345799998753322 2345677899999999999999999999988899


Q ss_pred             EEEEEeccCCchhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEee
Q psy11805         76 CVVLELIEGGELFERVIDDD---------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                      +++|||+++++|.+++....         ..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili--~~~~~~~L~D  162 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV--AHDFTVKIGD  162 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE--cCCCcEEECc
Confidence            99999999999999886522         235677889999999999999999999999999999999  8899999999


Q ss_pred             cccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCC
Q psy11805        147 FGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       147 f~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      ||++........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ  242 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999875432211   111234568999999988889999999999999999998 7899988777666655544332211


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                         ...++..+.+++.+||+.+|++|||+
T Consensus       243 ---~~~~~~~~~~li~~~l~~~p~~Rps~  268 (288)
T cd05061         243 ---PDNCPERVTDLMRMCWQFNPKMRPTF  268 (288)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChhHCcCH
Confidence               24568899999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=275.71  Aligned_cols=244  Identities=27%  Similarity=0.451  Sum_probs=201.3

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEEEEEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESS--NVMCVVLE   80 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e   80 (251)
                      |++.+.||+|++|.||+|.+..+++.+++|.+....  ......+.+|+..++.++|+|++++++++...  +..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            788999999999999999999889999999987553  33456788999999999999999999999887  88999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc--
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK--  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~--  158 (251)
                      ++++ +|.+.+......+++..++.++.|++.||++||+.|++|+||+|+||++  +.++.++|+|||.+........  
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~--~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI--NNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE--cCCCCEEEccccceeeccCCCccc
Confidence            9976 8888777665579999999999999999999999999999999999999  8899999999999977654331  


Q ss_pred             ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc-------------
Q psy11805        159 LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE-------------  224 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  224 (251)
                      .....++..|+|||.+.+ ..++.++||||||+++++|++|..||...+.......+..........             
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            223345778999998765 457889999999999999999999998877665555443221111110             


Q ss_pred             -------------cccC-CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 -------------CFNE-ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 -------------~~~~-~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                   .... ++..+.+++++||+.+|++||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~  278 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA  278 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence                         0112 38889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=269.12  Aligned_cols=242  Identities=26%  Similarity=0.487  Sum_probs=208.5

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.....  .....+.+|++.+++++|+|++++.+++.+.+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            68999999999999999999998899999999865543  3567889999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~  160 (251)
                      +++++|.+.+... ..+++..++.++.|++.+|.+||+.|++|+||+|+||++  +.++.++|+|||.+........ ..
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT--TKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE--CCCCCEEEeccccceecCCCccccc
Confidence            9999998888765 469999999999999999999999999999999999999  7789999999999987654433 22


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...++..|+|||...+...+.++|+||||++++++++|..||...+......+......   ......++..+.+++.+|
T Consensus       158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGISPELKDFLMQC  234 (254)
T ss_pred             ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCCCHHHHHHHHHH
Confidence            34577899999999887788999999999999999999999987775555544432221   222356789999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |..+|++|||+
T Consensus       235 l~~~p~~R~~~  245 (254)
T cd06627         235 FQKDPNLRPTA  245 (254)
T ss_pred             HhCChhhCcCH
Confidence            99999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.6e-42  Score=272.16  Aligned_cols=236  Identities=25%  Similarity=0.424  Sum_probs=191.7

Q ss_pred             ccCCccccc--ccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAF--SFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~l--g~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.+  |+|+||.||++.+..++..+++|.+........     |+.....+ +|+|++++++.+..++..++||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~   88 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM   88 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence            467777777  999999999999999999999999754322211     22222222 6999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-cEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~~~~~~  158 (251)
                      ||+++++|.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++ .++|+|||.+....... 
T Consensus        89 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~--~~~~~~~~l~dfg~~~~~~~~~-  164 (267)
T PHA03390         89 DYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY--DRAKDRIYLCDYGLCKIIGTPS-  164 (267)
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--eCCCCeEEEecCccceecCCCc-
Confidence            9999999999887664 79999999999999999999999999999999999998  6666 89999999987654322 


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT-MANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                        ...++..|+|||.+.+..++.++||||+|+++++|++|..||......+. ...+... .....+.++.++..+.++|
T Consensus       165 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li  241 (267)
T PHA03390        165 --CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-QQKKLPFIKNVSKNANDFV  241 (267)
T ss_pred             --cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-hcccCCcccccCHHHHHHH
Confidence              23478899999999888899999999999999999999999986544332 1222111 1233344467899999999


Q ss_pred             HHhcccCcCCCCC
Q psy11805        238 RKLLLKDREDAPE  250 (251)
Q Consensus       238 ~~~l~~~p~~Rps  250 (251)
                      .+||+.+|.+||+
T Consensus       242 ~~~l~~~p~~R~~  254 (267)
T PHA03390        242 QSMLKYNINYRLT  254 (267)
T ss_pred             HHHhccChhhCCc
Confidence            9999999999995

>KOG0596|consensus

Probab=100.00  E-value=1.3e-43  Score=286.15  Aligned_cols=244  Identities=22%  Similarity=0.359  Sum_probs=192.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEec--cccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~--~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +..|++.++||+||.+.||++..... ..+++|.+.  ..+.....-+.+|+..|.+++ |.+|++++|+-..++.+|+|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            35799999999999999999976644 455555543  233445788999999999996 99999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      ||+-+. +|...+......++.-.+..+..|++.|+.+.|..||||.||||.||++   -.|.+||+|||.+.....++.
T Consensus       439 mE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl---VkG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  439 MECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL---VKGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             eecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE---EeeeEEeeeechhcccCcccc
Confidence            998754 8888887766556655778888999999999999999999999999997   568999999999988766543


Q ss_pred             c---eeeccCcccccccccccCC-----------CCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccccCCC
Q psy11805        159 L---QVLFGTPEFVAPEVVNFDA-----------IGFGTDMWSVGVICYVLLSGLSPFMGET-DVQTMANVTIAQYDFDD  223 (251)
Q Consensus       159 ~---~~~~~~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~  223 (251)
                      .   ...+||+.|||||.+....           .++++|||||||+||+|+.|+.||..-. ....+..+.......+.
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief  594 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF  594 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence            3   5678999999999985432           4678999999999999999999996643 33333344333221121


Q ss_pred             ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+ -..++.++++.||+.||.+||++
T Consensus       595 p~~~-~~~~li~~mK~CL~rdPkkR~si  621 (677)
T KOG0596|consen  595 PDIP-ENDELIDVMKCCLARDPKKRWSI  621 (677)
T ss_pred             cCCC-CchHHHHHHHHHHhcCcccCCCc
Confidence            1111 12248999999999999999985

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-42  Score=276.49  Aligned_cols=245  Identities=22%  Similarity=0.349  Sum_probs=195.8

Q ss_pred             ccCCcccccccCCceEEEEEEE----ccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKE----KATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESS--NVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   75 (251)
                      +-|++.+.||+|+||.||+|..    ..++..+++|.+.... ......+.+|+..++.++|+|++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4579999999999999999985    4567899999986443 33456789999999999999999999998765  568


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      +++|||+++++|.+++......+++..+..++.|++.||.+||++|++|+||+|+||++  +.++.++|+|||++.....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~--~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE--cCCCCEEECCCcccccccc
Confidence            99999999999999887665568999999999999999999999999999999999999  8889999999999876543


Q ss_pred             CCcc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHHHHHhc
Q psy11805        156 EKKL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD--------------VQTMANVTIA  217 (251)
Q Consensus       156 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------~~~~~~~~~~  217 (251)
                      ....    ....++..|+|||.+.+..++.++||||||+++|+++++..|+.....              ..........
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            3221    122355679999999888899999999999999999998766432211              1111111111


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...  .+.+..++..+.+|+.+||+.+|++|||+
T Consensus       242 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  273 (284)
T cd05079         242 GKR--LPRPPNCPEEVYQLMRKCWEFQPSKRTTF  273 (284)
T ss_pred             Ccc--CCCCCCCCHHHHHHHHHHccCCcccCcCH
Confidence            111  12235688999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.6e-42  Score=275.94  Aligned_cols=246  Identities=24%  Similarity=0.420  Sum_probs=197.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||.|++|.||++.++.+++.+++|.+.....  .....+.+|++.+++++|+|++++++++.+++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            579999999999999999999999999999999864332  234678899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecccccccCCCCc
Q psy11805         81 LIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |+++ +|.+.+.... ..+++..++.++.|++.||.+||++|++|+||+|+||++  + .++.++|+|||++........
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill--~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEE--ECCCCEEEEcccccccccCCCcc
Confidence            9975 6767665433 346889999999999999999999999999999999997  5 456799999999976433221


Q ss_pred             -ceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc------------
Q psy11805        159 -LQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE------------  224 (251)
Q Consensus       159 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  224 (251)
                       .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+...++..........            
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence             1223467899999988653 57889999999999999999999998877655554432211111110            


Q ss_pred             -------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 -------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                   ....++..+.+++.+||+.+|++||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~  278 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA  278 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH
Confidence                         113568889999999999999999984

>KOG1095|consensus

Probab=100.00  E-value=2.4e-43  Score=307.31  Aligned_cols=242  Identities=21%  Similarity=0.393  Sum_probs=210.8

Q ss_pred             cCCcccccccCCceEEEEEEEccCCc-----eEEEEEecc-ccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGM-----TLAAKFVGI-AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~K~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      ..+..+.||+|+||.||.+.......     .|++|.+.. .+..+...+.+|+.++.++.||||++++|++.+.+..++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            45677899999999999999875433     388888753 345568889999999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         78 VLELIEGGELFERVIDD------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      ++|||.||+|..++++.      ...++..+...++.+++.|+.||+++++|||||..+|+|+  +....+|+.|||+++
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL--~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL--DERRVVKIADFGLAR  850 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee--cccCcEEEcccchhH
Confidence            99999999999999987      6679999999999999999999999999999999999999  888999999999998


Q ss_pred             cc-CCCC-cc-eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCcccc
Q psy11805        152 KF-DPEK-KL-QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       152 ~~-~~~~-~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      .. +.+. .. ....-+..|||||.+..+.++.++||||||++|||++| |..||.+.+..+.......+. +++.+  .
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P--~  927 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP--S  927 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC--C
Confidence            43 2211 11 11234569999999999999999999999999999999 999999999999998776666 44443  7


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      .+|+.+.+++.+||+.+|++||+
T Consensus       928 ~CP~~ly~lM~~CW~~~pe~RP~  950 (1025)
T KOG1095|consen  928 YCPEKLYQLMLQCWKHDPEDRPS  950 (1025)
T ss_pred             CCChHHHHHHHHHccCChhhCcc
Confidence            89999999999999999999997

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.6e-42  Score=272.82  Aligned_cols=242  Identities=22%  Similarity=0.443  Sum_probs=203.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +-|++.+.||+|+||.||++.+..++..+++|...... ......+.+|+..++.++|+|++++++.+..+...++|+||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            45888999999999999999998889999999875433 22356788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +++++|.+.+...  .++...+..++.|++.++.+||+.|++|+||+|+||++  +.++.++|+|||++....... ...
T Consensus        84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i--~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE--CCCCCEEEeecccceecccchhhhc
Confidence            9999998877543  58999999999999999999999999999999999999  888999999999886643322 122


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...++..|+|||.+.+...+.++|+||||++++++++|..||...........+.....   ......++..+.+++.+|
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHHHHHH
Confidence            33567789999999888888999999999999999999999987766555554433222   112245788999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.+|.+||++
T Consensus       237 l~~~p~~Rp~~  247 (277)
T cd06641         237 LNKEPSFRPTA  247 (277)
T ss_pred             ccCChhhCcCH
Confidence            99999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-42  Score=272.46  Aligned_cols=242  Identities=25%  Similarity=0.447  Sum_probs=209.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....  ......+.+|+..++.++|+||+++.+++.+....++++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5899999999999999999999999999999986433  23456778899999999999999999999999999999999


Q ss_pred             ccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         82 IEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      +++++|.+.+..   .+..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~--~~~~~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL--VANDLVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE--ecCCcEEEeeccchhhhccC-C
Confidence            999999888765   23458999999999999999999999999999999999999  77889999999999776544 3


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||.+.+..++.++|+||||++++++++|+.||...+..+....+.....+...   ..++.++++++.
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~  234 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQNFIR  234 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHHHHH
Confidence            33345788999999998888899999999999999999999999988877666666554433222   367889999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       235 ~~l~~~p~~Rp~~  247 (256)
T cd08530         235 SMLQVKPKLRPNC  247 (256)
T ss_pred             HHcCCCcccCCCH
Confidence            9999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0607|consensus

Probab=100.00  E-value=5.7e-44  Score=271.43  Aligned_cols=243  Identities=31%  Similarity=0.575  Sum_probs=211.4

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEEeccCCc
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLELIEGGE   86 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   86 (251)
                      .+.||+|+|+.|--+....+++.+|+|++.......+.+..+|++++.+.+ |+||++++++|+++...|+|||.|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            367999999999999999999999999998777777999999999999996 9999999999999999999999999999


Q ss_pred             hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeecccccccCCC--------C
Q psy11805         87 LFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFGLARKFDPE--------K  157 (251)
Q Consensus        87 L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~~~~~~~~--------~  157 (251)
                      |...+.... .+++.++..+.++|+.||.+||++||.|||+||+|||....+ -.-+|||||.+....-..        .
T Consensus       163 lLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  163 LLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             HHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            999998875 599999999999999999999999999999999999973322 235899999887553211        2


Q ss_pred             cceeeccCcccccccccc---c--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------------hHHHHHHHHhc
Q psy11805        158 KLQVLFGTPEFVAPEVVN---F--DAIGFGTDMWSVGVICYVLLSGLSPFMGET---------------DVQTMANVTIA  217 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~---~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------------~~~~~~~~~~~  217 (251)
                      ...+.+|+..|||||+..   +  .-|+.+.|.||||+++|=|++|..||.+.-               +.....++..+
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG  321 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG  321 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence            223456788999999862   2  247889999999999999999999997652               25567788999


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.++..-|.+++.+.+++|+.+|..++.+|.++
T Consensus       322 kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa  355 (463)
T KOG0607|consen  322 KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA  355 (463)
T ss_pred             CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence            9999999999999999999999999999999764

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.1e-42  Score=276.53  Aligned_cols=246  Identities=24%  Similarity=0.360  Sum_probs=197.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcC-CCceeeEeEEEeeCCE-----
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQ-HPRLIQIYDAFESSNV-----   74 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~-----   74 (251)
                      ++|++.+.||+|++|.||+|.+..+++.|++|........  ....+.+|+..++.+. |+|++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            5799999999999999999999999999999987644322  3467888999999995 6999999999876655     


Q ss_pred             EEEEEEeccCCchhHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeeccc
Q psy11805         75 MCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFGL  149 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~  149 (251)
                      .+++|||+++ +|.+.+...    ...+++..++.++.|++.||.|||+.|++|+||+|+||++  +. ++.++|+|||.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~--~~~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE--ecCCCeEEEeeccc
Confidence            8999999986 777776543    2358999999999999999999999999999999999998  66 88999999999


Q ss_pred             ccccCCCCc-ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC----
Q psy11805        150 ARKFDPEKK-LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD----  223 (251)
Q Consensus       150 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  223 (251)
                      +........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+...++.........    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            876432211 122346778999998865 45688999999999999999999999887776655544322110000    


Q ss_pred             --------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 --------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                          ...+.++..+.++|.+||.++|.+||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~  285 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA  285 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence                                1113578899999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.7e-42  Score=277.15  Aligned_cols=241  Identities=24%  Similarity=0.403  Sum_probs=203.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +.|+..+.||+|+||.||++.+..++..+++|.+.....   .....+.+|++.++.++|+|++++++++..++..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            458889999999999999999998899999999864322   23457889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+++ ++.+.+......+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++......   
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~--~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE--CCCCCEEEecCCCccccCCc---
Confidence            99976 7777776666679999999999999999999999999999999999999  88899999999988654322   


Q ss_pred             eeeccCcccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ....+++.|+|||.+.   ....+.++||||||+++|+|++|..||...+.......+.........  ...+++.++++
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l  256 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDYFRNF  256 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--CccccHHHHHH
Confidence            2345778999999973   456788999999999999999999999887776666665554432222  24578899999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      +.+||+.+|.+||++
T Consensus       257 i~~~l~~~p~~Rpt~  271 (317)
T cd06635         257 VDSCLQKIPQDRPTS  271 (317)
T ss_pred             HHHHccCCcccCcCH
Confidence            999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-42  Score=270.49  Aligned_cols=243  Identities=25%  Similarity=0.501  Sum_probs=203.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc-----cccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-----KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS--NVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   75 (251)
                      .+|++.+.||+|++|.||++.+..+++.+++|.+...     .......+.+|+..+++++|+|++++++.+.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            6899999999999999999999999999999987432     123456788999999999999999999998653  468


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++++|++++++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR--DSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--cCCCCEEECcccccccccc
Confidence            89999999999988887654 58999999999999999999999999999999999999  8889999999999976432


Q ss_pred             C----CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        156 E----KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       156 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      .    .......++..|+|||.+.+...+.++|+||||++++++++|+.||...+..+...++....  .....+..+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~~~~  236 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLPDGVSD  236 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCCcccCH
Confidence            1    11123357789999999988888999999999999999999999998877666555443322  22333467899


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.++|.+||+ +|.+||++
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~  255 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTA  255 (264)
T ss_pred             HHHHHHHHHhc-CcccCccH
Confidence            99999999999 47999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2e-42  Score=286.01  Aligned_cols=245  Identities=23%  Similarity=0.372  Sum_probs=199.7

Q ss_pred             ccCCcccccccCCceEEEEEEEc-----cCCceEEEEEecccccc-chHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   75 (251)
                      ++|.+.+.||+|+||.||+|.+.     .+++.|++|++...... ....+.+|+.++.++. |+||+++++.+..++..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            56888999999999999999864     34568999998643322 3457889999999997 99999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC------------------------------------------------------------
Q psy11805         76 CVVLELIEGGELFERVIDDD------------------------------------------------------------   95 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~------------------------------------------------------------   95 (251)
                      ++|+||+++++|.+++...+                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999998886432                                                            


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC
Q psy11805         96 -------------------------------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT  138 (251)
Q Consensus        96 -------------------------------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~  138 (251)
                                                           ..++...+..++.|++.||.|||+.|++|+||+|+||++  +.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl--~~  274 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI--CE  274 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE--eC
Confidence                                                 135677888999999999999999999999999999999  78


Q ss_pred             CCcEEEeecccccccCCCC---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy11805        139 GNRIKIIDFGLARKFDPEK---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV  214 (251)
Q Consensus       139 ~~~~~l~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  214 (251)
                      ++.++|+|||++.......   ......++..|+|||.+.+..++.++||||||+++++|++ |..||......+.....
T Consensus       275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~  354 (401)
T cd05107         275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA  354 (401)
T ss_pred             CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence            8899999999997643221   1122345678999999988888999999999999999998 89999876655554443


Q ss_pred             HhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....+..  .+..++..+.+++.+||..+|.+||++
T Consensus       355 ~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~  389 (401)
T cd05107         355 IKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDF  389 (401)
T ss_pred             HHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCH
Confidence            33332222  235678999999999999999999984

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.7e-42  Score=274.38  Aligned_cols=245  Identities=25%  Similarity=0.403  Sum_probs=201.1

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      +|++.+.||.|++|.||+|.+..++..+++|.+...... ....+.+|+..++.++|+|++++++++.+.+..++|||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            589999999999999999999999999999998654332 3567778999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-c
Q psy11805         83 EGGELFERVIDDD--FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-L  159 (251)
Q Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~  159 (251)
                      ++ +|.+.+....  ..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........ .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~--~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI--NKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE--CCCCcEEEeecchhhhhcCCcccc
Confidence            86 7877776543  468999999999999999999999999999999999999  8889999999999875433221 1


Q ss_pred             eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC---------------
Q psy11805        160 QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD---------------  223 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  223 (251)
                      ....+++.|++||.+.+. .++.++|+||||+++|++++|..||...+..+...++.........               
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            233467889999988654 4688999999999999999999999988776655544322110000               


Q ss_pred             ----------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ----------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                ...+..+..+.++|.+||+.+|.+||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~  275 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA  275 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH
Confidence                      0112457889999999999999999984

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=274.65  Aligned_cols=244  Identities=24%  Similarity=0.420  Sum_probs=199.6

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      |++.+.||.|++|.||+|.++.++..|++|++.....  .....+.+|++.++.++|+|++++++++.+++..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            7889999999999999999999999999999864432  23467888999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-e
Q psy11805         83 EGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-Q  160 (251)
Q Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-~  160 (251)
                      + ++|.+.+.... ..+++..++.++.|++.||.+||+.+++|+|++|+||++  +.++.++|+|||.+......... .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~--~~~~~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI--DREGALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE--cCCCcEEEeecccccccCCCccccC
Confidence            6 47888776543 368999999999999999999999999999999999999  77999999999998765432211 2


Q ss_pred             eeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-------------------
Q psy11805        161 VLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD-------------------  220 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------------  220 (251)
                      ...+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+......++......                   
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            22457789999987654 4688999999999999999999999887765544443222111                   


Q ss_pred             ------CCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 ------FDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                            ........++..+.++|.+||+++|++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  274 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA  274 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence                  1111224577899999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.6e-42  Score=272.78  Aligned_cols=236  Identities=32%  Similarity=0.570  Sum_probs=203.1

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      ||.|++|.||++.+..+++.+++|.+.....   .....+.+|++.+++++|+|++++++.+..++..++++|++++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999998899999999864433   3467788999999999999999999999999999999999999999


Q ss_pred             hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC---------c
Q psy11805         88 FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---------K  158 (251)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~---------~  158 (251)
                      .+.+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.......         .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE--cCCCCEEEEecccchhcccCccccccccccc
Confidence            88887654 68999999999999999999999999999999999999  889999999999887643321         1


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....++..|+|||...+...+.++|+||||++++++++|..||......+....+..+...++..  ..++..+.++++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~  235 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLIS  235 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHHH
Confidence            223356779999999988888999999999999999999999999888777776666544443322  235899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       236 ~~l~~~p~~Rpt~  248 (265)
T cd05579         236 KLLVPDPEKRLGA  248 (265)
T ss_pred             HHhcCCHhhcCCC
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.5e-42  Score=277.86  Aligned_cols=246  Identities=24%  Similarity=0.354  Sum_probs=194.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCC-------
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSN-------   73 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------   73 (251)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+......  ......+|+..+++++|||++++++++...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            5799999999999999999999999999999987543322  2445678999999999999999999886543       


Q ss_pred             -EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         74 -VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        74 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                       ..++|||++.+ +|.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+..
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~  168 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI--TKDGILKLADFGLARA  168 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--CCCCcEEECcCCCccc
Confidence             45999999965 7777777665579999999999999999999999999999999999999  8899999999999976


Q ss_pred             cCCCCcc-----eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcc-
Q psy11805        153 FDPEKKL-----QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC-  225 (251)
Q Consensus       153 ~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  225 (251)
                      .......     ....++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.......+... 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            5332211     223466789999988664 368899999999999999999999987765444332222111000000 


Q ss_pred             ---------------------------ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        226 ---------------------------FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       226 ---------------------------~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                 ....+..+.++|.+||..||.+|||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~  301 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA  301 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH
Confidence                                       01135678899999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=275.72  Aligned_cols=244  Identities=28%  Similarity=0.477  Sum_probs=203.6

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      |++.+.||+|++|.||++.+..+++.+++|.+......  ....+.+|++.++.++|++++++++++.+++..++++|++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            78899999999999999999989999999998644332  4577889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-ccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~~  161 (251)
                      ++ ++.+.+......+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... ....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili--~~~~~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI--NTEGVLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE--CCCCcEEEeeeeeeEecCCCcccccC
Confidence            76 7888887765679999999999999999999999999999999999999  888999999999987764433 2223


Q ss_pred             eccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC------------------
Q psy11805        162 LFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD------------------  222 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------  222 (251)
                      ..++..|+|||.+.+. .++.++|+||||+++|++++|+.||...+..+...++........                  
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            3467789999998776 688999999999999999999999988777665544322111100                  


Q ss_pred             --------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 --------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                              ......++..+.++|.+||++||.+||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~  274 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA  274 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence                    11223468899999999999999999984

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-42  Score=275.77  Aligned_cols=242  Identities=34%  Similarity=0.583  Sum_probs=209.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|.+.+.||+|++|.||++.+..++..+++|++...   .......+.+|+..++++. |+||+++++++.+.+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            5899999999999999999999999999999998542   2233567889999999998 99999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      ||++++++|.+.+...+ .+++..++.++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i--~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL--DKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--CCCCCEEecCCccccccCCccc
Confidence            99999999999887664 69999999999999999999999999999999999999  8899999999999876543221


Q ss_pred             ---------------------ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q psy11805        159 ---------------------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIA  217 (251)
Q Consensus       159 ---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  217 (251)
                                           .....++..|+|||...+..++.++|+||||++++++++|..||...+...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                 11224577899999998888899999999999999999999999988876666666544


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....+    ..++..+.++|.+||+.+|++|||+
T Consensus       238 ~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             CCCCC----CccCHHHHHHHHHHhcCCHhhCCCc
Confidence            33333    5668999999999999999999985

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.7e-42  Score=273.16  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=195.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|++|.||+|.+..++..+++|.+...... ....+.+|+..++.++|+|++++.+++.+++..++++|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46899999999999999999999999999999998644322 24467789999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~  159 (251)
                      ++.+ ++.+.+......++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++...... ...
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          84 YMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             cccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE--cCCCcEEEeccccccccCCCCCCC
Confidence            9964 6767666555568889999999999999999999999999999999999  88999999999988654222 112


Q ss_pred             eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccc------------------
Q psy11805        160 QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIAQY------------------  219 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~------------------  219 (251)
                      ....+++.|+|||.+.+. .++.++||||||+++++|++|..||...+.. +...+......                  
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            333467899999998754 4788999999999999999999999865542 22222111000                  


Q ss_pred             --------cCCCcccc--CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 --------DFDDECFN--EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 --------~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                              ......+.  ..+..+.+++.+||..||.+|||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~  282 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA  282 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH
Confidence                    00000111  135689999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.2e-42  Score=270.04  Aligned_cols=242  Identities=21%  Similarity=0.362  Sum_probs=201.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|++|.||++.+. .+..+++|.+... ......+.+|+.+++.++|+|++++.+.+.. ...+++||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            578999999999999999999865 4556889987532 2345678899999999999999999999887 678999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-  159 (251)
                      +++++|.+++... +..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE--cCCCcEEECCCcceeeccCCCccc
Confidence            9999999988753 3457889999999999999999999999999999999999  88999999999998765322211 


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       ....++..|+|||.+.+..++.++|+||||++++++++ |..||...+.......+..+..   .+.....+.++.+++
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i  236 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENCPEELYNIM  236 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---CCCcccCCHHHHHHH
Confidence             11224567999999988888999999999999999998 9999988877666665544322   122357889999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+++|++||++
T Consensus       237 ~~~l~~~p~~Rp~~  250 (260)
T cd05073         237 MRCWKNRPEERPTF  250 (260)
T ss_pred             HHHcccCcccCcCH
Confidence            99999999999984

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.3e-42  Score=270.26  Aligned_cols=233  Identities=18%  Similarity=0.233  Sum_probs=187.4

Q ss_pred             cccccCCceEEEEEEEccC------------CceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          9 SAFSFGKFGTVYRCKEKAT------------GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~------------~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      +.||.|++|.||++.....            ...+++|++..........+.+|+..++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999985421            2358888876555555667888999999999999999999999888899


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc-------EEEeeccc
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR-------IKIIDFGL  149 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~-------~~l~df~~  149 (251)
                      ++||++++++|..++......+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.       ++++|||.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill--~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILL--AREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEE--ecCCccCCCCceeEeCCCCC
Confidence            9999999999988877666679999999999999999999999999999999999998  44443       89999998


Q ss_pred             ccccCCCCcceeeccCcccccccccc-cCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhccccCCCcccc
Q psy11805        150 ARKFDPEKKLQVLFGTPEFVAPEVVN-FDAIGFGTDMWSVGVICYVLL-SGLSPFMGETDVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      +......   ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+... ........    ..
T Consensus       159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~----~~  230 (262)
T cd05077         159 PITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCML----VT  230 (262)
T ss_pred             CccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccC----CC
Confidence            8654322   2234677899999886 466889999999999999997 5889987765544332 21222211    13


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.++.+||.+||+.||.+||++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~  254 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFF  254 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCH
Confidence            346789999999999999999984

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.1e-42  Score=279.43  Aligned_cols=245  Identities=22%  Similarity=0.307  Sum_probs=201.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccC-------CceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT-------GMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESS   72 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   72 (251)
                      ..+|++.+.||+|+||.||.|.+...       +..+++|.+.... ......+.+|+++++++ +|+||+++++.+..+
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            35799999999999999999987432       2368899876432 22357888999999999 799999999999999


Q ss_pred             CEEEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec
Q psy11805         73 NVMCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK  137 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~  137 (251)
                      +..++++||+++++|.+++....               ..++...+..++.|++.||.+||+.|++|+||+|+||++  +
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill--~  168 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV--T  168 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE--c
Confidence            99999999999999998886532               247788899999999999999999999999999999999  8


Q ss_pred             CCCcEEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy11805        138 TGNRIKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN  213 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  213 (251)
                      .++.++|+|||.+.........   ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            8899999999998764332111   11223457999999998889999999999999999998 8999988877776666


Q ss_pred             HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +......   .....++..+.+++.+||+.+|.+|||+
T Consensus       249 ~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~  283 (334)
T cd05100         249 LKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTF  283 (334)
T ss_pred             HHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCH
Confidence            5443321   1224678899999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.1e-42  Score=270.16  Aligned_cols=243  Identities=25%  Similarity=0.493  Sum_probs=205.7

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +|++.+.||.|++|.||++.++.++..+++|.+....  ......+.+|++.++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5889999999999999999999999999999986532  23456788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-cEEEeecccccccCCCCcc
Q psy11805         82 IEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~~~~~~~  159 (251)
                      +++++|.+.+.... ..+++..+..++.|++.||.+||+.|++|+|++|+||++  +.++ .++++|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~--~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL--SKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE--cCCCCeEEecccccchhccCCccc
Confidence            99999988886543 357999999999999999999999999999999999998  6665 4699999988765433222


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                       ....+++.|+|||.+.+..++.++|+||||++++++++|..||...+..+............   ..+.++..+.++|.
T Consensus       159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~  235 (257)
T cd08225         159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRSLIS  235 (257)
T ss_pred             ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHHHHH
Confidence             23357889999999988889999999999999999999999998877666655554433322   22467889999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       236 ~~l~~~p~~Rpt~  248 (257)
T cd08225         236 QLFKVSPRDRPSI  248 (257)
T ss_pred             HHhccChhhCcCH
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.7e-42  Score=269.44  Aligned_cols=237  Identities=21%  Similarity=0.330  Sum_probs=198.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||.||.+..  +++.+++|.+...  .....+.+|+..++.++|+|++++++.+..++ .+++||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence            5799999999999999998864  5778999997543  23567889999999999999999999987654 68999999


Q ss_pred             cCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCccee
Q psy11805         83 EGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~  161 (251)
                      ++++|.+.+.... ..++...++.++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||.+.......  ..
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili--~~~~~~kl~Dfg~~~~~~~~~--~~  156 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV--SEDGVAKVSDFGLARVGSMGV--DN  156 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE--cCCCcEEECCCccceeccccC--CC
Confidence            9999999887543 358999999999999999999999999999999999999  888999999999986643221  12


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+. ...  ....+|..+.+++.+|
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~  233 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RME--PPEGCPADVYVLMTSC  233 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CCC--CCCcCCHHHHHHHHHH
Confidence            234568999999988889999999999999999998 999998887766666554442 222  1256789999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.+|++||++
T Consensus       234 l~~~p~~Rp~~  244 (254)
T cd05083         234 WETEPKKRPSF  244 (254)
T ss_pred             cCCChhhCcCH
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.9e-42  Score=272.57  Aligned_cols=246  Identities=25%  Similarity=0.402  Sum_probs=198.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~   79 (251)
                      ++|+..+.||.|++|.||++.+..+++.+++|.+..... .....+.+|++.+++++|+||+++++++..  .+..+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            578999999999999999999998999999999864332 346778999999999999999999998864  34689999


Q ss_pred             EeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         80 ELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ||+++++|.+.+..   ....++...+..++.|++.||.|||+.|++|+|++|+||++  +.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL--TRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--ecCCeEEEeecccccccccc
Confidence            99999999776542   34568999999999999999999999999999999999999  88889999999998654322


Q ss_pred             CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhccccCCC---ccccC
Q psy11805        157 KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET-----DVQTMANVTIAQYDFDD---ECFNE  228 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~---~~~~~  228 (251)
                      .. ....++..|+|||.+.+..++.++||||||+++|+|++|..||....     ..+....+.........   .....
T Consensus       159 ~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd06621         159 LA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK  237 (287)
T ss_pred             cc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence            21 23346778999999988889999999999999999999999998652     22333322221111111   10023


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +++.+.++|.+||+.+|.+|||+
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~  260 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTP  260 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCH
Confidence            46789999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.6e-42  Score=273.25  Aligned_cols=245  Identities=18%  Similarity=0.226  Sum_probs=201.8

Q ss_pred             CccCCcccccccCCceEEEEEEEcc----CCceEEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEee-CCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA----TGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFES-SNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   75 (251)
                      +++|++.+.||+|+||.||+|.+..    ++..+++|.+... .......+.+|+..++.++|+|++++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4789999999999999999999876    2578888887533 23346778899999999999999999998765 4668


Q ss_pred             EEEEEeccCCchhHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         76 CVVLELIEGGELFERVIDDD-------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                      +++++++++++|.+++....       ..+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~--~~~~~~kl~d~g  162 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI--DEELQVKITDNA  162 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE--cCCCcEEECCCC
Confidence            99999999999988876532       358999999999999999999999999999999999999  888999999999


Q ss_pred             cccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        149 LARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       149 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                      ++.........   ....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+..+ ....  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~--  239 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRLA--  239 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCCC--
Confidence            99765332211   11234567999999988889999999999999999999 99999887766655544433 2222  


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....+|+++.+++.+||..+|++|||+
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~  266 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSF  266 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence            224678999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.3e-43  Score=273.46  Aligned_cols=233  Identities=17%  Similarity=0.288  Sum_probs=188.6

Q ss_pred             cccccCCceEEEEEEEccCC-------ceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          9 SAFSFGKFGTVYRCKEKATG-------MTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~-------~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +.||+|+||.||+|.+..++       ..+++|..........+.+.+|+..++.+.|+|++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            47999999999999886543       34788887554444567788899999999999999999999998889999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc--------EEEeeccccccc
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR--------IKIIDFGLARKF  153 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~--------~~l~df~~~~~~  153 (251)
                      +++++|.+++...+..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.        ++++|||.+...
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili--~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLL--IREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE--ecccccccCCCceEEeccccccccc
Confidence            99999999988766678999999999999999999999999999999999998  44443        699999988654


Q ss_pred             CCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSG-LSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ...   ....++..|+|||.+.+ ..++.++||||||+++|++++| ..||...+........ ......+    ...+.
T Consensus       159 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~  230 (258)
T cd05078         159 LPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDRHQLP----APKWT  230 (258)
T ss_pred             CCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-HccccCC----CCCcH
Confidence            322   22346778999999876 4578899999999999999998 5666665554443322 2222222    34567


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.+++.+||+.+|++|||+
T Consensus       231 ~~~~li~~~l~~~p~~Rps~  250 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSF  250 (258)
T ss_pred             HHHHHHHHHhccChhhCCCH
Confidence            89999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.3e-42  Score=280.83  Aligned_cols=245  Identities=22%  Similarity=0.335  Sum_probs=194.4

Q ss_pred             ccCCcccccccCCceEEEEEEEc-----cCCceEEEEEeccccc-cchHHHHHHHHHHHHc-CCCceeeEeEEEee-CCE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAKR-NDRRNVEREVEIMREL-QHPRLIQIYDAFES-SNV   74 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~   74 (251)
                      ++|++.+.||.|+||.||+|.+.     .+++.||+|.+..... .....+.+|+..+.++ +|+||+++++++.. ...
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            68999999999999999999853     4567899999864332 2356788999999999 68999999998765 456


Q ss_pred             EEEEEEeccCCchhHHHhhCC-----------------------------------------------------------
Q psy11805         75 MCVVLELIEGGELFERVIDDD-----------------------------------------------------------   95 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-----------------------------------------------------------   95 (251)
                      .+++|||+++++|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            899999999999988876421                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc---ceeeccC
Q psy11805         96 -------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGT  165 (251)
Q Consensus        96 -------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~  165 (251)
                             ..++...+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++........   .....++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE--cCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                   236778889999999999999999999999999999999  8889999999999876432211   1112245


Q ss_pred             cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        166 PEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       166 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      ..|+|||.+.+..++.++||||||+++|++++ |..||......+..............+  ...++.+.+++.+||+.+
T Consensus       245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHccCC
Confidence            67999999988889999999999999999997 999997765433332222222222222  346789999999999999


Q ss_pred             cCCCCCC
Q psy11805        245 REDAPEV  251 (251)
Q Consensus       245 p~~Rps~  251 (251)
                      |++|||+
T Consensus       323 p~~Rps~  329 (343)
T cd05103         323 PSQRPTF  329 (343)
T ss_pred             hhhCcCH
Confidence            9999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.6e-42  Score=273.61  Aligned_cols=242  Identities=26%  Similarity=0.482  Sum_probs=203.6

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      |.-...||+|++|.||++....++..+++|.+..........+.+|+..++.++|+|++++++.+...+..+++||++++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            33456799999999999999999999999998654445567788999999999999999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~  163 (251)
                      ++|.+.+...  .+++..+..++.|++.||++||+.|++|+||+|+||++  +.++.++|+|||.+....... ......
T Consensus       102 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv--~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657         102 GALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCCEEEcccccceecccccccccccc
Confidence            9998876443  58999999999999999999999999999999999999  888999999999886653322 123345


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      +++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+....+.... +........++..+.+++.+||+.
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPKLKNLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CcccCCcccCCHHHHHHHHHHHhC
Confidence            7789999999988888999999999999999999999998877666555443322 222223356789999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      +|.+||++
T Consensus       257 ~P~~R~~~  264 (292)
T cd06657         257 DPAQRATA  264 (292)
T ss_pred             CcccCcCH
Confidence            99999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.7e-42  Score=275.50  Aligned_cols=244  Identities=23%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCc----eEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGM----TLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||+|++|.||++.+..++.    .+++|.+..... .....+.+|+..++.++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            3688999999999999999999877665    468887754322 2244678999999999999999999988754 467


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ++++++++++|.+.+......+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||.+......
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill--~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV--KSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee--cCCCceEEccccccccccCc
Confidence            8999999999999988776678999999999999999999999999999999999999  88889999999999765432


Q ss_pred             Ccc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        157 KKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       157 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      ...   ....++..|+|||.+.+..++.++||||||+++|++++ |..||.+....+....+..+. ..+  .....+..
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~  239 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLP--QPPICTID  239 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCC--CCCCCCHH
Confidence            221   12234568999999988889999999999999999997 999998766554444333222 222  22456889


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+++.+||..+|++||++
T Consensus       240 ~~~li~~c~~~~p~~Rp~~  258 (303)
T cd05110         240 VYMVMVKCWMIDADSRPKF  258 (303)
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.5e-42  Score=268.83  Aligned_cols=238  Identities=21%  Similarity=0.287  Sum_probs=191.9

Q ss_pred             cccccCCceEEEEEEEcc---CCceEEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEe-eCCEEEEEEEecc
Q psy11805          9 SAFSFGKFGTVYRCKEKA---TGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFE-SSNVMCVVLELIE   83 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~---~~~~~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~   83 (251)
                      +.||+|+||.||+|.+..   +...+++|.+... .......+.+|+..++.++|+|++++++++. .++..++++|+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998753   3457899987432 2334677888999999999999999999765 4566899999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-----
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-----  158 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-----  158 (251)
                      +++|.+++.......+...+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++........     
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili--~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE--cCCCcEEECCccccccccCCcceeecc
Confidence            999999887665567888889999999999999999999999999999999  8889999999999875432111     


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+....   ....+|+.+.+++
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li  235 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL---QPEYCPDPLYEVM  235 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCHHHHHHH
Confidence            112234568999999988889999999999999999999 567787776666655554433221   1245788999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.+|++||++
T Consensus       236 ~~cl~~~p~~Rp~~  249 (262)
T cd05058         236 LSCWHPKPEMRPTF  249 (262)
T ss_pred             HHHcCCChhhCCCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-42  Score=273.85  Aligned_cols=246  Identities=24%  Similarity=0.390  Sum_probs=200.4

Q ss_pred             CccCCcccccccCCceEEEEEEEcc----CCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEee--CCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA----TGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFES--SNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~   74 (251)
                      .++|++.+.||+|+||.||++.+..    +++.+++|.+...... ....+.+|++.++.++|+|++++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            4689999999999999999998753    4789999998654433 46789999999999999999999999877  557


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .+++||++++++|.+++......++...++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV--ESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE--cCCCCEEEcccccccccc
Confidence            899999999999999988766679999999999999999999999999999999999999  888999999999997765


Q ss_pred             CCCcce----eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHHh
Q psy11805        155 PEKKLQ----VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ--------------TMANVTI  216 (251)
Q Consensus       155 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~  216 (251)
                      ......    ....+..|++||.+.+..++.++||||||+++++|++|..||.......              .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            322211    1223456999999988889999999999999999999999986543221              1111112


Q ss_pred             ccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ......  ....++.++.+++.+||+.+|++|||+
T Consensus       241 ~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~  273 (284)
T cd05038         241 EGERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSF  273 (284)
T ss_pred             cCCcCC--CCccCCHHHHHHHHHHhccChhhCCCH
Confidence            222211  224678899999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.7e-42  Score=277.23  Aligned_cols=195  Identities=28%  Similarity=0.445  Sum_probs=159.7

Q ss_pred             ccccccCCceEEEEEEEc--cCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEEEEEEEecc
Q psy11805          8 HSAFSFGKFGTVYRCKEK--ATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVMCVVLELIE   83 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~   83 (251)
                      ..+||+|+||.||+|.+.  .+++.+++|.+...  .....+.+|+.++++++||||+++++++..  +...++++|++.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999975  46788999987532  234567899999999999999999998854  456899999986


Q ss_pred             CCchhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee--cCCCcEEEeeccccccc
Q psy11805         84 GGELFERVIDD--------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT--KTGNRIKIIDFGLARKF  153 (251)
Q Consensus        84 ~~~L~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~--~~~~~~~l~df~~~~~~  153 (251)
                      + +|.+.+...        ...+++..+..++.|++.||.|||+.|++|+||||+||++..  +.++.++|+|||++...
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            5 776766432        224899999999999999999999999999999999999843  34568999999999765


Q ss_pred             CCCC----cceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11805        154 DPEK----KLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGE  205 (251)
Q Consensus       154 ~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~  205 (251)
                      ....    ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||...
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            4322    1233467889999999876 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.7e-42  Score=271.59  Aligned_cols=238  Identities=21%  Similarity=0.367  Sum_probs=195.3

Q ss_pred             cccccCCceEEEEEEEccCC------ceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          9 SAFSFGKFGTVYRCKEKATG------MTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~------~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +.||.|++|.||++.+....      ..+++|.+.... ......+.+|++.++.++|+||+++++++...+..+++||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999986433      678888875432 23467788999999999999999999999998999999999


Q ss_pred             ccCCchhHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-----cEEEeecccc
Q psy11805         82 IEGGELFERVIDD------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-----RIKIIDFGLA  150 (251)
Q Consensus        82 ~~~~~L~~~~~~~------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-----~~~l~df~~~  150 (251)
                      +++++|.+.+...      ...+++..+..++.|++.||.|||+.+++|+||+|+||++  +.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~--~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV--SEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEE--ecCCCCCCcceEECCcccc
Confidence            9999999888642      2347889999999999999999999999999999999998  5555     8999999998


Q ss_pred             cccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccc
Q psy11805        151 RKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECF  226 (251)
Q Consensus       151 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (251)
                      ........   ......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+...   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~  235 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QKP  235 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CCc
Confidence            65432211   112234578999999998889999999999999999998 99999887777666555433211   223


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+|..+.++|.+||+.+|++||++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~  260 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTF  260 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCH
Confidence            5678999999999999999999985

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.9e-42  Score=274.40  Aligned_cols=246  Identities=25%  Similarity=0.384  Sum_probs=201.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-------
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSN-------   73 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------   73 (251)
                      ++|++.+.||+|++|.||+|.++.+++.|++|.+.....  .....+.+|+..++.++|||++++++++.+..       
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            689999999999999999999999999999999865432  23467788999999999999999999987654       


Q ss_pred             ---EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccc
Q psy11805         74 ---VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLA  150 (251)
Q Consensus        74 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~  150 (251)
                         ..++++|++++ ++...+......+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili--~~~~~~kl~dfg~~  163 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL--NNKGQIKLADFGLA  163 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCcEEeCccccc
Confidence               78999999987 6667666655579999999999999999999999999999999999999  88999999999999


Q ss_pred             cccCCCCcc--eeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC----
Q psy11805        151 RKFDPEKKL--QVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD----  223 (251)
Q Consensus       151 ~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  223 (251)
                      .........  ....++..|+|||.+.+ ...+.++||||||+++++|++|+.||...+..+....+.........    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            765433211  12235678999998864 34688999999999999999999999887766655544332111100    


Q ss_pred             ----------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ----------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                            ..+..+|..+.+++.+||+.+|++|||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~  293 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA  293 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH
Confidence                                  1123578999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=281.08  Aligned_cols=246  Identities=30%  Similarity=0.446  Sum_probs=195.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC-----CE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESS-----NV   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   74 (251)
                      ++++|++.+.||+|++|.||++.+..+++.|++|.+.... ......+.+|+..++.++|+|++++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            4689999999999999999999999999999999986432 22356678899999999999999999987543     35


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .++++|++++ +|.+.+..  ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++....
T Consensus        83 ~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          83 VYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--CCCCCEEECcccceeecc
Confidence            7999999975 77666644  358999999999999999999999999999999999999  889999999999987653


Q ss_pred             CCCc----ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-----------
Q psy11805        155 PEKK----LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ-----------  218 (251)
Q Consensus       155 ~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----------  218 (251)
                      ....    .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+....           
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            3221    122356788999998654 467889999999999999999999997765433322111100           


Q ss_pred             -----------c--cCC---CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        219 -----------Y--DFD---DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       219 -----------~--~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                 .  ...   ....+..+.++.++|.+||+.+|++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  286 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV  286 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH
Confidence                       0  000   01123567889999999999999999984

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.8e-42  Score=274.18  Aligned_cols=246  Identities=20%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|+..+.||+|++|.||++.+..++..+++|.+..... .....+.+|+..+.++. |+||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            467888999999999999999999999999999864332 34567889999999996 9999999999998889999999


Q ss_pred             eccCCchhHHHh---h-CCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         81 LIEGGELFERVI---D-DDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        81 ~~~~~~L~~~~~---~-~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++.+ ++.+...   . ....+++..+..++.+++.||+|||+. |++|+||+|+||++  +.++.++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE--ccCCcEEEeecchhHHhcc
Confidence            9865 5444322   1 235699999999999999999999975 99999999999999  8889999999999876544


Q ss_pred             CCcceeeccCcccccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccc-cCCCccccCCC
Q psy11805        156 EKKLQVLFGTPEFVAPEVVNFD---AIGFGTDMWSVGVICYVLLSGLSPFMGETD-VQTMANVTIAQY-DFDDECFNEIS  230 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~  230 (251)
                      ........+++.|+|||.+.+.   .++.++||||+|+++|+|++|+.||..... .+.......... .........++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS  240 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence            3333344578899999998766   678899999999999999999999976542 122222222211 11112224588


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++.+||.+||+.+|++|||+
T Consensus       241 ~~l~~li~~~l~~~p~~Rpt~  261 (288)
T cd06616         241 PSFVNFINLCLIKDESKRPKY  261 (288)
T ss_pred             HHHHHHHHHHccCChhhCcCH
Confidence            999999999999999999984

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.5e-42  Score=271.33  Aligned_cols=235  Identities=16%  Similarity=0.205  Sum_probs=186.8

Q ss_pred             cccccCCceEEEEEEEccC------------------------CceEEEEEeccccccchHHHHHHHHHHHHcCCCceee
Q psy11805          9 SAFSFGKFGTVYRCKEKAT------------------------GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQ   64 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~------------------------~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   64 (251)
                      ..||+|+||.||++....+                        ...+++|++..........+.+|+..++.++|+||++
T Consensus         1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence            4699999999999975321                        2357888876544444567888999999999999999


Q ss_pred             EeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-----CC
Q psy11805         65 IYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-----TG  139 (251)
Q Consensus        65 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-----~~  139 (251)
                      +++++..+...++||||+++++|...+......+++..+..++.|++.||.|||+.|++|+||+|+||++...     ..
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence            9999999999999999999999988887666678999999999999999999999999999999999998321     12


Q ss_pred             CcEEEeecccccccCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhc
Q psy11805        140 NRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLL-SGLSPFMGETDVQTMANVTIA  217 (251)
Q Consensus       140 ~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~  217 (251)
                      ..++++|||.+......   ....++..|+|||.+.+ ..++.++||||||+++|+++ +|..||......+...... .
T Consensus       161 ~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~  236 (274)
T cd05076         161 PFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE-K  236 (274)
T ss_pred             ceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH-h
Confidence            24899999987543221   22346778999998865 56789999999999999985 6999998776555433222 2


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....+    ...+..+.++|.+||+.+|++|||+
T Consensus       237 ~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~  266 (274)
T cd05076         237 KHRLP----EPSCKELATLISQCLTYEPTQRPSF  266 (274)
T ss_pred             ccCCC----CCCChHHHHHHHHHcccChhhCcCH
Confidence            22222    2345789999999999999999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2e-41  Score=273.04  Aligned_cols=240  Identities=24%  Similarity=0.394  Sum_probs=201.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .|...+.||+|++|.||+|.+..++..+++|.+.....   .....+.+|+..++.++|+|++++.+++.+....+++||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            46677889999999999999998999999999864332   234568889999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      |+.+ ++.+.+......+++..+..++.|++.+|.+||+.|++|+||+|+||++  +.++.++|+|||.+.....   ..
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili--~~~~~~kL~dfg~~~~~~~---~~  175 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFGSASKSSP---AN  175 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE--CCCCCEEEeecCCCcccCC---CC
Confidence            9965 6777776666679999999999999999999999999999999999999  8889999999998864322   22


Q ss_pred             eeccCcccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ...++..|+|||.+.   ...++.++||||||+++|+|++|..||...+......++.....+..  ....++..+++|+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li  253 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--QSNEWTDSFRGFV  253 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CccccCHHHHHHH
Confidence            345788999999984   35678899999999999999999999988877666655544333222  1245778899999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.+|.+||++
T Consensus       254 ~~~l~~~P~~Rp~~  267 (313)
T cd06633         254 DYCLQKIPQERPAS  267 (313)
T ss_pred             HHHccCChhhCcCH
Confidence            99999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0690|consensus

Probab=100.00  E-value=1.8e-43  Score=269.57  Aligned_cols=240  Identities=29%  Similarity=0.524  Sum_probs=214.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|...+.||.|.||+|-+|+-+.+++.+|+|+++..--   .+..--.-|-++|+..+||.+..+--.|+....+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            578899999999999999999999999999999864332   23444556778888899999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc-CCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~-~~~~~  158 (251)
                      ||..||.|.-++.... .+++..++-+...|++||.|||+++||+||+|.+|.|+  +.+|++|++|||++... ..+..
T Consensus       248 eyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL--DkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  248 EYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL--DKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee--ccCCceEeeecccchhcccccce
Confidence            9999999977776543 69999999999999999999999999999999999999  99999999999999763 33455


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ..+.||||.|+|||++....|+.+.|.|.+|++||||++|++||.+.+......-+......++    ..++++++.|+.
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----r~ls~eAktLLs  400 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----RTLSPEAKTLLS  400 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC----ccCCHHHHHHHH
Confidence            6778999999999999999999999999999999999999999999999999888888877777    678999999999


Q ss_pred             HhcccCcCCCC
Q psy11805        239 KLLLKDREDAP  249 (251)
Q Consensus       239 ~~l~~~p~~Rp  249 (251)
                      .+|.+||.+|.
T Consensus       401 GLL~kdP~kRL  411 (516)
T KOG0690|consen  401 GLLKKDPKKRL  411 (516)
T ss_pred             HHhhcChHhhc
Confidence            99999999995

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.4e-42  Score=268.65  Aligned_cols=231  Identities=16%  Similarity=0.236  Sum_probs=188.0

Q ss_pred             cccccCCceEEEEEEEccCC----------ceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          9 SAFSFGKFGTVYRCKEKATG----------MTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~----------~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +.||+|+||.||++.+..++          ..+++|.+...... ...+.+|+..++.++|+|++++++++.. ...+++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47899999999999998766          34777776543333 6788899999999999999999999887 778999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-------cEEEeeccccc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-------RIKIIDFGLAR  151 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-------~~~l~df~~~~  151 (251)
                      |||+++++|.+++...+..++...+..++.|++.||.|||+.|++|+||+|+||++  +.++       .++|+|||.+.
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill--~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV--ARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEE--ecCccccCCceeEEeCCCCccc
Confidence            99999999999887766578999999999999999999999999999999999998  5555       79999999987


Q ss_pred             ccCCCCcceeeccCcccccccccccC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccC
Q psy11805        152 KFDPEKKLQVLFGTPEFVAPEVVNFD--AIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      ....   .....++..|+|||.+.+.  .++.++||||||+++++|++ |..||...+..+........ ...+    ..
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~----~~  228 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLP----MP  228 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCC----CC
Confidence            6543   2233456789999999776  78899999999999999999 68888776544433333211 1111    11


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....+.+++.+||..+|++|||+
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~  251 (259)
T cd05037         229 DCAELANLINQCWTYDPTKRPSF  251 (259)
T ss_pred             CchHHHHHHHHHhccChhhCCCH
Confidence            23789999999999999999984

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=8.6e-42  Score=273.17  Aligned_cols=245  Identities=20%  Similarity=0.339  Sum_probs=197.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+..... .....+..|+..+.... |+||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            578999999999999999999998899999999864332 23455666777666665 9999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ++.+ ++.+........+++..+..++.|++.|+.|||+ .|++|+||+|+||++  +.++.++|+|||.+.........
T Consensus        95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill--~~~~~~kL~dfg~~~~~~~~~~~  171 (296)
T cd06618          95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL--DASGNVKLCDFGISGRLVDSKAK  171 (296)
T ss_pred             ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE--cCCCCEEECccccchhccCCCcc
Confidence            9855 6766666545579999999999999999999997 599999999999999  88999999999998765443333


Q ss_pred             eeeccCcccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDA----IGFGTDMWSVGVICYVLLSGLSPFMGETD-VQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      ....+++.|+|||.+.+..    ++.++||||||+++|+|++|+.||..... .+....+....... .+....++.++.
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  250 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-LPPNEGFSPDFC  250 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-CCCCCCCCHHHH
Confidence            3345678999999986553    78899999999999999999999976433 33444443332211 111235788999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      +|+.+||+.+|++||++
T Consensus       251 ~li~~~l~~~p~~Rp~~  267 (296)
T cd06618         251 SFVDLCLTKDHRKRPKY  267 (296)
T ss_pred             HHHHHHccCChhhCCCH
Confidence            99999999999999984

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0986|consensus

Probab=100.00  E-value=2.6e-43  Score=278.54  Aligned_cols=246  Identities=27%  Similarity=0.468  Sum_probs=216.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .+.|+..+.||.|+||.||.++-+.+|+-+|+|.+....   ..-..-..+|-.+|.+++.+.||.+--.|++.+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            467899999999999999999999999999998874322   22345567889999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         79 LELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      +..|+||+|.-++...+ ..+++..+.-++.+|+-||+.||+.+||+||+||+|||+  |++|++.|+|.|+++......
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL--Dd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL--DDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee--ccCCCeEeeccceEEecCCCC
Confidence            99999999987776654 359999999999999999999999999999999999999  999999999999999998888


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ......||.+|||||++.++.|+...|.|||||++|+|+.|+.||.........+.+.......+......++++++++.
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc  421 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLC  421 (591)
T ss_pred             ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHH
Confidence            88777999999999999999999999999999999999999999987655444444444444455555688999999999


Q ss_pred             HHhcccCcCCCC
Q psy11805        238 RKLLLKDREDAP  249 (251)
Q Consensus       238 ~~~l~~~p~~Rp  249 (251)
                      +.+|++||.+|.
T Consensus       422 ~~LL~Kdp~~RL  433 (591)
T KOG0986|consen  422 EGLLTKDPEKRL  433 (591)
T ss_pred             HHHHccCHHHhc
Confidence            999999999995

>KOG4721|consensus

Probab=100.00  E-value=1.6e-43  Score=286.81  Aligned_cols=229  Identities=23%  Similarity=0.402  Sum_probs=199.0

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      .+=||+|+.|.||+++..  +..||+|.++.       .-+-+++.|++|+|+||+.+.+++...-.++||||||..|.|
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            456899999999999888  67899998642       224678889999999999999999999999999999999999


Q ss_pred             hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCcc
Q psy11805         88 FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE  167 (251)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  167 (251)
                      .++++... +++......|..+|+.|+.|||.+.|+|||||.-||||  ..+..|||+|||.+.-...-......+||..
T Consensus       200 ~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI--s~~d~VKIsDFGTS~e~~~~STkMSFaGTVa  276 (904)
T KOG4721|consen  200 YEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI--SYDDVVKISDFGTSKELSDKSTKMSFAGTVA  276 (904)
T ss_pred             HHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe--eccceEEeccccchHhhhhhhhhhhhhhhHh
Confidence            88887654 79999999999999999999999999999999999999  9999999999999977655444456689999


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCC
Q psy11805        168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED  247 (251)
Q Consensus       168 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  247 (251)
                      |||||++.+++++.+.||||||++||||+||..||.+.+...++--+..+.  +..+.+..+|+.++=||++||+--|..
T Consensus       277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNs--L~LpvPstcP~GfklL~Kqcw~sKpRN  354 (904)
T KOG4721|consen  277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNS--LHLPVPSTCPDGFKLLLKQCWNSKPRN  354 (904)
T ss_pred             hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCc--ccccCcccCchHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999999999999998877655543332222  233344788999999999999999999


Q ss_pred             CCC
Q psy11805        248 APE  250 (251)
Q Consensus       248 Rps  250 (251)
                      |||
T Consensus       355 RPS  357 (904)
T KOG4721|consen  355 RPS  357 (904)
T ss_pred             Ccc
Confidence            997

>KOG0612|consensus

Probab=100.00  E-value=1e-43  Score=306.35  Aligned_cols=243  Identities=28%  Similarity=0.449  Sum_probs=215.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecc---ccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGI---AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +||.|++.||.|+||.|.+++++.+++.||+|++..   -...+...|..|-.++-.-..+=|+.+.-.|.+++++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            689999999999999999999999999999999865   33556788888888888888899999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||++||+|..++...+ +++++.+.-++..++.||..+|+.|+|||||||+|||+  +..|+++|.|||.|...+.+...
T Consensus       155 dY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl--d~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL--DKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             ecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe--cccCcEeeccchhHHhcCCCCcE
Confidence            9999999999988777 89999999999999999999999999999999999999  99999999999999988755433


Q ss_pred             --eeeccCcccccccccc----c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        160 --QVLFGTPEFVAPEVVN----F-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       160 --~~~~~~~~y~aPE~~~----~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                        ....|||.|.|||++.    + +.|++..|.||+|+++|||+.|..||...+..+++.+++.-.-.+..|....+|.+
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence              4567999999999983    2 56889999999999999999999999999999999999877544444433569999


Q ss_pred             HHHHHHHhcccCcCCCC
Q psy11805        233 AKDFIRKLLLKDREDAP  249 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rp  249 (251)
                      +++||++++.. |+.|.
T Consensus       312 akdLI~~ll~~-~e~RL  327 (1317)
T KOG0612|consen  312 AKDLIEALLCD-REVRL  327 (1317)
T ss_pred             HHHHHHHHhcC-hhhhc
Confidence            99999998875 55554

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-41  Score=276.48  Aligned_cols=247  Identities=27%  Similarity=0.423  Sum_probs=198.9

Q ss_pred             CCccCCc-ccccccCCceEEEEEEEccCCceEEEEEeccccccc--------------hHHHHHHHHHHHHcCCCceeeE
Q psy11805          1 MTTHQNQ-HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND--------------RRNVEREVEIMRELQHPRLIQI   65 (251)
Q Consensus         1 ~~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------------~~~~~~e~~~l~~l~~~~i~~~   65 (251)
                      +.++|.. .+.||+|++|.||+|.+..+++.|++|.+.......              ...+.+|+..+++++|+|++++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            3578875 577999999999999999999999999985433221              1247789999999999999999


Q ss_pred             eEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEe
Q psy11805         66 YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKII  145 (251)
Q Consensus        66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~  145 (251)
                      ++++..++..+++||++++ +|.+.+... ..++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill--~~~~~~kl~  161 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMAS-DLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI--NSKGICKIA  161 (335)
T ss_pred             eEEEecCCcEEEEEecccc-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE--CCCCCEEEC
Confidence            9999999999999999975 787777654 468999999999999999999999999999999999999  888999999


Q ss_pred             ecccccccCCC---------------CcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy11805        146 DFGLARKFDPE---------------KKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ  209 (251)
Q Consensus       146 df~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  209 (251)
                      |||.+......               .......+++.|+|||.+.+. .++.++|+||||+++++|++|..||...+..+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99998765411               111223457789999998764 46889999999999999999999999888766


Q ss_pred             HHHHHHhccccCCC------------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        210 TMANVTIAQYDFDD------------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       210 ~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....+.........                        ......+..+.++|.+||+.+|++|||+
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  307 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA  307 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence            65544321111100                        1123457889999999999999999984

>KOG0577|consensus

Probab=100.00  E-value=1.3e-43  Score=288.50  Aligned_cols=239  Identities=24%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      |.=.+.||.|+||.||.|.+..+...||+|.++....   +..+.+..|+.+|+++.|||.+.+-+.|..+...++||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            5557889999999999999999999999999975443   3478899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCccee
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV  161 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~  161 (251)
                      |-| +-.+.+.-..+++-+..+..|..+.+.||+|||+.+.+|+|||..|||+  ++.|.|||.|||.+....+.   ..
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL--se~g~VKLaDFGSAsi~~PA---ns  181 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL--SEPGLVKLADFGSASIMAPA---NS  181 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe--cCCCeeeeccccchhhcCch---hc
Confidence            966 7778777777789999999999999999999999999999999999999  99999999999999776543   45


Q ss_pred             eccCccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        162 LFGTPEFVAPEVV---NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       162 ~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ..|||.|||||++   ..+.|+-+.||||||++..||..+++|+-+++.-..+.++..+..+....  ..+++.|++|+.
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs--~eWS~~F~~Fvd  259 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS--NEWSDYFRNFVD  259 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC--chhHHHHHHHHH
Confidence            6799999999987   34678999999999999999999999999999988888887776654443  578999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      .||++-|++|||.
T Consensus       260 ~CLqKipqeRpts  272 (948)
T KOG0577|consen  260 SCLQKIPQERPTS  272 (948)
T ss_pred             HHHhhCcccCCcH
Confidence            9999999999984

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.2e-42  Score=279.14  Aligned_cols=247  Identities=29%  Similarity=0.405  Sum_probs=198.6

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeC-----C
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS-----N   73 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   73 (251)
                      +.++|++.+.||.|++|+||.+.+..+++.|++|.+...  .......+.+|+..++.++|+|++++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            467899999999999999999999999999999987542  233456677899999999999999999987643     3


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..++++||+. ++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++...
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARTT  158 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--cCCCCEEECcCcccccc
Confidence            4899999996 4787777654 469999999999999999999999999999999999999  88899999999999765


Q ss_pred             CCC-CcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc------------
Q psy11805        154 DPE-KKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY------------  219 (251)
Q Consensus       154 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------------  219 (251)
                      ... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.....            
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            433 22233456788999998864 4588899999999999999999999987654333322211000            


Q ss_pred             ---------------cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 ---------------DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                     .......+.+++.+.++|++||+.+|++|||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~  285 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV  285 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH
Confidence                           00011234678999999999999999999984

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-41  Score=273.70  Aligned_cols=242  Identities=23%  Similarity=0.381  Sum_probs=201.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|...+.||.|++|.||++.+..++..+++|.+....   ......+.+|++.++.++|+|++++.+++..+...++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            356888999999999999999999889999999875432   22345678899999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      +||+.+ ++.+.+......++...+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++......  
T Consensus        94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE--CCCCcEEECCcccceeecCc--
Confidence            999975 7777766555668999999999999999999999999999999999999  88899999999998765432  


Q ss_pred             ceeeccCcccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                       ....+++.|+|||.+.   ....+.++||||||+++|+|++|..||...+..+....+.....+...  ...++..+++
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  245 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRN  245 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC--cccccHHHHH
Confidence             2234778999999974   345788999999999999999999999887766655555444332221  2467889999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|++||+.+|.+||++
T Consensus       246 li~~cl~~~P~~Rp~~  261 (308)
T cd06634         246 FVDSCLQKIPQDRPTS  261 (308)
T ss_pred             HHHHHhhCCcccCCCH
Confidence            9999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-42  Score=278.91  Aligned_cols=244  Identities=29%  Similarity=0.448  Sum_probs=203.7

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-----EEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-----VMC   76 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   76 (251)
                      +|++.+.||+|++|.||+|.+..+++.+++|.+....  ....+.+.+|+..++.++|+|++++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6999999999999999999999889999999886433  334678899999999999999999999987764     789


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ++|+++++ +|.+.+.... .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......
T Consensus        81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili--~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV--NSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEcccCceEeeccc
Confidence            99999975 7877775544 79999999999999999999999999999999999999  88899999999999876544


Q ss_pred             C----cceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC--------
Q psy11805        157 K----KLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD--------  223 (251)
Q Consensus       157 ~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  223 (251)
                      .    ......+++.|+|||.+.+. .++.++|+||||+++++|++|..||...+..+....+.........        
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            2    22334577889999999877 7889999999999999999999999988776655544332211111        


Q ss_pred             -------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 -------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                         .....++..+.++|.+||+.+|.+||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  283 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA  283 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH
Confidence                               0113468899999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-41  Score=268.97  Aligned_cols=234  Identities=27%  Similarity=0.458  Sum_probs=186.7

Q ss_pred             ccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHH---cCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805         10 AFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRE---LQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus        10 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~---l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      .||+|+||.||++.+..+++.+++|.+.....   .......+|...++.   ..|++++.+.+.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999998999999998753321   112333444444433   369999999999999999999999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeec
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF  163 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~  163 (251)
                      +++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~--~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE--CCCCCEEEccCCcceeccccC-ccCcC
Confidence            999988876554 69999999999999999999999999999999999999  889999999999986554322 22345


Q ss_pred             cCcccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        164 GTPEFVAPEVVN-FDAIGFGTDMWSVGVICYVLLSGLSPFMGETD--VQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       164 ~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      +++.|+|||.+. +..++.++||||+|+++++|++|..||.....  .+.....   ........+..++..+.++|++|
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTVNVELPDSFSPELKSLLEGL  233 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hhcCCcCCccccCHHHHHHHHHH
Confidence            888999999986 45678999999999999999999999975432  2222222   12222233456899999999999


Q ss_pred             cccCcCCCCC
Q psy11805        241 LLKDREDAPE  250 (251)
Q Consensus       241 l~~~p~~Rps  250 (251)
                      |+.||++||+
T Consensus       234 l~~~p~~R~~  243 (279)
T cd05633         234 LQRDVSKRLG  243 (279)
T ss_pred             hcCCHHHhcC
Confidence            9999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0983|consensus

Probab=100.00  E-value=9.1e-43  Score=259.77  Aligned_cols=244  Identities=21%  Similarity=0.367  Sum_probs=207.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++.+.+..||+|+.|+|+++..+.++...|+|.+..+. .++.+++...+.+...-+ +|.||+++++|..+...++-||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            45567788999999999999999999999999986544 345667777777665554 9999999999999888889999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      .|.. ....++....+++++..+-++...+..||.||-++ |++|||+||+|||+  +..|++||||||.+-....+...
T Consensus       172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl--De~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE--ccCCCEEeecccccceeeccccc
Confidence            8843 56666666667899999999999999999999865 89999999999999  99999999999999888777777


Q ss_pred             eeeccCccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNF---DAIGFGTDMWSVGVICYVLLSGLSPFMGE-TDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      ....|-+.|+|||.+..   ..|+.++||||||+.++||+||..||.+. ++.+.+.++.....+ ..+....+++.+.+
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-~L~~~~gFSp~F~~  327 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-LLPGHMGFSPDFQS  327 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-CCCcccCcCHHHHH
Confidence            77789999999999954   36788999999999999999999999874 667778777765443 33333459999999


Q ss_pred             HHHHhcccCcCCCCC
Q psy11805        236 FIRKLLLKDREDAPE  250 (251)
Q Consensus       236 li~~~l~~~p~~Rps  250 (251)
                      |+..||++|+.+||.
T Consensus       328 fv~~CL~kd~r~RP~  342 (391)
T KOG0983|consen  328 FVKDCLTKDHRKRPK  342 (391)
T ss_pred             HHHHHhhcCcccCcc
Confidence            999999999999996

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.7e-42  Score=278.95  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=197.6

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--------
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS--------   72 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------   72 (251)
                      +..+|++.+.||.|++|.||+|.+..+++.|++|.+...+....+.+.+|++.++.++|+|++++++++...        
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            367999999999999999999999999999999998766666677889999999999999999999876543        


Q ss_pred             ------CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEe
Q psy11805         73 ------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKII  145 (251)
Q Consensus        73 ------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~  145 (251)
                            ...++++||+++ +|.+.+..  ..+++..++.++.|+++||.+||+.|++|+||+|+||++  + .++.++|+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili--~~~~~~~kl~  157 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI--NTEDLVLKIG  157 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--cCCCceEEEC
Confidence                  357899999975 78776654  358999999999999999999999999999999999997  5 45578999


Q ss_pred             ecccccccCCCCc----ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-
Q psy11805        146 DFGLARKFDPEKK----LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY-  219 (251)
Q Consensus       146 df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-  219 (251)
                      |||.+...+....    .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+.......... 
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999876532211    122346778999998754 4578899999999999999999999987766554443322110 


Q ss_pred             ----------------------cCC---CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 ----------------------DFD---DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ----------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                            ...   ......++.++.+||++||+.||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  294 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA  294 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence                                  000   01123578899999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.2e-41  Score=269.99  Aligned_cols=244  Identities=27%  Similarity=0.489  Sum_probs=196.6

Q ss_pred             cCCcccccccCCceEEEEEEEc---cCCceEEEEEecccc----ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK----RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   75 (251)
                      +|++.+.||.|++|.||.|.+.   .++..|++|++....    ....+.+.+|+++++.+ +|++|+++.+.++.++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999885   468899999986422    22356778899999999 599999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++|+|++++++|.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE--CCCCCEEEeeCccceeccc
Confidence            99999999999998887654 68999999999999999999999999999999999999  8889999999999876533


Q ss_pred             CC--cceeeccCcccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        156 EK--KLQVLFGTPEFVAPEVVNFD--AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ..  ......++..|+|||.+.+.  ..+.++||||||+++|+|++|..||...........+.........+....++.
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  237 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence            22  12234578899999998653  467889999999999999999999975433222222211111112222356789


Q ss_pred             HHHHHHHHhcccCcCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps  250 (251)
                      .+.+++++||+.+|++||+
T Consensus       238 ~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         238 LAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             HHHHHHHHHhcCCHHHhcC
Confidence            9999999999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=268.66  Aligned_cols=244  Identities=27%  Similarity=0.429  Sum_probs=199.2

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHc---CCCceeeEeEEEeeCCE-----
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMREL---QHPRLIQIYDAFESSNV-----   74 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~-----   74 (251)
                      |++.+.||+|++|.||++.++.+++.+++|.+......  ....+.+|+..++++   .|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            78899999999999999999988999999998643322  234566787777666   59999999999987766     


Q ss_pred             EEEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         75 MCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      .+++||++++ +|.+.+.... ..+++..++.++.|++.||.+||+.|++|+|++|+||++  +.++.++|+|||.+...
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili--~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV--TSDGQVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE--ccCCCEEEeccCcceec
Confidence            9999999976 7877776533 358999999999999999999999999999999999999  88899999999999776


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC------------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF------------  221 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  221 (251)
                      ..........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+...++.......            
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP  237 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence            54444344457789999999998889999999999999999999999998887776665553321100            


Q ss_pred             -----------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 -----------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                 .....+.++..+.++|.+||+.||.+||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  278 (287)
T cd07838         238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA  278 (287)
T ss_pred             hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence                       001112456788999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0579|consensus

Probab=100.00  E-value=1.1e-43  Score=291.25  Aligned_cols=246  Identities=25%  Similarity=0.433  Sum_probs=217.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      +.|+|+-.||.|+||+||+|..+.++...|.|++.....+..+.+.-|+.+|....||+|+.+++.|-.++.++++.|+|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            45788999999999999999999888888999998888888999999999999999999999999998889999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~~~~  161 (251)
                      .||-+...+..-+..+++.++..+++|++.||.|||+++|+|+|||..|||+  ..+|.++|.|||.+.... .......
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~--TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL--TLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE--EecCcEeeecccccccchhHHhhhcc
Confidence            9999988888878889999999999999999999999999999999999999  999999999999986632 2233456


Q ss_pred             eccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        162 LFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       162 ~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ..|||+|||||+..     ..+|++++||||||+.|.+|..+.+|-...+.-..+.++.+...+- .-.+++++..+.||
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT-LlqPS~Ws~~F~Df  268 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LLQPSHWSRSFSDF  268 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc-ccCcchhhhHHHHH
Confidence            78999999999874     4689999999999999999999999988777777776665544332 22346889999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      +++||.+||..||++
T Consensus       269 Lk~cL~Knp~~Rp~a  283 (1187)
T KOG0579|consen  269 LKRCLVKNPRNRPPA  283 (1187)
T ss_pred             HHHHHhcCCccCCCH
Confidence            999999999999985

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.3e-42  Score=278.33  Aligned_cols=247  Identities=27%  Similarity=0.423  Sum_probs=198.0

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee----CCE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES----SNV   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~   74 (251)
                      +.++|++.+.||.|++|.||+|.+..+++.|++|.+....  ......+.+|+..++.++|+||+++.+++..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            3578999999999999999999999999999999986432  2345677889999999999999999998753    356


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .++|+||+.+ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~--~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          83 VYVVMDLMES-DLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV--NEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEEehhhh-hHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCcEEecccccceeec
Confidence            8999999964 787777554 359999999999999999999999999999999999999  889999999999986643


Q ss_pred             CCCc-----ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----------
Q psy11805        155 PEKK-----LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ----------  218 (251)
Q Consensus       155 ~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------  218 (251)
                      ....     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+....          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            2221     123357788999998865 457889999999999999999999998776543332211100          


Q ss_pred             ------------ccCCC-----ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        219 ------------YDFDD-----ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       219 ------------~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                  .....     ......+..+.++|++||+.+|++|||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  288 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV  288 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH
Confidence                        00000     1124568899999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=263.09  Aligned_cols=234  Identities=31%  Similarity=0.531  Sum_probs=201.5

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      ||.|++|.||.+.+..+++.+++|.+......   ....+.+|+..++.++|+|++++++.+..++..+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68999999999999988999999998643322   456788999999999999999999999999999999999999999


Q ss_pred             hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-CcceeeccCc
Q psy11805         88 FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTP  166 (251)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~  166 (251)
                      .+.+.... .+++..++.++.|+++||.+||+.+++|+||+|+||++  +.++.++|+|||.+...... .......++.
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL--DADGHIKLTDFGLAKELSSEGSRTNTFCGTP  157 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE--cCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence            88887654 58999999999999999999999999999999999999  88899999999999775443 2233445778


Q ss_pred             ccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcC
Q psy11805        167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE  246 (251)
Q Consensus       167 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  246 (251)
                      .|+|||...+...+.++|+||||+++|++++|..||...+..+....+......    .....+..+.+++++||..||+
T Consensus       158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~i~~~l~~~p~  233 (250)
T cd05123         158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR----FPEFLSPEARDLISGLLQKDPT  233 (250)
T ss_pred             cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCHHHHHHHHHHhcCCHh
Confidence            999999998888899999999999999999999999888776666655543332    2355689999999999999999


Q ss_pred             CCCCC
Q psy11805        247 DAPEV  251 (251)
Q Consensus       247 ~Rps~  251 (251)
                      +||++
T Consensus       234 ~R~~~  238 (250)
T cd05123         234 KRLGS  238 (250)
T ss_pred             hCCCc
Confidence            99985

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-41  Score=275.54  Aligned_cols=244  Identities=24%  Similarity=0.378  Sum_probs=198.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-----
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSN-----   73 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   73 (251)
                      ++++|++.+.||+|++|.||++.+..++..|++|.+.....  .....+.+|+..++.++|+||+++.+++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            46799999999999999999999999999999998753222  23456889999999999999999999987543     


Q ss_pred             -EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         74 -VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        74 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                       ..++||+++ +++|.+.+..  ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+..
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill--~~~~~~kl~dfg~~~~  167 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV--NEDCELKILDFGLARQ  167 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEeecccccc
Confidence             358999998 6688776654  358999999999999999999999999999999999999  8889999999999976


Q ss_pred             cCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC---------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD---------  222 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  222 (251)
                      .....  ....+++.|+|||.+.+ ..++.++|+||||++++++++|..||...+......++........         
T Consensus       168 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         168 TDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cccCc--cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            54322  23346789999999865 4578899999999999999999999988766554443322111100         


Q ss_pred             ------------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ------------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        ...+..++..+.++|.+||+.||++|||+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~  292 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA  292 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH
Confidence                              01224678889999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4279|consensus

Probab=100.00  E-value=4.7e-43  Score=289.92  Aligned_cols=240  Identities=24%  Similarity=0.448  Sum_probs=207.2

Q ss_pred             ccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCchhH
Q psy11805         10 AFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFE   89 (251)
Q Consensus        10 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   89 (251)
                      .||.|+||+||.|+|..+....|+|.+...+....+.+..|+...++++|.|||+++|.+..+++.-+.||..+||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            58999999999999999999999999877777789999999999999999999999999999999999999999999999


Q ss_pred             HHhhCCCCC--CHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cceeeccCc
Q psy11805         90 RVIDDDFVL--TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTP  166 (251)
Q Consensus        90 ~~~~~~~~~--~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~  166 (251)
                      .++..=+++  ++..+.-+.+||++||+|||++.|||||||-+||++ ++-.|.+||.|||.+.....-+ ...+..||.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLv-NTySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLV-NTYSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEE-eeccceEEecccccchhhccCCccccccccch
Confidence            998865666  888999999999999999999999999999999995 5578899999999998865333 335567999


Q ss_pred             ccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        167 EFVAPEVVNFD--AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       167 ~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      .|||||++..+  .|+.++|||||||.+.||.||++||-........ ...-+.+.--++++..++.+++.||.+|+.++
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-MFkVGmyKvHP~iPeelsaeak~FilrcFepd  819 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-MFKVGMYKVHPPIPEELSAEAKNFILRCFEPD  819 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-hhhhcceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence            99999999765  4788999999999999999999999776543322 22233333334455678889999999999999


Q ss_pred             cCCCCCC
Q psy11805        245 REDAPEV  251 (251)
Q Consensus       245 p~~Rps~  251 (251)
                      |..||+|
T Consensus       820 ~~~R~sA  826 (1226)
T KOG4279|consen  820 PCDRPSA  826 (1226)
T ss_pred             cccCccH
Confidence            9999986

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.7e-41  Score=273.15  Aligned_cols=247  Identities=23%  Similarity=0.387  Sum_probs=196.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeC-------
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESS-------   72 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------   72 (251)
                      .++|++.+.||+|++|.||+|.+..++..+++|.+......  ......+|++.++.++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            36899999999999999999999999999999987543322  234677899999999999999999987432       


Q ss_pred             -CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         73 -NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                       ...+++++|+++ ++...+......+++..+..++.|+++||.+||+.|++|+|++|+||++  +.++.++|+|||++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI--DNQGILKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEECcCccch
Confidence             357999999976 6767766655679999999999999999999999999999999999999  889999999999997


Q ss_pred             ccCCCCcc------------eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q psy11805        152 KFDPEKKL------------QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ  218 (251)
Q Consensus       152 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  218 (251)
                      ........            ....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            65322211            112356789999987654 57889999999999999999999998877766555433211


Q ss_pred             ccCCC--------------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        219 YDFDD--------------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       219 ~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....                          ..+..++..+.++|.+||+.+|++|||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~  302 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA  302 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH
Confidence            11000                          0112455788999999999999999984

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.9e-41  Score=274.80  Aligned_cols=246  Identities=28%  Similarity=0.440  Sum_probs=197.6

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHc-CCCceeeEeEEEeeC--CEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMREL-QHPRLIQIYDAFESS--NVM   75 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~   75 (251)
                      +.++|++.+.||+|++|.||+|.+..++..+++|.+...  .......+.+|+..++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            357899999999999999999999988999999987432  223456677899999999 999999999988643  368


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++|||++++ +|.+.+...  .+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.....
T Consensus        85 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill--~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL--NSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCcEEEeeccchhcccc
Confidence            999999975 887777554  68999999999999999999999999999999999999  8999999999999876533


Q ss_pred             CCc------ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc---------
Q psy11805        156 EKK------LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY---------  219 (251)
Q Consensus       156 ~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------  219 (251)
                      ...      .....+++.|+|||.+.+ ...+.++||||||+++|+|++|+.||......+...++.....         
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221      122346788999998754 4578899999999999999999999987665544433322110         


Q ss_pred             ------------------cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 ------------------DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        .......+.++.++.++|.+||+.+|++|||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~  289 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA  289 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH
Confidence                              11111223478899999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.3e-41  Score=270.63  Aligned_cols=195  Identities=28%  Similarity=0.448  Sum_probs=158.7

Q ss_pred             ccccccCCceEEEEEEEcc--CCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEe--eCCEEEEEEEecc
Q psy11805          8 HSAFSFGKFGTVYRCKEKA--TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE--SSNVMCVVLELIE   83 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~   83 (251)
                      ..+||+|+||.||+|.+..  ++..+++|.+...  .....+.+|+.+++.++|+|++++.+++.  .+...++++|++.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3689999999999999754  5678999987532  23456789999999999999999999885  3567899999987


Q ss_pred             CCchhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee--cCCCcEEEeeccccccc
Q psy11805         84 GGELFERVIDD--------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT--KTGNRIKIIDFGLARKF  153 (251)
Q Consensus        84 ~~~L~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~--~~~~~~~l~df~~~~~~  153 (251)
                      + +|.+.+...        ...+++..++.++.|++.||.+||+.|++|+||||+||++..  +.++.++|+|||++...
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence            6 666665421        224889999999999999999999999999999999999733  34568999999999765


Q ss_pred             CCCC----cceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11805        154 DPEK----KLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGE  205 (251)
Q Consensus       154 ~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~  205 (251)
                      ....    ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            4322    1223457889999999876 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.4e-41  Score=263.90  Aligned_cols=240  Identities=21%  Similarity=0.277  Sum_probs=187.8

Q ss_pred             cccccCCceEEEEEEEcc--CCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          9 SAFSFGKFGTVYRCKEKA--TGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      +.||+|+||.||+|.+..  ++..+++|.+..... .....+.+|+..++.++|+|++++++.+.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998653  446788998764432 23457888999999999999999999999888899999999999


Q ss_pred             chhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc---
Q psy11805         86 ELFERVIDDD----FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---  158 (251)
Q Consensus        86 ~L~~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~---  158 (251)
                      +|.+.+....    ...+...+..++.|++.|+.|||+.|++|+||+|+||++  +.++.++|+|||.+........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~--~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL--TADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE--cCCCcEEECCccccccccCcceeec
Confidence            9988886422    245677888999999999999999999999999999999  8889999999999865432211   


Q ss_pred             ceeeccCcccccccccccC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc-cccCCCcc-ccC
Q psy11805        159 LQVLFGTPEFVAPEVVNFD-------AIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA-QYDFDDEC-FNE  228 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~-~~~  228 (251)
                      .....++..|+|||.+.+.       .++.++|+||||+++|+|++ |..||...+..+........ ......+. ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            1223456789999998542       35789999999999999996 99999887665554332222 22222221 234


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++.+.+++++|+ .+|++|||+
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~  260 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSA  260 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCH
Confidence            6788999999998 689999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.4e-41  Score=272.02  Aligned_cols=244  Identities=28%  Similarity=0.426  Sum_probs=195.9

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee-CCEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES-SNVMCV   77 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l   77 (251)
                      ++++|++.+.||.|++|.||+|.+..+++.+++|.+....  ....+.+.+|+..++.++|||++++.+++.. .+..++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            3689999999999999999999999999999999875322  2345678899999999999999999999865 557899


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      ++|++. ++|.+.+...  .++...+..++.|+++||.+||+.|++|+||+|+||++  +.++.++|+|||.+...+.. 
T Consensus        88 v~e~~~-~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili--~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          88 VTELLG-TDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI--NENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             Eeehhc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE--CCCCCEEeCccccccccCCC-
Confidence            999984 5787766543  48899999999999999999999999999999999999  88999999999998764332 


Q ss_pred             cceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------------
Q psy11805        158 KLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIA-------------------  217 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------------------  217 (251)
                       .....+++.|+|||.+.+ ..++.++||||||++++++++|..||...+.......+...                   
T Consensus       162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence             223346778999998765 56789999999999999999999999876653322111110                   


Q ss_pred             -----c---ccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 -----Q---YDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 -----~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                           .   ........+.++..+.++|++||+.+|++||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~  282 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA  282 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH
Confidence                 0   000011123578899999999999999999984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=268.27  Aligned_cols=244  Identities=23%  Similarity=0.414  Sum_probs=202.4

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      |++.+.||+|++|.||+|....+++.+++|.+....  ......+.+|+..++.++|+|++++.+++.+.+..++++|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            678899999999999999999999999999987543  334567788999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-ccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~~  161 (251)
                      ++ +|.+.+......+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... ....
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~--~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI--NRDGVLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE--cCCCCEEEecCCcccccCCCccccCc
Confidence            75 8988887764579999999999999999999999999999999999999  889999999999987654332 2223


Q ss_pred             eccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC-----------------
Q psy11805        162 LFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-----------------  223 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------------  223 (251)
                      ...+..|+|||.+.+. .++.++||||||++++++++|..||...+..+...++.........                 
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            3456789999998766 7889999999999999999999999887766555443221110000                 


Q ss_pred             --------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 --------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                              ...+..+..+.++|++||+.+|++||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~  273 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA  273 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCH
Confidence                    1122457889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=272.24  Aligned_cols=245  Identities=26%  Similarity=0.382  Sum_probs=193.1

Q ss_pred             cCCcccccccCCceEEEEEEEcc--CCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKA--TGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESS--NVMC   76 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   76 (251)
                      +|++.+.||+|++|.||+|.+..  ++..+++|.+....   ......+.+|+..++.++|||++++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  78999999987532   33457788899999999999999999999887  7899


Q ss_pred             EEEEeccCCchhHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC----CCcEEEeecc
Q psy11805         77 VVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT----GNRIKIIDFG  148 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~----~~~~~l~df~  148 (251)
                      +|||++++ ++.+.+...    ...+++..++.++.|++.||.+||+.|++|+||+|+||++  +.    ++.++|+|||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~--~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV--MGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEE--cCCCCccceEEECCCc
Confidence            99999976 565655432    2368999999999999999999999999999999999999  77    8899999999


Q ss_pred             cccccCCCCc----ceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHH
Q psy11805        149 LARKFDPEKK----LQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ---------TMANV  214 (251)
Q Consensus       149 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~  214 (251)
                      ++........    .....+++.|+|||.+.+. .++.++||||||+++++|++|..||.......         ....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9876533221    2233567889999988664 57889999999999999999999997654322         00000


Q ss_pred             Hh------------------------cc--ccCC-C------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TI------------------------AQ--YDFD-D------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~------------------------~~--~~~~-~------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..                        ..  .... .      +.+...+..+.+++.+||+.||++|||+
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~  307 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA  307 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence            00                        00  0000 0      0001466789999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG4236|consensus

Probab=100.00  E-value=8.2e-43  Score=280.71  Aligned_cols=241  Identities=32%  Similarity=0.520  Sum_probs=210.8

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCc
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGE   86 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   86 (251)
                      +.||+|-||+||-++++.+|+.||+|++....  .+....+.+|+.+|+++.||.|+.+.-.+++.+.+++|||.+.|.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            67999999999999999999999999986433  3346889999999999999999999999999999999999998755


Q ss_pred             hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeecccccccCCCCcceeeccC
Q psy11805         87 LFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFGLARKFDPEKKLQVLFGT  165 (251)
Q Consensus        87 L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~  165 (251)
                      |.-.+....+++++....-++.||+.||+|||.++|+|+|+||+|||+.+.+ --.+||||||.++............||
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGT  729 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGT  729 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCC
Confidence            5444445667899999999999999999999999999999999999984422 237999999999998877777788899


Q ss_pred             cccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCc
Q psy11805        166 PEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR  245 (251)
Q Consensus       166 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  245 (251)
                      |.|+|||++.+..|...-|+||+|+++|--++|..||...+  ++..++....+.++..-|+.++.++.+||..+|+..-
T Consensus       730 PAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm  807 (888)
T KOG4236|consen  730 PAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKM  807 (888)
T ss_pred             ccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999997654  3445566677788888899999999999999999998


Q ss_pred             CCCCCC
Q psy11805        246 EDAPEV  251 (251)
Q Consensus       246 ~~Rps~  251 (251)
                      .+|-|+
T Consensus       808 ~kRysv  813 (888)
T KOG4236|consen  808 RKRYSV  813 (888)
T ss_pred             HHhcch
Confidence            888763

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.9e-41  Score=263.48  Aligned_cols=240  Identities=21%  Similarity=0.291  Sum_probs=188.0

Q ss_pred             cccccCCceEEEEEEEcc--CCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          9 SAFSFGKFGTVYRCKEKA--TGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      +.||+|+||.||+|....  ....+++|.+..... .....+.+|+..++.++|+||+++++.+......+++||+++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999996543  345678887654332 23456788999999999999999999999999999999999999


Q ss_pred             chhHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc---
Q psy11805         86 ELFERVIDDDF----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---  158 (251)
Q Consensus        86 ~L~~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~---  158 (251)
                      +|.+++.....    ..++..+..++.|++.||+|||+.|++|+||||+||++  +.++.++|+|||++........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL--TADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe--cCCCcEEEeccccccccccchheec
Confidence            99998876432    24678889999999999999999999999999999999  8899999999999865322211   


Q ss_pred             ceeeccCccccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc-ccCCC-ccccC
Q psy11805        159 LQVLFGTPEFVAPEVVNF-------DAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ-YDFDD-ECFNE  228 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~-~~~~~  228 (251)
                      .....++..|+|||.+..       ..++.++||||||+++|+|++ |..||......+......... ...+. .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            122234567999998742       356789999999999999999 889998877666554443322 22222 22346


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++..+.+++..|+ .||++|||+
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~  260 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTA  260 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCH
Confidence            8889999999998 599999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.3e-41  Score=268.09  Aligned_cols=241  Identities=26%  Similarity=0.475  Sum_probs=195.9

Q ss_pred             cCCcccccccCCceEEEEEEEc---cCCceEEEEEecccc----ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK----RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   75 (251)
                      +|++.+.||.|++|.||++.+.   .++..+++|++....    ......+.+|+..+.++ +|++++++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5889999999999999999864   356889999875322    22346678899999999 599999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++||||+++++|.+.+... ..+++..+..++.|++.+|.+||+.|++|+||+|+||++  +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL--DSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--CCCCCEEEEECcccccccc
Confidence            9999999999998887654 368999999999999999999999999999999999999  8889999999999876433


Q ss_pred             CCc--ceeeccCcccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccccCCCcccc
Q psy11805        156 EKK--LQVLFGTPEFVAPEVVNFDA--IGFGTDMWSVGVICYVLLSGLSPFMGETD----VQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       156 ~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~  227 (251)
                      ...  .....++..|+|||.+.+..  .+.++|+||||+++++|++|..||.....    .+........    ..+...
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~  233 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS----KPPFPK  233 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc----CCCCCc
Confidence            221  12235788999999987654  67899999999999999999999964322    2222222222    222235


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++..+.+++.+||+.+|++|||+
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~  257 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGA  257 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCc
Confidence            678899999999999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.8e-41  Score=267.28  Aligned_cols=246  Identities=18%  Similarity=0.193  Sum_probs=182.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccC---CceEEEEEeccccccchH-----------HHHHHHHHHHHcCCCceeeEeE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT---GMTLAAKFVGIAKRNDRR-----------NVEREVEIMRELQHPRLIQIYD   67 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~-----------~~~~e~~~l~~l~~~~i~~~~~   67 (251)
                      .++|++.+.||+|+||.||+|.+..+   +..+++|+....+.....           ....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            47899999999999999999998877   667777765433322111           1112223344567999999998


Q ss_pred             EEeeCC----EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         68 AFESSN----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        68 ~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      .+....    ..+++++.+.. ++.+.+... ...++..+..++.|++.||.+||+.|++||||||+||++  +.++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill--~~~~~~~  166 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV--DGNNRGY  166 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCcEE
Confidence            765433    45778887744 555555432 346888999999999999999999999999999999999  8889999


Q ss_pred             EeecccccccCCCC--------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Q psy11805        144 IIDFGLARKFDPEK--------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT-MANV  214 (251)
Q Consensus       144 l~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~  214 (251)
                      |+|||++.......        ......+++.|+|||.+.+..++.++||||||+++++|++|..||........ ....
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            99999997653221        11223588999999999999999999999999999999999999987743222 1111


Q ss_pred             Hh---ccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TI---AQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..   .............++.+.++++.|++.+|++||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~  286 (294)
T PHA02882        247 KCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDY  286 (294)
T ss_pred             HHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCH
Confidence            10   01111111124568899999999999999999984

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-41  Score=273.17  Aligned_cols=244  Identities=27%  Similarity=0.421  Sum_probs=195.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC------
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESS------   72 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   72 (251)
                      +.++|.+.+.||+|++|.||++.+..+++.|++|.+....  ....+.+.+|+..+++++|+||+++.+++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            3689999999999999999999999999999999986432  22356678899999999999999999988543      


Q ss_pred             CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         73 NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ...+++++++ +++|.+.+...  .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++..
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll--~~~~~~kl~dfg~~~~  169 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDFGLARH  169 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE--cCCCCEEEeccccccc
Confidence            3467888877 66887766543  58999999999999999999999999999999999999  8889999999999876


Q ss_pred             cCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC----------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF----------  221 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------  221 (251)
                      ....  .....+++.|+|||.+.+ ..++.++||||||+++++|++|..||...+.......+.......          
T Consensus       170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             cccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            4332  233456788999998865 467889999999999999999999998766554443332211100          


Q ss_pred             -------------C----CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 -------------D----DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 -------------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                   +    .......++.+.++|.+||+.||.+||++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  294 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  294 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH
Confidence                         0    00112457889999999999999999984

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-41  Score=276.90  Aligned_cols=244  Identities=27%  Similarity=0.429  Sum_probs=199.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCE----
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNV----   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   74 (251)
                      +.++|++...||+|++|.||+|.+..++..+++|.+....  ......+.+|+..++.++|+|++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3578999999999999999999999999999999875422  2335667789999999999999999998765544    


Q ss_pred             --EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         75 --MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        75 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                        .++|+|++ +++|.+.+..  ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+..
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill--~~~~~~kL~dfg~~~~  167 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV--NEDCELKILDFGLARH  167 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--CCCCCEEEcccccccc
Confidence              89999998 5588887765  358999999999999999999999999999999999999  8889999999999977


Q ss_pred             cCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC--------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD--------  223 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  223 (251)
                      ....  .....++..|+|||.+.+ ..++.++||||||+++|++++|..||...+..+....+.........        
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            5433  223356778999999865 35788999999999999999999999887766655544332111110        


Q ss_pred             -------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 -------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                         ......+..+.++|++||+++|++|||+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~  292 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA  292 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH
Confidence                               1113468899999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-41  Score=265.95  Aligned_cols=244  Identities=25%  Similarity=0.412  Sum_probs=197.9

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEEec
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      |++.+.||+|++|+||+|.+..+++.+++|.+..... .......+|+..+++++ |+|++++++++..++..++|||++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7889999999999999999998899999998754322 22344567899999998 999999999999999999999999


Q ss_pred             cCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCccee
Q psy11805         83 EGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~  161 (251)
                       +++|.+.+.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||++  +.++.++|+|||.+...........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i--~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE--cCCCCEEEeecccceeccCCCCcCC
Confidence             668888776643 468999999999999999999999999999999999999  8899999999999977654433344


Q ss_pred             eccCcccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC------------------
Q psy11805        162 LFGTPEFVAPEVVN-FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD------------------  222 (251)
Q Consensus       162 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------  222 (251)
                      ..++..|+|||.+. +..++.++|+||||+++++|++|+.||...+..+.............                  
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            55778899999874 34578899999999999999999999987766554443322111000                  


Q ss_pred             --------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 --------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                              .......+..+.++|++||+.+|++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  274 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA  274 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH
Confidence                    00112336789999999999999999984

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-40  Score=263.25  Aligned_cols=242  Identities=20%  Similarity=0.334  Sum_probs=195.2

Q ss_pred             CCcccccccCCceEEEEEEEcc---CCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC------
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKA---TGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN------   73 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   73 (251)
                      |++.+.||+|++|.||+|.+..   ++..+++|++....  ....+.+.+|++.++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            7889999999999999998754   46789999886432  234667889999999999999999999886432      


Q ss_pred             EEEEEEEeccCCchhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         74 VMCVVLELIEGGELFERVIDD-----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                      ..+++++++.+++|.+.+...     ...++...+..++.|++.||+|||+.|++|+||+|+||++  +.++.++|+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili--~~~~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML--NENMTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE--cCCCCEEECccc
Confidence            347889999999987766432     2347889999999999999999999999999999999999  888999999999


Q ss_pred             cccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        149 LARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       149 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                      .+........   .....+++.|++||.+.+..++.++||||||+++|+|++ |..||...+..+....+......   .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~  235 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL---K  235 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC---C
Confidence            9876533221   112234568999999988888999999999999999999 89999887766655544433221   1


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....+..+.+++.+||+.+|++|||+
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~  262 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSF  262 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            124578899999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.6e-40  Score=262.28  Aligned_cols=233  Identities=26%  Similarity=0.442  Sum_probs=185.4

Q ss_pred             ccccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHH---HHHHcCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805         10 AFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVE---IMRELQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus        10 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~---~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      .||+|+||.||+|.+..+++.|++|.+......   .......|..   .++...|++++++.+.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999989999999987543211   1122333433   3344579999999999999999999999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeec
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF  163 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~  163 (251)
                      |++|.+.+... ..+++..+..++.|++.||.|||+.+++|+||+|+||++  +.++.++|+|||++....... .....
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili--~~~~~~kl~dfg~~~~~~~~~-~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK-PHASV  156 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE--CCCCCEEEccCcCccccCccC-CcCcC
Confidence            99998877654 469999999999999999999999999999999999999  888999999999987543322 23346


Q ss_pred             cCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        164 GTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDV--QTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       164 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ++..|+|||.+.++ .++.++||||+|+++|+|++|..||......  +.......   ......+..++..+.+++.+|
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~~li~~~  233 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TMAVELPDSFSPELRSLLEGL  233 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh---ccCCCCCCcCCHHHHHHHHHH
Confidence            88899999998754 5789999999999999999999999876322  22221111   112223345789999999999


Q ss_pred             cccCcCCCC
Q psy11805        241 LLKDREDAP  249 (251)
Q Consensus       241 l~~~p~~Rp  249 (251)
                      |..+|.+||
T Consensus       234 l~~~p~~R~  242 (278)
T cd05606         234 LQRDVNRRL  242 (278)
T ss_pred             hhcCHHhcc
Confidence            999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.7e-40  Score=269.28  Aligned_cols=243  Identities=15%  Similarity=0.274  Sum_probs=191.2

Q ss_pred             cccccccC--CceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          7 QHSAFSFG--KFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         7 ~~~~lg~g--~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      +...||.|  ++|+||+|.+..+++.|++|+......  ...+.+.+|+.+++.++|+||+++++++..++..++++|++
T Consensus         2 ~~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             hHHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            34567776  999999999999999999999864332  23577889999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      .++++.+.+... ...+++..+..++.|++.||.|||+.|++|+||||+||++  +.++.++++||+.+.........  
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill--~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--eCCCcEEEechHHHhhhhccCcccc
Confidence            999998887653 2358999999999999999999999999999999999999  88899999999755332111100  


Q ss_pred             ------eeeccCcccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-----------
Q psy11805        160 ------QVLFGTPEFVAPEVVNFD--AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD-----------  220 (251)
Q Consensus       160 ------~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  220 (251)
                            ....++..|+|||.+.+.  .++.++||||||+++++|++|..||......+...........           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                  111234579999998764  4678999999999999999999999877654443332221110           


Q ss_pred             --------------------------------CCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 --------------------------------FDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 --------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                      ...+....+++.+.+|+++||+.||++|||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta  302 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA  302 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH
Confidence                                            0011123467789999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-41  Score=285.86  Aligned_cols=246  Identities=23%  Similarity=0.296  Sum_probs=182.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCC-ceEEEE--------------Eec---cccccchHHHHHHHHHHHHcCCCceee
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATG-MTLAAK--------------FVG---IAKRNDRRNVEREVEIMRELQHPRLIQ   64 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~~K--------------~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~   64 (251)
                      ++|++.+.||+|+||+||+|..+... ...+.|              .+.   .........+.+|+.++++++|+||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            57999999999999999998765322 111111              010   111223566889999999999999999


Q ss_pred             EeEEEeeCCEEEEEEEeccCCchhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC
Q psy11805         65 IYDAFESSNVMCVVLELIEGGELFERVIDDD----FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN  140 (251)
Q Consensus        65 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~  140 (251)
                      +++++.+.+..|++++++.+ +|.+++....    .......+..++.|++.||.|||++||+|+||||+|||+  +.++
T Consensus       228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl--~~~~  304 (501)
T PHA03210        228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL--NCDG  304 (501)
T ss_pred             EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCC
Confidence            99999999999999999865 6666654321    224466788899999999999999999999999999999  8899


Q ss_pred             cEEEeecccccccCCCCc--ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCC-CCCCC--hHHHHHHHH
Q psy11805        141 RIKIIDFGLARKFDPEKK--LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSP-FMGET--DVQTMANVT  215 (251)
Q Consensus       141 ~~~l~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~--~~~~~~~~~  215 (251)
                      .++|+|||++........  .....++..|+|||.+.+..++.++||||||+++|+|++|..+ |....  ......++.
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            999999999977543322  2235689999999999999999999999999999999997754 43322  222222211


Q ss_pred             hccc----cCC----------------------Cc--cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        216 IAQY----DFD----------------------DE--CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       216 ~~~~----~~~----------------------~~--~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....    .++                      ..  ....++.++.++|.+||+.||.+|||+
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa  448 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA  448 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH
Confidence            1000    000                      00  011367788899999999999999985

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.1e-41  Score=263.00  Aligned_cols=242  Identities=24%  Similarity=0.417  Sum_probs=198.3

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccc-----cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-----KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +|.+.+.||+|++|.||++.+...+..+++|+.+..     .......+.+|+..++.++|||++++++.+.+.+..+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            699999999999999999999877666666665321     122345577889999999999999999999988899999


Q ss_pred             EEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         79 LELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      +||+++++|.+.+..   ....+++..++.++.|++.||.+||+.|++|+|++|+||++  + ++.++|+|||.+.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili--~-~~~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL--K-NNLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEe--e-cCCEeecccCceeecCC
Confidence            999999999887753   34568999999999999999999999999999999999998  4 35699999998876533


Q ss_pred             CC-cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        156 EK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      .. ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||......+....+..+..+.   ....++.++.
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  234 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETYSRQLN  234 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---CcchhcHHHH
Confidence            22 2223346788999999988888899999999999999999999998777666665554432221   2256788999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      ++|.+||+.+|++||++
T Consensus       235 ~li~~~l~~~p~~Rp~~  251 (260)
T cd08222         235 SIMQSMLNKDPSLRPSA  251 (260)
T ss_pred             HHHHHHhcCChhhCcCH
Confidence            99999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0584|consensus

Probab=100.00  E-value=6.8e-42  Score=280.03  Aligned_cols=239  Identities=25%  Similarity=0.415  Sum_probs=205.1

Q ss_pred             CcccccccCCceEEEEEEEccCCceEEEEEecccc----ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC--EEEEEE
Q psy11805          6 NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK----RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN--VMCVVL   79 (251)
Q Consensus         6 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~   79 (251)
                      +....||+|+|-+||+|.|..+|..||.-.++..+    ....+++..|+.+|+.|+|+||++++++|.+..  .+-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            45678999999999999999999999876554322    334689999999999999999999999997654  488999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC--CceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK--NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |.++.|+|+.+....+ .++...+..|++||+.||.|||++  .|+|||||.+||++ ....|.|||+|+|+|+......
T Consensus       123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFi-nG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFV-NGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEE-cCCcCceeecchhHHHHhhccc
Confidence            9999999999988776 689999999999999999999998  59999999999995 4467899999999999877665


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET-DVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ... ..|||.|||||..- ..|+...||||||+||+||+|+..||.... .-+++.++..+..+-....  --++++++|
T Consensus       201 aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~f  276 (632)
T KOG0584|consen  201 AKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREF  276 (632)
T ss_pred             cce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHH
Confidence            444 68999999999987 778999999999999999999999998654 5556777877776544443  337799999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |.+||.. ..+|||+
T Consensus       277 IekCl~~-~~~R~sa  290 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSA  290 (632)
T ss_pred             HHHHhcC-chhccCH
Confidence            9999999 9999985

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-40  Score=271.35  Aligned_cols=243  Identities=26%  Similarity=0.401  Sum_probs=193.9

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC------
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESS------   72 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   72 (251)
                      +.++|.+...||+|++|.||+|.+..++..+++|.+....  ......+.+|+..++.++|+||+++.+++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3578999999999999999999999899999999875432  22345678999999999999999999998654      


Q ss_pred             CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         73 NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ...+++++++.. +|....   +..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++..
T Consensus        93 ~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll--~~~~~~kL~dfg~~~~  166 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV--NEDCELKILDFGLARH  166 (342)
T ss_pred             ceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEeeCCCCcC
Confidence            246899999864 565443   2358999999999999999999999999999999999999  8899999999999876


Q ss_pred             cCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-----------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD-----------  220 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  220 (251)
                      ....  .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.||...+.......+......           
T Consensus       167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            4332  223346778999999865 45788999999999999999999999887654444333221100           


Q ss_pred             -------------CCC---ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 -------------FDD---ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 -------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                   ...   ..++..+..+.+||++||+.||++||++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~  291 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA  291 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH
Confidence                         000   0123567889999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0603|consensus

Probab=100.00  E-value=1.7e-41  Score=278.54  Aligned_cols=235  Identities=24%  Similarity=0.441  Sum_probs=199.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHH-HHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIM-RELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .+.|++...+|.|+||.|-.+.+..+++..++|++...    .....+|+..+ +.-+|+|+++..+++.+....|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            46789999999999999999999999999999998543    23334555444 44479999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      .++|+-+.+.+...+  .....+..|+.+|+.|+.+||++|++|||+||+|||+. +..++++|+|||.+......  ..
T Consensus       397 ~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~--~~  471 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS--CD  471 (612)
T ss_pred             hccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhhhCchh--hc
Confidence            999998888887654  33388889999999999999999999999999999972 47788999999999886655  34


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ..+-|..|.|||+.....++.++|+||||++||+|++|+.||...... +...++..+...      ..+|+.+++||++
T Consensus       472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAKDLLQQ  545 (612)
T ss_pred             ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHHHHHHH
Confidence            456777999999999999999999999999999999999999987766 555555443322      5789999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||++||.+||++
T Consensus       546 LL~~dP~~Rl~~  557 (612)
T KOG0603|consen  546 LLQVDPALRLGA  557 (612)
T ss_pred             hccCChhhCcCh
Confidence            999999999985

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.1e-40  Score=258.50  Aligned_cols=240  Identities=18%  Similarity=0.233  Sum_probs=187.8

Q ss_pred             cccccCCceEEEEEEEccCC--ceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          9 SAFSFGKFGTVYRCKEKATG--MTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~--~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      ++||+|+||+||++....++  ..+++|.+.... ......+.+|+..++.++|||++++++.+.+....++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999765332  356667655433 234678889999999999999999999999999999999999999


Q ss_pred             chhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC---Ccc
Q psy11805         86 ELFERVIDDD---FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE---KKL  159 (251)
Q Consensus        86 ~L~~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~---~~~  159 (251)
                      +|.+++....   ...+...+..++.|++.||.|||+.+++|+||+|+||++  +.++.++|+|||++......   ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~--~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL--TSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE--cCCccEEecccccccccCcchhhhcc
Confidence            9998887532   246677888999999999999999999999999999999  88899999999987542211   111


Q ss_pred             eeeccCccccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc-c-CCCccccCC
Q psy11805        160 QVLFGTPEFVAPEVVNF-------DAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQY-D-FDDECFNEI  229 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~-~-~~~~~~~~~  229 (251)
                      ....++..|+|||.+..       ..++.++||||||+++|+|++ |..||...+..+....+..... . ........+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            23456789999998743       235678999999999999997 6788987777666665543332 1 112223457


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.+.+++..|| .+|++||++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~  259 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATA  259 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCH
Confidence            889999999999 679999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0662|consensus

Probab=100.00  E-value=7.4e-41  Score=235.71  Aligned_cols=245  Identities=25%  Similarity=0.390  Sum_probs=210.6

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .|.-.++||+|+||+||+++..+++..|++|..+.++..  -.....+|+-+++.++|.||++++++...++...+|+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            577789999999999999999999999999998765543  367888999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-e
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-Q  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-~  160 (251)
                      |+. .|..++.+-.+.++.+.+..++.|++.||.++|++++.|+|+||+|.++  +.+|.+||.|||+++.+...-.. .
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli--n~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI--NRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe--ccCCcEEecccchhhhcCCceEeee
Confidence            987 7888888777789999999999999999999999999999999999999  99999999999999887654432 3


Q ss_pred             eeccCcccccccccccCC-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCcccc-----------
Q psy11805        161 VLFGTPEFVAPEVVNFDA-IGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFN-----------  227 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------  227 (251)
                      ....|.-|.+|.++.+.. ++...|+||.||++.|+.. |.+.|.+.+-.+++.++......+....|+           
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            345677899999998765 6788999999999999998 888899988888888775554444433333           


Q ss_pred             --------------CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 --------------EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 --------------~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                    ..+..-+++++++|.-+|.+|++|
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisa  277 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA  277 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH
Confidence                          234457899999999999999985

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.6e-40  Score=265.87  Aligned_cols=243  Identities=21%  Similarity=0.304  Sum_probs=188.9

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      |.+.+.+|.|  +.||.++...+++.+|+|++...  .......+.+|+..++.++|+||+++++++..++..+++||++
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            3344444444  55666677778999999998654  3445678999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc---
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---  158 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~---  158 (251)
                      ++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++++||+.+........   
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili--~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL--SGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE--ecCCceEEecCccceeecccccccc
Confidence            999998888753 3468999999999999999999999999999999999999  8889999999998865432111   


Q ss_pred             -----ceeeccCcccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC----------
Q psy11805        159 -----LQVLFGTPEFVAPEVVNFD--AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF----------  221 (251)
Q Consensus       159 -----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------  221 (251)
                           .....++..|+|||.+.+.  .++.++|+||+|+++++|++|..||..............+..+.          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence                 1223356689999998653  57889999999999999999999998765544332221111000          


Q ss_pred             --------------------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 --------------------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                          .......++.++.+|+.+||+.||++|||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  289 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA  289 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH
Confidence                                000111244678999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0574|consensus

Probab=100.00  E-value=1.4e-43  Score=267.80  Aligned_cols=242  Identities=23%  Similarity=0.400  Sum_probs=208.6

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      |.++.+||+|+||.||+|.++.+|..+|+|.+.  -..+.+++..|+.++++.+.++++++++.+-....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            567889999999999999999999999999964  356789999999999999999999999999888889999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~  163 (251)
                      |++.+.++...++++++.+..+++.-+.||+|||...-+|||||..|||+  +.+|..||.|||.+-+.... ....+..
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL--NT~G~AKLADFGVAGQLTDTMAKRNTVI  190 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL--NTDGIAKLADFGVAGQLTDTMAKRNTVI  190 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE--cccchhhhhhccccchhhhhHHhhCccc
Confidence            99999999988899999999999999999999999999999999999999  99999999999999765322 2335668


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      |||-|+|||++..-.|+.++||||||+...||..|++||.....-.....+ ....++....+..+++++-|||++||-+
T Consensus       191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-PT~PPPTF~KPE~WS~~F~DFi~~CLiK  269 (502)
T KOG0574|consen  191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-PTKPPPTFKKPEEWSSEFNDFIRSCLIK  269 (502)
T ss_pred             cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-cCCCCCCCCChHhhhhHHHHHHHHHhcC
Confidence            999999999998888999999999999999999999999776443222211 1111222223346789999999999999


Q ss_pred             CcCCCCCC
Q psy11805        244 DREDAPEV  251 (251)
Q Consensus       244 ~p~~Rps~  251 (251)
                      .|++|-||
T Consensus       270 ~PE~R~TA  277 (502)
T KOG0574|consen  270 KPEERKTA  277 (502)
T ss_pred             CHHHHHHH
Confidence            99999764

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.2e-40  Score=265.43  Aligned_cols=244  Identities=28%  Similarity=0.375  Sum_probs=192.9

Q ss_pred             cCCcccccccCCceEEEEEEEccC--CceEEEEEecccc--ccchHHHHHHHHHHHHc-CCCceeeEeEEEee----CCE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKAT--GMTLAAKFVGIAK--RNDRRNVEREVEIMREL-QHPRLIQIYDAFES----SNV   74 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~--~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~   74 (251)
                      +|++.+.||+|+||.||++.+..+  +..+++|.+....  ....+.+.+|+..++++ +|+||+++++....    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            588999999999999999999887  8899999875322  22356678899999999 59999999987532    245


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .+++++++.+ +|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....
T Consensus        81 ~~~~~e~~~~-~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili--~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELMEA-DLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV--NADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEecccC-CHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE--cCCCCEEeCcCCCceecc
Confidence            7889999864 787777544 468999999999999999999999999999999999999  888999999999997654


Q ss_pred             CCCc-----ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc---------
Q psy11805        155 PEKK-----LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY---------  219 (251)
Q Consensus       155 ~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------  219 (251)
                      ....     .....+++.|+|||.+.+ ..++.++|+||+|++++++++|..||...+..+....+.....         
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            2211     122357889999998765 4678999999999999999999999987765444332221110         


Q ss_pred             ------------------cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 ------------------DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        ......+...+..+.+++.+||+.+|++|||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~  286 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV  286 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH
Confidence                              00011223467899999999999999999984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0199|consensus

Probab=100.00  E-value=1.3e-40  Score=275.31  Aligned_cols=241  Identities=24%  Similarity=0.401  Sum_probs=211.9

Q ss_pred             cCCcccccccCCceEEEEEEEccCC---ceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATG---MTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +.++.++||+|.||.|+++.|+..+   ..||+|.+...... ....|.+|+..+.+|+|+|+++++|+..+ ..+.+|+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            4567899999999999999997533   57899998765554 68899999999999999999999999988 6688999


Q ss_pred             EeccCCchhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |.+++|+|.+.+.. ....+-......++.||+.|+.||.++++||||+..+|+++  .....+||+|||+.+.......
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll--asprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL--ASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee--cccceeeeecccceeccCCCCc
Confidence            99999999999987 55668889999999999999999999999999999999999  7788999999999998876655


Q ss_pred             ceeec----cCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        159 LQVLF----GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       159 ~~~~~----~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      .....    ....|+|||.+....++.++|||++|+.+|||++ |..||.+.....+++++..+. .++  ..+.+|.++
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-rLp--RPk~csedI  344 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-RLP--RPKYCSEDI  344 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-cCC--CCCCChHHH
Confidence            54332    3458999999999999999999999999999999 999999999999999887443 222  236789999


Q ss_pred             HHHHHHhcccCcCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPE  250 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps  250 (251)
                      .+++++||..+|+.|||
T Consensus       345 Y~imk~cWah~paDRpt  361 (1039)
T KOG0199|consen  345 YQIMKNCWAHNPADRPT  361 (1039)
T ss_pred             HHHHHHhccCCcccccc
Confidence            99999999999999997

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.5e-39  Score=252.11  Aligned_cols=220  Identities=19%  Similarity=0.249  Sum_probs=180.3

Q ss_pred             CCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCchhHHHhh
Q psy11805         14 GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVID   93 (251)
Q Consensus        14 g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   93 (251)
                      |.+++||+|.+..+++.+++|.+....     ...+|...+....|||++++++++.+.+..+++||++++++|.+.+..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999999999999999986532     223444445555799999999999999999999999999999888876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCcccccccc
Q psy11805         94 DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV  173 (251)
Q Consensus        94 ~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~  173 (251)
                      .. .+++..+..++.|+++||.+||+.|++|+||+|+||++  +.++.++++|||.+......  .....++..|+|||.
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~  153 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV  153 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--cCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence            54 58999999999999999999999999999999999999  88999999999987654432  222345668999999


Q ss_pred             cccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        174 VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       174 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+..++.++|+||+|+++|++++|..||........      ..  ........++..++++|++||+.||++||++
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------TH--TTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------cc--cccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            9888889999999999999999999988754322100      00  0111224578899999999999999999974

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.2e-39  Score=281.00  Aligned_cols=146  Identities=25%  Similarity=0.454  Sum_probs=132.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.++||+|+||.||+|.+..+++.||+|++....   ......+.+|+..++.++|+||+++++.+...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999986432   223477889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      ||+.+++|.+++...+ .+++..++.++.|++.||.|||+.||+|+||||+|||+  +.++.++|+|||++.
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl--~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI--SNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE--cCCCCEEEEeCCCCc
Confidence            9999999988886544 58999999999999999999999999999999999999  888999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0671|consensus

Probab=100.00  E-value=8e-41  Score=259.29  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=199.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC--C----CceeeEeEEEeeCCE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ--H----PRLIQIYDAFESSNV   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~--~----~~i~~~~~~~~~~~~   74 (251)
                      ++++|.+.+.+|+|+||.|-.+.+..++..||+|+++-. ..-.+...-|+++|.++.  .    .-++.+.++|...++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            468999999999999999999999999999999998532 334566677899999983  2    246777788999999


Q ss_pred             EEEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC---------------
Q psy11805         75 MCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT---------------  138 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~---------------  138 (251)
                      +++|+|.+ |.|+.+++.+++ -+++...+..++.|+++++++||+.+++|.||||+||++.++.               
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r  244 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR  244 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence            99999998 568999998754 4589999999999999999999999999999999999984421               


Q ss_pred             ---CCcEEEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy11805        139 ---GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVT  215 (251)
Q Consensus       139 ---~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  215 (251)
                         +..++++|||.++......  .....|..|.|||++.+-.++.++||||+||+|+|+++|...|...++.|.+..+.
T Consensus       245 ~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe  322 (415)
T KOG0671|consen  245 PLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME  322 (415)
T ss_pred             cCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence               2358999999998865443  55668889999999999999999999999999999999999999988777554331


Q ss_pred             hccccCCCcc------------------------------------------ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        216 IAQYDFDDEC------------------------------------------FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       216 ~~~~~~~~~~------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .-..+.+..+                                          .+.-..++.||+++||..||.+|+|+
T Consensus       323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl  400 (415)
T KOG0671|consen  323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL  400 (415)
T ss_pred             HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence            1111111100                                          00112258899999999999999985

>KOG1035|consensus

Probab=100.00  E-value=2.9e-40  Score=286.94  Aligned_cols=244  Identities=26%  Similarity=0.445  Sum_probs=200.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC---------
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESS---------   72 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------   72 (251)
                      ++|+..+.||.||||.||+|+.+-||..||+|.+.... ......+.+|+..+.+++||||++++..|...         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            57889999999999999999999999999999987543 34578899999999999999999998654000         


Q ss_pred             --------------------------------------------------------------------------------
Q psy11805         73 --------------------------------------------------------------------------------   72 (251)
Q Consensus        73 --------------------------------------------------------------------------------   72 (251)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ------------------------------CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCc
Q psy11805         73 ------------------------------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV  122 (251)
Q Consensus        73 ------------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi  122 (251)
                                                    ..+||-||||+..++.+.+..+...-.....|+++++|++||.|+|+.|+
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                          13689999999877777666654222588999999999999999999999


Q ss_pred             eecCCCCCcEEEeecCCCcEEEeecccccccC-------------------CCCcceeeccCcccccccccccCC---CC
Q psy11805        123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFD-------------------PEKKLQVLFGTPEFVAPEVVNFDA---IG  180 (251)
Q Consensus       123 ~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~---~~  180 (251)
                      +||||||.||++  +.++.|||+|||+++...                   .........||.-|+|||++.+..   |+
T Consensus       719 IHRDLKP~NIFL--d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  719 IHRDLKPRNIFL--DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeccCCcceeEE--cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            999999999999  899999999999998721                   111223457899999999997654   89


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        181 FGTDMWSVGVICYVLLSGLSPFMG-ETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       181 ~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.|+||||++++||+.   ||.. ++....+..+..+..+.+...+..--+.-+.+|+.||+.||.+||||
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA  865 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA  865 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence            99999999999999984   4765 56667788888777776644445555567889999999999999996

>KOG0614|consensus

Probab=100.00  E-value=4e-41  Score=269.57  Aligned_cols=242  Identities=27%  Similarity=0.487  Sum_probs=220.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEec---cccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .+.+++..||-|+||.|=++..+.....+|+|+++   +.+....+-+..|-+++.....|.|++++-.|.++.++|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            35778899999999999999988776668888775   344455667788999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |-|-||.|+..++..+ .+++..+.-++.-+++|++|||++||++|||||+|.++  +.+|.+||.|||++.....+...
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL--d~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL--DNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee--ccCCceEEeehhhHHHhccCCce
Confidence            9999999999998876 69999999999999999999999999999999999999  99999999999999999988888


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      -+.||||.|.|||++.+...+.+.|.||||+++|||++|.+||.+.+.-.+++.+.++.-....+  ..++....++|++
T Consensus       577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~  654 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKK  654 (732)
T ss_pred             eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHH
Confidence            89999999999999999999999999999999999999999999999999999998876554443  7899999999999


Q ss_pred             hcccCcCCCC
Q psy11805        240 LLLKDREDAP  249 (251)
Q Consensus       240 ~l~~~p~~Rp  249 (251)
                      +...+|.+|.
T Consensus       655 LCr~~P~ERL  664 (732)
T KOG0614|consen  655 LCRDNPTERL  664 (732)
T ss_pred             HHhcCcHhhh
Confidence            9999999995

>KOG4645|consensus

Probab=100.00  E-value=1.7e-41  Score=295.97  Aligned_cols=242  Identities=26%  Similarity=0.439  Sum_probs=209.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      -++.....||.|.||.||-|....+|...|+|.+....  ......+.+|..++..++|||+++++++-.+.+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            46778889999999999999999999999999876443  3357788999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC---
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---  157 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~---  157 (251)
                      ||++|+|.+.+. .+...++.....+-.|++.|+.|||+.||||+||||.||++  +.+|.+|++|||.+.......   
T Consensus      1315 yC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L--d~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL--DFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee--ecCCcEEeecccceeEecCchhcC
Confidence            999999987765 44568888889999999999999999999999999999999  999999999999998865442   


Q ss_pred             --cceeeccCcccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccccCCCccccCCCH
Q psy11805        158 --KLQVLFGTPEFVAPEVVNFDA---IGFGTDMWSVGVICYVLLSGLSPFMGETDVQ-TMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       158 --~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                        ..+...|||.|||||++.+..   -..++|||||||++.||+||+.||...+... +..++..+..+..+   ..++.
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P---~~ls~ 1468 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP---ERLSS 1468 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc---hhhhH
Confidence              224457999999999997654   4568999999999999999999999876644 55677777765554   45899


Q ss_pred             HHHHHHHHhcccCcCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps  250 (251)
                      +-++||.+||..||++|-+
T Consensus      1469 ~g~dFle~Cl~~dP~~Rw~ 1487 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWT 1487 (1509)
T ss_pred             hHHHHHHHHHhcCchhhhH
Confidence            9999999999999999944

>KOG4257|consensus

Probab=100.00  E-value=7e-40  Score=268.18  Aligned_cols=241  Identities=24%  Similarity=0.433  Sum_probs=207.8

Q ss_pred             cCCcccccccCCceEEEEEEEccC----CceEEEEEecc-ccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKAT----GMTLAAKFVGI-AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~----~~~~~~K~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +..+.++||.|-||.||.+....-    .-.||+|..+. ....+.+.+.+|+.+++++.||||++++|++++. ..++|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            345678999999999999987533    34688998865 3344588999999999999999999999999864 57899


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-  157 (251)
                      ||.++.|.|..++..++..++......++.||+.||.|||+.++|||||..+||++  .+..-+||+|||+++..+.+. 
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV--sSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV--SSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee--cCcceeeecccchhhhccccch
Confidence            99999999999999998899999999999999999999999999999999999998  777779999999998865432 


Q ss_pred             -cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        158 -KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                       ......-+.-|+|||.+....++.+||||-||++|||++. |..||.+....+.+-++..+.   ..++++++|+.+..
T Consensus       547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe---RlP~P~nCPp~LYs  623 (974)
T KOG4257|consen  547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE---RLPCPPNCPPALYS  623 (974)
T ss_pred             hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC---CCCCCCCCChHHHH
Confidence             2233334568999999999999999999999999999988 999999987777776665554   34455889999999


Q ss_pred             HHHHhcccCcCCCCC
Q psy11805        236 FIRKLLLKDREDAPE  250 (251)
Q Consensus       236 li~~~l~~~p~~Rps  250 (251)
                      |+.+||..+|.+||+
T Consensus       624 lmskcWayeP~kRPr  638 (974)
T KOG4257|consen  624 LMSKCWAYEPSKRPR  638 (974)
T ss_pred             HHHHHhccCcccCCc
Confidence            999999999999996

>KOG1094|consensus

Probab=100.00  E-value=1.4e-39  Score=264.48  Aligned_cols=245  Identities=20%  Similarity=0.339  Sum_probs=207.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccc-hHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +...++++||+|.||.|.+|+-.. +..||+|..+.....+ .+.+.+|++.|.+++||||+++++++..++.+++++||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            356789999999999999998764 6899999998766655 58999999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc--
Q psy11805         82 IEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK--  158 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~-~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~--  158 (251)
                      ++.|+|.+++.++.-+ ........|+.||++|++||.+.++||||+.++|+|+  +.++++|++|||+++....+.-  
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv--~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV--DGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee--cCcccEEecCcccccccccCCcee
Confidence            9999999999987433 3556667799999999999999999999999999999  9999999999999986543322  


Q ss_pred             c-eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHhcccc----CCCccccCCCH
Q psy11805        159 L-QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS--GLSPFMGETDVQTMANVTIAQYD----FDDECFNEISD  231 (251)
Q Consensus       159 ~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  231 (251)
                      . ....-+.+|+|||.+.-+.++.+||+|++|++|||+++  ...||...++++..++...-...    .-.+.+.-+|.
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence            1 22345679999999999999999999999999999876  88999999888776654322211    11233456899


Q ss_pred             HHHHHHHHhcccCcCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps  250 (251)
                      .+.+++-.||..|.++|||
T Consensus       775 ~lyelml~Cw~~es~~RPs  793 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPS  793 (807)
T ss_pred             HHHHHHHHHhchhhhcCCC
Confidence            9999999999999999998

>KOG4250|consensus

Probab=100.00  E-value=3.9e-40  Score=272.99  Aligned_cols=203  Identities=28%  Similarity=0.481  Sum_probs=179.7

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC------EEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN------VMCV   77 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~l   77 (251)
                      +.--+.||.|+||.||+++++.+|+.||+|.+.... ....+..-+|++++++++|+|||+.+++-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            345678999999999999999999999999986433 445788889999999999999999999876544      4789


Q ss_pred             EEEeccCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC--cEEEeeccccccc
Q psy11805         78 VLELIEGGELFERVID--DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN--RIKIIDFGLARKF  153 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~--~~~l~df~~~~~~  153 (251)
                      +||||.||+|...+..  +-..+++..++.++.++..|+.+||++||+||||||.||++....+|  ..||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            9999999999998875  33469999999999999999999999999999999999998776655  4699999999999


Q ss_pred             CCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETD  207 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  207 (251)
                      +.+......+||+.|++||..-. ..++...|.||||+++|+++||..||.....
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            98888888999999999999984 7889999999999999999999999976543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.8e-38  Score=245.11  Aligned_cols=233  Identities=38%  Similarity=0.689  Sum_probs=198.4

Q ss_pred             CceEEEEEEEccCCceEEEEEeccccccc-hHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCchhHHHhh
Q psy11805         15 KFGTVYRCKEKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVID   93 (251)
Q Consensus        15 ~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   93 (251)
                      ++|.||++.+..+++.+++|++....... ...+.+|++.+++++|++++++++.+......++++|++++++|.+.+..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            57999999999889999999987655444 78999999999999999999999999999999999999999899888876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCcccccccc
Q psy11805         94 DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV  173 (251)
Q Consensus        94 ~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~  173 (251)
                      .. .++...++.++.+++.++.+||+.|++|+|++|+||++  +.++.++++|||.+.............++..|++||.
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~  157 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL--DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV  157 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE--CCCCcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence            54 38999999999999999999999999999999999999  8889999999999988766544555667889999999


Q ss_pred             cccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        174 VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE-TDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       174 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+...+.++||||||++++++++|..||... +................ .....++..+.+++.+||..+|++||++
T Consensus       158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~  235 (244)
T smart00220      158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKRLTA  235 (244)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhccCH
Confidence            98888899999999999999999999999884 44444444433333222 2222278999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0196|consensus

Probab=100.00  E-value=2.8e-40  Score=276.01  Aligned_cols=242  Identities=22%  Similarity=0.388  Sum_probs=215.1

Q ss_pred             cCCcccccccCCceEEEEEEEccCC---ceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATG---MTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ..+|.+.||.|.||.|+.+..+..+   ..||+|.++... .+....|..|+.++-++.||||+++.|+.......+||.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4678999999999999999998665   579999987543 445888999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |||+.++|+.+++.+.+.++..++..+++.|+.|++||.+.|+|||||..+|||+  +.+-..|+.|||+++....+...
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV--NsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee--ccceEEEeccccceeecccCCCc
Confidence            9999999999999999999999999999999999999999999999999999999  99999999999999876444311


Q ss_pred             -eee---ccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        160 -QVL---FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       160 -~~~---~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                       .+.   -.+.+|.|||.+....++.+|||||+|++|||.++ |..||.+++..+.+..+..+. +++.+  .++|..+.
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy-RLPpP--mDCP~aL~  864 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY-RLPPP--MDCPAALY  864 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc-CCCCC--CCCcHHHH
Confidence             111   12459999999999999999999999999999888 999999999999999886654 44444  68999999


Q ss_pred             HHHHHhcccCcCCCCC
Q psy11805        235 DFIRKLLLKDREDAPE  250 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps  250 (251)
                      +|+..||++|-.+||.
T Consensus       865 qLMldCWqkdR~~RP~  880 (996)
T KOG0196|consen  865 QLMLDCWQKDRNRRPK  880 (996)
T ss_pred             HHHHHHHHHHhhcCCC
Confidence            9999999999999996

>KOG0696|consensus

Probab=100.00  E-value=1.5e-39  Score=255.20  Aligned_cols=240  Identities=25%  Similarity=0.454  Sum_probs=210.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .+|..+..||.|+||+|-+|..+.+...+|+|+++.+-   ..+.+--..|-++|... +-|.++++...|++-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            47888999999999999999999999999999886322   11233333445555544 366778888888998999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc-CCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~-~~~~  157 (251)
                      |||+.||.|...++.-+ ++.+..+.-++..|+-||-+||++||++||||.+|||+  +.+|++||.|||++... ..+.
T Consensus       429 MEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL--d~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--DSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe--ccCCceEeeecccccccccCCc
Confidence            99999999999988765 68888999999999999999999999999999999999  99999999999999763 4455


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ...+.+|||.|+|||++..++|+...|.||+|++||||+.|..||++.+..+..+.+......++    ..+|.++.+++
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----KslSkEAv~ic  581 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----KSLSKEAVAIC  581 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----ccccHHHHHHH
Confidence            66788999999999999999999999999999999999999999999999999999998887777    67899999999


Q ss_pred             HHhcccCcCCCC
Q psy11805        238 RKLLLKDREDAP  249 (251)
Q Consensus       238 ~~~l~~~p~~Rp  249 (251)
                      +..|.+.|.+|.
T Consensus       582 kg~ltK~P~kRL  593 (683)
T KOG0696|consen  582 KGLLTKHPGKRL  593 (683)
T ss_pred             HHHhhcCCcccc
Confidence            999999999996

>KOG4278|consensus

Probab=100.00  E-value=4e-39  Score=264.07  Aligned_cols=242  Identities=21%  Similarity=0.380  Sum_probs=210.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      .+.....+||.|-||.||.+.|+.-.-.||+|.++ .+.-..++|..|+.+++.++|||+++++++|..+-..|||+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            35667889999999999999999888899999984 34556899999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce-
Q psy11805         83 EGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ-  160 (251)
Q Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~-  160 (251)
                      ..|+|.+++++.. ..++.-..+.++.||.+|+.||..+.++||||..+|+|+  .++..+|+.|||+++.+..++-.. 
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV--gEnhiVKvADFGLsRlMtgDTYTAH  423 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHIVKVADFGLSRLMTGDTYTAH  423 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc--cccceEEeeccchhhhhcCCceecc
Confidence            9999999998743 457888899999999999999999999999999999999  899999999999999875443221 


Q ss_pred             -eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        161 -VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       161 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                       ..-.+.-|.|||.+....++.++|||+||++||||.| |..||.+.+..+.+.-+.+ .++...+  ..+|+.+..|++
T Consensus       424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~P--eGCPpkVYeLMr  500 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGP--EGCPPKVYELMR  500 (1157)
T ss_pred             cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-cccccCC--CCCCHHHHHHHH
Confidence             1123458999999999999999999999999999999 9999999887776665544 4444443  689999999999


Q ss_pred             HhcccCcCCCCC
Q psy11805        239 KLLLKDREDAPE  250 (251)
Q Consensus       239 ~~l~~~p~~Rps  250 (251)
                      +||+++|..||+
T Consensus       501 aCW~WsPsDRPs  512 (1157)
T KOG4278|consen  501 ACWNWSPSDRPS  512 (1157)
T ss_pred             HHhcCCcccCcc
Confidence            999999999997

>KOG0666|consensus

Probab=100.00  E-value=2.6e-38  Score=239.79  Aligned_cols=248  Identities=27%  Similarity=0.372  Sum_probs=193.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCC----ceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEee-CCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATG----MTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFES-SNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   75 (251)
                      ..|++...||+|+||.||+|..++++    +.+|+|.++.+..  ......-+|+.+++.++|+|++.+..++.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46899999999999999999665543    3789999865433  236777899999999999999999999876 7889


Q ss_pred             EEEEEeccCCchhHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec--CCCcEEEeeccc
Q psy11805         76 CVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK--TGNRIKIIDFGL  149 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~--~~~~~~l~df~~  149 (251)
                      ++++||.+. +|++.+..+    ...++......|++||+.|+.|||++=+.|||+||.|||+-.+  +.|.+||.|+|+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999976 888888653    2458999999999999999999999999999999999998222  348999999999


Q ss_pred             ccccCCC----CcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH
Q psy11805        150 ARKFDPE----KKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETD---------VQTMANVT  215 (251)
Q Consensus       150 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~~~~~  215 (251)
                      ++.+...    ........|.-|.|||++.|. .||.+.||||+||++.||++-.+.|.+.+.         ..++.++.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            9887533    123445677889999999876 589999999999999999999888866422         22233332


Q ss_pred             hccccCCCccc---------------------------------cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        216 IAQYDFDDECF---------------------------------NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       216 ~~~~~~~~~~~---------------------------------~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .-...+....|                                 ..-++...+|+.+||+.||.+|+|+
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta  331 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA  331 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence            21111111111                                 1234558899999999999999985

>KOG0695|consensus

Probab=100.00  E-value=1.1e-37  Score=239.21  Aligned_cols=240  Identities=23%  Similarity=0.452  Sum_probs=202.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecc---ccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGI---AKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|.+.+.||+|+|.+|.+++++.+.+.+|+|+++.   ...++..=.+.|-.+..+. +||.++-+...|.+++.+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            579999999999999999999999999999999863   3344455566666777666 599999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc-cCCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~-~~~~~  157 (251)
                      .||.+|+.|.=..+. ..+++++.++-+...|..||.|||++||+++|+|.+|+++  +..|++||+|+|++.. ..++.
T Consensus       330 ieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll--daeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE--ccCCceeecccchhhcCCCCCc
Confidence            999999988655544 3469999999999999999999999999999999999999  9999999999999976 34566


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC-------CChHHH-HHHHHhccccCCCccccCC
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG-------ETDVQT-MANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-------~~~~~~-~~~~~~~~~~~~~~~~~~~  229 (251)
                      ...+.+|||.|.|||.+.+..|+...|.|+||++|+||+.|+.||.-       .+..+. .+-+.....+.+    ..+
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip----rsl  482 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP----RSL  482 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc----cee
Confidence            67888999999999999999999999999999999999999999953       223333 333444433433    455


Q ss_pred             CHHHHHHHHHhcccCcCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rp  249 (251)
                      +-....+++.-|.+||.+|.
T Consensus       483 svkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  483 SVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ehhhHHHHHHhhcCCcHHhc
Confidence            66788899999999999985

>KOG0669|consensus

Probab=100.00  E-value=2.2e-39  Score=239.24  Aligned_cols=246  Identities=24%  Similarity=0.385  Sum_probs=198.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEee--------C
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFES--------S   72 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~   72 (251)
                      +.|+-..++|+|.||.||+|+.+++++.|++|..-..+++  -.....+|+.+|..++|+|++.+++++..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4577788999999999999999999999998876444433  36777899999999999999998887732        3


Q ss_pred             CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         73 NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ...|+||++|+. +|.-.+.....+++...+..++.++..||.|+|+..|.|||+|+.|++|  +.+|.++|.|||+++.
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI--t~dgilklADFGlar~  173 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI--TKDGILKLADFGLARA  173 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE--cCCceEEeeccccccc
Confidence            458999999976 7878887776789999999999999999999999999999999999999  9999999999999977


Q ss_pred             cCCCCcc-----eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccc
Q psy11805        153 FDPEKKL-----QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF  226 (251)
Q Consensus       153 ~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (251)
                      +......     .....|.-|++||.+.|. .++++.|||+.||+|.+|++|.+.|++.+...++..+...-.....+-|
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            6433322     122357789999999775 5889999999999999999999999988877766544222211111111


Q ss_pred             c-------------------------------CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 N-------------------------------EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~-------------------------------~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +                               .-+++..+|+.++|..||.+|+++
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a  309 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA  309 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch
Confidence            1                               123478899999999999999975

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.6e-37  Score=281.42  Aligned_cols=234  Identities=22%  Similarity=0.263  Sum_probs=178.7

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      .++....||+|+||.||+|.+..+++.||+|.+.....    ....|++.+++++||||+++++++.+.+..++||||++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~  766 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE  766 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence            46677889999999999999988999999998753322    22345888999999999999999999999999999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH---SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh---~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++|.+.+.    .+++..+..++.|++.|++|||   +.+++|||+||+||++  +.++..++. ++........   .
T Consensus       767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~--~~~~~~~~~-~~~~~~~~~~---~  836 (968)
T PLN00113        767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII--DGKDEPHLR-LSLPGLLCTD---T  836 (968)
T ss_pred             CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE--CCCCceEEE-eccccccccC---C
Confidence            999998884    3789999999999999999999   6799999999999999  666665554 4444322111   1


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHh---------ccccCCCccc
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD-----VQTMANVTI---------AQYDFDDECF  226 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~---------~~~~~~~~~~  226 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|||++|+.||.....     .+.......         ..........
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            22577899999999988999999999999999999999999854321     111110000         0000000000


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....++.+++.+||+.+|++|||+
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~  941 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCA  941 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCH
Confidence            1122357789999999999999985

>KOG0587|consensus

Probab=100.00  E-value=3.8e-37  Score=260.17  Aligned_cols=245  Identities=25%  Similarity=0.486  Sum_probs=210.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEe-----eCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFE-----SSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-----~~~~~~   76 (251)
                      +.++|++.||.|.+|.||+++.+.++...|+|+.... ....++++.|.++++... |||++.+++++-     ..+.++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            5689999999999999999999999999999998653 344677888999999885 999999999984     356799


Q ss_pred             EEEEeccCCchhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         77 VVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ||||+|.|||..+++.. .+..+.++.+..|++.++.||.+||...++|+|++-.||++  +.++.+||+|||.+.+.+.
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL--T~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE--eccCcEEEeeeeeeeeeec
Confidence            99999999999999875 35679999999999999999999999999999999999999  9999999999999988764


Q ss_pred             C-CcceeeccCcccccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCC
Q psy11805        156 E-KKLQVLFGTPEFVAPEVVNFD-----AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (251)
                      . ....+..|||.|||||++...     .++..+|+||||++..||..|.+|+..+.....+-.+-++. ++....+..+
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkLkrp~kW  254 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKLKRPKKW  254 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-CccccchhhH
Confidence            4 344667899999999999654     46788999999999999999999998887766655443332 3333346778


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+-+||..||.+|-++||+.
T Consensus       255 s~~FndFIs~cL~Kd~e~RP~~  276 (953)
T KOG0587|consen  255 SKKFNDFISTCLVKDYEQRPST  276 (953)
T ss_pred             HHHHHHHHHHHHhhccccCcch
Confidence            9999999999999999999974

>KOG1006|consensus

Probab=100.00  E-value=3.2e-39  Score=239.81  Aligned_cols=244  Identities=21%  Similarity=0.343  Sum_probs=200.7

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +.+-...||.|+||+|++..++.+|+..|+|.++..+. .+.+++..|.+...+- +.|+|++++|..-.++..++-||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            34456789999999999999999999999999987665 4677788888866555 699999999999999999999999


Q ss_pred             ccCCchhHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         82 IEGGELFERVID----DDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        82 ~~~~~L~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      |+- |+..+...    .+..++++.+-.|..-...||.||-+. .|+|||+||+|||+  +..|.+||||||.+-+...+
T Consensus       145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl--dr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL--DRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE--ecCCCEeeecccchHhHHHH
Confidence            965 67554432    344689999999999999999999864 89999999999999  99999999999999877665


Q ss_pred             CcceeeccCcccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccccCCCccc--cCCCH
Q psy11805        157 KKLQVLFGTPEFVAPEVVNFD--AIGFGTDMWSVGVICYVLLSGLSPFMGET-DVQTMANVTIAQYDFDDECF--NEISD  231 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~  231 (251)
                      .......|-..|+|||.+...  .++.+|||||||++|+|+.||..|+..=+ -.+++..+..+..+....-.  -+++.
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~  301 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF  301 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence            555556678899999999543  47899999999999999999999997743 45556666666554333211  25888


Q ss_pred             HHHHHHHHhcccCcCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps  250 (251)
                      .+..+|.-||.+|-..||+
T Consensus       302 ~~~~fintCl~Kd~~~Rpk  320 (361)
T KOG1006|consen  302 SMVRFINTCLIKDRSDRPK  320 (361)
T ss_pred             HHHHHHHHHhhcccccCcc
Confidence            9999999999999999996

>KOG0668|consensus

Probab=100.00  E-value=1.3e-37  Score=226.91  Aligned_cols=242  Identities=21%  Similarity=0.444  Sum_probs=195.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeC--CEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESS--NVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv   78 (251)
                      +++|++.+++|+|.+|.||.+....++..+++|++++.   ..+.+.+|+.+|+.+. +|||++++++..+.  ....++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            57899999999999999999998888999999998643   4788999999999997 99999999998764  457899


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      +|+.+..+.....    ..++.-.+..++.+++.||.|+|+.||+|||+||.|+++ +-....++|+|+|++..+-+...
T Consensus       114 FE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI-dh~~rkLrlIDWGLAEFYHp~~e  188 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKE  188 (338)
T ss_pred             hhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee-chhhceeeeeecchHhhcCCCce
Confidence            9999875543333    248889999999999999999999999999999999997 33455799999999999888877


Q ss_pred             ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhc-------------cccCCC
Q psy11805        159 LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIA-------------QYDFDD  223 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~-------------~~~~~~  223 (251)
                      -.....+..|-.||++.. +.++..-|+|||||++..|+..+.||- +.+..+++.++.+-             ...+++
T Consensus       189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp  268 (338)
T KOG0668|consen  189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP  268 (338)
T ss_pred             eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence            777778888899999864 567899999999999999999988874 44444444333111             001110


Q ss_pred             -----------ccc---------cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 -----------ECF---------NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 -----------~~~---------~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                 ..|         .-.++++.||+.++|.-|-++|+||
T Consensus       269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa  316 (338)
T KOG0668|consen  269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA  316 (338)
T ss_pred             hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch
Confidence                       001         1256899999999999999999986

>KOG0200|consensus

Probab=100.00  E-value=2.9e-36  Score=260.36  Aligned_cols=242  Identities=24%  Similarity=0.409  Sum_probs=202.0

Q ss_pred             cCCcccccccCCceEEEEEEEcc-------CCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKA-------TGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNV   74 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   74 (251)
                      +..+.+.+|+|.||.|+++....       ....||+|...... ..+.+.+..|+++++.+ +|+|++.+++.+...+.
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            34567799999999999998641       14578999876333 34688899999999998 59999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC
Q psy11805         75 MCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG  139 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~  139 (251)
                      .++|.||+..|+|.++++.+.               ..++..+.+.++.||+.|++||++.+++|||+..+||++  ..+
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi--~~~  454 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI--TKN  454 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe--cCC
Confidence            999999999999999998876               348999999999999999999999999999999999999  888


Q ss_pred             CcEEEeecccccccCCCCcce--eec--cCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHH
Q psy11805        140 NRIKIIDFGLARKFDPEKKLQ--VLF--GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGET-DVQTMAN  213 (251)
Q Consensus       140 ~~~~l~df~~~~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~-~~~~~~~  213 (251)
                      ..++++|||+++.......-.  ...  -+..|+|||.+....++.++||||+|++||||++ |..||.+.. ..+..+.
T Consensus       455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~  534 (609)
T KOG0200|consen  455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF  534 (609)
T ss_pred             CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence            999999999998643322221  111  3446999999999999999999999999999999 999998865 5555554


Q ss_pred             HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      +. ...+...+  ..+++++.++++.||+.+|++||+
T Consensus       535 l~-~G~r~~~P--~~c~~eiY~iM~~CW~~~p~~RP~  568 (609)
T KOG0200|consen  535 LK-EGNRMEQP--EHCSDEIYDLMKSCWNADPEDRPT  568 (609)
T ss_pred             Hh-cCCCCCCC--CCCCHHHHHHHHHHhCCCcccCCC
Confidence            44 44444433  677999999999999999999997

>KOG0608|consensus

Probab=100.00  E-value=2.4e-37  Score=253.80  Aligned_cols=237  Identities=28%  Similarity=0.465  Sum_probs=204.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .-|..++.||-|+||+|.++.-..+...+|+|.++..+.   ....-.+.|-.+|....++=||+++-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            346778999999999999999988899999999865442   23455678888999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-----
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-----  154 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-----  154 (251)
                      +|++||++..++...+ .|.++.++-++..+..|+++.|..|++||||||+||||  +.+|++||+|||+|+.+.     
T Consensus       709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI--DrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE--ccCCceeeeeccccccceecccc
Confidence            9999999999888765 79999999999999999999999999999999999999  999999999999996651     


Q ss_pred             ----CCCc----------------------------------ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHH
Q psy11805        155 ----PEKK----------------------------------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLL  196 (251)
Q Consensus       155 ----~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  196 (251)
                          .+..                                  .....||+.|+|||++....++..+|.||.|++||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                0000                                  00124899999999999999999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcc
Q psy11805        197 SGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL  242 (251)
Q Consensus       197 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (251)
                      .|..||...+..++..++......+..+...+++.++.++|.++..
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~  911 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC  911 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc
Confidence            9999999999888888887777666666667899999999988764

>KOG1025|consensus

Probab=100.00  E-value=3.8e-37  Score=258.68  Aligned_cols=241  Identities=22%  Similarity=0.336  Sum_probs=210.3

Q ss_pred             CCcccccccCCceEEEEEEEccCC----ceEEEEEec-cccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATG----MTLAAKFVG-IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~----~~~~~K~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .+..+.||+|+||+||++.+-..+    .+|++|++. ....+...++.+|+-.+.++.|||++++++++..+. ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            345678999999999999996544    478888874 333445888999999999999999999999998765 88999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      +|+++|+|.++++.++..+-.+..+.|..||++|+.|||++++|||||-++|||+  .+-+.+|+.|||++.....+...
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV--ksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV--KSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee--cCCCeEEEEecchhhccCccccc
Confidence            9999999999999998899999999999999999999999999999999999999  88999999999999887655433


Q ss_pred             e---eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        160 Q---VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       160 ~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      .   .....+.|+|-|.+....++.++||||+|+.+||++| |..|+.+....++...+..+..   .++++.++.++..
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---LsqPpiCtiDVy~  931 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---LSQPPICTIDVYM  931 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---CCCCCCccHHHHH
Confidence            2   2234568999999999999999999999999999999 9999999999888877766654   4444788999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      ++.+||..|+..||++
T Consensus       932 ~mvkCwmid~~~rp~f  947 (1177)
T KOG1025|consen  932 VMVKCWMIDADSRPTF  947 (1177)
T ss_pred             HHHHHhccCcccCccH
Confidence            9999999999999973

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.6e-36  Score=254.93  Aligned_cols=242  Identities=17%  Similarity=0.183  Sum_probs=161.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccC----CceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEE------Eee
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT----GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA------FES   71 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~----~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~~~   71 (251)
                      .++|++.+.||+|+||.||+|.+..+    +..|++|.+.....  .+....+  .++...+.++..+...      ...
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence            36899999999999999999999988    88999998643221  1111111  1122122222211111      245


Q ss_pred             CCEEEEEEEeccCCchhHHHhhCCCC-------------------CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcE
Q psy11805         72 SNVMCVVLELIEGGELFERVIDDDFV-------------------LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI  132 (251)
Q Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~ni  132 (251)
                      +...++|+||+++++|.+++......                   .....+..++.|++.||.|||+.||+||||||+||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI  286 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI  286 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence            56789999999999998887654321                   12345678999999999999999999999999999


Q ss_pred             EEeecC-CCcEEEeecccccccCCC--CcceeeccCcccccccccccCC----------------------CCcchhHHH
Q psy11805        133 LCLTKT-GNRIKIIDFGLARKFDPE--KKLQVLFGTPEFVAPEVVNFDA----------------------IGFGTDMWS  187 (251)
Q Consensus       133 l~~~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~~Di~s  187 (251)
                      |+  +. ++.++|+|||++......  .......+++.|+|||.+....                      ++.++||||
T Consensus       287 Ll--~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        287 IF--SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             EE--eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            97  54 678999999999764322  2223456889999999663221                      234569999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHH-HHhcccc-----------CC------CccccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        188 VGVICYVLLSGLSPFMGETDVQTMAN-VTIAQYD-----------FD------DECFNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       188 lG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~-----------~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      +||+||+|+++..++...  ...... +......           ..      ....+..+....+||.+||+.||++||
T Consensus       365 lGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~  442 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI  442 (566)
T ss_pred             HHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence            999999999977664322  111111 1111000           00      011112233456899999999999999


Q ss_pred             CC
Q psy11805        250 EV  251 (251)
Q Consensus       250 s~  251 (251)
                      |+
T Consensus       443 ta  444 (566)
T PLN03225        443 SA  444 (566)
T ss_pred             CH
Confidence            85

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.1e-35  Score=245.71  Aligned_cols=246  Identities=17%  Similarity=0.207  Sum_probs=176.7

Q ss_pred             CccCCcccccccCCceEEEEEEEc----------------cCCceEEEEEeccccccchHH--------------HHHHH
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK----------------ATGMTLAAKFVGIAKRNDRRN--------------VEREV   51 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~----------------~~~~~~~~K~~~~~~~~~~~~--------------~~~e~   51 (251)
                      .++|++.++||+|+||.||++.+.                ..++.|++|.+........+.              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            468999999999999999999752                234679999986443322222              33466


Q ss_pred             HHHHHcCCCce-----eeEeEEEee--------CCEEEEEEEeccCCchhHHHhhCC-----------------------
Q psy11805         52 EIMRELQHPRL-----IQIYDAFES--------SNVMCVVLELIEGGELFERVIDDD-----------------------   95 (251)
Q Consensus        52 ~~l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~-----------------------   95 (251)
                      ..+.+++|.++     +++++++..        .+..++|+||+++++|.+.+....                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            66666765543     666666642        356899999999999988775421                       


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce--eeccCcccccccc
Q psy11805         96 FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEV  173 (251)
Q Consensus        96 ~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~y~aPE~  173 (251)
                      ..+++..++.++.|++.+|.+||+.+++|+||||+||++  +.++.++|+|||++..........  ....++.|+|||.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV--TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE--CCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence            124567889999999999999999999999999999999  888999999999996654332222  2334789999998


Q ss_pred             cccCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCChHH-----------HHHHHHhccc
Q psy11805        174 VNFDAI----------------------GFGTDMWSVGVICYVLLSGLS-PFMGETDVQ-----------TMANVTIAQY  219 (251)
Q Consensus       174 ~~~~~~----------------------~~~~Di~slG~~l~~l~~g~~-pf~~~~~~~-----------~~~~~~~~~~  219 (251)
                      +.....                      ....||||+|+++++|++|.. ||.......           ........  
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~--  459 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ--  459 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc--
Confidence            753221                      124699999999999999875 775432111           11111111  


Q ss_pred             cCCCccccCCCHHHHHHHHHhcccCc---CCCCCC
Q psy11805        220 DFDDECFNEISDDAKDFIRKLLLKDR---EDAPEV  251 (251)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p---~~Rps~  251 (251)
                      ....+.++..++..++|+.+||..+|   .+|+|+
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa  494 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV  494 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCCCH
Confidence            22333457789999999999999866   689985

>KOG0665|consensus

Probab=100.00  E-value=9.1e-37  Score=231.91  Aligned_cols=243  Identities=24%  Similarity=0.387  Sum_probs=202.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecc--ccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC------
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGI--AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN------   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   73 (251)
                      ..||.-.+.+|.|+. .|..|.|.-.+.+|++|....  .+....++..+|...+..++|+|+++++.++....      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            468888999999998 788888988899999998753  33456788899999999999999999999996543      


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..|+|||+|+. +|.+.+.   -.++.+.+..|..|++.|+++||+.||+||||||+||++  ..++.+|+.|||++...
T Consensus        95 e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv--~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV--NSDCTLKILDFGLARTE  168 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee--cchhheeeccchhhccc
Confidence            47999999976 8888776   248999999999999999999999999999999999999  99999999999999887


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC----------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD----------  223 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  223 (251)
                      +..........+-.|.|||++.+-.+....||||+||++.||++|+..|.+.+..++..++......+.+          
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            7765666667888999999999888999999999999999999999999998876666544222111111          


Q ss_pred             ---------------------ccc-------cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ---------------------ECF-------NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ---------------------~~~-------~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                           ..|       ..-...+++++.+||-.+|++|.|+
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv  304 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV  304 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH
Confidence                                 000       1123358899999999999999874

>KOG1151|consensus

Probab=100.00  E-value=1.2e-36  Score=241.08  Aligned_cols=247  Identities=30%  Similarity=0.485  Sum_probs=192.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccc------hHHHHHHHHHHHHcCCCceeeEeEEEe-eC
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RND------RRNVEREVEIMRELQHPRLIQIYDAFE-SS   72 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~   72 (251)
                      +.++|-+...||.|+|+.||+|.|...++.||+|+..... +.+      .+-.-+|..+.+.+.||.||++++++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3578999999999999999999999999999999975432 111      223447888899999999999999986 45


Q ss_pred             CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC--CceecCCCCCcEEEee-cCCCcEEEeeccc
Q psy11805         73 NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK--NVLHLDMKPENILCLT-KTGNRIKIIDFGL  149 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--gi~h~dl~~~nil~~~-~~~~~~~l~df~~  149 (251)
                      ...|-|.|||+|.+|.=++..+ ..+++..++.|+.||+.||.||.+.  .|+|=||||.|||+.+ +.-|.+||+|||+
T Consensus       541 dsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            5688999999998885555554 4699999999999999999999976  5999999999999854 3456899999999


Q ss_pred             ccccCCCCcc--------eeeccCcccccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH-
Q psy11805        150 ARKFDPEKKL--------QVLFGTPEFVAPEVVNFD----AIGFGTDMWSVGVICYVLLSGLSPFMGETD-VQTMANVT-  215 (251)
Q Consensus       150 ~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~-  215 (251)
                      +..++.+...        ....||.-|++||.+.-+    ..+.+.||||+|+++|.++.|+.||..... ..+++.-. 
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI  699 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI  699 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence            9887543211        234578889999998432    357899999999999999999999976533 33333221 


Q ss_pred             --hccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        216 --IAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       216 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                        .....++..  +-++.+.++||++||+.--+.|.+
T Consensus       700 lkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~D  734 (775)
T KOG1151|consen  700 LKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRID  734 (775)
T ss_pred             hcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhh
Confidence              112222221  568999999999999887776654

>KOG0664|consensus

Probab=100.00  E-value=1.4e-37  Score=232.56  Aligned_cols=243  Identities=26%  Similarity=0.435  Sum_probs=195.2

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEec--cccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-----EEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-----VMC   76 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   76 (251)
                      +.+=-+.||.|+||.||.+.|..+++.|++|.+.  ..+....+.+.+|+.+|...+|.|++..+++....+     .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4455689999999999999999999999999874  333446888999999999999999999999876543     367


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +++|.+.. +|...+.+ +..++.+.+.-++.||+.||+|||+.||.||||||.|.++  ++++.+||||||+++..+.+
T Consensus       134 V~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV--NSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV--NSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe--ccCceEEecccccccccchh
Confidence            88888853 66555544 4579999999999999999999999999999999999999  99999999999999886554


Q ss_pred             Ccc--eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC-----------
Q psy11805        157 KKL--QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-----------  222 (251)
Q Consensus       157 ~~~--~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  222 (251)
                      ...  .....|..|.|||++.|. .|+.+.||||+||++.|++.++..|...+..++++.+......+.           
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            433  334567899999999875 578899999999999999999999998888777765532221111           


Q ss_pred             -------------Cc------cccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        223 -------------DE------CFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       223 -------------~~------~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                                   .+      ....-..+..+++.++|.+||..|.+
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris  336 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS  336 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc
Confidence                         10      00123336778999999999999986

>KOG0984|consensus

Probab=100.00  E-value=7.6e-36  Score=214.34  Aligned_cols=212  Identities=21%  Similarity=0.359  Sum_probs=176.4

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +..-+..||+|++|.|-+.++..+|...|+|.+..+- ....+++..|+++.++- .+|.++++++....++..++.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            3445678999999999999999999999999986433 33466777788876554 699999999999999999999999


Q ss_pred             ccCCchhHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         82 IEGGELFERVI---DDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |+. ||..+..   ..+..+++..+-+|+..+..||.+||++ .++|||+||+|||+  +.+|++|+||||.+-....+-
T Consensus       127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI--n~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI--NYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE--ccCCcEEEcccccceeehhhh
Confidence            965 7755443   3567899999999999999999999987 89999999999999  999999999999998776555


Q ss_pred             cceeeccCcccccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcc
Q psy11805        158 KLQVLFGTPEFVAPEVVNFD----AIGFGTDMWSVGVICYVLLSGLSPFMG-ETDVQTMANVTIAQ  218 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~  218 (251)
                      ......|-..|+|||.+..+    .|+.+|||||||+.+.||.+++.||.. .+..+++..+....
T Consensus       204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            44556688899999998543    578899999999999999999999987 45666666655444

>KOG1290|consensus

Probab=100.00  E-value=4e-35  Score=234.02  Aligned_cols=130  Identities=22%  Similarity=0.460  Sum_probs=112.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC--------CCceeeEeEEEee---
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ--------HPRLIQIYDAFES---   71 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~~---   71 (251)
                      .||-+.++||.|.|++||+|.|..+.+.||+|+.+. ...-.+....|+.+|+++.        ..+||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            789999999999999999999999999999999753 2334677789999999883        3579999999854   


Q ss_pred             -CCEEEEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEE
Q psy11805         72 -SNVMCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILC  134 (251)
Q Consensus        72 -~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~  134 (251)
                       ..++++|+|++ |-+|..++.... ..++...+..|++|++.||.|||+. ||+|.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence             45799999999 557878877543 3599999999999999999999965 99999999999998

>KOG1345|consensus

Probab=100.00  E-value=3.7e-36  Score=224.22  Aligned_cols=242  Identities=25%  Similarity=0.384  Sum_probs=195.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeE-EEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYD-AFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~~~~~~lv~   79 (251)
                      -+.|.|.+.+|+|.||.+-+|.++.++..+++|.+.. .....+.+.+|...--.+. |.||+.-++ .|++.+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4679999999999999999999999999999999753 3445788888887666664 999999888 468888999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |+++.|+|.+.+..++  +-+.....++.|+++|+.|+|++++||||||.+|||+.+.+..++||||||+....+..  .
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V  177 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--V  177 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--e
Confidence            9999999999887765  89999999999999999999999999999999999999988889999999999775422  1


Q ss_pred             eeeccCcccccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCC---h-HHHHHHHHhccccCCCccccCCC
Q psy11805        160 QVLFGTPEFVAPEVVNFD-----AIGFGTDMWSVGVICYVLLSGLSPFMGET---D-VQTMANVTIAQYDFDDECFNEIS  230 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~  230 (251)
                      ...-..-.|.+||.....     ...+.+|+|.||+++|.+++|..||+...   . -....+...+..+-.+..+..++
T Consensus       178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs  257 (378)
T KOG1345|consen  178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFS  257 (378)
T ss_pred             hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccC
Confidence            122234478888876322     24678999999999999999999997432   1 11223333333333344457789


Q ss_pred             HHHHHHHHHhcccCcCCC
Q psy11805        231 DDAKDFIRKLLLKDREDA  248 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~R  248 (251)
                      +.+..+.++-|.++|+.|
T Consensus       258 ~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  258 EKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             HHHHHHHHHhcCCccccc
Confidence            999999999999999887

>KOG0670|consensus

Probab=100.00  E-value=1.3e-36  Score=244.37  Aligned_cols=208  Identities=26%  Similarity=0.412  Sum_probs=179.4

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC------CCceeeEeEEEeeCCE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ------HPRLIQIYDAFESSNV   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~   74 (251)
                      +.++|.+....|.|-||+|..|.+...+..||||++. .+....+.-+.|+++|++|+      ..|+++++-.|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR-nNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIR-NNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEee-cchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            4679999999999999999999999999999999984 44556777889999999995      4589999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         75 MCVVLELIEGGELFERVIDDD--FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      +|+|+|.+.. +|.+++...+  -.+....+..++.|++.||..|-..|++|.||||+|||+ ......+||||||.|..
T Consensus       509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLV-NE~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILV-NESKNILKLCDFGSASF  586 (752)
T ss_pred             eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEe-ccCcceeeeccCccccc
Confidence            9999999865 8999988644  247888999999999999999999999999999999997 33345689999999977


Q ss_pred             cCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA  212 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  212 (251)
                      ...... .+...+--|.|||++.|-+|+...|+||+||+||||+||+..|.+.+.-..+.
T Consensus       587 ~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr  645 (752)
T KOG0670|consen  587 ASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR  645 (752)
T ss_pred             cccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence            654432 33345668999999999999999999999999999999999999998766655

>KOG3653|consensus

Probab=100.00  E-value=9.9e-36  Score=236.66  Aligned_cols=238  Identities=19%  Similarity=0.273  Sum_probs=184.6

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHH--cCCCceeeEeEEEeeCC----EEEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRE--LQHPRLIQIYDAFESSN----VMCVV   78 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~----~~~lv   78 (251)
                      .++.+.+|+|.||.||+|+..  ++.||||++.   ..+.+.+++|-+++..  ++|+||+++++.-....    .+.+|
T Consensus       212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc--CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            456788999999999999887  5899999985   3457788888887765  47999999999875433    78999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CceecCCCCCcEEEeecCCCcEEEeeccc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK---------NVLHLDMKPENILCLTKTGNRIKIIDFGL  149 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~---------gi~h~dl~~~nil~~~~~~~~~~l~df~~  149 (251)
                      +++.+.|+|.+++..+-  +++....+|+..++.||+|||+.         .|+|||||++|||+  .++++..|+|||+
T Consensus       287 t~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv--K~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV--KNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE--ccCCcEEeeccce
Confidence            99999999999998764  99999999999999999999963         59999999999999  9999999999999


Q ss_pred             ccccCCCCcc---eeeccCcccccccccccCCC-C-----cchhHHHHHHHHHHHHhCCCCCCC----------------
Q psy11805        150 ARKFDPEKKL---QVLFGTPEFVAPEVVNFDAI-G-----FGTDMWSVGVICYVLLSGLSPFMG----------------  204 (251)
Q Consensus       150 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~-~-----~~~Di~slG~~l~~l~~g~~pf~~----------------  204 (251)
                      +..+......   -...||.+|||||++-+... .     .+.||||+|.+|||++++...+..                
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            9988654332   23679999999999966422 1     368999999999999986544321                


Q ss_pred             -CChHHHHHHHHhccc--cCCCccccC-CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        205 -ETDVQTMANVTIAQY--DFDDECFNE-ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       205 -~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                       .+-++....+...+.  .++..+..+ -...+++.+..||..||+.|.||
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA  493 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA  493 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence             111222222222222  222222121 23358899999999999999885

>KOG2052|consensus

Probab=100.00  E-value=5.1e-35  Score=231.09  Aligned_cols=241  Identities=20%  Similarity=0.312  Sum_probs=188.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc--CCCceeeEeEEEeeC----CEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL--QHPRLIQIYDAFESS----NVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~----~~~   75 (251)
                      ..+..+.+.||.|.||.||++.++  |..||+|++..   .+.....+|.++++..  +|+||+.+++.-..+    ..+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            356778999999999999999999  78999999853   3456778888888775  899999999875432    258


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CceecCCCCCcEEEeecCCCcEEEeec
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK--------NVLHLDMKPENILCLTKTGNRIKIIDF  147 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--------gi~h~dl~~~nil~~~~~~~~~~l~df  147 (251)
                      ++|.+|.+.|||.+++..+  .++.+...+++..++.||++||..        .|.|||||+.|||+  ..++...|.|+
T Consensus       285 wLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--Kkn~~C~IADL  360 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADL  360 (513)
T ss_pred             EEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE--ccCCcEEEeec
Confidence            9999999999999999874  599999999999999999999953        59999999999999  99999999999


Q ss_pred             ccccccCCCC-----cceeeccCcccccccccccCCC------CcchhHHHHHHHHHHHHhC----------CCCCCCC-
Q psy11805        148 GLARKFDPEK-----KLQVLFGTPEFVAPEVVNFDAI------GFGTDMWSVGVICYVLLSG----------LSPFMGE-  205 (251)
Q Consensus       148 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~------~~~~Di~slG~~l~~l~~g----------~~pf~~~-  205 (251)
                      |++...+...     .....+||.+|||||++...-.      -..+||||||+++||++-+          .+||.+. 
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9998876553     2345679999999999964321      1358999999999998742          4677542 


Q ss_pred             ----ChHHHHHHHHhccccC-CCccccCCC--HHHHHHHHHhcccCcCCCCCC
Q psy11805        206 ----TDVQTMANVTIAQYDF-DDECFNEIS--DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       206 ----~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~li~~~l~~~p~~Rps~  251 (251)
                          ...+...-+...+.++ .++.|+..|  ..+..+++.||..+|..|.||
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence                2233333333333332 333444333  256789999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-33  Score=216.33  Aligned_cols=211  Identities=35%  Similarity=0.612  Sum_probs=181.8

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      |++.+.||+|++|.||++....+++.+++|.+...... ..+.+.+|+..++.++|+|++++++.+......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            67889999999999999999988899999998765544 67889999999999999999999999998899999999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--ccee
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--KLQV  161 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--~~~~  161 (251)
                      +++|.+.+......+++..++.++.+++.++.+||+.|++|+|++|+||++  +.++.++|+|||.+.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v--~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL--GMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEeeCceeeEecCcccccccc
Confidence            999988887654338999999999999999999999999999999999999  778999999999998765443  3344


Q ss_pred             eccCccccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHHHhc
Q psy11805        162 LFGTPEFVAPEVV-NFDAIGFGTDMWSVGVICYVLLSGLSPFMG-ETDV-QTMANVTIA  217 (251)
Q Consensus       162 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~-~~~~~~~~~  217 (251)
                      ..++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .... +..+.+..+
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~  217 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG  217 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence            5677889999998 666778899999999999999999999977 4444 444444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152|consensus

Probab=100.00  E-value=2e-35  Score=240.09  Aligned_cols=198  Identities=23%  Similarity=0.474  Sum_probs=173.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--------ccchHHHHHHHHHHHHcC---CCceeeEeEEEee
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--------RNDRRNVEREVEIMRELQ---HPRLIQIYDAFES   71 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--------~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~   71 (251)
                      .+|...+.+|+|+||.|++|.++.+...|++|.+...+        .......-.|+++|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46999999999999999999999999999999985432        223556778999999996   9999999999999


Q ss_pred             CCEEEEEEEec-cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccc
Q psy11805         72 SNVMCVVLELI-EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLA  150 (251)
Q Consensus        72 ~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~  150 (251)
                      ++++|++||.- +|..|.+++..++ .+++..+..|++|++.|++.||+.||+|||||-+||.+  +.+|-++|+|||.+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv--d~~g~~klidfgsa  717 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV--DSNGFVKLIDFGSA  717 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEE--ecCCeEEEeeccch
Confidence            99999999954 5567788876655 69999999999999999999999999999999999999  99999999999998


Q ss_pred             cccCCCCcceeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMG  204 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~  204 (251)
                      ... .+.......||..|.|||++.|.+| +..-|||+||++||.++....||.+
T Consensus       718 a~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            654 4455677789999999999999887 5678999999999999999999854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3.3e-33  Score=211.97  Aligned_cols=204  Identities=38%  Similarity=0.688  Sum_probs=179.2

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCchhH
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFE   89 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   89 (251)
                      ||+|.+|.||++.+..+++.+++|++...... ....+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999988999999998654332 35789999999999999999999999999899999999999889999


Q ss_pred             HHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeecccccccCCCC-cceeeccCcc
Q psy11805         90 RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFGLARKFDPEK-KLQVLFGTPE  167 (251)
Q Consensus        90 ~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~  167 (251)
                      ++......++...++.++.+++.++.+||+.|++|+|++|.||++  +. ++.++|+||+.+....... ..........
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~--~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE--eCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            887653468999999999999999999999999999999999998  66 7899999999997765432 1233457789


Q ss_pred             cccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcC
Q psy11805        168 FVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE  246 (251)
Q Consensus       168 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  246 (251)
                      |.+||..... ..+.++|+|++|++++++                                   ..+.+++..|++.+|+
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~~p~  203 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQKDPE  203 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhCCcc
Confidence            9999999876 778899999999999998                                   5789999999999999


Q ss_pred             CCCCC
Q psy11805        247 DAPEV  251 (251)
Q Consensus       247 ~Rps~  251 (251)
                      +||++
T Consensus       204 ~R~~~  208 (215)
T cd00180         204 KRPSA  208 (215)
T ss_pred             cCcCH
Confidence            99984

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027|consensus

Probab=100.00  E-value=4e-35  Score=246.87  Aligned_cols=237  Identities=27%  Similarity=0.406  Sum_probs=185.0

Q ss_pred             CcccccccCCceE-EEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          6 NQHSAFSFGKFGT-VYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         6 ~~~~~lg~g~~~~-v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      .-.+.+|.|+.|+ ||++...  ++.||+|.+-   .+.....++|++.|+.- .||||+++++.-.++.+.|+..|.|.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC--CceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            3456788999886 7888665  7899999873   23356788999999987 59999999999999999999999997


Q ss_pred             CCchhHHHhhCCCCC---CHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee---cCCCcEEEeecccccccCCCC
Q psy11805         84 GGELFERVIDDDFVL---TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT---KTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~---~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~---~~~~~~~l~df~~~~~~~~~~  157 (251)
                      . +|.+++.......   .....+..+.|++.||++||+.+||||||||+||||..   +...+++|.|||++...+.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            6 8999887641111   11455778899999999999999999999999999944   234579999999999986554


Q ss_pred             cc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        158 KL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       158 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      ..    ....||.+|.|||.+.....+.+.|||||||++|+.++ |..||...-..  -.++..+......-. +.-..+
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~-~~~d~e  742 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE-PLPDCE  742 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec-cCchHH
Confidence            33    34568999999999998888889999999999999998 59999665332  233434433222110 111228


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +++||.+|++++|..||+|
T Consensus       743 A~dLI~~ml~~dP~~RPsa  761 (903)
T KOG1027|consen  743 AKDLISRMLNPDPQLRPSA  761 (903)
T ss_pred             HHHHHHHhcCCCcccCCCH
Confidence            8999999999999999986

>KOG1024|consensus

Probab=100.00  E-value=1.3e-33  Score=220.29  Aligned_cols=244  Identities=17%  Similarity=0.235  Sum_probs=199.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCC-----ceEEEEEecc-ccccchHHHHHHHHHHHHcCCCceeeEeEEEee-CCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATG-----MTLAAKFVGI-AKRNDRRNVEREVEIMRELQHPRLIQIYDAFES-SNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~K~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   74 (251)
                      +.|+++...+-+|.||.||.+.++..+     +.|.+|..+. .++-....+..|...+..+.|||+.++.++... ...
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            357888889999999999999887443     3455565532 223346778888889999999999999998754 456


Q ss_pred             EEEEEEeccCCchhHHHh-----hC--CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeec
Q psy11805         75 MCVVLELIEGGELFERVI-----DD--DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDF  147 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~-----~~--~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df  147 (251)
                      .++++.+..-++|..++.     +.  ...++..+...++.|++.|+++||+.|++|.||..+|.+|  ++.-.+||+|=
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI--dd~LqVkltDs  440 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI--DDQLQVKLTDS  440 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee--hhheeEEeccc
Confidence            888899998899999988     22  2347888999999999999999999999999999999999  88899999999


Q ss_pred             ccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCC
Q psy11805        148 GLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDD  223 (251)
Q Consensus       148 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (251)
                      .+++...+..-.   ...-.+..|+|||.+....++.++|+||||++||||+| |+.|+...+..|...-+.. .++...
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd-GyRlaQ  519 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD-GYRLAQ  519 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc-cceecC
Confidence            999875433211   11224558999999999999999999999999999999 9999999988887765544 445544


Q ss_pred             ccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        224 ECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      +  -++|+++..++..||...|++||+
T Consensus       520 P--~NCPDeLf~vMacCWallpeeRPs  544 (563)
T KOG1024|consen  520 P--FNCPDELFTVMACCWALLPEERPS  544 (563)
T ss_pred             C--CCCcHHHHHHHHHHHhcCcccCCC
Confidence            4  589999999999999999999997

>KOG0576|consensus

Probab=100.00  E-value=5e-35  Score=241.07  Aligned_cols=247  Identities=22%  Similarity=0.410  Sum_probs=210.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +++|++...+|+|+||.||+|++..+++..++|+++.....+..-+++|+-+++..+|+||+.+++.+......++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            57999999999999999999999999999999999988888899999999999999999999999999988899999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~~  160 (251)
                      |.|++|.+.....+ ++++.++....+..+++|+|||+.|-+|||||-.||++  ++.|.+++.|||.+..+.. -....
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~gk~hRdiKGanill--td~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL--TDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCCcccccccccceee--cccCceeecccCchhhhhhhhhhhh
Confidence            99999988766554 79999999999999999999999999999999999999  9999999999999876532 23335


Q ss_pred             eeccCccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC-CccccCCCHHHHHH
Q psy11805        161 VLFGTPEFVAPEVV---NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-DECFNEISDDAKDF  236 (251)
Q Consensus       161 ~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  236 (251)
                      ...|+|.|+|||+.   ..+.+...+|||++|+...|+-.-+.|.........+.-..+-.+.++ ..-...+++.+.+|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            56799999999987   345577899999999999998877777555444444433333333222 22224578899999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      ++.+|..+|++||++
T Consensus       251 vK~altknpKkRpta  265 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTA  265 (829)
T ss_pred             HHHHhcCCCccCCCh
Confidence            999999999999985

>KOG1164|consensus

Probab=99.98  E-value=5.1e-31  Score=212.66  Aligned_cols=246  Identities=20%  Similarity=0.248  Sum_probs=193.4

Q ss_pred             cCCcccccccCCceEEEEEEEccCC-ceEEEEEeccccccchHHHHHHHHHHHHcC----CCceeeEeEEE-eeCCEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATG-MTLAAKFVGIAKRNDRRNVEREVEIMRELQ----HPRLIQIYDAF-ESSNVMCV   77 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~l   77 (251)
                      +|++.+.||+|+||.||.|.+..++ ..+|+|+...........+..|..++..+.    ..+++.+++.+ ..+.+.++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999988764 678888876544443348899999999886    36999999999 58889999


Q ss_pred             EEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-C--CcEEEeeccccc--
Q psy11805         78 VLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-G--NRIKIIDFGLAR--  151 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~--~~~~l~df~~~~--  151 (251)
                      ||+.+ |.+|.++....+ ..++..++..++.|++.+|+++|+.|++||||||+|+.+.... .  ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99988 779988876554 7899999999999999999999999999999999999983322 1  469999999998  


Q ss_pred             ccCCCCc---------ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC
Q psy11805        152 KFDPEKK---------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       152 ~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      .+.....         .....||..|+|+..+.+...++++|+||+++++.++..|..||....................
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~  257 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL  257 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence            4311111         1123389999999999999999999999999999999999999977664333333322222222


Q ss_pred             Cc-cccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        223 DE-CFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       223 ~~-~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      .. .....+.++.++...+-..+...+|+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pd  286 (322)
T KOG1164|consen  258 TDRFGDLKPEEFAKILEYIDSLDYEDKPD  286 (322)
T ss_pred             cccccCCChHHHHHHHHHhhccCCcCCCC
Confidence            11 22445678888888887788888775

>KOG1167|consensus

Probab=99.98  E-value=2.2e-32  Score=214.95  Aligned_cols=196  Identities=25%  Similarity=0.430  Sum_probs=165.8

Q ss_pred             CccCCcccccccCCceEEEEEEEcc---CCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA---TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   77 (251)
                      .+.|+++.+||.|.|++||++.+..   .++.|++|.+..  .+...++.+|++.|..+. +.||+.+.+.+..++...+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i  112 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI  112 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence            4679999999999999999999987   678999999754  345677999999999995 9999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |++|++...-.++...    ++...+.++++.++.||.++|.+||+|+|+||+||+ .+...++-.|+|||++...+...
T Consensus       113 vlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL-~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFL-YNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccc-cccccCCceEEechhHHHHHhhh
Confidence            9999988776666543    678999999999999999999999999999999999 56677889999999997321000


Q ss_pred             --------------c-------------------------------ceeeccCccccccccccc-CCCCcchhHHHHHHH
Q psy11805        158 --------------K-------------------------------LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVI  191 (251)
Q Consensus       158 --------------~-------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~  191 (251)
                                    .                               .....||++|.|||++.. ...+.+.||||.|++
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                          0                               001248999999999854 557889999999999


Q ss_pred             HHHHHhCCCCCCC
Q psy11805        192 CYVLLSGLSPFMG  204 (251)
Q Consensus       192 l~~l~~g~~pf~~  204 (251)
                      ++.++++..||-.
T Consensus       268 ~Lslls~~~PFf~  280 (418)
T KOG1167|consen  268 LLSLLSRRYPFFK  280 (418)
T ss_pred             eehhhcccccccc
Confidence            9999999999844

>KOG1163|consensus

Probab=99.97  E-value=7.8e-31  Score=192.85  Aligned_cols=245  Identities=21%  Similarity=0.258  Sum_probs=199.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ...|+++++||+|+||.+|++..-.+|..||+|+.+  +......+.-|..+++.++ -..|+++..++.+..+..+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es--~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES--SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeec--ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            467999999999999999999999999999999964  3344567788999999997 6789999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC-CcEEEeecccccccCCC---
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG-NRIKIIDFGLARKFDPE---  156 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~-~~~~l~df~~~~~~~~~---  156 (251)
                      .+ |++|.+.+.-....++..+.+.++.|++.-++|+|.++++|+||||+|+++.-..+ ..+.|+|||++..+-..   
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            88 88999988877778999999999999999999999999999999999999843333 36899999999886322   


Q ss_pred             -----CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccccCCCc-ccc
Q psy11805        157 -----KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD---VQTMANVTIAQYDFDDE-CFN  227 (251)
Q Consensus       157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~-~~~  227 (251)
                           .......||.+|.|--.+.+...+.++|+-|+|++|..+--|.+||++...   .+..+++.......+.+ .-.
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK  250 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence                 222345689999999999888889999999999999999999999998643   34445554444333322 235


Q ss_pred             CCCHHHHHHHHHhcccCcCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      .+|.++.-.+..|-..-=++-|
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~P  272 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKP  272 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCC
Confidence            7888888888888765544444

>KOG1165|consensus

Probab=99.96  E-value=5.5e-29  Score=190.88  Aligned_cols=245  Identities=20%  Similarity=0.296  Sum_probs=200.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +-.|++.++||.|.||.++.+..--++.+||+|...  ...+.-++..|...++.|. .++|+..+-+..+..+..+|+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            457999999999999999999999999999999953  3455778999999999985 8999999988888888999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC---CCcEEEeecccccccCCCC
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT---GNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~---~~~~~l~df~~~~~~~~~~  157 (251)
                      .+ |++|.+++.-.+..|+......+|.|++.-++++|++.++.|||||+|+||....   ...+-++|||++..+-...
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            88 8899999888888999999999999999999999999999999999999994322   2358999999998864322


Q ss_pred             c--------ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhccccCCC-cc
Q psy11805        158 K--------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE---TDVQTMANVTIAQYDFDD-EC  225 (251)
Q Consensus       158 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~-~~  225 (251)
                      .        .....||.+||+--.+.|...+.++|+.|||-++.+++-|.+||.+.   +..+.++++.......+. ..
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L  263 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL  263 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence            1        12345899999999999999999999999999999999999999874   556667777544432222 22


Q ss_pred             ccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        226 FNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      -.++|.++...++..-..+=.+-|
T Consensus       264 c~g~P~efa~Yl~yvR~L~F~E~P  287 (449)
T KOG1165|consen  264 CEGFPEEFATYLRYVRRLDFFETP  287 (449)
T ss_pred             HhcCHHHHHHHHHHHHhcCcccCC
Confidence            346788877777766555544444

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.8e-29  Score=186.92  Aligned_cols=153  Identities=20%  Similarity=0.200  Sum_probs=120.8

Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeecc
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG  164 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~  164 (251)
                      |+|.+.+...+..+++..++.++.|++.||.|||+.+      ||+||++  +.++.+++  ||.+.......    ..+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~--~~~~~~~~--fG~~~~~~~~~----~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL--TWDGLLKL--DGSVAFKTPEQ----SRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE--cCccceee--ccceEeecccc----CCC
Confidence            4788888876667999999999999999999999998      9999999  88898998  99987654332    257


Q ss_pred             CcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccccCCC---ccccCCCH--HHHHHHH
Q psy11805        165 TPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIAQYDFDD---ECFNEISD--DAKDFIR  238 (251)
Q Consensus       165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~--~~~~li~  238 (251)
                      ++.|+|||.+.+..++.++||||||+++|+|++|..||...... .....+.........   .....++.  .+.++|.
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  146 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR  146 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence            89999999999999999999999999999999999999765442 223333222211110   11123343  6999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|.+||++
T Consensus       147 ~cl~~~p~~Rp~~  159 (176)
T smart00750      147 VCASRLPQRREAA  159 (176)
T ss_pred             HHHhcccccccCH
Confidence            9999999999985

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.9e-29  Score=225.61  Aligned_cols=189  Identities=17%  Similarity=0.185  Sum_probs=133.7

Q ss_pred             cCC-CceeeEeEEE-------eeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCC
Q psy11805         57 LQH-PRLIQIYDAF-------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK  128 (251)
Q Consensus        57 l~~-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~  128 (251)
                      +.| +||+.+++++       ......++++|+++ ++|.+.+......+++..++.++.||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            344 4677777766       22245678889874 59999987655669999999999999999999999999999999


Q ss_pred             CCcEEEee-----------------cCCCcEEEeecccccccCCCC-----------------cceeeccCccccccccc
Q psy11805        129 PENILCLT-----------------KTGNRIKIIDFGLARKFDPEK-----------------KLQVLFGTPEFVAPEVV  174 (251)
Q Consensus       129 ~~nil~~~-----------------~~~~~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~  174 (251)
                      |+|||+..                 +.++.++++|||++.......                 ......+++.|+|||.+
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            99999821                 223445566666654321000                 00112467789999999


Q ss_pred             ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       175 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+..++.++|||||||+||||++|..|+.....  ....+.....  +... ........+++.+||+++|.+||++
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~  259 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVL--PPQI-LLNWPKEASFCLWLLHPEPSCRPSM  259 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhc--Chhh-hhcCHHHHHHHHHhCCCChhhCcCh
Confidence            999999999999999999999999888754321  1222211111  1111 1124456789999999999999985

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.3e-25  Score=181.59  Aligned_cols=241  Identities=31%  Similarity=0.525  Sum_probs=195.8

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHHHHHHcCCC-ceeeEeEEEeeCCEEEEEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIMRELQHP-RLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e   80 (251)
                      |++.+.||.|+|+.||.+.+.   ..+++|.+......   ....+.+|+..++.+.|+ +++++.+.+...+..+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            778899999999999999988   67888887644433   377899999999999988 79999999988877899999


Q ss_pred             eccCCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-cEEEeecccccccCCCC
Q psy11805         81 LIEGGELFERVIDDD--FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEK  157 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~~~~~  157 (251)
                      ++.++++.+.+....  ..++......++.|++.++.++|+.|++|+|++|+||++  +..+ .++++|||.+.......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~--~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee--cCCCCeEEEeccCcceecCCCC
Confidence            999999986665543  268999999999999999999999999999999999998  7777 79999999987554332


Q ss_pred             -------cceeeccCccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcccc-CC
Q psy11805        158 -------KLQVLFGTPEFVAPEVVNF---DAIGFGTDMWSVGVICYVLLSGLSPFMGETD----VQTMANVTIAQYD-FD  222 (251)
Q Consensus       158 -------~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~-~~  222 (251)
                             ......++..|.+||...+   .......|+||+|++++++++|..||.....    ......+.....+ ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence                   2355678999999999987   5788899999999999999999999877764    3444444444333 22


Q ss_pred             CccccCC----CHHHHHHHHHhcccCcCCCCC
Q psy11805        223 DECFNEI----SDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       223 ~~~~~~~----~~~~~~li~~~l~~~p~~Rps  250 (251)
                      .......    ...+.+++..++..+|..|.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~  268 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLS  268 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCC
Confidence            2221222    257899999999999999976

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.2e-27  Score=190.60  Aligned_cols=161  Identities=20%  Similarity=0.225  Sum_probs=125.3

Q ss_pred             CccCCcccccccCCceEEEEEEEcc-CCceEEEEEeccc-----cccchHHHHHHHHHHHHcCCCceee-EeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA-TGMTLAAKFVGIA-----KRNDRRNVEREVEIMRELQHPRLIQ-IYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||+||+|.+.. ++..+++|.....     .......+.+|++++++++|+|+++ +++.    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            4689999999999999999999876 5777899986422     1223567999999999999999885 4432    45


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCC-CCCcEEEeecCCCcEEEeeccccccc
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM-KPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl-~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      .++||||++|++|.. ...    ..   ...++.+++++|.+||+.|++|||| ||+||++  +.++.++|+|||++...
T Consensus        93 ~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv--~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         93 DGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM--GPDGEAAVIDFQLASVF  162 (365)
T ss_pred             cEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE--cCCCCEEEEECccceec
Confidence            799999999988852 211    11   1467889999999999999999999 9999999  78889999999999865


Q ss_pred             CCCCcc---------eeeccCccccccccccc
Q psy11805        154 DPEKKL---------QVLFGTPEFVAPEVVNF  176 (251)
Q Consensus       154 ~~~~~~---------~~~~~~~~y~aPE~~~~  176 (251)
                      ......         ....+++.|+|||.+..
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            432211         23346778999998844

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.94  E-value=5.3e-27  Score=176.86  Aligned_cols=171  Identities=15%  Similarity=0.146  Sum_probs=132.0

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHH---------HHHHHHHHHHcCCCceeeEeEEEee
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN---------VEREVEIMRELQHPRLIQIYDAFES   71 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~---------~~~e~~~l~~l~~~~i~~~~~~~~~   71 (251)
                      ++++|++.+.+|.|+||.||++.+  ++..+++|++..........         +.+|++.+.++.|+++..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            468999999999999999999755  36689999986443333222         6899999999999999999998654


Q ss_pred             C--------CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         72 S--------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        72 ~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      .        +..+++|||++|.+|.+..     .+++.    ...+++.++..+|+.|++|+|++|+||++  +.++ ++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili--~~~g-i~  174 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP-----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIV--SKNG-LR  174 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh-----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEE--eCCC-EE
Confidence            3        3588999999999886652     13332    35689999999999999999999999998  6677 99


Q ss_pred             EeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHH
Q psy11805        144 IIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLL  196 (251)
Q Consensus       144 l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  196 (251)
                      |+|||.............           ......++.++|+||||+.+..+.
T Consensus       175 liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEeehHHH
Confidence            999998866532221111           233344567899999999987653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.94  E-value=1.5e-26  Score=179.47  Aligned_cols=232  Identities=21%  Similarity=0.279  Sum_probs=151.3

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHHHHHHcC----------CCceeeEeEEEe
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIMRELQ----------HPRLIQIYDAFE   70 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~~l~~l~----------~~~i~~~~~~~~   70 (251)
                      .+...+.||.|+++.||.+.+..+++.+++|++......   ..+.+++|.-....+.          |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            345678999999999999999999999999998644422   3566666665554421          224444444432


Q ss_pred             e------------CCE-----EEEEEEeccCCchhHHHhh---CCCC---CCHHHHHHHHHHHHHHHHHHhhCCceecCC
Q psy11805         71 S------------SNV-----MCVVLELIEGGELFERVID---DDFV---LTEKAVAIFMRQICEGVEFIHSKNVLHLDM  127 (251)
Q Consensus        71 ~------------~~~-----~~lv~e~~~~~~L~~~~~~---~~~~---~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl  127 (251)
                      -            .+.     .+++|+.+.+ +|.+++..   ....   +.......+..|++..+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            1            111     3678887754 77666542   2211   223344555589999999999999999999


Q ss_pred             CCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCcccccccccccC--------CCCcchhHHHHHHHHHHHHhCC
Q psy11805        128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD--------AIGFGTDMWSVGVICYVLLSGL  199 (251)
Q Consensus       128 ~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~Di~slG~~l~~l~~g~  199 (251)
                      +|+||++  +.+|.+.|+||+.....+.....  ...+..|.+||.....        .++.+.|.|+||+++|.|++|.
T Consensus       172 ~~~nfll--~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  172 KPENFLL--DQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             SGGGEEE---TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             ceeeEEE--cCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999  99999999999888765433222  3345688999977442        4688999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCC
Q psy11805        200 SPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA  248 (251)
Q Consensus       200 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  248 (251)
                      .||.-.........       .-..|. ++|+.+++||+.+|+++|.+|
T Consensus       248 lPf~~~~~~~~~~~-------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW-------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG-------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc-------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99976643222111       112343 789999999999999999988

>KOG1240|consensus

Probab=99.94  E-value=4.3e-28  Score=210.07  Aligned_cols=238  Identities=16%  Similarity=0.194  Sum_probs=177.2

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHH--HHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIM--RELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l--~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +|...+-+|++.|=+|.+|++.+.  .|++|++-... ......+++++.-.  ..+++||++++.-+-+.+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            567789999999999999988753  58999985444 33455555554444  44589999999999888888999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC--CCCc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD--PEKK  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~--~~~~  158 (251)
                      |... +|.+++...+ .+..-+..+|++|++.||..+|..||+|||||.+|||+  ++-+.+.|+||.......  .++.
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi--TSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI--TSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE--eeechhhhhcccccCCccCCCCCc
Confidence            9865 8999998876 47888999999999999999999999999999999999  999999999998775432  1111


Q ss_pred             --cee----eccCcccccccccccC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccc
Q psy11805        159 --LQV----LFGTPEFVAPEVVNFD----------A-IGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD  220 (251)
Q Consensus       159 --~~~----~~~~~~y~aPE~~~~~----------~-~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  220 (251)
                        ...    ......|.|||.+...          + .+++.||||+||+++||++ |.+||.-..    +-....+...
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~~  253 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNAD  253 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCcc
Confidence              111    1123489999998541          2 5788999999999999998 899984321    1111111100


Q ss_pred             CCCcccc-CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 FDDECFN-EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 ~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.... --+..++.+|..|++.||.+|.||
T Consensus       254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSA  285 (1431)
T KOG1240|consen  254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSA  285 (1431)
T ss_pred             CHHHHHHhCcCccHHHHHHHHHccCchhccCH
Confidence            0000001 113468999999999999999885

>KOG0590|consensus

Probab=99.93  E-value=1.7e-27  Score=204.03  Aligned_cols=242  Identities=23%  Similarity=0.365  Sum_probs=186.1

Q ss_pred             CcccccccCCceEEEEEEEccCCceEEEEEecc-----ccccc-hHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          6 NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGI-----AKRND-RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         6 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~-----~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .-...+|.|++|.++.+......+.+..|.+..     ..... ...+..|+-+-..++|+|++..+....+.......|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456788999999899888877766666665431     11111 122555666667788999988888776665555569


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-  158 (251)
                      ||+++ +|..++... +.++...+.-+++|++.|++|+|+.|+.|+|+|++|+++  ..+|.++++|||.+........ 
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~--~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV--TENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE--ecCCceEEeecCcceeeccCcch
Confidence            99998 888888765 368999999999999999999999999999999999999  9999999999999977533222 


Q ss_pred             ----ceeeccCcccccccccccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH---HhccccCCCccccC
Q psy11805        159 ----LQVLFGTPEFVAPEVVNFDAIGF-GTDMWSVGVICYVLLSGLSPFMGETDVQTM--ANV---TIAQYDFDDECFNE  228 (251)
Q Consensus       159 ----~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~---~~~~~~~~~~~~~~  228 (251)
                          ....+|+..|+|||.+.+..+++ ..||||.|+++..|.+|+.||......+..  ...   .......+...+..
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL  556 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence                23456899999999999998875 589999999999999999999776544332  111   11111222234567


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +|.+.+.+|.+||+++|.+|.|+
T Consensus       557 lp~~~~~~~~~~l~~~P~~R~ti  579 (601)
T KOG0590|consen  557 LPRETRIIIYRMLQLDPTKRITI  579 (601)
T ss_pred             chhhHHHHHHHHccCChhheecH
Confidence            89999999999999999999885

>KOG0195|consensus

Probab=99.93  E-value=2.9e-26  Score=171.91  Aligned_cols=236  Identities=16%  Similarity=0.289  Sum_probs=187.0

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ..+..+|.....|..|+++++.  ..++.|++.....  .....+..|.-.|+-..||||+++++.+.......++..||
T Consensus       192 lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            4566788889999999999984  4566677643332  23567888888999999999999999999998999999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      +.++|.+.+.+. +..++..++.+++.+++.|..|||+..  +.--.+++..+++.++...++...|--++-+      .
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------e  343 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------E  343 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------c
Confidence            999999998764 345799999999999999999999875  4444688899999333344444555433321      1


Q ss_pred             eeeccCcccccccccccCCC---CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAI---GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ....-+|.|++||.+...+-   -.++|+|||++++||+.|+..||.....-|---++.....+...  ++.++..+..|
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i--ppgis~hm~kl  421 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI--PPGISRHMNKL  421 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC--CCCccHHHHHH
Confidence            22345789999999976553   35799999999999999999999998888877777666655443  37899999999


Q ss_pred             HHHhcccCcCCCCC
Q psy11805        237 IRKLLLKDREDAPE  250 (251)
Q Consensus       237 i~~~l~~~p~~Rps  250 (251)
                      ++-|+..||.+||.
T Consensus       422 m~icmnedpgkrpk  435 (448)
T KOG0195|consen  422 MNICMNEDPGKRPK  435 (448)
T ss_pred             HHHHhcCCCCcCCC
Confidence            99999999999996

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=1e-24  Score=162.47  Aligned_cols=140  Identities=20%  Similarity=0.238  Sum_probs=108.8

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEecccccc--c------------------------hHHHHHHHHHHHHcCCC
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--D------------------------RRNVEREVEIMRELQHP   60 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~------------------------~~~~~~e~~~l~~l~~~   60 (251)
                      +...||+|++|.||+|.+. +|+.||+|+++.....  .                        .....+|+..+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            3578999999999999987 8999999998643211  1                        11234589999999877


Q ss_pred             ceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hhCCceecCCCCCcEEEeecCC
Q psy11805         61 RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFI-HSKNVLHLDMKPENILCLTKTG  139 (251)
Q Consensus        61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~l-h~~gi~h~dl~~~nil~~~~~~  139 (251)
                      ++.....+....  .++||||++|+++...... ...++...+..++.|++.+|.++ |+.|++|+|+||+||++  + +
T Consensus        80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli--~-~  153 (190)
T cd05147          80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY--H-D  153 (190)
T ss_pred             CCCCCcEEEecC--CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--E-C
Confidence            764433332222  3899999998766544333 34689999999999999999999 79999999999999998  5 4


Q ss_pred             CcEEEeeccccccc
Q psy11805        140 NRIKIIDFGLARKF  153 (251)
Q Consensus       140 ~~~~l~df~~~~~~  153 (251)
                      +.++|+|||++...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=2.3e-23  Score=155.76  Aligned_cols=141  Identities=21%  Similarity=0.229  Sum_probs=111.2

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEeccccccc--------------------------hHHHHHHHHHHHHcCCC
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND--------------------------RRNVEREVEIMRELQHP   60 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------------------------~~~~~~e~~~l~~l~~~   60 (251)
                      +...||+|++|.||+|.+. +|+.||+|++.......                          .....+|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999987 89999999986532110                          12246788899999888


Q ss_pred             ceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCC
Q psy11805         61 RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTG  139 (251)
Q Consensus        61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~  139 (251)
                      ++.....+....  .++||||++|+++...... ...++...+..++.|++.++.++|+ .|++|+||||+||++  + +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll--~-~  153 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY--H-D  153 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE--E-C
Confidence            875444443333  4899999998755443222 2358889999999999999999999 999999999999998  5 7


Q ss_pred             CcEEEeecccccccC
Q psy11805        140 NRIKIIDFGLARKFD  154 (251)
Q Consensus       140 ~~~~l~df~~~~~~~  154 (251)
                      +.++|+|||++...+
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1e-22  Score=150.68  Aligned_cols=184  Identities=16%  Similarity=0.195  Sum_probs=135.0

Q ss_pred             CcccccccCCceEEEEEEEccCCceEEEEEecccccc----chHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEE
Q psy11805          6 NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         6 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .+...|++|+||+|+.+..  .+..++.+.+.....-    ....+.+|++++++++ ++++++++++    +..+++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4677899999999997755  4667776665433221    2336789999999995 6889999886    34689999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCC-CCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM-KPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl-~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |+.|.+|.+....       . ...++.|+..+|.++|++|++|+|| +|+||++  +.++.++|+|||++.........
T Consensus        79 yI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv--~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV--QEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE--cCCCCEEEEECCCceecCCcchH
Confidence            9999888543211       1 1356789999999999999999999 7999999  78899999999999865433211


Q ss_pred             --------------eeeccCcccccccccccC-CCC-cchhHHHHHHHHHHHHhCCCCCCCC
Q psy11805        160 --------------QVLFGTPEFVAPEVVNFD-AIG-FGTDMWSVGVICYVLLSGLSPFMGE  205 (251)
Q Consensus       160 --------------~~~~~~~~y~aPE~~~~~-~~~-~~~Di~slG~~l~~l~~g~~pf~~~  205 (251)
                                    .....++.+++|+...-. ..+ ...+.++.|..+|.++|+..+..+.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                          001135566666654322 223 5678999999999999998886543

>KOG0606|consensus

Probab=99.90  E-value=7.4e-24  Score=183.60  Aligned_cols=207  Identities=29%  Similarity=0.453  Sum_probs=160.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|+.++.|..|+||.||.++++.+...+++|+- ..+     -+.+.  ++....+|.++                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc-ccc-----hhhhc--cccccCCccee------------------
Confidence            36899999999999999999999999999998542 111     11110  12222233332                  


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC------
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP------  155 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~------  155 (251)
                      -+..+|   +... ++++.+.        +.+++|||+-||+|+|+||+|.+|  ..-|++|++|||++...-.      
T Consensus       136 gDc~tl---lk~~-g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI--T~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 GDCATL---LKNI-GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             chhhhh---cccC-CCCcchh--------hHHhHhhccCCeecCCCCCCccee--eecccccccchhhhhhhhhhccchh
Confidence            222222   2222 2344333        788999999999999999999999  9999999999998865311      


Q ss_pred             ----------CCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcc
Q psy11805        156 ----------EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC  225 (251)
Q Consensus       156 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (251)
                                .......+++|.|.|||++..+.|+...|.|++|+++|+++-|..||.+.+.++...........+++. 
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~-  280 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE-  280 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-
Confidence                      112233589999999999999999999999999999999999999999999999998888888877777 


Q ss_pred             ccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        226 FNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      ....+.+++++|.++|+.+|..|.
T Consensus       281 dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  281 DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             CcCCCHHHHHHHHHHHHhChHhhc
Confidence            356789999999999999999884

>KOG0603|consensus

Probab=99.90  E-value=1.4e-24  Score=179.32  Aligned_cols=223  Identities=29%  Similarity=0.531  Sum_probs=181.8

Q ss_pred             cccCCceEEEEEEEc---cCCceEEEEEecccccc--chHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805         11 FSFGKFGTVYRCKEK---ATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus        11 lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +|.|.+|.|+++.-.   ..+..+++|+.......  ....-..|..++...+ +|.++++.-.++.++..+++.++..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            689999999988542   33567888876432211  2224556677777776 99999999999999999999999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeecc
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG  164 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~  164 (251)
                      +.|...+.... .+++.....+...++.++..+|+.|++++|+|++||++  +.+|++++.|||++...-..+..   ||
T Consensus        82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill--d~~Ghi~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL--LLEGHIKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             chhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee--cccCccccCCchhhhHhHhhhhc---cc
Confidence            88877665544 57777888888889999999999999999999999999  99999999999999875443332   89


Q ss_pred             CcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        165 TPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      +..|+|||++.  .....+|.||+|+++++|++|..||..    +....+.+.....+    ..++..+++++.+++..+
T Consensus       156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p----~~l~~~a~~~~~~l~~r~  225 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP----RELSAEARSLFRQLFKRN  225 (612)
T ss_pred             chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc----hhhhHHHHHHHHHHHhhC
Confidence            99999999998  456789999999999999999999988    66666666555555    556778999999999999


Q ss_pred             cCCCC
Q psy11805        245 REDAP  249 (251)
Q Consensus       245 p~~Rp  249 (251)
                      |..|.
T Consensus       226 p~nrL  230 (612)
T KOG0603|consen  226 PENRL  230 (612)
T ss_pred             HHHHh
Confidence            99885

>KOG4158|consensus

Probab=99.89  E-value=1.1e-22  Score=160.02  Aligned_cols=187  Identities=21%  Similarity=0.332  Sum_probs=140.2

Q ss_pred             CCCceeeEeEEEee---------------------------CCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHH
Q psy11805         58 QHPRLIQIYDAFES---------------------------SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQI  110 (251)
Q Consensus        58 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l  110 (251)
                      +||||+++...|.+                           ....|+||..++. +|.+++-...  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            49999999988733                           2358999999977 8988886654  7888888899999


Q ss_pred             HHHHHHHhhCCceecCCCCCcEEEeecCCC--cEEEeecccccccCCCC-------cceeeccCcccccccccccCC---
Q psy11805        111 CEGVEFIHSKNVLHLDMKPENILCLTKTGN--RIKIIDFGLARKFDPEK-------KLQVLFGTPEFVAPEVVNFDA---  178 (251)
Q Consensus       111 ~~~l~~lh~~gi~h~dl~~~nil~~~~~~~--~~~l~df~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---  178 (251)
                      ++|+.+||.+|+.|+|+|++||++.-++++  .+++.|||++...+...       ..-..-|+..-+|||+..-.+   
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            999999999999999999999998444444  68899999885532210       011123566789999985432   


Q ss_pred             ---CCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        179 ---IGFGTDMWSVGVICYVLLSGLSPFMGETD--VQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       179 ---~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                         .-.++|.|+.|.+-||+++...||.....  .+... .....   .+...+.+|+.+++++..+|++||.+|+|.
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~q---LPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQ---LPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhhh---CCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence               12579999999999999999999977321  11111 11111   123346789999999999999999999984

>KOG1166|consensus

Probab=99.89  E-value=4.5e-23  Score=181.02  Aligned_cols=193  Identities=22%  Similarity=0.288  Sum_probs=156.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccc--hHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RND--RRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ..|.|...+|.|+||+||+|...+ ++.||+|+-+..+ ++-  +.++...   |+-.--+.|.++...+.-.+..++|+
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~R---Lk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMER---LKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHh---hchhhhcchHHHHHHHccCCcceeee
Confidence            578899999999999999999887 9999999976443 221  2222221   11111566777777777778889999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-----CCCcEEEeeccccccc-
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-----TGNRIKIIDFGLARKF-  153 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-----~~~~~~l~df~~~~~~-  153 (251)
                      +|.+.|+|.+++..+ +.+++....-++.|++..++.||..||+||||||+|+++...     .+--++|+|||.+..+ 
T Consensus       774 ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  774 EYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             eccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            999999999999854 469999999999999999999999999999999999998432     2335899999998654 


Q ss_pred             --CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q psy11805        154 --DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLS  200 (251)
Q Consensus       154 --~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~  200 (251)
                        .........+++-.+-.+|...|.+++++.|.|.|+.+++-|+.|+.
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence              33445566778899999999999999999999999999999999853

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=1.7e-21  Score=146.56  Aligned_cols=139  Identities=17%  Similarity=0.253  Sum_probs=108.0

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-----CCCceeeEeEEEeeCC---EEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-----QHPRLIQIYDAFESSN---VMC   76 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~~~   76 (251)
                      +.-.+.||+|+++.||.  +..++.. ++|++..........+.+|+..++++     .||||++++++++++.   ..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            44567899999999995  6666555 68887665455577899999999999     5799999999998863   434


Q ss_pred             -EEEEe--ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHhhCCceecCCCCCcEEEeec--CCCcEEEeecccc
Q psy11805         77 -VVLEL--IEGGELFERVIDDDFVLTEKAVAIFMRQICEGV-EFIHSKNVLHLDMKPENILCLTK--TGNRIKIIDFGLA  150 (251)
Q Consensus        77 -lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l-~~lh~~gi~h~dl~~~nil~~~~--~~~~~~l~df~~~  150 (251)
                       +|+|+  +.+++|.+++...  .+++.  ..++.+++.++ +|||+.+|+|+||||+||++...  .+.+++|+|++-+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             78999  5568999998653  36655  35567778777 89999999999999999998322  2347999995434

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=1.5e-21  Score=150.17  Aligned_cols=142  Identities=20%  Similarity=0.212  Sum_probs=111.7

Q ss_pred             cCCcccccccCCceEEEEEE-EccCCceEEEEEecccccc------------------------chHHHHHHHHHHHHcC
Q psy11805          4 HQNQHSAFSFGKFGTVYRCK-EKATGMTLAAKFVGIAKRN------------------------DRRNVEREVEIMRELQ   58 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~~K~~~~~~~~------------------------~~~~~~~e~~~l~~l~   58 (251)
                      .|++.+.||.|++|.||+|. +..++..|++|++......                        ....+.+|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 6678999999998643211                        0123578999999997


Q ss_pred             CC--ceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCC-ceecCCCCCcEEEe
Q psy11805         59 HP--RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLDMKPENILCL  135 (251)
Q Consensus        59 ~~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~g-i~h~dl~~~nil~~  135 (251)
                      +.  .++++++.    +..++|||+++|.+|....... .......+..++.|++.++.+||+.| ++|+|++|+||++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli-  182 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV-  182 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE-
Confidence            53  34444442    2358999999998776554333 34667778899999999999999999 9999999999998 


Q ss_pred             ecCCCcEEEeeccccccc
Q psy11805        136 TKTGNRIKIIDFGLARKF  153 (251)
Q Consensus       136 ~~~~~~~~l~df~~~~~~  153 (251)
                       + ++.++|+|||.+...
T Consensus       183 -~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      183 -H-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -E-CCCEEEEEChhhhcc
Confidence             5 788999999998653

>KOG1023|consensus

Probab=99.85  E-value=9e-21  Score=156.34  Aligned_cols=196  Identities=22%  Similarity=0.339  Sum_probs=156.5

Q ss_pred             HHHcCCCceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCc-eecCCCCCcE
Q psy11805         54 MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV-LHLDMKPENI  132 (251)
Q Consensus        54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi-~h~dl~~~ni  132 (251)
                      ++.+.|.|+.++++.+.++...+.|.++|..|+|.+.+......+++.-...++++++.|+.|||+-.+ .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            356789999999999999999999999999999999999877778999999999999999999998765 9999999999


Q ss_pred             EEeecCCCcEEEeecccccccCC---CCcceeeccCcccccccccccCC-------CCcchhHHHHHHHHHHHHhCCCCC
Q psy11805        133 LCLTKTGNRIKIIDFGLARKFDP---EKKLQVLFGTPEFVAPEVVNFDA-------IGFGTDMWSVGVICYVLLSGLSPF  202 (251)
Q Consensus       133 l~~~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~g~~pf  202 (251)
                      ++  +..-.+||+|||+......   ...........-|.|||.+.+..       .+.+.|+||+|++++|+++...||
T Consensus        81 lv--d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LV--DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             ee--eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            99  8888999999999877532   11112222445789999986631       456799999999999999999999


Q ss_pred             CCCC----hHHHHHHHHh-ccccCCCccc--cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        203 MGET----DVQTMANVTI-AQYDFDDECF--NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       203 ~~~~----~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....    ..+....+.. +...+.+..+  ..+++++..++++||..+|.+||++
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~  214 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI  214 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence            7632    2345555544 2322332222  2567789999999999999999984

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=6e-20  Score=139.83  Aligned_cols=134  Identities=24%  Similarity=0.310  Sum_probs=111.3

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccccc--------chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--------DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +.||+|++|.||++.+  ++..+++|........        ....+.+|+..+..+.+++++....++.+.+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            6799999999999987  4667888876432211        13467789999999999988877777777777899999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      +++|++|.+.+....    . ....++.+++.+|.++|+.|++|+|++|+||++  + ++.++++|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~--~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL--S-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE--E-CCCEEEEECCcccC
Confidence            999999988875432    2 788899999999999999999999999999998  5 78899999999865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.83  E-value=1.2e-19  Score=136.87  Aligned_cols=130  Identities=19%  Similarity=0.261  Sum_probs=104.2

Q ss_pred             ccccCCceEEEEEEEccCCceEEEEEeccccc--------cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805         10 AFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--------NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus        10 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .||+|++|.||++.+  ++..+++|.......        ....++.+|++.++.+.++++.....++...+..+++||+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999985  467889998543221        1236677899999999887765555555566667899999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ++|++|.+.+....  .      .++.+++.+|.+||+.|++|+|++|+||++  + ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~--~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV--R-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE--E-CCcEEEEECCCCcC
Confidence            99999987764432  1      788999999999999999999999999998  5 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033|consensus

Probab=99.83  E-value=2.8e-21  Score=157.05  Aligned_cols=166  Identities=22%  Similarity=0.359  Sum_probs=131.1

Q ss_pred             EEEEEEEeccCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         74 VMCVVLELIEGGELFERVID--DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      +.|+.|++|...+|.+.+..  .....+...++.++.|+..++.|   +|.+|+|++|.||+.  ..++.++|.|||+.+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~--~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF--SDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc--ccchhhhhhhhhhee
Confidence            57899999999999999964  34457888999999999999999   999999999999998  777789999999998


Q ss_pred             ccCCCC-------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCC
Q psy11805        152 KFDPEK-------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDD  223 (251)
Q Consensus       152 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (251)
                      ......       ......++..|++||.+.++.++.++||||||++|+|++. =...|   ........+..+.++  +
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip--~  479 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIP--P  479 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCC--h
Confidence            876554       4455678999999999999999999999999999999986 22232   222233333344333  1


Q ss_pred             ccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        224 ECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      ..+.+.| .-..|+.++|.+.|.+||+
T Consensus       480 ~~~~d~p-~e~~ll~~lls~~p~~RP~  505 (516)
T KOG1033|consen  480 EFLQDYP-EEYTLLQQLLSPSPEERPS  505 (516)
T ss_pred             HHhhcCc-HHHHHHHHhcCCCcccCch
Confidence            2223333 4468999999999999996

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=2.8e-19  Score=134.72  Aligned_cols=138  Identities=23%  Similarity=0.313  Sum_probs=106.9

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc----------------------chHHHHHHHHHHHHcCCC-
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN----------------------DRRNVEREVEIMRELQHP-   60 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----------------------~~~~~~~e~~~l~~l~~~-   60 (251)
                      .|.+.+.||.|++|.||++... ++..+++|++......                      ......+|...+..+.++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3888999999999999999875 7899999987542210                      112356788888888766 


Q ss_pred             -ceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC
Q psy11805         61 -RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG  139 (251)
Q Consensus        61 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~  139 (251)
                       .+++.++    .+..+++|||++|++|.....       ......++.+++.++.++|+.|++|+||+|+||++  +.+
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill--~~~  161 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV--DDD  161 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE--cCC
Confidence             3444443    234589999999988855422       13456788999999999999999999999999999  788


Q ss_pred             CcEEEeecccccccCC
Q psy11805        140 NRIKIIDFGLARKFDP  155 (251)
Q Consensus       140 ~~~~l~df~~~~~~~~  155 (251)
                      +.++|+|||.+.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            9999999999965443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=8.3e-19  Score=150.76  Aligned_cols=135  Identities=17%  Similarity=0.211  Sum_probs=108.6

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccc--c------ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--K------RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .|...+.||+|++|+||++.+...  .+++|.....  .      ....+.+.+|++.++.++|++++....+..+....
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            356688999999999999987643  3333332111  1      11245688999999999999998887777777778


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ++||||++|++|.+.+.         ....++.+++.+|.+||+.|++|||+||+||++   .++.++|+|||++..
T Consensus       412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl---~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV---RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE---ECCcEEEEeCccccc
Confidence            99999999999988764         346788999999999999999999999999998   367899999999965

>KOG0590|consensus

Probab=99.77  E-value=2.4e-20  Score=160.20  Aligned_cols=247  Identities=23%  Similarity=0.414  Sum_probs=194.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccC-CceEEEEEecccc--ccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKAT-GMTLAAKFVGIAK--RNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ..|++.+.||.|+++.|-.+....+ ...++.|.+....  ......+..|...-+.+. |.|+++.++...+.+..++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4688999999999999998877543 3456666654433  223445555676667776 99999999999999999999


Q ss_pred             EEeccCCchhHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHh-hCCceecCCCCCcEEEeecCCC-cEEEeecccccccCC
Q psy11805         79 LELIEGGELFERV-IDDDFVLTEKAVAIFMRQICEGVEFIH-SKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDP  155 (251)
Q Consensus        79 ~e~~~~~~L~~~~-~~~~~~~~~~~~~~i~~~l~~~l~~lh-~~gi~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~~~  155 (251)
                      .++.+|+++...+ .......+...+..++.|+..++.|+| ..++.|+|++|+|.++  +..+ .+++.|||++..+..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l--~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL--DESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh--ccCCCcccCCCchhhccccc
Confidence            9999999888877 333225778888889999999999999 9999999999999998  7777 999999999988654


Q ss_pred             -C---Ccceeecc-CcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhccccCCCccccC
Q psy11805        156 -E---KKLQVLFG-TPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM-ANVTIAQYDFDDECFNE  228 (251)
Q Consensus       156 -~---~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~  228 (251)
                       .   ......++ ++.|.|||...+. ......|+||.|+++..+++|..||......... ..............|..
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             2   22234567 9999999999884 4567899999999999999999999876554432 22222222334456788


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++....+++.+++..+|.+|.++
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~  280 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSI  280 (601)
T ss_pred             CChhhhhcccccccCCchhcccc
Confidence            99999999999999999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=7e-18  Score=126.00  Aligned_cols=138  Identities=23%  Similarity=0.282  Sum_probs=97.5

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEeccccccc--hHH----------------------HHHHHHHHHHcCCC--
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRN----------------------VEREVEIMRELQHP--   60 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~----------------------~~~e~~~l~~l~~~--   60 (251)
                      +.+.||+|++|+||.|.+. ++..|++|++.......  ...                      ...|...+..+.+.  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999887 78899999976432211  111                      13455555555433  


Q ss_pred             ceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCC
Q psy11805         61 RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTG  139 (251)
Q Consensus        61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~  139 (251)
                      .++++++.    ...+++||+++++.+........ ... ..+..++.+++.++.++|. .|++|+|++|+||++  + +
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili--~-~  150 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV--D-D  150 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE--E-C
Confidence            24444443    23589999999854322111111 011 6788899999999999999 999999999999998  5 8


Q ss_pred             CcEEEeecccccccC
Q psy11805        140 NRIKIIDFGLARKFD  154 (251)
Q Consensus       140 ~~~~l~df~~~~~~~  154 (251)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            899999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.75  E-value=3.3e-17  Score=117.91  Aligned_cols=132  Identities=26%  Similarity=0.281  Sum_probs=111.2

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCC--CceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH--PRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.+.||+|.++.||++....  ..+++|.......  ...+.+|+..++.+++  .++++++......+..++++|++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            56789999999999998764  6889998754332  5678899999999976  5899999988888889999999988


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK---NVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~---gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      .++...        +......++.+++.++..+|..   +++|+|++|+||++  +..+.++++||+.+..
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~--~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV--DDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE--ECCcEEEEEecccccC
Confidence            766443        5566777889999999999985   79999999999999  6678999999998854

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=5.6e-17  Score=125.13  Aligned_cols=134  Identities=19%  Similarity=0.246  Sum_probs=102.3

Q ss_pred             cccc-cCCceEEEEEEEccCCceEEEEEecccc-------------ccchHHHHHHHHHHHHcCCCce--eeEeEEEeeC
Q psy11805          9 SAFS-FGKFGTVYRCKEKATGMTLAAKFVGIAK-------------RNDRRNVEREVEIMRELQHPRL--IQIYDAFESS   72 (251)
Q Consensus         9 ~~lg-~g~~~~v~~~~~~~~~~~~~~K~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~   72 (251)
                      ..|| .|+-|+||.+...  +..+++|.+....             ......+.+|+..+..+.++++  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 7888899988775  6688888874211             1234678899999999988775  6777764332


Q ss_pred             -C---EEEEEEEeccC-CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeec
Q psy11805         73 -N---VMCVVLELIEG-GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDF  147 (251)
Q Consensus        73 -~---~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df  147 (251)
                       .   ..++|+|+++| .+|.+.+...  .++...    +.+++.+|.+||++|++|+||+|.|||+  +.++.++|+||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv--~~~~~v~LIDf  186 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL--DPDGKFWLIDF  186 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE--cCCCCEEEEEC
Confidence             2   23599999997 5787776542  355543    5689999999999999999999999999  77789999999


Q ss_pred             ccccc
Q psy11805        148 GLARK  152 (251)
Q Consensus       148 ~~~~~  152 (251)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            99865

>KOG1243|consensus

Probab=99.72  E-value=2.8e-16  Score=131.71  Aligned_cols=168  Identities=19%  Similarity=0.314  Sum_probs=132.7

Q ss_pred             EEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCH
Q psy11805         21 RCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTE  100 (251)
Q Consensus        21 ~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  100 (251)
                      .+..+.++.++.+.+++..+........+.++.++.++||||+++++.++.++..|+|+|.+.  .|...+.+    ++.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~  103 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGK  103 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHH
Confidence            355677888999998876665556778899999999999999999999999999999999984  45555554    336


Q ss_pred             HHHHHHHHHHHHHHHHHh-hCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-ceeeccCcccccccccccCC
Q psy11805        101 KAVAIFMRQICEGVEFIH-SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-LQVLFGTPEFVAPEVVNFDA  178 (251)
Q Consensus       101 ~~~~~i~~~l~~~l~~lh-~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~  178 (251)
                      ......+.||+.||.+|| +.+++|++++-+.|++  +..|.++|++|..+........ .......-.|..|+.+....
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV--n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV--NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE--cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            667777899999999997 6789999999999999  9999999999998865432221 12222233567776664333


Q ss_pred             CCcchhHHHHHHHHHHHHhC
Q psy11805        179 IGFGTDMWSVGVICYVLLSG  198 (251)
Q Consensus       179 ~~~~~Di~slG~~l~~l~~g  198 (251)
                        ...|.|.||+++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              456999999999999999

>KOG0601|consensus

Probab=99.67  E-value=5.7e-17  Score=134.24  Aligned_cols=239  Identities=20%  Similarity=0.209  Sum_probs=184.8

Q ss_pred             ccCCccccccc--CCceEEEEEEE--ccCCceEEEEEecc--ccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEE
Q psy11805          3 THQNQHSAFSF--GKFGTVYRCKE--KATGMTLAAKFVGI--AKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~--g~~~~v~~~~~--~~~~~~~~~K~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   75 (251)
                      ..+.+.+.+|+  |.+|.+|.+..  ..+...+++|.-+.  ........=.+|+...+.++ |.+.++....++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            35667888999  99999999988  77888899887332  22233444456666666664 99999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHhhCCceecCCCCCcEEEeecCC-CcEEEeecccc
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE----GVEFIHSKNVLHLDMKPENILCLTKTG-NRIKIIDFGLA  150 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~----~l~~lh~~gi~h~dl~~~nil~~~~~~-~~~~l~df~~~  150 (251)
                      ++-.|.+. .+|..........++...++....+..+    ||..+|+.+++|.|++|.||++  ..+ ...+++||++.
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~--~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT--TSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec--ccccceeecCCccee
Confidence            99999885 5888888776666899999999999999    9999999999999999999998  666 88999999999


Q ss_pred             cccCCCCcc-ee-----eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhccccCC
Q psy11805        151 RKFDPEKKL-QV-----LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE--TDVQTMANVTIAQYDFD  222 (251)
Q Consensus       151 ~~~~~~~~~-~~-----~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~  222 (251)
                      ......... ..     ..+...|++||...+ .++..+|+|++|.+..+-..+..+....  +.........     .+
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----ip  344 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----IP  344 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----Cc
Confidence            887544422 11     257779999999864 4678999999999999988877666554  2222222111     22


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      .+.....+..+...+.++++.+|..|++
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~  372 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLT  372 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhH
Confidence            2333456777888999999999998876

>KOG1266|consensus

Probab=99.65  E-value=2.5e-17  Score=127.17  Aligned_cols=224  Identities=17%  Similarity=0.223  Sum_probs=148.6

Q ss_pred             EEEEEEccCCceEEEEEeccccccc----hHHHHHHHHHHHHcCCCceeeEeEEEeeCC-----EEEEEEEeccCCchhH
Q psy11805         19 VYRCKEKATGMTLAAKFVGIAKRND----RRNVEREVEIMRELQHPRLIQIYDAFESSN-----VMCVVLELIEGGELFE   89 (251)
Q Consensus        19 v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~   89 (251)
                      ||++-++..+.+|+.-.++....++    .+....-...+-++-|.|++++..+|.+..     ...++.||+..+++.+
T Consensus        82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~  161 (458)
T KOG1266|consen   82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQ  161 (458)
T ss_pred             HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHH
Confidence            4555555555555544333222221    122222233445556999999999986543     4789999999999999


Q ss_pred             HHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhC--CceecCCCCCcEEEeecCCCcEEEeecccccccCCC-----Ccc
Q psy11805         90 RVID---DDFVLTEKAVAIFMRQICEGVEFIHSK--NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-----KKL  159 (251)
Q Consensus        90 ~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~--gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-----~~~  159 (251)
                      +++.   +...+......+|+.||++||.|||+.  -++|+++..+.|++  ..+|-+++.--........-     ...
T Consensus       162 fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi--q~ngLIkig~~ap~s~h~s~~~~~~~Ek  239 (458)
T KOG1266|consen  162 FLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI--QHNGLIKIGSVAPDSTHPSVNSTREAEK  239 (458)
T ss_pred             HHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee--cCCceEEecccCccccchhhhhhhHhhh
Confidence            8875   345688999999999999999999987  59999999999998  77887776533222111110     111


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET-DVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+.++|.+||.=.-...+-++|||++|++..+|.-+..--...+ ..+.-..+.....-..+.       --++++.
T Consensus       240 ~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len~-------lqr~~i~  312 (458)
T KOG1266|consen  240 SVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLENG-------LQRGSIT  312 (458)
T ss_pred             hccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccCc-------cccCcCc
Confidence            12235678999988665666778999999999999988765533332 222222222222222221       2367899


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +|++.+|..||++
T Consensus       313 kcl~~eP~~rp~a  325 (458)
T KOG1266|consen  313 KCLEGEPNGRPDA  325 (458)
T ss_pred             ccccCCCCCCcch
Confidence            9999999999986

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.63  E-value=1.5e-14  Score=107.14  Aligned_cols=139  Identities=16%  Similarity=0.198  Sum_probs=101.0

Q ss_pred             ccccccCCceEEEEEEEcc------CCceEEEEEecccc----------------------ccchHHHH----HHHHHHH
Q psy11805          8 HSAFSFGKFGTVYRCKEKA------TGMTLAAKFVGIAK----------------------RNDRRNVE----REVEIMR   55 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~------~~~~~~~K~~~~~~----------------------~~~~~~~~----~e~~~l~   55 (251)
                      .-.||.|..+.||.|....      .+..+|+|+++...                      ......+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999997653      35799999985211                      01122333    8899998


Q ss_pred             HcCC--CceeeEeEEEeeCCEEEEEEEeccCCchhH-HHhhCCCCCCHHHHHHHHHHHHHHHHHH-hhCCceecCCCCCc
Q psy11805         56 ELQH--PRLIQIYDAFESSNVMCVVLELIEGGELFE-RVIDDDFVLTEKAVAIFMRQICEGVEFI-HSKNVLHLDMKPEN  131 (251)
Q Consensus        56 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~i~~~l~~~l~~l-h~~gi~h~dl~~~n  131 (251)
                      ++..  -+++.++++    ...++|||++.+..+.. .+..  ..++.+.+..+..+++.++..+ |+.|++|||+++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            8864  456666654    34679999997643321 2222  2356667778889999999988 89999999999999


Q ss_pred             EEEeecCCCcEEEeecccccccCC
Q psy11805        132 ILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus       132 il~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      |++  . ++.+.++||+.+...+.
T Consensus       156 IL~--~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         156 MLW--H-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EEE--E-CCcEEEEECCCceeCCC
Confidence            998  3 46799999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.62  E-value=4.7e-15  Score=123.91  Aligned_cols=142  Identities=17%  Similarity=0.284  Sum_probs=97.3

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccc----h------------------------------------HHH
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND----R------------------------------------RNV   47 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~------------------------------------~~~   47 (251)
                      .++||+|++|.||+|... +|+.||+|+........    .                                    -.+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999876 68999999975321110    0                                    013


Q ss_pred             HHHHHHHHHc----CCCceeeEeEEE-eeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHhhCC
Q psy11805         48 EREVEIMREL----QHPRLIQIYDAF-ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE-GVEFIHSKN  121 (251)
Q Consensus        48 ~~e~~~l~~l----~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~-~l~~lh~~g  121 (251)
                      .+|+..+.++    ++.+-+.+-.++ ...+..++||||++|.+|.+.........+.   ..++..++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~---~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDR---KALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhCC
Confidence            3445544444    233333333333 2344578999999999998766532222332   345555554 467899999


Q ss_pred             ceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805        122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus       122 i~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++|+|++|.||++  ..+++++++|||++...+.
T Consensus       278 ~~H~D~hPgNilv--~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 FFHADLHPGNIFV--LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ceeCCCCcccEEE--CCCCcEEEEeCCCeeECCH
Confidence            9999999999999  8889999999999977643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.57  E-value=2.3e-14  Score=105.23  Aligned_cols=128  Identities=23%  Similarity=0.256  Sum_probs=95.3

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc-eeeEeEEEeeCCEEEEEEEeccCCc
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR-LIQIYDAFESSNVMCVVLELIEGGE   86 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~   86 (251)
                      ++.++.|..+.||++...  +..+++|....... ......+|+..++.+...+ +++++....  ...++|||+++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            467899999999999865  67899999753321 2345688999999886444 455555443  23579999999987


Q ss_pred             hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCc-----eecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         87 LFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV-----LHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        87 L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi-----~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      +...    .  .   ....++.+++.+|..||+.++     +|+|++|.||++  + ++.++++||+.+..
T Consensus        78 l~~~----~--~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~--~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTE----D--F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL--D-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc----c--c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE--E-CCeEEEEecccccC
Confidence            7542    0  1   113456789999999999985     999999999998  5 66899999999854

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=5.9e-14  Score=100.79  Aligned_cols=132  Identities=22%  Similarity=0.259  Sum_probs=101.4

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecc--------ccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGI--------AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~--------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ..++.|+.+.++.+.+.  +..+++|.-..        +......+-.+|+.++.+++...+....-+..+.....++||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46789999999999664  44566665321        112235677899999999987777666666777777889999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      |.+|..|.+.+...        ...++..+-.-+..||.+||+|||++++||++   .++.+.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl---~~~~i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL---SGGRIYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEE---eCCcEEEEECCccccc
Confidence            99998888887665        24566777788888999999999999999997   3445999999999653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=1.7e-14  Score=122.22  Aligned_cols=142  Identities=18%  Similarity=0.281  Sum_probs=93.9

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEecccccc----------------------------------chHH---
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN----------------------------------DRRN---   46 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----------------------------------~~~~---   46 (251)
                      +|.. ++||+|++|.||.|..+.+|+.||+|+.++.-..                                  ..+.   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4565 7899999999999999887999999998632100                                  0112   


Q ss_pred             ---HHHHHHHHHHc----CCCceeeEeEEEe-eCCEEEEEEEeccCCchhHHH--hhCCC---CCCHHHHHHHHHHHHHH
Q psy11805         47 ---VEREVEIMREL----QHPRLIQIYDAFE-SSNVMCVVLELIEGGELFERV--IDDDF---VLTEKAVAIFMRQICEG  113 (251)
Q Consensus        47 ---~~~e~~~l~~l----~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~--~~~~~---~~~~~~~~~i~~~l~~~  113 (251)
                         +.+|+..+.++    .+...+.+-.++. ..+..++||||++|+++.+.-  ...+.   .+.+..+..++.|    
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q----  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ----  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH----
Confidence               23344333333    2444444444443 245578999999999987642  22221   1233333333333    


Q ss_pred             HHHHhhCCceecCCCCCcEEEeecCCC----cEEEeecccccccCC
Q psy11805        114 VEFIHSKNVLHLDMKPENILCLTKTGN----RIKIIDFGLARKFDP  155 (251)
Q Consensus       114 l~~lh~~gi~h~dl~~~nil~~~~~~~----~~~l~df~~~~~~~~  155 (251)
                         +...|++|+|++|.||++  +.++    +++++|||++...+.
T Consensus       276 ---if~~GffHaDpHPGNIlv--~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 ---VFRDGFFHADMHPGNIFV--SYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ---HHhCCeeeCCCChHHeEE--ecCCCCCCeEEEEecceEEECCH
Confidence               446999999999999999  6666    999999999977643

>KOG3087|consensus

Probab=99.55  E-value=1.1e-13  Score=99.21  Aligned_cols=145  Identities=18%  Similarity=0.203  Sum_probs=107.6

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEec--------cccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVG--------IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~--------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ....+.+|+.+.|+.+.+.  |+..++|.--        .+......+.++|++.|.++.--.|.-..-++.+.....+.
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5677889999999998776  6676776421        12223467888999999988765665555566666667889


Q ss_pred             EEeccC-CchhHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-cEEEeeccccccc
Q psy11805         79 LELIEG-GELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKF  153 (251)
Q Consensus        79 ~e~~~~-~~L~~~~~~~~~~-~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~  153 (251)
                      |||++| .++.+++...... ........++..+-+.+..||.++++||||.++||++.++.+. .+.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999988 4777777654333 3333447889999999999999999999999999998443332 3589999999653

>KOG0606|consensus

Probab=99.55  E-value=1.9e-15  Score=132.16  Aligned_cols=245  Identities=22%  Similarity=0.379  Sum_probs=186.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +.+.+.+.+.+|.++.++.+.-..++.....|+.....   ..+.+.+.++-..+-...+|-+++....+......++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            45677788999999999988777777555555543222   112333333333333334566666655556667789999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-----
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-----  154 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-----  154 (251)
                      ++..++.|...+...+ ..+.+-+...+..+.+++++||...+.|+|++|.|.+.  ...++.++.+|+......     
T Consensus       884 ~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~--~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI--AYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             HHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhh--cccCCcccCccccccccccccCc
Confidence            9999988888777665 57777888888889999999999999999999999999  889999999997332210     


Q ss_pred             --C---------------------CC----cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy11805        155 --P---------------------EK----KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD  207 (251)
Q Consensus       155 --~---------------------~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  207 (251)
                        .                     ..    ......+++.|.+||...+......+|.|++|.++++.++|..||...+.
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence              0                     00    01123478899999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        208 VQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....+++.....+++... ...+.+.++++..++..+|.+|..+
T Consensus      1041 q~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             hhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCc
Confidence            999888887777666543 4578899999999999999999754

>KOG3741|consensus

Probab=99.53  E-value=8.8e-13  Score=108.09  Aligned_cols=202  Identities=16%  Similarity=0.251  Sum_probs=147.8

Q ss_pred             ceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEe----eCCEEEEEEEeccCC-chhHH
Q psy11805         16 FGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE----SSNVMCVVLELIEGG-ELFER   90 (251)
Q Consensus        16 ~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~lv~e~~~~~-~L~~~   90 (251)
                      ..+.|++..+.||..|++|++...........-.-++.++++.|.|++++.+++.    .+..+++|++|.++. +|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999999999999999985544444444455578899999999999999986    355689999998764 55554


Q ss_pred             HhhC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         91 VIDD--------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        91 ~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ...+              +.+.++..+|.++.|+..||.++|+.|+..+-+.|.+|++  ..+.+++|..+|.......+
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv--~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV--TGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe--eCcceEEEecccceeeecCC
Confidence            4332              2347889999999999999999999999999999999999  76778999888877655443


Q ss_pred             CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhccccCCCccccCCCHHHH
Q psy11805        157 KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT--MANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      ..           +|  +   .-..+.|.=.||.+++.|.+|..--...+....  ...+.           ...+.+++
T Consensus       447 ~~-----------~~--l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~r  499 (655)
T KOG3741|consen  447 PT-----------EP--L---ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDLR  499 (655)
T ss_pred             CC-----------cc--h---hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhhHHHH
Confidence            30           11  1   112467999999999999999654322222221  22221           34567778


Q ss_pred             HHHHHhcccCcC
Q psy11805        235 DFIRKLLLKDRE  246 (251)
Q Consensus       235 ~li~~~l~~~p~  246 (251)
                      ++|..+...++.
T Consensus       500 n~v~yl~s~~~~  511 (655)
T KOG3741|consen  500 NVVEYLESLNFR  511 (655)
T ss_pred             HHHHHHHhcCcc
Confidence            888777776666

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.42  E-value=4.2e-12  Score=101.99  Aligned_cols=238  Identities=13%  Similarity=0.134  Sum_probs=156.5

Q ss_pred             CcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeE------EEeeCC-EEEE
Q psy11805          6 NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYD------AFESSN-VMCV   77 (251)
Q Consensus         6 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~------~~~~~~-~~~l   77 (251)
                      ...+.||+|+.+.+|-.-.-.   ..+.|++.........   +.+..|... .||-+-.=+.      +..+.+ .+.+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchhh---chhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            356789999999999664332   2345777543332222   222233333 3443322111      112223 3788


Q ss_pred             EEEeccCCchhHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         78 VLELIEGGELFERVID------DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~------~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      +|..+.|..-...+..      +-...++.-+.+.++.++.+-..||+.|.+-||++++|+|+  ++++.+.|.|-....
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV--sd~~~V~LVdsDsfq  165 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV--SDDSKVVLVDSDSFQ  165 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee--ecCceEEEEccccee
Confidence            8988876422222221      11237889999999999999999999999999999999999  888999999877665


Q ss_pred             ccCCCCcceeeccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCh----HHHHH-HHHhcc--
Q psy11805        152 KFDPEKKLQVLFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSG-LSPFMGETD----VQTMA-NVTIAQ--  218 (251)
Q Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~----~~~~~-~~~~~~--  218 (251)
                      ....+.......+.+.|.+||...     +..-+..+|.|.||+++++++.| +.||.+...    ....+ .+..+.  
T Consensus       166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            555555555567889999999864     33456779999999999999885 999976421    11111 222221  


Q ss_pred             ---------ccCC-CccccCCCHHHHHHHHHhccc--CcCCCCCC
Q psy11805        219 ---------YDFD-DECFNEISDDAKDFIRKLLLK--DREDAPEV  251 (251)
Q Consensus       219 ---------~~~~-~~~~~~~~~~~~~li~~~l~~--~p~~Rps~  251 (251)
                               .+.+ ..-|..+|+.+..+..+|+..  +++-|||+
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a  290 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA  290 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence                     1112 123467899999999999975  46788874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.37  E-value=1.3e-11  Score=94.44  Aligned_cols=139  Identities=19%  Similarity=0.283  Sum_probs=104.3

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCC--ceeeEeEEEeeC---CEEEEEEEec
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHP--RLIQIYDAFESS---NVMCVVLELI   82 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~---~~~~lv~e~~   82 (251)
                      +.++.|..+.+|++.... ++.+++|....... .....+.+|+..++.+.+.  .+++++.+....   +..+++||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            678999999999998753 57899999754322 1456789999999999753  457777776553   3568999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-------------------------------------------  119 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-------------------------------------------  119 (251)
                      +|.++.+....  ..++.+....++.+++.+|..||+                                           
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99887665432  236777777777777777777773                                           


Q ss_pred             -------------CCceecCCCCCcEEEeecC--CCcEEEeecccccc
Q psy11805        120 -------------KNVLHLDMKPENILCLTKT--GNRIKIIDFGLARK  152 (251)
Q Consensus       120 -------------~gi~h~dl~~~nil~~~~~--~~~~~l~df~~~~~  152 (251)
                                   ..++|+|++|.||++  +.  ++.+.++||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~--~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLF--HPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEE--cCCCCcEEEEEecccccc
Confidence                         236999999999998  55  56688999998854

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.34  E-value=4.8e-11  Score=93.28  Aligned_cols=133  Identities=14%  Similarity=0.104  Sum_probs=95.4

Q ss_pred             EEEEEEEccCCceEEEEEecccccc-----------chHHHHHHHHHHHHcCCCce--eeEeEEEee-----CCEEEEEE
Q psy11805         18 TVYRCKEKATGMTLAAKFVGIAKRN-----------DRRNVEREVEIMRELQHPRL--IQIYDAFES-----SNVMCVVL   79 (251)
Q Consensus        18 ~v~~~~~~~~~~~~~~K~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-----~~~~~lv~   79 (251)
                      .|+.+..  .|+.+.+|........           ......+|...+..+...+|  ++++++.+.     ....++|+
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            4555544  3678999976432211           11247789999988864444  344555543     23578999


Q ss_pred             EeccCC-chhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-----cCCCcEEEeecccccc
Q psy11805         80 ELIEGG-ELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-----KTGNRIKIIDFGLARK  152 (251)
Q Consensus        80 e~~~~~-~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-----~~~~~~~l~df~~~~~  152 (251)
                      |++++. +|.+++... ....+......++.+++..+..||++|++|+|++++||++..     ..+..+.|+||+.+..
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999886 787777532 234567778899999999999999999999999999999842     1256899999998854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.32  E-value=3.3e-11  Score=89.05  Aligned_cols=126  Identities=26%  Similarity=0.363  Sum_probs=81.8

Q ss_pred             EEEEEEEccCCceEEEEEecccc--------------------------ccchHHHHHHHHHHHHcCCC--ceeeEeEEE
Q psy11805         18 TVYRCKEKATGMTLAAKFVGIAK--------------------------RNDRRNVEREVEIMRELQHP--RLIQIYDAF   69 (251)
Q Consensus        18 ~v~~~~~~~~~~~~~~K~~~~~~--------------------------~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~   69 (251)
                      .||.|... ++..+|+|++....                          .......++|.+.|.++...  ++++++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            37888664 56799999984210                          00135577999999999865  567776553


Q ss_pred             eeCCEEEEEEEecc--CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HhhCCceecCCCCCcEEEeecCCCcEEEee
Q psy11805         70 ESSNVMCVVLELIE--GGELFERVIDDDFVLTEKAVAIFMRQICEGVEF-IHSKNVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        70 ~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~-lh~~gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                        .  .++||||++  |..+.. +....  ++.+....++.+++..+.. +|+.|++|||+++.||++  ..+ .+.++|
T Consensus        80 --~--~~ivME~I~~~G~~~~~-l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv--~~~-~~~iID  149 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPR-LKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILV--DDG-KVYIID  149 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGC-HHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEE--ETT-CEEE--
T ss_pred             --C--CEEEEEecCCCccchhh-HHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEe--ecc-eEEEEe
Confidence              2  469999998  655533 33322  2355566677788884444 689999999999999998  544 899999


Q ss_pred             cccccccC
Q psy11805        147 FGLARKFD  154 (251)
Q Consensus       147 f~~~~~~~  154 (251)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99886643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.32  E-value=1.8e-11  Score=93.34  Aligned_cols=136  Identities=26%  Similarity=0.331  Sum_probs=104.9

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccc----------------------ccchHHHHHHHHHHHHcCCC--
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK----------------------RNDRRNVEREVEIMRELQHP--   60 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~----------------------~~~~~~~~~e~~~l~~l~~~--   60 (251)
                      +.+..+||-|..|.||.|.+. .+.++++|..+.-.                      .......++|.+.|..+...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            457789999999999999887 57799999874211                      11245677899999998755  


Q ss_pred             ceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC
Q psy11805         61 RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN  140 (251)
Q Consensus        61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~  140 (251)
                      .+++.+++    +...+|||+.+|..|...      +++.+.+..++..|+..+..+-..|++|||+++-||++  +++|
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV--~~dg  239 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV--TEDG  239 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE--ecCC
Confidence            67777654    456799999999666332      23456666777778888887779999999999999999  8999


Q ss_pred             cEEEeeccccccc
Q psy11805        141 RIKIIDFGLARKF  153 (251)
Q Consensus       141 ~~~l~df~~~~~~  153 (251)
                      .+.++||-.+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999887553

>KOG0601|consensus

Probab=99.32  E-value=8e-13  Score=109.90  Aligned_cols=238  Identities=20%  Similarity=0.185  Sum_probs=163.6

Q ss_pred             ccCCcccccccCCceEEEEEEEc-cCCceEEEEEeccccc--cchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK-ATGMTLAAKFVGIAKR--NDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++..+..||.|.++.|+.+.-+ .++..+++|.......  .....-..|+-....+ .|.+.+.....|......|+-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            57888999999999999988755 5667777776532111  1122233445555555 488888888888777778899


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC-CcEEEeecccccccCCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG-NRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~-~~~~l~df~~~~~~~~~~  157 (251)
                      -|++.++++....... ..+++...+.+..|++.++.++|+..++|+|++|+||++  ..+ +..++.||+..+...-..
T Consensus       345 ~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i--~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILI--SNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             hhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhccccccchhhhcccccccceee--ccchhhhhccccccccccceec
Confidence            9999998876655333 358888999999999999999999999999999999998  443 778899998886532111


Q ss_pred             cceeeccCccc-ccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        158 KLQVLFGTPEF-VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       158 ~~~~~~~~~~y-~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      .. ....+..| .+++......+..+.|++|||.-+.+.+++...-........+   ..+..+..    .....++..+
T Consensus       422 ~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i---~~~~~p~~----~~~~~~~q~~  493 (524)
T KOG0601|consen  422 GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI---RSGDTPNL----PGLKLQLQVL  493 (524)
T ss_pred             cc-ccccccccccchhhccccccccccccccccccccccccCcccCcccccceee---ecccccCC----CchHHhhhhh
Confidence            11 11122233 3555555566778999999999999999886554333222111   11211111    3334677888


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      .+.++.+++..||.+
T Consensus       494 ~kv~~~~~~~~~~l~  508 (524)
T KOG0601|consen  494 LKVMINPDRKRRPSA  508 (524)
T ss_pred             hhhhcCCccccchhh
Confidence            888888888888763

>KOG2137|consensus

Probab=99.26  E-value=1.8e-12  Score=109.65  Aligned_cols=141  Identities=20%  Similarity=0.355  Sum_probs=103.7

Q ss_pred             HHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc----------eeeccCccccccccccc
Q psy11805        108 RQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL----------QVLFGTPEFVAPEVVNF  176 (251)
Q Consensus       108 ~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~y~aPE~~~~  176 (251)
                      .+...|+.++|. .++||++|.|++|++  +.++.+||+.|+.+........-          ........|.|||.+.+
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~--na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVV--NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheee--ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999995 599999999999999  99999999999988664332111          01123458999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhccccCC-CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        177 DAIGFGTDMWSVGVICYVLL-SGLSPFMGETDVQTMANVTIAQYDFD-DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       177 ~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...+.++|+||+|+++|.+. .|+..+.......... ......... .-...++|.++++=+.+++..++.-||++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~  259 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL  259 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence            88999999999999999999 4666666554333222 111111111 11226899999999999999999999953

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.13  E-value=1.7e-09  Score=80.86  Aligned_cols=137  Identities=23%  Similarity=0.238  Sum_probs=87.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHH---------HHHHHHHHHHcC---CCceeeEeEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN---------VEREVEIMRELQ---HPRLIQIYDAF   69 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~---------~~~e~~~l~~l~---~~~i~~~~~~~   69 (251)
                      .++|++.+.+-......|.+..  -+++.+++|..........+.         ..+.+..+..+.   ......++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            5678888888887766666554  447899999875433221111         223333333333   23333333332


Q ss_pred             e-----eCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEE
Q psy11805         70 E-----SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKI  144 (251)
Q Consensus        70 ~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l  144 (251)
                      +     -....+++|||++|..|.+...     +++    .++..+.+++..+|+.|++|||.+|.||++  . ++.+.+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv--~-~~~i~i  175 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV--S-NNGIRI  175 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE--E-CCcEEE
Confidence            2     2234678999999987755431     333    244567788999999999999999999998  5 445999


Q ss_pred             eecccccc
Q psy11805        145 IDFGLARK  152 (251)
Q Consensus       145 ~df~~~~~  152 (251)
                      +|++....
T Consensus       176 ID~~~k~~  183 (229)
T PF06176_consen  176 IDTQGKRM  183 (229)
T ss_pred             EECccccc
Confidence            99977643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=99.11  E-value=4e-09  Score=78.61  Aligned_cols=137  Identities=17%  Similarity=0.154  Sum_probs=98.2

Q ss_pred             ccCCceEEEEEEEccCCceEEEEEec-c-----ccccchHHHHHHHHHHHHcCCCc--eeeEeEEEee----CCEEEEEE
Q psy11805         12 SFGKFGTVYRCKEKATGMTLAAKFVG-I-----AKRNDRRNVEREVEIMRELQHPR--LIQIYDAFES----SNVMCVVL   79 (251)
Q Consensus        12 g~g~~~~v~~~~~~~~~~~~~~K~~~-~-----~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~----~~~~~lv~   79 (251)
                      |.||.|.|+.....  |+.+-+|.-. .     ....-...+.+|...++++...+  ++++......    .-..+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56899999988655  3357777643 0     00224678999999999885333  4444422211    22478999


Q ss_pred             EeccCC-chhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc--EEEeecccccc
Q psy11805         80 ELIEGG-ELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR--IKIIDFGLARK  152 (251)
Q Consensus        80 e~~~~~-~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~--~~l~df~~~~~  152 (251)
                      |.+++. +|.+.+.... .+.+......++.+++.++..||+.|+.|+|+.+.||++  +.++.  +.++||.-+..
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll--~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYV--KTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheee--cCCCCeeEEEEEhhccch
Confidence            988643 6766665432 245777788999999999999999999999999999998  54555  99999987754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.09  E-value=2.3e-09  Score=81.08  Aligned_cols=107  Identities=20%  Similarity=0.268  Sum_probs=83.5

Q ss_pred             chHHHHHHHHHHHHcCCCc--eeeEeEEEeeC----CEEEEEEEeccCC-chhHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy11805         43 DRRNVEREVEIMRELQHPR--LIQIYDAFESS----NVMCVVLELIEGG-ELFERVIDDDFVLTEKAVAIFMRQICEGVE  115 (251)
Q Consensus        43 ~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~  115 (251)
                      ......+|...+..+...+  .++.+++.+..    ...++|+|.+++. +|.+.+..... .+......++.+++..+.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIA  132 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHH
Confidence            3556788888888775433  45666665542    2468999999885 68777765332 677788899999999999


Q ss_pred             HHhhCCceecCCCCCcEEEeecCCC---cEEEeecccccc
Q psy11805        116 FIHSKNVLHLDMKPENILCLTKTGN---RIKIIDFGLARK  152 (251)
Q Consensus       116 ~lh~~gi~h~dl~~~nil~~~~~~~---~~~l~df~~~~~  152 (251)
                      .||++|++|+|+++.|||+  ..++   .+.++||+.+..
T Consensus       133 ~lH~~gi~H~Dl~~~NILv--~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILV--DPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCcCCCCCCCcccEEE--eCCCCceeEEEEcchhcee
Confidence            9999999999999999999  5554   899999998865

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=99.06  E-value=2.4e-09  Score=90.57  Aligned_cols=143  Identities=21%  Similarity=0.337  Sum_probs=94.4

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEecccccc--------------------------c--------hHHH------H
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--------------------------D--------RRNV------E   48 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--------------------------~--------~~~~------~   48 (251)
                      .+|++++-|.||.|.... |+.||+|+.++.-.+                          +        .+.+      .
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            678899999999999885 899999997421100                          0        1122      2


Q ss_pred             HHHHHHHHc----C-CCceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCce
Q psy11805         49 REVEIMREL----Q-HPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL  123 (251)
Q Consensus        49 ~e~~~l~~l----~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~  123 (251)
                      +|+....++    + .+++.-.--+++..+.-.++|||++|..+.+...-....++...+.....+++  +..+-..|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence            333333332    2 23332222233445667899999999998887533333466555554433322  2444458999


Q ss_pred             ecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805        124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus       124 h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      |+|.+|.||++  ..+|++.+.|||+....++.
T Consensus       288 HaDpHpGNi~v--~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         288 HADPHPGNILV--RSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccCCCccceEE--ecCCcEEEEcCcceecCCHH
Confidence            99999999999  88899999999999776543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.94  E-value=3.8e-08  Score=75.48  Aligned_cols=71  Identities=20%  Similarity=0.241  Sum_probs=54.7

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc--eeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR--LIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      .+||.|..+.||+.    .+..+++|....  ......+.+|.+.++.+....  +++++++....+...++|++++|.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~--~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNP--GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCC--CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            57899999999974    244678888753  224566799999999986433  578888888777788999999996

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.93  E-value=2.1e-08  Score=75.99  Aligned_cols=135  Identities=22%  Similarity=0.274  Sum_probs=90.8

Q ss_pred             ccccCCceEEEEEEEccCCceEEEEEecccccc-------------------chHH-----HHHHHHHHHHcCC--Ccee
Q psy11805         10 AFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-------------------DRRN-----VEREVEIMRELQH--PRLI   63 (251)
Q Consensus        10 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------------------~~~~-----~~~e~~~l~~l~~--~~i~   63 (251)
                      .|++|..+.||+|.. .++..+|+|++......                   ....     ...|...|+++..  =.++
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            567889999999865 45789999998521111                   1111     2356666666643  3445


Q ss_pred             eEeEEEeeCCEEEEEEEeccCCch-hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCc
Q psy11805         64 QIYDAFESSNVMCVVLELIEGGEL-FERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNR  141 (251)
Q Consensus        64 ~~~~~~~~~~~~~lv~e~~~~~~L-~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~  141 (251)
                      +.+++..    ..+|||++..... .-.+  ....+..+.+..+..++++.+.-|-. .|+||+||+.-|||+  . ++.
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~--~-~~~  204 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV--H-DGE  204 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE--E-CCe
Confidence            5555443    4689999844210 0011  11123444678888889999988887 999999999999998  4 788


Q ss_pred             EEEeecccccccC
Q psy11805        142 IKIIDFGLARKFD  154 (251)
Q Consensus       142 ~~l~df~~~~~~~  154 (251)
                      +.++|++.+...+
T Consensus       205 p~iID~~QaV~~~  217 (268)
T COG1718         205 PYIIDVSQAVTID  217 (268)
T ss_pred             EEEEECccccccC
Confidence            9999999997654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.88  E-value=3.7e-08  Score=70.77  Aligned_cols=129  Identities=22%  Similarity=0.255  Sum_probs=95.6

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCce-eeEeEEEeeCCEEEEEEEecc
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRL-IQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      -+..+.|+.|..|.||++.++  +..+++|+-.  .......++.|+++|..++-.++ ++++.+..+.    +.|||.+
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr--~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~   95 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRR--RDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYID   95 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEec--CCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhc
Confidence            356778999999999999888  5688999843  45568999999999999975444 6666666543    5599999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCC-CCcEEEeecCCCcEEEeeccccc
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK-PENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~-~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      |.+|.+....    .+..++    ..+++....|-..||-|+.++ |...++  ..++.+.|+||.-++
T Consensus        96 G~~L~~~~~~----~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vl--v~~~~~~iIDFd~At  154 (201)
T COG2112          96 GRPLGKLEIG----GDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVL--VNDRDVYIIDFDSAT  154 (201)
T ss_pred             Ccchhhhhhc----ccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEE--ecCCcEEEEEccchh
Confidence            9888664432    134444    345666667888999999986 455555  455589999999886

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.85  E-value=6.6e-08  Score=74.53  Aligned_cols=78  Identities=21%  Similarity=0.252  Sum_probs=56.5

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCC--ceeeEeEEE---eeCCEEEEEEEec
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHP--RLIQIYDAF---ESSNVMCVVLELI   82 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~lv~e~~   82 (251)
                      ++.++.|..+.+|++....  ..+++|.....  .....+.+|..+++.+...  .+++++...   ......+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4678999999999998775  48899996543  4567788888888888533  356676644   2344579999999


Q ss_pred             cCCchhH
Q psy11805         83 EGGELFE   89 (251)
Q Consensus        83 ~~~~L~~   89 (251)
                      +|.++..
T Consensus        78 ~g~~~~~   84 (239)
T PF01636_consen   78 PGRPLDD   84 (239)
T ss_dssp             SSEEHHH
T ss_pred             ccccccc
Confidence            9987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235|consensus

Probab=98.73  E-value=1.9e-07  Score=79.11  Aligned_cols=143  Identities=17%  Similarity=0.229  Sum_probs=91.4

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEecccccc-------------------------------chHHHHHHHHHH--
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-------------------------------DRRNVEREVEIM--   54 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------------------------------~~~~~~~e~~~l--   54 (251)
                      .+.|+.-+.+.||+|+.++ |..||+|+-+..-..                               -.+.+-.|++.+  
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3678899999999999886 899999986421100                               012222232222  


Q ss_pred             ----H----HcCCCc------eeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q psy11805         55 ----R----ELQHPR------LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK  120 (251)
Q Consensus        55 ----~----~l~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~  120 (251)
                          .    .+.|-+      |++++..+  .....++|||++|..+.+.-.-....++...+..-+.++..  ..+-..
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~  320 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKT  320 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhc
Confidence                2    223444      34443333  34578999999998776553322234777765555444433  234457


Q ss_pred             CceecCCCCCcEEEeec--CCCcEEEeecccccccCC
Q psy11805        121 NVLHLDMKPENILCLTK--TGNRIKIIDFGLARKFDP  155 (251)
Q Consensus       121 gi~h~dl~~~nil~~~~--~~~~~~l~df~~~~~~~~  155 (251)
                      |++|+|-+|.||++.++  .++.+.+.|||+.....+
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            89999999999999543  467899999999976543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.73  E-value=1.3e-06  Score=65.28  Aligned_cols=131  Identities=19%  Similarity=0.307  Sum_probs=94.2

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEecccc----------------ccchHHHHHHHHHHHHcC------CCceee
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK----------------RNDRRNVEREVEIMRELQ------HPRLIQ   64 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~----------------~~~~~~~~~e~~~l~~l~------~~~i~~   64 (251)
                      -...||+|+.=.||.-  .. +...++|+.....                .....+..+|+..+..+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3567999999999943  33 3345778876544                223566777877777665      789999


Q ss_pred             EeEEEeeCCEEEEEEEeccC------CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC
Q psy11805         65 IYDAFESSNVMCVVLELIEG------GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT  138 (251)
Q Consensus        65 ~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~  138 (251)
                      ++|+.+++-...+|+|.+..      .+|.+++....  ++. .....   +-+-..+|-+.+|+.+|++|+||++....
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence            99999999889999997633      37777775443  665 33333   44445577889999999999999986666


Q ss_pred             CCc--EEEee
Q psy11805        139 GNR--IKIID  146 (251)
Q Consensus       139 ~~~--~~l~d  146 (251)
                      ++.  +.|+|
T Consensus       156 ~~~~~lvlID  165 (199)
T PF10707_consen  156 SGEFRLVLID  165 (199)
T ss_pred             CCceEEEEEe
Confidence            554  67777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.66  E-value=7.5e-07  Score=80.91  Aligned_cols=80  Identities=20%  Similarity=0.305  Sum_probs=57.4

Q ss_pred             ccccccCCceEEEEEEEccCC--ceEEEEEecccc-ccchHHHHHHHHHHHHcC-CCce--eeEeEEEeeC---CEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKATG--MTLAAKFVGIAK-RNDRRNVEREVEIMRELQ-HPRL--IQIYDAFESS---NVMCVV   78 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~--~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~lv   78 (251)
                      .+.++.|.++.+|++.....+  ..+++|+..... ......+.+|+..++.+. |.++  ++++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567889999999998776432  467777754322 123467889999999995 5654  7777777654   457899


Q ss_pred             EEeccCCch
Q psy11805         79 LELIEGGEL   87 (251)
Q Consensus        79 ~e~~~~~~L   87 (251)
                      ||+++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.66  E-value=7.1e-07  Score=69.44  Aligned_cols=75  Identities=21%  Similarity=0.184  Sum_probs=53.2

Q ss_pred             ccccCCc-eEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805         10 AFSFGKF-GTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus        10 ~lg~g~~-~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      .|..|.. +.||++...  +..+++|......   ...+.+|++.++.+. +--++++++.....+..++||++++|.++
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            4455555 788988653  3577888864322   456778999988884 45567788877766678999999999776


Q ss_pred             hH
Q psy11805         88 FE   89 (251)
Q Consensus        88 ~~   89 (251)
                      ..
T Consensus        80 ~~   81 (244)
T cd05150          80 AA   81 (244)
T ss_pred             hH
Confidence            53

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.45  E-value=2.5e-06  Score=65.98  Aligned_cols=74  Identities=14%  Similarity=0.119  Sum_probs=47.6

Q ss_pred             ccccccCCce-EEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCC---ceeeEeEEEeeC---CEEEEEEE
Q psy11805          8 HSAFSFGKFG-TVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHP---RLIQIYDAFESS---NVMCVVLE   80 (251)
Q Consensus         8 ~~~lg~g~~~-~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~e   80 (251)
                      ++.++.|+.+ .||++     +..+++|....  ......+.+|++.++.+...   .++++++.....   ...+++|+
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            3567766666 48976     23567787543  22356899999999888632   345555444332   23578999


Q ss_pred             eccCCchh
Q psy11805         81 LIEGGELF   88 (251)
Q Consensus        81 ~~~~~~L~   88 (251)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99997663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576|consensus

Probab=98.41  E-value=1.9e-08  Score=85.27  Aligned_cols=185  Identities=20%  Similarity=0.324  Sum_probs=135.1

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc-eeeEeEEEeeCCEEEEEEEecc
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR-LIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      |...+-++.++++++++.+...+...+ .+++...     ....-++++|.+++||| .+..++-++.+....++++++.
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            334456778889999988877665444 5554332     44456688999999999 6666666777788899999987


Q ss_pred             CC-chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceee
Q psy11805         84 GG-ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL  162 (251)
Q Consensus        84 ~~-~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~  162 (251)
                      ++ +.........-.+-+-+...+.+.-+.+++++|+.--+|+|    ||+.   .++..+..+|+....+.........
T Consensus       318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~---s~~~~~~~~~~v~~~L~~~~~~~t~  390 (829)
T KOG0576|consen  318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG---SEEEVKLLDFAVPPQLTRTMKPRTA  390 (829)
T ss_pred             CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc---cccccccccccCCcccCcccccccC
Confidence            76 22111111222355556677778888999999988767887    8874   5577899999988877666555667


Q ss_pred             ccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11805        163 FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPF  202 (251)
Q Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  202 (251)
                      .+++.++|||......+....|+|++|.=-.++.-|..|-
T Consensus       391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            7899999999998888999999999997666666666664

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.37  E-value=5.4e-06  Score=65.00  Aligned_cols=137  Identities=18%  Similarity=0.211  Sum_probs=78.7

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc-eeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR-LIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      ..+..|-.+.+|++.  .+++.+++|..............+|...++.+.... .++++....    -++|+++++|.++
T Consensus         2 ~~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         2 QTLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI   75 (256)
T ss_pred             CcCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence            346678888999886  346678888764332222124578889998886433 344444432    2589999998765


Q ss_pred             hHH----------H-------hhC---CCCCCH-HHHHHHHHHH---------HHHHHHHh--------hCCceecCCCC
Q psy11805         88 FER----------V-------IDD---DFVLTE-KAVAIFMRQI---------CEGVEFIH--------SKNVLHLDMKP  129 (251)
Q Consensus        88 ~~~----------~-------~~~---~~~~~~-~~~~~i~~~l---------~~~l~~lh--------~~gi~h~dl~~  129 (251)
                      ...          +       ...   +..++. ..+..+..++         ...+..+.        ...++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            321          0       010   111121 1111211111         11122121        12589999999


Q ss_pred             CcEEEeecCCCcEEEeecccccccC
Q psy11805        130 ENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus       130 ~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .||++  +.++ +.++||+.+...+
T Consensus       156 ~Nil~--~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       156 YNLVV--TPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             CcEEE--eCCC-CEEEeccccCcCC
Confidence            99998  5555 7899999886543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=98.33  E-value=2.1e-05  Score=63.00  Aligned_cols=78  Identities=12%  Similarity=0.167  Sum_probs=57.2

Q ss_pred             CcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCC---CceeeEeEEEee---CCEEEEEE
Q psy11805          6 NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH---PRLIQIYDAFES---SNVMCVVL   79 (251)
Q Consensus         6 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~~lv~   79 (251)
                      .-.+.||.|..+.||...... + .+++|..+.  ......+..|+..++.+..   -.++++++++..   .+..++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            345689999999999886542 3 466677422  2245689999999999853   368888887754   36689999


Q ss_pred             EeccCCch
Q psy11805         80 ELIEGGEL   87 (251)
Q Consensus        80 e~~~~~~L   87 (251)
                      |+++|.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.33  E-value=1.8e-05  Score=58.88  Aligned_cols=100  Identities=18%  Similarity=0.166  Sum_probs=77.9

Q ss_pred             HHHHHHHHHcCC-CceeeEeEEEeeCCEEEEEEEeccCCchhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhh---CC
Q psy11805         48 EREVEIMRELQH-PRLIQIYDAFESSNVMCVVLELIEGGELFERVI--DDDFVLTEKAVAIFMRQICEGVEFIHS---KN  121 (251)
Q Consensus        48 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~lh~---~g  121 (251)
                      .+|.-+++.+++ +++++++|++..    +++.|+...+++.....  ..-...++..+.+|+.++++.+.+|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357777888864 699999999843    56889887655532110  011236999999999999999999997   45


Q ss_pred             ceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805        122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus       122 i~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      +..+|++++||-+  +.+++++++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv--~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGV--NDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEE--eCCCcEEEEechhcchh
Confidence            8899999999999  88899999999877554

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.33  E-value=3.1e-05  Score=64.10  Aligned_cols=76  Identities=13%  Similarity=0.140  Sum_probs=54.0

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEecc------cc-ccchHHHHHHHHHHHHcC---CCceeeEeEEEeeCCEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGI------AK-RNDRRNVEREVEIMRELQ---HPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~------~~-~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l   77 (251)
                      .+.||.|..+.||++.+...++.+++|.-..      .. .....+...|.+.|+.+.   -..+++++.+-  .+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            4678999999999999874445889997431      11 124667778888888763   34577777763  355789


Q ss_pred             EEEeccCC
Q psy11805         78 VLELIEGG   85 (251)
Q Consensus        78 v~e~~~~~   85 (251)
                      |||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99998764

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.32  E-value=7.3e-06  Score=65.68  Aligned_cols=138  Identities=14%  Similarity=0.112  Sum_probs=82.4

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc--eeeEeEE------EeeCCEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR--LIQIYDA------FESSNVMCVVL   79 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv~   79 (251)
                      .+.+..|....+|++...  +..+++|++..   .....+..|+..++.+...+  +++++..      ....+..++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            566778888899988543  45788898753   33566778888888775332  4444432      23345678999


Q ss_pred             EeccCCchhH----HH----------hh--CCCCC--------CHHHH----------HHHHHHHHHHHHHHhh------
Q psy11805         80 ELIEGGELFE----RV----------ID--DDFVL--------TEKAV----------AIFMRQICEGVEFIHS------  119 (251)
Q Consensus        80 e~~~~~~L~~----~~----------~~--~~~~~--------~~~~~----------~~i~~~l~~~l~~lh~------  119 (251)
                      ++++|..+..    ..          ..  .+...        .+...          ......+..++..+.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999875422    00          00  01000        00000          0011112233333332      


Q ss_pred             -CCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        120 -KNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       120 -~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                       .+++|+|+.|.||++  +.++.+.++||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~--~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLF--DGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEE--eCCceEEEeehhhhcC
Confidence             479999999999998  6666668999998865

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.32  E-value=2.8e-05  Score=57.85  Aligned_cols=125  Identities=16%  Similarity=0.271  Sum_probs=88.4

Q ss_pred             ccCCcccccccCCc-eEEEEEEEccCCceEEEEEecc---ccc------------------cchHHHHHHHHHHHHcC--
Q psy11805          3 THQNQHSAFSFGKF-GTVYRCKEKATGMTLAAKFVGI---AKR------------------NDRRNVEREVEIMRELQ--   58 (251)
Q Consensus         3 ~~y~~~~~lg~g~~-~~v~~~~~~~~~~~~~~K~~~~---~~~------------------~~~~~~~~e~~~l~~l~--   58 (251)
                      .+++..+.||.|.. |.||+++..  |+.+|+|++..   ...                  .-...+..|++..-+++  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            46788899999999 999999877  77999999421   110                  11345778888887775  


Q ss_pred             -CCce--eeEeEEEeeC------------------CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy11805         59 -HPRL--IQIYDAFESS------------------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFI  117 (251)
Q Consensus        59 -~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~l  117 (251)
                       +.++  ++++|+..-.                  -...||.|+.+...          .++...+    .++++-+..+
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~~----~~~~~dl~~~  180 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRDI----PQMLRDLKIL  180 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhHH----HHHHHHHHHH
Confidence             4455  9999987211                  01356777765432          2344444    4566777789


Q ss_pred             hhCCceecCCCCCcEEEeecCCCcEEEeecccc
Q psy11805        118 HSKNVLHLDMKPENILCLTKTGNRIKIIDFGLA  150 (251)
Q Consensus       118 h~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~  150 (251)
                      |..||+-+|+++.|..       .-+|+|||.+
T Consensus       181 ~k~gI~~~Dv~~~ny~-------~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR-------GGKLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCcccccc-------CCEEEecccC
Confidence            9999999999999976       3489999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.29  E-value=2e-05  Score=60.95  Aligned_cols=75  Identities=21%  Similarity=0.305  Sum_probs=48.7

Q ss_pred             ccccccCCceEEEEEEEcc-CCceEEEEEeccccccchHHHHHHHHHHHHcCC-CceeeEeEEEeeCCEEEEEEEeccCC
Q psy11805          8 HSAFSFGKFGTVYRCKEKA-TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH-PRLIQIYDAFESSNVMCVVLELIEGG   85 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (251)
                      ++.|..|-...+|++.... +++.+++|+.... ........+|+..++.+.. .-.++++....  +  .++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence            4567888888999996553 3568889986532 2222344578888888853 33455544332  2  3799999987


Q ss_pred             ch
Q psy11805         86 EL   87 (251)
Q Consensus        86 ~L   87 (251)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035|consensus

Probab=98.26  E-value=7.2e-06  Score=74.40  Aligned_cols=195  Identities=16%  Similarity=0.133  Sum_probs=130.2

Q ss_pred             chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE----EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh
Q psy11805         43 DRRNVEREVEIMRELQHPRLIQIYDAFESSNVM----CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH  118 (251)
Q Consensus        43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh  118 (251)
                      +....+-|...+.++.|+|+..++.+.......    .+..+++.+.++...+..-+ ..+....+.+..++..||.++|
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHH
Confidence            345556677778888999999999988654332    24456777777777766554 6889999999999999999999


Q ss_pred             hCCceecCCCCCcEEE-eecCCCcEEEe--ecccccccCCCCcceeeccCcccccccccccCCCCc--chhHHHHHHHHH
Q psy11805        119 SKNVLHLDMKPENILC-LTKTGNRIKII--DFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGF--GTDMWSVGVICY  193 (251)
Q Consensus       119 ~~gi~h~dl~~~nil~-~~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di~slG~~l~  193 (251)
                      +....|.-+..+...- ..+..+.+...  ||+................+..+.++|.......+.  ..|+|.+|....
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            9966666655552221 00344455555  888777665554444555666788888776555544  479999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       194 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+..|..+-.......   .+..          ........+...+|+..++++|+++
T Consensus       384 ~~~~~~~i~~~~~~~~---~~l~----------~~~~~~~~d~~~~~~~~~~~~Rl~~  428 (1351)
T KOG1035|consen  384 QLSQGEDISEKSAVPV---SLLD----------VLSTSELLDALPKCLDEDSEERLSA  428 (1351)
T ss_pred             hhhhcCcccccccchh---hhhc----------cccchhhhhhhhhhcchhhhhccch
Confidence            9988765432211111   1100          1112256778888888888888764

>PRK05231 homoserine kinase; Provisional

Probab=98.13  E-value=7.8e-05  Score=60.43  Aligned_cols=75  Identities=9%  Similarity=0.014  Sum_probs=45.9

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc--eeeEeE------EEeeCCEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR--LIQIYD------AFESSNVMCVVL   79 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~------~~~~~~~~~lv~   79 (251)
                      .+.++.|....+|.+...  +..+++|++.   ......+..+...++.+...+  +++++.      +....+..++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~---~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE---RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEec---cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            356677888899988654  3368889875   223445555666666653222  333332      123355678999


Q ss_pred             EeccCCch
Q psy11805         80 ELIEGGEL   87 (251)
Q Consensus        80 e~~~~~~L   87 (251)
                      ++++|..+
T Consensus       102 ~~l~G~~~  109 (319)
T PRK05231        102 TFLEGKWP  109 (319)
T ss_pred             EecCCCCC
Confidence            99998643

>KOG2270|consensus

Probab=98.13  E-value=3.7e-05  Score=62.02  Aligned_cols=143  Identities=19%  Similarity=0.225  Sum_probs=97.0

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEecccc----------------------ccch----HHHHHHHHHHHHcCCC
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK----------------------RNDR----RNVEREVEIMRELQHP   60 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~----------------------~~~~----~~~~~e~~~l~~l~~~   60 (251)
                      |--+|+.|..+.||.|.-. +|..+|+|+++..-                      ...+    -=.+.|++.|+++...
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4457888999999998644 67789999984110                      0011    1145778888888766


Q ss_pred             ceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh-hCCceecCCCCCcEEEeecCC
Q psy11805         61 RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH-SKNVLHLDMKPENILCLTKTG  139 (251)
Q Consensus        61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh-~~gi~h~dl~~~nil~~~~~~  139 (251)
                      .|+-.--+...  ..+|||+++. ..-+-...-....++...+..+-.+++..+.-|- ..++||.||+--|+|+   .+
T Consensus       227 GIP~PePIlLk--~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly---hd  300 (520)
T KOG2270|consen  227 GIPCPEPILLK--NHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY---HD  300 (520)
T ss_pred             CCCCCCceeee--cceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE---EC
Confidence            65433333332  2578999984 3222222222334777888888788877777654 5699999999999996   67


Q ss_pred             CcEEEeecccccccCCC
Q psy11805        140 NRIKIIDFGLARKFDPE  156 (251)
Q Consensus       140 ~~~~l~df~~~~~~~~~  156 (251)
                      |.+.++|.+.+...+..
T Consensus       301 G~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             CEEEEEEccccccCCCh
Confidence            89999999988766544

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.08  E-value=7.5e-05  Score=60.21  Aligned_cols=139  Identities=12%  Similarity=0.111  Sum_probs=79.9

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc--eeeEeEE------EeeCCEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR--LIQIYDA------FESSNVMCVVL   79 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv~   79 (251)
                      .+.++.|....+|++...  +..+++|+.....  ....+..|.+.++.+...+  +++++..      ....+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            566778888899988643  3467888864321  2345566777777774322  3444432      12245678999


Q ss_pred             EeccCCchh----HHH----------hh--CCCCCC-----HHHHH----------------HHHHHHHHHHHHHh----
Q psy11805         80 ELIEGGELF----ERV----------ID--DDFVLT-----EKAVA----------------IFMRQICEGVEFIH----  118 (251)
Q Consensus        80 e~~~~~~L~----~~~----------~~--~~~~~~-----~~~~~----------------~i~~~l~~~l~~lh----  118 (251)
                      ++++|..+.    ...          ..  .+...+     ....+                .....+...+.++.    
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885431    100          00  110000     00000                00111223444443    


Q ss_pred             ---hCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        119 ---SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       119 ---~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                         ..+++|+|+++.||++  +.++...++||+.+..
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~--~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLF--DGDSVKGVIDFYFACT  217 (307)
T ss_pred             hcCCCccCCCCCCcCcEEE--ECCceEEEeecccccC
Confidence               3689999999999998  6666668999998855

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268|consensus

Probab=98.07  E-value=5.8e-06  Score=65.47  Aligned_cols=135  Identities=21%  Similarity=0.307  Sum_probs=93.6

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccccc----------------------chHHHHHHHHHHHHcCCC--
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN----------------------DRRNVEREVEIMRELQHP--   60 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----------------------~~~~~~~e~~~l~~l~~~--   60 (251)
                      +.+...||-|..|.+|.+-+. .|++.++|..+.-...                      ..-...+|...++.+...  
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            567889999999999999665 4778888876421110                      122345677777777543  


Q ss_pred             ceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC
Q psy11805         61 RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN  140 (251)
Q Consensus        61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~  140 (251)
                      -++..+++    +..++|||.++|.+|.+.-.-    .+.   ..+...+...+.-|-..|++|||..--||++  ..++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv--~dd~  239 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMV--KDDD  239 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec----CCh---HHHHHHHHHHHHHHHHcCceecccchheeEE--ecCC
Confidence            34444433    446889999999877554321    122   2334455566667888999999999999999  7889


Q ss_pred             cEEEeeccccccc
Q psy11805        141 RIKIIDFGLARKF  153 (251)
Q Consensus       141 ~~~l~df~~~~~~  153 (251)
                      .++++||-.....
T Consensus       240 ~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  240 KIVVIDFPQMVST  252 (465)
T ss_pred             CEEEeechHhhcc
Confidence            9999999766544

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.96  E-value=0.00015  Score=58.10  Aligned_cols=143  Identities=17%  Similarity=0.233  Sum_probs=90.1

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEec-cccccchHHHHHHHHHHHHcCCC--ceeeEeEEEeeCC--EEEEEEEe
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVG-IAKRNDRRNVEREVEIMRELQHP--RLIQIYDAFESSN--VMCVVLEL   81 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~-~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~--~~~lv~e~   81 (251)
                      +.+.+..|-...+|...+.  ++.++++... ...........+|...++.+..-  -++..++.+.++.  ..+.||++
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            4445545555556766555  6788887321 12233467778888888887533  3444455555444  67999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHH-HHHHHHHHHHhh-----------------------------------------
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHS-----------------------------------------  119 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~-~~l~~~l~~lh~-----------------------------------------  119 (251)
                      +.|..+.+....    .+..  ..++ ..+...|..||+                                         
T Consensus       107 veGe~~~~~~~~----~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         107 VEGEVVWSALPP----ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ecceeccCcCCc----ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            998533332211    1111  1222 366667777775                                         


Q ss_pred             -----------------CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805        120 -----------------KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus       120 -----------------~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                                       ..++|||+++.|+++  +.++-+-++||+.+..-++....
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii--~~~~~~gVlDwe~~~lGDP~~Dl  235 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLII--DPGRPTGVLDWELATLGDPLEDL  235 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEE--eCCCeeEEEeccccccCCcHHHH
Confidence                             248999999999998  66666999999999876655443

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.95  E-value=0.00016  Score=58.17  Aligned_cols=76  Identities=20%  Similarity=0.197  Sum_probs=49.9

Q ss_pred             ccccccCCceEEEEEEEcc------CCceEEEEEeccccccchHHHHHHHHHHHHcCCCc-eeeEeEEEeeCCEEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKA------TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR-LIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++.+..|-...+|++....      .++.+++|+..... .......+|...++.+...+ .++++.....    ..|++
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e   77 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE   77 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence            3566777778999997543      25788899975432 23456788888888885333 3455555532    25789


Q ss_pred             eccCCchh
Q psy11805         81 LIEGGELF   88 (251)
Q Consensus        81 ~~~~~~L~   88 (251)
                      +++|.++.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            98887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.77  E-value=0.0009  Score=55.51  Aligned_cols=74  Identities=12%  Similarity=0.088  Sum_probs=50.5

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEecc----ccc---cchHHHHHHHHHHHHcC---CCceeeEeEEEeeCCEEE
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGI----AKR---NDRRNVEREVEIMRELQ---HPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~----~~~---~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~   76 (251)
                      ..+.||.|....||++.+.  +..+++|.-..    ...   ....+...|+..|+.+.   -..+++++.+..+.  .+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--AL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CE
Confidence            3567899999999999864  45688887531    111   23455555567776653   24788888887743  67


Q ss_pred             EEEEeccC
Q psy11805         77 VVLELIEG   84 (251)
Q Consensus        77 lv~e~~~~   84 (251)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.75  E-value=0.00095  Score=54.40  Aligned_cols=75  Identities=11%  Similarity=0.112  Sum_probs=48.3

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEec----c--cc-ccchHHHHHHHHHHHHcC--CC-ceeeEeEEEeeCCEEEEE
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVG----I--AK-RNDRRNVEREVEIMRELQ--HP-RLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~----~--~~-~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv   78 (251)
                      +.||.|....||++.+...++.+++|.-.    .  .+ .....+..-|...|+...  .| .+++++.+  +++...++
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence            35899999999999976434688988642    1  11 334566667777777653  34 44554433  34446689


Q ss_pred             EEeccCC
Q psy11805         79 LELIEGG   85 (251)
Q Consensus        79 ~e~~~~~   85 (251)
                      ||+++..
T Consensus        79 MEdL~~~   85 (370)
T TIGR01767        79 MEDLSHH   85 (370)
T ss_pred             HhhCccc
Confidence            9988543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.73  E-value=0.00048  Score=54.60  Aligned_cols=30  Identities=30%  Similarity=0.488  Sum_probs=24.5

Q ss_pred             CceecCCCCCcEEEeecCCCc-EEEeecccccc
Q psy11805        121 NVLHLDMKPENILCLTKTGNR-IKIIDFGLARK  152 (251)
Q Consensus       121 gi~h~dl~~~nil~~~~~~~~-~~l~df~~~~~  152 (251)
                      .++|+|++|.||++  +.+++ .-++||+.+..
T Consensus       186 ~lvHGD~~~~Nilv--~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILI--DEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEE--eCCCCEEEEECcHhccc
Confidence            48999999999998  55355 46999999865

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.72  E-value=0.00061  Score=55.81  Aligned_cols=139  Identities=16%  Similarity=0.177  Sum_probs=81.3

Q ss_pred             ccccccCCceEEEEEEEcc----CCceEEEEEeccccccchHHHHHHHHHHHHcCCCce-eeEeEEEeeCCEEEEEEEec
Q psy11805          8 HSAFSFGKFGTVYRCKEKA----TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRL-IQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++.+..|-...+|++....    .++.+++|+...... ..-.-.+|..+++.+...++ +++++.+...    .|.+|+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            4456678888999987532    246888998754332 22233788888888864433 5566665332    478888


Q ss_pred             cCCchhHH----------H-------hhCC---C--CCCHHHHHHHHHHH-----------------HHHHHHH------
Q psy11805         83 EGGELFER----------V-------IDDD---F--VLTEKAVAIFMRQI-----------------CEGVEFI------  117 (251)
Q Consensus        83 ~~~~L~~~----------~-------~~~~---~--~~~~~~~~~i~~~l-----------------~~~l~~l------  117 (251)
                      ++.++...          +       ....   .  ....+.+..+..++                 ...+..|      
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87766321          0       0000   0  01122232332211                 1111111      


Q ss_pred             --hhCCceecCCCCCcEEEeecC-CCcEEEeeccccccc
Q psy11805        118 --HSKNVLHLDMKPENILCLTKT-GNRIKIIDFGLARKF  153 (251)
Q Consensus       118 --h~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~~~~~  153 (251)
                        +...++|+|+++.||++  +. ++.+.++||..+...
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~--~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMI--DEETRAITIIDYEYASYN  232 (344)
T ss_pred             cCCCceEEeCCCCcCcEEE--eCCCCcEEEEeehhcccc
Confidence              12368999999999997  44 467999999988653

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.71  E-value=0.0004  Score=57.27  Aligned_cols=75  Identities=17%  Similarity=0.337  Sum_probs=49.7

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEec----c-cc-ccchHHHHHHHHHHHHcC--CC-ceeeEeEEEeeCCEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVG----I-AK-RNDRRNVEREVEIMRELQ--HP-RLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~----~-~~-~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv   78 (251)
                      .+.||.|.-..||++.+...++.+++|.-.    . .+ .....+..-|...|+...  .| .+++++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            568899999999999885445678888532    1 11 334677777888887763  44 45555543  33446678


Q ss_pred             EEeccC
Q psy11805         79 LELIEG   84 (251)
Q Consensus        79 ~e~~~~   84 (251)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.49  E-value=0.002  Score=51.31  Aligned_cols=76  Identities=22%  Similarity=0.242  Sum_probs=50.1

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC---CCceeeEeEEEeeCCEEEEEEEe
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ---HPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .+-.+.|+.|..+.+|.+.  .+++.+.+|+-.   ......+..|+.-|+.|.   --.+++++++...++..++++|+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            3446778999999999886  557788999854   334567888888888884   45688999998888788999999


Q ss_pred             ccCC
Q psy11805         82 IEGG   85 (251)
Q Consensus        82 ~~~~   85 (251)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            8775

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.42  E-value=0.0016  Score=52.84  Aligned_cols=106  Identities=13%  Similarity=0.164  Sum_probs=70.8

Q ss_pred             CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         73 NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      .+.|++|++- |+++ ..+.    ....+++..++++.+..+.-+... ..-|+++...||+|  + +|++.|+||.+++
T Consensus       299 ~y~yl~~kdh-gt~i-s~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI--d-~GnvtLIDfklsR  369 (488)
T COG5072         299 LYLYLHFKDH-GTPI-SIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI--D-EGNVTLIDFKLSR  369 (488)
T ss_pred             eEEEEEEecC-Ccee-eeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee--e-cCceEEEEeeeee
Confidence            4567888865 4444 3332    246788889999988888877755 68999999999999  6 9999999999998


Q ss_pred             ccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHH
Q psy11805        152 KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC  192 (251)
Q Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l  192 (251)
                      .........    ....--|-.+.|. -+.+.|||-+--.|
T Consensus       370 l~~~q~~is----y~rldhp~lF~G~-dd~QFeIYrlMr~l  405 (488)
T COG5072         370 LSYSQGIIS----YNRLDHPDLFNGV-DDYQFEIYRLMRRL  405 (488)
T ss_pred             cccCCceee----ccccCchhhhcCc-cceeeeHHHHHHHH
Confidence            532222111    1133345555533 36667777654443

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.40  E-value=0.0058  Score=49.35  Aligned_cols=30  Identities=17%  Similarity=0.138  Sum_probs=27.2

Q ss_pred             CceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       121 gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      +++|+|+.++||++  +.++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~--~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLY--DETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEE--cCCCCEEEEEhhhccc
Confidence            79999999999999  7788899999998865

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1093|consensus

Probab=97.40  E-value=0.00083  Score=56.74  Aligned_cols=153  Identities=22%  Similarity=0.247  Sum_probs=95.4

Q ss_pred             chHHHHHHHHHHHHcCCCceeeEeEEEeeC-CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q psy11805         43 DRRNVEREVEIMRELQHPRLIQIYDAFESS-NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN  121 (251)
Q Consensus        43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~g  121 (251)
                      ....+.-..+.++.++|++....+++.... ....+|+|++.. ||.+......  +-..       +++          
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~--l~~~-------s~~----------   84 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN--LKDE-------SLL----------   84 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc--cchh-------hhc----------
Confidence            456677778899999999999999987643 347889999854 8877766543  1111       111          


Q ss_pred             ceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q psy11805        122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSP  201 (251)
Q Consensus       122 i~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  201 (251)
                       +|+-+ +.|++         ..+| .+....                 |     .+..+++||||+|.++.++.-|...
T Consensus        85 -~~~~~-~~~~~---------~~td-~~~t~~-----------------~-----~~~~pKsdVwsl~~i~~el~L~~~l  130 (725)
T KOG1093|consen   85 -AHGVL-HLNII---------YITD-HFLTKY-----------------P-----SPIGPKSDVWSLGFIILELYLGISL  130 (725)
T ss_pred             -ccccc-eehhh---------hccc-cccccC-----------------C-----CCCCcchhhhhHHHHHHHHHHhhHH
Confidence             22221 12222         2222 111110                 1     1112499999999999999999888


Q ss_pred             CCCCChHHHHHHHHhccccCCC--------ccccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        202 FMGETDVQTMANVTIAQYDFDD--------ECFNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       202 f~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      +......+....+.+-......        .....++..+.++...|+...|..||
T Consensus       131 ~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~  186 (725)
T KOG1093|consen  131 EAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP  186 (725)
T ss_pred             HHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence            8776665555544322211110        11134677889999999999999998

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.34  E-value=0.004  Score=50.79  Aligned_cols=75  Identities=15%  Similarity=0.259  Sum_probs=47.4

Q ss_pred             ccccccCCceEEEEEEEccC---CceEEEEEeccccccchHHHHHHHHHHHHcCCCce-eeEeEEEeeCCEEEEEEEecc
Q psy11805          8 HSAFSFGKFGTVYRCKEKAT---GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRL-IQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      ++.+..|-...+|++.....   +..+++|+..... ...-.-.+|..+++.+...++ +++++++. .+   ++.+|++
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~   93 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN   93 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence            34556677778998865432   2378898875432 223344678888888864444 56666653 22   4788887


Q ss_pred             CCch
Q psy11805         84 GGEL   87 (251)
Q Consensus        84 ~~~L   87 (251)
                      |.++
T Consensus        94 g~~l   97 (330)
T PLN02421         94 ARTL   97 (330)
T ss_pred             CCCC
Confidence            7655

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.28  E-value=0.0079  Score=48.54  Aligned_cols=30  Identities=33%  Similarity=0.482  Sum_probs=25.4

Q ss_pred             CCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       120 ~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      .+++|||+.+.||++  +. +.+.++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~--~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILL--KD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEE--eC-CcEEEEECccccc
Confidence            578999999999998  54 5689999997754

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.23  E-value=0.0067  Score=49.21  Aligned_cols=136  Identities=16%  Similarity=0.221  Sum_probs=78.7

Q ss_pred             ccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc------eeeEeEEE--eeCC--EEEEEE
Q psy11805         10 AFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR------LIQIYDAF--ESSN--VMCVVL   79 (251)
Q Consensus        10 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~--~~~~--~~~lv~   79 (251)
                      .|.+ ....+|++...+ + .+++|++...  ....++..|...++.+....      +...-|-.  .-++  ..+-++
T Consensus        33 ~l~s-~eN~~f~~~~~~-g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTED-G-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecC-C-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            3444 556789887663 3 4489998654  55777888888888873221      22222211  2234  788899


Q ss_pred             EeccCCchhH-----HH----------hh--CCCC---------CCHH-------------HHHHHHHHHHHHHHHHhh-
Q psy11805         80 ELIEGGELFE-----RV----------ID--DDFV---------LTEK-------------AVAIFMRQICEGVEFIHS-  119 (251)
Q Consensus        80 e~~~~~~L~~-----~~----------~~--~~~~---------~~~~-------------~~~~i~~~l~~~l~~lh~-  119 (251)
                      ++++|..+..     .+          ..  .+.+         ..+.             .......++...+..+.+ 
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999977652     00          00  0110         1111             000012233333333332 


Q ss_pred             -------CC--ceecCCCCCcEEEeecCCC-cEEEeecccccc
Q psy11805        120 -------KN--VLHLDMKPENILCLTKTGN-RIKIIDFGLARK  152 (251)
Q Consensus       120 -------~g--i~h~dl~~~nil~~~~~~~-~~~l~df~~~~~  152 (251)
                             .|  ++|+|+.|.||++  +.+. -+-++||+.++.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~--d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLF--DDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             chhhCCcccceeeecCCCccceeE--cCCCCeeeEEEcccccc
Confidence                   34  9999999999998  5555 488999998854

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.06  E-value=0.0043  Score=47.10  Aligned_cols=119  Identities=23%  Similarity=0.234  Sum_probs=59.0

Q ss_pred             CceEEEEEeccccccchHHHHHHHHHHHHcCC-CceeeEeEEEeeCCEEEEEEEeccCCchhHH-------Hh-------
Q psy11805         28 GMTLAAKFVGIAKRNDRRNVEREVEIMRELQH-PRLIQIYDAFESSNVMCVVLELIEGGELFER-------VI-------   92 (251)
Q Consensus        28 ~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-------~~-------   92 (251)
                      ++.|++|+.... ....-.-..|...++.+.. ..-+++++.+.+.    .+.+|++|.+|...       +.       
T Consensus         2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            457888887543 3446677788889988864 4446666665432    46688877654210       00       


Q ss_pred             ---h--C----CCCCCHHHHHHH----------------------HHHHHHHHHHHh--------hCCceecCCCCCcEE
Q psy11805         93 ---D--D----DFVLTEKAVAIF----------------------MRQICEGVEFIH--------SKNVLHLDMKPENIL  133 (251)
Q Consensus        93 ---~--~----~~~~~~~~~~~i----------------------~~~l~~~l~~lh--------~~gi~h~dl~~~nil  133 (251)
                         .  .    ...--...+..+                      +..+..-+..+.        ...+.|+|+.+.||+
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence               0  0    000011122222                      011111222221        135899999999999


Q ss_pred             EeecCCCcEEEeecccccc
Q psy11805        134 CLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       134 ~~~~~~~~~~l~df~~~~~  152 (251)
                      + ++.++.++|+||..+..
T Consensus       157 ~-~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 I-NNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             E-TSSSSCEEE--GTT-EE
T ss_pred             e-ccCCCeEEEecHHHHhh
Confidence            4 55778999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.94  E-value=0.036  Score=45.11  Aligned_cols=70  Identities=17%  Similarity=0.196  Sum_probs=43.1

Q ss_pred             CceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCce--eeEe---E--EEeeCCEEEEEEEeccCCc
Q psy11805         15 KFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRL--IQIY---D--AFESSNVMCVVLELIEGGE   86 (251)
Q Consensus        15 ~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~---~--~~~~~~~~~lv~e~~~~~~   86 (251)
                      ....||.+... ++..+++|+.... ......+..|...+..+....+  +...   +  ....++..+.++++++|..
T Consensus        37 ~eN~vy~v~~~-~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGDE-DGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEecC-CCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            44678988643 4567899987532 2346677788888877742222  1111   1  2233567888999988763

>KOG1826|consensus

Probab=96.81  E-value=0.00013  Score=68.64  Aligned_cols=156  Identities=17%  Similarity=0.084  Sum_probs=109.5

Q ss_pred             HHHHHHHHHHHHcCCCceeeEeEEEee--CCEEEEEEEeccCCchhHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHhh
Q psy11805         45 RNVEREVEIMRELQHPRLIQIYDAFES--SNVMCVVLELIEGGELFERVIDDDF---VLTEKAVAIFMRQICEGVEFIHS  119 (251)
Q Consensus        45 ~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lh~  119 (251)
                      +-...|...++...|+++.....-...  +..-+..++++.+|.+.+.+...-.   .+++.-....-.+.+....-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            344455556666788888776665432  2235778888888888888765321   23333333333444555666554


Q ss_pred             C-----CceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcceeeccCcccccccccccCCCCcchhHHHHHHHHH
Q psy11805        120 K-----NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY  193 (251)
Q Consensus       120 ~-----gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~  193 (251)
                      .     -.+|.++++-|.+|  ..+.++++.++|+.+..++ ........+++.|++|++...-.++.++|+|..|+-+|
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmI--Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMI--VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cccCCccchhhhhhhhccce--ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            3     26899999999999  8888999999999984332 23334556788899999988778888899999999999


Q ss_pred             HHHhCCCCC
Q psy11805        194 VLLSGLSPF  202 (251)
Q Consensus       194 ~l~~g~~pf  202 (251)
                      ....|..+|
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            887777665

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.78  E-value=0.018  Score=46.09  Aligned_cols=70  Identities=21%  Similarity=0.202  Sum_probs=46.4

Q ss_pred             ccCCceEEEEEEEcc----C----CceEEEEEecccccc------chHHHHHHHHHHHHcC-------------CCceee
Q psy11805         12 SFGKFGTVYRCKEKA----T----GMTLAAKFVGIAKRN------DRRNVEREVEIMRELQ-------------HPRLIQ   64 (251)
Q Consensus        12 g~g~~~~v~~~~~~~----~----~~~~~~K~~~~~~~~------~~~~~~~e~~~l~~l~-------------~~~i~~   64 (251)
                      |.|-.|.+|++....    +    ...+++|... .+..      ....+.+|+.+++.+-             ...+++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p-~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~   80 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPP-TNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPK   80 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCC-CchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeece
Confidence            677788899887754    2    2467888864 2211      3466888988887651             134577


Q ss_pred             EeEEEeeCCEEEEEEEec
Q psy11805         65 IYDAFESSNVMCVVLELI   82 (251)
Q Consensus        65 ~~~~~~~~~~~~lv~e~~   82 (251)
                      ++......+..++|||.+
T Consensus        81 ~~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   81 CYYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEEeccCCCceeeehhhh
Confidence            777766555678888866

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PTZ00296 choline kinase; Provisional

Probab=96.71  E-value=0.038  Score=46.90  Aligned_cols=76  Identities=16%  Similarity=0.214  Sum_probs=47.0

Q ss_pred             cccccccCCceEEEEEEEccC--------CceEEEEEeccccccchHHHHHHHHHHHHcCCCce-eeEeEEEeeCCEEEE
Q psy11805          7 QHSAFSFGKFGTVYRCKEKAT--------GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRL-IQIYDAFESSNVMCV   77 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~--------~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~l   77 (251)
                      -++.|..|-...+|++.....        ++.|+++++..... ..-.-.+|...++.+...++ +++++.+..    +.
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te-~lIdR~~E~~v~~~ls~~gi~P~l~~~f~g----g~  183 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD-ELYNPISEFEVYKTMSKYRIAPQLLNTFSG----GR  183 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc-ceeCHHHHHHHHHHHHHCCCCCceEEEeCC----CE
Confidence            345666777778898875421        46788888754322 22344667888877754444 455555532    35


Q ss_pred             EEEeccCCch
Q psy11805         78 VLELIEGGEL   87 (251)
Q Consensus        78 v~e~~~~~~L   87 (251)
                      +.+|++|.+|
T Consensus       184 I~efi~g~~l  193 (442)
T PTZ00296        184 IEEWLYGDPL  193 (442)
T ss_pred             EEEeeCCccC
Confidence            7899887644

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.50  E-value=0.068  Score=40.88  Aligned_cols=79  Identities=16%  Similarity=0.162  Sum_probs=58.8

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC---CCceeeEeEEEeeCCEEEEEEEe
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ---HPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .+..+.+..|..-..|.+.+.  ..++.+|+-   .......+..|+.-|+.+.   .-.+++++.+..+....|+|++|
T Consensus        18 i~er~~v~gG~inea~~v~dg--~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~   92 (286)
T COG3001          18 IKEREEVSGGDINEAWRLRDG--TDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY   92 (286)
T ss_pred             hhcccccCCccccceeEeecC--CcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence            445667778888888877655  457788873   2334667778888777774   45688899999999999999999


Q ss_pred             ccCCchh
Q psy11805         82 IEGGELF   88 (251)
Q Consensus        82 ~~~~~L~   88 (251)
                      ++.+.+.
T Consensus        93 L~~~~~d   99 (286)
T COG3001          93 LPTGPLD   99 (286)
T ss_pred             ccCCCCC
Confidence            9876553

>PTZ00384 choline kinase; Provisional

Probab=96.42  E-value=0.079  Score=44.12  Aligned_cols=77  Identities=14%  Similarity=0.100  Sum_probs=47.0

Q ss_pred             cccccccCCceEEEEEEEccCC-c-----eEEEEEeccccccchHHHHHHHHHHHHcCCC-ceeeEeEEEeeCCEEEEEE
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATG-M-----TLAAKFVGIAKRNDRRNVEREVEIMRELQHP-RLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~-~-----~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++.|..|-...+|++...... .     .|+++... ......-.-.+|+.+++.+... .=+++++.+..    +++.
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            3456667888899999754321 1     24444432 1222223346788899988654 44666666643    4889


Q ss_pred             EeccCCchh
Q psy11805         80 ELIEGGELF   88 (251)
Q Consensus        80 e~~~~~~L~   88 (251)
                      ||++|.++.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999887663

>KOG1236|consensus

Probab=96.37  E-value=0.027  Score=46.72  Aligned_cols=62  Identities=18%  Similarity=0.161  Sum_probs=43.3

Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh-hCCceecCCCCCcEEEeecC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH-SKNVLHLDMKPENILCLTKT  138 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh-~~gi~h~dl~~~nil~~~~~  138 (251)
                      ..++-+|..|.++..++...+  .++....+++.--..|+..+- -.+++|.|++|.||++.-..
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            456667888888877776554  455566666666666665443 45899999999999985433

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	251
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-74
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-65
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-63
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-63
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-60
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-60
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-60
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-59
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-58
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-58
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-58
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-58
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-58
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-58
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-58
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-58
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-58
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-58
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-58
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-58
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-57
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-57
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-56
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-56
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-56
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-56
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-56
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-53
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-45
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-40
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-38
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-38
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-38
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-38
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-38
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-38
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-38
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-37
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-37
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-37
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-37
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-37
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-37
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-37
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-36
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-36
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-36
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-36
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-36
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-35
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-35
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-35
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-35
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-34
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-34
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-34
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-34
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-33
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-33
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-33
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-32
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-32
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-32
3soa_A	444	Full-Length Human Camkii Length = 444		1e-31
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-31
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-31
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-31
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-31
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-31
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-31
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-31
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-31
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-31
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-31
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-31
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-31
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		9e-31
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-31
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-31
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-31
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-31
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-30
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-30
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-30
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-30
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-30
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-30
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-30
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-29
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-29
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-29
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-29
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-29
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-29
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-29
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-29
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-26
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-26
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-26
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-25
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-25
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-25
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-25
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-25
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-25
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-25
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-25
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-25
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-25
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-25
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-25
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-25
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-25
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-25
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-25
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-25
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-25
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-25
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-25
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-25
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-25
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-25
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-25
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-25
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-25
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-25
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-25
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-25
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-25
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-25
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-25
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-25
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-25
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-25
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-25
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-24
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-24
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-24
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-24
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-24
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-24
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-24
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-24
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-24
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-24
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-24
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-24
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-24
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-24
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-24
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-24
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-24
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-24
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-24
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-24
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-24
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-24
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-24
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-24
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-24
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-24
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-24
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-24
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-24
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-24
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-24
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-23
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-23
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-23
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-23
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-23
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-23
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-23
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-23
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-23
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-23
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-23
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-23
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-23
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-23
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-23
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-23
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-23
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-23
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-23
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-23
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-22
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-22
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-22
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-22
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-22
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-22
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-22
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-22
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-22
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-22
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-22
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-22
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-22
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-22
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-22
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-22
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-22
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-22
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-22
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-22
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-22
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-22
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-22
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-22
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-22
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-22
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-22
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-22
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-22
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-22
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-22
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-22
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-22
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-22
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-22
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-22
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-22
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-22
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-22
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-22
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-22
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-22
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-22
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-21
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-21
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-21
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-21
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-21
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-21
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-21
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-21
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-21
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-21
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-21
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-21
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-21
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-21
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-21
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-21
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-21
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-21
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-21
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-21
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-21
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-21
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-21
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-21
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-21
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-21
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-21
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-20
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-20
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-20
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-20
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-20
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-20
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-20
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-20
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-20
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-20
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-20
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-19
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-19
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-19
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-19
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-19
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-18
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-18
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-18
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-18
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-18
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-18
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-17
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-17
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-17
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-16
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-16
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-14
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-13
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		8e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-12
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-12
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-12
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-12
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-12
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-12
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-12
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-12
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-12
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-12
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-12
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-11
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-11
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		6e-11
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-11
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		6e-11
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-11
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		7e-11
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		7e-11
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		7e-11
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-11
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		7e-11
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		7e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-10
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-10
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-10
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-09
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		1e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-09
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-09
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		5e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		6e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-09
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		7e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-09
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		7e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-09
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		8e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-08
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		3e-08
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		3e-08
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		3e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-06

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 122/232 (52%), Positives = 172/232 (74%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G+FG V++C+E ATG+ LAAK +                +M +L H  LIQ+YDAFES N
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E ++GGELF+R+ID+ + LTE    +FM+QICEG+  +H   +LHLD+KPENIL
Sbjct: 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENIL 219
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
           C+ +   +IKIIDFGLAR++ P +KL+V FGTPEF+APEVVN+D + F TDMWSVGVI Y
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAY 279
Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           +LLSGLSPF+G+ D +T+ N+   ++D +DE F +IS++AK+FI KLL+K++
Sbjct: 280 MLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  243 bits (620), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 109/231 (47%), Positives = 159/231 (68%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG V+RC EKATG    AKF+                IM +L HP+LI ++DAFE   
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            M ++LE + GGELF+R+  +D+ ++E  V  +MRQ CEG++ +H  +++HLD+KPENI+
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
           C TK  + +KIIDFGLA K +P++ ++V   T EF APE+V+ + +GF TDMW++GV+ Y
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241
Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           VLLSGLSPF GE D++T+ NV    ++FD++ F+ +S +AKDFI+ LL K+
Sbjct: 242 VLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 292

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  238 bits (606), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 112/241 (46%), Positives = 150/241 (62%)
Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLI 63
           H + H     G FG V+R  E+ATG   AAKFV                 M  L+HP L+
Sbjct: 52  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 111
Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
            ++DAFE  N M ++ E + GGELFE+V D+   ++E     +MRQ+C+G+  +H  N +
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           HLD+KPENI+  TK  N +K+IDFGL    DP++ ++V  GT EF APEV     +G+ T
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 231
Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWSVGV+ Y+LLSGLSPF GE D +T+ NV    ++ DD  F+ IS+D KDFIRKLLL 
Sbjct: 232 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 291
Query: 244 D 244
           D
Sbjct: 292 D 292

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  237 bits (605), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 112/241 (46%), Positives = 150/241 (62%)
Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLI 63
           H + H     G FG V+R  E+ATG   AAKFV                 M  L+HP L+
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
            ++DAFE  N M ++ E + GGELFE+V D+   ++E     +MRQ+C+G+  +H  N +
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           HLD+KPENI+  TK  N +K+IDFGL    DP++ ++V  GT EF APEV     +G+ T
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 337
Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWSVGV+ Y+LLSGLSPF GE D +T+ NV    ++ DD  F+ IS+D KDFIRKLLL 
Sbjct: 338 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 397
Query: 244 D 244
           D
Sbjct: 398 D 398

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  226 bits (577), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 108/249 (43%), Positives = 159/249 (63%), Gaps = 9/249 (3%)
Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMREL 57
           H         G+F  V +C++K TG   AAKF+   +                  I+RE+
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFI 117
           +HP +I ++D FE+   + ++LEL+ GGELF+ + + +  LTE     F++QI +GV ++
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYL 124
Query: 118 HSKNVLHLDMKPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN 175
           HSK + H D+KPENI+ L K     RIK+IDFG+A K +   + + +FGTPEFVAPE+VN
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184
Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD 235
           ++ +G   DMWS+GVI Y+LLSG SPF+GET  +T+ N++   YDFD+E F+  S+ AKD
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 244
Query: 236 FIRKLLLKD 244
           FIR+LL+KD
Sbjct: 245 FIRRLLVKD 253

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  226 bits (577), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 158/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C++K TG   AAKF+   +                  I+RE++HP +I ++D
Sbjct: 23  GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 82
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            FE+   + ++LEL+ GGELF+ + + +  LTE     F++QI +GV ++HSK + H D+
Sbjct: 83  IFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDL 141
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L K     RIK+IDFG+A K +   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 142 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+GET  +T+ N++   YDFD+E F+  S+ AKDFIR+LL+KD
Sbjct: 202 WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKD 260

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  226 bits (577), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 108/249 (43%), Positives = 159/249 (63%), Gaps = 9/249 (3%)
Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFV------GIAKXXXXXXXXXXXXIMREL 57
           H         G+F  V +C++K TG   AAKF+         +            I+RE+
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI 86
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFI 117
           +HP +I ++D FE+   + ++LEL+ GGELF+ + + +  LTE     F++QI +GV ++
Sbjct: 87  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYL 145
Query: 118 HSKNVLHLDMKPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN 175
           HSK + H D+KPENI+ L K     RIK+IDFG+A K +   + + +FGTPEFVAPE+VN
Sbjct: 146 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 205
Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD 235
           ++ +G   DMWS+GVI Y+LLSG SPF+GET  +T+ N++   YDFD+E F+  S+ AKD
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 265
Query: 236 FIRKLLLKD 244
           FIR+LL+KD
Sbjct: 266 FIRRLLVKD 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  224 bits (570), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 108/239 (45%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           GKF  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  223 bits (567), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  223 bits (567), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  222 bits (566), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  222 bits (566), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 139
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 140 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 199
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 200 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 258

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  222 bits (566), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  222 bits (566), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 139
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 140 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 199
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 200 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 258

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  222 bits (565), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  222 bits (565), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  222 bits (565), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  222 bits (565), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  220 bits (561), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 107/239 (44%), Positives = 158/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  220 bits (560), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 106/239 (44%), Positives = 158/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTP FVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  219 bits (558), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 106/239 (44%), Positives = 158/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX------XIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I++E+QHP +I +++
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++ EL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 82  VYENKTDVILIGELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDL 140
Query: 128 KPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  218 bits (555), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 104/239 (43%), Positives = 161/239 (67%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXX------XXXXXXIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+   +                  I+R++ HP +I ++D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ +   + +  E+A + F++QI +GV ++H+K + H D+
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS-FIKQILDGVNYLHTKKIAHFDL 141
Query: 128 KPENILCLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L K      IK+IDFGLA + +   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+AN+T   YDFD+E F++ S+ AKDFIRKLL+K+
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKE 260

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  214 bits (545), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 103/239 (43%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV------GIAKXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+         +            I+R++ H  +I ++D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ +   +  L+E+    F++QI +GV ++H+K + H D+
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 128 KPENILCLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L K      IK+IDFGLA + +   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+AN+T   YDFD+E F++ S+ AKDFIRKLL+K+
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKE 260

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  214 bits (545), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 103/239 (43%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV------GIAKXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+         +            I+R++ H  +I ++D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ +   +  L+E+    F++QI +GV ++H+K + H D+
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 128 KPENILCLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L K      IK+IDFGLA + +   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+AN+T   YDFD+E F++ S+ AKDFIRKLL+K+
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKE 260

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  213 bits (542), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 103/239 (43%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV------GIAKXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+         +            I+R++ H  +I ++D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ +   + +  E+A + F++QI +GV ++H+K + H D+
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS-FIKQILDGVNYLHTKKIAHFDL 141
Query: 128 KPENILCLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L K      IK+IDFGLA + +   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+AN+T   YDFD+E F+  S+ AKDFIRKLL+K+
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKE 260

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  213 bits (542), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 103/239 (43%), Positives = 158/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV------GIAKXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+         +            I+R++ H  +I ++D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ +   +  L+E+    F++QI +GV ++H+K + H D+
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141
Query: 128 KPENILCLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L K      IK+IDFGLA + +   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+AN+T   YDFD+E F+  S+ AKDFIRKLL+K+
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKE 260

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  213 bits (542), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 103/239 (43%), Positives = 159/239 (66%), Gaps = 9/239 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV------GIAKXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+         +            I+R++ H  +I ++D
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ +   + +  E+A + F++QI +GV ++H+K + H D+
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS-FIKQILDGVNYLHTKKIAHFDL 141
Query: 128 KPENILCLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L K      IK+IDFGLA + +   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+GVI Y+LLSG SPF+G+T  +T+AN+T   YDFD+E F+  S+ AKDFIRKLL+K+
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKE 260

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  205 bits (522), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 93/234 (39%), Positives = 148/234 (63%), Gaps = 1/234 (0%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G+FG V+RC E ++  T  AKFV + K            I+   +H  ++ ++++FES  
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESME 74
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + ++ E I G ++FER+    F L E+ +  ++ Q+CE ++F+HS N+ H D++PENI+
Sbjct: 75  ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII 134
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             T+  + IKII+FG AR+  P    ++LF  PE+ APEV   D +   TDMWS+G + Y
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194
Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           VLLSG++PF+ ET+ Q + N+  A+Y FD+E F EIS +A DF+ +LL+K+R+ 
Sbjct: 195 VLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  176 bits (447), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 91/242 (37%), Positives = 151/242 (62%), Gaps = 7/242 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI-MRELQH--PRLIQIYDAFE 70
           GKF  V +C  K+TG   AAKF+   +            I + EL    PR+I +++ +E
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99
Query: 71  SSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +++ + ++LE   GGE+F   + +   +++E  V   ++QI EGV ++H  N++HLD+KP
Sbjct: 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKP 159
Query: 130 ENIL--CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           +NIL   +   G+ IKI+DFG++RK     +L+ + GTPE++APE++N+D I   TDMW+
Sbjct: 160 QNILLSSIYPLGD-IKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           +G+I Y+LL+  SPF+GE + +T  N++    D+ +E F+ +S  A DFI+ LL+K+ E 
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEK 278
Query: 248 AP 249
            P
Sbjct: 279 RP 280

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 84/233 (36%), Positives = 133/233 (57%), Gaps = 3/233 (1%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV-GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G F  V   +EKATG   A K +   A             ++R+++H  ++ + D +ES 
Sbjct: 33  GAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESP 92
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N + +V++L+ GGELF+R+++  F  TEK  +  +RQ+ + V ++H   ++H D+KPEN+
Sbjct: 93  NHLYLVMQLVSGGELFDRIVEKGF-YTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENL 151
Query: 133 LCLTK-TGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L  ++   ++I I DFGL++       +    GTP +VAPEV+         D WS+GVI
Sbjct: 152 LYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211
Query: 192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            Y+LL G  PF  E D +    +  A+Y+FD   +++ISD AKDFIR L+ KD
Sbjct: 212 AYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKD 264

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/233 (36%), Positives = 131/233 (56%), Gaps = 9/233 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G FG V +CK++ T    A K +    AK            ++++L HP ++++++  E 
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           S+   +V EL  GGELF+ +I      +E   A  ++Q+  G+ ++H  N++H D+KPEN
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151
Query: 132 ILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV--NFDAIGFGTDMWSV 188
           IL  +K  +  IKIIDFGL+  F    K++   GT  ++APEV+   +D      D+WS 
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSA 208
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           GVI Y+LLSG  PF G+ +   +  V   +Y FD   +  ISDDAKD IRK+L
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 73/195 (37%), Positives = 121/195 (62%), Gaps = 2/195 (1%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           ++ +++HP ++ + D +ES   + ++++L+ GGELF+R+++  F  TE+  +  + Q+ +
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLD 127
Query: 113 GVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  +    ++I I DFGL++  DP   L    GTP +VAP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD 231
           EV+         D WS+GVI Y+LL G  PF  E D +    +  A+Y+FD   +++ISD
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 232 DAKDFIRKLLLKDRE 246
            AKDFIR L+ KD E
Sbjct: 248 SAKDFIRHLMEKDPE 262

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 73/195 (37%), Positives = 121/195 (62%), Gaps = 2/195 (1%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           ++ +++HP ++ + D +ES   + ++++L+ GGELF+R+++  F  TE+  +  + Q+ +
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLD 127
Query: 113 GVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  +    ++I I DFGL++  DP   L    GTP +VAP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD 231
           EV+         D WS+GVI Y+LL G  PF  E D +    +  A+Y+FD   +++ISD
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 232 DAKDFIRKLLLKDRE 246
            AKDFIR L+ KD E
Sbjct: 248 SAKDFIRHLMEKDPE 262

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 73/195 (37%), Positives = 121/195 (62%), Gaps = 2/195 (1%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           ++ +++HP ++ + D +ES   + ++++L+ GGELF+R+++  F  TE+  +  + Q+ +
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLD 127
Query: 113 GVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  +    ++I I DFGL++  DP   L    GTP +VAP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD 231
           EV+         D WS+GVI Y+LL G  PF  E D +    +  A+Y+FD   +++ISD
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 232 DAKDFIRKLLLKDRE 246
            AKDFIR L+ KD E
Sbjct: 248 SAKDFIRHLMEKDPE 262

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/233 (36%), Positives = 131/233 (56%), Gaps = 9/233 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G FG V +CK++ T    A K +    AK            ++++L HP ++++++  E 
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           S+   +V EL  GGELF+ +I      +E   A  ++Q+  G+ ++H  N++H D+KPEN
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151
Query: 132 ILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV--NFDAIGFGTDMWSV 188
           IL  +K  +  IKIIDFGL+  F    K++   GT  ++APEV+   +D      D+WS 
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSA 208
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           GVI Y+LLSG  PF G+ +   +  V   +Y FD   +  ISDDAKD IRK+L
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  155 bits (391), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/235 (34%), Positives = 133/235 (56%), Gaps = 3/235 (1%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G F  V   ++K T   +A K +   A             ++ +++HP ++ + D +ES 
Sbjct: 29  GAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG 88
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + ++++L+ GGELF+R+++  F  TE+  +  + Q+ + V+++H   ++H D+KPEN+
Sbjct: 89  GHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 147
Query: 133 LCLT-KTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L  +    ++I I DFGL++  DP   L    GTP +VAPEV+         D WS+GVI
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
            Y+LL G  PF  E D +    +  A+Y+FD   +++ISD AKDFIR L+ KD E
Sbjct: 208 AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE 262

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  155 bits (391), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/233 (36%), Positives = 131/233 (56%), Gaps = 9/233 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G FG V +CK++ T    A K +    AK            ++++L HP ++++++  E 
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           S+   +V EL  GGELF+ +I      +E   A  ++Q+  G+ ++H  N++H D+KPEN
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151
Query: 132 ILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV--NFDAIGFGTDMWSV 188
           IL  +K  +  IKIIDFGL+  F    K++   GT  ++APEV+   +D      D+WS 
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSA 208
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           GVI Y+LLSG  PF G+ +   +  V   +Y FD   +  ISDDAKD IRK+L
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 84/238 (35%), Positives = 134/238 (56%), Gaps = 5/238 (2%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDA 68
           S    G    VYRCK+K T    A K   + K            ++  L HP +I++ + 
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           FE+   + +VLEL+ GGELF+R+++  +  +E+  A  ++QI E V ++H   ++H D+K
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 129 PENILCLTKTGNR-IKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           PEN+L  T   +  +KI DFGL++  + +  ++ + GTP + APE++   A G   DMWS
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 188 VGVICYVLLSGLSPFMGETDVQTM-ANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           VG+I Y+LL G  PF  E   Q M   +   +Y F    ++E+S +AKD +RKL++ D
Sbjct: 236 VGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLD 293

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 81/234 (34%), Positives = 132/234 (56%), Gaps = 10/234 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V  CK+K TG   A K +    + +            ++++L HP ++++Y+ FE
Sbjct: 43  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 102
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
                 +V E+  GGELF+ +I      +E   A  +RQ+  G+ ++H   ++H D+KPE
Sbjct: 103 DKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPE 161
Query: 131 NILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN--FDAIGFGTDMWS 187
           N+L  +K+ +  I+IIDFGL+  F+  KK++   GT  ++APEV++  +D      D+WS
Sbjct: 162 NLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE---KCDVWS 218
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
            GVI Y+LLSG  PF G  +   +  V   +Y F+   + ++S+ AKD IRK+L
Sbjct: 219 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 272

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 81/234 (34%), Positives = 132/234 (56%), Gaps = 10/234 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V  CK+K TG   A K +    + +            ++++L HP ++++Y+ FE
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
                 +V E+  GGELF+ +I      +E   A  +RQ+  G+ ++H   ++H D+KPE
Sbjct: 97  DKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPE 155
Query: 131 NILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN--FDAIGFGTDMWS 187
           N+L  +K+ +  I+IIDFGL+  F+  KK++   GT  ++APEV++  +D      D+WS
Sbjct: 156 NLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE---KCDVWS 212
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
            GVI Y+LLSG  PF G  +   +  V   +Y F+   + ++S+ AKD IRK+L
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 266

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 82/237 (34%), Positives = 132/237 (55%), Gaps = 16/237 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V  CK+K TG   A K +    + +            ++++L HP ++++Y+ FE
Sbjct: 61  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 120
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
                 +V E+  GGELF+ +I      +E   A  +RQ+  G+ ++H   ++H D+KPE
Sbjct: 121 DKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPE 179
Query: 131 NILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT-----D 184
           N+L  +K+ +  I+IIDFGL+  F+  KK++   GT  ++APEV++      GT     D
Sbjct: 180 NLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH------GTYDEKCD 233
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           +WS GVI Y+LLSG  PF G  +   +  V   +Y F+   + ++S+ AKD IRK+L
Sbjct: 234 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 290

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 82/237 (34%), Positives = 132/237 (55%), Gaps = 16/237 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V  CK+K TG   A K +    + +            ++++L HP ++++Y+ FE
Sbjct: 60  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 119
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
                 +V E+  GGELF+ +I      +E   A  +RQ+  G+ ++H   ++H D+KPE
Sbjct: 120 DKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPE 178
Query: 131 NILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT-----D 184
           N+L  +K+ +  I+IIDFGL+  F+  KK++   GT  ++APEV++      GT     D
Sbjct: 179 NLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH------GTYDEKCD 232
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           +WS GVI Y+LLSG  PF G  +   +  V   +Y F+   + ++S+ AKD IRK+L
Sbjct: 233 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 289

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 132/232 (56%), Gaps = 3/232 (1%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G F  V+  K++ TG   A K +  +             ++++++H  ++ + D +ES+ 
Sbjct: 20  GAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT 79
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              +V++L+ GGELF+R+++   V TEK  ++ ++Q+   V+++H   ++H D+KPEN+L
Sbjct: 80  HYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLL 138
Query: 134 CLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT   N +I I DFGL+ K +    +    GTP +VAPEV+         D WS+GVI 
Sbjct: 139 YLTPEENSKIMITDFGLS-KMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           Y+LL G  PF  ET+ +    +    Y+F+   +++IS+ AKDFI  LL KD
Sbjct: 198 YILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKD 249

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  150 bits (379), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 79/233 (33%), Positives = 133/233 (57%), Gaps = 9/233 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G +G V  C++K T +  A K +                  +++ L HP ++++YD FE 
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
                +V+E  +GGELF+ +I       E   A+ ++Q+  GV ++H  N++H D+KPEN
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPEN 166
Query: 132 ILCLTKTGNR-IKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV--NFDAIGFGTDMWSV 188
           +L  +K  +  IKI+DFGL+  F+ +KK++   GT  ++APEV+   +D      D+WS+
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDE---KCDVWSI 223
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           GVI ++LL+G  PF G+TD + +  V   +Y FD   +  +S+ AKD I+++L
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQML 276

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 78/234 (33%), Positives = 132/234 (56%), Gaps = 10/234 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G +G V  CK+K TG   A K +    +              ++++L HP ++++Y+ FE
Sbjct: 32  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE 91
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
                 +V+E+  GGELF+ +I      +E   A+ M+Q+  G  ++H  N++H D+KPE
Sbjct: 92  DKRNYYLVMEVYRGGELFDEIILRQ-KFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPE 150
Query: 131 NILCLTKTGNR-IKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV--NFDAIGFGTDMWS 187
           N+L  +K+ +  IKI+DFGL+  F+   K++   GT  ++APEV+   +D      D+WS
Sbjct: 151 NLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYDE---KCDVWS 207
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
            GVI Y+LL G  PF G+TD + +  V   ++ FD   + ++SD+AK  ++ +L
Sbjct: 208 CGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLML 261

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 78/234 (33%), Positives = 132/234 (56%), Gaps = 10/234 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G +G V  CK+K TG   A K +    +              ++++L HP ++++Y+ FE
Sbjct: 15  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE 74
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
                 +V+E+  GGELF+ +I      +E   A+ M+Q+  G  ++H  N++H D+KPE
Sbjct: 75  DKRNYYLVMEVYRGGELFDEIILRQ-KFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPE 133
Query: 131 NILCLTKTGNR-IKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV--NFDAIGFGTDMWS 187
           N+L  +K+ +  IKI+DFGL+  F+   K++   GT  ++APEV+   +D      D+WS
Sbjct: 134 NLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYDE---KCDVWS 190
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
            GVI Y+LL G  PF G+TD + +  V   ++ FD   + ++SD+AK  ++ +L
Sbjct: 191 CGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLML 244

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 124/231 (53%), Gaps = 3/231 (1%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +G V    +K T +  AAK +                IM+ L HP +I++Y+ FE + 
Sbjct: 20  GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+EL  GGELFERV+    V  E   A  M+ +   V + H  NV H D+KPEN L
Sbjct: 80  DIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFL 138
Query: 134 CLTKTGNR-IKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT + +  +K+IDFGLA +F P K ++   GTP +V+P+V+     G   D WS GV+ 
Sbjct: 139 FLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMM 197
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           YVLL G  PF   TD + M  +    + F ++ +  +S  A+  IR+LL K
Sbjct: 198 YVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTK 248

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/231 (36%), Positives = 124/231 (53%), Gaps = 3/231 (1%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +G V    +K T +  AAK +                IM+ L HP +I++Y+ FE + 
Sbjct: 37  GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT 96
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+EL  GGELFERV+    V  E   A  M+ +   V + H  NV H D+KPEN L
Sbjct: 97  DIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFL 155
Query: 134 CLTKTGNR-IKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT + +  +K+IDFGLA +F P K ++   GTP +V+P+V+     G   D WS GV+ 
Sbjct: 156 FLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMM 214
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           YVLL G  PF   TD + M  +    + F ++ +  +S  A+  IR+LL K
Sbjct: 215 YVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTK 265

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  147 bits (372), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 81/234 (34%), Positives = 128/234 (54%), Gaps = 10/234 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V  CK+K TG   A K +    + +            ++++L HP + ++Y+ FE
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFE 96
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
                 +V E+  GGELF+ +I      +E   A  +RQ+  G+ + H   ++H D+KPE
Sbjct: 97  DKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPE 155
Query: 131 NILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN--FDAIGFGTDMWS 187
           N+L  +K+ +  I+IIDFGL+  F+  KK +   GT  ++APEV++  +D      D+WS
Sbjct: 156 NLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYDE---KCDVWS 212
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
            GVI Y+LLSG  PF G  +   +  V   +Y F+   + ++S+ AKD IRK L
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXL 266

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 124/231 (53%), Gaps = 4/231 (1%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC  K TG+  AAK +   K              I R+LQHP +++++D+ + 
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 76
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            +   +V +L+ GGELFE ++  +F  +E   +  ++QI E + + HS  ++H ++KPEN
Sbjct: 77  ESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 135
Query: 132 ILCLTKT-GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           +L  +K  G  +K+ DFGLA + +  +      GTP +++PEV+  D      D+W+ GV
Sbjct: 136 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           I Y+LL G  PF  E   +  A +    YD+    ++ ++ +AK  I  +L
Sbjct: 196 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 124/231 (53%), Gaps = 4/231 (1%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC  K TG+  AAK +   K              I R+LQHP +++++D+ + 
Sbjct: 16  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 75
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            +   +V +L+ GGELFE ++  +F  +E   +  ++QI E + + HS  ++H ++KPEN
Sbjct: 76  ESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 134
Query: 132 ILCLTKT-GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           +L  +K  G  +K+ DFGLA + +  +      GTP +++PEV+  D      D+W+ GV
Sbjct: 135 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           I Y+LL G  PF  E   +  A +    YD+    ++ ++ +AK  I  +L
Sbjct: 195 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 245

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 124/231 (53%), Gaps = 4/231 (1%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC  K TG+  AAK +   K              I R+LQHP +++++D+ + 
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 76
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            +   +V +L+ GGELFE ++  +F  +E   +  ++QI E + + HS  ++H ++KPEN
Sbjct: 77  ESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 135
Query: 132 ILCLTKT-GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           +L  +K  G  +K+ DFGLA + +  +      GTP +++PEV+  D      D+W+ GV
Sbjct: 136 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           I Y+LL G  PF  E   +  A +    YD+    ++ ++ +AK  I  +L
Sbjct: 196 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 124/231 (53%), Gaps = 4/231 (1%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC  K TG+  AAK +   K              I R+LQHP +++++D+ + 
Sbjct: 40  GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 99
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            +   +V +L+ GGELFE ++  +F  +E   +  ++QI E + + HS  ++H ++KPEN
Sbjct: 100 ESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 158
Query: 132 ILCLTKT-GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           +L  +K  G  +K+ DFGLA + +  +      GTP +++PEV+  D      D+W+ GV
Sbjct: 159 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           I Y+LL G  PF  E   +  A +    YD+    ++ ++ +AK  I  +L
Sbjct: 219 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 269

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 82/241 (34%), Positives = 131/241 (54%), Gaps = 7/241 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX-XIMRELQHPRLIQIYDAFESS 72
           G FG V+  +E+++G+    K +   +             +++ L HP +I+I++ FE  
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92
Query: 73  NVMCVVLELIEGGELFERVIDDDF---VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           + M +V+E  EGGEL ER++        L+E  VA  M+Q+   + + HS++V+H D+KP
Sbjct: 93  HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKP 152
Query: 130 ENILCL-TKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           ENIL   T   + IKIIDFGLA  F  ++      GT  ++APEV   D + F  D+WS 
Sbjct: 153 ENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIWSA 211
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           GV+ Y LL+G  PF G +  +     T  + ++  EC   ++  A D ++++L KD E  
Sbjct: 212 GVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPLTPQAVDLLKQMLTKDPERR 270
Query: 249 P 249
           P
Sbjct: 271 P 271

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 123/232 (53%), Gaps = 5/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC +  TG   AAK +   K              I R L+HP +++++D+   
Sbjct: 15  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 74
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
                +V +L+ GGELFE ++  ++  +E   +  ++QI E V   H   ++H D+KPEN
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQILESVNHCHLNGIVHRDLKPEN 133
Query: 132 ILCLTKT-GNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSVG 189
           +L  +K+ G  +K+ DFGLA +   +++    F GTP +++PEV+  D  G   DMW+ G
Sbjct: 134 LLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           VI Y+LL G  PF  E   +    +    YDF    ++ ++ +AKD I K+L
Sbjct: 194 VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKML 245

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 123/232 (53%), Gaps = 5/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC +  TG   AAK +   K              I R L+HP +++++D+   
Sbjct: 15  GAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 74
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
                +V +L+ GGELFE ++  ++  +E   +  ++QI E V   H   ++H D+KPEN
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAREYY-SEADASHCIQQILESVNHCHLNGIVHRDLKPEN 133
Query: 132 ILCLTKT-GNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSVG 189
           +L  +K+ G  +K+ DFGLA +   +++    F GTP +++PEV+  D  G   DMW+ G
Sbjct: 134 LLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           VI Y+LL G  PF  E   +    +    YDF    ++ ++ +AKD I K+L
Sbjct: 194 VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKML 245

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 86/245 (35%), Positives = 124/245 (50%), Gaps = 16/245 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI-------------MRELQHP 60
           G +G V  CKEK      A K +  ++            I             ++ L HP
Sbjct: 47  GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106
Query: 61  RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
            +I+++D FE      +V E  EGGELFE++I+      E   A  M+QI  G+ ++H  
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKH 165
Query: 121 NVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI 179
           N++H D+KPENIL   K     IKI+DFGL+  F  + KL+   GT  ++APEV+     
Sbjct: 166 NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKY 224
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK 239
               D+WS GVI Y+LL G  PF G+ D   +  V   +Y FD   +  ISD+AK+ I+ 
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKL 284
Query: 240 LLLKD 244
           +L  D
Sbjct: 285 MLTYD 289

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 128/242 (52%), Gaps = 13/242 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXX-----XXIMRELQHPRLIQIYDA 68
           G F  V RC  + TG   A K V +AK                 I   L+HP ++++ + 
Sbjct: 35  GAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94
Query: 69  FESSNVMCVVLELIEGGEL-FERV--IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           + S  ++ +V E ++G +L FE V   D  FV +E   + +MRQI E + + H  N++H 
Sbjct: 95  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR 154
Query: 126 DMKPENILCLTKTGNR-IKIIDFGLARKFDPEKKLQV--LFGTPEFVAPEVVNFDAIGFG 182
           D+KPEN+L  +K  +  +K+ DFG+A +   E  L      GTP F+APEVV  +  G  
Sbjct: 155 DVKPENVLLASKENSAPVKLGDFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGKP 213
Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
            D+W  GVI ++LLSG  PF G T  +    +   +Y  +   ++ IS+ AKD +R++L+
Sbjct: 214 VDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM 272
Query: 243 KD 244
            D
Sbjct: 273 LD 274

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  137 bits (345), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 122/232 (52%), Gaps = 5/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC +K      AAK +   K              I R L+HP +++++D+   
Sbjct: 42  GAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 101
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
                +V +L+ GGELFE ++  ++  +E   +  + QI E V  IH  +++H D+KPEN
Sbjct: 102 EGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIHQILESVNHIHQHDIVHRDLKPEN 160
Query: 132 ILCLTK-TGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSVG 189
           +L  +K  G  +K+ DFGLA +   E++    F GTP +++PEV+  D  G   D+W+ G
Sbjct: 161 LLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACG 220
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           VI Y+LL G  PF  E   +    +    YDF    ++ ++ +AK+ I ++L
Sbjct: 221 VILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQML 272

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  137 bits (345), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 122/232 (52%), Gaps = 5/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC +   G   AAK +   K              I R L+HP +++++D+   
Sbjct: 33  GAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 92
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
                ++ +L+ GGELFE ++  ++  +E   +  ++QI E V   H   V+H D+KPEN
Sbjct: 93  EGHHYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQMGVVHRDLKPEN 151
Query: 132 ILCLTK-TGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSVG 189
           +L  +K  G  +K+ DFGLA + + E++    F GTP +++PEV+  D  G   D+W+ G
Sbjct: 152 LLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG 211
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           VI Y+LL G  PF  E   +    +    YDF    ++ ++ +AKD I K+L
Sbjct: 212 VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKML 263

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 126/237 (53%), Gaps = 10/237 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +    RC  KAT M  A K +  +K            ++R  QHP +I + D ++   
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKDVYDDGK 89
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV EL++GGEL ++++   F    +A A+    I + VE++H++ V+H D+KP NIL
Sbjct: 90  YVYVVTELMKGGELLDKILRQKFFSEREASAVLF-TITKTVEYLHAQGVVHRDLKPSNIL 148
Query: 134 CLTKTGN--RIKIIDFGLARKFDPEKKLQVL-FGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
            + ++GN   I+I DFG A++   E  L +    T  FVAPEV+         D+WS+GV
Sbjct: 149 YVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGV 208
Query: 191 ICYVLLSGLSPFMG---ETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           + Y +L+G +PF     +T  + +A +   ++      +N +SD AKD + K+L  D
Sbjct: 209 LLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVD 265

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/238 (34%), Positives = 127/238 (53%), Gaps = 10/238 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F  VYR +   TG+ +A K +    + K            I  +L+HP ++++Y+ FE
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            SN + +VLE+   GE+   + +     +E     FM QI  G+ ++HS  +LH D+   
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141
Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N+L LT+  N IKI DFGLA +   P +K   L GTP +++PE+    A G  +D+WS+G
Sbjct: 142 NLL-LTRNMN-IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLG 199
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
            + Y LL G  PF  +T   T+  V +A Y+      + +S +AKD I +LL ++  D
Sbjct: 200 CMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEAKDLIHQLLRRNPAD 253

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/248 (32%), Positives = 129/248 (52%), Gaps = 18/248 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--------XXXXXXXXIMRELQ-HPRLIQ 64
           G    V RC  +ATG   A K + +                      I+R++  HP +I 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           + D++ESS+ M +V +L+  GELF+  + +   L+EK     MR + E V F+H+ N++H
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFD-YLTEKVALSEKETRSIMRSLLEAVSFLHANNIVH 223
Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV--NFDAI--G 180
            D+KPENIL       +I++ DFG +   +P +KL+ L GTP ++APE++  + D    G
Sbjct: 224 RDLKPENILL--DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281
Query: 181 FG--TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR 238
           +G   D+W+ GVI + LL+G  PF     +  +  +   QY F    +++ S   KD I 
Sbjct: 282 YGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS 341
Query: 239 KLLLKDRE 246
           +LL  D E
Sbjct: 342 RLLQVDPE 349

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 121/232 (52%), Gaps = 5/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC +   G   AA  +   K              I R L+HP +++++D+   
Sbjct: 22  GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 81
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
                ++ +L+ GGELFE ++  ++  +E   +  ++QI E V   H   V+H ++KPEN
Sbjct: 82  EGHHYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQMGVVHRNLKPEN 140
Query: 132 ILCLTK-TGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSVG 189
           +L  +K  G  +K+ DFGLA + + E++    F GTP +++PEV+  D  G   D+W+ G
Sbjct: 141 LLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG 200
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           VI Y+LL G  PF  E   +    +    YDF    ++ ++ +AKD I K+L
Sbjct: 201 VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKML 252

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  131 bits (330), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 127/237 (53%), Gaps = 10/237 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +    RC  KAT M  A K +  +K            ++R  QHP +I + D ++   
Sbjct: 38  GSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKDVYDDGK 94
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V EL+ GGEL ++++   F  +E+  +  +  I + VE++HS+ V+H D+KP NIL
Sbjct: 95  HVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNIL 153
Query: 134 CLTKTGNR--IKIIDFGLARKFDPEKKLQVL-FGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
            + ++GN   ++I DFG A++   E  L +    T  FVAPEV+       G D+WS+G+
Sbjct: 154 YVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGI 213
Query: 191 ICYVLLSGLSPFM-GETDV--QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           + Y +L+G +PF  G +D   + +  +   ++      +N +S+ AKD + K+L  D
Sbjct: 214 LLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVD 270

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  131 bits (330), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 126/237 (53%), Gaps = 10/237 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +    RC  KAT M  A K +  +K            ++R  QHP +I + D ++   
Sbjct: 38  GSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKDVYDDGK 94
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V EL+ GGEL ++++   F  +E+  +  +  I + VE++HS+ V+H D+KP NIL
Sbjct: 95  HVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNIL 153
Query: 134 CLTKTGNR--IKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
            + ++GN   ++I DFG A++   E  L      T  FVAPEV+       G D+WS+G+
Sbjct: 154 YVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGI 213
Query: 191 ICYVLLSGLSPFM-GETDV--QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           + Y +L+G +PF  G +D   + +  +   ++      +N +S+ AKD + K+L  D
Sbjct: 214 LLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVD 270

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  131 bits (329), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 122/232 (52%), Gaps = 5/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXX--XXXXXXXXIMRELQHPRLIQIYDAFES 71
           G F  V RC +  TG   AAK +   K              I R L+H  +++++D+   
Sbjct: 15  GAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISE 74
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
                +V +L+ GGELFE ++  ++  +E   +  ++QI E V   H   V+H D+KPEN
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQMGVVHRDLKPEN 133
Query: 132 ILCLTK-TGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSVG 189
           +L  +K  G  +K+ DFGLA +   +++    F GTP +++PEV+  +A G   D+W+ G
Sbjct: 134 LLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACG 193
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           VI Y+LL G  PF  E   +    +    YDF    ++ ++ +AK+ I ++L
Sbjct: 194 VILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQML 245

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  130 bits (328), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 122/240 (50%), Gaps = 16/240 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +    RC  KAT    A K +  +K            ++R  QHP +I + D ++   
Sbjct: 33  GSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKDVYDDGK 89
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV EL +GGEL ++++   F    +A A+    I + VE++H++ V+H D+KP NIL
Sbjct: 90  YVYVVTELXKGGELLDKILRQKFFSEREASAVLF-TITKTVEYLHAQGVVHRDLKPSNIL 148
Query: 134 CLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTP----EFVAPEVVNFDAIGFGTDMWS 187
            + ++GN   I+I DFG A++   E  L     TP     FVAPEV+         D+WS
Sbjct: 149 YVDESGNPESIRICDFGFAKQLRAENGL---LXTPCYTANFVAPEVLERQGYDAACDIWS 205
Query: 188 VGVICYVLLSGLSPFMG---ETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +GV+ Y  L+G +PF     +T  + +A +   ++      +N +SD AKD + K L  D
Sbjct: 206 LGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVD 265

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  130 bits (327), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 125/242 (51%), Gaps = 13/242 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXX-----XXIMRELQHPRLIQIYDA 68
           G F  V RC  + TG   A K V +AK                 I   L+HP ++++ + 
Sbjct: 37  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 96
Query: 69  FESSNVMCVVLELIEGGEL-FERV--IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           + S  ++ +V E ++G +L FE V   D  FV +E   + +MRQI E + + H  N++H 
Sbjct: 97  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR 156
Query: 126 DMKPENILCLTKTGNR-IKIIDFGLARKFDPEKKLQV--LFGTPEFVAPEVVNFDAIGFG 182
           D+KP  +L  +K  +  +K+  FG+A +   E  L      GTP F+APEVV  +  G  
Sbjct: 157 DVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGKP 215
Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
            D+W  GVI ++LLSG  PF G T  +    +   +Y  +   ++ IS+ AKD +R++L+
Sbjct: 216 VDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM 274
Query: 243 KD 244
            D
Sbjct: 275 LD 276

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  130 bits (327), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 80  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 139
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 140 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 199
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 200 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 259
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 260 EWSEVSEEVKMLIRNLL 276

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  130 bits (326), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 116 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 175
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 176 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 235
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 236 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 295
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 296 EWSEVSEEVKMLIRNLL 312

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  130 bits (326), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 72  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 131
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 132 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 191
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 192 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 251
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 252 EWSEVSEEVKMLIRNLL 268

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  130 bits (326), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 229
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 290 EWSEVSEEVKMLIRNLL 306

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  130 bits (326), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 64  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 123
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 124 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 183
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 184 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 243
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 244 EWSEVSEEVKMLIRNLL 260

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  130 bits (326), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 125
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 185
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 186 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 245
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 246 EWSEVSEEVKMLIRNLL 262

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  130 bits (326), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 65  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 124
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 125 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 184
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 185 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 244
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 245 EWSEVSEEVKMLIRNLL 261

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  130 bits (326), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 70  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 129
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 130 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 189
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 190 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 249
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 250 EWSEVSEEVKMLIRNLL 266

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  130 bits (326), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 84/259 (32%), Positives = 128/259 (49%), Gaps = 31/259 (11%)
Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQH---- 59
           +Q        G  G V  C  + TG   A K +                  +E+ H    
Sbjct: 11  YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----------YDSPKARQEVDHHWQA 59
Query: 60  ---PRLIQIYDAFES----SNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQIC 111
              P ++ I D +E+       + +++E +EGGELF R+ +  D   TE+  A  MR I 
Sbjct: 60  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 119
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEFVA 170
             ++F+HS N+ H D+KPEN+L  +K  + + K+ DFG A++   +  LQ    TP +VA
Sbjct: 120 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVA 178
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA-----NVTIAQYDFDDEC 225
           PEV+  +      DMWS+GVI Y+LL G  PF   T  Q ++      + + QY F +  
Sbjct: 179 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNPE 237
Query: 226 FNEISDDAKDFIRKLLLKD 244
           ++E+S+DAK  IR LL  D
Sbjct: 238 WSEVSEDAKQLIRLLLKTD 256

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  130 bits (326), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 84/259 (32%), Positives = 128/259 (49%), Gaps = 31/259 (11%)
Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQH---- 59
           +Q        G  G V  C  + TG   A K +                  +E+ H    
Sbjct: 30  YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----------YDSPKARQEVDHHWQA 78
Query: 60  ---PRLIQIYDAFES----SNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQIC 111
              P ++ I D +E+       + +++E +EGGELF R+ +  D   TE+  A  MR I 
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEFVA 170
             ++F+HS N+ H D+KPEN+L  +K  + + K+ DFG A++   +  LQ    TP +VA
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVA 197
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA-----NVTIAQYDFDDEC 225
           PEV+  +      DMWS+GVI Y+LL G  PF   T  Q ++      + + QY F +  
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNPE 256
Query: 226 FNEISDDAKDFIRKLLLKD 244
           ++E+S+DAK  IR LL  D
Sbjct: 257 WSEVSEDAKQLIRLLLKTD 275

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  130 bits (326), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 125
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 185
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 186 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 245
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 246 EWSEVSEEVKMLIRNLL 262

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  130 bits (326), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 125/242 (51%), Gaps = 13/242 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXX-----XXIMRELQHPRLIQIYDA 68
           G F  V RC  + TG   A K V +AK                 I   L+HP ++++ + 
Sbjct: 35  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94
Query: 69  FESSNVMCVVLELIEGGEL-FERV--IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           + S  ++ +V E ++G +L FE V   D  FV +E   + +MRQI E + + H  N++H 
Sbjct: 95  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR 154
Query: 126 DMKPENILCLTKTGNR-IKIIDFGLARKFDPEKKLQV--LFGTPEFVAPEVVNFDAIGFG 182
           D+KP  +L  +K  +  +K+  FG+A +   E  L      GTP F+APEVV  +  G  
Sbjct: 155 DVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGKP 213
Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
            D+W  GVI ++LLSG  PF G T  +    +   +Y  +   ++ IS+ AKD +R++L+
Sbjct: 214 VDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM 272
Query: 243 KD 244
            D
Sbjct: 273 LD 274

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 71  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 130
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 131 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 190
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 191 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 250
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 251 EWSEVSEEVKMLIRNLL 267

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 64  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 123
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP +
Sbjct: 124 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYY 183
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
           VAPEV+  +      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 184 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 243
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 244 EWSEVSEEVKMLIRNLL 260

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  127 bits (319), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 119/197 (60%), Gaps = 7/197 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+++L HP +I+I + F++ +   +VLEL+EGGELF++V+ +   L E    ++  Q+  
Sbjct: 74  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLL 131
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  ++  +  IKI DFG ++       ++ L GTP ++AP
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 172 EV-VNFDAIGF--GTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIAQYDFDDECFN 227
           EV V+    G+    D WS+GVI ++ LSG  PF    T V     +T  +Y+F  E + 
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 251
Query: 228 EISDDAKDFIRKLLLKD 244
           E+S+ A D ++KLL+ D
Sbjct: 252 EVSEKALDLVKKLLVVD 268

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  127 bits (318), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 119/197 (60%), Gaps = 7/197 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+++L HP +I+I + F++ +   +VLEL+EGGELF++V+ +   L E    ++  Q+  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLL 125
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  ++  +  IKI DFG ++       ++ L GTP ++AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 172 EV-VNFDAIGF--GTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIAQYDFDDECFN 227
           EV V+    G+    D WS+GVI ++ LSG  PF    T V     +T  +Y+F  E + 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 228 EISDDAKDFIRKLLLKD 244
           E+S+ A D ++KLL+ D
Sbjct: 246 EVSEKALDLVKKLLVVD 262

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  127 bits (318), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 119/197 (60%), Gaps = 7/197 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+++L HP +I+I + F++ +   +VLEL+EGGELF++V+ +   L E    ++  Q+  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLL 125
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  ++  +  IKI DFG ++       ++ L GTP ++AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 172 EV-VNFDAIGF--GTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIAQYDFDDECFN 227
           EV V+    G+    D WS+GVI ++ LSG  PF    T V     +T  +Y+F  E + 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 228 EISDDAKDFIRKLLLKD 244
           E+S+ A D ++KLL+ D
Sbjct: 246 EVSEKALDLVKKLLVVD 262

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  127 bits (318), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 119/197 (60%), Gaps = 7/197 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+++L HP +I+I + F++ +   +VLEL+EGGELF++V+ +   L E    ++  Q+  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLL 125
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  ++  +  IKI DFG ++       ++ L GTP ++AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 172 EV-VNFDAIGF--GTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIAQYDFDDECFN 227
           EV V+    G+    D WS+GVI ++ LSG  PF    T V     +T  +Y+F  E + 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 228 EISDDAKDFIRKLLLKD 244
           E+S+ A D ++KLL+ D
Sbjct: 246 EVSEKALDLVKKLLVVD 262

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  127 bits (318), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 119/197 (60%), Gaps = 7/197 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+++L HP +I+I + F++ +   +VLEL+EGGELF++V+ +   L E    ++  Q+  
Sbjct: 67  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLL 124
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  ++  +  IKI DFG ++       ++ L GTP ++AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 172 EV-VNFDAIGF--GTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIAQYDFDDECFN 227
           EV V+    G+    D WS+GVI ++ LSG  PF    T V     +T  +Y+F  E + 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 228 EISDDAKDFIRKLLLKD 244
           E+S+ A D ++KLL+ D
Sbjct: 245 EVSEKALDLVKKLLVVD 261

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 119/197 (60%), Gaps = 7/197 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+++L HP +I+I + F++ +   +VLEL+EGGELF++V+ +   L E    ++  Q+  
Sbjct: 207 ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLL 264
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  ++  +  IKI DFG ++       ++ L GTP ++AP
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 324
Query: 172 EV-VNFDAIGF--GTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIAQYDFDDECFN 227
           EV V+    G+    D WS+GVI ++ LSG  PF    T V     +T  +Y+F  E + 
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 384
Query: 228 EISDDAKDFIRKLLLKD 244
           E+S+ A D ++KLL+ D
Sbjct: 385 EVSEKALDLVKKLLVVD 401

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 119/197 (60%), Gaps = 7/197 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+++L HP +I+I + F++ +   +VLEL+EGGELF++V+ +   L E    ++  Q+  
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLL 250
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            V+++H   ++H D+KPEN+L  ++  +  IKI DFG ++       ++ L GTP ++AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 172 EV-VNFDAIGF--GTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIAQYDFDDECFN 227
           EV V+    G+    D WS+GVI ++ LSG  PF    T V     +T  +Y+F  E + 
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370
Query: 228 EISDDAKDFIRKLLLKD 244
           E+S+ A D ++KLL+ D
Sbjct: 371 EVSEKALDLVKKLLVVD 387

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  124 bits (312), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 114/197 (57%), Gaps = 10/197 (5%)
Query: 53  IMRELQ-HPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           I+R++  HP +IQ+ D +E++    +V +L++ GELF+  + +   L+EK     MR + 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRALL 134
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
           E +  +H  N++H D+KPENIL L    N IK+ DFG + + DP +KL+ + GTP ++AP
Sbjct: 135 EVICALHKLNIVHRDLKPENIL-LDDDMN-IKLTDFGFSCQLDPGEKLRSVCGTPSYLAP 192
Query: 172 EVV----NFDAIGFG--TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
           E++    N +  G+G   DMWS GVI Y LL+G  PF     +  +  +    Y F    
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 226 FNEISDDAKDFIRKLLL 242
           +++ SD  KD + + L+
Sbjct: 253 WDDYSDTVKDLVSRFLV 269

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  124 bits (312), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 118/238 (49%), Gaps = 46/238 (19%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERV---IDD--------------- 94
           +M++L HP + ++Y+ +E    +C+V+EL  GG L +++   IDD               
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 95  ---------------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
                                DFV  EK ++  MRQI   + ++H++ + H D+KPEN L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKK-----LQVLFGTPEFVAPEVVNFDAIGFGT--DMW 186
             T     IK++DFGL+++F          +    GTP FVAPEV+N     +G   D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           S GV+ ++LL G  PF G  D  T++ V   +  F++  +N +S  A+D +  LL ++
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 106/198 (53%), Gaps = 10/198 (5%)
Query: 54  MRELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMR 108
            R  Q P +++I D +E+       + +V E ++GGELF R+ D  D   TE+  +   +
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXK 168
Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPE 167
            I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++      L     TP 
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDD 223
           +VAPEV+  +      D WS+GVI Y+LL G  PF     +         +   QY+F +
Sbjct: 229 YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPN 288
Query: 224 ECFNEISDDAKDFIRKLL 241
             ++E+S++ K  IR LL
Sbjct: 289 PEWSEVSEEVKXLIRNLL 306

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 114/197 (57%), Gaps = 10/197 (5%)
Query: 53  IMRELQ-HPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           I+R++  HP +IQ+ D +E++    +V +L++ GELF+  + +   L+EK     MR + 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRALL 134
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
           E +  +H  N++H D+KPENIL L    N IK+ DFG + + DP +KL+ + GTP ++AP
Sbjct: 135 EVICALHKLNIVHRDLKPENIL-LDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 172 EVV----NFDAIGFG--TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
           E++    N +  G+G   DMWS GVI Y LL+G  PF     +  +  +    Y F    
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 226 FNEISDDAKDFIRKLLL 242
           +++ SD  KD + + L+
Sbjct: 253 WDDYSDTVKDLVSRFLV 269

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  123 bits (309), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 114/197 (57%), Gaps = 10/197 (5%)
Query: 53  IMRELQ-HPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           I+R++  HP +IQ+ D +E++    +V +L++ GELF+  + +   L+EK     MR + 
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRALL 121
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
           E +  +H  N++H D+KPENIL L    N IK+ DFG + + DP +KL+ + GTP ++AP
Sbjct: 122 EVICALHKLNIVHRDLKPENIL-LDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 179
Query: 172 EVV----NFDAIGFG--TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
           E++    N +  G+G   DMWS GVI Y LL+G  PF     +  +  +    Y F    
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 239
Query: 226 FNEISDDAKDFIRKLLL 242
           +++ SD  KD + + L+
Sbjct: 240 WDDYSDTVKDLVSRFLV 256

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 117/240 (48%), Gaps = 12/240 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G F    +C  K +    A K   I+K            +     HP ++++++ F    
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKI--ISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              +V+EL+ GGELFER+       +E   +  MR++   V  +H   V+H D+KPEN+L
Sbjct: 80  HTFLVMELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138
Query: 134 CLTKTGN-RIKIIDFGLARKFDPEKK-LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
              +  N  IKIIDFG AR   P+ + L+    T  + APE++N +      D+WS+GVI
Sbjct: 139 FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVI 198
Query: 192 CYVLLSGLSPFMGE-------TDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            Y +LSG  PF          + V+ M  +    + F+ E +  +S +AKD I+ LL  D
Sbjct: 199 LYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVD 258

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 124/234 (52%), Gaps = 12/234 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V+  + +  G   A K +    + +            ++  + HP +I+++  F+
Sbjct: 17  GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++++ IEGGELF  ++             +  ++C  +E++HSK++++ D+KPE
Sbjct: 77  DAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE 135
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           NIL L K G+ IKI DFG A K+ P+     L GTP+++APEVV+        D WS G+
Sbjct: 136 NIL-LDKNGH-IKITDFGFA-KYVPDVTY-XLCGTPDYIAPEVVSTKPYNKSIDWWSFGI 191
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           + Y +L+G +PF     ++T   +  A+  F    FNE   D KD + +L+ +D
Sbjct: 192 LIYEMLAGYTPFYDSNTMKTYEKILNAELRF-PPFFNE---DVKDLLSRLITRD 241

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 128/236 (54%), Gaps = 10/236 (4%)
Query: 12  SFGKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           SFGK   V +     +G   A K +  A  K            I+ ++ HP +++++ AF
Sbjct: 40  SFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAF 99
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++   + ++L+ + GG+LF R +  + + TE+ V  ++ ++  G++ +HS  +++ D+KP
Sbjct: 100 QTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKP 158
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           ENIL L + G+ IK+ DFGL+++  D EKK     GT E++APEVVN        D WS 
Sbjct: 159 ENIL-LDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSY 216
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ + +L+G  PF G+   +TM  +  A+          +S +A+  +R L  ++
Sbjct: 217 GVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP----QFLSTEAQSLLRALFKRN 268

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 117/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    GE+++  +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 84  DATRVYLILEYAPRGEVYKE-LQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 142
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 143 NLLL--GSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGV 199
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 200 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 254

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 117/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    GE+++  +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 84  DATRVYLILEYAPRGEVYKE-LQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 142
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 143 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 199
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 200 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 254

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 82  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 140
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 141 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 197
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 198 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 252

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 18  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 77
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 78  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 136
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 137 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 193
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 194 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 248

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 80  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 139 NLLL--GSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGV 195
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 196 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 250

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 117/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 45  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 104
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 105 DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 163
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 164 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 220
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D  F  +++ A+D I +LL  +    P
Sbjct: 221 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--F--VTEGARDLISRLLKHNPSQRP 275

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 79  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 138 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 249

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 79  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 138 NLLL--GSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 249

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 84  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 142
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 143 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 199
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 200 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 117/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 36  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 95
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 96  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 154
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 155 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 211
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D  F  +++ A+D I +LL  +    P
Sbjct: 212 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--F--VTEGARDLISRLLKHNPSQRP 266

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 80  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 139 NLLL--GSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 195
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 196 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 250

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 82  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 140
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 141 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 197
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 198 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 252

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 23  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 82
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 83  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 141
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 142 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 198
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 199 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 253

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 82  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 140
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 141 NLLL--GSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGV 197
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 198 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 252

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 115/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 84  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 142
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE +         D+WS+GV
Sbjct: 143 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGV 199
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 200 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 254

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 21  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 80
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 81  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 139
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 140 NLLL--GSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 196
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 197 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 251

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 115/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 19  GKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            S  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 79  DSTRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 138 NLLL--GSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T   T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 195 LCYEFLVGKPPFEANTYQDTYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 249

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 79  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 138 NLLL--GSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 249

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 82  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 140
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 141 NLLL--GSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 197
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 198 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 252

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 115/231 (49%), Gaps = 11/231 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +E+ +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 23  GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 82
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 83  DATRVYLILEYAPLGTVY-RELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPE 141
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 142 NLLL--GSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 198
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           +CY  L G+ PF   T  +T   ++  ++ F D     +++ A+D I +LL
Sbjct: 199 LCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD----FVTEGARDLISRLL 245

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 79  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 138 NLLL--GSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 249

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 115/231 (49%), Gaps = 11/231 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +E+ +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 23  GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 82
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 83  DATRVYLILEYAPLGTVY-RELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPE 141
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 142 NLLL--GSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 198
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           +CY  L G+ PF   T  +T   ++  ++ F D     +++ A+D I +LL
Sbjct: 199 LCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD----FVTEGARDLISRLL 245

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 79  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 138 NLLL--GSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 249

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 115/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK     LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 16  GKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 75
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 76  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 134
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 135 NLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 191
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 192 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 246

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 21  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 80
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 81  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 139
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI +FG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 140 NLLL--GSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 196
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 197 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 251

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 24  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 83
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 84  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 142
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 143 NLLL--GSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 199
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 200 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 80  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 139 NLLL--GSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 195
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 196 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 250

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 82  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 140
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI +FG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 141 NLLL--GSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 197
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 198 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 252

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 79  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 138 NLLL--GSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 249

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 19  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 79  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 138 NLLL--GSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 249

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 117/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 45  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 104
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 105 DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 163
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 164 NLLL--GSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 220
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D  F  +++ A+D I +LL  +    P
Sbjct: 221 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--F--VTEGARDLISRLLKHNPSQRP 275

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  110 bits (276), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 123/236 (52%), Gaps = 13/236 (5%)
Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   +EKATG    M +  K V IAK            +++  +HP L  +  AF
Sbjct: 19  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAF 77
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K 
Sbjct: 78  QTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 136
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 137 ENLM-LDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 194
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD
Sbjct: 195 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD 246

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  110 bits (276), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 123/236 (52%), Gaps = 13/236 (5%)
Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   +EKATG    M +  K V IAK            +++  +HP L  +  AF
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAF 74
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K 
Sbjct: 75  QTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 134 ENLM-LDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD 243

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  110 bits (276), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K            I   L+HP ++++Y  F 
Sbjct: 22  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 81
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 82  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 140
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L    +   +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 141 NLLL--GSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 197
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 198 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 252

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 123/236 (52%), Gaps = 13/236 (5%)
Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   +EKATG    M +  K V IAK            +++  +HP L  +  AF
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAF 74
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K 
Sbjct: 75  QTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 134 ENLM-LDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD 243

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 108/199 (54%), Gaps = 5/199 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A + + + +            +MRE ++P ++   D++   +
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +    + E  +A   R+  + +EF+HS  V+H D+K +NIL
Sbjct: 91  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148
Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 149 -LGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 193 YVLLSGLSPFMGETDVQTM 211
             ++ G  P++ E  ++ +
Sbjct: 207 IEMIEGEPPYLNENPLRAL 225

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 123/236 (52%), Gaps = 13/236 (5%)
Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   +EKATG    M +  K V IAK            +++  +HP L  +  AF
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAF 74
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K 
Sbjct: 75  QTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 134 ENLM-LDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD 243

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 123/236 (52%), Gaps = 13/236 (5%)
Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   +EKATG    M +  K V IAK            +++  +HP L  +  AF
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAF 74
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K 
Sbjct: 75  QTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 134 ENLM-LDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD 243

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  110 bits (274), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 123/236 (52%), Gaps = 13/236 (5%)
Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   +EKATG    M +  K V IAK            +++  +HP L  +  AF
Sbjct: 21  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAF 79
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K 
Sbjct: 80  QTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 138
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 139 ENLM-LDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 196
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD
Sbjct: 197 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD 248

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  110 bits (274), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 108/199 (54%), Gaps = 5/199 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A + + + +            +MRE ++P ++   D++   +
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +    + E  +A   R+  + +EF+HS  V+H D+K +NIL
Sbjct: 91  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148
Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 149 -LGMDGS-VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 193 YVLLSGLSPFMGETDVQTM 211
             ++ G  P++ E  ++ +
Sbjct: 207 IEMIEGEPPYLNENPLRAL 225

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 123/236 (52%), Gaps = 13/236 (5%)
Query: 14  GKFGTVYRCKEKATG----MTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   +EKATG    M +  K V IAK            +++  +HP L  +  AF
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAF 74
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K 
Sbjct: 75  QTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 134 ENLM-LDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKD 243

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 108/199 (54%), Gaps = 5/199 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A + + + +            +MRE ++P ++   D++   +
Sbjct: 32  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 91
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +    + E  +A   R+  + +EF+HS  V+H D+K +NIL
Sbjct: 92  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 149
Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 150 -LGMDGS-VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 207
Query: 193 YVLLSGLSPFMGETDVQTM 211
             ++ G  P++ E  ++ +
Sbjct: 208 IEMIEGEPPYLNENPLRAL 226

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 114/193 (59%), Gaps = 8/193 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+ E+ HP +++++ AF++   + ++L+ + GG+LF R +  + + TE+ V  ++ ++  
Sbjct: 80  ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELAL 138
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAP 171
            ++ +HS  +++ D+KPENIL L + G+ IK+ DFGL+++  D EKK     GT E++AP
Sbjct: 139 ALDHLHSLGIIYRDLKPENIL-LDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 196
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD 231
           EVVN        D WS GV+ + +L+G  PF G+   +TM  +  A+          +S 
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSP 252
Query: 232 DAKDFIRKLLLKD 244
           +A+  +R L  ++
Sbjct: 253 EAQSLLRMLFKRN 265

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 103 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 161
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 162 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWA 219
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +    A +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 272

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 114/193 (59%), Gaps = 8/193 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+ E+ HP +++++ AF++   + ++L+ + GG+LF R +  + + TE+ V  ++ ++  
Sbjct: 79  ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELAL 137
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAP 171
            ++ +HS  +++ D+KPENIL L + G+ IK+ DFGL+++  D EKK     GT E++AP
Sbjct: 138 ALDHLHSLGIIYRDLKPENIL-LDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD 231
           EVVN        D WS GV+ + +L+G  PF G+   +TM  +  A+          +S 
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSP 251
Query: 232 DAKDFIRKLLLKD 244
           +A+  +R L  ++
Sbjct: 252 EAQSLLRMLFKRN 264

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 114/193 (59%), Gaps = 8/193 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I+ E+ HP +++++ AF++   + ++L+ + GG+LF R +  + + TE+ V  ++ ++  
Sbjct: 79  ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELAL 137
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAP 171
            ++ +HS  +++ D+KPENIL L + G+ IK+ DFGL+++  D EKK     GT E++AP
Sbjct: 138 ALDHLHSLGIIYRDLKPENIL-LDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD 231
           EVVN        D WS GV+ + +L+G  PF G+   +TM  +  A+          +S 
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSP 251
Query: 232 DAKDFIRKLLLKD 244
           +A+  +R L  ++
Sbjct: 252 EAQSLLRMLFKRN 264

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 11/231 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK     +A K +    + K            I   L+HP ++++Y+ F 
Sbjct: 26  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 85
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + ++LE    GEL++  +       E+  A FM ++ + + + H + V+H D+KPE
Sbjct: 86  DRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 144
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L   K    +KI DFG +    P  + + + GT +++ PE++         D+W  GV
Sbjct: 145 NLLMGYK--GELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 201
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           +CY  L G+ PF  ++   T  +  I   D     F  +SD +KD I KLL
Sbjct: 202 LCYEFLVGMPPF--DSPSHTETHRRIVNVDLKFPPF--LSDGSKDLISKLL 248

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 108/199 (54%), Gaps = 5/199 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A + + + +            +MRE ++P ++   D++   +
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +    + E  +A   R+  + +EF+HS  V+H D+K +NIL
Sbjct: 91  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148
Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 149 -LGMDGS-VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 193 YVLLSGLSPFMGETDVQTM 211
             ++ G  P++ E  ++ +
Sbjct: 207 IEMIEGEPPYLNENPLRAL 225

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 11/231 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK     +A K +    + K            I   L+HP ++++Y+ F 
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + ++LE    GEL++  +       E+  A FM ++ + + + H + V+H D+KPE
Sbjct: 85  DRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L   K    +KI DFG +    P  + + + GT +++ PE++         D+W  GV
Sbjct: 144 NLLMGYK--GELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 200
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           +CY  L G+ PF  ++   T  +  I   D     F  +SD +KD I KLL
Sbjct: 201 LCYEFLVGMPPF--DSPSHTETHRRIVNVDLKFPPF--LSDGSKDLISKLL 247

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 103 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 161
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 162 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +    A +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 272

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 31/197 (15%)
Query: 55  RELQHPRLIQIYDAFES----SNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQ 109
           R  Q P +++I D +E+       + +V+E ++GGELF R+ D  D   TE+  +  M+ 
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 125
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEF 168
           I E ++++HS N+ H D+KPEN+L  +K  N I K+ DFG A++   EK           
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK----------- 174
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDE 224
                  +D      DMWS+GVI Y+LL G  PF     +         + + QY+F + 
Sbjct: 175 -------YDK---SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 225 CFNEISDDAKDFIRKLL 241
            ++E+S++ K  IR LL
Sbjct: 225 EWSEVSEEVKMLIRNLL 241

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 108/199 (54%), Gaps = 5/199 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A + + + +            +MRE ++P ++   D++   +
Sbjct: 32  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 91
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +    + E  +A   R+  + +EF+HS  V+H ++K +NIL
Sbjct: 92  ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNIL 149
Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 150 -LGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 207
Query: 193 YVLLSGLSPFMGETDVQTM 211
             ++ G  P++ E  ++ +
Sbjct: 208 IEMIEGEPPYLNENPLRAL 226

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 101 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 159
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 160 NILL--NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 270

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 40  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 100 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 158
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 159 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 216
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 217 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 269

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 40  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 100 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 158
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 159 NILL--NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 216
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 217 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 269

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 25  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 84
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 85  DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 143
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 144 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 201
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 202 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 254

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 21  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 80
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 81  DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 139
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 140 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 197
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 198 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 250

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 103 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 161
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 162 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 272

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 101 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 159
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 160 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 270

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 101 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 159
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 160 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 270

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 19  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 79  DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 138 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 195
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 196 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 248

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 20  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 79
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 80  DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 138
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 139 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 196
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 197 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 249

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 122/246 (49%), Gaps = 11/246 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI---AKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G+F  VYR      G+ +A K V I                 ++++L HP +I+ Y +F 
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102
Query: 71  SSNVMCVVLELIEGGELFERVID----DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
             N + +VLEL + G+L  R+I        ++ E+ V  +  Q+C  +E +HS+ V+H D
Sbjct: 103 EDNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRD 161
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           +KP N+  +T TG  +K+ D GL R F  +      L GTP +++PE ++ +   F +D+
Sbjct: 162 IKPANVF-ITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           WS+G + Y + +  SPF G+          I Q D+     +  S++ +  +   +  D 
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 279
Query: 246 EDAPEV 251
           E  P+V
Sbjct: 280 EKRPDV 285

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 104 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 162
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 163 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 220
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 221 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 273

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 103 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 161
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 162 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 272

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 18  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 77
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 78  DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 136
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 137 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 194
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 195 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 247

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 103 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 161
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 162 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 219
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 272

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 104 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 162
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 163 NILL--NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 220
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 221 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 273

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 48  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQ 107
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 108 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 166
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 167 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 224
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 225 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 277

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 109/237 (45%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F T    +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 41  GSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 101 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 159
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 160 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 270

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 114/232 (49%), Gaps = 10/232 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A K +   +              IM+ L HP ++++++  E+
Sbjct: 18  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 77
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V+E   GGE+F+ ++   ++  ++A A F RQI   V++ H K ++H D+K EN
Sbjct: 78  EKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKF-RQIVSAVQYCHQKFIVHRDLKAEN 136
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGV 190
           +L        IKI DFG + +F    KL    G+P + APE+       G   D+WS+GV
Sbjct: 137 LLL--DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 194
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           I Y L+SG  PF G+   +    V   +Y         +S D ++ ++K L+
Sbjct: 195 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCENLLKKFLI 242

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 46  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 105
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 106 DDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 164
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 165 NILL--NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 222
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF    F +    A+D + KLL+ D
Sbjct: 223 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPK----ARDLVEKLLVLD 275

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 109/237 (45%), Gaps = 13/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K            +M  L HP  +++Y  F+
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + G L  + I       E     +  +I   +E++H K ++H D+KPE
Sbjct: 103 DDEKLYFGLSYAKNGCLL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 161
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 162 NILL--NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWA 219
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +G I Y L++GL PF    +      +   +YDF ++ F +    A+D + KLL+ D
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVLD 272

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 116/233 (49%), Gaps = 12/233 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V       TG  +A K +    +AK             +R L+HP +I++YD  +
Sbjct: 24  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           S + + +V+E   G ELF+ ++  D  ++E+    F +QI   VE+ H   ++H D+KPE
Sbjct: 84  SKDEIIMVIEY-AGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPE 141
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVG 189
           N+L L +  N +KI DFGL+        L+   G+P + APEV++     G   D+WS G
Sbjct: 142 NLL-LDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 199
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           VI YV+L    PF  E+      N++   Y         +S  A   I+++L+
Sbjct: 200 VILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLIKRMLI 248

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 116/233 (49%), Gaps = 12/233 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V       TG  +A K +    +AK             +R L+HP +I++YD  +
Sbjct: 15  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 74
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           S + + +V+E   G ELF+ ++  D  ++E+    F +QI   VE+ H   ++H D+KPE
Sbjct: 75  SKDEIIMVIEY-AGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPE 132
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVG 189
           N+L L +  N +KI DFGL+        L+   G+P + APEV++     G   D+WS G
Sbjct: 133 NLL-LDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 190
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           VI YV+L    PF  E+      N++   Y         +S  A   I+++L+
Sbjct: 191 VILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLIKRMLI 239

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 116/233 (49%), Gaps = 12/233 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V       TG  +A K +    +AK             +R L+HP +I++YD  +
Sbjct: 25  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 84
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           S + + +V+E   G ELF+ ++  D  ++E+    F +QI   VE+ H   ++H D+KPE
Sbjct: 85  SKDEIIMVIEY-AGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPE 142
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVG 189
           N+L L +  N +KI DFGL+        L+   G+P + APEV++     G   D+WS G
Sbjct: 143 NLL-LDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 200
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           VI YV+L    PF  E+      N++   Y         +S  A   I+++L+
Sbjct: 201 VILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLIKRMLI 249

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 116/233 (49%), Gaps = 12/233 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V       TG  +A K +    +AK             +R L+HP +I++YD  +
Sbjct: 19  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           S + + +V+E   G ELF+ ++  D  ++E+    F +QI   VE+ H   ++H D+KPE
Sbjct: 79  SKDEIIMVIEY-AGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPE 136
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVG 189
           N+L L +  N +KI DFGL+        L+   G+P + APEV++     G   D+WS G
Sbjct: 137 NLL-LDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 194
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           VI YV+L    PF  E+      N++   Y         +S  A   I+++L+
Sbjct: 195 VILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLIKRMLI 243

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 123/251 (49%), Gaps = 20/251 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   KEKATG   A K +    I              +++  +HP L  +  +F+
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKP 129
           + + +C V+E   GGELF   +  + V +E     +  +I   ++++HS KNV++ D+K 
Sbjct: 219 THDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 278 ENLM-LDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---- 244
           GV+ Y ++ G  PF  +   +    + + +  F       +  +AK  +  LL KD    
Sbjct: 336 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQR 391
Query: 245 ----REDAPEV 251
                EDA E+
Sbjct: 392 LGGGSEDAKEI 402

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 10/232 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A K +   +              IM+ L HP ++++++  E+
Sbjct: 25  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V+E   GGE+F+ ++    +  ++A A F RQI   V++ H K ++H D+K EN
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKFIVHRDLKAEN 143
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGV 190
           +L        IKI DFG + +F    KL    G+P + APE+       G   D+WS+GV
Sbjct: 144 LLL--DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           I Y L+SG  PF G+   +    V   +Y         +S D ++ ++K L+
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCENLLKKFLI 249

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 10/232 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A K +   +              IM+ L HP ++++++  E+
Sbjct: 25  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V+E   GGE+F+ ++    +  ++A A F RQI   V++ H K ++H D+K EN
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKFIVHRDLKAEN 143
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGV 190
           +L        IKI DFG + +F    KL    G+P + APE+       G   D+WS+GV
Sbjct: 144 LLL--DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           I Y L+SG  PF G+   +    V   +Y         +S D ++ ++K L+
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCENLLKKFLI 249

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 123/251 (49%), Gaps = 20/251 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   KEKATG   A K +    I              +++  +HP L  +  +F+
Sbjct: 162 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 221
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKP 129
           + + +C V+E   GGELF   +  + V +E     +  +I   ++++HS KNV++ D+K 
Sbjct: 222 THDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 280
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 281 ENLM-LDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 338
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---- 244
           GV+ Y ++ G  PF  +   +    + + +  F       +  +AK  +  LL KD    
Sbjct: 339 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQR 394
Query: 245 ----REDAPEV 251
                EDA E+
Sbjct: 395 LGGGSEDAKEI 405

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 123/251 (49%), Gaps = 20/251 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   KEKATG   A K +    I              +++  +HP L  +  +F+
Sbjct: 20  GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 79
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKP 129
           + + +C V+E   GGELF   +  + V +E     +  +I   ++++HS KNV++ D+K 
Sbjct: 80  THDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 138
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 139 ENLM-LDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 196
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---- 244
           GV+ Y ++ G  PF  +   +    + + +  F       +  +AK  +  LL KD    
Sbjct: 197 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQR 252
Query: 245 ----REDAPEV 251
                EDA E+
Sbjct: 253 LGGGSEDAKEI 263

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 123/251 (49%), Gaps = 20/251 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   KEKATG   A K +    I              +++  +HP L  +  +F+
Sbjct: 21  GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 80
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKP 129
           + + +C V+E   GGELF   +  + V +E     +  +I   ++++HS KNV++ D+K 
Sbjct: 81  THDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 139
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 140 ENLM-LDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 197
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---- 244
           GV+ Y ++ G  PF  +   +    + + +  F       +  +AK  +  LL KD    
Sbjct: 198 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQR 253
Query: 245 ----REDAPEV 251
                EDA E+
Sbjct: 254 LGGGSEDAKEI 264

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 123/251 (49%), Gaps = 20/251 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   KEKATG   A K +    I              +++  +HP L  +  +F+
Sbjct: 19  GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 78
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKP 129
           + + +C V+E   GGELF   +  + V +E     +  +I   ++++HS KNV++ D+K 
Sbjct: 79  THDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 137
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 138 ENLM-LDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGL 195
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---- 244
           GV+ Y ++ G  PF  +   +    + + +  F       +  +AK  +  LL KD    
Sbjct: 196 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQR 251
Query: 245 ----REDAPEV 251
                EDA E+
Sbjct: 252 LGGGSEDAKEI 262

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 8/210 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A K +   +              IM+ L HP ++++++  E+
Sbjct: 26  GNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V+E   GGE+F+ ++    +  ++A A F RQI   V++ H K ++H D+K EN
Sbjct: 86  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKYIVHRDLKAEN 144
Query: 132 ILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVG 189
           +L     G+  IKI DFG + +F    KL    G+P + APE+       G   D+WS+G
Sbjct: 145 LLL---DGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQY 219
           VI Y L+SG  PF G+   +    V   +Y
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKY 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 124/235 (52%), Gaps = 6/235 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  G V   +EK +G  +A K + + K            IMR+ QH  ++++Y ++    
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + V++E ++GG L +  I     L E+ +A     + + + ++H++ V+H D+K ++IL
Sbjct: 116 ELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSIL 173
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   +  K + L GTP ++APEV++        D+WS+G++ 
Sbjct: 174 -LTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
             ++ G  P+  ++ VQ M  +  +         +++S   +DF+ ++L++D ++
Sbjct: 232 IEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS-HKVSPVLRDFLERMLVRDPQE 285

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 112/232 (48%), Gaps = 10/232 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A K +   +              IM+ L HP ++++++  E+
Sbjct: 25  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V+E   GGE+F+ ++    +  ++A A F RQI   V++ H K ++H D+K EN
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKFIVHRDLKAEN 143
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGV 190
           +L        IKI DFG + +F    KL    G P + APE+       G   D+WS+GV
Sbjct: 144 LLL--DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           I Y L+SG  PF G+   +    V   +Y         +S D ++ ++K L+
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCENLLKKFLI 249

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 10/232 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A + +   +              IM+ L HP ++++++  E+
Sbjct: 25  GNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V+E   GGE+F+ ++    +  ++A A F RQI   V++ H K ++H D+K EN
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKFIVHRDLKAEN 143
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGV 190
           +L        IKI DFG + +F    KL    G+P + APE+       G   D+WS+GV
Sbjct: 144 LLL--DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           I Y L+SG  PF G+   +    V   +Y         +S D ++ ++K L+
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCENLLKKFLI 249

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 104
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 105 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 162 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 269

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 73  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 133 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 190 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 297

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I + +  P L+++  +F+
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +VLE   GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVLEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PENLL-IDQQG-YIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 115/248 (46%), Gaps = 16/248 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG     ++K +   +A K++   +              R L+HP +++  +   +  
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIIN-HRSLRHPNIVRFKEVILTPT 88
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E   GGELFER+ +     +E     F +Q+  GV + H+  V H D+K EN L
Sbjct: 89  HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 147
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV---NFDAIGFGTDMWSVGV 190
                  R+KI DFG ++      + +   GTP ++APEV+    +D  G   D+WS GV
Sbjct: 148 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKVADVWSCGV 205
Query: 191 ICYVLLSGLSPFMGETDV----QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD-- 244
             YV+L G  PF    +     +T+  +   QY   D  +  IS + +  I ++ + D  
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD--YVHISPECRHLISRIFVADPA 263
Query: 245 -REDAPEV 251
            R   PE+
Sbjct: 264 KRISIPEI 271

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 113/237 (47%), Gaps = 12/237 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG----IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   + KA  +  A K +     + K            +++ ++HP L+ ++ +F
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++++ +  VL+ I GGELF  +  +   L  +A   +  +I   + ++HS N+++ D+KP
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASALGYLHSLNIVYRDLKP 167
Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           ENIL    +   I + DFGL ++  +         GTPE++APEV++        D W +
Sbjct: 168 ENILL--DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           G + Y +L GL PF      +   N+              I++ A+  +  LL KDR
Sbjct: 226 GAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLLEGLLQKDR 278

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 104
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 105 DNSNLYMVMEYVPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 162 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 218 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 269

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 115/248 (46%), Gaps = 16/248 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG     ++K +   +A K++   +              R L+HP +++  +   +  
Sbjct: 29  GNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIIN-HRSLRHPNIVRFKEVILTPT 87
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E   GGELFER+ +     +E     F +Q+  GV + H+  V H D+K EN L
Sbjct: 88  HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 146
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV---NFDAIGFGTDMWSVGV 190
                  R+KI DFG ++      + +   GTP ++APEV+    +D  G   D+WS GV
Sbjct: 147 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKVADVWSCGV 204
Query: 191 ICYVLLSGLSPFMGETDV----QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD-- 244
             YV+L G  PF    +     +T+  +   QY   D  +  IS + +  I ++ + D  
Sbjct: 205 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD--YVHISPECRHLISRIFVADPA 262
Query: 245 -REDAPEV 251
            R   PE+
Sbjct: 263 KRISIPEI 270

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 6/209 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A K +   +              IM+ L HP ++++++  E+
Sbjct: 23  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 82
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +++E   GGE+F+ ++    +  ++A + F RQI   V++ H K ++H D+K EN
Sbjct: 83  EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-RQIVSAVQYCHQKRIVHRDLKAEN 141
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGV 190
           +L        IKI DFG + +F    KL    G+P + APE+       G   D+WS+GV
Sbjct: 142 LLL--DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 199
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQY 219
           I Y L+SG  PF G+   +    V   +Y
Sbjct: 200 ILYTLVSGSLPFDGQNLKELRERVLRGKY 228

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 10/232 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A + +   +              IM+ L HP ++++++  E+
Sbjct: 25  GNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIET 84
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V+E   GGE+F+ ++    +  ++A A F RQI   V++ H K ++H D+K EN
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF-RQIVSAVQYCHQKFIVHRDLKAEN 143
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGV 190
           +L        IKI DFG + +F    KL    G+P + APE+       G   D+WS+GV
Sbjct: 144 LLL--DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           I Y L+SG  PF G+   +    V   +Y         +S D ++ ++K L+
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCENLLKKFLI 249

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E   GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN++   +    IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PENLMIDQQ--GYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 53  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 117/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 114/248 (45%), Gaps = 16/248 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG     ++K     +A K++   +              R L+HP +++  +   +  
Sbjct: 30  GNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIIN-HRSLRHPNIVRFKEVILTPT 88
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E   GGELFER+ +     +E     F +Q+  GV + H+  V H D+K EN L
Sbjct: 89  HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTL 147
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV---NFDAIGFGTDMWSVGV 190
                  R+KI DFG ++      + +   GTP ++APEV+    +D  G   D+WS GV
Sbjct: 148 LDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYD--GKVADVWSCGV 205
Query: 191 ICYVLLSGLSPFMGETDV----QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD-- 244
             YV+L G  PF    +     +T+  +   QY   D  +  IS + +  I ++ + D  
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD--YVHISPECRHLISRIFVADPA 263
Query: 245 -REDAPEV 251
            R   PE+
Sbjct: 264 KRISIPEI 271

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 113/235 (48%), Gaps = 12/235 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V       T   +A KF+    + K             ++ L+HP +I++YD   
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +   + +V+E   GGELF+ +++    +TE     F +QI   +E+ H   ++H D+KPE
Sbjct: 80  TPTDIVMVIEY-AGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVG 189
           N+L L    N +KI DFGL+        L+   G+P + APEV+N     G   D+WS G
Sbjct: 138 NLL-LDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           ++ YV+L G  PF  E        V    Y   D     +S  A+  IR++++ D
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD----FLSPGAQSLIRRMIVAD 246

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 39  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 98
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 99  DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 155
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 156 PENLLIDEQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 211
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 212 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 263

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 6/209 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A K +   +              IM+ L HP ++++++  E+
Sbjct: 26  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +++E   GGE+F+ ++    +  ++A + F RQI   V++ H K ++H D+K EN
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-RQIVSAVQYCHQKRIVHRDLKAEN 144
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGV 190
           +L        IKI DFG + +F    KL    G P + APE+       G   D+WS+GV
Sbjct: 145 LLL--DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQY 219
           I Y L+SG  PF G+   +    V   +Y
Sbjct: 203 ILYTLVSGSLPFDGQNLKELRERVLRGKY 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 38  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 97
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 98  DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 154
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 155 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWAL 210
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 211 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ------HPRLIQIYD 67
           G FG V   K + TG  +A K +   K            I RE+Q      HP +I++Y 
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK---IRREIQNLKLFRHPHIIKLYQ 83
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
              + + + +V+E + GGELF+ +  +   L EK      +QI  GV++ H   V+H D+
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMW 186
           KPEN+L         KI DFGL+      + L+   G+P + APEV++     G   D+W
Sbjct: 143 KPENVLLDAHMN--AKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIW 200
Query: 187 SVGVICYVLLSGLSPF 202
           S GVI Y LL G  PF
Sbjct: 201 SSGVILYALLCGTLPF 216

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FAEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PEN-LIIDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 73  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   +     L GTPE++APE++         D W++
Sbjct: 190 PENLLIDQQ--GYIQVTDFGFAKRV--KGATWTLCGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 73  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 190 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 246 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 297

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E   GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN L + + G  IK+ DFGLA++   + +   L GTPE++APE++         D W++
Sbjct: 169 PEN-LMIDQQG-YIKVTDFGLAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 5/202 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  G V    EK TG  +A K + + K            IMR+  H  ++ +Y ++   +
Sbjct: 56  GSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGD 115
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     +   + ++H++ V+H D+K ++IL
Sbjct: 116 ELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSIL 173
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G RIK+ DFG   +   E  K + L GTP ++APEV++    G   D+WS+G++ 
Sbjct: 174 -LTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 231
Query: 193 YVLLSGLSPFMGETDVQTMANV 214
             ++ G  P+  E  +Q M  +
Sbjct: 232 IEMIDGEPPYFNEPPLQAMRRI 253

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 47  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 106
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 107 DNSNLYMVMEYVAGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 163
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 164 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 219
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 220 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 271

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 121/242 (50%), Gaps = 12/242 (4%)
Query: 12  SFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMREL-----QHPRLIQIY 66
           ++GK   V +     TG   A K +  A               R++     Q P L+ ++
Sbjct: 66  AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125
Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            AF++   + ++L+ I GGELF  +   +   TE  V I++ +I   +E +H   +++ D
Sbjct: 126 YAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRD 184
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGTPEFVAPEVVNFDAIGF--G 182
           +K ENIL    +   + + DFGL+++F  D  ++     GT E++AP++V     G    
Sbjct: 185 IKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA 242
Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
            D WS+GV+ Y LL+G SPF  + +  + A ++      +     E+S  AKD I++LL+
Sbjct: 243 VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLM 302
Query: 243 KD 244
           KD
Sbjct: 303 KD 304

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 124/240 (51%), Gaps = 17/240 (7%)
Query: 14  GKFGTVYRCKEKATG--------MTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI 65
           G +G V++ + K TG        M +  K + +              I+ E++HP ++ +
Sbjct: 28  GGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL 86
Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
             AF++   + ++LE + GGELF + ++ + +  E     ++ +I   +  +H K +++ 
Sbjct: 87  IYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHLHQKGIIYR 145
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTD 184
           D+KPENI+ L   G+ +K+ DFGL ++   +  +   F GT E++APE++         D
Sbjct: 146 DLKPENIM-LNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVD 203
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            WS+G + Y +L+G  PF GE   +T+  +   + +        ++ +A+D ++KLL ++
Sbjct: 204 WWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRN 259

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 124/240 (51%), Gaps = 17/240 (7%)
Query: 14  GKFGTVYRCKEKATG--------MTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI 65
           G +G V++ + K TG        M +  K + +              I+ E++HP ++ +
Sbjct: 28  GGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL 86
Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
             AF++   + ++LE + GGELF + ++ + +  E     ++ +I   +  +H K +++ 
Sbjct: 87  IYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHLHQKGIIYR 145
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTD 184
           D+KPENI+ L   G+ +K+ DFGL ++   +  +   F GT E++APE++         D
Sbjct: 146 DLKPENIM-LNHQGH-VKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVD 203
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            WS+G + Y +L+G  PF GE   +T+  +   + +        ++ +A+D ++KLL ++
Sbjct: 204 WWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRN 259

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GG++F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PENLL-IDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 6/209 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A K +   +              I + L HP ++++++  E+
Sbjct: 25  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIET 84
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V E   GGE+F+ ++       ++A A F RQI   V++ H K ++H D+K EN
Sbjct: 85  EKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF-RQIVSAVQYCHQKFIVHRDLKAEN 143
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGV 190
           +L        IKI DFG + +F    KL    G P + APE+       G   D+WS+GV
Sbjct: 144 LLL--DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQY 219
           I Y L+SG  PF G+   +    V   +Y
Sbjct: 202 ILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GG++F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L + + G  IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PENLL-IDQQG-YIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E   GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN L + + G  IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PEN-LMIDQQG-YIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE++AP ++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPAIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 115/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E   GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN L + + G  I++ DFGLA++   + +   L GTPE++APE++         D W++
Sbjct: 169 PEN-LMIDQQG-YIQVTDFGLAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E + GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN+L   +    I++ DFG A++   + +   L GTPE +APE++         D W++
Sbjct: 169 PENLLIDQQ--GYIQVTDFGFAKRV--KGRTWXLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 114/248 (45%), Gaps = 16/248 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG     ++K +   +A K++   +              R L+HP +++  +   +  
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIIN-HRSLRHPNIVRFKEVILTPT 88
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E   GGELFER+ +     +E     F +Q+  GV + H+  V H D+K EN L
Sbjct: 89  HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 147
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV---NFDAIGFGTDMWSVGV 190
                  R+KI  FG ++      + +   GTP ++APEV+    +D  G   D+WS GV
Sbjct: 148 LDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKVADVWSCGV 205
Query: 191 ICYVLLSGLSPFMGETDV----QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD-- 244
             YV+L G  PF    +     +T+  +   QY   D  +  IS + +  I ++ + D  
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD--YVHISPECRHLISRIFVADPA 263
Query: 245 -REDAPEV 251
            R   PE+
Sbjct: 264 KRISIPEI 271

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 109/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   +   +  T    A K V    + K            I R L H  ++  +  FE
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + VVLEL     L E +      LTE     ++RQI  G +++H   V+H D+K  
Sbjct: 86  DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 144
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  +D E+K +VL GTP ++APEV++     F  D+WS+
Sbjct: 145 NLF--LNEDLEVKIGDFGLATKVEYDGERK-KVLCGTPNYIAPEVLSKKGHSFEVDVWSI 201
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   I+K+L  D    
Sbjct: 202 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTAR 257
Query: 249 PEV 251
           P +
Sbjct: 258 PTI 260

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 109/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   +   +  T    A K V    + K            I R L H  ++  +  FE
Sbjct: 50  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 109
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + VVLEL     L E +      LTE     ++RQI  G +++H   V+H D+K  
Sbjct: 110 DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 168
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  +D E+K +VL GTP ++APEV++     F  D+WS+
Sbjct: 169 NLFL--NEDLEVKIGDFGLATKVEYDGERK-KVLCGTPNYIAPEVLSKKGHSFEVDVWSI 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   I+K+L  D    
Sbjct: 226 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTAR 281
Query: 249 PEV 251
           P +
Sbjct: 282 PTI 284

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 109/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   Y   +  T    A K V    + K            I + L +P ++  +  FE
Sbjct: 53  GGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFE 112
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             + + VVLE+     L E +      +TE     FMRQ  +GV+++H+  V+H D+K  
Sbjct: 113 DDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLG 171
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  FD E+K + L GTP ++APEV+      F  D+WS+
Sbjct: 172 NLFL--NDDMDVKIGDFGLATKIEFDGERK-KTLCGTPNYIAPEVLCKKGHSFEVDIWSL 228
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   IR++L  D    
Sbjct: 229 GCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP----RHINPVASALIRRMLHADPTLR 284
Query: 249 PEV 251
           P V
Sbjct: 285 PSV 287

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 109/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   +   +  T    A K V    + K            I R L H  ++  +  FE
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + VVLEL     L E +      LTE     ++RQI  G +++H   V+H D+K  
Sbjct: 112 DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  +D E+K +VL GTP ++APEV++     F  D+WS+
Sbjct: 171 NLFL--NEDLEVKIGDFGLATKVEYDGERK-KVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   I+K+L  D    
Sbjct: 228 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTAR 283
Query: 249 PEV 251
           P +
Sbjct: 284 PTI 286

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E   GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN L + + G  IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PEN-LMIDQQG-YIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 109/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   Y   +  T    A K V    + K            I + L +P ++  +  FE
Sbjct: 53  GGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFE 112
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             + + VVLE+     L E +      +TE     FMRQ  +GV+++H+  V+H D+K  
Sbjct: 113 DDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLG 171
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  FD E+K + L GTP ++APEV+      F  D+WS+
Sbjct: 172 NLFL--NDDMDVKIGDFGLATKIEFDGERK-KXLCGTPNYIAPEVLCKKGHSFEVDIWSL 228
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   IR++L  D    
Sbjct: 229 GCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP----RHINPVASALIRRMLHADPTLR 284
Query: 249 PEV 251
           P V
Sbjct: 285 PSV 287

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L ++  +F+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E   GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN L + + G  IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PEN-LMIDQQG-YIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L ++  +F+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E   GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN L + + G  IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PEN-LMIDQQG-YIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E   GGE+F   R I      +E     +  QI    E++HS ++++ D+K
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN L + + G  I++ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 169 PEN-LMIDQQG-YIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 276

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 114/248 (45%), Gaps = 16/248 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG     ++K +   +A K++   +              R L+HP +++  +   +  
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIIN-HRSLRHPNIVRFKEVILTPT 88
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E   GGELFER+ +     +E     F +Q+  GV + H+  V H D+K EN L
Sbjct: 89  HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 147
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV---NFDAIGFGTDMWSVGV 190
                  R+KI  FG ++      + +   GTP ++APEV+    +D  G   D+WS GV
Sbjct: 148 LDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYD--GKVADVWSCGV 205
Query: 191 ICYVLLSGLSPFMGETDV----QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD-- 244
             YV+L G  PF    +     +T+  +   QY   D  +  IS + +  I ++ + D  
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD--YVHISPECRHLISRIFVADPA 263
Query: 245 -REDAPEV 251
            R   PE+
Sbjct: 264 KRISIPEI 271

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 113/248 (45%), Gaps = 16/248 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG     ++K T   +A K++                  R L+HP +++  +   +  
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN-HRSLRHPNIVRFKEVILTPT 89
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GGEL+ER+ +     +E     F +Q+  GV + HS  + H D+K EN L
Sbjct: 90  HLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148
Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV---NFDAIGFGTDMWSVGV 190
                  R+KI DFG ++      + +   GTP ++APEV+    +D  G   D+WS GV
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD--GKIADVWSCGV 206
Query: 191 ICYVLLSGLSPFMGETDV----QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD-- 244
             YV+L G  PF    +     +T+  +   +Y   D+    IS +    I ++ + D  
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI--RISPECCHLISRIFVADPA 264
Query: 245 -REDAPEV 251
            R   PE+
Sbjct: 265 TRISIPEI 272

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 11/231 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   +A K +    I K            I   L HP ++++Y+ F 
Sbjct: 34  GKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFY 93
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + ++LE    GEL++  +       E+  A  M ++ + + + H K V+H D+KPE
Sbjct: 94  DRRRIYLILEYAPRGELYKE-LQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPE 152
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L   K    +KI DFG +    P  + + + GT +++ PE++         D+W +GV
Sbjct: 153 NLLLGLKGE--LKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGV 209
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
           +CY LL G  PF   +  +T   +      F       +   A+D I KLL
Sbjct: 210 LCYELLVGNPPFESASHNETYRRIVKVDLKFP----ASVPTGAQDLISKLL 256

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 109/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   Y   +  T    A K V    + K            I + L +P ++  +  FE
Sbjct: 37  GGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFE 96
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             + + VVLE+     L E +      +TE     FMRQ  +GV+++H+  V+H D+K  
Sbjct: 97  DDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLG 155
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  FD E+K + L GTP ++APEV+      F  D+WS+
Sbjct: 156 NLFL--NDDMDVKIGDFGLATKIEFDGERK-KDLCGTPNYIAPEVLCKKGHSFEVDIWSL 212
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   IR++L  D    
Sbjct: 213 GCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP----RHINPVASALIRRMLHADPTLR 268
Query: 249 PEV 251
           P V
Sbjct: 269 PSV 271

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   +   +  T    A K V    + K            I R L H  ++  +  FE
Sbjct: 28  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 87
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + VVLEL     L E +      LTE     ++RQI  G +++H   V+H D+K  
Sbjct: 88  DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 146
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  +D E+K + L GTP ++APEV++     F  D+WS+
Sbjct: 147 NLFL--NEDLEVKIGDFGLATKVEYDGERK-KTLCGTPNYIAPEVLSKKGHSFEVDVWSI 203
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   I+K+L  D    
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTAR 259
Query: 249 PEV 251
           P +
Sbjct: 260 PTI 262

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   +   +  T    A K V    + K            I R L H  ++  +  FE
Sbjct: 28  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 87
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + VVLEL     L E +      LTE     ++RQI  G +++H   V+H D+K  
Sbjct: 88  DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 146
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  +D E+K + L GTP ++APEV++     F  D+WS+
Sbjct: 147 NLFL--NEDLEVKIGDFGLATKVEYDGERK-KTLCGTPNYIAPEVLSKKGHSFEVDVWSI 203
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   I+K+L  D    
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTAR 259
Query: 249 PEV 251
           P +
Sbjct: 260 PTI 262

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   +   +  T    A K V    + K            I R L H  ++  +  FE
Sbjct: 32  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 91
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + VVLEL     L E +      LTE     ++RQI  G +++H   V+H D+K  
Sbjct: 92  DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 150
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  +D E+K + L GTP ++APEV++     F  D+WS+
Sbjct: 151 NLFL--NEDLEVKIGDFGLATKVEYDGERK-KTLCGTPNYIAPEVLSKKGHSFEVDVWSI 207
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   I+K+L  D    
Sbjct: 208 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTAR 263
Query: 249 PEV 251
           P +
Sbjct: 264 PTI 266

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 16/236 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V   K   TG   A K +    + K            I++ +  P L ++  +F+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 71  SSNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++ + +V+E   GGE+F   R I       E     +  QI    E++HS ++++ D+K
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGR---FXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           PEN L + + G  IK+ DFG A++   + +   L GTPE++APE++         D W++
Sbjct: 170 PEN-LMIDQQG-YIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GV+ Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVD 277

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 109/243 (44%), Gaps = 13/243 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F   Y   +  T    A K V    + K            I + L +P ++  +  FE
Sbjct: 53  GGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFE 112
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             + + VVLE+     L E +      +TE     FMRQ  +GV+++H+  V+H D+K  
Sbjct: 113 DDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLG 171
Query: 131 NILCLTKTGNRIKIIDFGLARK--FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           N+         +KI DFGLA K  FD E+K + L GTP ++APEV+      F  D+WS+
Sbjct: 172 NLFL--NDDMDVKIGDFGLATKIEFDGERK-KDLCGTPNYIAPEVLCKKGHSFEVDIWSL 228
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G I Y LL G  PF      +T   +   +Y         I+  A   IR++L  D    
Sbjct: 229 GCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP----RHINPVASALIRRMLHADPTLR 284
Query: 249 PEV 251
           P V
Sbjct: 285 PSV 287

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 36/261 (13%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-----AKXXXXXXXXXXXXIMRELQHPRLIQIYDA 68
           G+F TVY+ ++K T   +A K + +     AK            +++EL HP +I + DA
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F   + + +V + +E  +L   + D+  VLT   +  +M    +G+E++H   +LH D+K
Sbjct: 81  FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 139
Query: 129 PENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDA--IGFGTDM 185
           P N+L L + G  +K+ DFGLA+ F  P +       T  + APE++ F A   G G DM
Sbjct: 140 PNNLL-LDENG-VLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELL-FGARMYGVGVDM 196
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANV-----TIAQYDFDDEC--------------- 225
           W+VG I   LL  +    G++D+  +  +     T  +  + D C               
Sbjct: 197 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 256
Query: 226 ----FNEISDDAKDFIRKLLL 242
               F+   DD  D I+ L L
Sbjct: 257 LHHIFSAAGDDLLDLIQGLFL 277

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 121/232 (52%), Gaps = 6/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  G V     +++G  +A K + + K            IMR+ QH  ++++Y+++   +
Sbjct: 35  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 94
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     + + +  +H++ V+H D+K ++IL
Sbjct: 95  ELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 152
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   E  + + L GTP ++APE+++    G   D+WS+G++ 
Sbjct: 153 -LTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 210
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             ++ G  P+  E  ++ M  +         +  +++S   K F+ +LL++D
Sbjct: 211 IEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRD 261

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 121/232 (52%), Gaps = 6/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  G V     +++G  +A K + + K            IMR+ QH  ++++Y+++   +
Sbjct: 31  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 90
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     + + +  +H++ V+H D+K ++IL
Sbjct: 91  ELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 148
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   E  + + L GTP ++APE+++    G   D+WS+G++ 
Sbjct: 149 -LTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 206
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             ++ G  P+  E  ++ M  +         +  +++S   K F+ +LL++D
Sbjct: 207 IEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRD 257

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 121/232 (52%), Gaps = 6/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  G V     +++G  +A K + + K            IMR+ QH  ++++Y+++   +
Sbjct: 40  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 99
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     + + +  +H++ V+H D+K ++IL
Sbjct: 100 ELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 157
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   E  + + L GTP ++APE+++    G   D+WS+G++ 
Sbjct: 158 -LTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 215
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             ++ G  P+  E  ++ M  +         +  +++S   K F+ +LL++D
Sbjct: 216 IEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRD 266

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 121/232 (52%), Gaps = 6/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  G V     +++G  +A K + + K            IMR+ QH  ++++Y+++   +
Sbjct: 42  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 101
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     + + +  +H++ V+H D+K ++IL
Sbjct: 102 ELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 159
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   E  + + L GTP ++APE+++    G   D+WS+G++ 
Sbjct: 160 -LTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 217
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             ++ G  P+  E  ++ M  +         +  +++S   K F+ +LL++D
Sbjct: 218 IEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRD 268

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 121/232 (52%), Gaps = 6/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  G V     +++G  +A K + + K            IMR+ QH  ++++Y+++   +
Sbjct: 85  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     + + +  +H++ V+H D+K ++IL
Sbjct: 145 ELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 202
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   E  + + L GTP ++APE+++    G   D+WS+G++ 
Sbjct: 203 -LTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 260
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             ++ G  P+  E  ++ M  +         +  +++S   K F+ +LL++D
Sbjct: 261 IEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRD 311

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 120/243 (49%), Gaps = 16/243 (6%)
Query: 14  GKFGTVYRCKEKAT----GMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   + K+T     M L +KF  I K            IM     P ++Q++ AF
Sbjct: 85  GAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAF 143
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +    + +V+E + GG+L   + + D  + EK    +  ++   ++ IHS   +H D+KP
Sbjct: 144 QDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 201
Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEK--KLQVLFGTPEFVAPEVVNFDA----IGFGT 183
           +N+L L K+G+ +K+ DFG   K + E   +     GTP++++PEV+         G   
Sbjct: 202 DNML-LDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 259
Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           D WSVGV  Y +L G +PF  ++ V T + +   +        N+IS +AK+ I    L 
Sbjct: 260 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI-CAFLT 318
Query: 244 DRE 246
           DRE
Sbjct: 319 DRE 321

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 120/243 (49%), Gaps = 16/243 (6%)
Query: 14  GKFGTVYRCKEKAT----GMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   + K+T     M L +KF  I K            IM     P ++Q++ AF
Sbjct: 80  GAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAF 138
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +    + +V+E + GG+L   + + D  + EK    +  ++   ++ IHS   +H D+KP
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196
Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEK--KLQVLFGTPEFVAPEVVNFDA----IGFGT 183
           +N+L L K+G+ +K+ DFG   K + E   +     GTP++++PEV+         G   
Sbjct: 197 DNML-LDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 254
Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           D WSVGV  Y +L G +PF  ++ V T + +   +        N+IS +AK+ I    L 
Sbjct: 255 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI-CAFLT 313
Query: 244 DRE 246
           DRE
Sbjct: 314 DRE 316

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 120/243 (49%), Gaps = 16/243 (6%)
Query: 14  GKFGTVYRCKEKAT----GMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V   + K+T     M L +KF  I K            IM     P ++Q++ AF
Sbjct: 85  GAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAF 143
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +    + +V+E + GG+L   + + D  + EK    +  ++   ++ IHS   +H D+KP
Sbjct: 144 QDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 201
Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEK--KLQVLFGTPEFVAPEVVNFDA----IGFGT 183
           +N+L L K+G+ +K+ DFG   K + E   +     GTP++++PEV+         G   
Sbjct: 202 DNML-LDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 259
Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           D WSVGV  Y +L G +PF  ++ V T + +   +        N+IS +AK+ I    L 
Sbjct: 260 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI-CAFLT 318
Query: 244 DRE 246
           DRE
Sbjct: 319 DRE 321

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 121/232 (52%), Gaps = 6/232 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G  G V     +++G  +A K + + K            IMR+ QH  ++++Y+++   +
Sbjct: 162 GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E +EGG L + V      + E+ +A     + + +  +H++ V+H D+K ++IL
Sbjct: 222 ELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 279
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G R+K+ DFG   +   E  + + L GTP ++APE+++    G   D+WS+G++ 
Sbjct: 280 -LTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 337
Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             ++ G  P+  E  ++ M  +         +  +++S   K F+ +LL++D
Sbjct: 338 IEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSLKGFLDRLLVRD 388

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 34/214 (15%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           ++++ + FE      +V E ++GG +   +        E+  +  +R +   ++F+H+K 
Sbjct: 73  ILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLHTKG 131
Query: 122 VLHLDMKPENILCLTKTG-NRIKIIDFGLARKFD----------PEKKLQVLFGTPEFVA 170
           + H D+KPENILC +    + +KI DF L               PE  L    G+ E++A
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE--LTTPCGSAEYMA 189
Query: 171 PEVVNF--DAIGF---GTDMWSVGVICYVLLSGLSPFMGETDV---------------QT 210
           PEVV    D   F     D+WS+GV+ Y++LSG  PF+G                   + 
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 249
Query: 211 MANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             ++   +Y+F D+ +  IS +AKD I KLL++D
Sbjct: 250 FESIQEGKYEFPDKDWAHISSEAKDLISKLLVRD 283

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 95/196 (48%), Gaps = 13/196 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ------HPRLIQIYD 67
           G FG V   + + TG  +A K +   K            I RE+Q      HP +I++Y 
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK---IKREIQNLKLFRHPHIIKLYQ 78
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
              +     +V+E + GGELF+ +     V   +A  +F +QI   V++ H   V+H D+
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-QQILSAVDYCHRHMVVHRDL 137
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMW 186
           KPEN+L         KI DFGL+      + L+   G+P + APEV++     G   D+W
Sbjct: 138 KPENVLLDAHMNA--KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195
Query: 187 SVGVICYVLLSGLSPF 202
           S GVI Y LL G  PF
Sbjct: 196 SCGVILYALLCGTLPF 211

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 8/183 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K K TG   AAK +                I+    HP ++++  A+    
Sbjct: 22  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 81
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GG +   +++ D  LTE  + +  RQ+ E + F+HSK ++H D+K  N+L
Sbjct: 82  KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVL 141
Query: 134 CLTKTGNRIKIIDFGL-ARKFDPEKKLQVLFGTPEFVAPEVVNFDAIG-----FGTDMWS 187
            +T  G+ I++ DFG+ A+     +K     GTP ++APEVV  + +      +  D+WS
Sbjct: 142 -MTLEGD-IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 199
Query: 188 VGV 190
           +G+
Sbjct: 200 LGI 202

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 115/243 (47%), Gaps = 6/243 (2%)
Query: 6   NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXX---XXXXXXXXXIMRELQHPRL 62
            Q+     G FG V  C+ +ATG   A K +   +               I+ ++    +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 63  IQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR-QICEGVEFIHSKN 121
           + +  A+E+ + +C+VL L+ GG+L   +         +A A+F   +IC G+E +H + 
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           +++ D+KPENIL L   G+ I+I D GLA      + ++   GT  ++APEVV  +   F
Sbjct: 307 IVYRDLKPENIL-LDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
             D W++G + Y +++G SPF           V     +  +E     S  A+    +LL
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLL 424
Query: 242 LKD 244
            KD
Sbjct: 425 CKD 427

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 8/183 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K K TG   AAK +                I+    HP ++++  A+    
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GG +   +++ D  LTE  + +  RQ+ E + F+HSK ++H D+K  N+L
Sbjct: 90  KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVL 149
Query: 134 CLTKTGNRIKIIDFGL-ARKFDPEKKLQVLFGTPEFVAPEVVNFDAIG-----FGTDMWS 187
            +T  G+ I++ DFG+ A+     +K     GTP ++APEVV  + +      +  D+WS
Sbjct: 150 -MTLEGD-IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 207
Query: 188 VGV 190
           +G+
Sbjct: 208 LGI 210

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 115/243 (47%), Gaps = 6/243 (2%)
Query: 6   NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXX---XXXXXXXXXIMRELQHPRL 62
            Q+     G FG V  C+ +ATG   A K +   +               I+ ++    +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 63  IQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR-QICEGVEFIHSKN 121
           + +  A+E+ + +C+VL L+ GG+L   +         +A A+F   +IC G+E +H + 
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           +++ D+KPENIL L   G+ I+I D GLA      + ++   GT  ++APEVV  +   F
Sbjct: 307 IVYRDLKPENIL-LDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
             D W++G + Y +++G SPF           V     +  +E     S  A+    +LL
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLL 424
Query: 242 LKD 244
            KD
Sbjct: 425 CKD 427

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 95/196 (48%), Gaps = 13/196 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ------HPRLIQIYD 67
           G FG V   + + TG  +A K +   K            I RE+Q      HP +I++Y 
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK---IKREIQNLKLFRHPHIIKLYQ 78
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
              +     +V+E + GGELF+ +     V   +A  +F +QI   V++ H   V+H D+
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-QQILSAVDYCHRHMVVHRDL 137
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMW 186
           KPEN+L         KI DFGL+      + L+   G+P + APEV++     G   D+W
Sbjct: 138 KPENVLLDAHMNA--KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIW 195
Query: 187 SVGVICYVLLSGLSPF 202
           S GVI Y LL G  PF
Sbjct: 196 SCGVILYALLCGTLPF 211

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 117/244 (47%), Gaps = 13/244 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX--XIMRELQHPRLIQIYDAFES 71
           G FG     K    G     K + I++              ++  ++HP ++Q  ++FE 
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVL-TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +  + +V++  EGG+LF+R+     VL  E  +  +  QIC  ++ +H + +LH D+K +
Sbjct: 95  NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154
Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           NI  LTK G  +++ DFG+AR  +   +L +   GTP +++PE+         +D+W++G
Sbjct: 155 NIF-LTKDGT-VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALG 212
Query: 190 VICYVLLSGLSPFMGETDVQTMANVT--IAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
            + Y L +    F    +  +M N+   I    F     +  S D +  + +L  ++  D
Sbjct: 213 CVLYELCTLKHAF----EAGSMKNLVLKIISGSFPPVSLH-YSYDLRSLVSQLFKRNPRD 267
Query: 248 APEV 251
            P V
Sbjct: 268 RPSV 271

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 13/242 (5%)
Query: 14  GKFGTVYRCKEKATGMTLA---AKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V+ C+ KATG   A        + K            I+ ++    ++ +  AFE
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255
Query: 71  SSNVMCVVLELIEGGELFERV--IDDDFVLTEKAVAIFMR-QICEGVEFIHSKNVLHLDM 127
           +   +C+V+ ++ GG++   +  +D+D    ++  AIF   QI  G+E +H +N+++ D+
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L L   GN ++I D GLA +    + K +   GTP F+APE++  +   F  D +
Sbjct: 316 KPENVL-LDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF--NEISDDAKDFIRKLLLKD 244
           ++GV  Y +++   PF      + + N  + Q   +      ++ S  +KDF   LL KD
Sbjct: 374 ALGVTLYEMIAARGPFRARG--EKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKD 431
Query: 245 RE 246
            E
Sbjct: 432 PE 433

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 123/242 (50%), Gaps = 13/242 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXX---XXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V+ C+ KATG   A K +   +               I+ ++    ++ +  AFE
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255
Query: 71  SSNVMCVVLELIEGGELFERV--IDDDFVLTEKAVAIFMR-QICEGVEFIHSKNVLHLDM 127
           +   +C+V+ ++ GG++   +  +D+D    ++  AIF   QI  G+E +H +N+++ D+
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L L   GN ++I D GLA +    + K +   GTP F+APE++  +   F  D +
Sbjct: 316 KPENVL-LDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF--NEISDDAKDFIRKLLLKD 244
           ++GV  Y +++   PF      + + N  + Q   +      ++ S  +KDF   LL KD
Sbjct: 374 ALGVTLYEMIAARGPFRARG--EKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKD 431
Query: 245 RE 246
            E
Sbjct: 432 PE 433

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 123/242 (50%), Gaps = 13/242 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXX---XXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V+ C+ KATG   A K +   +               I+ ++    ++ +  AFE
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255
Query: 71  SSNVMCVVLELIEGGELFERV--IDDDFVLTEKAVAIFMR-QICEGVEFIHSKNVLHLDM 127
           +   +C+V+ ++ GG++   +  +D+D    ++  AIF   QI  G+E +H +N+++ D+
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L L   GN ++I D GLA +    + K +   GTP F+APE++  +   F  D +
Sbjct: 316 KPENVL-LDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF--NEISDDAKDFIRKLLLKD 244
           ++GV  Y +++   PF      + + N  + Q   +      ++ S  +KDF   LL KD
Sbjct: 374 ALGVTLYEMIAARGPFRARG--EKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKD 431
Query: 245 RE 246
            E
Sbjct: 432 PE 433

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 123/242 (50%), Gaps = 13/242 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXX---XXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG V+ C+ KATG   A K +   +               I+ ++    ++ +  AFE
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255
Query: 71  SSNVMCVVLELIEGGELFERV--IDDDFVLTEKAVAIFMR-QICEGVEFIHSKNVLHLDM 127
           +   +C+V+ ++ GG++   +  +D+D    ++  AIF   QI  G+E +H +N+++ D+
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L L   GN ++I D GLA +    + K +   GTP F+APE++  +   F  D +
Sbjct: 316 KPENVL-LDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF--NEISDDAKDFIRKLLLKD 244
           ++GV  Y +++   PF      + + N  + Q   +      ++ S  +KDF   LL KD
Sbjct: 374 ALGVTLYEMIAARGPFRARG--EKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKD 431
Query: 245 RE 246
            E
Sbjct: 432 PE 433

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 119/246 (48%), Gaps = 22/246 (8%)
Query: 14  GKFGTV----YRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG V    ++  +K   M L +KF  I K            IM     P ++Q++ AF
Sbjct: 86  GAFGEVQLVRHKASQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAF 144
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +    + +V+E + GG+L   + + D  + EK    +  ++   ++ IHS  ++H D+KP
Sbjct: 145 QDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKP 202
Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDA----IGFGT 183
           +N+L L K G+ +K+ DFG   K D    +      GTP++++PEV+         G   
Sbjct: 203 DNML-LDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGREC 260
Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF---NEISDDAKDFIRKL 240
           D WSVGV  + +L G +PF  ++ V T + +   +      CF    EIS  AK+ I   
Sbjct: 261 DWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL---CFPEDAEISKHAKNLICA- 316
Query: 241 LLKDRE 246
            L DRE
Sbjct: 317 FLTDRE 322

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 15/208 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQI 110
           I+++L HP ++++ +  +  N   + +V EL+  G + E  +     L+E     + + +
Sbjct: 89  ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLKPLSEDQARFYFQDL 146
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFV 169
            +G+E++H + ++H D+KP N+  L      IKI DFG++ +F   +  L    GTP F+
Sbjct: 147 IKGIEYLHYQKIIHRDIKPSNL--LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFM 204
Query: 170 APEVVNFDA---IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF 226
           APE ++       G   D+W++GV  Y  + G  PFM E  +   + +     +F D+  
Sbjct: 205 APESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQ-- 262
Query: 227 NEISDDAKDFIRKLLLKDRED---APEV 251
            +I++D KD I ++L K+ E     PE+
Sbjct: 263 PDIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 90.1 bits (222), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 13/194 (6%)
Query: 53  IMRELQHPRLIQIYDAF--ESSNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMR 108
           ++R L+H  +IQ+ D    E    M +V+E    G  E+ + V +  F + +     +  
Sbjct: 59  LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQ--AHGYFC 116
Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP---EKKLQVLFGT 165
           Q+ +G+E++HS+ ++H D+KP N+L LT TG  +KI   G+A    P   +   +   G+
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLL-LT-TGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 166 PEFVAPEVVN-FDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD 223
           P F  PE+ N  D   GF  D+WS GV  Y + +GL PF G+   +   N+    Y    
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG 234
Query: 224 ECFNEISDDAKDFI 237
           +C   +SD  K  +
Sbjct: 235 DCGPPLSDLLKGML 248

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 10  AFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---XXXXXXXXXXXXIMRELQHPRLIQIY 66
           A   G FG V   ++  T    A K++   K               IM+ L+HP L+ ++
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            +F+    M +V++L+ GG+L    +  +    E+ V +F+ ++   ++++ ++ ++H D
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD---AIGFGT 183
           MKP+NIL L + G+ + I DF +A     E ++  + GT  ++APE+ +        F  
Sbjct: 141 MKPDNIL-LDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198
Query: 184 DMWSVGVICYVLLSGLSPF 202
           D WS+GV  Y LL G  P+
Sbjct: 199 DWWSLGVTAYELLRGRRPY 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 16/246 (6%)
Query: 8   HSAFSFGKFGTVYRCKEKATGMTLAAKF----VGIAKXXXXXXXXXXXXIMRELQHPRLI 63
           H     G FG V+  + K T    A K     V +              +    +HP L 
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
            ++  F++   +  V+E + GG+L   +     F L+      +  +I  G++F+HSK +
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR--ATFYAAEIILGLQFLHSKGI 139
Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           ++ D+K +NIL L K G+ IKI DFG+ ++    + K     GTP+++APE++       
Sbjct: 140 VYRDLKLDNIL-LDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNH 197
Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE-ISDDAKDFIRKL 240
             D WS GV+ Y +L G SPF G+ + +   ++ +     D+  +   +  +AKD + KL
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYPRWLEKEAKDLLVKL 252
Query: 241 LLKDRE 246
            +++ E
Sbjct: 253 FVREPE 258

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 3   THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRL 62
           THQ +      G FG V+R K+K TG   A K     K                L  PR+
Sbjct: 75  THQPR---LGRGSFGEVHRMKDKQTGFQCAVK-----KVRLEVFRVEELVACAGLSSPRI 126
Query: 63  IQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           + +Y A      + + +EL+EGG L + +I     L E     ++ Q  EG+E++H++ +
Sbjct: 127 VPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 185
Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF------GTPEFVAPEVVNF 176
           LH D+K +N+L L+  G+R  + DFG A    P+   + L       GT   +APEVV  
Sbjct: 186 LHGDVKADNVL-LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 177 DAIGFGTDMWSVGVICYVLLSGLSPF 202
                  D+WS   +   +L+G  P+
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 16/246 (6%)
Query: 8   HSAFSFGKFGTVYRCKEKATGMTLAAKF----VGIAKXXXXXXXXXXXXIMRELQHPRLI 63
           H     G FG V+  + K T    A K     V +              +    +HP L 
Sbjct: 23  HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 82
Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
            ++  F++   +  V+E + GG+L   +     F L+      +  +I  G++F+HSK +
Sbjct: 83  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR--ATFYAAEIILGLQFLHSKGI 140
Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           ++ D+K +NIL L K G+ IKI DFG+ ++    + K     GTP+++APE++       
Sbjct: 141 VYRDLKLDNIL-LDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNH 198
Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE-ISDDAKDFIRKL 240
             D WS GV+ Y +L G SPF G+ + +   ++ +     D+  +   +  +AKD + KL
Sbjct: 199 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYPRWLEKEAKDLLVKL 253
Query: 241 LLKDRE 246
            +++ E
Sbjct: 254 FVREPE 259

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 93/187 (49%), Gaps = 11/187 (5%)
Query: 56  ELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVE 115
           +L H  ++ + D  E  +   +V+E IEG  L E +     +  + A+  F  QI +G++
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN-FTNQILDGIK 125
Query: 116 FIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV--LFGTPEFVAPEV 173
             H   ++H D+KP+NIL    +   +KI DFG+A+        Q   + GT ++ +PE 
Sbjct: 126 HAHDMRIVHRDIKPQNILI--DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 174 VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA 233
              +A    TD++S+G++ Y +L G  PF GET       V+IA     D   N  +D  
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKHIQDSVPNVTTDVR 237
Query: 234 KDFIRKL 240
           KD  + L
Sbjct: 238 KDIPQSL 244

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 3   THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRL 62
           THQ +      G FG V+R K+K TG   A K     K                L  PR+
Sbjct: 61  THQPR---VGRGSFGEVHRMKDKQTGFQCAVK-----KVRLEVFRVEELVACAGLSSPRI 112
Query: 63  IQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           + +Y A      + + +EL+EGG L + +I     L E     ++ Q  EG+E++H++ +
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF------GTPEFVAPEVVNF 176
           LH D+K +N+L L+  G+R  + DFG A    P+   + L       GT   +APEVV  
Sbjct: 172 LHGDVKADNVL-LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 177 DAIGFGTDMWSVGVICYVLLSGLSPF 202
                  D+WS   +   +L+G  P+
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 116/244 (47%), Gaps = 23/244 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ + K T +  AAK +                I+    HP ++++ DAF   N
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 107
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GG +   +++ +  LTE  + +  +Q  + + ++H   ++H D+K  NIL
Sbjct: 108 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 167
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDA-----IGFGTDMWS 187
             T  G+ IK+ DFG++ K     ++     GTP ++APEVV  +        +  D+WS
Sbjct: 168 -FTLDGD-IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 225
Query: 188 VGVICYVLLSGLSPFMGETD-------VQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
           +G I  + ++ + P   E +       +      T+AQ        +  S + KDF++K 
Sbjct: 226 LG-ITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-------SRWSSNFKDFLKKC 277
Query: 241 LLKD 244
           L K+
Sbjct: 278 LEKN 281

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 36/200 (18%)
Query: 77  VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT 136
           +V E + GG +    I       E   ++ ++ +   ++F+H+K + H D+KPENILC  
Sbjct: 88  LVFEKMRGGSILSH-IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 137 KTG-NRIKIIDFGLARKF------DPEKKLQVL--FGTPEFVAPEVVN--------FDAI 179
               + +KI DFGL           P    ++L   G+ E++APEVV         +D  
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK- 205
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETD-------------VQTM--ANVTIAQYDFDDE 224
               D+WS+GVI Y+LLSG  PF+G                 Q M   ++   +Y+F D+
Sbjct: 206 --RCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK 263
Query: 225 CFNEISDDAKDFIRKLLLKD 244
            +  IS  AKD I KLL++D
Sbjct: 264 DWAHISCAAKDLISKLLVRD 283

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 116/244 (47%), Gaps = 23/244 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ + K T +  AAK +                I+    HP ++++ DAF   N
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 107
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GG +   +++ +  LTE  + +  +Q  + + ++H   ++H D+K  NIL
Sbjct: 108 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 167
Query: 134 CLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDA-----IGFGTDMWS 187
             T  G+ IK+ DFG++ K     ++     GTP ++APEVV  +        +  D+WS
Sbjct: 168 -FTLDGD-IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 225
Query: 188 VGVICYVLLSGLSPFMGETD-------VQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
           +G I  + ++ + P   E +       +      T+AQ        +  S + KDF++K 
Sbjct: 226 LG-ITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-------SRWSSNFKDFLKKC 277
Query: 241 LLKD 244
           L K+
Sbjct: 278 LEKN 281

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 116/244 (47%), Gaps = 23/244 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ + K T +  AAK +                I+    HP ++++ DAF   N
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 107
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GG +   +++ +  LTE  + +  +Q  + + ++H   ++H D+K  NIL
Sbjct: 108 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 167
Query: 134 CLTKTGNRIKIIDFGL-ARKFDPEKKLQVLFGTPEFVAPEVVNFDA-----IGFGTDMWS 187
             T  G+ IK+ DFG+ A+     ++     GTP ++APEVV  +        +  D+WS
Sbjct: 168 -FTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 225
Query: 188 VGVICYVLLSGLSPFMGETD-------VQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
           +G I  + ++ + P   E +       +      T+AQ        +  S + KDF++K 
Sbjct: 226 LG-ITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-------SRWSSNFKDFLKKC 277
Query: 241 LLKD 244
           L K+
Sbjct: 278 LEKN 281

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 3   THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRL 62
           THQ +      G FG V+R K+K TG   A K     K                L  PR+
Sbjct: 77  THQPR---VGRGSFGEVHRMKDKQTGFQCAVK-----KVRLEVFRVEELVACAGLSSPRI 128
Query: 63  IQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           + +Y A      + + +EL+EGG L + +I     L E     ++ Q  EG+E++H++ +
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 187
Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF------GTPEFVAPEVVNF 176
           LH D+K +N+L L+  G+R  + DFG A    P+   + L       GT   +APEVV  
Sbjct: 188 LHGDVKADNVL-LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 177 DAIGFGTDMWSVGVICYVLLSGLSPF 202
                  D+WS   +   +L+G  P+
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 115/238 (48%), Gaps = 9/238 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX-XIMRELQHPRLIQIYDAFESS 72
           G FG VY+  +  T   +A K + + +             ++ +   P + + + ++  S
Sbjct: 30  GSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKS 89
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +++E + GG   + +      L E  +A  +R+I +G++++HS+  +H D+K  N+
Sbjct: 90  TKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSERKIHRDIKAANV 147
Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G+ +K+ DFG+A +  D + K     GTP ++APEV+   A  F  D+WS+G+ 
Sbjct: 148 L-LSEQGD-VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGIT 205
Query: 192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
              L  G  P    +D+  M  + +   +       + S   K+F+   L KD    P
Sbjct: 206 AIELAKGEPP---NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRP 260

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 16/239 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +G+VY+   K TG  +A K V +              IM++   P +++ Y ++  + 
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS--IMQQCDSPHVVKYYGSYFKNT 97
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E    G + + +   +  LTE  +A  ++   +G+E++H    +H D+K  NIL
Sbjct: 98  DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL 157
Query: 134 CLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFG--TDMWSVGV 190
               T    K+ DFG+A +  D   K   + GTP ++APEV+    IG+    D+WS+G+
Sbjct: 158 L--NTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQ--EIGYNCVADIWSLGI 213
Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE---ISDDAKDFIRKLLLKDRE 246
               +  G  P+    D+  M  + +   +     F +    SD+  DF+++ L+K  E
Sbjct: 214 TAIEMAEGKPPY---ADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDFVKQCLVKSPE 268

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 86/161 (53%), Gaps = 11/161 (6%)
Query: 57  LQHPRLIQIYDAFESSN----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           L HP ++ +YD  E+      +  +V+E ++G  L + ++  +  +T K     +   C+
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQ 127
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF----DPEKKLQVLFGTPEF 168
            + F H   ++H D+KP NIL      N +K++DFG+AR      +   +   + GT ++
Sbjct: 128 ALNFSHQNGIIHRDVKPANILI--SATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ 209
           ++PE    D++   +D++S+G + Y +L+G  PF G++ V 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXX-XXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 110/236 (46%), Gaps = 7/236 (2%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +G VY  ++ +  + +A K +                + + L+H  ++Q   +F  + 
Sbjct: 19  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 78
Query: 74  VMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            + + +E + GG L    R         E+ +  + +QI EG++++H   ++H D+K +N
Sbjct: 79  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 138
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFG--TDMWSV 188
           +L  T +G  +KI DFG +++          F GT +++APE+++    G+G   D+WS+
Sbjct: 139 VLINTYSG-VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL 197
Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           G     + +G  PF    + Q  A   +  +    E    +S +AK FI K    D
Sbjct: 198 GCTIIEMATGKPPFYELGEPQA-AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPD 252

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXX-XXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREG 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 137 LLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 195 GIVLTAMLAGELPWDQPSD 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 111/238 (46%), Gaps = 11/238 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +G VY  ++ +  + +A K +                + + L+H  ++Q   +F  + 
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92
Query: 74  VMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            + + +E + GG L    R         E+ +  + +QI EG++++H   ++H D+K +N
Sbjct: 93  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 152
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFG--TDMWSV 188
           +L  T +G  +KI DFG +++          F GT +++APE+++    G+G   D+WS+
Sbjct: 153 VLINTYSG-VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL 211
Query: 189 GVICYVLLSGLSPF--MGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           G     + +G  PF  +GE      A   +  +    E    +S +AK FI K    D
Sbjct: 212 GCTIIEMATGKPPFYELGEPQA---AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPD 266

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 2   TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPR 61
            THQ +      G FG V+R ++K TG   A K     K                L  PR
Sbjct: 95  ATHQLR---LGRGSFGEVHRMEDKQTGFQCAVK-----KVRLEVFRAEELMACAGLTSPR 146
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           ++ +Y A      + + +EL+EGG L + ++ +   L E     ++ Q  EG+E++HS+ 
Sbjct: 147 IVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEYLHSRR 205
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF------GTPEFVAPEVVN 175
           +LH D+K +N+L L+  G+   + DFG A    P+   + L       GT   +APEVV 
Sbjct: 206 ILHGDVKADNVL-LSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPF 202
             +     D+WS   +   +L+G  P+
Sbjct: 265 GRSCDAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXX-XXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 36/200 (18%)
Query: 77  VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT 136
           +V E + GG +    I       E   ++ ++ +   ++F+H+K + H D+KPENILC  
Sbjct: 88  LVFEKMRGGSILSH-IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 137 KTG-NRIKIIDFGLARKF------DPEKKLQVL--FGTPEFVAPEVVN--------FDAI 179
               + +KI DF L           P    ++L   G+ E++APEVV         +D  
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK- 205
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETD-------------VQTM--ANVTIAQYDFDDE 224
               D+WS+GVI Y+LLSG  PF+G                 Q M   ++   +Y+F D+
Sbjct: 206 --RCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK 263
Query: 225 CFNEISDDAKDFIRKLLLKD 244
            +  IS  AKD I KLL++D
Sbjct: 264 DWAHISCAAKDLISKLLVRD 283

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 57  LQHPRLIQIYDAFESSN----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           L HP ++ +YD  E+      +  +V+E ++G  L + ++  +  +T K     +   C+
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQ 127
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF----DPEKKLQVLFGTPEF 168
            + F H   ++H D+KP NI+      N +K++DFG+AR      +   +   + GT ++
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE 228
           ++PE    D++   +D++S+G + Y +L+G  PF G++ V ++A   + +        +E
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPIPPSARHE 244
Query: 229 -ISDDAKDFIRKLLLKDRED 247
            +S D    + K L K+ E+
Sbjct: 245 GLSADLDAVVLKALAKNPEN 264

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 86/161 (53%), Gaps = 11/161 (6%)
Query: 57  LQHPRLIQIYDAFESSN----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           L HP ++ +YD  E+      +  +V+E ++G  L + ++  +  +T K     +   C+
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQ 127
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF----DPEKKLQVLFGTPEF 168
            + F H   ++H D+KP NI+      N +K++DFG+AR      +   +   + GT ++
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ 209
           ++PE    D++   +D++S+G + Y +L+G  PF G++ V 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 57  LQHPRLIQIYDAFESSN----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           L HP ++ +YD  E+      +  +V+E ++G  L + ++  +  +T K     +   C+
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQ 144
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF----DPEKKLQVLFGTPEF 168
            + F H   ++H D+KP NI+      N +K++DFG+AR      +   +   + GT ++
Sbjct: 145 ALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE 228
           ++PE    D++   +D++S+G + Y +L+G  PF G++ V ++A   + +        +E
Sbjct: 203 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPIPPSARHE 261
Query: 229 -ISDDAKDFIRKLLLKDRED 247
            +S D    + K L K+ E+
Sbjct: 262 GLSADLDAVVLKALAKNPEN 281

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 16  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 75
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 76  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 135 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 193 GIVLTAMLAGELPWDQPSD 211

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 137 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 195 GIVLTAMLAGELPWDQPSD 213

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 17  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 76
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 77  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 135
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 136 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 193
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 194 GIVLTAMLAGELPWDQPSD 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 137 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 195 GIVLTAMLAGELPWDQPSD 213

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 2   TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPR 61
            THQ +      G FG V+R ++K TG   A K     K                L  PR
Sbjct: 76  ATHQLR---LGRGSFGEVHRMEDKQTGFQCAVK-----KVRLEVFRAEELMACAGLTSPR 127
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           ++ +Y A      + + +EL+EGG L + ++ +   L E     ++ Q  EG+E++HS+ 
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEYLHSRR 186
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF------GTPEFVAPEVVN 175
           +LH D+K +N+L L+  G+   + DFG A    P+   + L       GT   +APEVV 
Sbjct: 187 ILHGDVKADNVL-LSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPF 202
             +     D+WS   +   +L+G  P+
Sbjct: 246 GRSCDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 137 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 195 GIVLTAMLAGELPWDQPSD 213

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 137 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 195 GIVLTAMLAGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 137 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 195 GIVLTAMLAGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXX-IMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             I + L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 137 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 195 GIVLTAMLAGELPWDQPSD 213

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 39/255 (15%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF-- 69
           G +G   + + K+ G  L  K +  G               ++REL+HP +++ YD    
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 70  ESSNVMCVVLELIEGGELF---------ERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
            ++  + +V+E  EGG+L           + +D++FVL        M Q+   ++  H +
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR------VMTQLTLALKECHRR 130
Query: 121 N-----VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVV 174
           +     VLH D+KP N+    K    +K+ DFGLAR  + +      F GTP +++PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ-----YDFDDECFNEI 229
           N  +    +D+WS+G + Y L + + PF   +  +    +   +     Y + DE  NEI
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE-LNEI 247
Query: 230 SDDAKDFIRKLLLKD 244
                   R L LKD
Sbjct: 248 ------ITRMLNLKD 256

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 39/255 (15%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF-- 69
           G +G   + + K+ G  L  K +  G               ++REL+HP +++ YD    
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 70  ESSNVMCVVLELIEGGELF---------ERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
            ++  + +V+E  EGG+L           + +D++FVL        M Q+   ++  H +
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR------VMTQLTLALKECHRR 130
Query: 121 N-----VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVV 174
           +     VLH D+KP N+    K    +K+ DFGLAR  + +      F GTP +++PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 188
Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ-----YDFDDECFNEI 229
           N  +    +D+WS+G + Y L + + PF   +  +    +   +     Y + DE  NEI
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE-LNEI 247
Query: 230 SDDAKDFIRKLLLKD 244
                   R L LKD
Sbjct: 248 ------ITRMLNLKD 256

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 98/188 (52%), Gaps = 10/188 (5%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +  ++ AF+  N + +V++   GG+L   +   +  L E     ++ ++   ++ IH  +
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAI 179
            +H D+KP+N+L        I++ DFG   K + +  +Q  V  GTP++++PE++     
Sbjct: 212 YVHRDIKPDNVLL--DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 180 GFGT-----DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-DECFNEISDDA 233
           G G      D WS+GV  Y +L G +PF  E+ V+T   +   +  F       ++S++A
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 329
Query: 234 KDFIRKLL 241
           KD I++L+
Sbjct: 330 KDLIQRLI 337

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 85/158 (53%), Gaps = 11/158 (6%)
Query: 57  LQHPRLIQIYDAFESSN----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           L HP ++ +YD  E+      +  +V+E ++G  L + ++  +  +T K     +   C+
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQ 127
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF----DPEKKLQVLFGTPEF 168
            + F H   ++H D+KP NI+      N +K++DFG+AR      +   +   + GT ++
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET 206
           ++PE    D++   +D++S+G + Y +L+G  PF G++
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 98/188 (52%), Gaps = 10/188 (5%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +  ++ AF+  N + +V++   GG+L   +   +  L E     ++ ++   ++ IH  +
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAI 179
            +H D+KP+N+L        I++ DFG   K + +  +Q  V  GTP++++PE++     
Sbjct: 196 YVHRDIKPDNVLL--DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 180 GFGT-----DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-DECFNEISDDA 233
           G G      D WS+GV  Y +L G +PF  E+ V+T   +   +  F       ++S++A
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 313
Query: 234 KDFIRKLL 241
           KD I++L+
Sbjct: 314 KDLIQRLI 321

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G + TVY+   K TG+ +A K V + ++            +M+EL+H  ++++YD   + 
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE 75
Query: 73  NVMCVVLELIEGGELFERVIDDDFV------LTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
           N + +V E ++     ++ +D   V      L    V  F  Q+ +G+ F H   +LH D
Sbjct: 76  NKLTLVFEFMDND--LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRD 133
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVV-NFDAIGFGTD 184
           +KP+N+L + K G ++K+ DFGLAR F  P         T  + AP+V+          D
Sbjct: 134 LKPQNLL-INKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSID 191
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTM 211
           +WS G I   +++G   F G  D + +
Sbjct: 192 IWSCGCILAEMITGKPLFPGTNDEEQL 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 39/255 (15%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF-- 69
           G +G   + + K+ G  L  K +  G               ++REL+HP +++ YD    
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 70  ESSNVMCVVLELIEGGELF---------ERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
            ++  + +V+E  EGG+L           + +D++FVL        M Q+   ++  H +
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR------VMTQLTLALKECHRR 130
Query: 121 N-----VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVV 174
           +     VLH D+KP N+    K    +K+ DFGLAR  + ++     F GTP +++PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM 188
Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ-----YDFDDECFNEI 229
           N  +    +D+WS+G + Y L + + PF   +  +    +   +     Y + DE  NEI
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE-LNEI 247
Query: 230 SDDAKDFIRKLLLKD 244
                   R L LKD
Sbjct: 248 ------ITRMLNLKD 256

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 8/199 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRE-LQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +             +   L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREG 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 133 LCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L   +  + +KI DFGLA  F   + E+ L  + GT  +VAPE++          D+WS 
Sbjct: 137 LLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 189 GVICYVLLSGLSPFMGETD 207
           G++   +L+G  P+   +D
Sbjct: 195 GIVLTAMLAGELPWDQPSD 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 98/188 (52%), Gaps = 10/188 (5%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +  ++ AF+  N + +V++   GG+L   +   +  L E+    ++ ++   ++ +H  +
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAI 179
            +H D+KP+NI  L      I++ DFG   K   +  +Q  V  GTP++++PE++     
Sbjct: 196 YVHRDIKPDNI--LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 180 GFG-----TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-DECFNEISDDA 233
           G G      D WS+GV  Y +L G +PF  E+ V+T   +   +  F       ++S++A
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 234 KDFIRKLL 241
           KD IR+L+
Sbjct: 314 KDLIRRLI 321

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 7/159 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           I + L H  +++ Y      N+  + LE   GGELF+R I+ D  + E     F  Q+  
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMA 115
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTPEFV 169
           GV ++H   + H D+KPEN+L   +  + +KI DFGLA  F   + E+ L  + GT  +V
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 170 APEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETD 207
           APE++          D+WS G++   +L+G  P+   +D
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ K+ + G  +A K + +              I  ++EL HP ++ + D   S
Sbjct: 32  GTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V E +E     ++V+D++   L +  + I++ Q+  GV   H   +LH D+KP+
Sbjct: 91  ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148
Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVV-NFDAIGFGTDMWSV 188
           N+  L  +   +K+ DFGLAR F  P +       T  + AP+V+          D+WS+
Sbjct: 149 NL--LINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSI 206
Query: 189 GVICYVLLSGLSPFMGETDVQTMANV 214
           G I   +++G   F G TD   +  +
Sbjct: 207 GCIFAEMITGKPLFPGVTDDDQLPKI 232

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ K+ + G  +A K + +              I  ++EL HP ++ + D   S
Sbjct: 32  GTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V E +E     ++V+D++   L +  + I++ Q+  GV   H   +LH D+KP+
Sbjct: 91  ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148
Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVV-NFDAIGFGTDMWSV 188
           N+  L  +   +K+ DFGLAR F  P +       T  + AP+V+          D+WS+
Sbjct: 149 NL--LINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSI 206
Query: 189 GVICYVLLSGLSPFMGETDVQTMANV 214
           G I   +++G   F G TD   +  +
Sbjct: 207 GCIFAEMITGKPLFPGVTDDDQLPKI 232

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 57  LQHPRLIQIYDAFESSN----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           L HP ++ +Y   E+      +  +V+E ++G  L + ++  +  +T K     +   C+
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQ 127
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF----DPEKKLQVLFGTPEF 168
            + F H   ++H D+KP NI+      N +K++DFG+AR      +   +   + GT ++
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE 228
           ++PE    D++   +D++S+G + Y +L+G  PF G++ V ++A   + +        +E
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPIPPSARHE 244
Query: 229 -ISDDAKDFIRKLLLKDRED 247
            +S D    + K L K+ E+
Sbjct: 245 GLSADLDAVVLKALAKNPEN 264

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +GTV++ K + T   +A K V +              I  ++EL+H  +++++D   S
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 72  SNVMCVVLELIEG--GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V E  +    + F+    D   L  + V  F+ Q+ +G+ F HS+NVLH D+KP
Sbjct: 73  DKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMW 186
           +N+L + + G  +K+ DFGLAR F  P +       T  +  P+V+ F A  + T  DMW
Sbjct: 130 QNLL-INRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL-FGAKLYSTSIDMW 186
Query: 187 SVGVICYVLLSGLSPFMGETDV 208
           S G I   L +   P     DV
Sbjct: 187 SAGCIFAELANAARPLFPGNDV 208

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 75
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 76  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           EN+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 134 ENLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 191
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 192 LGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 75  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           EN+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 133 ENLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 190
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 191 LGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 86/152 (56%), Gaps = 6/152 (3%)
Query: 59  HPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
           HP L+ ++  F++ + +  V+E + GG+L    +     L E+    +  +I   + ++H
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFD 177
            + +++ D+K +N+L L   G+ IK+ D+G+ ++   P        GTP ++APE++  +
Sbjct: 171 ERGIIYRDLKLDNVL-LDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 178 AIGFGTDMWSVGVICYVLLSGLSPF--MGETD 207
             GF  D W++GV+ + +++G SPF  +G +D
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEF 116
           L+HP +I +         +C+V+E   GG L  RV+    +  +  V  +  QI  G+ +
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVN-WAVQIARGMNY 120
Query: 117 IHSK---NVLHLDMKPENILCLTKTGNR------IKIIDFGLARKFDPEKKLQVLFGTPE 167
           +H +    ++H D+K  NIL L K  N       +KI DFGLAR++    K+    G   
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA-GAYA 179
Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
           ++APEV+       G+D+WS GV+ + LL+G  PF G
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 74  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 132 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWS 189
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 190 LGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 86/152 (56%), Gaps = 6/152 (3%)
Query: 59  HPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
           HP L+ ++  F++ + +  V+E + GG+L    +     L E+    +  +I   + ++H
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFD 177
            + +++ D+K +N+L L   G+ IK+ D+G+ ++   P        GTP ++APE++  +
Sbjct: 139 ERGIIYRDLKLDNVL-LDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 196
Query: 178 AIGFGTDMWSVGVICYVLLSGLSPF--MGETD 207
             GF  D W++GV+ + +++G SPF  +G +D
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 228

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 80
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 81  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 138
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 139 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWS 196
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 197 LGCIFAEMVTRRALFPGDSEIDQLFRI 223

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 74  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKP 131
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 132 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 189
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 190 LGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 74  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 132 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 189
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 190 LGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 83/149 (55%), Gaps = 4/149 (2%)
Query: 60  PRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS 119
           P L Q++  F++ + +  V+E + GG+L    I       E     +  +I  G+ F+ S
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH-IQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDA 178
           K +++ D+K +N++ L   G+ IKI DFG+ ++   +      F GTP+++APE++ +  
Sbjct: 461 KGIIYRDLKLDNVM-LDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETD 207
            G   D W+ GV+ Y +L+G +PF GE +
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 86/156 (55%), Gaps = 4/156 (2%)
Query: 60  PRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS 119
           P L Q++  F++ + +  V+E + GG+L    I       E     +  +I  G+ F+ S
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH-IQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDA 178
           K +++ D+K +N++ L   G+ IKI DFG+ ++   +      F GTP+++APE++ +  
Sbjct: 140 KGIIYRDLKLDNVM-LDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
            G   D W+ GV+ Y +L+G +PF GE + +   ++
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 86/152 (56%), Gaps = 6/152 (3%)
Query: 59  HPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
           HP L+ ++  F++ + +  V+E + GG+L    +     L E+    +  +I   + ++H
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFD 177
            + +++ D+K +N+L L   G+ IK+ D+G+ ++   P        GTP ++APE++  +
Sbjct: 124 ERGIIYRDLKLDNVL-LDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 178 AIGFGTDMWSVGVICYVLLSGLSPF--MGETD 207
             GF  D W++GV+ + +++G SPF  +G +D
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 213

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 86/153 (56%), Gaps = 6/153 (3%)
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFI 117
            HP L+ ++  F++ + +  V+E + GG+L    +     L E+    +  +I   + ++
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYL 126
Query: 118 HSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNF 176
           H + +++ D+K +N+L L   G+ IK+ D+G+ ++   P        GTP ++APE++  
Sbjct: 127 HERGIIYRDLKLDNVL-LDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 177 DAIGFGTDMWSVGVICYVLLSGLSPF--MGETD 207
           +  GF  D W++GV+ + +++G SPF  +G +D
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +      ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 75  ENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           EN+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 133 ENLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 190
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 191 LGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 73  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 131 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 188
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 189 LGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 18  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 77
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 78  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 135
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 136 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 193
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 194 LGCIFAEMVTRRALFPGDSEIDQLFRI 220

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 73  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 131 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 188
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 189 LGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 74  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 132 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 189
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 190 LGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 73  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 131 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 188
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 189 LGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 74  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 132 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 189
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 190 LGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 74  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 132 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 189
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 190 LGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 75  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 133 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 190
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 191 LGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 75  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 133 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 190
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 191 LGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +      ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 77  ENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           EN+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 135 ENLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 192
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 193 LGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 74  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 132 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 189
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 190 LGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 73  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 131 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 188
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 189 LGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 75
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 76  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 134 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 191
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 192 LGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 74  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 132 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 189
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 190 LGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVID--DDFVLTEKAVAI---FMRQICEGVEFIHSKNVLHLD 126
            N + +V E      L + + D  D   LT   + +   ++ Q+ +G+ F HS  VLH D
Sbjct: 74  ENKLYLVFEF-----LHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTD 184
           +KPEN+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D
Sbjct: 129 LKPENLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           +WS+G I   +++  + F G++++  +  +
Sbjct: 187 IWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 74
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 75  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 133 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 190
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 191 LGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI--AKXXXXXXXXXXXXIMRELQ---HPRLIQIYDA 68
           G +GTVY+ ++  +G  +A K V +   +            ++R L+   HP ++++ D 
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDV 74
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKA---------VAIFMRQICEGVEFIHS 119
             +S         I+   +FE V  D     +KA         +   MRQ   G++F+H+
Sbjct: 75  CATSRTD----REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI 179
             ++H D+KPENIL    +G  +K+ DFGLAR +  +  L  +  T  + APEV+     
Sbjct: 131 NCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTY 188
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
               DMWSVG I   +      F G ++   +  +
Sbjct: 189 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 223

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 77  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 135 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 192
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 193 LGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 77  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 135 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 192
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 193 LGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 75
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 76  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 134 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 191
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 192 LGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 18  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 77
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 78  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 135
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 136 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 193
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 194 LGCIFAEMVTRRALFPGDSEIDQL 217

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI--AKXXXXXXXXXXXXIMRELQ---HPRLIQIYDA 68
           G +GTVY+ ++  +G  +A K V +   +            ++R L+   HP ++++ D 
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDV 74
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKA---------VAIFMRQICEGVEFIHS 119
             +S         I+   +FE V  D     +KA         +   MRQ   G++F+H+
Sbjct: 75  CATSRTD----REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI 179
             ++H D+KPENIL    +G  +K+ DFGLAR +  +  L  +  T  + APEV+     
Sbjct: 131 NCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTY 188
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
               DMWSVG I   +      F G ++   +  +
Sbjct: 189 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 223

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 80
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 81  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 138
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 139 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 196
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 197 LGCIFAEMVTRRALFPGDSEIDQLFRI 223

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E ++  +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 77  ENKLYLVFEHVD--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 135 QNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWS 192
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G I   +++  + F G++++  +
Sbjct: 193 LGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +GTVY+ ++  +G  +A K V +              + RE+    L++  +AFE  N
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVA---LLRRLEAFEHPN 75
Query: 74  VM-----CVVLEL---IEGGELFERVIDDDFVLTEKA---------VAIFMRQICEGVEF 116
           V+     C        I+   +FE V  D     +KA         +   MRQ   G++F
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF 176
           +H+  ++H D+KPENIL    +G  +K+ DFGLAR +  +  L  +  T  + APEV+  
Sbjct: 136 LHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ 193
Query: 177 DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
                  DMWSVG I   +      F G ++   +  +
Sbjct: 194 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 85/156 (54%), Gaps = 4/156 (2%)
Query: 60  PRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS 119
           P L Q++  F++ + +  V+E + GG+L    I       E     +  +I  G+ F+H 
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYH-IQQVGKFKEPQAVFYAAEISIGLFFLHK 138
Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDA 178
           + +++ D+K +N++ L   G+ IKI DFG+ ++   +      F GTP+++APE++ +  
Sbjct: 139 RGIIYRDLKLDNVM-LDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP 196
Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
            G   D W+ GV+ Y +L+G  PF GE + +   ++
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 232

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX-XIMRELQHPRLIQIYDAFESS 72
           G FG V++  +  T   +A K + + +             ++ +   P + + Y ++   
Sbjct: 38  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 97
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +++E + GG   + +  +   L E  +A  +R+I +G++++HS+  +H D+K  N+
Sbjct: 98  TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 155
Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G  +K+ DFG+A +  D + K     GTP ++APEV+   A     D+WS+G+ 
Sbjct: 156 L-LSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 213
Query: 192 CYVLLSGLSP 201
              L  G  P
Sbjct: 214 AIELARGEPP 223

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI---FMRQICEGVEFIHSKNVLHLDMK 128
            N + +V E +       +   D   LT   + +   ++ Q+ +G+ F HS  VLH D+K
Sbjct: 77  ENKLYLVFEFLHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 133
Query: 129 PENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMW 186
           P+N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+W
Sbjct: 134 PQNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 187 SVGVICYVLLSGLSPFMGETDVQTM 211
           S+G I   +++  + F G++++  +
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX-XIMRELQHPRLIQIYDAFESS 72
           G FG V++  +  T   +A K + + +             ++ +   P + + Y ++   
Sbjct: 18  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +++E + GG   + +  +   L E  +A  +R+I +G++++HS+  +H D+K  N+
Sbjct: 78  TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 135
Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G  +K+ DFG+A +  D + K     GTP ++APEV+   A     D+WS+G+ 
Sbjct: 136 L-LSEHGE-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 193
Query: 192 CYVLLSGLSP 201
              L  G  P
Sbjct: 194 AIELARGEPP 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX-XIMRELQHPRLIQIYDAFESS 72
           G FG V++  +  T   +A K + + +             ++ +   P + + Y ++   
Sbjct: 33  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +++E + GG   + +  +   L E  +A  +R+I +G++++HS+  +H D+K  N+
Sbjct: 93  TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150
Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G  +K+ DFG+A +  D + K     GTP ++APEV+   A     D+WS+G+ 
Sbjct: 151 L-LSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 208
Query: 192 CYVLLSGLSP 201
              L  G  P
Sbjct: 209 AIELARGEPP 218

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI---FMRQICEGVEFIHSKNVLHLDMK 128
            N + +V E +       +   D   LT   + +   ++ Q+ +G+ F HS  VLH D+K
Sbjct: 73  ENKLYLVFEHVHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 129 PENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMW 186
           P+N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+W
Sbjct: 130 PQNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 187 SVGVICYVLLSGLSPFMGETDVQTM 211
           S+G I   +++  + F G++++  +
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX-XIMRELQHPRLIQIYDAFESS 72
           G FG V++  +  T   +A K + + +             ++ +   P + + Y ++   
Sbjct: 18  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 77
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +++E + GG   + +  +   L E  +A  +R+I +G++++HS+  +H D+K  N+
Sbjct: 78  TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 135
Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G  +K+ DFG+A +  D + K     GTP ++APEV+   A     D+WS+G+ 
Sbjct: 136 L-LSEHGE-VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 193
Query: 192 CYVLLSGLSP 201
              L  G  P
Sbjct: 194 AIELARGEPP 203

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +GTV++ K + T   +A K V +              I  ++EL+H  +++++D   S
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 72  SNVMCVVLELIEG--GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V E  +    + F+    D   L  + V  F+ Q+ +G+ F HS+NVLH D+KP
Sbjct: 73  DKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMW 186
           +N+L + + G  +K+ +FGLAR F  P +       T  +  P+V+ F A  + T  DMW
Sbjct: 130 QNLL-INRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL-FGAKLYSTSIDMW 186
Query: 187 SVGVICYVLLSGLSPFMGETDV 208
           S G I   L +   P     DV
Sbjct: 187 SAGCIFAELANAGRPLFPGNDV 208

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI--AKXXXXXXXXXXXXIMRELQ---HPRLIQIYDA 68
           G +GTVY+ ++  +G  +A K V +   +            ++R L+   HP ++++ D 
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDV 74
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKA---------VAIFMRQICEGVEFIHS 119
             +S         I+   +FE V  D     +KA         +   MRQ   G++F+H+
Sbjct: 75  CATSRTD----REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI 179
             ++H D+KPENIL    +G  +K+ DFGLAR +  +  L  +  T  + APEV+     
Sbjct: 131 NCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTY 188
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
               DMWSVG I   +      F G ++   +  +
Sbjct: 189 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 223

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 75
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI---FMRQICEGVEFIHSKNVLHLDMK 128
            N + +V E +    +  +   D   LT   + +   ++ Q+ +G+ F HS  VLH D+K
Sbjct: 76  ENKLYLVFEFLS---MDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 132
Query: 129 PENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMW 186
           P+N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+W
Sbjct: 133 PQNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANV 214
           S+G I   +++  + F G++++  +  +
Sbjct: 191 SLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +              I  ++EL HP ++++ D   +
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 76
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI---FMRQICEGVEFIHSKNVLHLDMK 128
            N + +V E +    +  +   D   LT   + +   ++ Q+ +G+ F HS  VLH D+K
Sbjct: 77  ENKLYLVFEFLS---MDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 133
Query: 129 PENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMW 186
           P+N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+W
Sbjct: 134 PQNLLI--NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANV 214
           S+G I   +++  + F G++++  +  +
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A   + +              I  ++EL HP ++++ D   +
Sbjct: 14  GTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 74  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 132 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 189
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 190 LGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 10/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A   + +              I  ++EL HP ++++ D   +
Sbjct: 13  GTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            N + +V E +   +  ++ +D   +  +    +  ++ Q+ +G+ F HS  VLH D+KP
Sbjct: 73  ENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWS 187
           +N+L    T   IK+ DFGLAR F  P +       T  + APE+ +         D+WS
Sbjct: 131 QNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 188
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           +G I   +++  + F G++++  +  +
Sbjct: 189 LGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 113/238 (47%), Gaps = 9/238 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXX-XIMRELQHPRLIQIYDAFESS 72
           G FG V++  +  T   +A K + + +             ++ +     + + Y ++   
Sbjct: 34  GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKG 93
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           + + +++E + GG   + +    F   E  +A  +++I +G++++HS+  +H D+K  N+
Sbjct: 94  SKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV 151
Query: 133 LCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G+ +K+ DFG+A +  D + K     GTP ++APEV+   A     D+WS+G+ 
Sbjct: 152 L-LSEQGD-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGIT 209
Query: 192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
              L  G  P    +D+  M  + +   +       + +   K+FI   L KD    P
Sbjct: 210 AIELAKGEPP---NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRP 264

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXI--MRELQHPRLIQIYDAFES 71
           G +G V++C+ + TG  +A K    ++            I  +++L+HP L+ + + F  
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73
Query: 72  SNVMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V E  +   L E    D +   + E  V     Q  + V F H  N +H D+KP
Sbjct: 74  KRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKP 130
Query: 130 ENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDA-IGFGTDMWS 187
           ENIL +TK  + IK+ DFG AR    P         T  + +PE++  D   G   D+W+
Sbjct: 131 ENIL-ITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWA 188
Query: 188 VGVICYVLLSGLSPFMGETDVQTM 211
           +G +   LLSG+  + G++DV  +
Sbjct: 189 IGCVFAELLSGVPLWPGKSDVDQL 212

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDF--VLTEKAVAIFMRQI 110
           +M+ LQH +L+++Y        + ++ E +  G L + +  D+   VL  K +  F  QI
Sbjct: 61  LMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID-FSAQI 119
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTP-EF 168
            EG+ +I  KN +H D++  N+L         KI DFGLAR   D E   +     P ++
Sbjct: 120 AEGMAYIERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 177
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ--------- 218
            APE +NF      +D+WS G++ Y +++ G  P+ G T+   M  ++            
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCP 237
Query: 219 ---YDFDDECFNEISDDAKDF 236
              YD    C+ E +++   F
Sbjct: 238 DELYDIMKMCWKEKAEERPTF 258

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G +G VY+ +   TG   A K + +              + +   H  +   Y AF   N
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94
Query: 74  V------MCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
                  + +V+E    G + + + +     L E+ +A   R+I  G+  +H   V+H D
Sbjct: 95  PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRD 154
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVV----NFDAI-G 180
           +K +N+L LT+    +K++DFG++ + D    +     GTP ++APEV+    N DA   
Sbjct: 155 IKGQNVL-LTENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 212
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+WS+G+    +  G  P 
Sbjct: 213 FKSDLWSLGITAIEMAEGAPPL 234

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 16/163 (9%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVID-------DDFVLTEKAVAIF 106
           M +  HP ++  Y +F   + + +V++L+ GG + + +            VL E  +A  
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR------KFDPEKKLQ 160
           +R++ EG+E++H    +H D+K  NIL L + G+ ++I DFG++            K  +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNIL-LGEDGS-VQIADFGVSAFLATGGDITRNKVRK 184
Query: 161 VLFGTPEFVAPEVV-NFDAIGFGTDMWSVGVICYVLLSGLSPF 202
              GTP ++APEV+       F  D+WS G+    L +G +P+
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 16/163 (9%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVID-------DDFVLTEKAVAIF 106
           M +  HP ++  Y +F   + + +V++L+ GG + + +            VL E  +A  
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR------KFDPEKKLQ 160
           +R++ EG+E++H    +H D+K  NIL L + G+ ++I DFG++            K  +
Sbjct: 122 LREVLEGLEYLHKNGQIHRDVKAGNIL-LGEDGS-VQIADFGVSAFLATGGDITRNKVRK 179
Query: 161 VLFGTPEFVAPEVV-NFDAIGFGTDMWSVGVICYVLLSGLSPF 202
              GTP ++APEV+       F  D+WS G+    L +G +P+
Sbjct: 180 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDF--VLTEKAVAIFMRQI 110
           +M+ LQH +L+++Y        + ++ E +  G L + +  D+   VL  K +  F  QI
Sbjct: 60  LMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLID-FSAQI 118
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTP-EF 168
            EG+ +I  KN +H D++  N+  L       KI DFGLAR   D E   +     P ++
Sbjct: 119 AEGMAYIERKNYIHRDLRAANV--LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 176
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ--------- 218
            APE +NF      +++WS G++ Y +++ G  P+ G T+   M+ ++            
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCP 236
Query: 219 ---YDFDDECFNEISDDAKDF 236
              YD    C+ E +++   F
Sbjct: 237 DELYDIMKMCWKEKAEERPTF 257

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 8/197 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXX-XXXXXXXIMRELQHPRLIQIYDAFESS 72
           G + TVY+ K K T   +A K + +               ++++L+H  ++ ++D   + 
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +V E ++  +L + + D   ++    V +F+ Q+  G+ + H + VLH D+KP+N+
Sbjct: 73  KSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131
Query: 133 LCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWSVG 189
           L   +    +K+ DFGLAR K  P K       T  +  P+++   +  + T  DMW VG
Sbjct: 132 LINER--GELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL-LGSTDYSTQIDMWGVG 188
Query: 190 VICYVLLSGLSPFMGET 206
            I Y + +G   F G T
Sbjct: 189 CIFYEMATGRPLFPGST 205

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 35  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 90
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           +  + +V +  EG  L+  +   +     K +    RQ   G++++H+K+++H D+K  N
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN 150
Query: 132 ILCLTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIGFGTDM 185
           I       N +KI DFGLA    ++    + + L G+  ++APEV+     +   F +D+
Sbjct: 151 IFL--HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDV 208
Query: 186 WSVGVICYVLLSGLSPF 202
           ++ G++ Y L++G  P+
Sbjct: 209 YAFGIVLYELMTGQLPY 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 14  GKFGTVYRCKEKATGMTLAAK--FVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G V +C+ K TG  +A K                    ++++L+H  L+ + +  + 
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95
Query: 72  SNVMCVVLELIEGG-----ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
                +V E ++       ELF   +D       + V  ++ QI  G+ F HS N++H D
Sbjct: 96  KKRWYLVFEFVDHTILDDLELFPNGLD------YQVVQKYLFQIINGIGFCHSHNIIHRD 149
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDA-IGFGTD 184
           +KPENIL ++++G  +K+ DFG AR    P +       T  + APE++  D   G   D
Sbjct: 150 IKPENIL-VSQSG-VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVD 207
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTI 216
           +W++G +   +  G   F G++D+  + ++ +
Sbjct: 208 VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXX--XXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G VY+ +    G T A K + + K              I++EL+H  ++++YD   +
Sbjct: 13  GTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 72  SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V E ++  +  ++++D  +  L       F+ Q+  G+ + H + VLH D+KP+
Sbjct: 72  KKRLVLVFEHLD--QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWS 187
           N+L + + G  +KI DFGLAR F  P +K      T  + AP+V+   +  + T  D+WS
Sbjct: 130 NLL-INREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL-MGSKKYSTTIDIWS 186
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           VG I   +++G   F G ++   +  +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRI 213

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HPRLIQIY 66
           G FG V   + K TG   A K   + K             M E +       HP L Q++
Sbjct: 34  GSFGKVMLARVKETGDLYAVK---VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
             F++ + +  V+E + GG+L    I       E     +  +I   + F+H K +++ D
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFH-IQKSRRFDEARARFYAAEIISALMFLHDKGIIYRD 149
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDM 185
           +K +N+L L   G+  K+ DFG+ ++          F GTP+++APE++     G   D 
Sbjct: 150 LKLDNVL-LDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207
Query: 186 WSVGVICYVLLSGLSPFMGETD 207
           W++GV+ Y +L G +PF  E +
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENE 229

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXX--XXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G VY+ +    G T A K + + K              I++EL+H  ++++YD   +
Sbjct: 13  GTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 72  SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V E ++  +  ++++D  +  L       F+ Q+  G+ + H + VLH D+KP+
Sbjct: 72  KKRLVLVFEHLD--QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWS 187
           N+L + + G  +KI DFGLAR F  P +K      T  + AP+V+   +  + T  D+WS
Sbjct: 130 NLL-INREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL-MGSKKYSTTIDIWS 186
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           VG I   +++G   F G ++   +  +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRI 213

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXX--XXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G VY+ +    G T A K + + K              I++EL+H  ++++YD   +
Sbjct: 13  GTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 72  SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V E ++  +  ++++D  +  L       F+ Q+  G+ + H + VLH D+KP+
Sbjct: 72  KKRLVLVFEHLD--QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWS 187
           N+L + + G  +KI DFGLAR F  P +K      T  + AP+V+   +  + T  D+WS
Sbjct: 130 NLL-INREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL-MGSKKYSTTIDIWS 186
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
           VG I   +++G   F G ++   +  +
Sbjct: 187 VGCIFAEMVNGAPLFPGVSEADQLMRI 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 23  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 78
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V +  EG  L+  +   +     K +    RQ   G++++H+K+++H D+K  N
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN 138
Query: 132 ILCLTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIGFGTDM 185
           I       N +KI DFGLA    ++    + + L G+  ++APEV+     +   F +D+
Sbjct: 139 IFL--HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDV 196
Query: 186 WSVGVICYVLLSGLSPF 202
           ++ G++ Y L++G  P+
Sbjct: 197 YAFGIVLYELMTGQLPY 213

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 8   HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQH----PR 61
           H     G FG VY C++  TG   A K +     K            IM  L      P 
Sbjct: 193 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 252
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           ++ +  AF + + +  +L+L+ GG+L    +    V +E  +  +  +I  G+E +H++ 
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHMHNRF 311
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD-AIG 180
           V++ D+KP NIL L + G+ ++I D GLA  F  +KK     GT  ++APEV+    A  
Sbjct: 312 VVYRDLKPANIL-LDEHGH-VRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYD 368
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
              D +S+G + + LL G SPF
Sbjct: 369 SSADWFSLGCMLFKLLRGHSPF 390

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M +L HP+L+Q+Y        +C+V E +E G L + +     +   + +      +CE
Sbjct: 55  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 114
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++   +V+H D+   N  CL      IK+ DFG+ R F  + +     GT    ++ 
Sbjct: 115 GMAYLEEASVIHRDLAARN--CLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWA 171
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA----------- 217
           +PEV +F      +D+WS GV+ + + S G  P+   ++ + + +++             
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 231
Query: 218 -QYDFDDECFNEISDDAKDFIRKL 240
             Y   + C+ E  +D   F R L
Sbjct: 232 HVYQIMNHCWKERPEDRPAFSRLL 255

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 113/241 (46%), Gaps = 15/241 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G F  V   K K TG   A K +    + K            ++       + Q++ AF+
Sbjct: 72  GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             N + +V+E   GG+L   +      +  +    ++ +I   ++ +H    +H D+KP+
Sbjct: 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPD 191
Query: 131 NILCLTKTGNRIKIIDFG--LARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT----- 183
           NIL L + G+ I++ DFG  L  + D   +  V  GTP++++PE++     G GT     
Sbjct: 192 NIL-LDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 184 --DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE-ISDDAKDFIRKL 240
             D W++GV  Y +  G +PF  ++  +T   +   +        +E + ++A+DFI++L
Sbjct: 250 ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRL 309
Query: 241 L 241
           L
Sbjct: 310 L 310

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 8   HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQH----PR 61
           H     G FG VY C++  TG   A K +     K            IM  L      P 
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           ++ +  AF + + +  +L+L+ GG+L    +    V +E  +  +  +I  G+E +H++ 
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD-AIG 180
           V++ D+KP NIL L + G+ ++I D GLA  F  +KK     GT  ++APEV+    A  
Sbjct: 313 VVYRDLKPANIL-LDEHGH-VRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYD 369
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
              D +S+G + + LL G SPF
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPF 391

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 35  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 90
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V +  EG  L+  +   +     K +    RQ   G++++H+K+++H D+K  N
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN 150
Query: 132 ILCLTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIGFGTDM 185
           I       N +KI DFGLA    ++    + + L G+  ++APEV+     +   F +D+
Sbjct: 151 IFL--HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDV 208
Query: 186 WSVGVICYVLLSGLSPF 202
           ++ G++ Y L++G  P+
Sbjct: 209 YAFGIVLYELMTGQLPY 225

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 8   HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQH----PR 61
           H     G FG VY C++  TG   A K +     K            IM  L      P 
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           ++ +  AF + + +  +L+L+ GG+L    +    V +E  +  +  +I  G+E +H++ 
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD-AIG 180
           V++ D+KP NIL L + G+ ++I D GLA  F  +KK     GT  ++APEV+    A  
Sbjct: 313 VVYRDLKPANIL-LDEHGH-VRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYD 369
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
              D +S+G + + LL G SPF
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 8   HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQH----PR 61
           H     G FG VY C++  TG   A K +     K            IM  L      P 
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           ++ +  AF + + +  +L+L+ GG+L    +    V +E  +  +  +I  G+E +H++ 
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD-AIG 180
           V++ D+KP NIL L + G+ ++I D GLA  F  +KK     GT  ++APEV+    A  
Sbjct: 313 VVYRDLKPANIL-LDEHGH-VRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYD 369
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
              D +S+G + + LL G SPF
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPF 391

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 61  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 113
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDAEXTAREGAK 171
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 69  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 121
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 122 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEXTAREGAK 179
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGV-ICYVLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G+ +  ++  G  P+ G T+ + + N+        
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 239
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 240 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 272

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 67  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 119
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEXTAREGAK 177
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 237
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 61  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 113
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEXTAREGAK 171
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 70  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 122
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 123 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEXTAREGAK 180
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 240
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 241 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 273

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 61  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 113
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEXTAREGAK 171
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 62  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 114
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 115 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEXTAREGAK 172
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 232
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 233 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 63  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 115
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 116 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEXTAREGAK 173
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 233
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 234 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 266

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 14  GKFGTVYRCKE-KATGMTLAAKFVGI--AKXXXXXXXXXXXXIMRELQ---HPRLIQIYD 67
           G +G V++ ++ K  G  +A K V +   +            ++R L+   HP +++++D
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81
Query: 68  AFESSNV-----MCVVLELIEGG-ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
               S       + +V E ++     +   + +  V TE  +   M Q+  G++F+HS  
Sbjct: 82  VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQLLRGLDFLHSHR 140
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           V+H D+KP+NIL +T +G +IK+ DFGLAR +  +  L  +  T  + APEV+   +   
Sbjct: 141 VVHRDLKPQNIL-VTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
             D+WSVG I   +      F G +DV  +  +
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 71  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 123
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 124 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAK 181
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 241
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 242 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 274

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLI---QIYDAF 69
           G FG V R   + TG  +A K                   IM++L HP ++   ++ D  
Sbjct: 26  GGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 85
Query: 70  ES---SNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           +    +++  + +E  EGG+L  +    ++   L E  +   +  I   + ++H   ++H
Sbjct: 86  QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIH 145
Query: 125 LDMKPENILCLTKTGNRI--KIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
            D+KPENI+ L     R+  KIID G A++ D  +      GT +++APE++        
Sbjct: 146 RDLKPENIV-LQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 204
Query: 183 TDMWSVGVICYVLLSGLSPFM 203
            D WS G + +  ++G  PF+
Sbjct: 205 VDYWSFGTLAFECITGFRPFL 225

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLI---QIYDAF 69
           G FG V R   + TG  +A K                   IM++L HP ++   ++ D  
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84
Query: 70  ES---SNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           +    +++  + +E  EGG+L  +    ++   L E  +   +  I   + ++H   ++H
Sbjct: 85  QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIH 144
Query: 125 LDMKPENILCLTKTGNRI--KIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
            D+KPENI+ L     R+  KIID G A++ D  +      GT +++APE++        
Sbjct: 145 RDLKPENIV-LQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 203
Query: 183 TDMWSVGVICYVLLSGLSPFM 203
            D WS G + +  ++G  PF+
Sbjct: 204 VDYWSFGTLAFECITGFRPFL 224

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 66  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 118
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 119 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAK 176
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 236
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 237 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 269

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 67  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 119
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAK 177
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 237
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 56  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 108
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 109 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAK 166
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 226
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 227 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 259

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M +L HP+L+Q+Y        +C+V E +E G L + +     +   + +      +CE
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 117
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++    V+H D+   N  CL      IK+ DFG+ R F  + +     GT    ++ 
Sbjct: 118 GMAYLEEACVIHRDLAARN--CLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWA 174
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA----------- 217
           +PEV +F      +D+WS GV+ + + S G  P+   ++ + + +++             
Sbjct: 175 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 234
Query: 218 -QYDFDDECFNEISDDAKDFIRKL 240
             Y   + C+ E  +D   F R L
Sbjct: 235 HVYQIMNHCWRERPEDRPAFSRLL 258

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 15/213 (7%)
Query: 14  GKFGTVYRCKE-KATGMTLAAKFVGI--AKXXXXXXXXXXXXIMRELQ---HPRLIQIYD 67
           G +G V++ ++ K  G  +A K V +   +            ++R L+   HP +++++D
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81
Query: 68  AFESSNV-----MCVVLELIEGG-ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
               S       + +V E ++     +   + +  V TE  +   M Q+  G++F+HS  
Sbjct: 82  VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQLLRGLDFLHSHR 140
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           V+H D+KP+NIL +T +G  IK+ DFGLAR +  +  L  +  T  + APEV+   +   
Sbjct: 141 VVHRDLKPQNIL-VTSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
             D+WSVG I   +      F G +DV  +  +
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 61  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 113
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +    
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAK 171
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 14  GKFGTVYRCKE-KATGMTLAAKFVGI--AKXXXXXXXXXXXXIMRELQ---HPRLIQIYD 67
           G +G V++ ++ K  G  +A K V +   +            ++R L+   HP +++++D
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81
Query: 68  AFESSNV-----MCVVLELIEGG-ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
               S       + +V E ++     +   + +  V TE  +   M Q+  G++F+HS  
Sbjct: 82  VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQLLRGLDFLHSHR 140
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           V+H D+KP+NIL +T +G +IK+ DFGLAR +  +  L  +  T  + APEV+   +   
Sbjct: 141 VVHRDLKPQNIL-VTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
             D+WSVG I   +      F G +DV  +  +
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M +L HP+L+Q+Y        +C+V E +E G L + +     +   + +      +CE
Sbjct: 75  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 134
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++    V+H D+   N  CL      IK+ DFG+ R F  + +     GT    ++ 
Sbjct: 135 GMAYLEEACVIHRDLAARN--CLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWA 191
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA----------- 217
           +PEV +F      +D+WS GV+ + + S G  P+   ++ + + +++             
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 251
Query: 218 -QYDFDDECFNEISDDAKDFIRKL 240
             Y   + C+ E  +D   F R L
Sbjct: 252 HVYQIMNHCWKERPEDRPAFSRLL 275

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M +L HP+L+Q+Y        +C+V E +E G L + +     +   + +      +CE
Sbjct: 53  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 112
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++    V+H D+   N  CL      IK+ DFG+ R F  + +     GT    ++ 
Sbjct: 113 GMAYLEEACVIHRDLAARN--CLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWA 169
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA----------- 217
           +PEV +F      +D+WS GV+ + + S G  P+   ++ + + +++             
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 229
Query: 218 -QYDFDDECFNEISDDAKDFIRKL 240
             Y   + C+ E  +D   F R L
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLL 253

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M +L HP+L+Q+Y        +C+V E +E G L + +     +   + +      +CE
Sbjct: 55  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 114
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++    V+H D+   N  CL      IK+ DFG+ R F  + +     GT    ++ 
Sbjct: 115 GMAYLEEACVIHRDLAARN--CLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWA 171
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA----------- 217
           +PEV +F      +D+WS GV+ + + S G  P+   ++ + + +++             
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 231
Query: 218 -QYDFDDECFNEISDDAKDFIRKL 240
             Y   + C+ E  +D   F R L
Sbjct: 232 HVYQIMNHCWKERPEDRPAFSRLL 255

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDXELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 112/242 (46%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 150
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+       + +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 151 DIIHRDLKPSNLAV--NEDSELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 206
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 207 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 266
Query: 239 KL 240
            L
Sbjct: 267 SL 268

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M +L HP+L+Q+Y        +C+V E +E G L + +     +   + +      +CE
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++    V+H D+   N  CL      IK+ DFG+ R F  + +     GT    ++ 
Sbjct: 116 GMAYLEEACVIHRDLAARN--CLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWA 172
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA----------- 217
           +PEV +F      +D+WS GV+ + + S G  P+   ++ + + +++             
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 232
Query: 218 -QYDFDDECFNEISDDAKDFIRKL 240
             Y   + C+ E  +D   F R L
Sbjct: 233 HVYQIMNHCWRERPEDRPAFSRLL 256

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G VY+  +  T  T+A K + +   +            +++ELQH  +I++      
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           ++ + ++ E  E     ++ +D +  ++ + +  F+ Q+  GV F HS+  LH D+KP+N
Sbjct: 105 NHRLHLIFEYAEND--LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQN 162
Query: 132 ILCLTKTGNR---IKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DM 185
           +L      +    +KI DFGLAR F  P ++      T  +  PE++   +  + T  D+
Sbjct: 163 LLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL-LGSRHYSTSVDI 221
Query: 186 WSVGVICYVLLSGLSPFMGETDVQTM 211
           WS+  I   +L     F G++++  +
Sbjct: 222 WSIACIWAEMLMKTPLFPGDSEIDQL 247

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 47  GSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMGYMT 102
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            + + +V +  EG  L++ +   +       +    RQ  +G++++H+KN++H DMK  N
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN 162
Query: 132 ILCLTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIGFGTDM 185
           I      G  +KI DFGLA    ++   ++++   G+  ++APEV+     +   F +D+
Sbjct: 163 IFL--HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDV 220
Query: 186 WSVGVICYVLLSGLSPF 202
           +S G++ Y L++G  P+
Sbjct: 221 YSYGIVLYELMTGELPY 237

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 112/242 (46%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 146
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+       + +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 147 DIIHRDLKPSNLAV--NEDSELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 202
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 203 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 262
Query: 239 KL 240
            L
Sbjct: 263 SL 264

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNV-----MCVVLELIEGGELFERVIDDDFVLTEKAVAIFM 107
           I+   +H  +I I D   +S +     + +V +L+E  +L++ +      L+   +  F+
Sbjct: 94  ILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQ--LSNDHICYFL 150
Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK----LQVLF 163
            QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DPE      L    
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLINTTCD--LKICDFGLARIADPEHDHTGFLTEXV 208
Query: 164 GTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE 205
            T  + APE+ +N        D+WSVG I   +LS    F G+
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 251

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 114/247 (46%), Gaps = 16/247 (6%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+W
Sbjct: 131 VKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE---------ISDDAKDFI 237
           S+G+    +  G  P +   D +  +   +A ++  D   NE          S + +DF+
Sbjct: 188 SMGLSLVEMAVGRYP-IPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 246
Query: 238 RKLLLKD 244
            K L+K+
Sbjct: 247 NKCLIKN 253

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L    T + +KI DFGLAR  DP+ 
Sbjct: 123 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTSDLKICDFGLARVADPDH 180
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 181 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240
Query: 213 NV 214
           ++
Sbjct: 241 HI 242

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKSQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+       + +KI+DFGL R  D E  +     T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDSELKILDFGLCRHTDDE--MTGYVATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 33  SPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 149
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 150 DIIHRDLKPSNLAV--NEDXELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 205
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 206 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 265
Query: 239 KL 240
            L
Sbjct: 266 SL 267

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L    T   +KI DFGLAR  DP+ 
Sbjct: 121 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTXDLKIXDFGLARVADPDH 178
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 179 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 213 NV 214
           ++
Sbjct: 239 HI 240

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++LQH RL+++Y A  +   + ++ E +E G L       DF+ T   + + +     
Sbjct: 57  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLV------DFLKTPSGIKLTINKLLD 109
Query: 109 ---QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
              QI EG+ FI  +N +H +++  NIL         KI DFGLAR   D E   +    
Sbjct: 110 MAAQIAEGMAFIEERNYIHRNLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAK 167
Query: 165 TP-EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANVTIAQ---- 218
            P ++ APE +N+      +D+WS G++   ++  G  P+ G T+ + + N+        
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 227
Query: 219 --------YDFDDECFNEISDDAK--DFIRKLL 241
                   Y     C+ E  +D    D++R +L
Sbjct: 228 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 260

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 149
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 150 DIIHRDLKPSNLAV--NEDXELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 205
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 206 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 265
Query: 239 KL 240
            L
Sbjct: 266 SL 267

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L    T   +KI DFGLAR  DP+ 
Sbjct: 121 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTXDLKICDFGLARVADPDH 178
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 179 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 213 NV 214
           ++
Sbjct: 239 HI 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 39  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 155
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E  +     T  + APE+ +N+   
Sbjct: 156 DIIHRDLKPSNLAV--NEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHY 211
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 212 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 271
Query: 239 KL 240
            L
Sbjct: 272 SL 273

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L    T   +KI DFGLAR  DP+ 
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTXDLKICDFGLARVADPDH 182
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 213 NV 214
           ++
Sbjct: 243 HI 244

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L    T   +KI DFGLAR  DP+ 
Sbjct: 121 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTXDLKICDFGLARVADPDH 178
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 179 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 213 NV 214
           ++
Sbjct: 239 HI 240

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L    T   +KI DFGLAR  DP+ 
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTXDLKICDFGLARVADPDH 182
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 213 NV 214
           ++
Sbjct: 243 HI 244

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 15/172 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNV-----MCVVLELIEGGELFERVIDDDFVLTEKAVAIFM 107
           I+   +H  +I I D   +  +     + +V  L+ G +L++ +      L+   +  F+
Sbjct: 94  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH--LSNDHICYFL 150
Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK----LQVLF 163
            QI  G+++IHS NVLH D+KP N+L    T   +KI DFGLAR  DP+      L    
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLL--NTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 164 GTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
            T  + APE+ +N        D+WSVG I   +LS    F G+  +  + ++
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 150
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 151 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 206
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 207 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 266
Query: 239 KL 240
            L
Sbjct: 267 SL 268

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  +G+ +A K +                  +++ ++H  +I + 
Sbjct: 57  SPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 117 DVFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 173
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E  +     T  + APE+ +N+   
Sbjct: 174 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHY 229
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
               D+WSVG I   LL+G + F G   +  +  +
Sbjct: 230 NMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQI 264

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 25  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 141
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 142 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 197
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 198 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 257
Query: 239 KL 240
            L
Sbjct: 258 SL 259

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGXV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 121 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 178
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 179 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 213 NV 214
           ++
Sbjct: 239 HI 240

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 25  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 141
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 142 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 197
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 198 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 257
Query: 239 KL 240
            L
Sbjct: 258 SL 259

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 146
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 147 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 202
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 203 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 262
Query: 239 KL 240
            L
Sbjct: 263 SL 264

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 149
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 150 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 205
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 206 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 265
Query: 239 KL 240
            L
Sbjct: 266 SL 267

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 167
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 168 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 223
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 224 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 283
Query: 239 KL 240
            L
Sbjct: 284 SL 285

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 150
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 151 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 206
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 207 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 266
Query: 239 KL 240
            L
Sbjct: 267 SL 268

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 26  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 142
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 143 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 198
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 199 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 258
Query: 239 KL 240
            L
Sbjct: 259 SL 260

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 140
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 141 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 196
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 239 KL 240
            L
Sbjct: 257 SL 258

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 182
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 213 NV 214
           ++
Sbjct: 243 HI 244

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 123 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 180
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 181 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240
Query: 213 NV 214
           ++
Sbjct: 241 HI 242

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 119 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 176
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 177 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236
Query: 213 NV 214
           ++
Sbjct: 237 HI 238

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 129 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 186
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 187 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 246
Query: 213 NV 214
           ++
Sbjct: 247 HI 248

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 121 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 178
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 179 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 213 NV 214
           ++
Sbjct: 239 HI 240

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 167
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 168 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMXGYV--ATRWYRAPEIMLNWMHY 223
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 224 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 283
Query: 239 KL 240
            L
Sbjct: 284 SL 285

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 119 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 176
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 177 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236
Query: 213 NV 214
           ++
Sbjct: 237 HI 238

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 149
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 150 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 205
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 206 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 265
Query: 239 KL 240
            L
Sbjct: 266 SL 267

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 123 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 180
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 181 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240
Query: 213 NV 214
           ++
Sbjct: 241 HI 242

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 27  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 143
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 144 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 199
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 200 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 259
Query: 239 KL 240
            L
Sbjct: 260 SL 261

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 47  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 163
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 164 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 219
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 220 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 279
Query: 239 KL 240
            L
Sbjct: 280 SL 281

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 126 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 183
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 184 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243
Query: 213 NV 214
           ++
Sbjct: 244 HI 245

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 164
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 165 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 220
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 221 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 280
Query: 239 KL 240
            L
Sbjct: 281 SL 282

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 127 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 184
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 185 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 244
Query: 213 NV 214
           ++
Sbjct: 245 HI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 118 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 175
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 176 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 235
Query: 213 NV 214
           ++
Sbjct: 236 HI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 182
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 213 NV 214
           ++
Sbjct: 243 HI 244

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 156
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 157 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 212
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 213 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 272
Query: 239 KL 240
            L
Sbjct: 273 SL 274

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 151
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 152 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 207
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267
Query: 239 KL 240
            L
Sbjct: 268 SL 269

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 39  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 155
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 156 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 211
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 212 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 271
Query: 239 KL 240
            L
Sbjct: 272 SL 273

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 182
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 213 NV 214
           ++
Sbjct: 243 HI 244

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 156
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 157 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 212
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 213 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 272
Query: 239 KL 240
            L
Sbjct: 273 SL 274

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 156
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 157 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 212
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 213 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 272
Query: 239 KL 240
            L
Sbjct: 273 SL 274

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 141 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 198
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 199 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258
Query: 213 NV 214
           ++
Sbjct: 259 HI 260

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 146
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 147 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 202
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 203 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 262
Query: 239 KL 240
            L
Sbjct: 263 SL 264

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 182
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 183 DHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 213 NV 214
           ++
Sbjct: 243 HI 244

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 7/122 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+   +  F+ QI  G+++IHS NVLH D+KP N+L  T     +KI DFGLAR  DP+ 
Sbjct: 126 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 183
Query: 158 K----LQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                L     T  + APE+ +N        D+WSVG I   +LS    F G+  +  + 
Sbjct: 184 DHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243
Query: 213 NV 214
           ++
Sbjct: 244 HI 245

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 146
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 147 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 202
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 203 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 262
Query: 239 KL 240
            L
Sbjct: 263 SL 264

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 11/203 (5%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXX--------XXXXXXXXXXIMRELQHP 60
           S    G FG V+   +K     +  KF+   K                    I+  ++H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 61  RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
            +I++ D FE+     +V+E    G      ID    L E   +   RQ+   V ++  K
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI- 179
           +++H D+K ENI+        IK+IDFG A   +  K      GT E+ APEV+  +   
Sbjct: 150 DIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR 207
Query: 180 GFGTDMWSVGVICYVLLSGLSPF 202
           G   +MWS+GV  Y L+   +PF
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPF 230

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 92/195 (47%), Gaps = 7/195 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 80
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              +++E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 81  PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 139
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAPEVVNFDAIGFGTDMWSVGV 190
            CL    + +K+ DFGL+R    +          P ++ APE + ++     +D+W+ GV
Sbjct: 140 -CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 198
Query: 191 ICYVLLS-GLSPFMG 204
           + + + + G+SP+ G
Sbjct: 199 LLWEIATYGMSPYPG 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 92/195 (47%), Gaps = 7/195 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 83
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              +++E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 84  PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 142
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAPEVVNFDAIGFGTDMWSVGV 190
            CL    + +K+ DFGL+R    +          P ++ APE + ++     +D+W+ GV
Sbjct: 143 -CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 201
Query: 191 ICYVLLS-GLSPFMG 204
           + + + + G+SP+ G
Sbjct: 202 LLWEIATYGMSPYPG 216

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              +++E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 88  PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 146
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 147 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 204
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 205 VLLWEIATYGMSPYPG 220

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 83
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 84  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 142
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP-------EFVAPEVVNFDAIGFGTDM 185
            CL    + +K+ DFGL+R    +      +  P       ++ APE + ++     +D+
Sbjct: 143 -CLVGENHLVKVADFGLSRLMTGDT-----YTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 186 WSVGVICYVLLS-GLSPFMG 204
           W+ GV+ + + + G+SP+ G
Sbjct: 197 WAFGVLLWEIATYGMSPYPG 216

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 7/195 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G+FG VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 80
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 81  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 139
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAPEVVNFDAIGFGTDMWSVGV 190
            CL    + +K+ DFGL+R    +          P ++ APE + ++     +D+W+ GV
Sbjct: 140 -CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 198
Query: 191 ICYVLLS-GLSPFMG 204
           + + + + G+SP+ G
Sbjct: 199 LLWEIATYGMSPYPG 213

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 84
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 85  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 143
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP-------EFVAPEVVNFDAIGFGTDM 185
            CL    + +K+ DFGL+R    +      +  P       ++ APE + ++     +D+
Sbjct: 144 -CLVGENHLVKVADFGLSRLMTGDT-----YTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 186 WSVGVICYVLLS-GLSPFMG 204
           W+ GV+ + + + G+SP+ G
Sbjct: 198 WAFGVLLWEIATYGMSPYPG 217

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 113/243 (46%), Gaps = 19/243 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIG 180
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE++  +A+ 
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIM-LNAMH 199
Query: 181 FG--TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFI 237
           +    D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 238 RKL 240
           + L
Sbjct: 260 QSL 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              +++E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 83  PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 141
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 142 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 200 VLLWEIATYGMSPYPG 215

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              +++E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 83  PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 141
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 142 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 200 VLLWEIATYGMSPYPG 215

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 150
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 151 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 206
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 207 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 266
Query: 239 KL 240
            L
Sbjct: 267 SL 268

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 140
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E  +     T  + APE+ +N+   
Sbjct: 141 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHY 196
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 239 KL 240
            L
Sbjct: 257 SL 258

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 164
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 165 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMXGXV--ATRWYRAPEIMLNWMHY 220
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 221 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 280
Query: 239 KL 240
            L
Sbjct: 281 SL 282

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+D+GLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDYGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E  +     T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E  +     T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 140
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 141 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 196
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 239 KL 240
            L
Sbjct: 257 SL 258

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 47  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 163
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 164 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 219
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 220 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 279
Query: 239 KL 240
            L
Sbjct: 280 SL 281

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 164
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 165 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 220
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 221 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 280
Query: 239 KL 240
            L
Sbjct: 281 SL 282

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 91/195 (46%), Gaps = 7/195 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 146
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAPEVVNFDAIGFGTDMWSVGV 190
            CL    + +K+ DFGL+R    +          P ++ APE + ++     +D+W+ GV
Sbjct: 147 -CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 205
Query: 191 ICYVLLS-GLSPFMG 204
           + + + + G+SP+ G
Sbjct: 206 LLWEIATYGMSPYPG 220

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 112/247 (45%), Gaps = 22/247 (8%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 31  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 91  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 149
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+W
Sbjct: 150 VKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 206
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE---------ISDDAKDFI 237
           S+G+    +  G  P           + ++A ++  D   NE          S + +DF+
Sbjct: 207 SMGLSLVEMAVGRYPI-------GSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 259
Query: 238 RKLLLKD 244
            K L+K+
Sbjct: 260 NKCLIKN 266

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 80
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 81  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 139
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 140 -CLVGENHLVKVADFGLSRLMTGD-TFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 197
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 198 VLLWEIATYGMSPYPG 213

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 146
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 147 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 204
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 205 VLLWEIATYGMSPYPG 220

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 37  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 95
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 96  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 154
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 155 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 212
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 213 VLLWEIATYGMSPYPG 228

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 141
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 142 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 200 VLLWEIATYGMSPYPG 215

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 84
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 85  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 143
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 144 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 201
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 202 VLLWEIATYGMSPYPG 217

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 146
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 147 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 204
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 205 VLLWEIATYGMSPYPG 220

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 141
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 142 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 200 VLLWEIATYGMSPYPG 215

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 17/237 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF-- 69
           G +G+V    +  TG  +A K +                  +++ ++H  +I + D F  
Sbjct: 43  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 102
Query: 70  ----ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
               E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS +++H 
Sbjct: 103 ARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHR 159
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAIGFGTD 184
           D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+       D
Sbjct: 160 DLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHYNQTVD 215
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIRKL 240
           +WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+ L
Sbjct: 216 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 272

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 146
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 147 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 204
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 205 VLLWEIATYGMSPYPG 220

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FGTV+R +   + + +                     IM+ L+HP ++    A     
Sbjct: 48  GSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107
Query: 74  VMCVVLELIEGGELFERVIDDDFV---LTEKAVAIFMRQICEGVEFIHSKN--VLHLDMK 128
            + +V E +  G L+ R++        L E+        + +G+ ++H++N  ++H D+K
Sbjct: 108 NLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLK 166
Query: 129 PENILCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
             N+L   K    +K+ DFGL+R K       +   GTPE++APEV+  +     +D++S
Sbjct: 167 SPNLLVDKKYT--VKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYS 224
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
            GVI + L +   P+      Q +A V
Sbjct: 225 FGVILWELATLQQPWGNLNPAQVVAAV 251

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 84
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 85  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 143
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 144 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 201
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 202 VLLWEIATYGMSPYPG 217

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 70/127 (55%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE + + DF     +LT+  +  +M ++ + +++ HSK ++H D+KP N++ +     +
Sbjct: 113 VFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVM-IDHQQKK 171
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 172 LRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRRE 231
Query: 201 PFMGETD 207
           PF    D
Sbjct: 232 PFFHGQD 238

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 87  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 145
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 146 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 204 VLLWEIATYGMSPYPG 219

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCAKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR  D E    V   T  + APE+ +N+   
Sbjct: 141 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 196
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 239 KL 240
            L
Sbjct: 257 SL 258

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 141
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 142 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 200 VLLWEIATYGMSPYPG 215

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 141
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSVG 189
            CL    + +K+ DFGL+R    +       G     ++ APE + ++     +D+W+ G
Sbjct: 142 -CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199
Query: 190 VICYVLLS-GLSPFMG 204
           V+ + + + G+SP+ G
Sbjct: 200 VLLWEIATYGMSPYPG 215

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 19  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 74
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +  + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 132
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 133 NNIFLHEDLT-----VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPY 209

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 70/127 (55%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE + + DF     +LT+  +  +M ++ + +++ HSK ++H D+KP N++ +     +
Sbjct: 118 VFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVM-IDHQQKK 176
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 177 LRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRRE 236
Query: 201 PFMGETD 207
           PF    D
Sbjct: 237 PFFHGQD 243

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 117/244 (47%), Gaps = 18/244 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G+V    +K +G  +A K +                  +++ +QH  +I + D F  
Sbjct: 53  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 112
Query: 72  SNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           ++ +       +V+  ++     ++++  +F  +E+ +   + Q+ +G+++IHS  V+H 
Sbjct: 113 ASSLRNFYDFYLVMPFMQTD--LQKIMGMEF--SEEKIQYLVYQMLKGLKYIHSAGVVHR 168
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV-NFDAIGFGTD 184
           D+KP N+         +KI+DFGLAR  D E    V+  T  + APEV+ ++       D
Sbjct: 169 DLKPGNLAV--NEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILSWMHYNQTVD 224
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD-AKDFIRKLLLK 243
           +WSVG I   +L+G + F G+  +  +  +         E   +++D  AK +I+ L   
Sbjct: 225 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 284
Query: 244 DRED 247
            R+D
Sbjct: 285 PRKD 288

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM-----CVVLELIEGGELFERVIDDDFVLTEKAVAIFM 107
           +++ L+H  +I + D F  +  +       ++  + G +L   V      L+++ V   +
Sbjct: 80  LLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ--ALSDEHVQFLV 137
Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE 167
            Q+  G+++IHS  ++H D+KP N+       + ++I+DFGLAR+ D E  +     T  
Sbjct: 138 YQLLRGLKYIHSAGIIHRDLKPSNVAV--NEDSELRILDFGLARQADEE--MTGYVATRW 193
Query: 168 FVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF 226
           + APE+ +N+       D+WSVG I   LL G + F G   +  +  +         E  
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVL 253
Query: 227 NEISDD-AKDFIRKL 240
            +IS + A+ +I+ L
Sbjct: 254 AKISSEHARTYIQSL 268

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 47  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 102
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 160
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 161 NNIFLHEDLT-----VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 216 FQSDVYAFGIVLYELMTGQLPY 237

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 39  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 94
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 152
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 153 NNIFLHEDLT-----VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 207
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 208 FQSDVYAFGIVLYELMTGQLPY 229

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 47  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 102
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 160
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 161 NNIFLHEDLT-----VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 216 FQSDVYAFGIVLYELMTGQLPY 237

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 46  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 101
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 159
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 160 NNIFLHEDLT-----VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 215 FQSDVYAFGIVLYELMTGQLPY 236

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 24  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 79
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 137
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 138 NNIFLHEDLT-----VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 193 FQSDVYAFGIVLYELMTGQLPY 214

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 24  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 79
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 137
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 138 NNIFLHEDLT-----VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 193 FQSDVYAFGIVLYELMTGQLPY 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 21  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 76
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 134
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 135 NNIFLHEDLT-----VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 190 FQSDVYAFGIVLYELMTGQLPY 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 19  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 74
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 132
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 133 NNIFLHEDLT-----VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPY 209

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N+L +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVL-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX--XXXXIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +                ++R+ +H  ++ ++  + +
Sbjct: 19  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 74
Query: 72  SNVMCVVLELIEGGELFER--VIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V +  EG  L+    +I+  F +  K + I  RQ  +G++++H+K+++H D+K 
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDI-ARQTAQGMDYLHAKSIIHRDLKS 132
Query: 130 ENILC---LTKTGNRIKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIG 180
            NI     LT     +KI DFGLA    ++    + + L G+  ++APEV+     +   
Sbjct: 133 NNIFLHEDLT-----VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
           F +D+++ G++ Y L++G  P+
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPY 209

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 21/195 (10%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG   +   + TG  +  K +                +MR L+HP +++         
Sbjct: 21  GCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80
Query: 74  VMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            +  + E I+GG L    + +D  +  +++    F + I  G+ ++HS N++H D+   N
Sbjct: 81  RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS--FAKDIASGMAYLHSMNIIHRDLNSHN 138
Query: 132 ILCLTKTGNRIKIIDFGLAR-----KFDPE----------KKLQVLFGTPEFVAPEVVNF 176
             CL +    + + DFGLAR     K  PE          KK   + G P ++APE++N 
Sbjct: 139 --CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196
Query: 177 DAIGFGTDMWSVGVI 191
            +     D++S G++
Sbjct: 197 RSYDEKVDVFSFGIV 211

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 112/247 (45%), Gaps = 26/247 (10%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 15  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 75  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 133
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   E   + + GT  +++PE +        +D+W
Sbjct: 134 VKPSNILVNSR--GEIKLCDFGVSGQLIDEMANEFV-GTRSYMSPERLQGTHYSVQSDIW 190
Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE---------ISDDAKDFI 237
           S+G+    +  G  P              +A ++  D   NE          S + +DF+
Sbjct: 191 SMGLSLVEMAVGRYP-----------RPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFV 239
Query: 238 RKLLLKD 244
            K L+K+
Sbjct: 240 NKCLIKN 246

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+ FGLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILGFGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 151
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR    E    V   T  + APE+ +N+   
Sbjct: 152 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTADEMTGYV--ATRWYRAPEIMLNWMHY 207
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267
Query: 239 KL 240
            L
Sbjct: 268 SL 269

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 116/244 (47%), Gaps = 18/244 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G+V    +K +G  +A K +                  +++ +QH  +I + D F  
Sbjct: 35  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 94
Query: 72  SNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           ++ +       +V+  ++     ++++   F  +E+ +   + Q+ +G+++IHS  V+H 
Sbjct: 95  ASSLRNFYDFYLVMPFMQTD--LQKIMGLKF--SEEKIQYLVYQMLKGLKYIHSAGVVHR 150
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV-NFDAIGFGTD 184
           D+KP N+         +KI+DFGLAR  D E    V+  T  + APEV+ ++       D
Sbjct: 151 DLKPGNLAV--NEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILSWMHYNQTVD 206
Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD-AKDFIRKLLLK 243
           +WSVG I   +L+G + F G+  +  +  +         E   +++D  AK +I+ L   
Sbjct: 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 266
Query: 244 DRED 247
            R+D
Sbjct: 267 PRKD 270

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 151
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR    E    V   T  + APE+ +N+   
Sbjct: 152 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTADEMTGYV--ATRWYRAPEIMLNWMHY 207
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267
Query: 239 KL 240
            L
Sbjct: 268 SL 269

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 151
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DFGLAR    E    V   T  + APE+ +N+   
Sbjct: 152 DIIHRDLKPSNLAV--NEDCELKILDFGLARHTADEMTGYV--ATRWYRAPEIMLNWMHY 207
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267
Query: 239 KL 240
            L
Sbjct: 268 SL 269

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+D GLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDAGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 111 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 169
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 170 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
Query: 201 PFMGETD 207
           PF    D
Sbjct: 230 PFFHGHD 236

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FGTV+R +   + + +                     IM+ L+HP ++    A     
Sbjct: 48  GSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107
Query: 74  VMCVVLELIEGGELFERVIDDDFV---LTEKAVAIFMRQICEGVEFIHSKN--VLHLDMK 128
            + +V E +  G L+ R++        L E+        + +G+ ++H++N  ++H ++K
Sbjct: 108 NLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK 166
Query: 129 PENILCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
             N+L   K    +K+ DFGL+R K       +   GTPE++APEV+  +     +D++S
Sbjct: 167 SPNLLVDKKYT--VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYS 224
Query: 188 VGVICYVLLSGLSPFMGETDVQTMANV 214
            GVI + L +   P+      Q +A V
Sbjct: 225 FGVILWELATLQQPWGNLNPAQVVAAV 251

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 111 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 169
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 170 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
Query: 201 PFMGETD 207
           PF    D
Sbjct: 230 PFFHGHD 236

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 110 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 168
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 169 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 201 PFMGETD 207
           PF    D
Sbjct: 229 PFFHGHD 235

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 75/146 (51%), Gaps = 6/146 (4%)
Query: 97  VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE 156
            L+++ V   + Q+  G+++IHS  ++H D+KP N+       + ++I+DFGLAR+ D E
Sbjct: 127 ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAV--NEDSELRILDFGLARQADEE 184
Query: 157 KKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVT 215
             +     T  + APE+ +N+       D+WSVG I   LL G + F G   +  +  + 
Sbjct: 185 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIM 242
Query: 216 IAQYDFDDECFNEISDD-AKDFIRKL 240
                   E   +IS + A+ +I+ L
Sbjct: 243 EVVGTPSPEVLAKISSEHARTYIQSL 268

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 92/196 (46%), Gaps = 6/196 (3%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V + + + +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 22  SELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+ +   + E+ +      +  G+ ++  K+ ++H D
Sbjct: 82  AFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRD 140
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  ++APE +        +D+W
Sbjct: 141 VKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMAPERLQGTHYSVQSDIW 197
Query: 187 SVGVICYVLLSGLSPF 202
           S+G+    L  G  P 
Sbjct: 198 SMGLSLVELAVGRYPI 213

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+D GLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDRGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    F L   ++ ++  Q+   
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L  + + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 124 LAYLESKRFVHRDIAARNV--LVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAP 181
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 117 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 175
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 176 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 235
Query: 201 PFMGETD 207
           PF    D
Sbjct: 236 PFFHGHD 242

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAK-FVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G    V+R + K TG   A K F  I+             ++++L H  +++++   E +
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79
Query: 73  NVM--CVVLELIEGGELFERVID--DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
                 +++E    G L+  + +  + + L E    I +R +  G+  +    ++H ++K
Sbjct: 80  TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139
Query: 129 PENIL-CLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI------- 179
           P NI+  + + G  + K+ DFG AR+ + +++   L+GT E++ P++     +       
Sbjct: 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKK 199
Query: 180 -GFGTDMWSVGVICYVLLSGLSPF 202
            G   D+WS+GV  Y   +G  PF
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    F L   ++ ++  Q+   
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L  + + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 504 LAYLESKRFVHRDIAARNV--LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 92/196 (46%), Gaps = 6/196 (3%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 74  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 134 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 192
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+W
Sbjct: 193 VKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 249
Query: 187 SVGVICYVLLSGLSPF 202
           S+G+    +  G  P 
Sbjct: 250 SMGLSLVEMAVGRYPI 265

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG+ +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+D GLAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDGGLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMREL---QHPRLIQIYDAFE 70
           G FG V  CK K       AK V I +             +R+L    HP ++++Y A  
Sbjct: 20  GAFGVV--CKAK-----WRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA-- 70
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---QICEGVEFIHS---KNVLH 124
             N +C+V+E  EGG L+  V+     L     A  M    Q  +GV ++HS   K ++H
Sbjct: 71  CLNPVCLVMEYAEGGSLY-NVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTD 184
            D+KP N+L L   G  +KI DFG A   D +  +    G+  ++APEV          D
Sbjct: 130 RDLKPPNLL-LVAGGTVLKICDFGTA--CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 186
Query: 185 MWSVGVICYVLLSGLSPF 202
           ++S G+I + +++   PF
Sbjct: 187 VFSWGIILWEVITRRKPF 204

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMREL---QHPRLIQIYDAFE 70
           G FG V  CK K       AK V I +             +R+L    HP ++++Y A  
Sbjct: 19  GAFGVV--CKAK-----WRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA-- 69
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---QICEGVEFIHS---KNVLH 124
             N +C+V+E  EGG L+  V+     L     A  M    Q  +GV ++HS   K ++H
Sbjct: 70  CLNPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTD 184
            D+KP N+L L   G  +KI DFG A   D +  +    G+  ++APEV          D
Sbjct: 129 RDLKPPNLL-LVAGGTVLKICDFGTA--CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 185 MWSVGVICYVLLSGLSPF 202
           ++S G+I + +++   PF
Sbjct: 186 VFSWGIILWEVITRRKPF 203

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+KP N++ +     +
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-IDHEHRK 170
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P ++  V   +  F  PE +V++    +  DMWS+G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 201 PFMGETD 207
           PF    D
Sbjct: 231 PFFHGHD 237

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 92/196 (46%), Gaps = 6/196 (3%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 99  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 157
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+W
Sbjct: 158 VKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 214
Query: 187 SVGVICYVLLSGLSPF 202
           S+G+    +  G  P 
Sbjct: 215 SMGLSLVEMAVGRYPI 230

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 92/196 (46%), Gaps = 6/196 (3%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+W
Sbjct: 131 VKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 187 SVGVICYVLLSGLSPF 202
           S+G+    +  G  P 
Sbjct: 188 SMGLSLVEMAVGRYPI 203

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L E +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 84  YSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 143
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 144 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 201
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 202 DVWSFGVVLYELFT 215

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAK-FVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G    V+R + K TG   A K F  I+             ++++L H  +++++   E +
Sbjct: 20  GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79
Query: 73  NVM--CVVLELIEGGELFERVID--DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
                 +++E    G L+  + +  + + L E    I +R +  G+  +    ++H ++K
Sbjct: 80  TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139
Query: 129 PENIL-CLTKTGNRI-KIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI------- 179
           P NI+  + + G  + K+ DFG AR+ + +++   L+GT E++ P++     +       
Sbjct: 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKK 199
Query: 180 -GFGTDMWSVGVICYVLLSGLSPF 202
            G   D+WS+GV  Y   +G  PF
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 91/195 (46%), Gaps = 7/195 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H ++   N 
Sbjct: 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARN- 348
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAPEVVNFDAIGFGTDMWSVGV 190
            CL    + +K+ DFGL+R    +          P ++ APE + ++     +D+W+ GV
Sbjct: 349 -CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 407
Query: 191 ICYVLLS-GLSPFMG 204
           + + + + G+SP+ G
Sbjct: 408 LLWEIATYGMSPYPG 422

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 7/195 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEP 101
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              +V E +  G L + + + +       V ++M  QI   +E++  KN +H D+   N 
Sbjct: 102 PFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARN- 160
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAPEVVNFDAIGFGTDMWSVGV 190
            CL    + +K+ DFGL+R    +          P ++ APE + ++     +D+W+ GV
Sbjct: 161 -CLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGV 219
Query: 191 ICYVLLS-GLSPFMG 204
           + + + + G+SP+ G
Sbjct: 220 LLWEIATYGMSPYPG 234

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 92/196 (46%), Gaps = 6/196 (3%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+W
Sbjct: 131 VKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 187 SVGVICYVLLSGLSPF 202
           S+G+    +  G  P 
Sbjct: 188 SMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 92/196 (46%), Gaps = 6/196 (3%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+W
Sbjct: 131 VKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 187 SVGVICYVLLSGLSPF 202
           S+G+    +  G  P 
Sbjct: 188 SMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 92/196 (46%), Gaps = 6/196 (3%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KXXXXXXXXXXXXIMRELQHPRLIQIYD 67
           S    G  G V++   K +G+ +A K + +  K            ++ E   P ++  Y 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLD 126
           AF S   + + +E ++GG L ++V+     + E+ +      + +G+ ++  K+ ++H D
Sbjct: 72  AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           +KP NIL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+W
Sbjct: 131 VKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 187 SVGVICYVLLSGLSPF 202
           S+G+    +  G  P 
Sbjct: 188 SMGLSLVEMAVGRYPI 203

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 107/246 (43%), Gaps = 16/246 (6%)
Query: 14  GKFGTV----YRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V    YR ++K   + +     G  K            IM +L +P ++++    
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGVC 79
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++  +M +V+E+  GG L + ++     +    VA  + Q+  G++++  KN +H D+  
Sbjct: 80  QAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 138
Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----EFVAPEVVNFDAIGFGTDM 185
            N+L + +  +  KI DFGL++    +              ++ APE +NF      +D+
Sbjct: 139 RNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 196
Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS GV  +  LS G  P+      + MA +   +     EC  E   +    +    +  
Sbjct: 197 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALMSDCWIYK 253
Query: 245 REDAPE 250
            ED P+
Sbjct: 254 WEDRPD 259

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 91/195 (46%), Gaps = 7/195 (3%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +                +M+E++HP L+Q+        
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 328
Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-RQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +       V ++M  QI   +E++  KN +H ++   N 
Sbjct: 329 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARN- 387
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAPEVVNFDAIGFGTDMWSVGV 190
            CL    + +K+ DFGL+R    +          P ++ APE + ++     +D+W+ GV
Sbjct: 388 -CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 446
Query: 191 ICYVLLS-GLSPFMG 204
           + + + + G+SP+ G
Sbjct: 447 LLWEIATYGMSPYPG 461

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG-IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G FG V+  + +A    +A K                   I+++  HP ++++       
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +V+EL++GG+    +  +   L  K +   +     G+E++ SK  +H D+   N 
Sbjct: 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN- 243
Query: 133 LCLTKTGNRIKIIDFGLARK-----FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
            CL    N +KI DFG++R+     +     L+ +    ++ APE +N+      +D+WS
Sbjct: 244 -CLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEALNYGRYSSESDVWS 300
Query: 188 VGVICYVLLS-GLSPFMGETDVQT 210
            G++ +   S G SP+   ++ QT
Sbjct: 301 FGILLWETFSLGASPYPNLSNQQT 324

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 18/234 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPR---------LIQ 64
           G FG V +  +      +A K V   K             +R L+H R         +I 
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMNVIH 163
Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVL 123
           + + F   N +C+  EL+    L+E +  + F   +   V  F   I + ++ +H   ++
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRII 222
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           H D+KPENIL   +  + IK+IDFG +      +++     +  + APEV+     G   
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGARYGMPI 280
Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI 237
           DMWS+G I   LL+G     GE +   +A   I       +   + S  AK+F+
Sbjct: 281 DMWSLGCILAELLTGYPLLPGEDEGDQLA-CMIELLGMPSQKLLDASKRAKNFV 333

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 18/234 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPR---------LIQ 64
           G FG V +  +      +A K V   K             +R L+H R         +I 
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMNVIH 163
Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVL 123
           + + F   N +C+  EL+    L+E +  + F   +   V  F   I + ++ +H   ++
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRII 222
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           H D+KPENIL   +  + IK+IDFG +      +++     +  + APEV+     G   
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGARYGMPI 280
Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI 237
           DMWS+G I   LL+G     GE +   +A   I       +   + S  AK+F+
Sbjct: 281 DMWSLGCILAELLTGYPLLPGEDEGDQLA-CMIELLGMPSQKLLDASKRAKNFV 333

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 1   MTTHQNQHSAF----SFGKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXX 52
           MT  + +H  F      G FG+V  C+    +  TG  +A K +  +             
Sbjct: 22  MTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 81
Query: 53  IMRELQHPRLIQIYDAFESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQI 110
           I++ LQH  +++      S+    + +++E +  G L + +      +    +  +  QI
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPE 167
           C+G+E++ +K  +H D+   NI  L +  NR+KI DFGL +    +K   K++    +P 
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 168 F-VAPEVVNFDAIGFGTDMWSVGVICYVLLS 197
           F  APE +        +D+WS GV+ Y L +
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    + L   ++ ++  Q+   
Sbjct: 93  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 151
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L  + + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 152 LAYLESKRFVHRDIAARNV--LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 209
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 210 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 243

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 1   MTTHQNQHSAF----SFGKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXX 52
           MT  + +H  F      G FG+V  C+    +  TG  +A K +  +             
Sbjct: 22  MTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 81
Query: 53  IMRELQHPRLIQIYDAFESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQI 110
           I++ LQH  +++      S+    + +++E +  G L + +      +    +  +  QI
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPE 167
           C+G+E++ +K  +H D+   NI  L +  NR+KI DFGL +    +K   K++    +P 
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 168 F-VAPEVVNFDAIGFGTDMWSVGVICYVLLS 197
           F  APE +        +D+WS GV+ Y L +
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    + L   ++ ++  Q+   
Sbjct: 67  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 125
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L  + + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 126 LAYLESKRFVHRDIAARNV--LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 183
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 184 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 217

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    + L   ++ ++  Q+   
Sbjct: 70  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L  + + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 129 LAYLESKRFVHRDIAARNV--LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    + L   ++ ++  Q+   
Sbjct: 68  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 126
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L  + + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 127 LAYLESKRFVHRDIAARNV--LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 184
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 185 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    + L   ++ ++  Q+   
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L  + + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 124 LAYLESKRFVHRDIAARNV--LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    + L   ++ ++  Q+   
Sbjct: 62  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L  + + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 121 LAYLESKRFVHRDIAARNV--LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    + L   ++ ++  Q+   
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L  + + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 124 LAYLESKRFVHRDIAARNV--LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 79/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    F L   ++ ++  Q+   
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L    + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 504 LAYLESKRFVHRDIAARNV--LVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 17/242 (7%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIY 66
           S    G +G+V    +  TG  +A K +                  +++ ++H  +I + 
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 67  DAF------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
           D F      E  N + +V  L+ G +L   V      LT+  V   + QI  G+++IHS 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAI 179
           +++H D+KP N+         +KI+DF LAR  D E    V   T  + APE+ +N+   
Sbjct: 145 DIIHRDLKPSNLAV--NEDCELKILDFYLARHTDDEMTGYV--ATRWYRAPEIMLNWMHY 200
Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIR 238
               D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I+
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 239 KL 240
            L
Sbjct: 261 SL 262

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  L H +L+Q+Y        + ++ E +  G L   + +       + +    + +CE
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTP-EFVA 170
            +E++ SK  LH D+   N  CL      +K+ DFGL+R   D E+   V    P  +  
Sbjct: 132 AMEYLESKQFLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSP 189
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ----------- 218
           PEV+ +      +D+W+ GV+ + + S G  P+   T+ +T  +  IAQ           
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLAS 247
Query: 219 ---YDFDDECFNEISDDAKDFIRKLLLKD 244
              Y     C++E +D+   F  K+LL +
Sbjct: 248 EKVYTIMYSCWHEKADERPTF--KILLSN 274

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 79/154 (51%), Gaps = 6/154 (3%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           MR+  HP ++++     + N + +++EL   GEL   +    F L   ++ ++  Q+   
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT-P-EFVAP 171
           + ++ SK  +H D+   N+  L    + +K+ DFGL+R  +     +   G  P +++AP
Sbjct: 124 LAYLESKRFVHRDIAARNV--LVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 172 EVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMG 204
           E +NF      +D+W  GV  + +L+ G+ PF G
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 9/203 (4%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG-IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESS 72
           G FG V+  + +A    +A K                   I+++  HP ++++       
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184
Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +V+EL++GG+    +  +   L  K +   +     G+E++ SK  +H D+   N 
Sbjct: 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN- 243
Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE----FVAPEVVNFDAIGFGTDMWSV 188
            CL    N +KI DFG++R+ + +       G  +    + APE +N+      +D+WS 
Sbjct: 244 -CLVTEKNVLKISDFGMSRE-EADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 189 GVICYVLLS-GLSPFMGETDVQT 210
           G++ +   S G SP+   ++ QT
Sbjct: 302 GILLWETFSLGASPYPNLSNQQT 324

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 107/256 (41%), Gaps = 37/256 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAK---FVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG VY  ++      +A K   + G                +++L+HP  IQ    + 
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 71  SSNVMCVVLE--LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             +   +V+E  L    +L E        L E  +A       +G+ ++HS N++H D+K
Sbjct: 125 REHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV------NFDAIGFG 182
             NIL L++ G  +K+ DFG A    P        GTP ++APEV+       +D     
Sbjct: 182 AGNIL-LSEPG-LVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDG---K 233
Query: 183 TDMWSVGVICYVLLSGLSPF-----------MGETDVQTMANVTIAQY--DFDDECFNEI 229
            D+WS+G+ C  L     P            + + +   + +   ++Y  +F D C  +I
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293
Query: 230 SDDAKDFIRKLLLKDR 245
             D      ++LLK R
Sbjct: 294 PQDRP--TSEVLLKHR 307

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 6/146 (4%)
Query: 97  VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE 156
            L+++ V   + Q+  G+++IHS  ++H D+KP N+         ++I+DFGLAR+ D E
Sbjct: 119 ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAV--NEDCELRILDFGLARQADEE 176
Query: 157 KKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVT 215
             +     T  + APE+ +N+       D+WSVG I   LL G + F G   +  +  + 
Sbjct: 177 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIM 234
Query: 216 IAQYDFDDECFNEISDD-AKDFIRKL 240
                   E   +IS + A+ +I+ L
Sbjct: 235 EVVGTPSPEVLAKISSEHARTYIQSL 260

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FGTV   KEK+TGM++A K V I               +  L HP ++Q+   F +  
Sbjct: 34  GTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92
Query: 74  -------VMCVVLELIEGG------ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH-- 118
                   + VV+E +           + R +    +L    + +F+ Q+   +  +H  
Sbjct: 93  ERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL----IKVFLFQLIRSIGCLHLP 148
Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA 178
           S NV H D+KP N+L     G  +K+ DFG A+K  P +       +  + APE++ F  
Sbjct: 149 SVNVCHRDIKPHNVLVNEADGT-LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELI-FGN 206
Query: 179 IGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
             + T  D+WSVG I   ++ G   F G+     +  +
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 19  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 78
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 79  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 138
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 139 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 196
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 197 DVWSFGVVLYELFT 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 26  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 85
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 86  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 145
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 146 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 203
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 204 DVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 84  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 143
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 144 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 201
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 202 DVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 172 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 229
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 230 DVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 27  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 86
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 87  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 146
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 147 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 204
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 205 DVWSFGVVLYELFT 218

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 107/256 (41%), Gaps = 37/256 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAK---FVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFE 70
           G FG VY  ++      +A K   + G                +++L+HP  IQ    + 
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 71  SSNVMCVVLE--LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             +   +V+E  L    +L E        L E  +A       +G+ ++HS N++H D+K
Sbjct: 86  REHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV------NFDAIGFG 182
             NIL L++ G  +K+ DFG A    P        GTP ++APEV+       +D     
Sbjct: 143 AGNIL-LSEPG-LVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDG---K 194
Query: 183 TDMWSVGVICYVLLSGLSPF-----------MGETDVQTMANVTIAQY--DFDDECFNEI 229
            D+WS+G+ C  L     P            + + +   + +   ++Y  +F D C  +I
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 254
Query: 230 SDDAKDFIRKLLLKDR 245
             D      ++LLK R
Sbjct: 255 PQDRP--TSEVLLKHR 268

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 28  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 87
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 88  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 147
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 148 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 205
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 206 DVWSFGVVLYELFT 219

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 18/234 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPR---------LIQ 64
           G FG V +  +      +A K V   K             +R L+H R         +I 
Sbjct: 108 GXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMNVIH 163
Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVL 123
           + + F   N +C+  EL+    L+E +  + F   +   V  F   I + ++ +H   ++
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRII 222
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           H D+KPENIL   +  + IK+IDFG +      +++     +  + APEV+     G   
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGARYGMPI 280
Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI 237
           DMWS+G I   LL+G     GE +   +A   I       +   + S  AK+F+
Sbjct: 281 DMWSLGCILAELLTGYPLLPGEDEGDQLA-CMIELLGMPXQKLLDASKRAKNFV 333

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 140
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 141 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 198
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 199 DVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 140
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 141 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 198
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 199 DVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 20  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 79
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 80  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 139
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 140 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 197
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 198 DVWSFGVVLYELFT 211

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 107/246 (43%), Gaps = 16/246 (6%)
Query: 14  GKFGTV----YRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V    YR ++K   + +     G  K            IM +L +P ++++    
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGVC 405
Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++  +M +V+E+  GG L + ++     +    VA  + Q+  G++++  KN +H ++  
Sbjct: 406 QAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA 464
Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----EFVAPEVVNFDAIGFGTDM 185
            N+L + +  +  KI DFGL++    +              ++ APE +NF      +D+
Sbjct: 465 RNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 522
Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS GV  +  LS G  P+      + MA +   +     EC  E   +    +    +  
Sbjct: 523 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALMSDCWIYK 579
Query: 245 REDAPE 250
            ED P+
Sbjct: 580 WEDRPD 585

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 25  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 84
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 85  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 144
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 145 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 202
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 203 DVWSFGVVLYELFT 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G V   + + TG  +A K +  A               I++  +H  +I I D    
Sbjct: 65  GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124
Query: 72  S------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           +        + VVL+L+E      ++I     LT + V  F+ Q+  G++++HS  V+H 
Sbjct: 125 TVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHR 182
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEV-VNFDA 178
           D+KP N+L        +KI DFG+AR           F T E+V      APE+ ++   
Sbjct: 183 DLKPSNLLV--NENCELKIGDFGMARGLCTSPAEHQYFMT-EYVATRWYRAPELMLSLHE 239
Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
                D+WSVG I   +L+    F G+  V  +
Sbjct: 240 YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 272

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 140
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 141 ATRNI--LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVAS 198
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 199 DVWSFGVVLYELFT 212

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  L H +L+Q+Y        + ++ E +  G L   + +       + +    + +CE
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTP-EFVA 170
            +E++ SK  LH D+   N  CL      +K+ DFGL+R   D E    V    P  +  
Sbjct: 132 AMEYLESKQFLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 189
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ----------- 218
           PEV+ +      +D+W+ GV+ + + S G  P+   T+ +T  +  IAQ           
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLAS 247
Query: 219 ---YDFDDECFNEISDDAKDFIRKLLLKD 244
              Y     C++E +D+   F  K+LL +
Sbjct: 248 EKVYTIMYSCWHEKADERPTF--KILLSN 274

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  L H +L+Q+Y        + ++ E +  G L   + +       + +    + +CE
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 116
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTP-EFVA 170
            +E++ SK  LH D+   N  CL      +K+ DFGL+R   D E    V    P  +  
Sbjct: 117 AMEYLESKQFLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 174
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ----------- 218
           PEV+ +      +D+W+ GV+ + + S G  P+   T+ +T  +  IAQ           
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLAS 232
Query: 219 ---YDFDDECFNEISDDAKDFIRKLLLKD 244
              Y     C++E +D+   F  K+LL +
Sbjct: 233 EKVYTIMYSCWHEKADERPTF--KILLSN 259

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  L H +L+Q+Y        + ++ E +  G L   + +       + +    + +CE
Sbjct: 63  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 122
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTP-EFVA 170
            +E++ SK  LH D+   N  CL      +K+ DFGL+R   D E    V    P  +  
Sbjct: 123 AMEYLESKQFLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 180
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ----------- 218
           PEV+ +      +D+W+ GV+ + + S G  P+   T+ +T  +  IAQ           
Sbjct: 181 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLAS 238
Query: 219 ---YDFDDECFNEISDDAKDFIRKLLLKD 244
              Y     C++E +D+   F  K+LL +
Sbjct: 239 EKVYTIMYSCWHEKADERPTF--KILLSN 265

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  L H +L+Q+Y        + ++ E +  G L   + +       + +    + +CE
Sbjct: 56  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 115
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTP-EFVA 170
            +E++ SK  LH D+   N  CL      +K+ DFGL+R   D E    V    P  +  
Sbjct: 116 AMEYLESKQFLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 173
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ----------- 218
           PEV+ +      +D+W+ GV+ + + S G  P+   T+ +T  +  IAQ           
Sbjct: 174 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLAS 231
Query: 219 ---YDFDDECFNEISDDAKDFIRKLLLKD 244
              Y     C++E +D+   F  K+LL +
Sbjct: 232 EKVYTIMYSCWHEKADERPTF--KILLSN 258

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 23/178 (12%)
Query: 53  IMRELQHPRLIQIYDAFESS--------------NVMCVVLELIEGGELFERVIDDDFVL 98
           I+R L H  ++++++    S              N + +V E +E       V++   +L
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLL 118
Query: 99  TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP--- 155
            E A  +FM Q+  G+++IHS NVLH D+KP N+   T+    +KI DFGLAR  DP   
Sbjct: 119 EEHA-RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPHYS 176
Query: 156 -EKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
            +  L     T  + +P  +++ +      DMW+ G I   +L+G + F G  +++ M
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  L H +L+Q+Y        + ++ E +  G L   + +       + +    + +CE
Sbjct: 52  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 111
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTP-EFVA 170
            +E++ SK  LH D+   N  CL      +K+ DFGL+R   D E    V    P  +  
Sbjct: 112 AMEYLESKQFLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ----------- 218
           PEV+ +      +D+W+ GV+ + + S G  P+   T+ +T  +  IAQ           
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLAS 227
Query: 219 ---YDFDDECFNEISDDAKDFIRKLLLKD 244
              Y     C++E +D+   F  K+LL +
Sbjct: 228 EKVYTIMYSCWHEKADERPTF--KILLSN 254

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 7/163 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI-FMRQIC 111
           +M+ LQH +L++++ A  +   + ++ E +  G L + +  D+         I F  QI 
Sbjct: 236 VMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTP-EFV 169
           EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +     P ++ 
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTAREGAKFPIKWT 352
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTM 211
           APE +NF +    +D+WS G++   +++ G  P+ G ++ + +
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G V   + + TG  +A K +  A               I++  +H  +I I D    
Sbjct: 66  GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 125
Query: 72  S------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           +        + VVL+L+E      ++I     LT + V  F+ Q+  G++++HS  V+H 
Sbjct: 126 TVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHR 183
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEV-VNFDA 178
           D+KP N+  L      +KI DFG+AR           F T E+V      APE+ ++   
Sbjct: 184 DLKPSNL--LVNENCELKIGDFGMARGLCTSPAEHQYFMT-EYVATRWYRAPELMLSLHE 240
Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
                D+WSVG I   +L+    F G+  V  +
Sbjct: 241 YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 273

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 84  YSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 143
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 144 ATRNI--LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVAS 201
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 202 DVWSFGVVLYELFT 215

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 63  IQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTE-KAVAIFMRQICEGVEFIHSKN 121
           +Q++D F+    MC+  EL+ G   F+ + D++++      V     Q+C+ V+F+H   
Sbjct: 99  VQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNK 157
Query: 122 VLHLDMKPENILCLTK-----------------TGNRIKIIDFGLARKFDPEKKLQVLFG 164
           + H D+KPENIL +                       ++++DFG A  FD E     +  
Sbjct: 158 LTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSA-TFDHEHH-STIVS 215
Query: 165 TPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
           T  + APEV+         D+WS+G I +    G + F    + + +A
Sbjct: 216 TRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLA 263

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 14  GKFGTVYRC-KEKATGMTLAAKFV-GIAKXXXXXXXXXXXXIMRELQHP----RLIQIYD 67
           G FG V  C   KA G  +A K V  + +                   P    R +Q+ +
Sbjct: 25  GAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            FE    +C+V EL+ G   ++ + ++ F+      +     QIC+ V F+HS  + H D
Sbjct: 85  WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTD 143
Query: 127 MKPENILCL-----------------TKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV 169
           +KPENIL +                 T     IK++DFG A  +D E     L  T  + 
Sbjct: 144 LKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TYDDEHH-STLVSTRHYR 201
Query: 170 APEVVNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMA 212
           APEV+   A+G+    D+WS+G I      G + F      + +A
Sbjct: 202 APEVIL--ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 71/125 (56%), Gaps = 9/125 (7%)
Query: 54  MRELQHPRLIQIYDAFESS--NVMCVVL--ELIEGGELFERVIDDDFVLTEKAVAIFMRQ 109
           ++ LQHP +++ YD++ES+     C+VL  EL   G L +  +    V   K +  + RQ
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTL-KTYLKRFKVXKIKVLRSWCRQ 137
Query: 110 ICEGVEFIHSKN--VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE 167
           I +G++F+H++   ++H D+K +NI     TG+ +KI D GLA         + + GTPE
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS-VKIGDLGLA-TLKRASFAKAVIGTPE 195
Query: 168 FVAPE 172
           F APE
Sbjct: 196 FXAPE 200

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 19/164 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI-FMRQIC 111
           +M+ LQH +L++++ A  +   + ++ E +  G L + +  D+         I F  QI 
Sbjct: 230 VMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 288
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGTPEF 168
           EG+ FI  +N +H D++  NIL         KI DFGLAR   KF P K          +
Sbjct: 289 EGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVGAKF-PIK----------W 335
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTM 211
            APE +NF +    +D+WS G++   +++ G  P+ G ++ + +
Sbjct: 336 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 379

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 7/163 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI-FMRQIC 111
           +M+ LQH +L++++ A  +   + ++ E +  G L + +  D+         I F  QI 
Sbjct: 63  VMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 121
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTP-EFV 169
           EG+ FI  +N +H D++  NIL         KI DFGLAR   D E   +     P ++ 
Sbjct: 122 EGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 179
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTM 211
           APE +NF +    +D+WS G++   +++ G  P+ G ++ + +
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 222

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L E  +   + Q+ +G+ +IH+  ++H D+KP N+         +KI+DFGLAR+ D E 
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV--NEDCELKILDFGLARQADSEM 182
Query: 158 KLQVLFGTPEFVAPEVV-NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI 216
              V+  T  + APEV+ N+       D+WSVG I   +++G + F G   +  +  +  
Sbjct: 183 XGXVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240
Query: 217 AQYDFDDECFNEI-SDDAKDFIRKLLLKDRED 247
                  E    + SD+AK++++ L   +++D
Sbjct: 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD 272

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 103/249 (41%), Gaps = 29/249 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV-GIAKXXXXXXXXXXXXIMRELQHPRLIQIY-----D 67
           G +G V     K TG  +A K +    K            I++  +H  +I I+     D
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           +FE+ N + ++ EL++      RVI    +L++  +  F+ Q    V+ +H  NV+H D+
Sbjct: 82  SFENFNEVYIIQELMQTD--LHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDL 138
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFD-----------PEKKLQVLFGTPEFVAPEVVNF 176
           KP N+L    +   +K+ DFGLAR  D            +  +     T  + APEV+  
Sbjct: 139 KPSNLLI--NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLT 196
Query: 177 DA-IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM----ANVTIAQYDFDDECFNEISD 231
            A      D+WS G I   L      F G      +      +     D D  C    S 
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE--SP 254
Query: 232 DAKDFIRKL 240
            A+++I+ L
Sbjct: 255 RAREYIKSL 263

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 103/249 (41%), Gaps = 29/249 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV-GIAKXXXXXXXXXXXXIMRELQHPRLIQIY-----D 67
           G +G V     K TG  +A K +    K            I++  +H  +I I+     D
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           +FE+ N + ++ EL++      RVI    +L++  +  F+ Q    V+ +H  NV+H D+
Sbjct: 82  SFENFNEVYIIQELMQTD--LHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDL 138
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFD-----------PEKKLQVLFGTPEFVAPEVVNF 176
           KP N+L    +   +K+ DFGLAR  D            +  +     T  + APEV+  
Sbjct: 139 KPSNLLI--NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLT 196
Query: 177 DA-IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM----ANVTIAQYDFDDECFNEISD 231
            A      D+WS G I   L      F G      +      +     D D  C    S 
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE--SP 254
Query: 232 DAKDFIRKL 240
            A+++I+ L
Sbjct: 255 RAREYIKSL 263

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 59  VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 116
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 117 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 174
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 175 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 211

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 423 VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 480
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 481 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 538
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 539 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 424 VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 481
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 482 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 539
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 540 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 576

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 61  VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 118
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 65  VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 122
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 123 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENXYKAQTHGKWPVKW 180
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 181 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +             I++ LQH  +++     
Sbjct: 22  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 81
Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H ++
Sbjct: 82  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNL 141
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEF-VAPEVVNFDAIGFGT 183
              NI  L +  NR+KI DFGL +    +K   K++    +P F  APE +        +
Sbjct: 142 ATRNI--LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVAS 199
Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 200 DVWSFGVVLYELFT 213

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 79  VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 136
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 137 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 194
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 195 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 231

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 65  VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 122
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 123 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 180
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 181 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 81  VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 138
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 139 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 81  VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 138
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 139 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 103/249 (41%), Gaps = 29/249 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV-GIAKXXXXXXXXXXXXIMRELQHPRLIQIY-----D 67
           G +G V     K TG  +A K +    K            I++  +H  +I I+     D
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD 81
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           +FE+ N + ++ EL++      RVI    +L++  +  F+ Q    V+ +H  NV+H D+
Sbjct: 82  SFENFNEVYIIQELMQTD--LHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDL 138
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFD-----------PEKKLQVLFGTPEFVAPEVVNF 176
           KP N+L    +   +K+ DFGLAR  D            +  +     T  + APEV+  
Sbjct: 139 KPSNLLI--NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 177 DA-IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM----ANVTIAQYDFDDECFNEISD 231
            A      D+WS G I   L      F G      +      +     D D  C    S 
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE--SP 254
Query: 232 DAKDFIRKL 240
            A+++I+ L
Sbjct: 255 RAREYIKSL 263

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M++L +P ++++    E+ + M +V+E+ E G L  + +  +  + +K +   + Q+  
Sbjct: 71  VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSM 128
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP-EF 168
           G++++   N +H D+   N+L +T+  +  KI DFGL++    ++   K Q     P ++
Sbjct: 129 GMKYLEESNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            APE +N+      +D+WS GV+ +   S G  P+ G
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 53  IMREL-QHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           ++RE  +HP +I+ +   +      + +EL     L E V   DF          ++Q  
Sbjct: 70  LLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTT 128
Query: 112 EGVEFIHSKNVLHLDMKPENIL-CLTKTGNRIK--IIDFGLARKFDPEK----KLQVLFG 164
            G+  +HS N++H D+KP NIL  +     +IK  I DFGL +K    +    +   + G
Sbjct: 129 SGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 165 TPEFVAPEVVNFDA---IGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
           T  ++APE+++ D      +  D++S G + Y ++S G  PF G++ +Q  AN+ +    
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKS-LQRQANILLGACS 246
Query: 221 FDDECFN-EISDD--AKDFIRKLLLKDREDAP 249
            D  C + E  +D  A++ I K++  D +  P
Sbjct: 247 LD--CLHPEKHEDVIARELIEKMIAMDPQKRP 276

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 33/254 (12%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI---YDAFE 70
           G FG V++ K +  G T   K V                 + +L H  ++     +D F+
Sbjct: 22  GGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 71  -----------SSNVMC--VVLELIEGGELFERVIDDDFVLTEKAVAI-FMRQICEGVEF 116
                       S   C  + +E  + G L + +        +K +A+    QI +GV++
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137
Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF 176
           IHSK +++ D+KP NI  +     ++KI DFGL      + K     GT  +++PE ++ 
Sbjct: 138 IHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISS 195
Query: 177 DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA-KD 235
              G   D++++G+I   LL      + +T  +T    T    D  D   ++I D   K 
Sbjct: 196 QDYGKEVDLYALGLILAELL-----HVCDTAFETSKFFT----DLRDGIISDIFDKKEKT 246
Query: 236 FIRKLLLKDREDAP 249
            ++KLL K  ED P
Sbjct: 247 LLQKLLSKKPEDRP 260

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  L H +L+Q+Y        + ++ E +  G L   + +       + +    + +CE
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 116
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTP-EFVA 170
            +E++ SK  LH D+   N  CL      +K+ DFGL+R   D E         P  +  
Sbjct: 117 AMEYLESKQFLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSP 174
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ----------- 218
           PEV+ +      +D+W+ GV+ + + S G  P+   T+ +T  +  IAQ           
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQGLRLYRPHLAS 232
Query: 219 ---YDFDDECFNEISDDAKDFIRKLLLKD 244
              Y     C++E +D+   F  K+LL +
Sbjct: 233 EKVYTIMYSCWHEKADERPTF--KILLSN 259

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM+ L HP ++++    E      +++EL   GEL   +  +   L    + ++  QIC+
Sbjct: 62  IMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 120
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--KLQVLFGTPEFVA 170
            + ++ S N +H D+   NI  L  +   +K+ DFGL+R  + E   K  V     ++++
Sbjct: 121 AMAYLESINCVHRDIAVRNI--LVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 178
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
           PE +NF      +D+W   V  + +LS G  PF
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM+ L HP ++++    E      +++EL   GEL   +  +   L    + ++  QIC+
Sbjct: 66  IMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 124
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--KLQVLFGTPEFVA 170
            + ++ S N +H D+   NI  L  +   +K+ DFGL+R  + E   K  V     ++++
Sbjct: 125 AMAYLESINCVHRDIAVRNI--LVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 182
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
           PE +NF      +D+W   V  + +LS G  PF
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 30/219 (13%)
Query: 59  HPRLIQIYDAFESSNVMCVVLEL--IEGGELFE--RVIDDDFVLTEKAVAI-FMRQICEG 113
           HP +I+ Y +  +   + + LEL  +   +L E   V D++  L ++   I  +RQI  G
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 114 VEFIHSKNVLHLDMKPENILCLT--------KTGN---RIKIIDFGLARKFDP-----EK 157
           V  +HS  ++H D+KP+NIL  T        +TG    RI I DFGL +K D        
Sbjct: 146 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 158 KLQVLFGTPEFVAPEVVNFDA---IGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN 213
            L    GT  + APE++       +    D++S+G + Y +LS G  PF  +   ++  N
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--N 263
Query: 214 VTIAQYDFDD-ECFNEIS--DDAKDFIRKLLLKDREDAP 249
           +    +  D+ +C ++ S   +A D I +++  D    P
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 302

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM+ L HP ++++    E      +++EL   GEL   +  +   L    + ++  QIC+
Sbjct: 78  IMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 136
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--KLQVLFGTPEFVA 170
            + ++ S N +H D+   NI  L  +   +K+ DFGL+R  + E   K  V     ++++
Sbjct: 137 AMAYLESINCVHRDIAVRNI--LVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 194
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
           PE +NF      +D+W   V  + +LS G  PF
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 30/219 (13%)
Query: 59  HPRLIQIYDAFESSNVMCVVLEL--IEGGELFE--RVIDDDFVLTEKAVAI-FMRQICEG 113
           HP +I+ Y +  +   + + LEL  +   +L E   V D++  L ++   I  +RQI  G
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 114 VEFIHSKNVLHLDMKPENILCLT--------KTGN---RIKIIDFGLARKFDP-----EK 157
           V  +HS  ++H D+KP+NIL  T        +TG    RI I DFGL +K D        
Sbjct: 146 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 158 KLQVLFGTPEFVAPEVVNFDA---IGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN 213
            L    GT  + APE++       +    D++S+G + Y +LS G  PF  +   ++  N
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--N 263
Query: 214 VTIAQYDFDD-ECFNEIS--DDAKDFIRKLLLKDREDAP 249
           +    +  D+ +C ++ S   +A D I +++  D    P
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 302

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 108 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 166
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 167 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 226
Query: 201 PF 202
           PF
Sbjct: 227 PF 228

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 78/141 (55%), Gaps = 15/141 (10%)
Query: 54  MRELQHPRLIQIYDAFESSN-----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR 108
           + E+ HP ++QI++  E ++     V  +V+E + GG+  +R       + E A+A ++ 
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKRSKGQKLPVAE-AIA-YLL 189
Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF 168
           +I   + ++HS  +++ D+KPENI+    T  ++K+ID G   + +       L+GTP F
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIML---TEEQLKLIDLGAVSRIN---SFGYLYGTPGF 243
Query: 169 VAPEVVNFDAIGFGTDMWSVG 189
            APE+V        TD+++VG
Sbjct: 244 QAPEIVRTGPT-VATDIYTVG 263

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 107 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 165
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 166 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 225
Query: 201 PF 202
           PF
Sbjct: 226 PF 227

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX----XXXXIMRELQHPRLIQIYDAF 69
           G+FG V R + KA G   +   +   K                IM + +HP +I++    
Sbjct: 27  GEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVV 86
Query: 70  ESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +S  + ++ E +E G L  F R+ D  F + +  +   +R I  G+ ++   + +H D+
Sbjct: 87  TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ--LVGMLRGIASGMRYLAEMSYVHRDL 144
Query: 128 KPENILCLTKTGNRI-KIIDFGLAR-----KFDPEKKLQVLFGTP-EFVAPEVVNFDAIG 180
              NIL      N + K+ DFGL+R       DP +   +    P  + APE + F    
Sbjct: 145 AARNILV---NSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFT 201
Query: 181 FGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             +D WS G++ + ++S G  P+  M   DV
Sbjct: 202 SASDAWSYGIVMWEVMSFGERPYWDMSNQDV 232

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 107 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 165
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 166 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 225
Query: 201 PF 202
           PF
Sbjct: 226 PF 227

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 164
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 201 PF 202
           PF
Sbjct: 225 PF 226

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM  L HP ++++Y    +   M  V+E +  G+L+ R++D    +        M  I  
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 113 GVEFIHSKN--VLHLDMKPENILCLTKTGNR---IKIIDFGLARKFDPEKKLQVLFGTPE 167
           G+E++ ++N  ++H D++  NI   +   N     K+ DFGL+++      +  L G  +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSVSGLLGNFQ 191
Query: 168 FVAPEVVNFDAIGF--GTDMWSVGVICYVLLSGLSPF 202
           ++APE +  +   +    D +S  +I Y +L+G  PF
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 164
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 201 PF 202
           PF
Sbjct: 225 PF 226

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 164
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 201 PF 202
           PF
Sbjct: 225 PF 226

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 164
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 201 PF 202
           PF
Sbjct: 225 PF 226

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 164
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 201 PF 202
           PF
Sbjct: 225 PF 226

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 127 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 185
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 186 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 245
Query: 201 PF 202
           PF
Sbjct: 246 PF 247

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 87  LFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR 141
           +FE V + DF      LT+  +  ++ ++ + +++ HS+ ++H D+KP N++ +     +
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK 164
Query: 142 IKIIDFGLARKFDPEKKLQVLFGTPEFVAPE-VVNFDAIGFGTDMWSVGVICYVLLSGLS 200
           +++ID+GLA  + P K+  V   +  F  PE +V+     +  DMWS+G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 201 PF 202
           PF
Sbjct: 225 PF 226

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++        +  +V E +E G L  F R  D  F + +  +   +R +
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGV 160
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGT-P- 166
             G+ ++     +H D+   N+L    +    K+ DFGL+R    DP+       G  P 
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLV--DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANV 214
            + APE + F      +D+WS GV+ + VL  G  P+   T+   +++V
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++        +  +V E +E G L  F R  D  F + +  +   +R +
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGV 160
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGT-P- 166
             G+ ++     +H D+   N+L    +    K+ DFGL+R    DP+       G  P 
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLV--DSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPI 218
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANV 214
            + APE + F      +D+WS GV+ + VL  G  P+   T+   +++V
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 13/149 (8%)
Query: 102 AVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV 161
           A+ +F  QI +GV++IHSK ++H D+KP NI  +     ++KI DFGL      + K   
Sbjct: 138 ALELF-EQITKGVDYIHSKKLIHRDLKPSNIFLV--DTKQVKIGDFGLVTSLKNDGKRTR 194
Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF 221
             GT  +++PE ++    G   D++++G+I   LL      + +T  +T    T    D 
Sbjct: 195 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL-----HVCDTAFETSKFFT----DL 245
Query: 222 DDECFNEISDDA-KDFIRKLLLKDREDAP 249
            D   ++I D   K  ++KLL K  ED P
Sbjct: 246 RDGIISDIFDKKEKTLLQKLLSKKPEDRP 274

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGLAR    DPE       G  P
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 14  GKFGTVYRC-KEKATGMTLAAKFV-GIAKXXXXXXXXXXXXIMRELQHP----RLIQIYD 67
           G FG V  C   KA G  +A K V  + +                   P    R +Q+ +
Sbjct: 25  GAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            FE    +C+V EL+ G   ++ + ++ F+      +     QIC+ V F+HS  + H D
Sbjct: 85  WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTD 143
Query: 127 MKPENILCL-----------------TKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV 169
           +KPENIL +                 T     IK++DFG A  +D E     L     + 
Sbjct: 144 LKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TYDDEHH-STLVXXRHYR 201
Query: 170 APEVVNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMA 212
           APEV+   A+G+    D+WS+G I      G + F      + +A
Sbjct: 202 APEVIL--ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXX----XXXXIMRELQHPRLIQIYDAF 69
           G+FG V R + KA G   +   +   K                IM + +HP +I++    
Sbjct: 25  GEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVV 84
Query: 70  ESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +S  + ++ E +E G L  F R+ D  F + +  +   +R I  G+ ++   + +H D+
Sbjct: 85  TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ--LVGMLRGIASGMRYLAEMSYVHRDL 142
Query: 128 KPENILCLTKTGNRIKIIDFGLAR-----KFDPEKKLQVLFGTP-EFVAPEVVNFDAIGF 181
              NI  L  +    K+ DFGL+R       DP     +    P  + APE + F     
Sbjct: 143 AARNI--LVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTS 200
Query: 182 GTDMWSVGVICYVLLS-GLSPF--MGETDV 208
            +D WS G++ + ++S G  P+  M   DV
Sbjct: 201 ASDAWSYGIVMWEVMSFGERPYWDMSNQDV 230

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 21/176 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI+   K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVV--KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+    +G G     D+WSVGVI   ++ G   F G TD     N  I Q
Sbjct: 190 YYRAPEVI----LGMGYKENVDIWSVGVIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 21/176 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI+   K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVV--KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+    +G G     D+WSVGVI   ++ G   F G TD     N  I Q
Sbjct: 190 YYRAPEVI----LGMGYKENVDIWSVGVIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 14  GKFGTVYRCKEKATGMTL----AAKFVG-IAKXXXXXXXXXXXXIMRELQHPRLIQIYDA 68
           G FGTVY+      G T+    A K +                 IM  + HP L+++   
Sbjct: 26  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 85
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             S  +  +V +L+  G L E V +    +  + +  +  QI +G+ ++  + ++H D+ 
Sbjct: 86  CLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLA 144
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDM 185
             N+L   K+ N +KI DFGLAR  + ++K     G     +++A E +++      +D+
Sbjct: 145 ARNVL--VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDV 202
Query: 186 WSVGVICYVLLS-GLSPFMG 204
           WS GV  + L++ G  P+ G
Sbjct: 203 WSYGVTIWELMTFGGKPYDG 222

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 157 ASGMKYLSDMGAVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEF 116
           L+    ++   A +  + + + +E  E G L++ +  ++            RQI E + +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---------KFDPEK------KLQV 161
           IHS+ ++H D+KP NI         +KI DFGLA+         K D +        L  
Sbjct: 132 IHSQGIIHRDLKPMNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 162 LFGTPEFVAPEVVNFDAIGF---GTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIA 217
             GT  +VA EV+  D  G      DM+S+G+I + ++   S  M   ++ + + +V+I 
Sbjct: 190 AIGTAMYVATEVL--DGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIE 247
Query: 218 -QYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
              DFDD   N++  + K  IR L+  D    P
Sbjct: 248 FPPDFDD---NKMKVEKK-IIRLLIDHDPNKRP 276

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 127
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 128 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 59  HPRLIQIYDAFESSNVMCVVLEL--IEGGELFE--RVIDDDFVLTEKAVAI-FMRQICEG 113
           HP +I+ Y +  +   + + LEL  +   +L E   V D++  L ++   I  +RQI  G
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 114 VEFIHSKNVLHLDMKPENILCLT--------KTGN---RIKIIDFGLARKFDP-----EK 157
           V  +HS  ++H D+KP+NIL  T        +TG    RI I DFGL +K D        
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 158 KLQVLFGTPEFVAPEVV----NFDA---IGFGTDMWSVGVICYVLLS-GLSPFMGETDVQ 209
            L    GT  + APE++    N      +    D++S+G + Y +LS G  PF  +   +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 210 TMANVTIAQYDFDD-ECFNEIS--DDAKDFIRKLLLKDREDAP 249
           +  N+    +  D+ +C ++ S   +A D I +++  D    P
Sbjct: 248 S--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 97  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 154
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 155 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 211
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 257

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 127
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 128 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 87  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 144
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 145 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 247

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 59  HPRLIQIYDAFESSNVMCVVLEL--IEGGELFE--RVIDDDFVLTEKAVAI-FMRQICEG 113
           HP +I+ Y +  +   + + LEL  +   +L E   V D++  L ++   I  +RQI  G
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 114 VEFIHSKNVLHLDMKPENILCLT--------KTGN---RIKIIDFGLARKFDP-----EK 157
           V  +HS  ++H D+KP+NIL  T        +TG    RI I DFGL +K D        
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 187
Query: 158 KLQVLFGTPEFVAPEVV----NFDA---IGFGTDMWSVGVICYVLLS-GLSPFMGETDVQ 209
            L    GT  + APE++    N      +    D++S+G + Y +LS G  PF  +   +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 210 TMANVTIAQYDFDD-ECFNEIS--DDAKDFIRKLLLKDREDAP 249
           +  N+    +  D+ +C ++ S   +A D I +++  D    P
Sbjct: 248 S--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 103/234 (44%), Gaps = 42/234 (17%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRE------LQHPRLIQIYD 67
           G FG V+  K K      A K + +              +MRE      L+HP +++ ++
Sbjct: 16  GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-----VMREVKALAKLEHPGIVRYFN 70
Query: 68  AF-----------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---QICEG 113
           A+            S  V   +   +   E  +  ++    + E+  ++ +    QI E 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---------- 163
           VEF+HSK ++H D+KP NI       + +K+ DFGL    D +++ Q +           
Sbjct: 131 VEFLHSKGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 164 ---GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
              GT  +++PE ++ ++     D++S+G+I + LL   S  M    V+T+ +V
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMER--VRTLTDV 240

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM  L HP ++++Y    +   M  V+E +  G+L+ R++D    +        M  I  
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 113 GVEFIHSKN--VLHLDMKPENILCLTKTGNR---IKIIDFGLARKFDPEKKLQVLFGTPE 167
           G+E++ ++N  ++H D++  NI   +   N     K+ DFG +++      +  L G  +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ--SVHSVSGLLGNFQ 191
Query: 168 FVAPEVVNFDAIGF--GTDMWSVGVICYVLLSGLSPF 202
           ++APE +  +   +    D +S  +I Y +L+G  PF
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM +  HP +I +      S  + +V E +E G L   +  +D   T   +   +R I  
Sbjct: 76  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISA 135
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P-E 167
           G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P  
Sbjct: 136 GMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 192
Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETD 207
           + APE + F      +D+WS G++ + ++S G  P+   T+
Sbjct: 193 WTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTN 233

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V+E +  G L       DF+  E  +  ++R    
Sbjct: 66  VMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLL------DFLKGE--MGKYLRLPQL 116
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 117 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEXTAR 172
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 229
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  H  +I++         M ++ E +E G L  F R  D +F + +  +   +R I
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++ + N +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICY-VLLSGLSPFMGETDVQTMANV 214
             + APE +++      +D+WS G++ + V+  G  P+   ++ + M  +
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 10/193 (5%)
Query: 14  GKFGTVYRCKEKATGMTLA--AKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G FG VY+     T + +   A  V I              +M + QH  L+++      
Sbjct: 42  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101
Query: 72  SNVMCVVLELIEGGELFERV--IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            + +C+V   +  G L +R+  +D    L+        +    G+ F+H  + +H D+K 
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161
Query: 130 ENILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
            NIL         KI DFGLAR   KF        + GT  ++APE +  + I   +D++
Sbjct: 162 ANILL--DEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE-ITPKSDIY 218
Query: 187 SVGVICYVLLSGL 199
           S GV+   +++GL
Sbjct: 219 SFGVVLLEIITGL 231

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM +  HP +I +      S  + ++ E +E G L   +  +D   T   +   +R I  
Sbjct: 87  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 146
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLAR-----KFDPEKKLQVLFGTP 166
           G++++   N +H D+   NIL      N + K+ DFGL+R       DP     +    P
Sbjct: 147 GMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 203
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDE 224
             + APE + +      +D+WS G++ + ++S G  P+   T+ Q + N     Y     
Sbjct: 204 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPP 262
Query: 225 CFNEISDDAKDFIRKLLL----KDREDAPE 250
                  D    + +L+L    KDR   P+
Sbjct: 263 M------DCPSALHQLMLDCWQKDRNHRPK 286

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL R    DPE       G  P
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP +I++      S  + +V E +E G L  F R  D  F + +  +   +R I
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGI 156
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRI-KIIDFGLARKF--DPEKKLQVLFGT-P 166
             G++++     +H D+   NIL      N + K+ DFGL+R    DPE       G  P
Sbjct: 157 ASGMKYLSDMGFVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 167 -EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
             + +PE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 10/193 (5%)
Query: 14  GKFGTVYRCKEKATGMTLA--AKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G FG VY+     T + +   A  V I              +M + QH  L+++      
Sbjct: 36  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 95
Query: 72  SNVMCVVLELIEGGELFERV--IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            + +C+V   +  G L +R+  +D    L+        +    G+ F+H  + +H D+K 
Sbjct: 96  GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 155
Query: 130 ENILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
            NIL         KI DFGLAR   KF        + GT  ++APE +  + I   +D++
Sbjct: 156 ANILL--DEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE-ITPKSDIY 212
Query: 187 SVGVICYVLLSGL 199
           S GV+   +++GL
Sbjct: 213 SFGVVLLEIITGL 225

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 14  GKFGTVYRCKEKATGMTL----AAKFVG-IAKXXXXXXXXXXXXIMRELQHPRLIQIYDA 68
           G FGTVY+      G T+    A K +                 IM  + HP L+++   
Sbjct: 49  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 108
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             S  +  +V +L+  G L E V +    +  + +  +  QI +G+ ++  + ++H D+ 
Sbjct: 109 CLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLA 167
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDM 185
             N+L   K+ N +KI DFGLAR  + ++K     G     +++A E +++      +D+
Sbjct: 168 ARNVL--VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDV 225
Query: 186 WSVGVICYVLLS-GLSPFMG 204
           WS GV  + L++ G  P+ G
Sbjct: 226 WSYGVTIWELMTFGGKPYDG 245

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM  L HP ++++Y    +   M  V+E +  G+L+ R++D    +        M  I  
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 113 GVEFIHSKN--VLHLDMKPENILCLTKTGNR---IKIIDFGLARKFDPEKKLQVLFGTPE 167
           G+E++ ++N  ++H D++  NI   +   N     K+ DF L+++      +  L G  +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ--SVHSVSGLLGNFQ 191
Query: 168 FVAPEVVNFDAIGF--GTDMWSVGVICYVLLSGLSPF 202
           ++APE +  +   +    D +S  +I Y +L+G  PF
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 62/114 (54%), Gaps = 4/114 (3%)
Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL 162
           ++I++ Q+   V FIHS  + H D+KP+N+L  +K  N +K+ DFG A+K  P +     
Sbjct: 143 ISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD-NTLKLCDFGSAKKLIPSEPSVAX 201
Query: 163 FGTPEFVAPEVVNFDAIGF--GTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
             +  + APE++   A  +    D+WS+G +   L+ G   F GET +  +  +
Sbjct: 202 ICSRFYRAPELM-LGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRI 254

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 10/193 (5%)
Query: 14  GKFGTVYRCKEKATGMTLA--AKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G FG VY+     T + +   A  V I              +M + QH  L+++      
Sbjct: 42  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101
Query: 72  SNVMCVVLELIEGGELFERV--IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            + +C+V   +  G L +R+  +D    L+        +    G+ F+H  + +H D+K 
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161
Query: 130 ENILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
            NIL         KI DFGLAR   KF        + GT  ++APE +  + I   +D++
Sbjct: 162 ANILL--DEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE-ITPKSDIY 218
Query: 187 SVGVICYVLLSGL 199
           S GV+   +++GL
Sbjct: 219 SFGVVLLEIITGL 231

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQIC 111
           IM++L+H +L+Q+Y A  S   + +V E +  G L + + D +   L    +     Q+ 
Sbjct: 57  IMKKLKHDKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVA 115
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVLFGTP-E 167
            G+ +I   N +H D++  NIL     GN +  KI DFGLAR   D E   +     P +
Sbjct: 116 AGMAYIERMNYIHRDLRSANIL----VGNGLICKIADFGLARLIEDNEXTARQGAKFPIK 171
Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECF 226
           + APE   +      +D+WS G++   L++ G  P+ G  + + +  V   +  +   C 
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV---ERGYRMPCP 228
Query: 227 NEISDDAKDFIRKLLLKDREDAP 249
            +      + +     KD E+ P
Sbjct: 229 QDCPISLHELMIHCWKKDPEERP 251

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V+E +  G L       DF+  E  +  ++R    
Sbjct: 66  VMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLL------DFLKGE--MGKYLRLPQL 116
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 117 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTAR 172
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 229
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 27/222 (12%)
Query: 14  GKFGTVYRCKEKATGMTLAA----KFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIY--D 67
           G FG V  C + A G +  A    + VG  +            I  + +  + + +   D
Sbjct: 30  GTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            F     MC+  EL+ G   FE + +++F       V     Q+C  + F+H   + H D
Sbjct: 90  WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTD 148
Query: 127 MKPENIL---------------CLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFV 169
           +KPENIL               C  K+     I++ DFG A  FD E    ++  T  + 
Sbjct: 149 LKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-TFDHEHHTTIV-ATRHYR 206
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
            PEV+         D+WS+G I +    G + F    + + +
Sbjct: 207 PPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 27/222 (12%)
Query: 14  GKFGTVYRCKEKATGMTLAA----KFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIY--D 67
           G FG V  C + A G +  A    + VG  +            I  + +  + + +   D
Sbjct: 62  GTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSD 121
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            F     MC+  EL+ G   FE + +++F       V     Q+C  + F+H   + H D
Sbjct: 122 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTD 180
Query: 127 MKPENIL---------------CLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFV 169
           +KPENIL               C  K+     I++ DFG A  FD E    ++  T  + 
Sbjct: 181 LKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-TFDHEHHTTIV-ATRHYR 238
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
            PEV+         D+WS+G I +    G + F    + + +
Sbjct: 239 PPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 280

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 27/222 (12%)
Query: 14  GKFGTVYRCKEKATGMTLAA----KFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIY--D 67
           G FG V  C + A G +  A    + VG  +            I  + +  + + +   D
Sbjct: 39  GTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSD 98
Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            F     MC+  EL+ G   FE + +++F       V     Q+C  + F+H   + H D
Sbjct: 99  WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTD 157
Query: 127 MKPENIL---------------CLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFV 169
           +KPENIL               C  K+     I++ DFG A  FD E    ++  T  + 
Sbjct: 158 LKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-TFDHEHHTTIV-ATRHYR 215
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
            PEV+         D+WS+G I +    G + F    + + +
Sbjct: 216 PPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 257

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 62/105 (59%), Gaps = 6/105 (5%)
Query: 101 KAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL 159
           + +   ++ +     +IH+ KN+ H D+KP NIL + K G R+K+ DFG + ++  +KK+
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL-MDKNG-RVKLSDFGES-EYMVDKKI 207
Query: 160 QVLFGTPEFVAPEVVNFDAI--GFGTDMWSVGVICYVLLSGLSPF 202
           +   GT EF+ PE  + ++   G   D+WS+G+  YV+   + PF
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 12/152 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQI 110
           I+R L H  +I+     E +    + +V+E +  G L + +      L +  + +F +QI
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ--LLLFAQQI 143
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK----KLQVLFGTP 166
           CEG+ ++H+++ +H D+   N+  L      +KI DFGLA+   PE     +++    +P
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNV--LLDNDRLVKIGDFGLAKAV-PEGHEXYRVREDGDSP 200
Query: 167 EF-VAPEVVNFDAIGFGTDMWSVGVICYVLLS 197
            F  APE +      + +D+WS GV  Y LL+
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 11/187 (5%)
Query: 9   SAFSFGKFGTVYRCKEKATGMTLAAK-----FVGIAKXXXXXXXXXXXXIMRELQHPRLI 63
           S    G +G V++ + K  G   A K     F G                +   QHP  +
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG--QHPCCV 120
Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           ++  A+E   ++ +  EL  G  L +        L E  V  ++R     +  +HS+ ++
Sbjct: 121 RLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           HLD+KP NI    +   R K+ DFGL  +       +V  G P ++APE++   + G   
Sbjct: 180 HLDVKPANIFLGPR--GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAA 236
Query: 184 DMWSVGV 190
           D++S+G+
Sbjct: 237 DVFSLGL 243

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E  +  ++R    
Sbjct: 66  VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGE--MGKYLRLPQL 116
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 117 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTAR 172
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 229
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 21/176 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI+   K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVV--KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+    +G G     D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 190 YYRAPEVI----LGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E  +  ++R    
Sbjct: 55  VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGE--MGKYLRLPQL 105
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 106 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTAR 161
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 162 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 218
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 219 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 249

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E  +  ++R    
Sbjct: 66  VMKKLRHEKLVQLY-AVVSEEPIYIVCEYMSKGSLL------DFLKGE--MGKYLRLPQL 116
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 117 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTAR 172
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 229
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI+   K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVV--KSDXTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVI 191
            + APEV+    +G G     D+WSVG I
Sbjct: 190 YYRAPEVI----LGMGYKENVDIWSVGCI 214

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E  +  ++R    
Sbjct: 57  VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGE--MGKYLRLPQL 107
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 108 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTAR 163
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 164 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 220
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 221 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 251

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V+E +  G L       DF+  E  +  ++R    
Sbjct: 66  VMKKLRHEKLVQLY-AVVSEEPIYIVMEYMSKGCLL------DFLKGE--MGKYLRLPQL 116
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 117 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTAR 172
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 229
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 33/212 (15%)
Query: 56  ELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVI-----------DDD----FVLTE 100
            LQHP ++ +         + ++      G+L E ++           DDD      L  
Sbjct: 68  RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ 160
                 + QI  G+E++ S +V+H D+   N+L   K    +KI D GL R+       +
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLGLFREVYAADYYK 185
Query: 161 VLFGT--P-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETD---VQTMAN 213
           +L  +  P  ++APE + +      +D+WS GV+ + + S GL P+ G ++   V+ + N
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245
Query: 214 VTIAQ---------YDFDDECFNEISDDAKDF 236
             +           Y    EC+NE       F
Sbjct: 246 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRF 277

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSK 120
           L Q+Y          +VLEL+  G   E + D  D   T K V +   Q+   +E++HSK
Sbjct: 59  LPQVYYFGPXGKYNAMVLELL--GPSLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSK 116
Query: 121 NVLHLDMKPENILCLTKTGNR----IKIIDFGLARKF-DPEKKLQV-------LFGTPEF 168
           N+++ D+KPEN L + + GN+    I IIDFGLA+++ DPE K  +       L GT  +
Sbjct: 117 NLIYRDVKPENFL-IGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 175
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
           ++             D+ ++G +    L G  P+ G
Sbjct: 176 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 211

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 33/212 (15%)
Query: 56  ELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVI-----------DDD----FVLTE 100
            LQHP ++ +         + ++      G+L E ++           DDD      L  
Sbjct: 85  RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 144
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ 160
                 + QI  G+E++ S +V+H D+   N+L   K    +KI D GL R+       +
Sbjct: 145 PDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLGLFREVYAADYYK 202
Query: 161 VLFGT--P-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETD---VQTMAN 213
           +L  +  P  ++APE + +      +D+WS GV+ + + S GL P+ G ++   V+ + N
Sbjct: 203 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262
Query: 214 VTIAQ---------YDFDDECFNEISDDAKDF 236
             +           Y    EC+NE       F
Sbjct: 263 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRF 294

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQI 110
           IM +  HP ++ +         + +V+E +E G L  F R  D  F + +  +   +R I
Sbjct: 97  IMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQ--LVGMLRGI 154
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFG--TP 166
             G+ ++     +H D+   NI  L  +    K+ DFGL+R    DPE       G    
Sbjct: 155 AAGMRYLADMGYVHRDLAARNI--LVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPV 212
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
            + APE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 213 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 257

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 21/176 (11%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI+   K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+    +G G     D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 190 YYRAPEVI----LGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 9/160 (5%)
Query: 53  IMRELQHPRLIQIYDAF-----ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM 107
           ++    HP ++ + D F      + + + +V EL+   +L + + D   V++ + +  FM
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFM 140
Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE 167
             I  G+  +H   V+H D+ P NIL      N I I DF LAR+   +           
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 168 FVAPEVV-NFDAIGFGTDMWSVGVICYVLLSGLSPFMGET 206
           + APE+V  F       DMWS G +   + +  + F G T
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 60/116 (51%), Gaps = 9/116 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN-ILCLTKTGNRIKIIDFGLARKFD-- 154
           L+ K V +   Q+   VEF+HSK+ LH D+KP+N ++ L +  N++ IIDFGLA+K+   
Sbjct: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
Query: 155 ------PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
                 P ++ + L GT  + +             D+ S+G +    L G  P+ G
Sbjct: 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 9/160 (5%)
Query: 53  IMRELQHPRLIQIYDAF-----ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM 107
           ++    HP ++ + D F      + + + +V EL+   +L + + D   V++ + +  FM
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFM 140
Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE 167
             I  G+  +H   V+H D+ P NIL      N I I DF LAR+   +           
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 168 FVAPEVV-NFDAIGFGTDMWSVGVICYVLLSGLSPFMGET 206
           + APE+V  F       DMWS G +   + +  + F G T
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM----- 107
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E    + +     
Sbjct: 315 VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGETGKYLRLPQLVD 367
Query: 108 --RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVL 162
              QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +  
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFGLARLIEDNEYTARQG 423
Query: 163 FGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
              P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +  
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERG 480
Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   C  E  +   D + +   K+ E+ P
Sbjct: 481 YRMPCPPECPESLHDLMCQCWRKEPEERP 509

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM----- 107
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E    + +     
Sbjct: 232 VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGETGKYLRLPQLVD 284
Query: 108 --RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVL 162
              QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +  
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 163 FGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
              P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +  
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERG 397
Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   C  E  +   D + +   K+ E+ P
Sbjct: 398 YRMPCPPECPESLHDLMCQCWRKEPEERP 426

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI----YDAF 69
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++    Y + 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 86
Query: 70  ESSNVMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           E  +V+ + L L    E   RV          L    V ++M Q+   + +IHS  + H 
Sbjct: 87  EKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 146
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVNFD 177
           D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ F 
Sbjct: 147 DIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI-FG 196
Query: 178 AIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM----- 107
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E    + +     
Sbjct: 56  VMKKLRHEKLVQLY-AVVSEEPIXIVTEYMSKGSLL------DFLKGETGKYLRLPQLVD 108
Query: 108 --RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVL 162
              QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +  
Sbjct: 109 MAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEXTARQG 164
Query: 163 FGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
              P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +  
Sbjct: 165 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERG 221
Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   C  E  +   D + +   K+ E+ P
Sbjct: 222 YRMPCPPECPESLHDLMCQCWRKEPEERP 250

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM----- 107
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E    + +     
Sbjct: 232 VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGETGKYLRLPQLVD 284
Query: 108 --RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVL 162
              QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +  
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 163 FGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
              P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +  
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERG 397
Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   C  E  +   D + +   K+ E+ P
Sbjct: 398 YRMPCPPECPESLHDLMCQCWRKEPEERP 426

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++++H +L+Q+Y A  S   + +V E +  G L       DF+  E  +  ++R    
Sbjct: 66  VMKKIRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGE--MGKYLRLPQL 116
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 117 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTAR 172
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 229
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E  +  ++R    
Sbjct: 233 VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGE--MGKYLRLPQL 283
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGL R   D E   +
Sbjct: 284 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLGRLIEDNEYTAR 339
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 340 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 396
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 397 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 427

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM +  HP +I +      S  + ++ E +E G L   +  +D   T   +   +R I  
Sbjct: 61  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 120
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR-----KFDPEKKLQVLFGTP- 166
           G++++   N +H  +   NI  L  +    K+ DFGL+R       DP     +    P 
Sbjct: 121 GMKYLADMNYVHRALAARNI--LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDEC 225
            + APE + +      +D+WS G++ + ++S G  P+   T+ Q + N     Y      
Sbjct: 179 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPM 237
Query: 226 FNEISDDAKDFIRKLLL----KDREDAPE 250
                 D    + +L+L    KDR   P+
Sbjct: 238 ------DCPSALHQLMLDCWQKDRNHRPK 260

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI+   K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDXTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVI 191
            + APEV+    +G G     D+WSVG I
Sbjct: 190 YYRAPEVI----LGMGYKENVDIWSVGCI 214

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E  +  ++R    
Sbjct: 66  VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGE--MGKYLRLPQL 116
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D+   NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 117 VDMAAQIASGMAYVERMNYVHRDLAAANIL----VGENLVCKVADFGLARLIEDNEYTAR 172
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 229
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 60/121 (49%), Gaps = 3/121 (2%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L  + ++  + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR      
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTACTNF 180
Query: 158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIA 217
            +     T  + APEV+         D+WSVG I   L+ G   F G TD     N  I 
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQG-TDHIDQWNKVIE 239
Query: 218 Q 218
           Q
Sbjct: 240 Q 240

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEF 116
           L+    ++   A +  + + + +E  E   L++ +  ++            RQI E + +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---------KFDPEK------KLQV 161
           IHS+ ++H D+KP NI         +KI DFGLA+         K D +        L  
Sbjct: 132 IHSQGIIHRDLKPMNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 162 LFGTPEFVAPEVVNFDAIGF---GTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIA 217
             GT  +VA EV+  D  G      DM+S+G+I + ++   S  M   ++ + + +V+I 
Sbjct: 190 AIGTAMYVATEVL--DGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIE 247
Query: 218 -QYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
              DFDD   N++  + K  IR L+  D    P
Sbjct: 248 FPPDFDD---NKMKVEKK-IIRLLIDHDPNKRP 276

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 7/166 (4%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           M +L HP+L++ Y        + +V E I  G L   +      L    +      +CEG
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVA 170
           + F+ S   +H D+   N  CL      +K+ DFG+ R    ++ +  + GT    ++ A
Sbjct: 117 MAFLESHQFIHRDLAARN--CLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFPVKWSA 173
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           PEV ++      +D+W+ G++ + + S G  P+   T+ + +  V+
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 12/152 (7%)
Query: 53  IMRELQHPRLIQIYDAFE--SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQI 110
           I+R L H  +I+     E      + +V+E +  G L + +      L +  + +F +QI
Sbjct: 69  ILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ--LLLFAQQI 126
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK----KLQVLFGTP 166
           CEG+ ++HS++ +H ++   N+  L      +KI DFGLA+   PE     +++    +P
Sbjct: 127 CEGMAYLHSQHYIHRNLAARNV--LLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSP 183
Query: 167 EF-VAPEVVNFDAIGFGTDMWSVGVICYVLLS 197
            F  APE +      + +D+WS GV  Y LL+
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQME--LDHERMSYL 124
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI+   K+   +KI+DFGLAR       +     T 
Sbjct: 125 LYQMLXGIKHLHSAGIIHRDLKPSNIVV--KSDXTLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVI 191
            + APEV+    +G G     D+WSVG I
Sbjct: 183 YYRAPEVI----LGMGYKENVDIWSVGCI 207

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMR---- 108
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E  +  ++R    
Sbjct: 66  VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGCLL------DFLKGE--MGKYLRLPQL 116
Query: 109 -----QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQ 160
                QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +
Sbjct: 117 VDMAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTAR 172
Query: 161 VLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
                P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E 229
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +   C  E  +   D + +   KD E+ P
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI+   K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDATLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+         D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI+   K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVV--KSDXTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVI 191
            + APEV+    +G G     D+WSVG I
Sbjct: 190 YYRAPEVI----LGMGYKENVDIWSVGCI 214

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM +  HP +I +         + ++ E +E G L   +  +D   T   +   +R I  
Sbjct: 83  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS 142
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGT-P-EF 168
           G++++   + +H D+   NI  L  +    K+ DFG++R    DPE       G  P  +
Sbjct: 143 GMKYLSDMSAVHRDLAARNI--LVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 200
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
            APE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 201 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 243

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 60/121 (49%), Gaps = 3/121 (2%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L  + ++  + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR      
Sbjct: 121 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTASTNF 178
Query: 158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIA 217
            +     T  + APEV+         D+WSVG I   L+ G   F G TD     N  I 
Sbjct: 179 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG-TDHIDQWNKVIE 237
Query: 218 Q 218
           Q
Sbjct: 238 Q 238

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM----- 107
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E    + +     
Sbjct: 59  VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLL------DFLKGETGKYLRLPQLVD 111
Query: 108 --RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVL 162
              QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +  
Sbjct: 112 MAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTARQG 167
Query: 163 FGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
              P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +  
Sbjct: 168 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERG 224
Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   C  E  +   D + +   K+ E+ P
Sbjct: 225 YRMPCPPECPESLHDLMCQCWRKEPEERP 253

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 10  AFSFGKF--GTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HP 60
           A +FGK    T Y   +    MT+A K +  +             +M EL+       H 
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTEREALMSELKVLSYLGNHM 110
Query: 61  RLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAI------------- 105
            ++ +  A        V+ E    G+L  F R   D F+ ++ + AI             
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 106 --FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF 163
             F  Q+ +G+ F+ SKN +H D+   NIL LT  G   KI DFGLAR    +    V+ 
Sbjct: 171 LSFSYQVAKGMAFLASKNCIHRDLAARNIL-LTH-GRITKICDFGLARHIKNDSNY-VVK 227
Query: 164 GTP----EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           G      +++APE +      F +D+WS G+  + L S G SP+ G
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 273

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 5/152 (3%)
Query: 56  ELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVE 115
            LQ P ++ I+D  E    + V   LI G +L   +     +   +AVAI +RQI   ++
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAI-VRQIGSALD 148
Query: 116 FIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV--LFGTPEFVAPEV 173
             H+    H D+KPENIL      +   ++DFG+A     EK  Q+    GT  + APE 
Sbjct: 149 AAHAAGATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPER 206
Query: 174 VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE 205
            +     +  D++++  + Y  L+G  P+ G+
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQGD 238

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM----- 107
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E    + +     
Sbjct: 63  VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLL------DFLKGETGKYLRLPQLVD 115
Query: 108 --RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVL 162
              QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +  
Sbjct: 116 MSAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTARQG 171
Query: 163 FGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
              P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +  
Sbjct: 172 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERG 228
Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   C  E  +   D + +   K+ E+ P
Sbjct: 229 YRMPCPPECPESLHDLMCQCWRKEPEERP 257

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 10  AFSFGKF--GTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HP 60
           A +FGK    T Y   +    MT+A K +  +             +M EL+       H 
Sbjct: 49  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTEREALMSELKVLSYLGNHM 103
Query: 61  RLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAI------------- 105
            ++ +  A        V+ E    G+L  F R   D F+ ++ + AI             
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 106 --FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--KFDPEKKLQV 161
             F  Q+ +G+ F+ SKN +H D+   NIL LT  G   KI DFGLAR  K D    ++ 
Sbjct: 164 LSFSYQVAKGMAFLASKNCIHRDLAARNIL-LTH-GRITKICDFGLARDIKNDSNYVVKG 221
Query: 162 LFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
               P +++APE +      F +D+WS G+  + L S G SP+ G
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 266

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 10/193 (5%)
Query: 14  GKFGTVYRCKEKATGMTLA--AKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G FG VY+     T + +   A  V I              +  + QH  L+++      
Sbjct: 33  GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSD 92
Query: 72  SNVMCVVLELIEGGELFERV--IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            + +C+V      G L +R+  +D    L+        +    G+ F+H  + +H D+K 
Sbjct: 93  GDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKS 152
Query: 130 ENILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
            NIL         KI DFGLAR   KF        + GT  + APE +  + I   +D++
Sbjct: 153 ANILL--DEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE-ITPKSDIY 209
Query: 187 SVGVICYVLLSGL 199
           S GV+   +++GL
Sbjct: 210 SFGVVLLEIITGL 222

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM----- 107
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E    + +     
Sbjct: 63  VMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLL------DFLKGETGKYLRLPQLVD 115
Query: 108 --RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVL 162
              QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +  
Sbjct: 116 MSAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEWTARQG 171
Query: 163 FGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
              P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +  
Sbjct: 172 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERG 228
Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   C  E  +   D + +   K+ E+ P
Sbjct: 229 YRMPCPPECPESLHDLMCQCWRKEPEERP 257

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM +  HP +I +         + ++ E +E G L   +  +D   T   +   +R I  
Sbjct: 68  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS 127
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGT-P-EF 168
           G++++   + +H D+   NI  L  +    K+ DFG++R    DPE       G  P  +
Sbjct: 128 GMKYLSDMSYVHRDLAARNI--LVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 185
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
            APE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 186 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 228

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 10  AFSFGKF--GTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HP 60
           A +FGK    T Y   +    MT+A K +  +             +M EL+       H 
Sbjct: 33  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTEREALMSELKVLSYLGNHM 87
Query: 61  RLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAI------------- 105
            ++ +  A        V+ E    G+L  F R   D F+ ++ + AI             
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 106 --FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--KFDPEKKLQV 161
             F  Q+ +G+ F+ SKN +H D+   NIL LT  G   KI DFGLAR  K D    ++ 
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNIL-LTH-GRITKICDFGLARDIKNDSNYVVKG 205
Query: 162 LFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
               P +++APE +      F +D+WS G+  + L S G SP+ G
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 8/166 (4%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           M  L H  LI++Y    +   M +V EL   G L +R+           ++ +  Q+ EG
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTP-EFV 169
           + ++ SK  +H D+   N+L  T+  + +KI DFGL R     D    +Q     P  + 
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           APE +        +D W  GV  + + + G  P++G    Q +  +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           IM +  HP +I +         + ++ E +E G L   +  +D   T   +   +R I  
Sbjct: 62  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS 121
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGT-P-EF 168
           G++++   + +H D+   NI  L  +    K+ DFG++R    DPE       G  P  +
Sbjct: 122 GMKYLSDMSYVHRDLAARNI--LVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 179
Query: 169 VAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF--MGETDV 208
            APE + +      +D+WS G++ + ++S G  P+  M   DV
Sbjct: 180 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 222

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM----- 107
           +M++L+H +L+Q+Y A  S   + +V E +  G L       DF+  E    + +     
Sbjct: 232 VMKKLRHEKLVQLY-AVVSEEPIYIVGEYMSKGSLL------DFLKGETGKYLRLPQLVD 284
Query: 108 --RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRI--KIIDFGLARKF-DPEKKLQVL 162
              QI  G+ ++   N +H D++  NIL     G  +  K+ DFGLAR   D E   +  
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANIL----VGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 163 FGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
              P ++ APE   +      +D+WS G++   L + G  P+ G  + + +  V   +  
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERG 397
Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   C  E  +   D + +   K+ E+ P
Sbjct: 398 YRMPCPPECPESLHDLMCQCWRKEPEERP 426

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 10  AFSFGKF--GTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HP 60
           A +FGK    T Y   +    MT+A K +  +             +M EL+       H 
Sbjct: 51  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTEREALMSELKVLSYLGNHM 105
Query: 61  RLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAI------------- 105
            ++ +  A        V+ E    G+L  F R   D F+ ++ + AI             
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 106 --FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--KFDPEKKLQV 161
             F  Q+ +G+ F+ SKN +H D+   NIL LT  G   KI DFGLAR  K D    ++ 
Sbjct: 166 LSFSYQVAKGMAFLASKNCIHRDLAARNIL-LTH-GRITKICDFGLARDIKNDSNYVVKG 223
Query: 162 LFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
               P +++APE +      F +D+WS G+  + L S G SP+ G
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 268

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 10  AFSFGKF--GTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HP 60
           A +FGK    T Y   +    MT+A K +  +             +M EL+       H 
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTEREALMSELKVLSYLGNHM 110
Query: 61  RLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAI------------- 105
            ++ +  A        V+ E    G+L  F R   D F+ ++ + AI             
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 106 --FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--KFDPEKKLQV 161
             F  Q+ +G+ F+ SKN +H D+   NIL LT  G   KI DFGLAR  K D    ++ 
Sbjct: 171 LSFSYQVAKGMAFLASKNCIHRDLAARNIL-LTH-GRITKICDFGLARDIKNDSNYVVKG 228
Query: 162 LFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
               P +++APE +      F +D+WS G+  + L S G SP+ G
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 273

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 8/166 (4%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           M  L H  LI++Y    +   M +V EL   G L +R+           ++ +  Q+ EG
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTP-EFV 169
           + ++ SK  +H D+   N+L  T+  + +KI DFGL R     D    +Q     P  + 
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           APE +        +D W  GV  + + + G  P++G    Q +  +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+         D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 8/166 (4%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           M  L H  LI++Y    +   M +V EL   G L +R+           ++ +  Q+ EG
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTP-EFV 169
           + ++ SK  +H D+   N+L  T+  + +KI DFGL R     D    +Q     P  + 
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           APE +        +D W  GV  + + + G  P++G    Q +  +
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 53  IMRELQHPRLIQIYDAF---ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQ 109
           I+R L H  +++ Y      +  N + +++E +  G L E +  +   +  K    +  Q
Sbjct: 76  ILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL---FGTP 166
           IC+G++++ S+  +H D+   N+  L ++ +++KI DFGL +  + +K+   +     +P
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNV--LVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 192
Query: 167 EF-VAPEVVNFDAIGFGTDMWSVGVICYVLLS 197
            F  APE +        +D+WS GV  + LL+
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-----LTEKAVAIFMRQICEGVEF 116
           ++ +   F   N +C+V E++    L++ + + +F      LT K    F +Q+C  + F
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRK----FAQQMCTALLF 172
Query: 117 IHSK--NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV 174
           + +   +++H D+KPENIL      + IKI+DFG + +    +++     +  + +PEV+
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQXIQSRFYRSPEVL 230
Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
                    DMWS+G I   + +G   F G  +V  M  +
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-----LTEKAVAIFMRQICEGVEF 116
           ++ +   F   N +C+V E++    L++ + + +F      LT K    F +Q+C  + F
Sbjct: 99  IVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRK----FAQQMCTALLF 153
Query: 117 IHSK--NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV 174
           + +   +++H D+KPENIL      + IKI+DFG + +    +++     +  + +PEV+
Sbjct: 154 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQXIQSRFYRSPEVL 211
Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
                    DMWS+G I   + +G   F G  +V  M  +
Sbjct: 212 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 251

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 8/166 (4%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           M  L H  LI++Y    +   M +V EL   G L +R+           ++ +  Q+ EG
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTP-EFV 169
           + ++ SK  +H D+   N+L  T+  + +KI DFGL R     D    +Q     P  + 
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           APE +        +D W  GV  + + + G  P++G    Q +  +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 53  IMRELQHPRLIQIYDAF---ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQ 109
           I+R L H  +++ Y      +  N + +++E +  G L E +  +   +  K    +  Q
Sbjct: 64  ILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 122
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL---FGTP 166
           IC+G++++ S+  +H D+   N+  L ++ +++KI DFGL +  + +K+   +     +P
Sbjct: 123 ICKGMDYLGSRQYVHRDLAARNV--LVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 180
Query: 167 EF-VAPEVVNFDAIGFGTDMWSVGVICYVLLS 197
            F  APE +        +D+WS GV  + LL+
Sbjct: 181 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 8/166 (4%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           M  L H  LI++Y    +   M +V EL   G L +R+           ++ +  Q+ EG
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTP-EFV 169
           + ++ SK  +H D+   N+L  T+  + +KI DFGL R     D    +Q     P  + 
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           APE +        +D W  GV  + + + G  P++G    Q +  +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 86
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 87  EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 145 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI- 194
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 86
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 87  EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 145 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI- 194
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDXTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVI 191
            + APEV+    +G G     D+WSVG I
Sbjct: 190 YYRAPEVI----LGMGYKENVDIWSVGCI 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 8/166 (4%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           M  L H  LI++Y    +   M +V EL   G L +R+           ++ +  Q+ EG
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTP-EFV 169
           + ++ SK  +H D+   N+L  T+  + +KI DFGL R     D    +Q     P  + 
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           APE +        +D W  GV  + + + G  P++G    Q +  +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HPRLIQIY 66
           G FG V          T   + V +              +M EL+       H  ++ + 
Sbjct: 38  GAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97
Query: 67  DA-FESSNVMCVVLELIEGGEL--FERVIDDDFV---------LTEKAVAIFMRQICEGV 114
            A  +    + V++E  + G L  + R   ++FV         LT + +  +  Q+ +G+
Sbjct: 98  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGM 157
Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGTP-EFVAP 171
           EF+ S+  +H D+   NIL   K  N +KI DFGLAR    DP+   +     P +++AP
Sbjct: 158 EFLASRKXIHRDLAARNILLSEK--NVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAP 215
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           E +        +D+WS GV+ + + S G SP+ G
Sbjct: 216 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 12/152 (7%)
Query: 53  IMRELQHPRLIQIYDAFE--SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQI 110
           I+R L H  +I+     E      + +V+E +  G L + +      L +  + +F +QI
Sbjct: 69  ILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ--LLLFAQQI 126
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK----KLQVLFGTP 166
           CEG+ ++H+++ +H ++   N+  L      +KI DFGLA+   PE     +++    +P
Sbjct: 127 CEGMAYLHAQHYIHRNLAARNV--LLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSP 183
Query: 167 EF-VAPEVVNFDAIGFGTDMWSVGVICYVLLS 197
            F  APE +      + +D+WS GV  Y LL+
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 8/166 (4%)
Query: 54  MRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEG 113
           M  L H  LI++Y    +   M +V EL   G L +R+           ++ +  Q+ EG
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGTP-EFV 169
           + ++ SK  +H D+   N+L  T+  + +KI DFGL R     D    +Q     P  + 
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           APE +        +D W  GV  + + + G  P++G    Q +  +
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 16/174 (9%)
Query: 53  IMRELQHPRLIQIYDAFESSN------VMCVVLELIEGGELFERVIDDDFVLTEKA---- 102
           IMR ++HP ++ +   F S+        + +VLE +   E   R       L +      
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPMLL 142
Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL 162
           + ++M Q+   + +IHS  + H D+KP+N+L    +G  +K+IDFG A+     +     
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIAGEPNVSX 201
Query: 163 FGTPEFVAPEVVNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
             +  + APE++ F A  + T  D+WS G +   L+ G   F GE+ +  +  +
Sbjct: 202 ICSRYYRAPELI-FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 24/194 (12%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL-------FERVIDDD---FVLTEKA 102
           ++REL+HP +I +   F S     V L L +  E        F R    +     L    
Sbjct: 71  LLRELKHPNVISLQKVFLSHADRKVWL-LFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129
Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG--NRIKIIDFGLARKFD----PE 156
           V   + QI +G+ ++H+  VLH D+KP NIL + +     R+KI D G AR F+    P 
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 157 KKLQVLFGTPEFVAPEVVNFDAIGF--GTDMWSVGVICYVLLSGLSPFM-GETDVQTMAN 213
             L  +  T  + APE++   A  +    D+W++G I   LL+    F   + D++T   
Sbjct: 190 ADLDPVVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT--- 245
Query: 214 VTIAQYDFDDECFN 227
                +D  D  FN
Sbjct: 246 SNPYHHDQLDRIFN 259

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 24/172 (13%)
Query: 53  IMREL-QHPRLIQIYDAFESSNVMCVVLELIEGGELF------ERVIDDD-------FVL 98
           IM  L QH  ++ +  A      + V+ E    G+L        RV++ D         L
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 99  TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK 158
           + + +  F  Q+ +G+ F+ SKN +H D+   N+L LT  G+  KI DFGLAR    +  
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL-LT-NGHVAKIGDFGLARDIMNDSN 219
Query: 159 LQVLFGTP----EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             ++ G      +++APE + FD +    +D+WS G++ + + S GL+P+ G
Sbjct: 220 Y-IVKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 86
Query: 74  ------VMCVVLELIEG-----GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
                  + +VL+ +          + R      V+    V ++M Q+   + +IHS  +
Sbjct: 87  EKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHSFGI 143
Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVV 174
            H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++
Sbjct: 144 CHRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI 194
Query: 175 NFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
            F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 195 -FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DP 155
           LT + +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR    DP
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEK--NVVKICDFGLARDIXKDP 202
Query: 156 EKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           +   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 9   SAFSFGKFGTVYRCKEKA----TGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQ 64
           S    G FG+V  C+       TG  +A K +  +             I++ L H   I 
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 74
Query: 65  IYDAFE---SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
            Y           + +V+E +  G L + +      L    + ++  QIC+G+E++ S+ 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE----FVAPEVVNFD 177
            +H D+   NI  L ++   +KI DFGLA+    +K   V+    +    + APE ++ +
Sbjct: 135 CVHRDLAARNI--LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 178 AIGFGTDMWSVGVICYVLLS 197
                +D+WS GV+ Y L +
Sbjct: 193 IFSRQSDVWSFGVVLYELFT 212

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 95  DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF- 153
           DF+  E  +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR   
Sbjct: 134 DFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIX 190
Query: 154 -DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            DP+   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 191 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE +E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 134
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 135 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 192
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 193 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 235

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 9   SAFSFGKFGTVYRCKEKA----TGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQ 64
           S    G FG+V  C+       TG  +A K +  +             I++ L H   I 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 87
Query: 65  IYDAFE---SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
            Y           + +V+E +  G L + +      L    + ++  QIC+G+E++ S+ 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEF-VAPEVVNFD 177
            +H D+   NI  L ++   +KI DFGLA+    +K   V+     +P F  APE ++ +
Sbjct: 148 CVHRDLAARNI--LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 178 AIGFGTDMWSVGVICYVLLS 197
                +D+WS GV+ Y L +
Sbjct: 206 IFSRQSDVWSFGVVLYELFT 225

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 95  DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF- 153
           DF+  E  +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR   
Sbjct: 134 DFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIX 190
Query: 154 -DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            DP+   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 191 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 95  DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF- 153
           DF+  E  +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR   
Sbjct: 143 DFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIX 199
Query: 154 -DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            DP+   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF-- 69
           G +G+V +   K +G  +A K +   + +            +MR    P ++Q Y A   
Sbjct: 33  GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92
Query: 70  ESSNVMCVVLELIEGGELFERVID--DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           E    +C+ L      + ++ V    DD +  E    I +  +        +  ++H D+
Sbjct: 93  EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI 152
Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG----T 183
           KP NIL L ++GN IK+ DFG++ +           G   ++APE ++  A   G    +
Sbjct: 153 KPSNIL-LDRSGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS 210
Query: 184 DMWSVGVICYVLLSGLSPF 202
           D+WS+G+  Y L +G  P+
Sbjct: 211 DVWSLGITLYELATGRFPY 229

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 95  DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF- 153
           DF+  E  +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR   
Sbjct: 143 DFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIY 199
Query: 154 -DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            DP+   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DP 155
           LT + +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR    DP
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 245
Query: 156 EKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           +   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 246 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 296

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 95  DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF- 153
           DF+  E  +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR   
Sbjct: 143 DFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIX 199
Query: 154 -DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            DP+   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 9   SAFSFGKFGTVYRCKEKA----TGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQ 64
           S    G FG+V  C+       TG  +A K +  +             I++ L H   I 
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 75
Query: 65  IYDAFE---SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
            Y           + +V+E +  G L + +      L    + ++  QIC+G+E++ S+ 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE----FVAPEVVNFD 177
            +H D+   NI  L ++   +KI DFGLA+    +K   V+    +    + APE ++ +
Sbjct: 136 CVHRDLAARNI--LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 178 AIGFGTDMWSVGVICYVLLS 197
                +D+WS GV+ Y L +
Sbjct: 194 IFSRQSDVWSFGVVLYELFT 213

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DP 155
           LT + +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR    DP
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 252
Query: 156 EKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           +   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 253 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 303

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DP 155
           LT + +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR    DP
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 254
Query: 156 EKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           +   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 255 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 305

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DP 155
           LT + +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR    DP
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 247
Query: 156 EKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           +   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 95  DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF- 153
           DF+  E  +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR   
Sbjct: 134 DFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIY 190
Query: 154 -DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            DP+   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 191 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 95  DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF- 153
           DF+  E  +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR   
Sbjct: 134 DFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIY 190
Query: 154 -DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            DP+   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 191 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HPRLIQIY 66
           G FG V          T   + V +              +M EL+       H  ++ + 
Sbjct: 38  GAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97
Query: 67  DA-FESSNVMCVVLELIEGGEL--FERVIDDDFV---------LTEKAVAIFMRQICEGV 114
            A  +    + V++E  + G L  + R   ++FV         LT + +  +  Q+ +G+
Sbjct: 98  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGM 157
Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGTP-EFVAP 171
           EF+ S+  +H D+   NIL   K  N +KI DFGLAR    DP+   +     P +++AP
Sbjct: 158 EFLASRKXIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 215
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           E +        +D+WS GV+ + + S G SP+ G
Sbjct: 216 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 16/154 (10%)
Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           Q+Y          +VLEL+  G   E + D  D   + K V +   Q+   +E++HSKN+
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 123 LHLDMKPENILCLTKTGNR----IKIIDFGLARKF-DPEKKLQV-------LFGTPEFVA 170
           ++ D+KPEN L + + GN+    I IIDFGLA+++ DPE K  +       L GT  +++
Sbjct: 127 IYRDVKPENFL-IGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
                        D+ ++G +    L G  P+ G
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-----LTEKAVAIFMRQICEGVEF 116
           ++ +   F   N +C+V E++    L++ + + +F      LT K    F +Q+C  + F
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK----FAQQMCTALLF 172
Query: 117 IHSK--NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV 174
           + +   +++H D+KPENIL        IKI+DFG + +    +++     +  + +PEV+
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLG--QRIYQXIQSRFYRSPEVL 230
Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
                    DMWS+G I   + +G   F G  +V  M  +
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 15/195 (7%)
Query: 59  HPRLIQIYDAFESSNVMCVVLE-LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFI 117
           HP +I++ D FE+     +VLE  +   +LF+  I +   L E     F  Q+   ++  
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFD-YITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 118 HSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD 177
           HS+ V+H D+K ENIL   + G   K+IDFG       E       GT  +  PE ++  
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGC-AKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISRH 213
Query: 178 AI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF 236
                   +WS+G++ Y ++ G  PF  E D + +     A+  F       +S D    
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPF--ERDQEILE----AELHFP----AHVSPDCCAL 263
Query: 237 IRKLLLKDREDAPEV 251
           IR+ L       P +
Sbjct: 264 IRRCLAPKPSSRPSL 278

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 95  DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF- 153
           DF+  E  +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR   
Sbjct: 145 DFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIY 201
Query: 154 -DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            DP+   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 202 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 255

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+         D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI----YDAF 69
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++    Y + 
Sbjct: 50  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 105
Query: 70  ESSNVMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           E  + + + L L    E   RV          L    V ++M Q+   + +IHS  + H 
Sbjct: 106 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 165
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVNFD 177
           D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ F 
Sbjct: 166 DIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI-FG 215
Query: 178 AIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 254

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DP 155
           LT + +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR    DP
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 202
Query: 156 EKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           +   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 22/171 (12%)
Query: 53  IMREL-QHPRLIQIYDAFESSNVMCVVLELIEGGELF------ERVIDDD--FVLTEKAV 103
           IM  L QH  ++ +  A      + V+ E    G+L        RV++ D  F +     
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 104 AI-----FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK 158
           +      F  Q+ +G+ F+ SKN +H D+   N+L LT  G+  KI DFGLAR    +  
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL-LT-NGHVAKIGDFGLARDIMNDSN 219
Query: 159 LQVLFGTP---EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             V        +++APE + FD +    +D+WS G++ + + S GL+P+ G
Sbjct: 220 YIVKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 3/148 (2%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNXG 130
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 131 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 188
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDV 208
               +WS+G++ Y ++ G  PF  + ++
Sbjct: 189 RSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 95  DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF- 153
           DF+  E  +  +  Q+ +G+EF+ S+  +H D+   NIL   K  N +KI DFGLAR   
Sbjct: 180 DFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIY 236
Query: 154 -DPEKKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            DP+   +     P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 237 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 163 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 220
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 221 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIGGQVFFRQRVSSEC 263

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 59  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 114
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 115 EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 172
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 173 HRDIKPQNLLLDPDTA-VLKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI- 222
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 223 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 263

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI----YDAF 69
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++    Y + 
Sbjct: 39  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 94
Query: 70  ESSNVMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           E  + + + L L    E   RV          L    V ++M Q+   + +IHS  + H 
Sbjct: 95  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 154
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVNFD 177
           D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ F 
Sbjct: 155 DIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI-FG 204
Query: 178 AIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 243

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHERMSYL 132
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+         D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 241

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI----YDAF 69
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++    Y + 
Sbjct: 44  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 99
Query: 70  ESSNVMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           E  + + + L L    E   RV          L    V ++M Q+   + +IHS  + H 
Sbjct: 100 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 159
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVNFD 177
           D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ F 
Sbjct: 160 DIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI-FG 209
Query: 178 AIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 248

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 164 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 221
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 222 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIGGQVFFRQRVSSEC 264

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 163 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 220
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 221 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIGGQVFFRQRVSSEC 263

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 35/223 (15%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G VY   +K T   +A K V                  I+  L+   +I++YD    
Sbjct: 37  GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96
Query: 72  SNVM-----CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            +++      +VLE+ +     +++      LTE+ +   +  +  G  FIH   ++H D
Sbjct: 97  DDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRD 154
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE------------------- 167
           +KP N  CL      +K+ DFGLAR  + EK   ++    E                   
Sbjct: 155 LKPAN--CLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 168 ----FVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGE 205
               + APE++   +      D+WS G I   LL+ L   + +
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 164 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 221
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 222 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIGGQVFFRQRVSSEC 264

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 106/267 (39%), Gaps = 40/267 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HPRLIQIY 66
           G FG V + + K  G+ + A    I +               EL+       HP +I + 
Sbjct: 26  GNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 67  DAFESSNVMCVVLELIEGGELFE-----RVIDDD----------FVLTEKAVAIFMRQIC 111
            A E    + + +E    G L +     RV++ D            L+ + +  F   + 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            G++++  K  +H D+   NI  L       KI DFGL+R  +   K  +      ++A 
Sbjct: 143 RGMDYLSQKQFIHRDLAARNI--LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 200
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGET------------DVQTMANVTIAQ 218
           E +N+      +D+WS GV+ + ++S G +P+ G T             ++   N     
Sbjct: 201 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEV 260
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDR 245
           YD   +C+ E   +   F + L+  +R
Sbjct: 261 YDLMRQCWREKPYERPSFAQILVSLNR 287

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI----YDAF 69
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++    Y + 
Sbjct: 32  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 87
Query: 70  ESSNVMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           E  + + + L L    E   RV          L    V ++M Q+   + +IHS  + H 
Sbjct: 88  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 147
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVNFD 177
           D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ F 
Sbjct: 148 DIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI-FG 197
Query: 178 AIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 236

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 131 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 188
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 189 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIGGQVFFRQRVSSEC 231

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 86
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 87  EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 145 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI- 194
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI----YDAF 69
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++    Y + 
Sbjct: 43  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 98
Query: 70  ESSNVMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           E  + + + L L    E   RV          L    V ++M Q+   + +IHS  + H 
Sbjct: 99  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 158
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVNFD 177
           D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ F 
Sbjct: 159 DIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI-FG 208
Query: 178 AIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 46/79 (58%), Gaps = 9/79 (11%)
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILC-LTKTGNRIKIIDFGLARKFD----- 154
           K V +   Q+   +E+IHSKN +H D+KP+N L  L K GN + IIDFGLA+K+      
Sbjct: 105 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
Query: 155 ---PEKKLQVLFGTPEFVA 170
              P ++ + L GT  + +
Sbjct: 165 QHIPYRENKNLTGTARYAS 183

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+         D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 9/113 (7%)
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILC-LTKTGNRIKIIDFGLARKFD----- 154
           K V +   Q+   +E+IHSKN +H D+KP+N L  L K GN + IIDFGLA+K+      
Sbjct: 103 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 155 ---PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
              P ++ + L GT  + +             D+ S+G +      G  P+ G
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 215

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 86
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 87  EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 145 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI- 194
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 86
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 87  EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 145 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI- 194
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 106/267 (39%), Gaps = 40/267 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HPRLIQIY 66
           G FG V + + K  G+ + A    I +               EL+       HP +I + 
Sbjct: 36  GNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 67  DAFESSNVMCVVLELIEGGELFE-----RVIDDD----------FVLTEKAVAIFMRQIC 111
            A E    + + +E    G L +     RV++ D            L+ + +  F   + 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            G++++  K  +H D+   NI  L       KI DFGL+R  +   K  +      ++A 
Sbjct: 153 RGMDYLSQKQFIHRDLAARNI--LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 210
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGET------------DVQTMANVTIAQ 218
           E +N+      +D+WS GV+ + ++S G +P+ G T             ++   N     
Sbjct: 211 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEV 270
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDR 245
           YD   +C+ E   +   F + L+  +R
Sbjct: 271 YDLMRQCWREKPYERPSFAQILVSLNR 297

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 35  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 90
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 91  EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 148
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 149 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI- 198
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 199 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 239

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI----YDAF 69
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++    Y + 
Sbjct: 43  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 98
Query: 70  ESSNVMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           E  + + + L L    E   RV          L    V ++M Q+   + +IHS  + H 
Sbjct: 99  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 158
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVNFD 177
           D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ F 
Sbjct: 159 DIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI-FG 208
Query: 178 AIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 4   HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLI 63
           H    S    G FG+V  C+    G    A  V + +              R+ Q  R I
Sbjct: 8   HLKYISQLGKGNFGSVELCRYDPLGDNTGA-LVAVKQLQHSGPDQ-----QRDFQ--REI 59
Query: 64  QIYDAFESSNV--------------MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQ 109
           QI  A  S  +              + +V+E +  G L + +      L    + ++  Q
Sbjct: 60  QILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 119
Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE-- 167
           IC+G+E++ S+  +H D+   NI  L ++   +KI DFGLA+    +K   V+    +  
Sbjct: 120 ICKGMEYLGSRRCVHRDLAARNI--LVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP 177
Query: 168 --FVAPEVVNFDAIGFGTDMWSVGVICYVLLS 197
             + APE ++ +     +D+WS GV+ Y L +
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 46/79 (58%), Gaps = 9/79 (11%)
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILC-LTKTGNRIKIIDFGLARKFD----- 154
           K V +   Q+   +E+IHSKN +H D+KP+N L  L K GN + IIDFGLA+K+      
Sbjct: 105 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
Query: 155 ---PEKKLQVLFGTPEFVA 170
              P ++ + L GT  + +
Sbjct: 165 QHIPYRENKNLTGTARYAS 183

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 36  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 91
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 92  EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 149
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 150 HRDIKPQNLLLDPDTA-VLKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI- 199
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 200 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 240

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 120
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 121 EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 178
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 179 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSXICSRYYRAPELI- 228
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 120
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 121 EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 178
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 179 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI- 228
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 67  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 122
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 123 EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 180
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 181 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI- 230
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 231 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 271

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 163 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 220
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 221 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 263

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 110 GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 165
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 166 EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 223
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 224 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI- 273
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 274 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 314

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 164 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 221
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 222 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIGGQVFFRQRVSXEC 264

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 169
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
Query: 167 EFVAPEVVNFDAIGFG----TDMWSVGVI 191
            + APEV+    +G G     D+WSVG I
Sbjct: 228 YYRAPEVI----LGMGYKENVDIWSVGCI 252

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 164 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 221
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 222 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIGGQVFFRQRVSXEC 264

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V   K            IMR+L H  ++++   F SS 
Sbjct: 69  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSG 124
Query: 74  ------VMCVVLELIEGGELFERVIDD----DFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 125 EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 182
Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE--------FVAPEVVN 175
           H D+KP+N+L    T   +K+ DFG A+        Q++ G P         + APE++ 
Sbjct: 183 HRDIKPQNLLLDPDTAV-LKLCDFGSAK--------QLVRGEPNVSYICSRYYRAPELI- 232
Query: 176 FDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           F A  + +  D+WS G +   LL G   F G++ V  +  +
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 273

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 177
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 178 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 235
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 236 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 278

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 134
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 135 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 192
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 193 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 235

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 163 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 220
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 221 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIGGQVFFRQRVSXEC 263

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 135
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 136 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 193
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 194 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 236

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 135
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 136 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 193
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 194 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 236

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 150
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 151 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 208
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 209 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 251

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 177
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 178 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 235
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 236 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 278

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 149
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 150 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 207
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 208 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 250

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 38/179 (21%)
Query: 53  IMRELQHPRLIQIYDAFESSNV-----MCVVLELIEGGELFERVIDDDFVLTEKAVAIFM 107
           I+  L H  ++++ D     +V     + VVLE+ +    F+++      LTE  +   +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLL 162
Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTP 166
             +  GV+++HS  +LH D+KP N  CL      +K+ DFGLAR  D PE     L  +P
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPAN--CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 167 E---------------------------FVAPEVVNF-DAIGFGTDMWSVGVICYVLLS 197
                                       + APE++   +      D+WS+G I   LL+
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 135
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 136 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 193
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 194 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 236

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 131 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 188
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 189 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 231

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 133
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 134 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 191
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 192 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 234

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 169
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 170 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 227
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 228 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSSEC 270

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 3/148 (2%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 149
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 150 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 207
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDV 208
               +WS+G++ Y ++ G  PF  + ++
Sbjct: 208 RSAAVWSLGILLYDMVCGDIPFEHDEEI 235

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 3/148 (2%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 150
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 151 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 208
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDV 208
               +WS+G++ Y ++ G  PF  + ++
Sbjct: 209 RSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 11/186 (5%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G V + +   +G  +A K +   +               MR +  P  +  Y A   
Sbjct: 18  GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77
Query: 72  SNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMK 128
              + + +EL++    + +++VID    + E  +      I + +E +HSK +V+H D+K
Sbjct: 78  EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK 137
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN--FDAIGFG--TD 184
           P N+  L     ++K+ DFG++     +    +  G   ++APE +N   +  G+   +D
Sbjct: 138 PSNV--LINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSD 195
Query: 185 MWSVGV 190
           +WS+G+
Sbjct: 196 IWSLGI 201

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 169
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCI 252

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 78  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHERMSYL 133
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 134 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMVPFVVTR 191
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+         D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 192 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 242

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 3/148 (2%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 150
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 151 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 208
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDV 208
               +WS+G++ Y ++ G  PF  + ++
Sbjct: 209 RSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 61/120 (50%), Gaps = 19/120 (15%)
Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF----- 163
           QI E VEF+HSK ++H D+KP NI       + +K+ DFGL    D +++ Q +      
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 164 --------GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE----TDVQTM 211
                   GT  +++PE ++ +      D++S+G+I + LL   S  M      TDV+ +
Sbjct: 230 YATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNL 289

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 3/148 (2%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 177
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 178 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 235
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDV 208
               +WS+G++ Y ++ G  PF  + ++
Sbjct: 236 RSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPEVVTR 189
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
            + APEV+         D+WSVG I   ++ G   F G TD     N  I Q
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQ 240

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 3/148 (2%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 182
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 183 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 240
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDV 208
               +WS+G++ Y ++ G  PF  + ++
Sbjct: 241 RSAAVWSLGILLYDMVCGDIPFEHDEEI 268

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 77  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 132
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCI 215

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCI 214

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 70  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 125
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 183
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCI 208

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 75  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 130
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 131 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 188
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 189 YYRAPEVILGMGYKENVDIWSVGCI 213

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           +I++ D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 157
Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-G 180
           VLH D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G
Sbjct: 158 VLHRDIKDENILIDLNRGE-LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHG 215
Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
               +WS+G++ Y ++ G  PF  E D + +      +     EC
Sbjct: 216 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVSXEC 258

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 70  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 125
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 183
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCI 208

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCI 214

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 124
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCI 207

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 77  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME--LDHERMSYL 132
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCI 215

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 70  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHERMSYL 125
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 183
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 184 YYRAPEVILGMGYKENVDLWSVGCI 208

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 81  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHERMSYL 136
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       +     T 
Sbjct: 137 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 194
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 195 YYRAPEVILGMGYKENVDLWSVGCI 219

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIM--RELQHPRLIQIYDAFES 71
           G+FG VY  +       +A + + I +            +M  R+ +H  ++    A  S
Sbjct: 44  GRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + ++  L +G  L+  V D   VL         ++I +G+ ++H+K +LH D+K +N
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKN 160
Query: 132 ILCLTKTGNRIKIIDFGL------ARKFDPEKKLQVLFGTPEFVAPEVVNF-------DA 178
           +        ++ I DFGL       +    E KL++  G    +APE++         D 
Sbjct: 161 VFY---DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 179 IGFG--TDMWSVGVICYVLLSGLSPF 202
           + F   +D++++G I Y L +   PF
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 73/145 (50%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       ++    T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMEPEVVTR 189
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 190 YYRAPEVILGMGYKENVDLWSVGCI 214

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 14  GKFGTVYRCKEKATGMTLAAK--FVGIAKXXXXXXXXXXXXIMRELQ-HPRLIQIYDAFE 70
           G +G V++  ++ TG  +A K  F                 I+ EL  H  ++ + +   
Sbjct: 20  GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR 79
Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           + N   V L           VI  + +L        + Q+ + ++++HS  +LH DMKP 
Sbjct: 80  ADNDRDVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPS 138
Query: 131 NILCLTKTGNRIKIIDFGLARKF----------------------DPEKKLQVLFGTPEF 168
           NIL   +    +K+ DFGL+R F                      D +  L     T  +
Sbjct: 139 NILLNAEC--HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWY 196
Query: 169 VAPEVVNFDAIGF--GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF 221
            APE++   +  +  G DMWS+G I   +L G   F G + +  +  + I   DF
Sbjct: 197 RAPEIL-LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI-IGVIDF 249

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 25/246 (10%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G V + +   +G  +A K +   +               MR +  P  +  Y A   
Sbjct: 62  GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 121
Query: 72  SNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMK 128
              + + +EL++    + +++VID    + E  +      I + +E +HSK +V+H D+K
Sbjct: 122 EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK 181
Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN--FDAIGFG--TD 184
           P N+L       ++K+ DFG++          +  G   ++APE +N   +  G+   +D
Sbjct: 182 PSNVLI--NALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSD 239
Query: 185 MWSVGVICYVLL-------SGLSPF------MGETDVQTMANVTIAQY-DFDDECFNEIS 230
           +WS+G+    L        S  +PF      + E   Q  A+   A++ DF  +C  + S
Sbjct: 240 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNS 299
Query: 231 DDAKDF 236
            +   +
Sbjct: 300 KERPTY 305

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 106/267 (39%), Gaps = 40/267 (14%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQ-------HPRLIQIY 66
           G FG V + + K  G+ + A    I +               EL+       HP +I + 
Sbjct: 33  GNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 67  DAFESSNVMCVVLELIEGGELFE-----RVIDDD----------FVLTEKAVAIFMRQIC 111
            A E    + + +E    G L +     RV++ D            L+ + +  F   + 
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP 171
            G++++  K  +H ++   NIL         KI DFGL+R  +   K  +      ++A 
Sbjct: 150 RGMDYLSQKQFIHRNLAARNIL--VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 207
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGET------------DVQTMANVTIAQ 218
           E +N+      +D+WS GV+ + ++S G +P+ G T             ++   N     
Sbjct: 208 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEV 267
Query: 219 YDFDDECFNEISDDAKDFIRKLLLKDR 245
           YD   +C+ E   +   F + L+  +R
Sbjct: 268 YDLMRQCWREKPYERPSFAQILVSLNR 294

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 53  IMRELQHPRLIQIYDAF-ESSNVMCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQI 110
           +M +L+H  L+Q+     E    + +V E +  G L + +      VL    +  F   +
Sbjct: 58  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 117
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPE 167
           CE +E++   N +H D+   N+  L    N  K+ DFGL ++    +   KL V     +
Sbjct: 118 CEAMEYLEGNNFVHRDLAARNV--LVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----K 170
Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
           + APE +   A    +D+WS G++ + + S G  P+
Sbjct: 171 WTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 73/145 (50%), Gaps = 12/145 (8%)
Query: 53  IMRELQHPRLIQIYDAFESSNVM------CVVLELIEGGELFERVIDDDFVLTEKAVAIF 106
           +M+ + H  +I + + F     +       +V+EL++      +VI  +  L  + ++  
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME--LDHERMSYL 131
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP 166
           + Q+  G++ +HS  ++H D+KP NI  + K+   +KI+DFGLAR       ++    T 
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMEPEVVTR 189
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVI 191
            + APEV+         D+WSVG I
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCI 214

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           Q+Y          +VLEL+  G   E + D  D   + K V +   Q+   +E++HSKN+
Sbjct: 90  QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 147
Query: 123 LHLDMKPENILCLTKTGNR----IKIIDFGLARKF-DPEKKLQV-------LFGTPEFVA 170
           ++ D+KPEN L + + GN+    I IIDF LA+++ DPE K  +       L GT  +++
Sbjct: 148 IYRDVKPENFL-IGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 206
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
                        D+ ++G +    L G  P+ G
Sbjct: 207 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 240

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           Q+Y          +VLEL+  G   E + D  D   + K V +   Q+   +E++HSKN+
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 123 LHLDMKPENILCLTKTGNR----IKIIDFGLARKF-DPEKKLQV-------LFGTPEFVA 170
           ++ D+KPEN L + + GN+    I IIDF LA+++ DPE K  +       L GT  +++
Sbjct: 127 IYRDVKPENFL-IGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
                        D+ ++G +    L G  P+ G
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           Q+Y          +VLEL+  G   E + D  D   T K V +   Q+   +E++H+K++
Sbjct: 64  QVYYFGPXGKYNAMVLELL--GPSLEDLFDLCDRTFTLKTVLMIAIQLITRMEYVHTKSL 121
Query: 123 LHLDMKPENILC---LTKTGNRIKIIDFGLARKF-DPEKKLQV-------LFGTPEFVAP 171
           ++ D+KPEN L     TK  + I IIDFGLA+++ DPE K  +       L GT  +++ 
Sbjct: 122 IYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSI 181
Query: 172 EVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
                       D+ ++G +    L G  P+ G
Sbjct: 182 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 214

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 18/177 (10%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCV--VLELIEGGELFERVIDDDFVLTEKAVAIFMRQI 110
           I+R L H  +++     E      V  V+E +  G L + +      L +  + +F +QI
Sbjct: 63  ILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQ--LLLFAQQI 120
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK----KLQVLFGTP 166
           CEG+ ++H+++ +H  +   N+  L      +KI DFGLA+   PE     +++    +P
Sbjct: 121 CEGMAYLHAQHYIHRALAARNV--LLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSP 177
Query: 167 EF-VAPEVVNFDAIGFGTDMWSVGVICYVLL----SGLSPFMGETDV--QTMANVTI 216
            F  APE +      + +D+WS GV  Y LL    S  SP    T++   T   +T+
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTV 234

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 18/177 (10%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCV--VLELIEGGELFERVIDDDFVLTEKAVAIFMRQI 110
           I+R L H  +++     E      V  V+E +  G L + +      L +  + +F +QI
Sbjct: 64  ILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQ--LLLFAQQI 121
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK----KLQVLFGTP 166
           CEG+ ++H+++ +H  +   N+  L      +KI DFGLA+   PE     +++    +P
Sbjct: 122 CEGMAYLHAQHYIHRALAARNV--LLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSP 178
Query: 167 EF-VAPEVVNFDAIGFGTDMWSVGVICYVLL----SGLSPFMGETDV--QTMANVTI 216
            F  APE +      + +D+WS GV  Y LL    S  SP    T++   T   +T+
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTV 235

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 82  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 141
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPE---------KKLQV 161
           +G++F+ SK  +H D+   N  C+      +K+ DFGLAR  +D E          KL V
Sbjct: 142 KGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
                +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 200 -----KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 241

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 85  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 144
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPE---------KKLQV 161
           +G++F+ SK  +H D+   N  C+      +K+ DFGLAR  +D E          KL V
Sbjct: 145 KGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
                +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 203 -----KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 244

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 202
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPE---------KKLQV 161
           +G++F+ SK  +H D+   N  C+      +K+ DFGLAR  +D E          KL V
Sbjct: 203 KGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
                +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 261 -----KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 302

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 63/117 (53%), Gaps = 8/117 (6%)
Query: 93  DDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK 152
           +D  VLT + +  F  Q+ +G+EF+  K+ +H D+   N+  L   G  +KI DFGLAR 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV--LVTHGKVVKICDFGLARD 221
Query: 153 FDPEKKLQVLFGTP----EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
              +    V+ G      +++APE +        +D+WS G++ + + S G++P+ G
Sbjct: 222 IMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 143
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPE---------KKLQV 161
           +G++F+ SK  +H D+   N  C+      +K+ DFGLAR  +D E          KL V
Sbjct: 144 KGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
                +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 202 -----KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 243

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 89  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 148
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPE---------KKLQV 161
           +G++F+ SK  +H D+   N  C+      +K+ DFGLAR  +D E          KL V
Sbjct: 149 KGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
                +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 207 -----KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 248

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 143
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPE---------KKLQV 161
           +G++F+ SK  +H D+   N  C+      +K+ DFGLAR  +D E          KL V
Sbjct: 144 KGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
                +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 202 -----KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 243

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 77  VVLELIEGGELF---ERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
           ++L   + G L+   ER+ D    LTE  +   +  IC G+E IH+K   H D+KP NIL
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166
Query: 134 CLTKTGNRIKIIDFGLARK--FDPEKKLQVLF--------GTPEFVAPEVVNFDA---IG 180
            L   G  + ++D G   +     E   Q L          T  + APE+ +  +   I 
Sbjct: 167 -LGDEGQPV-LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224
Query: 181 FGTDMWSVGVICYVLLSGLSPF 202
             TD+WS+G + Y ++ G  P+
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGPY 246

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 65/113 (57%), Gaps = 10/113 (8%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK 157
           L+ + +  F  Q+ +G+ F+ SKN +H D+   N+L LT  G+  KI DFGLAR    + 
Sbjct: 163 LSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL-LT-NGHVAKIGDFGLARDIMNDS 220
Query: 158 KLQVLFGTP----EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
              ++ G      +++APE + FD +    +D+WS G++ + + S GL+P+ G
Sbjct: 221 NY-IVKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 8/101 (7%)
Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGTP 166
           Q+  G+EF+ S+  +H D+   NIL      N +KI DFGLAR    +P+   +     P
Sbjct: 207 QVARGMEFLSSRKCIHRDLAARNILL--SENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 167 -EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
            +++APE + FD I    +D+WS GV+ + + S G SP+ G
Sbjct: 265 LKWMAPESI-FDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG 304

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 53  IMREL-QHPRLIQIYDAFESSNVMCVVLELIEGGELF-------ERVID--DDFVLTEKA 102
           IM  L QH  ++ +  A      + V+ E    G+L        E  +D  D   L  + 
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL 162
           +  F  Q+ +G+ F+ SKN +H D+   N+L LT  G+  KI DFGLAR    +    V 
Sbjct: 162 LLHFSSQVAQGMAFLASKNCIHRDVAARNVL-LT-NGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 163 FGTP---EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
                  +++APE + FD +    +D+WS G++ + + S GL+P+ G
Sbjct: 220 GNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 142
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 143 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 242

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 85  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 144
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR-----KFDPEKKLQVLFGTP 166
           +G++F+ SK  +H D+   N  C+      +K+ DFGLAR     +FD            
Sbjct: 145 KGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 244

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-----KKLQ 160
           + + + E V  IH   ++H D+KP N L +      +K+IDFG+A +  P+     K  Q
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 161 VLFGTPEFVAPEVVN-----------FDAIGFGTDMWSVGVICYVLLSGLSPF 202
           V  GT  ++ PE +               I   +D+WS+G I Y +  G +PF
Sbjct: 217 V--GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 53  IMRELQHPRLIQIYDAF-ESSNVMCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQI 110
           +M +L+H  L+Q+     E    + +V E +  G L + +      VL    +  F   +
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPE 167
           CE +E++   N +H D+   N+  L    N  K+ DFGL ++    +   KL V     +
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNV--LVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----K 351
Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
           + APE +        +D+WS G++ + + S G  P+
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 143
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 144 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 243

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 76  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 135
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 136 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 235

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 53  IMREL-QHPRLIQIYDAFESSNVMCVVLELIEGGELF-------ERVID--DDFVLTEKA 102
           IM  L QH  ++ +  A      + V+ E    G+L        E  +D  D   L  + 
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL 162
           +  F  Q+ +G+ F+ SKN +H D+   N+L LT  G+  KI DFGLAR    +    V 
Sbjct: 154 LLHFSSQVAQGMAFLASKNCIHRDVAARNVL-LT-NGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 163 FGTP---EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
                  +++APE + FD +    +D+WS G++ + + S GL+P+ G
Sbjct: 212 GNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 82  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 141
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 142 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 241

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-----KKLQ 160
           + + + E V  IH   ++H D+KP N L +      +K+IDFG+A +  P+     K  Q
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 161 VLFGTPEFVAPEVVN-----------FDAIGFGTDMWSVGVICYVLLSGLSPF 202
           V  GT  ++ PE +               I   +D+WS+G I Y +  G +PF
Sbjct: 217 V--GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 102 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 161
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 162 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 219
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 220 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 261

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 53  IMRELQHPRLIQIYDAF-ESSNVMCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQI 110
           +M +L+H  L+Q+     E    + +V E +  G L + +      VL    +  F   +
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPE 167
           CE +E++   N +H D+   N+  L    N  K+ DFGL ++    +   KL V     +
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNV--LVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----K 179
Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
           + APE +        +D+WS G++ + + S G  P+
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 138
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 139 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 238

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 11/156 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVG--IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G +G VY   +K     +A K V                  I+  L+   +I+++D    
Sbjct: 39  GSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIP 98
Query: 72  SNVM-----CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            +++      +VLE+ +     +++      LTE+ V   +  +  G +FIH   ++H D
Sbjct: 99  EDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRD 156
Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL 162
           +KP N  CL      +KI DFGLAR  + +K + ++
Sbjct: 157 LKPAN--CLLNQDCSVKICDFGLARTINSDKDIHIV 190

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 81  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 140
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 141 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 240

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 142
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 143 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 242

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 143
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 144 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 243

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEF 116
           L H  ++++      S++  V  + +  G L + V      L  + +  +  QI +G+ +
Sbjct: 72  LDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG---TP-EFVAPE 172
           +    ++H ++   N+L   K+ +++++ DFG+A    P+ K Q+L+    TP +++A E
Sbjct: 131 LEEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLLPPDDK-QLLYSEAKTPIKWMALE 187
Query: 173 VVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            ++F      +D+WS GV  + L++ G  P+ G
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQHPR---LIQIYDA 68
           G FG V++ + + TG  +A K V +   K            I++ L+H     LI+I   
Sbjct: 29  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 88
Query: 69  FESSNVMC-----VVLELIE---GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
             S    C     +V +  E    G L   ++   F L+E  +   M+ +  G+ +IH  
Sbjct: 89  KASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSE--IKRVMQMLLNGLYYIHRN 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ----------VLFGTPEFVA 170
            +LH DMK  N+L +T+ G  +K+ DFGLAR F   K  Q          + +  PE + 
Sbjct: 145 KILHRDMKAANVL-ITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 202
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVT 215
            E       G   D+W  G I   + +  SP M G T+   +A ++
Sbjct: 203 GE----RDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQHQLALIS 243

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-----KKLQ 160
           + + + E V  IH   ++H D+KP N L +      +K+IDFG+A +  P+     K  Q
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 161 VLFGTPEFVAPEVVN-----------FDAIGFGTDMWSVGVICYVLLSGLSPF 202
           V  GT  ++ PE +               I   +D+WS+G I Y +  G +PF
Sbjct: 189 V--GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-----KKLQ 160
           + + + E V  IH   ++H D+KP N L +      +K+IDFG+A +  P+     K  Q
Sbjct: 113 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 161 VLFGTPEFVAPEVVN-----------FDAIGFGTDMWSVGVICYVLLSGLSPF 202
           V  GT  ++ PE +               I   +D+WS+G I Y +  G +PF
Sbjct: 170 V--GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 53  IMRELQHPRLIQIYD-AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQIC 111
           IM++  HP ++ +      S     VVL  ++ G+L   + ++    T K +  F  Q+ 
Sbjct: 103 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 162
Query: 112 EGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----- 166
           +G++++ SK  +H D+   N  C+      +K+ DFGLAR    ++   V   T      
Sbjct: 163 KGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQT 210
           +++A E +        +D+WS GV+ + L++ G  P+    DV T
Sbjct: 221 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNT 262

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-----KKLQ 160
           + + + E V  IH   ++H D+KP N L +      +K+IDFG+A +  P+     K  Q
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDXXXVVKDSQ 188
Query: 161 VLFGTPEFVAPEVVN-----------FDAIGFGTDMWSVGVICYVLLSGLSPF 202
           V  GT  ++ PE +               I   +D+WS+G I Y +  G +PF
Sbjct: 189 V--GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEF 116
           L H  ++++      S++  V  + +  G L + V      L  + +  +  QI +G+ +
Sbjct: 90  LDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG---TP-EFVAPE 172
           +    ++H ++   N+L   K+ +++++ DFG+A    P+ K Q+L+    TP +++A E
Sbjct: 149 LEEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLLPPDDK-QLLYSEAKTPIKWMALE 205
Query: 173 VVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
            ++F      +D+WS GV  + L++ G  P+ G
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 238

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 53  IMRELQHPRLIQIYDAF-ESSNVMCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQI 110
           +M +L+H  L+Q+     E    + +V E +  G L + +      VL    +  F   +
Sbjct: 52  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPE 167
           CE +E++   N +H D+   N+  L    N  K+ DFGL ++    +   KL V     +
Sbjct: 112 CEAMEYLEGNNFVHRDLAARNV--LVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----K 164
Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPF 202
           + APE +        +D+WS G++ + + S G  P+
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQHPR---LIQIYDA 68
           G FG V++ + + TG  +A K V +   K            I++ L+H     LI+I   
Sbjct: 29  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 88
Query: 69  FESSNVMC-----VVLELIE---GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
             S    C     +V +  E    G L   ++   F L+E  +   M+ +  G+ +IH  
Sbjct: 89  KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSE--IKRVMQMLLNGLYYIHRN 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ----------VLFGTPEFVA 170
            +LH DMK  N+L +T+ G  +K+ DFGLAR F   K  Q          + +  PE + 
Sbjct: 145 KILHRDMKAANVL-ITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 202
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVT 215
            E       G   D+W  G I   + +  SP M G T+   +A ++
Sbjct: 203 GE----RDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQHQLALIS 243

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQHPR---LIQIYDA 68
           G FG V++ + + TG  +A K V +   K            I++ L+H     LI+I   
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87
Query: 69  FESSNVMC-----VVLELIE---GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
             S    C     +V +  E    G L   ++   F L+E  +   M+ +  G+ +IH  
Sbjct: 88  KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSE--IKRVMQMLLNGLYYIHRN 143
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ----------VLFGTPEFVA 170
            +LH DMK  N+L +T+ G  +K+ DFGLAR F   K  Q          + +  PE + 
Sbjct: 144 KILHRDMKAANVL-ITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 201
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVT 215
            E       G   D+W  G I   + +  SP M G T+   +A ++
Sbjct: 202 GE----RDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQHQLALIS 242

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQHPR---LIQIYDA 68
           G FG V++ + + TG  +A K V +   K            I++ L+H     LI+I   
Sbjct: 29  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 88
Query: 69  FESSNVMC-----VVLELIE---GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
             S    C     +V +  E    G L   ++   F L+E  +   M+ +  G+ +IH  
Sbjct: 89  KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSE--IKRVMQMLLNGLYYIHRN 144
Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ----------VLFGTPEFVA 170
            +LH DMK  N+L +T+ G  +K+ DFGLAR F   K  Q          + +  PE + 
Sbjct: 145 KILHRDMKAANVL-ITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 202
Query: 171 PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVT 215
            E       G   D+W  G I   + +  SP M G T+   +A ++
Sbjct: 203 GE----RDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQHQLALIS 243

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-----KKLQ 160
           + + + E V  IH   ++H D+KP N L +      +K+IDFG+A +  P+     K  Q
Sbjct: 112 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQ 168
Query: 161 VLFGTPEFVAPEVVN-----------FDAIGFGTDMWSVGVICYVLLSGLSPF 202
           V  GT  ++ PE +               I   +D+WS+G I Y +  G +PF
Sbjct: 169 V--GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-----KKLQ 160
           + + + E V  IH   ++H D+KP N L +      +K+IDFG+A +  P+     K  Q
Sbjct: 116 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQ 172
Query: 161 VLFGTPEFVAPEVVN-----------FDAIGFGTDMWSVGVICYVLLSGLSPF 202
           V  GT  ++ PE +               I   +D+WS+G I Y +  G +PF
Sbjct: 173 V--GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 59/104 (56%), Gaps = 8/104 (7%)
Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT 165
           F  Q+ +G+ F+ SKN +H D+   N+L LT  G+  KI DFGLAR    +    V    
Sbjct: 163 FSSQVAQGMAFLASKNCIHRDVAARNVL-LT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 220
Query: 166 P---EFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
               +++APE + FD +    +D+WS G++ + + S GL+P+ G
Sbjct: 221 RLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFD 154
           L+ K +     Q+  G+E++ SK  +H D+   N+  L    N +KI DFGLAR     D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV--LVTEDNVMKIADFGLARDIHHID 204
Query: 155 PEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             KK        +++APE + FD I    +D+WS GV+ + + + G SP+ G
Sbjct: 205 XXKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 21/113 (18%)
Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-----KKLQ 160
           + + + E V  IH   ++H D+KP N L +      +K+IDFG+A +  P+     K  Q
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 161 VLFGTPEFVAPEVVN-----------FDAIGFGTDMWSVGVICYVLLSGLSPF 202
           V  G   ++ PE +               I   +D+WS+G I Y +  G +PF
Sbjct: 217 V--GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 24/187 (12%)
Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEF 116
           L+    ++   A +  + + +  E  E   L++ +  ++            RQI E + +
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---------KFDPEK------KLQV 161
           IHS+ ++H ++KP NI         +KI DFGLA+         K D +        L  
Sbjct: 132 IHSQGIIHRNLKPXNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 162 LFGTPEFVAPEVVNFDAIGF---GTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIA 217
             GT  +VA EV+  D  G      D +S+G+I +  +   S      ++ + + +V+I 
Sbjct: 190 AIGTAXYVATEVL--DGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRSVSIE 247
Query: 218 -QYDFDD 223
              DFDD
Sbjct: 248 FPPDFDD 254

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFD 154
           L+ K +     Q+  G+E++ SK  +H D+   N+  L    N +KI DFGLAR     D
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV--LVTEDNVMKIADFGLARDIHHID 193
Query: 155 PEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             KK        +++APE + FD I    +D+WS GV+ + + + G SP+ G
Sbjct: 194 YYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 244

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFD 154
           L+ K +     Q+  G+E++ SK  +H D+   N+  L    N +KI DFGLAR     D
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV--LVTEDNVMKIADFGLARDIHHID 197
Query: 155 PEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             KK        +++APE + FD I    +D+WS GV+ + + + G SP+ G
Sbjct: 198 YYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 248

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFD 154
           L+ K +     Q+  G+E++ SK  +H D+   N+  L    N +KI DFGLAR     D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV--LVTEDNVMKIADFGLARDIHHID 189
Query: 155 PEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             KK        +++APE + FD I    +D+WS GV+ + + + G SP+ G
Sbjct: 190 YYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFD 154
           L+ K +     Q+  G+E++ SK  +H D+   N+  L    N +KI DFGLAR     D
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV--LVTEDNVMKIADFGLARDIHHID 196
Query: 155 PEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             KK        +++APE + FD I    +D+WS GV+ + + + G SP+ G
Sbjct: 197 YYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFD 154
           L+ K +     Q+  G+E++ SK  +H D+   N+  L    N +KI DFGLAR     D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV--LVTEDNVMKIADFGLARDIHHID 204
Query: 155 PEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             KK        +++APE + FD I    +D+WS GV+ + + + G SP+ G
Sbjct: 205 YYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFD 154
           L+ K +     Q+  G+E++ SK  +H D+   N+  L    N +KI DFGLAR     D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV--LVTEDNVMKIADFGLARDIHHID 204
Query: 155 PEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             KK        +++APE + FD I    +D+WS GV+ + + + G SP+ G
Sbjct: 205 YYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFD 154
           L+ K +     Q+  G+E++ SK  +H D+   N+  L    N +KI DFGLAR     D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV--LVTEDNVMKIADFGLARDIHHID 204
Query: 155 PEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             KK        +++APE + FD I    +D+WS GV+ + + + G SP+ G
Sbjct: 205 YYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 36/224 (16%)
Query: 13  FGKF--GTVYRCKEKATGMTLAAKFVG-IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           FGK    T +  K +A   T+A K +   A             +++++ HP +I++Y A 
Sbjct: 36  FGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95
Query: 70  ESSNVMCVVLELIEGGEL--FER-------------------VID--DDFVLTEKAVAIF 106
                + +++E  + G L  F R                    +D  D+  LT   +  F
Sbjct: 96  SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVL 162
             QI +G++++   +++H D+   NIL     G ++KI DFGL+R    E    K+ Q  
Sbjct: 156 AWQISQGMQYLAEMSLVHRDLAARNILV--AEGRKMKISDFGLSRDVYEEDSXVKRSQGR 213
Query: 163 FGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
               +++A E + FD I    +D+WS GV+ + +++ G +P+ G
Sbjct: 214 IPV-KWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 32/201 (15%)
Query: 54  MRELQHPRLIQIYDAFESSN------VMCVVLELIEGGELF-----ERVIDDDFVLTEKA 102
           M+E  HP + ++      S       +  V+L  ++ G+L       R+ ++ F L  + 
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP------- 155
           +  FM  I  G+E++ S+N +H D+   N  C+      + + DFGL+RK          
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARN--CMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 156 -EKKLQVLFGTPEFVAPEV--VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
              KL V +   E +A  +  V+ D   FG  MW       ++  G +P+ G  + + + 
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWE------IMTRGQTPYAGIENAE-IY 249
Query: 213 NVTIAQYDFDD--ECFNEISD 231
           N  I         EC  E+ D
Sbjct: 250 NYLIGGNRLKQPPECMEEVYD 270

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 84/179 (46%), Gaps = 18/179 (10%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFVL----------TE 100
           ++  LQH  +++ Y      + + +V E ++ G+L  F R    D VL          T+
Sbjct: 68  LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQ 127
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ 160
             +    +QI  G+ ++ S++ +H D+   N  CL      +KI DFG++R        +
Sbjct: 128 SQMLHIAQQIAAGMVYLASQHFVHRDLATRN--CLVGENLLVKIGDFGMSRDVYSTDYYR 185
Query: 161 VLFGT--P-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           V   T  P  ++ PE + +      +D+WS+GV+ + + + G  P+   ++ + +  +T
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 8/112 (7%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFD 154
           L+ K +     Q+  G+E++ SK  +H D+   N+L      N +KI DFGLAR     D
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED--NVMKIADFGLARDIHHID 245
Query: 155 PEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
             KK        +++APE + FD I    +D+WS GV+ + + + G SP+ G
Sbjct: 246 YYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 13  FGKF--GTVYRCKEKATGMTLAAKFVG-IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           FGK    T +  K +A   T+A K +   A             +++++ HP +I++Y A 
Sbjct: 36  FGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95
Query: 70  ESSNVMCVVLELIEGGEL--FER-------------------VID--DDFVLTEKAVAIF 106
                + +++E  + G L  F R                    +D  D+  LT   +  F
Sbjct: 96  SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVL 162
             QI +G++++    ++H D+   NIL     G ++KI DFGL+R    E    K+ Q  
Sbjct: 156 AWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRDVYEEDSXVKRSQGR 213
Query: 163 FGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
               +++A E + FD I    +D+WS GV+ + +++ G +P+ G
Sbjct: 214 IPV-KWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 79/156 (50%), Gaps = 7/156 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  + +P + ++     +S V  ++++L+  G L + V +    +  + +  +  QI +
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG--TP-EFV 169
           G+ ++  + ++H D+   N+L   KT   +KI DFGLA+    E+K     G   P +++
Sbjct: 130 GMNYLEDRRLVHRDLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           A E +        +D+WS GV  + L++ G  P+ G
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 13  FGKF--GTVYRCKEKATGMTLAAKFVG-IAKXXXXXXXXXXXXIMRELQHPRLIQIYDAF 69
           FGK    T +  K +A   T+A K +   A             +++++ HP +I++Y A 
Sbjct: 36  FGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95
Query: 70  ESSNVMCVVLELIEGGEL--FER-------------------VID--DDFVLTEKAVAIF 106
                + +++E  + G L  F R                    +D  D+  LT   +  F
Sbjct: 96  SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155
Query: 107 MRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVL 162
             QI +G++++    ++H D+   NIL     G ++KI DFGL+R    E    K+ Q  
Sbjct: 156 AWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRDVYEEDSYVKRSQGR 213
Query: 163 FGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
               +++A E + FD I    +D+WS GV+ + +++ G +P+ G
Sbjct: 214 IPV-KWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 112/250 (44%), Gaps = 21/250 (8%)
Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--KXXXXXXXXXXXXIMRELQHPRLIQIYDAFES 71
           G  G V++ + + TG  +A K +  +  K            +++    P ++Q +  F +
Sbjct: 36  GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95
Query: 72  SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLDMKP 129
           +  + + +EL+  G   E++       + E+ +      I + + ++  K+ V+H D+KP
Sbjct: 96  NTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 153
Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV--------NFDAIGF 181
            NIL L + G +IK+ DFG++ +   +K      G   ++APE +        ++D    
Sbjct: 154 SNIL-LDERG-QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD---I 208
Query: 182 GTDMWSVGVICYVLLSGLSPFMG-ETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
             D+WS+G+    L +G  P+   +TD + +  V   +           S D + F++  
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG-FSGDFQSFVKDC 267
Query: 241 LLKDREDAPE 250
           L KD    P+
Sbjct: 268 LTKDHRKRPK 277

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 11  FSFGKFGTVYRC-----KEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI 65
            S G FGTVY+       EK        +                  +M  + +P + ++
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
                +S V  ++++L+  G L + V +    +  + +  +  QI +G+ ++  + ++H 
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR 148
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFG 182
           D+   N+L   KT   +KI DFGLA+    E+K     G     +++A E +        
Sbjct: 149 DLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 206
Query: 183 TDMWSVGVICYVLLS-GLSPFMG 204
           +D+WS GV  + L++ G  P+ G
Sbjct: 207 SDVWSYGVTVWELMTFGSKPYDG 229

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 53/242 (21%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL--FERVIDDDFV-------LTEKAV 103
           +M E  +P ++++         MC++ E +  G+L  F R +    V       L+ +A 
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 104 A--------------IFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGL 149
                             RQ+  G+ ++  +  +H D+   N  CL      +KI DFGL
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN--CLVGENMVVKIADFGL 220
Query: 150 AR--------KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLS 200
           +R        K D    + +      ++ PE + ++     +D+W+ GV+ + + S GL 
Sbjct: 221 SRNIYSADYYKADGNDAIPI-----RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 201 PFMGET---------DVQTMA---NVTIAQYDFDDECFNEISDDAKDF--IRKLLLKDRE 246
           P+ G           D   +A   N  +  Y+    C++++  D   F  I ++L +  E
Sbjct: 276 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335
Query: 247 DA 248
            A
Sbjct: 336 RA 337

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFE-----------------RVIDDDFVLTE 100
           +H  +I +  A      + V++E    G L E                 RV ++     +
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEK 157
                +  Q+  G+E++ S+  +H D+   N+  L    N +KI DFGLAR     D  K
Sbjct: 159 LVSCTY--QLARGMEYLASQKCIHRDLAARNV--LVTENNVMKIADFGLARDINNIDXXK 214
Query: 158 KLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
           K        +++APE + FD +    +D+WS GV+ + + + G SP+ G
Sbjct: 215 KTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 8/101 (7%)
Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGT 165
           Q+  G+E++ S+  +H D+   N+  L    N +KI DFGLAR     D  KK       
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNV--LVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 166 PEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
            +++APE + FD +    +D+WS GV+ + + + G SP+ G
Sbjct: 223 VKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 77/156 (49%), Gaps = 7/156 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  + +P + ++     +S V  ++ +L+  G L + V +    +  + +  +  QI E
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++  + ++H D+   N+L   KT   +KI DFGLA+    E+K     G     +++
Sbjct: 126 GMNYLEDRRLVHRDLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           A E +        +D+WS GV  + L++ G  P+ G
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 219

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  + +P + ++     +S V  ++++L+  G L + V +    +  + +  +  QI +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++  + ++H D+   N+L   KT   +KI DFGLA+    E+K     G     +++
Sbjct: 131 GMNYLEDRRLVHRDLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           A E +        +D+WS GV  + L++ G  P+ G
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  + +P + ++     +S V  ++++L+  G L + V +    +  + +  +  QI +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++  + ++H D+   N+L   KT   +KI DFGLA+    E+K     G     +++
Sbjct: 132 GMNYLEDRRLVHRDLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           A E +        +D+WS GV  + L++ G  P+ G
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  + +P + ++     +S V  ++++L+  G L + V +    +  + +  +  QI +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++  + ++H D+   N+L   KT   +KI DFGLA+    E+K     G     +++
Sbjct: 129 GMNYLEDRRLVHRDLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           A E +        +D+WS GV  + L++ G  P+ G
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  + +P + ++     +S V  ++++L+  G L + V +    +  + +  +  QI +
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++  + ++H D+   N+L   KT   +KI DFGLA+    E+K     G     +++
Sbjct: 130 GMNYLEDRRLVHRDLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           A E +        +D+WS GV  + L++ G  P+ G
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  + +P + ++     +S V  ++++L+  G L + V +    +  + +  +  QI +
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++  + ++H D+   N+L   KT   +KI DFGLA+    E+K     G     +++
Sbjct: 133 GMNYLEDRRLVHRDLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           A E +        +D+WS GV  + L++ G  P+ G
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 70/137 (51%), Gaps = 6/137 (4%)
Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           ++ + +V +L+  G L + V ++   L  + +  +  QI +G+ ++    ++H D+   N
Sbjct: 90  TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARN 149
Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFGTDMWSV 188
           +L   K+ N +KI DFGLAR  D ++      G     +++A E +        +D+WS 
Sbjct: 150 VL--VKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSY 207
Query: 189 GVICYVLLS-GLSPFMG 204
           GV  + L++ G  P+ G
Sbjct: 208 GVTVWELMTFGAKPYDG 224

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 7/128 (5%)
Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGT 165
           +I +G+ ++++K  +H D+   N  C+      +KI DFG+ R     D  +K       
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 166 PEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQY-DFDD 223
             ++APE +        +DMWS GV+ + + S    P+ G ++ Q +  V    Y D  D
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 252
Query: 224 ECFNEISD 231
            C   ++D
Sbjct: 253 NCPERVTD 260

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 25/168 (14%)
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFE-----------------RVIDDDFVLTE 100
           +H  +I +  A      + V++E    G L E                 RV ++     +
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEK 157
                +  Q+  G+E++ S+  +H D+   N+  L    N +KI DFGLAR     D  K
Sbjct: 159 LVSCTY--QLARGMEYLASQKCIHRDLAARNV--LVTENNVMKIADFGLARDINNIDYYK 214
Query: 158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           K        +++APE +        +D+WS GV+ + + + G SP+ G
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 7/128 (5%)
Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGT 165
           +I +G+ ++++K  +H D+   N  C+      +KI DFG+ R     D  +K       
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 166 PEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQY-DFDD 223
             ++APE +        +DMWS GV+ + + S    P+ G ++ Q +  V    Y D  D
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 224 ECFNEISD 231
            C   ++D
Sbjct: 256 NCPERVTD 263

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 77/156 (49%), Gaps = 7/156 (4%)
Query: 53  IMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
           +M  + +P + ++     +S V  ++ +L+  G L + V +    +  + +  +  QI +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFV 169
           G+ ++  + ++H D+   N+L   KT   +KI DFGLA+    E+K     G     +++
Sbjct: 129 GMNYLEDRRLVHRDLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
           A E +        +D+WS GV  + L++ G  P+ G
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 7/128 (5%)
Query: 109 QICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF---DPEKKLQVLFGT 165
           +I +G+ ++++K  +H D+   N  C+      +KI DFG+ R     D  +K       
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 166 PEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQY-DFDD 223
             ++APE +        +DMWS GV+ + + S    P+ G ++ Q +  V    Y D  D
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 224 ECFNEISD 231
            C   ++D
Sbjct: 256 NCPERVTD 263

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFE-----------------RVIDDDFVLTE 100
           +H  +I +  A      + V++E    G L E                 RV ++     +
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEK 157
                +  Q+  G+E++ S+  +H D+   N+  L    N +KI DFGLAR     D  K
Sbjct: 151 LVSCTY--QLARGMEYLASQKCIHRDLAARNV--LVTENNVMKIADFGLARDINNIDYYK 206
Query: 158 KLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
           K        +++APE + FD +    +D+WS GV+ + + + G SP+ G
Sbjct: 207 KTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFE-----------------RVIDDDFVLTE 100
           +H  +I +  A      + V++E    G L E                 RV ++     +
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEK 157
                +  Q+  G+E++ S+  +H D+   N+  L    N +KI DFGLAR     D  K
Sbjct: 146 LVSCTY--QLARGMEYLASQKCIHRDLTARNV--LVTENNVMKIADFGLARDINNIDYYK 201
Query: 158 KLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
           K        +++APE + FD +    +D+WS GV+ + + + G SP+ G
Sbjct: 202 KTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 249

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/127 (22%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAK-----FVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDA 68
           G+FG+V++C ++  G   A K       G               ++   QH  +++ + A
Sbjct: 20  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG--QHSHVVRYFSA 77
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLT---EKAVAIFMRQICEGVEFIHSKNVLHL 125
           +   + M +  E   GG L + + ++  +++   E  +   + Q+  G+ +IHS +++H+
Sbjct: 78  WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHM 137
Query: 126 DMKPENI 132
           D+KP NI
Sbjct: 138 DIKPSNI 144

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 60/140 (42%), Gaps = 31/140 (22%)
Query: 98  LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR------ 151
           L+ + V  +M  + + ++ IH   ++H D+KP N L   +   +  ++DFGLA+      
Sbjct: 114 LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFL-YNRRLKKYALVDFGLAQGTHDTK 172
Query: 152 ----KF-------------------DPEKKLQVLFGTPEFVAPEVVN-FDAIGFGTDMWS 187
               KF                      +++    GTP F APEV+          DMWS
Sbjct: 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232
Query: 188 VGVICYVLLSGLSPFMGETD 207
            GVI   LLSG  PF   +D
Sbjct: 233 AGVIFLSLLSGRYPFYKASD 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFE-----------------RVIDDDFVLTE 100
           +H  +I +  A      + V++E    G L E                 RV ++     +
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEK 157
                +  Q+  G+E++ S+  +H D+   N+  L    N +KI DFGLAR     D  K
Sbjct: 159 LVSCTY--QLARGMEYLASQKCIHRDLAARNV--LVTENNVMKIADFGLARDINNIDYYK 214
Query: 158 KLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
           K        +++APE + FD +    +D+WS GV+ + + + G SP+ G
Sbjct: 215 KTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFE-----------------RVIDDDFVLTE 100
           +H  +I +  A      + V++E    G L E                 RV ++     +
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEK 157
                +  Q+  G+E++ S+  +H D+   N+  L    N +KI DFGLAR     D  K
Sbjct: 148 LVSCTY--QLARGMEYLASQKCIHRDLAARNV--LVTENNVMKIADFGLARDINNIDYYK 203
Query: 158 KLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
           K        +++APE + FD +    +D+WS GV+ + + + G SP+ G
Sbjct: 204 KTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 251

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/127 (22%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAK-----FVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDA 68
           G+FG+V++C ++  G   A K       G               ++   QH  +++ + A
Sbjct: 22  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG--QHSHVVRYFSA 79
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLT---EKAVAIFMRQICEGVEFIHSKNVLHL 125
           +   + M +  E   GG L + + ++  +++   E  +   + Q+  G+ +IHS +++H+
Sbjct: 80  WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHM 139
Query: 126 DMKPENI 132
           D+KP NI
Sbjct: 140 DIKPSNI 146

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 12/203 (5%)
Query: 11  FSFGKFGTVYRC-----KEKATGMTLAAKFVGIAKXXXXXXXXXXXXIMRELQHPRLIQI 65
            S G FGTVY+       EK        +                  +M  + +P + ++
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
                +S V  ++ +L+  G L + V +    +  + +  +  QI +G+ ++  + ++H 
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR 141
Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---EFVAPEVVNFDAIGFG 182
           D+   N+L   KT   +KI DFGLA+    E+K     G     +++A E +        
Sbjct: 142 DLAARNVL--VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 183 TDMWSVGVICYVLLS-GLSPFMG 204
           +D+WS GV  + L++ G  P+ G
Sbjct: 200 SDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 58  QHPRLIQIYDAFESSNVMCVVLELIEGGELFE-----------------RVIDDDFVLTE 100
           +H  +I +  A      + V++E    G L E                 RV ++     +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 101 KAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR---KFDPEK 157
                +  Q+  G+E++ S+  +H D+   N+  L    N +KI DFGLAR     D  K
Sbjct: 205 LVSCTY--QLARGMEYLASQKCIHRDLAARNV--LVTENNVMKIADFGLARDINNIDYYK 260
Query: 158 KLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLS-GLSPFMG 204
           K        +++APE + FD +    +D+WS GV+ + + + G SP+ G
Sbjct: 261 KTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/127 (22%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 14  GKFGTVYRCKEKATGMTLAAK-----FVGIAKXXXXXXXXXXXXIMRELQHPRLIQIYDA 68
           G+FG+V++C ++  G   A K       G               ++   QH  +++ + A
Sbjct: 20  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG--QHSHVVRYFSA 77
Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLT---EKAVAIFMRQICEGVEFIHSKNVLHL 125
           +   + M +  E   GG L + + ++  +++   E  +   + Q+  G+ +IHS +++H+
Sbjct: 78  WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHM 137
Query: 126 DMKPENI 132
           D+KP NI
Sbjct: 138 DIKPSNI 144
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	251
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-140
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-138
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-137
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-137
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-130
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-130
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-129
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-129
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-128
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-100
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-98
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-96
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-94
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-92
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-89
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-89
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-89
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-88
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-88
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-88
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-86
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-86
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-86
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-85
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-85
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-84
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-84
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-83
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-72
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-70
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-70
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-70
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-70
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-68
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-68
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-68
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-66
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-66
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-64
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-64
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-64
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-63
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-62
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-61
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-60
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-60
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-60
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-59
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-59
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-59
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-59
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-58
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-58
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-58
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-57
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-57
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-56
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-56
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-56
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-55
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-55
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-54
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-54
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-53
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-52
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-50
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-49
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-48
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-48
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-48
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-48
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-48
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-47
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-46
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-45
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-45
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-44
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-43
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-43
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-42
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-42
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-41
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-41
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-40
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-40
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-40
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-40
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-39
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-39
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-39
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-39
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-39
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-39
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-38
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-38
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-38
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-38
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-38
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-38
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-38
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-37
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-37
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-37
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-37
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-37
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-36
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-36
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-36
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-36
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-36
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-35
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-35
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-35
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-34
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-34
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-34
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-33
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-32
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-32
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-32
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-31
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-30
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-30
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-29
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-28
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-28
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-27
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-27
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-27
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-27
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-27
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-27
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-25
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-24
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-24
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-23
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-23
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-23
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-21
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-19
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-18
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-17
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-06
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	8e-04

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  397 bits (1021), Expect = e-140
 Identities = 125/234 (53%), Positives = 178/234 (76%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G+FG V++C+E ATG+ LAAK +      D+  V+ E+ +M +L H  LIQ+YDAFES N
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E ++GGELF+R+ID+ + LTE    +FM+QICEG+  +H   +LHLD+KPENIL
Sbjct: 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENIL 219

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
           C+ +   +IKIIDFGLAR++ P +KL+V FGTPEF+APEVVN+D + F TDMWSVGVI Y
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAY 279

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           +LLSGLSPF+G+ D +T+ N+   ++D +DE F +IS++AK+FI KLL+K++  
Sbjct: 280 MLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSW 333

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  398 bits (1025), Expect = e-138
 Identities = 113/234 (48%), Positives = 155/234 (66%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V+R  E+ATG   AAKFV     +D+  V +E++ M  L+HP L+ ++DAFE  N
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            M ++ E + GGELFE+V D+   ++E     +MRQ+C+G+  +H  N +HLD+KPENI+
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 287

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             TK  N +K+IDFGL    DP++ ++V  GT EF APEV     +G+ TDMWSVGV+ Y
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           +LLSGLSPF GE D +T+ NV    ++ DD  F+ IS+D KDFIRKLLL D   
Sbjct: 348 ILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  388 bits (1000), Expect = e-137
 Identities = 96/242 (39%), Positives = 155/242 (64%), Gaps = 6/242 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G+FG V+RC E ++  T  AKF  +  +  D+  V++E+ I+   +H  ++ ++++FES 
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKF--VKVKGTDQVLVKKEISILNIARHRNILHLHESFESM 73

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + ++ E I G ++FER+    F L E+ +  ++ Q+CE ++F+HS N+ H D++PENI
Sbjct: 74  EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
           +  T+  + IKII+FG AR+  P    ++LF  PE+ APEV   D +   TDMWS+G + 
Sbjct: 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---REDAP 249
           YVLLSG++PF+ ET+ Q + N+  A+Y FD+E F EIS +A DF+ +LL+K+   R  A 
Sbjct: 194 YVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTAS 253

Query: 250 EV 251
           E 
Sbjct: 254 EA 255

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  390 bits (1003), Expect = e-137
 Identities = 113/241 (46%), Positives = 167/241 (69%), Gaps = 3/241 (1%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V+RC EKATG    AKF+      D+  V+ E+ IM +L HP+LI ++DAFE   
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            M ++LE + GGELF+R+  +D+ ++E  V  +MRQ CEG++ +H  +++HLD+KPENI+
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
           C TK  + +KIIDFGLA K +P++ ++V   T EF APE+V+ + +GF TDMW++GV+ Y
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---REDAPE 250
           VLLSGLSPF GE D++T+ NV    ++FD++ F+ +S +AKDFI+ LL K+   R    +
Sbjct: 242 VLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301

Query: 251 V 251
            
Sbjct: 302 A 302

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  368 bits (948), Expect = e-130
 Identities = 116/251 (46%), Positives = 167/251 (66%), Gaps = 16/251 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--------DRRNVEREVEIMRELQHPRLIQI 65
           G+F  V +C++K TG   AAKF  I KR          R  +EREV I+RE++HP +I +
Sbjct: 16  GQFAIVRKCRQKGTGKEYAAKF--IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           +D FE+   + ++LEL+ GGELF+ + + +  LTE     F++QI +GV ++HSK + H 
Sbjct: 74  HDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILDGVHYLHSKRIAHF 132

Query: 126 DMKPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           D+KPENI+ L K     RIK+IDFG+A K +   + + +FGTPEFVAPE+VN++ +G   
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEA 192

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWS+GVI Y+LLSG SPF+GET  +T+ N++   YDFD+E F+  S+ AKDFIR+LL+K
Sbjct: 193 DMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVK 252

Query: 244 D---REDAPEV 251
           D   R    + 
Sbjct: 253 DPKRRMTIAQS 263

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  370 bits (951), Expect = e-130
 Identities = 89/238 (37%), Positives = 151/238 (63%), Gaps = 9/238 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQH-PRLIQIYDA 68
           GKF  V +C  K+TG   AAKF  + KR      R  +  E+ ++   +  PR+I +++ 
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKF--LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           +E+++ + ++LE   GGE+F   + +   +++E  V   ++QI EGV ++H  N++HLD+
Sbjct: 98  YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDL 157

Query: 128 KPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KP+NIL  +      IKI+DFG++RK     +L+ + GTPE++APE++N+D I   TDMW
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMW 217

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           ++G+I Y+LL+  SPF+GE + +T  N++    D+ +E F+ +S  A DFI+ LL+K+
Sbjct: 218 NIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKN 275

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  368 bits (946), Expect = e-129
 Identities = 113/251 (45%), Positives = 167/251 (66%), Gaps = 16/251 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--------DRRNVEREVEIMRELQHPRLIQI 65
           G+F  V +C+EK+TG+  AAKF  I KR          R  +EREV I+R++ H  +I +
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKF--IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           +D +E+   + ++LEL+ GGELF+ +   +  L+E+    F++QI +GV ++H+K + H 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLHTKKIAHF 139

Query: 126 DMKPENILCLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           D+KPENI+ L K      IK+IDFGLA + +   + + +FGTPEFVAPE+VN++ +G   
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA 199

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWS+GVI Y+LLSG SPF+G+T  +T+AN+T   YDFD+E F+  S+ AKDFIRKLL+K
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVK 259

Query: 244 D---REDAPEV 251
           +   R    E 
Sbjct: 260 ETRKRLTIQEA 270

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  368 bits (947), Expect = e-129
 Identities = 114/251 (45%), Positives = 169/251 (67%), Gaps = 16/251 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--------DRRNVEREVEIMRELQHPRLIQI 65
           G+F  V +C+EK+TG+  AAKF  I KR          R  +EREV I+R++ HP +I +
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKF--IKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           +D +E+   + ++LEL+ GGELF+ +   +  L+E+    F++QI +GV ++H+K + H 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLHTKKIAHF 139

Query: 126 DMKPENILCLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           D+KPENI+ L K      IK+IDFGLA + +   + + +FGTPEFVAPE+VN++ +G   
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA 199

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWS+GVI Y+LLSG SPF+G+T  +T+AN+T   YDFD+E F++ S+ AKDFIRKLL+K
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVK 259

Query: 244 D---REDAPEV 251
           +   R    E 
Sbjct: 260 ETRKRLTIQEA 270

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  365 bits (940), Expect = e-128
 Identities = 116/251 (46%), Positives = 169/251 (67%), Gaps = 16/251 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--------DRRNVEREVEIMRELQHPRLIQI 65
           G+F  V +C+EK+TG+  AAKF  I KR          R ++EREV I++E+QHP +I +
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           ++ +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQIAHF 138

Query: 126 DMKPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           D+KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           DMWS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258

Query: 244 D---REDAPEV 251
           D   R    + 
Sbjct: 259 DPKKRMTIQDS 269

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  292 bits (749), Expect = e-100
 Identities = 87/248 (35%), Positives = 138/248 (55%), Gaps = 14/248 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V+  +E+++G+    K   I K         +E E+E+++ L HP +I+I++ FE
Sbjct: 33  GAFGDVHLVEERSSGLERVIKT--INKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFV---LTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
             + M +V+E  EGGEL ER++        L+E  VA  M+Q+   + + HS++V+H D+
Sbjct: 91  DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL 150

Query: 128 KPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPENIL    + +  IKIIDFGLA  F  ++      GT  ++APEV   D + F  D+W
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIW 209

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD-- 244
           S GV+ Y LL+G  PF G +  +     T  + ++  EC   ++  A D ++++L KD  
Sbjct: 210 SAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTPQAVDLLKQMLTKDPE 268

Query: 245 -REDAPEV 251
            R  A +V
Sbjct: 269 RRPSAAQV 276

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  288 bits (739), Expect = 8e-98
 Identities = 81/282 (28%), Positives = 130/282 (46%), Gaps = 51/282 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK-----RNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G +G V    E  T    A K +   K       D   ++ EV +M++L HP + ++Y+ 
Sbjct: 37  GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96

Query: 69  FESSNVMCVVLELIEGGELFERVID----------------------------------- 93
           +E    +C+V+EL  GG L +++                                     
Sbjct: 97  YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156

Query: 94  ----DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGL 149
                DFV  EK ++  MRQI   + ++H++ + H D+KPEN L  T     IK++DFGL
Sbjct: 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGL 216

Query: 150 ARKFDPEK-----KLQVLFGTPEFVAPEVVNFDAIGFG--TDMWSVGVICYVLLSGLSPF 202
           +++F          +    GTP FVAPEV+N     +G   D WS GV+ ++LL G  PF
Sbjct: 217 SKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

Query: 203 MGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            G  D  T++ V   +  F++  +N +S  A+D +  LL ++
Sbjct: 277 PGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  281 bits (721), Expect = 8e-96
 Identities = 77/236 (32%), Positives = 130/236 (55%), Gaps = 8/236 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQHPRLIQIYDAF 69
           G F  V RC  K TG+  AAK   I  +     D + +ERE  I R+LQHP +++++D+ 
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKI--INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +  +   +V +L+ GGELFE ++  +F  +E   +  ++QI E + + HS  ++H ++KP
Sbjct: 75  QEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSNGIVHRNLKP 133

Query: 130 ENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN+L  +K     +K+ DFGLA + +  +      GTP +++PEV+  D      D+W+ 
Sbjct: 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 193

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GVI Y+LL G  PF  E   +  A +    YD+    ++ ++ +AK  I  +L  +
Sbjct: 194 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 249

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  282 bits (723), Expect = 3e-95
 Identities = 86/233 (36%), Positives = 139/233 (59%), Gaps = 5/233 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G    VYRCK+K T    A K   + K  D++ V  E+ ++  L HP +I++ + FE+  
Sbjct: 64  GATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +VLEL+ GGELF+R+++  +  +E+  A  ++QI E V ++H   ++H D+KPEN+L
Sbjct: 122 EISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180

Query: 134 CLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
             T   +  +KI DFGL++  + +  ++ + GTP + APE++   A G   DMWSVG+I 
Sbjct: 181 YATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

Query: 193 YVLLSGLSPFMGETDVQTM-ANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           Y+LL G  PF  E   Q M   +   +Y F    ++E+S +AKD +RKL++ D
Sbjct: 241 YILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLD 293

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  282 bits (723), Expect = 4e-95
 Identities = 77/236 (32%), Positives = 130/236 (55%), Gaps = 8/236 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQHPRLIQIYDAF 69
           G F  V RC  K TG+  AAK   I  +     D + +ERE  I R+LQHP +++++D+ 
Sbjct: 40  GAFSVVRRCVHKTTGLEFAAKI--INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           +  +   +V +L+ GGELFE ++  +F  +E   +  ++QI E + + HS  ++H ++KP
Sbjct: 98  QEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSNGIVHRNLKP 156

Query: 130 ENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN+L  +K     +K+ DFGLA + +  +      GTP +++PEV+  D      D+W+ 
Sbjct: 157 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GVI Y+LL G  PF  E   +  A +    YD+    ++ ++ +AK  I  +L  +
Sbjct: 217 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 272

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  277 bits (711), Expect = 2e-94
 Identities = 88/242 (36%), Positives = 132/242 (54%), Gaps = 6/242 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G +G V    +K T +  AAK +      D    ++E+EIM+ L HP +I++Y+ FE + 
Sbjct: 20  GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+EL  GGELFERV+       E   A  M+ +   V + H  NV H D+KPEN L
Sbjct: 80  DIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFL 138

Query: 134 CLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT + +  +K+IDFGLA +F P K ++   GTP +V+P+V+     G   D WS GV+ 
Sbjct: 139 FLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMM 197

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---REDAP 249
           YVLL G  PF   TD + M  +    + F ++ +  +S  A+  IR+LL K    R  + 
Sbjct: 198 YVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL 257

Query: 250 EV 251
           + 
Sbjct: 258 QA 259

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  279 bits (717), Expect = 2e-94
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 15/243 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN-------DRRNVEREVEIMRELQHPRLIQIY 66
           G F  V RC  + TG   A K   +              +++RE  I   L+HP ++++ 
Sbjct: 35  GPFSVVRRCINRETGQQFAVKI--VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92

Query: 67  DAFESSNVMCVVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           + + S  ++ +V E ++G +L   ++      FV +E   + +MRQI E + + H  N++
Sbjct: 93  ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNII 152

Query: 124 HLDMKPENILCLTKTGN-RIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           H D+KP  +L  +K  +  +K+  FG+A +  +         GTP F+APEVV  +  G 
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGK 212

Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
             D+W  GVI ++LLSG  PF G  + +    +   +Y  +   ++ IS+ AKD +R++L
Sbjct: 213 PVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRML 271

Query: 242 LKD 244
           + D
Sbjct: 272 MLD 274

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  275 bits (707), Expect = 2e-93
 Identities = 80/232 (34%), Positives = 136/232 (58%), Gaps = 3/232 (1%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G F  V+  K++ TG   A K +  +      ++E E+ ++++++H  ++ + D +ES+ 
Sbjct: 20  GAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT 79

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              +V++L+ GGELF+R+++     TEK  ++ ++Q+   V+++H   ++H D+KPEN+L
Sbjct: 80  HYYLVMQLVSGGELFDRILERGV-YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLL 138

Query: 134 CLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT   N +I I DFGL+ K +    +    GTP +VAPEV+         D WS+GVI 
Sbjct: 139 YLTPEENSKIMITDFGLS-KMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           Y+LL G  PF  ET+ +    +    Y+F+   +++IS+ AKDFI  LL KD
Sbjct: 198 YILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKD 249

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  272 bits (698), Expect = 3e-92
 Identities = 90/236 (38%), Positives = 135/236 (57%), Gaps = 9/236 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG V +CK++ T    A K   I K +    D   + REVE++++L HP ++++++  
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKV--INKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           E S+   +V EL  GGELF+ +I      +E   A  ++Q+  G+ ++H  N++H D+KP
Sbjct: 91  EDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149

Query: 130 ENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           ENIL  +K  +  IKIIDFGL+  F    K++   GT  ++APEV+         D+WS 
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSA 208

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GVI Y+LLSG  PF G+ +   +  V   +Y FD   +  ISDDAKD IRK+L   
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  265 bits (680), Expect = 2e-89
 Identities = 79/257 (30%), Positives = 126/257 (49%), Gaps = 22/257 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK---------RNDRRNVEREVEIMREL-QHPRLI 63
           G    V RC  K T    A K + +           +  R    +EV+I+R++  HP +I
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           Q+ D +E++    +V +L++ GELF+ + +    L+EK     MR + E +  +H  N++
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKLNIV 146

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           H D+KPENIL        IK+ DFG + + DP +KL+ + GTP ++APE++         
Sbjct: 147 HRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204

Query: 184 ------DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI 237
                 DMWS GVI Y LL+G  PF     +  +  +    Y F    +++ SD  KD +
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264

Query: 238 RKLLLKD---REDAPEV 251
            + L+     R  A E 
Sbjct: 265 SRFLVVQPQKRYTAEEA 281

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  269 bits (690), Expect = 5e-89
 Identities = 76/237 (32%), Positives = 126/237 (53%), Gaps = 9/237 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQHPRLIQIYDAF 69
           G F  V RC +   G   AA    I  +     D + +ERE  I R L+HP +++++D+ 
Sbjct: 22  GAFSVVRRCVKVLAGQEYAAMI--INTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
                  ++ +L+ GGELFE ++  ++  +E   +  ++QI E V   H   V+H ++KP
Sbjct: 80  SEEGHHYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQMGVVHRNLKP 138

Query: 130 ENILCLTKTGN-RIKIIDFGLARKFDPEKK-LQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           EN+L  +K     +K+ DFGLA + + E++      GTP +++PEV+  D  G   D+W+
Sbjct: 139 ENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWA 198

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            GVI Y+LL G  PF  E   +    +    YDF    ++ ++ +AKD I K+L  +
Sbjct: 199 CGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN 255

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  270 bits (692), Expect = 7e-89
 Identities = 90/236 (38%), Positives = 135/236 (57%), Gaps = 9/236 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG V +CK++ T    A K   I K +    D   + REVE++++L HP ++++++  
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKV--INKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           E S+   +V EL  GGELF+ +I      +E   A  ++Q+  G+ ++H  N++H D+KP
Sbjct: 91  EDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149

Query: 130 ENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           ENIL  +K  +  IKIIDFGL+  F    K++   GT  ++APEV+         D+WS 
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSA 208

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GVI Y+LLSG  PF G+ +   +  V   +Y FD   +  ISDDAKD IRK+L   
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  268 bits (688), Expect = 3e-88
 Identities = 83/236 (35%), Positives = 137/236 (58%), Gaps = 9/236 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQHPRLIQIYDAF 69
           G +G V  C++K T +  A K   I K +        +  EV +++ L HP ++++YD F
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKI--IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF 105

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           E      +V+E  +GGELF+ +I       E   A+ ++Q+  GV ++H  N++H D+KP
Sbjct: 106 EDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKP 164

Query: 130 ENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN+L  +K  +  IKI+DFGL+  F+ +KK++   GT  ++APEV+         D+WS+
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSI 223

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           GVI ++LL+G  PF G+TD + +  V   +Y FD   +  +S+ AKD I+++L  D
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFD 279

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  265 bits (678), Expect = 3e-88
 Identities = 82/256 (32%), Positives = 129/256 (50%), Gaps = 21/256 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK--------RNDRRNVEREVEIMREL-QHPRLIQ 64
           G    V RC  +ATG   A K + +             R    RE  I+R++  HP +I 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           + D++ESS+ M +V +L+  GELF+ + +    L+EK     MR + E V F+H+ N++H
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-LSEKETRSIMRSLLEAVSFLHANNIVH 223

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT- 183
            D+KPENIL       +I++ DFG +   +P +KL+ L GTP ++APE++          
Sbjct: 224 RDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281

Query: 184 -----DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR 238
                D+W+ GVI + LL+G  PF     +  +  +   QY F    +++ S   KD I 
Sbjct: 282 YGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS 341

Query: 239 KLLLKD---REDAPEV 251
           +LL  D   R  A + 
Sbjct: 342 RLLQVDPEARLTAEQA 357

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  268 bits (687), Expect = 4e-88
 Identities = 87/237 (36%), Positives = 139/237 (58%), Gaps = 10/237 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN-----DRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG V  CK+K TG   A K   I+KR      D+ ++ REV+++++L HP ++++Y+ 
Sbjct: 37  GSFGEVILCKDKITGQECAVKV--ISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           FE      +V E+  GGELF+ +I      +E   A  +RQ+  G+ ++H   ++H D+K
Sbjct: 95  FEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153

Query: 129 PENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           PEN+L  +K+ +  I+IIDFGL+  F+  KK++   GT  ++APEV++        D+WS
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWS 212

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            GVI Y+LLSG  PF G  +   +  V   +Y F+   + ++S+ AKD IRK+L   
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 269

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  264 bits (677), Expect = 2e-86
 Identities = 88/247 (35%), Positives = 126/247 (51%), Gaps = 20/247 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN---------------DRRNVEREVEIMRELQ 58
           G +G V  CKEK      A K   I K                     +  E+ +++ L 
Sbjct: 47  GAYGEVLLCKEKNGHSEKAIK--VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104

Query: 59  HPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
           HP +I+++D FE      +V E  EGGELFE++I+      E   A  M+QI  G+ ++H
Sbjct: 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLH 163

Query: 119 SKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD 177
             N++H D+KPENIL   K     IKI+DFGL+  F  + KL+   GT  ++APEV+   
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-K 222

Query: 178 AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI 237
                 D+WS GVI Y+LL G  PF G+ D   +  V   +Y FD   +  ISD+AK+ I
Sbjct: 223 KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELI 282

Query: 238 RKLLLKD 244
           + +L  D
Sbjct: 283 KLMLTYD 289

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  258 bits (662), Expect = 3e-86
 Identities = 78/241 (32%), Positives = 123/241 (51%), Gaps = 14/241 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESS 72
           G F    +C  K +    A K   I+KR    N ++E+  ++  + HP ++++++ F   
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKI--ISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
               +V+EL+ GGELFER+       +E   +  MR++   V  +H   V+H D+KPEN+
Sbjct: 79  LHTFLVMELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137

Query: 133 LCLTKTGN-RIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           L   +  N  IKIIDFG AR   P+ + L+    T  + APE++N +      D+WS+GV
Sbjct: 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV 197

Query: 191 ICYVLLSGLSPFMGETDVQT-------MANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           I Y +LSG  PF       T       M  +    + F+ E +  +S +AKD I+ LL  
Sbjct: 198 ILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTV 257

Query: 244 D 244
           D
Sbjct: 258 D 258

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  257 bits (658), Expect = 9e-86
 Identities = 87/256 (33%), Positives = 140/256 (54%), Gaps = 22/256 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKR----------NDRRNVEREVEIMRELQHPRLI 63
           G  G V    E+ T   +A K   I+KR          +   NVE E+EI+++L HP +I
Sbjct: 21  GACGEVKLAFERKTCKKVAIKI--ISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           +I + F++ +   +VLEL+EGGELF++V+ +   L E    ++  Q+   V+++H   ++
Sbjct: 79  KIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGII 136

Query: 124 HLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GF 181
           H D+KPEN+L  ++  +  IKI DFG ++       ++ L GTP ++APEV+      G+
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 196

Query: 182 GT--DMWSVGVICYVLLSGLSPFMGE-TDVQTMANVTIAQYDFDDECFNEISDDAKDFIR 238
               D WS+GVI ++ LSG  PF    T V     +T  +Y+F  E + E+S+ A D ++
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 256

Query: 239 KLLLKD---REDAPEV 251
           KLL+ D   R    E 
Sbjct: 257 KLLVVDPKARFTTEEA 272

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  259 bits (664), Expect = 1e-85
 Identities = 79/242 (32%), Positives = 123/242 (50%), Gaps = 16/242 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFE-- 70
           G  G V +   K T    A K +      D     REVE+       P +++I D +E  
Sbjct: 73  GINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENL 127

Query: 71  --SSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
                 + +V+E ++GGELF R+ D  D   TE+  +  M+ I E ++++HS N+ H D+
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187

Query: 128 KPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L  +K  N  +K+ DFG A++      L     TP +VAPEV+  +      DMW
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 247

Query: 187 SVGVICYVLLSGLSPFMGETDVQT----MANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           S+GVI Y+LL G  PF     +         + + QY+F +  ++E+S++ K  IR LL 
Sbjct: 248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 307

Query: 243 KD 244
            +
Sbjct: 308 TE 309

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  257 bits (658), Expect = 2e-85
 Identities = 84/248 (33%), Positives = 134/248 (54%), Gaps = 15/248 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIM-RELQHPRLIQIYDAFESS 72
           G +    RC  KAT M  A K   I K   +R+   E+EI+ R  QHP +I + D ++  
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKI--IDKS--KRDPTEEIEILLRYGQHPNIITLKDVYDDG 88

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + VV EL++GGEL ++++   F  +E+  +  +  I + VE++H++ V+H D+KP NI
Sbjct: 89  KYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147

Query: 133 LCLTKTGN--RIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           L + ++GN   I+I DFG A++   E   L     T  FVAPEV+         D+WS+G
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207

Query: 190 VICYVLLSGLSPFMG---ETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD-- 244
           V+ Y +L+G +PF     +T  + +A +   ++      +N +SD AKD + K+L  D  
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPH 267

Query: 245 -REDAPEV 251
            R  A  V
Sbjct: 268 QRLTAALV 275

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  254 bits (650), Expect = 1e-84
 Identities = 73/261 (27%), Positives = 117/261 (44%), Gaps = 31/261 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESS 72
           G    V  C    T    A K +     + R  V REVE++ + Q H  ++++ + FE  
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           +   +V E + GG +   +        E   ++ ++ +   ++F+H+K + H D+KPENI
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLHNKGIAHRDLKPENI 142

Query: 133 LCLTKTGN-RIKIIDFGLARKFDPEK--------KLQVLFGTPEFVAPEVVNFDAIGFGT 183
           LC        +KI DF L                +L    G+ E++APEVV   +     
Sbjct: 143 LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202

Query: 184 -----DMWSVGVICYVLLSGLSPFMGETDVQT---------------MANVTIAQYDFDD 223
                D+WS+GVI Y+LLSG  PF+G                       ++   +Y+F D
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD 262

Query: 224 ECFNEISDDAKDFIRKLLLKD 244
           + +  IS  AKD I KLL++D
Sbjct: 263 KDWAHISCAAKDLISKLLVRD 283

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  253 bits (647), Expect = 6e-84
 Identities = 83/242 (34%), Positives = 124/242 (51%), Gaps = 17/242 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIM-RELQHPRLIQIYDAFESS 72
           G  G V  C  + TG   A K +      D     +EV+   +    P ++ I D +E+ 
Sbjct: 40  GVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCILDVYENM 94

Query: 73  NVMC----VVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           +       +++E +EGGELF R+ +  D   TE+  A  MR I   ++F+HS N+ H D+
Sbjct: 95  HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDV 154

Query: 128 KPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L  +K  +  +K+ DFG A++      LQ    TP +VAPEV+  +      DMW
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMW 213

Query: 187 SVGVICYVLLSGLSPFMGETDVQT----MANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           S+GVI Y+LL G  PF   T           + + QY F +  ++E+S+DAK  IR LL 
Sbjct: 214 SLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLK 273

Query: 243 KD 244
            D
Sbjct: 274 TD 275

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  255 bits (652), Expect = 1e-83
 Identities = 84/256 (32%), Positives = 142/256 (55%), Gaps = 22/256 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKR----------NDRRNVEREVEIMRELQHPRLI 63
           G  G V    E+ T   +A +   I+KR          +   NVE E+EI+++L HP +I
Sbjct: 146 GACGEVKLAFERKTCKKVAIRI--ISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 203

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           +I + F++ +   +VLEL+EGGELF++V+ +   L E    ++  Q+   V+++H   ++
Sbjct: 204 KIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGII 261

Query: 124 HLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV-NFDAIGF 181
           H D+KPEN+L  ++  +  IKI DFG ++       ++ L GTP ++APEV+ +    G+
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 321

Query: 182 GT--DMWSVGVICYVLLSGLSPFMGETDVQTMAN-VTIAQYDFDDECFNEISDDAKDFIR 238
               D WS+GVI ++ LSG  PF       ++ + +T  +Y+F  E + E+S+ A D ++
Sbjct: 322 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 381

Query: 239 KLLLKD---REDAPEV 251
           KLL+ D   R    E 
Sbjct: 382 KLLVVDPKARFTTEEA 397

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  221 bits (566), Expect = 3e-72
 Identities = 73/242 (30%), Positives = 113/242 (46%), Gaps = 37/242 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFE-- 70
           G  G V +   K T    A K +      D     REVE+     Q P +++I D +E  
Sbjct: 29  GINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENL 83

Query: 71  --SSNVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
                 + +V+E ++GGELF R+ D  D   TE+  +  M+ I E ++++HS N+ H D+
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143

Query: 128 KPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L  +K  N  +K+ DFG A                     E    +      DMW
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFA--------------------KETTG-EKYDKSCDMW 182

Query: 187 SVGVICYVLLSGLSPFMGETDVQT----MANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           S+GVI Y+LL G  PF     +         + + QY+F +  ++E+S++ K  IR LL 
Sbjct: 183 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 242

Query: 243 KD 244
            +
Sbjct: 243 TE 244

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  217 bits (554), Expect = 1e-70
 Identities = 83/235 (35%), Positives = 131/235 (55%), Gaps = 10/235 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G F  VYR +   TG+ +A K +    + K    + V+ EV+I  +L+HP ++++Y+ FE
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            SN + +VLE+   GE+   + +     +E     FM QI  G+ ++HS  +LH D+   
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141

Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N+L LT+  N IKI DFGLA +   P +K   L GTP +++PE+    A G  +D+WS+G
Sbjct: 142 NLL-LTRNMN-IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLG 199

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            + Y LL G  PF  +T   T+  V +A Y+        +S +AKD I +LL ++
Sbjct: 200 CMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIEAKDLIHQLLRRN 250

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  218 bits (558), Expect = 1e-70
 Identities = 73/235 (31%), Positives = 111/235 (47%), Gaps = 11/235 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G F   +   +  T    A K V    + K + R  +  E+ I R L H  ++  +  FE
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + VVLEL     L E        LTE     ++RQI  G +++H   V+H D+K  
Sbjct: 112 DNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170

Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N+  L +    +KI DFGLA K +   ++ +VL GTP ++APEV++     F  D+WS+G
Sbjct: 171 NLF-LNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            I Y LL G  PF      +T   +   +Y         I+  A   I+K+L  D
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTD 279

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  218 bits (556), Expect = 2e-70
 Identities = 51/292 (17%), Positives = 109/292 (37%), Gaps = 50/292 (17%)

Query: 1   MTTHQNQHSAFSFGK------FGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREV 51
           M +    +  +             V+R + K TG   A K       +         RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKV--FNNISFLRPVDVQMREF 58

Query: 52  EIMRELQHPRLIQIYDAFE--SSNVMCVVLELIEGGELFERVIDD--DFVLTEKAVAIFM 107
           E++++L H  +++++   E  ++    +++E    G L+  + +    + L E    I +
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR--IKIIDFGLARKFDPEKKLQVLFGT 165
           R +  G+  +    ++H ++KP NI+ +     +   K+ DFG AR+ + +++   L+GT
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT 178

Query: 166 PEFVAPEVVNFDAI--------GFGTDMWSVGVICYVLLSGLSPF----MGETDVQTMAN 213
            E++ P++     +        G   D+WS+GV  Y   +G  PF        + + M  
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 214 VTIAQYDFDDECFNE---------------------ISDDAKDFIRKLLLKD 244
           +   +         +                     +       +  +L  D
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  216 bits (552), Expect = 5e-70
 Identities = 73/235 (31%), Positives = 111/235 (47%), Gaps = 11/235 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G F   +   +  T    A K V    + K + R  +  E+ I R L H  ++  +  FE
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + VVLEL     L E        LTE     ++RQI  G +++H   V+H D+K  
Sbjct: 86  DNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 144

Query: 131 NILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N+  L +    +KI DFGLA K +   ++ +VL GTP ++APEV++     F  D+WS+G
Sbjct: 145 NLF-LNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            I Y LL G  PF      +T   +   +Y         I+  A   I+K+L  D
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTD 253

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  212 bits (542), Expect = 2e-68
 Identities = 57/260 (21%), Positives = 104/260 (40%), Gaps = 34/260 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF---- 69
           G FG V + +        A K +   +      +  EV ++  L H  +++ Y A+    
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAWLERR 75

Query: 70  ---------ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
                    +  + + + +E  E G L++ +  ++            RQI E + +IHS+
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD---------------PEKKLQVLFGT 165
            ++H D+KP NI  + ++ N +KI DFGLA+                      L    GT
Sbjct: 136 GIIHRDLKPMNIF-IDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGT 193

Query: 166 PEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE 224
             +VA EV++         DM+S+G+I + ++       G   V  +  +     +F  +
Sbjct: 194 AMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPPD 251

Query: 225 CFNEISDDAKDFIRKLLLKD 244
             +      K  IR L+  D
Sbjct: 252 FDDNKMKVEKKIIRLLIDHD 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  211 bits (540), Expect = 2e-68
 Identities = 71/234 (30%), Positives = 120/234 (51%), Gaps = 11/234 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K      + REVEI   L+HP ++++Y  F 
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++  +        E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 80  DATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L L   G  +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 139 NLL-LGSAGE-LKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 195

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +
Sbjct: 196 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHN 245

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  214 bits (547), Expect = 3e-68
 Identities = 52/272 (19%), Positives = 112/272 (41%), Gaps = 29/272 (10%)

Query: 1   MTTHQNQHSAFSFGK------FGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REV 51
           M +    +  +             V+R + K TG   A K       +  R V+   RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKV--FNNISFLRPVDVQMREF 58

Query: 52  EIMRELQHPRLIQIYDAFE--SSNVMCVVLELIEGGELFERVIDD--DFVLTEKAVAIFM 107
           E++++L H  +++++   E  ++    +++E    G L+  + +    + L E    I +
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 108 RQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR--IKIIDFGLARKFDPEKKLQVLFGT 165
           R +  G+  +    ++H ++KP NI+ +     +   K+ DFG AR+ + +++   L+GT
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT 178

Query: 166 PEFVAPEVVNFDAI--------GFGTDMWSVGVICYVLLSGLSPF----MGETDVQTMAN 213
            E++ P++     +        G   D+WS+GV  Y   +G  PF        + + M  
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           +   +         +  +   D+   + +   
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  206 bits (526), Expect = 2e-66
 Identities = 69/234 (29%), Positives = 116/234 (49%), Gaps = 11/234 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK     +A K +    + K      + RE+EI   L+HP ++++Y+ F 
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + ++LE    GEL++ +        E+  A FM ++ + + + H + V+H D+KPE
Sbjct: 85  DRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L +   G  +KI DFG +    P  + + + GT +++ PE++         D+W  GV
Sbjct: 144 NLL-MGYKGE-LKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 200

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +CY  L G+ PF   +  +T   +      F       +SD +KD I KLL   
Sbjct: 201 LCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYH 250

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  206 bits (526), Expect = 6e-66
 Identities = 53/260 (20%), Positives = 109/260 (41%), Gaps = 30/260 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHP--RLIQIYDAF 69
           G    V++   +      A K+V + + +     +   E+  + +LQ    ++I++YD  
Sbjct: 39  GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            +   + +V+E     +L    +     +       + + + E V  IH   ++H D+KP
Sbjct: 98  ITDQYIYMVMEC-GNIDLNS-WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEFVAPEVV-----------N 175
            N L +      +K+IDFG+A +  P+    V     GT  ++ PE +           +
Sbjct: 156 ANFL-IVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETD-VQTMANVTIAQYDFDDECFNEISDDAK 234
              I   +D+WS+G I Y +  G +PF    + +  +  +    ++ +    +    D +
Sbjct: 213 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQ 270

Query: 235 DFIRKLLLKD---REDAPEV 251
           D ++  L +D   R   PE+
Sbjct: 271 DVLKCCLKRDPKQRISIPEL 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  204 bits (520), Expect = 1e-64
 Identities = 53/260 (20%), Positives = 109/260 (41%), Gaps = 30/260 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHP--RLIQIYDAF 69
           G    V++   +      A K+V + + +     +   E+  + +LQ    ++I++YD  
Sbjct: 20  GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            +   + +V+E     +L    +     +       + + + E V  IH   ++H D+KP
Sbjct: 79  ITDQYIYMVMEC-GNIDLNS-WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEFVAPEVV-----------N 175
            N L +      +K+IDFG+A +  P+    V     GT  ++ PE +           +
Sbjct: 137 ANFL-IVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETD-VQTMANVTIAQYDFDDECFNEISDDAK 234
              I   +D+WS+G I Y +  G +PF    + +  +  +    ++ +    +    D +
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQ 251

Query: 235 DFIRKLLLKD---REDAPEV 251
           D ++  L +D   R   PE+
Sbjct: 252 DVLKCCLKRDPKQRISIPEL 271

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  205 bits (524), Expect = 2e-64
 Identities = 63/253 (24%), Positives = 108/253 (42%), Gaps = 21/253 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESS 72
           G  GT+   +       +A K             +REV+++RE  +HP +I+ +   +  
Sbjct: 35  GAEGTIV-YRGMFDNRDVAVK---RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR 90

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
               + +EL     L E V   DF          ++Q   G+  +HS N++H D+KP NI
Sbjct: 91  QFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149

Query: 133 LCLTKTGN---RIKIIDFGLARKFDPEK----KLQVLFGTPEFVAPEVVNFDAIGFGT-- 183
           L      +   +  I DFGL +K    +    +   + GT  ++APE+++ D     T  
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209

Query: 184 -DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-ECFNEISDDAKDFIRKLL 241
            D++S G + Y ++S  S   G++  Q  AN+ +     D           A++ I K++
Sbjct: 210 VDIFSAGCVFYYVISEGSHPFGKSL-QRQANILLGACSLDCLHPEKHEDVIARELIEKMI 268

Query: 242 LKD---REDAPEV 251
             D   R  A  V
Sbjct: 269 AMDPQKRPSAKHV 281

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  210 bits (536), Expect = 4e-64
 Identities = 53/233 (22%), Positives = 101/233 (43%), Gaps = 14/233 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G FG V R   + TG  +A K     +    +N E    E++IM++L HP ++   +  +
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIKQ--CRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82

Query: 71  SSN------VMCVVLELIEGGELFERVID--DDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
                    +  + +E  EGG+L + +    +   L E  +   +  I   + ++H   +
Sbjct: 83  GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRI 142

Query: 123 LHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
           +H D+KPENI+          KIID G A++ D  +      GT +++APE++       
Sbjct: 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTV 202

Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK 234
             D WS G + +  ++G  PF+              + +     +++++   K
Sbjct: 203 TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 255

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  202 bits (515), Expect = 2e-63
 Identities = 52/260 (20%), Positives = 108/260 (41%), Gaps = 30/260 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHP--RLIQIYDAF 69
           G    V++   +      A K+V + + +     +   E+  + +LQ    ++I++YD  
Sbjct: 67  GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
            +   + +V+E     +L    +     +       + + + E V  IH   ++H D+KP
Sbjct: 126 ITDQYIYMVMEC-GNIDLNS-WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEFVAPEVV-----------N 175
            N L +      +K+IDFG+A +  P+    V     G   ++ PE +           +
Sbjct: 184 ANFL-IVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETD-VQTMANVTIAQYDFDDECFNEISDDAK 234
              I   +D+WS+G I Y +  G +PF    + +  +  +    ++ +    +    D +
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQ 298

Query: 235 DFIRKLLLKD---REDAPEV 251
           D ++  L +D   R   PE+
Sbjct: 299 DVLKCCLKRDPKQRISIPEL 318

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  197 bits (503), Expect = 4e-62
 Identities = 60/245 (24%), Positives = 118/245 (48%), Gaps = 12/245 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G FG     K    G     K + I++ +  +R    REV ++  ++HP ++Q  ++FE 
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94

Query: 72  SNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +  + +V++  EGG+LF+R+     V   E  +  +  QIC  ++ +H + +LH D+K +
Sbjct: 95  NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           NI  LTK G  +++ DFG+AR  +   +L +   GTP +++PE+         +D+W++G
Sbjct: 155 NIF-LTKDGT-VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALG 212

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD---RE 246
            + Y L +    F   +    +  +    +      +   S D +  + +L  ++   R 
Sbjct: 213 CVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY---SYDLRSLVSQLFKRNPRDRP 269

Query: 247 DAPEV 251
               +
Sbjct: 270 SVNSI 274

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  194 bits (495), Expect = 2e-61
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 12/234 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMREL-QHPRLIQIYDAFE 70
           G +G V++ + K  G   A K      R   DR     EV    ++ QHP  +++  A+E
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              ++ +  EL  G  L +        L E  V  ++R     +  +HS+ ++HLD+KP 
Sbjct: 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           NI  L   G R K+ DFGL  +       +V  G P ++APE++   + G   D++S+G+
Sbjct: 187 NIF-LGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGL 243

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
               +   +    G    Q +            E    +S + +  +  +L  D
Sbjct: 244 TILEVACNMELPHGGEGWQQLRQG-----YLPPEFTAGLSSELRSVLVMMLEPD 292

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  191 bits (488), Expect = 1e-60
 Identities = 63/254 (24%), Positives = 121/254 (47%), Gaps = 21/254 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAF-- 69
           G +G   + + K+ G  L  K +        +++ +  EV ++REL+HP +++ YD    
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76

Query: 70  ESSNVMCVVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKN----- 121
            ++  + +V+E  EGG+L   +     +   L E+ V   M Q+   ++  H ++     
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-QVLFGTPEFVAPEVVNFDAIG 180
           VLH D+KP N+  L    N +K+ DFGLAR  + +    +   GTP +++PE +N  +  
Sbjct: 137 VLHRDLKPANVF-LDGKQN-VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN 194

Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
             +D+WS+G + Y L + + PF   +  +    +   ++      +   SD+  + I ++
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY---SDELNEIITRM 251

Query: 241 LLKD---REDAPEV 251
           L      R    E+
Sbjct: 252 LNLKDYHRPSVEEI 265

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  193 bits (492), Expect = 2e-60
 Identities = 52/274 (18%), Positives = 117/274 (42%), Gaps = 48/274 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV-----------------GIAKRNDRRNVEREVEIMRE 56
           GKF  +  C++       A K                    I+ ++   + + E++I+ +
Sbjct: 42  GKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99

Query: 57  LQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-------LTEKAVAIFMRQ 109
           +++   +       + + + ++ E +E   + +       +       +  + +   ++ 
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS 159

Query: 110 ICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF 168
           +     +IH+ KN+ H D+KP NIL + K G  +K+ DFG + ++  +KK++   GT EF
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNIL-MDKNGR-VKLSDFGES-EYMVDKKIKGSRGTYEF 216

Query: 169 VAPEVVNFDAI--GFGTDMWSVGVICYVLLSGLSPFMGETDVQTM-ANVTIAQYDF---- 221
           + PE  + ++   G   D+WS+G+  YV+   + PF  +  +  +  N+     ++    
Sbjct: 217 MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276

Query: 222 -----------DDECFNEISDDAKDFIRKLLLKD 244
                           N +S++  DF++  L K+
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  190 bits (485), Expect = 7e-60
 Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 28/262 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF---- 69
           G F  V   +    G   A K +   ++ DR   +RE ++ R   HP ++++        
Sbjct: 40  GGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99

Query: 70  ESSNVMCVVLELIEGGELF---ERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            + +   ++L   + G L+   ER+ D    LTE  +   +  IC G+E IH+K   H D
Sbjct: 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRD 159

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKK-------LQVL---FGTPEFVAPEVVNF 176
           +KP NIL L   G    ++D G   +     +       LQ       T  + APE+ + 
Sbjct: 160 LKPTNIL-LGDEGQ-PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217

Query: 177 ---DAIGFGTDMWSVGVICYVLLSGLSPFMGET-DVQTMANVTIAQYDFDDECFNEISDD 232
                I   TD+WS+G + Y ++ G  P+        ++A     Q           S  
Sbjct: 218 QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ--SPRHSSA 275

Query: 233 AKDFIRKLLLKD---REDAPEV 251
               +  ++  D   R   P +
Sbjct: 276 LWQLLNSMMTVDPHQRPHIPLL 297

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  188 bits (481), Expect = 1e-59
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 11/235 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   + + TG  +A K +    I   +    ++RE++ ++  +HP +I++Y    
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +     +V+E + GGELF+ +      + E       +QI   V++ H   V+H D+KPE
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPE 140

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA-IGFGTDMWSVG 189
           N+L L    N  KI DFGL+      + L+   G+P + APEV++     G   D+WS G
Sbjct: 141 NVL-LDAHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           VI Y LL G  PF  E        +    +         ++      +  +L  D
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVF----YIPEYLNRSVATLLMHMLQVD 249

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  193 bits (492), Expect = 1e-59
 Identities = 67/275 (24%), Positives = 111/275 (40%), Gaps = 44/275 (16%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESS 72
           G  GTV   +    G  +A K       +       E++++ E   HP +I+ Y +  + 
Sbjct: 26  GSSGTVV-FQGSFQGRPVAVK---RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81

Query: 73  NVMCVVLELIEGGELFERVIDDDF------VLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
             + + LEL     L + V   +       +  E      +RQI  GV  +HS  ++H D
Sbjct: 82  RFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRD 140

Query: 127 MKPENILCLTKTGN-----------RIKIIDFGLARKFDPEK-----KLQVLFGTPEFVA 170
           +KP+NIL  T +             RI I DFGL +K D  +      L    GT  + A
Sbjct: 141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRA 200

Query: 171 PEVVNFDAIGFGT-------DMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD 222
           PE++                D++S+G + Y +LS G  PF  +      +N+    +  D
Sbjct: 201 PELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--RESNIIRGIFSLD 258

Query: 223 D---ECFNEISDDAKDFIRKLLLKD---REDAPEV 251
           +        +  +A D I +++  D   R  A +V
Sbjct: 259 EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  188 bits (480), Expect = 6e-59
 Identities = 71/234 (30%), Positives = 121/234 (51%), Gaps = 10/234 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G F  V   +   TG  +A K +   + N    + + REV IM+ L HP ++++++  E+
Sbjct: 26  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +++E   GGE+F+ ++    +  ++A + F RQI   V++ H K ++H D+K EN
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-RQIVSAVQYCHQKRIVHRDLKAEN 144

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA-IGFGTDMWSVGV 190
           +L L    N IKI DFG + +F    KL    G P + APE+       G   D+WS+GV
Sbjct: 145 LL-LDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 202

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           I Y L+SG  PF G+   +    V   +Y         +S D ++ +++ L+ +
Sbjct: 203 ILYTLVSGSLPFDGQNLKELRERVLRGKY----RIPFYMSTDCENLLKRFLVLN 252

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  189 bits (481), Expect = 9e-59
 Identities = 69/238 (28%), Positives = 116/238 (48%), Gaps = 13/238 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG     ++K T   +A K++      D  NV+RE+   R L+HP +++  +   +  
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRFKEVILTPT 89

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GGEL+ER+ +     +E     F +Q+  GV + HS  + H D+K EN L
Sbjct: 90  HLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN---FDAIGFGTDMWSVGV 190
                  R+KI DFG ++      + +   GTP ++APEV+    +D  G   D+WS GV
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD--GKIADVWSCGV 206

Query: 191 ICYVLLSGLSPFMGETDVQ----TMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
             YV+L G  PF    + +    T+  +   +Y   D+    IS +    I ++ + D
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCHLISRIFVAD 262

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  186 bits (475), Expect = 3e-58
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 12/248 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND---RRNVEREVEIMRELQHPRLIQIYDAFE 70
           G+F  VYR      G+ +A K V I    D   R +  +E++++++L HP +I+ Y +F 
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102

Query: 71  SSNVMCVVLELIEGGELFERV---IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
             N + +VLEL + G+L   +        ++ E+ V  +  Q+C  +E +HS+ V+H D+
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDI 162

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KP N+  +T TG  +K+ D GL R F  +      L GTP +++PE ++ +   F +D+W
Sbjct: 163 KPANVF-ITATGV-VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD-- 244
           S+G + Y + +  SPF G+          I Q D+     +  S++ +  +   +  D  
Sbjct: 221 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPE 280

Query: 245 -REDAPEV 251
            R D   V
Sbjct: 281 KRPDVTYV 288

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  185 bits (472), Expect = 3e-58
 Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 31/255 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE--- 70
           G FG V++ K +  G T   K V    + +    EREV+ + +L H  ++     ++   
Sbjct: 22  GGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77

Query: 71  -------------SSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEF 116
                         +  + + +E  + G L + +       L +        QI +GV++
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137

Query: 117 IHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF 176
           IHSK +++ D+KP NI  L  T   +KI DFGL      + K     GT  +++PE ++ 
Sbjct: 138 IHSKKLINRDLKPSNIF-LVDTKQ-VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS 195

Query: 177 DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF 236
              G   D++++G+I   LL         +   T     +      D          K  
Sbjct: 196 QDYGKEVDLYALGLILAELLHVCDTAFETSKFFT----DLRDGIISD----IFDKKEKTL 247

Query: 237 IRKLLLKDREDAPEV 251
           ++KLL K  ED P  
Sbjct: 248 LQKLLSKKPEDRPNT 262

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  185 bits (471), Expect = 4e-58
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 13/238 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +  D   N+++E+ I + L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R+  D   + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEFVAPEVVN---FDAIGFGTDMW 186
           L L +  N +KI DFGLA  F    + ++L    GT  +VAPE++    F       D+W
Sbjct: 137 L-LDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH--AEPVDVW 192

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           S G++   +L+G  P+   +D     +    +       + +I       + K+L+++
Sbjct: 193 SCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEKKTYLNPWKKIDSAPLALLHKILVEN 249

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  183 bits (467), Expect = 6e-57
 Identities = 75/235 (31%), Positives = 119/235 (50%), Gaps = 12/235 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V       T   +A KF+    + K +    VERE+  ++ L+HP +I++YD   
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +   + +V+E   GGELF+ +++    +TE     F +QI   +E+ H   ++H D+KPE
Sbjct: 80  TPTDIVMVIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA-IGFGTDMWSVG 189
           N+L L    N +KI DFGL+        L+   G+P + APEV+N     G   D+WS G
Sbjct: 138 NLL-LDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           ++ YV+L G  PF  E        V    Y       + +S  A+  IR++++ D
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSCVY----VMPDFLSPGAQSLIRRMIVAD 246

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  182 bits (463), Expect = 2e-56
 Identities = 66/238 (27%), Positives = 113/238 (47%), Gaps = 13/238 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +  D   N+++E+ I + L H  +++ Y      
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R+  D   + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 78  NIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEFVAPEVVN---FDAIGFGTDMW 186
           L L +  N +KI DFGLA  F    + ++L    GT  +VAPE++    F       D+W
Sbjct: 137 L-LDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH--AEPVDVW 192

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           S G++   +L+G  P+   +D          +       + +I       + K+L+++
Sbjct: 193 SCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEKKTYLNPWKKIDSAPLALLHKILVEN 249

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  181 bits (461), Expect = 2e-56
 Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 25/246 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK----RNDRRNVEREVEIMRELQHPRLIQIYD-- 67
           G +G V    +  T    A K +   K     N   NV++E++++R L+H  +IQ+ D  
Sbjct: 16  GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL 75

Query: 68  AFESSNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
             E    M +V+E    G  E+ + V +            +  Q+ +G+E++HS+ ++H 
Sbjct: 76  YNEEKQKMYMVMEYCVCGMQEMLDSVPEK--RFPVCQAHGYFCQLIDGLEYLHSQGIVHK 133

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEFVAPEVVN----FDA 178
           D+KP N+L LT  G  +KI   G+A    P           G+P F  PE+ N    F  
Sbjct: 134 DIKPGNLL-LTTGGT-LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS- 190

Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR 238
            GF  D+WS GV  Y + +GL PF G+   +   N+    Y        +      D ++
Sbjct: 191 -GFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY----AIPGDCGPPLSDLLK 245

Query: 239 KLLLKD 244
            +L  +
Sbjct: 246 GMLEYE 251

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  186 bits (473), Expect = 2e-56
 Identities = 69/235 (29%), Positives = 113/235 (48%), Gaps = 11/235 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   K + TG  +A K +    I   +    + RE++ ++  +HP +I++Y    
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           + + + +V+E + GGELF+ +  +   L EK      +QI  GV++ H   V+H D+KPE
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPE 145

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA-IGFGTDMWSVG 189
           N+L L    N  KI DFGL+      + L+   G+P + APEV++     G   D+WS G
Sbjct: 146 NVL-LDAHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSG 203

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           VI Y LL G  PF  +        +    +         ++      ++ +L  D
Sbjct: 204 VILYALLCGTLPFDDDHVPTLFKKICDGIF----YTPQYLNPSVISLLKHMLQVD 254

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  180 bits (457), Expect = 4e-55
 Identities = 37/275 (13%), Positives = 68/275 (24%), Gaps = 45/275 (16%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G    V+  ++       A K   +   N R  +E           L      +  D   
Sbjct: 73  GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132

Query: 71  SSNVM--------------------------CVVLELIEG-----GELFERVIDDDFVLT 99
                                           +++              + V        
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192

Query: 100 EKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL 159
             A+ I   Q+      + SK ++H    P+N+  +   G R+ + D     K     + 
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF-IMPDG-RLMLGDVSALWKVG--TRG 248

Query: 160 QVLFGTPEFVAPEVVNFDAIGFG--TDMWSVGVICYVLLSGLSPFMGET-----DVQTMA 212
                   +   E +N     F    + W +G+  Y +     PF   T       +  +
Sbjct: 249 PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308

Query: 213 NVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
                           + D  K  I + L  DR  
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR 343

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  178 bits (454), Expect = 5e-55
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 23/241 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV--------GIAKRNDRRNVEREVEIMRELQHPRLIQI 65
           G FG V+   +K     +  KF+           +      V  E+ I+  ++H  +I++
Sbjct: 35  GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94

Query: 66  YDAFESSNVMCVVLEL-IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
            D FE+     +V+E    G +LF   ID    L E   +   RQ+   V ++  K+++H
Sbjct: 95  LDIFENQGFFQLVMEKHGSGLDLFAF-IDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIH 153

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA-IGFGT 183
            D+K ENI+ + +    IK+IDFG A   +  K      GT E+ APEV+  +   G   
Sbjct: 154 RDIKDENIV-IAEDFT-IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPEL 211

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           +MWS+GV  Y L+   +PF    +         A           +S +    +  LL  
Sbjct: 212 EMWSLGVTLYTLVFEENPFCELEETVE------AAI----HPPYLVSKELMSLVSGLLQP 261

Query: 244 D 244
            
Sbjct: 262 V 262

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  175 bits (447), Expect = 2e-54
 Identities = 65/263 (24%), Positives = 122/263 (46%), Gaps = 38/263 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV--------------------------GIAKRNDRRNV 47
           G +G V     +      A K +                           I  R     V
Sbjct: 24  GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83

Query: 48  EREVEIMRELQHPRLIQIYDAFE--SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI 105
            +E+ I+++L HP ++++ +  +  + + + +V EL+  G + E        L+E     
Sbjct: 84  YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARF 141

Query: 106 FMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFG 164
           + + + +G+E++H + ++H D+KP N+L + + G+ IKI DFG++ +F   +  L    G
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLL-VGEDGH-IKIADFGVSNEFKGSDALLSNTVG 199

Query: 165 TPEFVAPEVVNFDA---IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF 221
           TP F+APE ++       G   D+W++GV  Y  + G  PFM E  +   + +     +F
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF 259

Query: 222 DDECFNEISDDAKDFIRKLLLKD 244
            D    +I++D KD I ++L K+
Sbjct: 260 PD--QPDIAEDLKDLITRMLDKN 280

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  175 bits (447), Expect = 4e-54
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 23/241 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRN---VEREVEIMRELQH--PRLIQI 65
           G FG+VY     +  + +A K V    I+   +  N   V  EV +++++      +I++
Sbjct: 54  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113

Query: 66  YDAFESSNVMCVVLELIEG-GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
            D FE  +   ++LE  E   +LF+ + +    L E+    F  Q+ E V   H+  VLH
Sbjct: 114 LDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLH 172

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA-IGFGT 183
            D+K ENIL     G  +K+IDFG       +       GT  +  PE + +    G   
Sbjct: 173 RDIKDENILIDLNRGE-LKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 230

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
            +WS+G++ Y ++ G  PF  + ++     V   Q          +S + +  IR  L  
Sbjct: 231 AVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQR---------VSSECQHLIRWCLAL 280

Query: 244 D 244
            
Sbjct: 281 R 281

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  172 bits (438), Expect = 8e-53
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 25/243 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV------GIAKRNDRRNVEREVEIMREL----QHPRLI 63
           G FGTV+        + +A K +      G +  +D      EV ++ ++     HP +I
Sbjct: 42  GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101

Query: 64  QIYDAFESSNVMCVVLEL-IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
           ++ D FE+     +VLE  +   +LF+ + +    L E     F  Q+   ++  HS+ V
Sbjct: 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGV 160

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA-IGF 181
           +H D+K ENIL   + G   K+IDFG       ++      GT  +  PE ++       
Sbjct: 161 VHRDIKDENILIDLRRGC-AKLIDFGSGA-LLHDEPYTDFDGTRVYSPPEWISRHQYHAL 218

Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
              +WS+G++ Y ++ G  PF  + ++   A +    +         +S D    IR+ L
Sbjct: 219 PATVWSLGILLYDMVCGDIPFERDQEILE-AELHFPAH---------VSPDCCALIRRCL 268

Query: 242 LKD 244
              
Sbjct: 269 APK 271

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  172 bits (438), Expect = 3e-52
 Identities = 37/280 (13%), Positives = 78/280 (27%), Gaps = 59/280 (21%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQ------------ 58
                     ++ TG +              N  + ++ EV  +R L+            
Sbjct: 84  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143

Query: 59  -------------HPRLIQIYDAFESSNVMCVVL-------ELIEGGELFERVIDDDFVL 98
                          ++I++        V+            L   GE+          L
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203

Query: 99  TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK 158
              A      Q+   +  +H   ++H  ++P +I+ L + G  + +  F    +      
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV-LDQRGG-VFLTGFEHLVRDGARVV 261

Query: 159 LQVLFGTPEFVAPEVVNFDAI-----------GFGTDMWSVGVICYVLLSGLSPFMGETD 207
                 +  F  PE+    A             F  D W++G++ Y +     P   +  
Sbjct: 262 SS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318

Query: 208 VQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           +         ++ F       I    +  +   L   +ED
Sbjct: 319 LGGS------EWIFRSC--KNIPQPVRALLEGFLRYPKED 350

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  166 bits (422), Expect = 2e-50
 Identities = 61/266 (22%), Positives = 111/266 (41%), Gaps = 35/266 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG V+  K K      A K + +  R   R  V REV+ + +L+HP +++ ++A+   
Sbjct: 16  GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75

Query: 73  N------------VMCVVLELIEGGELFERVIDDDFV--LTEKAVAIFMRQICEGVEFIH 118
           N             + + ++L     L + +     +             QI E VEF+H
Sbjct: 76  NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH 135

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-------------GT 165
           SK ++H D+KP NI   T     +K+ DFGL    D +++ Q +              GT
Sbjct: 136 SKGLMHRDLKPSNIF-FTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193

Query: 166 PEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC 225
             +++PE ++ ++     D++S+G+I + L   L PF  + +        +    F    
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPFSTQMERVRTLTD-VRNLKFPPL- 248

Query: 226 FNEISDDAKDFIRKLLLKDREDAPEV 251
           F +        ++ +L     + PE 
Sbjct: 249 FTQKYPCEYVMVQDMLSPSPMERPEA 274

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  164 bits (417), Expect = 9e-49
 Identities = 39/276 (14%), Positives = 80/276 (28%), Gaps = 52/276 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAK---FVGIAKRNDRRNVEREVEIMRELQ------------ 58
                     ++ TG +       F      N  + ++ EV  +R L+            
Sbjct: 89  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148

Query: 59  -------------HPRLIQIYDAFESSNVMCVVL-------ELIEGGELFERVIDDDFVL 98
                          ++I++        V+            L   GE+          L
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208

Query: 99  TEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK 158
              A      Q+   +  +H   ++H  ++P +I+ L + G  + +  F    +      
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV-LDQRG-GVFLTGFEHLVRDGASAV 266

Query: 159 LQV--LFGTPEFVAPEVVNFD-----AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM 211
             +   F  PE  A  ++ F       + F  D W++G+  Y +     P   +  +   
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 212 ANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
             +      F       I    +  +   L   +ED
Sbjct: 327 EWI------FRSC--KNIPQPVRALLEGFLRYPKED 354

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  161 bits (410), Expect = 1e-48
 Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 31/253 (12%)

Query: 11  FSFGK------FGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPR 61
           F FGK      F TV   +E AT    A K +    I K N    V RE ++M  L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 62  LIQIYDAFESSNVMCVVLELIEGGELF-----ERVIDDDFVLTEKAVAIF-MRQICEGVE 115
            +++Y  F+    +   L   + GEL          D+           F   +I   +E
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAEIVSALE 144

Query: 116 FIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV---LFGTPEFVAPE 172
           ++H K ++H D+KPENIL L +  + I+I DFG A+   PE K        GT ++V+PE
Sbjct: 145 YLHGKGIIHRDLKPENIL-LNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 173 VVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD 232
           ++   +    +D+W++G I Y L++GL PF    +      +   +YDF +    +    
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPK 258

Query: 233 AKDFIRKLLLKDR 245
           A+D + KLL+ D 
Sbjct: 259 ARDLVEKLLVLDA 271

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  162 bits (411), Expect = 2e-48
 Identities = 40/259 (15%), Positives = 78/259 (30%), Gaps = 29/259 (11%)

Query: 14  GKFGTVYRCKEKA-----TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G F  VY   +              K    A   +     + +E ++       ++ Y A
Sbjct: 76  GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135

Query: 69  FESSNVMCVVLELIEGGELFERV----IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
               N   +V EL   G L   +       + V+ +  V  F  ++   +E +H   ++H
Sbjct: 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIH 195

Query: 125 LDMKPENILCLTKTGNR---------IKIIDFGLA---RKFDPEKKLQVLFGTPEFVAPE 172
            D+KP+N +       +         + +ID G +   + F           T  F   E
Sbjct: 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255

Query: 173 VVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD 232
           +++     +  D + V    Y +L G    +     +        +    D         
Sbjct: 256 MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMW------- 308

Query: 233 AKDFIRKLLLKDREDAPEV 251
             +F   +L          
Sbjct: 309 -NEFFHVMLNIPDCHHLPS 326

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  160 bits (406), Expect = 3e-48
 Identities = 59/243 (24%), Positives = 116/243 (47%), Gaps = 11/243 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G +G VY  ++ +  + +A K +        + +  E+ + + L+H  ++Q   +F  + 
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92

Query: 74  VMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            + + +E + GG L    R         E+ +  + +QI EG++++H   ++H D+K +N
Sbjct: 93  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 152

Query: 132 ILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGT--DMWSV 188
           +L  T +G  +KI DFG +++        +   GT +++APE+++    G+G   D+WS+
Sbjct: 153 VLINTYSGV-LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL 211

Query: 189 GVICYVL--LSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           G  C ++   +G  PF  E      A   +  +    E    +S +AK FI K    D +
Sbjct: 212 G--CTIIEMATGKPPF-YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPD 268

Query: 247 DAP 249
              
Sbjct: 269 KRA 271

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  162 bits (412), Expect = 3e-48
 Identities = 64/242 (26%), Positives = 123/242 (50%), Gaps = 16/242 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   ++  T    A K++      +RN+ RNV +E++IM+ L+HP L+ ++ +F+
Sbjct: 26  GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               M +V++L+ GG+L    +  +    E+ V +F+ ++   ++++ ++ ++H DMKP+
Sbjct: 86  DEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPD 144

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI---GFGTDMWS 187
           NIL L + G+ + I DF +A     E ++  + GT  ++APE+ +        F  D WS
Sbjct: 145 NIL-LDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202

Query: 188 VGVICYVLLSGLSPFMGETD---VQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +GV  Y LL G  P+   +     + +         +        S +    ++KLL  +
Sbjct: 203 LGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKLLEPN 258

Query: 245 RE 246
            +
Sbjct: 259 PD 260

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  161 bits (409), Expect = 3e-48
 Identities = 68/245 (27%), Positives = 107/245 (43%), Gaps = 20/245 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V+R K+K TG   A K V +           E+     L  PR++ +Y A     
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP 123

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + + +EL+EGG L + +I     L E     ++ Q  EG+E++H++ +LH D+K +N+L
Sbjct: 124 WVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL 182

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLF------GTPEFVAPEVVNFDAIGFGTDMWS 187
            L+  G+R  + DFG A    P+   + L       GT   +APEVV         D+WS
Sbjct: 183 -LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241

Query: 188 VGVICYVL--LSGLSPFMGETDVQTMANVTIAQYDFDD-ECFNEISDDAKDFIRKLLLKD 244
               C +L  L+G  P+           + IA       E     +      I++ L K+
Sbjct: 242 SC--CMMLHMLNGCHPWTQYFRGPLC--LKIASEPPPIREIPPSCAPLTAQAIQEGLRKE 297

Query: 245 REDAP 249
                
Sbjct: 298 PVHRA 302

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  159 bits (405), Expect = 1e-47
 Identities = 61/270 (22%), Positives = 104/270 (38%), Gaps = 41/270 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAF--- 69
           G F  VY  ++  +G   A K +   +    R + +EV  M++L  HP ++Q   A    
Sbjct: 39  GGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98

Query: 70  -----ESSNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN- 121
                       ++ EL +G   E  +++      L+   V     Q C  V+ +H +  
Sbjct: 99  KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHRQKP 157

Query: 122 -VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL-------------FGTPE 167
            ++H D+K EN+L L+  G  IK+ DFG A                           TP 
Sbjct: 158 PIIHRDLKVENLL-LSNQGT-IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM 215

Query: 168 FVAPEVVNFDA---IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE 224
           +  PE+++  +   IG   D+W++G I Y+L     PF     ++    +   +Y     
Sbjct: 216 YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPP- 270

Query: 225 CFNEISDDAKDFIRKLLLKD---REDAPEV 251
             +         IR +L  +   R    EV
Sbjct: 271 -HDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  155 bits (393), Expect = 2e-46
 Identities = 49/256 (19%), Positives = 97/256 (37%), Gaps = 35/256 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMREL-QHPRLIQIYDAFE 70
           G+FG+V++C ++  G   A K          D +N  REV     L QH  +++ + A+ 
Sbjct: 22  GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 81

Query: 71  SSNVMCVVLELIEGGELFERV---IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
             + M +  E   GG L + +           E  +   + Q+  G+ +IHS +++H+D+
Sbjct: 82  EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDI 141

Query: 128 KPENILCLTKTGNR------------------IKIIDFGLARKFDPEKKLQVLFGTPEFV 169
           KP NI  +++T                      KI D G   +       QV  G   F+
Sbjct: 142 KPSNIF-ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS---SPQVEEGDSRFL 197

Query: 170 APEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE 228
           A EV+  +       D++++ +                    +    + +          
Sbjct: 198 ANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPR------IPQV 251

Query: 229 ISDDAKDFIRKLLLKD 244
           +S +  + ++ ++  D
Sbjct: 252 LSQEFTELLKVMIHPD 267

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  154 bits (392), Expect = 4e-45
 Identities = 61/246 (24%), Positives = 116/246 (47%), Gaps = 15/246 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G F  V   K K TG   A K +    + KR +      E +++       + Q++ AF+
Sbjct: 72  GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             N + +V+E   GG+L   +      +  +    ++ +I   ++ +H    +H D+KP+
Sbjct: 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPD 191

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAIGFGT----- 183
           NIL L + G+ I++ DFG   K   +  ++  V  GTP++++PE++     G GT     
Sbjct: 192 NIL-LDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249

Query: 184 --DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN-EISDDAKDFIRKL 240
             D W++GV  Y +  G +PF  ++  +T   +   +        +  + ++A+DFI++L
Sbjct: 250 ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRL 309

Query: 241 LLKDRE 246
           L     
Sbjct: 310 LCPPET 315

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  155 bits (394), Expect = 5e-45
 Identities = 64/242 (26%), Positives = 118/242 (48%), Gaps = 13/242 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   K K      A K +    + KR +      E +++       +  ++ AF+
Sbjct: 85  GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             N + +V++   GG+L   +   +  L E+    ++ ++   ++ +H  + +H D+KP+
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAIGFGT----- 183
           NIL +   G+ I++ DFG   K   +  +Q  V  GTP++++PE++     G G      
Sbjct: 205 NIL-MDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-DECFNEISDDAKDFIRKLLL 242
           D WS+GV  Y +L G +PF  E+ V+T   +   +  F       ++S++AKD IR+L+ 
Sbjct: 263 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC 322

Query: 243 KD 244
             
Sbjct: 323 SR 324

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  156 bits (397), Expect = 1e-44
 Identities = 70/239 (29%), Positives = 115/239 (48%), Gaps = 10/239 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V  C+ +ATG   A K +    I KR        E +I+ ++    ++ +  A+E
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254

Query: 71  SSNVMCVVLELIEGGELF---ERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           + + +C+VL L+ GG+L      +    F   E     +  +IC G+E +H + +++ D+
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGF--PEARAVFYAAEICCGLEDLHRERIVYRDL 312

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
           KPENIL L   G+ I+I D GLA      + ++   GT  ++APEVV  +   F  D W+
Sbjct: 313 KPENIL-LDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 370

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           +G + Y +++G SPF           V     +  +E     S  A+    +LL KD  
Sbjct: 371 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPA 429

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  153 bits (389), Expect = 2e-44
 Identities = 74/242 (30%), Positives = 123/242 (50%), Gaps = 14/242 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVG---IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   + K+T    A K +    + KR+D      E +IM     P ++Q++ AF+
Sbjct: 80  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + +V+E + GG+L   + + D    EK    +  ++   ++ IHS   +H D+KP+
Sbjct: 140 DDRYLYMVMEYMPGGDLVNLMSNYDV--PEKWARFYTAEVVLALDAIHSMGFIHRDVKPD 197

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVV----NFDAIGFGTD 184
           N+L L K+G+ +K+ DFG   K + E  ++     GTP++++PEV+         G   D
Sbjct: 198 NML-LDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            WSVGV  Y +L G +PF  ++ V T + +   +        N+IS +AK+ I    L D
Sbjct: 256 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTD 314

Query: 245 RE 246
           RE
Sbjct: 315 RE 316

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  146 bits (371), Expect = 5e-43
 Identities = 58/245 (23%), Positives = 120/245 (48%), Gaps = 15/245 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAF-- 69
           G F TVY+  +  T + +A   +   K  +++R+  + E E+++ LQHP +++ YD++  
Sbjct: 37  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96

Query: 70  --ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN--VLHL 125
             +    + +V EL+  G L    +    V+  K +  + RQI +G++F+H++   ++H 
Sbjct: 97  TVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           D+K +NI     TG+ +KI D GLA          V+ GTPEF+APE+   +      D+
Sbjct: 156 DLKCDNIFITGPTGS-VKIGDLGLATLKRASFAKAVI-GTPEFMAPEMYE-EKYDESVDV 212

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFIRKLLLKD 244
           ++ G+    + +   P+    +   +              F+++   + K+ I   + ++
Sbjct: 213 YAFGMCMLEMATSEYPYSECQNAAQI--YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQN 270

Query: 245 REDAP 249
           +++  
Sbjct: 271 KDERY 275

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  151 bits (384), Expect = 7e-43
 Identities = 68/244 (27%), Positives = 122/244 (50%), Gaps = 17/244 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V+ C+ KATG   A K +    + KR   +    E +I+ ++    ++ +  AFE
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255

Query: 71  SSNVMCVVLELIEGGELF---ERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           +   +C+V+ ++ GG++      V +D+    E     +  QI  G+E +H +N+++ D+
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L L   GN ++I D GLA +    +     + GTP F+APE++  +   F  D +
Sbjct: 316 KPENVL-LDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373

Query: 187 SVGVICYVLLSGLSPFMGE---TDVQTMANVTIAQYDFDDECF-NEISDDAKDFIRKLLL 242
           ++GV  Y +++   PF       + + +    +         + ++ S  +KDF   LL 
Sbjct: 374 ALGVTLYEMIAARGPFRARGEKVENKELKQRVL----EQAVTYPDKFSPASKDFCEALLQ 429

Query: 243 KDRE 246
           KD E
Sbjct: 430 KDPE 433

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  147 bits (372), Expect = 1e-42
 Identities = 65/235 (27%), Positives = 116/235 (49%), Gaps = 12/235 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K     +   E  I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + +V+E + GGE+F   +      +E     +  QI    E++HS ++++ D+KPE
Sbjct: 112 DNSNLYMVMEYVAGGEMFSH-LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L + + G  I++ DFG A++     +   L GTPE +APE++         D W++GV
Sbjct: 171 NLL-IDQQGY-IQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           + Y + +G  PF  +  +Q    +   +  F     +  S D KD +R LL  D 
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDL 277

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  152 bits (386), Expect = 1e-42
 Identities = 64/241 (26%), Positives = 113/241 (46%), Gaps = 18/241 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRR--NVEREV-EIMRELQHPRLIQIYD 67
           G FG VY C++  TG   A K +    I  +        ER +  ++     P ++ +  
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           AF + + +  +L+L+ GG+L    +    V +E  +  +  +I  G+E +H++ V++ D+
Sbjct: 260 AFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 318

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMW 186
           KP NIL L + G+ ++I D GLA     +KK     GT  ++APEV+          D +
Sbjct: 319 KPANIL-LDEHGH-VRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 375

Query: 187 SVGVICYVLLSGLSPFMGET--DVQTMANVTIAQYDFDDECF-NEISDDAKDFIRKLLLK 243
           S+G + + LL G SPF      D   +  +T+           +  S + +  +  LL +
Sbjct: 376 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TMAVELPDSFSPELRSLLEGLLQR 431

Query: 244 D 244
           D
Sbjct: 432 D 432

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  142 bits (360), Expect = 4e-41
 Identities = 64/240 (26%), Positives = 128/240 (53%), Gaps = 12/240 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  G V   +EK +G  +A K + + K+  R  +  EV IMR+ QH  ++++Y ++    
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + V++E ++GG L +  I     L E+ +A     + + + ++H++ V+H D+K ++IL
Sbjct: 116 ELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSIL 173

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            LT  G  +K+ DFG   +   +  K + L GTP ++APEV++        D+WS+G++ 
Sbjct: 174 -LTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYD---FDDECFNEISDDAKDFIRKLLLKDREDAP 249
             ++ G  P+  ++ VQ M    +         +   +++S   +DF+ ++L++D ++  
Sbjct: 232 IEMVDGEPPYFSDSPVQAM--KRLRDSPPPKLKNS--HKVSPVLRDFLERMLVRDPQERA 287

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  142 bits (360), Expect = 5e-41
 Identities = 70/241 (29%), Positives = 124/241 (51%), Gaps = 24/241 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V+  + +  G   A K +    + +     +   E  ++  + HP +I+++  F+
Sbjct: 17  GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76

Query: 71  SSNVMCVVLELIEGGELF-----ERVIDDDFVLTEKAVAIF-MRQICEGVEFIHSKNVLH 124
            +  + ++++ IEGGELF      +   +        VA F   ++C  +E++HSK++++
Sbjct: 77  DAQQIFMIMDYIEGGELFSLLRKSQRFPNP-------VAKFYAAEVCLALEYLHSKDIIY 129

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTD 184
            D+KPENIL L K G+ IKI DFG A+          L GTP+++APEVV+        D
Sbjct: 130 RDLKPENIL-LDKNGH-IKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYNKSID 185

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            WS G++ Y +L+G +PF     ++T   +  A+  F        ++D KD + +L+ +D
Sbjct: 186 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRD 241

Query: 245 R 245
            
Sbjct: 242 L 242

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  141 bits (358), Expect = 1e-40
 Identities = 73/237 (30%), Positives = 126/237 (53%), Gaps = 11/237 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   +EKATG   A K +    I  +++  +   E  +++  +HP L  +  AF+
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           + + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K E
Sbjct: 76  THDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134

Query: 131 NILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +G
Sbjct: 135 NLM-LDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           V+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD +
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPK 245

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  140 bits (355), Expect = 1e-40
 Identities = 69/246 (28%), Positives = 123/246 (50%), Gaps = 17/246 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K K TG   AAK +      +  +   E+EI+    HP ++++  A+    
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GG +   +++ D  LTE  + +  RQ+ E + F+HSK ++H D+K  N+L
Sbjct: 90  KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVL 149

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAI-----GFGTDMWS 187
            +T  G+ I++ DFG++ K      K     GTP ++APEVV  + +      +  D+WS
Sbjct: 150 -MTLEGD-IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 207

Query: 188 VGVICYVLLSGLSPFMGETDVQTM-ANVTIAQYD---FDDECFNEISDDAKDFIRKLLLK 243
           +G+    +     P     ++  M   + IA+ D         ++ S + +DF++  L K
Sbjct: 208 LGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDPPTLLTP--SKWSVEFRDFLKIALDK 262

Query: 244 DREDAP 249
           + E  P
Sbjct: 263 NPETRP 268

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  140 bits (354), Expect = 2e-40
 Identities = 69/240 (28%), Positives = 127/240 (52%), Gaps = 12/240 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A + + + ++  +  +  E+ +MRE ++P ++   D++   +
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L +  +  +  + E  +A   R+  + +EF+HS  V+H D+K +NIL
Sbjct: 91  ELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 149 -LGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYD---FDDECFNEISDDAKDFIRKLLLKDREDAP 249
             ++ G  P++ E  ++ +    IA        +    ++S   +DF+ + L  D E   
Sbjct: 207 IEMIEGEPPYLNENPLRAL--YLIATNGTPELQNP--EKLSAIFRDFLNRCLEMDVEKRG 262

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  142 bits (359), Expect = 7e-40
 Identities = 72/238 (30%), Positives = 124/238 (52%), Gaps = 12/238 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   KEKATG   A K +    I  +++  +   E  +++  +HP L  +  +F+
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKP 129
           + + +C V+E   GGELF   +  + V +E     +  +I   ++++HS KNV++ D+K 
Sbjct: 219 THDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277

Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           EN++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +
Sbjct: 278 ENLM-LDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 335

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           GV+ Y ++ G  PF  +   +    + + +  F       +  +AK  +  LL KD +
Sbjct: 336 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPK 389

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  138 bits (351), Expect = 1e-39
 Identities = 62/239 (25%), Positives = 124/239 (51%), Gaps = 15/239 (6%)

Query: 14  GKFGTVYRCKE---KATGMTLAAKF----VGIAKRNDRRNVEREVEIMRELQHPRLIQIY 66
           G +G V++ ++     TG   A K     + +    D  + + E  I+ E++HP ++ + 
Sbjct: 28  GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI 87

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            AF++   + ++LE + GGELF + ++ + +  E     ++ +I   +  +H K +++ D
Sbjct: 88  YAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRD 146

Query: 127 MKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           +KPENI+ L   G+ +K+ DFGL ++            GT E++APE++         D 
Sbjct: 147 LKPENIM-LNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDW 204

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS+G + Y +L+G  PF GE   +T+  +   + +        ++ +A+D ++KLL ++
Sbjct: 205 WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRN 259

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  138 bits (350), Expect = 3e-39
 Identities = 70/239 (29%), Positives = 121/239 (50%), Gaps = 14/239 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNV--EREVEIMRELQHPRLIQIYDA 68
           G FG V   + KA  +  A K +    I K+ + +++  ER V +++ ++HP L+ ++ +
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGLHFS 107

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F++++ +  VL+ I GGELF   +  +    E     +  +I   + ++HS N+++ D+K
Sbjct: 108 FQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 166

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWS 187
           PENIL L   G+ I + DFGL ++          F GTPE++APEV++        D W 
Sbjct: 167 PENIL-LDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           +G + Y +L GL PF      +   N+              I++ A+  +  LL KDR 
Sbjct: 225 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLLEGLLQKDRT 279

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  137 bits (347), Expect = 6e-39
 Identities = 58/250 (23%), Positives = 111/250 (44%), Gaps = 27/250 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRE-LQHPRLIQIYDAF 69
           G +  V   + K T    A K V    +    D   V+ E  +  +   HP L+ ++  F
Sbjct: 20  GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +  V+E + GG+L    +     L E+    +  +I   + ++H + +++ D+K 
Sbjct: 80  QTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 138

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSV 188
           +N+L L   G+ IK+ D+G+ ++          F GTP ++APE++  +  GF  D W++
Sbjct: 139 DNVL-LDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-DECFNEI-----------SDDAKDF 236
           GV+ + +++G SPF        +   +        D  F  I           S  A   
Sbjct: 197 GVLMFEMMAGRSPF-------DIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 249

Query: 237 IRKLLLKDRE 246
           ++  L KD +
Sbjct: 250 LKSFLNKDPK 259

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  136 bits (345), Expect = 6e-39
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE----REVEIMRELQHPRLIQIYDAF 69
           G +G V++C+ + TG  +A K     +  D   ++    RE+ ++++L+HP L+ + + F
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIK--KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF 71

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
                + +V E  +   +   +      + E  V     Q  + V F H  N +H D+KP
Sbjct: 72  RRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKP 130

Query: 130 ENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEVVNFDAIGFGT 183
           ENIL +TK    IK+ DFG AR    P           E       +PE++      +G 
Sbjct: 131 ENIL-ITKHSV-IKLCDFGFARLLTGPSDYY-----DDEVATRWYRSPELL-VGDTQYGP 182

Query: 184 --DMWSVGVICYVLLSGLSPFMGETDVQ 209
             D+W++G +   LLSG+  + G++DV 
Sbjct: 183 PVDVWAIGCVFAELLSGVPLWPGKSDVD 210

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  137 bits (347), Expect = 6e-39
 Identities = 59/239 (24%), Positives = 110/239 (46%), Gaps = 14/239 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRN--VEREVEIMRELQHPRLIQIYDA 68
           G FG V   + K TG   A K +    I + +D      E+ + +     HP L Q++  
Sbjct: 34  GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI-LSLARNHPFLTQLFCC 92

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F++ + +  V+E + GG+L    I       E     +  +I   + F+H K +++ D+K
Sbjct: 93  FQTPDRLFFVMEFVNGGDLMFH-IQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLK 151

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWS 187
            +N+L L   G+  K+ DFG+ ++          F GTP+++APE++     G   D W+
Sbjct: 152 LDNVL-LDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWA 209

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           +GV+ Y +L G +PF  E +      +   +  +       + +DA   ++  + K+  
Sbjct: 210 MGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTKNPT 264

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  136 bits (346), Expect = 8e-39
 Identities = 67/239 (28%), Positives = 118/239 (49%), Gaps = 14/239 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRND--RRNVEREVEIMRELQHPRLIQIYDA 68
           G FG V+  + K T    A K +    +   +D     VE+ V +    +HP L  ++  
Sbjct: 28  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHMFCT 86

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F++   +  V+E + GG+L    I             +  +I  G++F+HSK +++ D+K
Sbjct: 87  FQTKENLFFVMEYLNGGDLMYH-IQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK 145

Query: 129 PENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
            +NIL L K G+ IKI DFG+ ++    + K     GTP+++APE++         D WS
Sbjct: 146 LDNIL-LDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWS 203

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
            GV+ Y +L G SPF G+ + +   ++ +    +       +  +AKD + KL +++ E
Sbjct: 204 FGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREPE 258

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  135 bits (342), Expect = 1e-38
 Identities = 62/240 (25%), Positives = 117/240 (48%), Gaps = 12/240 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G +G+VY+   K TG  +A K V +   +D + + +E+ IM++   P +++ Y ++  + 
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +V+E    G + + +   +  LTE  +A  ++   +G+E++H    +H D+K  NIL
Sbjct: 98  DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL 157

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+  K+ DFG+A +      K   + GTP ++APEV+         D+WS+G+  
Sbjct: 158 -LNTEGH-AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITA 215

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYD---FDDECFNEISDDAKDFIRKLLLKDREDAP 249
             +  G  P+     ++ +    I       F        SD+  DF+++ L+K  E   
Sbjct: 216 IEMAEGKPPYADIHPMRAI--FMIPTNPPPTFRKP--ELWSDNFTDFVKQCLVKSPEQRA 271

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  140 bits (355), Expect = 2e-38
 Identities = 59/238 (24%), Positives = 112/238 (47%), Gaps = 12/238 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIM-RELQHPRLIQIYDAF 69
           G FG V   + K T    A K +    + + +D      E  ++    + P L Q++  F
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +  V+E + GG+L    I       E     +  +I  G+ F+ SK +++ D+K 
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYH-IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL 470

Query: 130 ENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           +N++ L   G+ IKI DFG+ ++        +   GTP+++APE++ +   G   D W+ 
Sbjct: 471 DNVM-LDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 528

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           GV+ Y +L+G +PF GE + +   ++      +       +S +A    + L+ K   
Sbjct: 529 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPG 582

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  135 bits (343), Expect = 2e-38
 Identities = 68/212 (32%), Positives = 112/212 (52%), Gaps = 28/212 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE-------REVEIMRELQHPRLIQIY 66
           G+F TVY+ ++K T   +A K   I   +     +       RE+++++EL HP +I + 
Sbjct: 21  GQFATVYKARDKNTNQIVAIK--KIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           DAF   + + +V + +E  +L E +I D   VLT   +  +M    +G+E++H   +LH 
Sbjct: 79  DAFGHKSNISLVFDFMET-DL-EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 136

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEVVNFDAI 179
           D+KP N+L L + G  +K+ DFGLA+ F  P +       T + V     APE++ F A 
Sbjct: 137 DLKPNNLL-LDENGV-LKLADFGLAKSFGSPNRAY-----THQVVTRWYRAPELL-FGAR 188

Query: 180 GFGT--DMWSVGVICYVLLSGLSPFMGETDVQ 209
            +G   DMW+VG I   LL  +    G++D+ 
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  135 bits (343), Expect = 5e-38
 Identities = 57/249 (22%), Positives = 111/249 (44%), Gaps = 25/249 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRE-LQHPRLIQIYDAF 69
           G +  V   + K T    A + V    +    D   V+ E  +  +   HP L+ ++  F
Sbjct: 63  GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++ + +  V+E + GG+L    +     L E+    +  +I   + ++H + +++ D+K 
Sbjct: 123 QTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 181

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVVNFDAIGFGTDMWSV 188
           +N+L L   G+ IK+ D+G+ ++          F GTP ++APE++  +  GF  D W++
Sbjct: 182 DNVL-LDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-----------SDDAKDFI 237
           GV+ + +++G SPF                 + +D  F  I           S  A   +
Sbjct: 240 GVLMFEMMAGRSPFDIVGSSDNPDQ------NTEDYLFQVILEKQIRIPRSLSVKAASVL 293

Query: 238 RKLLLKDRE 246
           +  L KD +
Sbjct: 294 KSFLNKDPK 302

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  135 bits (341), Expect = 5e-38
 Identities = 61/237 (25%), Positives = 114/237 (48%), Gaps = 14/237 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRN--VEREVEIMRELQHPRLIQIYDA 68
           G FG V   + K T    A K +    + + +D     VE+ V +    + P L Q++  
Sbjct: 31  GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQLHSC 89

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F++ + +  V+E + GG+L    I       E     +  +I  G+ F+ SK +++ D+K
Sbjct: 90  FQTMDRLYFVMEYVNGGDLMYH-IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 148

Query: 129 PENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWS 187
            +N++ L   G+ IKI DFG+ ++        +   GTP+++APE++ +   G   D W+
Sbjct: 149 LDNVM-LDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 206

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            GV+ Y +L+G +PF GE + +   ++      +       +S +A    + L+ K 
Sbjct: 207 FGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKH 259

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  134 bits (339), Expect = 6e-38
 Identities = 73/241 (30%), Positives = 132/241 (54%), Gaps = 17/241 (7%)

Query: 14  GKFGTVYRCKE---KATGMTLAAKFV---GIAKRNDRR-NVEREVEIMRELQHPRLIQIY 66
           G FG V+  K+          A K +    +  R+  R  +ER+  I+ E+ HP +++++
Sbjct: 35  GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD--ILVEVNHPFIVKLH 92

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            AF++   + ++L+ + GG+LF R +  + + TE+ V  ++ ++   ++ +HS  +++ D
Sbjct: 93  YAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151

Query: 127 MKPENILCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           +KPENIL L + G+ IK+ DFGL+++  D EKK     GT E++APEVVN        D 
Sbjct: 152 LKPENIL-LDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 209

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           WS GV+ + +L+G  PF G+   +TM  +  A+          +S +A+  +R L  ++ 
Sbjct: 210 WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRNP 265

Query: 246 E 246
            
Sbjct: 266 A 266

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  132 bits (335), Expect = 1e-37
 Identities = 63/208 (30%), Positives = 108/208 (51%), Gaps = 22/208 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIYDAFES 71
           G +GTV++ K + T   +A K V +   ++       RE+ +++EL+H  +++++D   S
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72

Query: 72  SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V E  +  +L ++  D  +  L  + V  F+ Q+ +G+ F HS+NVLH D+KP+
Sbjct: 73  DKKLTLVFEFCDQ-DL-KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130

Query: 131 NILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEVVNFDAIGFGT- 183
           N+L + + G  +K+ +FGLAR F  P +       + E V      P+V+ F A  + T 
Sbjct: 131 NLL-INRNGE-LKLANFGLARAFGIPVRCY-----SAEVVTLWYRPPDVL-FGAKLYSTS 182

Query: 184 -DMWSVGVICYVLLSGLSP-FMGETDVQ 209
            DMWS G I   L +   P F G     
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDD 210

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  132 bits (334), Expect = 1e-37
 Identities = 49/217 (22%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE-------REVEIMRELQHPRLIQIY 66
           G FG V++ +       +A K + +        +        REV IM  L HP ++++Y
Sbjct: 30  GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN--VLH 124
                 N   +V+E +  G+L+ R++D    +        M  I  G+E++ ++N  ++H
Sbjct: 90  GL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVH 147

Query: 125 LDMKPENILCLTKTGNR---IKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGF 181
            D++  NI   +   N     K+ DFGL+++        +  G  +++APE +  +   +
Sbjct: 148 RDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL--GNFQWMAPETIGAEEESY 205

Query: 182 GT--DMWSVGVICYVLLSGLSPF--MGETDVQTMANV 214
               D +S  +I Y +L+G  PF       ++ +  +
Sbjct: 206 TEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  132 bits (335), Expect = 2e-37
 Identities = 60/268 (22%), Positives = 118/268 (44%), Gaps = 49/268 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIYDAFES 71
           G +G VY+  +  T  T+A K + +    +       REV +++ELQH  +I++      
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           ++ + ++ E  E  +L ++ +D +  ++ + +  F+ Q+  GV F HS+  LH D+KP+N
Sbjct: 105 NHRLHLIFEYAEN-DL-KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQN 162

Query: 132 IL----CLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEVVNFDAIGF 181
           +L      ++T   +KI DFGLAR F  P ++      T E +      PE++   +  +
Sbjct: 163 LLLSVSDASETPV-LKIGDFGLARAFGIPIRQF-----THEIITLWYRPPEIL-LGSRHY 215

Query: 182 GT--DMWSVGVICYVLLSGLSPFMGETDVQTM-----------------------ANVTI 216
            T  D+WS+  I   +L     F G++++  +                          + 
Sbjct: 216 STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF 275

Query: 217 AQY---DFDDECFNEISDDAKDFIRKLL 241
            ++            + D+  D +  +L
Sbjct: 276 PKFRGKTLKRVLGALLDDEGLDLLTAML 303

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  132 bits (333), Expect = 3e-37
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 17/220 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG   +   + TG  +  K +       +R   +EV++MR L+HP +++         
Sbjct: 21  GCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            +  + E I+GG L   +   D          F + I  G+ ++HS N++H D+   N  
Sbjct: 81  RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN-- 138

Query: 134 CLTKTGNRIKIIDFGLAR---------------KFDPEKKLQVLFGTPEFVAPEVVNFDA 178
           CL +    + + DFGLAR               K    KK   + G P ++APE++N  +
Sbjct: 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS 198

Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQ 218
                D++S G++   ++  ++             + +  
Sbjct: 199 YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  131 bits (333), Expect = 5e-37
 Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 25/209 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE----REVEIMRELQHPRLIQIYDAF 69
           G +G V +C+ K TG  +A K     + +D + V+    RE++++++L+H  L+ + +  
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIK--KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC 93

Query: 70  ESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           +      +V E ++   +    ++     L  + V  ++ QI  G+ F HS N++H D+K
Sbjct: 94  KKKKRWYLVFEFVDH-TI-LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK 151

Query: 129 PENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEVVNFDAIGFG 182
           PENIL  +++G  +K+ DFG AR    P +         E       APE++    + +G
Sbjct: 152 PENILV-SQSGV-VKLCDFGFARTLAAPGEVY-----DDEVATRWYRAPELL-VGDVKYG 203

Query: 183 T--DMWSVGVICYVLLSGLSPFMGETDVQ 209
              D+W++G +   +  G   F G++D+ 
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDID 232

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  130 bits (328), Expect = 1e-36
 Identities = 59/242 (24%), Positives = 118/242 (48%), Gaps = 17/242 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR-RNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG V++  +  T   +A K + + +  D   ++++E+ ++ +   P + + Y ++   
Sbjct: 33  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +++E + GG   + +      L E  +A  +R+I +G++++HS+  +H D+K  N+
Sbjct: 93  TKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150

Query: 133 LCLTKTGNRIKIIDFGLARK-FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L L++ G  +K+ DFG+A +  D + K     GTP ++APEV+   A     D+WS+G+ 
Sbjct: 151 L-LSEHGE-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 208

Query: 192 CYVLLSGLSPFMGETDVQTM-ANVTIAQYD---FDDECFNEISDDAKDFIRKLLLKDRED 247
              L  G  P     ++  M     I + +    +       S   K+F+   L K+   
Sbjct: 209 AIELARGEPPHS---ELHPMKVLFLIPKNNPPTLEG----NYSKPLKEFVEACLNKEPSF 261

Query: 248 AP 249
            P
Sbjct: 262 RP 263

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  129 bits (326), Expect = 3e-36
 Identities = 60/257 (23%), Positives = 111/257 (43%), Gaps = 23/257 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN-VEREVEIMRELQHPRLIQIYDAFESS 72
           G    V           +A K + + K     + + +E++ M +  HP ++  Y +F   
Sbjct: 26  GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85

Query: 73  NVMCVVLELIEGG-------ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           + + +V++L+ GG        +  +      VL E  +A  +R++ EG+E++H    +H 
Sbjct: 86  DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 145

Query: 126 DMKPENILCLTKTGNRIKIIDFGLA------RKFDPEKKLQVLFGTPEFVAPEVV-NFDA 178
           D+K  NIL L + G+ ++I DFG++            K  +   GTP ++APEV+     
Sbjct: 146 DVKAGNIL-LGEDGS-VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG 203

Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV------TIAQYDFDDECFNEISDD 232
             F  D+WS G+    L +G +P+     ++ +         ++     D E   +    
Sbjct: 204 YDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263

Query: 233 AKDFIRKLLLKDREDAP 249
            +  I   L KD E  P
Sbjct: 264 FRKMISLCLQKDPEKRP 280

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  129 bits (327), Expect = 3e-36
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 39/218 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--------REVEIMRELQHPRLIQI 65
           G + TVY+   K TG+ +A K V       + + E        RE+ +M+EL+H  ++++
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFV------LTEKAVAIFMRQICEGVEFIHS 119
           YD   + N + +V E ++  +L ++ +D   V      L    V  F  Q+ +G+ F H 
Sbjct: 69  YDVIHTENKLTLVFEFMDN-DL-KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126

Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEV 173
             +LH D+KP+N+L + K G  +K+ DFGLAR F  P         + E V     AP+V
Sbjct: 127 NKILHRDLKPQNLL-INKRGQ-LKLGDFGLARAFGIPVNTF-----SSEVVTLWYRAPDV 179

Query: 174 VNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQ 209
           +   +  + T  D+WS G I   +++G   F G  D +
Sbjct: 180 L-MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  129 bits (327), Expect = 3e-36
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 22/207 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIYDAFES 71
           G +G VY+ K+   G  +A K + +   ++       RE+ +++EL HP ++ + D   S
Sbjct: 32  GTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90

Query: 72  SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V E +E  +L ++V+D+    L +  + I++ Q+  GV   H   +LH D+KP+
Sbjct: 91  ERCLTLVFEFMEK-DL-KKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148

Query: 131 NILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEVVNFDAIGFGT- 183
           N+L +   G  +K+ DFGLAR F  P +       T E V     AP+V+   +  + T 
Sbjct: 149 NLL-INSDGA-LKLADFGLARAFGIPVRSY-----THEVVTLWYRAPDVL-MGSKKYSTS 200

Query: 184 -DMWSVGVICYVLLSGLSPFMGETDVQ 209
            D+WS+G I   +++G   F G TD  
Sbjct: 201 VDIWSIGCIFAEMITGKPLFPGVTDDD 227

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  129 bits (327), Expect = 3e-36
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 34/213 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--------REVEIMRELQHPRLIQI 65
           G + TVY+ K K T   +A K +       R   E        REV ++++L+H  ++ +
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLH 124
           +D   +   + +V E ++  +L ++ +DD   ++    V +F+ Q+  G+ + H + VLH
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DL-KQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLH 123

Query: 125 LDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEVVNFDA 178
            D+KP+N+L + + G  +K+ DFGLAR    P K         E V      P+++   +
Sbjct: 124 RDLKPQNLL-INERGE-LKLADFGLARAKSIPTKTY-----DNEVVTLWYRPPDIL-LGS 175

Query: 179 IGFGT--DMWSVGVICYVLLSGLSPFMGETDVQ 209
             + T  DMW VG I Y + +G   F G T  +
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (325), Expect = 5e-36
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 23/218 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR--RNVEREVEIMRELQHPRLIQIYDAFES 71
           G+FG VY  +       +A + + I + N+   +  +REV   R+ +H  ++    A  S
Sbjct: 44  GRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + ++  L +G  L+  V D   VL         ++I +G+ ++H+K +LH D+K +N
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKN 160

Query: 132 ILCLTKTGNRIKIIDFGLAR------KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT-- 183
           +        ++ I DFGL            E KL++  G    +APE++   +       
Sbjct: 161 VF-YDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDK 217

Query: 184 -------DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
                  D++++G I Y L +   PF  +     +  +
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  129 bits (326), Expect = 7e-36
 Identities = 71/254 (27%), Positives = 122/254 (48%), Gaps = 37/254 (14%)

Query: 14  GKFGTVYRCKE---KATGMTLAAKF----VGIAKRNDRRNVEREVEIMRELQH-PRLIQI 65
           G +G V+  ++     TG   A K       + K     +   E +++  ++  P L+ +
Sbjct: 65  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           + AF++   + ++L+ I GGELF   +      TE  V I++ +I   +E +H   +++ 
Sbjct: 125 HYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           D+K ENIL L   G+ + + DFGL+++F  D  ++     GT E++AP++V     G   
Sbjct: 184 DIKLENIL-LDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 241

Query: 184 --DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-----------S 230
             D WS+GV+ Y LL+G SPF  + +  +             E    I           S
Sbjct: 242 AVDWWSLGVLMYELLTGASPFTVDGEKNSQ-----------AEISRRILKSEPPYPQEMS 290

Query: 231 DDAKDFIRKLLLKD 244
             AKD I++LL+KD
Sbjct: 291 ALAKDLIQRLLMKD 304

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  127 bits (321), Expect = 1e-35
 Identities = 62/207 (29%), Positives = 110/207 (53%), Gaps = 22/207 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIYDAFES 71
           G +G VY+ +    G T A K + + K ++       RE+ I++EL+H  ++++YD   +
Sbjct: 13  GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71

Query: 72  SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
              + +V E ++  +L ++++D  +  L       F+ Q+  G+ + H + VLH D+KP+
Sbjct: 72  KKRLVLVFEHLDQ-DL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129

Query: 131 NILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEVVNFDAIGFGT- 183
           N+L + + G  +KI DFGLAR F  P +K      T E V     AP+V+   +  + T 
Sbjct: 130 NLL-INREGE-LKIADFGLARAFGIPVRKY-----THEIVTLWYRAPDVL-MGSKKYSTT 181

Query: 184 -DMWSVGVICYVLLSGLSPFMGETDVQ 209
            D+WSVG I   +++G   F G ++  
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEAD 208

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  128 bits (322), Expect = 1e-35
 Identities = 43/223 (19%), Positives = 86/223 (38%), Gaps = 24/223 (10%)

Query: 38  IAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV 97
           ++  +       ++  M        +           + + ++L     L +  ++    
Sbjct: 99  LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDW-MNRRCS 157

Query: 98  LT---EKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD 154
           L             QI E VEF+HSK ++H D+KP NI   T     +K+ DFGL    D
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIF-FTMDDV-VKVGDFGLVTAMD 215

Query: 155 PEKKLQVLF-------------GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSP 201
            +++ Q +              GT  +++PE ++ +      D++S+G+I + LL   S 
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275

Query: 202 FMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
            M    V+ + +V   ++      F +        ++ +L   
Sbjct: 276 QM--ERVRIITDVRNLKFPLL---FTQKYPQEHMMVQDMLSPS 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  127 bits (320), Expect = 3e-35
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 11/208 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR--RNVEREVEIMRELQHPRLIQIYDAFES 71
           G FGTV+R +    G  +A K +     +        REV IM+ L+HP ++    A   
Sbjct: 48  GSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105

Query: 72  SNVMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLDM 127
              + +V E +  G L+           L E+        + +G+ ++H++N  ++H ++
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL 165

Query: 128 KPENILCLTKTGNRIKIIDFGLAR-KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           K  N+L + K    +K+ DFGL+R K       +   GTPE++APEV+  +     +D++
Sbjct: 166 KSPNLL-VDKKYT-VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANV 214
           S GVI + L +   P+      Q +A V
Sbjct: 224 SFGVILWELATLQQPWGNLNPAQVVAAV 251

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  129 bits (325), Expect = 3e-35
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 32/214 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V      D+R   RE++IMR+L H  ++++   F SS 
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 120

Query: 74  ------VMCVVLELIEGGELFERVIDDDF----VLTEKAVAIFMRQICEGVEFIHSKNVL 123
                  + +VL+ +   E   RV          L    V ++M Q+   + +IHS  + 
Sbjct: 121 EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 178

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEVVNFD 177
           H D+KP+N+L    T   +K+ DFG A++    +          ++      APE++ F 
Sbjct: 179 HRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNV------SYICSRYYRAPELI-FG 230

Query: 178 AIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQ 209
           A  + +  D+WS G +   LL G   F G++ V 
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  126 bits (318), Expect = 4e-35
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V + K +     +A K   I   ++R+    E+  +  + HP ++++Y A    N
Sbjct: 19  GAFGVVCKAKWR--AKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGA--CLN 72

Query: 74  VMCVVLELIEGGELFE--RVIDDDFVLTEKAVAIFMRQICEGVEFIHS---KNVLHLDMK 128
            +C+V+E  EGG L+      +     T      +  Q  +GV ++HS   K ++H D+K
Sbjct: 73  PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           P N+L L   G  +KI DFG A             G+  ++APEV          D++S 
Sbjct: 133 PPNLL-LVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPEVFEGSNYSEKCDVFSW 189

Query: 189 GVICYVLLSGLSPF--MGETDVQTMANVT 215
           G+I + +++   PF  +G    + M  V 
Sbjct: 190 GIILWEVITRRKPFDEIGGPAFRIMWAVH 218

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  125 bits (317), Expect = 1e-34
 Identities = 62/246 (25%), Positives = 107/246 (43%), Gaps = 22/246 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G FG VY  ++      +A K +  + +      +   +EV  +++L+HP  IQ    + 
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             +   +V+E   G    + +      L E  +A       +G+ ++HS N++H D+K  
Sbjct: 125 REHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 183

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD---AIGFGTDMWS 187
           NIL L++ G  +K+ DFG A             GTP ++APEV+            D+WS
Sbjct: 184 NIL-LSEPGL-VKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 238

Query: 188 VGVICYVLLSGLSPFMGETDVQTM-ANVTIAQYD---FDDECFNEISDDAKDFIRKLLLK 243
           +G+ C  L     P     ++  M A   IAQ +        +   S+  ++F+   L K
Sbjct: 239 LGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQK 292

Query: 244 DREDAP 249
             +D P
Sbjct: 293 IPQDRP 298

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  126 bits (319), Expect = 1e-34
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 33/214 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG V++ K   +        V I K   D+R   RE++IMR ++HP ++ +   F S+
Sbjct: 51  GSFGVVFQAKLVESDE------VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSN 104

Query: 73  ------NVMCVVLELIEGGELFERVIDDDF----VLTEKAVAIFMRQICEGVEFIHSKNV 122
                   + +VLE +   E   R           +    + ++M Q+   + +IHS  +
Sbjct: 105 GDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI 162

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APEVVNFD 177
            H D+KP+N+L    +G  +K+IDFG A+     +                 APE++ F 
Sbjct: 163 CHRDIKPQNLLLDPPSGV-LKLIDFGSAKILIAGEPN-----VSYICSRYYRAPELI-FG 215

Query: 178 AIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQ 209
           A  + T  D+WS G +   L+ G   F GE+ + 
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  123 bits (312), Expect = 3e-34
 Identities = 64/237 (27%), Positives = 113/237 (47%), Gaps = 9/237 (3%)

Query: 17  GTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER---EVEIMRELQHPRLIQIYDAFESSN 73
            TVY  ++    + +A K + I  R     ++R   EV    +L H  ++ + D  E  +
Sbjct: 25  STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              +V+E IEG  L E  I+    L+      F  QI +G++  H   ++H D+KP+NIL
Sbjct: 85  CYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL 143

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
            +      +KI DFG+A+        Q   + GT ++ +PE    +A    TD++S+G++
Sbjct: 144 -IDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIV 201

Query: 192 CYVLLSGLSPFMGETDVQT-MANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
            Y +L G  PF GET V   + ++  +  +   +   +I     + I +   KD+ +
Sbjct: 202 LYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKAN 258

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  123 bits (312), Expect = 3e-34
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 41/222 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE-----REVEIMRELQ---HPRLIQI 65
           G +GTVY+ ++  +G  +A K V +               REV ++R L+   HP ++++
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79

Query: 66  YDAFESSNVMCV-----VLELIEGGELFERVIDD--DFVLTEKAVAIFMRQICEGVEFIH 118
            D   +S          V E ++  +L    +D      L  + +   MRQ   G++F+H
Sbjct: 80  MDVCATSRTDREIKVTLVFEHVDQ-DL-RTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 137

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APEV 173
           +  ++H D+KPENIL +T  G  +K+ DFGLAR +  +  L     TP  V     APEV
Sbjct: 138 ANCIVHRDLKPENIL-VTSGGT-VKLADFGLARIYSYQMAL-----TPVVVTLWYRAPEV 190

Query: 174 VNFDAIGFGT------DMWSVGVICYVLLSGLSPFMGETDVQ 209
           +        +      DMWSVG I   +      F G ++  
Sbjct: 191 L------LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  124 bits (313), Expect = 5e-34
 Identities = 48/196 (24%), Positives = 95/196 (48%), Gaps = 18/196 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESS 72
           GK+  V+          +  K   I K   ++ ++RE++I+  L+  P +I + D  +  
Sbjct: 47  GKYSEVFEAINITNNEKVVVK---ILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP 103

Query: 73  NVMCVVLELIEGGELFERVIDDDF-----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
                 L       +FE V + DF      LT+  +  +M +I + +++ HS  ++H D+
Sbjct: 104 VSRTPAL-------VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDV 156

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMW 186
           KP N++ +     ++++ID+GLA  + P ++  V   +  F  PE+ V++    +  DMW
Sbjct: 157 KPHNVM-IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMW 215

Query: 187 SVGVICYVLLSGLSPF 202
           S+G +   ++    PF
Sbjct: 216 SLGCMLASMIFRKEPF 231

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  122 bits (309), Expect = 5e-34
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 18/214 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR----RNVEREVEIMRELQHPRLIQIYDAF 69
           G FG VYR      G  +A K        D      NV +E ++   L+HP +I +    
Sbjct: 18  GGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC 75

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN---VLHLD 126
                +C+V+E   GG L  RV+     +    +  +  QI  G+ ++H +    ++H D
Sbjct: 76  LKEPNLCLVMEFARGGPLN-RVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133

Query: 127 MKPENIL------CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIG 180
           +K  NIL          +   +KI DFGLAR++    K+    G   ++APEV+      
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA-GAYAWMAPEVIRASMFS 192

Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
            G+D+WS GV+ + LL+G  PF G   +     V
Sbjct: 193 KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  122 bits (307), Expect = 1e-33
 Identities = 48/204 (23%), Positives = 97/204 (47%), Gaps = 14/204 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +     ++      EV ++R+ +H  ++       +
Sbjct: 35  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V +  EG  L+  +   +     K +    RQ   G++++H+K+++H D+K  N
Sbjct: 92  PQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN 150

Query: 132 ILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT---DM 185
           I  L +    +KI DFGLA    ++    + + L G+  ++APEV+        +   D+
Sbjct: 151 IF-LHEDNT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDV 208

Query: 186 WSVGVICYVLLSGLSPFMGETDVQ 209
           ++ G++ Y L++G  P+    +  
Sbjct: 209 YAFGIVLYELMTGQLPYSNINNRD 232

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (315), Expect = 5e-33
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G  G +Y     A    +  + V +           +     E + + E+ HP ++QI++
Sbjct: 91  GGLGWIYL----ALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 68  AFESSNVMCV-----VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
             E ++         V+E + G  L +R       + E A+A  + +I   + ++HS  +
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAE-AIAY-LLEILPALSYLHSIGL 203

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
           ++ D+KPENI+    T  ++K+ID G   + +       L+GTP F APE+V        
Sbjct: 204 VYNDLKPENIML---TEEQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTV-A 256

Query: 183 TDMWSVGVICYVLLSGLSPFMGET 206
           TD+++VG     L   L    G  
Sbjct: 257 TDIYTVGRTLAALTLDLPTRNGRY 280

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  121 bits (305), Expect = 5e-33
 Identities = 62/254 (24%), Positives = 114/254 (44%), Gaps = 27/254 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESS 72
           G +G VY+ +   TG   A K + +   ++   +++E+ ++++   H  +   Y AF   
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93

Query: 73  NVMC------VVLELIEGGELFERV-IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           N         +V+E    G + + +       L E+ +A   R+I  G+  +H   V+H 
Sbjct: 94  NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR 153

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGT- 183
           D+K +N+L LT+    +K++DFG++ + D    +     GTP ++APEV+  D     T 
Sbjct: 154 DIKGQNVL-LTENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 211

Query: 184 ----DMWSVGVICYVLLSGLSPFMGETDVQTM-ANVTIAQYD---FDDECFNEISDDAKD 235
               D+WS+G+    +  G  P     D+  M A   I +        + +   S   + 
Sbjct: 212 DFKSDLWSLGITAIEMAEGAPPLC---DMHPMRALFLIPRNPAPRLKSKKW---SKKFQS 265

Query: 236 FIRKLLLKDREDAP 249
           FI   L+K+    P
Sbjct: 266 FIESCLVKNHSQRP 279

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (303), Expect = 8e-33
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 10/196 (5%)

Query: 17  GTVYRCKEKATGMTLAAKFVGIAKRND---RRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G VY  ++      +A K +     +D   R  ++RE      LQ P ++ I+D  E   
Sbjct: 48  GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107

Query: 74  VMCVVLELIEGGELFERVIDDDFVLT-EKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
            + V + LI G +L   ++     L   +AVAI +RQI   ++  H+    H D+KPENI
Sbjct: 108 QLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAI-VRQIGSALDAAHAAGATHRDVKPENI 165

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQ--VLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           L ++       ++DFG+A     EK  Q     GT  ++APE  +     +  D++++  
Sbjct: 166 L-VSADD-FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTC 223

Query: 191 ICYVLLSGLSPFMGET 206
           + Y  L+G  P+ G+ 
Sbjct: 224 VLYECLTGSPPYQGDQ 239

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  118 bits (299), Expect = 1e-32
 Identities = 36/211 (17%), Positives = 86/211 (40%), Gaps = 18/211 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR--RNVEREVEIMRELQHPRLIQIYDAFES 71
              G +++ + +  G  +  K + +   + R  R+   E   +R   HP ++ +  A +S
Sbjct: 21  NHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78

Query: 72  --SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLD 126
             +    ++   +  G L+  + +  +FV+ +     F   +  G+ F+H+    +    
Sbjct: 79  PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA 138

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN---FDAIGFGT 183
           +   +++ + +     +I    +   F    ++      P +VAPE +     D      
Sbjct: 139 LNSRSVM-IDEDMT-ARISMADVKFSFQSPGRM----YAPAWVAPEALQKKPEDTNRRSA 192

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           DMWS  V+ + L++   PF   ++++    V
Sbjct: 193 DMWSFAVLLWELVTREVPFADLSNMEIGMKV 223

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  121 bits (305), Expect = 2e-32
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 38/227 (16%)

Query: 14  GKFGTVY--RCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G VY  + K+       A K +     +   +  RE+ ++REL+HP +I +   F S
Sbjct: 32  GTYGHVYKAKRKDGKDDKDYALKQIEGTGISM--SACREIALLRELKHPNVISLQKVFLS 89

Query: 72  SNVMCV--VLE--------LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
                V  + +        +I+     +        L    V   + QI +G+ ++H+  
Sbjct: 90  HADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHANW 148

Query: 122 VLHLDMKPENILCLTKTGNR--IKIIDFGLARKF-DPEKKLQVLFGTPEFV-----APEV 173
           VLH D+KP NIL + +   R  +KI D G AR F  P K L  L   P  V     APE+
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL--DPVVVTFWYRAPEL 206

Query: 174 VNFDAIGFGT-------DMWSVGVICYVLLSGLSPFMGETDVQTMAN 213
           +       G        D+W++G I   LL+    F    +    +N
Sbjct: 207 L------LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  120 bits (302), Expect = 2e-32
 Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 47/226 (20%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---------REVEIMRELQHPRLIQ 64
           G FG V++ + + TG  +A K V           E         RE++I++ L+H  ++ 
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALREIKILQLLKHENVVN 80

Query: 65  IYDAFESSNVMCVVLELIEGGEL------FE-------RVIDD-DFVLTEKAVAIFMRQI 110
           + +       +C                 F+        ++ +     T   +   M+ +
Sbjct: 81  LIE-------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV- 169
             G+ +IH   +LH DMK  N+L +T+ G  +K+ DFGLAR F   K  Q    T   V 
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVL-ITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVT 191

Query: 170 ----APEVVNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQ 209
                PE++      +G   D+W  G I   + +      G T+  
Sbjct: 192 LWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  118 bits (299), Expect = 4e-32
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 49/225 (21%)

Query: 14  GKFGTVYRCKE-KATGMTLAAKFVGIAKRNDRRNVE--REVEIMRELQ---HPRLIQIYD 67
           G +G V++ ++ K  G  +A K V +    +   +   REV ++R L+   HP +++++D
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81

Query: 68  AFESSNVMCVVLELIEGGELF----------ERVIDD--DFVLTEKAVAIFMRQICEGVE 115
                  +C V       +L              +D   +  +  + +   M Q+  G++
Sbjct: 82  -------VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134

Query: 116 FIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----A 170
           F+HS  V+H D+KP+NIL +T +G  IK+ DFGLAR +  +  L     T   V     A
Sbjct: 135 FLHSHRVVHRDLKPQNIL-VTSSGQ-IKLADFGLARIYSFQMAL-----TSVVVTLWYRA 187

Query: 171 PEVVNFDAIGFGT------DMWSVGVICYVLLSGLSPFMGETDVQ 209
           PEV+        +      D+WSVG I   +      F G +DV 
Sbjct: 188 PEVL------LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  117 bits (295), Expect = 3e-31
 Identities = 39/204 (19%), Positives = 88/204 (43%), Gaps = 17/204 (8%)

Query: 13  FGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRR--NVEREVEIMRELQHPRLIQIYDAFE 70
           F    TV   + K TG  +  + + +   ++     ++ E+ + +   HP ++     F 
Sbjct: 37  FEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96

Query: 71  SSNVMCVVLELIEGGELFERVIDDDF--VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           + N + VV   +  G   + +I   F   + E A+A  ++ + + +++IH    +H  +K
Sbjct: 97  ADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVK 155

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVLF-------GTPEFVAPEVVNFDAIG 180
             +IL ++  G  + +             ++ +V+            +++PEV+  +  G
Sbjct: 156 ASHIL-ISVDGK-VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG 213

Query: 181 FGT--DMWSVGVICYVLLSGLSPF 202
           +    D++SVG+    L +G  PF
Sbjct: 214 YDAKSDIYSVGITACELANGHVPF 237

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  115 bits (291), Expect = 2e-30
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND---RRNVEREVEIMRELQH------PRLIQ 64
           G FG V +  +      +A K V    RN+    R    E+ I+  L+         +I 
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 65  IYDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSKNVL 123
           + + F   N +C+  EL+    L+E +  + F   +   V  F   I + ++ +H   ++
Sbjct: 164 MLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRII 222

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIG 180
           H D+KPENIL   +  + IK+IDFG +  ++ ++    +Q  F    + APEV+     G
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVYTYIQSRF----YRAPEVILGARYG 277

Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
              DMWS+G I   LL+G     GE +   +A
Sbjct: 278 MPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (286), Expect = 3e-30
 Identities = 49/204 (24%), Positives = 96/204 (47%), Gaps = 14/204 (6%)

Query: 17  GTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER---EVEIMRELQHPRLIQIYDAFESSN 73
             V+  ++      +A K +      D     R   E +    L HP ++ +YD  E+  
Sbjct: 26  SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85

Query: 74  VMCV----VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
                   V+E ++G  L + ++  +  +T K     +   C+ + F H   ++H D+KP
Sbjct: 86  PAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKL----QVLFGTPEFVAPEVVNFDAIGFGTDM 185
            NI+ ++ T   +K++DFG+AR              + GT ++++PE    D++   +D+
Sbjct: 145 ANIM-ISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202

Query: 186 WSVGVICYVLLSGLSPFMGETDVQ 209
           +S+G + Y +L+G  PF G++ V 
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDSPVS 226

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  112 bits (281), Expect = 7e-30
 Identities = 33/242 (13%), Positives = 64/242 (26%), Gaps = 43/242 (17%)

Query: 17  GTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER---EVEIMRELQHPRLIQIYDAFESSN 73
              ++  + A    +A  FV          ++        +  +  P + ++ D   +  
Sbjct: 45  LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              VV E I GG L E    D       A+   M+ +    +  H   V      P  + 
Sbjct: 105 GGLVVAEWIRGGSLQEVA--DTSPSPVGAIRA-MQSLAAAADAAHRAGVALSIDHPSRVR 161

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
            ++  G  + +         +P+                           D+  +G   Y
Sbjct: 162 -VSIDG-DVVLAYPATMPDANPQ--------------------------DDIRGIGASLY 193

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDE------CFNEISDDAKDFIRKLLLKDRED 247
            LL    P         +A    A+ D   +         +I         + +  D   
Sbjct: 194 ALLVNRWPLPEAGVRSGLA---PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGI 250

Query: 248 AP 249
             
Sbjct: 251 RS 252

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  111 bits (281), Expect = 9e-30
 Identities = 56/249 (22%), Positives = 114/249 (45%), Gaps = 20/249 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKRNDRRNVEREVEI-MRELQHPRLIQIYDAFES 71
           G +G V + +   +G  +A K +       +++ +  +++I MR +  P  +  Y A   
Sbjct: 18  GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77

Query: 72  SNVMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMK 128
              + + +EL++    + +++VID    + E  +      I + +E +HSK +V+H D+K
Sbjct: 78  EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK 137

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG----TD 184
           P N+L +   G  +K+ DFG++     +    +  G   ++APE +N +    G    +D
Sbjct: 138 PSNVL-INALGQ-VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSD 195

Query: 185 MWSVGVICYVLLSGLSPFMG-ETDVQTMANVTIAQYD---FDDECFNEISDDAKDFIRKL 240
           +WS+G+    L     P+    T  Q +    + +        + F   S +  DF  + 
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLK--QVVEEPSPQLPADKF---SAEFVDFTSQC 250

Query: 241 LLKDREDAP 249
           L K+ ++ P
Sbjct: 251 LKKNSKERP 259

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  112 bits (282), Expect = 1e-29
 Identities = 58/253 (22%), Positives = 108/253 (42%), Gaps = 23/253 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  G V+   +      +A K + +      ++  RE++I+R L H  ++++++    S 
Sbjct: 22  GGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81

Query: 74  VMCVVLELIEGG--------ELFE----RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
                               E  E     V++    L E+   +FM Q+  G+++IHS N
Sbjct: 82  SQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG-PLLEEHARLFMYQLLRGLKYIHSAN 140

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEV-V 174
           VLH D+KP N+  +      +KI DFGLAR  DP         + E +      +P + +
Sbjct: 141 VLHRDLKPANLF-INTEDLVLKIGDFGLARIMDPHYS-HKGHLS-EGLVTKWYRSPRLLL 197

Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK 234
           + +      DMW+ G I   +L+G + F G  +++ M  +  +     +E   E+     
Sbjct: 198 SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIP 257

Query: 235 DFIRKLLLKDRED 247
            +IR  + +  + 
Sbjct: 258 VYIRNDMTEPHKP 270

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  111 bits (279), Expect = 3e-29
 Identities = 56/251 (22%), Positives = 111/251 (44%), Gaps = 20/251 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKRNDRRNVEREVEI-MRELQHPRLIQIYDAFES 71
           G +G+V +   K +G  +A K +       +++ +  ++++ MR    P ++Q Y A   
Sbjct: 33  GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92

Query: 72  SNVMCVVLELIEGG--ELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDM 127
                + +EL+     + ++ V    D V+ E+ +        + +  +     ++H D+
Sbjct: 93  EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI 152

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG----T 183
           KP NIL L ++GN IK+ DFG++ +           G   ++APE ++  A   G    +
Sbjct: 153 KPSNIL-LDRSGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS 210

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANV--TIAQYD---FDDECFNEISDDAKDFIR 238
           D+WS+G+  Y L +G  P+       ++ +    + + D     +    E S    +F+ 
Sbjct: 211 DVWSLGITLYELATGRFPY---PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVN 267

Query: 239 KLLLKDREDAP 249
             L KD    P
Sbjct: 268 LCLTKDESKRP 278

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  111 bits (279), Expect = 5e-29
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 8/205 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G  G V++   K +G+ +A K + +  K   R  + RE++++ E   P ++  Y AF S 
Sbjct: 44  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPEN 131
             + + +E ++GG L ++V+     + E+ +      + +G+ ++  K  ++H D+KP N
Sbjct: 104 GEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 162

Query: 132 ILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           IL +   G  IK+ DFG++ +  D      V  GT  +++PE +        +D+WS+G+
Sbjct: 163 IL-VNSRGE-IKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGTHYSVQSDIWSMGL 218

Query: 191 ICYVLLSGLSPFMGETDVQTMANVT 215
               +  G  P       +      
Sbjct: 219 SLVEMAVGRYPIPPPDAKELELMFG 243

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  110 bits (276), Expect = 2e-28
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 36/218 (16%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL---QHPRLIQIYDAFE 70
           G FGTV   KEK+TGM++A K V      D R   RE++IM++L    HP ++Q+   F 
Sbjct: 34  GTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89

Query: 71  SSNV-------MCVVLELIEGGELFERVIDDDF----VLTEKAVAIFMRQICEGVEFIH- 118
           +          + VV+E +   +   R   + +          + +F+ Q+   +  +H 
Sbjct: 90  TLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147

Query: 119 -SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APE 172
            S NV H D+KP N+L     G  +K+ DFG A+K  P +                 APE
Sbjct: 148 PSVNVCHRDIKPHNVLVNEADGT-LKLCDFGSAKKLSPSE-----PNVAYICSRYYRAPE 201

Query: 173 VVNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDV 208
           ++ F    + T  D+WSVG I   ++ G   F G+   
Sbjct: 202 LI-FGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  109 bits (273), Expect = 4e-28
 Identities = 49/224 (21%), Positives = 95/224 (42%), Gaps = 31/224 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQ-----------H 59
           G F TV+  K+      +A K V    R D+   E    E+++++ +             
Sbjct: 30  GHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 60  PRLIQIYDAFESSNV----MCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGV 114
             ++++ D F         + +V E++ G  L   +   +   +    V    +Q+  G+
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144

Query: 115 EFIHSK-NVLHLDMKPENIL----CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV 169
           +++H +  ++H D+KPEN+L       +   +IKI D G A  +  E     +  T E+ 
Sbjct: 145 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-WYDEHYTNSI-QTREYR 202

Query: 170 APEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMAN 213
           +PEV+     G G D+WS   + + L++G   F  +       +
Sbjct: 203 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (268), Expect = 9e-28
 Identities = 53/249 (21%), Positives = 111/249 (44%), Gaps = 21/249 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI-AKRNDRRNVEREVEI-MRELQHPRLIQIYDAFES 71
           G  G V++ + + TG  +A K +     + + + +  ++++ ++    P ++Q +  F +
Sbjct: 36  GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPE 130
           +  + + +EL+      +        + E+ +      I + + ++  K  V+H D+KP 
Sbjct: 96  NTDVFIAMELMGTC-AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGT-----DM 185
           NIL L + G  IK+ DFG++ +   +K      G   ++APE ++             D+
Sbjct: 155 NIL-LDERGQ-IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADV 212

Query: 186 WSVGVICYVLLSGLSPFMG-ETDVQTMANVTIAQYD----FDDECFNEISDDAKDFIRKL 240
           WS+G+    L +G  P+   +TD + +    + Q +         F   S D + F++  
Sbjct: 213 WSLGISLVELATGQFPYKNCKTDFEVLT--KVLQEEPPLLPGHMGF---SGDFQSFVKDC 267

Query: 241 LLKDREDAP 249
           L KD    P
Sbjct: 268 LTKDHRKRP 276

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  108 bits (271), Expect = 9e-28
 Identities = 57/245 (23%), Positives = 96/245 (39%), Gaps = 62/245 (25%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V    +  +G   A K V      D R   RE++IM+ L H  +I++ D F ++ 
Sbjct: 18  GSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTG 73

Query: 74  VMC--------------------------------------VVLELIEGGELFERVIDDD 95
                                                    V++E +   +   +V+   
Sbjct: 74  DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP--DTLHKVLKSF 131

Query: 96  F----VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR 151
                 +    ++I++ Q+   V FIHS  + H D+KP+N+L  +K    +K+ DFG A+
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT-LKLCDFGSAK 190

Query: 152 KFDPEKKLQVLFGTPEFV-----APEVVNFDAIGFGT--DMWSVGVICYVLLSGLSPFMG 204
           K  P +                 APE++   A  +    D+WS+G +   L+ G   F G
Sbjct: 191 KLIPSE-----PSVAYICSRFYRAPELM-LGATEYTPSIDLWSIGCVFGELILGKPLFSG 244

Query: 205 ETDVQ 209
           ET + 
Sbjct: 245 ETSID 249

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  109 bits (273), Expect = 1e-27
 Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 50/219 (22%)

Query: 14  GKFGTVYRCKEKATGMTLAAK-----F--VGIAKRNDRRNVEREVEIMRELQHPRLIQIY 66
           G +G V    +K     +A K     F  +   KR     + RE+ I+  L H  ++++ 
Sbjct: 64  GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-----ILREIAILNRLNHDHVVKVL 118

Query: 67  DAFESSNVMC-----VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
           D     +V       VVLE+ +    F+++      LTE  +   +  +  GV+++HS  
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP--------------- 166
           +LH D+KP N L + +  + +K+ DFGLAR  D  +                        
Sbjct: 177 ILHRDLKPANCL-VNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234

Query: 167 -------EFV------APEV-VNFDAIGFGTDMWSVGVI 191
                    V      APE+ +  +      D+WS+G I
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  106 bits (268), Expect = 2e-27
 Identities = 66/271 (24%), Positives = 102/271 (37%), Gaps = 59/271 (21%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G +G V     K TG  +A K +        A R       RE++I++  +H  +I I++
Sbjct: 22  GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-----TLREIKILKHFKHENIITIFN 76

Query: 68  AFESSNVMC-----VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
                +        ++ EL++  +L  RVI    +L++  +  F+ Q    V+ +H  NV
Sbjct: 77  IQRPDSFENFNEVYIIQELMQT-DL-HRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNV 133

Query: 123 LHLDMKPENIL----CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP-----EFV---- 169
           +H D+KP N+L    C       +K+ DFGLAR  D                 EFV    
Sbjct: 134 IHRDLKPSNLLINSNC------DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187

Query: 170 --APEVV-NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD------ 220
             APEV+          D+WS G I   L      F G             Q        
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD--------YRHQLLLIFGII 239

Query: 221 ---FDDECFNEI-SDDAKDFIRKLLLKDRED 247
                D     I S  A+++I+ L +     
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAP 270

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  107 bits (269), Expect = 2e-27
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 33/218 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER-------EVEIMRELQHP------ 60
           G FG V +  ++     +A K +        +N +        EV ++  +         
Sbjct: 65  GSFGQVVKAYDRVEQEWVAIKII--------KNKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 61  RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHS 119
            ++ +   F   N +C+V E++    L++ + + +F  ++      F +Q+C  + F+ +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 120 K--NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVV 174
              +++H D+KPENIL      + IKI+DFG +     ++    +Q  F    + +PEV+
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC-QLGQRIYQYIQSRF----YRSPEVL 230

Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
                    DMWS+G I   + +G   F G  +V  M 
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  107 bits (268), Expect = 2e-27
 Identities = 58/250 (23%), Positives = 116/250 (46%), Gaps = 29/250 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G V    +  TG  +A K +    ++    +   RE+ +++ ++H  +I + D F  
Sbjct: 36  GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 95

Query: 72  SNVMC------VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
              +       +V+  +   +L  +++  +  L E  +   + Q+ +G+ +IH+  ++H 
Sbjct: 96  DETLDDFTDFYLVMPFMGT-DL-GKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGIIHR 152

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEVV-NFDA 178
           D+KP N+         +KI+DFGLAR+ D E           +V      APEV+ N+  
Sbjct: 153 DLKPGNLAV--NEDCELKILDFGLARQADSEM--------TGYVVTRWYRAPEVILNWMR 202

Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFI 237
                D+WSVG I   +++G + F G   +  +  +         E    + SD+AK+++
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262

Query: 238 RKLLLKDRED 247
           + L   +++D
Sbjct: 263 KGLPELEKKD 272

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  107 bits (269), Expect = 3e-27
 Identities = 60/298 (20%), Positives = 106/298 (35%), Gaps = 72/298 (24%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G VY   +K T   +A K V     +  D + + RE+ I+  L+   +I++YD    
Sbjct: 37  GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96

Query: 72  SNVMC-----VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
            +++      +VLE+ +     +++      LTE+ +   +  +  G  FIH   ++H D
Sbjct: 97  DDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRD 154

Query: 127 MKPENIL----CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP---------------- 166
           +KP N L    C       +K+ DFGLAR  + EK   ++                    
Sbjct: 155 LKPANCLLNQDC------SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208

Query: 167 -EFV------APEV-VNFDAIGFGTDMWSVGVICYVLLSGLSP-----------FMGETD 207
              V      APE+ +  +      D+WS G I   LL+ L             F G + 
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSC 268

Query: 208 VQTMANVTIAQYDFDDEC--FNEI----------------SDDAKDFIRKLLLKDRED 247
                +    +          N I                  +   +I+    +   +
Sbjct: 269 FPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  106 bits (267), Expect = 3e-27
 Identities = 60/252 (23%), Positives = 119/252 (47%), Gaps = 30/252 (11%)

Query: 12  SFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAF 69
             G +G+V    +K +G  +A K +    ++    +   RE+ +++ +QH  +I + D F
Sbjct: 33  GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF 92

Query: 70  ESSNVMC------VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
             ++ +       +V+  ++  +L ++++      +E+ +   + Q+ +G+++IHS  V+
Sbjct: 93  TPASSLRNFYDFYLVMPFMQT-DL-QKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAGVV 148

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEVV-NF 176
           H D+KP N+         +KI+DFGLAR  D E           +V      APEV+ ++
Sbjct: 149 HRDLKPGNLAV--NEDCELKILDFGLARHADAEM--------TGYVVTRWYRAPEVILSW 198

Query: 177 DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKD 235
                  D+WSVG I   +L+G + F G+  +  +  +         E   ++    AK 
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258

Query: 236 FIRKLLLKDRED 247
           +I+ L    R+D
Sbjct: 259 YIQSLPQTPRKD 270

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  106 bits (267), Expect = 3e-27
 Identities = 69/255 (27%), Positives = 114/255 (44%), Gaps = 31/255 (12%)

Query: 12  SFGKFGTVYRCKEKATGMTLAAK----F--VGIAKRNDRRNVEREVEIMRELQHPRLIQI 65
             G +G V    +    + +A K    F      +R       RE++I+   +H  +I I
Sbjct: 36  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-----TLREIKILLRFRHENIIGI 90

Query: 66  YDAFESSNVMC-----VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK 120
            D   +  +       +V +L+E      +++     L+   +  F+ QI  G+++IHS 
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA 147

Query: 121 NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEVV 174
           NVLH D+KP N+L    T   +KI DFGLAR  DP+      F T E+V      APE++
Sbjct: 148 NVLHRDLKPSNLLL--NTTCDLKICDFGLARVADPDHD-HTGFLT-EYVATRWYRAPEIM 203

Query: 175 -NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDD 232
            N        D+WSVG I   +LS    F G+  +  + ++         E  N I +  
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263

Query: 233 AKDFIRKLLLKDRED 247
           A++++  L  K++  
Sbjct: 264 ARNYLLSLPHKNKVP 278

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  105 bits (264), Expect = 8e-27
 Identities = 61/250 (24%), Positives = 115/250 (46%), Gaps = 29/250 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G+V    +  TG+ +A K +    ++    +   RE+ +++ ++H  +I + D F  
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99

Query: 72  SNVMC------VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           +  +       +V  L+   +L   ++     LT+  V   + QI  G+++IHS +++H 
Sbjct: 100 ARSLEEFNDVYLVTHLMGA-DL-NNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHR 156

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEVV-NFDA 178
           D+KP N+         +KI+DFGLAR    E           +V      APE++ N+  
Sbjct: 157 DLKPSNLAV--NEDCELKILDFGLARHTADEM--------TGYVATRWYRAPEIMLNWMH 206

Query: 179 IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-SDDAKDFI 237
                D+WSVG I   LL+G + F G   +  +  +         E   +I S+ A+++I
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266

Query: 238 RKLLLKDRED 247
           + L    + +
Sbjct: 267 QSLTQMPKMN 276

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  106 bits (267), Expect = 8e-27
 Identities = 52/260 (20%), Positives = 99/260 (38%), Gaps = 38/260 (14%)

Query: 8   HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQI 65
                 G  G V    +      +A K +    +N    +   RE+ +M+ + H  +I +
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126

Query: 66  YDAFESSNVMCVVLELIEGGELFE----RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
            + F     +    ++    EL +    +VI  +  L  + ++  + Q+  G++ +HS  
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 184

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV------APEVVN 175
           ++H D+KP NI  + K+   +KI+DFGLAR       +        +V      APEV+ 
Sbjct: 185 IIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRYYRAPEVIL 236

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF--------DDECFN 227
                   D+WSVG I   ++     F G           I Q++           E   
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD--------YIDQWNKVIEQLGTPCPEFMK 288

Query: 228 EISDDAKDFIRKLLLKDRED 247
           ++    ++++          
Sbjct: 289 KLQPTVRNYVENRPKYAGLT 308

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  105 bits (263), Expect = 1e-26
 Identities = 55/256 (21%), Positives = 102/256 (39%), Gaps = 30/256 (11%)

Query: 8   HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQI 65
                 G  G V    +      +A K +    +N    +   RE+ +M+ + H  +I +
Sbjct: 30  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89

Query: 66  YDAFESSNVMC------VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS 119
            + F     +       +V+EL++   L  +VI  +  L  + ++  + Q+  G++ +HS
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDA-NL-CQVIQME--LDHERMSYLLYQMLCGIKHLHS 145

Query: 120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAI 179
             ++H D+KP NI  + K+   +KI+DFGLAR       +     T  + APEV+     
Sbjct: 146 AGIIHRDLKPSNI--VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203

Query: 180 GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF--------DDECFNEISD 231
               D+WSVG I   ++ G   F G           I Q++           E   ++  
Sbjct: 204 KENVDIWSVGCIMGEMIKGGVLFPGTD--------HIDQWNKVIEQLGTPCPEFMKKLQP 255

Query: 232 DAKDFIRKLLLKDRED 247
             + ++          
Sbjct: 256 TVRTYVENRPKYAGYS 271

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  101 bits (255), Expect = 2e-25
 Identities = 54/215 (25%), Positives = 83/215 (38%), Gaps = 40/215 (18%)

Query: 49  REVEIMRELQHPRLIQIYDAFESSNVMC-----VVLELIEGGELFERVI-DDDFVLTEKA 102
           RE+ ++    HP ++ + D F            +V EL+       +VI D   V++ + 
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQH 135

Query: 103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL 162
           +  FM  I  G+  +H   V+H D+ P NIL      N I I DF LAR+   +      
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDTADANK--- 190

Query: 163 FGTPEFV------APEVV-NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVT 215
                +V      APE+V  F       DMWS G +   + +  + F G T         
Sbjct: 191 ---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST--------F 239

Query: 216 IAQYDF--------DDECFNEI-SDDAKDFIRKLL 241
             Q +           E      S  A+D++R  L
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL 274

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  100 bits (252), Expect = 4e-25
 Identities = 51/242 (21%), Positives = 99/242 (40%), Gaps = 61/242 (25%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER-------EVEIMRELQH-----PR 61
           G FG V  C+        A K V        RN+++       E +I++++Q+       
Sbjct: 46  GTFGRVLLCQHIDNKKYYAVKVV--------RNIKKYTRSAKIEADILKKIQNDDINNNN 97

Query: 62  LIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIHSK 120
           +++ +  F   + MC++ E + G  L+E +  +++     + + ++  +I + + ++   
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156

Query: 121 NVLHLDMKPENIL-----------------------CLTKTGNRIKIIDFGLARKFDPEK 157
           ++ H D+KPENIL                               IK+IDFG A  F  + 
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-TFKSDY 215

Query: 158 KLQVL---FGTPEFVAPEVVNFDAIGFG----TDMWSVGVICYVLLSGLSPFMGETDVQT 210
              ++        + APEV+    +  G    +DMWS G +   L +G   F     ++ 
Sbjct: 216 HGSIINTRQ----YRAPEVI----LNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267

Query: 211 MA 212
           +A
Sbjct: 268 LA 269

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 99.3 bits (248), Expect = 1e-24
 Identities = 49/216 (22%), Positives = 96/216 (44%), Gaps = 13/216 (6%)

Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG+V  C+       TG  +A K +  +  + +R+ +RE++I++ L    +++     
Sbjct: 34  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93

Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
                  + +V+E +  G L + +      L    + ++  QIC+G+E++ S+  +H D+
Sbjct: 94  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDL 153

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGT 183
              N   L ++   +KI DFGLA+    +K   V+    +      APE ++ +     +
Sbjct: 154 AARN--ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQS 211

Query: 184 DMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQ 218
           D+WS GV+ Y L +          +   M       
Sbjct: 212 DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 98.6 bits (246), Expect = 1e-24
 Identities = 46/224 (20%), Positives = 85/224 (37%), Gaps = 40/224 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAK-FVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA---- 68
           G++G V+R   +  G  +A K F    +++  R  E E+     L+H  ++    +    
Sbjct: 19  GRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFR--ETELYNTVMLRHENILGFIASDMTS 74

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDF----VLTEKAVAIFMRQICEGVEFIHSK---- 120
             SS  + ++    E G L+      D+     L   +    +  I  G+  +H +    
Sbjct: 75  RHSSTQLWLITHYHEMGSLY------DYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 121 ----NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-----GTPEFVAP 171
                + H D+K +NIL   K   +  I D GLA           +      GT  ++AP
Sbjct: 129 QGKPAIAHRDLKSKNIL--VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 172 EV----VNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQ 209
           EV    +  D        D+W+ G++ + +   +       D +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 97.9 bits (244), Expect = 4e-24
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 42/225 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAK-FVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA---- 68
           G+FG V+R K +  G  +A K F    +R+  R  E E+     L+H  ++    A    
Sbjct: 53  GRFGEVWRGKWR--GEEVAVKIFSSREERSWFR--EAEIYQTVMLRHENILGFIAADNKD 108

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDF----VLTEKAVAIFMRQICEGVEFIHSK---- 120
             +   + +V +  E G LF      D+     +T + +         G+  +H +    
Sbjct: 109 NGTWTQLWLVSDYHEHGSLF------DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 121 ----NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-----GTPEFVAP 171
                + H D+K +NIL   K      I D GLA + D       +      GT  ++AP
Sbjct: 163 QGKPAIAHRDLKSKNIL--VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 172 EVVNFDAIGFGT-------DMWSVGVICYVLLSGLSPFMGETDVQ 209
           EV++ D+I           D++++G++ + +    S      D Q
Sbjct: 221 EVLD-DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 97.1 bits (242), Expect = 6e-24
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 12/194 (6%)

Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +     R+ ERE+EI++ LQH  +++     
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111

Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGT 183
              N   L +  NR+KI DFGL +    +K+   +    E      APE +        +
Sbjct: 172 ATRN--ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVAS 229

Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 230 DVWSFGVVLYELFT 243

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 98.7 bits (246), Expect = 6e-24
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 35/220 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G++G VY    K   +T+A K +    + D   VE   +E  +M+E++HP L+Q+     
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286

Query: 71  SSNVMCVVLELIEGGELFERVIDDDF-------VLTEKAVAIFMRQICEGVEFIHSKNVL 123
                 ++ E +  G L       D+        ++   +     QI   +E++  KN +
Sbjct: 287 REPPFYIITEFMTYGNL------LDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 340

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFD-------PEKKLQVLFGTPEFVAPEVVNF 176
           H ++   N  CL    + +K+ DFGL+R             K  +     ++ APE + +
Sbjct: 341 HRNLAARN--CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-----KWTAPESLAY 393

Query: 177 DAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           +     +D+W+ GV+ + + + G+SP+ G    Q    + 
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 96.7 bits (241), Expect = 8e-24
 Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 38/223 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G++G V+  K +  G  +A K     +       E E+     ++H  ++    A     
Sbjct: 48  GRYGEVWMGKWR--GEKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFIAADIKGT 104

Query: 74  V----MCVVLELIEGGELFERVIDDDF----VLTEKAVAIFMRQICEGVEFIHSKN---- 121
                + ++ +  E G L+      D+     L  K++         G+  +H++     
Sbjct: 105 GSWTQLYLITDYHENGSLY------DYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 122 ----VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-----GTPEFVAPE 172
               + H D+K +NIL   K      I D GLA KF  +     +      GT  ++ PE
Sbjct: 159 GKPAIAHRDLKSKNIL--VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 173 V----VNFDAIGFGT--DMWSVGVICYVLLSGLSPFMGETDVQ 209
           V    +N +        DM+S G+I + +           + Q
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 95.8 bits (239), Expect = 1e-23
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 12/194 (6%)

Query: 14  GKFGTVYRCK----EKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG+V  C+    +  TG  +A K +  +     R+ ERE+EI++ LQH  +++     
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80

Query: 70  ESSNV--MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            S+    + +++E +  G L + +      +    +  +  QIC+G+E++ +K  +H D+
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 140

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGT 183
              N   L +  NR+KI DFGL +    +K+   +    E      APE +        +
Sbjct: 141 ATRN--ILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVAS 198

Query: 184 DMWSVGVICYVLLS 197
           D+WS GV+ Y L +
Sbjct: 199 DVWSFGVVLYELFT 212

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 96.9 bits (242), Expect = 1e-23
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 9/208 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G FG V+  + +A    +A K        + +    +E  I+++  HP ++++       
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + +V+EL++GG+    +  +   L  K +   +     G+E++ SK  +H D+   N 
Sbjct: 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN- 243

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGTDMWSV 188
            CL    N +KI DFG++R+   +       G  +      APE +N+      +D+WS 
Sbjct: 244 -CLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301

Query: 189 GVICYVLLS-GLSPFMGETDVQTMANVT 215
           G++ +   S G SP+   ++ QT   V 
Sbjct: 302 GILLWETFSLGASPYPNLSNQQTREFVE 329

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 96.1 bits (240), Expect = 1e-23
 Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 14/211 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FGTVY+      G  +    V I            + +  E  +M  + +P + ++  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
              +S V  ++ +L+  G L + V +    +  + +  +  QI +G+ ++  + ++H D+
Sbjct: 85  ICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 143

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT--P-EFVAPEVVNFDAIGFGTD 184
              N   L KT   +KI DFGLA+    E+K     G   P +++A E +        +D
Sbjct: 144 AARN--VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201

Query: 185 MWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +WS GV  + L++ G  P+ G    +  + +
Sbjct: 202 VWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 96.3 bits (240), Expect = 2e-23
 Identities = 66/278 (23%), Positives = 113/278 (40%), Gaps = 58/278 (20%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQ-HPRLIQIYDAF- 69
           G +G V++  ++ TG  +A K +  A +N  D +   RE+ I+ EL  H  ++ + +   
Sbjct: 20  GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR 79

Query: 70  -ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            ++   + +V + +E       VI  + +L        + Q+ + ++++HS  +LH DMK
Sbjct: 80  ADNDRDVYLVFDYMETD--LHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMK 136

Query: 129 PENIL----CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP----------------EF 168
           P NIL    C       +K+ DFGL+R F   +++                       ++
Sbjct: 137 PSNILLNAEC------HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190

Query: 169 V------APEV-VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF 221
           V      APE+ +       G DMWS+G I   +L G   F G +        T+ Q + 
Sbjct: 191 VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG-SS-------TMNQLER 242

Query: 222 --------DDECFNEI-SDDAKDFIRKLLLKDREDAPE 250
                    +E    I S  AK  I  L  K       
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSN 280

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 95.1 bits (237), Expect = 4e-23
 Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 57/238 (23%)

Query: 14  GKFGTVYRCKEKATGMTLAA-KFVGIAKRNDRRNVER-------EVEIMRELQHP----- 60
           G FG V  C + A G +  A K +        RNV +       E+ ++++++       
Sbjct: 30  GTFGKVVECLDHARGKSQVALKII--------RNVGKYREAARLEINVLKKIKEKDKENK 81

Query: 61  -RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIH 118
              + + D F     MC+  EL+ G   FE + +++F       V     Q+C  + F+H
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 119 SKNVLHLDMKPENIL-----------------CLTKTGNRIKIIDFGLARKFDPEKKLQV 161
              + H D+KPENIL                   +     I++ DFG A  FD E    +
Sbjct: 141 ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-TFDHEHHTTI 199

Query: 162 L---FGTPEFVAPEVVNFDAIGFG----TDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
           +        +  PEV+    +  G     D+WS+G I +    G + F    + + + 
Sbjct: 200 VATRH----YRPPEVI----LELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 95.0 bits (237), Expect = 4e-23
 Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 61/240 (25%)

Query: 14  GKFGTVYRCKEKATGMTLAA-KFVGIAKRNDRRNVER-------EVEIMRELQHP----- 60
           G FG V  C +   G    A K V        +NV+R       E++++  L        
Sbjct: 25  GAFGKVVECIDHKAGGRHVAVKIV--------KNVDRYCEAARSEIQVLEHLNTTDPNST 76

Query: 61  -RLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFV-LTEKAVAIFMRQICEGVEFIH 118
            R +Q+ + FE    +C+V EL+ G   ++ + ++ F+      +     QIC+ V F+H
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135

Query: 119 SKNVLHLDMKPENIL-----------------CLTKTGNRIKIIDFGLARKFDPEKKLQV 161
           S  + H D+KPENIL                   T     IK++DFG A  +D E    +
Sbjct: 136 SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TYDDEHHSTL 194

Query: 162 LFGTPEFV-----APEVVNFDAIGFG----TDMWSVGVICYVLLSGLSPFMGETDVQTMA 212
           +            APEV+    +  G     D+WS+G I      G + F      + +A
Sbjct: 195 V------STRHYRAPEVI----LALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 96.6 bits (240), Expect = 4e-23
 Identities = 50/209 (23%), Positives = 98/209 (46%), Gaps = 11/209 (5%)

Query: 14  GKFGTVYR--CKEKATGMTLAAK-FVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG+V +   + +   + +A K      ++ D   + RE +IM +L +P ++++    +
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +  +M +V+E+  GG L + ++     +    VA  + Q+  G++++  KN +H ++   
Sbjct: 407 AEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAAR 465

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGTDMW 186
           N   L    +  KI DFGL++    +          ++     APE +NF      +D+W
Sbjct: 466 N--VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 523

Query: 187 SVGVICYVLLS-GLSPFMGETDVQTMANV 214
           S GV  +  LS G  P+      + MA +
Sbjct: 524 SYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 94.4 bits (235), Expect = 6e-23
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 45/224 (20%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEI--MRELQHPRLIQIYDA--- 68
           G+FG V++ +       +A K   I    D+++ + E E+  +  ++H  ++Q   A   
Sbjct: 35  GRFGCVWKAQLL--NEYVAVK---IFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKR 89

Query: 69  -FESSNVMCVVLELIEGGELFERVIDDDF----VLTEKAVAIFMRQICEGVEFIHSK--- 120
                  + ++    E G L       DF    V++   +      +  G+ ++H     
Sbjct: 90  GTSVDVDLWLITAFHEKGSLS------DFLKANVVSWNELCHIAETMARGLAYLHEDIPG 143

Query: 121 -------NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-----KLQVLFGTPEF 168
                   + H D+K +N+L   K      I DFGLA KF+  K       QV  GT  +
Sbjct: 144 LKDGHKPAISHRDIKSKNVL--LKNNLTACIADFGLALKFEAGKSAGDTHGQV--GTRRY 199

Query: 169 VAPEV----VNFDAIGFG-TDMWSVGVICYVLLSGLSPFMGETD 207
           +APEV    +NF    F   DM+++G++ + L S  +   G  D
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 93.9 bits (234), Expect = 7e-23
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 13/195 (6%)

Query: 14  GKFGTVYRCK----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG V  C+       TG  +A K +   +  N   ++++E+EI+R L H  +++    
Sbjct: 32  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 91

Query: 69  --FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
              +  N + +++E +  G L E +  +   +  K    +  QIC+G++++ S+  +H D
Sbjct: 92  CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRD 151

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFG 182
           +   N   L ++ +++KI DFGL +  + +K+   +    +      APE +        
Sbjct: 152 LAARN--VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA 209

Query: 183 TDMWSVGVICYVLLS 197
           +D+WS GV  + LL+
Sbjct: 210 SDVWSFGVTLHELLT 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 93.1 bits (232), Expect = 8e-23
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 11/209 (5%)

Query: 14  GKFGTVYR--CKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG+V +   + +   + +A K +    ++ D   + RE +IM +L +P ++++    +
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 80

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +  +M +V+E+  GG L + ++     +    VA  + Q+  G++++  KN +H D+   
Sbjct: 81  AEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR 139

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGTDMW 186
           N   L    +  KI DFGL++    +          ++     APE +NF      +D+W
Sbjct: 140 N--VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197

Query: 187 SVGVICYVLLS-GLSPFMGETDVQTMANV 214
           S GV  +  LS G  P+      + MA +
Sbjct: 198 SYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 93.2 bits (232), Expect = 2e-22
 Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 14/211 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FGTVY+      G  +    V I            + +  E  +M  + +P + ++  
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
              +S V  ++ +L+  G L + V +    +  + +  +  QI +G+ ++  + ++H D+
Sbjct: 85  ICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 143

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT--P-EFVAPEVVNFDAIGFGTD 184
              N   L KT   +KI DFGLA+    E+K     G   P +++A E +        +D
Sbjct: 144 AARN--VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201

Query: 185 MWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +WS GV  + L++ G  P+ G    +  + +
Sbjct: 202 VWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 91.5 bits (228), Expect = 4e-22
 Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 14/212 (6%)

Query: 14  GKFGTVYR--CKEKATGMTLAA----KFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG V R      +      A    K   +++     +  REV  M  L H  LI++Y 
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY- 87

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
               +  M +V EL   G L +R+           ++ +  Q+ EG+ ++ SK  +H D+
Sbjct: 88  GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGT 183
              N   L  T + +KI DFGL R         V+    +      APE +        +
Sbjct: 148 AARN--LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 205

Query: 184 DMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           D W  GV  + + + G  P++G    Q +  +
Sbjct: 206 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 91.2 bits (227), Expect = 5e-22
 Identities = 47/210 (22%), Positives = 94/210 (44%), Gaps = 13/210 (6%)

Query: 14  GKFGTVYR--CKEKATGMTLAAKF--VGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FGTV +   + K    T+A K           +  +  E  +M++L +P ++++    
Sbjct: 28  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI-GI 86

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
             +    +V+E+ E G L + +  +   + +K +   + Q+  G++++   N +H D+  
Sbjct: 87  CEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNFVHRDLAA 145

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGTDM 185
            N   L  T +  KI DFGL++    ++         ++     APE +N+      +D+
Sbjct: 146 RN--VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 203

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           WS GV+ +   S G  P+ G    +  A +
Sbjct: 204 WSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 91.6 bits (228), Expect = 5e-22
 Identities = 44/211 (20%), Positives = 95/211 (45%), Gaps = 14/211 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FGTV++      G ++    V I      + R   + V   +  +  L H  ++++  
Sbjct: 24  GVFGTVHKGVWIPEGESIKIP-VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG 82

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
               S++  +V + +  G L + V      L  + +  +  QI +G+ ++    ++H ++
Sbjct: 83  LCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNL 141

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT--P-EFVAPEVVNFDAIGFGTD 184
              N   L K+ +++++ DFG+A    P+ K  +      P +++A E ++F      +D
Sbjct: 142 AARN--VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSD 199

Query: 185 MWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +WS GV  + L++ G  P+ G    +    +
Sbjct: 200 VWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 91.2 bits (227), Expect = 7e-22
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 16/213 (7%)

Query: 14  GKFGTVYRCK----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG V           TG  +A K +   A    R   ++E++I+R L H  +I+    
Sbjct: 42  GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGC 101

Query: 69  --FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
                +  + +V+E +  G L + +      +    + +F +QICEG+ ++H+++ +H D
Sbjct: 102 CEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRD 159

Query: 127 MKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFG 182
           +   N   L      +KI DFGLA+      +   +    +      APE +      + 
Sbjct: 160 LAARN--VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA 217

Query: 183 TDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +D+WS GV  Y LL+   S     T    +  +
Sbjct: 218 SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 90.4 bits (225), Expect = 2e-21
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 11/211 (5%)

Query: 14  GKFGTVYRCKEKATG---MTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G  G V   + +  G   + +A K +        RR+   E  IM +  HP +I++    
Sbjct: 60  GDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV 119

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
               +  +V E +E G L   +   D   T   +   +R +  G+ ++     +H D+  
Sbjct: 120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAA 179

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGTDM 185
            N   L  +    K+ DFGL+R  + +          +      APE + F      +D+
Sbjct: 180 RN--VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDV 237

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           WS GV+ + +L+ G  P+   T+   +++V 
Sbjct: 238 WSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 90.7 bits (225), Expect = 2e-21
 Identities = 41/231 (17%), Positives = 83/231 (35%), Gaps = 44/231 (19%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMR--ELQHPRLIQIYDA--- 68
           G++G VY+         +A K   +    +R+N   E  I R   ++H  + +       
Sbjct: 24  GRYGAVYKGSLD--ERPVAVK---VFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDER 78

Query: 69  --FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS------- 119
              +      +V+E    G L + +          +       +  G+ ++H+       
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDH 136

Query: 120 --KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---------GTPEF 168
               + H D+   N+L   K      I DFGL+ +    + ++            GT  +
Sbjct: 137 YKPAISHRDLNSRNVL--VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194

Query: 169 VAPEV-------VNFDAIGFGTDMWSVGVICYVLLSG---LSPFMGETDVQ 209
           +APEV        + ++     DM+++G+I + +      L P     + Q
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 91.5 bits (227), Expect = 2e-21
 Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 21/212 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V+      T   +A K +            +E ++M++L+H +L+Q+Y       
Sbjct: 278 GCFGEVWMGTWNGTT-RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP 335

Query: 74  VMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           +  +V E +  G L  F +     ++   + V     QI  G+ ++   N +H D++  N
Sbjct: 336 IY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD-MAAQIASGMAYVERMNYVHRDLRAAN 393

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFDAIGFGTD 184
              L       K+ DFGLAR  +          K  +     ++ APE   +      +D
Sbjct: 394 --ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-----KWTAPEAALYGRFTIKSD 446

Query: 185 MWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           +WS G++   L + G  P+ G  + + +  V 
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 88.9 bits (221), Expect = 5e-21
 Identities = 51/231 (22%), Positives = 98/231 (42%), Gaps = 40/231 (17%)

Query: 14  GKFGTVYRCK---EKATGMTLAAKFV--GIAKRNDRRNVEREVEIMRELQHPRLIQIY-- 66
           G+FG+V   +   E  + + +A K +   I   +D     RE   M+E  HP + ++   
Sbjct: 34  GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93

Query: 67  ----DAFESSNVMCVVLELIEGGELFE-----RVIDDDFVLTEKAVAIFMRQICEGVEFI 117
                A     +  V+L  ++ G+L       R+ ++ F L  + +  FM  I  G+E++
Sbjct: 94  SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL 153

Query: 118 HSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVLFGTPEFV---A 170
            S+N +H D+   N  C+      + + DFGL+RK        +        P  V   A
Sbjct: 154 SSRNFIHRDLAARN--CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--P--VKWLA 207

Query: 171 PEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
            E     ++        +D+W+ GV  + +++ G +P+ G  + +    + 
Sbjct: 208 LE-----SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 88.1 bits (219), Expect = 7e-21
 Identities = 38/219 (17%), Positives = 73/219 (33%), Gaps = 22/219 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA-------KRNDRRNVEREVEIMRELQHPRLIQIY 66
           G F  +++   +  G         +         RN   +      +M +L H  L+  Y
Sbjct: 19  GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNY 78

Query: 67  DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
                 +   +V E ++ G L   +  +   +         +Q+   + F+    ++H +
Sbjct: 79  GVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGN 138

Query: 127 MKPENIL------CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTP-EFVAPEVVNFDAI 179
           +  +NIL        T     IK+ D G++    P+  LQ        +V PE +     
Sbjct: 139 VCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE----RIPWVPPECIENPKN 194

Query: 180 GFGT--DMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
                 D WS G   + + S G  P       + +    
Sbjct: 195 -LNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 87.3 bits (217), Expect = 1e-20
 Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 31/221 (14%)

Query: 14  GKFGTVYRCKEKATG---MTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA- 68
           G FG VY  +        +  A K +  I +        RE  +MR L HP ++ +    
Sbjct: 32  GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
                +  V+L  +  G+L + +       T K +  F  Q+  G+E++  +  +H D+ 
Sbjct: 92  LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA 151

Query: 129 PENILCLTKTGNRIKIIDFGLARK------FDPEKKLQVLFGTPEFV---APEVVNFDAI 179
             N  C+      +K+ DFGLAR       +  ++        P  V   A E     ++
Sbjct: 152 ARN--CMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--P--VKWTALE-----SL 200

Query: 180 GFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
                   +D+WS GV+ + LL+ G  P+           +
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 86.9 bits (216), Expect = 2e-20
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 25/215 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G++G VY    K   +T+A K +    + D   VE   +E  +M+E++HP L+Q+     
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 71  SSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
                 ++ E +  G L  + R  +    ++   +     QI   +E++  KN +H D+ 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFDAIGF 181
             N  CL    + +K+ DFGL+R    +        K  +     ++ APE + ++    
Sbjct: 139 ARN--CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-----KWTAPESLAYNKFSI 191

Query: 182 GTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
            +D+W+ GV+ + + + G+SP+ G    Q    + 
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 88.6 bits (220), Expect = 2e-20
 Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 29/213 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA-FESS 72
           G+FG V     +  G  +A K   I      +    E  +M +L+H  L+Q+     E  
Sbjct: 204 GEFGDVMLGDYR--GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259

Query: 73  NVMCVVLELIEGGELFERVIDDDF-------VLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
             + +V E +  G L       D+       VL    +  F   +CE +E++   N +H 
Sbjct: 260 GGLYIVTEYMAKGSL------VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313

Query: 126 DMKPENILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
           D+   N   L    N  K+ DFGL +         KL V     ++ APE +        
Sbjct: 314 DLAARN--VLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTK 366

Query: 183 TDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +D+WS G++ + + S G  P+        +  V
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 88.7 bits (220), Expect = 2e-20
 Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 21/212 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V+      T   +A K +            +E ++M++L+H +L+Q+Y       
Sbjct: 195 GCFGEVWMGTWNGTT-RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP 252

Query: 74  VMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           +  +V E +  G L  F +     ++   + V     QI  G+ ++   N +H D++  N
Sbjct: 253 IY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD-MAAQIASGMAYVERMNYVHRDLRAAN 310

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFDAIGFGTD 184
              L       K+ DFGLAR  +          K  +     ++ APE   +      +D
Sbjct: 311 --ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-----KWTAPEAALYGRFTIKSD 363

Query: 185 MWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           +WS G++   L + G  P+ G  + + +  V 
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 87.4 bits (217), Expect = 3e-20
 Identities = 46/211 (21%), Positives = 89/211 (42%), Gaps = 11/211 (5%)

Query: 14  GKFGTVYRCKEKATG---MTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G+FG V   + K      +++A K +        RR+   E  IM +  HP +I++    
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
             S  + +V E +E G L   +   D   T   +   +R I  G++++     +H D+  
Sbjct: 116 TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 175

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGTDM 185
            N   L  +    K+ DFGL R  + + +        +      +PE + +      +D+
Sbjct: 176 RN--ILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           WS G++ + ++S G  P+   ++   +  V 
Sbjct: 234 WSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 87.5 bits (217), Expect = 3e-20
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 23/218 (10%)

Query: 14  GKFGTVYRCKEKATG---MTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA- 68
           G FG VY           +  A K +  I    +      E  IM++  HP ++ +    
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 159

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             S     VVL  ++ G+L   + ++    T K +  F  Q+ +G++F+ SK  +H D+ 
Sbjct: 160 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 219

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV-----APEVVNFDAIGFG- 182
             N  C+      +K+ DFGLAR    ++   V   T   +     A E     ++    
Sbjct: 220 ARN--CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-----SLQTQK 272

Query: 183 ----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
               +D+WS GV+ + L++ G  P+           + 
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 85.7 bits (213), Expect = 4e-20
 Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 20/214 (9%)

Query: 14  GKFGTVYR---CKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FG VY       K   + +A K        +++     E  IM+ L HP ++++    
Sbjct: 23  GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           E      +++EL   GEL   +  +   L    + ++  QIC+ + ++ S N +H D+  
Sbjct: 83  EEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAV 141

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFDAIGFG 182
            N   L  +   +K+ DFGL+R  + E        +L +     ++++PE +NF      
Sbjct: 142 RN--ILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-----KWMSPESINFRRFTTA 194

Query: 183 TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           +D+W   V  + +LS G  PF    +   +  + 
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 88.0 bits (218), Expect = 5e-20
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 20/213 (9%)

Query: 14  GKFGTVYR---CKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G+FG V++      +   M +A K        + R    +E   MR+  HP ++++    
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
             + V  +++EL   GEL   +    F L   ++ ++  Q+   + ++ SK  +H D+  
Sbjct: 461 TENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 519

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFDAIGFG 182
            N   L  + + +K+ DFGL+R  +          KL +     +++APE +NF      
Sbjct: 520 RN--VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-----KWMAPESINFRRFTSA 572

Query: 183 TDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +D+W  GV  + +L  G+ PF G  +   +  +
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 85.3 bits (212), Expect = 5e-20
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 37/220 (16%)

Query: 14  GKFGTVYRCKEKAT----------GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLI 63
           G+FG V+                 G      F+             E E+M +L HP+L+
Sbjct: 19  GQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFI------------EEAEVMMKLSHPKLV 66

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           Q+Y        +C+V E +E G L + +     +   + +      +CEG+ ++    V+
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNF 176
           H D+   N  CL      IK+ DFG+ R    +        K  V     ++ +PEV +F
Sbjct: 127 HRDLAARN--CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWASPEVFSF 179

Query: 177 DAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
                 +D+WS GV+ + + S G  P+   ++ + + +++
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 85.8 bits (213), Expect = 6e-20
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 31/211 (14%)

Query: 14  GKFGTVYRCKEKATG---MTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA- 68
           G FG VY           +  A K +  I    +      E  IM++  HP ++ +    
Sbjct: 36  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             S     VVL  ++ G+L   + ++    T K +  F  Q+ +G++++ SK  +H D+ 
Sbjct: 96  LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155

Query: 129 PENILCLTKTGNRIKIIDFGLARK------FDPEKKLQVLFGTPEFV---APEVVNFDAI 179
             N  C+      +K+ DFGLAR       +    K       P  V   A E     ++
Sbjct: 156 ARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--P--VKWMALE-----SL 204

Query: 180 GFG-----TDMWSVGVICYVLLS-GLSPFMG 204
                   +D+WS GV+ + L++ G  P+  
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 86.2 bits (214), Expect = 6e-20
 Identities = 44/213 (20%), Positives = 91/213 (42%), Gaps = 14/213 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G+FG VY+   K +        V I           R +   E  IM +  H  +I++  
Sbjct: 55  GEFGEVYKGMLKTSSGKKEVP-VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
                  M ++ E +E G L + + + D   +   +   +R I  G++++ + N +H D+
Sbjct: 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 173

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEF----VAPEVVNFDAIGFGT 183
              N   L  +    K+ DFGL+R  + + +        +      APE +++      +
Sbjct: 174 AARN--ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 231

Query: 184 DMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           D+WS G++ + +++ G  P+   ++ + M  + 
Sbjct: 232 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.4 bits (212), Expect = 8e-20
 Identities = 45/229 (19%), Positives = 95/229 (41%), Gaps = 39/229 (17%)

Query: 14  GKFGTVYRCK---EKATGMTLAAKFV--GIAKRNDRRNVEREVEIMRELQHPRLIQIY-- 66
           G+FG+V       E  T + +A K +    + + +      E   M++  HP +I++   
Sbjct: 45  GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104

Query: 67  ---DAFESSNVMCVVLELIEGGELFE-----RVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
               + +      V+L  ++ G+L       R+      +  + +  FM  I  G+E++ 
Sbjct: 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS 164

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVLFGTPEFV---AP 171
           ++N LH D+   N  C+ +    + + DFGL++K        +        P  V   A 
Sbjct: 165 NRNFLHRDLAARN--CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--P--VKWIAI 218

Query: 172 EVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           E     ++        +D+W+ GV  + + + G++P+ G  + +    +
Sbjct: 219 E-----SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 85.0 bits (211), Expect = 9e-20
 Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 20/213 (9%)

Query: 14  GKFGTVYR---CKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G+FG V++      +   + +A K        + R    +E   MR+  HP ++++    
Sbjct: 26  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
             + V  +++EL   GEL   +    + L   ++ ++  Q+   + ++ SK  +H D+  
Sbjct: 86  TENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 144

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFDAIGFG 182
            N   L  + + +K+ DFGL+R  +          KL +      ++APE +NF      
Sbjct: 145 RN--VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-----WMAPESINFRRFTSA 197

Query: 183 TDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           +D+W  GV  + +L  G+ PF G  +   +  +
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 84.2 bits (209), Expect = 2e-19
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G+FG V   K K     +A K +    +    + +   +E + M +L HP+L++ Y    
Sbjct: 19  GQFGVVKLGKWKGQ-YDVAVKMI----KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + +V E I  G L   +      L    +      +CEG+ F+ S   +H D+   
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAAR 133

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           N  CL      +K+ DFG+ R    +        K  V     ++ APEV ++      +
Sbjct: 134 N--CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV-----KWSAPEVFHYFKYSSKS 186

Query: 184 DMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           D+W+ G++ + + S G  P+   T+ + +  V+
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 85.9 bits (213), Expect = 2e-19
 Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 21/212 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G+FG V+          +A K +             E  +M+ LQH +L++++ A  +  
Sbjct: 199 GQFGEVWMATYNKHT-KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLH-AVVTKE 255

Query: 74  VMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            + ++ E +  G L  F +  +       K +  F  QI EG+ FI  +N +H D++  N
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-FSAQIAEGMAFIEQRNYIHRDLRAAN 314

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEK-------KLQVLFGTPEFVAPEVVNFDAIGFGTD 184
              L       KI DFGLAR  +  +       K  +     ++ APE +NF +    +D
Sbjct: 315 --ILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-----KWTAPEAINFGSFTIKSD 367

Query: 185 MWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           +WS G++   +++ G  P+ G ++ + +  + 
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 83.8 bits (208), Expect = 2e-19
 Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 21/210 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDA-FES 71
           G+FG V        G  +A K +   K +   +    E  +M +L+H  L+Q+     E 
Sbjct: 32  GEFGDVMLGD--YRGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86

Query: 72  SNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              + +V E +  G L  + R      VL    +  F   +CE +E++   N +H D+  
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 145

Query: 130 ENILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
            N   L    N  K+ DFGL +         KL V     ++ APE +        +D+W
Sbjct: 146 RN--VLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSDVW 198

Query: 187 SVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           S G++ + + S G  P+        +  V 
Sbjct: 199 SFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 83.4 bits (207), Expect = 3e-19
 Identities = 48/213 (22%), Positives = 92/213 (43%), Gaps = 23/213 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G+FG V   K +     +A K +    +    + +    E ++M  L H +L+Q+Y    
Sbjct: 35  GQFGVVKYGKWRGQ-YDVAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               + ++ E +  G L   + +       + +    + +CE +E++ SK  LH D+   
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 149

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPE-------KKLQVLFGTPEFVAPEVVNFDAIGFGT 183
           N  CL      +K+ DFGL+R    +        K  V      +  PEV+ +      +
Sbjct: 150 N--CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-----RWSPPEVLMYSKFSSKS 202

Query: 184 DMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           D+W+ GV+ + + S G  P+   T+ +T  ++ 
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 82.8 bits (205), Expect = 6e-19
 Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 22/196 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH----PRLIQIYDAF 69
           G FG +Y   + A G  +A K      +     +  E +I + +Q     P +     A 
Sbjct: 20  GSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRW-CGAE 76

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              NVM  V+EL+ G  L +         + K V +   Q+   +E+IHSKN +H D+KP
Sbjct: 77  GDYNVM--VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 133

Query: 130 ENILC-LTKTGNRIKIIDFGLARKF-DPEKKLQV-------LFGTPEFVAPEVVNFDAIG 180
           +N L  L K GN + IIDFGLA+K+ D      +       L GT  + +          
Sbjct: 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193

Query: 181 FGTDMWSVGVICYVLL 196
              D+ S+G   YVL+
Sbjct: 194 RRDDLESLG---YVLM 206

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 82.8 bits (205), Expect = 1e-18
 Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 37/229 (16%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG VY  +        + + +A K +  +    D  +   E  I+ +  H  +++   
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141

Query: 68  AFESSNVMCVVLELIEGGEL--FER----VIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
               S    ++LEL+ GG+L  F R           L    +    R I  G +++   +
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201

Query: 122 VLHLDMKPENILCLTKTGNRI-KIIDFGLAR--------KFDPEKKLQVLFGTPEFVAPE 172
            +H D+   N L       R+ KI DFG+AR        +      L V     +++ PE
Sbjct: 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV-----KWMPPE 256

Query: 173 VVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
                A   G     TD WS GV+ + + S G  P+  +++ + +  VT
Sbjct: 257 -----AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 82.4 bits (204), Expect = 1e-18
 Identities = 50/229 (21%), Positives = 89/229 (38%), Gaps = 37/229 (16%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG VY  +        + + +A K +  +    D  +   E  I+ +  H  +++   
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 100

Query: 68  AFESSNVMCVVLELIEGGELFE------RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN 121
               S    +++EL+ GG+L                L    +    R I  G +++   +
Sbjct: 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160

Query: 122 VLHLDMKPENILCLTKTGNRI-KIIDFGLAR--------KFDPEKKLQVLFGTPEFVAPE 172
            +H D+   N L       R+ KI DFG+AR        +      L V     +++ PE
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-----KWMPPE 215

Query: 173 VVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
                A   G     TD WS GV+ + + S G  P+  +++ + +  VT
Sbjct: 216 -----AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 82.5 bits (204), Expect = 1e-18
 Identities = 30/184 (16%), Positives = 65/184 (35%), Gaps = 34/184 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS- 72
           G FG +Y           A   V + +  +   +  E++  + +     I+ +   +   
Sbjct: 48  GGFGLIYLAFPTNKPEKDARHVVKV-EYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD 106

Query: 73  --------------------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICE 112
                                 M  V+E +  G   +++   +    +  V     ++ +
Sbjct: 107 YLGIPLFYGSGLTEFKGRSYRFM--VMERL--GIDLQKISGQNGTFKKSTVLQLGIRMLD 162

Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEKKLQV-------LFG 164
            +E+IH    +H D+K  N+L   K  +++ + D+GL+ ++       Q          G
Sbjct: 163 VLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG 222

Query: 165 TPEF 168
           T EF
Sbjct: 223 TIEF 226

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 81.7 bits (202), Expect = 2e-18
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 32/202 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH----PRLIQIYDAF 69
           G FG +   K   T   +A K      ++    +  E    ++L      P++   +   
Sbjct: 20  GNFGELRLGKNLYTNEYVAIKLE--PMKSRAPQLHLEYRFYKQLGSGDGIPQVYY-FGPC 76

Query: 70  ESSNVMCVVLELIEGG----ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
              N M  VLEL+  G    +LF+     D   + K V +   Q+   +E++HSKN+++ 
Sbjct: 77  GKYNAM--VLELL--GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKNLIYR 129

Query: 126 DMKPENIL---CLTKTGNRIKIIDFGLARKF-DPEKKLQV-------LFGTPEFVAPEVV 174
           D+KPEN L      KT   I IIDF LA+++ DPE K  +       L GT  +++    
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTH 189

Query: 175 NFDAIGFGTDMWSVGVICYVLL 196
                    D+ ++G   ++ +
Sbjct: 190 LGKEQSRRDDLEALG---HMFM 208

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 81.6 bits (202), Expect = 2e-18
 Identities = 46/235 (19%), Positives = 94/235 (40%), Gaps = 45/235 (19%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG V+  +      +   M +A K +  A  + R++ +RE E++  LQH  +++ +  
Sbjct: 52  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 111

Query: 69  FESSNVMCVVLELIEGGEL--------------FERVIDDDFVLTEKAVAIFMRQICEGV 114
                 + +V E +  G+L                        L    +     Q+  G+
Sbjct: 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171

Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--------KFDPEKKLQVLFGTP 166
            ++   + +H D+   N  CL   G  +KI DFG++R        +      L +     
Sbjct: 172 VYLAGLHFVHRDLATRN--CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI----- 224

Query: 167 EFVAPEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
            ++ PE     +I +      +D+WS GV+ + + + G  P+   ++ + +  +T
Sbjct: 225 RWMPPE-----SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 82.7 bits (204), Expect = 3e-18
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 25/207 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH----PRLIQIYDAF 69
           G FG +Y      T   +A K      +     +  E +I R LQ     P +   +   
Sbjct: 18  GSFGEIYLGTNIQTNEEVAIKLE--NVKTKHPQLLYESKIYRILQGGTGIPNVRW-FGVE 74

Query: 70  ESSNVMCVVLELIEG---GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
              NV+  V++L+ G    +LF         L+ K V +   Q+   VEF+HSK+ LH D
Sbjct: 75  GDYNVL--VMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128

Query: 127 MKPENILC-LTKTGNRIKIIDFGLARKF-DPEKKLQV-------LFGTPEFVAPEVVNFD 177
           +KP+N L  L +  N++ IIDFGLA+K+ D      +       L GT  + +       
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI 188

Query: 178 AIGFGTDMWSVGVICYVLLSGLSPFMG 204
                 D+ S+G +    L G  P+ G
Sbjct: 189 EQSRRDDLESLGYVLMYFLRGSLPWQG 215

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 80.7 bits (200), Expect = 3e-18
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 39/221 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVE---REVEIMRELQHPRLIQIYDAFE 70
           G+FG V+          +A K +    +    + +    E  +M++LQH RL+++Y A  
Sbjct: 24  GQFGEVWMGYYNGH-TKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 77

Query: 71  SSNVMCVVLELIEGGEL--FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           +   + ++ E +E G L  F +       LT   +     QI EG+ FI  +N +H D++
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136

Query: 129 PENILCLTKTGNRIKIIDFGLAR-------------KFDPEKKLQVLFGTPEFVAPEVVN 175
             N   L       KI DFGLAR             KF P K            APE +N
Sbjct: 137 AAN--ILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWT----------APEAIN 183

Query: 176 FDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           +      +D+WS G++   +++ G  P+ G T+ + + N+ 
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 80.9 bits (200), Expect = 3e-18
 Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 27/209 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH----PRLIQIYDAF 69
           G FG ++          +A KF    +R+D   +  E    + L      P +   +   
Sbjct: 21  GSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYY-FGQE 77

Query: 70  ESSNVMCVVLELIEG---GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
              NV+  V++L+ G    +L +         + K VA+  +Q+   V+ IH K++++ D
Sbjct: 78  GLHNVL--VIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 131

Query: 127 MKPENILC---LTKTGNRIKIIDFGLARKF-DPEKKLQV-------LFGTPEFVAPEVVN 175
           +KP+N L     +K  N I ++DFG+ + + DP  K  +       L GT  +++     
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 191

Query: 176 FDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
                   D+ ++G +    L G  P+ G
Sbjct: 192 GREQSRRDDLEALGHVFMYFLRGSLPWQG 220

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.7 bits (200), Expect = 4e-18
 Identities = 48/236 (20%), Positives = 95/236 (40%), Gaps = 46/236 (19%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FG V+  +          M +A K +       R++ +RE E++  LQH  +++ Y  
Sbjct: 26  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 85

Query: 69  FESSNVMCVVLELIEGGEL---------------FERVIDDDFVLTEKAVAIFMRQICEG 113
               + + +V E ++ G+L                 +       L    +     QI  G
Sbjct: 86  CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145

Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--------KFDPEKKLQVLFGT 165
           + ++ S++ +H D+   N  CL      +KI DFG++R        +      L +    
Sbjct: 146 MVYLASQHFVHRDLATRN--CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI---- 199

Query: 166 PEFVAPEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
             ++ PE     +I +      +D+WS GVI + + + G  P+   ++ + +  +T
Sbjct: 200 -RWMPPE-----SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 79.2 bits (196), Expect = 1e-17
 Identities = 50/236 (21%), Positives = 84/236 (35%), Gaps = 45/236 (19%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
            +FG VY+            + V I      A+   R     E  +   LQHP ++ +  
Sbjct: 20  DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLG 79

Query: 68  AFESSNVMCVVLELIEGGEL---------------FERVIDDDFVLTEKAVAIFMRQICE 112
                  + ++      G+L                +        L        + QI  
Sbjct: 80  VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 139

Query: 113 GVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVLFGTPEF 168
           G+E++ S +V+H D+   N   L      +KI D GL R+             L   P  
Sbjct: 140 GMEYLSSHHVVHKDLATRN--VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL--P-- 193

Query: 169 V---APEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           +   APE     AI +G     +D+WS GV+ + + S GL P+ G ++   +  + 
Sbjct: 194 IRWMAPE-----AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 78.5 bits (194), Expect = 3e-17
 Identities = 44/231 (19%), Positives = 88/231 (38%), Gaps = 41/231 (17%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG VY        +      +A K V   A   +R     E  +M+E     ++++  
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95

Query: 68  AFESSNVMCVVLELIEGGELFE---------RVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
                    V++EL+  G+L                    +   +     +I +G+ +++
Sbjct: 96  VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 155

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--------KFDPEKKLQVLFGTPEFVA 170
           +   +H D+   N  C+      +KI DFG+ R        +   +  L V      +++
Sbjct: 156 ANKFVHRDLAARN--CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-----RWMS 208

Query: 171 PEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           PE     ++  G     +D+WS GV+ + + +    P+ G ++ Q +  V 
Sbjct: 209 PE-----SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 79.2 bits (195), Expect = 3e-17
 Identities = 48/252 (19%), Positives = 92/252 (36%), Gaps = 67/252 (26%)

Query: 13  FGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-----HP---RLIQ 64
           +G F TV+   +      +A K V  +  +       E+ +++ ++      P    ++Q
Sbjct: 47  WGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105

Query: 65  IYDAFESSNV----MCVVLELIEGGELFERVID--DDFVLTEKAVAIFMRQICEGVEFIH 118
           + D F+ S V    +C+V E++  G    + I   +   L    V   ++Q+ +G++++H
Sbjct: 106 LLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163

Query: 119 SK-NVLHLDMKPENIL-------------------------------------------- 133
           +K  ++H D+KPENIL                                            
Sbjct: 164 TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVN 223

Query: 134 ---CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
                     ++KI D G A      K       T ++ + EV+         D+WS   
Sbjct: 224 PLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTAC 281

Query: 191 ICYVLLSGLSPF 202
           + + L +G   F
Sbjct: 282 MAFELATGDYLF 293

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 76.9 bits (190), Expect = 1e-16
 Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 42/231 (18%)

Query: 14  GKFGTVYRC--KEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAF 69
           G FG V +   K+    M  A K +   A ++D R+   E+E++ +L  HP +I +  A 
Sbjct: 36  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95

Query: 70  ESSNVMCVVLELIEGGEL---------------FERVIDDDFVLTEKAVAIFMRQICEGV 114
           E    + + +E    G L               F         L+ + +  F   +  G+
Sbjct: 96  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155

Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-----PEKKLQVLFGTPEFV 169
           +++  K  +H D+   N   L       KI DFGL+R  +        +L V      ++
Sbjct: 156 DYLSQKQFIHRDLAARN--ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RWM 208

Query: 170 APEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANV 214
           A E     ++ +      +D+WS GV+ + ++S G +P+ G T  +    +
Sbjct: 209 AIE-----SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 75.2 bits (185), Expect = 6e-16
 Identities = 39/215 (18%), Positives = 81/215 (37%), Gaps = 40/215 (18%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRN--VEREVEIMRELQHPRLIQIYDAFES 71
           G FG +Y   +  +  ++ +    + K     N  +  E++  +    P  IQ +     
Sbjct: 46  GGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104

Query: 72  S---------------------NVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQ 109
                                   M  +++    G   +++ +      + K V     +
Sbjct: 105 LKYLGVPKYWGSGLHDKNGKSYRFM--IMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ--------V 161
           I + +E+IH    +H D+K  N+L   K  +++ ++D+GLA ++ PE   +         
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC 220

Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLL 196
             GT EF + +  N  A     D+  +G   Y ++
Sbjct: 221 HDGTIEFTSIDAHNGVAPSRRGDLEILG---YCMI 252

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 74.3 bits (183), Expect = 1e-15
 Identities = 49/248 (19%), Positives = 91/248 (36%), Gaps = 61/248 (24%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG V++ +            +A K +   A  + + + +RE  +M E  +P ++++  
Sbjct: 58  GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 117

Query: 68  AFESSNVMCVVLELIEGGEL-----------------------FERVIDDDFVLTEKAVA 104
                  MC++ E +  G+L                                 L+     
Sbjct: 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 177

Query: 105 IFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--------KFDPE 156
              RQ+  G+ ++  +  +H D+   N  CL      +KI DFGL+R        K D  
Sbjct: 178 CIARQVAAGMAYLSERKFVHRDLATRN--CLVGENMVVKIADFGLSRNIYSADYYKADGN 235

Query: 157 KKLQVLFGTPEFV---APEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETD 207
             +      P  +    PE     +I +      +D+W+ GV+ + + S GL P+ G   
Sbjct: 236 DAI------P--IRWMPPE-----SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282

Query: 208 VQTMANVT 215
            + +  V 
Sbjct: 283 EEVIYYVR 290

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.0 bits (177), Expect = 8e-15
 Identities = 54/239 (22%), Positives = 92/239 (38%), Gaps = 48/239 (20%)

Query: 14  GKFGTVYRCK-------EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQ 64
           G FG V   +       +      +A K +   A   D  ++  E+E+M+ + +H  +I 
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 139

Query: 65  IYDAFESSNVMCVVLELIEGGEL---------------FERVIDDDFVLTEKAVAIFMRQ 109
           +  A      + V++E    G L               +    + +  L+ K +     Q
Sbjct: 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVLFGT 165
           +  G+E++ SK  +H D+   N   L    N +KI DFGLAR         K        
Sbjct: 200 VARGMEYLASKKCIHRDLAARN--VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL-- 255

Query: 166 PEFV---APEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           P  V   APE     A+        +D+WS GV+ + + + G SP+ G    +    + 
Sbjct: 256 P--VKWMAPE-----ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 70.7 bits (174), Expect = 1e-14
 Identities = 53/244 (21%), Positives = 102/244 (41%), Gaps = 53/244 (21%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G+FG V +        +A   T+A K +   A  ++ R++  E  +++++ HP +I++Y 
Sbjct: 34  GEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYG 93

Query: 68  AFESSNVMCVVLELIEGGEL-----------------------FERVIDDDFVLTEKAVA 104
           A      + +++E  + G L                             D+  LT   + 
Sbjct: 94  ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLI 153

Query: 105 IFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQ 160
            F  QI +G++++    ++H D+   N   L   G ++KI DFGL+R    E    K+ Q
Sbjct: 154 SFAWQISQGMQYLAEMKLVHRDLAARN--ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ 211

Query: 161 VLFGTPEFV---APEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTM 211
                P  V   A E     ++        +D+WS GV+ + +++ G +P+ G    +  
Sbjct: 212 GRI--P--VKWMAIE-----SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262

Query: 212 ANVT 215
             + 
Sbjct: 263 NLLK 266

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 41/163 (25%), Positives = 65/163 (39%), Gaps = 26/163 (15%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQIY 66
           G FG V         +    MT+A K +   A   +R  +  E++++  L  H  ++ + 
Sbjct: 34  GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93

Query: 67  DAFESSNVMCVVLELIEGGEL-----------------FERVIDDDFVLTEKAVAIFMRQ 109
            A        V+ E    G+L                    + DD+  L  + +  F  Q
Sbjct: 94  GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK 152
           + +G+ F+ SKN +H D+   N   L   G   KI DFGLAR 
Sbjct: 154 VAKGMAFLASKNCIHRDLAARN--ILLTHGRITKICDFGLARD 194

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 54/239 (22%), Positives = 95/239 (39%), Gaps = 48/239 (20%)

Query: 14  GKFGTVYRCK-------EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQ 64
           G FG V   +       +    +T+A K +   A   D  ++  E+E+M+ + +H  +I 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105

Query: 65  IYDAFESSNVMCVVLELIEGGEL---------------FERVIDDDFVLTEKAVAIFMRQ 109
           +  A      + V++E    G L               ++     +  +T K +     Q
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 165

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVLFGT 165
           +  G+E++ S+  +H D+   N   L    N +KI DFGLAR  +      K        
Sbjct: 166 LARGMEYLASQKCIHRDLAARN--VLVTENNVMKIADFGLARDINNIDYYKKTTNGRL-- 221

Query: 166 PEFV---APEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
           P  V   APE     A+        +D+WS GV+ + + + G SP+ G    +    + 
Sbjct: 222 P--VKWMAPE-----ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 47/227 (20%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQIY 66
           G FG V         + AT  T+A K +   A  ++ R +  E++I+  +  H  ++ + 
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97

Query: 67  DA-FESSNVMCVVLELIEGGEL---------------FERVIDDDFVLTEKAVAIFMRQI 110
            A  +    + V++E  + G L                         LT + +  +  Q+
Sbjct: 98  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 157

Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVLFGTP 166
            +G+EF+ S+  +H D+   N   L    N +KI DFGLAR    +    +K       P
Sbjct: 158 AKGMEFLASRKCIHRDLAARN--ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--P 213

Query: 167 EFV---APEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMG 204
             +   APE      I        +D+WS GV+ + + S G SP+ G
Sbjct: 214 --LKWMAPE-----TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 54/229 (23%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQIY 66
           G FG V         ++   + +A K +   A  +++  +  E++IM  L QH  ++ + 
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116

Query: 67  DAFESSNVMCVVLELIEGGEL-------------FERVIDDDFVLTEKAVAIFMRQICEG 113
            A      + V+ E    G+L                    +   + + +  F  Q+ +G
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG 176

Query: 114 VEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFV---- 169
           + F+ SKN +H D+   N+L     G+  KI DFGLAR          +     ++    
Sbjct: 177 MAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD---------IMNDSNYIVKGN 225

Query: 170 --------APEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMG 204
                   APE     +I        +D+WS G++ + + S GL+P+ G
Sbjct: 226 ARLPVKWMAPE-----SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.8 bits (171), Expect = 4e-14
 Identities = 18/80 (22%), Positives = 37/80 (46%), Gaps = 8/80 (10%)

Query: 97  VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP- 155
           VL+E++V     ++ + +EF+H    +H ++  ENI    +  +++ +  +G A ++ P 
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214

Query: 156 -------EKKLQVLFGTPEF 168
                  E       G  EF
Sbjct: 215 GKHVAYVEGSRSPHEGDLEF 234

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 69.7 bits (171), Expect = 5e-14
 Identities = 54/240 (22%), Positives = 98/240 (40%), Gaps = 50/240 (20%)

Query: 14  GKFGTVYRCK-------EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQ 64
           G FG V   +       +    +T+A K +   A   D  ++  E+E+M+ + +H  +I 
Sbjct: 92  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 151

Query: 65  IYDAFESSNVMCVVLELIEGGEL---------------FERVIDDDFVLTEKAVAIFMRQ 109
           +  A      + V++E    G L               ++     +  +T K +     Q
Sbjct: 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR--------KFDPEKKLQV 161
           +  G+E++ S+  +H D+   N   L    N +KI DFGLAR        K     +L V
Sbjct: 212 LARGMEYLASQKCIHRDLAARN--VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269

Query: 162 LFGTPEFVAPEVVNFDAIGFG-----TDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT 215
                +++APE     A+        +D+WS GV+ + + + G SP+ G    +    + 
Sbjct: 270 -----KWMAPE-----ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 65.0 bits (159), Expect = 2e-12
 Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 31/168 (18%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQIY 66
           G FG V         +    + +A K +   A  ++R  +  E+++M +L  H  ++ + 
Sbjct: 56  GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 115

Query: 67  DAFESSNVMCVVLELIEGGEL----------------------FERVIDDDFVLTEKAVA 104
            A   S  + ++ E    G+L                           +D  VLT + + 
Sbjct: 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175

Query: 105 IFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK 152
            F  Q+ +G+EF+  K+ +H D+   N   L   G  +KI DFGLAR 
Sbjct: 176 CFAYQVAKGMEFLEFKSCVHRDLAARN--VLVTHGKVVKICDFGLARD 221

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 35/118 (29%), Positives = 58/118 (49%), Gaps = 10/118 (8%)

Query: 93  DDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK 152
                LT + +  +  Q+ +G+EF+ S+  +H D+   N   L    N +KI DFGLAR 
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN--ILLSEKNVVKICDFGLARD 242

Query: 153 FDPE----KKLQVLFGTP-EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMG 204
              +    +K       P +++APE +        +D+WS GV+ + + S G SP+ G
Sbjct: 243 IYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 39.1 bits (91), Expect = 8e-04
 Identities = 21/136 (15%), Positives = 52/136 (38%), Gaps = 15/136 (11%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMREL-QHPRLIQIY 66
           G FG V         + AT  T+A K +   A  ++ R +  E++I+  +  H  ++ + 
Sbjct: 33  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92

Query: 67  DA-FESSNVMCVVLELIEGGELFERVIDDDFVLTEK-AVAIFMRQICEGVEFIHSKNVLH 124
            A  +    + V++E  + G L        ++ +++     +  +     +       + 
Sbjct: 93  GACTKPGGPLMVIVEFCKFGNL------STYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 125 LDMKPENILCLTKTGN 140
           +D+K       +   +
Sbjct: 147 VDLKRRLDSITSSQSS 162

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 52.9 bits (128), Expect = 2e-08
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 36/209 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER----EVEIMRELQHPRLIQIYDAF 69
           G FG VY  K      T+A K +          +++    E+++M + QH  L+++    
Sbjct: 42  GGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS 99

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAI---FMR-QICEGV----EFIHSKN 121
              + +C+V   +  G L       D +            MR +I +G      F+H  +
Sbjct: 100 SDGDDLCLVYVYMPNGSL------LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV---LFGTPEFVAPEVVNFDA 178
            +H D+K  NIL L +     KI DFGLAR  +   +  +   + GT  ++APE +    
Sbjct: 154 HIHRDIKSANIL-LDEAFTA-KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR--- 208

Query: 179 IGFG-----TDMWSVGVICYVLLSGLSPF 202
              G     +D++S GV+   +++GL   
Sbjct: 209 ---GEITPKSDIYSFGVVLLEIITGLPAV 234

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 50.3 bits (119), Expect = 2e-07
 Identities = 38/245 (15%), Positives = 68/245 (27%), Gaps = 68/245 (27%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--------KRNDRRNVEREVEIMRELQH------ 59
           G FG V++     T   +A K + I          +     +  E+ I +EL        
Sbjct: 31  GVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC 88

Query: 60  --------------------PRLIQIYDAFESSNVMC-------------VVLELIEGGE 86
                               P L++ +D + S+                 +VLE   GG 
Sbjct: 89  NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGI 148

Query: 87  LFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKII 145
             E++     + +       + Q+   +    +     H D+   N+  L K  +  K+ 
Sbjct: 149 DLEQMRTK--LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV--LLKKTSLKKLH 204

Query: 146 DFGLARKFD-PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG 204
                +    P   LQV                            V+   +      F G
Sbjct: 205 YTLNGKSSTIPSCGLQVSIID-------------YTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 205 ETDVQ 209
           + D Q
Sbjct: 252 DGDYQ 256

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 45.3 bits (108), Expect = 7e-06
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 25/173 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR---RNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG VY+   +  G  +A K                E E+E +   +HP L+ +    +
Sbjct: 50  GVFGKVYKGVLR-DGAKVALK---RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105

Query: 71  SSNVMCVVLELIEGGELFERVIDDD---FVLTEKAVAIFMR-QICEGV----EFIHSKNV 122
             N M ++ + +E G L   +   D     ++ +      R +IC G      ++H++ +
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ-----RLEICIGAARGLHYLHTRAI 160

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV---LFGTPEFVAPE 172
           +H D+K  NIL L +     KI DFG+++K     +  +   + GT  ++ PE
Sbjct: 161 IHRDVKSINIL-LDENFV-PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 41.4 bits (98), Expect = 1e-04
 Identities = 46/208 (22%), Positives = 82/208 (39%), Gaps = 32/208 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVER----EVEIMRELQHPRLIQIYDAF 69
           G FG VY+ +    G  +A K +   K    +  E     EVE++    H  L+++    
Sbjct: 41  GGFGKVYKGRLA-DGTLVAVKRL---KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFM-----RQIC----EGVEFIHSK 120
            +     +V   +  G +         +         +     ++I      G+ ++H  
Sbjct: 97  MTPTERLLVYPYMANGSV------ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150

Query: 121 ---NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV---LFGTPEFVAPEVV 174
               ++H D+K  NIL L +      + DFGLA+     K   V   + GT   +APE +
Sbjct: 151 CDPKIIHRDVKAANIL-LDEEFE-AVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYL 207

Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPF 202
           +       TD++  GV+   L++G   F
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAF 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.2 bits (93), Expect = 5e-04
 Identities = 32/302 (10%), Positives = 79/302 (26%), Gaps = 82/302 (27%)

Query: 8   HSAFSFGKF-GTVYRCKEKATGM----TLAAKFVG-IAKRNDR-RNVEREVE-------- 52
                F  F   +  C    T +     L  +       R+D   N++  +         
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 53  IMRELQHPR--LI-------QIYDAFESSNVMCVVL---------ELIEGGELFERVIDD 94
           +++   +    L+       + ++AF   N+ C +L         + +         +D 
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAWNAF---NLSCKILLTTRFKQVTDFLSAATTTHISLDH 293

Query: 95  -DFVLTE-KAVAIFM-----------RQICEG--------VEFI-----HSKNVLHLD-M 127
               LT  +  ++ +           R++            E I        N  H++  
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353

Query: 128 KPENIL-----CLTKTGNRIKIIDFGLARKFD---PEKKLQVLFG-----TPEFVAPEVV 174
           K   I+      L     R       +        P   L +++          V  ++ 
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPP-SAHIPTILLSLIWFDVIKSDVMVVVNKLH 412

Query: 175 NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE-CFNEISDDA 233
            +  +    +         +    L   +   +   +    +  Y+       +++    
Sbjct: 413 KYSLV----EKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468

Query: 234 KD 235
            D
Sbjct: 469 LD 470

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 38.8 bits (90), Expect = 8e-04
 Identities = 25/111 (22%), Positives = 45/111 (40%), Gaps = 15/111 (13%)

Query: 40  KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLT 99
                R+   E   +++LQ   + ++Y          V++ELI+  EL+        V  
Sbjct: 144 SVLAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR-------VRV 192

Query: 100 EKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLA 150
           E    +    I E V   + + ++H D+   N+L    +   I IIDF  +
Sbjct: 193 ENPDEVL-DMILEEVAKFYHRGIVHGDLSQYNVLV---SEEGIWIIDFPQS 239

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	251
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.6
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.33
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.31
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.09
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	99.01
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.95
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.77
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.74
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.7
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.69
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.4
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.39
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.29
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.29
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.09
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.08
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	98.06
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.89
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.84
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.83
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.71
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.62
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.52
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.37
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.19
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.77
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.47
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.33
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.91
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.77

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.6e-64  Score=399.20  Aligned_cols=242  Identities=29%  Similarity=0.518  Sum_probs=221.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++...   +....+.+.+|++++++++||||+++++++++++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999999999999999998643   2345788999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC---
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE---  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~---  156 (251)
                      ||++||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||+  +.++.+||+|||++......   
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl--~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE--cCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999987754 69999999999999999999999999999999999999  99999999999999876433   


Q ss_pred             CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        157 KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++..+...++    ..+++++++|
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  264 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDL  264 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHHHH
Confidence            234556899999999999999999999999999999999999999999999999998888776554    5789999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |++||++||++|||+
T Consensus       265 i~~lL~~dp~~R~t~  279 (311)
T 4aw0_A          265 VEKLLVLDATKRLGC  279 (311)
T ss_dssp             HHHHSCSSGGGSTTS
T ss_pred             HHHHccCCHhHCcCh
Confidence            999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-63  Score=400.44  Aligned_cols=244  Identities=25%  Similarity=0.477  Sum_probs=221.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.++||+|+||+||+|.++.+++.||+|++........+.+.+|+.++++++||||+++++++.+++.+|+||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999999999999999998777677888999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~~  161 (251)
                      +|++|.+++...  .+++..++.++.|++.||.|||++||+||||||+|||+  +.+|++||+|||++...... .....
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE--CCCCCEEEecCcCceecCCCCCcccc
Confidence            999999988764  59999999999999999999999999999999999999  99999999999999876543 34456


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhc
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL  241 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (251)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.... ......+..+|+++++||.+||
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~dli~~~L  308 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKGFLDRLL  308 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCCCSCGGGSCHHHHHHHHHHS
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccccCCHHHHHHHHHHc
Confidence            789999999999999999999999999999999999999999998888887776543 3344455789999999999999


Q ss_pred             ccCcCCCCCC
Q psy11805        242 LKDREDAPEV  251 (251)
Q Consensus       242 ~~~p~~Rps~  251 (251)
                      +.||++|||+
T Consensus       309 ~~dP~~R~ta  318 (346)
T 4fih_A          309 VRDPAQRATA  318 (346)
T ss_dssp             CSSTTTSCCH
T ss_pred             CCChhHCcCH
Confidence            9999999985

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-63  Score=401.87  Aligned_cols=244  Identities=23%  Similarity=0.481  Sum_probs=213.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++++.||+|+||+||+|+++.+++.||+|++....  ....+.+.+|++++++++||||+++++++++++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999986443  3346789999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-c
Q psy11805         81 LIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-K  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~  158 (251)
                      |++|++|.+++...+ ..+++..++.|+.|++.||.|||++||+||||||+|||+  +.++++||+|||+++...... .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL--TKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE--CTTCCEEECSTTEESCCCHHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE--CCCCCEEEcccccceeecCCccc
Confidence            999999999997643 457999999999999999999999999999999999999  899999999999998764332 2


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+...++..+..+.   .+..+|+++++||.
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~li~  258 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHH
T ss_pred             ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHHHHH
Confidence            234579999999999999999999999999999999999999999999999888888776543   33678999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       259 ~~L~~dP~~R~s~  271 (350)
T 4b9d_A          259 QLFKRNPRDRPSV  271 (350)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHccCChhHCcCH
Confidence            9999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.6e-63  Score=386.54  Aligned_cols=241  Identities=30%  Similarity=0.532  Sum_probs=202.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|++++++++||||+++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999999999999999986432   334678999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+ +++|.+.+...+ .+++..+..++.|++.||.|||++||+||||||+|||+  +.++++||+|||++.........
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL--DEHLNVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE--CTTCCEEECCSSCC---------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE--CCCCCEEEeecCCCeecCCCCcc
Confidence            999 568988887764 69999999999999999999999999999999999999  89999999999999887666666


Q ss_pred             eeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ...+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+..+....+..+...++    ..+|+++++||+
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  244 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLIK  244 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHHH
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            67789999999999998876 5799999999999999999999999988888888877765544    578999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       245 ~~L~~dP~~R~s~  257 (275)
T 3hyh_A          245 RMLIVNPLNRISI  257 (275)
T ss_dssp             HHSCSSGGGSCCH
T ss_pred             HHccCChhHCcCH
Confidence            9999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.7e-62  Score=402.12  Aligned_cols=244  Identities=25%  Similarity=0.477  Sum_probs=222.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.++||+|+||+||+|.++.+++.||+|++........+.+.+|+.+++.++||||+++++++.+++.+|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            57999999999999999999999999999999998777777888999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~~  161 (251)
                      +|++|.+++...  .+++..++.++.|++.||.|||++||+||||||+|||+  +.+|.+||+|||++...... .....
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl--~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE--CTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE--cCCCCEEEecCccceECCCCCccccc
Confidence            999999988654  49999999999999999999999999999999999999  99999999999999876543 34456


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhc
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL  241 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (251)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.... ......+..+++++++||.+||
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~dli~~~L  385 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKGFLDRLL  385 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSCTTSSCHHHHHHHHHHS
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCcccccCCHHHHHHHHHHc
Confidence            789999999999999999999999999999999999999999998888887776543 3334445789999999999999


Q ss_pred             ccCcCCCCCC
Q psy11805        242 LKDREDAPEV  251 (251)
Q Consensus       242 ~~~p~~Rps~  251 (251)
                      +.||++|||+
T Consensus       386 ~~dP~~R~ta  395 (423)
T 4fie_A          386 VRDPAQRATA  395 (423)
T ss_dssp             CSSTTTSCCH
T ss_pred             CCChhHCcCH
Confidence            9999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.2e-63  Score=390.25  Aligned_cols=242  Identities=29%  Similarity=0.513  Sum_probs=210.3

Q ss_pred             ccCCcccccccCCceEEEEEEEc---cCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      ++|++.+.||+|+||+||+|++.   .+++.||+|++....  ......+.+|++++++++||||+++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999884   457899999986432  2345578899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PE  156 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~  156 (251)
                      ||||++|++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||+  +.++++||+|||+++... ..
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE--CTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE--cCCCCEEecccccceeccCCC
Confidence            999999999999987754 69999999999999999999999999999999999999  999999999999997643 33


Q ss_pred             CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        157 KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ......+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......++    ..+|+++++|
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  256 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSL  256 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHHHH
Confidence            344566899999999999999999999999999999999999999999999999888887765543    5789999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |++||++||++|||+
T Consensus       257 i~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          257 LRMLFKRNPANRLGA  271 (304)
T ss_dssp             HHHHTCSSGGGSTTC
T ss_pred             HHHHcccCHHHCCCC
Confidence            999999999999984

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-61  Score=384.55  Aligned_cols=244  Identities=19%  Similarity=0.334  Sum_probs=213.9

Q ss_pred             ccCCcccccccCCceEEEEEEEc-----cCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      ++|.+.+.||+|+||+||+|.+.     .++..||+|++........+.+.+|++++++++||||+++++++.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            67999999999999999999875     3578899999976666667889999999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEe
Q psy11805         78 VLELIEGGELFERVIDD------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKII  145 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~  145 (251)
                      ||||+++|+|.+++...            ...+++..+..|+.|++.||.|||+++|+||||||+|||+  +.++.+||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl--~~~~~~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV--GENLLVKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE--CCCCcEEEC
Confidence            99999999999999753            2469999999999999999999999999999999999999  889999999


Q ss_pred             ecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccC
Q psy11805        146 DFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDF  221 (251)
Q Consensus       146 df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  221 (251)
                      |||+++........   ....+|+.|+|||.+.+..++.++||||||++||||+| |+.||.+.+..+....+..+....
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~  250 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ  250 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999765433222   23458999999999999999999999999999999998 999999999988888887765432


Q ss_pred             CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                         .+..+|+++.+|+.+||+.||++|||+
T Consensus       251 ---~p~~~~~~~~~li~~cl~~dP~~RPs~  277 (299)
T 4asz_A          251 ---RPRTCPQEVYELMLGCWQREPHMRKNI  277 (299)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ---CCccchHHHHHHHHHHcCCChhHCcCH
Confidence               236789999999999999999999984

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-61  Score=388.45  Aligned_cols=240  Identities=25%  Similarity=0.357  Sum_probs=208.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      +.|++.++||+|+||+||+|+++.+++.||+|++.....     ..+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            357788899999999999999999999999999865322     247999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-cEEEeecccccccCCCCc---
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEKK---  158 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~~~~~~---  158 (251)
                      +|++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||+  +.+| ++||+|||++........   
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL--SSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE--CTTSCCEEECCCTTCEEC--------
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE--eCCCCEEEEeeCCCCeEccCCCcccc
Confidence            9999999987654 69999999999999999999999999999999999999  7776 699999999987643321   


Q ss_pred             ---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        159 ---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                         ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++.....+. ...++.+|+.+++
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~~~~  288 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI-REIPPSCAPLTAQ  288 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG-GGSCTTSCHHHHH
T ss_pred             eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc-hhcCccCCHHHHH
Confidence               123469999999999999999999999999999999999999999887777777776654332 2345789999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      ||.+||+.||++|||+
T Consensus       289 li~~~L~~dP~~R~sa  304 (336)
T 4g3f_A          289 AIQEGLRKEPVHRASA  304 (336)
T ss_dssp             HHHHHTCSSGGGSCCH
T ss_pred             HHHHHccCCHhHCcCH
Confidence            9999999999999985

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.4e-60  Score=372.64  Aligned_cols=240  Identities=24%  Similarity=0.402  Sum_probs=204.4

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee----CCEEEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES----SNVMCVV   78 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv   78 (251)
                      |++.++||+|+||+||+|.+..++..||+|.+....  ....+.+.+|+.++++++||||+++++++.+    ++.+|+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            377888999999999999999999999999986432  3346779999999999999999999999865    3568999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeec-CCCcEEEeecccccccCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTK-TGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~~~  155 (251)
                      |||++|++|.+++...+ .+++..+..++.|++.||.|||++|  |+||||||+|||+  + .++.+||+|||++.... 
T Consensus       108 mEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl--~~~~g~vKl~DFGla~~~~-  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKR-  183 (290)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE--SSTTSCEEECCTTGGGGCC-
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE--ECCCCCEEEEeCcCCEeCC-
Confidence            99999999999987654 6999999999999999999999998  9999999999998  6 47899999999997643 


Q ss_pred             CCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhccccCCCccccCCCHHHH
Q psy11805        156 EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT-MANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      .......+||+.|+|||++.+ .++.++||||||+++|+|++|+.||...+.... ...+..+..  +...+..++++++
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~  260 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVK  260 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHH
T ss_pred             CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCCHHHH
Confidence            334456789999999999865 689999999999999999999999987655444 444443322  2234467889999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      +||.+||+.||++|||+
T Consensus       261 ~li~~~L~~dP~~R~s~  277 (290)
T 3fpq_A          261 EIIEGCIRQNKDERYSI  277 (290)
T ss_dssp             HHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHccCChhHCcCH
Confidence            99999999999999985

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.4e-60  Score=381.00  Aligned_cols=244  Identities=18%  Similarity=0.316  Sum_probs=208.5

Q ss_pred             ccCCcccccccCCceEEEEEEEc-----cCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      +++.+.++||+|+||+||+|.+.     .+++.||+|++...+....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56788899999999999999875     3578999999976666667889999999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         78 VLELIEGGELFERVIDD--------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      ||||+++|+|.+++...              ..++++..+..|+.|++.||.|||+.+|+||||||+|||+  +.++.+|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl--~~~~~~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--ETTTEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE--CCCCcEE
Confidence            99999999999988653              2458999999999999999999999999999999999999  8999999


Q ss_pred             EeecccccccCCCC---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc
Q psy11805        144 IIDFGLARKFDPEK---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQY  219 (251)
Q Consensus       144 l~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  219 (251)
                      |+|||+++......   ......+|+.|+|||.+.+..++.++||||||++||||+| |+.||...+..+....+..+..
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~  278 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE  278 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999998654332   2234568999999999999999999999999999999999 9999999998888888776542


Q ss_pred             cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .   +.+..+|+++.+|+.+||+.||++|||+
T Consensus       279 ~---~~p~~~~~~~~~li~~cl~~dP~~RPs~  307 (329)
T 4aoj_A          279 L---ERPRACPPEVYAIMRGCWQREPQQRHSI  307 (329)
T ss_dssp             C---CCCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred             C---CCcccccHHHHHHHHHHcCcChhHCcCH
Confidence            2   2336789999999999999999999984

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-59  Score=373.49  Aligned_cols=243  Identities=23%  Similarity=0.412  Sum_probs=202.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +++++.++||+|+||+||+|.+..   .||+|+++...  ....+.+.+|+.++++++||||+++++++.. +..++|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            578899999999999999997653   58999986433  3346789999999999999999999998865 45799999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC---C
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE---K  157 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~---~  157 (251)
                      |+++++|.+++......+++..+..|+.|++.||.|||++||+||||||+|||+  +.++.+||+|||++......   .
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl--~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL--HEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE--ETTEEEEECCCSSCBC--------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE--CCCCcEEEeeccCceecccCCcce
Confidence            999999999998777789999999999999999999999999999999999999  89999999999999765432   2


Q ss_pred             cceeeccCccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-cC-CCccccCCCHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNF---DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQY-DF-DDECFNEISDD  232 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~  232 (251)
                      .....+||+.|+|||++.+   ..++.++||||||++||||+||+.||...+............. .+ ....+..+|+.
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  269 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA  269 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence            2345579999999999864   3588999999999999999999999998776655544433332 22 22345688999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+|+.+||+.||++|||+
T Consensus       270 l~~li~~cl~~dP~~RPs~  288 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLF  288 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCH
T ss_pred             HHHHHHHHcCCCHhHCcCH
Confidence            9999999999999999984

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-59  Score=373.28  Aligned_cols=244  Identities=20%  Similarity=0.338  Sum_probs=211.3

Q ss_pred             ccCCcccccccCCceEEEEEEEc-----cCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      +++++.++||+|+||+||+|.+.     .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            46778899999999999999864     356889999986433 234678999999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc
Q psy11805         77 VVLELIEGGELFERVIDD---------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR  141 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~  141 (251)
                      +||||+++|+|.+++...               ...+++..+..|+.|++.||.|||+.+++||||||+|||+  +.+++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--~~~~~  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLN  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGC
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE--CCCCC
Confidence            999999999999998643               2358999999999999999999999999999999999999  89999


Q ss_pred             EEEeecccccccCCC---CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q psy11805        142 IKIIDFGLARKFDPE---KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA  217 (251)
Q Consensus       142 ~~l~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  217 (251)
                      +||+|||+++.....   .......+|+.|+|||.+.+..++.++||||||++||||+| |..||.+.+..+....+..+
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~  263 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR  263 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999999999765332   22334578999999999999999999999999999999998 89999999998888887765


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...   +.+..+|+++.+|+.+||+.||++|||+
T Consensus       264 ~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~  294 (308)
T 4gt4_A          264 QVL---PCPDDCPAWVYALMIECWNEFPSRRPRF  294 (308)
T ss_dssp             CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCC---CCcccchHHHHHHHHHHcCCChhHCcCH
Confidence            432   2346789999999999999999999984

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.7e-59  Score=398.07  Aligned_cols=249  Identities=46%  Similarity=0.813  Sum_probs=233.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++........+.+.+|+++|+.++||||+++++++.+++.+|+||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            68999999999999999999999999999999987666666788999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL  162 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~  162 (251)
                      +|++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||+..+..+.+||+|||++............
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~  316 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT  316 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEE
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeee
Confidence            99999999877666899999999999999999999999999999999999984445689999999999998877777788


Q ss_pred             ccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcc
Q psy11805        163 FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL  242 (251)
Q Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (251)
                      +||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++...+..+|+++++||++||+
T Consensus       317 ~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~  396 (573)
T 3uto_A          317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL  396 (573)
T ss_dssp             CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSC
T ss_pred             EECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence            99999999999999999999999999999999999999999999999999999988888888888999999999999999


Q ss_pred             cCcCCCCCC
Q psy11805        243 KDREDAPEV  251 (251)
Q Consensus       243 ~~p~~Rps~  251 (251)
                      .||.+|||+
T Consensus       397 ~dp~~R~t~  405 (573)
T 3uto_A          397 ADPNTRMTI  405 (573)
T ss_dssp             SSGGGSCCH
T ss_pred             CChhHCcCH
Confidence            999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.5e-58  Score=363.21  Aligned_cols=241  Identities=26%  Similarity=0.442  Sum_probs=191.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCC--------
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSN--------   73 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   73 (251)
                      ++|++++.||+|+||+||+|.++.+++.||+|++...+. ...+.+.+|++++++++||||+++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            479999999999999999999999999999999865443 34677899999999999999999999986543        


Q ss_pred             ----EEEEEEEeccCCchhHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeec
Q psy11805         74 ----VMCVVLELIEGGELFERVIDDDF--VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDF  147 (251)
Q Consensus        74 ----~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df  147 (251)
                          ..|+||||+++++|.+++.....  ..+...++.++.|+++||.|||++||+||||||+|||+  +.++.+||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl--~~~~~vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF--TMDDVVKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE--CCCCcEEEccC
Confidence                37999999999999999876542  24567789999999999999999999999999999999  89999999999


Q ss_pred             ccccccCCCCcc-------------eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q psy11805        148 GLARKFDPEKKL-------------QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD-VQTMAN  213 (251)
Q Consensus       148 ~~~~~~~~~~~~-------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~  213 (251)
                      |+++..+.....             ...+||+.|+|||++.+..++.++|||||||++|||++   ||.+... ......
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~  239 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD  239 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence            999876543221             23469999999999999999999999999999999996   7865322 222233


Q ss_pred             HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +.....   ++.+...++.+.+||++||++||++|||+
T Consensus       240 ~~~~~~---p~~~~~~~~~~~~li~~~L~~dP~~Rps~  274 (299)
T 4g31_A          240 VRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEA  274 (299)
T ss_dssp             HHTTCC---CHHHHHHCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhcCCC---CCCCcccCHHHHHHHHHHcCCChhHCcCH
Confidence            332222   22334567788999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-57  Score=372.23  Aligned_cols=246  Identities=24%  Similarity=0.363  Sum_probs=210.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee------CC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES------SN   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~   73 (251)
                      .++|++++.||+|+||+||+|.++.+++.||+|++....  ....+.+.+|+++++.++||||+++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            578999999999999999999999999999999986432  2345678899999999999999999999764      35


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      .+|+||||++| +|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||+  +.++.+||+|||++...
T Consensus       133 ~~~ivmE~~~g-~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~--~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          133 SVYVVLDLMES-DLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV--NENCELKIGDFGMARGL  208 (398)
T ss_dssp             CEEEEEECCSE-EHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTCCEEECCCTTCBCC
T ss_pred             EEEEEEeCCCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc--CCCCCEEEeecceeeec
Confidence            78999999975 788888665 479999999999999999999999999999999999999  99999999999999765


Q ss_pred             CCC-----CcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc---
Q psy11805        154 DPE-----KKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE---  224 (251)
Q Consensus       154 ~~~-----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  224 (251)
                      ...     ......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+......+...   
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            322     223456899999999998775 56899999999999999999999999999988888776554433321   


Q ss_pred             ------------------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 ------------------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                              .++.+++++.+||++||+.||++||||
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  339 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA  339 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH
Confidence                                    123578899999999999999999985

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.5e-57  Score=367.07  Aligned_cols=245  Identities=21%  Similarity=0.317  Sum_probs=205.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCC-----ceEEEEEecccc-ccchHHHHHHHHHHHHcCC-CceeeEeEEEee-CCE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATG-----MTLAAKFVGIAK-RNDRRNVEREVEIMRELQH-PRLIQIYDAFES-SNV   74 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~-~~~   74 (251)
                      ++|++.+.||+|+||+||+|.+..++     +.||+|.+.... ....+.+.+|+.+++++.| |||+++++++.. ++.
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            68999999999999999999987543     579999986433 2346779999999999965 899999999865 456


Q ss_pred             EEEEEEeccCCchhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC
Q psy11805         75 MCVVLELIEGGELFERVIDD---------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG  139 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~  139 (251)
                      .++|||||++|+|.+++...               ...+++..+..++.|++.||.|||+++++||||||+|||+  +.+
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl--~~~  221 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEK  221 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGG
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--CCC
Confidence            89999999999999998753               2348999999999999999999999999999999999999  889


Q ss_pred             CcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy11805        140 NRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVT  215 (251)
Q Consensus       140 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~  215 (251)
                      +.+||+|||+++.......   .....+|+.|+|||++.+..++.++||||||++||||+| |..||.+.+..+......
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i  301 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  301 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999987543322   233568999999999999999999999999999999998 999999876544443333


Q ss_pred             hccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        216 IAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....++.  .+..+|+++.+++.+||+.||++|||+
T Consensus       302 ~~g~~~~--~p~~~~~~~~~li~~c~~~dP~~RPt~  335 (353)
T 4ase_A          302 KEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTF  335 (353)
T ss_dssp             HHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HcCCCCC--CCccCCHHHHHHHHHHcCcChhHCcCH
Confidence            3333332  236789999999999999999999984

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-55  Score=358.84  Aligned_cols=243  Identities=24%  Similarity=0.383  Sum_probs=198.1

Q ss_pred             CCccCCcccccccCCceEEEEEEEc---cCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   76 (251)
                      +.++|++.+.||+|+||+||+|.++   .+++.||+|.+..  ......+.+|++.++.+ +||||+++++++.+++..|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~--~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIP--TSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECT--TSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcc--ccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            3578999999999999999999885   3567899998753  33466788999999998 5999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC-CcEEEeecccccccCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG-NRIKIIDFGLARKFDP  155 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~-~~~~l~df~~~~~~~~  155 (251)
                      +||||++|++|.+.+.    .+++..+..++.|++.||.|||++||+||||||+|||+  +.+ +.+||+|||+++....
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl--~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLY--NRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--ETTTTEEEECCCTTCEECTT
T ss_pred             EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEE--eCCCCeEEECcCCCCcccCC
Confidence            9999999999988873    48999999999999999999999999999999999998  655 7999999999975432


Q ss_pred             CC-----------------------------cceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11805        156 EK-----------------------------KLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGE  205 (251)
Q Consensus       156 ~~-----------------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~  205 (251)
                      ..                             .....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            21                             12234699999999999775 4889999999999999999999999654


Q ss_pred             -ChHHHHHHHHhcc--------------------------------------------------ccCCCccccCCCHHHH
Q psy11805        206 -TDVQTMANVTIAQ--------------------------------------------------YDFDDECFNEISDDAK  234 (251)
Q Consensus       206 -~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~~~  234 (251)
                       +..+.+..+....                                                  .....+.|..+|+++.
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence             4444433332100                                                  0011123567899999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      |||++||+.||++||||
T Consensus       331 DLl~~lL~~dP~~R~ta  347 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITA  347 (361)
T ss_dssp             HHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHCcCChhHCcCH
Confidence            99999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.5e-55  Score=373.79  Aligned_cols=240  Identities=25%  Similarity=0.425  Sum_probs=204.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHH---HHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVERE---VEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++....   ........+|   +.+++.++||||+++++++.+++.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            68999999999999999999999999999999985322   2223333444   45556678999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+  +.+|++||+|||++......
T Consensus       269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl--d~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE--eCCCCEEecccceeeecCCC
Confidence            9999999999999987764 69999999999999999999999999999999999999  99999999999999876543


Q ss_pred             CcceeeccCcccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccccCCCccccCCCHH
Q psy11805        157 KKLQVLFGTPEFVAPEVVN-FDAIGFGTDMWSVGVICYVLLSGLSPFMGET---DVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      . ....+||+.|+|||++. +..++.++|+|||||+||+|++|..||.+.+   ..+....+......    .+..+|++
T Consensus       346 ~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~----~p~~~S~~  420 (689)
T 3v5w_A          346 K-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPE  420 (689)
T ss_dssp             C-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC----CCTTSCHH
T ss_pred             C-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC----CCccCCHH
Confidence            3 35568999999999996 4578999999999999999999999997642   33344444444333    34678999


Q ss_pred             HHHHHHHhcccCcCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps  250 (251)
                      +++||++||+.||.+|++
T Consensus       421 a~dLI~~lL~~dP~~Rl~  438 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLG  438 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTT
T ss_pred             HHHHHHHHccCCHhHCCC
Confidence            999999999999999997

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-54  Score=348.11  Aligned_cols=250  Identities=38%  Similarity=0.730  Sum_probs=229.0

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.+++|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            468999999999999999999999999999999998643 3446778899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      ++++++|.+.+...+..+++..++.++.|++.||.|||+.|++|+||||+||++....++.++|+|||++..........
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~  161 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence            99999999998876667999999999999999999999999999999999999833337899999999998877666666


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+......+....+..+|.++.+||.+|
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  241 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred             cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence            77899999999999988889999999999999999999999999999999999988888887777789999999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.||.+|||+
T Consensus       242 L~~dp~~Rpt~  252 (321)
T 1tki_A          242 LVKERKSRMTA  252 (321)
T ss_dssp             SCSSGGGSCCH
T ss_pred             cCCChhHCcCH
Confidence            99999999985

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.1e-54  Score=350.78  Aligned_cols=248  Identities=44%  Similarity=0.823  Sum_probs=226.0

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc------chHHHHHHHHHHHHcCCCceeeEeEEEeeCCE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN------DRRNVEREVEIMRELQHPRLIQIYDAFESSNV   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            357899999999999999999999999999999998643322      35789999999999999999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC----cEEEeecccc
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN----RIKIIDFGLA  150 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~----~~~l~df~~~  150 (251)
                      .++|||+++|++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++    .++|+|||++
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll--~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--SCTTSSSCCEEECCCSSC
T ss_pred             EEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--eCCCCCccCEEEEecCCc
Confidence            99999999999999988664 469999999999999999999999999999999999998  5555    7999999999


Q ss_pred             cccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCC
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEIS  230 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (251)
                      ............++++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+......++...+..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence            88766655566779999999999999899999999999999999999999999999999999998888888877888999


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+++||++||..||.+|||+
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~  267 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTI  267 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHHHHHCCCChhHCcCH
Confidence            999999999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.6e-54  Score=345.47  Aligned_cols=244  Identities=20%  Similarity=0.239  Sum_probs=189.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC----EEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN----VMC   76 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   76 (251)
                      +.++|.+.+.||+|+||+||+|.++  ++.||+|++..... .....+.|+..+.+++||||+++++++..++    ..+
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            4578999999999999999999874  78999999854321 2223345666667889999999999997653    589


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK--------NVLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--------gi~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                      +||||+++++|.+++...  .++++.+..++.|++.||.|||++        ||+||||||+|||+  +.++++||+|||
T Consensus        78 lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl--~~~~~~Ki~DFG  153 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE--CTTSCEEECCCT
T ss_pred             EEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE--CCCCCEEEEeCC
Confidence            999999999999999765  489999999999999999999987        99999999999999  999999999999


Q ss_pred             cccccCCCCcc-----eeeccCcccccccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCC-----------
Q psy11805        149 LARKFDPEKKL-----QVLFGTPEFVAPEVVNFD------AIGFGTDMWSVGVICYVLLSGLSPFMGET-----------  206 (251)
Q Consensus       149 ~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----------  206 (251)
                      ++.........     ...+||+.|+|||++.+.      .++.++||||||++||||+||..||....           
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876543322     234799999999998654      36779999999999999999977653221           


Q ss_pred             ----hHHHHHHHHhccccCCCc-cc--cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        207 ----DVQTMANVTIAQYDFDDE-CF--NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       207 ----~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                          ..+....+.....++..+ .+  ...+..+.+|+.+||+.||++|||+
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  285 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  285 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH
Confidence                122233333333322221 11  1234578999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-54  Score=352.12  Aligned_cols=250  Identities=45%  Similarity=0.832  Sum_probs=228.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++..........+.+|+.+++.++|+||+++++++.+.+..++|||+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46899999999999999999999999999999998765555677899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCccee
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV  161 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~  161 (251)
                      +++++|.+.+...+..+++..++.++.|++.||.|||+.|++|+||||+||++..+.++.++|+|||++...........
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  209 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  209 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence            99999999888766679999999999999999999999999999999999998333567899999999988776666666


Q ss_pred             eccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhc
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL  241 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (251)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+...........+..+++++.+||++||
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  289 (387)
T 1kob_A          210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL  289 (387)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTS
T ss_pred             eccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHc
Confidence            78999999999999999999999999999999999999999999998888888888777777777889999999999999


Q ss_pred             ccCcCCCCCC
Q psy11805        242 LKDREDAPEV  251 (251)
Q Consensus       242 ~~~p~~Rps~  251 (251)
                      +.||++|||+
T Consensus       290 ~~dP~~Rpt~  299 (387)
T 1kob_A          290 QKEPRKRLTV  299 (387)
T ss_dssp             CSSGGGSCCH
T ss_pred             CCChhHCcCH
Confidence            9999999985

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-53  Score=344.05  Aligned_cols=242  Identities=28%  Similarity=0.512  Sum_probs=219.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            57999999999999999999999999999999986432  3346778899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      ++++++|.+.+...+ .+++..++.++.|++.||.|||++|++||||||+||++  +.+++++|+|||++..........
T Consensus        95 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           95 YASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL--DADMNIKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECSTTCCGGGSSSCGGG
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE--cCCCCEEEeeccCceecCCCCccc
Confidence            999999999887654 69999999999999999999999999999999999999  999999999999998776666666


Q ss_pred             eeccCcccccccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIG-FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ..++++.|+|||.+.+..++ .++||||||+++|+|++|..||.+.+..+....+..+....+    ..+++++.+||++
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~  247 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCENLLKR  247 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHH
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHH
Confidence            67899999999999887764 799999999999999999999999999888888887766554    4579999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||.+|||+
T Consensus       248 ~L~~dP~~R~t~  259 (328)
T 3fe3_A          248 FLVLNPIKRGTL  259 (328)
T ss_dssp             HCCSSTTTSCCH
T ss_pred             HCCCChhHCcCH
Confidence            999999999985

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.6e-53  Score=335.68  Aligned_cols=245  Identities=27%  Similarity=0.505  Sum_probs=218.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++........+.+.+|+..++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999999999999999999777767788899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +++++|.+++...  .+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++....... ...
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE--CCCCCEEEeeCCCceecCCcccccC
Confidence            9999999988765  48999999999999999999999999999999999999  899999999999987754433 234


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...... .......++..+.+||.+|
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~  253 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDFLNRC  253 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHHHHHHHHH
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHHHHHHHHH
Confidence            457899999999999999999999999999999999999999988877766655444332 2223467899999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.||++|||+
T Consensus       254 l~~dp~~Rps~  264 (297)
T 3fxz_A          254 LEMDVEKRGSA  264 (297)
T ss_dssp             SCSSTTTSCCH
T ss_pred             ccCChhHCcCH
Confidence            99999999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-53  Score=340.99  Aligned_cols=247  Identities=45%  Similarity=0.827  Sum_probs=223.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc------cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR------NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....      ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4679999999999999999999999999999999864332      1467899999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC----cEEEeeccccc
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN----RIKIIDFGLAR  151 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~----~~~l~df~~~~  151 (251)
                      ++|||++++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++    .++|+|||++.
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll--~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEE--ecCCCCCCCEEEEECCCCe
Confidence            9999999999999988654 469999999999999999999999999999999999998  6666    89999999998


Q ss_pred             ccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        152 KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+...........+..++.
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  246 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence            87655555666799999999999988999999999999999999999999999998888888887777777667788999


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+||++||+.||++|||+
T Consensus       247 ~~~~li~~~L~~dP~~Rpt~  266 (326)
T 2y0a_A          247 LAKDFIRRLLVKDPKKRMTI  266 (326)
T ss_dssp             HHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHHccCChhhCCCH
Confidence            99999999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.4e-53  Score=345.89  Aligned_cols=249  Identities=31%  Similarity=0.610  Sum_probs=223.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357999999999999999999999999999999986433  234577899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |++++++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++..+ .++.++|+|||++........
T Consensus       108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            9999999988887654 69999999999999999999999999999999999998322 234699999999987765555


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+..+...++.+.|..+++++.+||.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  266 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  266 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            55567999999999999989999999999999999999999999999998888888888888877778899999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       267 ~~L~~dP~~R~t~  279 (362)
T 2bdw_A          267 SMLTVNPKKRITA  279 (362)
T ss_dssp             HHSCSSGGGSCCH
T ss_pred             HHcCCChhhCcCH
Confidence            9999999999984

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-52  Score=337.32  Aligned_cols=240  Identities=29%  Similarity=0.523  Sum_probs=216.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            6899999999999999999999999999999998643   2345678889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~~  158 (251)
                      ||++|++|.+.+...+ .+++..++.++.|++.||.|||++|++||||||+||++  +.+++++|+|||++.... ....
T Consensus        85 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTTCC
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE--CCCCCEEEeeccchhhcccCCCc
Confidence            9999999988887654 69999999999999999999999999999999999999  899999999999997632 3334


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....++++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+......++    ..+++++++||+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  237 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLA  237 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            4566799999999999999999999999999999999999999999888888887777655544    568999999999


Q ss_pred             HhcccCcCCCC
Q psy11805        239 KLLLKDREDAP  249 (251)
Q Consensus       239 ~~l~~~p~~Rp  249 (251)
                      +||+.||++||
T Consensus       238 ~lL~~dP~~R~  248 (337)
T 1o6l_A          238 GLLKKDPKQRL  248 (337)
T ss_dssp             HHTCSSTTTST
T ss_pred             HHhhcCHHHhc
Confidence            99999999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=350.96  Aligned_cols=249  Identities=31%  Similarity=0.575  Sum_probs=222.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            468999999999999999999999999999999986433  234677899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |+++|++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++... .++.++|+|||++........
T Consensus        90 E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           90 DLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            9999999999887764 69999999999999999999999999999999999998332 467899999999977654332


Q ss_pred             -ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        159 -LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       159 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..+...++.+.|..+++++.+||
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence             2445789999999999998999999999999999999999999999999999999999988888888889999999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.||++|||+
T Consensus       249 ~~~L~~dP~~Rpta  262 (444)
T 3soa_A          249 NKMLTINPSKRITA  262 (444)
T ss_dssp             HHHSCSSTTTSCCH
T ss_pred             HHHcCCChhHCCCH
Confidence            99999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=344.50  Aligned_cols=244  Identities=51%  Similarity=0.956  Sum_probs=219.1

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccCCch
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEGGEL   87 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (251)
                      .+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999999999999999998766556678899999999999999999999999999999999999999999


Q ss_pred             hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCcc
Q psy11805         88 FERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPE  167 (251)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  167 (251)
                      .+.+......+++..++.++.|++.||.|||+.|++|+||||+||++..+.++.++|+|||++.............+++.
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~  253 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE  253 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCT
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCc
Confidence            99888766679999999999999999999999999999999999998666778999999999988766665566679999


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCC
Q psy11805        168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED  247 (251)
Q Consensus       168 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  247 (251)
                      |+|||.+.+..++.++||||||+++|+|++|..||...+..+....+...........+..+++++.+||.+||+.||.+
T Consensus       254 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  333 (373)
T 2x4f_A          254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSW  333 (373)
T ss_dssp             TCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGG
T ss_pred             EeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhh
Confidence            99999999888999999999999999999999999999999888888888777777777889999999999999999999


Q ss_pred             CCCC
Q psy11805        248 APEV  251 (251)
Q Consensus       248 Rps~  251 (251)
                      |||+
T Consensus       334 Rps~  337 (373)
T 2x4f_A          334 RISA  337 (373)
T ss_dssp             SCCH
T ss_pred             CCCH
Confidence            9985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-52  Score=340.99  Aligned_cols=242  Identities=23%  Similarity=0.421  Sum_probs=213.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++...   .......+.+|..+++.+ +||||+++++++.+.+..|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            6899999999999999999999999999999998643   234567788999999988 699999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~  157 (251)
                      |||++|++|.+.+...+ .+++..++.++.|++.||.|||++|++||||||+||++  +.+++++|+|||++.... ...
T Consensus       103 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl--~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL--DHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCC---
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE--CCCCCEEEccccceeecccCCc
Confidence            99999999998887654 69999999999999999999999999999999999999  999999999999997633 233


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....++|+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+......++    ..++..+.+||
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  255 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGIL  255 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            34556799999999999988899999999999999999999999999999999988887766554    45799999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.||++||++
T Consensus       256 ~~lL~~dP~~R~~~  269 (353)
T 3txo_A          256 KSFMTKNPTMRLGS  269 (353)
T ss_dssp             HHHTCSSGGGSTTS
T ss_pred             HHHhhhCHHHccCC
Confidence            99999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-51  Score=327.17  Aligned_cols=248  Identities=30%  Similarity=0.601  Sum_probs=224.4

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.|++|++....  ....+.+.+|+.++++++|+||+++++++..++..+++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4689999999999999999999999999999999986433  23457788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC---cEEEeecccccccCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN---RIKIIDFGLARKFDP  155 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~---~~~l~df~~~~~~~~  155 (251)
                      ||++++++|.+.+...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++   .++|+|||.+.....
T Consensus        84 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLL--ASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--SSSSTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEE--ecCCCCCcEEEeeceeeEEccc
Confidence            99999999988887654 69999999999999999999999999999999999998  5444   499999999987766


Q ss_pred             CCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        156 EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+....+.+.+..+++++.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence            55555667899999999999999999999999999999999999999999999988888888887777777889999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      ||.+||+.||++|||+
T Consensus       241 li~~~l~~dp~~Rps~  256 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITA  256 (284)
T ss_dssp             HHHHHSCSSTTTSCCH
T ss_pred             HHHHHcccChhhCCCH
Confidence            9999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.8e-52  Score=327.73  Aligned_cols=248  Identities=35%  Similarity=0.598  Sum_probs=225.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+..+++++||||+++++++.+.+..++|||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            46899999999999999999999999999999998776667788999999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-cCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+.+...+ .+++..++.++.|++.||.+||++|++|+||+|+||++.. +.++.++|+|||.+..........
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~  166 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR  166 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBC
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchh
Confidence            99999988887654 5999999999999999999999999999999999999743 456789999999998877666666


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+. ++.++||||||+++|+|++|..||...+..+....+..+....+...+..+++.+.++|++|
T Consensus       167 ~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  245 (277)
T 3f3z_A          167 TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRL  245 (277)
T ss_dssp             CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHH
T ss_pred             ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHH
Confidence            67799999999998755 88999999999999999999999999999999888888887777766778999999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.||++|||+
T Consensus       246 l~~dp~~R~s~  256 (277)
T 3f3z_A          246 LTKSPKQRITS  256 (277)
T ss_dssp             TCSSTTTSCCH
T ss_pred             ccCChhhCcCH
Confidence            99999999984

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-51  Score=335.26  Aligned_cols=242  Identities=26%  Similarity=0.465  Sum_probs=215.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++....   ......+..|..+++.+ +||||+++++++.+.+..|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            68999999999999999999999999999999986432   33467788899999877 899999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~  157 (251)
                      |||++|++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||++  +.+++++|+|||++..... ..
T Consensus        97 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE--CCCCCEEEeEChhhhhcccCCC
Confidence            99999999999887654 69999999999999999999999999999999999999  8999999999999976432 23


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....++++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+......++    ..++.++++||
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  249 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLL  249 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHHH
Confidence            34556799999999999999999999999999999999999999999998888888877654443    56899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.||++||++
T Consensus       250 ~~lL~~dp~~R~~~  263 (345)
T 1xjd_A          250 VKLFVREPEKRLGV  263 (345)
T ss_dssp             HHHSCSSGGGSBTT
T ss_pred             HHHhcCCHhHcCCC
Confidence            99999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.3e-52  Score=339.61  Aligned_cols=247  Identities=30%  Similarity=0.583  Sum_probs=215.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-----ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-----RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            468999999999999999999999999999999985322     224678999999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC---cEEEeecccc
Q psy11805         77 VVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN---RIKIIDFGLA  150 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~---~~~l~df~~~  150 (251)
                      +||||+++++|.+.+..   .+..+++..++.++.|++.||.|||++|++|+||||+||++  +.++   .++|+|||++
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~--~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLL--ASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CSSSTTCCEEECCCTTC
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEE--ecCCCCCcEEEecCcce
Confidence            99999999999877754   23458999999999999999999999999999999999998  5444   4999999999


Q ss_pred             cccCCCCc-ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCC
Q psy11805        151 RKFDPEKK-LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       151 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (251)
                      ........ .....+++.|+|||.+.+..++.++||||||+++|+|++|..||... ..+....+..+........+..+
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~  259 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHI  259 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccC
Confidence            87654432 34457899999999999989999999999999999999999999875 45566667677766666667789


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+.+||++||+.||++|||+
T Consensus       260 s~~~~~li~~~L~~dP~~R~s~  281 (351)
T 3c0i_A          260 SESAKDLVRRMLMLDPAERITV  281 (351)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CHHHHHHHHHHCCCChhHCcCH
Confidence            9999999999999999999984

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.7e-52  Score=333.38  Aligned_cols=247  Identities=43%  Similarity=0.813  Sum_probs=222.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc------chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN------DRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++......      ..+.+.+|+..+++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            46799999999999999999999999999999998643322      367899999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC----cEEEeeccccc
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN----RIKIIDFGLAR  151 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~----~~~l~df~~~~  151 (251)
                      ++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++    .++|+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~--~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--SCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE--ecCCCCcCCEEEccCccce
Confidence            9999999999999988764 469999999999999999999999999999999999998  6666    79999999998


Q ss_pred             ccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        152 KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+...+..++.
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE  247 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence            77665555566789999999999999999999999999999999999999999998888888887777666666678999


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+||++||+.||++|||+
T Consensus       248 ~~~~li~~~l~~dp~~Rps~  267 (321)
T 2a2a_A          248 LAKDFIRKLLVKETRKRLTI  267 (321)
T ss_dssp             HHHHHHHTTSCSSTTTSCCH
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            99999999999999999984

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.9e-51  Score=338.62  Aligned_cols=242  Identities=22%  Similarity=0.434  Sum_probs=208.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++....   ......+.+|..+++++ +||||+++++++.+++..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            58999999999999999999999999999999986432   23456688999999887 799999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc-cCCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK-FDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~-~~~~~  157 (251)
                      |||+++++|...+...+ .+++..++.++.|++.||.|||++||+||||||+||++  +.+++++|+|||++.. .....
T Consensus       132 ~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl--~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE--CCCCCEEEeecceeeecccCCC
Confidence            99999999988887654 69999999999999999999999999999999999999  9999999999999976 33444


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHhccccCCCccccC
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET---------DVQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      .....++|+.|+|||++.+..++.++||||||+++|+|++|..||....         .......+.......+    ..
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~  284 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RS  284 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----TT
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----Cc
Confidence            4566789999999999999999999999999999999999999996432         2223444444443333    56


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.++++||++||+.||++||++
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCC
Confidence            89999999999999999999984

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-51  Score=334.98  Aligned_cols=241  Identities=24%  Similarity=0.444  Sum_probs=216.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...   .....+.+.+|..++..+ +||+|+++++++.+.+..|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            6899999999999999999999999999999998643   234567788999999887 799999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~  157 (251)
                      |||++|++|.+++...+ .+++..++.++.|++.||.|||+.|++||||||+||++  +.+++++|+|||++.... ...
T Consensus       100 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE--cCCCcEEEEeCCcccccccCCc
Confidence            99999999999887654 69999999999999999999999999999999999999  999999999999997643 233


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....+|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+......++    ..++.++.+||
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  252 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAIC  252 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Confidence            44556799999999999999999999999999999999999999999998888888887765544    56899999999


Q ss_pred             HHhcccCcCCCCC
Q psy11805        238 RKLLLKDREDAPE  250 (251)
Q Consensus       238 ~~~l~~~p~~Rps  250 (251)
                      ++||+.||++||+
T Consensus       253 ~~lL~~dP~~R~~  265 (353)
T 2i0e_A          253 KGLMTKHPGKRLG  265 (353)
T ss_dssp             HHHTCSCTTSCTT
T ss_pred             HHHhhcCHHHcCC
Confidence            9999999999996

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-51  Score=328.89  Aligned_cols=238  Identities=27%  Similarity=0.529  Sum_probs=215.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            68999999999999999999999999999999986432   235677889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||++|++|.+++...+ .+++..++.++.|++.||.+||++|++||||||+||++  +.++.++|+|||++.....  ..
T Consensus        86 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--DKNGHIKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--CTTSCEEECCCSSCEECSS--CB
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE--cCCCCEEEeecCcceecCC--cc
Confidence            9999999999887654 69999999999999999999999999999999999999  8999999999999977543  23


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...++++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+...++......++    ..++.++.++|++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~  236 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSR  236 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHH
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHH
Confidence            455799999999999999999999999999999999999999999988888888877765544    5679999999999


Q ss_pred             hcccCcCCCC
Q psy11805        240 LLLKDREDAP  249 (251)
Q Consensus       240 ~l~~~p~~Rp  249 (251)
                      ||+.||++||
T Consensus       237 lL~~dp~~R~  246 (318)
T 1fot_A          237 LITRDLSQRL  246 (318)
T ss_dssp             HTCSCTTTCT
T ss_pred             HhccCHHHcC
Confidence            9999999999

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-51  Score=331.91  Aligned_cols=242  Identities=23%  Similarity=0.424  Sum_probs=209.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++....   ......+.+|..+++++ +||||+++++++.+++..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            68999999999999999999999999999999986443   22356688999999988 799999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~  157 (251)
                      |||+++++|.+.+...+ .+++..++.++.|++.||.|||++|++||||||+||++  +.+++++|+|||++.... ...
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCGGGCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE--CCCCCEEEEeccccccccCCCC
Confidence            99999999988887654 69999999999999999999999999999999999999  899999999999997632 333


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhccccCCCccccC
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE---------TDVQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      .....++++.|+|||.+.+..++.++||||||+++|+|++|..||...         ......+.+.......+    ..
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~  241 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RS  241 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----TT
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----CC
Confidence            445567999999999999999999999999999999999999999752         22334444444443333    56


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++..+++||++||+.||++||++
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCC
Confidence            89999999999999999999984

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=336.30  Aligned_cols=247  Identities=34%  Similarity=0.622  Sum_probs=200.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  ...+.+.+|+..+++++|+||+++++++.+.+..++|||+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            46799999999999999999999999999999998643  3456788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-cCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++.. +.++.++|+|||++..........
T Consensus       130 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  208 (349)
T 2w4o_A          130 VTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK  208 (349)
T ss_dssp             CCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence            99999988887654 6999999999999999999999999999999999999832 237899999999998766554455


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ-TMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||......+ ....+.........+.+..++..+.+||++
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  288 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK  288 (349)
T ss_dssp             ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred             cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHH
Confidence            6678999999999999899999999999999999999999998766554 566666666666666778899999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||++|||+
T Consensus       289 ~L~~dP~~Rpt~  300 (349)
T 2w4o_A          289 LIVLDPKKRLTT  300 (349)
T ss_dssp             TSCSSGGGSCCH
T ss_pred             HccCChhhCcCH
Confidence            999999999984

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.5e-51  Score=328.12  Aligned_cols=246  Identities=26%  Similarity=0.420  Sum_probs=209.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|+||.||+|.+..+++.|++|.+.....   ...+.+.+|+..+++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            5789999999999999999999999999999999854332   2357788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-  157 (251)
                      ||++++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++....... 
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI--DSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCSSSTTC-----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCCEEEEeCCCccccccccc
Confidence            99999999999887654 69999999999999999999999999999999999999  899999999999997754332 


Q ss_pred             -cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC-CccccCCCHHHHH
Q psy11805        158 -KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-DECFNEISDDAKD  235 (251)
Q Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (251)
                       ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+..........+.. ......+|+.+.+
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence             22345689999999999999999999999999999999999999999888776655544433222 2234678999999


Q ss_pred             HHHHhcccCcCCCCC
Q psy11805        236 FIRKLLLKDREDAPE  250 (251)
Q Consensus       236 li~~~l~~~p~~Rps  250 (251)
                      +|.+||+.||.+||+
T Consensus       247 li~~~l~~dp~~R~~  261 (294)
T 4eqm_A          247 VILRATEKDKANRYK  261 (294)
T ss_dssp             HHHHHSCSSGGGSCS
T ss_pred             HHHHHhcCCHhHccc
Confidence            999999999999995

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.6e-51  Score=332.28  Aligned_cols=239  Identities=27%  Similarity=0.484  Sum_probs=216.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999985432   335677889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+++++|.+.+...+ .+++..++.++.|++.||.|||++|++||||||+||++  +.++.++|+|||++......  .
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~g~~kL~DFg~a~~~~~~--~  195 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC--B
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE--CCCCCEEEcccccceeccCC--c
Confidence            9999999999887654 59999999999999999999999999999999999999  89999999999999875433  3


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...++++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+...++    ..++.++.++|++
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~  271 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRN  271 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHHH
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            345789999999999999999999999999999999999999999998888888887765544    5689999999999


Q ss_pred             hcccCcCCCCC
Q psy11805        240 LLLKDREDAPE  250 (251)
Q Consensus       240 ~l~~~p~~Rps  250 (251)
                      ||+.||.+||+
T Consensus       272 lL~~dp~~R~~  282 (350)
T 1rdq_E          272 LLQVDLTKRFG  282 (350)
T ss_dssp             HSCSCTTTCTT
T ss_pred             HhhcCHHhccC
Confidence            99999999997

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.4e-51  Score=334.07  Aligned_cols=241  Identities=27%  Similarity=0.513  Sum_probs=211.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            6899999999999999999999999999999998543   2345678889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |+++|++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++.........
T Consensus        95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTCCB
T ss_pred             ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE--CCCCCEEEeccceeeeccCCCce
Confidence            999999998888765 469999999999999999999999999999999999999  99999999999999887666666


Q ss_pred             eeeccCccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        160 QVLFGTPEFVAPEVVNF---DAIGFGTDMWSVGVICYVLLSGLSPFMGET---DVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ...++|+.|+|||.+.+   ..++.++||||||+++|+|++|..||....   ..+....+.......+    ..++..+
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s~~~  247 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEM  247 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCCHHH
Confidence            77789999999999964   457899999999999999999999997543   3344444444433333    5689999


Q ss_pred             HHHHHHhcccCcCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPE  250 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps  250 (251)
                      .+||++||+.||.+||+
T Consensus       248 ~~li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFS  264 (384)
T ss_dssp             HHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHhcCCHhHhcc
Confidence            99999999999999997

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.7e-51  Score=346.89  Aligned_cols=248  Identities=36%  Similarity=0.640  Sum_probs=222.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999999999999999985432  345788999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-cCCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |++++++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++.. ..++.++|+|||++........
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            9999999988887654 6999999999999999999999999999999999999833 2345799999999987766665


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+..+......+.|..+|+++++||+
T Consensus       180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  258 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (486)
T ss_dssp             --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHH
T ss_pred             cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHH
Confidence            666789999999999976 5899999999999999999999999999999999999999888888888899999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||.+|||+
T Consensus       259 ~~L~~dp~~R~t~  271 (486)
T 3mwu_A          259 KMLTFHPSLRITA  271 (486)
T ss_dssp             HHTCSSTTTSCCH
T ss_pred             HHcCCChhhCcCH
Confidence            9999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.2e-51  Score=339.90  Aligned_cols=245  Identities=28%  Similarity=0.448  Sum_probs=216.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++...   .......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999998542   2334566889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc-
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK-  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~-  158 (251)
                      ||++|++|.+++...  .+++..++.++.|++.||.|||+.|++||||||+||++  +.+++++|+|||++........ 
T Consensus       149 E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl--~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          149 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             CCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTSEE
T ss_pred             eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE--CCCCCEEEeccceeEeeccCCcc
Confidence            999999999988764  48999999999999999999999999999999999999  9999999999999987654432 


Q ss_pred             -ceeeccCcccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        159 -LQVLFGTPEFVAPEVVNFDA----IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       159 -~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                       ....+||+.|+|||++.+..    ++.++||||||+++|+|++|..||.+.+..+...++.........+.+..++.++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  304 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence             23567999999999997665    7889999999999999999999999999988888887765444444456789999


Q ss_pred             HHHHHHhcccCcCC--CCCC
Q psy11805        234 KDFIRKLLLKDRED--APEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~--Rps~  251 (251)
                      ++||++||+.+|.+  ||++
T Consensus       305 ~~li~~lL~~~~~rlgR~~~  324 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGV  324 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCH
T ss_pred             HHHHHHHccChhhhCCCCCH
Confidence            99999999998988  8874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.5e-51  Score=347.58  Aligned_cols=247  Identities=33%  Similarity=0.633  Sum_probs=219.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|+||+||+|.+..++..+|+|++....  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            57999999999999999999999999999999986433  3346788999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |+++++|.+.+.... .+++..++.++.|++.||.|||+.|++||||||+||++... .++.++|+|||++.........
T Consensus       117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            999999988887654 69999999999999999999999999999999999998321 2456999999999887666666


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+..+...+..+.|..+|+.+++||++
T Consensus       196 ~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  274 (494)
T 3lij_A          196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ  274 (494)
T ss_dssp             CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence            6678999999999986 468999999999999999999999999999999999999999888888889999999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||.+|||+
T Consensus       275 ~L~~dp~~R~s~  286 (494)
T 3lij_A          275 MLQFDSQRRISA  286 (494)
T ss_dssp             HTCSSTTTSCCH
T ss_pred             HCCCChhhCccH
Confidence            999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.8e-51  Score=323.37  Aligned_cols=247  Identities=45%  Similarity=0.856  Sum_probs=216.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc------cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR------NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++.....      ...+.+.+|+..+++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            4789999999999999999999999999999999864321      2467899999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC----cEEEeeccccc
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN----RIKIIDFGLAR  151 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~----~~~l~df~~~~  151 (251)
                      ++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++    .++|+|||.+.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--SCSSSSSCCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEE--ecCCCCCCceEEEecccce
Confidence            99999999999999887643 69999999999999999999999999999999999998  6555    89999999998


Q ss_pred             ccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        152 KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+...........+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            76655555556789999999999988999999999999999999999999999988888888877776666666678899


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.++|++||+.||++|||+
T Consensus       241 ~~~~li~~~l~~dp~~Rps~  260 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTI  260 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCH
T ss_pred             HHHHHHHHHccCCHhHCcCH
Confidence            99999999999999999984

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-51  Score=348.89  Aligned_cols=248  Identities=33%  Similarity=0.637  Sum_probs=225.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            368999999999999999999999999999999985432   34578899999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-cCCCcEEEeecccccccCCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-~~~~~~~l~df~~~~~~~~~~  157 (251)
                      ||++.+++|.+.+...+ .+++..++.++.|++.||.|||++|++|+||||+||++.. +.++.++|+|||++.......
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            99999999988887654 6999999999999999999999999999999999999833 346789999999998877666


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+....+..+...+..+.|..+|+.+++||
T Consensus       184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  262 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI  262 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHH
T ss_pred             ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHH
Confidence            6666789999999999876 689999999999999999999999999999999999999988888888889999999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.+|.+|||+
T Consensus       263 ~~~L~~dp~~R~s~  276 (484)
T 3nyv_A          263 RKMLTYVPSMRISA  276 (484)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHCCCChhHCcCH
Confidence            99999999999985

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.1e-51  Score=326.28  Aligned_cols=247  Identities=23%  Similarity=0.428  Sum_probs=206.5

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +.++|++.+.||+|+||+||+|.+. +++.||+|++......  ....+.+|+.++++++||||+++++++.+++..++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            4589999999999999999999986 4889999998644322  357788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-C
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-K  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~  157 (251)
                      ||++++ +|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++...... .
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI--NSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEETTSCCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE--CCCCCEEEccCcCceecCCCcc
Confidence            999986 7888888777779999999999999999999999999999999999999  89999999999999876433 2


Q ss_pred             cceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc------------
Q psy11805        158 KLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE------------  224 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  224 (251)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+..........            
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            2344568999999999876 567999999999999999999999999887766666554322211111            


Q ss_pred             --------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 --------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                    ..+.+++++.+||++||+.||++|||+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  295 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA  295 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH
Confidence                          123477899999999999999999985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.2e-52  Score=335.83  Aligned_cols=241  Identities=30%  Similarity=0.516  Sum_probs=209.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+..++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            68999999999999999999999999999999985322   233568899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+ +++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.........
T Consensus        89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll--~~~~~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL--DDNLNVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE--CTTCCEEECCSSCTBTTTTSBTT
T ss_pred             ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE--cCCCCEEEEEeccceeccCCccc
Confidence            999 568888877654 69999999999999999999999999999999999999  89999999999999887666666


Q ss_pred             eeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ...++++.|+|||.+.+..+ +.++||||||+++|+|++|..||......+....+......    ....+++.+.+||+
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~li~  240 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV----MPDFLSPGAQSLIR  240 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCC----CCTTSCHHHHHHHH
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC----CcccCCHHHHHHHH
Confidence            77789999999999988776 68999999999999999999999876554433333222222    23567999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||.+|||+
T Consensus       241 ~~L~~dP~~Rpt~  253 (336)
T 3h4j_B          241 RMIVADPMQRITI  253 (336)
T ss_dssp             TTSCSSGGGSCCH
T ss_pred             HHcCCChhHCcCH
Confidence            9999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.3e-51  Score=346.80  Aligned_cols=246  Identities=35%  Similarity=0.611  Sum_probs=221.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-------------cchHHHHHHHHHHHHcCCCceeeEeEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-------------NDRRNVEREVEIMRELQHPRLIQIYDA   68 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~   68 (251)
                      .++|++.+.||+|+||+||+|.+..++..||+|++.....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            5789999999999999999999999999999999864321             335778999999999999999999999


Q ss_pred             EeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC---cEEEe
Q psy11805         69 FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN---RIKII  145 (251)
Q Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~---~~~l~  145 (251)
                      +.+.+..++|||++++++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++  +.++   .++|+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~--~~~~~~~~~kl~  191 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILL--ENKNSLLNIKIV  191 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--SSTTCCSSEEEC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEE--ecCCCCccEEEE
Confidence            999999999999999999988887654 69999999999999999999999999999999999998  5554   69999


Q ss_pred             ecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcc
Q psy11805        146 DFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC  225 (251)
Q Consensus       146 df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (251)
                      |||++.............+++.|+|||.+. ..++.++||||||+++|+|++|..||.+.+..+....+..+...+..+.
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  270 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND  270 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            999998877666666778999999999987 4689999999999999999999999999999999999999888888788


Q ss_pred             ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        226 FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      |..+|+++++||++||+.||.+|||+
T Consensus       271 ~~~~s~~~~~li~~~L~~dp~~R~t~  296 (504)
T 3q5i_A          271 WKNISDEAKELIKLMLTYDYNKRCTA  296 (504)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cCCCCHHHHHHHHHHcCCChhHCCCH
Confidence            88999999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.5e-51  Score=325.89  Aligned_cols=248  Identities=32%  Similarity=0.611  Sum_probs=218.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++..........+.+|+..++.++||||+++++++.+.+..++|||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            46899999999999999999999999999999998765555567889999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-cCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+.+...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++.. +.++.++|+|||.+...... ...
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~  165 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMS  165 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTH
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccc
Confidence            99999988887654 6899999999999999999999999999999999999733 45678999999998764432 233


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+....+.+.+..++..+.++|.+|
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  245 (304)
T 2jam_A          166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL  245 (304)
T ss_dssp             HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred             cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHH
Confidence            45689999999999999999999999999999999999999999998888888888877777777788999999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.||++|||+
T Consensus       246 l~~dp~~Rps~  256 (304)
T 2jam_A          246 LEKDPNERYTC  256 (304)
T ss_dssp             HCSSTTTSCCH
T ss_pred             cCCChhHCcCH
Confidence            99999999984

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.6e-50  Score=321.90  Aligned_cols=246  Identities=24%  Similarity=0.379  Sum_probs=207.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++......  ....+.+|+..+++++|+||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5899999999999999999999999999999998654332  35778899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~  159 (251)
                      ++++ ++.+.+......+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||.+...... ...
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECCSCCSCC
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEeecccceecCCccccc
Confidence            9986 6667776666679999999999999999999999999999999999999  89999999999999876433 223


Q ss_pred             eeeccCcccccccccccCC-CCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhccccCCCc-------------
Q psy11805        160 QVLFGTPEFVAPEVVNFDA-IGFGTDMWSVGVICYVLLSGLSP-FMGETDVQTMANVTIAQYDFDDE-------------  224 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~-------------  224 (251)
                      ....+++.|+|||.+.+.. ++.++||||||+++|+|++|..| |...+..+....+..........             
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence            4456899999999997765 79999999999999999987777 55566666666554432222111             


Q ss_pred             ------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 ------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                  ....++..+++||++||+.||++|||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  277 (292)
T 3o0g_A          239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA  277 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH
Confidence                        123578899999999999999999985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.1e-52  Score=332.86  Aligned_cols=248  Identities=23%  Similarity=0.408  Sum_probs=208.5

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCC----
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSN----   73 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   73 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++.....   .....+.+|+..+++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            35789999999999999999999999999999999865432   23567889999999999999999999987544    


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..++||||+++++|.+++...+ .+++..++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++...
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--ETTSCEEECCCSCC---
T ss_pred             ccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE--cCCCCEEEeeccCcccc
Confidence            3599999999999999887654 69999999999999999999999999999999999999  88999999999999765


Q ss_pred             CCCC----cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCC
Q psy11805        154 DPEK----KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       154 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (251)
                      ....    ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+...................+
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            4332    223345899999999999999999999999999999999999999998888777666666555444445678


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++.++|.+||+.||++||++
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~  268 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQT  268 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSS
T ss_pred             CHHHHHHHHHHHhcCHhhChhh
Confidence            9999999999999999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.3e-51  Score=334.73  Aligned_cols=242  Identities=26%  Similarity=0.502  Sum_probs=207.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHH-HHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEI-MRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++.....   .....+.+|... ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            689999999999999999999999999999999864432   234455566665 4667899999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc-CCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~-~~~~  157 (251)
                      |||++|++|.+.+...+ .+++..++.++.|++.||.|||++|++||||||+||++  +.+++++|+|||++... ....
T Consensus       118 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--~~~g~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCCBCGGGBCCCC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE--CCCCCEEEeeCccccccccCCC
Confidence            99999999988887654 68999999999999999999999999999999999999  89999999999999763 3333


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....++|+.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.......+    ..++..+++||
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li  270 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLL  270 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHHHH
T ss_pred             ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHHHH
Confidence            44566799999999999999999999999999999999999999999998888888877655443    56899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.||++||++
T Consensus       271 ~~lL~~dp~~R~~~  284 (373)
T 2r5t_A          271 EGLLQKDRTKRLGA  284 (373)
T ss_dssp             HHHTCSSGGGSTTT
T ss_pred             HHHcccCHHhCCCC
Confidence            99999999999984

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=322.64  Aligned_cols=243  Identities=27%  Similarity=0.507  Sum_probs=205.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--------------------------cchHHHHHHHHHHHH
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--------------------------NDRRNVEREVEIMRE   56 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------------------------~~~~~~~~e~~~l~~   56 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....                          ...+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            689999999999999999999999999999999854321                          124668899999999


Q ss_pred             cCCCceeeEeEEEee--CCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE
Q psy11805         57 LQHPRLIQIYDAFES--SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILC  134 (251)
Q Consensus        57 l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~  134 (251)
                      ++||||+++++++.+  .+..++|||++++++|.+....  ..+++..++.++.|++.||.|||+.|++|+||||+||++
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            999999999999986  5689999999999999776433  469999999999999999999999999999999999999


Q ss_pred             eecCCCcEEEeecccccccCCCC-cceeeccCcccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy11805        135 LTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDA---IGFGTDMWSVGVICYVLLSGLSPFMGETDVQT  210 (251)
Q Consensus       135 ~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  210 (251)
                        +.++.++|+|||++....... ......+++.|+|||.+.+..   .+.++||||||+++|+|++|..||........
T Consensus       171 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          171 --GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             --CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             --CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence              889999999999998765432 223456899999999997665   37789999999999999999999998887777


Q ss_pred             HHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        211 MANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...+.......+.  ...+++.+.+||.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~  287 (298)
T 2zv2_A          249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVV  287 (298)
T ss_dssp             HHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCH
Confidence            6666655544332  35789999999999999999999984

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=323.79  Aligned_cols=247  Identities=25%  Similarity=0.428  Sum_probs=209.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-----cchHHHHHHHHHHHHcC---CCceeeEeEEEeeCC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-----NDRRNVEREVEIMRELQ---HPRLIQIYDAFESSN   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-----~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~   73 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.....     .......+|+..++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            5799999999999999999999999999999999864331     22456778888777764   999999999997654


Q ss_pred             -----EEEEEEEeccCCchhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeec
Q psy11805         74 -----VMCVVLELIEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDF  147 (251)
Q Consensus        74 -----~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df  147 (251)
                           ..+++||++++ +|.+++..... .+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+||
T Consensus        88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~--~~~~~~kl~Df  164 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV--TSGGTVKLADF  164 (308)
T ss_dssp             SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE--CTTSCEEECSC
T ss_pred             CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--cCCCCEEEeeC
Confidence                 58999999975 89888876542 38999999999999999999999999999999999999  89999999999


Q ss_pred             ccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc---
Q psy11805        148 GLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE---  224 (251)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  224 (251)
                      |.+.............+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..........   
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            99987766555566678999999999998999999999999999999999999999998888777665433222211   


Q ss_pred             --------------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 --------------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 --------------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                          ..+.+++.+.+||.+||+.||++|||+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  291 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA  291 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH
Confidence                                123678999999999999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-50  Score=326.53  Aligned_cols=243  Identities=31%  Similarity=0.590  Sum_probs=195.0

Q ss_pred             ccCCcc---cccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQH---SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~---~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.   +.||+|+||.||+|.+..+++.||+|++..   .......+|+..++.+. ||||+++++++.+++..++|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            356664   789999999999999999999999999853   34567889999999997 99999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC---cEEEeecccccccCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN---RIKIIDFGLARKFDP  155 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~---~~~l~df~~~~~~~~  155 (251)
                      ||++++++|.+.+...+ .+++..++.++.|++.||.|||++|++|+||||+||++  +.++   .++|+|||++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll--~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           85 MELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF--TDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             ECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--EC----CEEEECCCTTCEECCC
T ss_pred             EEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEE--ecCCCcccEEEeccccceecCC
Confidence            99999999999887754 69999999999999999999999999999999999998  4444   899999999976543


Q ss_pred             C-CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhccccCCCcccc
Q psy11805        156 E-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET-------DVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      . .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+       ..+....+..+......+.+.
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (325)
T 3kn6_A          162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK  241 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred             CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence            3 22345567999999999999999999999999999999999999998643       356677777777777777778


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+++++++||++||+.||.+|||+
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rpt~  265 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRLKM  265 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCCCT
T ss_pred             CCCHHHHHHHHHHCCCChhHCCCH
Confidence            899999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-50  Score=326.54  Aligned_cols=242  Identities=25%  Similarity=0.516  Sum_probs=204.0

Q ss_pred             CccCCcccccccCCceEEEEEEEc---cCCceEEEEEecccc----ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK----RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+.   .+++.||+|++....    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            368999999999999999999985   678999999986432    2345668899999999999999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .++|||++++++|.+.+...+ .+++..++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill--~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML--NHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE--CTTSCEEECCCSCC----
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE--CCCCcEEEEeCCcccccc
Confidence            999999999999998887654 68999999999999999999999999999999999999  899999999999987643


Q ss_pred             CC-CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        155 PE-KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      .. .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..++..+
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~  248 (327)
T 3a62_A          173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEA  248 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred             cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence            22 223345689999999999988899999999999999999999999999988888888777655443    5679999


Q ss_pred             HHHHHHhcccCcCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPE  250 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps  250 (251)
                      .+||.+||+.||++||+
T Consensus       249 ~~li~~~L~~dp~~R~~  265 (327)
T 3a62_A          249 RDLLKKLLKRNAASRLG  265 (327)
T ss_dssp             HHHHHHHSCSCGGGSTT
T ss_pred             HHHHHHHHhcCHhhccC
Confidence            99999999999999995

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=329.88  Aligned_cols=242  Identities=21%  Similarity=0.327  Sum_probs=207.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||+||+|.+..+++.|++|.+...+....+.+.+|+..+++++||||+++++++.+++..++|||+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            36899999999999999999999999999999998666666788899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce-
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ-  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~-  160 (251)
                      +++++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.......... 
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV--RENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE--CTTSCEEECCCTTCEECC-------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE--CCCCCEEEeecccceeccccccccc
Confidence            99999999998877789999999999999999999999999999999999999  899999999999997754332211 


Q ss_pred             --------------eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhccccC
Q psy11805        161 --------------VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT-----MANVTIAQYDF  221 (251)
Q Consensus       161 --------------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~  221 (251)
                                    ...+++.|+|||.+.+..++.++||||||+++|+|++|..||........     .......    
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----  242 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----  242 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----
Confidence                          34689999999999999999999999999999999999999865322110     1111111    


Q ss_pred             CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                        .....+|+.+.+++.+||+.||++|||+
T Consensus       243 --~~~~~~~~~l~~li~~~l~~dP~~Rps~  270 (310)
T 3s95_A          243 --YCPPNCPPSFFPITVRCCDLDPEKRPSF  270 (310)
T ss_dssp             --TCCTTCCTTHHHHHHHHTCSSGGGSCCH
T ss_pred             --cCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence              1125678899999999999999999984

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-50  Score=341.11  Aligned_cols=242  Identities=28%  Similarity=0.489  Sum_probs=217.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+..++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999986432   234678899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+++++|.+++... +.+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.........
T Consensus        96 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll--~~~~~vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           96 EYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             ECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE--CTTCCEEECCCSSCEECCTTCCB
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE--ecCCCeEEEeccchhhccccccc
Confidence            999999999988754 469999999999999999999999999999999999999  89999999999999887666556


Q ss_pred             eeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ...++++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..+...++..+....+    ..+++++.+||+
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~  248 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVISLLK  248 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHHHHHH
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHHHHHH
Confidence            66789999999999988765 6899999999999999999999999888888888776654433    567899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||.+|||+
T Consensus       249 ~~L~~dP~~Rpt~  261 (476)
T 2y94_A          249 HMLQVDPMKRATI  261 (476)
T ss_dssp             HHTCSSTTTSCCH
T ss_pred             HHcCCCchhCcCH
Confidence            9999999999985

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4e-50  Score=323.56  Aligned_cols=243  Identities=26%  Similarity=0.495  Sum_probs=214.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      .|+..+.||+|+||.||+|.+..+++.||+|++........+.+.+|+..++.++|+||+++++++...+..++||||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            36777899999999999999999999999999977666677889999999999999999999999999999999999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cceee
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQVL  162 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~~~  162 (251)
                      +++|.+.+...  .+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++....... .....
T Consensus       126 ~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          126 GGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             SCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--CCCCcEEEeeeeeeeecccCccccccc
Confidence            99998887643  59999999999999999999999999999999999999  889999999999987764432 23445


Q ss_pred             ccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcc
Q psy11805        163 FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL  242 (251)
Q Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (251)
                      .+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.....+ .......+++.+.++|.+||+
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  280 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNSHKVSPVLRDFLERMLV  280 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCTTGGGSCHHHHHHHHHHSC
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CcCccccCCHHHHHHHHHHcc
Confidence            7899999999999989999999999999999999999999988887777666554332 222235689999999999999


Q ss_pred             cCcCCCCCC
Q psy11805        243 KDREDAPEV  251 (251)
Q Consensus       243 ~~p~~Rps~  251 (251)
                      .||++|||+
T Consensus       281 ~dp~~Rps~  289 (321)
T 2c30_A          281 RDPQERATA  289 (321)
T ss_dssp             SSTTTSCCH
T ss_pred             CChhhCcCH
Confidence            999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.3e-51  Score=327.78  Aligned_cols=245  Identities=25%  Similarity=0.451  Sum_probs=205.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      -++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4799999999999999999999999999999999864332 235778899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC---C
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE---K  157 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~---~  157 (251)
                      |+++++|.+.+... ..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++......   .
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE--eCCCCEEEEEeeccceeccCCccc
Confidence            99999998888654 369999999999999999999999999999999999999  89999999999999765322   1


Q ss_pred             cceeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhccccCCCccccCCCHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQT-MANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||........ .........  ....+..++..+.+
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  240 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLA  240 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSCHHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCCHHHHH
Confidence            2234568999999999987765 7789999999999999999999987655432 222222222  22234678999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      ||.+||+.||++|||+
T Consensus       241 li~~~L~~dP~~R~t~  256 (323)
T 3tki_A          241 LLHKILVENPSARITI  256 (323)
T ss_dssp             HHHHHSCSSTTTSCCH
T ss_pred             HHHHHccCChhhCcCH
Confidence            9999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.5e-51  Score=330.18  Aligned_cols=245  Identities=32%  Similarity=0.613  Sum_probs=212.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.....    ...+|++.+.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4679999999999999999999999999999999864332    345678888887 79999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC--CcEEEeecccccccCCC-C
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG--NRIKIIDFGLARKFDPE-K  157 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~--~~~~l~df~~~~~~~~~-~  157 (251)
                      +++|++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++.+..+  +.++|+|||++...... .
T Consensus        97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A           97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            999999999887654 6999999999999999999999999999999999999733222  35999999999875433 2


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMG---ETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      .....++++.|+|||.+.+..++.++||||||+++|+|++|..||..   .+..+....+..+........|..++++++
T Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  255 (342)
T 2qr7_A          176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK  255 (342)
T ss_dssp             CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred             ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHH
Confidence            33455789999999999888889999999999999999999999986   355667778888887777777889999999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      +||++||+.||++|||+
T Consensus       256 ~li~~~L~~dP~~R~t~  272 (342)
T 2qr7_A          256 DLVSKMLHVDPHQRLTA  272 (342)
T ss_dssp             HHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHCCCChhHCcCH
Confidence            99999999999999984

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-50  Score=320.54  Aligned_cols=248  Identities=33%  Similarity=0.605  Sum_probs=209.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|+||.||+|.+..++..+++|++.... ....+.+.+|++.+++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            468999999999999999999999999999999986544 3357889999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-cCCCcEEEeecccccccCCC
Q psy11805         81 LIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        81 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-~~~~~~~l~df~~~~~~~~~  156 (251)
                      ++++++|.+.+...   +..+++..++.++.|++.||.+||+.|++|+||+|+||++.+ +.++.++|+|||++......
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            99999998888542   356999999999999999999999999999999999999843 23578999999999876665


Q ss_pred             CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        157 KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      .......+++.|+|||.+. ..++.++||||||+++|+|++|..||...+..+................ ..+++.+.+|
T Consensus       181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l  258 (285)
T 3is5_A          181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPLTPQAVDL  258 (285)
T ss_dssp             ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHH
T ss_pred             ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-CcCCHHHHHH
Confidence            5556667899999999986 5678999999999999999999999999888777776665554443332 4579999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |++||+.||++|||+
T Consensus       259 i~~~L~~dP~~Rps~  273 (285)
T 3is5_A          259 LKQMLTKDPERRPSA  273 (285)
T ss_dssp             HHHHTCSCTTTSCCH
T ss_pred             HHHHccCChhhCcCH
Confidence            999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.6e-50  Score=324.02  Aligned_cols=248  Identities=29%  Similarity=0.536  Sum_probs=208.1

Q ss_pred             CCccCCcc-cccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          1 MTTHQNQH-SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         1 ~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      +.++|++. +.||+|+||.||+|.+..+++.||+|++..........+.+|+..++++ +||||+++++++.+++..++|
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            35789985 7899999999999999999999999998766666678899999999985 799999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc---EEEeecccccccCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR---IKIIDFGLARKFDP  155 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~---~~l~df~~~~~~~~  155 (251)
                      ||++++++|.+.+...+ .+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.   ++|+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC--EHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--SCSSSSCSEEECCTTCCC----
T ss_pred             EEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE--ccCCCcCceEEEEccCcccccc
Confidence            99999999999887654 69999999999999999999999999999999999998  65554   99999999876432


Q ss_pred             CC--------cceeeccCccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------------
Q psy11805        156 EK--------KLQVLFGTPEFVAPEVVNF-----DAIGFGTDMWSVGVICYVLLSGLSPFMGETD---------------  207 (251)
Q Consensus       156 ~~--------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------  207 (251)
                      ..        ......+++.|+|||.+.+     ..++.++||||||+++|+|++|..||.....               
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            11        1223458999999999865     4578899999999999999999999987542               


Q ss_pred             HHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        208 VQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ......+..+....+...+..++..+++||++||+.||.+|||+
T Consensus       247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  290 (316)
T 2ac3_A          247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA  290 (316)
T ss_dssp             HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH
Confidence            33455566666655555556789999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.5e-51  Score=332.32  Aligned_cols=246  Identities=26%  Similarity=0.461  Sum_probs=196.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+..++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            47899999999999999999999999999999998643 33457788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCccee
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV  161 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~  161 (251)
                      +++++|.+.+...+ .+++..++.++.|++.||.|||++|++||||||+||++..+..++++|+|||++...........
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~  176 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  176 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCC
Confidence            99999998887654 69999999999999999999999999999999999999333334599999999976544444455


Q ss_pred             eccCcccccccccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        162 LFGTPEFVAPEVVNFDAIGFG-TDMWSVGVICYVLLSGLSPFMGETD----VQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       162 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ..+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.....    ......+.......+  ....+++.+.+|
T Consensus       177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  254 (361)
T 3uc3_A          177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP--DDIRISPECCHL  254 (361)
T ss_dssp             ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--TTSCCCHHHHHH
T ss_pred             CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--CcCCCCHHHHHH
Confidence            679999999999988777655 8999999999999999999987544    333344433333332  224689999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |++||+.||++|||+
T Consensus       255 i~~~L~~dP~~Rps~  269 (361)
T 3uc3_A          255 ISRIFVADPATRISI  269 (361)
T ss_dssp             HHHHSCSCTTTSCCH
T ss_pred             HHHHccCChhHCcCH
Confidence            999999999999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-51  Score=330.65  Aligned_cols=248  Identities=33%  Similarity=0.590  Sum_probs=214.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc-----cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-----KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...     .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            47899999999999999999999999999999998543     2345688999999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q psy11805         77 VVLELIEGGELFERVIDD---------------------------------------DFVLTEKAVAIFMRQICEGVEFI  117 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~---------------------------------------~~~~~~~~~~~i~~~l~~~l~~l  117 (251)
                      +|||++++++|.+.+...                                       ...+++..++.++.|++.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999998887420                                       12346788999999999999999


Q ss_pred             hhCCceecCCCCCcEEEeecCCC--cEEEeecccccccCCCC-----cceeeccCccccccccccc--CCCCcchhHHHH
Q psy11805        118 HSKNVLHLDMKPENILCLTKTGN--RIKIIDFGLARKFDPEK-----KLQVLFGTPEFVAPEVVNF--DAIGFGTDMWSV  188 (251)
Q Consensus       118 h~~gi~h~dl~~~nil~~~~~~~--~~~l~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~sl  188 (251)
                      |+.|++|+||+|+||++  +.++  .++|+|||.+.......     ......+++.|+|||.+.+  ..++.++|||||
T Consensus       185 H~~~ivH~Dlkp~NIll--~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          185 HNQGICHRDIKPENFLF--STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             HHTTEECCCCCGGGEEE--SCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             HHCCccccCCChhhEEE--ecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence            99999999999999999  5554  89999999997653221     2244568999999999965  678899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       189 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      |+++|+|++|..||...+..+....+.........+.+..+++.+.+||.+||+.||.+|||+
T Consensus       263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            999999999999999999999888888888877777777899999999999999999999984

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-50  Score=320.86  Aligned_cols=245  Identities=24%  Similarity=0.417  Sum_probs=205.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|.+....  ......+.+|+..+++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            6899999999999999999998 568899999986433  2235778899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~  159 (251)
                      ++++ +|.+.+......+++..++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++...... ...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC-----
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCCEEEeECccccccCcccccc
Confidence            9986 8888888766679999999999999999999999999999999999999  89999999999999775432 222


Q ss_pred             eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC----------------
Q psy11805        160 QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD----------------  222 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  222 (251)
                      ....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+........                
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            344689999999999764 579999999999999999999999999887777665543211110                


Q ss_pred             ---------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ---------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               ......++.++.+||++||+.||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  275 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA  275 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH
Confidence                     01124578999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-50  Score=337.82  Aligned_cols=248  Identities=24%  Similarity=0.428  Sum_probs=215.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++....   ......+.+|..++..++|+||+++++++.+++..++|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            368999999999999999999999999999999986422   22345588999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+++......+++..++.++.|++.||.|||+.||+||||||+|||+  +.++.++|+|||++........
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl--~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTSC
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE--cCCCCEEEcchhhhhhcccCCC
Confidence            99999999999998766679999999999999999999999999999999999999  9999999999999977544333


Q ss_pred             c--eeeccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc-cccCCC
Q psy11805        159 L--QVLFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE-CFNEIS  230 (251)
Q Consensus       159 ~--~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  230 (251)
                      .  ...+||+.|+|||++.     ...++.++||||||+++|+|++|..||.+.+..+...++.........+ .+..++
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  310 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS  310 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence            2  2357999999999986     4568899999999999999999999999999888888886544322222 235689


Q ss_pred             HHHHHHHHHhcccCcCC--CCCC
Q psy11805        231 DDAKDFIRKLLLKDRED--APEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~--Rps~  251 (251)
                      +++++||++||..+|++  ||++
T Consensus       311 ~~~~dLi~~lL~~~~~r~~r~~~  333 (437)
T 4aw2_A          311 ENAKDLIRRLICSREHRLGQNGI  333 (437)
T ss_dssp             HHHHHHHHTTSSCGGGCTTTTTT
T ss_pred             HHHHHHHHHHhcccccccCCCCH
Confidence            99999999999988888  8875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=327.34  Aligned_cols=245  Identities=21%  Similarity=0.338  Sum_probs=211.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCc---eEEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGM---TLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|++.+.||+|+||.||+|.+..++.   .||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            4689999999999999999999986554   5999998643 23346788999999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |||++++++|.+++......+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++.......
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV--DSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCSSCEECC---
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--CCCCCEEECCCCcccccccCc
Confidence            999999999999998776789999999999999999999999999999999999999  899999999999998764332


Q ss_pred             cc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        158 KL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       158 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      ..    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+...   +....+++.
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  282 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL---PAPMGCPHA  282 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---CCCTTCCHH
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC---CCCCCcCHH
Confidence            21    22235668999999998899999999999999999999 99999999888888777665322   223578999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++|.+||+.||++|||+
T Consensus       283 l~~li~~~l~~dp~~Rps~  301 (325)
T 3kul_A          283 LHQLMLDCWHKDRAQRPRF  301 (325)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHccCChhhCcCH
Confidence            9999999999999999984

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.5e-50  Score=319.10  Aligned_cols=247  Identities=31%  Similarity=0.586  Sum_probs=221.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---------ccchHHHHHHHHHHHHcC-CCceeeEeEEEee
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---------RNDRRNVEREVEIMRELQ-HPRLIQIYDAFES   71 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   71 (251)
                      .++|++.+.||+|++|.||+|.+..+++.|++|++....         ....+.+.+|+..++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            578999999999999999999999999999999986443         123567889999999996 9999999999999


Q ss_pred             CCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccc
Q psy11805         72 SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLAR  151 (251)
Q Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~  151 (251)
                      ++..++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL--DDDMNIKLTDFGFSC  172 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--cCCCcEEEecccchh
Confidence            99999999999999999988765 369999999999999999999999999999999999999  889999999999998


Q ss_pred             ccCCCCcceeeccCcccccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcc
Q psy11805        152 KFDPEKKLQVLFGTPEFVAPEVVN------FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC  225 (251)
Q Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (251)
                      ............+++.|+|||.+.      ...++.++||||||+++++|++|..||...+..+....+..+......+.
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  252 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence            876665556667899999999984      44678899999999999999999999999988888888888777777666


Q ss_pred             ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        226 FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..++..+.++|.+||+.||++|||+
T Consensus       253 ~~~~~~~l~~li~~~l~~dp~~Rps~  278 (298)
T 1phk_A          253 WDDYSDTVKDLVSRFLVVQPQKRYTA  278 (298)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCH
Confidence            67899999999999999999999984

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.9e-50  Score=323.94  Aligned_cols=247  Identities=25%  Similarity=0.412  Sum_probs=195.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+..+++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999999999999999986543 2345788899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         81 LIEGGELFERVIDD-----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        81 ~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++++ +|.+.+...     ...+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.....
T Consensus        84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI--NKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCSSCEETTS
T ss_pred             ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE--cCCCCEEECcCccceecCC
Confidence            9985 888877643     2358999999999999999999999999999999999999  8999999999999987643


Q ss_pred             C-CcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC----------
Q psy11805        156 E-KKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD----------  223 (251)
Q Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  223 (251)
                      . .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.........          
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            2 22344568999999999976 46799999999999999999999999998887777666432211111          


Q ss_pred             --------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 --------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                          .....++.++.+||++||+.||++|||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  288 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA  288 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence                                0112578899999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.2e-50  Score=325.89  Aligned_cols=248  Identities=36%  Similarity=0.690  Sum_probs=216.5

Q ss_pred             CccCCcc-cccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQH-SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|++....  ......+.+|+..++.+. ||||+++++++.+.+..++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            4578887 89999999999999999999999999986433  234678999999999995 6999999999999999999


Q ss_pred             EEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC---CCcEEEeeccccccc
Q psy11805         78 VLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT---GNRIKIIDFGLARKF  153 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~---~~~~~l~df~~~~~~  153 (251)
                      |||++++++|.+.+... ...+++..++.++.|++.||.+||+.|++|+||+|+||++  +.   ++.++|+|||++...
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~--~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL--SSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--SCBTTBCCEEECCGGGCEEC
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEE--ecCCCCCcEEEeeCcccccc
Confidence            99999999998887643 3569999999999999999999999999999999999998  55   789999999999887


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+...........+..++..+
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  264 (327)
T 3lm5_A          185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA  264 (327)
T ss_dssp             ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence            66555556679999999999999999999999999999999999999999999988888888877777777778899999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .+||.+||+.||++|||+
T Consensus       265 ~~li~~~L~~dP~~Rpt~  282 (327)
T 3lm5_A          265 TDFIQSLLVKNPEKRPTA  282 (327)
T ss_dssp             HHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHcCCChhhCcCH
Confidence            999999999999999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-50  Score=323.26  Aligned_cols=244  Identities=24%  Similarity=0.376  Sum_probs=202.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|+||+||+|.+.  +..||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            368999999999999999999774  7789999986443  223567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         80 ELIEGGELFERVIDDDF--VLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      |++++++|.+.+...+.  .+++..++.++.|++.||.|||+.|  ++|+||||+||++  +.++.++|+|||++.....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE--CTTCCEEECCCC-------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE--eCCCcEEECCCCCCccccc
Confidence            99999999998876442  3899999999999999999999999  9999999999999  8999999999999976443


Q ss_pred             CC-cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        156 EK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      .. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+........  ....+++.+.
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~  269 (309)
T 3p86_A          192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLNPQVA  269 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHHHH
T ss_pred             cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCccCCHHHH
Confidence            32 23445689999999999999999999999999999999999999999888877766644433322  3367899999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      +||++||+.||.+|||+
T Consensus       270 ~li~~~l~~dP~~Rps~  286 (309)
T 3p86_A          270 AIIEGCWTNEPWKRPSF  286 (309)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHccCChhhCcCH
Confidence            99999999999999984

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3e-50  Score=329.61  Aligned_cols=246  Identities=33%  Similarity=0.625  Sum_probs=220.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--------cchHHHHHHHHHHHHc-CCCceeeEeEEEeeCC
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--------NDRRNVEREVEIMREL-QHPRLIQIYDAFESSN   73 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   73 (251)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++.....        ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999998999999999864331        1246678999999999 7999999999999999


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..++||||+++++|.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||++  +.++.++|+|||++...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~--~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL--DDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--CCCCCEEEEecCccccc
Confidence            9999999999999999887653 69999999999999999999999999999999999999  89999999999999887


Q ss_pred             CCCCcceeeccCccccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNF------DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      ..........+++.|+|||.+.+      ..++.++||||||+++|+|++|..||...+.......+..+......+.+.
T Consensus       251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  330 (365)
T 2y7j_A          251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD  330 (365)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred             CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            76666666789999999999863      357889999999999999999999999988888888888887777777778


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++..+.++|++||+.||++|||+
T Consensus       331 ~~~~~~~~li~~~L~~dP~~Rps~  354 (365)
T 2y7j_A          331 DRSSTVKDLISRLLQVDPEARLTA  354 (365)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH
Confidence            899999999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.8e-50  Score=333.32  Aligned_cols=242  Identities=31%  Similarity=0.561  Sum_probs=201.0

Q ss_pred             ccCCcc-cccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHH-HcCCCceeeEeEEEee----CCEEE
Q psy11805          3 THQNQH-SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMR-ELQHPRLIQIYDAFES----SNVMC   76 (251)
Q Consensus         3 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~----~~~~~   76 (251)
                      ++|.+. +.||.|+||+||+|.+..+++.||+|++..     ...+.+|+..+. ..+|+||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            467776 689999999999999999999999999742     356778888874 4579999999999875    56789


Q ss_pred             EEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC---CCcEEEeecccccc
Q psy11805         77 VVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT---GNRIKIIDFGLARK  152 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~---~~~~~l~df~~~~~  152 (251)
                      +||||+++++|.+++...+ ..+++..++.++.|++.||.|||+.|++|+||||+||++  +.   ++.++|+|||++..
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill--~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY--TSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SSSSTTCCEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEE--ecCCCCccEEEEecccccc
Confidence            9999999999999987653 359999999999999999999999999999999999998  55   78899999999987


Q ss_pred             cCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhccccCCCccccC
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV----QTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~  228 (251)
                      ..........++++.|+|||++.+..++.++||||||+++|+|++|..||......    .....+..+....+.+.+..
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  293 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  293 (400)
T ss_dssp             CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred             cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence            66555556667899999999999999999999999999999999999999876432    24455666666666666788


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.++.+||++||+.||++|||+
T Consensus       294 ~s~~~~~li~~~L~~dP~~Rpt~  316 (400)
T 1nxk_A          294 VSEEVKMLIRNLLKTEPTQRMTI  316 (400)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCH
Confidence            99999999999999999999984

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-50  Score=315.31  Aligned_cols=243  Identities=21%  Similarity=0.357  Sum_probs=211.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+. +++.|++|++... ....+.+.+|+..+++++||||+++++++.+++..++|||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            368999999999999999999987 4667999998643 33467799999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--cc
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--KL  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--~~  159 (251)
                      +++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.......  ..
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE--cCCCCEEeccccccccccccccccc
Confidence            99999999998777779999999999999999999999999999999999999  888999999999997654322  11


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+........   ....++.+.+++.
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~  241 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIMN  241 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHH
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHHHHHHH
Confidence            22345678999999998899999999999999999999 9999999988888877766533222   2567999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       242 ~~l~~~p~~Rps~  254 (269)
T 4hcu_A          242 HCWRERPEDRPAF  254 (269)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHccCCcccCcCH
Confidence            9999999999984

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-50  Score=317.84  Aligned_cols=243  Identities=33%  Similarity=0.551  Sum_probs=188.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.|++|++....   ....+.+.+|+..+++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            68999999999999999999999999999999985432   223578899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~  158 (251)
                      |++++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... ..
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL--TRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE--CTTCCEEECCCTTCEECC-----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--cCCCCEEEEeecceeeccCCCCc
Confidence            9999999999988776679999999999999999999999999999999999999  88999999999999775432 22


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+......    ....++.++.++|.
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~  244 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE----MPSFLSIEAKDLIH  244 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC----CCTTSCHHHHHHHH
T ss_pred             ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC----CccccCHHHHHHHH
Confidence            23456889999999999888999999999999999999999999887665555444333222    23567899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       245 ~~l~~dp~~Rps~  257 (278)
T 3cok_A          245 QLLRRNPADRLSL  257 (278)
T ss_dssp             HHSCSSGGGSCCH
T ss_pred             HHcccCHhhCCCH
Confidence            9999999999984

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=326.33  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=204.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+|+..++.++|+||+++++++.+++..++|||+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5899999999999999999999999999999998644322 223455799999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~  160 (251)
                      +++ +|.+.+...+..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++...... ....
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE--CTTCCEEECSSSEEECC--------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE--CCCCCEEEccCcccccccCCccccc
Confidence            985 8888888877789999999999999999999999999999999999999  88999999999999765432 2233


Q ss_pred             eeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcc--------------
Q psy11805        161 VLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC--------------  225 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------  225 (251)
                      ...+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+...........              
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            4467999999999876 5679999999999999999999999999988887776655333222221              


Q ss_pred             ------------ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        226 ------------FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       226 ------------~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                  ...+++++.+||++||+.||++|||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  276 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA  276 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH
Confidence                        23578899999999999999999985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-50  Score=339.46  Aligned_cols=244  Identities=23%  Similarity=0.339  Sum_probs=200.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeC------C
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS------N   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   73 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            36899999999999999999999999999999998643  333467888999999999999999999999654      4


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..|+||||+++ +|.+.+..   .+++..++.++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++...
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll--~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCCCC---
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE--eCCCCEEEEEEEeeeec
Confidence            67999999987 45565532   48999999999999999999999999999999999999  89999999999999887


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN------  227 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------  227 (251)
                      ..........+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+...........+.      
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence            66555566789999999999999999999999999999999999999999998877777665432222111100      


Q ss_pred             --------------------------------CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 --------------------------------EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 --------------------------------~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                      ..++++.+||++||+.||++|||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  350 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV  350 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH
Confidence                                            014578999999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.4e-50  Score=315.67  Aligned_cols=241  Identities=28%  Similarity=0.539  Sum_probs=211.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|++|.||+|.+..++..|++|++....   ......+.+|+..++.++||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            68999999999999999999999999999999985322   234677899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |++++++|.+.+.... .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... .
T Consensus        89 e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili--~~~~~~~l~Dfg~~~~~~~~~-~  164 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSR-R  164 (279)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE--CTTSCEEECSCCEESCC------
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE--cCCCCEEEEeccccccCCccc-c
Confidence            9999999988887654 59999999999999999999999999999999999999  899999999999886544332 2


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..++..+.+||.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~  240 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISR  240 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHH
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHHHHH
Confidence            345689999999999998999999999999999999999999999988888877766655443    5678999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||.+|||+
T Consensus       241 ~l~~~p~~Rps~  252 (279)
T 3fdn_A          241 LLKHNPSQRPML  252 (279)
T ss_dssp             HCCSSGGGSCCH
T ss_pred             HhccChhhCCCH
Confidence            999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-49  Score=315.61  Aligned_cols=243  Identities=30%  Similarity=0.495  Sum_probs=214.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++....   ....+.+.+|+..++.++|+||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999999999999999999986432   23467788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-C
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-K  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~  157 (251)
                      ||++++++|.+.+...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... .
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEECCSTTC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE--cCCCCEEEEeccCceecccCcc
Confidence            99999999988876643 69999999999999999999999999999999999999  88999999999999775422 2


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+.......+    ..++..+.++|
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li  246 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLI  246 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHHHHH
Confidence            33445688999999999988899999999999999999999999999888887777766554433    56789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.||++|||+
T Consensus       247 ~~~l~~~p~~Rps~  260 (294)
T 2rku_A          247 QKMLQTDPTARPTI  260 (294)
T ss_dssp             HHHTCSSGGGSCCG
T ss_pred             HHHcccChhhCcCH
Confidence            99999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-50  Score=339.26  Aligned_cols=240  Identities=28%  Similarity=0.513  Sum_probs=204.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            6799999999999999999999999999999998643   2334566778999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccC-CCC
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD-PEK  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~-~~~  157 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.|||+ .|++||||||+||++  +.++.++|+|||++.... ...
T Consensus       228 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          228 EYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             CCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE--CSSSCEEECCCCCCCTTCC---
T ss_pred             eeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE--CCCCCEEEccCCCceeccCCCc
Confidence            9999999988887654 69999999999999999999998 999999999999999  889999999999997633 223


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....++++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+......++    ..+++++.+||
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  380 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLL  380 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHH
Confidence            33456799999999999999999999999999999999999999999998888888877665544    56799999999


Q ss_pred             HHhcccCcCCCC
Q psy11805        238 RKLLLKDREDAP  249 (251)
Q Consensus       238 ~~~l~~~p~~Rp  249 (251)
                      .+||+.||.+||
T Consensus       381 ~~~L~~dP~~R~  392 (446)
T 4ejn_A          381 SGLLKKDPKQRL  392 (446)
T ss_dssp             HHHTCSSTTTST
T ss_pred             HHHcccCHHHhC
Confidence            999999999999

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.5e-50  Score=325.15  Aligned_cols=245  Identities=21%  Similarity=0.264  Sum_probs=207.9

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+|+.+++.+ +|+||+++++++.+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            357899999999999999999999999999999997543  2345688999999999 8999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc-----EEEeecccccccC
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR-----IKIIDFGLARKFD  154 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~-----~~l~df~~~~~~~  154 (251)
                      |++ +++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.     ++|+|||++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill--~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI--GRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CCGGGTCTTSEEECCCTTCEESB
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee--ccCCCCCCceEEEEEcccceeee
Confidence            999 889999988766689999999999999999999999999999999999999  77776     9999999998754


Q ss_pred             CCCc--------ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccccCCC
Q psy11805        155 PEKK--------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET---DVQTMANVTIAQYDFDD  223 (251)
Q Consensus       155 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~  223 (251)
                      ....        .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+   ..+....+.........
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            3322        234578999999999999999999999999999999999999998743   34445555444433333


Q ss_pred             cc-ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 EC-FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ~~-~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .. ...+| ++.+++.+||+.+|.+||++
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~  269 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDY  269 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCH
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCH
Confidence            22 23355 99999999999999999984

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-50  Score=332.22  Aligned_cols=245  Identities=23%  Similarity=0.417  Sum_probs=212.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++....   ......+.+|..++..++|+||+++++++.+++..|+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            468999999999999999999999999999999986422   23456688999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||++|++|.+++...+..+++..++.++.|++.||.|||+.|++||||||+||++  +.+++++|+|||++........
T Consensus       140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl--d~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTSC
T ss_pred             EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee--cCCCCEEEeechhheeccCCCc
Confidence            99999999999998766679999999999999999999999999999999999999  9999999999999987654433


Q ss_pred             c--eeeccCcccccccccc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc-cccC
Q psy11805        159 L--QVLFGTPEFVAPEVVN-------FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE-CFNE  228 (251)
Q Consensus       159 ~--~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  228 (251)
                      .  ...+||+.|+|||++.       +..++.++||||||+++|+|++|..||...+..+...++.........+ ....
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  297 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG  297 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----C
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccC
Confidence            2  2357999999999987       3568899999999999999999999999999888888776544322222 2357


Q ss_pred             CCHHHHHHHHHhcccCcCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      +|.++++||++||. +|.+|+
T Consensus       298 ~s~~~~dli~~lL~-~p~~Rl  317 (412)
T 2vd5_A          298 VPEEARDFIQRLLC-PPETRL  317 (412)
T ss_dssp             CCHHHHHHHHTTSS-CGGGCT
T ss_pred             CCHHHHHHHHHHcC-ChhhcC
Confidence            89999999999999 999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-49  Score=323.83  Aligned_cols=241  Identities=23%  Similarity=0.384  Sum_probs=209.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+..+++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            458999999999999999999999999999999864332   23567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||++| +|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++......   
T Consensus       134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSSB---
T ss_pred             ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--CCCCCEEEeeccCceecCCC---
Confidence            99975 7878877666679999999999999999999999999999999999999  88999999999999765432   


Q ss_pred             eeeccCcccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ....+++.|+|||.+.   +..++.++||||||+++|+|++|..||...+..+....+.....+...  ...++..+.+|
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l  285 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRNF  285 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC--CTTSCHHHHHH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHH
Confidence            3456899999999984   567889999999999999999999999998887777666655433222  25679999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |.+||+.||++|||+
T Consensus       286 i~~~l~~dP~~Rps~  300 (348)
T 1u5q_A          286 VDSCLQKIPQDRPTS  300 (348)
T ss_dssp             HHHHTCSSGGGSCCH
T ss_pred             HHHHcccChhhCcCH
Confidence            999999999999984

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.9e-50  Score=342.11  Aligned_cols=243  Identities=28%  Similarity=0.457  Sum_probs=212.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            36799999999999999999999999999999998543   233466788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         79 LELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |||++|++|.+.+...+ ..+++..++.++.|++.||.|||+.||+||||||+||++  +.+++++|+|||++.......
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl--d~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTSCEEECCCTTCEECCTTC
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE--eCCCCeEEEecccceecccCc
Confidence            99999999998887643 349999999999999999999999999999999999999  899999999999998876655


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccccCCCccccCCCHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD----VQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      .....+||+.|+|||++.+..++.++||||||+++|+|++|..||.....    .+....+.....    .....++.++
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~----~~p~~~s~~~  416 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----EYSERFSPQA  416 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC----CCCTTSCHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc----cCCccCCHHH
Confidence            55666899999999999998899999999999999999999999987642    333444433322    2336789999


Q ss_pred             HHHHHHhcccCcCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPE  250 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps  250 (251)
                      ++||++||+.||++||+
T Consensus       417 ~dLI~~lL~~dP~~R~g  433 (576)
T 2acx_A          417 RSLCSQLLCKDPAERLG  433 (576)
T ss_dssp             HHHHHHHTCSSGGGSTT
T ss_pred             HHHHHHhccCCHHHcCC
Confidence            99999999999999994

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.9e-50  Score=313.47  Aligned_cols=243  Identities=21%  Similarity=0.326  Sum_probs=211.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++... ......+.+|+..+++++||||+++++++.+++..++|||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            478999999999999999999777 4667999998643 33467789999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      +++++|.+++...+..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.........  
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV--DRDLCVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE--CTTCCEEECCTTCEEECCTTCEEEC
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE--CCCCCEEEccCccceecchhhhhcc
Confidence            99999999998776679999999999999999999999999999999999999  89999999999999765443322  


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+......   ...++.+.++|.
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~  239 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTIYQIMY  239 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHHHHHHHH
T ss_pred             cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHHHHHHHH
Confidence            12234567999999998889999999999999999999 99999998888887777665433332   457899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       240 ~~l~~~p~~Rps~  252 (268)
T 3sxs_A          240 SCWHELPEKRPTF  252 (268)
T ss_dssp             HTTCSSGGGSCCH
T ss_pred             HHcCCChhhCcCH
Confidence            9999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-49  Score=312.97  Aligned_cols=242  Identities=27%  Similarity=0.477  Sum_probs=205.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++....   ....+.+.+|+..++.++|+||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            68999999999999999999999999999999986432   234678899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |++++++|.+.+...+ .+++..++.++.|++.||.+||++|++|+||+|+||++  +.++.++|+|||.+.........
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE--CTTSCEEECCCCGGGCCCC----
T ss_pred             eccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE--CCCCCEEEeecccccccCCCcce
Confidence            9999999999887654 58999999999999999999999999999999999999  88999999999999876655544


Q ss_pred             eeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..+ +.++||||||+++++|++|..||...+..+....+.......+    ..++..+.++|.
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~  243 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLM  243 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHHHHH
Confidence            55678999999999987765 6899999999999999999999998888777777766544333    567899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       244 ~~l~~~p~~Rps~  256 (276)
T 2h6d_A          244 HMLQVDPLKRATI  256 (276)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHccCChhhCCCH
Confidence            9999999999985

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=318.63  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=203.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      |-++|++.+.||+|++|.||+|.+..+++.||+|++......  ..+.+.+|+..+++++|+||+++++++.+.+..++|
T Consensus         1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            457999999999999999999999999999999988543322  356788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-C
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-K  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~  157 (251)
                      ||++++++|.+..... ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... .
T Consensus        81 ~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI--TKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECC----
T ss_pred             EEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE--cCCCCEEEeeCCCchhccCccc
Confidence            9999998887766544 469999999999999999999999999999999999999  88999999999999775432 2


Q ss_pred             cceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC--------------
Q psy11805        158 KLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD--------------  222 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  222 (251)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+........              
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            2344568899999999976 5679999999999999999999999999887776655433211100              


Q ss_pred             -------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 -------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                   ....+.++..+.+||++||+.||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  279 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC  279 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH
Confidence                         01124688899999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.8e-50  Score=339.91  Aligned_cols=243  Identities=26%  Similarity=0.465  Sum_probs=211.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999986432   234577889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         80 ELIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ||++|++|.+.+...   ...+++..++.++.|++.||.|||+.|++||||||+||++  +.+++++|+|||++......
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl--~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTSCEEECCCTTCEECCTT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE--eCCCCEEEeecceeeeccCC
Confidence            999999999888754   3469999999999999999999999999999999999999  99999999999999876544


Q ss_pred             Cc-ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhccccCCCccccCCCH
Q psy11805        157 KK-LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET----DVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      .. ....+||+.|+|||++.+..++.++||||||+++|+|++|..||....    ..+....+.......+    ..++.
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~~s~  418 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSP  418 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cccCH
Confidence            33 234479999999999999999999999999999999999999998753    3445555554443333    67899


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+++||++||+.||++||++
T Consensus       419 ~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCC
T ss_pred             HHHHHHHHhccCCHhHCCCC
Confidence            99999999999999999973

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-49  Score=315.11  Aligned_cols=242  Identities=21%  Similarity=0.376  Sum_probs=204.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccc-------hHHHHHHHHHHHHcCCCceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND-------RRNVEREVEIMRELQHPRLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.......       .+.+.+|+..+++++|+||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            578999999999999999999999999999999986433221       277899999999999999999999997765 


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeecCCCc-----EEEeec
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTKTGNR-----IKIIDF  147 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~~~~~-----~~l~df  147 (251)
                       ++|||++++++|.+.+......+++..++.++.|++.||.+||+.|  ++|+||||+||++  +.++.     ++|+||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~--~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL--QSLDENAPVCAKVADF  173 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE--SCCCTTCSCCEEECCC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE--eccCCCCceeEEeCCC
Confidence             6899999999999988877778999999999999999999999999  9999999999999  66665     999999


Q ss_pred             ccccccCCCCcceeeccCccccccccc--ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhccccCCC
Q psy11805        148 GLARKFDPEKKLQVLFGTPEFVAPEVV--NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT--MANVTIAQYDFDD  223 (251)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  223 (251)
                      |++.....  ......+++.|+|||.+  ....++.++||||||+++|+|++|..||........  .........  ..
T Consensus       174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~  249 (287)
T 4f0f_A          174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--RP  249 (287)
T ss_dssp             TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--CC
T ss_pred             Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--CC
Confidence            99975433  33445689999999998  345678899999999999999999999987654443  333333332  23


Q ss_pred             ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....+|+.+.++|.+||+.||++|||+
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~  277 (287)
T 4f0f_A          250 TIPEDCPPRLRNVIELCWSGDPKKRPHF  277 (287)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCcccCHHHHHHHHHHhcCChhhCcCH
Confidence            3346789999999999999999999984

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.2e-49  Score=321.09  Aligned_cols=243  Identities=30%  Similarity=0.495  Sum_probs=215.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|+||.||++.+..+++.+++|++....   ....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999999999999999986432   23467788999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-C
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-K  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~  157 (251)
                      ||++++++|.+.+.... .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... .
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEEECCCTTCEECCSTTC
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE--cCCCCEEEeeccCceecccCcc
Confidence            99999999988876643 69999999999999999999999999999999999999  88999999999999875422 2


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+.......+    ..++..+.+||
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li  272 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLI  272 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence            33445689999999999988899999999999999999999999999888877777766554433    56789999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.||++|||+
T Consensus       273 ~~~l~~dp~~Rps~  286 (335)
T 2owb_A          273 QKMLQTDPTARPTI  286 (335)
T ss_dssp             HHHTCSSGGGSCCG
T ss_pred             HHHccCChhHCcCH
Confidence            99999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.1e-49  Score=323.21  Aligned_cols=246  Identities=23%  Similarity=0.356  Sum_probs=208.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEee--------C
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFES--------S   72 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~   72 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......  ....+.+|+.+++.++|+||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            6899999999999999999999999999999998544322  35678899999999999999999999976        4


Q ss_pred             CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         73 NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      +..++|||++++ +|.+.+......+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++..
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI--TRDGVLKLADFGLARA  173 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE--cCCCCEEEccchhccc
Confidence            568999999986 7778777766679999999999999999999999999999999999999  8999999999999976


Q ss_pred             cCCC-----CcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccc
Q psy11805        153 FDPE-----KKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF  226 (251)
Q Consensus       153 ~~~~-----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (251)
                      ....     .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+...........+
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            5422     22233467899999999876 45799999999999999999999999999888877777655444443333


Q ss_pred             cC----------------------------CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NE----------------------------ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~----------------------------~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +.                            .++.+.+||.+||+.||++|||+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  306 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS  306 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH
Confidence            32                            26789999999999999999985

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1e-49  Score=329.31  Aligned_cols=248  Identities=16%  Similarity=0.245  Sum_probs=204.7

Q ss_pred             CccCCcccccccC--CceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFG--KFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|++.+.||+|  +||.||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  99999999999999999999986543  2346778899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         78 VLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      |||++++++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+||++  +.++.++|+|||.+......
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll--~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCGGGCEECEET
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--cCCCCEEEcccccceeeccc
Confidence            99999999999988764 3469999999999999999999999999999999999999  89999999999987653211


Q ss_pred             --------CcceeeccCccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc------
Q psy11805        157 --------KKLQVLFGTPEFVAPEVVNF--DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD------  220 (251)
Q Consensus       157 --------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  220 (251)
                              .......+++.|+|||.+.+  ..++.++||||||+++|+|++|..||.+.+..+.......+..+      
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence                    11122367889999999987  57899999999999999999999999887655544433222211      


Q ss_pred             ------------------------------------CCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 ------------------------------------FDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 ------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                          ...+.+..+++.+.+||++||+.||++|||+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta  328 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA  328 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence                                                0112335688999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-49  Score=313.50  Aligned_cols=241  Identities=27%  Similarity=0.531  Sum_probs=214.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|++|.||+|.+..++..|++|++....   ......+.+|+..++.++|+||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999985432   233577899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |++++++|.+.+...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... ..
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~-~~  169 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM--GYKGELKIADFGWSVHAPSL-RR  169 (284)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE--CTTCCEEECCCTTCEECSSS-CB
T ss_pred             EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE--cCCCCEEEecccccccCccc-cc
Confidence            9999999999887654 69999999999999999999999999999999999999  88999999999998665432 23


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.......+    ..++..+.++|.+
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~  245 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLISK  245 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHH
T ss_pred             ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHHHH
Confidence            445689999999999998899999999999999999999999999888887777766544333    5679999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||.+|||+
T Consensus       246 ~l~~~p~~Rps~  257 (284)
T 2vgo_A          246 LLRYHPPQRLPL  257 (284)
T ss_dssp             HSCSSGGGSCCH
T ss_pred             HhhcCHhhCCCH
Confidence            999999999984

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.2e-50  Score=331.86  Aligned_cols=244  Identities=21%  Similarity=0.356  Sum_probs=211.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++..++..++|||+
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            67899999999999999999999899999999986432 22356788999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      +++++|.+++...+..++...++.++.|++.||.|||++|++|+||+|+||++  +.++.++|+|||++.........  
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~--~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV--TEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCGGGCEECTTSEEECC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE--cCCCcEEECcCCCceecCCCceeec
Confidence            99999999998776679999999999999999999999999999999999999  88999999999999764332111  


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+...   +....+|+.+.++|
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  348 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL---PCPELCPDAVFRLM  348 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred             CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence             11224668999999998889999999999999999998 99999998887777666554322   22356899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.||++|||+
T Consensus       349 ~~cl~~dP~~Rps~  362 (377)
T 3cbl_A          349 EQCWAYEPGQRPSF  362 (377)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHcCCCchhCcCH
Confidence            99999999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.6e-49  Score=314.17  Aligned_cols=248  Identities=36%  Similarity=0.642  Sum_probs=219.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|++|.||+|.+..+++.|++|++....  ......+.+|+..+++++||||+++++++.+.+..++|+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            368999999999999999999999999999999986433  335788999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |++++++|.+.+...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++... .++.++|+|||.+........
T Consensus       101 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            9999999988887654 69999999999999999999999999999999999998322 234799999999987765555


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      .....+++.|+|||.+.+. ++.++||||||+++|+|++|..||...+..+....+..+......+.+..+++++.++|+
T Consensus       180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  258 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR  258 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHH
T ss_pred             cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHH
Confidence            5556688999999998754 889999999999999999999999999988888888888777777777789999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       259 ~~l~~dp~~Rps~  271 (287)
T 2wei_A          259 KMLTFHPSLRITA  271 (287)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHcccChhhCcCH
Confidence            9999999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.7e-49  Score=316.63  Aligned_cols=245  Identities=19%  Similarity=0.253  Sum_probs=209.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|++|.||+|.+..+++.||+|++..  ......+.+|+..++.+ +|++++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEEC--CTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEecc--CCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            5789999999999999999999999999999999753  23456788999999999 79999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc-----EEEeecccccccCC
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR-----IKIIDFGLARKFDP  155 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~-----~~l~df~~~~~~~~  155 (251)
                      ++ +++|.+++...+..+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.     ++|+|||++.....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI--GRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--CCSSSTTTTCEEECCCTTCEESBC
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe--ccCCCCCCCeEEEEECcccccccc
Confidence            99 889999998777679999999999999999999999999999999999999  66655     99999999987644


Q ss_pred             CCc--------ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhccccCC-C
Q psy11805        156 EKK--------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE---TDVQTMANVTIAQYDFD-D  223 (251)
Q Consensus       156 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~-~  223 (251)
                      ...        .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...   ...+....+........ .
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  243 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence            322        23456899999999999999999999999999999999999999874   34444444443333222 2


Q ss_pred             ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....+|+++.+++.+||+.||++|||+
T Consensus       244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~  271 (298)
T 1csn_A          244 ELCAGFPEEFYKYMHYARNLAFDATPDY  271 (298)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred             HHHhhCcHHHHHHHHHHhcCCcccCCCH
Confidence            2335789999999999999999999984

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=320.42  Aligned_cols=250  Identities=21%  Similarity=0.377  Sum_probs=206.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC--EEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN--VMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv   78 (251)
                      +++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            578999999999999999999999999999999986433 334677889999999999999999999987655  78999


Q ss_pred             EEeccCCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee--cCCCcEEEeecccccccC
Q psy11805         79 LELIEGGELFERVIDDD--FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT--KTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~--~~~~~~~l~df~~~~~~~  154 (251)
                      ||++++++|.+++....  ..+++..++.++.|++.||.|||+.|++|+||||+||++..  +.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            99999999999887643  23899999999999999999999999999999999998633  344569999999998876


Q ss_pred             CCCcceeeccCcccccccccc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcccc--
Q psy11805        155 PEKKLQVLFGTPEFVAPEVVN--------FDAIGFGTDMWSVGVICYVLLSGLSPFMGET----DVQTMANVTIAQYD--  220 (251)
Q Consensus       155 ~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~--  220 (251)
                      .........+++.|+|||.+.        +..++.++||||||+++|+|++|..||....    ..+....+..+...  
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (319)
T 4euu_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (319)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred             CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence            666556667999999999986        4678899999999999999999999997533    23444444433321  


Q ss_pred             -------------------CCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 -------------------FDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                         ........++..+.++|++||+.||++|||+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~  297 (319)
T 4euu_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF  297 (319)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred             chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH
Confidence                               1111223455688999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.5e-49  Score=325.90  Aligned_cols=244  Identities=22%  Similarity=0.322  Sum_probs=208.9

Q ss_pred             ccCCcccccccCCceEEEEEEEcc-------CCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCC
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKA-------TGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSN   73 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   73 (251)
                      ++|++.+.||+|+||.||+|.+..       ++..||+|++.... ......+.+|+.+++.+ +||||+++++++.+.+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            689999999999999999999752       34579999986443 23467899999999999 8999999999999999


Q ss_pred             EEEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC
Q psy11805         74 VMCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT  138 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~  138 (251)
                      ..++||||+++++|.+++....               ..++...++.++.|++.||.|||++|++|+||||+||++  +.
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~  238 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TE  238 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CT
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE--CC
Confidence            9999999999999999987643               348999999999999999999999999999999999999  89


Q ss_pred             CCcEEEeecccccccCCCC---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy11805        139 GNRIKIIDFGLARKFDPEK---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV  214 (251)
Q Consensus       139 ~~~~~l~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  214 (251)
                      ++.++|+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus       239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~  318 (370)
T 2psq_A          239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  318 (370)
T ss_dssp             TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999997654322   1223346778999999999999999999999999999999 99999988877777666


Q ss_pred             HhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+...   .....++.++.++|.+||+.||++|||+
T Consensus       319 ~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~  352 (370)
T 2psq_A          319 KEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTF  352 (370)
T ss_dssp             HTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            554322   2235789999999999999999999984

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-49  Score=328.56  Aligned_cols=245  Identities=25%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCC--EEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSN--VMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~   76 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+..++.+. |+||+++++++..++  ..|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            36899999999999999999999999999999997532  3345677889999999997 999999999997544  689


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-  155 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-  155 (251)
                      +|||++++ +|.+.+...  .+++..+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++..... 
T Consensus        88 lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           88 LVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL--NAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEEECCSE-EHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEESSSC
T ss_pred             EEecccCc-CHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE--cCCCCEEecCCccccccccc
Confidence            99999975 888888764  59999999999999999999999999999999999999  9999999999999976432 


Q ss_pred             ---------------------CCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy11805        156 ---------------------EKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMAN  213 (251)
Q Consensus       156 ---------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  213 (251)
                                           .......++|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                                 111233468999999999976 6789999999999999999999999999988877776


Q ss_pred             HHhccccCCCc-------------------------------------------cccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        214 VTIAQYDFDDE-------------------------------------------CFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       214 ~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      +......+...                                           ....+++++.+||++||+.||++|||
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            64322111100                                           01267889999999999999999998


Q ss_pred             C
Q psy11805        251 V  251 (251)
Q Consensus       251 ~  251 (251)
                      +
T Consensus       323 ~  323 (388)
T 3oz6_A          323 A  323 (388)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.4e-49  Score=317.76  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=209.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++........+.+.+|+..++.++||||+++++++..++..++|||+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            47899999999999999999999999999999998776666788999999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCcce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~~~  160 (251)
                      +++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++..... .....
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKRD  175 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--CTTSCEEECCCHHHHHHHHHHHC--
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE--CCCCCEEEEECCCCccccccccccc
Confidence            99999998887766679999999999999999999999999999999999999  8899999999998754321 11123


Q ss_pred             eeccCccccccccc-----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        161 VLFGTPEFVAPEVV-----NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       161 ~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      ...+++.|+|||.+     .+..++.++||||||+++|+|++|..||...+..+....+.....+. ......++..+.+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  254 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTPSKWSVEFRD  254 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGSCHHHHH
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCccccCHHHHH
Confidence            34688999999998     35678899999999999999999999999988877776665554322 2223568999999


Q ss_pred             HHHHhcccCcCCCCCC
Q psy11805        236 FIRKLLLKDREDAPEV  251 (251)
Q Consensus       236 li~~~l~~~p~~Rps~  251 (251)
                      +|.+||+.||++|||+
T Consensus       255 li~~~l~~dp~~Rps~  270 (302)
T 2j7t_A          255 FLKIALDKNPETRPSA  270 (302)
T ss_dssp             HHHHHSCSCTTTSCCH
T ss_pred             HHHHHcccChhhCCCH
Confidence            9999999999999984

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4e-50  Score=319.95  Aligned_cols=245  Identities=22%  Similarity=0.366  Sum_probs=202.1

Q ss_pred             CccCCcccccccCCceEEEEEE----EccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCK----EKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   75 (251)
                      .++|++.+.||+|+||+||+|.    +..+++.||+|++........+.+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            5789999999999999999998    456789999999876666667889999999999999999999999854  3458


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++|||++++++|.+++...+..+++..++.++.|++.||.+||+.|++|+||||+||++  +.+++++|+|||++.....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~--~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECCCCSCC----
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE--cCCCeEEEccCcccccccC
Confidence            99999999999999998877679999999999999999999999999999999999999  8889999999999987643


Q ss_pred             CCc----ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----------------HHHHHHH
Q psy11805        156 EKK----LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV----------------QTMANVT  215 (251)
Q Consensus       156 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~  215 (251)
                      ...    .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......                .....+.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  246 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence            322    12234566799999999999999999999999999999999998654221                1111111


Q ss_pred             hccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        216 IAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                       ...  ..+....+|+++.++|.+||+.||++|||+
T Consensus       247 -~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  279 (295)
T 3ugc_A          247 -NNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSF  279 (295)
T ss_dssp             -TTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             -ccC--cCCCCcCcCHHHHHHHHHHcCCChhhCCCH
Confidence             111  222346789999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-49  Score=323.33  Aligned_cols=247  Identities=28%  Similarity=0.484  Sum_probs=206.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-----chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-----DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++......     ....+.+|+..++.++|+||+++++++.+.+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            46899999999999999999999999999999998643221     2356889999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +|||++++ +|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++......
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECCCGGGSTTTSC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE--cCCCCEEEEecccceeccCC
Confidence            99999987 8888887776779999999999999999999999999999999999999  89999999999999876432


Q ss_pred             -CcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc----------
Q psy11805        157 -KKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE----------  224 (251)
Q Consensus       157 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  224 (251)
                       .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+...++..........          
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence             233445689999999998654 57899999999999999999999999998888777765543222211          


Q ss_pred             --------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 --------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                    .+..++.++.+||++||+.||++|||+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  286 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA  286 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH
Confidence                          124567899999999999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.1e-49  Score=345.63  Aligned_cols=242  Identities=24%  Similarity=0.440  Sum_probs=217.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...   .....+.+..|..++..+ +|++|+++++++.+.+..|+|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            5799999999999999999999999999999998643   234567788899999887 699999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc-CCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF-DPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~-~~~~  157 (251)
                      |||+++++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+|||+  +.+++++|+|||++... ....
T Consensus       421 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl--~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE--CSSSCEEECCCTTCEECCCTTC
T ss_pred             EeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE--cCCCcEEEeecceeeccccCCc
Confidence            99999999999887654 69999999999999999999999999999999999999  99999999999999763 2333


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....+||+.|+|||++.+..++.++||||||++||||++|..||.+.+..+....+......++    ..++.++.+||
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  573 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAIC  573 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHH
Confidence            44566799999999999999999999999999999999999999999999999998887766554    57899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.||++||++
T Consensus       574 ~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          574 KGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHHSCSSSTTCTTC
T ss_pred             HHHccCCHHHCCCC
Confidence            99999999999974

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-50  Score=320.20  Aligned_cols=240  Identities=23%  Similarity=0.341  Sum_probs=197.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.....  ........|+..+..+ +|+||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            679999999999999999999999999999998754322  2334455555555555 8999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |++ +++|.+.+...+..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++.........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll--~~~~~~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CGGGCEEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--CCCCCEEEccceeeeecccCCCC
Confidence            999 558888888777779999999999999999999999999999999999999  88999999999999877655555


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.....   ...+..+.  ........+++++.++|.+
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~l~~li~~  287 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGLSSELRSVLVM  287 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTSCHHHHHHHHH
T ss_pred             cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCCCHHHHHHHHH
Confidence            56678999999999876 689999999999999999999777655432   22222222  2333446789999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||++|||+
T Consensus       288 ~L~~dP~~Rpt~  299 (311)
T 3p1a_A          288 MLEPDPKLRATA  299 (311)
T ss_dssp             HSCSSTTTSCCH
T ss_pred             HcCCChhhCcCH
Confidence            999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.3e-50  Score=333.17  Aligned_cols=246  Identities=32%  Similarity=0.567  Sum_probs=201.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--------ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--------RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....        ......+.+|+.++++++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            468999999999999999999999999999999986432        1123458899999999999999999999865 4


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC---CcEEEeecccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG---NRIKIIDFGLA  150 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~---~~~~l~df~~~  150 (251)
                      ..++|||++++++|.+.+...+ .+++..++.++.|++.||.|||++|++|+||||+||++  +.+   ..++|+|||++
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll--~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL--SSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--SSSSSSCCEEECCSSTT
T ss_pred             ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE--ecCCCcceEEEeecccc
Confidence            5789999999999988876554 69999999999999999999999999999999999998  443   45999999999


Q ss_pred             cccCCCCcceeeccCccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccccCCCccc
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNF---DAIGFGTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIAQYDFDDECF  226 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  226 (251)
                      ............++++.|+|||.+.+   ..++.++||||||+++|+|++|..||...... .....+..+........+
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            88766555566779999999999853   56788999999999999999999999875443 344555566666666667


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+++.+.+||++||+.||++|||+
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~  394 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTT  394 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCH
Confidence            7899999999999999999999984

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-49  Score=322.61  Aligned_cols=245  Identities=20%  Similarity=0.355  Sum_probs=211.4

Q ss_pred             CccCCcccccccCCceEEEEEEEcc-----CCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.+..     +++.|++|++.... ......+.+|+..+++++||||+++++++.+.+..
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            4789999999999999999999973     45889999986543 23467789999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcE
Q psy11805         76 CVVLELIEGGELFERVIDDD-----------------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI  132 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~ni  132 (251)
                      ++||||+++++|.+++....                       ..+++..++.++.|++.||.+||++|++|+||||+||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  205 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC  205 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence            99999999999999987642                       4689999999999999999999999999999999999


Q ss_pred             EEeecCCCcEEEeecccccccCCC---CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q psy11805        133 LCLTKTGNRIKIIDFGLARKFDPE---KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDV  208 (251)
Q Consensus       133 l~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  208 (251)
                      ++  +.++.++|+|||++......   .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus       206 l~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  283 (343)
T 1luf_A          206 LV--GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  283 (343)
T ss_dssp             EE--CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             EE--CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence            99  88899999999999765322   12233457889999999998889999999999999999999 99999998888


Q ss_pred             HHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        209 QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +....+..+....   ....+|..+.++|++||+.||++|||+
T Consensus       284 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~  323 (343)
T 1luf_A          284 EVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSF  323 (343)
T ss_dssp             HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCH
Confidence            8877776654432   235789999999999999999999984

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-49  Score=320.82  Aligned_cols=248  Identities=23%  Similarity=0.381  Sum_probs=200.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      -++|++.+.||+|+||+||+|.+..+++.||+|++......  ....+.+|+.++++++|+||+++++++.+++..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            36899999999999999999999999999999998644322  3566789999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee---cCCCcEEEeecccccccCCC
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT---KTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~---~~~~~~~l~df~~~~~~~~~  156 (251)
                      |++++ +|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++..   +.++.++|+|||++......
T Consensus       113 e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             ECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             ecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            99986 8988887664 5999999999999999999999999999999999999832   23345999999999776433


Q ss_pred             -CcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccc--------
Q psy11805        157 -KKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF--------  226 (251)
Q Consensus       157 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  226 (251)
                       .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+...........+        
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD  270 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence             223445679999999999774 4799999999999999999999999998888777766543322221111        


Q ss_pred             ------------------cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 ------------------NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ------------------~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        ..+++++.+||.+||+.||++|||+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  313 (329)
T 3gbz_A          271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA  313 (329)
T ss_dssp             CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH
Confidence                              1268899999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-49  Score=314.36  Aligned_cols=244  Identities=20%  Similarity=0.342  Sum_probs=199.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccC---CceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT---GMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|++.+.||+|+||.||+|.+..+   +..|++|.+.... ....+.+.+|+..+++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            47899999999999999999998654   4569999876432 334677899999999999999999999985 456889


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |||++++++|.+++...+..+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++.......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECC-----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE--CCCCCEEECccccccccCccc
Confidence            999999999999998777679999999999999999999999999999999999999  788999999999997764332


Q ss_pred             c--ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        158 K--LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      .  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+...   +....+|+.+.
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~  247 (281)
T 1mp8_A          171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLY  247 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHHHH
T ss_pred             ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCCCCHHHH
Confidence            2  223346778999999998889999999999999999997 99999988887777766554322   23367899999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      ++|.+||+.||++|||+
T Consensus       248 ~li~~~l~~~p~~Rps~  264 (281)
T 1mp8_A          248 SLMTKCWAYDPSRRPRF  264 (281)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHccCChhhCcCH
Confidence            99999999999999984

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.2e-49  Score=323.10  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=207.8

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-----CCceeeEeEEEeeCCEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-----HPRLIQIYDAFESSNVM   75 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~   75 (251)
                      +.++|++.+.||+|+||+||+|.+..+++.||+|++.. ..........|+.+++.+.     |+||+++++++...+..
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~  111 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM  111 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence            35799999999999999999999999999999999853 2334667788999999986     99999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee------------------
Q psy11805         76 CVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT------------------  136 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~------------------  136 (251)
                      ++|||++ +++|.+++.... ..++...++.++.|++.||.|||+.|++|+||||+||++..                  
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~  190 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK  190 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence            9999999 789999887654 35899999999999999999999999999999999999832                  


Q ss_pred             -----cCCCcEEEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy11805        137 -----KTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM  211 (251)
Q Consensus       137 -----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  211 (251)
                           ..++.++|+|||++......  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+..
T Consensus       191 ~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  268 (360)
T 3llt_A          191 IQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL  268 (360)
T ss_dssp             EEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence                 13788999999999764432  23456899999999999999999999999999999999999999998887776


Q ss_pred             HHHHhccccCCCcc------------------------------------------ccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        212 ANVTIAQYDFDDEC------------------------------------------FNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       212 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      ..+.....+.+...                                          ....++.+.+||++||+.||++||
T Consensus       269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  348 (360)
T 3llt_A          269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP  348 (360)
T ss_dssp             HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence            66544333222110                                          011246788999999999999999


Q ss_pred             CC
Q psy11805        250 EV  251 (251)
Q Consensus       250 s~  251 (251)
                      |+
T Consensus       349 ta  350 (360)
T 3llt_A          349 SP  350 (360)
T ss_dssp             CH
T ss_pred             CH
Confidence            85

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-49  Score=315.75  Aligned_cols=243  Identities=23%  Similarity=0.318  Sum_probs=200.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.|++|++......   ..+.+.+|+..+++++||||+++++++..++..+++|
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            6899999999999999999999999999999998654322   2577899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      |++++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.......  
T Consensus       114 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          114 RLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             ECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECSCCC----------
T ss_pred             EecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE--cCCCCEEEecCccCccccccccc
Confidence            9999999999887654 69999999999999999999999999999999999999  889999999999987654332  


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+ .............+|..+.++|
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li  269 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFDAVI  269 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHHHHHH
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHHHHHH
Confidence            223456889999999999888999999999999999999999999877655433333 3333333344567899999999


Q ss_pred             HHhcccCcCCCC
Q psy11805        238 RKLLLKDREDAP  249 (251)
Q Consensus       238 ~~~l~~~p~~Rp  249 (251)
                      .+||+.||++||
T Consensus       270 ~~~l~~dP~~Rp  281 (309)
T 2h34_A          270 ARGMAKNPEDRY  281 (309)
T ss_dssp             HHHTCSSGGGSC
T ss_pred             HHhccCCHHHHH
Confidence            999999999999

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=325.46  Aligned_cols=245  Identities=20%  Similarity=0.295  Sum_probs=208.1

Q ss_pred             CccCCcccccccCCceEEEEEEE-----ccCCceEEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKE-----KATGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|++... .......+.+|+.++++++|+||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            36899999999999999999994     456778999998543 233456788999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC---cEEEee
Q psy11805         76 CVVLELIEGGELFERVIDDD------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN---RIKIID  146 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~---~~~l~d  146 (251)
                      ++|||++++++|.+++....      ..++...++.++.|++.||.|||++|++||||||+||++  +.++   .++|+|
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~~~~~~~kL~D  227 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL--TCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--SCSSTTCCEEECC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE--ecCCCCceEEECC
Confidence            99999999999999987643      358999999999999999999999999999999999999  6444   599999


Q ss_pred             cccccccCC---CCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCC
Q psy11805        147 FGLARKFDP---EKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       147 f~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      ||++.....   ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.....
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~  307 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP  307 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999975421   122234457889999999998899999999999999999998 9999999988888877766553222


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                         ...++..+.+||.+||+.||++|||+
T Consensus       308 ---~~~~~~~l~~li~~~l~~dP~~Rps~  333 (367)
T 3l9p_A          308 ---PKNCPGPVYRIMTQCWQHQPEDRPNF  333 (367)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ---CccCCHHHHHHHHHHcCCCHhHCcCH
Confidence               25789999999999999999999984

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=321.92  Aligned_cols=237  Identities=27%  Similarity=0.416  Sum_probs=205.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--------cchHHHHHHHHHHHHcCCCceeeEeEEEeeCC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--------NDRRNVEREVEIMRELQHPRLIQIYDAFESSN   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....        .....+.+|+.++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4689999999999999999999999999999999864321        23456788999999999999999999999999


Q ss_pred             EEEEEEEeccCC-chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         74 VMCVVLELIEGG-ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        74 ~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ..++|||++.++ +|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++..
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI--AEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTCEE
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE--cCCCcEEEeecccceE
Confidence            999999998666 8888776654 69999999999999999999999999999999999999  8899999999999988


Q ss_pred             cCCCCcceeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ...........+++.|+|||.+.+..+ +.++||||||+++|+|++|..||......          ..........+++
T Consensus       180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~~~~  249 (335)
T 3dls_A          180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------VEAAIHPPYLVSK  249 (335)
T ss_dssp             CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------TTTCCCCSSCCCH
T ss_pred             CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------HhhccCCCcccCH
Confidence            776666667789999999999988776 78999999999999999999999763221          1111122245799


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.+||.+||+.||++|||+
T Consensus       250 ~l~~li~~~L~~dP~~Rps~  269 (335)
T 3dls_A          250 ELMSLVSGLLQPVPERRTTL  269 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHccCChhhCcCH
Confidence            99999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.3e-49  Score=312.86  Aligned_cols=243  Identities=19%  Similarity=0.337  Sum_probs=208.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||++.+. ++..|++|++... ......+.+|+..+++++|+||+++++++.+.+..++|||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            368999999999999999999877 5678999998643 33467789999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc--c
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK--L  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~--~  159 (251)
                      +++++|.+++......+++..++.++.|++.||.+||++|++|+||||+||++  +.++.++|+|||.+........  .
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili--~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVLDDEYTSS  178 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE--CTTSCEEECSTTGGGGBCCHHHHST
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE--cCCCCEEEccccccccccccccccc
Confidence            99999999998756679999999999999999999999999999999999999  8999999999999976543221  1


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+........   ....++.+.++|.
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~  255 (283)
T 3gen_A          179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYTIMY  255 (283)
T ss_dssp             TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred             cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCHHHHHHHH
Confidence            22235678999999998889999999999999999998 9999999988888877766543322   2567899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.+|++|||+
T Consensus       256 ~~l~~~p~~Rps~  268 (283)
T 3gen_A          256 SCWHEKADERPTF  268 (283)
T ss_dssp             HTTCSSGGGSCCH
T ss_pred             HHccCChhHCcCH
Confidence            9999999999984

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.5e-49  Score=310.15  Aligned_cols=243  Identities=26%  Similarity=0.442  Sum_probs=198.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc----cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR----NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|++.+.||+|+||.||+|.+.  ++.+++|++.....    ...+.+.+|+..++.++||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            368999999999999999999876  77999999864332    235788999999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---ceecCCCCCcEEEeec------CCCcEEEeecc
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN---VLHLDMKPENILCLTK------TGNRIKIIDFG  148 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~g---i~h~dl~~~nil~~~~------~~~~~~l~df~  148 (251)
                      |||++++++|.+.+..  ..+++..++.++.|++.||.+||++|   ++|+||+|+||++...      .++.++|+|||
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999888753  36999999999999999999999999   8899999999998221      26789999999


Q ss_pred             cccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccC
Q psy11805        149 LARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      .+........ ....+++.|+|||.+.+..++.++||||||+++++|++|..||...+.................  ...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  238 (271)
T 3dtc_A          162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PST  238 (271)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTT
T ss_pred             cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Ccc
Confidence            9976544332 3456899999999999888999999999999999999999999998888777766665544333  367


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +++.+.++|.+||+.||++|||+
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~  261 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSF  261 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCH
Confidence            89999999999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-49  Score=315.43  Aligned_cols=240  Identities=17%  Similarity=0.281  Sum_probs=204.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCC-------ceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATG-------MTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||+||+|.+..++       ..|++|++........+.+.+|+..+++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            478999999999999999999998776       4699999876666678889999999999999999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc--------EEEee
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR--------IKIID  146 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~--------~~l~d  146 (251)
                      .++|||++++++|.+++...+..+++..++.++.|++.||.|||++|++|+||||+||++  +.++.        ++|+|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL--IREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--EECCBGGGTBCCEEEECC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEE--ecCCcccccccceeeecc
Confidence            999999999999999998876669999999999999999999999999999999999999  65555        99999


Q ss_pred             cccccccCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        147 FGLARKFDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSG-LSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       147 f~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                      ||.+......   ....+++.|+|||.+.+ ..++.++||||||+++|+|++| ..||...+........ ......+  
T Consensus       165 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~--  238 (289)
T 4fvq_A          165 PGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDRHQLP--  238 (289)
T ss_dssp             CCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCCC--
T ss_pred             CcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hccCCCC--
Confidence            9998664322   33457889999999987 6789999999999999999995 5555555554444333 3222222  


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                        ...+.++.++|.+||+.||++|||+
T Consensus       239 --~~~~~~l~~li~~~l~~dp~~Rps~  263 (289)
T 4fvq_A          239 --APKAAELANLINNCMDYEPDHRPSF  263 (289)
T ss_dssp             --CCSSCTTHHHHHHHSCSSGGGSCCH
T ss_pred             --CCCCHHHHHHHHHHcCCChhHCcCH
Confidence              4557889999999999999999984

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-48  Score=311.15  Aligned_cols=243  Identities=22%  Similarity=0.434  Sum_probs=213.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++.... ....+.+.+|+..++.++|+||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            367999999999999999999999999999999986543 3357889999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~  159 (251)
                      ++++++|.+++..  ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... ..
T Consensus       101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A          101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECBTTBCCB
T ss_pred             eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE--CCCCCEEEeecccceecCcccccc
Confidence            9999999888764  359999999999999999999999999999999999999  889999999999997754332 23


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+......   .....++..+.+||.+
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHHHHHHH
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHHHHHHH
Confidence            4456889999999999989999999999999999999999999988877766655544322   2235789999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||++|||+
T Consensus       254 ~l~~dp~~Rps~  265 (303)
T 3a7i_A          254 CLNKEPSFRPTA  265 (303)
T ss_dssp             HCCSSGGGSCCH
T ss_pred             HcCCChhhCcCH
Confidence            999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.9e-49  Score=323.79  Aligned_cols=244  Identities=23%  Similarity=0.358  Sum_probs=195.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC------
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN------   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   73 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+..++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            36899999999999999999999999999999998643  2334677889999999999999999999997654      


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..++|||++++ +|.+.+.   ..+++..+..++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++...
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECCCCC----
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE--cCCCCEEEEEeeccccc
Confidence            78999999986 7777764   248999999999999999999999999999999999999  88999999999999876


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccc-------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF-------  226 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------  226 (251)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+...........+       
T Consensus       178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            6554445567899999999999989999999999999999999999999998887777666443221111000       


Q ss_pred             -------------------------------cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 -------------------------------NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 -------------------------------~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                     ...+..+++||++||+.||++|||+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  313 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV  313 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH
Confidence                                           0125678999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-49  Score=322.79  Aligned_cols=245  Identities=22%  Similarity=0.309  Sum_probs=211.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCC-------ceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATG-------MTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESS   72 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   72 (251)
                      .++|++.+.||+|+||.||+|.+..++       ..||+|++.... ......+.+|+.+++.+ +||||+++++++..+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468999999999999999999986433       579999986443 23457889999999999 899999999999999


Q ss_pred             CEEEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec
Q psy11805         73 NVMCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK  137 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~  137 (251)
                      +..++|||++++++|.+++....               ..+++..++.++.|++.||.+||+.|++|+||||+||++  +
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~  225 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--T  225 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--C
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE--c
Confidence            99999999999999999987653               358999999999999999999999999999999999999  8


Q ss_pred             CCCcEEEeecccccccCCCC---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy11805        138 TGNRIKIIDFGLARKFDPEK---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN  213 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  213 (251)
                      .++.++|+|||++.......   ......+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~  305 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  305 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            89999999999997654332   2233446788999999999999999999999999999999 9999999888877776


Q ss_pred             HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+....   ....+++++.+||++||+.||++|||+
T Consensus       306 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~  340 (382)
T 3tt0_A          306 LKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTF  340 (382)
T ss_dssp             HHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCH
Confidence            66554322   235789999999999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-49  Score=325.05  Aligned_cols=244  Identities=21%  Similarity=0.354  Sum_probs=200.6

Q ss_pred             ccCCcccccccCCceEEEEEEEc---cCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||.||+|.+.   .++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            58999999999999999999887   456789999986542 33467899999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+++...+..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++........
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI--NSNLVCKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCC-----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--cCCCCEEECcCccccccccCCc
Confidence            99999999999998777779999999999999999999999999999999999999  8999999999999977543321


Q ss_pred             c----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        159 L----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       159 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      .    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.....   ...++..+
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l  279 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---PMDCPAAL  279 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---CTTCBHHH
T ss_pred             cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CccccHHH
Confidence            1    12234678999999998899999999999999999998 9999999888877776655432221   24678999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .++|.+||+.||++|||+
T Consensus       280 ~~li~~cl~~dp~~RPs~  297 (373)
T 2qol_A          280 YQLMLDCWQKDRNNRPKF  297 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHhCcChhhCcCH
Confidence            999999999999999984

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.2e-49  Score=309.12  Aligned_cols=244  Identities=25%  Similarity=0.450  Sum_probs=206.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++..... ...+.+.+|+..++.++|+||+++++++.+++..++|||+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            689999999999999999999999999999999864432 3467889999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC---c
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---K  158 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~---~  158 (251)
                      +++++|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.......   .
T Consensus        87 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTEECC
T ss_pred             cCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE--ccCCCEEEeeCCCccccCCCcchhc
Confidence            9999998887654 469999999999999999999999999999999999999  889999999999997653221   2


Q ss_pred             ceeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQ-TMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||....... ..........  ....+..++..+.++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLAL  241 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--TSTTGGGSCHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--ccCchhhcCHHHHHH
Confidence            234568899999999987665 778999999999999999999998765432 2333322221  122346789999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |.+||+.||++|||+
T Consensus       242 i~~~l~~~p~~Rps~  256 (276)
T 2yex_A          242 LHKILVENPSARITI  256 (276)
T ss_dssp             HHHHSCSSTTTSCCH
T ss_pred             HHHHCCCCchhCCCH
Confidence            999999999999984

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-49  Score=320.63  Aligned_cols=246  Identities=21%  Similarity=0.362  Sum_probs=206.6

Q ss_pred             CccCCcccccccCCceEEEEEEEc-----cCCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+.     .++..|++|++.... ....+.+.+|+..++++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            368899999999999999999983     345689999986432 33567899999999999 89999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcE
Q psy11805         75 MCVVLELIEGGELFERVIDDDF----------------------VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI  132 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~ni  132 (251)
                      .++|||++++++|.+++.....                      .+++..++.++.|++.||.+||+.|++|+||||+||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI  203 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  203 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence            9999999999999999876542                      378999999999999999999999999999999999


Q ss_pred             EEeecCCCcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q psy11805        133 LCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDV  208 (251)
Q Consensus       133 l~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  208 (251)
                      ++  +.++.++|+|||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus       204 ll--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          204 LV--THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             EE--ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             EE--cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            99  8899999999999976543322   123346778999999988899999999999999999998 99999887766


Q ss_pred             HHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        209 QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..............  ...+++.+.+||.+||+.||.+|||+
T Consensus       282 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~  322 (344)
T 1rjb_A          282 ANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSF  322 (344)
T ss_dssp             HHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            655555444433332  35679999999999999999999984

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-49  Score=323.80  Aligned_cols=244  Identities=23%  Similarity=0.389  Sum_probs=201.8

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-----
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-----   73 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   73 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++|+||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            3578999999999999999999999999999999985332  234677889999999999999999999997653     


Q ss_pred             -EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         74 -VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        74 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                       ..|+|||++ +++|.+++...  .+++..+..++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++..
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV--NEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE--cCCCCEEEEeeecccc
Confidence             469999999 67998888763  59999999999999999999999999999999999999  8899999999999987


Q ss_pred             cCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC--------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD--------  223 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  223 (251)
                      ....  .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.||.+.+..+....+.......+.        
T Consensus       178 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            5432  334568999999999877 67899999999999999999999999998887776665443222111        


Q ss_pred             -------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 -------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                         ..+...++.+.+||.+||+.||++|||+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~  302 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA  302 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH
Confidence                               1234678999999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.4e-49  Score=317.22  Aligned_cols=246  Identities=24%  Similarity=0.427  Sum_probs=203.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|+||.||+|.+..+++.|++|++......  ....+.+|+..+++++|+||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            6899999999999999999999999999999998543322  35667899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~  159 (251)
                      ++++++|.+.... ...+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...... ...
T Consensus       105 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          105 FVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             CCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCTTC----------
T ss_pred             cCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE--cCCCcEEEEeCCCceeecCCcccc
Confidence            9999887666544 3469999999999999999999999999999999999999  89999999999999765432 223


Q ss_pred             eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC----------------
Q psy11805        160 QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD----------------  222 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  222 (251)
                      ....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+........                
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            445688999999999775 678999999999999999999999999888776655533211110                


Q ss_pred             -----------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 -----------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                 ....+.+++.+.+||.+||+.||++|||+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  301 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC  301 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG
T ss_pred             cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH
Confidence                       01123678999999999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.4e-49  Score=318.35  Aligned_cols=244  Identities=21%  Similarity=0.309  Sum_probs=203.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCce----EEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMT----LAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||+|+||+||+|.+..+++.    |++|.+... .......+.+|+..+++++||||+++++++.+++ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            46899999999999999999999877665    477776432 2345678999999999999999999999998765 77


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ++++++.+++|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||++  +.+++++|+|||++......
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--EETTEEEECCTTHHHHHTTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE--CCCCCEEEccCcceeEccCC
Confidence            8999999999999998877789999999999999999999999999999999999999  88899999999999876443


Q ss_pred             Ccc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        157 KKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       157 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      ...   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+....   ....++..
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  247 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICTID  247 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTBCHH
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCccCCHH
Confidence            322   22345779999999999999999999999999999999 999999888777766665543222   22567899


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+++.+||+.+|.+|||+
T Consensus       248 ~~~li~~~l~~~p~~Rps~  266 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKF  266 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCH
T ss_pred             HHHHHHHHcCCChhhCCCH
Confidence            9999999999999999984

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=312.07  Aligned_cols=245  Identities=24%  Similarity=0.417  Sum_probs=208.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+..+++.|++|.+...  .....+.+|+..++.++|+||+++++++...+..++|||+
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            46899999999999999999999999999999998643  3467889999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....... ...
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~  183 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL--NTEGHAKLADFGVAGQLTDTMAKRN  183 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCEECBTTBSCBC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE--CCCCCEEEeecccchhhhhhccccC
Confidence            99999999887666679999999999999999999999999999999999999  889999999999997754332 233


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+..... ........++..+.++|.+|
T Consensus       184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~  262 (314)
T 3com_A          184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PTFRKPELWSDNFTDFVKQC  262 (314)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHH
T ss_pred             ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-cccCCcccCCHHHHHHHHHH
Confidence            45688999999999988899999999999999999999999998877666554433322 22223356799999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |+.||.+|||+
T Consensus       263 l~~dp~~Rpt~  273 (314)
T 3com_A          263 LVKSPEQRATA  273 (314)
T ss_dssp             TCSCTTTSCCH
T ss_pred             ccCChhhCcCH
Confidence            99999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.7e-49  Score=312.20  Aligned_cols=244  Identities=20%  Similarity=0.354  Sum_probs=212.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|++|.||+|.+..++..|++|.+.. .....+.+.+|+..+++++|+||+++++++.+++..++|||+
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            4789999999999999999999999999999999864 334577899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-  159 (251)
                      +++++|.+++... ...+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......... 
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~~~~~  168 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTA  168 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE--CGGGCEEECCCCGGGTSCSSSSEE
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE--cCCCCEEEccCccceeccCCcccc
Confidence            9999999998763 3458999999999999999999999999999999999999  88899999999999876543322 


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.....   ......+|+.+.++|
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li  245 (288)
T 3kfa_A          169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPEKVYELM  245 (288)
T ss_dssp             ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHHHH
T ss_pred             ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---CCCCCCCCHHHHHHH
Confidence             22345778999999998899999999999999999999 9999998887776666554422   222367899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.||.+|||+
T Consensus       246 ~~~l~~dp~~Rps~  259 (288)
T 3kfa_A          246 RACWQWNPSDRPSF  259 (288)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHhCCChhhCcCH
Confidence            99999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-49  Score=320.24  Aligned_cols=246  Identities=33%  Similarity=0.573  Sum_probs=205.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--------ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--------RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....        ......+.+|+.++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            468999999999999999999999999999999985432        122456889999999999999999999997765


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC---cEEEeecccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN---RIKIIDFGLA  150 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~---~~~l~df~~~  150 (251)
                       .++|||++++++|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++   .++|+|||.+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~--~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL--SSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--SSSSSSCCEEECCCTTC
T ss_pred             -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--ecCCCCCeEEEccCccc
Confidence             89999999999998887654 469999999999999999999999999999999999998  5544   4999999999


Q ss_pred             cccCCCCcceeeccCcccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccccCCCccc
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIAQYDFDDECF  226 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  226 (251)
                      .............+++.|+|||.+.   ...++.++||||||+++|+|++|..||...... .....+..+........+
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            8765544444556899999999974   456789999999999999999999999875443 334445555555555556


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..++..+.+||.+||+.||++|||+
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~  269 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTT  269 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCH
Confidence            7889999999999999999999984

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.9e-49  Score=316.06  Aligned_cols=246  Identities=23%  Similarity=0.350  Sum_probs=209.3

Q ss_pred             CccCCcccccccCCceEEEEEEE-----ccCCceEEEEEeccccc-cchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKE-----KATGMTLAAKFVGIAKR-NDRRNVEREVEIMREL-QHPRLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+     ..+++.|++|++..... ...+.+.+|+..++++ +||||+++++++..++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46899999999999999999986     34568999999864432 3467899999999999 89999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec
Q psy11805         75 MCVVLELIEGGELFERVIDDDF-----------------VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK  137 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~-----------------~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~  137 (251)
                      .++|||++++++|.+++.....                 .+++..++.++.|++.||.+||+.|++|+||||+||++  +
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~  179 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--T  179 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--E
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE--c
Confidence            9999999999999999876543                 48999999999999999999999999999999999999  8


Q ss_pred             CCCcEEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy11805        138 TGNRIKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN  213 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  213 (251)
                      .++.++|+|||.+.........   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  259 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence            8999999999999876544322   22346778999999988899999999999999999998 9999988776555544


Q ss_pred             HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..........  ...+|..+.++|.+||+.||.+|||+
T Consensus       260 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~  295 (313)
T 1t46_A          260 MIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTF  295 (313)
T ss_dssp             HHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCH
Confidence            4444333222  25689999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.9e-49  Score=318.09  Aligned_cols=244  Identities=23%  Similarity=0.392  Sum_probs=207.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceE--EEEEeccc-cccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTL--AAKFVGIA-KRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~--~~K~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||.||+|.+..++..+  ++|.+... .......+.+|+..++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999999888755  88887532 233567789999999999 899999999999999999999


Q ss_pred             EEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         79 LELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      ||++++++|.+++....               ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--~~~~~~k  182 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAK  182 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CGGGCEE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE--cCCCeEE
Confidence            99999999999887643               469999999999999999999999999999999999999  8889999


Q ss_pred             EeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCC
Q psy11805        144 IIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       144 l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      |+|||++.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+..   
T Consensus       183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---  259 (327)
T 1fvr_A          183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---  259 (327)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---
T ss_pred             EcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC---
Confidence            999999975443333344456789999999988889999999999999999998 9999999888877776655422   


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ......+++.+.++|.+||+.+|.+|||+
T Consensus       260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~  288 (327)
T 1fvr_A          260 LEKPLNCDDEVYDLMRQCWREKPYERPSF  288 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            12235679999999999999999999984

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.7e-49  Score=323.43  Aligned_cols=246  Identities=22%  Similarity=0.328  Sum_probs=204.7

Q ss_pred             CccCCcccccccCCceEEEEEEE-----ccCCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCC-
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKE-----KATGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSN-   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-   73 (251)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|++.... ....+.+.+|+..++++ +||||+++++++.+.+ 
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            47899999999999999999994     4456899999986433 23456789999999999 7899999999987754 


Q ss_pred             EEEEEEEeccCCchhHHHhhCCC---------------------------------------------------------
Q psy11805         74 VMCVVLELIEGGELFERVIDDDF---------------------------------------------------------   96 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~---------------------------------------------------------   96 (251)
                      ..++||||+++++|.+++.....                                                         
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence            48999999999999999876432                                                         


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc---ceeeccC
Q psy11805         97 --------VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK---LQVLFGT  165 (251)
Q Consensus        97 --------~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~  165 (251)
                              .+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++........   .....++
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE--cCCCcEEEEeccceeeecccccchhccccCCC
Confidence                    28999999999999999999999999999999999999  8889999999999976533222   2334578


Q ss_pred             cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        166 PEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       166 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      +.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.............  ....+++++.++|.+||+.|
T Consensus       259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSS
T ss_pred             ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHccCC
Confidence            89999999998999999999999999999998 9999988765554444333332222  22568999999999999999


Q ss_pred             cCCCCCC
Q psy11805        245 REDAPEV  251 (251)
Q Consensus       245 p~~Rps~  251 (251)
                      |++|||+
T Consensus       337 P~~Rps~  343 (359)
T 3vhe_A          337 PSQRPTF  343 (359)
T ss_dssp             GGGSCCH
T ss_pred             hhhCCCH
Confidence            9999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.5e-49  Score=318.33  Aligned_cols=245  Identities=20%  Similarity=0.331  Sum_probs=194.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCc---eEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE-
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGM---TLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM-   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-   75 (251)
                      .++|++.+.||+|+||.||+|.+..++.   .||+|++...  .....+.+.+|+..+++++||||+++++++...+.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4689999999999999999999887664   8999998644  334578899999999999999999999999876654 


Q ss_pred             -----EEEEEeccCCchhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEe
Q psy11805         76 -----CVVLELIEGGELFERVIDD-----DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKII  145 (251)
Q Consensus        76 -----~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~  145 (251)
                           +++||++++++|.+++...     ...+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli--~~~~~~kl~  179 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML--AEDMTVCVA  179 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTSCEEEC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE--cCCCCEEEe
Confidence                 9999999999999888642     2258999999999999999999999999999999999999  889999999


Q ss_pred             ecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccC
Q psy11805        146 DFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDF  221 (251)
Q Consensus       146 df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  221 (251)
                      |||++.........   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+....
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~  259 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK  259 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence            99999775433222   23345678999999999999999999999999999999 999999988888777766554322


Q ss_pred             CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                         ....+++.+.+||.+||+.||++|||+
T Consensus       260 ---~~~~~~~~l~~li~~~l~~dp~~Rps~  286 (323)
T 3qup_A          260 ---QPPECMEEVYDLMYQCWSADPKQRPSF  286 (323)
T ss_dssp             ---CCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             ---CCCccCHHHHHHHHHHccCChhhCcCH
Confidence               235789999999999999999999983

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.8e-49  Score=308.09  Aligned_cols=243  Identities=21%  Similarity=0.353  Sum_probs=211.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|++|.||+|.+. ++..|++|.+.... ...+.+.+|+..+++++||||+++++++.+++..+++||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            368999999999999999999987 56789999986533 3457899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--cc
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--KL  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--~~  159 (251)
                      +++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.......  ..
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE--CGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE--CCCCCEEEccccccccccccccccc
Confidence            99999999998876779999999999999999999999999999999999999  888999999999997653321  11


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.....   ....+..+.+++.
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~  239 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIMN  239 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHH
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHHHHHHH
Confidence            22345678999999998889999999999999999999 9999999888888777765533222   2467899999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       240 ~~l~~~p~~Rps~  252 (267)
T 3t9t_A          240 HCWRERPEDRPAF  252 (267)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHccCChhhCcCH
Confidence            9999999999984

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.2e-49  Score=314.87  Aligned_cols=245  Identities=21%  Similarity=0.341  Sum_probs=209.9

Q ss_pred             CccCCcccccccCCceEEEEEEEc-----cCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.+.     .++..|++|++.... ....+.+.+|+..+++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            468999999999999999999984     345789999986433 33467889999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcE
Q psy11805         76 CVVLELIEGGELFERVIDDD-----------------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI  132 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~ni  132 (251)
                      ++|||++++++|.+++....                       ..+++..++.++.|++.||.+||+.|++|+||||+||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI  181 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI  181 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence            99999999999999987643                       2389999999999999999999999999999999999


Q ss_pred             EEeecCCCcEEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q psy11805        133 LCLTKTGNRIKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDV  208 (251)
Q Consensus       133 l~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  208 (251)
                      ++  +.++.++|+|||++.........   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus       182 li--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          182 LV--AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             EE--ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EE--cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99  88999999999999765433221   23346778999999998889999999999999999999 99999988877


Q ss_pred             HHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        209 QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +....+..+...   .....+++.+.++|.+||+.||++|||+
T Consensus       260 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~  299 (314)
T 2ivs_A          260 RLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVF  299 (314)
T ss_dssp             GHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            776666554322   2235789999999999999999999984

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.4e-49  Score=318.76  Aligned_cols=244  Identities=19%  Similarity=0.303  Sum_probs=205.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCce----EEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMT----LAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||+|+||+||+|.+..++..    +++|.+.... ......+.+|+..+++++|+||+++++++.+ +..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            46899999999999999999999887765    6777664322 3345677899999999999999999999874 5588


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +|||++++++|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++......
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE--SSSSCEEECSCSGGGGSCCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE--CCCCeEEECCCCcccccCcc
Confidence            9999999999999998776679999999999999999999999999999999999999  88999999999999876433


Q ss_pred             Cc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        157 KK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      ..   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+.....   ...++.+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  245 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQICTID  245 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CTTBCTT
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CCcCcHH
Confidence            22   233456779999999998899999999999999999999 9999998887777766655543222   2456888


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++|.+||+.||.+|||+
T Consensus       246 ~~~li~~~l~~dp~~Rps~  264 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTF  264 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            9999999999999999984

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-48  Score=309.65  Aligned_cols=245  Identities=21%  Similarity=0.318  Sum_probs=190.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++......  ....+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            47899999999999999999999999999999998643222  2334445555577789999999999999999999999


Q ss_pred             EeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         80 ELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        80 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      |++++ +|.+.+..   .+..+++..++.++.|++.||.+||++ |++|+||||+||++  +.++.++|+|||++.....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI--NALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE--CTTCCEEBCCC--------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE--CCCCCEEEeecCCcccccc
Confidence            99986 77666543   455799999999999999999999998 99999999999999  8899999999999987765


Q ss_pred             CCcceeeccCccccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccccCCCccccCCC
Q psy11805        156 EKKLQVLFGTPEFVAPEVV----NFDAIGFGTDMWSVGVICYVLLSGLSPFMGE-TDVQTMANVTIAQYDFDDECFNEIS  230 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  230 (251)
                      ........+++.|+|||.+    .+..++.++||||||+++|+|++|..||... .................  ....++
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  240 (290)
T 3fme_A          163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL--PADKFS  240 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC--CTTTSC
T ss_pred             cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc--ccccCC
Confidence            5555556789999999996    5567889999999999999999999999874 33344444333332222  125689


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +++.++|.+||+.||++|||+
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~  261 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTY  261 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHhhcChhhCcCH
Confidence            999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.5e-48  Score=310.82  Aligned_cols=245  Identities=27%  Similarity=0.520  Sum_probs=196.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||.||+|.+..+++.|++|++....   ......+.+|+..++.++|+||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            58999999999999999999999999999999986432   334677889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         80 ELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      |++++++|.+++..   ....+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++......
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~--~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI--TATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCC---------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE--cCCCCEEEEeccceeeecCC
Confidence            99999999888764   34568999999999999999999999999999999999999  88999999999998765433


Q ss_pred             C-cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        157 K-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET--DVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      . ......+++.|+|||.+.+..++.++||||||+++|+|++|..||....  ..+....+.....+.  .....++.++
T Consensus       190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  267 (310)
T 2wqm_A          190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP--LPSDHYSEEL  267 (310)
T ss_dssp             ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC--CCTTTSCHHH
T ss_pred             CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC--CcccccCHHH
Confidence            2 2234468899999999998899999999999999999999999997643  333444444333322  2235689999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .++|.+||+.||++|||+
T Consensus       268 ~~li~~~l~~dp~~Rps~  285 (310)
T 2wqm_A          268 RQLVNMCINPDPEKRPDV  285 (310)
T ss_dssp             HHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHcCCChhhCCCH
Confidence            999999999999999984

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.6e-49  Score=312.90  Aligned_cols=246  Identities=22%  Similarity=0.354  Sum_probs=202.4

Q ss_pred             CccCCcccccccCCceEEEEEE----EccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--CE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCK----EKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESS--NV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   74 (251)
                      +++|++.+.||+|+||.||+|.    +..+++.||+|++.... ....+.+.+|+..++.++|+||+++++++..+  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            4679999999999999999998    46678999999986443 33468899999999999999999999999876  66


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .++|||++++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE--cCCCCEEECccccccccc
Confidence            899999999999999997776779999999999999999999999999999999999999  888999999999998765


Q ss_pred             CCCcc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHHh
Q psy11805        155 PEKKL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET--------------DVQTMANVTI  216 (251)
Q Consensus       155 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------------~~~~~~~~~~  216 (251)
                      .....    ....++..|+|||.+.+..++.++||||||+++|+|++|..|+....              ..........
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            44322    23346778999999998889999999999999999999998864321              1111112222


Q ss_pred             ccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...  ..+....+|+.+.+||.+||+.||.+|||+
T Consensus       258 ~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  290 (302)
T 4e5w_A          258 EGK--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSF  290 (302)
T ss_dssp             TTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             ccC--CCCCCCCCCHHHHHHHHHHcCCCCCCCCCH
Confidence            221  222346789999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.8e-48  Score=309.86  Aligned_cols=243  Identities=26%  Similarity=0.451  Sum_probs=206.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc----ccchHHHHHHHHHHHHcCCCceeeEeEEE--eeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK----RNDRRNVEREVEIMRELQHPRLIQIYDAF--ESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++....    ......+.+|+..++.++|+||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            578999999999999999999999999999999986432    23467899999999999999999999998  445678


Q ss_pred             EEEEEeccCCchhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         76 CVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      ++|||+++++ |.+.+.. ....+++..++.++.|++.||.+||++|++|+||+|+||++  +.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~--~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE--cCCCcEEeeccccccccC
Confidence            9999999875 6566654 34569999999999999999999999999999999999999  889999999999997754


Q ss_pred             CC---CcceeeccCcccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCC
Q psy11805        155 PE---KKLQVLFGTPEFVAPEVVNFDA--IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       155 ~~---~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (251)
                      ..   .......+++.|+|||.+.+..  .+.++||||||+++|+|++|..||...+..+....+.......+    ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----~~~  236 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----GDC  236 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----SSS
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----Ccc
Confidence            32   2223446889999999997644  37799999999999999999999999888888877776655433    567


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.+.++|++||+.||.+|||+
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~  258 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSI  258 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CHHHHHHHHHHccCChhhCCCH
Confidence            9999999999999999999984

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-48  Score=320.34  Aligned_cols=243  Identities=24%  Similarity=0.365  Sum_probs=202.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee----------
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES----------   71 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   71 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+|+.+++.++|+||+++++++..          
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            578999999999999999999999999999999875332    233479999999999999999999843          


Q ss_pred             ----------------------------CCEEEEEEEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhC
Q psy11805         72 ----------------------------SNVMCVVLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSK  120 (251)
Q Consensus        72 ----------------------------~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~  120 (251)
                                                  ....++||||+++ +|.+.+..   .+..+++..++.++.|++.||.|||+.
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  160 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL  160 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence                                        3348899999986 77666543   455799999999999999999999999


Q ss_pred             CceecCCCCCcEEEeec-CCCcEEEeecccccccCCCCcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhC
Q psy11805        121 NVLHLDMKPENILCLTK-TGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSG  198 (251)
Q Consensus       121 gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g  198 (251)
                      |++|+||||+||++  + .++.++|+|||.+.............+++.|+|||.+.+. .++.++||||+|+++|+|++|
T Consensus       161 gi~H~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  238 (383)
T 3eb0_A          161 GICHRDIKPQNLLV--NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG  238 (383)
T ss_dssp             TEECSCCCGGGEEE--ETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             cCccCccCHHHEEE--cCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence            99999999999998  6 5789999999999877666666666789999999998765 489999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhccccCCC-------------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        199 LSPFMGETDVQTMANVTIAQYDFDD-------------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       199 ~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..||.+.+..+....+.........                         .....+|..+.+||++||+.||++|||+
T Consensus       239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (383)
T 3eb0_A          239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP  316 (383)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            9999998888777666432211100                         0123578899999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8e-49  Score=309.98  Aligned_cols=245  Identities=25%  Similarity=0.450  Sum_probs=209.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEe--eCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFE--SSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l   77 (251)
                      .++|++.+.||+|+||.||+|.+..+++.|++|.+....  ....+.+.+|+..+++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            368999999999999999999999999999999986433  334677899999999999999999999875  4668999


Q ss_pred             EEEeccCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC-----ceecCCCCCcEEEeecCCCcEEEeeccc
Q psy11805         78 VLELIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSKN-----VLHLDMKPENILCLTKTGNRIKIIDFGL  149 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~g-----i~h~dl~~~nil~~~~~~~~~~l~df~~  149 (251)
                      |||++++++|.+++...   ...+++..++.++.|++.||.+||+.|     ++|+||+|+||++  +.++.++|+|||.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~--~~~~~~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE--CSSSCEEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE--cCCCCEEEecCch
Confidence            99999999999988653   335899999999999999999999999     9999999999999  8899999999999


Q ss_pred             ccccCCCCc-ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccC
Q psy11805        150 ARKFDPEKK-LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       150 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      +........ .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+....   ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~  239 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYR  239 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---CCTT
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---CCcc
Confidence            977544322 233468899999999998889999999999999999999999999988877777776665432   2256


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++..+.++|.+||+.||++|||+
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~  262 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSV  262 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCHHHHHHHHHHcCCCcccCCCH
Confidence            79999999999999999999984

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-48  Score=314.18  Aligned_cols=245  Identities=19%  Similarity=0.343  Sum_probs=204.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCC----ceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATG----MTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||+|+||.||+|.+..++    ..|++|.+.... ......+.+|+..++.++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            367889999999999999999987553    359999986433 234567889999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +|||++++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCCCC-------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE--CCCCcEEECCCCcchhhccc
Confidence            9999999999999998776789999999999999999999999999999999999999  88999999999999775433


Q ss_pred             Cc----ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        157 KK----LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       157 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ..    .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+...   +....++.
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~  277 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTPMDCPS  277 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTCBH
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---CCcccCCH
Confidence            21    122235678999999998899999999999999999999 99999998888777776554322   22357899


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.++|.+||+.+|++||++
T Consensus       278 ~l~~li~~~l~~~p~~Rps~  297 (333)
T 1mqb_A          278 AIYQLMMQCWQQERARRPKF  297 (333)
T ss_dssp             HHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            99999999999999999984

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.8e-49  Score=317.64  Aligned_cols=246  Identities=21%  Similarity=0.359  Sum_probs=206.8

Q ss_pred             CccCCcccccccCCceEEEEEE----EccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEe--eCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCK----EKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE--SSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.    +..+++.|++|++........+.+.+|++.+++++|+||+++++++.  +.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            4789999999999999999998    45678899999987666666788999999999999999999999886  45679


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++|||++++++|.+++......+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||.+.....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV--ESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEECCGGGCEECCT
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE--CCCCCEEEcccccceeccc
Confidence            99999999999999998766679999999999999999999999999999999999999  8889999999999987654


Q ss_pred             CCcc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHHHhc
Q psy11805        156 EKKL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV--------------QTMANVTIA  217 (251)
Q Consensus       156 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------~~~~~~~~~  217 (251)
                      ....    ....+++.|+|||.+.+..++.++||||||+++|+|++|..||......              .........
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            3322    2234677899999999888999999999999999999999998654332              111111122


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..  ..+....+++.+.++|.+||+.||++|||+
T Consensus       260 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  291 (327)
T 3lxl_A          260 GQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSF  291 (327)
T ss_dssp             TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cc--CCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence            22  222336789999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-48  Score=311.26  Aligned_cols=245  Identities=22%  Similarity=0.445  Sum_probs=203.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEee------CCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFES------SNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++... ......+.+|+..++++ +|+||+++++++..      .+.
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            57899999999999999999999999999999998643 34567889999999999 79999999999976      467


Q ss_pred             EEEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         75 MCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      .++|||++++++|.+++... +..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++...
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--CTTCCEEECCCTTTC--
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE--cCCCCEEEeeCcCceec
Confidence            99999999999999988764 2468999999999999999999999999999999999999  88999999999999775


Q ss_pred             CCCC-cceeeccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc
Q psy11805        154 DPEK-KLQVLFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      .... ......+++.|+|||.+.     +..++.++||||||+++|+|++|..||...........+.....+..  ...
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  257 (326)
T 2x7f_A          180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL--KSK  257 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCS
T ss_pred             CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC--Ccc
Confidence            4332 223456899999999986     45688999999999999999999999998887776665544433222  235


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++..+.+||.+||+.||.+|||+
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~  281 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPAT  281 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccCHHHHHHHHHHhccChhhCCCH
Confidence            689999999999999999999984

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.9e-49  Score=322.01  Aligned_cols=249  Identities=18%  Similarity=0.248  Sum_probs=194.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccC-----CceEEEEEecccccc-----------chHHHHHHHHHHHHcCCCceeeE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT-----GMTLAAKFVGIAKRN-----------DRRNVEREVEIMRELQHPRLIQI   65 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~   65 (251)
                      .++|++.+.||+|+||.||+|.+..+     ++.||+|++......           ......+|+..++.++|+||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            45899999999999999999999765     578999997543311           11122334445566679999999


Q ss_pred             eEEEeeC----CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc
Q psy11805         66 YDAFESS----NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR  141 (251)
Q Consensus        66 ~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~  141 (251)
                      ++++...    ...++|||++ +++|.+++...+..+++..++.++.|++.||.|||+.|++||||||+||++..+.++.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            9998764    5689999999 8899999988767899999999999999999999999999999999999993338899


Q ss_pred             EEEeecccccccCCCCcc--------eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy11805        142 IKIIDFGLARKFDPEKKL--------QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMAN  213 (251)
Q Consensus       142 ~~l~df~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  213 (251)
                      ++|+|||++.........        ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            999999999765432211        233489999999999999999999999999999999999999986433222221


Q ss_pred             HHhccccCC-----Cccc--cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFD-----DECF--NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~-----~~~~--~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .........     ..++  ..+|.++.+++..||+.+|.+|||+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~  317 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLY  317 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCH
Confidence            111111000     1111  4679999999999999999999984

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=315.11  Aligned_cols=244  Identities=22%  Similarity=0.322  Sum_probs=203.3

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceE----EEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTL----AAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~----~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+.||+|+||.||+|.+..+++.+    ++|.+... .......+.+|+..++.++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            478999999999999999999998877655    66665432 3345788999999999999999999999998765 78


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      ++++++.+++|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++......
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~--~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--EETTEEEECCTTC-------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE--cCCCCEEEccCcceeEccCc
Confidence            8999999999999998877789999999999999999999999999999999999999  88899999999999875433


Q ss_pred             Ccc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        157 KKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       157 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      ...   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+........   ...++.+
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  247 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICTID  247 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTBCHH
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHH
Confidence            222   22345778999999999999999999999999999999 9999999888777766655543222   2567999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++|++||+.||.+|||+
T Consensus       248 l~~li~~~l~~dp~~Rps~  266 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKF  266 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHcCCChhHCcCH
Confidence            9999999999999999984

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-48  Score=307.57  Aligned_cols=244  Identities=23%  Similarity=0.413  Sum_probs=208.3

Q ss_pred             CccCCccc-ccccCCceEEEEEEEc--cCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHS-AFSFGKFGTVYRCKEK--ATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~-~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|.+.. .||+|+||.||+|.+.  .++..|++|++.... ....+.+.+|+..+++++||||+++++++. .+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence            35777877 9999999999999864  457789999986543 335778999999999999999999999994 556899


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |||++++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL--VNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--EETTEEEECCCTTCEECTTCS
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE--cCCCCEEECcccceeeeccCc
Confidence            999999999999987766679999999999999999999999999999999999999  788999999999998764333


Q ss_pred             cc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        158 KL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       158 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      ..    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+...   .....+|+.
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~  241 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECPPE  241 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTCCHH
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCCCcCHH
Confidence            22    22235788999999988889999999999999999998 99999998887777766654322   223678999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++|.+||+.+|++|||+
T Consensus       242 l~~li~~~l~~~p~~Rps~  260 (287)
T 1u59_A          242 LYALMSDCWIYKWEDRPDF  260 (287)
T ss_dssp             HHHHHHHTTCSSGGGSCCH
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            9999999999999999984

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-48  Score=315.41  Aligned_cols=242  Identities=25%  Similarity=0.404  Sum_probs=197.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCC--------
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSN--------   73 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   73 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            589999999999999999999999999999999865443 35678999999999999999999999885432        


Q ss_pred             -------------------------------------------------EEEEEEEeccCCchhHHHhhCCC--CCCHHH
Q psy11805         74 -------------------------------------------------VMCVVLELIEGGELFERVIDDDF--VLTEKA  102 (251)
Q Consensus        74 -------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~  102 (251)
                                                                       ..++|||++++++|.+++.....  ..++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999998876432  356677


Q ss_pred             HHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-------------cceeeccCcccc
Q psy11805        103 VAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-------------KLQVLFGTPEFV  169 (251)
Q Consensus       103 ~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~y~  169 (251)
                      ++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++.......             ......+++.|+
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEE--eCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            99999999999999999999999999999999  889999999999998765432             122346899999


Q ss_pred             cccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCC
Q psy11805        170 APEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       170 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      |||.+.+..++.++||||||+++|+|++|..|+..  ............   ....+...++.+.+||.+||+.||++||
T Consensus       244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK---FPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC---CCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC---CCcccccCChhHHHHHHHHccCCCCcCC
Confidence            99999999999999999999999999998766421  112222222221   1222345678899999999999999999


Q ss_pred             CC
Q psy11805        250 EV  251 (251)
Q Consensus       250 s~  251 (251)
                      |+
T Consensus       319 s~  320 (332)
T 3qd2_B          319 EA  320 (332)
T ss_dssp             CH
T ss_pred             CH
Confidence            85

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-48  Score=318.16  Aligned_cols=246  Identities=27%  Similarity=0.416  Sum_probs=206.1

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC-----CE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESS-----NV   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   74 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3579999999999999999999999999999999986433 23457888999999999999999999999654     36


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .++|||++++ +|.+.+...  .+++..++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||.+....
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred             EEEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE--CCCCCEEEEeCcceEecC
Confidence            8999999975 888888664  49999999999999999999999999999999999999  899999999999997754


Q ss_pred             CCCc----ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC------
Q psy11805        155 PEKK----LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD------  223 (251)
Q Consensus       155 ~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------  223 (251)
                      ....    .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.........      
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            3322    234478999999998754 45899999999999999999999999988877766655432211111      


Q ss_pred             ---------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ---------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                           .....++.++.+||.+||+.||++|||+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  308 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV  308 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence                                 1124678999999999999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.7e-48  Score=307.35  Aligned_cols=244  Identities=22%  Similarity=0.327  Sum_probs=205.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccC---CceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT---GMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|++.+.||+|+||.||+|.+..+   +..|++|.+.... ....+.+.+|+..++.++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            46899999999999999999987643   3469999986542 33467889999999999999999999998754 4689


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |||++++++|.+.+...+..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV--ASPECVKLGDFGLSRYIEDED  167 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--EETTEEEECCCCGGGCC----
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE--CCCCcEEeCccCCCccccccc
Confidence            999999999999998777679999999999999999999999999999999999999  788999999999997754332


Q ss_pred             c--ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        158 K--LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      .  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.......   ....+++.+.
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~  244 (281)
T 3cc6_A          168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KPDLCPPVLY  244 (281)
T ss_dssp             -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CCTTCCHHHH
T ss_pred             ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence            1  223346778999999988889999999999999999998 999998877777666665543322   2256899999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      ++|.+||+.||++|||+
T Consensus       245 ~li~~~l~~~p~~Rps~  261 (281)
T 3cc6_A          245 TLMTRCWDYDPSDRPRF  261 (281)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHccCCchhCcCH
Confidence            99999999999999984

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.9e-48  Score=317.71  Aligned_cols=247  Identities=24%  Similarity=0.339  Sum_probs=198.8

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-----------chHHHHHHHHHHHHcCCCceeeEeEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-----------DRRNVEREVEIMRELQHPRLIQIYDAF   69 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~   69 (251)
                      ++++|++.+.||+|+||.||+|.+.. ++.||+|++......           ..+.+.+|+..+++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            46899999999999999999998865 889999988532221           137889999999999999999999998


Q ss_pred             ee-----CCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEE
Q psy11805         70 ES-----SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKI  144 (251)
Q Consensus        70 ~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l  144 (251)
                      ..     ....++|||++++ +|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--~~~~~~kl  175 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITI  175 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEE
T ss_pred             EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE--cCCCCEEE
Confidence            43     3468999999985 8888888776679999999999999999999999999999999999999  88999999


Q ss_pred             eecccccccCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC
Q psy11805        145 IDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD  223 (251)
Q Consensus       145 ~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (251)
                      +|||.+.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.........
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999986655555556678999999999876 67899999999999999999999999998877776665432211110


Q ss_pred             ----------------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ----------------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                  ......++.+.+||.+||+.||++|||+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  311 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST  311 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence                                        1123568899999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.7e-47  Score=304.11  Aligned_cols=243  Identities=23%  Similarity=0.388  Sum_probs=204.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee----CCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES----SNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~   76 (251)
                      +.|++.+.||+|+||.||+|.+..++..|++|.+....  ....+.+.+|+..+++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            46889999999999999999999999999999986432  3346788999999999999999999999865    45689


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeec-CCCcEEEeeccccccc
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTK-TGNRIKIIDFGLARKF  153 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~  153 (251)
                      +|||++++++|.+++...+ .++...++.++.|++.||.+||+.|  ++|+||+|+||++  + .++.++|+|||++...
T Consensus       106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCTTGGGGC
T ss_pred             EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE--ECCCCCEEEeeCCCcccc
Confidence            9999999999999887653 5999999999999999999999999  9999999999998  6 7889999999999764


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||................. .........++.+
T Consensus       183 ~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  259 (290)
T 1t4h_A          183 RAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPASFDKVAIPEV  259 (290)
T ss_dssp             CTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCGGGGGCCCHHH
T ss_pred             ccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC-CccccCCCCCHHH
Confidence            433 3345568999999998874 588999999999999999999999988655544433333222 2223345678899


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .++|.+||+.||.+|||+
T Consensus       260 ~~li~~~l~~dp~~Rps~  277 (290)
T 1t4h_A          260 KEIIEGCIRQNKDERYSI  277 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHccCChhhCCCH
Confidence            999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.2e-49  Score=317.16  Aligned_cols=247  Identities=22%  Similarity=0.323  Sum_probs=203.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+. +++.|++|.+........+.+.+|+..++.++||||+++++++...+..++|||+
T Consensus        38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  116 (321)
T 2qkw_B           38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY  116 (321)
T ss_dssp             CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred             HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence            578999999999999999999865 6889999998766666678899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-
Q psy11805         82 IEGGELFERVIDDD---FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-  157 (251)
Q Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-  157 (251)
                      +++++|.+.+....   ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++....... 
T Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~  194 (321)
T 2qkw_B          117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL--DENFVPKITDFGISKKGTELDQ  194 (321)
T ss_dssp             CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE--CTTCCEEECCCTTCEECSSSSC
T ss_pred             CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE--CCCCCEEEeecccccccccccc
Confidence            99999998886543   358999999999999999999999999999999999999  899999999999997643221 


Q ss_pred             --cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HHHHhcccc------CC
Q psy11805        158 --KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTM-------ANVTIAQYD------FD  222 (251)
Q Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~------~~  222 (251)
                        ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+..       .....+...      ..
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
T 2qkw_B          195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA  274 (321)
T ss_dssp             CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred             cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence              223345789999999998889999999999999999999999999765332111       111111110      01


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .......+..+.+++.+||+.||++|||+
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~  303 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSM  303 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCH
Confidence            11123356679999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.7e-48  Score=313.20  Aligned_cols=245  Identities=21%  Similarity=0.316  Sum_probs=208.6

Q ss_pred             CccCCcccccccCCceEEEEEEEc-------cCCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-------ATGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESS   72 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   72 (251)
                      .++|++.+.||+|+||.||+|.+.       .++..||+|++.... ......+.+|+..++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999986       356789999986443 23467789999999999 899999999999999


Q ss_pred             CEEEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec
Q psy11805         73 NVMCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK  137 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~  137 (251)
                      +..++|||++++++|.+++....               ..+++..++.++.|++.||.+||+.|++|+||||+||++  +
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~  191 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--T  191 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--C
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE--c
Confidence            99999999999999999987643               248999999999999999999999999999999999999  8


Q ss_pred             CCCcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy11805        138 TGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN  213 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  213 (251)
                      .++.++|+|||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  271 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  271 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence            899999999999977544322   122346778999999988889999999999999999999 9999999888777766


Q ss_pred             HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+...   .....++..+.++|.+||+.+|.+|||+
T Consensus       272 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~  306 (334)
T 2pvf_A          272 LKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTF  306 (334)
T ss_dssp             HHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            6555422   2235789999999999999999999984

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-48  Score=318.21  Aligned_cols=244  Identities=21%  Similarity=0.395  Sum_probs=206.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++.... ......+.+|+..++.++|+||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            478999999999999999999999999999999986542 3346788999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |+++++|.+++...+ .+++..+..++.|++.||.+||+. |++|+||+|+||++  +.++.++|+|||++...... ..
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~-~~  187 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS-MA  187 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE--CTTCCEEECCCCCCHHHHHH-C-
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE--CCCCCEEEEECCCCcccccc-cc
Confidence            999999999887654 699999999999999999999996 99999999999999  88999999999998654322 22


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------------------
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV-------------------------  214 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------------------------  214 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+.....                         
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF  267 (360)
T ss_dssp             ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred             cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence            3346899999999999999999999999999999999999999877654432211                         


Q ss_pred             -----------------HhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 -----------------TIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 -----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                       .....  .......++.++.+||++||+.||++|||+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  319 (360)
T 3eqc_A          268 GMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADL  319 (360)
T ss_dssp             ------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCH
T ss_pred             ccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCH
Confidence                             11111  111123578899999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1e-48  Score=320.44  Aligned_cols=243  Identities=26%  Similarity=0.415  Sum_probs=189.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeC------C
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS------N   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   73 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+..++.++|+||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            57899999999999999999999999999999998543  233467788999999999999999999998654      5


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..+++++++ +++|.+.+..  ..+++..++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++...
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll--~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDFGLARHT  182 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECC-------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE--CCCCCEEEeeccccccc
Confidence            579999999 5689888765  359999999999999999999999999999999999999  89999999999999775


Q ss_pred             CCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC---------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD---------  223 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  223 (251)
                      ...  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......+..         
T Consensus       183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          183 ADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             ccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            432  334568999999999876 67899999999999999999999999998887776665442211110         


Q ss_pred             ------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        ..+...++.+.+||++||+.||++|||+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~  306 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  306 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH
Confidence                              1123568899999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.2e-48  Score=308.17  Aligned_cols=244  Identities=23%  Similarity=0.434  Sum_probs=193.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|+||.||++.+..   .+++|++....  ....+.+.+|+..+++++|+||++++++. ..+..++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            5789999999999999999997653   58999986443  23467789999999999999999999965 455688999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC---C
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP---E  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~---~  156 (251)
                      |++++++|.+.+......+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||++.....   .
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL--HEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--ETTTEEEECCCC-----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--CCCCCEEEccceecccccccccc
Confidence            9999999999987777789999999999999999999999999999999999999  8889999999999976532   1


Q ss_pred             CcceeeccCcccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhccccCC-CccccCCCH
Q psy11805        157 KKLQVLFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA-NVTIAQYDFD-DECFNEISD  231 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~  231 (251)
                      .......+++.|+|||.+.   +..++.++||||||+++|+|++|..||......+... .+..+..... ......+|+
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK  256 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCH
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCH
Confidence            2223446899999999986   5667889999999999999999999998876655444 3333333222 223457899


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+||.+||+.+|.+|||+
T Consensus       257 ~l~~li~~~l~~~p~~Rps~  276 (289)
T 3og7_A          257 RMKRLMAECLKKKRDERPSF  276 (289)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHccCChhhCCCH
Confidence            99999999999999999984

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.9e-48  Score=309.19  Aligned_cols=247  Identities=22%  Similarity=0.269  Sum_probs=203.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEE-EeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA-FESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|++|.||+|.+..+++.||+|++....  ....+.+|+..++.++|++++..+.. ....+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            579999999999999999999999999999999975432  34568899999999988776555554 467788999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEe-ecCCCcEEEeecccccccCCCCc-
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCL-TKTGNRIKIIDFGLARKFDPEKK-  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~-~~~~~~~~l~df~~~~~~~~~~~-  158 (251)
                      ++ +++|.+++......+++..++.++.|++.||.+||++|++|+||||+||++. ++.++.++|+|||.+........ 
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            99 7899999986666799999999999999999999999999999999999982 13678899999999987654322 


Q ss_pred             -------ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccccCCC-cccc
Q psy11805        159 -------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET---DVQTMANVTIAQYDFDD-ECFN  227 (251)
Q Consensus       159 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~-~~~~  227 (251)
                             .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....   ..+....+.......+. ....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK  244 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTT
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHh
Confidence                   234568999999999999999999999999999999999999998643   22333333333332221 2235


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+|+.+.++|.+||+.||++|||+
T Consensus       245 ~~~~~l~~li~~~l~~dp~~Rps~  268 (296)
T 3uzp_A          245 GYPSEFATYLNFCRSLRFDDKPDY  268 (296)
T ss_dssp             TSCHHHHHHHHHHHTSCTTCCCCH
T ss_pred             hCCHHHHHHHHHHHhcCcCcCCCH
Confidence            689999999999999999999984

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.4e-48  Score=324.30  Aligned_cols=238  Identities=20%  Similarity=0.340  Sum_probs=205.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-EEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-VMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~   81 (251)
                      ++|++.+.||+|+||.||++.+.  ++.||+|++...  ...+.+.+|+.++++++||||+++++++...+ ..++|||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            67899999999999999999886  679999998643  35678999999999999999999999987654 79999999


Q ss_pred             ccCCchhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+++...+. .++...++.++.|++.||.|||++|++|+||+|+||++  +.++.++|+|||++.......  .
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~~--~  344 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEASSTQ--D  344 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE--CCCCCEEEeeCCCcccccccc--c
Confidence            999999999987543 37999999999999999999999999999999999999  889999999999997643322  2


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+..   .+....+|+.+.++|.+
T Consensus       345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~~~~l~~li~~  421 (450)
T 1k9a_A          345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVYDVMKN  421 (450)
T ss_dssp             --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTCCHHHHHHHHH
T ss_pred             CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHHHHHHHHH
Confidence            3356789999999999999999999999999999998 9999998887777776655432   22336789999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||.+|||+
T Consensus       422 cl~~dp~~Rpt~  433 (450)
T 1k9a_A          422 CWHLDAATRPTF  433 (450)
T ss_dssp             HTCSSGGGSCCH
T ss_pred             HcCCChhHCcCH
Confidence            999999999984

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.2e-48  Score=305.09  Aligned_cols=239  Identities=16%  Similarity=0.300  Sum_probs=206.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC--CEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESS--NVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv   78 (251)
                      ++|++.+.||+|+||.||+|.+.  ++.+++|++....  ....+.+.+|+..+++++||||+++++++.+.  +..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            68999999999999999999986  7789999986543  23466789999999999999999999999876  778999


Q ss_pred             EEeccCCchhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         79 LELIEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ||++++++|.+++...+. .+++..++.++.|++.||.|||+.|  ++|+||+|+||++  +.++.+++.||++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE--CTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE--cCCcceeEEeccceeeecc
Confidence            999999999999876543 5899999999999999999999999  9999999999999  8889999999888755332


Q ss_pred             CCcceeeccCcccccccccccCCCCc---chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        156 EKKLQVLFGTPEFVAPEVVNFDAIGF---GTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                          ....+++.|+|||.+.+...+.   ++||||||+++|+|++|..||...+..+.............  ....+++.
T Consensus       166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  239 (271)
T 3kmu_A          166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPPGISPH  239 (271)
T ss_dssp             ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCTTCCHH
T ss_pred             ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCCCCCHH
Confidence                2345789999999998765544   79999999999999999999999888887776665554433  33678999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++|.+||+.||++|||+
T Consensus       240 ~~~li~~~l~~~p~~Rps~  258 (271)
T 3kmu_A          240 VSKLMKICMNEDPAKRPKF  258 (271)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            9999999999999999984

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.2e-48  Score=325.40  Aligned_cols=246  Identities=24%  Similarity=0.345  Sum_probs=185.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEee-----CCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFES-----SNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.+++.++|+||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            57899999999999999999999999999999998542  23346788999999999999999999999843     356


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .|+|||+++ ++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||+  +.++.++|+|||++....
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl--~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV--NQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTCCEEECCCTTCBCTT
T ss_pred             EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE--CCCCCEeecccccchhcc
Confidence            999999985 5888877654 469999999999999999999999999999999999999  999999999999998754


Q ss_pred             CCC----------------------------cceeeccCccccccccc-ccCCCCcchhHHHHHHHHHHHHh--------
Q psy11805        155 PEK----------------------------KLQVLFGTPEFVAPEVV-NFDAIGFGTDMWSVGVICYVLLS--------  197 (251)
Q Consensus       155 ~~~----------------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~--------  197 (251)
                      ...                            .....++|+.|+|||++ .+..++.++|||||||++|||++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            221                            12334678999999976 55678999999999999999998        


Q ss_pred             ---CCCCCCCCCh--------------------HHHHHHHHhccc---------------------------cCCCcccc
Q psy11805        198 ---GLSPFMGETD--------------------VQTMANVTIAQY---------------------------DFDDECFN  227 (251)
Q Consensus       198 ---g~~pf~~~~~--------------------~~~~~~~~~~~~---------------------------~~~~~~~~  227 (251)
                         |..+|.+.+.                    .+.+..+.....                           ......++
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               6777766432                    112221111000                           00112235


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.++.+||++||+.||++|||+
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~  391 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITI  391 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCHHHHHHHHHHhccCccccCCH
Confidence            678999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.1e-48  Score=322.47  Aligned_cols=247  Identities=25%  Similarity=0.375  Sum_probs=196.5

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEeeC-----C
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS-----N   73 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   73 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++|+||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            468999999999999999999999999999999998642  233467889999999999999999999999766     5


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..|+|||++++ +|.+.+... ..+++..++.++.|++.||.|||++|++||||||+||++  +.++.++|+|||++...
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl--~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL--NQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecCCc-CHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE--CCCCCEEEccCCCcccc
Confidence            69999999975 898888654 469999999999999999999999999999999999999  89999999999999876


Q ss_pred             CCCCc-----------------------ceeeccCccccccccc-ccCCCCcchhHHHHHHHHHHHHhC-----------
Q psy11805        154 DPEKK-----------------------LQVLFGTPEFVAPEVV-NFDAIGFGTDMWSVGVICYVLLSG-----------  198 (251)
Q Consensus       154 ~~~~~-----------------------~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g-----------  198 (251)
                      .....                       .....+|+.|+|||++ .+..++.++|||||||++|+|++|           
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            43321                       2445689999999986 556789999999999999999984           


Q ss_pred             CCCCCCCCh-----------------HHHHHHHHhccc------------------------cCCC---ccccCCCHHHH
Q psy11805        199 LSPFMGETD-----------------VQTMANVTIAQY------------------------DFDD---ECFNEISDDAK  234 (251)
Q Consensus       199 ~~pf~~~~~-----------------~~~~~~~~~~~~------------------------~~~~---~~~~~~~~~~~  234 (251)
                      .++|.+.+.                 .+.+..+.....                        ....   ..++.+++++.
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  339 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI  339 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence            444444321                 112211111000                        0000   12246899999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      +||++||+.||++|||+
T Consensus       340 dLl~~mL~~dP~~R~ta  356 (432)
T 3n9x_A          340 NLLESMLKFNPNKRITI  356 (432)
T ss_dssp             HHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHhcCCcccCCCH
Confidence            99999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.3e-48  Score=313.38  Aligned_cols=245  Identities=18%  Similarity=0.271  Sum_probs=209.9

Q ss_pred             CccCCcccccccCCceEEEEEEEc-----cCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.+.     .+++.|++|.+.... ......+.+|+..++.++|+||+++++++.+.+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  103 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT  103 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence            478999999999999999999887     356789999986432 23456788999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEee
Q psy11805         76 CVVLELIEGGELFERVIDDD---------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                      ++|||++++++|.+++...+         ..++...++.++.|++.||.+||++|++|+||||+||++  +.++.++|+|
T Consensus       104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli--~~~~~~kl~D  181 (322)
T 1p4o_A          104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGD  181 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE--CTTCCEEECC
T ss_pred             EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE--cCCCeEEECc
Confidence            99999999999999886532         357999999999999999999999999999999999999  8899999999


Q ss_pred             cccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCC
Q psy11805        147 FGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       147 f~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      ||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.....
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK  261 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCC
Confidence            999976533221   123346788999999998889999999999999999999 8999999888877777665543222


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                         ...++..+.++|.+||+.||++|||+
T Consensus       262 ---~~~~~~~l~~li~~~l~~dp~~Rps~  287 (322)
T 1p4o_A          262 ---PDNCPDMLFELMRMCWQYNPKMRPSF  287 (322)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ---CCCCCHHHHHHHHHHcCCCcccCcCH
Confidence               35789999999999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-48  Score=329.73  Aligned_cols=243  Identities=20%  Similarity=0.351  Sum_probs=211.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+... ....+.+.+|+.++++++||||+++++++...+..++|||++
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            5788999999999999999999998999999998643 345788999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      ++++|.+++... ...++...++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++.........  
T Consensus       299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~~~~~  376 (495)
T 1opk_A          299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAH  376 (495)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CGGGCEEECCTTCEECCTTCCEECC
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE--CCCCcEEEeecccceeccCCceeec
Confidence            999999998764 3468999999999999999999999999999999999999  88899999999999875432211  


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+..   ...+..+|+.+.+||.
T Consensus       377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~  453 (495)
T 1opk_A          377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPEKVYELMR  453 (495)
T ss_dssp             TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHHHHH
T ss_pred             CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHH
Confidence            12234678999999998889999999999999999999 9999999887777666554322   2233678999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       454 ~cl~~dP~~RPs~  466 (495)
T 1opk_A          454 ACWQWNPSDRPSF  466 (495)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHcCcChhHCcCH
Confidence            9999999999984

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3e-48  Score=312.21  Aligned_cols=246  Identities=26%  Similarity=0.414  Sum_probs=200.7

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEe----------
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE----------   70 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----------   70 (251)
                      +.++|++.+.||+|++|.||+|.+..+++.|++|++...+....+.+.+|+..+++++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            3679999999999999999999999999999999987666666788999999999999999999999873          


Q ss_pred             ----eCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEe
Q psy11805         71 ----SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKII  145 (251)
Q Consensus        71 ----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~  145 (251)
                          ..+..++|||++++ +|.+.+..  ..+++..++.++.|++.||.+||++|++|+||+|+||++  + .++.++|+
T Consensus        89 ~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~~kl~  163 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYMET-DLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI--NTEDLVLKIG  163 (320)
T ss_dssp             --CCSCSEEEEEEECCSE-EHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE--ETTTTEEEEC
T ss_pred             ccccccCceeEEeeccCC-CHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--cCCCCeEEEc
Confidence                34678999999985 89888754  358999999999999999999999999999999999997  5 56789999


Q ss_pred             ecccccccCCC----CcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc
Q psy11805        146 DFGLARKFDPE----KKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYD  220 (251)
Q Consensus       146 df~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  220 (251)
                      |||.+......    .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+......
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999875432    12233456889999998865 67899999999999999999999999998887766655433211


Q ss_pred             CC--------------------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 FD--------------------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 ~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..                          ......++.++.+||++||+.||++|||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  300 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA  300 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH
Confidence            10                          11234689999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.4e-48  Score=314.71  Aligned_cols=246  Identities=21%  Similarity=0.351  Sum_probs=207.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCc-----eEEEEEeccccc-cchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGM-----TLAAKFVGIAKR-NDRRNVEREVEIMREL-QHPRLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~K~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+..++.     .|++|.+..... .....+.+|+..++.+ +||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            4679999999999999999999976554     799999864432 3467789999999999 89999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc
Q psy11805         75 MCVVLELIEGGELFERVIDD-------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR  141 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~  141 (251)
                      .++|||++++++|.+++...             ...++...++.++.|++.||.+||+.|++|+||+|+||++  +.++.
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--~~~~~  202 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHV  202 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE--EGGGE
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE--CCCCe
Confidence            99999999999999988653             2358999999999999999999999999999999999999  88899


Q ss_pred             EEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q psy11805        142 IKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIA  217 (251)
Q Consensus       142 ~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  217 (251)
                      ++|+|||++.........   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...............
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  282 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD  282 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence            999999999765333221   22345778999999988889999999999999999998 99999887765555555444


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ......  ....|..+.++|.+||+.||.+|||+
T Consensus       283 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~  314 (333)
T 2i1m_A          283 GYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTF  314 (333)
T ss_dssp             TCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCC--CCCCCHHHHHHHHHHhccChhhCcCH
Confidence            433332  25678999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-47  Score=309.74  Aligned_cols=241  Identities=21%  Similarity=0.435  Sum_probs=201.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEee--CCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFES--SNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv   78 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..   ...+.+.+|+.++++++ |+||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            4689999999999999999999999999999999853   34678999999999997 9999999999987  6678999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-cEEEeecccccccCCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~~~~~  157 (251)
                      ||++++++|.+.+.    .+++..++.++.|++.||.|||++|++|+||||+||++  +.++ .++|+|||++.......
T Consensus       112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--ETTTTEEEECCCTTCEECCTTC
T ss_pred             EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE--cCCCCEEEEEeCCCceEcCCCC
Confidence            99999999988764    38999999999999999999999999999999999998  6555 89999999998776666


Q ss_pred             cceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHh-------------ccccC-
Q psy11805        158 KLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGET-DVQTMANVTI-------------AQYDF-  221 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~-------------~~~~~-  221 (251)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..+....+..             ..... 
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence            5566678999999999977 668999999999999999999999995543 3222222211             11000 


Q ss_pred             -------------------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 -------------------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                         .......+++++.+||++||+.||++|||+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  314 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA  314 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH
Confidence                               011123379999999999999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.6e-48  Score=308.72  Aligned_cols=245  Identities=23%  Similarity=0.362  Sum_probs=202.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccC-Cc--eEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT-GM--TLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~-~~--~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.+..+ ++  .|++|++....   ....+.+.+|+..+++++|+||+++++++.++. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            46899999999999999999987543 33  68999886432   334678899999999999999999999998765 7


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++|+|++++++|.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili--~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--EETTEEEECCCTTCEECCC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE--cCCCCEEEccccccccccc
Confidence            89999999999999998766679999999999999999999999999999999999999  8889999999999977644


Q ss_pred             CCcc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCC
Q psy11805        156 EKKL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEIS  230 (251)
Q Consensus       156 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (251)
                      ....    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.........  ...+|
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~  251 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCP  251 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTCC
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcCcC
Confidence            3322    22346678999999988888999999999999999999 99999999888887777665443332  35789


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.++|.+||+.||++|||+
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~  272 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTF  272 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHccCCcccCcCH
Confidence            999999999999999999984

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=304.86  Aligned_cols=244  Identities=23%  Similarity=0.438  Sum_probs=200.8

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      +|.....||+|+||.||+|.+..+++.|++|.+........+.+.+|+..++.++|+||+++++++...+..++|||+++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            34555599999999999999999999999999876666667889999999999999999999999999999999999999


Q ss_pred             CCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeecccccccCCCC-cc
Q psy11805         84 GGELFERVIDDD--FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFGLARKFDPEK-KL  159 (251)
Q Consensus        84 ~~~L~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~~~~~~~~~-~~  159 (251)
                      +++|.+++....  ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +. ++.++|+|||.+....... ..
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~~kl~Dfg~~~~~~~~~~~~  180 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGINPCT  180 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--ETTTCCEEECCTTTCEESCC-----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE--ECCCCCEEEeecccccccCCCCCcc
Confidence            999999887653  246789999999999999999999999999999999998  65 7899999999997754322 22


Q ss_pred             eeeccCcccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhccccCCCccccCCCHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDA--IGFGTDMWSVGVICYVLLSGLSPFMGETDVQT-MANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ....+++.|+|||.+.+..  ++.++||||||+++|+|++|..||........ .......  .........++..+.++
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l  258 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAEAKAF  258 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHHHHHH
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHHHHHH
Confidence            3446889999999997653  78899999999999999999999976544332 2222111  22223346789999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |.+||+.||++|||+
T Consensus       259 i~~~l~~dp~~Rps~  273 (295)
T 2clq_A          259 ILKCFEPDPDKRACA  273 (295)
T ss_dssp             HHHTTCSSTTTSCCH
T ss_pred             HHHHccCChhhCCCH
Confidence            999999999999984

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-47  Score=309.38  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=207.2

Q ss_pred             CccCCcccccccCCceEEEEEEEc-cCCceEEEEEeccccc--cchHHHHHHHHHHHHc---CCCceeeEeEEEe-----
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-ATGMTLAAKFVGIAKR--NDRRNVEREVEIMREL---QHPRLIQIYDAFE-----   70 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----   70 (251)
                      .++|++.+.||+|+||.||+|.+. .+++.||+|++.....  .....+.+|+..++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            478999999999999999999995 6788999999864332  2244667788777766   8999999999987     


Q ss_pred             eCCEEEEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccc
Q psy11805         71 SSNVMCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGL  149 (251)
Q Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~  149 (251)
                      .....++|||++++ +|.+.+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.
T Consensus        90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili--~~~~~~kl~Dfg~  166 (326)
T 1blx_A           90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGL  166 (326)
T ss_dssp             SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECSCCS
T ss_pred             CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE--cCCCCEEEecCcc
Confidence            45678999999985 8988887643 348999999999999999999999999999999999999  8899999999999


Q ss_pred             ccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC--------
Q psy11805        150 ARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF--------  221 (251)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  221 (251)
                      +.............+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+.......        
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence            987654444455678999999999998889999999999999999999999999988877776664321111        


Q ss_pred             ---------------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 ---------------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                     .......++..+.+||.+||+.||++|||+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  291 (326)
T 1blx_A          247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  291 (326)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH
Confidence                           011235688999999999999999999984

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=316.72  Aligned_cols=246  Identities=15%  Similarity=0.182  Sum_probs=192.3

Q ss_pred             CccCCcccccccCCceEEEEEEEcc---CCceEEEEEecccccc-----------chHHHHHHHHHHHHcCCCceeeEeE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA---TGMTLAAKFVGIAKRN-----------DRRNVEREVEIMRELQHPRLIQIYD   67 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~   67 (251)
                      .++|++.+.||+|+||.||+|.+..   ++..+++|+.......           ....+.+|+..++.++|+||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4789999999999999999999987   7789999998643321           2234667788888899999999999


Q ss_pred             EEee----CCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC--c
Q psy11805         68 AFES----SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN--R  141 (251)
Q Consensus        68 ~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~--~  141 (251)
                      ++..    ....++|||++ +++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||||+||++  +.++  .
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~~  191 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL--GYKNPDQ  191 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--ESSSTTS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE--ccCCCCc
Confidence            9987    77899999999 889999887655 79999999999999999999999999999999999999  5555  9


Q ss_pred             EEEeecccccccCCCC--------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHH
Q psy11805        142 IKIIDFGLARKFDPEK--------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE-TDVQTMA  212 (251)
Q Consensus       142 ~~l~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~  212 (251)
                      ++|+|||++.......        ......+++.|+|||.+.+..++.++||||||+++|+|++|..||... .......
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            9999999997653221        113346899999999999988999999999999999999999999653 2222222


Q ss_pred             HHHhcc-ccCCCc---cc--cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        213 NVTIAQ-YDFDDE---CF--NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       213 ~~~~~~-~~~~~~---~~--~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...... ...+..   +.  ..+|.++.++|.+||+.||++|||+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  316 (345)
T 2v62_A          272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY  316 (345)
T ss_dssp             HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH
Confidence            211111 111111   11  1789999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.4e-48  Score=305.73  Aligned_cols=243  Identities=21%  Similarity=0.358  Sum_probs=204.9

Q ss_pred             CccCCccc-ccccCCceEEEEEEE--ccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          2 TTHQNQHS-AFSFGKFGTVYRCKE--KATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         2 ~~~y~~~~-~lg~g~~~~v~~~~~--~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      .++|++.+ .||+|+||.||+|.+  ..+++.|++|++.....  ...+.+.+|+..++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35788888 999999999999965  45678899999864432  2367899999999999999999999999 556689


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +|||++++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++......
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL--VTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE--eCCCcEEEccCCcceeeccC
Confidence            9999999999999887754 69999999999999999999999999999999999999  78899999999999876544


Q ss_pred             Ccc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        157 KKL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       157 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ...    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+...   .....+|+
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  247 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPR  247 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred             CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            322    12235678999999988888999999999999999999 99999998887777766554422   22357899


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.++|.+||+.||++|||+
T Consensus       248 ~l~~li~~~l~~dp~~Rps~  267 (291)
T 1xbb_A          248 EMYDLMNLCWTYDVENRPGF  267 (291)
T ss_dssp             HHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            99999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-48  Score=318.23  Aligned_cols=240  Identities=28%  Similarity=0.500  Sum_probs=200.8

Q ss_pred             ccCCcccccccCCceEEEEEEEc---cCCceEEEEEecccc----ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK----RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNV   74 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   74 (251)
                      ++|++.+.||+|+||.||+|.+.   .+++.||+|++....    ......+.+|+++++++ +|+||+++++++..++.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            68999999999999999999984   478999999986432    23456778899999999 69999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .++||||+++++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||++....
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--CCCCcEEEeeCCCCeecc
Confidence            999999999999999887654 69999999999999999999999999999999999999  899999999999997653


Q ss_pred             CCC--cceeeccCccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccccCCCccc
Q psy11805        155 PEK--KLQVLFGTPEFVAPEVVNF--DAIGFGTDMWSVGVICYVLLSGLSPFMGETD----VQTMANVTIAQYDFDDECF  226 (251)
Q Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~  226 (251)
                      ...  ......+++.|+|||.+.+  ..++.++||||||+++|+|++|..||.....    .+....+....    .+..
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~  286 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----PPYP  286 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----CCCC
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC----CCCC
Confidence            222  2234568999999999985  3468899999999999999999999975432    23333333332    2233


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAP  249 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp  249 (251)
                      ..++..+.+||.+||+.||.+||
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~  309 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRL  309 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGST
T ss_pred             cccCHHHHHHHHHHhhhCHHHhc
Confidence            67899999999999999999999

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=311.51  Aligned_cols=242  Identities=21%  Similarity=0.363  Sum_probs=196.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCC--CceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQH--PRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~l   77 (251)
                      +++|++.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+..++.++|  +||+++++++.+++..++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            578999999999999999999885 58899999986443  2235778999999999976  999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |||+ .+++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||||+||++  + ++.++|+|||++.......
T Consensus        87 v~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll--~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--V-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--E-TTEEEECCCSSSCCC----
T ss_pred             EEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE--E-CCcEEEeecccccccCccc
Confidence            9995 5679999887754 69999999999999999999999999999999999998  4 5789999999998764332


Q ss_pred             c---ceeeccCccccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccccCC
Q psy11805        158 K---LQVLFGTPEFVAPEVVNF-----------DAIGFGTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIAQYDFD  222 (251)
Q Consensus       158 ~---~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~  222 (251)
                      .   .....+++.|+|||.+.+           ..++.++||||||+++|+|++|..||...... .....+......  
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--  239 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--  239 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc--
Confidence            2   234568999999999864           66788999999999999999999999875443 333333332222  


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .......+..+.+||.+||+.||.+|||+
T Consensus       240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~  268 (343)
T 3dbq_A          240 IEFPDIPEKDLQDVLKCCLKRDPKQRISI  268 (343)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cCCcccCCHHHHHHHHHHcCCChhHCCCH
Confidence            22335567899999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=314.15  Aligned_cols=245  Identities=22%  Similarity=0.324  Sum_probs=199.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee----CCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES----SNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l   77 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+..++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            4689999999999999999999999999999999876666677889999999999999999999999862    347899


Q ss_pred             EEEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         78 VLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      |||++++++|.+.+..   .+..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~--~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL--GDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTSCEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--cCCCCEEEEecCcchhcc
Confidence            9999999999888875   35679999999999999999999999999999999999999  889999999999886543


Q ss_pred             CCCc----------ceeeccCcccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhccc
Q psy11805        155 PEKK----------LQVLFGTPEFVAPEVVNFDA---IGFGTDMWSVGVICYVLLSGLSPFMGETD--VQTMANVTIAQY  219 (251)
Q Consensus       155 ~~~~----------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~  219 (251)
                      ....          .....+++.|+|||.+.+..   ++.++||||||+++|+|++|..||.....  ......+ ....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~  264 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-QNQL  264 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-HCC-
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-hccC
Confidence            2111          01234688999999987554   68899999999999999999999954211  1111111 1122


Q ss_pred             cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .  .+....++..+.++|.+||+.||.+|||+
T Consensus       265 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~  294 (317)
T 2buj_A          265 S--IPQSPRHSSALWQLLNSMMTVDPHQRPHI  294 (317)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             C--CCccccCCHHHHHHHHHHhhcChhhCCCH
Confidence            2  22235789999999999999999999984

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-48  Score=321.72  Aligned_cols=250  Identities=21%  Similarity=0.369  Sum_probs=205.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC--EEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN--VMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv   78 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            578999999999999999999999999999999986433 334677889999999999999999999998655  78999


Q ss_pred             EEeccCCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee--cCCCcEEEeecccccccC
Q psy11805         79 LELIEGGELFERVIDDD--FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT--KTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~--~~~~~~~l~df~~~~~~~  154 (251)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+.|++|+||||+||++..  +.++.++|+|||++....
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            99999999999887543  23899999999999999999999999999999999998643  334569999999998876


Q ss_pred             CCCcceeeccCccccccccccc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhccccC-
Q psy11805        155 PEKKLQVLFGTPEFVAPEVVNF--------DAIGFGTDMWSVGVICYVLLSGLSPFMGE----TDVQTMANVTIAQYDF-  221 (251)
Q Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~-  221 (251)
                      .........+++.|+|||.+.+        ..++.++||||||+++|+|++|..||...    ...+....+..+.... 
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (396)
T 4eut_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (396)
T ss_dssp             CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred             CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence            6555556679999999999865        56778999999999999999999999753    3344455554433211 


Q ss_pred             --------------------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 --------------------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                          .......++..+.++|++||+.||++|||+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~  297 (396)
T 4eut_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF  297 (396)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred             chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH
Confidence                                111113355678999999999999999984

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.6e-48  Score=314.86  Aligned_cols=244  Identities=20%  Similarity=0.383  Sum_probs=208.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccc-----------------hHHHHHHHHHHHHcCCCceeeE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRND-----------------RRNVEREVEIMRELQHPRLIQI   65 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~i~~~   65 (251)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++.......                 ...+.+|+..+++++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            6899999999999999999998  78999999986433221                 1889999999999999999999


Q ss_pred             eEEEeeCCEEEEEEEeccCCchhHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeec
Q psy11805         66 YDAFESSNVMCVVLELIEGGELFER------VIDD-DFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTK  137 (251)
Q Consensus        66 ~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~  137 (251)
                      ++++.+.+..++|||++++++|.++      +... ...+++..++.++.|++.||.+||+ .|++|+||+|+||++  +
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~--~  186 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM--D  186 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE--C
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE--c
Confidence            9999999999999999999999887      5442 4579999999999999999999999 999999999999999  8


Q ss_pred             CCCcEEEeecccccccCCCCcceeeccCcccccccccccC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q psy11805        138 TGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD-AIGF-GTDMWSVGVICYVLLSGLSPFMGETD-VQTMANV  214 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~  214 (251)
                      .++.++|+|||.+...... ......+++.|+|||.+.+. .++. ++||||||+++|+|++|..||...+. .+....+
T Consensus       187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i  265 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI  265 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred             CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9999999999999775443 33445688999999999877 5655 99999999999999999999998777 6666666


Q ss_pred             HhccccCCCc---------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TIAQYDFDDE---------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+....+..               ....++..+.+||.+||+.||.+|||+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~  317 (348)
T 2pml_X          266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS  317 (348)
T ss_dssp             TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH
Confidence            5554443321               115689999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.1e-48  Score=307.73  Aligned_cols=248  Identities=22%  Similarity=0.269  Sum_probs=199.7

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEE-EeeCCEEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDA-FESSNVMCVVL   79 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv~   79 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|+....  .....+.+|+..++.++|++++..+.. +...+..+++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            468999999999999999999999999999999986433  234568899999999987776665554 47788899999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEe-ecCCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCL-TKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~-~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |++ +++|.+++......+++..++.++.|++.||.+||+.|++|+||||+||++. ++.++.++|+|||.+........
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            999 8899999887666799999999999999999999999999999999999972 24677899999999987644322


Q ss_pred             --------ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccccCCC-ccc
Q psy11805        159 --------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD---VQTMANVTIAQYDFDD-ECF  226 (251)
Q Consensus       159 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~  226 (251)
                              .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....   .+....+.......+. ...
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence                    2345689999999999999999999999999999999999999987432   2233333333332222 223


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+|+++.++|.+||+.||++|||+
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rpt~  268 (296)
T 4hgt_A          244 KGYPSEFATYLNFCRSLRFDDKPDY  268 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCH
T ss_pred             ccCCHHHHHHHHHHHhcCCCCCCCH
Confidence            5679999999999999999999984

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.5e-48  Score=306.25  Aligned_cols=241  Identities=21%  Similarity=0.339  Sum_probs=201.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      .++|++.+.||+|+||+||+|.+..+++.|++|++....  ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            468999999999999999999999999999999986432  33467788999999999 899999999999999999999


Q ss_pred             EEeccCCchhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-----------------C
Q psy11805         79 LELIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-----------------T  138 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-----------------~  138 (251)
                      ||++++++|.+.+...   ...+++..++.++.|++.||.+||++|++|+||||+||++..+                 .
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            9999999999988753   2468999999999999999999999999999999999998221                 3


Q ss_pred             CCcEEEeecccccccCCCCcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q psy11805        139 GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIA  217 (251)
Q Consensus       139 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  217 (251)
                      ...++|+|||.+.......   ...+++.|+|||.+.+. .++.++||||||+++++|++|..++.....   ...+..+
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~  243 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG  243 (289)
T ss_dssp             CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTT
T ss_pred             ceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcC
Confidence            4479999999998765432   23589999999999766 566899999999999999999988755533   2333333


Q ss_pred             cccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        218 QYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+   .....+++.+.++|.+||+.||++|||+
T Consensus       244 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~  274 (289)
T 1x8b_A          244 RLP---RIPQVLSQEFTELLKVMIHPDPERRPSA  274 (289)
T ss_dssp             CCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCC---CCCcccCHHHHHHHHHHhCCCcccCCCH
Confidence            322   2235789999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-47  Score=320.54  Aligned_cols=244  Identities=25%  Similarity=0.340  Sum_probs=204.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc------CCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL------QHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~   75 (251)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            46899999999999999999999999999999998542 33456777888888877      477999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCc--EEEeecccccc
Q psy11805         76 CVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNR--IKIIDFGLARK  152 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~--~~l~df~~~~~  152 (251)
                      ++|||++.+ +|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.  ++|+|||++..
T Consensus       175 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl--~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          175 CMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL--KQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE--SSTTSCCEEECCCTTCEE
T ss_pred             EEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--ccCCCcceEEeeccccee
Confidence            999999975 8888887654 358999999999999999999999999999999999999  76665  99999999976


Q ss_pred             cCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc--------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE--------  224 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------  224 (251)
                      ....  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..........        
T Consensus       252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~  329 (429)
T 3kvw_A          252 EHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA  329 (429)
T ss_dssp             TTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred             cCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence            5432  334568999999999999999999999999999999999999999988877766554321111100        


Q ss_pred             -----------------------------------------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 -----------------------------------------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 -----------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                                     .....++.+.+||++||+.||++|||+
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                                                           001237789999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.9e-48  Score=310.71  Aligned_cols=247  Identities=20%  Similarity=0.300  Sum_probs=204.0

Q ss_pred             CccCCcccccccCCceEEEEEE-----EccCCceEEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCK-----EKATGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||.||+|.     +..++..|++|.+... .......+.+|+..+++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            4789999999999999999999     4567789999998533 233466788999999999999999999999999899


Q ss_pred             EEEEEeccCCchhHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecc
Q psy11805         76 CVVLELIEGGELFERVIDDD------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFG  148 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~  148 (251)
                      ++|||++++++|.+++....      ..++...++.++.|++.||.+||+.|++|+||+|+||++..+ .+..++|+|||
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg  188 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG  188 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence            99999999999999988653      358999999999999999999999999999999999998211 34569999999


Q ss_pred             cccccCCCC---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        149 LARKFDPEK---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       149 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                      ++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+....   
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---  265 (327)
T 2yfx_A          189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---  265 (327)
T ss_dssp             HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC---
T ss_pred             cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC---
Confidence            997543222   1223456889999999988889999999999999999998 999999988877777666554322   


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....++..+.++|.+||+.||.+|||+
T Consensus       266 ~~~~~~~~l~~li~~~l~~dp~~Rps~  292 (327)
T 2yfx_A          266 PPKNCPGPVYRIMTQCWQHQPEDRPNF  292 (327)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence            225789999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-48  Score=311.15  Aligned_cols=248  Identities=23%  Similarity=0.415  Sum_probs=189.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|++|.||+|.+..+++.|++|.+.... ......+.+|+..+++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            478999999999999999999998889999999986443 3346778899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         81 LIEGGELFERVID-------DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        81 ~~~~~~L~~~~~~-------~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ++++++|.+++..       ....+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL--GEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--CTTCCEEECCCHHHHHC
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE--cCCCCEEEEeccchhee
Confidence            9999999988864       24569999999999999999999999999999999999999  88999999999998765


Q ss_pred             CCCC------cceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC----
Q psy11805        154 DPEK------KLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD----  222 (251)
Q Consensus       154 ~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  222 (251)
                      ....      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....................    
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  251 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV  251 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence            4321      1233468899999999865 5678999999999999999999999988776665544433322211    


Q ss_pred             --CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 --DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                        ......++..+.++|.+||+.||.+|||+
T Consensus       252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  282 (303)
T 2vwi_A          252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTA  282 (303)
T ss_dssp             ---CCCCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccchhhhhhhHHHHHHHHHHccCChhhCcCH
Confidence              12235688999999999999999999984

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-47  Score=303.57  Aligned_cols=242  Identities=24%  Similarity=0.382  Sum_probs=206.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+. ++..|++|.+... ....+.+.+|++.++.++|+||+++++++.. +..++|||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            478999999999999999999876 4668999998643 3357789999999999999999999999874 458899999


Q ss_pred             ccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc-
Q psy11805         82 IEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL-  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~-  159 (251)
                      +++++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+......... 
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~  166 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV--SDTLSCKIADFGLARLIEDNEYTA  166 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE--cCCCCEEECCCcccccccCccccc
Confidence            99999999886532 258999999999999999999999999999999999999  88999999999999876443221 


Q ss_pred             -eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        160 -QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       160 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                       ....+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+..+...   .....++..+.+++
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  243 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNCPEELYQLM  243 (279)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred             ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCcccccHHHHHHH
Confidence             22345678999999988889999999999999999999 99999998888877776554322   22357899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.||++|||+
T Consensus       244 ~~~l~~~p~~Rps~  257 (279)
T 1qpc_A          244 RLCWKERPEDRPTF  257 (279)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHhccChhhCCCH
Confidence            99999999999984

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.6e-48  Score=310.26  Aligned_cols=246  Identities=22%  Similarity=0.322  Sum_probs=204.2

Q ss_pred             CccCCcccccccCCceEEEEEEEc-----cCCceEEEEEeccccc-cchHHHHHHHHHHHHc-CCCceeeEeEEEeeCC-
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAKR-NDRRNVEREVEIMREL-QHPRLIQIYDAFESSN-   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-   73 (251)
                      .++|++.+.||+|+||.||+|.+.     .+++.|++|++..... .....+.+|+..++++ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            478999999999999999999863     4568899999864332 2456789999999999 6999999999987654 


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCC---------------CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFV---------------LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT  138 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~---------------~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~  138 (251)
                      ..+++||++++++|.+++......               +++..++.++.|++.||.+||+.|++|+||+|+||++  +.
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--~~  183 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SE  183 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CG
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--CC
Confidence            589999999999999998765432               8999999999999999999999999999999999999  88


Q ss_pred             CCcEEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy11805        139 GNRIKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANV  214 (251)
Q Consensus       139 ~~~~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  214 (251)
                      ++.++|+|||++.........   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.....
T Consensus       184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  263 (316)
T 2xir_A          184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  263 (316)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence            899999999999765433221   23456789999999998899999999999999999998 99999887654443333


Q ss_pred             HhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ........  ....+++.+.++|.+||+.||.+|||+
T Consensus       264 ~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~  298 (316)
T 2xir_A          264 LKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTF  298 (316)
T ss_dssp             HHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hccCccCC--CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            33222222  225679999999999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-47  Score=308.21  Aligned_cols=245  Identities=18%  Similarity=0.315  Sum_probs=198.8

Q ss_pred             CccCCcccccccCCceEEEEEEEcc---CCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC---
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA---TGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN---   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   73 (251)
                      .++|++.+.||+|+||.||+|.+..   ++..|++|.+....  ....+.+.+|+..+++++||||+++++++...+   
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            4689999999999999999998875   34589999986543  234577899999999999999999999987654   


Q ss_pred             --EEEEEEEeccCCchhHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEee
Q psy11805         74 --VMCVVLELIEGGELFERVID-----DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        74 --~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                        ..+++||++++++|.+++..     ....+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli--~~~~~~kl~D  190 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML--RDDMTVCVAD  190 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE--CTTSCEEECS
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE--cCCCcEEEee
Confidence              35999999999999988853     33569999999999999999999999999999999999999  8899999999


Q ss_pred             cccccccCCCC---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCC
Q psy11805        147 FGLARKFDPEK---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       147 f~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      ||++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+...  
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--  268 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--  268 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC--
Confidence            99997654332   1223346779999999999999999999999999999999 99999988887777766555422  


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                       .....+++.+.++|.+||+.||.+|||+
T Consensus       269 -~~~~~~~~~l~~li~~~l~~dp~~Rps~  296 (313)
T 3brb_A          269 -KQPEDCLDELYEIMYSCWRTDPLDRPTF  296 (313)
T ss_dssp             -CCBTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             -CCCccccHHHHHHHHHHcCCChhhCcCH
Confidence             2236789999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.8e-48  Score=315.74  Aligned_cols=242  Identities=25%  Similarity=0.398  Sum_probs=201.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE----
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM----   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----   75 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+..++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            578999999999999999999999999999999986433  22367788999999999999999999999876654    


Q ss_pred             --EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         76 --CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        76 --~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                        ++|||++++ +|.+.+.   ..+++..++.++.|++.||.|||+.|++|+||||+||++  +.++.++|+|||.+...
T Consensus       121 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          121 DFYLVMPFMQT-DLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV--NEDCELKILDFGLARHA  194 (371)
T ss_dssp             CCEEEEECCCE-EHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECSTTCC---
T ss_pred             eEEEEEccccc-cHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE--CCCCCEEEEecCccccc
Confidence              999999975 7766652   349999999999999999999999999999999999999  89999999999999765


Q ss_pred             CCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC---------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD---------  223 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  223 (251)
                      ...  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.........         
T Consensus       195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          195 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            432  234467999999999977 67899999999999999999999999998877776665432211111         


Q ss_pred             ------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        ..+..+++.+.+||++||+.||++|||+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  318 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA  318 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH
Confidence                              1224578999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.9e-47  Score=311.80  Aligned_cols=246  Identities=23%  Similarity=0.373  Sum_probs=203.1

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC-----CE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESS-----NV   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   74 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+..+++++|+||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4689999999999999999999999999999999986433 23456788999999999999999999988654     67


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .+++||++++ +|.+.+...  .+++..++.++.|++.||.+||++|++|+||+|+||++  +.++.++|+|||++....
T Consensus        89 ~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           89 VYIIQELMQT-DLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI--NSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEEECCCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCc-cHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--cCCCcEEEEecccccccc
Confidence            8999999975 888887763  59999999999999999999999999999999999999  889999999999997754


Q ss_pred             CCCc-----------ceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC
Q psy11805        155 PEKK-----------LQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       155 ~~~~-----------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      ....           .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            3221           122357899999998754 6789999999999999999999999998877665544322111000


Q ss_pred             ----------------------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ----------------------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                  ...++.+++.+.+||++||+.||++|||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  300 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA  300 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH
Confidence                                        01234689999999999999999999985

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.5e-48  Score=323.87  Aligned_cols=242  Identities=21%  Similarity=0.364  Sum_probs=207.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||+|.+.. +..||+|++... ....+.+.+|+.++++++||||+++++++. .+..++|||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            3678999999999999999998864 678999998653 345788999999999999999999999986 5568999999


Q ss_pred             ccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc--
Q psy11805         82 IEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK--  158 (251)
Q Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~--  158 (251)
                      +++++|.+++.... ..++...+..++.|++.||.|||++|++||||||+||++  +.++.++|+|||++........  
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill--~~~~~~kl~DFG~a~~~~~~~~~~  341 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTA  341 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE--CTTCCEEECSTTGGGGBCCHHHHT
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE--CCCCcEEEeeCCCceEcCCCceec
Confidence            99999999987532 358999999999999999999999999999999999999  8899999999999987543211  


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..+...   +....+|+.+.++|
T Consensus       342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li  418 (454)
T 1qcf_A          342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPEELYNIM  418 (454)
T ss_dssp             TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCTTSCHHHHHHH
T ss_pred             cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence            122235678999999998899999999999999999999 99999999888887777655322   22367899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.||++|||+
T Consensus       419 ~~cl~~dp~~RPt~  432 (454)
T 1qcf_A          419 MRCWKNRPEERPTF  432 (454)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHccCChhHCcCH
Confidence            99999999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.9e-48  Score=305.62  Aligned_cols=236  Identities=24%  Similarity=0.401  Sum_probs=201.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee----------
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES----------   71 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   71 (251)
                      .++|++.+.||+|+||.||+|.+..+++.|++|.+....    ..+.+|+..+++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            468999999999999999999999999999999986432    467789999999999999999998854          


Q ss_pred             ------CCEEEEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEE
Q psy11805         72 ------SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKI  144 (251)
Q Consensus        72 ------~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l  144 (251)
                            ....++|||++++++|.+++... ...+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~kl  163 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL--VDTKQVKI  163 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE--cCCCCEEE
Confidence                  44589999999999999998753 3469999999999999999999999999999999999999  88899999


Q ss_pred             eecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        145 IDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       145 ~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                      +|||.+.............+++.|+|||.+.+..++.++||||||+++|+|++|..||...  ......+....      
T Consensus       164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~------  235 (284)
T 2a19_B          164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI------  235 (284)
T ss_dssp             CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC------
T ss_pred             CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc------
Confidence            9999998776555555567899999999999888999999999999999999999887432  12222222221      


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....++..+.++|.+||+.||.+|||+
T Consensus       236 ~~~~~~~~~~~li~~~l~~dp~~Rps~  262 (284)
T 2a19_B          236 ISDIFDKKEKTLLQKLLSKKPEDRPNT  262 (284)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCH
Confidence            124678999999999999999999984

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.8e-47  Score=314.50  Aligned_cols=241  Identities=20%  Similarity=0.373  Sum_probs=197.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcC--CCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQ--HPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||.||+|.+.. ++.||+|++....  ......+.+|+.++++++  |+||+++++++..++..++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            469999999999999999998875 8899999986433  334678899999999996  59999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      || +.+++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||++  + ++.++|+|||++........
T Consensus       135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll--~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--V-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE--S-SSCEEECCCSSSCCC-----
T ss_pred             Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE--E-CCeEEEEecCccccccCCCc
Confidence            99 55779988887654 68999999999999999999999999999999999998  4 57899999999987643322


Q ss_pred             ---ceeeccCccccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccccCCC
Q psy11805        159 ---LQVLFGTPEFVAPEVVNF-----------DAIGFGTDMWSVGVICYVLLSGLSPFMGETD-VQTMANVTIAQYDFDD  223 (251)
Q Consensus       159 ---~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~  223 (251)
                         .....+++.|+|||.+.+           ..++.++||||||+++|+|++|..||..... ......+........ 
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~-  288 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-  288 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC-
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC-
Confidence               234568999999999865           3688899999999999999999999987543 344444444333322 


Q ss_pred             ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                       .....+..+.+||.+||+.||++|||+
T Consensus       289 -~~~~~~~~~~~li~~~L~~dP~~Rps~  315 (390)
T 2zmd_A          289 -FPDIPEKDLQDVLKCCLKRDPKQRISI  315 (390)
T ss_dssp             -CCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             -CCccchHHHHHHHHHHcccChhhCCCH
Confidence             224458899999999999999999984

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.2e-48  Score=307.33  Aligned_cols=244  Identities=24%  Similarity=0.416  Sum_probs=201.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee----------
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES----------   71 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   71 (251)
                      .++|++.+.||+|+||.||+|.+..+++.|++|.+.. .......+.+|+..+++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            4689999999999999999999999999999999854 23446788999999999999999999998754          


Q ss_pred             ---CCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         72 ---SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        72 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                         .+..++|||++++++|.+++...+..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~--~~~~~~kl~dfg  161 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI--DESRNVKIGDFG  161 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE--cCCCCEEEeeCc
Confidence               456899999999999999998777678999999999999999999999999999999999999  899999999999


Q ss_pred             cccccCCC---------------CcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHH
Q psy11805        149 LARKFDPE---------------KKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGE-TDVQTM  211 (251)
Q Consensus       149 ~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~  211 (251)
                      .+......               .......+++.|+|||.+.+. .++.++||||||+++|+|++   ||... +..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            99765422               122344688899999999764 68899999999999999998   66543 333444


Q ss_pred             HHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        212 ANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.......+.......+..+.++|++||+.||.+|||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  278 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA  278 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH
Confidence            5555544555555556778899999999999999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.7e-48  Score=311.67  Aligned_cols=242  Identities=21%  Similarity=0.265  Sum_probs=193.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC----EEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN----VMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv   78 (251)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++.... .......+|+..+++++||||+++++++....    ..++|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            68999999999999999999876  7899999986433 33455667888899999999999999997643    47999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK----------NVLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~----------gi~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                      |||+++++|.+++....  +++..++.++.|++.||.|||+.          |++|+||||+||++  +.++.++|+|||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill--~~~~~~kL~DFg  176 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--KNNLTACIADFG  176 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE--CTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE--CCCCeEEEccCC
Confidence            99999999999987654  99999999999999999999999          99999999999999  899999999999


Q ss_pred             cccccCCCCc---ceeeccCccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-------------
Q psy11805        149 LARKFDPEKK---LQVLFGTPEFVAPEVVNF-----DAIGFGTDMWSVGVICYVLLSGLSPFMGETD-------------  207 (251)
Q Consensus       149 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------  207 (251)
                      ++........   .....+++.|+|||.+.+     ..++.++||||||+++|+|++|+.||.+...             
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            9977644332   223468999999999976     3556789999999999999999999976422             


Q ss_pred             ---HHHHHHHHhccccCCC-cccc--CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        208 ---VQTMANVTIAQYDFDD-ECFN--EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       208 ---~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                         ................ ..+.  ..+..+.+||.+||+.||++|||+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (322)
T 3soc_A          257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA  306 (322)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence               1122222222211111 1111  234569999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-47  Score=310.70  Aligned_cols=246  Identities=33%  Similarity=0.563  Sum_probs=176.5

Q ss_pred             CCccCCccc-ccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee----CCEE
Q psy11805          1 MTTHQNQHS-AFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES----SNVM   75 (251)
Q Consensus         1 ~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~   75 (251)
                      +.++|++.+ .||+|+||+||+|.+..+++.||+|++...    .....+....++.++|+|++++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            357899955 699999999999999999999999998532    2222333334667789999999999876    4568


Q ss_pred             EEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeeccccccc
Q psy11805         76 CVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLARKF  153 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~  153 (251)
                      ++||||+++++|.+.+...+ ..+++..++.++.|++.||.|||++|++|+||+|+||++..+ .++.++|+|||++...
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            99999999999999988654 369999999999999999999999999999999999998321 2456999999999765


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhccccCCCccccCC
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT----MANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~  229 (251)
                      ... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||........    ...+.......+.+.+..+
T Consensus       182 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (336)
T 3fhr_A          182 TQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV  260 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred             ccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence            432 23445679999999999888899999999999999999999999977655443    2333344445555556789


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+.+||.+||+.||.+|||+
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~  282 (336)
T 3fhr_A          261 SEDAKQLIRLLLKTDPTERLTI  282 (336)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CHHHHHHHHHHCCCChhHCcCH
Confidence            9999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-47  Score=314.19  Aligned_cols=211  Identities=23%  Similarity=0.408  Sum_probs=182.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CC-----ceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HP-----RLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~~~   75 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+..++.+. |+     +++++.+++...+..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            47899999999999999999999999999999998632 234567778888888875 44     499999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHh--hCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         76 CVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIH--SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh--~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      ++|||++++ +|.+.+.... ..+++..++.++.|++.||.|||  +.||+||||||+||++..+.++.++|+|||++..
T Consensus       132 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             EEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            999999976 8988887653 46999999999999999999999  5799999999999998545578899999999987


Q ss_pred             cCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI  216 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  216 (251)
                      ....  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus       211 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~  272 (382)
T 2vx3_A          211 LGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE  272 (382)
T ss_dssp             TTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            6432  3345689999999999999999999999999999999999999999888877766654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=305.78  Aligned_cols=245  Identities=21%  Similarity=0.356  Sum_probs=185.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc--chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|+||.||+|.+..+++.|++|++......  ....+.++...++.++|+||+++++++.+++..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            5789999999999999999999999999999998654322  23344455556778899999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ++ ++.+..........+++..++.++.|++.||.+||++ |++|+||+|+||++  +.++.++|+|||++.........
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~~~~~  181 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL--DERGQIKLCDFGISGRLVDDKAK  181 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE--CTTSCEEECCCTTC---------
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE--CCCCCEEEEECCCchhccCCccc
Confidence            99 5456555554456799999999999999999999996 99999999999999  88999999999999776555545


Q ss_pred             eeeccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        160 QVLFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGE-TDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ....+++.|+|||.+.     +..++.++||||||+++|+|++|..||... ...+....+...... ..+....++.++
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  260 (318)
T 2dyl_A          182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP-LLPGHMGFSGDF  260 (318)
T ss_dssp             -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-CCCSSSCCCHHH
T ss_pred             cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-CCCccCCCCHHH
Confidence            5567899999999994     456788999999999999999999999874 444555555444332 222234689999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .++|.+||+.||.+|||+
T Consensus       261 ~~li~~~l~~dp~~Rps~  278 (318)
T 2dyl_A          261 QSFVKDCLTKDHRKRPKY  278 (318)
T ss_dssp             HHHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHHccCChhHCcCH
Confidence            999999999999999984

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-47  Score=318.07  Aligned_cols=242  Identities=23%  Similarity=0.320  Sum_probs=198.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee------CCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES------SNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~   76 (251)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+++++.++|+||+++++++..      ....+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            3699999999999999999999999999999997532    2234579999999999999999998843      22477


Q ss_pred             EEEEeccCCchhHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-CCcEEEeecccccc
Q psy11805         77 VVLELIEGGELFERVI---DDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-GNRIKIIDFGLARK  152 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~~~~  152 (251)
                      +||||+++ ++.+.+.   .....+++..++.++.|++.||.|||+.||+||||||+|||+  +. .+.++|+|||++..
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl--~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE--ETTTTEEEECCCTTCEE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEE--eCCCCeEEeccchhhhh
Confidence            99999986 5555543   345579999999999999999999999999999999999998  64 46789999999987


Q ss_pred             cCCCCcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC----------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF----------  221 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------  221 (251)
                      ...........+++.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+.......          
T Consensus       207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~  286 (420)
T 1j1b_A          207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  286 (420)
T ss_dssp             CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred             cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            6555555556789999999998764 68999999999999999999999999988777666554321110          


Q ss_pred             -------CC--------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 -------DD--------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 -------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                             +.        .....++.++.+||++||+.||.+|||+
T Consensus       287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~  331 (420)
T 1j1b_A          287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP  331 (420)
T ss_dssp             CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH
Confidence                   00        0113568899999999999999999984

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.1e-48  Score=310.81  Aligned_cols=246  Identities=22%  Similarity=0.361  Sum_probs=203.7

Q ss_pred             CccCCcccccccCCceEEEEEEE----ccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC--EE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKE----KATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN--VM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~   75 (251)
                      .++|++.+.||+|++|.||+|.+    ..+++.|++|++........+.+.+|+..+++++|+||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35799999999999999999984    5678899999987666666788999999999999999999999986544  68


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP  155 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~  155 (251)
                      ++|||++++++|.+++...+..+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||++.....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli--~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV--ENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--EETTEEEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE--cCCCcEEEecCcchhhccc
Confidence            99999999999999998877779999999999999999999999999999999999999  8889999999999987654


Q ss_pred             CCcc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH------------H---HHHHHHh
Q psy11805        156 EKKL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV------------Q---TMANVTI  216 (251)
Q Consensus       156 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------~---~~~~~~~  216 (251)
                      ....    ....++..|+|||.+.+..++.++||||||+++|+|++|..||......            .   .......
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  277 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence            4321    2234566799999998888999999999999999999999998643111            0   0111111


Q ss_pred             ccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ....  .+....+|.++.++|.+||+.||++|||+
T Consensus       278 ~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~  310 (326)
T 2w1i_A          278 NNGR--LPRPDGCPDEIYMIMTECWNNNVNQRPSF  310 (326)
T ss_dssp             TTCC--CCCCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cCCC--CCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence            1111  22236789999999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-47  Score=305.06  Aligned_cols=244  Identities=20%  Similarity=0.281  Sum_probs=203.6

Q ss_pred             ccCCcccccccCCceEEEEEEEccCC---ceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEE-eeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATG---MTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAF-ESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~l   77 (251)
                      .+|++.+.||+|+||.||+|.+..++   ..+++|.+.... ....+.+.+|+..+++++||||+++++++ ..++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            46899999999999999999975433   358888875432 33467889999999999999999999985 45667899


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      +||++++++|.+++......++...++.++.|++.||.+||++|++|+||||+||++  +.++.++|+|||.+.......
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTCCEEECSCGGGCCCSCGG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE--CCCCCEEECcccccccccccc
Confidence            999999999999998777779999999999999999999999999999999999999  899999999999997654322


Q ss_pred             c-----ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        158 K-----LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       158 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      .     .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.....   ...+|+
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  259 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCPD  259 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---CTTCCH
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---CccCCH
Confidence            1     123346678999999998899999999999999999999 6778887777666666655543332   256799


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+++.+||+.+|++|||+
T Consensus       260 ~l~~li~~~l~~~p~~Rps~  279 (298)
T 3f66_A          260 PLYEVMLKCWHPKAEMRPSF  279 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHcCCChhhCcCH
Confidence            99999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.9e-47  Score=312.56  Aligned_cols=245  Identities=25%  Similarity=0.331  Sum_probs=192.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-------EE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-------VM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------~~   75 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++... ........++++.++.++||||+++++++...+       ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            6899999999999999999999999999999987543 334556678888899999999999999986533       38


Q ss_pred             EEEEEeccCCchhHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHh--hCCceecCCCCCcEEEeecC-CCcEEEeeccc
Q psy11805         76 CVVLELIEGGELFERVI---DDDFVLTEKAVAIFMRQICEGVEFIH--SKNVLHLDMKPENILCLTKT-GNRIKIIDFGL  149 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lh--~~gi~h~dl~~~nil~~~~~-~~~~~l~df~~  149 (251)
                      ++||||+++ +|...+.   .....+++..++.++.|++.||.+||  +.|++|+||||+||++  +. ++.++|+|||+
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll--~~~~~~~kl~Dfg~  178 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGS  178 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEE--ETTTTEEEECCCTT
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEE--eCCCCcEEEeeCCC
Confidence            899999987 4444433   24456899999999999999999999  9999999999999998  65 88999999999


Q ss_pred             ccccCCCCcceeeccCcccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc----
Q psy11805        150 ARKFDPEKKLQVLFGTPEFVAPEVVNFDA-IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE----  224 (251)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  224 (251)
                      +.............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+..........    
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            98876665555667899999999986554 7999999999999999999999999988877776665432211110    


Q ss_pred             ------------------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 ------------------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                              .....+.++.+||.+||+.||.+|||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  309 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP  309 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH
Confidence                                    011246789999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.3e-49  Score=324.94  Aligned_cols=236  Identities=12%  Similarity=0.164  Sum_probs=189.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHH---HHHHcCCCceeeEe-------EE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVE---IMRELQHPRLIQIY-------DA   68 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~---~l~~l~~~~i~~~~-------~~   68 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.   .+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999999989999999998633   3334678899995   44555799999998       66


Q ss_pred             EeeCC-----------------EEEEEEEeccCCchhHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHhhCCceec
Q psy11805         69 FESSN-----------------VMCVVLELIEGGELFERVIDDDF------VLTEKAVAIFMRQICEGVEFIHSKNVLHL  125 (251)
Q Consensus        69 ~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lh~~gi~h~  125 (251)
                      +.+.+                 ..+++||++ +++|.+++...+.      .+++..++.++.|++.||.|||+.|++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            66553                 278999999 5699998876421      23358888999999999999999999999


Q ss_pred             CCCCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCcccccccccccC-----------CCCcchhHHHHHHHHHH
Q psy11805        126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD-----------AIGFGTDMWSVGVICYV  194 (251)
Q Consensus       126 dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~  194 (251)
                      ||||+||++  +.++.++|+|||++.....  ......+ +.|+|||.+.+.           .++.++||||||+++|+
T Consensus       231 Dikp~NIll--~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVL--DQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEE--CTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEE--cCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999  8899999999999986433  3344456 999999999887           89999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        195 LLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       195 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      |++|..||...+..+....+        ...+..+|+++.+||.+||+.||++|||+
T Consensus       306 lltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHSSCCC------CCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHCCCCCcccccccchhhh--------hhhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            99999999765543322211        11225789999999999999999999984

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=310.29  Aligned_cols=241  Identities=24%  Similarity=0.391  Sum_probs=184.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEe--------eC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFE--------SS   72 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--------~~   72 (251)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+..++++. |+||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            358999999999999999999999999999999986665566788899999999996 999999999983        34


Q ss_pred             CEEEEEEEeccCCchhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         73 NVMCVVLELIEGGELFERVID--DDFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                      ...+++||+++| +|.+.+..  ....+++..++.++.|++.||.|||+.|  ++|+||||+||++  +.++.++|+|||
T Consensus       107 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~--~~~~~~kl~Dfg  183 (337)
T 3ll6_A          107 AEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--CTTSCEEBCCCT
T ss_pred             ceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--CCCCCEEEecCc
Confidence            568999999974 88887764  3456999999999999999999999999  9999999999999  889999999999


Q ss_pred             cccccCCCCcc-------------eeeccCccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy11805        149 LARKFDPEKKL-------------QVLFGTPEFVAPEVV---NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA  212 (251)
Q Consensus       149 ~~~~~~~~~~~-------------~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  212 (251)
                      ++.........             ....+++.|+|||.+   .+..++.++||||||+++|+|++|..||..........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  263 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN  263 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence            99876433221             134588899999998   56678899999999999999999999997665443332


Q ss_pred             HHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        213 NVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                          .....  +.....+..+.+||++||+.||.+|||+
T Consensus       264 ----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~  296 (337)
T 3ll6_A          264 ----GKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSI  296 (337)
T ss_dssp             ------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCH
T ss_pred             ----CcccC--CcccccchHHHHHHHHHccCChhhCcCH
Confidence                22221  2225667889999999999999999984

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-47  Score=302.65  Aligned_cols=243  Identities=20%  Similarity=0.266  Sum_probs=202.6

Q ss_pred             cCCcccccccCCceEEEEEEEccCCc---eEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE-EEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGM---TLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVM-CVV   78 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~lv   78 (251)
                      .|++.+.||+|+||.||+|.+..++.   .+++|.+.... ....+.+.+|+..++.++||||+++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46677999999999999999865554   78999876433 23467888999999999999999999999766554 999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC--
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE--  156 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~--  156 (251)
                      ||++.+++|.+.+......+++..++.++.|++.||.+||+.|++|+||||+||++  +.++.++|+|||.+......  
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili--~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML--DESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTCCEEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE--cCCCcEEeCcCCCcccccCCcc
Confidence            99999999999998767779999999999999999999999999999999999999  89999999999999754322  


Q ss_pred             ---CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        157 ---KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       157 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                         .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+.......   ....+++.
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  256 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QPEYCPDS  256 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---CCTTCCHH
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---CCccchHH
Confidence               12233456789999999999999999999999999999999 555566666666655555443222   23568999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+++.+||+.||.+|||+
T Consensus       257 l~~li~~~l~~~p~~Rps~  275 (298)
T 3pls_A          257 LYQVMQQCWEADPAVRPTF  275 (298)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHccCChhhCcCH
Confidence            9999999999999999984

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-47  Score=316.51  Aligned_cols=242  Identities=24%  Similarity=0.350  Sum_probs=196.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC------EE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN------VM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   75 (251)
                      ..+|++.+.||+|+||.||+|.+..++. +++|.+....    ....+|+++++.++|+||+++++++...+      ..
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3579999999999999999999987665 7777653322    22347999999999999999999985433      48


Q ss_pred             EEEEEeccCCchhHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeeccccc
Q psy11805         76 CVVLELIEGGELFERVI---DDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLAR  151 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~  151 (251)
                      ++||||++++ +.+.+.   .....+++..++.++.|++.||.|||+.|++||||||+||++  + .++.++|+|||++.
T Consensus       114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill--~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--ETTTTEEEECCCTTCE
T ss_pred             EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEE--cCCCCcEEEeeCCCcc
Confidence            8999999874 433332   234579999999999999999999999999999999999998  6 78899999999998


Q ss_pred             ccCCCCcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC--------
Q psy11805        152 KFDPEKKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD--------  222 (251)
Q Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  222 (251)
                      ............+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+........        
T Consensus       191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            87665555566789999999998765 589999999999999999999999999888777666544211111        


Q ss_pred             -----------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 -----------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                       ......+++++.+||.+||+.||.+|||+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA  316 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence                             01123478999999999999999999984

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.5e-47  Score=309.06  Aligned_cols=246  Identities=26%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             CccCCcccccccCCceEEEEEEE-ccCCceEEEEEeccccccchHHHHHHHHHHHHcCCC------ceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKE-KATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHP------RLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+..++.++|+      +++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            57999999999999999999998 567889999998532 33467788999999888644      59999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC---------------
Q psy11805         75 MCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT---------------  138 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~---------------  138 (251)
                      .++|||++ +++|.+.+...+ ..+++..++.++.|++.||.|||++|++|+||||+||++....               
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~  170 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT  170 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence            99999999 678988887654 3589999999999999999999999999999999999982221               


Q ss_pred             --CCcEEEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q psy11805        139 --GNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI  216 (251)
Q Consensus       139 --~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  216 (251)
                        ++.++|+|||.+......  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  248 (339)
T 1z57_A          171 LINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER  248 (339)
T ss_dssp             ESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred             ccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence              668999999999764432  2345689999999999998999999999999999999999999998887766554433


Q ss_pred             ccccCCCcc----------------------------------------ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDFDDEC----------------------------------------FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~~~~~----------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...+.+...                                        ....++.+.+||.+||+.||.+|||+
T Consensus       249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            222211110                                        01234678999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-47  Score=321.39  Aligned_cols=241  Identities=22%  Similarity=0.359  Sum_probs=202.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.++++++||||+++++++.+ +..++|||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            578999999999999999999875 4579999986433 346789999999999999999999999876 6689999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc--c
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK--L  159 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~--~  159 (251)
                      ++++|.+++... +..++...+..++.|++.||.|||++|++|+||+|+||++  +.++.++|+|||++........  .
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~~~~  338 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTAR  338 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCCCTTC----------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE--CCCCCEEECCCccceecCCCceecc
Confidence            999999998753 3458999999999999999999999999999999999999  8889999999999977543221  1


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..+...   +....+|+.+.++|.
T Consensus       339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~  415 (452)
T 1fmk_A          339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPESLHDLMC  415 (452)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCHHHHHHHH
T ss_pred             cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHH
Confidence            22345678999999998899999999999999999999 99999999888887777655322   223578999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       416 ~cl~~dP~~Rpt~  428 (452)
T 1fmk_A          416 QCWRKEPEERPTF  428 (452)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHccCChhhCcCH
Confidence            9999999999984

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.4e-47  Score=303.76  Aligned_cols=242  Identities=19%  Similarity=0.306  Sum_probs=192.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHH--cCCCceeeEeEEEee----CCE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRE--LQHPRLIQIYDAFES----SNV   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~~~   74 (251)
                      +.++|++.+.||+|+||+||+|.+  +++.||+|++...   ......+|.+++..  ++||||+++++++..    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            467999999999999999999987  4889999998542   34556667777776  789999999998654    346


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCceecCCCCCcEEEeecCCCcEEEee
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH--------SKNVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh--------~~gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                      .++|||++++++|.+++...  .+++..++.++.|++.||.|||        +.|++|+||||+||++  +.++.++|+|
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill--~~~~~~kl~D  156 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV--KKNGQCCIAD  156 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE--CTTSCEEECC
T ss_pred             eEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE--cCCCCEEEee
Confidence            89999999999999988543  5999999999999999999999        9999999999999999  8999999999


Q ss_pred             cccccccCCCCcc-----eeeccCcccccccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCC
Q psy11805        147 FGLARKFDPEKKL-----QVLFGTPEFVAPEVVNFD------AIGFGTDMWSVGVICYVLLSG----------LSPFMGE  205 (251)
Q Consensus       147 f~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~pf~~~  205 (251)
                      ||++.........     ....+++.|+|||.+.+.      .++.++||||||+++|+|++|          ..||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            9999765443322     223689999999999876      456799999999999999999          8888653


Q ss_pred             C----hHHHHHHHHh-ccccCCCc---cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        206 T----DVQTMANVTI-AQYDFDDE---CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       206 ~----~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .    ..+....... .......+   .....+..+.+|+.+||+.||++|||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  290 (301)
T 3q4u_A          237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA  290 (301)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH
Confidence            2    2222222221 11111111   112355789999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-47  Score=307.76  Aligned_cols=244  Identities=20%  Similarity=0.313  Sum_probs=200.1

Q ss_pred             CccC-CcccccccCCceEEEEEEE----ccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEee--CC
Q psy11805          2 TTHQ-NQHSAFSFGKFGTVYRCKE----KATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFES--SN   73 (251)
Q Consensus         2 ~~~y-~~~~~lg~g~~~~v~~~~~----~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~   73 (251)
                      .++| ++.+.||+|+||+||++..    ..+++.||+|++.... ......+.+|+.++++++||||+++++++.+  ..
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            4566 9999999999999988764    3467899999986543 2346778999999999999999999999987  46


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..++|||++++++|.+++...+  +++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+...
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL--DNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCGGGCEEC
T ss_pred             eEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE--cCCCCEEECCccccccc
Confidence            7899999999999999887654  9999999999999999999999999999999999999  88999999999999876


Q ss_pred             CCCCc----ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHH
Q psy11805        154 DPEKK----LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ--------------TMANVT  215 (251)
Q Consensus       154 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~  215 (251)
                      .....    .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......              ......
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            54432    223346778999999998889999999999999999999999997643211              111111


Q ss_pred             hccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        216 IAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...  ...+....++..+.+||++||+.||++|||+
T Consensus       265 ~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  298 (318)
T 3lxp_A          265 ERG--ERLPRPDKCPAEVYHLMKNCWETEASFRPTF  298 (318)
T ss_dssp             HTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hcc--cCCCCCccccHHHHHHHHHHcCCCcccCcCH
Confidence            111  1222336789999999999999999999984

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=313.17  Aligned_cols=242  Identities=16%  Similarity=0.222  Sum_probs=197.1

Q ss_pred             CccCCcccccccCCceEEEEEEEcc--------CCceEEEEEeccccccchHHHHHHHHHHHHcCCCceee---------
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA--------TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQ---------   64 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~---------   64 (251)
                      +++|++.+.||+|+||.||+|.+..        +++.||+|++...     ..+.+|+.++++++|+|+++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999999987        4789999997532     56889999999999998887         


Q ss_pred             ------EeEEEee-CCEEEEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee
Q psy11805         65 ------IYDAFES-SNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT  136 (251)
Q Consensus        65 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~  136 (251)
                            +++++.. ++..++|||++ +++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||++  
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~--  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV--  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE--
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE--
Confidence                  6777766 77899999999 88999998865 3569999999999999999999999999999999999999  


Q ss_pred             cCCC--cEEEeecccccccCCCCc--------ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy11805        137 KTGN--RIKIIDFGLARKFDPEKK--------LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET  206 (251)
Q Consensus       137 ~~~~--~~~l~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  206 (251)
                      +.++  .++|+|||++........        .....+++.|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            7777  899999999976543221        123368899999999999899999999999999999999999998764


Q ss_pred             -hHHHHHHHHhccccCC------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        207 -DVQTMANVTIAQYDFD------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       207 -~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                       ..+.............      ...+..++..+.+||.+||+.||++|||+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  324 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY  324 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence             2222222221111111      11234679999999999999999999984

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-47  Score=302.97  Aligned_cols=238  Identities=20%  Similarity=0.333  Sum_probs=196.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee-CCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES-SNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~   81 (251)
                      ++|++.+.||+|++|.||++.+.  ++.|++|++..  ....+.+.+|+..+++++|+||+++++++.. .+..++|||+
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            68999999999999999999875  77999999753  3356788999999999999999999998754 4468999999


Q ss_pred             ccCCchhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+++...+. .+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+.......  .
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~--~  172 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEASSTQ--D  172 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTSCEEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE--eCCCcEEEeeccccccccccc--c
Confidence            999999998876432 37999999999999999999999999999999999999  889999999999987654332  2


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+..   ......+|+.+.++|++
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~  249 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVYEVMKN  249 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHHHHHHH
T ss_pred             CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHHHHHHHH
Confidence            3357789999999998889999999999999999998 9999998877776666654422   22336789999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||++|||+
T Consensus       250 ~l~~~p~~Rps~  261 (278)
T 1byg_A          250 CWHLDAAMRPSF  261 (278)
T ss_dssp             HTCSSGGGSCCH
T ss_pred             HhcCChhhCCCH
Confidence            999999999984

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2e-48  Score=319.58  Aligned_cols=244  Identities=15%  Similarity=0.134  Sum_probs=185.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHc--CCCceeeEe-------EEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMREL--QHPRLIQIY-------DAFE   70 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~~   70 (251)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+..++.+  +|||+++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            358999999999999999999999999999999875432   3466777885555544  699977755       5554


Q ss_pred             eC-----------------CEEEEEEEeccCCchhHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHhhCCceecCC
Q psy11805         71 SS-----------------NVMCVVLELIEGGELFERVIDDDFVLTEKAV------AIFMRQICEGVEFIHSKNVLHLDM  127 (251)
Q Consensus        71 ~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~------~~i~~~l~~~l~~lh~~gi~h~dl  127 (251)
                      .+                 ...++||||++ ++|.+++...+..++...+      +.++.|++.||.|||++|++||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            33                 34899999998 6999999875444566666      788899999999999999999999


Q ss_pred             CCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy11805        128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNF--DAIGFGTDMWSVGVICYVLLSGLSPFMGE  205 (251)
Q Consensus       128 ~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~  205 (251)
                      ||+||++  +.++.++|+|||++......  .....+++.|+|||.+.+  ..++.++||||||+++|+|++|..||...
T Consensus       221 kp~NIll--~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          221 TPDNLFI--MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             SGGGEEE--CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CHHHEEE--CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999  89999999999999875432  224456799999999987  67899999999999999999999999876


Q ss_pred             ChHHHH--HH---HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        206 TDVQTM--AN---VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       206 ~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ......  ..   ..........+.+..+|+.+.+||.+||+.||++|||+
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  347 (371)
T 3q60_A          297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP  347 (371)
T ss_dssp             CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH
T ss_pred             CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence            432110  00   11111222333345789999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-47  Score=313.97  Aligned_cols=243  Identities=21%  Similarity=0.280  Sum_probs=196.4

Q ss_pred             cCCcccccccCCceEEEEEEEccCC---ceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEe-eCCEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATG---MTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFE-SSNVMCVV   78 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv   78 (251)
                      .|++.+.||+|+||.||+|.+..++   ..+++|.+.... ....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4778899999999999999986443   468888875432 335678999999999999999999999864 45678999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+++......++...++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++........
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCC-----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE--CCCCCEEEeecccccccccccc
Confidence            99999999999998777779999999999999999999999999999999999999  8899999999999976532221


Q ss_pred             -----ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        159 -----LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       159 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                           .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.....   ...+|..
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~~~~~~  324 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCPDP  324 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CTTCCHH
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHH
Confidence                 122346678999999999999999999999999999999 7888988776666665555443222   2568999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.++|.+||+.||++|||+
T Consensus       325 l~~li~~cl~~dp~~RPs~  343 (373)
T 3c1x_A          325 LYEVMLKCWHPKAEMRPSF  343 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            9999999999999999984

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=309.24  Aligned_cols=242  Identities=25%  Similarity=0.391  Sum_probs=200.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCE-----
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNV-----   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   74 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+..++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            478999999999999999999999999999999986432  2235778899999999999999999999977653     


Q ss_pred             -EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         75 -MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        75 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                       .+++||++++ +|.+.+.   ..+++..++.++.|++.||.+||++|++|+||+|+||++  +.++.++|+|||.+...
T Consensus       103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          103 DFYLVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV--NEDCELKILDFGLARHA  176 (353)
T ss_dssp             CCEEEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE--CTTCCEEECSTTCTTC-
T ss_pred             eEEEEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE--CCCCcEEEeecccccCC
Confidence             4999999975 7876653   248999999999999999999999999999999999999  88999999999999765


Q ss_pred             CCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC-----------
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF-----------  221 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  221 (251)
                      ...  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.......           
T Consensus       177 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          177 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             CCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            432  234468899999999876 678899999999999999999999999988776665543321110           


Q ss_pred             ----------------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 ----------------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                      ....+..++..+.+||.+||+.||++|||+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  300 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA  300 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH
Confidence                            011234678999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-47  Score=316.49  Aligned_cols=244  Identities=21%  Similarity=0.335  Sum_probs=195.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC--------CCceeeEeEEEe---
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ--------HPRLIQIYDAFE---   70 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~---   70 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999999999999999998632 334677889999999885        788999999987   


Q ss_pred             -eCCEEEEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCC-------
Q psy11805         71 -SSNVMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGN-------  140 (251)
Q Consensus        71 -~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~-------  140 (251)
                       +....++|||++.+ +|.+.+... ...+++..++.++.|++.||.|||++ |++||||||+||++  +.++       
T Consensus       115 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll--~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL--SVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE--CCCHHHHHHHH
T ss_pred             CCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE--eccchhhhhhh
Confidence             45679999999955 555655543 35699999999999999999999998 99999999999998  5554       


Q ss_pred             ------------------------------------------cEEEeecccccccCCCCcceeeccCcccccccccccCC
Q psy11805        141 ------------------------------------------RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDA  178 (251)
Q Consensus       141 ------------------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (251)
                                                                .++|+|||.+......  .....+++.|+|||.+.+..
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence                                                      7999999999775433  33456899999999999999


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhccccCCC-----------------------------
Q psy11805        179 IGFGTDMWSVGVICYVLLSGLSPFMGETD------VQTMANVTIAQYDFDD-----------------------------  223 (251)
Q Consensus       179 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~-----------------------------  223 (251)
                      ++.++||||||+++|+|++|..||...+.      ......+.......+.                             
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            99999999999999999999999986542      2222222111111000                             


Q ss_pred             ---------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ---------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               ......+..+.+||.+||+.||++|||+
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  386 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA  386 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH
Confidence                     0112334678899999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-46  Score=316.63  Aligned_cols=248  Identities=22%  Similarity=0.281  Sum_probs=205.9

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCC-CceeeEeEEEeeCCEEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH-PRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+|+.+++.++| +++..+..++...+..++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            3689999999999999999999999999999999875432  34568899999999976 66666767778888999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-cCCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |++ +++|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||+.. +.++.++|+|||++........
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            999 88999999876678999999999999999999999999999999999999822 3678899999999987654322


Q ss_pred             c--------eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccccCC-Cccc
Q psy11805        159 L--------QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD---VQTMANVTIAQYDFD-DECF  226 (251)
Q Consensus       159 ~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~-~~~~  226 (251)
                      .        ....+++.|+|||.+.+..++.++||||||++||+|++|..||.....   .+....+........ ....
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~  241 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC  241 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence            1        245689999999999999999999999999999999999999987543   333444433332222 2233


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+|.++.+||.+||+.+|++||++
T Consensus       242 ~~~p~~l~~li~~cl~~dP~~RPs~  266 (483)
T 3sv0_A          242 RGYPTEFASYFHYCRSLRFDDKPDY  266 (483)
T ss_dssp             TTSCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             cCCcHHHHHHHHHHhcCChhhCcCH
Confidence            5789999999999999999999984

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=301.60  Aligned_cols=236  Identities=24%  Similarity=0.416  Sum_probs=192.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||.||++.+.  ++.|++|.+..  ....+.+.+|+..+++++||||+++++++.+.  .++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcC
Confidence            68999999999999999999876  67899999753  34567889999999999999999999988743  78999999


Q ss_pred             cCCchhHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhh---CCceecCCCCCcEEEeecCCCc-EEEeecccccccCCC
Q psy11805         83 EGGELFERVIDDDF--VLTEKAVAIFMRQICEGVEFIHS---KNVLHLDMKPENILCLTKTGNR-IKIIDFGLARKFDPE  156 (251)
Q Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lh~---~gi~h~dl~~~nil~~~~~~~~-~~l~df~~~~~~~~~  156 (251)
                      ++++|.+.+.....  .++...++.++.|++.||.|||+   +|++|+||||+||++  +.++. ++|+|||++......
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll--~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE--ETTTTEEEECCCCC-------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE--eCCCCEEEEcccccccccccc
Confidence            99999998876542  37899999999999999999999   899999999999998  67775 799999999765432


Q ss_pred             CcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhccccCCCccccCCCHHHH
Q psy11805        157 KKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ--TMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                        .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......  .......+.   ..+....+|..+.
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~  234 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNLPKPIE  234 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTCCHHHH
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcccccCHHHH
Confidence              233458999999999999899999999999999999999999998654332  222222222   2233467899999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      ++|.+||+.||++|||+
T Consensus       235 ~li~~~l~~dp~~Rps~  251 (307)
T 2eva_A          235 SLMTRCWSKDPSQRPSM  251 (307)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHhcCChhhCcCH
Confidence            99999999999999984

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.5e-47  Score=305.47  Aligned_cols=247  Identities=18%  Similarity=0.250  Sum_probs=198.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+..++.++|+||+++++++.+.+..++|||
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  107 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP  107 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred             hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence            578999999999999999999754 5889999998654322 34478999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         81 LIEGGELFERVIDDD---FVLTEKAVAIFMRQICEGVEFIHSK---NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lh~~---gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      ++++++|.+.+....   ..+++..++.++.|++.||.+||+.   |++|+||+|+||++  +.++.++|+|||++....
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~  185 (326)
T 3uim_A          108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMD  185 (326)
T ss_dssp             CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE--CTTCCEEECCCSSCEECC
T ss_pred             eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE--CCCCCEEeccCccccccC
Confidence            999999999887643   3489999999999999999999999   99999999999999  889999999999998764


Q ss_pred             CCCc--ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcccc--------
Q psy11805        155 PEKK--LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE----TDVQTMANVTIAQYD--------  220 (251)
Q Consensus       155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~~--------  220 (251)
                      ....  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...    ...............        
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (326)
T 3uim_A          186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV  265 (326)
T ss_dssp             SSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred             cccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence            3322  23345899999999998888999999999999999999999999521    110011111111100        


Q ss_pred             ---CCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        221 ---FDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                         .........+..+.+++.+||+.||.+|||+
T Consensus       266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  299 (326)
T 3uim_A          266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM  299 (326)
T ss_dssp             CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH
Confidence               0011112234679999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=315.65  Aligned_cols=246  Identities=25%  Similarity=0.359  Sum_probs=183.1

Q ss_pred             ccCCc-ccccccCCceEEEEEEEc--cCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEEEE
Q psy11805          3 THQNQ-HSAFSFGKFGTVYRCKEK--ATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVMCV   77 (251)
Q Consensus         3 ~~y~~-~~~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l   77 (251)
                      +.|++ .++||+|+||.||+|.++  .+++.||+|++...  .....+.+|+.+++.++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            45776 558999999999999976  56789999998532  335678899999999999999999999954  678999


Q ss_pred             EEEeccCCchhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee--cCCCcEEEeec
Q psy11805         78 VLELIEGGELFERVIDD--------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT--KTGNRIKIIDF  147 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~--~~~~~~~l~df  147 (251)
                      ||||+++ +|.+.+...        ...+++..++.++.|++.||.|||+.|++|+||||+||++..  +.++.++|+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            9999976 777766532        124899999999999999999999999999999999999843  35678999999


Q ss_pred             ccccccCCC----CcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHH
Q psy11805        148 GLARKFDPE----KKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETD---------VQTMAN  213 (251)
Q Consensus       148 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~~~  213 (251)
                      |++......    .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+...         .+....
T Consensus       177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~  256 (405)
T 3rgf_A          177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  256 (405)
T ss_dssp             TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred             CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence            999876432    223445689999999999874 589999999999999999999999976544         233333


Q ss_pred             HHhccccCCCcccc----------------------------------CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFDDECFN----------------------------------EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~~~~~~----------------------------------~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +...........|.                                  ..+..+.+||++||+.||.+|||+
T Consensus       257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence            33222222211111                                  127789999999999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=326.10  Aligned_cols=240  Identities=23%  Similarity=0.417  Sum_probs=202.7

Q ss_pred             Cccc-ccccCCceEEEEEEEcc--CCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          6 NQHS-AFSFGKFGTVYRCKEKA--TGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         6 ~~~~-~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .+.. .||+|+||.||+|.++.  ++..||+|++.... ....+.+.+|++++++++|+||+++++++.. +..++|||+
T Consensus       338 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~  416 (613)
T 2ozo_A          338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM  416 (613)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             eEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEe
Confidence            3344 79999999999998863  45679999986543 3357889999999999999999999999976 458999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      +++++|.+++......+++..++.++.|++.||.|||++|++|+||||+||++  +.++.++|+|||++.........  
T Consensus       417 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL--VNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             CTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECCCSTTTTCC-------
T ss_pred             CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE--cCCCcEEEeeccCcccccCCCceee
Confidence            99999999988777779999999999999999999999999999999999999  88899999999999875433211  


Q ss_pred             --eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        160 --QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       160 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                        ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+...   .....+|+++.+|
T Consensus       495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~l  571 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECPPELYAL  571 (613)
T ss_dssp             -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCTTCCHHHHHH
T ss_pred             eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHHHHH
Confidence              22234578999999998899999999999999999998 99999999888888777665432   2335789999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |.+||+.+|++|||+
T Consensus       572 i~~cl~~dP~~RPs~  586 (613)
T 2ozo_A          572 MSDCWIYKWEDRPDF  586 (613)
T ss_dssp             HHHTTCSSTTTSCCH
T ss_pred             HHHHcCCChhHCcCH
Confidence            999999999999984

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.8e-47  Score=305.51  Aligned_cols=247  Identities=21%  Similarity=0.357  Sum_probs=179.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHH-HHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVE-IMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+. .++.++||||+++++++..++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            3689999999999999999999999999999999865432 23445556665 666678999999999999999999999


Q ss_pred             EeccCCchhHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         80 ELIEGGELFERVID----DDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        80 e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      |++++ +|.+.+..    ....+++..++.++.|++.||.+||+. |++|+||+|+||++  +.++.++|+|||++....
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll--~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL--DRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE--ETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE--cCCCCEEEccCCCceecc
Confidence            99986 77676653    245699999999999999999999999 99999999999999  889999999999998765


Q ss_pred             CCCcceeeccCccccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccc-cCCCccccC
Q psy11805        155 PEKKLQVLFGTPEFVAPEVV----NFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV-QTMANVTIAQY-DFDDECFNE  228 (251)
Q Consensus       155 ~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~~~~  228 (251)
                      .........+++.|+|||.+    .+..++.++||||||+++|+|++|..||...... +....+..+.. .........
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE  257 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred             cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence            54444455789999999998    4566889999999999999999999999875432 22222222111 122222346


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++..+.+||.+||+.||++|||+
T Consensus       258 ~~~~l~~li~~~l~~dp~~Rps~  280 (327)
T 3aln_A          258 FSPSFINFVNLCLTKDESKRPKY  280 (327)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHHhhCChhhCcCH
Confidence            89999999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-46  Score=306.73  Aligned_cols=246  Identities=21%  Similarity=0.355  Sum_probs=200.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCC-ceEEEEEeccccccchHHHHHHHHHHHHcCCCc------eeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATG-MTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR------LIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||+||+|.+..++ ..||+|++... ......+.+|+..++.++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            579999999999999999999998776 68999998532 334677888999999886544      8999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-----------------
Q psy11805         75 MCVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-----------------  136 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-----------------  136 (251)
                      .++|||++.+ ++.+.+.... ..+++..++.++.|++.||.+||++|++|+||||+||++..                 
T Consensus        97 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~  175 (355)
T 2eu9_A           97 MCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS  175 (355)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred             EEEEEeccCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence            9999999955 6666666543 46999999999999999999999999999999999999832                 


Q ss_pred             cCCCcEEEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q psy11805        137 KTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI  216 (251)
Q Consensus       137 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  216 (251)
                      +.++.++|+|||.+......  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..
T Consensus       176 ~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (355)
T 2eu9_A          176 VKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK  253 (355)
T ss_dssp             ESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            34678999999999764432  2345689999999999999999999999999999999999999998887766554433


Q ss_pred             ccccCCCcc----------------------------------------ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDFDDEC----------------------------------------FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~~~~~----------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....+...                                        ....+..+.+||++||+.||++|||+
T Consensus       254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            322211110                                        01124478899999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.5e-46  Score=302.64  Aligned_cols=237  Identities=25%  Similarity=0.431  Sum_probs=200.6

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc------chHHHHHHHHHHHHcC--CCceeeEeEEEeeC
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN------DRRNVEREVEIMRELQ--HPRLIQIYDAFESS   72 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~   72 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++......      ....+.+|+..+++++  |+|++++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            357899999999999999999999999999999998654322      2356778999999996  59999999999999


Q ss_pred             CEEEEEEEeccC-CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecccc
Q psy11805         73 NVMCVVLELIEG-GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLA  150 (251)
Q Consensus        73 ~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~  150 (251)
                      +..++++|++.+ ++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++  + .++.++|+|||++
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSG  197 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--ETTTTEEEECCCTTC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEE--eCCCCCEEEeeCccc
Confidence            999999999976 78988887654 69999999999999999999999999999999999998  6 6789999999999


Q ss_pred             cccCCCCcceeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCC
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (251)
                      ...... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.....      .......    ....+
T Consensus       198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~----~~~~~  266 (320)
T 3a99_A          198 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVF----FRQRV  266 (320)
T ss_dssp             EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCC----CSSCC
T ss_pred             cccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccccc----ccccC
Confidence            776533 2334568999999999977665 6789999999999999999999965421      2222222    22578


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++++.+||.+||+.||++|||+
T Consensus       267 ~~~~~~li~~~l~~dp~~Rps~  288 (320)
T 3a99_A          267 SSECQHLIRWCLALRPSDRPTF  288 (320)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CHHHHHHHHHHccCChhhCcCH
Confidence            9999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=306.66  Aligned_cols=236  Identities=17%  Similarity=0.204  Sum_probs=194.0

Q ss_pred             CccCCcccccccCCceEEEEE-----EEccCCceEEEEEeccccccchHHHHHHHHHHHHcC---CCceeeEeEEEeeCC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRC-----KEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ---HPRLIQIYDAFESSN   73 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~-----~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~   73 (251)
                      .++|++.+.||+|+||+||+|     .+..+++.||+|++...   ....+.+|++.++.++   |+|++++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            467999999999999999999     46778899999998543   4567788888888886   899999999999999


Q ss_pred             EEEEEEEeccCCchhHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC-----------
Q psy11805         74 VMCVVLELIEGGELFERVID----DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT-----------  138 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~-----------  138 (251)
                      ..++||||+++++|.+++..    ....+++..++.++.|++.||.|||+.||+||||||+||++  +.           
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll--~~~~~~~~~~~~~  218 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL--GNGFLEQDDEDDL  218 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE--CGGGTCC------
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEe--cccccCccccccc
Confidence            99999999999999999874    34569999999999999999999999999999999999999  66           


Q ss_pred             CCcEEEeecccccccC---CCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy11805        139 GNRIKIIDFGLARKFD---PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVT  215 (251)
Q Consensus       139 ~~~~~l~df~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  215 (251)
                      ++.++|+|||++....   ........++|+.|+|||.+.+..++.++||||||+++|+|++|+.||........     
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----  293 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----  293 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence            7899999999996543   23333445689999999999999999999999999999999999999965432110     


Q ss_pred             hccccCCCccccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        216 IAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                        ........ ...++.+.+++..||+.+|.+|++
T Consensus       294 --~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~  325 (365)
T 3e7e_A          294 --KPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLP  325 (365)
T ss_dssp             --EECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred             --eechhccc-cCcHHHHHHHHHHHcCCCCCCcch
Confidence              00000000 123667899999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1e-46  Score=322.56  Aligned_cols=242  Identities=22%  Similarity=0.359  Sum_probs=206.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.+.||+|+||.||++.+.. +..||+|++.... ...+.+.+|+.++++++|+||+++++++.+ +..++|||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            3578999999999999999999875 4579999986533 346789999999999999999999999876 668999999


Q ss_pred             ccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--c
Q psy11805         82 IEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--K  158 (251)
Q Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--~  158 (251)
                      +++++|.+++... +..+++..++.++.|++.||.|||++|++|+||+|+|||+  +.++.++|+|||++.......  .
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~~~~  420 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTA  420 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCTTSTTTCCCHHHHT
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE--cCCCcEEEcccccceecCCCceec
Confidence            9999999998753 3458999999999999999999999999999999999999  888999999999997654321  1


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      .....++..|+|||.+.+..++.++||||||++||+|++ |..||......+....+..+..   .+....++..+.+||
T Consensus       421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l~~li  497 (535)
T 2h8h_A          421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPESLHDLM  497 (535)
T ss_dssp             TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHHHHHH
T ss_pred             ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHH
Confidence            122235678999999998899999999999999999999 9999999988888777765432   222357899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.||++|||+
T Consensus       498 ~~cl~~dP~~RPt~  511 (535)
T 2h8h_A          498 CQCWRKEPEERPTF  511 (535)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHcCCChhHCcCH
Confidence            99999999999984

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=304.30  Aligned_cols=242  Identities=21%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|+||.||+|.+..   .+++|++....  ....+.+.+|+..+++++|+||+++++++.+.+..+++|
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            3689999999999999999998763   48899876433  234567888999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC----
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP----  155 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~----  155 (251)
                      |++++++|.+++...+..+++..++.++.|++.||.+||+.|++|+||+|+||++  + ++.++|+|||++.....    
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~--~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY--D-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE--C---CCEECCCSCCC--------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE--e-CCCEEEeecCCcccccccccc
Confidence            9999999999988776679999999999999999999999999999999999998  5 67999999999765421    


Q ss_pred             --CCcceeeccCccccccccccc---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        156 --EKKLQVLFGTPEFVAPEVVNF---------DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       156 --~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                        ........+++.|+|||.+.+         ..++.++||||||+++|+|++|..||......+....+..+..+... 
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  264 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS-  264 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC-
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC-
Confidence              122233458889999999864         34688999999999999999999999998887777766655433222 


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                       ...++..+.++|.+||+.||++|||+
T Consensus       265 -~~~~~~~l~~li~~~l~~~p~~Rpt~  290 (319)
T 2y4i_B          265 -QIGMGKEISDILLFCWAFEQEERPTF  290 (319)
T ss_dssp             -CSSCCTTHHHHHHHHHCSSTTTSCCH
T ss_pred             -cCCCCHHHHHHHHHHhcCChhhCcCH
Confidence             24678999999999999999999984

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.2e-46  Score=323.28  Aligned_cols=236  Identities=22%  Similarity=0.373  Sum_probs=199.6

Q ss_pred             cccccCCceEEEEEEEc--cCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEK--ATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      +.||+|+||.||+|.+.  .+++.||+|++.....  ...+.+.+|++++++++|+||+++++++..+ ..++|||++++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence            37999999999999664  4567899999864332  3467899999999999999999999999754 47899999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc----ce
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK----LQ  160 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~----~~  160 (251)
                      ++|.+++...+ .+++..++.++.|++.||.|||+.||+|+||||+||++  +.++.++|+|||++........    ..
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE--eCCCCEEEEEcCCccccccCcccccccc
Confidence            99999987654 69999999999999999999999999999999999999  8889999999999987643322    12


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..+...   .....+|+++.+||.+
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~~  607 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMNL  607 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHH
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHH
Confidence            2345678999999998899999999999999999998 99999999988888777665432   2235789999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||++|||+
T Consensus       608 cl~~dP~~RPs~  619 (635)
T 4fl3_A          608 CWTYDVENRPGF  619 (635)
T ss_dssp             HTCSSTTTSCCH
T ss_pred             HcCCCHhHCcCH
Confidence            999999999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.4e-46  Score=323.42  Aligned_cols=244  Identities=21%  Similarity=0.347  Sum_probs=206.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccC---CceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT---GMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|++.+.||+|+||.||+|.+..+   +..+++|.+.... ....+.+.+|+..+++++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            35789999999999999999998654   4578999875432 2345788999999999999999999999854 56899


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |||++++++|.+++...+..+++..++.++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++.......
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl--~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECCCCCCCSCCC--
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE--eCCCCEEEEecCCCeecCCCc
Confidence            999999999999998777679999999999999999999999999999999999999  888999999999998764332


Q ss_pred             c--ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        158 K--LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      .  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+..+...   +....+|+.+.
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~  622 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLY  622 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---CCCTTCCHHHH
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCccccHHHH
Confidence            2  123346679999999998899999999999999999997 99999998888877777655432   22357899999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      ++|.+||+.||++|||+
T Consensus       623 ~li~~~l~~dP~~RPs~  639 (656)
T 2j0j_A          623 SLMTKCWAYDPSRRPRF  639 (656)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHcCCChhHCcCH
Confidence            99999999999999984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2e-45  Score=295.21  Aligned_cols=242  Identities=21%  Similarity=0.374  Sum_probs=195.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcC--CCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQ--HPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+..+++++  |+||+++++++.+++..++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            468999999999999999999886 48899999986433  334678899999999997  5999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      +|| +.+++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++  + ++.++|+|||++.......
T Consensus       106 v~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--V-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--E-TTEEEECCCSSSCC-----
T ss_pred             EEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE--E-CCeEEEeeccccccccCcc
Confidence            999 55779999887654 68999999999999999999999999999999999998  4 4889999999997754332


Q ss_pred             c---ceeeccCccccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccccCC
Q psy11805        158 K---LQVLFGTPEFVAPEVVNF-----------DAIGFGTDMWSVGVICYVLLSGLSPFMGETD-VQTMANVTIAQYDFD  222 (251)
Q Consensus       158 ~---~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~  222 (251)
                      .   .....+++.|+|||.+.+           ..++.++||||||+++|+|++|..||..... .............. 
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-  259 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-  259 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc-
Confidence            2   234468999999999865           4678899999999999999999999987643 33333333332222 


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                       ......+..+.++|.+||+.||++|||+
T Consensus       260 -~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (313)
T 3cek_A          260 -EFPDIPEKDLQDVLKCCLKRDPKQRISI  287 (313)
T ss_dssp             -CCCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             -CCcccchHHHHHHHHHHccCCcccCcCH
Confidence             2224568899999999999999999985

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.4e-46  Score=296.86  Aligned_cols=242  Identities=21%  Similarity=0.349  Sum_probs=195.2

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccc----ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK----RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      |...+.||+|+||.||+|.+  +++.+++|.+....    ....+.+.+|+..+++++||||+++++++.+.+..+++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            45569999999999999976  47899999985422    2346789999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         81 LIEGGELFERVIDD--DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      ++++++|.+.+...  ...+++..++.++.|++.||.+||+.|++|+||+|+||++  +.++.++|+|||.+........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL--DEAFTAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEEECCCTTCEECCSCSS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE--cCCCcEEEeecccccccccccc
Confidence            99999999988642  3458999999999999999999999999999999999999  8899999999999976543322


Q ss_pred             ---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhccc-------cCCCc
Q psy11805        159 ---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA----NVTIAQY-------DFDDE  224 (251)
Q Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~-------~~~~~  224 (251)
                         .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+...    .+.....       .....
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence               123468899999999875 47889999999999999999999998754432221    1111110       00111


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....+..+.+++.+||+.+|.+|||+
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~  294 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDI  294 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCH
Confidence            123345679999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=299.82  Aligned_cols=237  Identities=25%  Similarity=0.429  Sum_probs=192.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc------cchHHHHHHHHHHHHc----CCCceeeEeEEEe
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR------NDRRNVEREVEIMREL----QHPRLIQIYDAFE   70 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~e~~~l~~l----~~~~i~~~~~~~~   70 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.|++|++.....      .....+.+|+..++++    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            35789999999999999999999999999999999864432      2344566789999998    8999999999999


Q ss_pred             eCCEEEEEEEe-ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecc
Q psy11805         71 SSNVMCVVLEL-IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFG  148 (251)
Q Consensus        71 ~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~  148 (251)
                      ..+..++++|+ +.+++|.+.+...+ .+++..++.++.|++.||.+||+.|++|+||+|+||++  + .++.++|+|||
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~~kl~dfg  185 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFG  185 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEE--ETTTTEEEECCCS
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEE--eCCCCeEEEEEcc
Confidence            98999999999 78889999887654 69999999999999999999999999999999999998  6 78899999999


Q ss_pred             cccccCCCCcceeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCcccc
Q psy11805        149 LARKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN  227 (251)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (251)
                      .+....... .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....      +......    ...
T Consensus       186 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~----~~~  254 (312)
T 2iwi_A          186 SGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELH----FPA  254 (312)
T ss_dssp             SCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCCC----CCT
T ss_pred             hhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------HhhhccC----Ccc
Confidence            997765432 344568899999999876665 4589999999999999999999965321      2222222    225


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .++..+.++|.+||+.||++|||+
T Consensus       255 ~~~~~~~~li~~~l~~~p~~Rps~  278 (312)
T 2iwi_A          255 HVSPDCCALIRRCLAPKPSSRPSL  278 (312)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCH
Confidence            689999999999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=297.35  Aligned_cols=241  Identities=20%  Similarity=0.287  Sum_probs=188.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc--CCCceeeEeEEEeeC----CEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL--QHPRLIQIYDAFESS----NVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~----~~~   75 (251)
                      .++|++.+.||+|+||.||+|.++  ++.||+|++...   ......+|.+++...  +|+||+++++++...    ...
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            468999999999999999999876  789999998432   234445555555544  899999999999877    789


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CceecCCCCCcEEEeecCCCcEEEeec
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK--------NVLHLDMKPENILCLTKTGNRIKIIDF  147 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--------gi~h~dl~~~nil~~~~~~~~~~l~df  147 (251)
                      ++||||+++++|.+++...  .+++..++.++.|++.||.|||+.        |++|+||||+||++  +.++.++|+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill--~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--KKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE--CTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE--CCCCCEEEEeC
Confidence            9999999999999998765  499999999999999999999999        99999999999999  88999999999


Q ss_pred             ccccccCCCCcc-----eeeccCcccccccccccCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCC
Q psy11805        148 GLARKFDPEKKL-----QVLFGTPEFVAPEVVNFDAIGFG------TDMWSVGVICYVLLSG----------LSPFMGET  206 (251)
Q Consensus       148 ~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~------~Di~slG~~l~~l~~g----------~~pf~~~~  206 (251)
                      |++.........     ....+++.|+|||.+.+...+..      +||||||+++|+|++|          ..||....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            999765433222     23468999999999987766554      9999999999999999          77775432


Q ss_pred             ----hHH-HHHHHHhccccCCCcc---ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        207 ----DVQ-TMANVTIAQYDFDDEC---FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       207 ----~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                          ... ..............+.   ...+++.+.++|.+||+.||++|||+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  319 (337)
T 3mdy_A          267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA  319 (337)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence                112 2222222222211111   12456789999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-45  Score=299.38  Aligned_cols=241  Identities=21%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHH--cCCCceeeEeEEEeeCC----EE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRE--LQHPRLIQIYDAFESSN----VM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~----~~   75 (251)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++..   .....+.+|+++++.  ++||||+++++++...+    ..
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            368999999999999999999884  88999999853   235677888898888  68999999999998765    79


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCceecCCCCCcEEEeecCCCcEEEeec
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH--------SKNVLHLDMKPENILCLTKTGNRIKIIDF  147 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh--------~~gi~h~dl~~~nil~~~~~~~~~~l~df  147 (251)
                      ++|||++++++|.+++...  .+++..++.++.|++.||.+||        +.|++|+||||+||++  +.++.++|+||
T Consensus       116 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll--~~~~~~kL~Df  191 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADL  191 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE--CTTSCEEECCC
T ss_pred             EEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE--CCCCCEEEEEC
Confidence            9999999999999998764  4999999999999999999999        8999999999999999  88999999999


Q ss_pred             ccccccCCCCc-----ceeeccCcccccccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q psy11805        148 GLARKFDPEKK-----LQVLFGTPEFVAPEVVNFD------AIGFGTDMWSVGVICYVLLSG----------LSPFMGET  206 (251)
Q Consensus       148 ~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~pf~~~~  206 (251)
                      |++........     .....+++.|+|||.+.+.      .++.++||||||+++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99977654432     2334688999999999765      234689999999999999999          78887642


Q ss_pred             -----hHHHHHHHHhccccCCCc-c--ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        207 -----DVQTMANVTIAQYDFDDE-C--FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       207 -----~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                           .......+.........+ .  ....++.+.++|.+||+.||++|||+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  324 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  324 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH
Confidence                 223333333322222211 1  11345679999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.9e-46  Score=305.55  Aligned_cols=246  Identities=21%  Similarity=0.366  Sum_probs=195.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-----------CCceeeEeEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-----------HPRLIQIYDAFE   70 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~   70 (251)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.. .......+.+|+..++++.           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            4689999999999999999999999999999999863 2334677889999998875           789999999987


Q ss_pred             eCC----EEEEEEEeccCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeec----CCC
Q psy11805         71 SSN----VMCVVLELIEGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTK----TGN  140 (251)
Q Consensus        71 ~~~----~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~----~~~  140 (251)
                      ..+    ..+++||++ +++|.+.+... ...++...++.++.|++.||.+||++ |++|+||||+||++..+    ..+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            654    789999999 77998988763 34599999999999999999999998 99999999999998332    233


Q ss_pred             cEEEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHH
Q psy11805        141 RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETD------VQTMANV  214 (251)
Q Consensus       141 ~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~  214 (251)
                      .++|+|||++......  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.      .+....+
T Consensus       176 ~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  253 (373)
T 1q8y_A          176 QIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  253 (373)
T ss_dssp             EEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence            7999999999775432  2344689999999999999999999999999999999999999986542      2222222


Q ss_pred             HhccccCCC--------------------------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        215 TIAQYDFDD--------------------------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       215 ~~~~~~~~~--------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .......+.                                      ......+.++.+||++||+.||++|||+
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            211111000                                      0112346788999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.7e-46  Score=320.91  Aligned_cols=247  Identities=21%  Similarity=0.393  Sum_probs=199.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEee------CCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFES------SNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   75 (251)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999999999999999998643 23346778999999999999999999998755      6678


Q ss_pred             EEEEEeccCCchhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC---cEEEeecccc
Q psy11805         76 CVVLELIEGGELFERVIDDD--FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN---RIKIIDFGLA  150 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~---~~~l~df~~~  150 (251)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||.|||+.|++|+||+|+||++  +.++   .++|+|||.+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl--~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL--QPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEE--ECCSSSCEEEECSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEe--ecCCCceeEEEcccccc
Confidence            99999999999999887643  258999999999999999999999999999999999998  5444   4899999999


Q ss_pred             cccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------------Hh
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV--------------TI  216 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--------------~~  216 (251)
                      .............+++.|+|||.+.+..++.++||||||+++|+|++|..||............              ..
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            8876665556667899999999999999999999999999999999999999775443221100              00


Q ss_pred             ccc------cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQY------DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..      +.+......+++.+.++|.+||+.||++|||+
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa  292 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD  292 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH
Confidence            000      11112233467889999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=298.88  Aligned_cols=240  Identities=18%  Similarity=0.265  Sum_probs=182.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHH--HHHcCCCceeeEeEEEee-----CCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEI--MRELQHPRLIQIYDAFES-----SNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~-----~~~~   75 (251)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++....   ......|..+  +..++|+||+++++.+..     ....
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            6899999999999999999976  47899999985432   3334444444  445789999999986532     3367


Q ss_pred             EEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CceecCCCCCcEEEeecCCCcEEEee
Q psy11805         76 CVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK---------NVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~---------gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                      ++||||+++++|.+++....  .++..++.++.|++.||.|||+.         |++|+||||+||++  +.++.++|+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill--~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV--KNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE--CTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE--cCCCcEEEee
Confidence            89999999999999987655  69999999999999999999999         99999999999999  8889999999


Q ss_pred             cccccccCCCC---------cceeeccCccccccccccc-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---
Q psy11805        147 FGLARKFDPEK---------KLQVLFGTPEFVAPEVVNF-------DAIGFGTDMWSVGVICYVLLSGLSPFMGETD---  207 (251)
Q Consensus       147 f~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---  207 (251)
                      ||++.......         ......+++.|+|||.+.+       ..++.++||||||+++|+|++|..||.....   
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            99997754321         1123458999999999976       4566789999999999999999777643211   


Q ss_pred             --------------HHHHHHHH-hccccCCCc-c---ccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        208 --------------VQTMANVT-IAQYDFDDE-C---FNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       208 --------------~~~~~~~~-~~~~~~~~~-~---~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                    .+...... ........+ .   ....++.+.+||.+||+.||++|||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA  306 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch
Confidence                          11111111 111111110 0   11244579999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=303.53  Aligned_cols=243  Identities=24%  Similarity=0.349  Sum_probs=187.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .+|++.+.||+|+||+|+. ....+++.||+|++....   .....+|+.+++.+ +||||+++++++.+.+..++|||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            4689999999999999764 445678999999985432   23467899999999 799999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee---cCCCcEEEeecccccccCCCC-
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT---KTGNRIKIIDFGLARKFDPEK-  157 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~---~~~~~~~l~df~~~~~~~~~~-  157 (251)
                      +++ +|.+.+.......+...++.++.|++.||.|||+.|++||||||+||++..   +....++|+|||++....... 
T Consensus       100 ~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          100 CAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             CSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             CCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            975 999998877666777778899999999999999999999999999999832   122358899999998764332 


Q ss_pred             ---cceeeccCcccccccccc---cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCC
Q psy11805        158 ---KLQVLFGTPEFVAPEVVN---FDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEIS  230 (251)
Q Consensus       158 ---~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (251)
                         ......+|+.|+|||.+.   +..++.++||||||+++|+|++ |..||.................... ......+
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  257 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL-HPEKHED  257 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS-CTTCHHH
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc-Ccccccc
Confidence               223456899999999997   4567789999999999999999 9999976554443332221111111 1112345


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+.+||.+||+.||.+|||+
T Consensus       258 ~~~~~li~~~L~~dP~~Rps~  278 (432)
T 3p23_A          258 VIARELIEKMIAMDPQKRPSA  278 (432)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHHHHhCCHhhCCCH
Confidence            568999999999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.7e-44  Score=286.91  Aligned_cols=222  Identities=31%  Similarity=0.568  Sum_probs=181.6

Q ss_pred             CccCCcc-cccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHH-HHcCCCceeeEeEEEee----CCEE
Q psy11805          2 TTHQNQH-SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIM-RELQHPRLIQIYDAFES----SNVM   75 (251)
Q Consensus         2 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~~   75 (251)
                      -++|.+. +.||+|+||.||+|.+..+++.||+|++..     .....+|+..+ +..+||||+++++++..    .+..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3577777 789999999999999999999999999742     35677888887 55689999999999977    6779


Q ss_pred             EEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecC---CCcEEEeeccccc
Q psy11805         76 CVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKT---GNRIKIIDFGLAR  151 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~---~~~~~l~df~~~~  151 (251)
                      ++|||++++++|.+.+...+ ..+++..++.++.|++.||.|||+.|++|+||+|+||++  +.   ++.++|+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY--TSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--SSSSTTCCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--ecCCCCCcEEEecccccc
Confidence            99999999999999988754 369999999999999999999999999999999999998  55   7889999999985


Q ss_pred             ccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhccccCCCcccc
Q psy11805        152 KFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMAN----VTIAQYDFDDECFN  227 (251)
Q Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~  227 (251)
                      ...                     +..++.++||||||+++|+|++|..||......+....    +.......+.+.+.
T Consensus       169 ~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (299)
T 3m2w_A          169 ETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS  227 (299)
T ss_dssp             ECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHT
T ss_pred             ccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcc
Confidence            432                     24567899999999999999999999987655443221    12222233333346


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        228 EISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       228 ~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+++++.+||.+||+.||.+|||+
T Consensus       228 ~~~~~~~~li~~~l~~dP~~Rps~  251 (299)
T 3m2w_A          228 EVSEEVKMLIRNLLKTEPTQRMTI  251 (299)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cCCHHHHHHHHHHcccChhhCCCH
Confidence            789999999999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-44  Score=287.33  Aligned_cols=219  Identities=13%  Similarity=0.051  Sum_probs=181.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc---chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++......   ..+.+.+|+..+++++|+||+++++++.+++..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            357899999999999999999999999999999998654332   34788999999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      ||||++|++|.+++...   .+...+..++.|++.||.|||++|++|+||||+||++  +.++.++|++++         
T Consensus       109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll--~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV--SIDGDVVLAYPA---------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--ETTSCEEECSCC---------
T ss_pred             EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE--cCCCCEEEEecc---------
Confidence            99999999999988432   4666789999999999999999999999999999999  888999987432         


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhccccCCCccccCCCHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA---NVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                                |++       +++.++||||||+++|+|++|+.||...+..+...   ................+|+++.
T Consensus       175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                      333       36889999999999999999999998765433110   1111111212223457899999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      ++|.+||+.||++| |+
T Consensus       238 ~li~~~l~~dP~~R-s~  253 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SA  253 (286)
T ss_dssp             HHHHHHHCTTSSCC-CH
T ss_pred             HHHHHHcccCCccC-CH
Confidence            99999999999999 74

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.7e-44  Score=300.53  Aligned_cols=244  Identities=27%  Similarity=0.406  Sum_probs=186.6

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      +++.|.+.+.||+|+||+||.+ ...+++.||+|++...   ....+.+|+..++.+ +||||+++++++.+++..++||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            3567778899999999999875 4557899999997542   345678999999876 8999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-----------CCCcE
Q psy11805         80 ELIEGGELFERVIDDDFV------LTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-----------TGNRI  142 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~------~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-----------~~~~~  142 (251)
                      |++++ +|.+++......      .++..++.++.|++.||.|||+.|++|+||||+||++..+           .++.+
T Consensus        89 E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            99965 999988764321      1233457899999999999999999999999999998321           34589


Q ss_pred             EEeecccccccCCCCc-----ceeeccCccccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q psy11805        143 KIIDFGLARKFDPEKK-----LQVLFGTPEFVAPEVVNF-------DAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQ  209 (251)
Q Consensus       143 ~l~df~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  209 (251)
                      +|+|||++........     .....+++.|+|||.+.+       ..++.++||||||+++|+|++ |..||......+
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            9999999987654322     223468999999999965       568899999999999999999 999997765444


Q ss_pred             HHHHHHhccccCCCc---cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        210 TMANVTIAQYDFDDE---CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       210 ~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                        ..+..+.......   ....++.++.+||.+||+.||.+|||+
T Consensus       248 --~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  290 (434)
T 2rio_A          248 --SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA  290 (434)
T ss_dssp             --HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             --HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH
Confidence              2233333222211   112356789999999999999999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-44  Score=314.34  Aligned_cols=230  Identities=22%  Similarity=0.352  Sum_probs=188.8

Q ss_pred             CccCCcccccccCCceEEEEEEEcc-CCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCE-----
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA-TGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNV-----   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   74 (251)
                      .++|++.+.||+|+||+||+|.+.. +++.|++|++.... ......+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4789999999999999999999976 68999999875433 2345678899999999999999999999987654     


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .|+||||++|++|.+.+..   .+++..++.++.|++.||.|||++||+|+||||+||++  +. +.++|+|||++....
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll--~~-~~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML--TE-EQLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CS-SCEEECCCTTCEETT
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE--eC-CcEEEEecccchhcc
Confidence            7999999999999886643   59999999999999999999999999999999999998  54 489999999998765


Q ss_pred             CCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        155 PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                      ..   ....+|+.|+|||.+.+.. +.++||||||+++++|++|..||......         ..+ ........++.+.
T Consensus       233 ~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~-~~~~~~~~~~~l~  298 (681)
T 2pzi_A          233 SF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP-EDDPVLKTYDSYG  298 (681)
T ss_dssp             CC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC-TTCHHHHHCHHHH
T ss_pred             cC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------ccc-ccccccccCHHHH
Confidence            43   3456899999999987654 88999999999999999999888653111         000 0111123467899


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      ++|.+||+.||.+||+.
T Consensus       299 ~li~~~l~~dP~~R~~~  315 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTT  315 (681)
T ss_dssp             HHHHHHTCSSGGGSCSS
T ss_pred             HHHhhhccCChhhCCCH
Confidence            99999999999999973

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4e-44  Score=297.70  Aligned_cols=234  Identities=14%  Similarity=0.163  Sum_probs=182.0

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCC-Cc---------ee-------
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQH-PR---------LI-------   63 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~-~~---------i~-------   63 (251)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+..++.++| .+         ++       
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            47788999999999999999999999999999863332   236788999999998876 21         11       


Q ss_pred             -----eEeEEEee-----CCEEEEEEEeccCCchhHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCC
Q psy11805         64 -----QIYDAFES-----SNVMCVVLELIEGGELFERVI------DDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM  127 (251)
Q Consensus        64 -----~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl  127 (251)
                           .+..++..     ....+++|+.+ +++|.+++.      ..+..+++..++.++.|++.||.|||+.||+||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                 11111111     12357777766 458888774      22445888999999999999999999999999999


Q ss_pred             CCCcEEEeecCCCcEEEeecccccccCCCCcceeeccCccccccccc----------ccCCCCcchhHHHHHHHHHHHHh
Q psy11805        128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV----------NFDAIGFGTDMWSVGVICYVLLS  197 (251)
Q Consensus       128 ~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Di~slG~~l~~l~~  197 (251)
                      ||+|||+  +.++.++|+|||++......  ....++ +.|+|||.+          .+..++.++||||||+++|+|++
T Consensus       238 Kp~NILl--~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          238 RPVDIVL--DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CGGGEEE--CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             ccceEEE--ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            9999999  89999999999998765433  334456 999999999          55568889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        198 GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       198 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      |+.||...+..+....+        ......+|+.+.+||.+||+.||++||++
T Consensus       313 g~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             SSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCH
Confidence            99999876543332221        11224689999999999999999999984

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.6e-44  Score=288.72  Aligned_cols=231  Identities=16%  Similarity=0.214  Sum_probs=182.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--------ccchHHHHHHHHHHHHcC---------CCceeeE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--------RNDRRNVEREVEIMRELQ---------HPRLIQI   65 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--------~~~~~~~~~e~~~l~~l~---------~~~i~~~   65 (251)
                      ++|++.+.||+|+||+||+|.+  +++.||+|++....        ....+.+.+|+.+++.++         |+||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            6799999999999999999988  57899999986542        223478899999998885         7777777


Q ss_pred             eEEEe------------------------------eCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q psy11805         66 YDAFE------------------------------SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVE  115 (251)
Q Consensus        66 ~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~  115 (251)
                      .+++.                              +.+..++||||++++++.+.+..  ..+++..++.++.|++.||.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            77642                              26789999999999977777654  45899999999999999999


Q ss_pred             HHh-hCCceecCCCCCcEEEeecCCC--------------------cEEEeecccccccCCCCcceeeccCccccccccc
Q psy11805        116 FIH-SKNVLHLDMKPENILCLTKTGN--------------------RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV  174 (251)
Q Consensus       116 ~lh-~~gi~h~dl~~~nil~~~~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~  174 (251)
                      ||| +.||+||||||+|||+  +.++                    .++|+|||++......    ...+|+.|+|||++
T Consensus       176 ~lH~~~~ivHrDlKp~NILl--~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLL--KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEE--EECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred             HHHHhCCEeECCCCHHHEEE--eccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence            999 9999999999999999  5554                    8999999999876532    44789999999999


Q ss_pred             ccCCCCcchhHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHh---ccccCCCccccCCCHHHHHHHHHhcccC
Q psy11805        175 NFDAIGFGTDMWSVGVI-CYVLLSGLSPFMGETDVQ-TMANVTI---AQYDFDDECFNEISDDAKDFIRKLLLKD  244 (251)
Q Consensus       175 ~~~~~~~~~Di~slG~~-l~~l~~g~~pf~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~  244 (251)
                      .+.. +.++||||||.+ .+++++|..||....... ....+..   .........+..+++++++||++||+.|
T Consensus       250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred             cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence            8776 899999998777 667888999984421111 1222221   1112222334568899999999999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.2e-35  Score=250.57  Aligned_cols=182  Identities=13%  Similarity=0.125  Sum_probs=131.6

Q ss_pred             cccCCceEEEEEEEccCCceEEEEEecccc----------ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEEE
Q psy11805         11 FSFGKFGTVYRCKEKATGMTLAAKFVGIAK----------RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus        11 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~----------~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ...|+.|....++....+..+++|++....          ....+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            456666777777777789999999985321          22356799999999999 6999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~  158 (251)
                      ||++|++|.+.+...+ +++..   .|+.||+.||.|+|++||+||||||+|||+  +.+|++||+|||+++..... ..
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL--~~dg~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV--DARQHARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE--CTTSCEEECCCTTEESCC---CC
T ss_pred             ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE--CCCCCEEEeecccCeeCCCCCcc
Confidence            9999999999997654 57664   478999999999999999999999999999  89999999999999775433 33


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCC
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGL  199 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  199 (251)
                      ....+||+.|+|||++.+. ...++|+||+|++++++.++.
T Consensus       396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             SHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             ccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence            4556799999999999764 567899999999987765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.3e-29  Score=216.46  Aligned_cols=181  Identities=15%  Similarity=0.123  Sum_probs=140.0

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEeccccc--------cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--------NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ..+.||+|+||.||++..  .+..+++|.......        ...+.+.+|++++++++||||+++..+....+..++|
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            356899999999999943  467888887533211        1245589999999999999999655555566677999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+++..         +..++.|++.||.|||++|++|+||||+||++  +.  +++|+|||++........
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl--~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF--DK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE--SS--SEEECCCTTCEECCCHHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE--CC--eEEEEECccCEECCCccc
Confidence            999999999888765         56899999999999999999999999999998  55  999999999988755322


Q ss_pred             c--------eeeccCccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11805        159 L--------QVLFGTPEFVAPEVVNF--DAIGFGTDMWSVGVICYVLLSGLSPF  202 (251)
Q Consensus       159 ~--------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf  202 (251)
                      .        ....+|+.|+|||++..  ..|+...|+||..+-..+-+.++-+|
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1        24578999999999976  55777889999988888877665554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=4.8e-27  Score=185.19  Aligned_cols=144  Identities=22%  Similarity=0.258  Sum_probs=115.2

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc------------------cchHHHHHHHHHHHHcCCCceeeE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR------------------NDRRNVEREVEIMRELQHPRLIQI   65 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------------------~~~~~~~~e~~~l~~l~~~~i~~~   65 (251)
                      .|++.+.||+|++|.||+|.+ .+++.||+|++.....                  .....+.+|+.++++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            355669999999999999999 7899999999864321                  12466889999999998  4 666


Q ss_pred             eEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEe
Q psy11805         66 YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKII  145 (251)
Q Consensus        66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~  145 (251)
                      .+++.. +..++||||++|++|.+ +..       .....++.|++.||.+||+.|++|+||||+||++  + ++.++|+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl--~-~~~vkl~  234 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV--S-EEGIWII  234 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE--E-TTEEEEC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE--E-CCcEEEE
Confidence            665544 44699999999999977 421       2345699999999999999999999999999998  6 8999999


Q ss_pred             ecccccccCCCCcceeeccCcccccccccc
Q psy11805        146 DFGLARKFDPEKKLQVLFGTPEFVAPEVVN  175 (251)
Q Consensus       146 df~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (251)
                      |||++...            ..+.|||.+.
T Consensus       235 DFG~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             CCTTCEET------------TSTTHHHHHH
T ss_pred             ECCCCeEC------------CCCCHHHHHH
Confidence            99999642            3467788763

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=1.7e-23  Score=163.00  Aligned_cols=137  Identities=21%  Similarity=0.248  Sum_probs=106.2

Q ss_pred             CCcccccccCCceEEEEEEEccCCce--EEEEEecccccc------------------------chHHHHHHHHHHHHcC
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMT--LAAKFVGIAKRN------------------------DRRNVEREVEIMRELQ   58 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~--~~~K~~~~~~~~------------------------~~~~~~~e~~~l~~l~   58 (251)
                      |++.+.||+|+||.||+|.+..+++.  ||+|++......                        ....+.+|+..++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999999778888  999987543211                        1136789999999998


Q ss_pred             CCce--eeEeEEEeeCCEEEEEEEeccC-C----chhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh-hCCceecCCCCC
Q psy11805         59 HPRL--IQIYDAFESSNVMCVVLELIEG-G----ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH-SKNVLHLDMKPE  130 (251)
Q Consensus        59 ~~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh-~~gi~h~dl~~~  130 (251)
                      |+++  +.+++.    +..++||||+.+ +    +|.+....    .++..+..++.|++.+|.+|| +.|++|+||||+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            7754  444432    246899999942 2    56554322    345577889999999999999 999999999999


Q ss_pred             cEEEeecCCCcEEEeeccccccc
Q psy11805        131 NILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus       131 nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      |||+  +.  .++|+|||++...
T Consensus       201 NILl--~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMY--ID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEE--SS--SEEECCCTTCEET
T ss_pred             HEEE--cC--cEEEEECcccccC
Confidence            9998  55  8999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=1.2e-19  Score=147.15  Aligned_cols=141  Identities=15%  Similarity=0.131  Sum_probs=99.5

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEecccccc--------------ch--------HHHHHHHHHHHHcCCCce
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN--------------DR--------RNVEREVEIMRELQHPRL   62 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--------------~~--------~~~~~e~~~l~~l~~~~i   62 (251)
                      |++..+||.|++|.||+|.+. +|+.||+|+++.....              ..        ....+|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            889999999999999999875 6899999997532110              00        112356667777754444


Q ss_pred             eeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC--
Q psy11805         63 IQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN--  140 (251)
Q Consensus        63 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~--  140 (251)
                      ....-+....  .++|||+++|.+|.+...       .+.+..++.|++.+|.+||+.|++||||||.|||+.++.++  
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            2222222222  379999999988755321       12345678999999999999999999999999999443322  


Q ss_pred             ------cEEEeecccccccCC
Q psy11805        141 ------RIKIIDFGLARKFDP  155 (251)
Q Consensus       141 ------~~~l~df~~~~~~~~  155 (251)
                            .+.++||+.+...+.
T Consensus       247 ~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             TTSEEEEEEECCCTTCEETTS
T ss_pred             ccccccceEEEEeCCcccCCC
Confidence                  489999998866543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.60  E-value=1e-14  Score=113.62  Aligned_cols=140  Identities=18%  Similarity=0.160  Sum_probs=110.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +.|++...++.|+.+.||++...  +..+++|+...........+.+|+..++.+. +..+++++++..+.+..++|||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            46888888999999999999644  5789999976432234567999999999985 67788999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh------------------------------------------
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS------------------------------------------  119 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~------------------------------------------  119 (251)
                      ++|.+|.+...      +......++.++..+|..||+                                          
T Consensus        92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            99998866531      122234677889999999998                                          


Q ss_pred             -----------------CCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        120 -----------------KNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       120 -----------------~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                                       .+++|+|++|.||++  +.++.+.++||+.+..
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE--ETTEEEEECCCTTCEE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEE--ECCcEEEEEEchhccc
Confidence                             458999999999998  5544556999988743

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.42  E-value=2.3e-12  Score=99.97  Aligned_cols=133  Identities=17%  Similarity=0.115  Sum_probs=97.1

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc--eeeEeEEEeeCCEEEEEEEec
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR--LIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      |.+....+.|..+.||++.. .++..+++|+....   ....+.+|+..++.+.+.+  +++++++....+..++|||++
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44444444666799999954 45678999996432   3456889999999885434  567888888878899999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-----------------------------------------  121 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~g-----------------------------------------  121 (251)
                      +|.++.  ..    ..+.   ..++.++...|..||+..                                         
T Consensus        98 ~G~~l~--~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998873  21    1222   245677778888888643                                         


Q ss_pred             -----------------ceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        122 -----------------VLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       122 -----------------i~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                                       ++|+|++|.||++  +.++.+.|+||+.+..
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMV--ENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEE--ECCcEEEEEcchhccc
Confidence                             9999999999998  5555566999998844

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.33  E-value=9.2e-12  Score=101.23  Aligned_cols=140  Identities=15%  Similarity=0.271  Sum_probs=104.4

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEec--ccc-ccchHHHHHHHHHHHHcC--CCceeeEeEEEeeC---CEEEEE
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVG--IAK-RNDRRNVEREVEIMRELQ--HPRLIQIYDAFESS---NVMCVV   78 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~--~~~-~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~---~~~~lv   78 (251)
                      ..+.++.|.++.+|++...  +..+++|+..  ... ......+.+|+.+++.+.  ...+++++.++.+.   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4567899999999998754  4578888864  222 123567889999999997  44578888888766   458899


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS---------------------------------------  119 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~---------------------------------------  119 (251)
                      ||+++|.++.+..   ...++......++.++..+|..||+                                       
T Consensus       120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999997774421   1236788888999999999999997                                       


Q ss_pred             -------------------CCceecCCCCCcEEEeecCCC--cEEEeeccccccc
Q psy11805        120 -------------------KNVLHLDMKPENILCLTKTGN--RIKIIDFGLARKF  153 (251)
Q Consensus       120 -------------------~gi~h~dl~~~nil~~~~~~~--~~~l~df~~~~~~  153 (251)
                                         .+++|||+++.||++  +.++  .+.++||+.+...
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~--~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMF--HPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEE--CSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEE--eCCCCcEEEEECccccccC
Confidence                               368999999999998  5443  3689999988654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.31  E-value=5.6e-12  Score=100.16  Aligned_cols=181  Identities=20%  Similarity=0.253  Sum_probs=121.4

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCc--eeeEeEEEeeCC---EEEEEEEe
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPR--LIQIYDAFESSN---VMCVVLEL   81 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv~e~   81 (251)
                      .+.++.|..+.||++.     ..+++|+...  ......+.+|+..++.+. +..  +++++......+   ..|+||++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568899999999873     4688888542  234678899999998884 332  455555543333   35889999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh------------------------------------------
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS------------------------------------------  119 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~------------------------------------------  119 (251)
                      ++|.++......   .++.++...++.++...+..||+                                          
T Consensus        98 i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           98 IKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             cCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999888654332   36777888888888888888885                                          


Q ss_pred             ----------------CCceecCCCCCcEEEeecC--CCcEEEeecccccccCCCCcceeeccC-----c--------cc
Q psy11805        120 ----------------KNVLHLDMKPENILCLTKT--GNRIKIIDFGLARKFDPEKKLQVLFGT-----P--------EF  168 (251)
Q Consensus       120 ----------------~gi~h~dl~~~nil~~~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~-----~--------~y  168 (251)
                                      ..++|+|++|.||++  +.  .+.+.++||+.+...+...........     +        .|
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~--~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILF--DTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEE--ETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEE--eCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                            136999999999998  54  456789999988664432111110000     0        11


Q ss_pred             --cc-ccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11805        169 --VA-PEVVNFDAIGFGTDMWSVGVICYVLLSGLSPF  202 (251)
Q Consensus       169 --~a-PE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  202 (251)
                        .. |+...  ......+.|++|.+++.+.+|..+|
T Consensus       253 ~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              11 11111  1122368999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=99.01  E-value=6.2e-09  Score=81.05  Aligned_cols=132  Identities=20%  Similarity=0.195  Sum_probs=97.5

Q ss_pred             cccCCce-EEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEEeccCCchh
Q psy11805         11 FSFGKFG-TVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLELIEGGELF   88 (251)
Q Consensus        11 lg~g~~~-~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   88 (251)
                      +..|..+ .||+.....++..+++|+...   .....+.+|...++.+. +--++++++++.+.+..++||++++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445444 689988877778889998542   23567889999999885 334788899999999999999999998876


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------------
Q psy11805         89 ERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-------------------------------------------------  119 (251)
Q Consensus        89 ~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-------------------------------------------------  119 (251)
                      +.....     ......+..++...|..||+                                                 
T Consensus       109 ~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  183 (272)
T 4gkh_A          109 QVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM  183 (272)
T ss_dssp             HHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred             ccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence            654332     12233456667777777774                                                 


Q ss_pred             ---------CCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        120 ---------KNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       120 ---------~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                               ..++|||+++.||++  +.++.+-|+||+.+..
T Consensus       184 ~~~~~~~~~~~l~HGDl~~~Nil~--~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          184 HKLLPFSPDSVVTHGDFSLDNLIF--DEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HTTCCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCEE
T ss_pred             HhcccccCCcEEEcCCCCCCeEEE--ECCeEEEEEECccccc
Confidence                     126899999999998  6666667999998854

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.95  E-value=1.7e-08  Score=80.10  Aligned_cols=136  Identities=20%  Similarity=0.194  Sum_probs=94.4

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCC---ceeeEeEEEe-eCCEEEEEEEecc
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHP---RLIQIYDAFE-SSNVMCVVLELIE   83 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e~~~   83 (251)
                      .+.++.|....||++     +..+++|+..  .......+.+|+..++.+.+.   .+++++.+.. ..+..+++|++++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456788998999988     4678888842  223467899999999999642   3667776664 4556789999999


Q ss_pred             CCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC-------------------------------------------
Q psy11805         84 GGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-------------------------------------------  120 (251)
Q Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-------------------------------------------  120 (251)
                      |.++......   .++......++.++...|..||+.                                           
T Consensus        97 G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           97 GQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             SEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            9888653221   134445555555555555555532                                           


Q ss_pred             -----------------CceecCCCCCcEEEeecC---CCc-EEEeecccccccCC
Q psy11805        121 -----------------NVLHLDMKPENILCLTKT---GNR-IKIIDFGLARKFDP  155 (251)
Q Consensus       121 -----------------gi~h~dl~~~nil~~~~~---~~~-~~l~df~~~~~~~~  155 (251)
                                       .++|+|+++.||++  +.   ++. +.++||+.+...++
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~--~~~~~~~~~~~~iD~~~a~~gd~  227 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLT--NLNSRQTPLTGIIDFGDAAISDP  227 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEE--CTTCSSCCEEEECCCTTCEEECG
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEE--ecCCCCCceEEEEehhhcCCCCH
Confidence                             45999999999998  54   355 47999998866443

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.70  E-value=4.5e-08  Score=79.31  Aligned_cols=81  Identities=12%  Similarity=0.081  Sum_probs=56.1

Q ss_pred             cccc-ccCCceEEEEEEEc--c----CCceEEEEEecccc---ccchHHHHHHHHHHHHcC-C--CceeeEeEEEeeC--
Q psy11805          8 HSAF-SFGKFGTVYRCKEK--A----TGMTLAAKFVGIAK---RNDRRNVEREVEIMRELQ-H--PRLIQIYDAFESS--   72 (251)
Q Consensus         8 ~~~l-g~g~~~~v~~~~~~--~----~~~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~--   72 (251)
                      .+.| +.|..+.+|++...  .    ++..+++|......   ......+.+|+..++.+. +  -.+++++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88888999988654  1    15678888864322   112356788999888884 2  3577888877655  


Q ss_pred             -CEEEEEEEeccCCchh
Q psy11805         73 -NVMCVVLELIEGGELF   88 (251)
Q Consensus        73 -~~~~lv~e~~~~~~L~   88 (251)
                       +..++|||+++|.++.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.69  E-value=1.4e-07  Score=77.59  Aligned_cols=76  Identities=11%  Similarity=0.101  Sum_probs=50.0

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccc-------cchHHHHHHHHHHHHcCC--C-ceeeEeEEEeeCCEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-------NDRRNVEREVEIMRELQH--P-RLIQIYDAFESSNVMCV   77 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~l   77 (251)
                      .+.+|.|..+.||++....+++.+++|.......       .....+..|...++.+..  + .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5678999999999997765678899997542211       234567788888887742  3 45566654  3344579


Q ss_pred             EEEeccCC
Q psy11805         78 VLELIEGG   85 (251)
Q Consensus        78 v~e~~~~~   85 (251)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.40  E-value=2.6e-06  Score=68.29  Aligned_cols=73  Identities=12%  Similarity=0.125  Sum_probs=42.2

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCC--CceeeEeE------EEeeCCEEEEEEE
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH--PRLIQIYD------AFESSNVMCVVLE   80 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~------~~~~~~~~~lv~e   80 (251)
                      +.|+.|..+.+|++...  +..+++|+...    ....+..|...++.+..  -.+++++.      +....+..+++++
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            44566778899998754  33588998754    12344555666655531  13344443      1234677899999


Q ss_pred             eccCCch
Q psy11805         81 LIEGGEL   87 (251)
Q Consensus        81 ~~~~~~L   87 (251)
                      +++|.++
T Consensus       112 ~i~G~~~  118 (346)
T 2q83_A          112 WIEGRPF  118 (346)
T ss_dssp             CCCCBCC
T ss_pred             eecCccC
Confidence            9998654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.39  E-value=5.9e-06  Score=61.12  Aligned_cols=123  Identities=15%  Similarity=0.052  Sum_probs=83.3

Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeec
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF  163 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~  163 (251)
                      -+|.+.+...+.+++++++|.++.|.+.+|..+-. +.-...=+.|..|++  ..+|+|.+.+- .+.           .
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l--~~dG~V~f~~~-~s~-----------~   98 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV--WRDGAVTLAPA-ADD-----------A   98 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE--ETTSCEEECCC----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE--ecCCceecccc-ccc-----------c
Confidence            38999999888899999999999999999887722 122234456788888  88888777641 110           1


Q ss_pred             cCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhccc
Q psy11805        164 GTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK  243 (251)
Q Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  243 (251)
                      ....+.|||... ...+.+.-|||||+++|.-+--..|                     ......+|+.+.+||..|...
T Consensus        99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence            223567887763 3456788999999999987753222                     222357899999999998765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.29  E-value=1.7e-06  Score=71.70  Aligned_cols=78  Identities=10%  Similarity=0.117  Sum_probs=47.6

Q ss_pred             hhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceeecc--CcccccccccccC---CCCcchhHHHHHHHH
Q psy11805        118 HSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFG--TPEFVAPEVVNFD---AIGFGTDMWSVGVIC  192 (251)
Q Consensus       118 h~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~---~~~~~~Di~slG~~l  192 (251)
                      +...++|||++|.||++  +.++ +.++||+.+...++.........  ...|.+|+.....   .......+.+....+
T Consensus       230 ~~~~liHGDl~~~Nil~--~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMV--TQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             BCCEEECSCCSGGGEEE--CSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEE--eCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            46789999999999998  5555 99999998876433222211111  1245555544311   112335566777777


Q ss_pred             HHHHhC
Q psy11805        193 YVLLSG  198 (251)
Q Consensus       193 ~~l~~g  198 (251)
                      |+.+.+
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            776653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.29  E-value=1.1e-05  Score=63.90  Aligned_cols=76  Identities=13%  Similarity=0.139  Sum_probs=60.3

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC---CCceeeEeEEEeeCCEEEEEEEecc
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ---HPRLIQIYDAFESSNVMCVVLELIE   83 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~   83 (251)
                      -.+.|+.|..+.+|++..  ++..+++|+...   .....+..|+..++.+.   ...+++++.+....+..++|||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            346789999999999864  466888898643   23667889999998884   3678889988888888999999999


Q ss_pred             CCch
Q psy11805         84 GGEL   87 (251)
Q Consensus        84 ~~~L   87 (251)
                      |.++
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.09  E-value=7.9e-06  Score=64.48  Aligned_cols=75  Identities=15%  Similarity=0.078  Sum_probs=46.8

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCce-eeEeEEEeeCCEEEEEEEec-
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRL-IQIYDAFESSNVMCVVLELI-   82 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~-   82 (251)
                      +.-.+.|+.|....+|++      ..+++|+..... .......+|+..++.+...++ +++++...  +.-+++++++ 
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~   90 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIA   90 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCT
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecC
Confidence            333678889999999998      467888875321 112234568888877742222 56655433  2346889999 


Q ss_pred             cCCchh
Q psy11805         83 EGGELF   88 (251)
Q Consensus        83 ~~~~L~   88 (251)
                      +|.++.
T Consensus        91 ~g~~l~   96 (301)
T 3dxq_A           91 GAQTMS   96 (301)
T ss_dssp             TCEECC
T ss_pred             CCccCC
Confidence            776553

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.08  E-value=2.6e-05  Score=61.03  Aligned_cols=78  Identities=12%  Similarity=0.000  Sum_probs=55.5

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCC---ceeeEeEEEeeCCEEEEEEEe
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHP---RLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      ..-.+.+|.|..+.||++... +|+.+++|+...........+..|+..|+.+...   -++++++.  +.  .+++||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence            445678899999999999765 6789999987544444456788999999988522   34555543  22  3688999


Q ss_pred             ccCCch
Q psy11805         82 IEGGEL   87 (251)
Q Consensus        82 ~~~~~L   87 (251)
                      +++...
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            877643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=98.06  E-value=2.4e-05  Score=63.72  Aligned_cols=141  Identities=16%  Similarity=0.178  Sum_probs=82.2

Q ss_pred             ccccccCCceEEEEEEEcc-------CCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKA-------TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .+.+..|-...+|++....       +++.+++|+... .......+.+|..+++.+. +.-.+++++.+.+    .+|+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            3567778888899997642       347899998632 2234566779999998885 3334666666543    2899


Q ss_pred             EeccCCchhHH----------H-------hhC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q psy11805         80 ELIEGGELFER----------V-------IDD----DFVLT--EKAVAIFMRQICE-------------------GVEFI  117 (251)
Q Consensus        80 e~~~~~~L~~~----------~-------~~~----~~~~~--~~~~~~i~~~l~~-------------------~l~~l  117 (251)
                      |+++|.++...          +       ...    +....  ..++..+..++-.                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998765321          0       011    11122  3455555544322                   12222


Q ss_pred             ----hh----CCceecCCCCCcEEEeec--CCCcEEEeeccccccc
Q psy11805        118 ----HS----KNVLHLDMKPENILCLTK--TGNRIKIIDFGLARKF  153 (251)
Q Consensus       118 ----h~----~gi~h~dl~~~nil~~~~--~~~~~~l~df~~~~~~  153 (251)
                          ..    ..++|+|+.+.||++.++  ..+.+.++||..+...
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence                22    359999999999998332  1368999999988653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.89  E-value=3.3e-05  Score=61.42  Aligned_cols=139  Identities=15%  Similarity=0.145  Sum_probs=75.5

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc--eeeEeEE------EeeCCEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR--LIQIYDA------FESSNVMCVVL   79 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv~   79 (251)
                      .+.++.|....+|++...  +..+++|+....  .....+..|...++.+...+  +++++..      ....+..++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeC--CccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            345667888899998654  336888987542  23445667777777764222  3333321      12346678999


Q ss_pred             EeccCCchhH--------------HHhh--CCC--C----CC---HHHHHH------------HHHHHHHHHHHHh----
Q psy11805         80 ELIEGGELFE--------------RVID--DDF--V----LT---EKAVAI------------FMRQICEGVEFIH----  118 (251)
Q Consensus        80 e~~~~~~L~~--------------~~~~--~~~--~----~~---~~~~~~------------i~~~l~~~l~~lh----  118 (251)
                      ++++|.++..              .+..  .+.  .    ..   +...+.            +...+...+..+.    
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998865321              0111  010  0    01   111000            0001233344443    


Q ss_pred             ---hCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        119 ---SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       119 ---~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                         ..+++|+|+++.||++  +.++.+.++||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~--~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFF--LGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEE--eCCceEEEecchhccC
Confidence               2479999999999998  5555457999988855

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.84  E-value=7.7e-05  Score=61.86  Aligned_cols=74  Identities=15%  Similarity=0.135  Sum_probs=49.8

Q ss_pred             ccccccCCceEEEEEEEcc-------CCceEEEEEeccccccchHHHHHHHHHHHHcCCCc-eeeEeEEEeeCCEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKA-------TGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR-LIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~   79 (251)
                      .+.|+.|....+|++....       ++..+++|+....  .....+.+|...++.+...+ .+++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4567888889999997653       2568899987321  11255668999888885333 3666665542    2799


Q ss_pred             EeccCCch
Q psy11805         80 ELIEGGEL   87 (251)
Q Consensus        80 e~~~~~~L   87 (251)
                      +|++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.83  E-value=0.00031  Score=56.06  Aligned_cols=140  Identities=15%  Similarity=0.164  Sum_probs=71.5

Q ss_pred             ccccccCCceE-EEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCC--CceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          8 HSAFSFGKFGT-VYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH--PRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         8 ~~~lg~g~~~~-v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      .+.|+.|.... +|++.. .++..+++|......   ...+..|+..++.+..  -.+++++.+....+  +++||++.+
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~   96 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD   96 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence            34566665554 566643 235677777643221   1344566677766642  23566776644444  689999877


Q ss_pred             CchhHHHhhCC-------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH--
Q psy11805         85 GELFERVIDDD-------------------------FVLTEKAVA-------I-FM------------RQICEGVEFI--  117 (251)
Q Consensus        85 ~~L~~~~~~~~-------------------------~~~~~~~~~-------~-i~------------~~l~~~l~~l--  117 (251)
                      .++.+.+....                         ..++.....       . +.            ..+...+..+  
T Consensus        97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~  176 (333)
T 3csv_A           97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS  176 (333)
T ss_dssp             CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred             cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence            65543322100                         012221110       0 00            0111122222  


Q ss_pred             ----hhCCceecCCCCCcEEEeecCC----CcEEEeecccccccCC
Q psy11805        118 ----HSKNVLHLDMKPENILCLTKTG----NRIKIIDFGLARKFDP  155 (251)
Q Consensus       118 ----h~~gi~h~dl~~~nil~~~~~~----~~~~l~df~~~~~~~~  155 (251)
                          +...++|||+++.||++  +.+    +.+.++||+.+.....
T Consensus       177 ~~~~~~~~lvHgD~~~~Nil~--~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          177 AQLEGDMVFVHRDFHAQNLLW--LPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             HHCCSCCEEECSCCSGGGEEE--CTTSCGGGGEEECCCTTCEEECT
T ss_pred             hcccCCCeeEeCCcCcccEEe--ccCcCCCCCeEEEeCCCcCcCCC
Confidence                23579999999999998  443    6789999998876543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.71  E-value=0.00029  Score=57.10  Aligned_cols=75  Identities=15%  Similarity=0.199  Sum_probs=45.3

Q ss_pred             ccccccCCceEEEEEEEccC--------CceEEEEEeccccccchHHHHHHHHHHHHcCCCc-eeeEeEEEeeCCEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKAT--------GMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR-LIQIYDAFESSNVMCVV   78 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~--------~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv   78 (251)
                      .+.++.|....+|++.....        +..+++|+..... ........|...++.+...+ .+++++..  .+  +++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence            45677888889999976531        2688898874322 12223467888888775333 45666544  22  579


Q ss_pred             EEeccCCch
Q psy11805         79 LELIEGGEL   87 (251)
Q Consensus        79 ~e~~~~~~L   87 (251)
                      +++++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988644

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.62  E-value=0.00098  Score=52.92  Aligned_cols=138  Identities=13%  Similarity=0.130  Sum_probs=79.5

Q ss_pred             cccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc--eeeEeEE-----EeeCCEEEEEEEe
Q psy11805          9 SAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR--LIQIYDA-----FESSNVMCVVLEL   81 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv~e~   81 (251)
                      ..++ |....+|++... +++.+++|...... .....+..|...++.+....  +++++..     ...++..++++++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3455 777889987543 45678999975321 23566777888888774222  3444432     2235667889999


Q ss_pred             ccCCchh----HH----------Hhh--CC------CCCCHHHH----------------------HHHHHHHHHHHHHH
Q psy11805         82 IEGGELF----ER----------VID--DD------FVLTEKAV----------------------AIFMRQICEGVEFI  117 (251)
Q Consensus        82 ~~~~~L~----~~----------~~~--~~------~~~~~~~~----------------------~~i~~~l~~~l~~l  117 (251)
                      ++|.++.    +.          +..  ..      ...+....                      ...+..++..+..+
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9885432    00          100  00      01121110                      11122222223222


Q ss_pred             ----hhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805        118 ----HSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus       118 ----h~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                          ....++|||+++.||++  + + .+.++||+.+...
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~--~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILW--R-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEE--S-S-SEEECCCTTCCEE
T ss_pred             hhhcCCeeeeeCCCCcccEeE--c-C-CCEEEECCCCCcC
Confidence                23468999999999998  5 3 7999999887654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.52  E-value=0.0013  Score=54.98  Aligned_cols=75  Identities=21%  Similarity=0.262  Sum_probs=48.9

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCce-eeEeEEEeeCCEEEEEEEeccCCc
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRL-IQIYDAFESSNVMCVVLELIEGGE   86 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~   86 (251)
                      .+.|+.|-...+|++.....+..+++|+..... .......+|...++.+...++ +++++.+.  +  ..|++|++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            456788888999999876434788899874321 122223688999998864444 66776663  2  25999998865


Q ss_pred             h
Q psy11805         87 L   87 (251)
Q Consensus        87 L   87 (251)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.19  E-value=0.0072  Score=48.33  Aligned_cols=33  Identities=24%  Similarity=0.268  Sum_probs=27.5

Q ss_pred             CCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805        120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus       120 ~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .+++|+|+.+.||++  +.++.+.++||+.+...+
T Consensus       206 ~~~~HgD~~~~N~l~--~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLV--GNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEE--CGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEE--eCCCeEEEEECCCCeeCC
Confidence            469999999999998  666789999998876543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.77  E-value=0.014  Score=48.19  Aligned_cols=75  Identities=15%  Similarity=0.142  Sum_probs=49.3

Q ss_pred             ccccccCCceEEEEEEEccC-------CceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKAT-------GMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .+.+..|-...+|++.....       +..+++|+.... ........+|...++.+. +.-.+++++.+  .+  +.|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence            45677788889999987531       578899886432 222334467888888875 33345666533  22  6789


Q ss_pred             EeccCCch
Q psy11805         80 ELIEGGEL   87 (251)
Q Consensus        80 e~~~~~~L   87 (251)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.47  E-value=0.011  Score=48.45  Aligned_cols=32  Identities=28%  Similarity=0.386  Sum_probs=26.1

Q ss_pred             ceecCCCCCcEEEee----cCCCcEEEeeccccccc
Q psy11805        122 VLHLDMKPENILCLT----KTGNRIKIIDFGLARKF  153 (251)
Q Consensus       122 i~h~dl~~~nil~~~----~~~~~~~l~df~~~~~~  153 (251)
                      ++|+|+.+.||++.+    +.++.+.++||..+..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            679999999999743    34567999999988653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.33  E-value=0.57  Score=34.54  Aligned_cols=115  Identities=11%  Similarity=0.156  Sum_probs=79.2

Q ss_pred             CCCceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec
Q psy11805         58 QHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK  137 (251)
Q Consensus        58 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~  137 (251)
                      .+|++++. .+-++++.+.+.++.-+...-...+.    ..+....++++..|+.....+  ..-+|--++|+|+++  +
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f--~  113 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFF--T  113 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEE--C
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEE--c
Confidence            68999987 57777777777777654222122232    378899999999998866333  334688999999999  9


Q ss_pred             CCCcEEEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11805        138 TGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPF  202 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  202 (251)
                      .++.+++.-.|.-..                ++|     ...+...=.-..=+++..+++++..|
T Consensus       114 ~~~~p~i~~RGik~~----------------l~P-----~~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          114 RDGLPIAKTRGLQNV----------------VDP-----LPVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             TTSCEEESCCEETTT----------------BSC-----CCCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CCCCEEEEEccCccC----------------CCC-----CCCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999988876555422                233     22344445667778888888888887

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.91  E-value=1.4  Score=32.57  Aligned_cols=115  Identities=17%  Similarity=0.132  Sum_probs=78.0

Q ss_pred             CCCceeeEeEEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec
Q psy11805         58 QHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK  137 (251)
Q Consensus        58 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~  137 (251)
                      .+|++  -..+-.+++.+.+.++.-++..-...+.    ..+....++++..++.... -|...-.|--++|+|+++  +
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f--~  118 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMF--N  118 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEE--C
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEE--e
Confidence            68888  4445577787888787654443333332    3788999999888888554 133556788999999999  9


Q ss_pred             CCCcEEEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy11805        138 TGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPF  202 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  202 (251)
                      .++.+++.-.|.-.                -++|.     ..+...=.-+.=+++..++.++..|
T Consensus       119 ~~~~p~i~hRGi~~----------------~lpP~-----e~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          119 RALEPFFLHVGVKE----------------SLPPD-----EWDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             TTCCEEESCCEETT----------------TBSSC-----SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             CCCcEEEEEcCCcc----------------cCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999997665542                23332     2233344556777788888887776

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.77  E-value=0.24  Score=41.32  Aligned_cols=61  Identities=13%  Similarity=0.096  Sum_probs=17.2

Q ss_pred             cccccccCCceEEEEEEEccCCceEEE------EEeccc--cccchHHHHHHHHHHHHcCCCceeeEeEEEe
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAA------KFVGIA--KRNDRRNVEREVEIMRELQHPRLIQIYDAFE   70 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~------K~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   70 (251)
                      +.+.+|   ||.||.+.+.....+||+      |.....  .......+.+|....+..+|+|+++.+.+..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            456666   999999998765567777      554321  1223456777888888889999999888753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	251
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-78
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-77
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-73
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-64
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-63
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-63
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-63
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-62
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-61
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-59
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-54
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-54
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-53
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-53
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-51
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-51
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-50
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-49
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-47
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-46
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-46
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-45
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-44
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-43
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-43
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-42
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-41
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-39
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-39
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-37
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-33
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-17

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  237 bits (605), Expect = 5e-78
 Identities = 113/236 (47%), Positives = 155/236 (65%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V+R  E+ATG   AAKFV     +D+  V +E++ M  L+HP L+ ++DAFE  N
Sbjct: 37  GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            M ++ E + GGELFE+V D+   ++E     +MRQ+C+G+  +H  N +HLD+KPENI+
Sbjct: 97  EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 156

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             TK  N +K+IDFGL    DP++ ++V  GT EF APEV     +G+ TDMWSVGV+ Y
Sbjct: 157 FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 216

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +LLSGLSPF GE D +T+ NV    ++ DD  F+ IS+D KDFIRKLLL D     
Sbjct: 217 ILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM 272

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  235 bits (600), Expect = 3e-77
 Identities = 112/236 (47%), Positives = 165/236 (69%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V+RC EKATG    AKF+      D+  V+ E+ IM +L HP+LI ++DAFE   
Sbjct: 40  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            M ++LE + GGELF+R+  +D+ ++E  V  +MRQ CEG++ +H  +++HLD+KPENI+
Sbjct: 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 159

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
           C TK  + +KIIDFGLA K +P++ ++V   T EF APE+V+ + +GF TDMW++GV+ Y
Sbjct: 160 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 219

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           VLLSGLSPF GE D++T+ NV    ++FD++ F+ +S +AKDFI+ LL K+     
Sbjct: 220 VLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 8e-73
 Identities = 96/236 (40%), Positives = 155/236 (65%), Gaps = 1/236 (0%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G+FG V+RC E ++  T  AKFV + K  D+  V++E+ I+   +H  ++ ++++FES  
Sbjct: 16  GEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESME 74

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + ++ E I G ++FER+    F L E+ +  ++ Q+CE ++F+HS N+ H D++PENI+
Sbjct: 75  ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII 134

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICY 193
             T+  + IKII+FG AR+  P    ++LF  PE+ APEV   D +   TDMWS+G + Y
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194

Query: 194 VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           VLLSG++PF+ ET+ Q + N+  A+Y FD+E F EIS +A DF+ +LL+K+R+   
Sbjct: 195 VLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM 250

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 4e-64
 Identities = 82/238 (34%), Positives = 138/238 (57%), Gaps = 3/238 (1%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRR-NVEREVEIMRELQHPRLIQIYDAFESS 72
           G F  V   ++K T   +A K +       +  ++E E+ ++ +++HP ++ + D +ES 
Sbjct: 20  GAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG 79

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
             + ++++L+ GGELF+R+++  F  TE+  +  + Q+ + V+++H   ++H D+KPEN+
Sbjct: 80  GHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138

Query: 133 LCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           L  +   + +I I DFGL++  DP   L    GTP +VAPEV+         D WS+GVI
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198

Query: 192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
            Y+LL G  PF  E D +    +  A+Y+FD   +++ISD AKDFIR L+ KD E   
Sbjct: 199 AYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF 256

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-63
 Identities = 60/242 (24%), Positives = 118/242 (48%), Gaps = 9/242 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ + K T +  AAK +      +  +   E++I+    HP ++++ DAF   N
Sbjct: 23  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + +++E   GG +   +++ +  LTE  + +  +Q  + + ++H   ++H D+K  NIL
Sbjct: 83  NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 142

Query: 134 CLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVV-----NFDAIGFGTDMWS 187
             T  G+ IK+ DFG++ K     ++     GTP ++APEVV           +  D+WS
Sbjct: 143 -FTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 200

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           +G+    +     P      ++ +  +  ++     +  +  S + KDF++K L K+ + 
Sbjct: 201 LGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ-PSRWSSNFKDFLKKCLEKNVDA 259

Query: 248 AP 249
             
Sbjct: 260 RW 261

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 4e-63
 Identities = 73/239 (30%), Positives = 122/239 (51%), Gaps = 11/239 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           GKFG VY  +EK +   LA K +    + K      + REVEI   L+HP ++++Y  F 
Sbjct: 17  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++LE    G ++ R +       E+  A ++ ++   + + HSK V+H D+KPE
Sbjct: 77  DATRVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 135

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L L   G  +KI DFG +    P  +   L GT +++ PE++         D+WS+GV
Sbjct: 136 NLL-LGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 192

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +CY  L G  PF   T  +T   ++  ++ F D     +++ A+D I +LL  +    P
Sbjct: 193 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRP 247

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-63
 Identities = 68/237 (28%), Positives = 126/237 (53%), Gaps = 6/237 (2%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G  GTVY   + ATG  +A + + + ++  +  +  E+ +MRE ++P ++   D++   +
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + VV+E + GG L + V +      E  +A   R+  + +EF+HS  V+H D+K +NIL
Sbjct: 91  ELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148

Query: 134 CLTKTGNRIKIIDFGLARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVIC 192
            L   G+ +K+ DFG   +  PE+ K   + GTP ++APEVV   A G   D+WS+G++ 
Sbjct: 149 -LGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206

Query: 193 YVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
             ++ G  P++ E  ++ +  +       + +   ++S   +DF+ + L  D E   
Sbjct: 207 IEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG 262

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-62
 Identities = 112/244 (45%), Positives = 167/244 (68%), Gaps = 9/244 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV------GIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G+F  V +C+EK+TG+  AAKF+         +   R ++EREV I++E+QHP +I +++
Sbjct: 21  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
            +E+   + ++LEL+ GGELF+ + + +  LTE+    F++QI  GV ++HS  + H D+
Sbjct: 81  VYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQIAHFDL 139

Query: 128 KPENILCLTKTGN--RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           KPENI+ L +     RIKIIDFGLA K D   + + +FGTPEFVAPE+VN++ +G   DM
Sbjct: 140 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 199

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           WS+GVI Y+LLSG SPF+G+T  +T+ANV+   Y+F+DE F+  S  AKDFIR+LL+KD 
Sbjct: 200 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDP 259

Query: 246 EDAP 249
           +   
Sbjct: 260 KKRM 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  192 bits (490), Expect = 1e-61
 Identities = 80/252 (31%), Positives = 128/252 (50%), Gaps = 19/252 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK---------RNDRRNVEREVEIMRELQ-HPRLI 63
           G    V RC  K T    A K + +           +  R    +EV+I+R++  HP +I
Sbjct: 14  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73

Query: 64  QIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
           Q+ D +E++    +V +L++ GELF+  + +   L+EK     MR + E +  +H  N++
Sbjct: 74  QLKDTYETNTFFFLVFDLMKKGELFDY-LTEKVTLSEKETRKIMRALLEVICALHKLNIV 132

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV------NFD 177
           H D+KPENIL L    N IK+ DFG + + DP +KL+ + GTP ++APE++      N  
Sbjct: 133 HRDLKPENIL-LDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 190

Query: 178 AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI 237
             G   DMWS GVI Y LL+G  PF     +  +  +    Y F    +++ SD  KD +
Sbjct: 191 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 250

Query: 238 RKLLLKDREDAP 249
            + L+   +   
Sbjct: 251 SRFLVVQPQKRY 262

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-61
 Identities = 71/242 (29%), Positives = 113/242 (46%), Gaps = 13/242 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G F TV   +E AT    A K +    I K N    V RE ++M  L HP  +++Y  F+
Sbjct: 19  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
               +   L   + GEL + +        E     +  +I   +E++H K ++H D+KPE
Sbjct: 79  DDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 137

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQV---LFGTPEFVAPEVVNFDAIGFGTDMWS 187
           NIL        I+I DFG A+   PE K        GT ++V+PE++   +    +D+W+
Sbjct: 138 NILL--NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 195

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           +G I Y L++GL PF    +      +   +YDF +    +    A+D + KLL+ D   
Sbjct: 196 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDATK 251

Query: 248 AP 249
             
Sbjct: 252 RL 253

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (479), Expect = 2e-59
 Identities = 62/242 (25%), Positives = 107/242 (44%), Gaps = 14/242 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG VY  ++      +A K +   G       +++ +EV  +++L+HP  IQ    + 
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
             +   +V+E   G       +     L E  +A       +G+ ++HS N++H D+K  
Sbjct: 86  REHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 144

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV---NFDAIGFGTDMWS 187
           NIL L++ G  +K+ DFG A    P        GTP ++APEV+   +        D+WS
Sbjct: 145 NIL-LSEPGL-VKLGDFGSASIMAPANSFV---GTPYWMAPEVILAMDEGQYDGKVDVWS 199

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           +G+ C  L     P      +  + +  IAQ +         S+  ++F+   L K  +D
Sbjct: 200 LGITCIELAERKPPLFNMNAMSALYH--IAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Query: 248 AP 249
            P
Sbjct: 258 RP 259

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 6e-59
 Identities = 66/241 (27%), Positives = 116/241 (48%), Gaps = 9/241 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND-RRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G +G V     + T   +A K V + +  D   N+++E+ I + L H  +++ Y      
Sbjct: 16  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 75

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           N+  + LE   GGELF+R I+ D  + E     F  Q+  GV ++H   + H D+KPEN+
Sbjct: 76  NIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEFVAPEVVNFDAI-GFGTDMWSV 188
           L L +  N +KI DFGLA  F    + ++L    GT  +VAPE++          D+WS 
Sbjct: 135 L-LDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           G++   +L+G  P+   +D     +    +  + +  + +I       + K+L+++    
Sbjct: 193 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-WKKIDSAPLALLHKILVENPSAR 251

Query: 249 P 249
            
Sbjct: 252 I 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-57
 Identities = 81/247 (32%), Positives = 126/247 (51%), Gaps = 16/247 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIM-RELQHPRLIQIYDAFESS 72
           G  G V +   K T    A K +      D     REVE+  R  Q P +++I D +E+ 
Sbjct: 23  GINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENL 77

Query: 73  ----NVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
                 + +V+E ++GGELF R+ D  D   TE+  +  M+ I E ++++HS N+ H D+
Sbjct: 78  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 137

Query: 128 KPENILCLTKTGN-RIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMW 186
           KPEN+L  +K  N  +K+ DFG A++      L     TP +VAPEV+  +      DMW
Sbjct: 138 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 197

Query: 187 SVGVICYVLLSGLSPFMGETDVQTM----ANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           S+GVI Y+LL G  PF     +         + + QY+F +  ++E+S++ K  IR LL 
Sbjct: 198 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 257

Query: 243 KDREDAP 249
            +     
Sbjct: 258 TEPTQRM 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-56
 Identities = 63/249 (25%), Positives = 119/249 (47%), Gaps = 18/249 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF-- 69
           G +G   + + K+ G  L  K +  G     +++ +  EV ++REL+HP +++ YD    
Sbjct: 15  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74

Query: 70  ESSNVMCVVLELIEGGELFE---RVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN----- 121
            ++  + +V+E  EGG+L     +   +   L E+ V   M Q+   ++  H ++     
Sbjct: 75  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQVLFGTPEFVAPEVVNFDAIG 180
           VLH D+KP N+  L    N +K+ DFGLAR  + +    +   GTP +++PE +N  +  
Sbjct: 135 VLHRDLKPANVF-LDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN 192

Query: 181 FGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL 240
             +D+WS+G + Y L + + PF   +  +    +   ++          SD+  + I ++
Sbjct: 193 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---RYSDELNEIITRM 249

Query: 241 LLKDREDAP 249
           L       P
Sbjct: 250 LNLKDYHRP 258

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-56
 Identities = 57/244 (23%), Positives = 118/244 (48%), Gaps = 13/244 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G F TVY+  +  T + +A   +   K  +++R+  + E E+++ LQHP +++ YD++ES
Sbjct: 20  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79

Query: 72  S----NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN--VLHL 125
           +      + +V EL+  G L    +    V+  K +  + RQI +G++F+H++   ++H 
Sbjct: 80  TVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 138

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           D+K +NI  +T     +KI D GLA         + + GTPEF+APE+   +      D+
Sbjct: 139 DLKCDNIF-ITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDV 195

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           ++ G+    + +   P+    +   +    +               + K+ I   + +++
Sbjct: 196 YAFGMCMLEMATSEYPYSECQNAAQIYRR-VTSGVKPASFDKVAIPEVKEIIEGCIRQNK 254

Query: 246 EDAP 249
           ++  
Sbjct: 255 DERY 258

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 4e-54
 Identities = 54/278 (19%), Positives = 110/278 (39%), Gaps = 46/278 (16%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G  G V++   K +G+ +A K + +  K   R  + RE++++ E   P ++  Y AF S 
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 76

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN-VLHLDMKPEN 131
             + + +E ++GG L + V+     + E+ +      + +G+ ++  K+ ++H D+KP N
Sbjct: 77  GEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           IL  ++    IK+ DFG++ +   +       GT  +++PE +        +D+WS+G+ 
Sbjct: 136 ILVNSR--GEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 192

Query: 192 CYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE----------------------- 228
              +  G  P       +              E                           
Sbjct: 193 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252

Query: 229 -----------------ISDDAKDFIRKLLLKDREDAP 249
                             S + +DF+ K L+K+  +  
Sbjct: 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 5e-54
 Identities = 55/246 (22%), Positives = 117/246 (47%), Gaps = 16/246 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G FGTVY+ K       +A K + +        +  + EV ++R+ +H  ++     + +
Sbjct: 19  GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YST 74

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
           +  + +V +  EG  L+  +   +       +    RQ  +G++++H+K+++H D+K  N
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN 134

Query: 132 ILCLTKTGNRIKIIDFGLAR---KFDPEKKLQVLFGTPEFVAPEVV---NFDAIGFGTDM 185
           I  L +    +KI DFGLA    ++    + + L G+  ++APEV+   + +   F +D+
Sbjct: 135 IF-LHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV 192

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD--ECFNEISDDAKDFIRKLLLK 243
           ++ G++ Y L++G  P+    +   +  +    Y   D  +  +      K  + + L K
Sbjct: 193 YAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 252

Query: 244 DREDAP 249
            R++ P
Sbjct: 253 KRDERP 258

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  172 bits (437), Expect = 1e-53
 Identities = 50/245 (20%), Positives = 102/245 (41%), Gaps = 10/245 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G    V+  ++      +A K +        +      RE +    L HP ++ +YD  E
Sbjct: 18  GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77

Query: 71  SSN----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLD 126
           +      +  +V+E ++G  L +  +  +  +T K     +   C+ + F H   ++H D
Sbjct: 78  AETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 136

Query: 127 MKPENILCLTKTGNRIK--IIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTD 184
           +KP NI+       ++    I   +A   +   +   + GT ++++PE    D++   +D
Sbjct: 137 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 196

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           ++S+G + Y +L+G  PF G++ V                    +S D    + K L K+
Sbjct: 197 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256

Query: 245 REDAP 249
            E+  
Sbjct: 257 PENRY 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-53
 Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 12/241 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIM-RELQHPRLIQIYDAF 69
           G FG V+  + K T    A K +    +   +D      E  ++    +HP L  ++  F
Sbjct: 13  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           ++   +  V+E + GG+L    I             +  +I  G++F+HSK +++ D+K 
Sbjct: 73  QTKENLFFVMEYLNGGDLMYH-IQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL 131

Query: 130 ENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSV 188
           +NIL        IKI DFG+ ++    + K     GTP+++APE++         D WS 
Sbjct: 132 DNILL--DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189

Query: 189 GVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDA 248
           GV+ Y +L G SPF G+ + +   ++ +    +       +  +AKD + KL +++ E  
Sbjct: 190 GVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREPEKR 245

Query: 249 P 249
            
Sbjct: 246 L 246

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (424), Expect = 3e-51
 Identities = 66/237 (27%), Positives = 120/237 (50%), Gaps = 12/237 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V+  + +  G   A K +    + +     +   E  ++  + HP +I+++  F+
Sbjct: 15  GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            +  + ++++ IEGGELF  +              +  ++C  +E++HSK++++ D+KPE
Sbjct: 75  DAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE 133

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           NIL L K G+ IKI DFG A+            GTP+++APEVV+        D WS G+
Sbjct: 134 NIL-LDKNGH-IKITDFGFAKYVPDVTYTLC--GTPDYIAPEVVSTKPYNKSIDWWSFGI 189

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           + Y +L+G +PF     ++T   +  A+  F        ++D KD + +L+ +D   
Sbjct: 190 LIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQ 242

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 9e-51
 Identities = 73/238 (30%), Positives = 126/238 (52%), Gaps = 11/238 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   +EKATG   A K +    I  +++  +   E  +++  +HP L  +  AF+
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           + + +C V+E   GGELF   +  + V TE+    +  +I   +E++HS++V++ D+K E
Sbjct: 76  THDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134

Query: 131 NILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVG 189
           N++ L K G+ IKI DFGL ++       ++   GTPE++APEV+  +  G   D W +G
Sbjct: 135 NLM-LDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           V+ Y ++ G  PF  +   +    + + +  F       +S +AK  +  LL KD + 
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQ 246

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-50
 Identities = 61/245 (24%), Positives = 102/245 (41%), Gaps = 21/245 (8%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND------RRNVEREVEIMRELQ--HPRLIQI 65
           G FG+VY     +  + +A K V   + +D         V  EV +++++      +I++
Sbjct: 15  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
            D FE  +   ++LE  E  +     I +   L E+    F  Q+ E V   H+  VLH 
Sbjct: 75  LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR 134

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFD-AIGFGTD 184
           D+K ENIL +      +K+IDFG               GT  +  PE + +    G    
Sbjct: 135 DIKDENIL-IDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAA 192

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +WS+G++ Y ++ G  PF  + ++         Q  F       +S + +  IR  L   
Sbjct: 193 VWSLGILLYDMVCGDIPFEHDEEIIR------GQVFFRQ----RVSSECQHLIRWCLALR 242

Query: 245 REDAP 249
             D P
Sbjct: 243 PSDRP 247

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  166 bits (420), Expect = 3e-50
 Identities = 63/241 (26%), Positives = 112/241 (46%), Gaps = 12/241 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR------RNVEREVEIMRELQHPRLIQIYD 67
           G FG VY C++  TG   A K +   +   +       N    + ++     P ++ +  
Sbjct: 15  GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
           AF + + +  +L+L+ GG+L    +    V +E  +  +  +I  G+E +H++ V++ D+
Sbjct: 75  AFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 133

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV-NFDAIGFGTDMW 186
           KP NIL L + G+ ++I D GLA  F  +KK     GT  ++APEV+    A     D +
Sbjct: 134 KPANIL-LDEHGH-VRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 190

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
           S+G + + LL G SPF      +    +         E  +  S + +  +  LL +D  
Sbjct: 191 SLGCMLFKLLRGHSPFRQHKT-KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 249

Query: 247 D 247
            
Sbjct: 250 R 250

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-49
 Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 34/262 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND-----RRNVEREVEIMRELQHPRLIQIYDA 68
           G+F TVY+ ++K T   +A K + +  R++      R   RE+++++EL HP +I + DA
Sbjct: 9   GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 68

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           F   + + +V + +E       + D+  VLT   +  +M    +G+E++H   +LH D+K
Sbjct: 69  FGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 127

Query: 129 PENILCLTKTGNRIKIIDFGLARKF-DPEKKLQVLFGTPEFVAPEVVN-FDAIGFGTDMW 186
           P N+L L + G  +K+ DFGLA+ F  P +       T  + APE++      G G DMW
Sbjct: 128 PNNLL-LDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185

Query: 187 SVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE---------------------- 224
           +VG I   LL  +    G++D+  +  +        +E                      
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245

Query: 225 --CFNEISDDAKDFIRKLLLKD 244
              F+   DD  D I+ L L +
Sbjct: 246 HHIFSAAGDDLLDLIQGLFLFN 267

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-49
 Identities = 56/244 (22%), Positives = 107/244 (43%), Gaps = 14/244 (5%)

Query: 14  GKFGTVYRCKEKAT--GMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG+V +   +     + +A K +    ++ D   + RE +IM +L +P ++++    +
Sbjct: 20  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
           +   + +V+E+  GG L + ++     +    VA  + Q+  G++++  KN +H D+   
Sbjct: 80  AEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR 138

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF----GTPEFVAPEVVNFDAIGFGTDMW 186
           N+  L       KI DFGL++    +              ++ APE +NF      +D+W
Sbjct: 139 NV-LLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196

Query: 187 SVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           S GV  +  LS G  P+      + MA +   +     EC  E   +    +    +   
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPECPPELYALMSDCWIYKW 253

Query: 246 EDAP 249
           ED P
Sbjct: 254 EDRP 257

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 3e-49
 Identities = 58/265 (21%), Positives = 101/265 (38%), Gaps = 39/265 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG VY+ K   +G  +A K V      D+R   RE++IMR+L H  ++++   F SS 
Sbjct: 31  GSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 86

Query: 74  ------VMCVVLELIEGG--ELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
                  + +VL+ +      +          L    V ++M Q+   + +IHS  + H 
Sbjct: 87  EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 146

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAP-EVVNFDAIGFGTD 184
           D+KP+N+  L      +K+ DFG A++    +       +  + AP  +          D
Sbjct: 147 DIKPQNL-LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID 205

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANV-------------------------TIAQY 219
           +WS G +   LL G   F G++ V  +  +                          I  +
Sbjct: 206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265

Query: 220 DFDDECFNEISDDAKDFIRKLLLKD 244
            +          +A     +LL   
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYT 290

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-47
 Identities = 49/239 (20%), Positives = 93/239 (38%), Gaps = 14/239 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF-ESS 72
           G+FG V     +  G  +A K   I      +    E  +M +L+H  L+Q+     E  
Sbjct: 18  GEFGDVMLGDYR--GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73

Query: 73  NVMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
             + +V E +  G L + +      VL    +  F   +CE +E++   N +H D+   N
Sbjct: 74  GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 133

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
           +L      N  K+ DFGL ++    +         ++ APE +        +D+WS G++
Sbjct: 134 VLVSED--NVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDVWSFGIL 189

Query: 192 CYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
            + + S G  P+        +  V   +  +  +  +       + ++     D    P
Sbjct: 190 LWEIYSFGRVPYPRIPLKDVVPRV---EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 245

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  155 bits (392), Expect = 9e-47
 Identities = 53/247 (21%), Positives = 96/247 (38%), Gaps = 16/247 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRN----DRRNVEREVEIMRELQHPRLIQIYDAF 69
           G+FG V     K  G       +   K       RR+   E  IM +  HP +I +    
Sbjct: 37  GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
             S  + ++ E +E G L   +  +D   T   +   +R I  G++++   N +H D+  
Sbjct: 97  TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA 156

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL------FGTPEFVAPEVVNFDAIGFGT 183
            NIL +       K+ DFGL+R  + +                 + APE + +      +
Sbjct: 157 RNIL-VNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSAS 214

Query: 184 DMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           D+WS G++ + ++S G  P+   T+   +  +   + D+      +        +     
Sbjct: 215 DVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPPPMDCPSALHQLMLDCWQ 271

Query: 243 KDREDAP 249
           KDR   P
Sbjct: 272 KDRNHRP 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 2e-46
 Identities = 53/249 (21%), Positives = 90/249 (36%), Gaps = 15/249 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG +Y   + A G  +A K      +     +  E +I + +Q    I       +  
Sbjct: 18  GSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG 75

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
              V++  + G  L +         + K V +   Q+   +E+IHSKN +H D+KP+N L
Sbjct: 76  DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL 135

Query: 134 C-LTKTGNRIKIIDFGLARKFDPEKKLQVLF--------GTPEFVAPEVVNFDAIGFGTD 184
             L K GN + IIDFGLA+K+   +  Q +         GT  + +             D
Sbjct: 136 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDD 195

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF----DDECFNEISDDAKDFIRKL 240
           + S+G +      G  P+ G                      +        +   ++   
Sbjct: 196 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFC 255

Query: 241 LLKDREDAP 249
                +D P
Sbjct: 256 RSLRFDDKP 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-46
 Identities = 56/269 (20%), Positives = 106/269 (39%), Gaps = 37/269 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMREL-QHPRLIQIY 66
           G FG V          T  +  V +      A  ++R  +  E+++M +L  H  ++ + 
Sbjct: 48  GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107

Query: 67  DAFESSNVMCVVLELIEGGELFERV----------------------IDDDFVLTEKAVA 104
            A   S  + ++ E    G+L   +                       +D  VLT + + 
Sbjct: 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 167

Query: 105 IFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV--- 161
            F  Q+ +G+EF+  K+ +H D+   N+L     G  +KI DFGLAR    +    V   
Sbjct: 168 CFAYQVAKGMEFLEFKSCVHRDLAARNVLV--THGKVVKICDFGLARDIMSDSNYVVRGN 225

Query: 162 LFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
                +++APE +        +D+WS G++ + + S G++P+ G           + Q  
Sbjct: 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK--LIQNG 283

Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
           F  +     +++    ++     D    P
Sbjct: 284 FKMDQPFYATEEIYIIMQSCWAFDSRKRP 312

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-46
 Identities = 48/239 (20%), Positives = 100/239 (41%), Gaps = 10/239 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G+FG V   K +     +A K +     ++      E ++M  L H +L+Q+Y       
Sbjct: 15  GQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTKQR 72

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            + ++ E +  G L   + +       + +    + +CE +E++ SK  LH D+   N L
Sbjct: 73  PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL 132

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLF--GTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
            +   G  +K+ DFGL+R    ++    +       +  PEV+ +      +D+W+ GV+
Sbjct: 133 -VNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 190

Query: 192 CYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
            + + S G  P+   T+ +T  ++      +        S+     +     +  ++ P
Sbjct: 191 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---LASEKVYTIMYSCWHEKADERP 246

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-46
 Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 16/247 (6%)

Query: 14  GKFGTVYRCKEKAT---GMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG V R +  A     +++A K +    +++     +  REV  M  L H  LI++Y 
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78

Query: 68  AFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDM 127
              +   M +V EL   G L +R+           ++ +  Q+ EG+ ++ SK  +H D+
Sbjct: 79  VVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 137

Query: 128 KPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF----GTPEFVAPEVVNFDAIGFGT 183
              N+L L      +KI DFGL R         V+         + APE +        +
Sbjct: 138 AARNLL-LATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 195

Query: 184 DMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL 242
           D W  GV  + + + G  P++G    Q +  +             +   D  + + +   
Sbjct: 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--EDCPQDIYNVMVQCWA 253

Query: 243 KDREDAP 249
              ED P
Sbjct: 254 HKPEDRP 260

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-45
 Identities = 51/239 (21%), Positives = 102/239 (42%), Gaps = 10/239 (4%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G+FG V+          +A K +     ++      E E+M +L HP+L+Q+Y       
Sbjct: 16  GQFGLVHLGYWL-NKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVCLEQA 73

Query: 74  VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL 133
            +C+V E +E G L + +     +   + +      +CEG+ ++    V+H D+   N L
Sbjct: 74  PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 133

Query: 134 CLTKTGNRIKIIDFGLARKFDPEKKLQVLF--GTPEFVAPEVVNFDAIGFGTDMWSVGVI 191
            + +    IK+ DFG+ R    ++           ++ +PEV +F      +D+WS GV+
Sbjct: 134 -VGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 191

Query: 192 CYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
            + + S G  P+   ++ + + +++     +        S      +     +  ED P
Sbjct: 192 MWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR---LASTHVYQIMNHCWKERPEDRP 247

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-45
 Identities = 56/256 (21%), Positives = 108/256 (42%), Gaps = 25/256 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAK---FVGIAKRNDRRNVEREVEIMREL-QHPRLIQIYDAF 69
           G FG V + + K  G+ + A        A ++D R+   E+E++ +L  HP +I +  A 
Sbjct: 21  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFV---------------LTEKAVAIFMRQICEGV 114
           E    + + +E    G L + +     +               L+ + +  F   +  G+
Sbjct: 81  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 140

Query: 115 EFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV 174
           +++  K  +H D+   NIL         KI DFGL+R  +   K  +      ++A E +
Sbjct: 141 DYLSQKQFIHRDLAARNILV--GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 198

Query: 175 NFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA 233
           N+      +D+WS GV+ + ++S G +P+ G T  +    +      +  E      D+ 
Sbjct: 199 NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQGYRLEKPLNCDDEV 255

Query: 234 KDFIRKLLLKDREDAP 249
            D +R+   +   + P
Sbjct: 256 YDLMRQCWREKPYERP 271

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 8e-45
 Identities = 54/245 (22%), Positives = 109/245 (44%), Gaps = 16/245 (6%)

Query: 14  GKFGTVYRC--KEKATGMTLAAKFV--GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G FGTV +   + K    T+A K +         +  +  E  +M++L +P ++++    
Sbjct: 18  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 77

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
           E+ +   +V+E+ E G L +  +  +  + +K +   + Q+  G++++   N +H D+  
Sbjct: 78  EAES-WMLVMEMAELGPLNK-YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA 135

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPE----KKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
            N+L +T+  +  KI DFGL++    +    K         ++ APE +N+      +D+
Sbjct: 136 RNVLLVTQ--HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS GV+ +   S G  P+ G    +  A +   +      C      +  D +      D
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDLMNLCWTYD 250

Query: 245 REDAP 249
            E+ P
Sbjct: 251 VENRP 255

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (381), Expect = 1e-44
 Identities = 64/237 (27%), Positives = 112/237 (47%), Gaps = 12/237 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV---GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFE 70
           G FG V   K K +G   A K +    + K     +   E  I++ +  P L+++  +F+
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111

Query: 71  SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            ++ + +V+E + GGE+F  +       +E     +  QI    E++HS ++++ D+KPE
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           N+L   +    I++ DFG A++         L GTPE +APE++         D W++GV
Sbjct: 171 NLLIDQQ--GYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDWWALGV 226

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRED 247
           + Y + +G  PF  +  +Q    +   +  F        S D KD +R LL  D   
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTK 279

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-44
 Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 12/240 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G+FG V+          +A K +     +       E  +M++LQH RL+++Y       
Sbjct: 24  GQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQEP 81

Query: 74  VMCVVLELIEGGELFERV-IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           +  ++ E +E G L + +       LT   +     QI EG+ FI  +N +H D++  NI
Sbjct: 82  I-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEK--KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           L         KI DFGLAR  +  +    +      ++ APE +N+      +D+WS G+
Sbjct: 141 LV--SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198

Query: 191 ICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   +++ G  P+ G T+ + + N+         +      ++    +R    +  ED P
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD---NCPEELYQLMRLCWKERPEDRP 255

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-44
 Identities = 68/246 (27%), Positives = 126/246 (51%), Gaps = 15/246 (6%)

Query: 14  GKFGTVYRCKE---KATGMTLAAKFV----GIAKRNDRRNVEREVEIMRELQH-PRLIQI 65
           G +G V+  ++     TG   A K +     + K     +   E +++  ++  P L+ +
Sbjct: 35  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94

Query: 66  YDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
           + AF++   + ++L+ I GGELF   +      TE  V I++ +I   +E +H   +++ 
Sbjct: 95  HYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPE--KKLQVLFGTPEFVAPEVVNFDAIGFG- 182
           D+K ENIL    +   + + DFGL+++F  +  ++     GT E++AP++V     G   
Sbjct: 154 DIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 211

Query: 183 -TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLL 241
             D WS+GV+ Y LL+G SPF  + +  + A ++      +     E+S  AKD I++LL
Sbjct: 212 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL 271

Query: 242 LKDRED 247
           +KD + 
Sbjct: 272 MKDPKK 277

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (374), Expect = 5e-44
 Identities = 47/252 (18%), Positives = 95/252 (37%), Gaps = 19/252 (7%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLI-QIYDAFESS 72
           G FG ++          +A KF    +R+D   +  E    + L     I  +Y   +  
Sbjct: 16  GSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73

Query: 73  NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
               +V++L+ G  L + +       + K VA+  +Q+   V+ IH K++++ D+KP+N 
Sbjct: 74  LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132

Query: 133 LC---LTKTGNRIKIIDFGLARKFDPE--------KKLQVLFGTPEFVAPEVVNFDAIGF 181
           L     +K  N I ++DFG+ + +           ++ + L GT  +++           
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192

Query: 182 GTDMWSVGVICYVLLSGLSPFMGETDVQTMANV----TIAQYDFDDECFNEISDDAKDFI 237
             D+ ++G +    L G  P+ G                 Q     E      ++   ++
Sbjct: 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252

Query: 238 RKLLLKDREDAP 249
                   +  P
Sbjct: 253 HYARNLAFDATP 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (370), Expect = 2e-43
 Identities = 47/239 (19%), Positives = 101/239 (42%), Gaps = 8/239 (3%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G++G VY    K   +T+A K +      +     +E  +M+E++HP L+Q+        
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86

Query: 74  VMCVVLELIEGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
              ++ E +  G L + + + +   ++   +     QI   +E++  KN +H D+   N 
Sbjct: 87  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146

Query: 133 LCLTKTGNRIKIIDFGLARKF--DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           L + +    +K+ DFGL+R    D            ++ APE + ++     +D+W+ GV
Sbjct: 147 L-VGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 204

Query: 191 ICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           + + + +         D+  +    + + D+  E      +   + +R     +  D P
Sbjct: 205 LLWEIATYGMSPYPGIDLSQVYE--LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 261

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-43
 Identities = 48/243 (19%), Positives = 99/243 (40%), Gaps = 13/243 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV----GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF 69
           G+FG V++    +      A  +         + R    +E   MR+  HP ++++    
Sbjct: 18  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77

Query: 70  ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKP 129
              N + +++EL   GEL   +    + L   ++ ++  Q+   + ++ SK  +H D+  
Sbjct: 78  TE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 136

Query: 130 ENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF--GTPEFVAPEVVNFDAIGFGTDMWS 187
            N+L    + + +K+ DFGL+R  +     +        +++APE +NF      +D+W 
Sbjct: 137 RNVLV--SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194

Query: 188 VGVICY-VLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDRE 246
            GV  + +L+ G+ PF G  +   +  +   +                  + K    D  
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCPPTLYSLMTKCWAYDPS 251

Query: 247 DAP 249
             P
Sbjct: 252 RRP 254

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  146 bits (369), Expect = 6e-43
 Identities = 54/269 (20%), Positives = 109/269 (40%), Gaps = 46/269 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFES- 71
           GK+  V+          +  K +   K   ++ ++RE++I+  L+  P +I + D  +  
Sbjct: 46  GKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIVKDP 102

Query: 72  -SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPE 130
            S    +V E +   +  +        LT+  +  +M +I + +++ HS  ++H D+KP 
Sbjct: 103 VSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 158

Query: 131 NILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVG 189
           N++ +     ++++ID+GLA  + P ++  V   +  F  PE+ V++    +  DMWS+G
Sbjct: 159 NVM-IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 217

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIA-------------------------------- 217
            +   ++    PF    D                                          
Sbjct: 218 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK 277

Query: 218 --QYDFDDECFNEISDDAKDFIRKLLLKD 244
             +     E  + +S +A DF+ KLL  D
Sbjct: 278 RWERFVHSENQHLVSPEALDFLDKLLRYD 306

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 7e-43
 Identities = 62/270 (22%), Positives = 111/270 (41%), Gaps = 36/270 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAA-KFV--GIAKRNDRRNVEREVEIMREL---QHPRLIQIYD 67
           G +G V++ ++   G    A K V     +     +  REV ++R L   +HP +++++D
Sbjct: 18  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77

Query: 68  AFESS-----NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNV 122
               S       + +V E ++           +  +  + +   M Q+  G++F+HS  V
Sbjct: 78  VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV 137

Query: 123 LHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFG 182
           +H D+KP+NIL    +  +IK+ DFGLAR +  +  L  +  T  + APEV+   +    
Sbjct: 138 VHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 195

Query: 183 TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE------------------ 224
            D+WSVG I   +      F G +DV  +  +        +E                  
Sbjct: 196 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 255

Query: 225 -----CFNEISDDAKDFIRKLLLKDREDAP 249
                   +I +  KD + K L  +     
Sbjct: 256 QPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 7e-43
 Identities = 54/240 (22%), Positives = 104/240 (43%), Gaps = 12/240 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G FG V+      T   +A K +     +      +E ++M++L+H +L+Q+Y       
Sbjct: 28  GCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSEEP 85

Query: 74  VMCVVLELIEGGELFERVIDDDF-VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI 132
           +  +V E +  G L + +  +    L    +     QI  G+ ++   N +H D++  NI
Sbjct: 86  I-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144

Query: 133 LCLTKTGNRIKIIDFGLARKFDPEK--KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGV 190
           L + +     K+ DFGLAR  +  +    Q      ++ APE   +      +D+WS G+
Sbjct: 145 L-VGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 202

Query: 191 ICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAP 249
           +   L + G  P+ G  + + +  V   +  +   C  E  +   D + +   K+ E+ P
Sbjct: 203 LLTELTTKGRVPYPGMVNREVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERP 259

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  144 bits (364), Expect = 1e-42
 Identities = 61/265 (23%), Positives = 113/265 (42%), Gaps = 33/265 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G VY+ +    G T A K + + K ++       RE+ I++EL+H  ++++YD   +
Sbjct: 13  GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V E ++  +L + +   +  L       F+ Q+  G+ + H + VLH D+KP+N
Sbjct: 72  KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130

Query: 132 ILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEV-VNFDAIGFGTDMWSVG 189
           +L   +    +KI DFGLAR F  P +K      T  + AP+V +         D+WSVG
Sbjct: 131 LLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE------------------------- 224
            I   +++G   F G ++   +  +       + +                         
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248

Query: 225 CFNEISDDAKDFIRKLLLKDREDAP 249
               + +   D + K+L  D     
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRI 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-42
 Identities = 49/245 (20%), Positives = 99/245 (40%), Gaps = 15/245 (6%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV-----GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G FGTVY+      G  +                  + +  E  +M  + +P + ++   
Sbjct: 20  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 79

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             +S V  +  +L+  G L + V +    +  + +  +  QI +G+ ++  + ++H D+ 
Sbjct: 80  CLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 138

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEFVAPEVVNFDAIGFGTDM 185
             N+L   KT   +KI DFGLA+    E+K           +++A E +        +D+
Sbjct: 139 ARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 196

Query: 186 WSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           WS GV  + L++ G  P+ G    +  + +   +           + D    + K  + D
Sbjct: 197 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPICTIDVYMIMVKCWMID 253

Query: 245 REDAP 249
            +  P
Sbjct: 254 ADSRP 258

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-42
 Identities = 61/285 (21%), Positives = 108/285 (37%), Gaps = 50/285 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G FG V++ + + TG  +A K V +    +       RE++I++ L+H  ++ + +   +
Sbjct: 21  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80

Query: 72  S--------NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVL 123
                      + +V +  E         +     T   +   M+ +  G+ +IH   +L
Sbjct: 81  KASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKIL 139

Query: 124 HLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV-----LFGTPEFVAPEVV-NFD 177
           H DMK  N+L +T+ G  +K+ DFGLAR F   K  Q         T  +  PE++    
Sbjct: 140 HRDMKAANVL-ITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197

Query: 178 AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI-------- 229
             G   D+W  G I   + +      G T+   +A ++        E +  +        
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257

Query: 230 --------------------SDDAKDFIRKLLLKD---REDAPEV 251
                                  A D I KLL+ D   R D+ + 
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (360), Expect = 5e-42
 Identities = 49/269 (18%), Positives = 98/269 (36%), Gaps = 38/269 (14%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG V++ +            V +      A  + + + +RE  +M E  +P ++++  
Sbjct: 24  GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 83

Query: 68  AFESSNVMCVVLELIEGGELFERV-----------------------IDDDFVLTEKAVA 104
                  MC++ E +  G+L E +                             L+     
Sbjct: 84  VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 143

Query: 105 IFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL-- 162
              RQ+  G+ ++  +  +H D+   N L + +    +KI DFGL+R        +    
Sbjct: 144 CIARQVAAGMAYLSERKFVHRDLATRNCL-VGENMV-VKIADFGLSRNIYSADYYKADGN 201

Query: 163 -FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYD 220
                 ++ PE + ++     +D+W+ GV+ + + S GL P+ G    + +  V      
Sbjct: 202 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI- 260

Query: 221 FDDECFNEISDDAKDFIRKLLLKDREDAP 249
               C      +  + +R    K   D P
Sbjct: 261 --LACPENCPLELYNLMRLCWSKLPADRP 287

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 5e-42
 Identities = 63/273 (23%), Positives = 108/273 (39%), Gaps = 41/273 (15%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESS 72
           G +G V    +    + +A K +     +   +   RE++I+   +H  +I I D   + 
Sbjct: 19  GAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78

Query: 73  NV----MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
            +       ++  + G +L++ +      L+   +  F+ QI  G+++IHS NVLH D+K
Sbjct: 79  TIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLHRDLK 136

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGT----PEFVAPEVV-NFDAIGFGT 183
           P N+L L  T + +KI DFGLAR  DP+               + APE++ N        
Sbjct: 137 PSNLL-LNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE------------------- 224
           D+WSVG I   +LS    F G+  +  + ++         E                   
Sbjct: 195 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254

Query: 225 --------CFNEISDDAKDFIRKLLLKDREDAP 249
                    F      A D + K+L  +     
Sbjct: 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-42
 Identities = 57/265 (21%), Positives = 112/265 (42%), Gaps = 31/265 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G VY+ + K TG  +A K + +    +       RE+ +++EL HP ++++ D   +
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
            N + +V E +               +    +  ++ Q+ +G+ F HS  VLH D+KP+N
Sbjct: 73  ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132

Query: 132 ILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-GTPEFVAPEVV-NFDAIGFGTDMWSVG 189
           +L  T+    IK+ DFGLAR F    +       T  + APE++          D+WS+G
Sbjct: 133 LLINTE--GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190

Query: 190 VICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-------------------------E 224
            I   +++  + F G++++  +  +       D+                         +
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSK 250

Query: 225 CFNEISDDAKDFIRKLLLKDREDAP 249
               + +D +  + ++L  D     
Sbjct: 251 VVPPLDEDGRSLLSQMLHYDPNKRI 275

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-41
 Identities = 46/245 (18%), Positives = 97/245 (39%), Gaps = 13/245 (5%)

Query: 14  GKFGTVYRCKEKATG----MTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA 68
           G+FG VY+   K +     + +A K +        R +   E  IM +  H  +I++   
Sbjct: 18  GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
                 M ++ E +E G L + + + D   +   +   +R I  G++++ + N +H D+ 
Sbjct: 78  ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKK----LQVLFGTPEFVAPEVVNFDAIGFGTD 184
             NIL +       K+ DFGL+R  + + +             + APE +++      +D
Sbjct: 138 ARNIL-VNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 195

Query: 185 MWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKD 244
           +WS G++ + +++       E     +         F      +        + +   ++
Sbjct: 196 VWSFGIVMWEVMTYGERPYWELSNHEVMK--AINDGFRLPTPMDCPSAIYQLMMQCWQQE 253

Query: 245 REDAP 249
           R   P
Sbjct: 254 RARRP 258

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 8e-41
 Identities = 58/263 (22%), Positives = 98/263 (37%), Gaps = 30/263 (11%)

Query: 14  GKFGTVYRCK-----EKATGMTLAAKFVGIAKR-NDRRNVEREVEIMREL-QHPRLIQIY 66
           G FG V         +    MT+A K +  +    +R  +  E++++  L  H  ++ + 
Sbjct: 34  GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93

Query: 67  DAFESSNVMCVVLELIEGGELFERV-----------------IDDDFVLTEKAVAIFMRQ 109
            A        V+ E    G+L   +                  DD+  L  + +  F  Q
Sbjct: 94  GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQV---LFGTP 166
           + +G+ F+ SKN +H D+   NIL     G   KI DFGLAR    +    V        
Sbjct: 154 VAKGMAFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIKNDSNYVVKGNARLPV 211

Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF 226
           +++APE +      F +D+WS G+  + L S  S       V +     + +  F     
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-YKMIKEGFRMLSP 270

Query: 227 NEISDDAKDFIRKLLLKDREDAP 249
                +  D ++     D    P
Sbjct: 271 EHAPAEMYDIMKTCWDADPLKRP 293

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 8e-40
 Identities = 57/269 (21%), Positives = 102/269 (37%), Gaps = 37/269 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G V    +  TG  +A K +          +   RE+ +++ ++H  +I + D F  
Sbjct: 29  GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88

Query: 72  SNVMCVVLELIEGGELFERVIDD---DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
              +    +           +        L E  +   + Q+ +G+ +IH+  ++H D+K
Sbjct: 89  DETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 148

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV-NFDAIGFGTDMWS 187
           P N+         +KI+DFGLAR+ D E    V   T  + APEV+ N+       D+WS
Sbjct: 149 PGNLAV--NEDCELKILDFGLARQADSEMTGYV--VTRWYRAPEVILNWMRYTQTVDIWS 204

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE----------------------- 224
           VG I   +++G + F G   +  +  +         E                       
Sbjct: 205 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 264

Query: 225 ----CFNEISDDAKDFIRKLLLKDREDAP 249
                    S  A + + K+L+ D E   
Sbjct: 265 DFASILTNASPLAVNLLEKMLVLDAEQRV 293

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-39
 Identities = 51/246 (20%), Positives = 95/246 (38%), Gaps = 14/246 (5%)

Query: 14  GKFGTVYRCK---EKATGMTLAAKFV-GIAKRNDRRNVEREVEIMRELQHPRLIQIYDA- 68
           G FG VY           +  A K +  I    +      E  IM++  HP ++ +    
Sbjct: 38  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 97

Query: 69  FESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
             S     VVL  ++ G+L   + ++    T K +  F  Q+ +G++F+ SK  +H D+ 
Sbjct: 98  LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 157

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF-----GTPEFVAPEVVNFDAIGFGT 183
             N +        +K+ DFGLAR    ++   V          +++A E +        +
Sbjct: 158 ARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 215

Query: 184 DMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLK 243
           D+WS GV+ + L++  +P   + +   +    +              D   + + K    
Sbjct: 216 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--EYCPDPLYEVMLKCWHP 273

Query: 244 DREDAP 249
             E  P
Sbjct: 274 KAEMRP 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-39
 Identities = 50/246 (20%), Positives = 99/246 (40%), Gaps = 14/246 (5%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAF-- 69
           G  G V    +      +A K +      +   +   RE+ +M+ + H  +I + + F  
Sbjct: 28  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87

Query: 70  ----ESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHL 125
               E    + +V+EL++        ++ D     + ++  + Q+  G++ +HS  ++H 
Sbjct: 88  QKTLEEFQDVYLVMELMDANLCQVIQMELD----HERMSYLLYQMLCGIKHLHSAGIIHR 143

Query: 126 DMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDM 185
           D+KP N   + K+   +KI+DFGLAR       +     T  + APEV+         D+
Sbjct: 144 DLKPSN--IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201

Query: 186 WSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDR 245
           WSVG I   ++     F G   +     V         E   ++    ++++        
Sbjct: 202 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 261

Query: 246 EDAPEV 251
              P++
Sbjct: 262 LTFPKL 267

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 5e-39
 Identities = 61/267 (22%), Positives = 110/267 (41%), Gaps = 37/267 (13%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFV--GIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +G+V    +  TG+ +A K +          +   RE+ +++ ++H  +I + D F  
Sbjct: 29  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88

Query: 72  SNVMCVVLELIEGGELFERVIDDDF---VLTEKAVAIFMRQICEGVEFIHSKNVLHLDMK 128
           +  +    ++     L    +++      LT+  V   + QI  G+++IHS +++H D+K
Sbjct: 89  ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 148

Query: 129 PENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVV-NFDAIGFGTDMWS 187
           P N+         +KI+DFGLAR  D E        T  + APE++ N+       D+WS
Sbjct: 149 PSNLAV--NEDCELKILDFGLARHTDDEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWS 204

Query: 188 VGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDEC---------------------- 225
           VG I   LL+G + F G   +  +  +         E                       
Sbjct: 205 VGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 264

Query: 226 -----FNEISDDAKDFIRKLLLKDRED 247
                F   +  A D + K+L+ D + 
Sbjct: 265 NFANVFIGANPLAVDLLEKMLVLDSDK 291

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-38
 Identities = 59/266 (22%), Positives = 110/266 (41%), Gaps = 33/266 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRND--RRNVEREVEIMRELQHPRLIQIYDAFES 71
           G +GTV++ K + T   +A K V +   ++    +  RE+ +++EL+H  +++++D   S
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72

Query: 72  SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPEN 131
              + +V E  +          +  +   + V  F+ Q+ +G+ F HS+NVLH D+KP+N
Sbjct: 73  DKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131

Query: 132 ILCLTKTGNRIKIIDFGLARKFD-PEKKLQVLFGTPEFVAPEVV-NFDAIGFGTDMWSVG 189
           +L        +K+ +FGLAR F  P +       T  +  P+V+          DMWS G
Sbjct: 132 LLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189

Query: 190 VICYVLLSGLSP-FMGETDVQTMANVTIAQYDFDDE------------------------ 224
            I   L +   P F G      +  +        +E                        
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249

Query: 225 -CFNEISDDAKDFIRKLLLKDREDAP 249
               +++   +D ++ LL  +     
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRI 275

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 6e-37
 Identities = 44/255 (17%), Positives = 91/255 (35%), Gaps = 24/255 (9%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG VY    K          V I      A   +R     E  +M+E     ++++  
Sbjct: 31  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 90

Query: 68  AFESSNVMCVVLELIEGGELFERV---------IDDDFVLTEKAVAIFMRQICEGVEFIH 118
                    V++EL+  G+L   +                +   +     +I +G+ +++
Sbjct: 91  VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 150

Query: 119 SKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLF---GTPEFVAPEVVN 175
           +   +H D+   N  C+      +KI DFG+ R        +          +++PE + 
Sbjct: 151 ANKFVHRDLAARN--CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208

Query: 176 FDAIGFGTDMWSVGVICYVLLSGL-SPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK 234
                  +D+WS GV+ + + +    P+ G ++ Q +  V         +  +   D   
Sbjct: 209 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL---LDKPDNCPDMLF 265

Query: 235 DFIRKLLLKDREDAP 249
           + +R     + +  P
Sbjct: 266 ELMRMCWQYNPKMRP 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-35
 Identities = 52/264 (19%), Positives = 100/264 (37%), Gaps = 33/264 (12%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIA--------KRNDRRNVEREVEIMREL-QHPRLIQ 64
           G FG V   +          +   +A           D  ++  E+E+M+ + +H  +I 
Sbjct: 24  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 83

Query: 65  IYDAFESSNVMCVVLELIEGGELFERV---------------IDDDFVLTEKAVAIFMRQ 109
           +  A      + V++E    G L E +                + +  L+ K +     Q
Sbjct: 84  LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 143

Query: 110 ICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTP 166
           +  G+E++ SK  +H D+   N+L      N +KI DFGLAR         K        
Sbjct: 144 VARGMEYLASKKCIHRDLAARNVLVTED--NVMKIADFGLARDIHHIDYYKKTTNGRLPV 201

Query: 167 EFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDEC 225
           +++APE +        +D+WS GV+ + + + G SP+ G    +    +   +     + 
Sbjct: 202 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL---KEGHRMDK 258

Query: 226 FNEISDDAKDFIRKLLLKDREDAP 249
            +  +++    +R          P
Sbjct: 259 PSNCTNELYMMMRDCWHAVPSQRP 282

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-33
 Identities = 49/263 (18%), Positives = 96/263 (36%), Gaps = 31/263 (11%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGI------AKRNDRRNVEREVEIMRELQHPRLIQIYD 67
           G FG V          T   + V +      A  ++ R +  E++I+  + H   +    
Sbjct: 24  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83

Query: 68  A--FESSNVMCVVLELIEGGELFERVIDDDF---------------VLTEKAVAIFMRQI 110
               +    + V++E  + G L   +                     LT + +  +  Q+
Sbjct: 84  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 143

Query: 111 CEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPE 167
            +G+EF+ S+  +H D+   NIL L++    +KI DFGLAR    +    +        +
Sbjct: 144 AKGMEFLASRKCIHRDLAARNIL-LSEKNV-VKICDFGLARDIYKDPDYVRKGDARLPLK 201

Query: 168 FVAPEVVNFDAIGFGTDMWSVGVICYVLLSGL-SPFMGETDVQTMANVTIAQYDFDDECF 226
           ++APE +        +D+WS GV+ + + S   SP+ G    +                 
Sbjct: 202 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAP 259

Query: 227 NEISDDAKDFIRKLLLKDREDAP 249
           +  + +    +      +    P
Sbjct: 260 DYTTPEMYQTMLDCWHGEPSQRP 282

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-32
 Identities = 51/277 (18%), Positives = 93/277 (33%), Gaps = 48/277 (17%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN 73
           G+FG V+R K    G  +A K     +       E E+     L+H  ++    A    N
Sbjct: 14  GRFGEVWRGKW--RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNKDN 70

Query: 74  ----VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS--------KN 121
                + +V +  E G LF+ +  + + +T + +         G+  +H           
Sbjct: 71  GTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128

Query: 122 VLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-----KLQVLFGTPEFVAPEVVNF 176
           + H D+K +NIL + K G    I D GLA + D              GT  ++APEV++ 
Sbjct: 129 IAHRDLKSKNIL-VKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 177 DAIGFG------TDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFN--- 227
                        D++++G++ + +    S      D Q      +      +E      
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 228 ---------------EISDDAKDFIRKLLLKDREDAP 249
                          E        +R+    +     
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.4 bits (241), Expect = 3e-24
 Identities = 44/221 (19%), Positives = 86/221 (38%), Gaps = 23/221 (10%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQ--------- 64
           G F TV+  K+      +A K V    +      E E+++++ +      +         
Sbjct: 24  GHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82

Query: 65  ------IYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIH 118
                       +   + +V E++    L      +   +    V    +Q+  G++++H
Sbjct: 83  LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH 142

Query: 119 SK-NVLHLDMKPENIL----CLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEV 173
            +  ++H D+KPEN+L       +   +IKI D G A  +D          T E+ +PEV
Sbjct: 143 RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSPEV 200

Query: 174 VNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANV 214
           +     G G D+WS   + + L++G   F  +       + 
Sbjct: 201 LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.2 bits (184), Expect = 2e-17
 Identities = 32/205 (15%), Positives = 66/205 (32%), Gaps = 48/205 (23%)

Query: 14  GKFGTVYRCKEKATGMTLAAKFVGIAKRNDR------------------RNVEREVEIMR 55
           GK   V+ C  +        KF  +   + +                  R+   E   ++
Sbjct: 11  GKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69

Query: 56  ELQHPRLIQIYDAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVE 115
           +LQ   + ++Y    ++ +M +                + + +  +     +  I E V 
Sbjct: 70  KLQGLAVPKVYAWEGNAVLMEL------------IDAKELYRVRVENPDEVLDMILEEVA 117

Query: 116 FIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVN 175
             + + ++H D+   N+L    +   I IIDF  + +   E          E +  +V N
Sbjct: 118 KFYHRGIVHGDLSQYNVLV---SEEGIWIIDFPQSVEVGEEG-------WREILERDVRN 167

Query: 176 FDAI-----GFGTDMWSVGVICYVL 195
                        D+ S   I  +L
Sbjct: 168 IITYFSRTYRTEKDINS--AIDRIL 190

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	251
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.07
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.44
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.43
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.79
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.78
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.46

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-62  Score=396.63  Aligned_cols=249  Identities=46%  Similarity=0.813  Sum_probs=232.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++........+.+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999999999999999987666666788999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL  162 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~  162 (251)
                      +|++|.+.+....+.+++..++.++.||+.||.|||++|++||||||+|||+..+.++.+||+|||++............
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~  185 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT  185 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence            99999999877666799999999999999999999999999999999999985555789999999999988777777778


Q ss_pred             ccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcc
Q psy11805        163 FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL  242 (251)
Q Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (251)
                      .+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+.......+...+..+|+++++||++||+
T Consensus       186 ~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  265 (350)
T d1koaa2         186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL  265 (350)
T ss_dssp             CSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCC
T ss_pred             cCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence            89999999999999999999999999999999999999999999999999998888888877778999999999999999


Q ss_pred             cCcCCCCCC
Q psy11805        243 KDREDAPEV  251 (251)
Q Consensus       243 ~~p~~Rps~  251 (251)
                      .||++|||+
T Consensus       266 ~dP~~R~t~  274 (350)
T d1koaa2         266 ADPNTRMTI  274 (350)
T ss_dssp             SSGGGSCCH
T ss_pred             CChhHCcCH
Confidence            999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-62  Score=383.07  Aligned_cols=245  Identities=27%  Similarity=0.502  Sum_probs=219.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      +++|++.+.||+|+||+||+|.++.+++.||+|++........+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            35899999999999999999999999999999999876666788899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~  160 (251)
                      ++|++|.+.+...  .+++..++.++.|++.||.|||++||+||||||+|||+  +.+++++|+|||++...... ....
T Consensus        99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl--~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE--CCCCcEeeccchhheeecccccccc
Confidence            9999998877654  49999999999999999999999999999999999999  88999999999999876543 3345


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ..+||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+.....+ ....+..+|+++++||.+|
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~  253 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDFLNRC  253 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHHHHHHH
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHHHHHHH
Confidence            567999999999999999999999999999999999999999998887777666554432 2234467899999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |++||++|||+
T Consensus       254 L~~dP~~R~s~  264 (293)
T d1yhwa1         254 LDMDVEKRGSA  264 (293)
T ss_dssp             TCSSTTTSCCH
T ss_pred             ccCChhHCcCH
Confidence            99999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.3e-62  Score=394.69  Aligned_cols=249  Identities=45%  Similarity=0.838  Sum_probs=232.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++......+...+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999999999999999987665556778899999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcceee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQVL  162 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~~~  162 (251)
                      +|++|.+.+...+..+++..++.++.|++.||.|||++||+||||||+|||+....++.++|+|||++............
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~  188 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  188 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeec
Confidence            99999988877777799999999999999999999999999999999999984446789999999999988877777788


Q ss_pred             ccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHhcc
Q psy11805        163 FGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKLLL  242 (251)
Q Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (251)
                      .+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++...+..+|+++++||++||+
T Consensus       189 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  268 (352)
T d1koba_         189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ  268 (352)
T ss_dssp             CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSC
T ss_pred             cCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence            89999999999999999999999999999999999999999999999999998888888887788999999999999999


Q ss_pred             cCcCCCCCC
Q psy11805        243 KDREDAPEV  251 (251)
Q Consensus       243 ~~p~~Rps~  251 (251)
                      .||++|||+
T Consensus       269 ~dp~~R~s~  277 (352)
T d1koba_         269 KEPRKRLTV  277 (352)
T ss_dssp             SSGGGSCCH
T ss_pred             CChhHCcCH
Confidence            999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-62  Score=377.93  Aligned_cols=241  Identities=29%  Similarity=0.545  Sum_probs=218.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++...   +....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999999999999999998532   2345778899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||+++++|.+.+...+ .+++..+..++.|++.||.|||++|++||||||+|||+  +.++++||+|||++...... ..
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill--~~~~~~kl~DFG~a~~~~~~-~~  161 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKIADFGWSVHAPSS-RR  161 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEECCCCSCSCCCCC-CC
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee--cCCCCEeecccceeeecCCC-cc
Confidence            9999999999887654 69999999999999999999999999999999999999  88999999999999765443 33


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+...++.......+    +.+|+++++||.+
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~  237 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISR  237 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHH
T ss_pred             cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHHH
Confidence            456799999999999999999999999999999999999999999998888888877665544    5689999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||++|||+
T Consensus       238 ~L~~dp~~R~t~  249 (263)
T d2j4za1         238 LLKHNPSQRPML  249 (263)
T ss_dssp             HTCSSGGGSCCH
T ss_pred             HccCCHhHCcCH
Confidence            999999999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-62  Score=388.47  Aligned_cols=250  Identities=32%  Similarity=0.628  Sum_probs=209.2

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++++|++.+.||+|+||+||+|+++.+++.||+|++.... ......+.+|+.++++++||||+++++++.+++..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4678999999999999999999999999999999986433 223567889999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-cCCCcEEEeecccccccCCCCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      ||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++.. +.++.++|+|||++...+....
T Consensus        87 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          87 QLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             eccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            999999999988765 46999999999999999999999999999999999999843 3478999999999988766666


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+.+.+..+|+++++||+
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  245 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR  245 (307)
T ss_dssp             -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHH
Confidence            66778999999999999999999999999999999999999999999999999999888888887777899999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       246 ~~L~~dP~~R~s~  258 (307)
T d1a06a_         246 HLMEKDPEKRFTC  258 (307)
T ss_dssp             HHSCSSGGGSCCH
T ss_pred             HHccCCHhHCcCH
Confidence            9999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=381.66  Aligned_cols=246  Identities=24%  Similarity=0.414  Sum_probs=218.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      +.|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56999999999999999999999999999999997766677889999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Cccee
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKLQV  161 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~~~  161 (251)
                      ++++|.+.+...+..+++..+..++.|++.||.|||++||+||||||+|||+  +.++++||+|||++...... .....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll--~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE--CCCCCEEEEechhhhccCCCcccccc
Confidence            9999999887766679999999999999999999999999999999999999  88999999999999764322 12234


Q ss_pred             eccCcccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        162 LFGTPEFVAPEVVN-----FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       162 ~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      ..||+.|+|||++.     +..++.++||||||+++|+|++|..||.+.+..+...++.....+. ...+..+|+++++|
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~~~~l  248 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSNFKDF  248 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-CSSGGGSCHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCccccCCHHHHHH
Confidence            57899999999984     4567899999999999999999999999998888887777665432 23346789999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |++||+.||++|||+
T Consensus       249 i~~~L~~dp~~R~t~  263 (288)
T d2jfla1         249 LKKCLEKNVDARWTT  263 (288)
T ss_dssp             HHHHSCSSTTTSCCH
T ss_pred             HHHHccCChhHCcCH
Confidence            999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-61  Score=378.41  Aligned_cols=242  Identities=29%  Similarity=0.518  Sum_probs=216.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++...   .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999998642   2345678999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      ||++|++|.+.+...+ .+++..++.++.|++.||.|||+.||+||||||+||++  +.++.++|+|||++.......  
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll--~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTCEECC-----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc--CCCceEEecccccceecccCCcc
Confidence            9999999988877654 69999999999999999999999999999999999999  899999999999998764322  


Q ss_pred             -cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        158 -KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                       .....+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+...++......++    ..+++++++|
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  240 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDL  240 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHHH
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence             22345799999999999999999999999999999999999999999998888888877765443    5789999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |++||+.||++|||+
T Consensus       241 i~~~L~~dP~~R~t~  255 (288)
T d1uu3a_         241 VEKLLVLDATKRLGC  255 (288)
T ss_dssp             HHTTSCSSGGGSTTS
T ss_pred             HHHHccCCHhHCcCH
Confidence            999999999999985

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-61  Score=376.54  Aligned_cols=246  Identities=25%  Similarity=0.434  Sum_probs=207.9

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc-cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR-NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      -++|++.+.||+|+||+||+|.++.+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            4789999999999999999999999999999999865432 235678999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC---
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK---  157 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~---  157 (251)
                      |+++++|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||+  +.++++||+|||++.......   
T Consensus        84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl--~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--CTTCCEEECCCTTCEECEETTEEC
T ss_pred             ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE--CCCCCEEEccchhheeeccCCccc
Confidence            99999999988654 469999999999999999999999999999999999999  889999999999998754322   


Q ss_pred             cceeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                      .....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.................. ....+..+|+++.+|
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGSCHHHHHH
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccCCHHHHHH
Confidence            2344579999999999988776 57899999999999999999999876554333322222222 223346789999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |++||+.||++|||+
T Consensus       240 i~~~L~~dP~~R~t~  254 (271)
T d1nvra_         240 LHKILVENPSARITI  254 (271)
T ss_dssp             HHHHSCSSTTTSCCH
T ss_pred             HHHHcCCChhHCcCH
Confidence            999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-61  Score=379.00  Aligned_cols=248  Identities=45%  Similarity=0.834  Sum_probs=226.2

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc------ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK------RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNV   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (251)
                      +.++|++.+.||+|+||+||+|+++.+++.||+|++....      ....+.+.+|+.++++++||||+++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3578999999999999999999999999999999985322      2236789999999999999999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC----cEEEeecccc
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN----RIKIIDFGLA  150 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~----~~~l~df~~~  150 (251)
                      .|+||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++||||||+||++  +.++    .++++|||++
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill--~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--SCSSSSSCCEEECCCTTC
T ss_pred             EEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEE--ecCCCcccceEecchhhh
Confidence            999999999999999887654 69999999999999999999999999999999999998  5554    5999999999


Q ss_pred             cccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCC
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEIS  230 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (251)
                      .............+++.|+|||.+.+..++.++||||+|+++|+|++|..||.+.+..+....+......++...++.+|
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence            88776666667789999999999999999999999999999999999999999999999999988888877777778899


Q ss_pred             HHHHHHHHHhcccCcCCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+++||++||+.||++|||+
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~  265 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTI  265 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCH
T ss_pred             HHHHHHHHHHccCChhHCcCH
Confidence            999999999999999999985

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-60  Score=380.62  Aligned_cols=250  Identities=38%  Similarity=0.730  Sum_probs=230.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      +-++|++.+.||+|+||+||+|.++.+++.||+|++... ..+...+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            457999999999999999999999999999999998653 3345678899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      |++|++|.+.+...+..+++..++.++.||+.||.|||+.||+||||||+||++..+..+.++|+|||++..........
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~  161 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence            99999999999877767999999999999999999999999999999999999844456689999999998877766667


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHHh
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRKL  240 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (251)
                      ...+++.|+|||...+..++.++||||||+++|+|++|..||...+..+...++......++...++.+|+++++||++|
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  241 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence            77899999999999999999999999999999999999999999999999999998888888878889999999999999


Q ss_pred             cccCcCCCCCC
Q psy11805        241 LLKDREDAPEV  251 (251)
Q Consensus       241 l~~~p~~Rps~  251 (251)
                      |..||++|||+
T Consensus       242 L~~dp~~R~s~  252 (321)
T d1tkia_         242 LVKERKSRMTA  252 (321)
T ss_dssp             SCSSGGGSCCH
T ss_pred             ccCChhHCcCH
Confidence            99999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-60  Score=371.14  Aligned_cols=245  Identities=25%  Similarity=0.448  Sum_probs=205.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee--CCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES--SNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l   77 (251)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++....  ....+.+.+|++++++++||||+++++++.+  ++..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            478999999999999999999999999999999986543  3346778999999999999999999999864  456899


Q ss_pred             EEEeccCCchhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC-----ceecCCCCCcEEEeecCCCcEEEeeccc
Q psy11805         78 VLELIEGGELFERVID---DDFVLTEKAVAIFMRQICEGVEFIHSKN-----VLHLDMKPENILCLTKTGNRIKIIDFGL  149 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~g-----i~h~dl~~~nil~~~~~~~~~~l~df~~  149 (251)
                      ||||+++++|.+++..   .+..+++..++.++.|++.||.|||+.|     |+||||||+|||+  +.++.+||+|||+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll--~~~~~vkl~DFG~  160 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGL  160 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE--CTTSCEEECCHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc--CCCCcEEEeeccc
Confidence            9999999999998764   3456999999999999999999999976     9999999999999  8899999999999


Q ss_pred             ccccCCCC-cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccC
Q psy11805        150 ARKFDPEK-KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNE  228 (251)
Q Consensus       150 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (251)
                      +....... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..+....   .+..
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~  237 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYR  237 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTT
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence            98765433 2345678999999999999999999999999999999999999999998888888877765543   2357


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        229 ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       229 ~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +|+++.+||++||+.||++|||+
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~  260 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSV  260 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCHHHHHHHHHHcCCChhHCcCH
Confidence            89999999999999999999985

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-59  Score=374.09  Aligned_cols=241  Identities=29%  Similarity=0.521  Sum_probs=219.4

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++++.||+|+||+||+|+++.+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            6899999999999999999999999999999998643   2345678899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCC-CCc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDP-EKK  158 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~-~~~  158 (251)
                      ||++|++|.+.+...+ .++++.++.++.|++.||.|||++||+||||||+|||+  +.+|+++|+|||++..... ...
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl--~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTTCC
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe--cCCCCEEEeecccccccccCCcc
Confidence            9999999988887654 69999999999999999999999999999999999999  8999999999999987543 344


Q ss_pred             ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        159 LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......++    ..+|+++++||+
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli~  237 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLA  237 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHH
Confidence            4567899999999999999999999999999999999999999999999888888877765544    678999999999


Q ss_pred             HhcccCcCCCCC
Q psy11805        239 KLLLKDREDAPE  250 (251)
Q Consensus       239 ~~l~~~p~~Rps  250 (251)
                      +||++||++||+
T Consensus       238 ~~L~~dP~~R~~  249 (337)
T d1o6la_         238 GLLKKDPKQRLG  249 (337)
T ss_dssp             HHTCSSTTTSTT
T ss_pred             hhccCCchhhcc
Confidence            999999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.5e-59  Score=364.04  Aligned_cols=248  Identities=31%  Similarity=0.577  Sum_probs=224.2

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc---------chHHHHHHHHHHHHcC-CCceeeEeEEEe
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN---------DRRNVEREVEIMRELQ-HPRLIQIYDAFE   70 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---------~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   70 (251)
                      +.++|++.+.||+|+||+||+|++..+++.||+|++......         ..+.+.+|+.++++++ ||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            468999999999999999999999999999999998643321         2346889999999997 999999999999


Q ss_pred             eCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccc
Q psy11805         71 SSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLA  150 (251)
Q Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~  150 (251)
                      +++..|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++|++||||||+||++  +.++.+||+|||++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill--~~~~~~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL--DDDMNIKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTCCEEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE--cCCCCeEEccchhe
Confidence            9999999999999999999997754 69999999999999999999999999999999999999  99999999999999


Q ss_pred             cccCCCCcceeeccCccccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNF------DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE  224 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (251)
                      .............||+.|+|||.+.+      ..++.++||||+|+++|+|++|+.||.+.+..+....+..+...+..+
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            98776666666789999999999853      346789999999999999999999999999988888888888777777


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.++|+++++||++||++||++|||+
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~  264 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTA  264 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCH
Confidence            778899999999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.4e-59  Score=369.31  Aligned_cols=240  Identities=23%  Similarity=0.384  Sum_probs=210.8

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .|++.+.||+|+||+||+|.+..+++.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999865432   235678899999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      |+++++|....... ..+++..++.++.|++.||.|||++||+||||||+|||+  +.++++||+|||++......   .
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl--~~~~~~Kl~DFG~a~~~~~~---~  169 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA---N  169 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSSB---C
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE--CCCCCEEEeecccccccCCC---C
Confidence            99998886555443 479999999999999999999999999999999999999  89999999999999875433   3


Q ss_pred             eeccCccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNF---DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ...||+.|+|||++.+   ..++.++||||||+++|+|++|..||.+.+..+...++.....+...  ...+|+++++||
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li  247 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRNFV  247 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHHHHHH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHHHHHH
Confidence            4579999999999864   35788999999999999999999999998888887777666544333  256899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      .+||+.||++|||+
T Consensus       248 ~~~L~~dP~~Rpt~  261 (309)
T d1u5ra_         248 DSCLQKIPQDRPTS  261 (309)
T ss_dssp             HHHTCSSGGGSCCH
T ss_pred             HHHCcCChhHCcCH
Confidence            99999999999985

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.5e-58  Score=365.72  Aligned_cols=238  Identities=27%  Similarity=0.535  Sum_probs=216.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++++.||+|+||+||+|+++.+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5899999999999999999999999999999998632   2345778999999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      ||++|++|...+.... .+++..++.++.|++.||.|||++||+||||||+|||+  +.++++||+|||++......  .
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl--~~~g~vkL~DFG~a~~~~~~--~  158 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--DKNGHIKITDFGFAKYVPDV--T  158 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--CTTSCEEECCCSSCEECSSC--B
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE--cCCCCEEEecCccceEeccc--c
Confidence            9999999988776654 68999999999999999999999999999999999999  89999999999999876433  3


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+...++..+....+    ..+|++++++|++
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~  234 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSR  234 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHH
T ss_pred             ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            456799999999999999999999999999999999999999999999998888887765544    5689999999999


Q ss_pred             hcccCcCCCC
Q psy11805        240 LLLKDREDAP  249 (251)
Q Consensus       240 ~l~~~p~~Rp  249 (251)
                      ||+.||.+|+
T Consensus       235 ~L~~dp~~R~  244 (316)
T d1fota_         235 LITRDLSQRL  244 (316)
T ss_dssp             HTCSCTTTCT
T ss_pred             HhhhCHHhcc
Confidence            9999999997

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-58  Score=357.25  Aligned_cols=241  Identities=24%  Similarity=0.400  Sum_probs=204.3

Q ss_pred             cC-CcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee----CCEEE
Q psy11805          4 HQ-NQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES----SNVMC   76 (251)
Q Consensus         4 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~   76 (251)
                      +| ++.++||+|+||+||+|.+..+++.||+|.+....  ....+.+.+|++++++++||||+++++++.+    ++..+
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            44 77889999999999999999999999999986433  3346778999999999999999999999865    45689


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEeec-CCCcEEEeeccccccc
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKN--VLHLDMKPENILCLTK-TGNRIKIIDFGLARKF  153 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~g--i~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~  153 (251)
                      +||||+++++|.+++...+ .+++..++.++.|++.||.|||++|  |+||||||+|||+  + .++.+||+|||++...
T Consensus        89 ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl--~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCTTGGGGC
T ss_pred             EEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhcee--eCCCCCEEEeecCcceec
Confidence            9999999999999887654 6999999999999999999999999  9999999999998  5 4789999999999764


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhccccCCCccccCCCHH
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQT-MANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      .. .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+. ...+..+..  +.......+++
T Consensus       166 ~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~  241 (270)
T d1t4ha_         166 RA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPE  241 (270)
T ss_dssp             CT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHH
T ss_pred             cC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCCHH
Confidence            43 33455679999999999865 589999999999999999999999987655444 444443322  23344678999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +++||.+||+.||++|||+
T Consensus       242 ~~~li~~~l~~dp~~R~s~  260 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSI  260 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHccCCHhHCcCH
Confidence            9999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.8e-58  Score=362.79  Aligned_cols=247  Identities=23%  Similarity=0.408  Sum_probs=211.5

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc---cchHHHHHHHHHHHHcCCCceeeEeEEEeeCC----
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR---NDRRNVEREVEIMRELQHPRLIQIYDAFESSN----   73 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   73 (251)
                      +.++|++.+.||+|+||+||+|.+..+++.||+|++.....   .....+.+|+++++.++||||+++++++..++    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            46899999999999999999999999999999999864332   23567899999999999999999999987643    


Q ss_pred             EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeeccccccc
Q psy11805         74 VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKF  153 (251)
Q Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~  153 (251)
                      ..|+||||++|++|.+.+...+ .+++..+..++.|++.||.|||++|++||||||+||++  +.++..+++|||.+...
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll--~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--ETTSCEEECCCTTCEEC
T ss_pred             eEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc--Cccccceeehhhhhhhh
Confidence            4899999999999988876654 69999999999999999999999999999999999999  89999999999988654


Q ss_pred             CCCC----cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCC
Q psy11805        154 DPEK----KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       154 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (251)
                      ....    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+...++.......+...+..+
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence            3322    234457899999999999999999999999999999999999999999888888777777666666666789


Q ss_pred             CHHHHHHHHHhcccCcCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps  250 (251)
                      |+++.++|++||++||.+||+
T Consensus       242 s~~l~~li~~~L~~dp~~R~~  262 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQ  262 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCS
T ss_pred             CHHHHHHHHHHccCCHhHCHh
Confidence            999999999999999999994

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-58  Score=361.99  Aligned_cols=243  Identities=20%  Similarity=0.336  Sum_probs=208.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.. +....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECC-ccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            578899999999999999999999999999999864 3445778999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         83 EGGELFERVID-DDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        83 ~~~~L~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      ++++|.+.+.. ....+++..+..++.|++.||.|||++||+||||||+|||+  +.++++||+|||++.........  
T Consensus        96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl--~~~~~~Kl~DFG~a~~~~~~~~~~~  173 (287)
T d1opja_          96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAH  173 (287)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred             cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE--CCCCcEEEccccceeecCCCCceee
Confidence            99999998875 34568999999999999999999999999999999999999  88999999999999876544332  


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|||++|..||. ..+..+....+..+ ..+  +.+..+|+++.+||.
T Consensus       174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~--~~~~~~~~~l~~li~  250 (287)
T d1opja_         174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM--ERPEGCPEKVYELMR  250 (287)
T ss_dssp             TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC--CCCTTCCHHHHHHHH
T ss_pred             ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC--CCCccchHHHHHHHH
Confidence            22347889999999999999999999999999999999666554 44554444444333 322  334678999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       251 ~cl~~dP~~Rps~  263 (287)
T d1opja_         251 ACWQWNPSDRPSF  263 (287)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHcCCCHhHCcCH
Confidence            9999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-59  Score=371.62  Aligned_cols=245  Identities=21%  Similarity=0.397  Sum_probs=205.6

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999999999999999986543 3346788999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSK-NVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |++|++|.+++...+ .+++..++.++.|++.||.|||++ ||+||||||+|||+  +.++++||+|||+|....... .
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~~~~-~  160 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSM-A  160 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE--CTTCCEEECCCCCCHHHHHHT-C
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE--CCCCCEEEeeCCCccccCCCc-c
Confidence            999999999887654 699999999999999999999974 99999999999999  899999999999998754322 2


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------------------------
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVT------------------------  215 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------------------------  215 (251)
                      ...+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+......                        
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY  240 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred             ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence            34579999999999999999999999999999999999999998765432211000                        


Q ss_pred             -----------------hccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        216 -----------------IAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       216 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                       .... .+......++.++++||++||+.||++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta  292 (322)
T d1s9ja_         241 GMDSRPPMAIFELLDYIVNEP-PPKLPSGVFSLEFQDFVNKCLIKNPAERADL  292 (322)
T ss_dssp             -----CCCCHHHHHHHHHTSC-CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             ccccccchhHHHHHhhhhccC-CccCccccCCHHHHHHHHHHcCCChhHCcCH
Confidence                             0000 0000112367899999999999999999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-58  Score=364.44  Aligned_cols=242  Identities=26%  Similarity=0.465  Sum_probs=214.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHH-HcCCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMR-ELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++...   .....+.+..|...+. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            6799999999999999999999999999999998642   2334556667777654 68999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-C
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-K  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~  157 (251)
                      |||+++++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+|||+  +.+++++|+|||++...... .
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~--~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee--cCCCceeccccchhhhcccccc
Confidence            99999999999887654 69999999999999999999999999999999999999  89999999999999865433 3


Q ss_pred             cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHH
Q psy11805        158 KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFI  237 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (251)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++..+....+    ..+|+++++||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  234 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLL  234 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHH
Confidence            33446799999999999999999999999999999999999999999999888888877655443    57899999999


Q ss_pred             HHhcccCcCCCCCC
Q psy11805        238 RKLLLKDREDAPEV  251 (251)
Q Consensus       238 ~~~l~~~p~~Rps~  251 (251)
                      ++||+.||++|||+
T Consensus       235 ~~~L~~dP~~R~s~  248 (320)
T d1xjda_         235 VKLFVREPEKRLGV  248 (320)
T ss_dssp             HHHSCSSGGGSBTT
T ss_pred             HHhcccCCCCCcCH
Confidence            99999999999985

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-58  Score=359.20  Aligned_cols=244  Identities=22%  Similarity=0.383  Sum_probs=202.1

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      .++|++.+.||+|+||+||+|+.+   ..||+|++....  ....+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            368999999999999999999754   369999986432  3457889999999999999999999998754 4579999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--  157 (251)
                      ||+++++|.+++...+..+++..+..++.|++.||.|||++||+||||||+|||+  +.++++||+|||++.......  
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl--~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL--HEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--ETTSSEEECCCCCSCC-------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE--cCCCCEEEccccceeeccccCCc
Confidence            9999999999998777789999999999999999999999999999999999999  899999999999997754322  


Q ss_pred             -cceeeccCcccccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-ccccCC-CccccCCCH
Q psy11805        158 -KLQVLFGTPEFVAPEVVNFD---AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTI-AQYDFD-DECFNEISD  231 (251)
Q Consensus       158 -~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~  231 (251)
                       ......+|+.|+|||++.+.   .++.++||||||+++|||+||+.||.+.+.......... +...+. ......+|+
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  240 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK  240 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence             22345689999999998643   478899999999999999999999998776655444433 332222 234567899


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      ++.+||.+||+.||++|||+
T Consensus       241 ~l~~li~~cl~~dp~~RPt~  260 (276)
T d1uwha_         241 AMKRLMAECLKKKRDERPLF  260 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHcCCCHhHCcCH
Confidence            99999999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-58  Score=362.92  Aligned_cols=244  Identities=22%  Similarity=0.345  Sum_probs=201.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCc---eEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGM---TLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||+||+|.++.+++   .|++|.+.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            578999999999999999999976654   57888875432 33467899999999999999999999999999999999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+++......+++..+..++.|++.||.|||+.|++||||||+|||+  +.++.+||+|||++........
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl--~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE--CCCCcEEECCcccceEccCCCC
Confidence            99999999999888777779999999999999999999999999999999999999  8999999999999987643322


Q ss_pred             c------eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        159 L------QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       159 ~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      .      ....+++.|+|||.+.+..++.++||||||+++|||+| |..||.+.+..+....+..+...   +.+..+|+
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~  260 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---PPPMDCPS  260 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCccchH
Confidence            2      12346889999999999999999999999999999998 89999999988888777655332   22357899


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+||.+||+.||++|||+
T Consensus       261 ~l~~li~~cl~~~P~~RPs~  280 (299)
T d1jpaa_         261 ALHQLMLDCWQKDRNHRPKF  280 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHcCCCHhHCcCH
Confidence            99999999999999999984

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-57  Score=351.55  Aligned_cols=243  Identities=19%  Similarity=0.323  Sum_probs=215.2

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++|++.++||+|+||+||+|+++ ++..||+|+++.. ....+.+.+|+..+++++||||+++++++.+++..++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            378999999999999999999985 6778999998653 33567899999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc--c
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK--L  159 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~--~  159 (251)
                      +++++|.+.+......+++..++.++.|+++||.|||+.|++||||||+||++  +.++.+||+|||++........  .
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill--~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE--CTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE--cCCCcEEECcchhheeccCCCceee
Confidence            99999999887777779999999999999999999999999999999999999  8999999999999976543322  2


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...+..+....+..+...   ..+...|.++.+||+
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHH
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---CCcccccHHHHHHHH
Confidence            23458889999999999999999999999999999998 89999999998888888765432   223678999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       236 ~cl~~dP~~RPt~  248 (258)
T d1k2pa_         236 SCWHEKADERPTF  248 (258)
T ss_dssp             HTTCSSGGGSCCH
T ss_pred             HHccCCHhHCcCH
Confidence            9999999999984

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-57  Score=365.98  Aligned_cols=238  Identities=27%  Similarity=0.488  Sum_probs=216.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccc---cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA---KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++|++++.||+|+||+||+|+++.+++.||+|++...   .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6899999999999999999999999999999998532   2345678899999999999999999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL  159 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~  159 (251)
                      |++.+++|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+|||+  +.++++||+|||++......  .
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl--~~~g~ikL~DFG~a~~~~~~--~  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC--B
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc--CCCCCEEeeeceeeeecccc--c
Confidence            9999999988887664 69999999999999999999999999999999999999  88999999999999876533  3


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++.......+    ..+|+++.+||++
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~  271 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRN  271 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHHH
T ss_pred             ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHH
Confidence            445799999999999999999999999999999999999999999998888888877765544    5789999999999


Q ss_pred             hcccCcCCCC
Q psy11805        240 LLLKDREDAP  249 (251)
Q Consensus       240 ~l~~~p~~Rp  249 (251)
                      ||+.||.+|+
T Consensus       272 ~L~~dP~kR~  281 (350)
T d1rdqe_         272 LLQVDLTKRF  281 (350)
T ss_dssp             HSCSCTTTCT
T ss_pred             HhhhCHHhcc
Confidence            9999999995

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=355.03  Aligned_cols=242  Identities=21%  Similarity=0.348  Sum_probs=203.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||+||+|.+. ++..||+|++.. .....+.+.+|++.+++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            68999999999999999999987 466899999864 3345678999999999999999999999999999999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc--ce
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK--LQ  160 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~--~~  160 (251)
                      ++++|.+++......++++.++.++.|++.||.|||+.+++||||||+||++  +.++.+||+|||++........  ..
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE--CGGGCEEECSCC--------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee--cCCCCeEecccchheeccCCCceeec
Confidence            9999999988777789999999999999999999999999999999999999  8899999999999977644322  23


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...+|+.|+|||.+.+..++.++||||||+++|||+| |.+||...+..+....+..+....   .+..+|+++.+||.+
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVYQIMNH  237 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHH
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHHHHHH
Confidence            3568899999999999999999999999999999999 677788778777777776654322   235679999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||++|||+
T Consensus       238 cl~~~p~~Rps~  249 (263)
T d1sm2a_         238 CWKERPEDRPAF  249 (263)
T ss_dssp             HTCSSGGGSCCH
T ss_pred             HccCCHhHCcCH
Confidence            999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=356.37  Aligned_cols=243  Identities=23%  Similarity=0.414  Sum_probs=208.9

Q ss_pred             ccCCccc-ccccCCceEEEEEEEcc--CCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHS-AFSFGKFGTVYRCKEKA--TGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~-~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|.+.+ +||+|+||+||+|.++.  ++..||+|++.... ....+.+.+|++++++++||||+++++++.++ ..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            5677777 49999999999998764  34579999986433 33467899999999999999999999998764 47899


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCc
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKK  158 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~  158 (251)
                      |||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||++  +.++.+||+|||++........
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL--VNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--EETTEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee--ccCCceeeccchhhhccccccc
Confidence            99999999999887766789999999999999999999999999999999999999  8899999999999987654332


Q ss_pred             c----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        159 L----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       159 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      .    ....+|+.|+|||.+.+..++.++||||||+++|||+| |..||...+..+....+..+...   +.++.+|+++
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l  241 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECPPEL  241 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTCCHHH
T ss_pred             ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHH
Confidence            2    23357889999999998999999999999999999998 99999998888888777665432   2336789999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .+||.+||+.||++|||+
T Consensus       242 ~~li~~cl~~~p~~RPs~  259 (285)
T d1u59a_         242 YALMSDCWIYKWEDRPDF  259 (285)
T ss_dssp             HHHHHHTTCSSGGGSCCH
T ss_pred             HHHHHHHcCCCHhHCcCH
Confidence            999999999999999984

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=361.95  Aligned_cols=245  Identities=21%  Similarity=0.363  Sum_probs=208.1

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCc-----eEEEEEeccc-cccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGM-----TLAAKFVGIA-KRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~K~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   75 (251)
                      ++|++.+.||+|+||+||+|.+..+++     .|++|.+... .......+.+|+..++++ +||||+++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            678999999999999999999876543     6888887543 334567889999999998 799999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEE
Q psy11805         76 CVVLELIEGGELFERVIDDD----------------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENIL  133 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil  133 (251)
                      ++||||+++++|.+++....                      ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            99999999999999987643                      24899999999999999999999999999999999999


Q ss_pred             EeecCCCcEEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q psy11805        134 CLTKTGNRIKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQ  209 (251)
Q Consensus       134 ~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  209 (251)
                      +  +.++++||+|||+++........   ....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+
T Consensus       197 l--~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         197 V--THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             E--ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             c--ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            9  89999999999999775443322   23457999999999999999999999999999999998 899999877766


Q ss_pred             HHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        210 TMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ...++.....+++.  +..+|+++++||.+||+.||++|||+
T Consensus       275 ~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~  314 (325)
T d1rjba_         275 NFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSF  314 (325)
T ss_dssp             HHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCH
Confidence            66666555544433  36789999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=364.80  Aligned_cols=245  Identities=32%  Similarity=0.560  Sum_probs=207.9

Q ss_pred             CccCCccc-ccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHH-cCCCceeeEeEEEee----CCEE
Q psy11805          2 TTHQNQHS-AFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRE-LQHPRLIQIYDAFES----SNVM   75 (251)
Q Consensus         2 ~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~----~~~~   75 (251)
                      -++|++.. .||+|+||+||+|.+..+++.||+|++..     ...+.+|+.++.+ .+||||+++++++.+    +..+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            36899875 59999999999999999999999999742     4567889988655 489999999999875    4678


Q ss_pred             EEEEEeccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeeccccccc
Q psy11805         76 CVVLELIEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLARKF  153 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~~~~  153 (251)
                      |+||||++|++|.+++...+ ..+++..++.++.|++.||.|||+.|++||||||+||++... ..+.++|+|||++...
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence            99999999999999997653 469999999999999999999999999999999999998332 2567999999999887


Q ss_pred             CCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhccccCCCccccCC
Q psy11805        154 DPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMA----NVTIAQYDFDDECFNEI  229 (251)
Q Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~  229 (251)
                      .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...    .+......++.+.+..+
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (335)
T d2ozaa1         165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  244 (335)
T ss_dssp             CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred             cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence            77666677789999999999999999999999999999999999999998766544433    33334444555556679


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      |+++++||++||+.||++|||+
T Consensus       245 s~~~~~li~~~L~~dP~~R~s~  266 (335)
T d2ozaa1         245 SEEVKMLIRNLLKTEPTQRMTI  266 (335)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CHHHHHHHHHHccCChhHCcCH
Confidence            9999999999999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.7e-56  Score=362.99  Aligned_cols=243  Identities=25%  Similarity=0.432  Sum_probs=203.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc---ccchHHHHHH---HHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK---RNDRRNVERE---VEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      ++|++.+.||+|+||+||+|++..+++.||+|++....   ......+.+|   +..++.++||||+++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            68999999999999999999999999999999985322   2223334444   55666678999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +||||++|++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+|||+  +.++.+||+|||++......
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl--~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CSSSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE--cCCCcEEEeeeceeeecCCC
Confidence            9999999999999887654 68999999999999999999999999999999999999  89999999999999876544


Q ss_pred             CcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHH
Q psy11805        157 KKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKD  235 (251)
Q Consensus       157 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (251)
                      . .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+... +...........+..+|+++++
T Consensus       161 ~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~  238 (364)
T d1omwa3         161 K-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRS  238 (364)
T ss_dssp             C-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHHHHH
T ss_pred             c-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHHHHH
Confidence            3 345579999999999864 568999999999999999999999998765433222 2222233334445689999999


Q ss_pred             HHHHhcccCcCCCCC
Q psy11805        236 FIRKLLLKDREDAPE  250 (251)
Q Consensus       236 li~~~l~~~p~~Rps  250 (251)
                      ||.+||+.||++|||
T Consensus       239 li~~~L~~dP~~R~t  253 (364)
T d1omwa3         239 LLEGLLQRDVNRRLG  253 (364)
T ss_dssp             HHHHHTCSSTTTSTT
T ss_pred             HHHHHcccCHHHhCC
Confidence            999999999999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=352.74  Aligned_cols=247  Identities=23%  Similarity=0.392  Sum_probs=207.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.....  .....+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            689999999999999999999999999999999865432  246789999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC-Ccc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE-KKL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~-~~~  159 (251)
                      ++.++.+..........+++..++.++.|++.||.|||++||+||||||+|||+  +.++.++|+|||.+...... ...
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~--~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee--cccCcceeccCCcceeccCCcccc
Confidence            998755544444555679999999999999999999999999999999999999  89999999999999876543 333


Q ss_pred             eeeccCcccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc--------------
Q psy11805        160 QVLFGTPEFVAPEVVNFDA-IGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE--------------  224 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  224 (251)
                      ....+++.|+|||.+.... ++.++||||||+++|+|++|+.||.+.+..+...++..........              
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            4557999999999876655 5789999999999999999999999988877766654332221111              


Q ss_pred             -----------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 -----------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 -----------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                 ....++.++++||++||+.||++|||+
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~  277 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA  277 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH
Confidence                       113567899999999999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=349.23  Aligned_cols=241  Identities=24%  Similarity=0.386  Sum_probs=205.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||+||+|.++ ++..||+|++... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            68899999999999999999986 5678999998643 3456789999999999999999999998765 4568999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc--
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL--  159 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~--  159 (251)
                      ++++|.+.+... +..+++..+..|+.|++.||.|||+.|++||||||+||++  +.++.+||+|||++.........  
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll--~~~~~~Kl~DFGla~~~~~~~~~~~  167 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV--SDTLSCKIADFGLARLIEDNEYTAR  167 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CTTSCEEECCCTTCEECSSSCEECC
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee--ecccceeeccccceEEccCCccccc
Confidence            999998876543 2358999999999999999999999999999999999999  99999999999999876543322  


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|||+| |.+||...+..+....+..+....   .+..+|+++.+||.
T Consensus       168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~  244 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEELYQLMR  244 (272)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHH
T ss_pred             cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CcccChHHHHHHHH
Confidence            23457889999999998899999999999999999999 566677777777777776553322   23678999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       245 ~cl~~~P~~Rpt~  257 (272)
T d1qpca_         245 LCWKERPEDRPTF  257 (272)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHcCCCHhHCcCH
Confidence            9999999999984

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-56  Score=346.54  Aligned_cols=236  Identities=22%  Similarity=0.373  Sum_probs=200.7

Q ss_pred             cccccCCceEEEEEEEcc--CCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEeccC
Q psy11805          9 SAFSFGKFGTVYRCKEKA--TGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELIEG   84 (251)
Q Consensus         9 ~~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (251)
                      ++||+|+||+||+|.++.  +++.||+|++....  ....+.+.+|+.++++++||||+++++++.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            369999999999998754  45789999985432  23367899999999999999999999999765 46899999999


Q ss_pred             CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc----e
Q psy11805         85 GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL----Q  160 (251)
Q Consensus        85 ~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~----~  160 (251)
                      ++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||++  +.++.++|+|||++.........    .
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill--~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--EETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc--cccCcccccchhhhhhcccccccccccc
Confidence            99999887654 69999999999999999999999999999999999999  88999999999999876443322    2


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+..+...   +.+..+|+++.+||.+
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~li~~  245 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMNL  245 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHH
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHHHHHH
Confidence            3457889999999999999999999999999999998 89999999888877777665432   2336789999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||++|||+
T Consensus       246 cl~~dp~~RPs~  257 (277)
T d1xbba_         246 CWTYDVENRPGF  257 (277)
T ss_dssp             HTCSSTTTSCCH
T ss_pred             HcCCCHhHCcCH
Confidence            999999999984

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=347.53  Aligned_cols=244  Identities=19%  Similarity=0.338  Sum_probs=201.3

Q ss_pred             ccCCcccccccCCceEEEEEEEccCC----ceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATG----MTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      ++|++.+.||+|+||+||+|.++.++    ..||+|.+.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            57899999999999999999987654    479999986433 2345678899999999999999999999999999999


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      +||++.++++.+.+......+++..+..++.|++.||.|||+.|++||||||+|||+  +.++.+||+|||++.......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl--~~~~~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCCCC--------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE--CCCCeEEEcccchhhcccCCC
Confidence            999999999988888777789999999999999999999999999999999999999  999999999999997754332


Q ss_pred             c----ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccccCCCccccCCCHH
Q psy11805        158 K----LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSG-LSPFMGETDVQTMANVTIAQYDFDDECFNEISDD  232 (251)
Q Consensus       158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (251)
                      .    .....+|+.|+|||.+.+..++.++||||||+++|||++| ..||...+..+....+..+.. .  +.+..+|..
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~--~~~~~~~~~  241 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-L--PTPMDCPSA  241 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-C--CCCTTCBHH
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-C--CCchhhHHH
Confidence            1    1234578899999999999999999999999999999995 555666666666666655432 2  223578999


Q ss_pred             HHHHHHHhcccCcCCCCCC
Q psy11805        233 AKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       233 ~~~li~~~l~~~p~~Rps~  251 (251)
                      +.+||.+||+.||++|||+
T Consensus       242 l~~li~~cl~~~p~~RPt~  260 (283)
T d1mqba_         242 IYQLMMQCWQQERARRPKF  260 (283)
T ss_dssp             HHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHCcCCHhHCcCH
Confidence            9999999999999999984

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-56  Score=347.76  Aligned_cols=244  Identities=20%  Similarity=0.348  Sum_probs=201.4

Q ss_pred             CccCCcccccccCCceEEEEEEEccCC---ceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATG---MTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      .++|++.+.||+|+||+||+|.+..++   ..|++|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            368999999999999999999987543   468888875433 334677999999999999999999999986 466899


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      |||++++++|.+++......+++..++.++.|++.||.|||+.|++||||||+||++  +.++.+||+|||++.......
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll--~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--EETTEEEECC-----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee--cCCCcEEEccchhheeccCCc
Confidence            999999999999888777789999999999999999999999999999999999999  888999999999998754332


Q ss_pred             --cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHH
Q psy11805        158 --KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAK  234 (251)
Q Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (251)
                        ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+..+...   +.++.+|+.+.
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~  239 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLY  239 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHHHH
T ss_pred             ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHH
Confidence              2234457899999999999999999999999999999998 89999999888888877665432   33478999999


Q ss_pred             HHHHHhcccCcCCCCCC
Q psy11805        235 DFIRKLLLKDREDAPEV  251 (251)
Q Consensus       235 ~li~~~l~~~p~~Rps~  251 (251)
                      +||.+||+.||++|||+
T Consensus       240 ~li~~cl~~dp~~Rps~  256 (273)
T d1mp8a_         240 SLMTKCWAYDPSRRPRF  256 (273)
T ss_dssp             HHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHcCCCHhHCcCH
Confidence            99999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=349.32  Aligned_cols=248  Identities=24%  Similarity=0.378  Sum_probs=208.5

Q ss_pred             CccCCcccccccCCceEEEEEEEccC-CceEEEEEecccc--ccchHHHHHHHHHHHHc---CCCceeeEeEEEee----
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKAT-GMTLAAKFVGIAK--RNDRRNVEREVEIMREL---QHPRLIQIYDAFES----   71 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~----   71 (251)
                      .++|++++.||+|+||+||+|++..+ ++.||+|++....  ......+.+|+..++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999765 5679999986433  22345566788877766   79999999999853    


Q ss_pred             -CCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccc
Q psy11805         72 -SNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLA  150 (251)
Q Consensus        72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~  150 (251)
                       ....+++||+++++.+..........+++..++.++.|++.||.|||++||+||||||+|||+  +.++.++|+|||.+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi--~~~~~~kl~dfg~~  163 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGLA  163 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECSCCSC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE--cCCCCeeecchhhh
Confidence             346899999999877755555556679999999999999999999999999999999999999  89999999999999


Q ss_pred             cccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC--------
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD--------  222 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  222 (251)
                      .............||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.+.+..+...++........        
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            877666666777899999999999999999999999999999999999999999988887776643221111        


Q ss_pred             ---------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ---------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                     ......+++.+++||++||+.||++|||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa  287 (305)
T d1blxa_         244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  287 (305)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence                           11234678899999999999999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=349.00  Aligned_cols=242  Identities=29%  Similarity=0.482  Sum_probs=202.4

Q ss_pred             cccccccCCceEEEEEEEccCCceEEEEEecccccc-----chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEe
Q psy11805          7 QHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN-----DRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLEL   81 (251)
Q Consensus         7 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (251)
                      .++.||+|+||+||+|.++.+++.||+|++......     ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            457899999999999999999999999998643322     245688999999999999999999999999999999999


Q ss_pred             ccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cce
Q psy11805         82 IEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~~  160 (251)
                      +.++++.. +......+++..+..++.|++.||+|||++|++||||||+||++  +.++.+||+|||.+....... ...
T Consensus        82 ~~~~~~~~-~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli--~~~~~~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          82 METDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CSEEHHHH-HTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred             hcchHHhh-hhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe--cCCCccccccCccccccCCCccccc
Confidence            98876644 44555679999999999999999999999999999999999999  999999999999997764433 334


Q ss_pred             eeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc---------------
Q psy11805        161 VLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE---------------  224 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  224 (251)
                      ..++|+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+...++..........               
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            4578999999999865 457999999999999999999999999999888877765432221111               


Q ss_pred             ---------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 ---------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               ..+.+++++.+||++||+.||++||||
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa  274 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA  274 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH
Confidence                     123578899999999999999999985

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=344.92  Aligned_cols=244  Identities=23%  Similarity=0.355  Sum_probs=203.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCC---ceEEEEEecccc---ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATG---MTLAAKFVGIAK---RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      ++|++.+.||+|+||.||+|.+..+.   ..||+|++....   ....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            67999999999999999999875432   368999875432   33467899999999999999999999999764 568


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCC
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~  156 (251)
                      +||||++++++.+.+....+.+++..+..++.|++.||.|||++|++||||||+||++  +.++.++|+|||++......
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll--~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--EETTEEEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc--ccccceeeccchhhhhcccC
Confidence            9999999999998888777779999999999999999999999999999999999999  88899999999999886544


Q ss_pred             Ccc----eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCH
Q psy11805        157 KKL----QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISD  231 (251)
Q Consensus       157 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (251)
                      ...    ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+......++  .++.+|+
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~  242 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDCPQ  242 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTCCH
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--CcccccH
Confidence            332    22346779999999999999999999999999999998 8999999999998888877765543  3368899


Q ss_pred             HHHHHHHHhcccCcCCCCCC
Q psy11805        232 DAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       232 ~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+||.+||+.||++|||+
T Consensus       243 ~l~~li~~cl~~dp~~RPt~  262 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTF  262 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHcCCChhHCcCH
Confidence            99999999999999999984

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=349.18  Aligned_cols=243  Identities=21%  Similarity=0.315  Sum_probs=205.0

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCc----eEEEEEeccc-cccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGM----TLAAKFVGIA-KRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   77 (251)
                      ++|++++.||+|+||+||+|.+..+++    .||+|.+... .....+.+.+|+.++++++||||+++++++.+++ .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            579999999999999999999987765    5788877533 3345778999999999999999999999998755 567


Q ss_pred             EEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC
Q psy11805         78 VLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~  157 (251)
                      +++++.+++|.+.+......+++..++.++.|++.||.|||++|++||||||+||++  +.++.+||+|||++.......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll--~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--EETTEEEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee--CCCCCeEeeccccceeccccc
Confidence            888888999999888887789999999999999999999999999999999999999  889999999999998764433


Q ss_pred             cc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHH
Q psy11805        158 KL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDA  233 (251)
Q Consensus       158 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (251)
                      ..   ....+|+.|+|||.+.+..++.++||||||+++|||+| |..||...+..+....+..+...   +.+..+|+.+
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~~~~~~  242 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPICTIDV  242 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---CCCTTBCHHH
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHH
Confidence            22   23357899999999999999999999999999999998 89999988887777766655432   2235789999


Q ss_pred             HHHHHHhcccCcCCCCCC
Q psy11805        234 KDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       234 ~~li~~~l~~~p~~Rps~  251 (251)
                      .+||.+||+.||++|||+
T Consensus       243 ~~li~~cl~~dP~~RPs~  260 (317)
T d1xkka_         243 YMIMVKCWMIDADSRPKF  260 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHhCCCChhhCcCH
Confidence            999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=345.16  Aligned_cols=237  Identities=26%  Similarity=0.432  Sum_probs=199.6

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccccc------chHHHHHHHHHHHHcC--CCceeeEeEEEeeC
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRN------DRRNVEREVEIMRELQ--HPRLIQIYDAFESS   72 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~   72 (251)
                      +.++|++.+.||+|+||+||+|.+..+++.||+|++......      ....+.+|+.++++++  ||||+++++++.++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            578999999999999999999999999999999998643211      2345778999999996  89999999999999


Q ss_pred             CEEEEEEEeccC-CchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec-CCCcEEEeecccc
Q psy11805         73 NVMCVVLELIEG-GELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK-TGNRIKIIDFGLA  150 (251)
Q Consensus        73 ~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~-~~~~~~l~df~~~  150 (251)
                      +..++|||++.+ +++.+.+... ..+++..++.++.|++.||.|||++|++||||||+||++  + +++.++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll--~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSG  158 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--ETTTTEEEECCCTTC
T ss_pred             CeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEE--ecCCCeEEECccccc
Confidence            999999999976 4666666554 469999999999999999999999999999999999998  6 4578999999999


Q ss_pred             cccCCCCcceeeccCcccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCC
Q psy11805        151 RKFDPEKKLQVLFGTPEFVAPEVVNFDAI-GFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEI  229 (251)
Q Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (251)
                      ...... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+      .+..+....    .+.+
T Consensus       159 ~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~----~~~~  227 (273)
T d1xwsa_         159 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF----RQRV  227 (273)
T ss_dssp             EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC----SSCC
T ss_pred             eecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCC----CCCC
Confidence            765433 3345679999999999987665 567899999999999999999997532      233333332    3678


Q ss_pred             CHHHHHHHHHhcccCcCCCCCC
Q psy11805        230 SDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       230 ~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      |+++++||++||+.||++|||+
T Consensus       228 s~~~~~li~~~L~~dp~~R~s~  249 (273)
T d1xwsa_         228 SSECQHLIRWCLALRPSDRPTF  249 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CHHHHHHHHHHccCCHhHCcCH
Confidence            9999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-55  Score=342.27  Aligned_cols=241  Identities=22%  Similarity=0.355  Sum_probs=200.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEEec
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      ++|++.+.||+|+||+||+|.++.+ ..||+|++... ....+.+.+|+.++++++|+||+++++++.+ +..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            6899999999999999999998755 57999998643 4456789999999999999999999999865 4578999999


Q ss_pred             cCCchhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC--cc
Q psy11805         83 EGGELFERVIDD-DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK--KL  159 (251)
Q Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~--~~  159 (251)
                      ++++|.+.+... ...+++..++.++.|++.||+|||+.|++||||||+|||+  +.++.++|+|||++.......  ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CGGGCEEECCCCTTC----------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE--CCCCcEEEcccchhhhccCCCceee
Confidence            999998877643 3459999999999999999999999999999999999999  888999999999997754332  22


Q ss_pred             eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHH
Q psy11805        160 QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSG-LSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIR  238 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (251)
                      ....+++.|+|||.+.+..++.++||||||+++|||++| .+|+......+....+..+..   .+....+|.++++||.
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l~~li~  248 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPESLHDLMC  248 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCHHHHHHHH
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCCcccCHHHHHHHH
Confidence            335688999999999999999999999999999999995 555666677777776665432   2234678999999999


Q ss_pred             HhcccCcCCCCCC
Q psy11805        239 KLLLKDREDAPEV  251 (251)
Q Consensus       239 ~~l~~~p~~Rps~  251 (251)
                      +||+.||++|||+
T Consensus       249 ~cl~~dP~~Rps~  261 (285)
T d1fmka3         249 QCWRKEPEERPTF  261 (285)
T ss_dssp             HHTCSSGGGSCCH
T ss_pred             HHcccCHhHCcCH
Confidence            9999999999984

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-54  Score=342.48  Aligned_cols=245  Identities=20%  Similarity=0.337  Sum_probs=211.1

Q ss_pred             CccCCcccccccCCceEEEEEEEcc-----CCceEEEEEecccccc-chHHHHHHHHHHHHcCCCceeeEeEEEeeCCEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAKRN-DRRNVEREVEIMRELQHPRLIQIYDAFESSNVM   75 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (251)
                      +++|++.+.||+|+||+||+|++..     +++.||+|++...... ....+.+|+.++++++|||++++++++...+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            3689999999999999999999863     4578999998654333 356799999999999999999999999999999


Q ss_pred             EEEEEeccCCchhHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcE
Q psy11805         76 CVVLELIEGGELFERVIDDD-----------------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENI  132 (251)
Q Consensus        76 ~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~ni  132 (251)
                      +++||++++++|.+++....                       ..+++..+..++.|++.||+|||+.|++||||||+||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI  171 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC  171 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence            99999999999999886432                       2488999999999999999999999999999999999


Q ss_pred             EEeecCCCcEEEeecccccccCCCC---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChH
Q psy11805        133 LCLTKTGNRIKIIDFGLARKFDPEK---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSG-LSPFMGETDV  208 (251)
Q Consensus       133 l~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~  208 (251)
                      ++  +.++.+||+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|||++| ..||...+..
T Consensus       172 Ll--d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         172 LV--GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             EE--CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             EE--CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            99  889999999999997653332   22345678899999999999999999999999999999997 4789999999


Q ss_pred             HHHHHHHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        209 QTMANVTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +....+..+..+   +.+..+|+++.+||.+||+.+|++|||+
T Consensus       250 e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~  289 (301)
T d1lufa_         250 EVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSF  289 (301)
T ss_dssp             HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCH
Confidence            888888776543   2346789999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=344.03  Aligned_cols=244  Identities=23%  Similarity=0.371  Sum_probs=207.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCce--EEEEEeccc-cccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMT--LAAKFVGIA-KRNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNVMCVV   78 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~~K~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   78 (251)
                      ++|++.+.||+|+||+||+|.++.++..  |++|.+... .....+.+.+|++.++++ +||||+++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            5899999999999999999999988764  667776432 333567899999999998 699999999999999999999


Q ss_pred             EEeccCCchhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEE
Q psy11805         79 LELIEGGELFERVIDD---------------DFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIK  143 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~  143 (251)
                      |||+++++|.+++...               ...+++..++.++.|++.||.|||+.|++||||||+|||+  +.++.+|
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~--~~~~~~k  167 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAK  167 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--CGGGCEE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE--cCCCceE
Confidence            9999999999988643               3569999999999999999999999999999999999999  8889999


Q ss_pred             EeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccccCC
Q psy11805        144 IIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSG-LSPFMGETDVQTMANVTIAQYDFD  222 (251)
Q Consensus       144 l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~  222 (251)
                      |+|||++.............++..|+|||.+.+..++.++||||||+++|||++| ..||...+..+....+..+..   
T Consensus       168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~---  244 (309)
T d1fvra_         168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---  244 (309)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---
T ss_pred             EccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---
Confidence            9999999876555555556689999999999999999999999999999999996 567988888888887765532   


Q ss_pred             CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .+.+..+|+++.+||.+||+.||++|||+
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~  273 (309)
T d1fvra_         245 LEKPLNCDDEVYDLMRQCWREKPYERPSF  273 (309)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence            22346789999999999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.1e-54  Score=338.15  Aligned_cols=245  Identities=24%  Similarity=0.401  Sum_probs=204.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++....  ....+.+.+|+.++++++||||+++++.+.+++..+++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            68999999999999999999986 67899999986543  3346789999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~  159 (251)
                      ++.++.+ ..+....+.+++..++.++.|++.||+|||+.||+||||||+|||+  +.++.++++|||.+....... ..
T Consensus        81 ~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll--~~~~~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          81 HLDQDLK-KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             CCSEEHH-HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC-----
T ss_pred             eehhhhH-HHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE--cCCCCEEecccccceecccCcccc
Confidence            9987555 5555555679999999999999999999999999999999999999  899999999999998765432 23


Q ss_pred             eeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC----------------
Q psy11805        160 QVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD----------------  222 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  222 (251)
                      ....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+...++........                
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            445688999999998654 568999999999999999999999999888777666543222111                


Q ss_pred             ---------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ---------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                               ......+++.+.+||++||+.||++|||+
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~  275 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA  275 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence                     11234578899999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=337.15  Aligned_cols=238  Identities=20%  Similarity=0.329  Sum_probs=198.7

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee-CCEEEEEEEe
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES-SNVMCVVLEL   81 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~   81 (251)
                      ++|++.+.||+|+||.||+|.++  ++.||+|+++.  ....+.+.+|++.+++++||||+++++++.+ ++..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            57999999999999999999985  67899999853  4456889999999999999999999998854 4568999999


Q ss_pred             ccCCchhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcce
Q psy11805         82 IEGGELFERVIDDD-FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKLQ  160 (251)
Q Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~~  160 (251)
                      +++++|.+++...+ ..+++..++.++.|++.||.|||+.+++||||+|+||++  +.++.++++|||++......  ..
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~--~~~~~~kl~dfg~s~~~~~~--~~  158 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEASST--QD  158 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTSCEEECCCCC-----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee--cCCCCEeecccccceecCCC--Cc
Confidence            99999999986543 358999999999999999999999999999999999999  99999999999999875433  23


Q ss_pred             eeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccCCCccccCCCHHHHHHHHH
Q psy11805        161 VLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMANVTIAQYDFDDECFNEISDDAKDFIRK  239 (251)
Q Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (251)
                      ...+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+..+..+   +....+++++.+||++
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~li~~  235 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVYEVMKN  235 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHHHHHHHH
T ss_pred             cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHH
Confidence            4457889999999998999999999999999999998 79999888888777777554322   2336789999999999


Q ss_pred             hcccCcCCCCCC
Q psy11805        240 LLLKDREDAPEV  251 (251)
Q Consensus       240 ~l~~~p~~Rps~  251 (251)
                      ||+.||++|||+
T Consensus       236 cl~~dP~~Rps~  247 (262)
T d1byga_         236 CWHLDAAMRPSF  247 (262)
T ss_dssp             HTCSSGGGSCCH
T ss_pred             HcccCHhHCcCH
Confidence            999999999985

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=338.04  Aligned_cols=245  Identities=21%  Similarity=0.317  Sum_probs=205.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCC-------ceEEEEEeccccc-cchHHHHHHHHHHHHc-CCCceeeEeEEEeeC
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATG-------MTLAAKFVGIAKR-NDRRNVEREVEIMREL-QHPRLIQIYDAFESS   72 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~~~K~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   72 (251)
                      .++|++.+.||+|+||.||+|++..++       ..||+|++..... .....+.+|...+.++ +||||+++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            378999999999999999999986554       3789999865443 3467788899999888 799999999999999


Q ss_pred             CEEEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec
Q psy11805         73 NVMCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK  137 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~  137 (251)
                      +..++||||+++++|.+++....               ..+++..++.++.|++.||.|||+.|++||||||+|||+  +
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--~  169 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--T  169 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--C
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee--c
Confidence            99999999999999999987543               358999999999999999999999999999999999999  9


Q ss_pred             CCCcEEEeecccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy11805        138 TGNRIKIIDFGLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN  213 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  213 (251)
                      .++.+||+|||++........   .....+++.|+|||.+.++.++.++||||||+++|+|++ |..||...+..+....
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~  249 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  249 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            999999999999987644332   233568889999999999999999999999999999998 7999998888877776


Q ss_pred             HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +..+.. +  +.+..+|+.+.+||.+||+.||.+|||+
T Consensus       250 i~~~~~-~--~~p~~~~~~l~~li~~cl~~dP~~Rps~  284 (299)
T d1fgka_         250 LKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTF  284 (299)
T ss_dssp             HHTTCC-C--CCCSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHcCCC-C--CCCccchHHHHHHHHHHccCCHhHCcCH
Confidence            655432 2  2336789999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=341.16  Aligned_cols=244  Identities=23%  Similarity=0.389  Sum_probs=199.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-----
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-----   73 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   73 (251)
                      +.++|++++.||+|+||+||+|.++.+++.||+|++....  ....+.+.+|++++++++||||+++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            4689999999999999999999999999999999986432  234677889999999999999999999997654     


Q ss_pred             -EEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         74 -VMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        74 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                       ..|+|||++ +.+|.......  .+++..++.++.|++.||.|||++||+||||||+|||+  +.++.++++|||.+..
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~--~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV--NEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc--ccccccccccccceec
Confidence             479999999 55776665543  59999999999999999999999999999999999999  9999999999999987


Q ss_pred             cCCCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC---------
Q psy11805        153 FDPEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD---------  222 (251)
Q Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  222 (251)
                      .+..  .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+...............+         
T Consensus       171 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         171 ADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            6543  344568999999999876 4568999999999999999999999998887666554433222111         


Q ss_pred             ------------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ------------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        ......+++.+.+||++||..||++|||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta  295 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA  295 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH
Confidence                              11234678999999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=336.42  Aligned_cols=245  Identities=20%  Similarity=0.304  Sum_probs=194.2

Q ss_pred             ccCCcccccccCCceEEEEEEEccC-----CceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEee-CCE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKAT-----GMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFES-SNV   74 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~   74 (251)
                      ++|++.+.||+|+||+||+|.+...     ++.||+|++.... ....+.+.+|...+.++ +|+||+.+++++.. ++.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            6899999999999999999998643     4689999986433 23456677888888777 68999999998765 456


Q ss_pred             EEEEEEeccCCchhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC
Q psy11805         75 MCVVLELIEGGELFERVIDDD---------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG  139 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~  139 (251)
                      .++||||+++++|.+++....               ..+++..+..++.|++.||.|||++||+||||||+|||+  +.+
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--~~~  170 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEK  170 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CGG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--CCC
Confidence            899999999999999986532               348999999999999999999999999999999999999  889


Q ss_pred             CcEEEeecccccccCCCC---cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q psy11805        140 NRIKIIDFGLARKFDPEK---KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSG-LSPFMGETDVQTMANVT  215 (251)
Q Consensus       140 ~~~~l~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~  215 (251)
                      +.+||+|||++.......   ......||+.|+|||.+.+..++.++||||||+++|||++| ..||......+......
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~  250 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  250 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999997653322   22345689999999999999999999999999999999985 57888776555544443


Q ss_pred             hccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        216 IAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....+.  .+..+|+++.++|.+||+.||++|||+
T Consensus       251 ~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~  284 (299)
T d1ywna1         251 KEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTF  284 (299)
T ss_dssp             HHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hcCCCCC--CCccCCHHHHHHHHHHcCCChhHCcCH
Confidence            3333322  336789999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=334.70  Aligned_cols=246  Identities=22%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee--------C
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES--------S   72 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~   72 (251)
                      ++|+++++||+|+||+||+|.++.+++.||+|++....  ......+.+|+.++++++|+|++++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            68999999999999999999999999999999975433  3346778899999999999999999998854        3


Q ss_pred             CEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805         73 NVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      +..+++||++.++.+ .........+++..++.++.|++.||.|||+.||+||||||+||++  +.++.++++|||++..
T Consensus        90 ~~~~iv~e~~~~~~~-~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl--~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          90 GSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI--TRDGVLKLADFGLARA  166 (318)
T ss_dssp             -CEEEEEECCCEEHH-HHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTSCEEECCCTTCEE
T ss_pred             ceEEEEEeccCCCcc-chhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee--cCCCcEEeeecceeee
Confidence            458999999987655 4445555679999999999999999999999999999999999999  9999999999999976


Q ss_pred             cCCC-----CcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccc
Q psy11805        153 FDPE-----KKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECF  226 (251)
Q Consensus       153 ~~~~-----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (251)
                      ....     ......++|+.|+|||.+.+. .++.++||||+|+++|+|++|+.||.+.+..+....+...........+
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            5422     222334689999999998765 6789999999999999999999999998888877766554433332221


Q ss_pred             cC----------------------------CCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NE----------------------------ISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~----------------------------~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..                            .++.+.+||.+||+.||++||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa  299 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS  299 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence            11                            36678899999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-53  Score=340.01  Aligned_cols=246  Identities=27%  Similarity=0.407  Sum_probs=199.6

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC-----E
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSN-----V   74 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~   74 (251)
                      ++++|++++.||+|+||+||+|.++.+++.||+|++...+ ....+.+.+|+.++++++|||++++++++....     .
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            4689999999999999999999999999999999986443 234667889999999999999999999997643     2


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .+++ +++.+++|.+++...  .+++..++.++.|++.||.|||++||+||||||+|||+  +.++.++|+|||++....
T Consensus        86 ~~l~-~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl--~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          86 VYLV-THLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEE-EECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred             EEEE-EeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE--CCCCCEEEcccCceeecc
Confidence            4554 556688999988765  49999999999999999999999999999999999999  899999999999997653


Q ss_pred             CCC----cceeeccCcccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCC-------
Q psy11805        155 PEK----KLQVLFGTPEFVAPEVVN-FDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFD-------  222 (251)
Q Consensus       155 ~~~----~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  222 (251)
                      ...    ......+++.|+|||.+. +..++.++||||+|+++|+|++|+.||.+.+..+...........+.       
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            322    234456899999999984 45678899999999999999999999998876655544322111110       


Q ss_pred             --------------------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 --------------------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                          ...++.+++++++||.+||+.||++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta  289 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV  289 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH
Confidence                                11234678899999999999999999985

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=334.51  Aligned_cols=246  Identities=23%  Similarity=0.356  Sum_probs=209.5

Q ss_pred             CccCCcccccccCCceEEEEEEEc-----cCCceEEEEEecccc-ccchHHHHHHHHHHHHc-CCCceeeEeEEEeeCCE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEK-----ATGMTLAAKFVGIAK-RNDRRNVEREVEIMREL-QHPRLIQIYDAFESSNV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   74 (251)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++.... ......+.+|+..++++ +||||+++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            368899999999999999999874     345789999986543 33466788999999999 69999999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeec
Q psy11805         75 MCVVLELIEGGELFERVIDDD-----------------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTK  137 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~  137 (251)
                      .+++|||+++++|.+++....                 ..+++..+..++.|++.||+|||++|++||||||+||++  +
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~--~  179 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--T  179 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--E
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc--c
Confidence            999999999999999887532                 258999999999999999999999999999999999999  8


Q ss_pred             CCCcEEEeecccccccCCCCcc---eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy11805        138 TGNRIKIIDFGLARKFDPEKKL---QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLS-GLSPFMGETDVQTMAN  213 (251)
Q Consensus       138 ~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  213 (251)
                      .++.++++|||.+.........   ....+++.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+...+
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            8999999999999875433222   23468899999999999999999999999999999998 7777877777666665


Q ss_pred             HHhccccCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        214 VTIAQYDFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      +.....+...+  ..+|+.+.+||.+||+.||++|||+
T Consensus       260 ~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~  295 (311)
T d1t46a_         260 MIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTF  295 (311)
T ss_dssp             HHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCH
Confidence            55554444333  5689999999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=338.17  Aligned_cols=242  Identities=24%  Similarity=0.303  Sum_probs=199.9

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEee------CCEEEE
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFES------SNVMCV   77 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~l   77 (251)
                      +|+..+.||+|+||+||+|++..+++.||+|++....    ....+|++++++++|+||+++++++..      ..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6899999999999999999999999999999985432    233579999999999999999999853      335899


Q ss_pred             EEEeccCCchhHHH--hhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCC-cEEEeecccccccC
Q psy11805         78 VLELIEGGELFERV--IDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGN-RIKIIDFGLARKFD  154 (251)
Q Consensus        78 v~e~~~~~~L~~~~--~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~-~~~l~df~~~~~~~  154 (251)
                      ||||++++.+....  ......+++..++.++.|++.||+|||++||+||||||+|||+  +.++ .+||+|||++....
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl--~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--CTTTCCEEECCCTTCEECC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE--ecCCCceeEecccchhhcc
Confidence            99999875432222  2345579999999999999999999999999999999999998  7664 89999999998877


Q ss_pred             CCCcceeeccCccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccC------------
Q psy11805        155 PEKKLQVLFGTPEFVAPEVVNF-DAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDF------------  221 (251)
Q Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  221 (251)
                      .........+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+..+....+.......            
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            6666667789999999998765 468999999999999999999999999888777766553321110            


Q ss_pred             -------------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        222 -------------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       222 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                   .......+++++.+||++||+.||++||||
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  297 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP  297 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH
Confidence                         001123578899999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=338.26  Aligned_cols=245  Identities=27%  Similarity=0.489  Sum_probs=208.7

Q ss_pred             ccCCcccccccCCceEEEEEEEc---cCCceEEEEEecccc----ccchHHHHHHHHHHHHcCC-CceeeEeEEEeeCCE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEK---ATGMTLAAKFVGIAK----RNDRRNVEREVEIMRELQH-PRLIQIYDAFESSNV   74 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~----~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~   74 (251)
                      ++|++++.||+|+||+||+|.+.   .+++.||+|++....    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            57999999999999999999884   468899999985432    3346778899999999965 899999999999999


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .+++||++.+++|.+.+...+ .+++..+..++.|++.||.|||+.|++||||||+||++  +.++.++|+|||++....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill--~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee--cCCCCEEEeeccchhhhc
Confidence            999999999999999887665 58899999999999999999999999999999999999  889999999999997653


Q ss_pred             CC--CcceeeccCcccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCccccCCC
Q psy11805        155 PE--KKLQVLFGTPEFVAPEVVNFD--AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDECFNEIS  230 (251)
Q Consensus       155 ~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (251)
                      ..  .......+++.|+|||.+.+.  .++.++|||||||+||+|++|..||...+..+....+.........+.+..+|
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            32  233456789999999999654  46789999999999999999999998876655555555554444555557889


Q ss_pred             HHHHHHHHHhcccCcCCCCC
Q psy11805        231 DDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       231 ~~~~~li~~~l~~~p~~Rps  250 (251)
                      +++.+||++||++||++|||
T Consensus       261 ~~~~~li~~~l~~dP~~R~s  280 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLG  280 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTT
T ss_pred             HHHHHHHHHHcccCHHHcCC
Confidence            99999999999999999996

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=330.79  Aligned_cols=239  Identities=20%  Similarity=0.256  Sum_probs=197.3

Q ss_pred             ccccccCCceEEEEEEEccCC---ceEEEEEecc-ccccchHHHHHHHHHHHHcCCCceeeEeEEEee-CCEEEEEEEec
Q psy11805          8 HSAFSFGKFGTVYRCKEKATG---MTLAAKFVGI-AKRNDRRNVEREVEIMRELQHPRLIQIYDAFES-SNVMCVVLELI   82 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~   82 (251)
                      .+.||+|+||+||+|.+..++   ..||+|.+.. .+....+.+.+|++++++++||||+++++++.. ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            568999999999999986543   3688998863 334456889999999999999999999999765 56899999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCCcc---
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEKKL---  159 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~~~---  159 (251)
                      ++++|.+++......+++..+..++.|++.||.|||+.|++||||||+|||+  +.++.++|+|||++.........   
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl--~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--CTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE--CCCCCEEEecccchhhccccccccce
Confidence            9999999888777778999999999999999999999999999999999999  89999999999999875433221   


Q ss_pred             --eeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhccccCCCccccCCCHHHHHH
Q psy11805        160 --QVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGE-TDVQTMANVTIAQYDFDDECFNEISDDAKDF  236 (251)
Q Consensus       160 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (251)
                        ....+++.|+|||.+.+..++.++||||||+++|||++|..||... +..+....+..+... .  ....+++.+.+|
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-~--~p~~~~~~l~~l  266 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-L--QPEYCPDPLYEV  266 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-C--CCTTCCHHHHHH
T ss_pred             ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-C--CcccCcHHHHHH
Confidence              2235788999999999999999999999999999999977776554 344445555544332 2  225789999999


Q ss_pred             HHHhcccCcCCCCCC
Q psy11805        237 IRKLLLKDREDAPEV  251 (251)
Q Consensus       237 i~~~l~~~p~~Rps~  251 (251)
                      |.+||+.||++|||+
T Consensus       267 i~~cl~~dP~~RPs~  281 (311)
T d1r0pa_         267 MLKCWHPKAEMRPSF  281 (311)
T ss_dssp             HHHHTCSSGGGSCCH
T ss_pred             HHHHcCCCHhHCcCH
Confidence            999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-52  Score=330.56  Aligned_cols=248  Identities=21%  Similarity=0.271  Sum_probs=199.4

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCc-eeeEeEEEeeCCEEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPR-LIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~   79 (251)
                      ++++|++.+.||+|+||+||+|.+..+++.||+|++....  ....+.+|+++++.++|++ |+.+.+++.+.+..++||
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            3589999999999999999999999999999999875432  3456889999999997665 556666778888999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee-cCCCcEEEeecccccccCCCC-
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT-KTGNRIKIIDFGLARKFDPEK-  157 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~-~~~~~~~l~df~~~~~~~~~~-  157 (251)
                      |++.+ ++...+......+++..+..++.|++.||+|||++||+||||||+||++.. +.+..++|+|||++....... 
T Consensus        83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            99954 676777776778999999999999999999999999999999999999732 345579999999998764332 


Q ss_pred             -------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhccccCC-Cccc
Q psy11805        158 -------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMAN---VTIAQYDFD-DECF  226 (251)
Q Consensus       158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~-~~~~  226 (251)
                             ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...........   ........+ ....
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence                   12344689999999999999999999999999999999999999987655433322   222222222 2234


Q ss_pred             cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        227 NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      ..+|+++.++|.+||+.+|++||++
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~  266 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDY  266 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCH
Confidence            6789999999999999999999983

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-51  Score=331.71  Aligned_cols=241  Identities=22%  Similarity=0.416  Sum_probs=199.8

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEee--CCEEEEE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFES--SNVMCVV   78 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv   78 (251)
                      .++|+++++||+|+||+||+|++..+++.||+|++..   ...+.+.+|++++++++ ||||+++++++..  ....++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            4689999999999999999999999999999999853   34678899999999996 9999999999974  4569999


Q ss_pred             EEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCC-CcEEEeecccccccCCCC
Q psy11805         79 LELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTG-NRIKIIDFGLARKFDPEK  157 (251)
Q Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~-~~~~l~df~~~~~~~~~~  157 (251)
                      ||++++++|....    ..+++..++.++.|++.||.|||++||+||||||+|||+  +.+ +.++|+|||++.......
T Consensus       111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi--~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--ETTTTEEEECCGGGCEECCTTC
T ss_pred             EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE--cCCCCeeeecccccceeccCCC
Confidence            9999999886543    359999999999999999999999999999999999998  654 469999999998877666


Q ss_pred             cceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhc-------------cc---
Q psy11805        158 KLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQ-TMANVTIA-------------QY---  219 (251)
Q Consensus       158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~-------------~~---  219 (251)
                      ......+|+.|+|||.+.+. .++.++||||+|++++++++|+.||....+.. ....+...             ..   
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            66777899999999998765 47899999999999999999999997765422 22211100             00   


Q ss_pred             -----------------cCCCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        220 -----------------DFDDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       220 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                       .........+++++.+||++||+.||++|||+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta  313 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA  313 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH
Confidence                             01111223578899999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-51  Score=326.13  Aligned_cols=247  Identities=19%  Similarity=0.248  Sum_probs=206.4

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCC-CceeeEeEEEeeCCEEEEEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH-PRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++++|++++.||+|+||+||+|.+..+++.||+|++...  .+...+.+|++.++.++| +|++.+++++......++||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            468999999999999999999999999999999987532  345567889999999974 89999999999999999999


Q ss_pred             EeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEee---cCCCcEEEeecccccccCCC
Q psy11805         80 ELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLT---KTGNRIKIIDFGLARKFDPE  156 (251)
Q Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~---~~~~~~~l~df~~~~~~~~~  156 (251)
                      |++ +++|.+.+...+..++...+..++.|++.||.+||+.|++||||||+||++..   ...+.++|+|||+++.....
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            999 56898888887778999999999999999999999999999999999999832   13578999999999875432


Q ss_pred             C--------cceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhccccCC-Cc
Q psy11805        157 K--------KLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGET---DVQTMANVTIAQYDFD-DE  224 (251)
Q Consensus       157 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~-~~  224 (251)
                      .        ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+..   ..+....+.......+ ..
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence            1        1234468999999999999999999999999999999999999997643   3333333333322222 22


Q ss_pred             cccCCCHHHHHHHHHhcccCcCCCCC
Q psy11805        225 CFNEISDDAKDFIRKLLLKDREDAPE  250 (251)
Q Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rps  250 (251)
                      ..+.+|+++.+++..|++.+|++||+
T Consensus       240 l~~~~p~~l~~ii~~~~~~~~~~rP~  265 (293)
T d1csna_         240 LCAGFPEEFYKYMHYARNLAFDATPD  265 (293)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred             hcCCCCHHHHHHHHHHhcCCcccCcC
Confidence            33678999999999999999999997

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=331.35  Aligned_cols=244  Identities=18%  Similarity=0.262  Sum_probs=209.8

Q ss_pred             ccCCcccccccCCceEEEEEEEcc-----CCceEEEEEecccc-ccchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKA-----TGMTLAAKFVGIAK-RNDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMC   76 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (251)
                      ++|++.+.||+|+||+||+|.+..     ++..||+|++.... ......+.+|++++++++||||+++++++..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            688999999999999999998863     35689999986432 233566889999999999999999999999999999


Q ss_pred             EEEEeccCCchhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeec
Q psy11805         77 VVLELIEGGELFERVIDDD---------FVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDF  147 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df  147 (251)
                      +|||++++++|.+++....         ..++...+..++.|++.||.|||+++++||||||+|||+  +.++++||+||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl--d~~~~~Kl~DF  177 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDF  177 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE--CTTCCEEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee--cCCceEEEeec
Confidence            9999999999988876421         246899999999999999999999999999999999999  99999999999


Q ss_pred             ccccccCCCCc---ceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccccCCC
Q psy11805        148 GLARKFDPEKK---LQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSG-LSPFMGETDVQTMANVTIAQYDFDD  223 (251)
Q Consensus       148 ~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~  223 (251)
                      |++........   .....+++.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+....+..+....  
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~--  255 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD--  255 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC--
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC--
Confidence            99976543322   2333578999999999999999999999999999999997 68899998888888777655432  


Q ss_pred             ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                       ..+.+|+.+.++|.+||+.+|++|||+
T Consensus       256 -~p~~~~~~l~~li~~cl~~~P~~RPs~  282 (308)
T d1p4oa_         256 -KPDNCPDMLFELMRMCWQYNPKMRPSF  282 (308)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             -CcccchHHHHHHHHHHcCCChhHCcCH
Confidence             236789999999999999999999984

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=324.32  Aligned_cols=246  Identities=23%  Similarity=0.334  Sum_probs=204.9

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccc--cchHHHHHHHHHHHHcCCCceeeEeEEEeeCCEEEEEEE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR--NDRRNVEREVEIMRELQHPRLIQIYDAFESSNVMCVVLE   80 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (251)
                      ++|++++.||+|+||+||+|.+..+++.||+|+++....  .....+.+|+.+++.++|+||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            589999999999999999999999999999999864432  346889999999999999999999999999999999999


Q ss_pred             eccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccCCCC-cc
Q psy11805         81 LIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFDPEK-KL  159 (251)
Q Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~~~~-~~  159 (251)
                      ++.++++..... ..+.+++..+..++.|++.||+|||++||+||||||+||++  +.++.++|+|||.+....... ..
T Consensus        82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli--~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--CTTCCEEECCCTTCEECCSCCSCC
T ss_pred             eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc--ccCCceeeeecchhhcccCCCccc
Confidence            999887766554 44579999999999999999999999999999999999999  889999999999998765433 23


Q ss_pred             eeeccCcccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhccccCC---------------
Q psy11805        160 QVLFGTPEFVAPEVVNFDA-IGFGTDMWSVGVICYVLLSGLSPFM-GETDVQTMANVTIAQYDFD---------------  222 (251)
Q Consensus       160 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~---------------  222 (251)
                      ....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||. +.+..+...++........               
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence            3345678899999987654 6899999999999999999998864 4455555554433222111               


Q ss_pred             ----------CccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        223 ----------DECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       223 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                ......+++.+.+||++||+.||.+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa  277 (292)
T d1unla_         239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA  277 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH
Confidence                      11223578899999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-52  Score=335.02  Aligned_cols=243  Identities=23%  Similarity=0.320  Sum_probs=192.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEee------CCE
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFES------SNV   74 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   74 (251)
                      ++|++++.||+|+||+||+|.++.+++.||+|++....  ......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999999999999999986432  3345678899999999999999999999953      467


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .|+||||+.++.+ +.+.   ..+++..++.++.|++.||.|||+.||+|+||||+|||+  +.++.++++|||++....
T Consensus        97 ~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~--~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--KSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--CTTCCEEECCCCC-----
T ss_pred             eEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc--ccccceeeechhhhhccc
Confidence            9999999977544 4442   358999999999999999999999999999999999999  889999999999998877


Q ss_pred             CCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCC-----------
Q psy11805        155 PEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDD-----------  223 (251)
Q Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  223 (251)
                      ........++|+.|+|||.+.+..++.++||||+|+++++|++|+.||.+.+......++.........           
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            766667778999999999999999999999999999999999999999988877666554332221110           


Q ss_pred             ---------------------------ccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        224 ---------------------------ECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       224 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                                 ......++++.+||++||+.||++||||
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta  305 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV  305 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH
Confidence                                       0111246678999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=333.76  Aligned_cols=244  Identities=25%  Similarity=0.391  Sum_probs=200.7

Q ss_pred             CccCCcccccccCCceEEEEEEEccCCceEEEEEecccc--ccchHHHHHHHHHHHHcCCCceeeEeEEEeeC-----CE
Q psy11805          2 TTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAK--RNDRRNVEREVEIMRELQHPRLIQIYDAFESS-----NV   74 (251)
Q Consensus         2 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   74 (251)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++|+|++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            478999999999999999999999999999999986433  23456788999999999999999999998532     23


Q ss_pred             EEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEeecccccccC
Q psy11805         75 MCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIIDFGLARKFD  154 (251)
Q Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~~~  154 (251)
                      .+++++++.+++|.+++...  .+++..++.++.|++.||+|||++||+||||||+||++  +.++.++++|||.+....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi--~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDFGLARHTD  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--CTTCCEEECCC----CCT
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc--cccccccccccchhcccC
Confidence            45566777888998887543  59999999999999999999999999999999999999  999999999999997643


Q ss_pred             CCCcceeeccCcccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccCCCc---------
Q psy11805        155 PEKKLQVLFGTPEFVAPEVVNFD-AIGFGTDMWSVGVICYVLLSGLSPFMGETDVQTMANVTIAQYDFDDE---------  224 (251)
Q Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------  224 (251)
                      .  ......+++.|+|||...+. .++.++||||||+++|+|++|..||.+.+.......+..........         
T Consensus       173 ~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         173 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             G--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             c--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence            2  33445688999999987665 46889999999999999999999999988777766654443322211         


Q ss_pred             ------------------cccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        225 ------------------CFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       225 ------------------~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                                        .+..+++++++||++||+.||++||||
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta  295 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  295 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH
Confidence                              124578999999999999999999985

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=318.19  Aligned_cols=244  Identities=20%  Similarity=0.236  Sum_probs=187.3

Q ss_pred             CCccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCceeeEeEEEeeCC----EEE
Q psy11805          1 MTTHQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLIQIYDAFESSN----VMC   76 (251)
Q Consensus         1 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   76 (251)
                      +..+|.+.+.||+|+||.||+|+++  ++.||+|++.... ......+.|+..+..++||||+++++++.+++    ..+
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            3578999999999999999999864  7899999985432 22222344555556789999999999987643    589


Q ss_pred             EEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh--------CCceecCCCCCcEEEeecCCCcEEEeecc
Q psy11805         77 VVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS--------KNVLHLDMKPENILCLTKTGNRIKIIDFG  148 (251)
Q Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~--------~gi~h~dl~~~nil~~~~~~~~~~l~df~  148 (251)
                      +||||+++++|.+++...  .++++.++.++.|++.||.+||+        .||+||||||+|||+  +.++.+||+|||
T Consensus        78 lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl--~~~~~~Kl~DFG  153 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE--CTTSCEEECCCT
T ss_pred             EEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE--cCCCCeEEEecC
Confidence            999999999999999875  48999999999999999999996        599999999999999  899999999999


Q ss_pred             cccccCCCC-----cceeeccCcccccccccccCC------CCcchhHHHHHHHHHHHHhCCCCCCCCC-----------
Q psy11805        149 LARKFDPEK-----KLQVLFGTPEFVAPEVVNFDA------IGFGTDMWSVGVICYVLLSGLSPFMGET-----------  206 (251)
Q Consensus       149 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~~~-----------  206 (251)
                      ++.......     ......||+.|+|||.+.+..      ++.++||||||++||||++|..||....           
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            998764432     223456899999999986542      5678999999999999999988774321           


Q ss_pred             ----hHHHHHHHHhccccCCC-ccc--cCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        207 ----DVQTMANVTIAQYDFDD-ECF--NEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       207 ----~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                          ..+..........++.. ..+  ...+..+.+|+.+||+.||++|||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  285 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  285 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH
Confidence                12222222222222111 111  1233468999999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.8e-44  Score=290.76  Aligned_cols=246  Identities=22%  Similarity=0.332  Sum_probs=183.5

Q ss_pred             ccCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-----------CCceeeEeEEEee
Q psy11805          3 THQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-----------HPRLIQIYDAFES   71 (251)
Q Consensus         3 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~   71 (251)
                      .+|++++.||+|+||+||+|++..+++.||+|++.... ...+...+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            36999999999999999999999999999999986432 23567788998888774           5789999998754


Q ss_pred             --CCEEEEEEEeccCCchh--HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEEeecCC----CcE
Q psy11805         72 --SNVMCVVLELIEGGELF--ERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-KNVLHLDMKPENILCLTKTG----NRI  142 (251)
Q Consensus        72 --~~~~~lv~e~~~~~~L~--~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~gi~h~dl~~~nil~~~~~~----~~~  142 (251)
                        ....++++.++......  .........+++..+..++.|++.||.+||+ .||+||||||+|||+..+..    ..+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence              45566666665444322  2223345578999999999999999999997 89999999999999833222    149


Q ss_pred             EEeecccccccCCCCcceeeccCcccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHh
Q psy11805        143 KIIDFGLARKFDPEKKLQVLFGTPEFVAPEVVNFDAIGFGTDMWSVGVICYVLLSGLSPFMGETDV------QTMANVTI  216 (251)
Q Consensus       143 ~l~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~  216 (251)
                      +++|||.+.....  ......+++.|+|||.+.+..++.++||||+|+++++|++|+.||......      +.......
T Consensus       172 kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         172 KIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             EECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             eEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            9999999976433  334567999999999999999999999999999999999999999764321      11111110


Q ss_pred             ccccC--------------------------------------CCccccCCCHHHHHHHHHhcccCcCCCCCC
Q psy11805        217 AQYDF--------------------------------------DDECFNEISDDAKDFIRKLLLKDREDAPEV  251 (251)
Q Consensus       217 ~~~~~--------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  251 (251)
                      .....                                      ........++.+.+||.+||+.||++||||
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            00000                                      000112346689999999999999999985

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=4.6e-27  Score=173.32  Aligned_cols=165  Identities=20%  Similarity=0.208  Sum_probs=120.0

Q ss_pred             CCcccccccCCceEEEEEEEccCCceEEEEEeccccc------------------cchHHHHHHHHHHHHcCCCceeeEe
Q psy11805          5 QNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKR------------------NDRRNVEREVEIMRELQHPRLIQIY   66 (251)
Q Consensus         5 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------------------~~~~~~~~e~~~l~~l~~~~i~~~~   66 (251)
                      +.+.++||+|+||+||+|.+. +++.||+|+++....                  .......+|...+.++.+.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999885 688999998753211                  0123445678888999999998887


Q ss_pred             EEEeeCCEEEEEEEeccCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEeecCCCcEEEee
Q psy11805         67 DAFESSNVMCVVLELIEGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHSKNVLHLDMKPENILCLTKTGNRIKIID  146 (251)
Q Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~gi~h~dl~~~nil~~~~~~~~~~l~d  146 (251)
                      ++..    .+++||++++..+.+        ++...+..++.|++.++.+||+.|++|+||||+|||+  +. +.++|+|
T Consensus        81 ~~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv--~~-~~~~liD  145 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV--SE-EGIWIID  145 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE--ET-TEEEECC
T ss_pred             EecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee--eC-CCEEEEE
Confidence            6542    268999998865422        3445567889999999999999999999999999998  54 4589999


Q ss_pred             cccccccCCCCcceeeccCccccccc-----ccccCCCCcchhHHHHHHHH
Q psy11805        147 FGLARKFDPEKKLQVLFGTPEFVAPE-----VVNFDAIGFGTDMWSVGVIC  192 (251)
Q Consensus       147 f~~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~Di~slG~~l  192 (251)
                      ||.+.........       .|....     .+....++.++|+||+.--+
T Consensus       146 FG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999765433221       111110     01235677889999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.07  E-value=6.1e-10  Score=84.52  Aligned_cols=139  Identities=18%  Similarity=0.164  Sum_probs=97.4

Q ss_pred             cCCcccccccCCceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEEEec
Q psy11805          4 HQNQHSAFSFGKFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVLELI   82 (251)
Q Consensus         4 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~   82 (251)
                      .|+..+..+.++.+.||++.  .++..+++|............+.+|...++.+. +--+++++++..+++..++||+++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            45555554555567899885  345677888876555556667889999998885 444788888888899999999999


Q ss_pred             cCCchhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q psy11805         83 EGGELFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-------------------------------------------  119 (251)
Q Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-------------------------------------------  119 (251)
                      +|.++.+.....   ..   ...++.++...+..||+                                           
T Consensus        93 ~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          93 DGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             cccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            998775543221   11   22234455555555653                                           


Q ss_pred             ----------------CCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        120 ----------------KNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       120 ----------------~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                                      ..++|+|+.|.||++  +.++...++||+.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~--~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceee--cCCceEEEeechhccc
Confidence                            127899999999998  6655566999988854

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.44  E-value=1.5e-06  Score=64.98  Aligned_cols=128  Identities=17%  Similarity=0.158  Sum_probs=83.7

Q ss_pred             ccccCCc-eEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCC--CceeeEeEEEeeCCEEEEEEEeccCCc
Q psy11805         10 AFSFGKF-GTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQH--PRLIQIYDAFESSNVMCVVLELIEGGE   86 (251)
Q Consensus        10 ~lg~g~~-~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~   86 (251)
                      .+..|.. +.||++... ++..+++|.....   ....+..|+..++.+..  -.+++++.+..+++..++||++++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3444443 578988654 4556788875432   34567888888887742  336778888888888999999998876


Q ss_pred             hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q psy11805         87 LFERVIDDDFVLTEKAVAIFMRQICEGVEFIHS-----------------------------------------------  119 (251)
Q Consensus        87 L~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-----------------------------------------------  119 (251)
                      +.+.      ..+..   ..+.++...|..||+                                               
T Consensus        93 ~~~~------~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          93 LLSS------HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTTS------CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             cccc------cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            5331      01111   112334444444442                                               


Q ss_pred             -----------CCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        120 -----------KNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       120 -----------~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                                 ..++|+|+.|.||++  +.+..+.++||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~--~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMV--ENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEE--eCCceEEEEEchhccc
Confidence                       137999999999998  6555567999988854

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.43  E-value=1.2e-06  Score=69.94  Aligned_cols=78  Identities=9%  Similarity=0.055  Sum_probs=50.6

Q ss_pred             ccccccCCceEEEEEEEccCCceEEEEEeccc------c-ccchHHHHHHHHHHHHcC--C-CceeeEeEEEeeCCEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKATGMTLAAKFVGIA------K-RNDRRNVEREVEIMRELQ--H-PRLIQIYDAFESSNVMCV   77 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~------~-~~~~~~~~~e~~~l~~l~--~-~~i~~~~~~~~~~~~~~l   77 (251)
                      .+.||.|....||++.+..+++.+++|.-...      . .....+...|...|+.+.  . ..+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45789999999999988877889999964321      1 123455677888887763  2 346666654  3444578


Q ss_pred             EEEeccCCch
Q psy11805         78 VLELIEGGEL   87 (251)
Q Consensus        78 v~e~~~~~~L   87 (251)
                      +||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977544

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.79  E-value=8.8e-05  Score=58.85  Aligned_cols=74  Identities=15%  Similarity=0.117  Sum_probs=52.0

Q ss_pred             ccccccCCceEEEEEEEccC-------CceEEEEEeccccccchHHHHHHHHHHHHcC-CCceeeEeEEEeeCCEEEEEE
Q psy11805          8 HSAFSFGKFGTVYRCKEKAT-------GMTLAAKFVGIAKRNDRRNVEREVEIMRELQ-HPRLIQIYDAFESSNVMCVVL   79 (251)
Q Consensus         8 ~~~lg~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (251)
                      ++.|+.|-.-.+|++.....       .+.++++++..  ........+|..+++.+. +.-.+++++++.+    +.|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            45788888899999987532       35677777642  233456678999998885 4445677777653    5789


Q ss_pred             EeccCCch
Q psy11805         80 ELIEGGEL   87 (251)
Q Consensus        80 e~~~~~~L   87 (251)
                      +|++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99988655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.78  E-value=9.2e-05  Score=57.13  Aligned_cols=70  Identities=13%  Similarity=0.161  Sum_probs=45.7

Q ss_pred             CceEEEEEEEccCCceEEEEEeccccccchHHHHHHHHHHHHcCCCcee--eEe-----EEEeeCCEEEEEEEeccCCc
Q psy11805         15 KFGTVYRCKEKATGMTLAAKFVGIAKRNDRRNVEREVEIMRELQHPRLI--QIY-----DAFESSNVMCVVLELIEGGE   86 (251)
Q Consensus        15 ~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~e~~~l~~l~~~~i~--~~~-----~~~~~~~~~~lv~e~~~~~~   86 (251)
                      ....||++... +|..+++|+.+.. ....+++..|...+..+...++.  ...     ..+...+..+.++++++|..
T Consensus        34 ~EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          34 YENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ccceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            34679998664 5778999998643 23467788898888887422221  111     12245667889999987753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.46  E-value=4.7e-05  Score=58.48  Aligned_cols=31  Identities=26%  Similarity=0.388  Sum_probs=26.9

Q ss_pred             CCceecCCCCCcEEEeecCCCcEEEeecccccc
Q psy11805        120 KNVLHLDMKPENILCLTKTGNRIKIIDFGLARK  152 (251)
Q Consensus       120 ~gi~h~dl~~~nil~~~~~~~~~~l~df~~~~~  152 (251)
                      .|++|+|+.++||++  +.+...-++||+.++.
T Consensus       183 ~giIHgDl~~dNvl~--~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFF--LGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhc--ccccceeEeccccccc
Confidence            479999999999998  6666668999999865